PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Arredondo, C; Orellana, M; Vecchiola, A; Pereira, LA; Galdames, L; Andres, ME				Arredondo, Cristian; Orellana, Marcelo; Vecchiola, Andrea; Alberto Pereira, Luis; Galdames, Leopoldo; Estela Andres, Maria			PIAS gamma Enhanced SUMO-2 Modification of Nurr1 Activation-Function-1 Domain Limits Nurr1 Transcriptional Synergy	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; ANDROGEN RECEPTOR; DOPAMINE NEURONS; SUMOYLATION; PATHWAY; MOTIF; RECOGNITION; MECHANISMS; REPRESSES; PROMOTER	Nurr1 (NR4A2) is a transcription factor that belongs to the orphan NR4A group of the nuclear receptor superfamily. Nurr1 plays key roles in the origin and maintenance of midbrain dopamine neurons, and peripheral inflammatory processes. PIAS gamma, a SUMO-E3 ligase, represses Nurr1 transcriptional activity. We report that Nurr1 is SUMOylated by SUMO-2 in the lysine 91 located in the transcriptional activation function 1 domain of Nurr1. Nurr1 SUMOylation by SUMO-2 is markedly facilitated by overexpressing wild type PIAS gamma, but not by a mutant form of PIAS gamma lacking its first LXXLL motif (PIAS gamma mut1). This PIAS gamma mut1 is also unable to interact with Nurr1 and to repress Nurr1 transcriptional activity. Interestingly, the mutant PIAS gamma C342A that lacks SUMO ligase activity is still able to significantly repress Nurr1-dependent transcriptional activity, but not to enhance Nurr1 SUMOylation. A SUMOylation-deficient Nurr1 mutant displays higher transcriptional activity than the wild type Nurr1 only in promoters harboring more than one Nurr1 response element. Furthermore, lysine 91, the major target of Nurr1 SUMOylation is contained in a canonical synergy control motif, indicating that SUMO-2 posttranslational modification of Nurr1 regulates its transcriptional synergy in complex promoters. In conclusion, PIAS gamma can exert two types of negative regulations over Nurr1. On one hand, PIAS gamma limits Nurr1 transactivation in complex promoters by SUMOylating its lysine 91. On the other hand, PIAS gamma fully represses Nurr1 transactivation through a direct interaction, independently of its E3-ligase activity.	[Arredondo, Cristian; Orellana, Marcelo; Vecchiola, Andrea; Alberto Pereira, Luis; Galdames, Leopoldo; Estela Andres, Maria] Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Fac Biol Sci, Santiago, Chile	Pontificia Universidad Catolica de Chile	Andres, ME (corresponding author), Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Fac Biol Sci, Alameda 340, Santiago, Chile.	mandres@bio.puc.cl			Fondo Nacional de Desarrollo Cientifico y Tecnologico [1110352]; Millennium Scientific Initiative [P10/063-F]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Scientific Initiative; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile	This work was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico (www.fondecyt.cl) grant No 1110352 and Millennium Scientific Initiative (http://www.iniciativamilenio.cl) grant No P10/063-F. LAP is recipient of a doctoral fellowship of the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (www.conicyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafiz H, 2009, J BIOL CHEM, V284, P9099, DOI 10.1074/jbc.M805226200; Abdel-Hafiz HA, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-10; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Belaguli NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035717; Blanco EH, 2011, NEUROPEPTIDES, V45, P273, DOI 10.1016/j.npep.2011.05.002; Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Galleguillos D, 2010, J NEUROCHEM, V114, P1158, DOI 10.1111/j.1471-4159.2010.06841.x; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Georges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025463; Gomez AV, 2008, MOL CELL, V31, P222, DOI 10.1016/j.molcel.2008.06.015; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jo AY, 2009, STEM CELLS, V27, P2238, DOI 10.1002/stem.146; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim KS, 2003, J NEUROCHEM, V85, P622, DOI 10.1046/j.1471-4159.2003.01671.x; Maruyama K, 1998, INT J ONCOL, V12, P1237; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mukherjee S, 2012, J BIOL CHEM, V287, P31195, DOI 10.1074/jbc.M112.395210; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Sacchetti P, 1999, MOL BRAIN RES, V74, P167, DOI 10.1016/S0169-328X(99)00275-2; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Tremblay AM, 2008, MOL ENDOCRINOL, V22, P570, DOI 10.1210/me.2007-0357; vanSteensel B, 1996, J CELL SCI, V109, P787; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	35	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55035	10.1371/journal.pone.0055035	http://dx.doi.org/10.1371/journal.pone.0055035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358114	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600145
J	Dalko, E; Gaudreault, V; Dardon, JS; Moreau, R; Scorza, T				Dalko, Esther; Gaudreault, Veronique; Dardon, Jaime Sanchez; Moreau, Robert; Scorza, Tatiana			Preconditioning with Hemin Decreases Plasmodium chabaudi adami Parasitemia and Inhibits Erythropoiesis in BALB/c Mice	PLOS ONE			English	Article							SEVERE MALARIAL ANEMIA; IFN-GAMMA RESPONSES; T-CELL SUBSETS; BLOOD-STAGE; IN-VITRO; IMMUNE-RESPONSES; OXIDATIVE STRESS; PATHOGENESIS; OXYGENASE-1; MACROPHAGES	Increased susceptibility to bacterial and viral infections and dysfunctional erythropoiesis are characteristic of malaria and other hemolytic hemoglobinopathies. High concentrations of free heme are common in these conditions but little is known about the effect of heme on adaptive immunity and erythropoiesis. Herein, we investigated the impact of heme (hemin) administration on immune parameters and steady state erythropoiesis in BALB/c mice, and on parasitemia and anemia during Plasmodium chabaudi adami infection. Intra-peritoneal injection of hemin (5 mg/Kg body weight) over three consecutive days decreased the numbers of splenic and bone marrow macrophages, IFN-gamma responses to CD3 stimulation and T(h)1 differentiation. Our results show that the numbers of erythroid progenitors decreased in the bone marrow and spleen of mice treated with hemin, which correlated with reduced numbers of circulating reticulocytes, without affecting hemoglobin concentrations. Although blunted IFN-gamma responses were measured in hemin-preconditioned mice, the mice developed lower parasitemia following P.c. adami infection. Importantly, anemia was exacerbated in hemin-preconditioned mice with malaria despite the reduced parasitemia. Altogether, our data indicate that free heme has dual effects on malaria pathology.	[Dalko, Esther] Inst Pasteur, Basic & Clin Immunol Parasit Dis Grp, Ctr Infect & Immun Lille, F-59019 Lille, France; [Dalko, Esther] Inst Pasteur, INSERM, U547, F-59019 Lille, France; [Dalko, Esther; Gaudreault, Veronique; Dardon, Jaime Sanchez; Moreau, Robert; Scorza, Tatiana] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Quebec; University of Quebec Montreal	Scorza, T (corresponding author), Univ Quebec, Dept Sci Biol, CP 8888, Montreal, PQ H3C 3P8, Canada.	scorza.tatiana@uqam.ca	Scorza, Tatiana/AAM-8992-2020	Dalko, Esther/0000-0001-7166-7417	Discovery Grant (Natural Sciences and Engineering Research Council); Bone Catalyst Grant (Canadian Institutes of Health Research)	Discovery Grant (Natural Sciences and Engineering Research Council); Bone Catalyst Grant (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR))	This study was partially funded by a Discovery Grant (Natural Sciences and Engineering Research Council) and a Bone Catalyst Grant (Canadian Institutes of Health Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey NM, 1996, T ROY SOC TROP MED H, V90, P147, DOI 10.1016/S0035-9203(96)90118-2; Barcellini W, 2000, BRIT J HAEMATOL, V111, P452, DOI 10.1046/j.1365-2141.2000.02380.x; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bisol GD, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P203; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Cambos M, 2011, J LEUKOCYTE BIOL, V89, P159, DOI 10.1189/jlb.0510249; Cambos M, 2010, INT J PARASITOL, V40, P1003, DOI 10.1016/j.ijpara.2010.02.007; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P362, DOI 10.1128/CDLI.10.3.362-366.2003; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dang TN, 2011, GLIA, V59, P1540, DOI 10.1002/glia.21198; DeSouza JB, 1997, INFECT IMMUN, V65, P1593, DOI 10.1128/IAI.65.5.1593-1598.1997; Elghazali G, 1997, CLIN EXP IMMUNOL, V109, P84, DOI 10.1046/j.1365-2249.1997.4401337.x; ERSLEV AJ, 1980, BRIT J HAEMATOL, V45, P65, DOI 10.1111/j.1365-2141.1980.tb03811.x; Fagiolo E, 2003, AUTOIMMUNITY, V36, P199, DOI 10.1080/0891693031000151238; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Gadsby N, 2009, INT J PARASITOL, V39, P347, DOI 10.1016/j.ijpara.2008.07.005; Gatidis S, 2009, ANN HEMATOL, V88, P721, DOI 10.1007/s00277-009-0697-7; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Gharagozloo M, 2009, ANN HEMATOL, V88, P21, DOI 10.1007/s00277-008-0564-y; Giuliani AL, 2001, EUR J HAEMATOL, V66, P221, DOI 10.1034/j.1600-0609.2001.066004221.x; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Malu DT, 2011, J IMMUNOL, V186, P6271, DOI 10.4049/jimmunol.1003355; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; McCall MBB, 2010, J INFECT DIS, V201, P142, DOI 10.1086/648596; Mohan K, 1998, BRIT J HAEMATOL, V103, P942, DOI 10.1046/j.1365-2141.1998.01126.x; Moreau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046101; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Murata Y, 2002, INT IMMUNOL, V14, P201, DOI 10.1093/intimm/14.2.201; Musa BOP, 2010, CLIN VACCINE IMMUNOL, V17, P602, DOI 10.1128/CVI.00145-09; Nuchsongsin F, 2007, AM J TROP MED HYG, V77, P617, DOI 10.4269/ajtmh.2007.77.617; Omodeo-Sale F, 2005, EUR J HAEMATOL, V74, P324, DOI 10.1111/j.1600-0609.2004.00352.x; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; Perlmann P, 1997, INFECT IMMUN, V65, P116, DOI 10.1128/IAI.65.1.116-121.1997; Perlmann Peter, 1998, Tokai Journal of Experimental and Clinical Medicine, V23, P55; Rivella S, 2012, BLOOD REV, V26, pS12, DOI 10.1016/S0268-960X(12)70005-X; Roussilhon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009309; SANCHEZMEDAL L, 1968, ANN NY ACAD SCI, V149, P377, DOI 10.1111/j.1749-6632.1968.tb15171.x; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; STEVENSON MM, 1993, CLIN EXP IMMUNOL, V92, P77, DOI 10.1111/j.1365-2249.1993.tb05951.x; SUTHERLAND RM, 1995, INT IMMUNOL, V7, P771, DOI 10.1093/intimm/7.5.771; Toriani-Terenzi C, 2005, ANN NY ACAD SCI, V1051, P29, DOI 10.1196/annals.1361.044; Varon J, 1999, J EMERG MED, V17, P87, DOI 10.1016/S0736-4679(98)00128-0; Wanachiwanawin W, 1996, EUR J HAEMATOL, V56, P153; Yin XJ, 2004, TOXICOL SCI, V82, P143, DOI 10.1093/toxsci/kfh255	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54744	10.1371/journal.pone.0054744	http://dx.doi.org/10.1371/journal.pone.0054744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358441	Green Submitted, gold, Green Published			2022-12-27	WOS:000314023600103
J	Nistico, R; Mango, D; Mandolesi, G; Piccinin, S; Berretta, N; Pignatelli, M; Feligioni, M; Musella, A; Gentile, A; Mori, F; Bernardi, G; Nicoletti, F; Mercuri, NB; Centonze, D				Nistico, Robert; Mango, Dalila; Mandolesi, Georgia; Piccinin, Sonia; Berretta, Nicola; Pignatelli, Marco; Feligioni, Marco; Musella, Alessandra; Gentile, Antonietta; Mori, Francesco; Bernardi, Giorgio; Nicoletti, Ferdinando; Mercuri, Nicola B.; Centonze, Diego			Inflammation Subverts Hippocampal Synaptic Plasticity in Experimental Multiple Sclerosis	PLOS ONE			English	Article							LONG-TERM POTENTIATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IN-VITRO; GAMMA-OSCILLATIONS; NETWORK OSCILLATIONS; GABAERGIC INHIBITION; PYRAMIDAL CELLS; VISUAL-CORTEX; MOTOR CORTEX; RAT	Abnormal use-dependent synaptic plasticity is universally accepted as the main physiological correlate of memory deficits in neurodegenerative disorders. It is unclear whether synaptic plasticity deficits take place during neuroinflammatory diseases, such as multiple sclerosis (MS) and its mouse model, experimental autoimmune encephalomyelitis (EAE). In EAE mice, we found significant alterations of synaptic plasticity rules in the hippocampus. When compared to control mice, in fact, hippocampal long-term potentiation (LTP) induction was favored over long-term depression (LTD) in EAE, as shown by a significant rightward shift in the frequency-synaptic response function. Notably, LTP induction was also enhanced in hippocampal slices from control mice following interleukin-1 beta (IL-1 beta) perfusion, and both EAE and IL-1 beta inhibited GABAergic spontaneous inhibitory postsynaptic currents (sIPSC) without affecting glutamatergic transmission and AMPA/NMDA ratio. EAE was also associated with selective loss of GABAergic interneurons and with reduced gamma-frequency oscillations in the CA1 region of the hippocampus. Finally, we provided evidence that microglial activation in the EAE hippocampus was associated with IL-1 beta expression, and hippocampal slices from control mice incubated with activated microglia displayed alterations of GABAergic transmission similar to those seen in EAE brains, through a mechanism dependent on enhanced IL-1 beta signaling. These data may yield novel insights into the basis of cognitive deficits in EAE and possibly of MS.	[Nistico, Robert; Mango, Dalila; Mandolesi, Georgia; Berretta, Nicola; Musella, Alessandra; Gentile, Antonietta; Mori, Francesco; Bernardi, Giorgio; Mercuri, Nicola B.; Centonze, Diego] IRCSS Fdn Santa Lucia, Rome, Italy; [Nistico, Robert; Piccinin, Sonia; Pignatelli, Marco; Nicoletti, Ferdinando] Univ Roma La Sapienza, Dipartimento Fisiol & Farmacol, Rome, Italy; [Mango, Dalila; Musella, Alessandra; Gentile, Antonietta; Mori, Francesco; Bernardi, Giorgio; Mercuri, Nicola B.; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy; [Piccinin, Sonia; Pignatelli, Marco; Feligioni, Marco] EBRI, Lab Farmacol Plast Sinapt, Rome, Italy; [Nicoletti, Ferdinando] IRCCS Neuromed, Pozzilli, Italy	IRCCS Santa Lucia; Sapienza University Rome; University of Rome Tor Vergata; IRCCS Neuromed	Nistico, R (corresponding author), IRCSS Fdn Santa Lucia, Rome, Italy.	robert.nistico@uniroma1.it; centonze@uniroma2.it	Berretta, Nicola/K-5667-2016; musella, alessandra/K-6372-2016; Centonze, Diego/J-7767-2016; Mandolesi, Georgia/G-6595-2011; Mango, Dalila/Z-2190-2019; Nicoletti, Ferdinando/K-4410-2016; Gentile, Antonietta/I-5765-2018; Gentile, Antonietta/P-5638-2019; Mercuri, Nicola Biagio/K-5348-2016; Mori, Francesco/AGX-1659-2022; Nicoletti, Ferdinando/T-4898-2019; Nicoletti, Ferdinando/A-2446-2010	Berretta, Nicola/0000-0001-8097-6238; musella, alessandra/0000-0001-7889-9253; Centonze, Diego/0000-0002-8390-8545; Gentile, Antonietta/0000-0003-2456-0769; Gentile, Antonietta/0000-0003-2456-0769; Mercuri, Nicola Biagio/0000-0001-6700-7491; Mori, Francesco/0000-0002-4761-6174; Mango, Dalila/0000-0003-3358-4068; piccinin, sonia/0000-0001-7363-2699; Nistico, Robert/0000-0003-3433-9232; NICOLETTI, Ferdinando/0000-0003-3366-7269; Nicoletti, Ferdinando/0000-0003-0917-443X; Mandolesi, Georgia/0000-0003-3612-6820	Ministero della Salute	Ministero della Salute(Ministry of Health, Italy)	This investigation was supported by a grant from Ministero della Salute to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2003, CURR PHARM DESIGN, V9, P245, DOI 10.2174/1381612033392152; Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bobholz JA, 2003, CURR OPIN NEUROL, V16, P283, DOI 10.1097/00019052-200306000-00006; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Caramia AD, 2004, CLIN NEUROPHYSIOL, V115, P956, DOI 10.1016/j.clinph.2003.11.024; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Chapman CA, 1998, HIPPOCAMPUS, V8, P289, DOI 10.1002/(SICI)1098-1063(1998)8:3<289::AID-HIPO10>3.0.CO;2-X; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Clements RJ, 2008, EXP BRAIN RES, V187, P459, DOI 10.1007/s00221-008-1317-9; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Dickinson R, 2003, NEUROPHARMACOLOGY, V44, P864, DOI 10.1016/S0028-3908(03)00083-2; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Foong J, 1998, J NEUROL NEUROSUR PS, V64, P529, DOI 10.1136/jnnp.64.4.529; Gambrill AC, 2011, J NEUROPHYSIOL, V105, P162, DOI 10.1152/jn.00457.2010; Gong N, 2009, J NEUROSCI, V29, P15836, DOI 10.1523/JNEUROSCI.4643-09.2009; Grover LM, 1999, J NEUROPHYSIOL, V81, P2814, DOI 10.1152/jn.1999.81.6.2814; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; Huang YZ, 2011, CLIN NEUROPHYSIOL, V122, P1011, DOI 10.1016/j.clinph.2010.08.016; Jansen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026586; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Komaki A, 2007, NEUROSCI LETT, V422, P181, DOI 10.1016/j.neulet.2007.06.017; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Levkovitz Y, 1999, J NEUROSCI, V19, P10977, DOI 10.1523/JNEUROSCI.19-24-10977.1999; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Lynch MA, 2010, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.006.2009; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Mandolesi G, 2012, NEUROBIOL DIS, V46, P414, DOI 10.1016/j.nbd.2012.02.005; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Mori F, 2011, NEUROPSYCHOPHARMACOL, V36, P559, DOI 10.1038/npp.2010.187; Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; Rossi S, 2012, MULT SCLER J, V18, P1633, DOI 10.1177/1352458512440207; Rossi S, 2012, ANN NEUROL, V71, P76, DOI 10.1002/ana.22512; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P947, DOI 10.1016/j.bbi.2010.10.004; Rossi S, 2010, BRAIN BEHAV IMMUN, V24, P1379, DOI 10.1016/j.bbi.2010.07.241; Rossi S, 2009, NEUROBIOL DIS, V36, P51, DOI 10.1016/j.nbd.2009.06.013; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Sederberg PB, 2003, J NEUROSCI, V23, P10809; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Stanton PK, 1996, HIPPOCAMPUS, V6, P35, DOI 10.1002/(SICI)1098-1063(1996)6:1<35::AID-HIPO7>3.0.CO;2-6; Staubli U, 1999, J NEUROSCI, V19, P4609; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Traub RD, 1997, J COMPUT NEUROSCI, V4, P141, DOI 10.1023/A:1008839312043; Trepel C, 2000, SYNAPSE, V35, P120, DOI 10.1002/(SICI)1098-2396(200002)35:2<120::AID-SYN4>3.0.CO;2-6; WIGSTROM H, 1983, ACTA PHYSIOL SCAND, V119, P455, DOI 10.1111/j.1748-1716.1983.tb07362.x; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Ziehn MO, 2012, J NEUROSCI, V32, P12312, DOI 10.1523/JNEUROSCI.2796-12.2012; Ziehn MO, 2010, LAB INVEST, V90, P774, DOI 10.1038/labinvest.2010.6	58	109	109	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54666	10.1371/journal.pone.0054666	http://dx.doi.org/10.1371/journal.pone.0054666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355887	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500102
J	Ruusuvirta, T; Lipponen, A; Pellinen, E; Penttonen, M; Astikainen, P				Ruusuvirta, Timo; Lipponen, Arto; Pellinen, Eeva; Penttonen, Markku; Astikainen, Piia			Auditory Cortical and Hippocampal-System Mismatch Responses to Duration Deviants in Urethane-Anesthetized Rats	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; STIMULUS-SPECIFIC ADAPTATION; NEGATIVITY MMN; ODDBALL SITUATION; NEURAL MECHANISM; PITCH DEVIANCES; CORTEX; DISCRIMINATION; ATTENTION; MEMORY	Any change in the invariant aspects of the auditory environment is of potential importance. The human brain preattentively or automatically detects such changes. The mismatch negativity (MMN) of event-related potentials (ERPs) reflects this initial stage of auditory change detection. The origin of MMN is held to be cortical. The hippocampus is associated with a later generated P3a of ERPs reflecting involuntarily attention switches towards auditory changes that are high in magnitude. The evidence for this cortico-hippocampal dichotomy is scarce, however. To shed further light on this issue, auditory cortical and hippocampal-system (CA1, dentate gyrus, subiculum) local-field potentials were recorded in urethane-anesthetized rats. A rare tone in duration (deviant) was interspersed with a repeated tone (standard). Two standard-to-standard (SSI) and standard-to-deviant (SDI) intervals (200 ms vs. 500 ms) were applied in different combinations to vary the observability of responses resembling MMN (mismatch responses). Mismatch responses were observed at 51.5-89 ms with the 500-ms SSI coupled with the 200-ms SDI but not with the three remaining combinations. Most importantly, the responses appeared in both the auditory-cortical and hippocampal locations. The findings suggest that the hippocampus may play a role in (cortical) manifestation of MMN.	[Ruusuvirta, Timo] Univ Turku, Dept Psychol, Turku, Finland; [Ruusuvirta, Timo] Univ Turku, Ctr Learning Res, Turku, Finland; [Lipponen, Arto] Univ Eastern Finland, Fac Hlth Sci, AIV Inst, Dept Neurobiol, Kuopio, Finland; [Pellinen, Eeva; Penttonen, Markku; Astikainen, Piia] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland	University of Turku; University of Turku; University of Eastern Finland; University of Jyvaskyla	Ruusuvirta, T (corresponding author), Univ Turku, Dept Psychol, Turku, Finland.	timo.ruusuvirta@utu.fi	Penttonen, Markku/B-8348-2013; Astikainen, Piia/ABE-4699-2020	Penttonen, Markku/0000-0002-1033-7286; Astikainen, Piia/0000-0003-4842-7460; Lipponen, Arto/0000-0001-6201-6647	Academy of Finland [127595, 139767]	Academy of Finland(Academy of Finland)	The study was supported by the Academy of Finland (project number 127595 for PA and 139767 for MP). The supporter had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00283; ALHO K, 1990, ELECTROEN CLIN NEURO, V77, P151, DOI 10.1016/0168-5597(90)90031-8; [Anonymous], 2006, FDN PERCEPTION; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Aubie B, 2012, J NEUROSCI, V32, P6373, DOI 10.1523/JNEUROSCI.5624-11.2012; Cheour M, 2002, NATURE, V415, P599, DOI 10.1038/415599b; CSEPE V, 1987, ELECTROEN CLIN NEURO, V66, P571, DOI 10.1016/0013-4694(87)90103-9; Dolan RJ, 2003, NEUROPSYCHOLOGY MEMO, P204; Eriksson J, 2005, BIOSYSTEMS, V79, P207, DOI 10.1016/j.biosystems.2004.09.017; FORD JM, 1981, PSYCHOPHYSIOLOGY, V18, P322, DOI 10.1111/j.1469-8986.1981.tb03043.x; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Grimm S, 2010, PSYCHOPHYSIOLOGY, DOI 10.1111.j.1469-8986.2010.01073.x; IMADA T, 1993, ELECTROEN CLIN NEURO, V87, P144, DOI 10.1016/0013-4694(93)90120-K; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jaaskelainen IP, 1999, NEUROREPORT, V10, P1305; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; JAVITT DC, 1994, BRAIN RES, V667, P192, DOI 10.1016/0006-8993(94)91496-6; Javitt DC, 1998, EVOKED POTENTIAL, V108, P143, DOI 10.1016/S0168-5597(97)00073-7; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; KROPOTOV JD, 1995, PSYCHOPHYSIOLOGY, V32, P418, DOI 10.1111/j.1469-8986.1995.tb01226.x; Lazar R, 2003, HEARING RES, V181, P51, DOI 10.1016/S0378-5955(03)00166-7; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; MAY PJC, 2009, PSYCHOPHYSIOLOGY, V46, P1; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Naatanen R., 1987, EVOKED POTENTIAL, P392; Nakamura T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00367; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pincze Z, 2001, CLIN NEUROPHYSIOL, V112, P778, DOI 10.1016/S1388-2457(01)00509-0; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Roger C, 2009, PSYCHOPHYSIOLOGY, V46, P1028, DOI 10.1111/j.1469-8986.2009.00840.x; Rosburg T, 2007, NEUROIMAGE, V37, P274, DOI 10.1016/j.neuroimage.2007.05.002; Ruusuvirta T, 1998, NEUROSCI LETT, V248, P45, DOI 10.1016/S0304-3940(98)00330-9; Ruusuvirta T, 2010, NEUROSCIENCE, V170, P232, DOI 10.1016/j.neuroscience.2010.06.062; RUUSUVIRTA T, 1995, INT J PSYCHOPHYSIOL, V20, P33, DOI 10.1016/0167-8760(95)00024-M; Ruusuvirta T, 2009, EUR J NEUROSCI, V30, P1620, DOI 10.1111/j.1460-9568.2009.06938.x; Schroger E, 1996, J COGNITIVE NEUROSCI, V8, P527, DOI 10.1162/jocn.1996.8.6.527; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Takegata R, 2001, NEUROREPORT, V12, P1783, DOI 10.1097/00001756-200106130-00053; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Vinogradova O.S., 1975, HIPPOCAMPUS, V2, P3; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; YAMAGUCHI S, 1993, ELECTROEN CLIN NEURO, V88, P151, DOI 10.1016/0168-5597(93)90066-X; Zhao L, 2011, NEUROSCIENCE, V181, P163, DOI 10.1016/j.neuroscience.2011.01.060	53	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54624	10.1371/journal.pone.0054624	http://dx.doi.org/10.1371/journal.pone.0054624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355884	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500098
J	Basavanna, S; Chimalapati, S; Maqbool, A; Rubbo, B; Yuste, J; Wilson, RJ; Hosie, A; Ogunniyi, AD; Paton, JC; Thomas, G; Brown, JS				Basavanna, Shilpa; Chimalapati, Suneeta; Maqbool, Abbas; Rubbo, Bruna; Yuste, Jose; Wilson, Robert J.; Hosie, Arthur; Ogunniyi, Abiodun D.; Paton, James C.; Thomas, Gavin; Brown, Jeremy S.			The Effects of Methionine Acquisition and Synthesis on Streptococcus Pneumoniae Growth and Virulence	PLOS ONE			English	Article							POTD PROTECTS MICE; ABC TRANSPORTER; IRON UPTAKE; IDENTIFICATION; GENES; IMMUNIZATION; PROTEINS; LIPOPROTEINS; METABOLISM; INFECTION	Bacterial pathogens need to acquire nutrients from the host, but for many nutrients their importance during infection remain poorly understood. We have investigated the importance of methionine acquisition and synthesis for Streptococcus pneumoniae growth and virulence using strains with gene deletions affecting a putative methionine ABC transporter lipoprotein (Sp_0149, metQ) and/or methionine biosynthesis enzymes (Sp_0585 - Sp_0586, metE and metF). Immunoblot analysis confirmed MetQ was a lipoprotein and present in all S. pneumoniae strains investigated. However, vaccination with MetQ did not prevent fatal S. pneumoniae infection in mice despite stimulating a strong specific IgG response. Tryptophan fluorescence spectroscopy and isothermal titration calorimetry demonstrated that MetQ has both a high affinity and specificity for L-methionine with a K-D of similar to 25 nM, and a Delta metQ strain had reduced uptake of C-14-methionine. Growth of the Delta metQ/Delta metEF strain was greatly impaired in chemically defined medium containing low concentrations of methionine and in blood but was partially restored by addition of high concentrations of exogenous methionine. Mixed infection models showed no attenuation of the Delta metQ, Delta metEF and Delta metQ/Delta metEF strains in their ability to colonise the mouse nasopharnyx. In a mouse model of systemic infection although significant infection was established in all mice, there were reduced spleen bacterial CFU after infection with the Delta metQ/Delta metEF strain compared to the wild-type strain. These data demonstrate that Sp_0149 encodes a high affinity methionine ABC transporter lipoprotein and that Sp_0585 - Sp_0586 are likely to be required for methionine synthesis. Although Sp_0149 and Sp_0585 - Sp_0586 make a contribution towards full virulence, neither was essential for S. pneumoniae survival during infection.	[Basavanna, Shilpa] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX USA; [Chimalapati, Suneeta; Rubbo, Bruna; Wilson, Robert J.; Brown, Jeremy S.] UCL, Rayne Inst, Sch Med, Ctr Inflammat & Tissue Repair,Dept Med, London, England; [Maqbool, Abbas; Thomas, Gavin] Univ York, Dept Biol, Area 10, York YO10 5DD, N Yorkshire, England; [Yuste, Jose] CSIC, Ctr Invest Biol, Madrid, Spain; [Yuste, Jose] Enfermedades Resp CIBERES, Madrid, Spain; [Hosie, Arthur] Univ Bedfordshire, Div Sci, Luton, Beds, England; [Ogunniyi, Abiodun D.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia	University of Texas System; University of Texas Health Science Center Houston; University of London; King's College London; University College London; UCL Medical School; University of York - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Bedfordshire; University of Adelaide	Brown, JS (corresponding author), UCL, Rayne Inst, Sch Med, Ctr Inflammat & Tissue Repair,Dept Med, London, England.	jeremy.brown@ucl.ac.uk	Thomas, Gavin H/E-5753-2011; YUSTE, JOSE/ABG-9851-2020; Hosie, Arthur/J-9615-2012; Maqbool, Abbas/AAA-9052-2020; Maqbool, Abbas/G-3191-2016	Thomas, Gavin H/0000-0002-9763-1313; Hosie, Arthur/0000-0002-1327-7901; Brown, Jeremy/0000-0002-5650-5361; Maqbool, Abbas/0000-0002-6189-5560; YUSTE, JOSE/0000-0001-7996-0837; Ogunniyi, Abiodun/0000-0001-9308-5629	Department of Health's NIHR Biomedical Research Centre's funding scheme; British Lung Foundation [P05/3]; Wellcome Trust [076442]; UCL Charities funding	Department of Health's NIHR Biomedical Research Centre's funding scheme(National Institute for Health Research (NIHR)); British Lung Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); UCL Charities funding	This work was undertaken at UCLH/UCL, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme, and was supported by the UCL Charities funding and grants from the British Lung Foundation (P05/3) and the Wellcome Trust (grant reference 076442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo MT, 2009, FEMS IMMUNOL MED MIC, V55, P346, DOI 10.1111/j.1574-695X.2008.00518.x; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Bryan JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-607; CHU J, 1985, ARCH BIOCHEM BIOPHYS, V239, P467, DOI 10.1016/0003-9861(85)90713-1; Darwin AJ, 2005, CURR ISSUES MOL BIOL, V7; den Hengst CD, 2006, J BACTERIOL, V188, P3280, DOI 10.1128/JB.188.9.3280-3289.2006; Ejim LJ, 2004, INFECT IMMUN, V72, P3310, DOI 10.1128/IAI.72.6.3310-3314.2004; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; GREENE RC, 1996, ESCHERICHIA COLI SAL, P542; Hill CE, 2003, VET MICROBIOL, V96, P189, DOI 10.1016/S0378-1135(03)00212-8; Himpsl SD, 2008, J MED MICROBIOL, V57, P1068, DOI 10.1099/jmm.0.2008/002071-0; Hullo MF, 2004, RES MICROBIOL, V155, P80, DOI 10.1016/j.resmic.2003.11.008; Johnston JW, 2004, INFECT IMMUN, V72, P5858, DOI 10.1128/IAI.72.10.5858-5867.2004; Jomaa M, 2005, INFECT IMMUN, V73, P6852, DOI 10.1128/IAI.73.10.6852-6859.2005; Jomaa M, 2006, VACCINE, V24, P5133, DOI 10.1016/j.vaccine.2006.04.012; Khandavilli S, 2008, MOL MICROBIOL, V67, P541, DOI 10.1111/j.1365-2958.2007.06065.x; Kovaleva GY, 2007, FEMS MICROBIOL LETT, V276, P207, DOI 10.1111/j.1574-6968.2007.00934.x; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lei BF, 2004, J INFECT DIS, V189, P79, DOI 10.1086/380491; Lestrate P, 2000, MOL MICROBIOL, V38, P543, DOI 10.1046/j.1365-2958.2000.02150.x; Maqbool A, 2011, J BIOL CHEM, V286, P31512, DOI 10.1074/jbc.M111.267179; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; Novak R, 1999, J BACTERIOL, V181, P1126, DOI 10.1128/JB.181.4.1126-1133.1999; Ogunniyi AD, 2012, INFECT IMMUN, V80, P3268, DOI 10.1128/IAI.00295-12; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SAMBROOK J, 1989, MOL CLONING LAB CLON; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Shah P, 2006, INFECT IMMUN, V74, P5888, DOI 10.1128/IAI.00553-06; Shah P, 2009, EXP BIOL MED, V234, P403, DOI 10.3181/0809-RM-269; Shelver D, 2003, J BACTERIOL, V185, P6592, DOI 10.1128/JB.185.22.6592-6599.2003; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Sperandio B, 2007, J BACTERIOL, V189, P7032, DOI 10.1128/JB.00703-07; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thomas GH, 2006, MICROBIOL-SGM, V152, P187, DOI 10.1099/MIC.0.28334-0; Tomasz A, 1964, 64 GEN M AM SOC MICR; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07; Yuste J, 2006, J IMMUNOL, V176, P6112, DOI 10.4049/jimmunol.176.10.6112; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09	47	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e49638	10.1371/journal.pone.0049638	http://dx.doi.org/10.1371/journal.pone.0049638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349662	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100004
J	Graziano, A; Foffani, G; Knudsen, EB; Shumsky, J; Moxon, KA				Graziano, Alessandro; Foffani, Guglielmo; Knudsen, Eric B.; Shumsky, Jed; Moxon, Karen A.			Passive Exercise of the Hind Limbs after Complete Thoracic Transection of the Spinal Cord Promotes Cortical Reorganization	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL REORGANIZATION; VOLUNTARY EXERCISE; ADENYLYL-CYCLASE; H-REFLEX; NEUROPATHIC PAIN; MOTOR CORTEX; INJURY; PLASTICITY	Physical exercise promotes neural plasticity in the brain of healthy subjects and modulates pathophysiological neural plasticity after sensorimotor loss, but the mechanisms of this action are not fully understood. After spinal cord injury, cortical reorganization can be maximized by exercising the non-affected body or the residual functions of the affected body. However, exercise per se also produces systemic changes - such as increased cardiovascular fitness, improved circulation and neuroendocrine changes - that have a great impact on brain function and plasticity. It is therefore possible that passive exercise therapies typically applied below the level of the lesion in patients with spinal cord injury could put the brain in a more plastic state and promote cortical reorganization. To directly test this hypothesis, we applied passive hindlimb bike exercise after complete thoracic transection of the spinal cord in adult rats. Using western blot analysis, we found that the level of proteins associated with plasticity - specifically ADCY1 and BDNF - increased in the somatosensory cortex of transected animals that received passive bike exercise compared to transected animals that received sham exercise. Using electrophysiological techniques, we then verified that neurons in the deafferented hindlimb cortex increased their responsiveness to tactile stimuli delivered to the forelimb in transected animals that received passive bike exercise compared to transected animals that received sham exercise. Passive exercise below the level of the lesion, therefore, promotes cortical reorganization after spinal cord injury, uncovering a brain-body interaction that does not rely on intact sensorimotor pathways connecting the exercised body parts and the brain.	[Foffani, Guglielmo; Knudsen, Eric B.; Moxon, Karen A.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Graziano, Alessandro] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA; [Shumsky, Jed; Moxon, Karen A.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Foffani, Guglielmo] Hosp Nacl Paraplejicos, Serv Salud Castilla La Mancha, Toledo, Spain	Drexel University; Drexel University; Drexel University; Hospital Nacional de Paraplejicos	Graziano, A (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA.	Alessandro.Graziano@DrexelMed.edu	Moxon, Karen/K-7407-2012; Foffani, Guglielmo/ABD-5897-2020	Moxon, Karen/0000-0002-5790-097X; Foffani, Guglielmo/0000-0001-7289-6668	Neilsen Foundation [36206]; National Institutes of Health [P01 NS 055976, R01 NS05741]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055976] Funding Source: NIH RePORTER	Neilsen Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant 36206 from the Neilsen Foundation and grants P01 NS 055976 and R01 NS05741 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Ang ET, 2007, CURR MED CHEM, V14, P2564, DOI 10.2174/092986707782023280; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Bowes C, 2012, P NATL ACAD SCI USA, V109, P2595, DOI 10.1073/pnas.1121604109; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; de Mello MT, 2004, SPINAL CORD, V42, P218, DOI 10.1038/sj.sc.3101575; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; ERZURUMLU RS, 1990, J COMP NEUROL, V292, P443, DOI 10.1002/cne.902920310; Faggin BM, 1997, P NATL ACAD SCI USA, V94, P9428, DOI 10.1073/pnas.94.17.9428; Faghri P D, 1997, IEEE Trans Rehabil Eng, V5, P62, DOI 10.1109/86.559350; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Felix MS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00045; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Fumagalli F, 2009, NEUROSCIENCE, V159, P936, DOI 10.1016/j.neuroscience.2009.01.030; Ghosh A, 2012, CEREB CORTEX, V22, P1309, DOI 10.1093/cercor/bhr191; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032298; Graziano A, 2009, J NEUROSCI, V29, P3738, DOI 10.1523/JNEUROSCI.5388-08.2009; Green JB, 1998, NEUROLOGY, V50, P1115, DOI 10.1212/WNL.50.4.1115; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; HANGARTNER TN, 1994, J REHABIL RES DEV, V31, P50; Hoffman LR, 2007, PHYS THER, V87, P208, DOI 10.2522/ptj.20050365; House DRC, 2011, NEURON, V72, P819, DOI 10.1016/j.neuron.2011.09.008; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; JAIN N, 1995, J NEUROPHYSIOL, V73, P1537, DOI 10.1152/jn.1995.73.4.1537; Jain N, 1997, NATURE, V386, P495, DOI 10.1038/386495a0; Jain N, 2008, J NEUROSCI, V28, P11042, DOI 10.1523/JNEUROSCI.2334-08.2008; Ji B, 2006, MOL CELL NEUROSCI, V33, P311, DOI 10.1016/j.mcn.2006.08.003; Jones EG, 2000, ANNU REV NEUROSCI, V23, P1, DOI 10.1146/annurev.neuro.23.1.1; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; Kaas JH, 2000, PROG BRAIN RES, V128, P173; Kao T, 2011, J NEUROPHYSIOL, V106, P2662, DOI 10.1152/jn.01017.2010; Kao T, 2009, J NEUROSCI, V29, P7549, DOI 10.1523/JNEUROSCI.2474-08.2009; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kiser TS, 2005, J SPINAL CORD MED, V28, P241, DOI 10.1080/10790268.2005.11753818; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Knikou M, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/254948; Lauer RT, 2011, SPINAL CORD, V49, P917, DOI 10.1038/sc.2011.19; Leergaard TB, 2004, J COMP NEUROL, V478, P306, DOI 10.1002/cne.20289; Li XY, 2010, SCIENCE, V330, P1400, DOI 10.1126/science.1191792; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Mendonca HR, 2010, NEUROSCI LETT, V477, P23, DOI 10.1016/j.neulet.2010.04.027; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mizutani K, 2011, BRAIN RES, V1416, P61, DOI 10.1016/j.brainres.2011.08.012; Moore CI, 2000, P NATL ACAD SCI USA, V97, P14703, DOI 10.1073/pnas.250348997; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Moxon KA, 2008, NEUROSCIENCE, V156, P1083, DOI 10.1016/j.neuroscience.2008.08.009; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nothias JM, 2005, NEUROREHAB NEURAL RE, V19, P296, DOI 10.1177/1545968305281209; Paxinos G., 1986, RAT BRAIN STEREOTAXI, pxxvi; Petrinovic MM, 2010, DEVELOPMENT, V137, P2539, DOI 10.1242/dev.048371; Phadke CP, 2009, ARCH PHYS MED REHAB, V90, P1218, DOI 10.1016/j.apmr.2009.01.022; Phillips AA, 2011, SPINAL CORD, V49, P702, DOI 10.1038/sc.2010.193; Phillips WT, 1998, CURR PROB CARDIOLOGY, V23, P649; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; Ravary A, 2003, J NEUROSCI, V23, P2228; Rayegani Seyed Mansoor, 2011, Front Neurol, V2, P39, DOI 10.3389/fneur.2011.00039; Seifert T, 2011, PROG NEUROBIOL, V95, P406, DOI 10.1016/j.pneurobio.2011.09.008; Simoes EL, 2012, J NEUROSCI, V32, P3211, DOI 10.1523/JNEUROSCI.4592-11.2012; Skinner RD, 1996, BRAIN RES, V729, P127, DOI 10.1016/S0006-8993(96)00556-2; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Thomas SL, 2005, J NEUROPHYSIOL, V94, P2844, DOI 10.1152/jn.00532.2005; TWIST DJ, 1992, AM J PHYS MED REHAB, V71, P156, DOI 10.1097/00002060-199206000-00006; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Viswanath V, 2000, P NATL ACAD SCI USA, V97, P2270, DOI 10.1073/pnas.030365297; WALL PD, 1971, NATURE, V232, P542, DOI 10.1038/232542a0; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Wei HF, 2011, NEUROSCI LETT, V500, P187, DOI 10.1016/j.neulet.2011.06.029; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; Winchester P, 2005, NEUROREHAB NEURAL RE, V19, P313, DOI 10.1177/1545968305281515; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Yague JG, 2011, EXP NEUROL, V227, P252, DOI 10.1016/j.expneurol.2010.11.011; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026; Zhu HC, 2012, BRAIN RES B	99	30	32	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54350	10.1371/journal.pone.0054350	http://dx.doi.org/10.1371/journal.pone.0054350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349859	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100059
J	Vincent, K; Tauskela, JS; Mealing, GA; Thivierge, JP				Vincent, Kathleen; Tauskela, Joseph S.; Mealing, Geoffrey A.; Thivierge, Jean-Philippe			Altered Network Communication Following a Neuroprotective Drug Treatment	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD; CONNECTIVITY; PLASTICITY; POPULATION; TOPOLOGY; DYNAMICS; BRAIN; MODEL	Preconditioning is defined as a range of stimuli that allow cells to withstand subsequent anaerobic and other deleterious conditions. While cell protection under preconditioning is well established, this paper investigates the influence of neuroprotective preconditioning drugs, 4-aminopyridine and bicuculline (4-AP/bic), on synaptic communication across a broad network of in vitro rat cortical neurons. Using a permutation test, we evaluated cross-correlations of extracellular spiking activity across all pairs of recording electrodes on a 64-channel multielectrode array. The resulting functional connectivity maps were analyzed in terms of their graph-theoretic properties. A small-world effect was found, characterized by a functional network with high clustering coefficient and short average path length. Twenty-four hours after exposure to 4-AP/bic, small-world properties were comparable to control cultures that were not treated with the drug. Four hours following drug washout, however, the density of functional connections increased, while path length decreased and clustering coefficient increased. These alterations in functional connectivity were maintained at four days post-washout, suggesting that 4-AP/bic preconditioning leads to long-term effects on functional networks of cortical neurons. Because of their influence on communication efficiency in neuronal networks, alterations in small-world properties hold implications for information processing in brain systems. The observed relationship between density, path length, and clustering coefficient is captured by a phenomenological model where connections are added randomly within a spatially-embedded network. Taken together, results provide information regarding functional consequences of drug therapies that are overlooked in traditional viability studies and present the first investigation of functional networks under neuroprotective preconditioning.	[Vincent, Kathleen; Thivierge, Jean-Philippe] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; [Tauskela, Joseph S.; Mealing, Geoffrey A.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Ottawa; National Research Council Canada	Thivierge, JP (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada.	jthivier@uottawa.ca		Vincent, Kathleen/0000-0001-6098-9998	NAKFI Keck Future Initiatives; National Research Council Canada	NAKFI Keck Future Initiatives; National Research Council Canada	This research was supported by a grant to J.P.T. from the NAKFI Keck Future Initiatives and intramural funding from the National Research Council Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; AERTSEN AMHJ, 1985, BRAIN RES, V340, P341, DOI 10.1016/0006-8993(85)90931-X; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Cadotte AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003355; Chen J, 1997, NEUROLOGY, V48, P306, DOI 10.1212/WNL.48.2.306; Chiappalone M, 2003, BIOSENS BIOELECTRON, V18, P627, DOI 10.1016/S0956-5663(03)00041-1; Cramer H., 1946, MATH METHODS STAT; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Keppel G, 1991, DESIGN ANAL RES HDB; Kleinberg J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P163, DOI 10.1145/335305.335325; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Koulakov AA, 2009, J NEUROSCI, V29, P3685, DOI 10.1523/JNEUROSCI.4500-08.2009; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Novellino Antonio, 2010, Advances in Artificial Intelligence, DOI 10.1155/2010/209254; PerezPinzon MA, 1996, NEUROSCIENCE, V75, P687; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Thivierge JP, 2007, TRENDS NEUROSCI, V30, P251, DOI 10.1016/j.tins.2007.04.004; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Pelt J, 2005, PROG BRAIN RES, V147, P173, DOI 10.1016/S0079-6123(04)47013-7; Vincent K, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00086; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54478	10.1371/journal.pone.0054478	http://dx.doi.org/10.1371/journal.pone.0054478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349901	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100072
J	Fischer, S; Kittler, S; Klein, G; Glunder, G				Fischer, Samuel; Kittler, Sophie; Klein, Guenter; Gluender, Gerhard			Microplate-Test for the Rapid Determination of Bacteriophage-Susceptibility of Campylobacter Isolates-Development and Validation	PLOS ONE			English	Article							HOST-RANGE; JEJUNI; PHAGE; INFECTION; COLI; IDENTIFICATION	A simple susceptibility test using 800 isolates of one Campylobacter strain with different degrees of susceptibility and four bacteriophages of the British phage typing scheme was developed and examined for its suitability. The test presented is economically cheaper and less time consuming than the conventional agar overlay plate assay and therefore enables the monitoring of changes in the susceptibility pattern during phage therapy under practical field conditions. The main objective of this study was to compare the simplified test with the conventional agar overlay plate assay. The conventional test describes for a population of Campylobacter: i. the rate of resistant isolates (0 plaques) and ii. the degree of susceptibility, also called relative efficiency of plating (EOP), for the remaining isolates. The simplified test divides the isolates into four susceptibility ranks, which are easily distinguishable to the naked eye. Ten Campylobacter isolates out of each rank were subjected to the conventional method for validation of the simplified test. Each resistance rank contained isolates showing certain degrees of susceptibility, reflecting decreasing susceptibility by an increase of the rank. Thus, the simplified test correlated well with the conventional method. Nevertheless, it can be suggested for a clear cut to summarise the first thee ranks as "high susceptible'' and to mark out the fourth rank as reduced susceptible. Further test improvements will enable the monitoring of the degree of susceptibility and potentially also of resistance during phage therapy in the field. To ensure a long-lasting successful use of phage therapy, further studies on both the loss of susceptibility and the development of resistance of Campylobacter against phages combined with their impact on phage therapy will be necessary.	[Fischer, Samuel; Gluender, Gerhard] Univ Vet Med, Clin Poultry, Hannover, Lower Saxony, Germany; [Kittler, Sophie; Klein, Guenter] Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Lower Saxony, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Fischer, S (corresponding author), Univ Vet Med, Clin Poultry, Hannover, Lower Saxony, Germany.	samuel.fischer@tiho-hannover.de	Klein, Günter/G-5321-2013	Klein, Günter/0000-0003-1931-2701	Clinic For Poultry	Clinic For Poultry	Work was funded through own recources of the Clinic For Poultry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2012, BACTERIOPHAGE, V2, P1; Abedon S, 2011, ADV APPL MICROBIOL, V77, P1, DOI 10.1016/B978-0-12-387044-5.00001-7; Abedon Stephen T, 2011, Bacteriophage, V1, P179; Abedon Stephen T., 2009, V501, P161, DOI 10.1007/978-1-60327-164-6_17; Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P6302, DOI 10.1128/AEM.69.10.6302-6306.2003; Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P4511, DOI 10.1128/AEM.69.8.4511-4518.2003; BfR, 2009, GRUNDL ZUM VORK CAMP; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Coffey B, 2010, ANNU REV FOOD SCI T, V1, P449, DOI 10.1146/annurev.food.102308.124046; Connerton PL, 2004, APPL ENVIRON MICROB, V70, P3877, DOI 10.1128/AEM.70.7.3877-3883.2004; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; European Food Safety Authority, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1503; Eurosurveillance Editorial Team, 2012, EUROSURVEILLANCE, V17, P21; Frost JA, 1999, EPIDEMIOL INFECT, V123, P47, DOI 10.1017/S095026889900254X; Gillespie IA, 2002, EMERG INFECT DIS, V8, P937, DOI 10.3201/eid0809.010817; Glunder G, 1998, P 1 INT S TURK DIS 1, P307; GRAJEWSKI BA, 1985, J CLIN MICROBIOL, V22, P13, DOI 10.1128/JCM.22.1.13-18.1985; Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.04.006; Hansen VM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-90; Hirsch K, 2010, DEV STRATEGIES MINIM; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Guenter K, 2007, ANTON LEEUW INT J G, V92, P267, DOI 10.1007/s10482-007-9157-3; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Lammerding AM, 2000, INT J FOOD MICROBIOL, V58, P147, DOI 10.1016/S0168-1605(00)00269-5; Lindqvist R, 2001, EMERG INFECT DIS, V7, P588; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; Pichard K, 1998, LEBENSMITTELMIKROBIO; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Shane SM, 2000, REV SCI TECH OIE, V19, P376, DOI 10.20506/rst.19.2.1224; Sorensen MCH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00011; Sorensen MCH, 2011, J BACTERIOL, V193, P6742, DOI 10.1128/JB.05276-11; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002	36	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53899	10.1371/journal.pone.0053899	http://dx.doi.org/10.1371/journal.pone.0053899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349761	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900026
J	Genung, MA; Bailey, JK; Schweitzer, JA				Genung, Mark A.; Bailey, Joseph K.; Schweitzer, Jennifer A.			The Afterlife of Interspecific Indirect Genetic Effects: Genotype Interactions Alter Litter Quality with Consequences for Decomposition and Nutrient Dynamics	PLOS ONE			English	Article							EVOLUTIONARY CONSEQUENCES; ECOSYSTEM GENETICS; SOLIDAGO-ALTISSIMA; TRIFOLIUM-REPENS; COMMUNITY; DIVERSITY; NITROGEN; DETERMINANTS; BIODIVERSITY; INTEGRATION	Aboveground-belowground linkages are recognized as divers of community dynamics and ecosystem processes, but the impacts of plant-neighbor interactions on these linkages are virtually unknown. Plant-neighbor interactions are a type of interspecific indirect genetic effect (IIGE) if the focal plant's phenotype is altered by the expression of genes in a neighboring heterospecific plant, and IIGEs could persist after plant senescence to affect ecosystem processes. This perspective can provide insight into how plant-neighbor interactions affect evolution, as IIGEs are capable of altering species interactions and community composition over time. Utilizing genotypes of Solidago altissima and Solidago gigantea, we experimentally tested whether IIGEs that had affected living focal plants would affect litter decomposition rate, as well as nitrogen (N) and phosphorous (P) dynamics after the focal plant senesced. We found that species interactions affected N release and genotype interactions affected P immobilization. From a previous study we knew that neighbor genotype influenced patterns of biomass allocation for focal plants. Here we extend those previous results to show that these changes in biomass allocation altered litter quality, that then altered rates of decomposition and nutrient cycling. Our results provide insights into above- and belowground linkages by showing that, through their effects on plant litter quality (e.g., litter lignin: N), IIGEs can have afterlife effects, tying plant-neighbor interactions to ecosystem processes. This holistic approach advances our understanding of decomposition and nutrient cycling by showing that evolutionary processes (i.e., IIGEs) can influence ecosystem functioning after plant senescence. Because plant traits are determined by the combined effects of genetic and environmental influences, and because these traits are known to affect decomposition and nutrient cycling, we suggest that ecosystem processes can be described as gene-less products of genetic interactions among the species comprising ecological communities.	[Genung, Mark A.; Bailey, Joseph K.; Schweitzer, Jennifer A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Genung, MA (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	mgenung@utk.edu		Genung, Mark/0000-0002-9383-667X	Department of Ecology and Evolutionary Biology at the University of Tennessee; National Science Foundation [DEB-0743437]; Australian Research Council [FT0991727]	Department of Ecology and Evolutionary Biology at the University of Tennessee; National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council)	The Department of Ecology and Evolutionary Biology at the University of Tennessee, the National Science Foundation (DEB-0743437) and The Australian Research Council (FT0991727) provided financial support to the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1985, J ECOL, V73, P605, DOI 10.2307/2260497; ABRAHAMSON WG, 1991, AM J BOT, V78, P1508, DOI 10.2307/2444976; Abrahamson WG, 2005, PLANT ECOL, V177, P43, DOI 10.1007/s11258-005-2069-2; Abrahamson WG, 1997, MONOGRAPHS POPULATIO, V29; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; BLAIR JM, 1992, BIOL FERT SOILS, V12, P241, DOI 10.1007/BF00336039; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; Bossdorf O, 2009, OIKOS, V118, P1541, DOI 10.1111/j.1600-0706.2009.17559.x; Briones MJI, 1996, SOIL BIOL BIOCHEM, V28, P1381, DOI 10.1016/S0038-0717(96)00158-7; CALDWELL M, 1995, AMBIO, V24, P166; CARACO T, 1991, ECOLOGY, V72, P81, DOI 10.2307/1938904; Chapman SK, 2010, OECOLOGIA, V162, P763, DOI 10.1007/s00442-009-1498-3; CHOUDHURY D, 1988, OIKOS, V51, P389, DOI 10.2307/3565324; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dawkins R., 1982, pi; Findlay S, 1996, ECOL APPL, V6, P269, DOI 10.2307/2269570; Finzi AC, 1998, FOREST ECOL MANAG, V105, P129, DOI 10.1016/S0378-1127(97)00277-6; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Genung MA, 2012, ECOL LETT, V15, P65, DOI 10.1111/j.1461-0248.2011.01710.x; Genung MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008711; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Hansen RA, 1998, APPL SOIL ECOL, V9, P17, DOI 10.1016/S0929-1393(98)00048-1; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; MADDOX GD, 1987, OECOLOGIA, V72, P8, DOI 10.1007/BF00385037; Madritch M, 2006, ECOSYSTEMS, V9, P528, DOI 10.1007/s10021-006-0008-2; Madritch MD, 2011, OIKOS, V120, P1696, DOI 10.1111/j.1600-0706.2011.19195.x; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Moya-Larano J, 2012, TRENDS ECOL EVOL, V27, P139, DOI 10.1016/j.tree.2011.11.013; OBRIEN WJ, 1974, ECOLOGY, V55, P135, DOI 10.2307/1934626; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Shuster SM, 2006, EVOLUTION, V60, P991, DOI 10.1111/j.0014-3820.2006.tb01177.x; Thompson J. N., 2005, INTERSPEC INTERACT; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; TURKINGTON R, 1979, J ECOL, V67, P245, DOI 10.2307/2259348; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitham TG, 2012, TRENDS PLANT SCI, V17, P271, DOI 10.1016/j.tplants.2012.01.005; WIEDER RK, 1982, ECOLOGY, V63, P1636, DOI 10.2307/1940104; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0	49	23	23	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53718	10.1371/journal.pone.0053718	http://dx.doi.org/10.1371/journal.pone.0053718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349735	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900017
J	Estallo, EL; Mas, G; Vergara-Cid, C; Lanfri, MA; Luduena-Almeida, F; Scavuzzo, CM; Introini, MV; Zaidenberg, M; Almiron, WR				Lilia Estallo, Elizabet; Mas, Guillermo; Vergara-Cid, Carolina; Alberto Lanfri, Mario; Luduena-Almeida, Francisco; Marcelo Scavuzzo, Carlos; Virginia Introini, Maria; Zaidenberg, Mario; Ricardo Almiron, Walter			Spatial Patterns of High Aedes aegypti Oviposition Activity in Northwestern Argentina	PLOS ONE			English	Article							BUENOS-AIRES; DENGUE; EPIDEMIOLOGY; DIPTERA	Background: was to analyze the spatial patterns of high Aedes aegypti oviposition activity in San Ramon de la Nueva Oran, northwestern Argentina. The location of clusters as hot spot areas should help control programs to identify priority areas and allocate their resources more effectively. Methodology: Oviposition activity was detected in Oran City (Salta province) using ovitraps, weekly replaced (October 2005-2007). Spatial autocorrelation was measured with Moran's Index and depicted through cluster maps to identify hot spots. Total egg numbers were spatially interpolated and a classified map with Ae. aegypti high oviposition activity areas was performed. Potential breeding and resting (PBR) sites were geo-referenced. A logistic regression analysis of interpolated egg numbers and PBR location was performed to generate a predictive mapping of mosquito oviposition activity. Principal Findings: Both cluster maps and predictive map were consistent, identifying in central and southern areas of the city high Ae. aegypti oviposition activity. A logistic regression model was successfully developed to predict Ae. aegypti oviposition activity based on distance to PBR sites, with tire dumps having the strongest association with mosquito oviposition activity. A predictive map reflecting probability of oviposition activity was produced. The predictive map delimitated an area of maximum probability of Ae. aegypti oviposition activity in the south of Oran city where tire dumps predominate. The overall fit of the model was acceptable (ROC = 0.77), obtaining 99% of sensitivity and 75.29% of specificity. Conclusions: Distance to tire dumps is inversely associated with high mosquito activity, allowing us to identify hot spots. These methodologies are useful for prevention, surveillance, and control of tropical vector borne diseases and might assist National Health Ministry to focus resources more effectively.	[Lilia Estallo, Elizabet; Luduena-Almeida, Francisco; Ricardo Almiron, Walter] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Invest Entomol Cordoba, Inst Invest Biol & Tecnol,CONICET, RA-5000 Cordoba, Argentina; [Mas, Guillermo] INTA EEA San Luis, Villa Mercedes, San Luis, Argentina; [Vergara-Cid, Carolina] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, RA-5000 Cordoba, Argentina; [Alberto Lanfri, Mario; Marcelo Scavuzzo, Carlos] Ctr Espacial Teofilo Tabanera, Comis Nacl Actividades Espaciales CONAE, Inst Altos Estudios Espaciales Mario Gulich, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Cordoba	Estallo, EL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Invest Entomol Cordoba, Inst Invest Biol & Tecnol,CONICET, Ciudad Univ, RA-5000 Cordoba, Argentina.	eelizabet@gmail.com	scavuzzo, carlos marcelo/M-9829-2015	carlos marcelo, scavuzzo/0000-0003-0905-6361; Vergara Cid, Carolina/0000-0003-0221-8620; Estallo, Elizabet/0000-0002-6723-6929	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); SECYT - Universidad Nacional de Cordoba; FONCYT - Fondo Nacional de Ciencia y Tecnica [PICT 38060]; REd Latinoamericana de COntrol de Vectores (RELCOV) Ministerio de Salud de La Nacion; programa VIGIA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); SECYT - Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); FONCYT - Fondo Nacional de Ciencia y Tecnica; REd Latinoamericana de COntrol de Vectores (RELCOV) Ministerio de Salud de La Nacion; programa VIGIA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), SECYT - Universidad Nacional de Cordoba, FONCYT (PICT 38060) - Fondo Nacional de Ciencia y Tecnica, REd Latinoamericana de COntrol de Vectores (RELCOV) Ministerio de Salud de La Nacion, programa VIGIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almiron Walter R, 2003, Rev Fac Cien Med Univ Nac Cordoba, V60, P37; [Anonymous], 2006, IDR AND; [Anonymous], 2007, KEY CONCEPTS TECHNIQ; [Anonymous], ARCVIEW 3 2; Anosike JC, 2007, ANN AGR ENV MED, V14, P31; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 2019, GEODA WORKBOOK; Aviles G, 1999, EMERG INFECT DIS, V5, P575, DOI 10.3201/eid0504.990424; Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Carbajo AE, 2004, MEDICINA-BUENOS AIRE, V64, P231; Christophers SR, 1960, YELLOW FEVER MOSQUIT; Di Rienzo J., INFOSTAT VERSION 201; Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411; Focks Dana A., 1999, American Entomologist, V45, P173; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Graham AJ, 2004, ACTA TROP, V91, P219, DOI 10.1016/j.actatropica.2004.05.001; King RJ, 2004, EMERG INFECT DIS, V10, P598, DOI 10.3201/eid1004.030241; Mangudo C, 2010, 7 JORN REG MOSQ, P37; Marquetti María del Carmen, 2005, Rev Cubana Med Trop, V57, P159; Ministerio de Salud de la Nacion, 2009, PLAN NAC PREV CONTR; MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225; Naish S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025688; Natiello M, 2008, EMERG INFECT DIS, V14, P1498, DOI 10.3201/eid1409.080143; OPS, 1990, ORG PANAMERICANA SAL, V524, P1; Pérez Martínez Teresita Tamara, 2003, Rev Cubana Salud Pública, V29, P0; Reiter P., 2001, GUIDELINES ASSESSING; Rodhain Francois, 1997, P45; Duenas JCR, 2009, J MED ENTOMOL, V46, P1344, DOI 10.1603/033.046.0613; Ryan PA, 2004, J MED ENTOMOL, V41, P1143, DOI 10.1603/0022-2585-41.6.1143; Schweigmann N., 1997, Entomologia y Vectores, V4, P185; Sciarretta A, 2010, B ENTOMOL RES, V100, P661, DOI 10.1017/S0007485309990733; Service M. W., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P681; Stein M, 2002, REV SAUDE PUBL, V36, P627, DOI 10.1590/S0034-89102002000600013; Stein M, 2011, MEM I OSWALDO CRUZ, V106, P400, DOI 10.1590/S0074-02762011000400004; TINKER MILTON E., 1964, MOSQUITO NEWS, V24, P426	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54167	10.1371/journal.pone.0054167	http://dx.doi.org/10.1371/journal.pone.0054167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349813	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900047
J	Muley, VY; Ranjan, A				Muley, Vijaykumar Yogesh; Ranjan, Akash			Evaluation of Physical and Functional Protein-Protein Interaction Prediction Methods for Detecting Biological Pathways	PLOS ONE			English	Article							ESCHERICHIA-COLI; PHYLOGENETIC TREES; GENOMIC CONTEXT; GENE ORDER; LINKAGES; DATABASE; TRANSCRIPTOME; CONSERVATION; SEQUENCES; INFERENCE	Background: Cellular activities are governed by the physical and the functional interactions among several proteins involved in various biological pathways. With the availability of sequenced genomes and high-throughput experimental data one can identify genome-wide protein-protein interactions using various computational techniques. Comparative assessments of these techniques in predicting protein interactions have been frequently reported in the literature but not their ability to elucidate a particular biological pathway. Methods: Towards the goal of understanding the prediction capabilities of interactions among the specific biological pathway proteins, we report the analyses of 14 biological pathways of Escherichia coli catalogued in KEGG database using five protein-protein functional linkage prediction methods. These methods are phylogenetic profiling, gene neighborhood, co-presence of orthologous genes in the same gene clusters, a mirrortree variant, and expression similarity. Conclusions: Our results reveal that the prediction of metabolic pathway protein interactions continues to be a challenging task for all methods which possibly reflect flexible/independent evolutionary histories of these proteins. These methods have predicted functional associations of proteins involved in amino acids, nucleotide, glycans and vitamins & co-factors pathways slightly better than the random performance on carbohydrate, lipid and energy metabolism. We also make similar observations for interactions involved among the environmental information processing proteins. On the contrary, genetic information processing or specialized processes such as motility related protein-protein linkages that occur in the subset of organisms are predicted with comparable accuracy. Metabolic pathways are best predicted by using neighborhood of orthologous genes whereas phyletic pattern is good enough to reconstruct central dogma pathway protein interactions. We have also shown that the effective use of a particular prediction method depends on the pathway under investigation. In case one is not focused on specific pathway, gene expression similarity method is the best option.	[Muley, Vijaykumar Yogesh; Ranjan, Akash] Ctr DNA Fingerprinting & Diagnost, Computat & Funct Genom Grp, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Ranjan, A (corresponding author), Ctr DNA Fingerprinting & Diagnost, Computat & Funct Genom Grp, Hyderabad, Andhra Pradesh, India.	akash@cdfd.org.in	Muley, Vijaykumar/HGC-7068-2022; Muley, Vijaykumar/A-4700-2011	Muley, Vijaykumar/0000-0001-5329-600X; Ranjan, Akash/0000-0002-4582-1553	Department of Biotechnology, Ministry of Science and Technology, Government of India; Indo-German Research Training Group program [GRK1673]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Indo-German Research Training Group program	V.Y.M. was supported by research fellowship from the Department of Biotechnology, Ministry of Science and Technology, Government of India (http://dbtindia.nic.in/index.asp). Research work in A.R.'s laboratory is funded by core institutional grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India (http://dbtindia.nic.in/index.asp). This work is partially supported under GRK1673 Indo-German Research Training Group program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Castresana J, 2001, BBA-BIOENERGETICS, V1506, P147, DOI 10.1016/S0005-2728(01)00227-4; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Choi K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-423; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Enault F, 2003, BIOINFORMATICS, V19, pi105, DOI 10.1093/bioinformatics/btg1013; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fani R, 2009, PHYS LIFE REV, V6, P23, DOI 10.1016/j.plrev.2008.12.003; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Janga SC, 2005, NUCLEIC ACIDS RES, V33, P2521, DOI 10.1093/nar/gki545; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karimpour-Fard A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-397; Koonin EV, 1996, CURR OPIN GENET DEV, V6, P757, DOI 10.1016/S0959-437X(96)80032-3; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Marcotte EM, 2000, CURR OPIN STRUC BIOL, V10, P359, DOI 10.1016/S0959-440X(00)00097-X; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Muley VY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042057; Mushegian AR, 1996, TRENDS GENET, V12, P289, DOI 10.1016/0168-9525(96)20006-X; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qi YJ, 2006, PROTEINS, V63, P490, DOI 10.1002/prot.20865; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Tamames J, 1997, J MOL EVOL, V44, P66, DOI 10.1007/PL00006122; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607	47	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54325	10.1371/journal.pone.0054325	http://dx.doi.org/10.1371/journal.pone.0054325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349851	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900060
J	Jackson, RE				Jackson, Russell E.			Preference for the Nearer of Otherwise Equivalent Navigational Goals Quantifies Behavioral Motivation and Natural Selection	PLOS ONE			English	Article							DISTANCE; PERCEPTION; RATS	Navigation and environmental perception precede most actions in mobile organisms. Navigation is based upon the fundamental assumption of a ubiquitous Preference for the Nearest of otherwise equivalent navigational goals (PfN). However, the magnitude and triggers for PfN are unknown and there is no clear evidence that PfN exists. I tested for PfN in human participants on a retrieval task. Results of these experiments provide the first evidence for PfN. Further, these data quantify the three primary PfN triggers and provide an experimental structure for using PfN as a behavioral metric across domains. Surprisingly, PfN exists at a high, but not universal, magnitude. Further, PfN derives most from the absolute distance to the farthest of multiple goals (d(f)), with little influence of the distance to the nearest goal (d(n)). These data provide previously unavailable quantification of behavioral motivation across species and may provide a measurable index of selection. These methods hold particular import for behavioral modification because proximity is a powerful determinant of decision outcomes across most behaviors.	Univ Idaho, Psychol & Commun Studies Dept, Moscow, ID 83843 USA	Idaho; University of Idaho	Jackson, RE (corresponding author), Univ Idaho, Psychol & Commun Studies Dept, Moscow, ID 83843 USA.	rjackson@uidaho.edu						De Camp J.E., 1920, PSYCHOBIOLOGY, V2, P245, DOI [10.1037/h0075411, DOI 10.1037/H0075411]; Forero MG, 1999, ECOLOGY, V80, P1298, DOI 10.1890/0012-9658(1999)080[1298:CACOTC]2.0.CO;2; GEISLER WS, 1989, PSYCHOL REV, V96, P267, DOI 10.1037/0033-295X.96.2.267; Gibson J.J., 1966, SENSES CONSIDERED PE; Green DM, 1966, SIGNAL DETECTION THE; Jackson RE, 2009, P R SOC B, V276, P1665, DOI 10.1098/rspb.2009.0004; Marr D., 1982, VISION; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; SADALLA EK, 1980, ENVIRON BEHAV, V12, P65, DOI 10.1177/0013916580121005; Sinai MJ, 1998, NATURE, V395, P497, DOI 10.1038/26747; SOLOMON RL, 1949, J EXP PSYCHOL, V39, P73, DOI 10.1037/h0056048; Srinivasan M. V, 1992, CURR DIR PSYCHOL SCI, V1, P22, DOI DOI 10.1111/1467-8721.EP10767830; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; WALK RD, 1957, SCIENCE, V126, P80, DOI 10.1126/science.126.3263.80-a; Yang ZY, 2003, NAT NEUROSCI, V6, P632, DOI 10.1038/nn1059; Zajonc RB, 2001, CURR DIR PSYCHOL SCI, V10, P224, DOI 10.1111/1467-8721.00154	16	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54725	10.1371/journal.pone.0054725	http://dx.doi.org/10.1371/journal.pone.0054725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23355894	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500117
J	Mo, WC; Zhang, ZJ; Liu, Y; Bartlett, PF; He, RQ				Mo, Wei-chuan; Zhang, Zi-jian; Liu, Ying; Bartlett, Perry F.; He, Rong-qiao			Magnetic Shielding Accelerates the Proliferation of Human Neuroblastoma Cell by Promoting G1-Phase Progression	PLOS ONE			English	Article							STRESS-INDUCED ANALGESIA; HYPOMAGNETIC FIELD; MODEL; EXPOSURE; EMBRYOS; GROWTH	Organisms have been exposed to the geomagnetic field (GMF) throughout evolutionary history. Exposure to the hypomagnetic field (HMF) by deep magnetic shielding has recently been suggested to have a negative effect on the structure and function of the central nervous system, particularly during early development. Although changes in cell growth and differentiation have been observed in the HMF, the effects of the HMF on cell cycle progression still remain unclear. Here we show that continuous HMF exposure significantly increases the proliferation of human neuroblastoma (SH-SY5Y) cells. The acceleration of proliferation results from a forward shift of the cell cycle in G1-phase. The G2/M-phase progression is not affected in the HMF. Our data is the first to demonstrate that the HMF can stimulate the proliferation of SH-SY5Y cells by promoting cell cycle progression in the G1-phase. This provides a novel way to study the mechanism of cells in response to changes of environmental magnetic field including the GMF.	[Mo, Wei-chuan; Zhang, Zi-jian; Liu, Ying; He, Rong-qiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Mo, Wei-chuan; Zhang, Zi-jian; Liu, Ying; He, Rong-qiao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Mo, Wei-chuan; Bartlett, Perry F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Queensland	Liu, Y (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	liuy@moon.ibp.ac.cn; herq@sun5.ibp.ac.cn	Zhang, Zijian/H-6190-2016; Bartlett, Perry/F-3813-2012; Liu, Ying/D-8933-2013	Liu, Ying/0000-0003-0802-3832; Mo, Weichuan/0000-0002-8529-4399	Queensland-Chinese Academy of Sciences Biotechnology Fund [GJHZ1131]; Chinese Academy of Sciences [YZ201148]; National Nature Science Foundation of China [31200628]	Queensland-Chinese Academy of Sciences Biotechnology Fund; Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Queensland-Chinese Academy of Sciences Biotechnology Fund (Grant No. GJHZ1131), the project of Chinese Academy of Sciences for the development of major scientific research equipment (Grant No. YZ201148), and the National Nature Science Foundation of China (Grant No. 31200628). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Beischer DE, 1962, NASACR127721, P1; Belyaev IY, 1997, BBA-GEN SUBJECTS, V1336, P465, DOI 10.1016/S0304-4165(97)00059-7; Belyavskaya NA, 2004, ADV SPACE RES-SERIES, V34, P1566, DOI 10.1016/j.asr.2004.01.021; Berguig MS, 2011, ARAB J GEOSCI, P1; Binhi VN, 2009, ELECTROMAGN BIOL MED, V28, P310, DOI [10.1080/15368370903167246, 10.3109/15368370903167246]; BLISS VL, 1976, NATURE, V261, P411, DOI 10.1038/261411a0; Borodin Iu I, 1990, Biull Eksp Biol Med, V109, P191; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Choleris E, 2002, P ROY SOC B-BIOL SCI, V269, P193, DOI 10.1098/rspb.2001.1866; Del Seppia C, 2000, LIFE SCI, V66, P1299, DOI 10.1016/S0024-3205(00)00437-9; Dubrov AP, 1989, GEOMAGNETIC FIELD LI; Eldashev I. S., 2010, Biofizika, V55, P868; Gopalakrishnan Kalpana, 2010, Genome Integr, V1, P16, DOI 10.1186/2041-9414-1-16; [贾斌 JIA Bin], 2009, [航天医学与医学工程, Space Medicine & Medical Engineering], V22, P308; Jiang JC, 1998, ACTA SEISMOL SIN, V20, P421; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Kolmakov V. M., 2002, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P68; Lohmann KJ, 2010, NATURE, V464, P1140, DOI 10.1038/4641140a; Lohmann KJ, 2000, TRENDS NEUROSCI, V23, P153, DOI 10.1016/S0166-2236(99)01542-8; Martino CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022753; Martino CF, 2010, BIOELECTROMAGNETICS, V31, P649, DOI 10.1002/bem.20606; Mo WC, 2012, PROG BIOCHEM BIOPHYS, V39, P835, DOI 10.3724/SP.J.1206.2011.00597; Mo WC, 2012, BIOELECTROMAGNETICS, V33, P238, DOI 10.1002/bem.20699; Mo WC, 2011, ADV SPACE RES, V47, P1616, DOI 10.1016/j.asr.2010.12.024; Nepomniashchikh L M, 1997, Biull Eksp Biol Med, V124, P455; Nicolini G, 1998, ANTICANCER RES, V18, P2477; Osipenko M. A., 2008, Biofizika, V53, P705; Owens KM, 2012, FREE RADICAL BIO MED, V52, P160, DOI 10.1016/j.freeradbiomed.2011.10.435; Prato FS, 2005, BIOELECTROMAGNETICS, V26, P109, DOI 10.1002/bem.20056; Quah BJC, 2010, JOVE-J VIS EXP, V44, P2259, DOI [10. 3791/2259, DOI 10.3791/2259]; Sandodze V, 2000, RAD STUDIES, V5, P188; Steinhilber F, 2010, J GEOPHYS RES, V115, P1; TrulA Z, 2005, ROMANIAN J BIOPHYS, V15, P73; Wang DL, 2008, BIOCHEM BIOPH RES CO, V376, P363, DOI 10.1016/j.bbrc.2008.08.156; Wang XB, 2003, CHINESE SCI BULL, V48, P2454; Wang XK, 2008, GEOMICROBIOL J, V25, P296, DOI 10.1080/01490450802258295; Watters TR, 2007, ANNU REV EARTH PL SC, V35, P621, DOI 10.1146/annurev.earth.35.031306.140220; Wever R, 1970, Life Sci Space Res, V8, P177; Xiao Y, 2009, ADV SPACE RES, V44, P226, DOI 10.1016/j.asr.2009.04.013; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Zamoshchina T A, 2012, Aviakosm Ekolog Med, V46, P17; Zhang B, 2004, NEUROSCI LETT, V371, P190, DOI 10.1016/j.neulet.2004.08.072; Zhang X, 2007, BIOELECTROMAGNETICS, V28, P155, DOI 10.1002/bem.20290; 肖颖, 2009, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V39, P392	45	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54775	10.1371/journal.pone.0054775	http://dx.doi.org/10.1371/journal.pone.0054775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355897	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500123
J	Kierans, C; Padilla-Altamira, C; Garcia-Garcia, G; Ibarra-Hernandez, M; Mercado, FJ				Kierans, Ciara; Padilla-Altamira, Cesar; Garcia-Garcia, Guillermo; Ibarra-Hernandez, Margarita; Mercado, Francisco J.			When Health Systems Are Barriers to Health Care: Challenges Faced by Uninsured Mexican Kidney Patients	PLOS ONE			English	Article							STAGE RENAL-DISEASE; REPLACEMENT THERAPY; DIALYSIS; END; INSURANCE; JALISCO; BURDEN; EQUITY; REFORM	Background: Chronic Kidney Disease disproportionately affects the poor in Low and Middle Income Countries (LMICs). Mexico exemplifies the difficulties faced in supporting Renal Replacement Therapy (RRT) and providing equitable patient care, despite recent attempts at health reform. The objective of this study is to document the challenges faced by uninsured, poor Mexican families when attempting to access RRT. Methods: The article takes an ethnographic approach, using interviewing and observation to generate detailed accounts of the problems that accompany attempts to secure care. The study, based in the state of Jalisco, comprised interviews with patients, their caregivers, health and social care professionals, among others. Observations were carried out in both clinical and social settings. Results: In the absence of organised health information and stable pathways to renal care, patients and their families work extraordinarily hard and at great expense to secure care in a mixed public-private healthcare system. As part of this work, they must navigate challenging health and social care environments, negotiate treatments and costs, resource and finance healthcare and manage a wide range of formal and informal health information. Conclusions: Examining commonalities across pathways to adequate healthcare reveals major failings in the Mexican system. These systemic problems serve to reproduce and deepen health inequalities. A system, in which the costs of renal care are disproportionately borne by those who can least afford them, faces major difficulties around the sustainability and resourcing of RRTs. Attempts to increase access to renal therapies, therefore, need to take into account the complex social and economic demands this places on those who need access most. This paper further shows that ethnographic studies of the concrete ways in which healthcare is accessed in practice provide important insights into the plight of CKD patients and so constitute an important source of evidence in that effort.	[Kierans, Ciara; Padilla-Altamira, Cesar] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Garcia-Garcia, Guillermo; Ibarra-Hernandez, Margarita] Univ Guadalajara, Hlth Sci Ctr, Hosp 278, Div Nephrol,Hosp Civil Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Mercado, Francisco J.] Univ Guadalajara, CUCS, Depto Salud Publ, Guadalajara 44430, Jalisco, Mexico	University of Liverpool; Universidad de Guadalajara; Universidad de Guadalajara	Kierans, C (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.	c.kierans@liv.ac.uk		Garcia Garcia, Guillermo/0000-0003-0558-0035; Kierans, Ciara/0000-0001-7268-4438	Darwin Initiative [14-032]; Cambridge Conservation Initiative [CCI 05/10/006]; Leverhulme Trust [F/01 503/B]	Darwin Initiative; Cambridge Conservation Initiative; Leverhulme Trust(Leverhulme Trust)	This work was supported by grants from The Darwin Initiative (14-032), The Cambridge Conservation Initiative (CCI 05/10/006) and The Leverhulme Trust (F/01 503/B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gutierrez-Padilla JA, 2010, AM J KIDNEY DIS, V55, P474, DOI 10.1053/j.ajkd.2009.07.023; Amato DK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09702.x; [Anonymous], 2012, LANCET, V380, P76, DOI 10.1016/S0140-6736(12)61158-1; Aviles-Gomez R, 2006, ETHNIC DIS, V16; Ayodele OE, 2010, ADV CHRONIC KIDNEY D, V17, P215, DOI 10.1053/j.ackd.2010.02.001; Barsoum RS, 2003, KIDNEY INT, V63, P111, DOI 10.1046/j.1523-1755.63.s83.23.x; Barsoum RS, 2002, ARTIF ORGANS, V26, P737, DOI 10.1046/j.1525-1594.2002.07061.x; Becker Howard, 1961, BOYS WHITE STUDENT C; Bello AK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09802.x; Consejo Estatal de Poplacion Jalisco, 2011, DIEZ PROBL POBL JAL; Corbin J M, 1991, Sch Inq Nurs Pract, V5, P155; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Laurell AC, 2010, SALUD COLECT, V6, P137, DOI 10.18294/sc.2010.362; Cueto-Manzano AM, 2007, PERITON DIALYSIS INT, V27, P142; Eibenschutz Catalina, 2008, Rev. salud pública, V10, P119; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Garcia-Diaz R, 2011, J HEALTH ECON, V30, P707, DOI 10.1016/j.jhealeco.2011.04.003; Garcia-Garcia G, 2005, KIDNEY INT, V68, pS58, DOI 10.1111/j.1523-1755.2005.09710.x; Garcia-Garcia G, 2007, J AM SOC NEPHROL, V18, P1922, DOI 10.1681/ASN.2006121388; Garcia-Garcia G, 2010, SEMIN NEPHROL, V30, P3, DOI 10.1016/j.semnephrol.2009.10.001; Goffman E, 1961, ENCOUNTERS 2 STUDIES; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Homedes N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000124; Kher V, 2002, KIDNEY INT, V62, P350, DOI 10.1046/j.1523-1755.2002.00426.x; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Lakin JM, 2010, J HEALTH POLIT POLIC, V35, P313, DOI 10.1215/03616878-2010-002; Latour B., 1988, SCI ACTION FOLLOW SC; Laurell AC, 2011, CIENCIA SAUDE COLETI, V16, P2796; Laurell AC, 2007, INT J HEALTH SERV, V37, P515, DOI 10.2190/0133-572V-564N-4831; Lopez-Cervantes M., 2010, ENFERMEDAD RENAL CRO; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Lustig N, 2007, REV NEXOS, V358; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mendez-Duran A, 2010, DIALISIS TRASPL, V31, P7, DOI DOI 10.1016/S1886-2845(10)70004-7; Moosa MR, 2006, KIDNEY INT, V70, P1107, DOI 10.1038/sj.ki.5001750; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Paniagua R, 2007, PERITON DIALYSIS INT, V27, P405; Sosa-Rubi SG, 2011, SALUD PUBLICA MEXICO, V53, pS425; Tamez González Silvia, 2005, Rev. Mex. Sociol, V67, P321; Tamez Gonzalez Silvia, 2008, Rev Salud Publica (Bogota), V10 Suppl, P133; Urbina M, 2008, SISTEMA PROTECCION S; Victora CG, 2009, LANCET, V373, P1404, DOI 10.1016/S0140-6736(09)60564-X; Wacquant Loic, 2003, ETHNOGRAPHY, V4, P5; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X	47	58	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54380	10.1371/journal.pone.0054380	http://dx.doi.org/10.1371/journal.pone.0054380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349868	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100063
J	Piraveenan, M; Prokopenko, M; Hossain, L				Piraveenan, Mahendra; Prokopenko, Mikhail; Hossain, Liaquat			Percolation Centrality: Quantifying Graph-Theoretic Impact of Nodes during Percolation in Networks	PLOS ONE			English	Article							STATISTICAL-MECHANICS; EPIDEMICS; ASSORTATIVENESS; INFORMATION; POWER	A number of centrality measures are available to determine the relative importance of a node in a complex network, and betweenness is prominent among them. However, the existing centrality measures are not adequate in network percolation scenarios (such as during infection transmission in a social network of individuals, spreading of computer viruses on computer networks, or transmission of disease over a network of towns) because they do not account for the changing percolation states of individual nodes. We propose a new measure, percolation centrality, that quantifies relative impact of nodes based on their topological connectivity, as well as their percolation states. The measure can be extended to include random walk based definitions, and its computational complexity is shown to be of the same order as that of betweenness centrality. We demonstrate the usage of percolation centrality by applying it to a canonical network as well as simulated and real world scale-free and random networks.	[Piraveenan, Mahendra; Hossain, Liaquat] Univ Sydney, Fac Engn & IT, Ctr Complex Syst Res, Sydney, NSW 2006, Australia; [Prokopenko, Mikhail] CSIRO Informat & Commun Technol Ctr, Epping, NSW, Australia; [Prokopenko, Mikhail] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney	Piraveenan, M (corresponding author), Univ Sydney, Fac Engn & IT, Ctr Complex Syst Res, Sydney, NSW 2006, Australia.	mahendrarajah.piraveenan@sydney.edu.au	Prokopenko, Mikhail/A-3995-2008; /E-7946-2010	Prokopenko, Mikhail/0000-0002-4215-0344; /0000-0002-7616-9182	University of Sydney; Commonwealth Science and Industrial Research Organization	University of Sydney(University of Sydney); Commonwealth Science and Industrial Research Organization	The work was not specifically funded by any grant. The University of Sydney and the Commonwealth Science and Industrial Research Organization support the positions of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamatzky A, 2012, INT J PARALLEL EMERG; Adamatzky A, 2012, INT J PARALLEL EMERG, V27, P275, DOI 10.1080/17445760.2011.616204; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2007, INTRO SYSTEMS BIOL D; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Bauer F, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/68007; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bonacich P, 2001, SOC NETWORKS, V23, P191, DOI 10.1016/S0378-8733(01)00038-7; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Cavagna A, 2009, SCALE FREE CORRELATI; Crucitti P, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.045104; Cupac V, 2012, INT J ELECT IN PRESS; De P, 2004, SEX TRANSM INFECT, V80, P280, DOI 10.1136/sti.2003.007187; Dolev S, 2010, J ACM, V57, DOI 10.1145/1734213.1734219; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Ferrari MJ, 2006, P ROY SOC B-BIOL SCI, V273, P2743, DOI 10.1098/rspb.2006.3636; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1991, SOC NETWORKS, V13, P141, DOI 10.1016/0378-8733(91)90017-N; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Kepes F., 2007, BIOL NETWORKS; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; Klemm K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00292; LIZIER JT, 2009, P EUR C COMPL SYST E, P54; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Meyers LA, 2003, EMERG INFECT DIS, V9, P204, DOI 10.3201/eid0902.020188; Meyers LA, 2007, B AM MATH SOC, V44, P63; Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004; Mitchell M, 2006, ARTIF INTELL, V170, P1194, DOI 10.1016/j.artint.2006.10.002; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Newman M.E.J., 2008, NEW PALGRAVE ENCY EC, P312, DOI [DOI 10.1057/978-1-349-95121-5_2565-1, 10.1057/978-1-349-95121-5_2565-1]; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Piraveenan M, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/49901; Piraveenan M, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/28002; Piraveenan M, 2009, EUR PHYS J B, V67, P291, DOI 10.1140/epjb/e2008-00473-5; Piraveenan M, 2009, EUR PHYS J B, V70, P275, DOI 10.1140/epjb/e2009-00219-y; Piraveenan M, 2007, LECT NOTES ARTIF INT, V4648, P42; Piraveenan M, 2012, IEEE ACM T COMPUT BI, V9, P66, DOI 10.1109/TCBB.2010.80; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Sander LM, 2002, MATH BIOSCI, V180, P293, DOI 10.1016/S0025-5564(02)00117-7; Shen Y, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.033201; Sole R. V., 2002, Complexity, V8, P20, DOI 10.1002/cplx.10055; Sole RV, 2004, LECT NOTES PHYS, V650, P189; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426; Zhou S, 2003, PHYS REV E, V67	54	93	97	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53095	10.1371/journal.pone.0053095	http://dx.doi.org/10.1371/journal.pone.0053095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349699	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100015
J	Tzitzilonis, C; Eichmann, C; Maslennikov, I; Choe, S; Riek, R				Tzitzilonis, Christos; Eichmann, Cedric; Maslennikov, Innokentiy; Choe, Senyon; Riek, Roland			Detergent/Nanodisc Screening for High-Resolution NMR Studies of an Integral Membrane Protein Containing a Cytoplasmic Domain	PLOS ONE			English	Article							BILAYER NANODISCS; ACTIVE PEPTIDES; RHODANESE; DYNAMICS	Because membrane proteins need to be extracted from their natural environment and reconstituted in artificial milieus for the 3D structure determination by X-ray crystallography or NMR, the search for membrane mimetic that conserve the native structure and functional activities remains challenging. We demonstrate here a detergent/nanodisc screening study by NMR of the bacterial alpha-helical membrane protein YgaP containing a cytoplasmic rhodanese domain. The analysis of 2D [N-15,H-1]-TROSY spectra shows that only a careful usage of low amounts of mixed detergents did not perturb the cytoplasmic domain while solubilizing in parallel the transmembrane segments with good spectral quality. In contrast, the incorporation of YgaP into nanodiscs appeared to be straightforward and yielded a surprisingly high quality [N-15,H-1]-TROSY spectrum opening an avenue for the structural studies of a helical membrane protein in a bilayer system by solution state NMR.	[Tzitzilonis, Christos; Eichmann, Cedric; Riek, Roland] ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Tzitzilonis, Christos; Maslennikov, Innokentiy; Choe, Senyon; Riek, Roland] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Salk Institute	Riek, R (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch	Eichmann, Cédric/U-1360-2018; Maslennikov, Innokentiy/I-2524-2012	Eichmann, Cédric/0000-0002-8476-1936; Maslennikov, Innokentiy/0000-0003-4292-5821				Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Billeter M, 1995, J BIOMOL NMR, V5, P1; Brewer KD, 2011, P NATL ACAD SCI USA, V108, P12723, DOI 10.1073/pnas.1105128108; Cipollone R, 2008, J MOL MICROB BIOTECH, V15, P199, DOI 10.1159/000121331; Columbus L, 2009, J AM CHEM SOC, V131, P7320, DOI 10.1021/ja808776j; Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; Gueune H, 2008, APPL ENVIRON MICROB, V74, P1954, DOI 10.1128/AEM.02294-07; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li HW, 2008, BIOCHEMISTRY-US, V47, P4377, DOI 10.1021/bi800039n; Lyukmanova EN, 2008, J AM CHEM SOC, V130, P2140, DOI 10.1021/ja0777988; Maslennikov I, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-74; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Raschle T, 2010, CURR OPIN STRUC BIOL, V20, P471, DOI 10.1016/j.sbi.2010.05.006; Raschle T, 2009, J AM CHEM SOC, V131, P17777, DOI 10.1021/ja907918r; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sambrook J., 2002, MOL CLONING LAB MANU; Savage DF, 2007, PROTEIN SCI, V16, P966, DOI 10.1110/ps.062696307; Shenkarev ZO, 2009, BIOCHEMISTRY-MOSCOW+, V74, P756, DOI 10.1134/S0006297909070086; Shenkarev ZO, 2010, J AM CHEM SOC, V132, P5628, DOI 10.1021/ja9097498; Shih AY, 2005, BIOPHYS J, V88, P548, DOI 10.1529/biophysj.104.046896; Tate CG, 2010, METHODS MOL BIOL, V601, P187, DOI 10.1007/978-1-60761-344-2_12; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Yu TY, 2012, BBA-BIOMEMBRANES, V1818, P1562, DOI 10.1016/j.bbamem.2011.11.012	27	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54378	10.1371/journal.pone.0054378	http://dx.doi.org/10.1371/journal.pone.0054378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349867	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100062
J	Shiau, MY; Fan, LC; Yang, SC; Tsao, CH; Lee, H; Cheng, YW; Lai, LC; Chang, YH				Shiau, Ming-Yuh; Fan, Li-Ching; Yang, Shun-Chun; Tsao, Chang-Hui; Lee, Huei; Cheng, Ya-Wen; Lai, Li-Chuan; Chang, Yih-Hsin			Human Papillomavirus Up-Regulates MMP-2 and MMP-9 Expression and Activity by Inducing Interleukin-8 in Lung Adenocarcinomas	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN-MELANOMA CELLS; TUMOR ANGIOGENESIS; TYPE-16 E6; MATRIX-METALLOPROTEINASE; PROMOTES ANGIOGENESIS; MCL-1 EXPRESSION; PATIENT SURVIVAL; DOWN-REGULATION; SERUM LEVELS	Human papillomavirus (HPV) infection is associated with non-smoking female lung cancer. Our previous report demonstrated that HPV 16 promotes lung tumor cell progression by up-regulating interleukin-17 (IL-17). IL-17 and its downstream signaling mediator, interleukin-8 (IL-8), have been implicated to modulate a variety of pro-angiogenic factors and play important roles in tumor angiogenesis and metastasis. Accordingly, we hypothesized that HPV infection may potentiate tumorigenic and metastatic characteristics of the infected cells through IL-8. The goal of the present study was to determine whether HPV infection in lung adenocarcinoma cells can promote the expression of IL-8 and metalloproteinases (MMPs) to make the transformed cells equipped with angiogenic and metastatic characteristics. The expression of IL-8 and MMPs in HPV 16 E6-transfected H1299 cells was analyzed to examine the hypothesis. HPV 16 E6 up-regulates pro-angiogenic MMP-2 and MMP-9 through inducing IL-8 expression in lung cancer cells. The results indicate that, in addition to cell proliferation-related machinery, HPV infection promotes the expression and activities of angiogenic and metastatic molecules in lung adenocarcinoma cells. The cytokines induced by HPV infection may work together to confer the malignant and tumorigenic potentials on the infected cells by promoting machineries of growth, angiogenic and metastatic characteristics.	[Shiau, Ming-Yuh] Hungkuang Univ, Taichung, Taiwan; [Fan, Li-Ching] Chung Shan Med Univ, Inst Med & Mol Toxicol, Taichung, Taiwan; [Yang, Shun-Chun; Lai, Li-Chuan] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Tsao, Chang-Hui] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lee, Huei; Cheng, Ya-Wen] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Chang, Yih-Hsin] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan	Hungkuang University; Chung Shan Medical University; Chung Shan Medical University; National Defense Medical Center; Taipei Medical University; National Yang Ming Chiao Tung University	Chang, YH (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan.	cyh@ym.edu.tw			National Science Council, Taiwan, Republic of China [NSC98-2320-B-010-034-MY3, NSC101-2320-B-010-052-MY3, NSC100-2320-B-241-003]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from the National Science Council, Taiwan, Republic of China (NSC98-2320-B-010-034-MY3, NSC101-2320-B-010-052-MY3 and NSC100-2320-B-241-003). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Bequet-Romero M, 2000, BIOCHEM BIOPH RES CO, V277, P55, DOI 10.1006/bbrc.2000.3628; Chang YH, 2010, CANCER-AM CANCER SOC, V116, P4800, DOI 10.1002/cncr.25224; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Cheng YW, 2008, CLIN CANCER RES, V14, P4705, DOI 10.1158/1078-0432.CCR-07-4675; Cheng YW, 2007, CANCER RES, V67, P10686, DOI 10.1158/0008-5472.CAN-07-1461; Cheng YW, 2001, CANCER RES, V61, P2799; D'Amico Thomas A, 2004, Semin Thorac Cardiovasc Surg, V16, P13; Evander M, 1997, J VIROL, V71, P2449, DOI 10.1128/JVI.71.3.2449-2456.1997; Folkman J, 1976, Int Rev Exp Pathol, V16, P207; Garzetti GG, 1998, CANCER-AM CANCER SOC, V82, P886, DOI 10.1002/(SICI)1097-0142(19980301)82:5<886::AID-CNCR13>3.0.CO;2-X; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Herbst RS, 2005, J CLIN ONCOL, V23, P3243, DOI 10.1200/JCO.2005.18.853; Hsieh HG, 2002, CYTOKINE, V19, P159, DOI 10.1006/cyto.2002.1952; Hu MW, 2004, SURGERY, V135, P87, DOI 10.1016/S0039-6060(03)00347-7; Huang SM, 2002, J VIROL, V76, P8710, DOI 10.1128/JVI.76.17.8710-8721.2002; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Laan M, 2002, CURR PHARM DESIGN, V8, P1855, DOI 10.2174/1381612023393864; Leuenroth SJ, 2000, J LEUKOCYTE BIOL, V68, P158; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li G, 2011, CANCER LETT, V311, P160, DOI 10.1016/j.canlet.2011.07.012; Lopez-Ocejo O, 2000, ONCOGENE, V19, P4611, DOI 10.1038/sj.onc.1203817; Luca M, 1997, AM J PATHOL, V151, P1105; Masuya D, 2001, CANCER, V92, P2628, DOI 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F; Mian BM, 2003, CLIN CANCER RES, V9, P3167; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Mulayim N, 2004, FERTIL STERIL, V81, P904, DOI 10.1016/j.fertnstert.2003.11.015; Nor JE, 2001, CANCER RES, V61, P2183; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Orditura M, 2002, J INTERF CYTOK RES, V22, P1129, DOI 10.1089/10799900260442557; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Pillai MR, 2000, EXP MOL PATHOL, V69, P233, DOI 10.1006/exmp.2000.2335; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Shijubo N, 2003, MICROSC RES TECHNIQ, V60, P186, DOI 10.1002/jemt.10257; SINGH RK, 1994, CANCER RES, V54, P3242; Singh RK, 2000, EXP HEMATOL, V28, P499, DOI 10.1016/S0301-472X(00)00145-4; SMITH DR, 1994, J EXP MED, V179, P1409, DOI 10.1084/jem.179.5.1409; Smola-Hess S, 2005, J GEN VIROL, V86, P1291, DOI 10.1099/vir.0.80551-0; Tjalma WA, 2001, EUR J OBSTET GYN R B, V97, P223, DOI 10.1016/S0301-2115(00)00541-8; Toussaint-Smith E, 2004, ONCOGENE, V23, P2988, DOI 10.1038/sj.onc.1207442; UEDA T, 1994, J GASTROENTEROL, V29, P423, DOI 10.1007/BF02361238; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Wang JY, 1996, J INTERF CYTOK RES, V16, P53, DOI 10.1089/jir.1996.16.53; Yuan A, 2000, AM J RESP CRIT CARE, V162, P1957, DOI 10.1164/ajrccm.162.5.2002108; Zhu YM, 2004, BRIT J CANCER, V91, P1970, DOI 10.1038/sj.bjc.6602227	47	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54423	10.1371/journal.pone.0054423	http://dx.doi.org/10.1371/journal.pone.0054423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349885	Green Published, Green Submitted, gold			2022-12-27	WOS:000313943000036
J	Bennett, VA; Doerr, VAJ; Doerr, ED; Manning, AD; Lindenmayer, DB; Yoon, HJ				Bennett, Victoria A.; Doerr, Veronica A. J.; Doerr, Erik D.; Manning, Adrian D.; Lindenmayer, David B.; Yoon, Hwan-Jin			Habitat Selection and Behaviour of a Reintroduced Passerine: Linking Experimental Restoration, Behaviour and Habitat Ecology	PLOS ONE			English	Article							SOUTH-EASTERN AUSTRALIA; BROWN TREECREEPER; TEMPERATE WOODLANDS; FORAGING BEHAVIOR; EXPERIMENTAL MANIPULATION; EUCALYPT WOODLANDS; ANIMAL BEHAVIOR; MULLIGANS FLAT; BIRDS; TRANSLOCATION	Habitat restoration can play an important role in recovering functioning ecosystems and improving biodiversity. Restoration may be particularly important in improving habitat prior to species reintroductions. We reintroduced seven brown treecreeper (Climacteris picumnus) social groups into two nature reserves in the Australian Capital Territory in south-eastern Australia. This study provided a unique opportunity to understand the interactions between restoration ecology, behavioural ecology and habitat ecology. We examined how experimental restoration treatments (addition of coarse woody debris, variations in ground vegetation cover and nest box installation) influenced the behaviour and microhabitat use of radio-tracked individuals to evaluate the success of restoration treatments. The addition of coarse woody debris benefited the brown treecreeper through increasing the probability of foraging on a log or on the ground. This demonstrated the value of using behaviour as a bio-indicator for restoration success. Based on previous research, we predicted that variations in levels of ground vegetation cover would influence behaviour and substrate use, particularly that brown treecreepers would choose sites with sparse ground cover because this allows better access to food and better vigilance for predators. However, there was little effect of this treatment, which was likely influenced by the limited overall use of the ground layer. There was also little effect of nest boxes on behaviour or substrate use. These results somewhat confound our understanding of the species based on research from extant populations. Our results also have a significant impact regarding using existing knowledge on a species to inform how it will respond to reintroduction and habitat restoration. This study also places great emphasis on the value of applying an experimental framework to ecological restoration, particularly when reintroductions produce unexpected outcomes.	[Bennett, Victoria A.; Manning, Adrian D.; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & soc, Canberra, ACT, Australia; [Doerr, Veronica A. J.; Doerr, Erik D.] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Canberra, ACT, Australia; [Doerr, Veronica A. J.; Doerr, Erik D.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Yoon, Hwan-Jin] Australian Natl Univ, Sch Math Sci, Stat Consulting Unit, Canberra, ACT, Australia	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Australian National University	Bennett, VA (corresponding author), Australian Natl Univ, Fenner Sch Environm & soc, Canberra, ACT, Australia.	victoria.bennett325@gmail.com	Manning, Adrian/AAG-2949-2019; Manning, Adrian/AAX-7288-2021; Lindenmayer, David B/P-7183-2017; Doerr, Erik/A-9797-2011; Doerr, Veronica/A-2150-2011	Manning, Adrian/0000-0003-0989-9203; Lindenmayer, David B/0000-0002-4766-4088; Doerr, Erik/0000-0003-4511-9972; Doerr, Veronica/0000-0003-4330-4576; Yoon, Hwan-Jin/0000-0003-1772-7911	Birding NSW; Birdlife Australia - Stuart Leslie Bird Research Award; Canberra Ornithologists Group, Canberra Birds Conservation Fund; Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University; Fenner School of Environment and Society at The Australian National University; Foundation for National Parks and Wildlife; Gould League of NSW Centenary Year Cayley Memorial Scholarship; Mulligans Flat-Goorooyarroo Woodland Experiment (ARC) [LP0561817]; Norman Wettenhall Foundation [20108002]; Conservation and Landscape Ecology Group; Mulligans Flat-Goorooyarroo Woodland Experiment	Birding NSW; Birdlife Australia - Stuart Leslie Bird Research Award; Canberra Ornithologists Group, Canberra Birds Conservation Fund; Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University; Fenner School of Environment and Society at The Australian National University; Foundation for National Parks and Wildlife; Gould League of NSW Centenary Year Cayley Memorial Scholarship; Mulligans Flat-Goorooyarroo Woodland Experiment (ARC); Norman Wettenhall Foundation; Conservation and Landscape Ecology Group; Mulligans Flat-Goorooyarroo Woodland Experiment	The project has been made possible by funding from Birding NSW (www.birdingnsw.org.au), Birdlife Australia - Stuart Leslie Bird Research Award (www.birdlife.org.au), Canberra Ornithologists Group, Canberra Birds Conservation Fund (www.canberrabirds.org.au), the Conservation and Landscape Ecology Group within the Fenner School of Environment and Society at The Australian National University (http://fennerschool-research.anu.edu.au/cle/), the Fenner School of Environment and Society at The Australian National University (http://fennerschool.anu.edu.au/), the Foundation for National Parks and Wildlife (www.fnpw.org.au), Gould League of NSW 2010 Centenary Year Cayley Memorial Scholarship (www.gould.edu.au), the Mulligans Flat-Goorooyarroo Woodland Experiment (ARC Linkage Project LP0561817) (http://www.mfgowoodlandexperiment.org.au/), and the Norman Wettenhall Foundation (reference 20108002) (www.nwf.org.au). In-kind contribution was greatly appreciated from CSIRO Ecosystem Sciences (http://www.csiro.au/Organisation-Structure/Divisions/Ecosystem-Sciences.aspx) and The Parks and Conservation Service within the Australian Capital Territory Government Department of Territory and Municipal Services (http://www.tams.act.gov.au/parks-recreation). One field assistant was employed (Jenny Newport) using funds from Conservation and Landscape Ecology Group and the Mulligans Flat-Goorooyarroo Woodland Experiment to assist in collecting data obtained through radio-tracking reintroduced brown treecreepers. Otherwise, individuals that were employed or contracted by the funders (other than the named authors) did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos MJ, 2008, EMU, V108, P201, DOI 10.1071/MU08005; Antos MJ, 2006, EMU, V106, P29, DOI 10.1071/MU05039; Barton PS, 2011, J APPL ECOL, V48, P943, DOI 10.1111/j.1365-2664.2011.01994.x; Bennett VA, AUSTRAL ECO IN PRESS; Bennett VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050612; Bennett VA, 2012, EMU, V112, P298, DOI 10.1071/MU11048; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BRIGHT PW, 1994, J APPL ECOL, V31, P699, DOI 10.2307/2404160; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butler H, 2005, WILDLIFE RES, V32, P157, DOI 10.1071/WR04027; Butler SJ, 2005, ANIM BEHAV, V69, P337, DOI 10.1016/j.anbehav.2004.06.006; Cabezas S, 2011, ANIMAL CONSERVATION; Cooper CB, 2002, ECOL APPL, V12, P1576, DOI 10.1890/1051-0761(2002)012[1576:LPADSS]2.0.CO;2; Cooper CB, 2002, BIOL CONSERV, V105, P1, DOI 10.1016/S0006-3207(01)00172-0; Cooper CB, 2002, CONSERV BIOL, V16, P471, DOI 10.1046/j.1523-1739.2002.00346.x; Doerr ED, 2007, J ANIM ECOL, V76, P966, DOI 10.1111/j.1365-2656.2007.01280.x; Doerr ED, 2006, ANIM BEHAV, V72, P147, DOI 10.1016/j.anbehav.2005.10.017; Doerr VAJ, 2006, EMU, V106, P93, DOI 10.1071/MU05020; Doerr Veronica A. J., 2002, Corella, V26, P19; Doerr VAJ, 2011, EMU, V111, P71, DOI 10.1071/MU09118; Evans AM, 2003, FOREST ECOL MANAG, V184, P251, DOI 10.1016/S0378-1127(03)00158-0; Ewen JG, 2007, ECOSCIENCE, V14, P401, DOI 10.2980/1195-6860(2007)14[401:SMORIE]2.0.CO;2; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Ford HA, 2011, EMU, V111, P1, DOI 10.1071/MU09115; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Gilroy JJ, 2008, BIOL CONSERV, V141, P3116, DOI 10.1016/j.biocon.2008.09.019; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Higgins P.J., 2001, HDB AUSTR NZ ANTARCT; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; Holl KD, 2003, BIOSCIENCE, V53, P491, DOI 10.1641/0006-3568(2003)053[0491:LRMFGT]2.0.CO;2; IUCN, 1998, IUCN GUID REINTR; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Lindell CA, 2008, RESTOR ECOL, V16, P197, DOI 10.1111/j.1526-100X.2008.00389.x; Lindenmayer David, 2010, Ecological Management & Restoration, V11, P201, DOI 10.1111/j.1442-8903.2010.00550.x; Luck GW, 2002, AUSTRAL ECOL, V27, P229, DOI 10.1046/j.1442-9993.2002.01173.x; Mac Nally R, 2006, FOREST ECOL MANAG, V229, P155, DOI 10.1016/j.foreco.2006.03.024; Mac Nally R, 2007, J ANIM ECOL, V76, P643, DOI 10.1111/j.1365-2656.2007.01247.x; Manning A.D., 2011, Australian Zoologist, V35, P633; Maron M, 2005, BIOL CONSERV, V124, P439, DOI 10.1016/j.biocon.2005.02.002; McCullagh P, 1989, GEN LINEAR MODELS; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McIntyre S., 2010, Cunninghamia, V11, P319; Montague-Drake RM, 2009, BIOL CONSERV, V142, P2896, DOI 10.1016/j.biocon.2009.07.009; Morris AJ, 2001, BIOL CONSERV, V101, P197, DOI 10.1016/S0006-3207(01)00067-2; Morrison EB, 2010, J APPL ECOL, V47, P130, DOI 10.1111/j.1365-2664.2009.01743.x; NOSKE RA, 1991, EMU, V91, P73, DOI 10.1071/MU9910073; Noske RA, 1982, COMP BEHAV ECOLOGY S; Ortega-Alvarez Ruben, 2012, Ecological Restoration, V30, P116, DOI 10.3368/er.30.2.116; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinter-Wollman N, 2009, BIOL CONSERV, V142, P1116, DOI 10.1016/j.biocon.2009.01.027; Pomara LY, 2003, AUK, V120, P1000, DOI 10.1642/0004-8038(2003)120[1000:MFAFBO]2.0.CO;2; Prober SM, 2002, AUST J BOT, V50, P687, DOI 10.1071/BT02043; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Richards JD, 2003, BIOL CONSERV, V109, P181, DOI 10.1016/S0006-3207(02)00140-4; Riffell S, 2011, FOREST ECOL MANAG, V261, P878, DOI 10.1016/j.foreco.2010.12.021; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; SCANLAN JC, 1990, AUST J ECOL, V15, P191, DOI 10.1111/j.1442-9993.1990.tb01527.x; Sheean VA, 2012, AUSTRAL ECOL, V37, P204, DOI 10.1111/j.1442-9993.2011.02264.x; Shorthouse David J., 2012, Ecological Management & Restoration, V13, P112, DOI 10.1111/j.1442-8903.2012.00654.x; SPECHT RL, 1981, AUST J ECOL, V6, P193, DOI 10.1111/j.1442-9993.1981.tb01290.x; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stokes VL, 2004, BIOL CONSERV, V117, P331, DOI 10.1016/j.biocon.2003.12.012; Unck CE, 2009, ANIM BEHAV, V78, P625, DOI 10.1016/j.anbehav.2009.05.028; Van Zant JL, 2003, BIOL CONSERV, V112, P405, DOI 10.1016/S0006-3207(02)00338-5; WALKER J, 1986, AUST J ECOL, V11, P135, DOI 10.1111/j.1442-9993.1986.tb01384.x; Walters JR, 1999, BIOL CONSERV, V90, P13, DOI 10.1016/S0006-3207(99)00016-6; Watson DM, 2011, EMU, V111, P10, DOI 10.1071/MU09109; Whittingham MJ, 2008, BASIC APPL ECOL, V9, P779, DOI 10.1016/j.baae.2007.08.002; Yates CJ, 1997, AUST J BOT, V45, P949, DOI 10.1071/BT96091	71	10	11	4	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54539	10.1371/journal.pone.0054539	http://dx.doi.org/10.1371/journal.pone.0054539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349923	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800062
J	Guardia, D; Carey, A; Cottencin, O; Thomas, P; Luyat, M				Guardia, Dewi; Carey, Aurelie; Cottencin, Olivier; Thomas, Pierre; Luyat, Marion			Disruption of Spatial Task Performance in Anorexia Nervosa	PLOS ONE			English	Article							BODY-IMAGE; HAPTIC PERCEPTION; EATING-DISORDERS; ORIENTATION; TILT; REPRESENTATIONS; LOCALIZATION; INFORMATION; AWARENESS; TACTILE	In anorexia nervosa (AN), body distortions have been associated with parietal cortex (PC) dysfunction. The PC is the anatomical substrate for a supramodal reference framework involved in spatial orientation constancy. Here, we sought to evaluate spatial orientation constancy and the perception of body orientation in AN patients. In the present study, we investigated the effect of passive lateral body inclination on the visual and tactile subjective vertical (SV) and body Z-axis in 25 AN patients and 25 healthy controls. Subjects performed visual-and tactile-spatial judgments of axis orientations in an upright position and tilted 90 degrees clockwise or counterclockwise. We observed a significant deviation of the tactile and visual SV towards the body (an A-effect) under tilted conditions, suggesting a multisensory impairment in spatial orientation. Deviation of the Z-axis in the direction of the tilt was also observed in the AN group. The greater A-effect in AN patients may reflect reduced interoceptive awareness and thus inadequate consideration of gravitational inflow. Furthermore, marked body weight loss could decrease the somatosensory inputs required for spatial orientation. Our study results suggest that spatial references are impaired in AN. This may be due to particular integration of visual, tactile and gravitational information (e. g. vestibular and proprioceptive cues) in the PC.	[Guardia, Dewi; Cottencin, Olivier; Thomas, Pierre; Luyat, Marion] Univ Lille N France, EA 4559, Lab Neurosci Fonct & Pathol, Lille, France; [Guardia, Dewi; Carey, Aurelie; Cottencin, Olivier; Luyat, Marion] CHRU Lille, Hop Calmette, Serv Addictol, Lille, France; [Thomas, Pierre] CHRU Lille, Hop Fontan, Serv Psychiat, Lille, France; [Luyat, Marion] Univ Lille 3, UFR Psychol, Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Guardia, D (corresponding author), Univ Lille N France, EA 4559, Lab Neurosci Fonct & Pathol, Lille, France.	dewi.guardia@chru-lille.fr	COTTENCIN, Olivier OC/I-4024-2015; Luyat, Marion/HIR-3502-2022	COTTENCIN, Olivier OC/0000-0003-3663-1405; Luyat, Marion/0000-0002-5640-5002				Adenzato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044414; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anastasopoulos D, 1999, ANN NY ACAD SCI, V871, P379, DOI 10.1111/j.1749-6632.1999.tb09199.x; Barra J, 2012, NEUROPSYCHOLOGIA, V50, P2492, DOI 10.1016/j.neuropsychologia.2012.06.021; BAUERMEISTER M, 1964, J EXP PSYCHOL, V67, P142, DOI 10.1037/h0046424; BAUERMEISTER M, 1964, AM J PSYCHOL, V77, P451, DOI 10.2307/1421016; Bortolami SB, 2006, EXP BRAIN RES, V173, P364, DOI 10.1007/s00221-006-0385-y; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Case LK, 2012, EXP BRAIN RES, V217, P79, DOI 10.1007/s00221-011-2974-7; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Ceyte H, 2007, EXP BRAIN RES, V176, P504, DOI 10.1007/s00221-006-0764-4; Ceyte H, 2009, NEUROSCI LETT, V462, P85, DOI 10.1016/j.neulet.2009.06.048; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Colby CL, 1996, COGNITIVE BRAIN RES, V5, P105, DOI 10.1016/S0926-6410(96)00046-8; Daprati E, 2010, NEUROPSYCHOLOGIA, V48, P756, DOI 10.1016/j.neuropsychologia.2009.10.008; de Vignemont F, 2008, Q J EXP PSYCHOL, V61, P90, DOI 10.1080/17470210701508764; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Exterkate CC, 2009, EAT BEHAV, V10, P16, DOI 10.1016/j.eatbeh.2008.10.002; Farrell C, 2005, EUR EAT DISORD REV, V13, P75, DOI 10.1002/erv.622; Franko DL, 2002, J PSYCHOSOM RES, V53, P975, DOI 10.1016/S0022-3999(02)00490-7; Frith U, 2005, CONSCIOUS COGN, V14, P719, DOI 10.1016/j.concog.2005.04.006; Funk J, 2010, NEUROPSYCHOLOGIA, V48, P1616, DOI 10.1016/j.neuropsychologia.2010.01.029; Gallagher S., 2005, BODY SHAPES MIND; Garner D. M., 1991, EDI 2 EATING DISORDE; Gentaz E, 2008, EXP BRAIN RES, V187, P331, DOI 10.1007/s00221-008-1382-0; Graziano Michael S. A., 1995, P1021; Grunwald M, 2004, J CLIN EXP NEUROPSYC, V26, P608, DOI 10.1080/13803390490504407; Grunwald M, 2002, ARCH CLIN NEUROPSYCH, V17, P485, DOI 10.1016/S0887-6177(01)00131-7; Grunwald M, 2001, J CLIN EXP NEUROPSYC, V23, P520, DOI 10.1076/jcen.23.4.520.1229; Guardia D, 2012, PLOS ONE IN PRESS; Guardia D, 2012, PSYCHIAT RES, V195, P56, DOI 10.1016/j.psychres.2011.08.003; Guardia D, 2010, NEUROPSYCHOLOGIA, V48, P3961, DOI 10.1016/j.neuropsychologia.2010.09.004; HEILBRUN AB, 1990, J CLIN PSYCHOL, V46, P398, DOI 10.1002/1097-4679(199007)46:4<398::AID-JCLP2270460404>3.0.CO;2-5; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Keizer A, 2011, PSYCHIAT RES, V190, P115, DOI 10.1016/j.psychres.2011.04.031; Kerkhoff G, 1999, NEUROPSYCHOLOGIA, V37, P1387, DOI 10.1016/S0028-3932(99)00031-7; Kinsbourne M., 1984, PSYCHOBIOLOGY AFFECT, P259; Luyat M, 2001, PERCEPT PSYCHOPHYS, V63, P541, DOI 10.3758/BF03194419; Luyat M, 2002, J EXP PSYCHOL HUMAN, V28, P1002, DOI 10.1037//0096-1523.28.4.1002; Luyat M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-28; McAdams CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P54, DOI 10.1016/j.pscychresns.2011.06.016; Mittelstaedt H, 1996, BIOL PSYCHOL, V42, P53, DOI 10.1016/0301-0511(95)05146-5; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Mittelstaedt H, 1997, J VESTIBUL RES-EQUIL, V7, P283, DOI 10.1016/S0957-4271(97)00027-X; Nico D, 2010, PSYCHOL MED, V40, P1531, DOI 10.1017/S0033291709991851; Nico D, 2009, BRAIN COGNITION, V69, P227, DOI 10.1016/j.bandc.2008.07.011; Oldershaw A, 2010, PSYCHOSOM MED, V72, P73, DOI 10.1097/PSY.0b013e3181c6c7ca; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paillard J., 1999, MOTOR CONTROL TODAY, P197, DOI DOI 10.1016/J.NEUROPSYCHOLOGIA.2009.09.022; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Roberts ME, 2010, J PSYCHIATR RES, V44, P964, DOI 10.1016/j.jpsychires.2010.03.001; Russell TA, 2009, PSYCHIAT RES, V168, P181, DOI 10.1016/j.psychres.2008.10.028; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Santonastaso P, 2009, INT J EAT DISORDER, V42, P464, DOI 10.1002/eat.20706; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; Tchanturia K, 2004, J INT NEUROPSYCH SOC, V10, P513, DOI 10.1017/S1355617704104086; Tchanturia K, 2001, J BEHAV THER EXP PSY, V32, P107, DOI 10.1016/S0005-7916(01)00025-8; Tomasino SJ, 1996, J NERV MENT DIS, V184, P758, DOI 10.1097/00005053-199612000-00007; Trousselard M, 2004, COGNITIVE BRAIN RES, V20, P355, DOI 10.1016/j.cogbrainres.2004.03.008; Wagner A, 2003, NEUROREPORT, V14, P2193, DOI 10.1097/00001756-200312020-00012	66	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54928	10.1371/journal.pone.0054928	http://dx.doi.org/10.1371/journal.pone.0054928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GQ	23349990	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800080
J	Trognitz, B; Cros, E; Assemat, S; Davrieux, F; Forestier-Chiron, N; Ayestas, E; Kuant, A; Scheldeman, X; Hermann, M				Trognitz, Bodo; Cros, Emile; Assemat, Sophie; Davrieux, Fabrice; Forestier-Chiron, Nelly; Ayestas, Eusebio; Kuant, Aldo; Scheldeman, Xavier; Hermann, Michael			Diversity of Cacao Trees in Waslala, Nicaragua: Associations between Genotype Spectra, Product Quality and Yield Potential	PLOS ONE			English	Article							THEOBROMA-CACAO	The sensory quality and the contents of quality-determining chemical compounds in unfermented and fermented cocoa from 100 cacao trees (individual genotypes) representing groups of nine genotype spectra (GG), grown at smallholder plantings in the municipality of Waslala, Nicaragua, were evaluated for two successive harvest periods. Cocoa samples were fermented using a technique mimicking recommended on-farm practices. The sensory cocoa quality was assessed by experienced tasters, and seven major chemical taste compounds were quantified by near infrared spectrometry (NIRS). The association of the nine, partially admixed, genotype spectra with the analytical and sensory quality parameters was tested. The individual parameters were analyzed as a function of the factors GG and harvest (including the date of fermentation), individual trees within a single GG were used as replications. In fermented cocoa, significant GG-specific differences were observed for methylxanthines, theobromine-to-caffeine (T/C) ratio, total fat, procyanidin B5 and epicatechin, as well as the sensory attributes global score, astringency, and dry fruit aroma, but differences related to harvest were also apparent. The potential cocoa yield was also highly determined by the individual GG, although there was significant tree-to-tree variation within every single GG. Non-fermented samples showed large harvest-to-harvest variation of their chemical composition, while differences between GG were insignificant. These results suggest that selection by the genetic background, represented here by groups of partially admixed genotype spectra, would be a useful strategy toward enhancing quality and yield of cocoa in Nicaragua. Selection by the GG within the local, genetically segregating populations of seed-propagated cacao, followed by clonal propagation of best-performing individuals of the selected GG could be a viable alternative to traditional propagation of cacao by seed from open pollination. Fast and gentle air-drying of the fermented beans and their permanent dry storage were an efficient and comparatively easy precondition for high cocoa quality.	[Trognitz, Bodo] AIT Austrian Inst Technol, Dept Hlth & Environm, Tulln, Austria; [Trognitz, Bodo] CSF Campus Sci Support Facil, Plant Growth & Phenotyping Facil, Vienna, Austria; [Cros, Emile; Assemat, Sophie; Davrieux, Fabrice; Forestier-Chiron, Nelly] CIRAD Ctr Cooperat Int Rech Agron Dev, Dept Persyst Performances Syst Prod & Transformat, Montpellier, France; [Ayestas, Eusebio] Univ Nacl Agr, Fac Agron, Managua, Nicaragua; [Kuant, Aldo] Pro Mundo Humano, Waslala, Nicaragua; [Scheldeman, Xavier; Hermann, Michael] Biovers Int, Reg Off Amer, Cali, Colombia; [Hermann, Michael] Crops Future, Serdang, Malaysia	CIRAD; Alliance; Bioversity International	Trognitz, B (corresponding author), AIT Austrian Inst Technol, Dept Hlth & Environm, Tulln, Austria.	bodo.trognitz@ait.ac.at	Scheldeman, Xavier/ABE-9909-2021; Scheldeman, Xavier/AAF-7960-2021	Scheldeman, Xavier/0000-0001-7967-7361; 	Austrian Development Agency, ADA [2006/05]; Bioversity International; Austrian Institute of Technology, AIT [1.U4.00077]	Austrian Development Agency, ADA; Bioversity International; Austrian Institute of Technology, AIT	This study was conducted in the framework of a research and development project entitled "Sustainable futures for indigenous smallholders in Nicaragua: harnessing the high value potential of native cacao diversity" funded by the Austrian Development Agency, ADA (http://www.entwicklung.at/en/), Project reference No. 2006/05, Bioversity International (www.bioversityinternational.org), and the Austrian Institute of Technology, AIT (1.U4.00077) (http://www.ait.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publication content is solely the responsibility of the authors and does not necessarily represent the official views of ADA, Bioversity or AIT. The project aims at assisting farmers in Waslala to make a gradual transition from their current production of only average-quality cocoa to the production of differentiated high-value cocoa based on the improved use of cacao biodiversity, choice of locality and appropriate post-harvest procedures.	BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Bonvehi JS, 2000, EUR FOOD RES TECHNOL, V210, P189; CLAPPERTON J, 1994, TROP AGR, V71, P303; Clapperton J. F., 1994, Cocoa Growers' Bulletin, P47; Davrieux F, 2007, P 12 INT C NEAR INFR, P382; Elwers S., 2008, THESIS; Elwers S, 2010, J APPL BOT FOOD QUAL, V83, P182; Figueira A, 1997, TROP AGR, V74, P132; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT, P15; Robbins RJ, 2012, J AOAC INT, V95, P1153, DOI 10.5740/jaoacint.12-162; SAS Institute Inc, 1989, SAS STAT USERS GUIDE; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Stark T, 2006, J AGR FOOD CHEM, V54, P5530, DOI 10.1021/jf0608726; Trognitz B, 2012, PLOS ONE; Trognitz B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016056; Wintgens JN, 1992, 2ND INTL CONGR COCOA; Wood GAR, 1985, TROPICAL AGRICULTURE; YOUNG AM, 1994, THE CHOCOLATE TREE A	20	25	25	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54079	10.1371/journal.pone.0054079	http://dx.doi.org/10.1371/journal.pone.0054079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349790	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800024
J	Hayes, S; Kamma-Lorger, CS; Boote, C; Young, RD; Quantock, AJ; Rost, A; Khatib, Y; Harris, J; Yagi, N; Terrill, N; Meek, KM				Hayes, Sally; Kamma-Lorger, Christina S.; Boote, Craig; Young, Robert D.; Quantock, Andrew J.; Rost, Anika; Khatib, Yasmeen; Harris, Jonathan; Yagi, Naoto; Terrill, Nicholas; Meek, Keith M.			The Effect of Riboflavin/UVA Collagen Cross-linking Therapy on the Structure and Hydrodynamic Behaviour of the Ungulate and Rabbit Corneal Stroma	PLOS ONE			English	Article							X-RAY-DIFFRACTION; ULTRAVIOLET-A; FIBRILS; PROTEOGLYCANS; TRANSPARENCY; PRESERVATION; SCATTERING; GLYCATION; KERATITIS; HYDRATION	Purpose: To examine the effect of riboflavin/UVA corneal crosslinking on stromal ultrastructure and hydrodynamic behaviour. Methods: One hundred and seventeen enucleated ungulate eyes (112 pig and 5 sheep) and 3 pairs of rabbit eyes, with corneal epithelium removed, were divided into four treatment groups: Group 1 (28 pig, 2 sheep and 3 rabbits) were untreated; Group 2 (24 pig) were exposed to UVA light (3.04 mW/cm(2)) for 30 minutes and Group 3 (29 pig) and Group 4 (31 pig, 3 sheep and 3 rabbits) had riboflavin eye drops applied to the corneal surface every 5 minutes for 35 minutes. Five minutes after the initial riboflavin instillation, the corneas in Group 4 experienced a 30 minute exposure to UVA light (3.04 mW/cm(2)). X-ray scattering was used to obtain measurements of collagen interfibrillar spacing, spatial order, fibril diameter, D-periodicity and intermolecular spacing throughout the whole tissue thickness and as a function of tissue depth in the treated and untreated corneas. The effect of each treatment on the hydrodynamic behaviour of the cornea (its ability to swell in saline solution) and its resistance to enzymatic digestion were assessed using in vitro laboratory techniques. Results: Corneal thickness decreased significantly following riboflavin application (p<0.01) and also to a lesser extent after UVA exposure (p<0.05). With the exception of the spatial order factor, which was higher in Group 4 than Group 1 (p<0.01), all other measured collagen parameters were unaltered by cross-linking, even within the most anterior 300 microns of the cornea. The cross-linking treatment had no effect on the hydrodynamic behaviour of the cornea but did cause a significant increase in its resistance to enzymatic digestion. Conclusions: It seems likely that cross-links formed during riboflavin/UVA therapy occur predominantly at the collagen fibril surface and in the protein network surrounding the collagen.	[Hayes, Sally; Kamma-Lorger, Christina S.; Boote, Craig; Young, Robert D.; Quantock, Andrew J.; Rost, Anika; Khatib, Yasmeen; Harris, Jonathan; Meek, Keith M.] Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF10 3AX, S Glam, Wales; [Yagi, Naoto] Japan Synchrotron Radiat Res Inst, Kobe, Hyogo, Japan; [Terrill, Nicholas] Diamond Light Source, Didcot, Oxon, England	Cardiff University; Japan Synchrotron Radiation Research Institute; Diamond Light Source	Meek, KM (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF10 3AX, S Glam, Wales.	meekkm@cf.ac.uk	Terrill, Nick J/D-2639-2017	Terrill, Nick J/0000-0002-8783-1282; Young, Robert D./0000-0002-1452-6682; Hayes, Sally/0000-0001-8550-0108; Boote, Craig/0000-0003-0348-6547	5-year Medical Research Council Grant [G06007]; Science and Technology Facilities Council Grant [SM-1536]; MRC [MR/K000837/1, G0600755] Funding Source: UKRI; Medical Research Council [G0600755, MR/K000837/1] Funding Source: researchfish	5-year Medical Research Council Grant; Science and Technology Facilities Council Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a 5-year Medical Research Council Grant (G0600755) and a Science and Technology Facilities Council Grant (SM-1536). Keith Meek is a Royal Society-Wolfson Research Merit Award Holder. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Blanco T, 2008, ARVO FORT LAUDERDALE, P3911; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Bottos KM, 2010, CORNEA, V29, P789, DOI 10.1097/ICO.0b013e3181bd9f12; Brummer G, 2011, INVEST OPHTH VIS SCI, V52, P6363, DOI 10.1167/iovs.11-7585; CRAIG AS, 1981, J ULTRA MOL STRUCT R, V74, P232, DOI 10.1016/S0022-5320(81)80081-0; CRAIG AS, 1986, J ULTRA MOL STRUCT R, V96, P172, DOI 10.1016/0889-1605(86)90018-2; Faber C, 2008, SCAND J LAB ANIM SCI, V35, P39; FRATZL P, 1993, BIOPHYS J, V64, P1210, DOI 10.1016/S0006-3495(93)81487-5; FULLWOOD NJ, 1993, J MICROSC-OXFORD, V169, P53, DOI 10.1111/j.1365-2818.1993.tb03277.x; FULLWOOD NJ, 1994, J MOL BIOL, V236, P749, DOI 10.1006/jmbi.1994.1187; Ghanem RC, 2010, J CATARACT REFR SURG, V36, P273, DOI 10.1016/j.jcrs.2009.07.041; Gharaee H, 2011, MIDDLE EAST AFR J OP, V18, P58, DOI 10.4103/0974-9233.75889; HART RW, 1969, J OPT SOC AM, V59, P766, DOI 10.1364/JOSA.59.000766; Hayes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022405; Iseli HP, 2008, CORNEA, V27, P590, DOI 10.1097/ICO.0b013e318169d698; KIKKAWA Y, 1970, INVEST OPHTH VISUAL, V9, P735; Krueger RR, 2008, J REFRACT SURG, V24, pS730, DOI 10.3928/1081597X-20080901-17; LEE D, 1981, CURR EYE RES, V1, P457, DOI 10.3109/02713688109019986; Lewis PN, 2010, STRUCTURE, V18, P239, DOI 10.1016/j.str.2009.11.013; Makdoumi K, 2012, GRAEF ARCH CLIN EXP, V250, P95, DOI 10.1007/s00417-011-1754-1; Malik NS, 1996, AGE AGEING, V25, P279, DOI 10.1093/ageing/25.4.279; MALIK NS, 1992, BIOCHIM BIOPHYS ACTA, V1138, P222, DOI 10.1016/0925-4439(92)90041-K; MALIK NS, 1994, BIOCHEM BIOPH RES CO, V199, P683, DOI 10.1006/bbrc.1994.1282; MAROUDAS A, 1991, BIOCHIM BIOPHYS ACTA, V1073, P285, DOI 10.1016/0304-4165(91)90133-2; MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758; MEEK KM, 1991, BIOPHYS J, V60, P467, DOI 10.1016/S0006-3495(91)82073-2; Meek KM, 2001, PROG RETIN EYE RES, V20, P95, DOI 10.1016/S1350-9462(00)00016-1; Meek KM, 2008, ARVO FORT LAUDERDALE, P3913; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; Rahman I, 2009, EYE, V23, P1288, DOI 10.1038/eye.2008.305; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; RAWE IM, 1994, BIOPHYS J, V67, P1743, DOI 10.1016/S0006-3495(94)80648-4; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; SCOTT JE, 1992, J ANAT, V180, P155; Seiler T, 2006, CORNEA, V25, P1057, DOI 10.1097/01.ico.0000225720.38748.58; SLACK JW, 1992, CORNEA, V11, P204; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Spoerl E, 2004, OPHTHALMOLOGICA, V218, P136, DOI 10.1159/000076150; Spoerl E, 2012, FORT LAUDER IN PRESS; TWERSKY V, 1975, J OPT SOC AM, V65, P524, DOI 10.1364/JOSA.65.000524; VANHORN DL, 1975, ARCH OPHTHALMOL-CHIC, V93, P275, DOI 10.1001/archopht.1975.01010020285007; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2004, CORNEA, V23, P43, DOI 10.1097/00003226-200401000-00008; Wollensak G, 2011, BRIT J OPHTHALMOL, V95, P876, DOI 10.1136/bjo.2010.190843; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2007, J CATARACT REFR SURG, V33, P516, DOI 10.1016/j.jcrs.2006.11.015; Wollensak G, 2009, OPHTHALMIC RES, V41, P114, DOI 10.1159/000187630; WORTHINGTON CR, 1985, INT J BIOL MACROMOL, V7, P2, DOI 10.1016/0141-8130(85)90057-1; Zhang YT, 2011, J BIOL CHEM, V286, P13011, DOI 10.1074/jbc.M110.169813	51	120	124	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e52860	10.1371/journal.pone.0052860	http://dx.doi.org/10.1371/journal.pone.0052860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349690	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000313738900006
J	Ling, H; Roux, E; Hempel, D; Tao, JZ; Smith, M; Lonning, S; Zuk, A; Arbeeny, C; Ledbetter, S				Ling, Hong; Roux, Eric; Hempel, Donna; Tao, Jingzang; Smith, Mandy; Lonning, Scott; Zuk, Anna; Arbeeny, Cynthia; Ledbetter, Steve			Transforming Growth Factor beta Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; BILE-DUCT LIGATION; TGF-BETA; LIVER FIBROSIS; STELLATE CELL; II RECEPTOR; CIRRHOSIS; INJURY; REVERSIBILITY; PATHWAYS	Considerable evidence has demonstrated that transforming growth factor beta (TGF-beta) plays a key role in hepatic fibrosis, the final common pathway for a variety of chronic liver diseases leading to liver insufficiency. Although a few studies have reported that blocking TGF-beta with soluble receptors or siRNA can prevent the progression of hepatic fibrosis, as yet no evidence has been provided that TGF-beta antagonism can improve pre-existing hepatic fibrosis. The aim of this study was to examine the effects of a murine neutralizing TGF-beta monoclonal antibody (1D11), in a rat model of thioacetamide (TAA)-induced hepatic fibrosis. TAA administration for 8 weeks induced extensive hepatic fibrosis, whereupon 1D11 dosing was initiated and maintained for 8 additional weeks. Comparing the extent of fibrosis at two time points, pre- and post-1D11 dosing, we observed a profound regression of tissue injury and fibrosis upon treatment, as reflected by a reduction of collagen deposition to a level significantly less than that observed before 1D11 dosing. Hepatic TGF-beta 1 mRNA, tissue hydroxyproline, and plasminogen activator inhibitor 1 (PAI-1) levels were significantly elevated at the end of the 8 week TAA treatment. Vehicle and antibody control groups demonstrated progressive injury through 16 weeks, whereas those animals treated for 8 weeks with 1D11 showed striking improvement in histologic and molecular endpoints. During the course of tissue injury, TAA also induced cholangiocarcinomas. At the end of study, the number and area of cholangiocarcinomas were significantly diminished in rats receiving 1D11 as compared to control groups, presumably by the marked reduction of supporting fibrosis/stroma. The present study demonstrates that 1D11 can reverse pre- existing hepatic fibrosis induced by extended dosing of TAA. The regression of fibrosis was accompanied by a marked reduction in concomitantly developed cholangiocarcinomas. These data provide evidence that therapeutic dosing of a TGF-beta antagonist can diminish and potentially reverse hepatic fibrosis and also reduce the number and size of attendant cholangiocarcinomas.	[Ling, Hong; Roux, Eric; Hempel, Donna; Tao, Jingzang; Smith, Mandy; Lonning, Scott; Zuk, Anna; Arbeeny, Cynthia; Ledbetter, Steve] Sanofi Genzyme R&D Ctr, Framingham, MA USA	Sanofi-Aventis; Genzyme Corporation	Ling, H (corresponding author), Sanofi Genzyme R&D Ctr, Framingham, MA USA.	Hong.ling@genzyme.com						Al-Bader A, 2000, MOL CELL BIOCHEM, V208, P1, DOI 10.1023/A:1007082515548; Arteel GE, 2008, J GASTROEN HEPATOL, V23, pS54, DOI 10.1111/j.1440-1746.2007.05285.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bergheim I, 2006, J PHARMACOL EXP THER, V316, P592, DOI 10.1124/jpet.105.095042; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell DM, 2001, EXP MOL MED, V33, P179, DOI 10.1038/emm.2001.31; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Farazi PA, 2006, CANCER RES, V66, P6622, DOI 10.1158/0008-5472.CAN-05-4609; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2007, NAT CLIN PRACT GASTR, V4, P236, DOI 10.1038/ncpgasthep0813; George J, 1999, P NATL ACAD SCI USA, V96, P12719, DOI 10.1073/pnas.96.22.12719; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner OA, 2008, J GASTROEN HEPATOL, V23, P1024, DOI 10.1111/j.1440-1746.2008.05345.x; Guerra R. R., 2010, Brazilian Journal of Veterinary Pathology, V3, P9; Hu PF, 2009, J HEPATOL, V51, P102, DOI 10.1016/j.jhep.2009.02.025; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Kaminska B, 2005, ACTA BIOCHIM POL, V52, P329; Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x; Marquez-Aguirre A, 2009, J GENE MED, V11, P207, DOI 10.1002/jgm.1303; Martinez-Rizo A, 2010, LIVER INT, V30, P298, DOI 10.1111/j.1478-3231.2009.02155.x; Matsuzaki K, 2006, J GASTROENTEROL, V41, P295, DOI 10.1007/s00535-006-1795-0; Roldan FP, 2010, GASTROENT HEPAT-BARC, V33, P498, DOI 10.1016/j.gastrohep.2010.04.007; Pilette C, 1998, J HEPATOL, V28, P439, DOI 10.1016/S0168-8278(98)80318-8; Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075; Stroescu Cezar, 2006, J Gastrointestin Liver Dis, V15, P9; Tangkijvanich P, 2002, EUR J SURG, V168, P100; TSUKAMOTO H, 1990, SEMIN LIVER DIS, V10, P56, DOI 10.1055/s-2008-1040457; Wang H, 2007, FEBS LETT, V581, P3098, DOI 10.1016/j.febslet.2007.05.049; Wang HT, 2005, HEPATOLOGY, V42, P1099, DOI 10.1002/hep.20903; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Xu W, 2009, HEPATOB PANCREAT DIS, V8, P300; Yata Y, 2002, HEPATOLOGY, V35, P1022, DOI 10.1053/jhep.2002.32673; Yeh CN, 2004, CARCINOGENESIS, V25, P631, DOI 10.1093/carcin/bgh037	35	62	65	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54499	10.1371/journal.pone.0054499	http://dx.doi.org/10.1371/journal.pone.0054499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349909	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900073
J	Mortuza, R; Chen, SL; Feng, BA; Sen, S; Chakrabarti, S				Mortuza, Rokhsana; Chen, Shali; Feng, Biao; Sen, Subhrojit; Chakrabarti, Subrata			High Glucose Induced Alteration of SIRTs in Endothelial Cells Causes Rapid Aging in a p300 and FOXO Regulated Pathway	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; EXPRESSION; PROTEIN; ACETYLATION; BIOCHEMISTRY; DIVERSITY; INSULIN; STRESS; HEALTH	In diabetes, some of the cellular changes are similar to aging. We hypothesized that hyperglycemia accelerates aging-like changes in the endothelial cells (ECs) and tissues leading to structural and functional damage. We investigated glucose-induced aging in 3 types of ECs using senescence associated beta-gal (SA beta-gal) staining and cell morphology. Alterations of sirtuins (SIRTs) and their downstream mediator FOXO and oxidative stress were investigated. Relationship of such alteration with histone acetylase (HAT) p300 was examined. Similar examinations were performed in tissues of diabetic animals. ECs in high glucose (HG) showed evidence of early senescence as demonstrated by increased SA beta-gal positivity and reduced replicative capacities. These alterations were pronounced in microvascular ECs. They developed an irregular and hypertrophic phenotype. Such changes were associated with decreased SIRT (1-7) mRNA expressions. We also found that p300 and SIRT1 regulate each other in such process, as silencing one led to increase of the others' expression. Furthermore, HG caused reduction in FOXO1's DNA binding ability and antioxidant target gene expressions. Chemically induced increased SIRT1 activity and p300 knockdown corrected these abnormalities slowing aging-like changes. Diabetic animals showed increased cellular senescence in renal glomerulus and retinal blood vessels along with reduced SIRT1 mRNA expressions in these tissues. Data from this study demonstrated that hyperglycemia accelerates aging-like process in the vascular ECs and such process is mediated via downregulation of SIRT1, causing reduction of mitochondrial antioxidant enzyme in a p300 and FOXO1 mediated pathway.	[Mortuza, Rokhsana; Chen, Shali; Feng, Biao; Sen, Subhrojit; Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario)	Chakrabarti, S (corresponding author), Univ Western Ontario, Dept Pathol, Schulich Sch Med & Dent, London, ON, Canada.	subrata.chakrabarti@schulich.uwo.ca		Chakrabarti, Subrata/0000-0002-0208-1401	Canadian Diabetes Association; Heart and Stroke Foundation of Canada	Canadian Diabetes Association; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study was supported by grants from the Canadian Diabetes Association and the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Adams JD, 2007, LETT DRUG DES DISCOV, V4, P44; Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen S.Y, 2003, FLORA YUNNAN, V14, P1; Chen SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE127, DOI 10.1152/ajpendo.00432.2009; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Finkenzeller G, 2009, CELL PROLIFERAT, V42, P498, DOI 10.1111/j.1365-2184.2009.00610.x; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gerrits PO, 2010, NEUROSCI RES, V67, P267, DOI 10.1016/j.neures.2010.04.010; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Han L, 2012, NUCLEIC ACIDS RES, V38, P7458; Hendrickx J, 2004, PHYSIOL GENOMICS, V19, P198, DOI 10.1152/physiolgenomics.00143.2004; Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006; Kaur H, 2006, DIABETES, V55, P3104, DOI 10.2337/db06-0519; Khan Zia A., 2006, Current Vascular Pharmacology, V4, P45, DOI 10.2174/157016106775203081; Kloet DEA, 2011, BBA-MOL CELL RES, V1813, P1926, DOI 10.1016/j.bbamcr.2011.04.003; Kousteni S, 2011, J BONE MINER RES, V26, P912, DOI 10.1002/jbmr.306; Malik AI, 2011, GENE, V485, P114, DOI 10.1016/j.gene.2011.06.014; Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Nakagawa T, 2009, AGING-US, V1, P578, DOI 10.18632/aging.100062; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Ozden O, 2011, AGING-US, V3, P102, DOI 10.18632/aging.100291; Patlak Margie, 2002, FASEB Journal, V16, P1853, DOI 10.1096/fj.02-0974bkt; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Rao KS, 2009, INDIAN J BIOCHEM BIO, V46, P9; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rother KI, 2007, NEW ENGL J MED, V356, P1499, DOI 10.1056/NEJMp078030; Sangaralingham SJ, 2011, AM J PHYSIOL-RENAL, V301, pF943, DOI 10.1152/ajprenal.00170.2011; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sen S, 2012, PHYTOMEDICINE, V19, P494, DOI 10.1016/j.phymed.2012.01.001; Smith JR, 2007, INVEST OPHTH VIS SCI, V48, P2676, DOI 10.1167/iovs.06-0598; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Taylor DM, 2008, CELL MOL LIFE SCI, V65, P4000, DOI 10.1007/s00018-008-8357-y; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wu YX, 2010, CAN J PHYSIOL PHARM, V88, P607, DOI 10.1139/Y10-033; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079	45	130	141	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54514	10.1371/journal.pone.0054514	http://dx.doi.org/10.1371/journal.pone.0054514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342163	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700120
J	Loening, NM; Wilson, ZN; Zobel-Thropp, PA; Binford, GJ				Loening, Nikolaus M.; Wilson, Zachary N.; Zobel-Thropp, Pamela A.; Binford, Greta J.			Solution Structures of Two Homologous Venom Peptides from Sicarius dolichocephalus	PLOS ONE			English	Article							NMR CHEMICAL-SHIFTS; INSECTICIDAL NEUROTOXINS; CYSTINE KNOT; SPIDERS; DISCOVERY; TOXINS; IDENTIFICATION; POLYPEPTIDES; LOXOSCELES; ASSIGNMENT	We present solution-state NMR structures for two putative venom peptides from Sicarius dolichocephalus. These peptides were identified from cDNA libraries created from venom gland mRNA and then recombinantly expressed. They are the first structures from any species of Sicarius spiders, and the first peptide structures for any haplogyne spiders. These peptides are homologous to one another, and while they have at most only 20% sequence identity with known venom peptides their structures follow the inhibitor cystine knot motif that has been found in a broad range of venom peptides.	[Loening, Nikolaus M.; Wilson, Zachary N.] Lewis & Clark Coll, Dept Chem, Portland, OR 97219 USA; [Zobel-Thropp, Pamela A.; Binford, Greta J.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA		Loening, NM (corresponding author), Lewis & Clark Coll, Dept Chem, Portland, OR 97219 USA.	loening@lclark.edu		Loening, Nikolaus/0000-0002-5074-6906; Wilson, Zachary/0000-0003-4269-4058	National Institute of General Medical Sciences [R15GM085733, R15GM097696]; National Science Foundation [IOB-0546858]; John S. Rogers Science Research Program at Lewis Clark College; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM085733, R15GM097696] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); John S. Rogers Science Research Program at Lewis Clark College; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.M.L. was supported by Award Number R15GM085733 from the National Institute of General Medical Sciences. G.J.B and P.A.Z were supported by Award Number R15GM097696 from the National Institute of General Medical Sciences and CAREER Award IOB-0546858 from the National Science Foundation. Z.N.W. acknowledges support from the John S. Rogers Science Research Program at Lewis & Clark College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Binford GJ, 2003, COMP BIOCHEM PHYS B, V135, P25, DOI 10.1016/S1096-4959(03)00045-9; Binford GJ, 2008, MOL PHYLOGENET EVOL, V49, P538, DOI 10.1016/j.ympev.2008.08.003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Castro CS, 2004, TOXICON, V44, P273, DOI 10.1016/j.toxicon.2004.05.028; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Jensen JE, 2009, TOXICON, V54, P56, DOI 10.1016/j.toxicon.2009.03.014; King GF, 2002, J TOXICOL-TOXIN REV, V21, P359, DOI 10.1081/TXR-120014409; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Liang SP, 1999, J PROTEIN CHEM, V18, P619, DOI 10.1023/A:1020693920990; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Ostrow KL, 2003, TOXICON, V42, P263, DOI 10.1016/S0041-0101(03)00141-7; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Platnick N. I., 1991, AM MUS NOVIT, V3016, P1; Platnick N.I., 2012, WORLD SPIDER CATALOG; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Selden PA, 2010, BIOL REV, V85, P171, DOI 10.1111/j.1469-185X.2009.00099.x; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Wang XH, 2001, J BIOL CHEM, V276, P40306, DOI 10.1074/jbc.M105206200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001	38	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54401	10.1371/journal.pone.0054401	http://dx.doi.org/10.1371/journal.pone.0054401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342149	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400159
J	Hull, JJ; Geib, SM; Fabrick, JA; Brent, CS				Hull, J. Joe; Geib, Scott M.; Fabrick, Jeffrey A.; Brent, Colin S.			Sequencing and De Novo Assembly of the Western Tarnished Plant Bug (Lygus hesperus) Transcriptome	PLOS ONE			English	Article							HETEROPTERA MIRIDAE; BROWN PLANTHOPPER; STRESS-RESPONSE; PROTEIN; POPULATIONS; RESISTANCE; EXPRESSION; HEMIPTERA; DIAPAUSE; GENES	Background: Mirid plant bugs (Hemiptera: Miridae) are economically important insect pests of many crops worldwide. The western tarnished plant bug Lygus hesperus Knight is a pest of cotton, alfalfa, fruit and vegetable crops, and potentially of several emerging biofuel and natural product feedstocks in the western US. However, little is known about the underlying molecular genetics, biochemistry, or physiology of L. hesperus, including their ability to survive extreme environmental conditions. Methodology/Principal Findings: We used 454 pyrosequencing of a normalized adult cDNA library and de novo assembly to obtain an adult L. hesperus transcriptome consisting of 1,429,818 transcriptomic reads representing 36,131 transcript isoforms (isotigs) that correspond to 19,742 genes. A search of the transcriptome against deposited L. hesperus protein sequences revealed that 86 out of 87 were represented. Comparison with the non-redundant database indicated that 54% of the transcriptome exhibited similarity (e-value <= 1(-5)) with known proteins. In addition, Gene Ontology (GO) terms, Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations, and potential Pfam domains were assigned to each transcript isoform. To gain insight into the molecular basis of the L. hesperus thermal stress response we used transcriptomic sequences to identify 52 potential heat shock protein (Hsp) homologs. A subset of these transcripts was sequence verified and their expression response to thermal stress monitored by semi-quantitative PCR. Potential homologs of Hsp70, Hsp40, and 2 small Hsps were found to be upregulated in the heat-challenged adults, suggesting a role in thermotolerance. Conclusions/Significance: The L. hesperus transcriptome advances the underlying molecular understanding of this arthropod pest by significantly increasing the number of known genes, and provides the basis for further exploration and understanding of the fundamental mechanisms of abiotic stress responses.	[Hull, J. Joe; Fabrick, Jeffrey A.; Brent, Colin S.] ARS, Pest Management & Biocontrol Res Unit, USDA, Maricopa, AZ USA; [Geib, Scott M.] ARS, Trop Crop & Commod Protect Res Unit, USDA, Hilo, HI USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Hull, JJ (corresponding author), ARS, Pest Management & Biocontrol Res Unit, USDA, Maricopa, AZ USA.	joe.hull@ars.usda.gov		Fabrick, Jeffrey/0000-0002-3893-9545; Brent, Colin/0000-0003-2078-1417; Geib, Scott/0000-0002-9511-5139	Cotton Inc.	Cotton Inc.(Cotton R&D Corp)	The research described in this manuscript was partially supported by funds from Cotton Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BEARDS GW, 1966, HILGARDIA, V37, P345, DOI 10.3733/hilg.v37n10p345; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BUTTS RA, 1990, ANN APPL BIOL, V117, P253, DOI 10.1111/j.1744-7348.1990.tb04211.x; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colinet H, 2010, J EXP BIOL, V213, P4146, DOI 10.1242/jeb.051003; Comeault AA, 2012, MOL ECOL RESOUR, V12, P549, DOI 10.1111/j.1755-0998.2012.03121.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; DEBOLT JW, 1982, ANN ENTOMOL SOC AM, V75, P119, DOI 10.1093/aesa/75.2.119; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frydenberg J, 2003, MOL ECOL, V12, P2025, DOI 10.1046/j.1365-294X.2002.01882.x; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Graham AM, 2012, J HERED, V103, P400, DOI 10.1093/jhered/esr150; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Jia Haibo, 2011, Int J Biochem Mol Biol, V2, P47; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kelton L.A., 1975, Memoirs Ent Soc Can, VNo. 95, P1; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; LEIGH TF, 1966, J ECON ENTOMOL, V59, P1280, DOI 10.1093/jee/59.5.1280; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Liu FS, 2012, MOL BIOL REP, V39, P1927, DOI 10.1007/s11033-011-0939-3; Lu ZC, 2011, J EXP BIOL, V214, P764, DOI 10.1242/jeb.047415; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Naranjo SE, 2008, J INSECT SCI, V8, P49; Naranjo SE, 2011, J ECON ENTOMOL, V104, P1575, DOI 10.1603/EC11089; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; PATANA R, 1982, J ECON ENTOMOL, V75, P668, DOI 10.1093/jee/75.4.668; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ranford JC, 2002, J CLIN PATHOL-MOL PA, V55, P209, DOI 10.1136/mp.55.4.209; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Ritter RA, 2010, J KANSAS ENTOMOL SOC, V83, P297, DOI 10.2317/JKES0912.23.1; Scott DR, 1977, ENTOMOL SOC AM B, V23, P19; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Snodgrass GL, 2009, J ECON ENTOMOL, V102, P699, DOI 10.1603/029.102.0231; Snodgrass GL, 1996, J ECON ENTOMOL, V89, P783, DOI 10.1093/jee/89.4.783; Snodgrass GL, 2000, J ECON ENTOMOL, V93, P441, DOI 10.1603/0022-0493-93.2.441; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Spurgeon DW, 2010, J ENTOMOL SCI, V45, P303, DOI 10.18474/0749-8004-45.4.303; Sze SH, 2012, INSECT MOL BIOL, V21, P205, DOI 10.1111/j.1365-2583.2011.01127.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TURNOCK WJ, 1995, CAN J PLANT SCI, V75, P731, DOI 10.4141/cjps95-124; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; Wheelock CE, 2005, J PESTIC SCI, V30, P75, DOI 10.1584/jpestics.30.75; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yebenes H, 2011, TRENDS BIOCHEM SCI, V36, P424, DOI 10.1016/j.tibs.2011.05.003; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037586; [No title captured]	72	45	51	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55105	10.1371/journal.pone.0055105	http://dx.doi.org/10.1371/journal.pone.0055105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23357950	Green Published, gold			2022-12-27	WOS:000314023600153
J	Athavale, SS; Gossett, JJ; Bowman, JC; Hud, NV; Williams, LD; Harvey, SC				Athavale, Shreyas S.; Gossett, J. Jared; Bowman, Jessica C.; Hud, Nicholas V.; Williams, Loren Dean; Harvey, Stephen C.			In Vitro Secondary Structure of the Genomic RNA of Satellite Tobacco Mosaic Virus	PLOS ONE			English	Article							SHAPE CHEMISTRY; CONSTRAINTS; TRANSCRIPTS; PREDICTION; RESOLUTION; IONS	Satellite tobacco mosaic virus (STMV) is a T = 1 icosahedral virus with a single-stranded RNA genome. It is widely accepted that the RNA genome plays an important structural role during assembly of the STMV virion. While the encapsidated form of the RNA has been extensively studied, less is known about the structure of the free RNA, aside from a purported tRNA-like structure at the 3' end. Here we use selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) analysis to examine the secondary structure of in vitro transcribed STMV RNA. The predicted secondary structure is unusual in the sense that it is highly extended, which could be significant for protecting the RNA from degradation. The SHAPE data are also consistent with the previously predicted tRNA-like fold at the 3' end of the molecule, which is also known to hinder degradation. Our data are not consistent with the secondary structure proposed for the encapsidated RNA by Schroeder et al., suggesting that, if the Schroeder structure is correct, either the RNA is packaged as it emerges from the replication complex, or the RNA undergoes extensive refolding upon encapsidation. We also consider the alternative, i.e., that the structure of the encapsidated STMV RNA might be the same as the in vitro structure presented here, and we examine how this structure might be organized in the virus. This possibility is not rigorously ruled out by the available data, so it remains open to examination by experiment.	[Athavale, Shreyas S.; Gossett, J. Jared; Harvey, Stephen C.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Bowman, Jessica C.; Hud, Nicholas V.; Williams, Loren Dean; Harvey, Stephen C.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Gossett, J. Jared] Georgia Inst Technol, Sch Computat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Harvey, SC (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	steve.harvey@biology.gatech.edu	Hud, Nicholas V/T-7017-2017	Hud, Nicholas/0000-0001-7711-6472; Bowman, Jessica/0000-0002-6219-2680	National Institutes of Health [GM 70785]; NASA Astrobiology Institute [NNA09DA78A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA Astrobiology Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by grant GM 70785 to SCH from the National Institutes of Health (URL: www.nih.gov) and by grant NNA09DA78A to LDW from the NASA Astrobiology Institute (URL: astrobiology.nasa.gov/nai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athavale SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038024; Athavale SS, 2012, RNA, V18, P752, DOI 10.1261/rna.030692.111; Bindewald E, 2011, RNA, V17, P1688, DOI 10.1261/rna.2640111; Bowman JC, 2012, CURR OPIN STRUC BIOL, V22, P262, DOI 10.1016/j.sbi.2012.04.006; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Choi YG, 2002, P NATL ACAD SCI USA, V99, P655, DOI 10.1073/pnas.022618199; Cordero P, 2012, BIOCHEMISTRY-US, V51, P7037, DOI 10.1021/bi3008802; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Dodds JA, 1998, ANNU REV PHYTOPATHOL, V36, P295, DOI 10.1146/annurev.phyto.36.1.295; Draper DE, 2008, BIOPHYS J, V95, P5489, DOI 10.1529/biophysj.108.131813; Dreher TW, 1999, ANNU REV PHYTOPATHOL, V37, P151, DOI 10.1146/annurev.phyto.37.1.151; FELDEN B, 1994, NUCLEIC ACIDS RES, V22, P2882, DOI 10.1093/nar/22.15.2882; GALLIE DR, 1991, NUCLEIC ACIDS RES, V19, P5031, DOI 10.1093/nar/19.18.5031; Gossele V, 2002, PLANT J, V32, P859, DOI 10.1046/j.1365-313X.2002.01471.x; GULTYAEV AP, 1994, J GEN VIROL, V75, P2851, DOI 10.1099/0022-1317-75-10-2851; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Kladwang W, 2011, BIOCHEMISTRY-US, V50, P8049, DOI [10.1021/bi4200524n, 10.1021/bi200524n]; Kuznetsov YG, 2010, NUCLEIC ACIDS RES, V38, P8284, DOI 10.1093/nar/gkq662; Larson SB, 1998, J MOL BIOL, V277, P37, DOI 10.1006/jmbi.1997.1570; Larson SB, 2001, CURR OPIN STRUC BIOL, V11, P59, DOI 10.1016/S0959-440X(00)00166-4; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; McGinnis JL, 2012, J AM CHEM SOC, V134, P6617, DOI 10.1021/ja2104075; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; MIRKOV TE, 1989, VIROLOGY, V170, P139, DOI 10.1016/0042-6822(89)90361-9; MIRKOV TE, 1990, VIROLOGY, V179, P395, DOI 10.1016/0042-6822(90)90307-D; Mortimer SA, 2008, J AM CHEM SOC, V130, P16178, DOI 10.1021/ja8061216; RAO ALN, 1989, P NATL ACAD SCI USA, V86, P5335, DOI 10.1073/pnas.86.14.5335; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; ROUTH G, 1995, VIROLOGY, V212, P121, DOI 10.1006/viro.1995.1460; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Schneemann A, 2006, ANNU REV MICROBIOL, V60, P51, DOI 10.1146/annurev.micro.60.080805.142304; Schroeder SJ, 2011, BIOPHYS J, V101, P167, DOI 10.1016/j.bpj.2011.05.053; Soll D, 1995, TRNA STRUCTURE BIOSY, Vxiii; Vicens Q, 2007, RNA, V13, P536, DOI 10.1261/rna.400207; Wang MB, 2004, P NATL ACAD SCI USA, V101, P3275, DOI 10.1073/pnas.0400104101; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2009, RNA, V15, P1314, DOI 10.1261/rna.1536209; Xu WX, 2012, MOL PLANT PATHOL, V13, P666, DOI 10.1111/j.1364-3703.2011.00776.x; Yoffe AM, 2008, P NATL ACAD SCI USA, V105, P16153, DOI 10.1073/pnas.0808089105; Zeng YY, 2012, J STRUCT BIOL, V180, P110, DOI 10.1016/j.jsb.2012.06.008	40	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54384	10.1371/journal.pone.0054384	http://dx.doi.org/10.1371/journal.pone.0054384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349871	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100064
J	Cervera, J; Manzanares, JA; Mafe, S				Cervera, Javier; Manzanares, Jose A.; Mafe, Salvador			Biologically Inspired Information Processing and Synchronization in Ensembles of Non-Identical Threshold-Potential Nanostructures	PLOS ONE			English	Article							NANOELECTRODES; NANOPARTICLES; VARIABILITY; RELIABILITY; NEURONS; ARRAYS; SIGNAL; NOISE	Nanotechnology produces basic structures that show a significant variability in their individual physical properties. This experimental fact may constitute a serious limitation for most applications requiring nominally identical building blocks. On the other hand, biological diversity is found in most natural systems. We show that reliable information processing can be achieved with heterogeneous groups of non-identical nanostructures by using some conceptual schemes characteristic of biological networks (diversity, frequency-based signal processing, rate and rank order coding, and synchronization). To this end, we simulate the integrated response of an ensemble of single-electron transistors (SET) whose individual threshold potentials show a high variability. A particular experimental realization of a SET is a metal nanoparticle-based transistor that mimics biological spiking synapses and can be modeled as an integrate-and-fire oscillator. The different shape and size distributions of nanoparticles inherent to the nanoscale fabrication procedures result in a significant variability in the threshold potentials of the SET. The statistical distributions of the nanoparticle physical parameters are characterized by experimental average and distribution width values. We consider simple but general information processing schemes to draw conclusions that should be of relevance for other threshold-based nanostructures. Monte Carlo simulations show that ensembles of non-identical SET may show some advantages over ensembles of identical nanostructures concerning the processing of weak signals. The results obtained are also relevant for understanding the role of diversity in biophysical networks.	[Cervera, Javier; Manzanares, Jose A.; Mafe, Salvador] Univ Valencia, Fac Fis, Valencia, Spain	University of Valencia	Mafe, S (corresponding author), Univ Valencia, Fac Fis, Valencia, Spain.	smafe@uv.es	Manzanares, Jose A/M-3918-2014; Cervera, Javier/F-4836-2015; Manzanares, Jose A./ABG-6772-2020; Mafe, Salvador/O-2393-2014	Manzanares, Jose A/0000-0002-5402-6842; Cervera, Javier/0000-0001-8965-9298; Mafe, Salvador/0000-0003-3248-7020	Generalitat Valenciana [PROMETEO/GV/0069]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	Funding provided by Generalitat Valenciana (project PROMETEO/GV/0069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benda J, 2006, NEURON, V52, P347, DOI 10.1016/j.neuron.2006.08.008; Bichler O, 2010, IEEE T ELECTRON DEV, V57, P3115, DOI 10.1109/TED.2010.2065951; Campbell SR, 1999, NEURAL COMPUT, V11, P1595, DOI 10.1162/089976699300016160; Cervera J, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3691630; Cervera J, 2011, J NANOSCI NANOTECHNO, V11, P7537, DOI 10.1166/jnn.2011.4743; Cervera J, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/43/435201; Cervera J, 2010, NANOSCALE, V2, P1033, DOI 10.1039/c0nr00059k; Cervera J, 2009, J APPL PHYS, V105, DOI 10.1063/1.3095487; Chaki NK, 2006, PHYS CHEM CHEM PHYS, V8, P1837, DOI 10.1039/b516650k; Chen SW, 1998, SCIENCE, V280, P2098, DOI 10.1126/science.280.5372.2098; de Gyvez JP, 2004, IEEE J SOLID-ST CIRC, V39, P157, DOI 10.1109/JSSC.2003.820873; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Garcia-Morales V, 2007, J PHYS CHEM C, V111, P7242, DOI 10.1021/jp067920+; Jehl X, 2011, PROCEDIA COMPUT SCI, V7, P266, DOI 10.1016/j.procs.2011.09.016; Kano S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.105003; Kasai S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3428784; Kikombo AK, 2009, 2009 INTERNATIONAL SYMPOSIUM ON INTELLIGENT SIGNAL PROCESSING AND COMMUNICATION SYSTEMS (ISPACS 2009), P429, DOI 10.1109/ISPACS.2009.5383809; Liu WP, 2011, PHYSCS PROC, V22, P170, DOI 10.1016/j.phpro.2011.11.027; Luo K, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/46/465203; Manzanares JA, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3650712; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; McDonnell M.D., 2008, STOCH RES SUPR, DOI DOI 10.1017/CBO9780511535239; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; McDonnell MD, 2006, PHYS LETT A, V352, P183, DOI 10.1016/j.physleta.2005.11.068; McGuinness J., 2011, BMC NEUROSCI S1, V12, P127; Murray RW, 2008, CHEM REV, V108, P2688, DOI 10.1021/cr068077e; Okabayashi N, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3676191; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Pillow JW, 2011, NEURAL COMPUT, V23, P1, DOI 10.1162/NECO_a_00058; Schreiber S, 2009, J NEUROPHYSIOL, V101, P2239, DOI 10.1152/jn.90711.2008; Shadlen MN, 2002, ENCY COGNITIVE SCI, P819; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Wang KL, 2008, P IEEE, V96, P212, DOI 10.1109/JPROC.2007.911055; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Yarom Y, 2011, PHYSIOL REV, V91, P917, DOI 10.1152/physrev.00019.2010	37	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53821	10.1371/journal.pone.0053821	http://dx.doi.org/10.1371/journal.pone.0053821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349746	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100032
J	Samaniego, S; Marcu, KB				Samaniego, Sylvia; Marcu, Kenneth B.			IKK beta in Myeloid Cells Controls the Host Response to Lethal and Sublethal Francisella tularensis LVS Infection	PLOS ONE			English	Article							LIVE-VACCINE-STRAIN; NF-KAPPA-B; INNATE IMMUNE-RESPONSE; ALTERNATIVE ACTIVATION; INFLAMMATORY RESPONSES; INTRACELLULAR PATHOGEN; MACROPHAGE ACTIVATION; MURINE MACROPHAGES; DEFENSE MECHANISMS; REACTIVE NITROGEN	Background: The NF-kappa B activating kinases, IKK alpha and IKK beta, are key regulators of inflammation and immunity in response to infection by a variety of pathogens. Both IKK alpha and IKK beta have been reported to modulate either pro- or anti- inflammatory programs, which may be specific to the infectious organism or the target tissue. Here, we analyzed the requirements for the IKKs in myeloid cells in vivo in response to Francisella tularensis Live Vaccine Strain (Ft. LVS) infection. Methods and Principal Findings: In contrast to prior reports in which conditional deletion of IKK beta in the myeloid lineage promoted survival and conferred resistance to an in vivo group B streptococcus infection, we show that mice with a comparable conditional deletion (IKK beta cKO) succumb more rapidly to lethal Ft. LVS infection and are unable to control bacterial growth at sublethal doses. Flow cytometry analysis of hepatic non-parenchymal cells from infected mice reveals that IKK beta inhibits M1 classical macrophage activation two days post infection, which has the collateral effect of suppressing IFN-gamma(+) CD8(+) T cells. Despite this early enhanced inflammation, IKK beta cKO mice are unable to control infection; and this coincides with a shift toward M2a polarized macrophages. In comparison, we find that myeloid IKK beta is dispensable for survival and bacterial control. However, both IKK alpha and IKK beta have effects on hepatic granuloma development. IKK alpha cKO mice develop fewer, but well-contained granulomas that accumulate excess necrotic cells after 9 days of infection; while IKK beta cKO mice develop numerous micro-granulomas that are less well contained. Conclusions: Taken together our findings reveal that unlike IKK alpha, IKK beta has multiple, contrasting roles in this bacterial infection model by acting in an anti-inflammatory capacity at early times towards sublethal Ft. LVS infection; but in spite of this, macrophage IKK beta is also a critical effector for host survival and efficient pathogen clearance.	[Samaniego, Sylvia; Marcu, Kenneth B.] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Samaniego, Sylvia; Marcu, Kenneth B.] SUNY Stony Brook, Biochem & Cell Biol Dept, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Samaniego, S (corresponding author), SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA.	sysamani@gmail.com; kenneth.marcu@stonybrook.edu	Samaniego, Sylvia/M-3167-2014	Samaniego, Sylvia/0000-0002-1076-5459	National Institutes of Health [GM066882]; Boehringer Ingelheim Pharmaceuticals, Inc.; NCI through the Genetics Graduate Program of Stony Brook University [5 T32 CA009176]; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Pharmaceuticals, Inc.(Boehringer Ingelheim); NCI through the Genetics Graduate Program of Stony Brook University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM066882 and a research contract from Boehringer Ingelheim Pharmaceuticals, Inc. both awarded to KBM. NCI training grant 5 T32 CA009176 awarded to SS through the Genetics Graduate Program of Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Ben Nasr A, 2008, J LEUKOCYTE BIOL, V84, P77, DOI 10.1189/jlb.0807526; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bokhari SM, 2008, INFECT IMMUN, V76, P1379, DOI 10.1128/IAI.00745-07; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chen WX, 2005, IMMUNOL LETT, V97, P151, DOI 10.1016/j.imlet.2004.10.001; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Chiavolini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011156; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clay CD, 2008, J IMMUNOL, V181, P5568, DOI 10.4049/jimmunol.181.8.5568; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; Collazo CM, 2006, MICROBES INFECT, V8, P779, DOI 10.1016/j.micinf.2005.09.014; Conlan JW, 2008, MOL IMMUNOL, V45, P2962, DOI 10.1016/j.molimm.2008.01.022; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; Duenas AI, 2006, INT IMMUNOL, V18, P785, DOI 10.1093/intimm/dxl015; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; ELKINS KL, 1993, INFECT IMMUN, V61, P823, DOI 10.1128/IAI.61.3.823-829.1993; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Forestal CA, 2003, J IMMUNOL, V171, P2563, DOI 10.4049/jimmunol.171.5.2563; Fortier A H, 1994, Immunol Ser, V60, P349; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; GOLOVLIOV I, 1995, INFECT IMMUN, V63, P534, DOI 10.1128/IAI.63.2.534-538.1995; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hall JD, 2006, INFECT IMMUN, P01254; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hong KJ, 2007, INFECT IMMUN, V75, P5338, DOI 10.1128/IAI.00561-07; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Lindgren H, 2004, INFECT IMMUN, V72, P7172, DOI 10.1128/IAI.72.12.7172-7182.2004; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Parsa KVL, 2008, MOL IMMUNOL, V45, P3428, DOI 10.1016/j.molimm.2008.04.006; Penzo M, 2010, J IMMUNOL, V184, P4497, DOI 10.4049/jimmunol.0903131; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rasmussen JW, 2006, INFECT IMMUN, V74, P6590, DOI 10.1128/IAI.00868-06; SANDSTROM G, 1988, INFECT IMMUN, V56, P1194; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; SJOSTEDT A, 1994, INFECT IMMUN, V62, P2779; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Timmer AM, 2008, J EXP MED, V205, P1255, DOI 10.1084/jem.20081056; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Yee D, 1996, J IMMUNOL, V157, P5042	75	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54124	10.1371/journal.pone.0054124	http://dx.doi.org/10.1371/journal.pone.0054124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349802	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100046
J	Shang, JC; Fu, QF; Dienes, Z; Shao, C; Fu, XL				Shang, Junchen; Fu, Qiufang; Dienes, Zoltan; Shao, Can; Fu, Xiaolan			Negative Affect Reduces Performance in Implicit Sequence Learning	PLOS ONE			English	Article							POSITIVE EMOTIONS; ATTENTION; JUDGMENTS; MOOD; AWARENESS; ACCURACY; BROADEN; AROUSAL; MEMORY; MODEL	Background: It is well documented that positive rather than negative moods encourage integrative processing of conscious information. However, the extent to which implicit or unconscious learning can be influenced by affective states remains unclear. Methodology/Principal Findings: A Serial Reaction Time (SRT) task with sequence structures requiring integration over past trials was adopted to examine the effect of affective states on implicit learning. Music was used to induce and maintain positive and negative affective states. The present study showed that participants in negative rather than positive states learned less of the regularity. Moreover, the knowledge was shown by a Bayesian analysis to be largely unconscious as participants were poor at recognizing the regularity. Conclusions/Significance: The results demonstrated that negative rather than positive affect inhibited implicit learning of complex structures. Our findings help to understand the effects of affective states on unconscious or implicit processing.	[Shang, Junchen; Fu, Qiufang; Fu, Xiaolan] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Shao, Can] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Dienes, Zoltan] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Dienes, Zoltan] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	Chinese Academy of Sciences; Institute of Psychology, CAS; Beijing Normal University; University of Sussex; University of Sussex	Fu, QF (corresponding author), Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	fuqf@psych.ac.cn	, Grace/ABB-4349-2021; Shang, Junchen/GYU-4942-2022	Dienes, Zoltan/0000-0001-7454-3161	Chinese Ministry of Science and Technology [2011CB302201]; National Natural Science Foundation of China [30900395, 31270024]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by grants from 973 Program of Chinese Ministry of Science and Technology (2011CB302201), the National Natural Science Foundation of China (30900395, 31270024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Anderson AK, 2003, J NEUROSCI, V23, P5627; [白露 BAI Lu], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P719; Berry CJ, 2008, TRENDS COGN SCI, V12, P367, DOI 10.1016/j.tics.2008.06.005; Berry D. C., 1993, IMPLICIT LEARNING TH; Bolte A, 2003, PSYCHOL SCI, V14, P416, DOI 10.1111/1467-9280.01456; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Casper K, 2001, THEORIES MOOD COGNIT, P27; Clark M. S., 1982, COGNITIVE SOCIAL PSY, P73, DOI DOI 10.2307/3033676; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Clore G.L., 2006, AFFECT SOCIAL THINKI, P123; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Derryberry D, 1998, PERS INDIV DIFFER, V25, P745, DOI 10.1016/S0191-8869(98)00117-2; Derryberry D., 1994, HEARTS EYE EMOTIONAL, P167, DOI [10.1016/B978-0-12-410560-7.50014-4, DOI 10.1016/B978-0-12-410560-7.50014-4]; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Destrebecqz A., 2003, ADV CONSCIOUSNESS RE, V48, P181, DOI [10.1075/aicr.48.11des, DOI 10.1075/AICR.48.11DES]; Dienes Z, 2005, PSYCHOL RES-PSYCH FO, V69, P338, DOI 10.1007/s00426-004-0208-3; Dienes Z, 2003, Q J EXP PSYCHOL-A, V56, P117, DOI 10.1080/02724980244000305; Dienes Z., 2008, UNDERSTANDING PSYCHO; Dienes Z., 2012, STAT LEARN LANG ACQU, V1, P337; Dienes Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033400; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; DULANY DE, 1984, J EXP PSYCHOL GEN, V113, P541, DOI 10.1037/0096-3445.113.4.541; Eitam B, 2009, Q J EXP PSYCHOL, V62, P228, DOI 10.1080/17470210802479113; Esses V. M., 1994, PSYCHOL PREJUDICE ON, V5, P77; EYSENCK HJ, 1965, BRIT J PSYCHOL, V56, P163, DOI 10.1111/j.2044-8295.1965.tb00956.x; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Fu QF, 2008, CONSCIOUS COGN, V17, P185, DOI 10.1016/j.concog.2007.01.007; Fu QF, 2010, CONSCIOUS COGN, V19, P462, DOI 10.1016/j.concog.2009.10.001; Goschke T, 2007, J EXP PSYCHOL LEARN, V33, P394, DOI 10.1037/0278-7393.33.2.394; Hull C.L., 1951, ESSENTIALS BEHAV; ISEN AM, 1982, SOC PSYCHOL QUART, V45, P58, DOI 10.2307/3033676; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Kensinger EA, 2007, CURR DIR PSYCHOL SCI, V16, P213, DOI 10.1111/j.1467-8721.2007.00506.x; Kiyokawa S, 2012, COGNITION, V124, P16, DOI 10.1016/j.cognition.2012.03.009; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Morey RD, 2008, J MATH PSYCHOL, V52, P21, DOI 10.1016/j.jmp.2007.09.007; Morris JD, 1995, J ADVERTISING RES, V35, P63; Naismith SL, 2010, J AFFECT DISORDERS, V125, P256, DOI 10.1016/j.jad.2010.02.114; Naismith SL, 2006, PSYCHOL MED, V36, P313, DOI 10.1017/S0033291705006835; Norman E, 2007, CONSCIOUS COGN, V16, P809, DOI 10.1016/j.concog.2007.02.004; Norman E, 2011, CONSCIOUS COGN, V20, P1920, DOI 10.1016/j.concog.2011.07.008; Pretz JE, 2010, LEARN INDIVID DIFFER, V20, P215, DOI 10.1016/j.lindif.2009.12.003; Reber A.S., 1993, IMPLICIT LEARNING TA; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Schvaneveldt RW, 1998, PSYCHOL RES-PSYCH FO, V61, P175, DOI 10.1007/s004260050023; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Scott R, 2010, TRENDS AND PROSPECTS IN METACOGNITION RESEARCH, P37, DOI 10.1007/978-1-4419-6546-2_3; Scott RB, 2008, J EXP PSYCHOL LEARN, V34, P1264, DOI 10.1037/a0012943; SERVANSCHREIBER E, 1990, J EXP PSYCHOL LEARN, V16, P592, DOI 10.1037/0278-7393.16.4.592; Seth AK, 2008, TRENDS COGN SCI, V12, P314, DOI 10.1016/j.tics.2008.04.008; Shanks D. R., 2005, HDB COGNITION, P203, DOI [10.4135/9781848608177.n8, DOI 10.4135/9781848608177.N8]; Shanks DR, 2010, ANNU REV PSYCHOL, V61, P273, DOI 10.1146/annurev.psych.093008.100519; Shanks DR, 2003, J EXP PSYCHOL LEARN, V29, P248, DOI 10.1037/0278-7393.29.2.248; Soto D, 2009, P NATL ACAD SCI USA, V106, P6011, DOI 10.1073/pnas.0811681106; Storbeck J, 2005, PSYCHOL SCI, V16, P785, DOI 10.1111/j.1467-9280.2005.01615.x; Storbeck J, 2007, COGNITION EMOTION, V21, P1212, DOI 10.1080/02699930701438020; Storbeck J, 2008, SOC PERSONAL PSYCHOL, V2, P1824, DOI 10.1111/j.1751-9004.2008.00138.x; Sun R., 2002, DUALITY MIND; Tanaka D, 2008, PSYCHON B REV, V15, P1154, DOI 10.3758/PBR.15.6.1154; Tunney RJ, 2003, CONSCIOUS COGN, V12, P201, DOI 10.1016/S1053-8100(02)00068-5; Vermeulen N, 2010, PERS INDIV DIFFER, V49, P542, DOI 10.1016/j.paid.2010.04.003; Wilkinson L, 2004, J EXP PSYCHOL LEARN, V30, P354, DOI 10.1037/0278-7393.30.2.354; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Ziessler M, 1998, J EXP PSYCHOL LEARN, V24, P962, DOI 10.1037/0278-7393.24.4.962	69	15	15	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54693	10.1371/journal.pone.0054693	http://dx.doi.org/10.1371/journal.pone.0054693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349953	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100091
J	Baiamonte, BA; Lee, FA; Brewer, ST; Spano, D; LaHoste, GJ				Baiamonte, Brandon A.; Lee, Franklin A.; Brewer, Steve T.; Spano, Daniela; LaHoste, Gerald J.			Attenuation of Rhes Activity Significantly Delays the Appearance of Behavioral Symptoms in a Mouse Model of Huntington's Disease	PLOS ONE			English	Article							MUTANT-HUNTINGTIN; CAG REPEATS; HD GENE; PATHOGENESIS; MECHANISMS; PROTEIN	Huntington's disease (HD) is a neuropsychiatric disorder characterized by choreiform movement of the limbs, cognitive disability, psychosis and dementia. It is invariably associated with an abnormally long CAG expansion within the IT15 gene on human chromosome 4. Although the mutant huntingtin protein is ubiquitously expressed in HD patients, cellular degeneration occurs predominantly in neurons within the corpus striatum and cerebral cortex. The Ras homolog Rhes is expressed very selectively in the precise brain areas affected by HD. Recent in vitro work suggests that Rhes may be a cofactor with mutant huntingtin in cell death. The objective of the present study was to examine whether the inhibition of Rhes would attenuate or delay the symptoms of HD in vivo. We used a transgenic mouse model of HD crossed with Rhes knockout mice to show that the behavioral symptoms of HD are regulated by Rhes. HD+/Rhes(-/-) mice showed significantly delayed expression of HD-like symptoms in this in vivo model. Drugs that block or inhibit the actions of Rhes may be useful as the first treatments for HD.	[Baiamonte, Brandon A.; Lee, Franklin A.; Brewer, Steve T.; LaHoste, Gerald J.] Univ New Orleans, Dept Psychol, Appl Biopsychol Program, New Orleans, LA 70148 USA; [Spano, Daniela] Univ Naples Federico II, Dipartimento Biochem & Biotecnol Med, Naples, Italy; [Spano, Daniela] CEINGE Biotecnol Avanzate, Naples, Italy	University of Louisiana System; University of New Orleans; University of Naples Federico II; CEINGE Biotecnologie Avanzate	LaHoste, GJ (corresponding author), Univ New Orleans, Dept Psychol, Appl Biopsychol Program, New Orleans, LA 70148 USA.	glahoste@uno.edu		Spano, Daniela/0000-0003-3567-6492				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Harrison LM, 2006, NEUROSCIENCE, V137, P483, DOI 10.1016/j.neuroscience.2005.08.017; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huntington G., 1872, MED SURGICAL REPORTE, V26, P320; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Pineda JR, 2005, J NEUROCHEM, V93, P1057, DOI 10.1111/j.1471-4159.2005.03047.x; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sathasivam K, 1997, HUM GENET, V99, P692, DOI 10.1007/s004390050432; Spalding JF, 1982, ENERGY CITATIONS DAT; Spano D, 2004, MOL CELL BIOL, V24, P5788, DOI 10.1128/MCB.24.13.5788-5796.2004; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Steffan JS, 2010, CELL CYCLE, V9, P3401, DOI [10.4161/cc.9.17.12718, 10.4161/cc.9.17.12671]; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	29	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53606	10.1371/journal.pone.0053606	http://dx.doi.org/10.1371/journal.pone.0053606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349722	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000014
J	Sato, S; Kamada, H; Watanabe, T; Tsuji, I; Fan, JH				Sato, Shuji; Kamada, Hiroko; Watanabe, Takahiro; Tsuji, Isamu; Fan, Jinhong			Identification of the Cancer Cell Proliferation and Survival Functions of proHB-EGF by Using an Anti-HB-EGF Antibody	PLOS ONE			English	Article							DIPHTHERIA-TOXIN RECEPTOR; GROWTH-FACTOR ACTIVITY; TERMINAL FRAGMENT; EPITHELIAL-CELLS; BINDING; MEMBRANE; PROTEIN; EXPRESSION; FORM; ACTIVATION	Purpose: Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the epidermal growth factor family. The membrane-bound proHB-EGF is known to be a precursor of the soluble form of HB-EGF (sHB-EGF), which promotes cell proliferation and survival. While the functions of sHB-EGF have been extensively studied, it is not yet fully understood if proHB-EGF is also involved in cellular signaling events. In this study, we utilized the anti-HB-EGF monoclonal antibodies Y-142 and Y-073, which have differential specificities toward proHB-EGF, in order to elucidate proHB-EGF functions in cancer cells. Experimental Design: The biological activities of proHB-EGF were assessed in cell proliferation, caspase activation, and juxtacrine activity assays by using a 3D spheroid culture of NUGC-3 cells. Results: Y-142 and Y-073 exhibited similar binding and neutralizing activities for sHB-EGF. However, only Y-142 bound to proHB-EGF. We could detect the function of endogenously expressed proHB-EGF in a 3D spheroid culture. Blocking proHB-EGF with Y-142 reduced spheroid formation, suppressed cell proliferation, and increased caspase activation in the 3D spheroid culture of NUGC-3 cells. Conclusions: Our results show that proHB-EGF acts as a cell proliferation and cell survival factor in cancer cells. The results suggest that proHB-EGF may play an important role in tumor progression.	[Sato, Shuji; Fan, Jinhong] Takeda San Francisco Inc, San Francisco, CA USA; [Sato, Shuji; Kamada, Hiroko; Watanabe, Takahiro; Tsuji, Isamu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd	Sato, S (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	shuji.sato@takeda.com		Sato, Shuji/0000-0002-8423-9750				Beerli RR, 1996, J BIOL CHEM, V271, P6071, DOI 10.1074/jbc.271.11.6071; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hirata M, 2001, BIOCHEM BIOPH RES CO, V283, P915, DOI 10.1006/bbrc.2001.4879; Iwamoto R, 1999, J BIOL CHEM, V274, P25906, DOI 10.1074/jbc.274.36.25906; Kinugasa Y, 2007, J BIOL CHEM, V282, P14797, DOI 10.1074/jbc.M611036200; KOBRIN MS, 1994, BIOCHEM BIOPH RES CO, V202, P1705, DOI 10.1006/bbrc.1994.2131; Lin JQ, 2001, J BIOL CHEM, V276, P30127, DOI 10.1074/jbc.M010237200; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; MITAMURA T, 1992, J CELL BIOL, V118, P1389, DOI 10.1083/jcb.118.6.1389; MIYAGAWA J, 1995, J CLIN INVEST, V95, P404, DOI 10.1172/JCI117669; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Miyoshi E, 1997, J BIOL CHEM, V272, P14349, DOI 10.1074/jbc.272.22.14349; Mort JS, 1999, J CLIN PATHOL-MOL PA, V52, P11, DOI 10.1136/mp.52.1.11; Naef M, 1996, INT J CANCER, V66, P315; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Nakagawa T, 1996, J BIOL CHEM, V271, P30858, DOI 10.1074/jbc.271.48.30858; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Raab G, 1996, DEVELOPMENT, V122, P637; Santini MT, 1999, PATHOBIOLOGY, V67, P148, DOI 10.1159/000028065; Sato S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051964; Shimura T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-205; SHISHIDO Y, 1995, J BIOL CHEM, V270, P29578, DOI 10.1074/jbc.270.49.29578; Singh AB, 2007, J BIOL CHEM, V282, P32890, DOI 10.1074/jbc.M702677200; Suo ZH, 2002, INT J SURG PATHOL, V10, P91, DOI 10.1177/106689690201000202; Takemura T, 1997, J BIOL CHEM, V272, P31036, DOI 10.1074/jbc.272.49.31036; Takemura T, 1999, KIDNEY INT, V55, P71, DOI 10.1046/j.1523-1755.1999.00259.x; Takenobu H, 2003, J BIOL CHEM, V278, P17255, DOI 10.1074/jbc.M211835200; Thogersen VB, 2001, CANCER RES, V61, P6227; Tsuji I, 2012, MABS-AUSTIN, V4, P732, DOI 10.4161/mabs.21929; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035	39	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54509	10.1371/journal.pone.0054509	http://dx.doi.org/10.1371/journal.pone.0054509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349913	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000041
J	Hoesein, FAAM; Wauters, E; Janssens, W; Groen, HJM; Smolonska, J; Wijmenga, C; Postma, DS; Boezen, HM; De Jong, PA; Decramer, M; Lammers, JWJ; Lambrechts, D; Zanen, P				Hoesein, Firdaus A. A. Mohamed; Wauters, Els; Janssens, Wim; Groen, Harry J. M.; Smolonska, Joanna; Wijmenga, Cisca; Postma, Dirkje S.; Boezen, H. Marike; De Jong, Pim A.; Decramer, Marc; Lammers, Jan-Willem J.; Lambrechts, Diether; Zanen, Pieter			Variants in the 15q24/25 Locus Associate with Lung Function Decline in Active Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; SUSCEPTIBILITY LOCUS; EPITHELIAL-CELLS; CANCER; SMOKING; SUBUNIT; GENES; 15Q25.1	Genetic variation in nicotinic acetylcholine receptor subunit genes (nAChRs) is associated with lung function level and chronic obstructive pulmonary disease (COPD). It is unknown whether these variants also predispose to an accelerated lung function decline. We investigated the association of nAChR susceptibility variants with lung function decline and COPD severity. The rs1051730 and rs8034191 variants were genotyped in a population-based cohort of 1,226 heavy smokers (COPACETIC) and in an independent cohort of 883 heavy smokers, of which 653 with COPD of varying severity (LEUVEN). Participants underwent pulmonary function tests at baseline. Lung function decline was assessed over a median follow-up of 3 years in COPACETIC. Current smokers homozygous for the rs1051730 A-allele or rs8034191 G-allele had significantly greater FEV1/FVC decline than homozygous carriers of wild-type alleles (3.3% and 4.3%, p = 0.026 and p = 0.009, respectively). In the LEUVEN cohort, rs1051730 AA-carriers and rs8034191 GG-carriers had a two-fold increased risk to suffer from COPD GOLD IV (OR 2.29, 95% confidence interval [CI] = 1.11-4.75; p = 0.025 and OR = 2.42, 95% [CI] = 1.18-4.95; p = 0.016, respectively). The same risk alleles conferred, respectively, a five-and four-fold increased risk to be referred for lung transplantation because of end-stage COPD (OR = 5.0, 95% [CI] = 1.68-14.89; p = 0.004 and OR = 4.06, 95% [CI] = 1.39-11.88; p = 0.010). In Europeans, variants in nAChRs associate with an accelerated lung function decline in current smokers and with clinically relevant COPD.	[Hoesein, Firdaus A. A. Mohamed; Lammers, Jan-Willem J.; Zanen, Pieter] Univ Med Ctr, Div Heart & Lungs, Dept Resp Med, Utrecht, Netherlands; [Wauters, Els; Janssens, Wim; Decramer, Marc] Katholieke Univ Leuven, Div Resp, Univ Hosp Gasthuisberg, Louvain, Belgium; [Wauters, Els; Lambrechts, Diether] VIB, Vesalius Res Ctr, Louvain, Belgium; [Wauters, Els; Lambrechts, Diether] Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [Groen, Harry J. M.; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Smolonska, Joanna; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [De Jong, Pim A.] Univ Med Ctr, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center	Hoesein, FAAM (corresponding author), Univ Med Ctr, Div Heart & Lungs, Dept Resp Med, Utrecht, Netherlands.	fmohamedhoesein@gmail.com	Wijmenga, Cisca/D-2173-2009; Groen, Harry/AAP-2242-2021; Wijmenga, Cisca/AAE-7719-2019; de Jong, Pim A/G-7220-2014; Lambrechts, Diether/AAJ-3167-2020	Wijmenga, Cisca/0000-0002-5635-1614; de Jong, Pim A/0000-0003-4840-6854; Lambrechts, Diether/0000-0002-3429-302X; zanen, pieter/0000-0002-5318-8276; Wauters, Els/0000-0002-0115-0030; Janssens, Wim/0000-0003-1830-2982; Groen, Harry J.M./0000-0002-2978-5265	Vlaamse Liga tegen Kanker (VLK); Fund for Scientific Research Flanders (FWO); European Union [201379, COPACETIC]; Zorg Onderzoek Nederland-Medische Wetenschappen; KWF Kankerbestrijding; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; Siemens Germany; G. Ph. Verhagen Stichting; Rotterdam Oncologic Thoracic Steering Committee; Erasmus Trust; Stichting tegen Kanker; AstraZeneca; GSK; Nycomed; Chiesi; Boehringer Ingelheim	Vlaamse Liga tegen Kanker (VLK); Fund for Scientific Research Flanders (FWO)(FWO); European Union(European Commission); Zorg Onderzoek Nederland-Medische Wetenschappen; KWF Kankerbestrijding(KWF Kankerbestrijding); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; Siemens Germany(Siemens AG); G. Ph. Verhagen Stichting; Rotterdam Oncologic Thoracic Steering Committee; Erasmus Trust; Stichting tegen Kanker; AstraZeneca(AstraZeneca); GSK(GlaxoSmithKline); Nycomed; Chiesi(Chiesi Pharmaceuticals Inc); Boehringer Ingelheim(Boehringer Ingelheim)	Supported by the Vlaamse Liga tegen Kanker (VLK) (E. W), the Fund for Scientific Research Flanders (FWO) (W. J. and E. W) and a European Union FP7 grant (201379, COPACETIC) (F. M. H., P. Z., H. J. M. G., D. S. P., C. W., J. S. and J. L.). NELSON was funded by 'Zorg Onderzoek Nederland-Medische Wetenschappen, KWF Kankerbestrijding, Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen, Siemens Germany, G. Ph. Verhagen Stichting, Rotterdam Oncologic Thoracic Steering Committee, Erasmus Trust Fund, Stichting tegen Kanker (P. A. J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DS Postma received funding for research from AstraZeneca, GSK, Nycomed. Travel to ERS or ATS has been partially funded by AstraZeneca, GSK, Chiesi, Nycomed. DS Postma has been consultant to AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Nycomed, TEVA. W Janssens has been consultant and received travel grants from Boehringer Ingelheim, Astra Zeneca, Nycomed. All the other authors state that they have no conflicts of interests. The above commercial funding was not for this specific study. This study was, however, funded by 'Zorg Onderzoek Nederland-Medische Wetenschappen, KWF Kankerbestrijding, Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen, Siemens Germany, G. Ph. Verhagen Stichting, Rotterdam Oncologic Thoracic Steering Committee, Erasmus Trust Fund, Stichting tegen Kanker. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 2009, DRUG ALCOHOL DEPEN, V104, pS64, DOI 10.1016/j.drugalcdep.2009.06.003; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Castaldi PJ, 2011, AM J RESP CELL MOL, V45, P1147, DOI 10.1165/rcmb.2011-0055OC; Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fu XW, 2009, AM J RESP CELL MOL, V41, P93, DOI 10.1165/rcmb.2008-0352OC; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janssens W, 2010, AM J RESP CRIT CARE, V182, P163, DOI 10.1164/rccm.200905-0767OC; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Lambrechts D, 2010, AM J RESP CRIT CARE, V181, P486, DOI 10.1164/rccm.200909-1364OC; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Paliwal A, 2010, CANCER RES, V70, P2779, DOI 10.1158/0008-5472.CAN-09-4550; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Silverman EK, 2009, NEW ENGL J MED, V360, P2749, DOI 10.1056/NEJMcp0900449; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Zhou H, 2012, J HUM GENET IN PRESS	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53219	10.1371/journal.pone.0053219	http://dx.doi.org/10.1371/journal.pone.0053219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349703	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800007
J	Ribeiro, JF; dos Anjos, EHM; Mello, MLS; Vidal, BD				Ribeiro, Juliana Fulan; Martins dos Anjos, Eli Heber; Mello, Maria Luiza S.; Vidal, Benedicto de Campos			Skin Collagen Fiber Molecular Order: A Pattern of Distributional Fiber Orientation as Assessed by Optical Anisotropy and Image Analysis	PLOS ONE			English	Article							FORM BIREFRINGENCE; MACROMOLECULAR ORIENTATION; CHORDAE TENDINEAE; TISSUE; PROTEOGLYCANS; SCATTERING; REPAIR; AGE	Background: Birefringence can reveal much of the morphology, molecular order, heterogeneity of fiber orientation, and nonlinear optical properties of biopolymers such as collagen. However, the detailed characterization of skin collagen fibers using optical anisotropy methods remains elusive. A clear understanding of collagen fiber organization in skin tissues may be important in the interpretation of their structural-functional relationships under normal and pathological conditions. In this study, fiber orientation in collagen bundles (CBs) and their supramolecular organization were examined in rat skin using polarization microscopy and image analysis. Methodology/Principal Findings: Image variations with rotation of the microscope stage and selection of the in-depth focus plane were investigated in unstained sections of varying thicknesses from rat skin fragments. Total birefringence (image analysis) and form and intrinsic birefringence (Senarmont's method) were estimated. Based on the birefringent images, CBs were found to contain intercrossing points with a twisted helical distribution of collagen fibers (chiral elements) and frequently presented circular structures. Collagen fibers were observed to extend from the surface level to deeper planes, creating a 3D-network of oriented intertwined CBs. At least three levels of birefringent brilliance intensity were revealed by image analysis, indicating a heterogeneous spatial organization of the CBs. Slight differences in optical retardations were found for CBs immersed in some of the fluids used in a comparison of 170- and 240-day old rats. Conclusion/Significance: Polarization microscopy studies provide detailed high-quality structural information on rat skin CBs. A 3D-network structure based on image analysis and birefringence compensation for collagen fibers is suggested for CBs. Form and intrinsic birefringence evaluation can reveal differences in the rat skin associated with age at the levels of collagen fiber crystallinity and macromolecular organization. These findings may inspire future studies of the feedback mechanisms by which spatial, bioelectrical and biomechanical information is transmitted from CBs to skin cells.	[Ribeiro, Juliana Fulan; Martins dos Anjos, Eli Heber; Mello, Maria Luiza S.; Vidal, Benedicto de Campos] Univ Campinas Unicamp, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Vidal, BD (corresponding author), Univ Campinas Unicamp, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil.	camposvi@unicamp.br	Mello, Maria Luiza Silveira/D-9158-2012; de Campos Vidal, Benedicto/ABH-6617-2020; Anjos, Eli Heber/ABH-6793-2020; Vidal, Benedicto/I-3227-2012	Mello, Maria Luiza Silveira/0000-0003-1629-5619; de Campos Vidal, Benedicto/0000-0003-0285-1653; Anjos, Eli Heber/0000-0002-9181-715X; Vidal, Benedicto/0000-0003-1629-5619	Sao Paulo State Research Foundation (FAPESP) [2003/04597-0]; Brazilian National Council for Research and Development (CNPq) [501011/2010-2]; CNPq [371286/2011-5]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grant no. 2003/04597-0 from the Sao Paulo State Research Foundation (FAPESP) and grant no. 501011/2010-2 from the Brazilian National Council for Research and Development (CNPq). JFR received a Technical Fellowship from CNPq (371286/2011-5). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aharon O, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3609003; Aldrovani M, 2007, VISION RES, V47, P3229, DOI 10.1016/j.visres.2007.02.011; Aldrovani M, 2007, PROGR BIOPOLYMER RES, P225; Alenin AS, 2011, PROC SPIE, V8160, DOI 10.1117/12.895552; Basil-Jones MM, 2011, J AGR FOOD CHEM, V59, P9972, DOI 10.1021/jf202579b; Beche B, 2003, OPT COMMUN, V219, P15, DOI 10.1016/S0030-4018(03)01291-4; BENNETT HS, 1967, MCCLUNGS HDB MICROSC, P591; Carrino DA, 2011, GLYCOBIOLOGY, V21, P257, DOI 10.1093/glycob/cwq162; CASSIM JY, 1968, BIOCHIM BIOPHYS ACTA, V168, P463, DOI 10.1016/0005-2795(68)90180-3; da Cunha A, 2001, ULTRASOUND MED BIOL, V27, P1691, DOI 10.1016/S0301-5629(01)00477-X; GIBSON T, 1965, BRIT J SURG, V52, P764, DOI 10.1002/bjs.1800521017; HASKELL RC, 1989, BIOPHYS J, V56, P401, DOI 10.1016/S0006-3495(89)82686-4; Jor JWY, 2011, BIOMECH MODEL MECHAN, V10, P767, DOI 10.1007/s10237-010-0272-0; Liu B, 2006, APPL OPTICS, V45, P4464, DOI 10.1364/AO.45.004464; MELLO MLS, 1973, ANN HISTOCHIM, V18, P103; MELLO MLS, 1979, GERONTOLOGY, V25, P2, DOI 10.1159/000212314; MELLO MLS, 1975, ANN HISTOCHIM, V20, P145; Okamoto N, 2010, J BONE JOINT SURG AM, V92A, P2776, DOI 10.2106/JBJS.I.01325; Park J, 2009, OPT EXPRESS, V17, P13402, DOI 10.1364/OE.17.013402; ROTH S, 1981, BIOPOLYMERS, V20, P1271, DOI 10.1002/bip.1981.360200613; ROTH S, 1982, J APPL CRYSTALLOGR, V15, P72, DOI 10.1107/S0021889882011376; Sakai S, 2008, J INVEST DERMATOL, V128, P1641, DOI 10.1038/jid.2008.8; Sakai S, 2011, PROC SPIE, V7883, DOI 10.1117/12.873501; Verhaegen PDHM, 2010, SKIN RES TECHNOL, V16, P325, DOI 10.1111/j.1600-0846.2010.00436.x; Vidal BC, 2010, BIOTECH HISTOCHEM, V85, P365, DOI 10.3109/10520290903430496; Vidal BD, 2003, MICRON, V34, P423, DOI 10.1016/S0968-4328(03)00039-8; VIDAL BD, 1980, CELL MOL BIOL, V26, P415; VIDAL BD, 1988, ACTA HISTOCHEM, V83, P189; VIDAL BD, 1986, CELL MOL BIOL, V32, P527; VIDAL BD, 1965, PROTOPLASMA, V59, P472, DOI 10.1007/BF01252450; VIDAL BDC, 1977, CELL MOL BIOL, V22, P45; Vidal BD, 2010, ACTA HISTOCHEM, V112, P53, DOI 10.1016/j.acthis.2008.07.005; Vidal BD, 2009, J STRUCT BIOL, V167, P166, DOI 10.1016/j.jsb.2009.05.004; VILARTA R, 1989, MATRIX, V9, P55, DOI 10.1016/S0934-8832(89)80019-8; WHITTAKER P, 1987, BRIT HEART J, V57, P264; Zubarev ER, 1999, SCIENCE, V283, P523, DOI 10.1126/science.283.5401.523	36	39	40	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54724	10.1371/journal.pone.0054724	http://dx.doi.org/10.1371/journal.pone.0054724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349957	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800072
J	Wang, YB; Liu, YF; Lu, XT; Yan, FF; Wang, B; Bai, WW; Zhao, YX				Wang, Ying-Bin; Liu, Yun-Fang; Lu, Xiao-Ting; Yan, Fang-Fang; Wang, Bo; Bai, Wen-Wu; Zhao, Yu-Xia			Rehmannia Glutinosa Extract Activates Endothelial Progenitor Cells in a Rat Model of Myocardial Infarction through a SDF-1 alpha/CXCR4 Cascade	PLOS ONE			English	Article							CORONARY-ARTERY DISEASE; STEM-CELLS; BONE-MARROW; CXCR4 RECEPTOR; TRANSPLANTATION; EXPRESSION; BINDING; REPAIR; HEART; DIFFERENTIATION	Objectives: Endothelial progenitor cells (EPCs) can be used to repair tissues after myocardial infarction (MI) but EPC activators have adverse reactions. Rehmannia glutinosa is a herb used in traditional Chinese medicine, which can promote bone-marrow proliferation and protect the ischemic myocardium. We investigated the effects of Rehmannia glutinosa extract (RGE) on EPCs in a rat model of MI. Methods: A total of 120 male Wistar rats were randomized to 2 groups (n = 60 each) for treatment: high-dose RGE (1.5 g.kg(-1).day(-1) orally) for 8 weeks, then left anterior descending coronary artery ligation, mock surgery or no treatment, then RGE orally for 4 weeks; or normal saline (NS) as the above protocol. The infarct region of the left ventricle was assessed by serial sectioning and morphology. EPCs were evaluated by number and function. Protein and mRNA levels of CD133, vascular endothelial growth factor receptor 2 (VEGFR2), chemokine C-X-C motif receptor 4 (CXCR4), stromal cell-derived factor-1 alpha (SDF-1 alpha) were measured by immunohistochemistry, Western blot and quantitative PCR analysis. Results: RGE significantly improved left ventricular function, decreased the ischemic area and the apoptotic index in the infarct myocardium, also decreased the concentration of serum cardiac troponin T and brain natriuretic peptide at the chronic stage after MI (from week 2 to week 4). RGE increased EPC number, proliferation, migration and tube-formation capacity. It was able to up-regulate the expression of angiogenesis-associated ligand/receptor, including CD133, VEGFR2 and SDF-1 alpha/CXCR4. In vitro, the effect of RGE on SDF-1 alpha/CXCR4 cascade was reversed by the CXCR4 specific antagonist AMD3100. Conclusion: RGE may enhance the mobilization, migration and therapeutic angiogenesis of EPCs after MI by activating the SDF-1 alpha/CXCR4 cascade.	[Wang, Ying-Bin; Lu, Xiao-Ting; Bai, Wen-Wu] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Wang, Ying-Bin; Yan, Fang-Fang; Wang, Bo; Zhao, Yu-Xia] Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan, Shandong, Peoples R China; [Liu, Yun-Fang] Shandong Univ, Dept Diag, Coll Med, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Zhao, YX (corresponding author), Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan, Shandong, Peoples R China.	yuxia_zhao@126.com			National 973 Basic Research Program of China [2012CB518603]; National Natural Science Foundation of China [30873325, 81100103, 81173251]; Natural Science Foundation of Shandong Province [ZR2011HQ020, ZR2009CM049]; postdoctoral special foundation for innovative projects of Shandong Province [201103049]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); postdoctoral special foundation for innovative projects of Shandong Province	This study was partially supported by grants from the National 973 Basic Research Program of China (No. 2012CB518603), National Natural Science Foundation of China (Nos. 30873325, 81100103, 81173251), Natural Science Foundation of Shandong Province (Nos. ZR2011HQ020, ZR2009CM049), and postdoctoral special foundation for innovative projects of Shandong Province (No. 201103049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Caplice NM, 2003, CIRC RES, V92, P6, DOI 10.1161/01.RES.0000052826.35667.40; Chae HJ, 2005, LIFE SCI, V76, P2027, DOI 10.1016/j.lfs.2004.07.032; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa; de Lemos JA, 2002, CIRCULATION, V106, P2868, DOI 10.1161/01.CIR.0000042763.07757.C0; Frederick JR, 2010, CIRCULATION, V122, pS107, DOI 10.1161/CIRCULATIONAHA.109.930404; Gehling UM, 2000, BLOOD, V95, P3106; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Huang XQ, 2003, BIOPHYS J, V84, P171, DOI 10.1016/S0006-3495(03)74840-1; Iwami Y, 2004, J CELL MOL MED, V8, P488, DOI 10.1111/j.1582-4934.2004.tb00473.x; Jiang L, 2008, BIOCHEM BIOPH RES CO, V371, P185, DOI 10.1016/j.bbrc.2008.03.129; Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4; Kawamoto A, 2001, CIRCULATION, V103, P634; Kucia M, 2005, LEUKEMIA, V19, P1118, DOI 10.1038/sj.leu.2403796; LIU FJ, 1994, CHIN J PHAM TOXICOL, V8, P118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0; OSHIO H, 1981, Shoyakugaku Zasshi, V35, P291; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Rae PC, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-11; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rosenkilde MM, J BIOL CHEM, V279, P3033; Shi AW, 2009, ACTA PHARMACOL SIN, V30, P299, DOI 10.1038/aps.2009.6; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Wojciech W, 2005, FOLIA HISTOCHEM CYTO, V43, P229; Yu Z, 2001, J TRANDIT CHIN MED, V28, P240; Zhang L, 2006, EUR J HAEMATOL, V76, P1, DOI 10.1111/j.1600-0609.2005.00579.x; Zhang RX, 2008, J ETHNOPHARMACOL, V117, P199, DOI 10.1016/j.jep.2008.02.018	40	18	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54303	10.1371/journal.pone.0054303	http://dx.doi.org/10.1371/journal.pone.0054303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349848	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800038
J	Gupta, V; Vinay, DG; Sovio, U; Rafiq, S; Kumar, MVK; Janipalli, CS; Evans, D; Mani, KR; Sandeep, MN; Taylor, A; Kinra, S; Sullivan, R; Bowen, L; Timpson, N; Smith, GD; Dudbridge, F; Prabhakaran, D; Ben-Shlomo, Y; Reddy, KS; Ebrahim, S; Chandak, GR				Gupta, Vipin; Vinay, Donipadi Guru; Sovio, Ulla; Rafiq, Sajjad; Kumar, Madamchetty Venkata Kranthi; Janipalli, Charles Spurgeon; Evans, David; Mani, Kulathu Radha; Sandeep, Madana Narasimha; Taylor, Amy; Kinra, Sanjay; Sullivan, Ruth; Bowen, Liza; Timpson, Nicholas; Smith, George Davey; Dudbridge, Frank; Prabhakaran, Dorairaj; Ben-Shlomo, Yoav; Reddy, Kolli Srinath; Ebrahim, Shah; Chandak, Giriraj Ratan		Indian Migration Study Grp	Association Study of 25 Type 2 Diabetes Related Loci with Measures of Obesity in Indian Sib Pairs	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; METABOLIC TRAITS; GENETIC-VARIANTS; FTO GENE; RISK; METAANALYSIS; INDIVIDUALS; REPLICATION; LINKAGE	Obesity is an established risk factor for type 2 diabetes (T2D) and they are metabolically related through the mechanism of insulin resistance. In order to explore how common genetic variants associated with T2D correlate with body mass index (BMI), we examined the influence of 25 T2D associated loci on obesity risk. We used 5056 individuals (2528 sib-pairs) recruited in Indian Migration Study and conducted within sib-pair analysis for six obesity phenotypes. We found associations of variants in CXCR4 (rs932206) and HHEX (rs5015480) with higher body mass index (BMI) (b = 0.13, p = 0.001) and (beta = 0.09, p = 0.002), respectively and weight (beta = 0.13, p = 0.001) and (beta = 0.09, p = 0.001), respectively. CXCR4 variant was also strongly associated with body fat (beta = 0.10, p = 0.0004). In addition, we demonstrated associations of CXCR4 and HHEX with overweight/obesity (OR = 1.6, p = 0.003) and (OR = 1.4, p = 0.002), respectively, in 1333 sib-pairs (2666 individuals). We observed marginal evidence of associations between variants at six loci (TCF7L2, NGN3, FOXA2, LOC646279, FLJ3970 and THADA) and waist hip ratio (WHR), BMI and/or overweight which needs to be validated in larger set of samples. All the above findings were independent of daily energy consumption and physical activity level. The risk score estimates based on eight significant loci (including nominal associations) showed associations with WHR and body fat which were independent of BMI. In summary, we establish the role of T2D associated loci in influencing the measures of obesity in Indian population, suggesting common underlying pathophysiology across populations.	[Gupta, Vipin; Reddy, Kolli Srinath; Ebrahim, Shah] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India; [Vinay, Donipadi Guru; Kumar, Madamchetty Venkata Kranthi; Janipalli, Charles Spurgeon; Mani, Kulathu Radha; Sandeep, Madana Narasimha; Chandak, Giriraj Ratan] CSIC, CCMB, Hyderabad, Andhra Pradesh, India; [Sovio, Ulla; Kinra, Sanjay; Sullivan, Ruth; Bowen, Liza; Dudbridge, Frank; Ebrahim, Shah] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Rafiq, Sajjad] Univ Southampton, Southampton, Hants, England; [Evans, David; Taylor, Amy; Timpson, Nicholas; Smith, George Davey; Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Evans, David; Taylor, Amy; Timpson, Nicholas; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India	Public Health Foundation of India; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of London; London School of Hygiene & Tropical Medicine; University of Southampton; University of Bristol; University of Bristol	Gupta, V (corresponding author), Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India.	udaiig@gmail.com; chandakgrc@ccmb.res.in	Sovio, Ulla/H-8532-2019; Bowen, Liza/AAA-5502-2019; Davey Smith, George/A-7407-2013; Gupta, Vipin/D-1704-2014; Prabhakaran, Dorairaj/B-4147-2011; Timpson, Nicholas John/O-7548-2015; Fox, Laura J/C-6249-2016; Attrill, Lauren/V-1688-2018; Ben-Shlomo, Yoav/ABD-2004-2021; Evans, David/H-6325-2013	Sovio, Ulla/0000-0002-0799-1105; Davey Smith, George/0000-0002-1407-8314; Gupta, Vipin/0000-0002-0607-5543; Prabhakaran, Dorairaj/0000-0002-3172-834X; Timpson, Nicholas John/0000-0002-7141-9189; Ben-Shlomo, Yoav/0000-0001-6648-3007; Evans, David/0000-0003-0663-4621; Bowen, Liza/0000-0001-8318-8421; Reddy, K Srinath/0000-0003-3416-3548; Chandak, Giriraj Ratan/0000-0002-3095-9453; Rafiq, Sajjad/0000-0003-4873-4540	Wellcome Trust [GR070797MF, 083541/Z/07/Z]; Wellcome Trust Sabbatical Award [089645/Z/09/Z]; MRC [G1000718] Funding Source: UKRI; Medical Research Council [G1000718] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Wellcome Trust Sabbatical Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Indian Migration Study was funded by the Wellcome Trust (grant number GR070797MF). The genetic work was funded by a project grant from the Wellcome Trust (083541/Z/07/Z). GDS was supported by a Wellcome Trust Sabbatical Award (089645/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson P, 2004, SCIENCE, V304, P1413, DOI 10.1126/science.304.5676.1413; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; Been LF, 2010, OBESITY, V18, P425, DOI 10.1038/oby.2009.254; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Bowen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014822; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Freathy RM, 2009, DIABETES, V58, P1428, DOI 10.2337/db08-1739; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Gupta V, 2012, DIABETOLOGIA, V55, P349, DOI 10.1007/s00125-011-2355-6; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Janipalli CS, 2012, DIABETIC MED, V29, P121, DOI 10.1111/j.1464-5491.2011.03438.x; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Li S, 2011, DIABETOLOGIA, V54, P776, DOI 10.1007/s00125-011-2044-5; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Pecioska S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008541; Puigserver P, 2006, NAT MED, V12, P38, DOI 10.1038/nm0106-38; PURCELL S, 2003, BIOINFORMATICS, V19, P149, DOI [DOI 10.1093/BIOINFORMATICS/19.1.149, 10.1093/bioinformatics/19.1.149]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramya K., 2011, DIABETES TECHNOL THE, V13, P33, DOI DOI 10.1089/dia.2010.0071; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tabassum R, 2008, J HUM GENET, V53, P957, DOI 10.1007/s10038-008-0335-6; Tabassum R, 2012, DIABETES, V61, P626, DOI 10.2337/db11-1501; Taylor AE, 2011, J OBES, V2011, DOI 10.1155/2011/307542; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang X, 2009, DIABETOLOGIA, V52, P2578, DOI 10.1007/s00125-009-1524-3; WHO, 2004, LANCET, V363, P902; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhao JH, 2010, DIABETES, V59, P751, DOI 10.2337/db09-0972	41	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53944	10.1371/journal.pone.0053944	http://dx.doi.org/10.1371/journal.pone.0053944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349771	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000313738900029
J	Maltby, R; Leatham-Jensen, MP; Gibson, T; Cohen, PS; Conway, T				Maltby, Rosalie; Leatham-Jensen, Mary P.; Gibson, Terri; Cohen, Paul S.; Conway, Tyrrell			Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CARBON NUTRITION; IN-VITRO; MODELS; STREPTOMYCIN; MICROBIOTA; VIRULENCE; MUTANTS; ENTEROTOXINS; RESPIRATION	Escherichia coli is a single species consisting of many biotypes, some of which are commensal colonizers of mammals and others that cause disease. Humans are colonized on average with five commensal biotypes, and it is widely thought that the commensals serve as a barrier to infection by pathogens. Previous studies showed that a combination of three pre-colonized commensal E. coli strains prevents colonization of E. coli O157:H7 in a mouse model (Leatham, et al., 2010, Infect Immun 77: 2876-7886). The commensal biotypes included E. coli HS, which is known to successfully colonize humans at high doses with no adverse effects, and E. coli Nissle 1917, a human commensal strain that is used in Europe as a preventative of traveler's diarrhea. We hypothesized that commensal biotypes could exert colonization resistance by consuming nutrients needed by E. coli O157: H7 to colonize, thus preventing this first step in infection. Here we report that to colonize streptomycin-treated mice E. coli HS consumes six of the twelve sugars tested and E. coli Nissle 1917 uses a complementary yet divergent set of seven sugars to colonize, thus establishing a nutritional basis for the ability of E. coli HS and Nissle 1917 to occupy distinct niches in the mouse intestine. Together these two commensals use the five sugars previously determined to be most important for colonization of E. coli EDL933, an O157:H7 strain. As predicted, the two commensals prevented E. coli EDL933 colonization. The results support a model in which invading pathogenic E. coli must compete with the gut microbiota to obtain the nutrients needed to colonize and establish infection; accordingly, the outcome of the challenge is determined by the aggregate capacity of the native microbiota to consume the nutrients required by the pathogen.	[Maltby, Rosalie; Gibson, Terri; Conway, Tyrrell] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Leatham-Jensen, Mary P.; Cohen, Paul S.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Rhode Island	Conway, T (corresponding author), Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.	tconway@ou.edu		Maltby, Rosalie/0000-0002-7278-9544	Public Health Service [AI48945, GM095370]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048945, R01AI048945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095370] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Public Health Service grants AI48945 and GM095370 to TC and PSC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MMWR RECOMM REP, V60, P1762; [Anonymous], 2009, NAT DIG DIS INF; APPERLOORENKEMA HZ, 1990, EPIDEMIOL INFECT, V105, P355, DOI 10.1017/S0950268800047944; Araya M, 2001, JOINT FAO WHO EXPERT; Autieri SM, 2007, INFECT IMMUN, V75, P5465, DOI 10.1128/IAI.00822-07; BARKULIS IL, 1953, J BACTERIOL, V65, P337, DOI 10.1128/JB.65.3.337-343.1953; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bjarnason A, 2008, LANCET, V372, P114, DOI 10.1016/S0140-6736(08)61028-4; Bleich A, 2008, INT J EXP PATHOL, V89, P45, DOI 10.1111/j.1365-2613.2007.00560.x; Bryan A, 2006, INFECT IMMUN, V74, P1072, DOI 10.1128/IAI.74.2.1072-1083.2006; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; FORMAL SB, 1971, ANN NY ACAD SCI, V176, P190, DOI 10.1111/j.1749-6632.1971.tb35004.x; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franklin T.J., 2005, BIOCH MOL BIOL ANTIM, P121; FRETER R, 1983, INFECT IMMUN, V39, P666, DOI 10.1128/IAI.39.2.666-675.1983; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; FRETER R, 1983, REV INFECT DIS, V5, pS647; FRETER R, 1983, INFECT IMMUN, V39, P686, DOI 10.1128/IAI.39.2.686-703.1983; FRETER R, 1983, INFECT IMMUN, V39, P60, DOI 10.1128/IAI.39.1.60-84.1983; Gronbach K, 2010, INFECT IMMUN, V78, P3036, DOI 10.1128/IAI.00218-10; HENRY RJ, 1949, J BACTERIOL, V57, P447, DOI 10.1128/JB.57.4.447-451.1949; Hentges D., 1984, MICROECOL THER, V14, P53; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; Jones SA, 2011, INFECT IMMUN, V79, P4218, DOI 10.1128/IAI.05395-11; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Leatham MP, 2009, INFECT IMMUN, V77, P2876, DOI 10.1128/IAI.00059-09; Leatham MP, 2005, INFECT IMMUN, V73, P8039, DOI 10.1128/IAI.73.12.8039-8049.2005; Leatham-Jensen MP, 2012, INFECT IMMUN, V80, P1716, DOI 10.1128/IAI.06193-11; LeDoux D, 2006, INT J STD AIDS, V17, P280, DOI 10.1258/095646206776253507; LEVINE MM, 1978, LANCET, V1, P1119; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; NISSLE A, 1951, Z Klin Med, V2, P68; PAINE TF, 1953, SCIENCE, V118, P73, DOI 10.1126/science.118.3055.73; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Plumbridge J, 2009, J BACTERIOL, V191, P5641, DOI 10.1128/JB.00448-09; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; ROBINSBROWNE RM, 1982, INFECT IMMUN, V38, P798, DOI 10.1128/IAI.38.2.798-801.1982; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Schumann S, 2011, APPL ENVIRON MICROB; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tilman D., 1982, Monographs in Population Biology, pi; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; UMBREIT WW, 1949, J BIOL CHEM, V177, P703; WELLS CL, 1987, INFECT IMMUN, V55, P2689, DOI 10.1128/IAI.55.11.2689-2694.1987; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	64	145	149	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53957	10.1371/journal.pone.0053957	http://dx.doi.org/10.1371/journal.pone.0053957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349773	Green Published, gold			2022-12-27	WOS:000313738900030
J	Reichmann, F; Painsipp, E; Holzer, P				Reichmann, Florian; Painsipp, Evelin; Holzer, Peter			Environmental Enrichment and Gut Inflammation Modify Stress-Induced c-Fos Expression in the Mouse Corticolimbic System	PLOS ONE			English	Article							HYPOTHALAMIC MAGNOCELLULAR NEURONS; WATER-AVOIDANCE STRESS; PSYCHOLOGICAL STRESS; PREFRONTAL CORTEX; HIPPOCAMPAL NEUROGENESIS; MUCOSAL PERMEABILITY; NEUROTROPHIN LEVELS; RESTRAINT STRESS; INDUCED COLITIS; BRAIN	Environmental enrichment (EE) has a beneficial effect on rodent behaviour, neuronal plasticity and brain function. Although it may also improve stress coping, it is not known whether EE influences the brain response to an external (psychological) stressor such as water avoidance stress (WAS) or an internal (systemic) stressor such as gastrointestinal inflammation. This study hence explored whether EE modifies WAS-induced activation of the mouse corticolimbic system and whether this stress response is altered by gastritis or colitis. Male C67BL/6N mice were housed under standard or enriched environment for 9 weeks, after which they were subjected to a 1-week treatment with oral iodoacetamide to induce gastritis or oral dextran sulfate sodium to induce colitis. Following exposure to WAS the expression of c-Fos, a marker of neuronal activation, was measured by immunocytochemistry. EE aggravated experimentally induced colitis, but not gastritis, as shown by an increase in the disease activity score and the colonic myeloperoxidase content. In the brain, EE enhanced the WAS-induced activation of the dentate gyrus and unmasked an inhibitory effect of gastritis and colitis on WAS-evoked c-Fos expression within this part of the hippocampus. Conversely, EE inhibited the WAS-evoked activation of the central amygdala and prevented the inhibitory effect of gastritis and colitis on WAS-evoked c-Fos expression in this region. EE, in addition, blunted the WAS-induced activation of the infralimbic cortex and attenuated the inhibitory effect of gastritis and colitis on WAS-evoked c-Fos expression in this area. These data reveal that EE has a region-specific effect on stress-induced c-Fos expression in the corticolimbic system, which is likely to improve stress resilience. The response of the prefrontal cortex - amygdala - hippocampus circuitry to psychological stress is also modified by the systemic stress of gut inflammation, and this interaction between external and internal stressors is modulated by the housing environment.	[Reichmann, Florian; Painsipp, Evelin; Holzer, Peter] Med Univ Graz, Res Unit Translat Neurogastroenterol, Inst Expt & Clin Pharmacol, Graz, Austria	Medical University of Graz	Reichmann, F (corresponding author), Med Univ Graz, Res Unit Translat Neurogastroenterol, Inst Expt & Clin Pharmacol, Graz, Austria.	florian.reichmann@medunigraz.at	Holzer, Peter/F-7578-2011; Reichmann, Florian/Q-1279-2019	Holzer, Peter/0000-0002-5754-395X; Reichmann, Florian/0000-0002-5833-3698	Federal Ministry of Science and Research of the Republic of Austria [GZ 80.104/2-BrGT/2007]; Zukunftsfonds Steiermark [262]	Federal Ministry of Science and Research of the Republic of Austria; Zukunftsfonds Steiermark	This study was supported by the Federal Ministry of Science and Research of the Republic of Austria (URL: http://www.bmwf.gv.at/home/, grant GZ 80.104/2-BrGT/2007) and the Zukunftsfonds Steiermark (URL:http://www.zukunftsfonds.steiermark.at/, grant 262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 2001, EUR J NEUROSCI, V14, P719, DOI 10.1046/j.0953-816x.2001.01687.x; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Amaral OB, 2008, PHYSIOL BEHAV, V93, P388, DOI 10.1016/j.physbeh.2007.09.009; Belz EE, 2003, PHARMACOL BIOCHEM BE, V76, P481, DOI 10.1016/j.pbb.2003.09.005; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; BONAZ B, 1994, BRAIN RES, V641, P21, DOI 10.1016/0006-8993(94)91810-4; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Brenes JC, 2009, BEHAV BRAIN RES, V197, P125, DOI 10.1016/j.bbr.2008.08.014; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Busnardo C, 2010, AUTON NEUROSCI-BASIC, V158, P51, DOI 10.1016/j.autneu.2010.06.003; Cakir B, 2004, PEPTIDES, V25, P95, DOI 10.1016/j.peptides.2003.11.005; Cetinel S, 2010, REGUL PEPTIDES, V160, P146, DOI 10.1016/j.regpep.2009.11.011; Chang L, 2011, GASTROENTEROLOGY, V140, P761, DOI 10.1053/j.gastro.2011.01.032; DAVIS S, 1992, J NEUROSCI, V12, P21; de Sousa AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015597; Eijkelkamp N, 2007, AM J PHYSIOL-GASTR L, V293, pG749, DOI 10.1152/ajpgi.00114.2007; Elsenbruch S, 2010, GASTROENTEROLOGY, V139, P1310, DOI 10.1053/j.gastro.2010.06.054; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Gabriel AF, 2010, BEHAV BRAIN RES, V208, P90, DOI 10.1016/j.bbr.2009.11.015; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Green TA, 2010, BIOL PSYCHIAT, V67, P28, DOI 10.1016/j.biopsych.2009.06.022; Harbuz MS, 1999, BRAIN BEHAV IMMUN, V13, P335, DOI 10.1006/brbi.1998.0536; Hays W., 2007, STATISTICS; Hendriksen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011943; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Ibeakanma C, 2011, GASTROENTEROLOGY, V141, P2098, DOI 10.1053/j.gastro.2011.08.006; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Ishikawa A, 2003, J NEUROSCI, V23, P9987; Iwaya H, 2012, EXP BIOL MED, V237, P451, DOI 10.1258/ebm.2011.011269; Jennings M, 1998, LAB ANIM-UK, V32, P233, DOI 10.1258/002367798780559301; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim JJ, 2001, J NEUROSCI, V21, P5222, DOI 10.1523/JNEUROSCI.21-14-05222.2001; Kirk RE, 1995, EXPT DESIGN; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kresse AE, 2001, AM J PHYSIOL-GASTR L, V281, pG1203, DOI 10.1152/ajpgi.2001.281.5.G1203; Lamb K, 2003, GASTROENTEROLOGY, V125, P1410, DOI 10.1016/j.gastro.2003.07.010; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Larsson M H, 2009, Stress, V12, P434, DOI 10.1080/10253890802626603; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Lin EJD, 2011, BEHAV BRAIN RES, V216, P349, DOI 10.1016/j.bbr.2010.08.019; Llorens-Martin MV, 2007, NEUROSCIENCE, V147, P631, DOI 10.1016/j.neuroscience.2007.04.054; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; LUCKMAN SM, 1994, J NEUROSCI, V14, P4825; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Melgar S, 2008, STRESS, V11, P348, DOI 10.1080/10253890701820166; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Mitrovic M, 2010, BRIT J PHARMACOL, V160, P1430, DOI 10.1111/j.1476-5381.2010.00794.x; Moncek F, 2004, J NEUROENDOCRINOL, V16, P423, DOI 10.1111/j.1365-2826.2004.01173.x; Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011; Morley-Fletcher S, 2003, EUR J NEUROSCI, V18, P3367, DOI 10.1111/j.1460-9568.2003.03070.x; Nagalingam NA, 2011, INFLAMM BOWEL DIS, V17, P917, DOI 10.1002/ibd.21462; O'Mahony CM, 2010, BEHAV BRAIN RES, V213, P148, DOI 10.1016/j.bbr.2010.04.038; Painsipp E, 2007, NEUROSCIENCE, V150, P522, DOI 10.1016/j.neuroscience.2007.09.024; Painsipp E, 2011, BRIT J PHARMACOL, V163, P1302, DOI 10.1111/j.1476-5381.2011.01326.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Pinard CR, 2012, NEUROSCIENCE, V205, P112, DOI 10.1016/j.neuroscience.2011.12.036; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Rizzi S, 2011, BRAIN RES, V1415, P23, DOI 10.1016/j.brainres.2011.08.007; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Schrijver NCA, 2002, PHARMACOL BIOCHEM BE, V73, P209, DOI 10.1016/S0091-3057(02)00790-6; Segovia G, 2008, NEUROCHEM INT, V52, P1198, DOI 10.1016/j.neuint.2007.12.007; Segovia G, 2008, BEHAV BRAIN RES, V187, P304, DOI 10.1016/j.bbr.2007.09.024; Senba E, 1997, NEUROSCI RES, V29, P183, DOI 10.1016/S0168-0102(97)00095-3; Sherwin CM, 1997, LAB ANIM, V31, P125, DOI 10.1258/002367797780600134; Shum FWF, 2007, LEARN MEMORY, V14, P304, DOI 10.1101/lm.530607; Snoek SA, 2010, EXPERT REV GASTROENT, V4, P637, DOI [10.1586/egh.10.51, 10.1586/EGH.10.51]; Spannuth BM, 2011, NEUROSCIENCE, V179, P104, DOI 10.1016/j.neuroscience.2011.01.042; Sundquist SJ, 2005, J NEUROSCI METH, V141, P9, DOI 10.1016/j.jneumeth.2004.05.007; Sztainberg Y, 2010, MOL PSYCHIATR, V15, P905, DOI 10.1038/mp.2009.151; Tache Y, 2004, NEUROGASTROENT MOTIL, V16, P137, DOI 10.1111/j.1743-3150.2004.00490.x; Tall JM, 2009, BEHAV BRAIN RES, V197, P230, DOI 10.1016/j.bbr.2008.08.010; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Van de Weerd Heleen A., 2002, Journal of Applied Animal Welfare Science, V5, P87, DOI 10.1207/S15327604JAWS0502_01; Van Loo PLP, 2004, LAB ANIM-UK, V38, P169, DOI 10.1258/002367704322968858; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152; Velin AK, 2004, GUT, V53, P494, DOI 10.1136/gut.2003.028506; von Bohlen und Halbach O, 2002, NEUROSCI RES, V44, P91, DOI 10.1016/S0168-0102(02)00092-5; Winer B.J., 1991, STAT PRINCIPLES EXPT; Wultsch T, 2008, PAIN, V134, P245, DOI 10.1016/j.pain.2007.04.025; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Zhu SW, 2006, BEHAV BRAIN RES, V169, P10, DOI 10.1016/j.bbr.2005.11.024; Zimmermann A, 2001, BEHAV BRAIN RES, V121, P11, DOI 10.1016/S0166-4328(00)00377-6	101	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54811	10.1371/journal.pone.0054811	http://dx.doi.org/10.1371/journal.pone.0054811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349972	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900084
J	Benoit, J; Adnet, S; El Mabrouk, E; Khayati, H; Ali, MB; Marivaux, L; Merzeraud, G; Merigeaud, S; Vianey-Liaud, M; Tabuce, R				Benoit, Julien; Adnet, Sylvain; El Mabrouk, Essid; Khayati, Hayet; Ali, Mustapha Ben Haj; Marivaux, Laurent; Merzeraud, Gilles; Merigeaud, Samuel; Vianey-Liaud, Monique; Tabuce, Rodolphe			Cranial Remain from Tunisia Provides New Clues for the Origin and Evolution of Sirenia (Mammalia, Afrotheria) in Africa	PLOS ONE			English	Article							NUMIDOTHERIUM-KOHOLENSE; EAR REGION; EOCENE; PROBOSCIDEA; ANATOMY	Sea cows (manatees, dugongs) are the only living marine mammals to feed solely on aquatic plants. Unlike whales or dolphins (Cetacea), the earliest evolutionary history of sirenians is poorly documented, and limited to a few fossils including skulls and skeletons of two genera composing the stem family of Prorastomidae (Prorastomus and Pezosiren). Surprisingly, these fossils come from the Eocene of Jamaica, while stem Hyracoidea and Proboscidea - the putative sister-groups to Sirenia - are recorded in Africa as early as the Late Paleocene. So far, the historical biogeography of early Sirenia has remained obscure given this paradox between phylogeny and fossil record. Here we use X-ray microtomography to investigate a newly discovered sirenian petrosal from the Eocene of Tunisia. This fossil represents the oldest occurrence of sirenians in Africa. The morphology of this petrosal is more primitive than the Jamaican prorastomids' one, which emphasizes the basal position of this new African taxon within the Sirenia clade. This discovery testifies to the great antiquity of Sirenia in Africa, and therefore supports their African origin. While isotopic analyses previously suggested sirenians had adapted directly to the marine environment, new paleoenvironmental evidence suggests that basal-most sea cows were likely restricted to fresh waters.	[Benoit, Julien; Adnet, Sylvain; Marivaux, Laurent; Vianey-Liaud, Monique; Tabuce, Rodolphe] Univ Montpellier 2, Inst Sci Evolut, Montpellier, France; [El Mabrouk, Essid; Khayati, Hayet; Ali, Mustapha Ben Haj] Off Natl Mines, Tunis, Tunisia; [Merigeaud, Samuel] CHU Montpellier, Hop Lapeyronie, Serv Imagerie Med, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Office National des Mines; Universite de Montpellier; CHU de Montpellier	Benoit, J (corresponding author), Univ Montpellier 2, Inst Sci Evolut, Montpellier, France.	Julien.benoit@univ-montp2.fr		Tabuce, Rodolphe/0000-0002-4713-3981; Benoit, Julien/0000-0001-5378-3940	Agence nationale de la recherche (ANR) (Conseil Europeen de la Recherche (ERC) programme Palasiafrica [ANR-08-JCJC-0017-01]	Agence nationale de la recherche (ANR) (Conseil Europeen de la Recherche (ERC) programme Palasiafrica(French National Research Agency (ANR))	This work has been conducted with the support of the Agence nationale de la recherche (ANR) (Conseil Europeen de la Recherche (ERC) programme Palasiafrica (ANR-08-JCJC-0017-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1913, Palaeontographica Stuttgart, V59, P289; Adaci M, 2007, CR PALEVOL, V6, P535, DOI 10.1016/j.crpv.2007.09.001; Badiola A, 2011, INT SENCK C 22, P22; Beatty BL, 2010, NEUES JAHRB GEOL P-A, V258, P185, DOI 10.1127/0077-7749/2010/0095; Benoit J, 2012, J SYST PALE IN PRESS; CIFELLI RL, 1982, J PALEONTOL, V56, P795; Clementz MT, 2006, J VERTEBR PALEONTOL, V26, P355, DOI 10.1671/0272-4634(2006)26[355:IRFEWA]2.0.CO;2; Clementz MT, 2003, PALEOBIOLOGY, V29, P506, DOI 10.1666/0094-8373(2003)029<0506:APPTHA>2.0.CO;2; COURT N, 1994, ZOOL J LINN SOC-LOND, V112, P13, DOI 10.1006/zjls.1994.1032; Court N., 1990, Journal of Vertebrate Paleontology, V10, P170; COURT N, 1994, ZOOL J LINN SOC-LOND, V111, P297, DOI 10.1111/j.1096-3642.1994.tb01487.x; COURT N, 1992, LETHAIA, V25, P211, DOI 10.1111/j.1502-3931.1992.tb01385.x; Court Nicholas, 1993, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V226, P125; Domning D.P., 1982, Smithsonian Contributions to Paleobiology, P1; Domning Daryl P., 2010, P147; Domning Daryl P., 1994, Proceedings of the San Diego Society of Natural History, V29, P177; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; Domning DP, 2012, SIRENIA DUGONGS MANA, DOI 101002/9780470015902a0001576pub3; Ekdale EG, 2009, THESIS U TEXAS AUSTI; Ekdale EG, 2011, J MORPHOL, V272, P452, DOI 10.1002/jmor.10924; Fischer MS, 1993, MAMMAL PHYLOGENY, P217; Gaeth AP, 1999, P NATL ACAD SCI USA, V96, P5555, DOI 10.1073/pnas.96.10.5555; Gheerbrant E, 2005, GEODIVERSITAS, V27, P239; Gheerbrant Emmanuel, 2005, P84; Gheerbrant E, 2009, P NATL ACAD SCI USA, V106, P10717, DOI 10.1073/pnas.0900251106; Gingerich PD., 1994, CONTRIBUTIONS MUSEUM, V29, P41; Hartenberger JL, 2001, T GEOBIOL, V18, P237; Hautier L, 2012, J VERTEBR PALEONTOL, V32, P1218, DOI 10.1080/02724634.2012.687421; KETTEN DR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P717; KETTEN DR, 1992, MARINE MAMMAL SENSORY SYSTEMS, P77; Liu AGSC, 2008, P NATL ACAD SCI USA, V105, P5786, DOI 10.1073/pnas.0800884105; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; MCCOY ED, 1976, SYST ZOOL, V25, P201, DOI 10.2307/2412488; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Novacek M.J., 1987, American Museum Novitates, P1; Robineau D., 1969, Memoires du Museum Nationale d'Histoire Naturelle Paris (Zool), V60, P1; Ruf I, 2009, J ANAT, V214, P679, DOI 10.1111/j.1469-7580.2009.01059.x; Sagne C, 2001, THESIS MUSEUM NATL H; Samonds KE, 2009, J VERTEBR PALEONTOL, V29, P1233, DOI 10.1671/039.029.0417; SAVAGE RJG, 1976, SYST ZOOL, V25, P344, DOI 10.2307/2412509; SAVAGE RJG, 1994, J VERTEBR PALEONTOL, V14, P427, DOI 10.1080/02724634.1994.10011569; SEGALL W, 1970, Fieldiana Zoology, V51, P169; Sickenberg O., 1934, Memoires du Musee Histoire Naturelle Belgique, V63, P1; Spoor F, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P257; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Tabuce R, 2008, MAMMALIA, V72, P2, DOI 10.1515/MAMM.2008.004; Thewissen J. G. M., 2000, Journal of Vertebrate Paleontology, V20, p73A; Zalmout IS, 2008, THESIS U MICHIGAN AN	48	49	50	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54307	10.1371/journal.pone.0054307	http://dx.doi.org/10.1371/journal.pone.0054307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342128	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700105
J	Conklin, JR; Battley, PF; Potter, MA				Conklin, Jesse R.; Battley, Phil F.; Potter, Murray A.			Absolute Consistency: Individual versus Population Variation in Annual-Cycle Schedules of a Long-Distance Migrant Bird	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; STOPOVER ECOLOGY; NEW-ZEALAND; MIGRATION; MOLT; ARRIVAL; NORTH; CONSEQUENCES; STRATEGIES; DEPARTURE	Flexibility in scheduling varies throughout an organism's annual cycle, reflecting relative temporal constraints and fitness consequences among life-history stages. Time-selection can act at different scales, either by limiting the range of alternative strategies in the population, or by increasing the precision of individual performance. We tracked individual bar-tailed godwits Limosa lapponica baueri for two full years (including direct observation during non-breeding seasons in New Zealand and geolocator tracking of round-trip migrations to Alaska) to present a full annual-cycle view of molt, breeding, and migration schedules. At both population and individual scales, temporal variation was greater in post-breeding than pre-breeding stages, and greater in molts than in movements, but schedules did not tighten across successive stages of migration toward the breeding grounds. In general, individual godwits were quite consistent in timing of events throughout the year, and repeatability of pre-breeding movements was particularly high (r = 0.82-0.92). However, we demonstrate that r values misrepresent absolute consistency by confounding inter- and intra-individual variation; the biological significance of r values can only be understood when these are considered separately. By doing so, we show that some stages have considerable tolerance for alternative strategies within the population, whereas scheduling of northbound migratory movements was similar for all individuals. How time-selection simultaneously shapes both individual and population variation is central to understanding and predicting adaptive phenological responses to environmental change.	[Conklin, Jesse R.; Battley, Phil F.; Potter, Murray A.] Massey Univ, Inst Nat Resources, Ecol Grp, Palmerston North, New Zealand	Massey University	Conklin, JR (corresponding author), Univ Groningen, Anim Ecol Grp, Groningen, Netherlands.	conklin.jesse@gmail.com	Battley, Philip/AAI-1443-2021	Battley, Philip/0000-0002-8590-8098; Potter, Murray/0000-0002-0246-8294	David and Lucile Packard Foundation through the Pacific Shorebird Migration Project; Marsden Fund grant; Department of Conservation Research and Development [3739-01, 3599]	David and Lucile Packard Foundation through the Pacific Shorebird Migration Project; Marsden Fund grant(Royal Society of New ZealandMarsden Fund (NZ)); Department of Conservation Research and Development	This project was supported by the David and Lucile Packard Foundation through the Pacific Shorebird Migration Project, and by a Marsden Fund grant administered by The Royal Society of New Zealand to P. Battley. Color-banding was conducted under Department of Conservation Research and Development contracts 3739-01 and 3599. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Barshep Y, 2011, ARDEA, V99, P43, DOI 10.5253/078.099.0106; Battley PF, 2004, IBIS, V146, P46, DOI 10.1111/j.1474-919X.2004.00210.x; Battley PF, 2012, J AVIAN BIOL, V43, P21, DOI 10.1111/j.1600-048X.2011.05473.x; Battley PF, 2006, BIOL LETTERS, V2, P517, DOI 10.1098/rsbl.2006.0535; Becker WA, 1984, A MANUAL OF QUANTITA; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bety J, 2004, BEHAV ECOL SOCIOBIOL, V57, P1, DOI 10.1007/s00265-004-0840-3; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Catry P, 1999, OIKOS, V84, P473, DOI 10.2307/3546426; Conklin JR, 2012, J AVIAN BIOL, V43, P252, DOI 10.1111/j.1600-048X.2012.05606.x; Conklin JR, 2011, EMU, V111, P330, DOI 10.1071/MU11011; Conklin JR, 2011, BEHAV ECOL, V22, P854, DOI 10.1093/beheco/arr054; Conklin JR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1072; Conklin JR, 2011, THESIS; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Dawson A, 2006, GEN COMP ENDOCR, V147, P314, DOI 10.1016/j.ygcen.2006.02.001; Dohm MR, 2002, FUNCT ECOL, V16, P273; Drent R, 2003, OIKOS, V103, P274, DOI 10.1034/j.1600-0706.2003.12274.x; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Eichhorn G, 2006, ARDEA, V94, P667; Farmer AH, 1999, ECOLOGY, V80, P2566, DOI 10.2307/177241; Fox J., 2010, GEOLOCATOR MANUAL VE; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; HAHN TP, 1992, ORNIS SCAND, V23, P314, DOI 10.2307/3676655; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Helm B., 2006, ACTA ZOOL SIN S, V52, P703; HOLMGREN N, 1995, EVOL ECOL, V9, P354, DOI 10.1007/BF01237759; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Lourenco PM, 2011, J ORNITHOL, V152, P1023, DOI 10.1007/s10336-011-0692-3; LYONS JE, 1995, CONDOR, V97, P427, DOI 10.2307/1369028; Madsen J, 2001, ARDEA, V89, P43; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; McCaffery B. J., 2001, BIRDS N AM; McNamara JM, 1998, J AVIAN BIOL, V29, P416, DOI 10.2307/3677160; Mitchell GW, 2012, IBIS, V154, P325, DOI 10.1111/j.1474-919X.2012.01212.x; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; NOSKOV G. A., 1999, P 22 INT ORN C DURB, P544; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Pulido F, 2007, CLIM RES, V35, P5, DOI 10.3354/cr00711; REES EC, 1989, ANIM BEHAV, V38, P384, DOI 10.1016/S0003-3472(89)80031-4; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Vardanis Y, 2011, BIOL LETTERS, V7, P502, DOI 10.1098/rsbl.2010.1180; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warnock N, 2004, CAN J ZOOL, V82, P1687, DOI 10.1139/Z04-154; Warnock N, 1998, CONDOR, V100, P456, DOI 10.2307/1369711; Weber TP, 1998, EVOL ECOL, V12, P377, DOI 10.1023/A:1006560420310	57	96	101	2	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54535	10.1371/journal.pone.0054535	http://dx.doi.org/10.1371/journal.pone.0054535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342168	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700123
J	Burcharth, J; Pedersen, M; Bisgaard, T; Pedersen, C; Rosenberg, J				Burcharth, Jakob; Pedersen, Michael; Bisgaard, Thue; Pedersen, Carsten; Rosenberg, Jacob			Nationwide Prevalence of Groin Hernia Repair	PLOS ONE			English	Article							INGUINAL-HERNIA	Introduction: Groin hernia repair is a commonly performed surgical procedure in the western world but large-scaled epidemiologic data are sparse. Large-scale data on the occurrence of groin hernia repair may provide further understanding to the pathophysiology of groin hernia development. This study was undertaken to investigate the age and gender dependent prevalence of groin hernia repair. Methods: In a nationwide register-based study, using data from the Civil Registration System covering all Danish citizens, we established a population-based cohort of all people living in Denmark on December 31st, 2010. Within this population all groin hernia repairs during the past 5 years were identified using data from the ICD 10th edition in the Danish National Hospital Register. Results: The study population covered n = 5,639,885 persons. During the five years study period 46,717 groin hernia repairs were performed (88.6% males, 11.4% females). Inguinal hernias comprised 97% of groin hernia repairs (90.2% males, 9.8% females) and femoral hernias 3% of groin hernia repairs (29.8% males, 70.2% females). Patients between 0-5 years and 75-80 years constituted the two dominant groups for inguinal hernia repair. In contrast, the age-specific prevalence of femoral hernia repair increased steadily throughout life peaking at age 80-90 years in both men and women. Conclusion: The age distribution of inguinal hernia repair is bimodal peaking at early childhood and old age, whereas the prevalence of femoral hernia repair increased steadily throughout life. This information can be used to formulate new hypotheses regarding disease etiology with regard to age and gender specifications.	[Burcharth, Jakob; Rosenberg, Jacob] Univ Copenhagen, Herlev Hosp, Dept Surg, Ctr Perioperat Optimizat, DK-2730 Herlev, Denmark; [Pedersen, Michael; Pedersen, Carsten] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Bisgaard, Thue] Univ Copenhagen, Koge Hosp, Dept Surg, Koge, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; University of Copenhagen	Burcharth, J (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Surg, Ctr Perioperat Optimizat, DK-2730 Herlev, Denmark.	jakobburcharth@gmail.com	Burcharth, Jakob/S-9147-2019; Pedersen, Carsten Bøcker/B-8441-2013	Burcharth, Jakob/0000-0001-8367-7831; Pedersen, Carsten Bøcker/0000-0003-2077-8533; Rosenberg, Jacob/0000-0002-0063-1086				ABRAMSON JH, 1978, J EPIDEMIOL COMMUN H, V32, P59, DOI 10.1136/jech.32.1.59; Akin M L, 1997, J R Army Med Corps, V143, P101; Al-Shanafey S, 1999, J PEDIATR SURG, V34, P1104, DOI 10.1016/S0022-3468(99)90576-6; Andersen TF, 1999, DAN MED BULL, V46, P263; Bay-Nielsen M, 2001, LANCET, V358, P1124, DOI 10.1016/S0140-6736(01)06251-1; Dabbas Natalie, 2011, JRSM Short Rep, V2, P5, DOI 10.1258/shorts.2010.010071; Ein SH, 2006, J PEDIATR SURG, V41, P980, DOI 10.1016/j.jpedsurg.2006.01.020; Fitzgibbons RJ, 2006, JAMA-J AM MED ASSOC, V295, P285, DOI 10.1001/jama.295.3.285; Kingsnorth A, 2003, LANCET, V362, P1561, DOI 10.1016/S0140-6736(03)14746-0; Kingsworth A., 2000, BAILEY LOVE SHORT PR, V23, P1149; Nilsson H, 2007, ANN SURG, V245, P656, DOI 10.1097/01.sla.0000251364.32698.4b; Nilsson JR, 1937, SURG GYNECOL OBSTET, V64, P400; Pedersen CB, 2006, DAN MED BULL, V53, P441; Phillips W, 2004, HLTH CARE NEEDS ASSE; Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4; Sandblom G, 1999, HERNIA, V3, P131; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID, P1609; van Wessem K J P, 2003, Hernia, V7, P76; Zimmerman L, 1967, ANATOMY SURG HERNIA	19	107	114	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54367	10.1371/journal.pone.0054367	http://dx.doi.org/10.1371/journal.pone.0054367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342139	Green Published, gold			2022-12-27	WOS:000314759400154
J	Xu, YD; Qian, CX				Xu, Yidong; Qian, Chunxiang			Application of Gurson-Tvergaard-Needleman Constitutive Model to the Tensile Behavior of Reinforcing Bars with Corrosion Pits	PLOS ONE			English	Article							INDUCED CRACKING; VOID NUCLEATION; STRESS; EVOLUTION; FRACTURE	Based on meso-damage mechanics and finite element analysis, the aim of this paper is to describe the feasibility of the Gurson-Tvergaard-Needleman (GTN) constitutive model in describing the tensile behavior of corroded reinforcing bars. The orthogonal test results showed that different fracture pattern and the related damage evolution process can be simulated by choosing different material parameters of GTN constitutive model. Compared with failure parameters, the two constitutive parameters are significant factors affecting the tensile strength. Both the nominal yield and ultimate tensile strength decrease markedly with the increase of constitutive parameters. Combining with the latest data and trial-and-error method, the suitable material parameters of GTN constitutive model were adopted to simulate the tensile behavior of corroded reinforcing bars in concrete under carbonation environment attack. The numerical predictions can not only agree very well with experimental measurements, but also simplify the finite element modeling process.	[Xu, Yidong; Qian, Chunxiang] Southeast Univ, Sch Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Xu, Yidong] Zhejiang Univ, Ningbo Inst Technol, Res Ctr Green Bldg Mat & Waste Resources Reuse, Ningbo, Zhejiang, Peoples R China	Southeast University - China; Zhejiang University	Qian, CX (corresponding author), Southeast Univ, Sch Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China.	30397604@163.com	徐, 亦冬/J-6680-2019	徐, 亦冬/0000-0003-3756-032X; Qian, Chunxiang/0000-0002-7547-5890	National Key Basic Research and Development Plan of China (973 Program) [2009CB623203]; National Natural Science Foundation of China [51008276]; Ningbo Scientific and technological innovation teams of safety and durability in coastal structures [2011B81005]	National Key Basic Research and Development Plan of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningbo Scientific and technological innovation teams of safety and durability in coastal structures	(1) National Key Basic Research and Development Plan of China (973 Program) 2009CB623203, (2) National Natural Science Foundation of China 51008276, (3) Ningbo Scientific and technological innovation teams of safety and durability in coastal structures 2011B81005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almusallam AA, 2001, CONSTR BUILD MATER, V15, P361, DOI 10.1016/S0950-0618(01)00009-5; [安琳 An Lin], 2005, [东南大学学报. 自然科学版, Journal of southeast university. Natural science edition], V35, P940; Apostolopoulos CA, 2006, CONSTR BUILD MATER, V20, P782, DOI 10.1016/j.conbuildmat.2005.01.065; Bai Y, 2010, T NONFERR METAL SOC, V20, P1392, DOI 10.1016/S1003-6326(09)60310-1; Beardsmore D, 2006, ASME PVP DIV C VANC; Benseddiq N, 2008, INT J PRES VES PIP, V85, P219, DOI 10.1016/j.ijpvp.2007.09.003; Cerit M, 2009, ENG FAIL ANAL, V16, P2467, DOI 10.1016/j.engfailanal.2009.04.004; CHU CC, 1980, J ENG MATER-T ASME, V102, P249, DOI 10.1115/1.3224807; Du YG, 2005, MAG CONCRETE RES, V57, P407, DOI 10.1680/macr.2005.57.7.407; Du YG, 2005, MAG CONCRETE RES, V57, P135, DOI 10.1680/macr.57.3.135.60482; [范颖芳 Fan Yingfang], 2003, [建筑材料学报, Journal of building materials], V6, P248; GURSON AL, 1977, J ENG MATER-T ASME, V99, P2, DOI 10.1115/1.3443401; Horner DA, 2011, CORROS SCI, V53, P3466, DOI 10.1016/j.corsci.2011.05.050; Mullard JA, 2011, ACI STRUCT J, V108, P71; Turnbull A, 2010, CORROS SCI, V52, P1492, DOI 10.1016/j.corsci.2009.12.004; Turnbull A, 2009, ENG FRACT MECH, V76, P633, DOI 10.1016/j.engfracmech.2008.09.004; TVERGAARD V, 1984, ACTA METALL MATER, V32, P157, DOI 10.1016/0001-6160(84)90213-X; Vu K, 2005, ACI STRUCT J, V102, P719; Xu YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029956; Yu HH, 2007, INT J BIOL MACROMOL, V40, P276, DOI 10.1016/j.ijbiomac.2006.06.020; Zhang RJ, 2010, CEMENT CONCRETE RES, V40, P415, DOI 10.1016/j.cemconres.2009.09.026; Zhang WP, 2012, CONSTR BUILD MATER, V34, P409, DOI 10.1016/j.conbuildmat.2012.02.071; Zhang ZL, 2000, ENG FRACT MECH, V67, P155, DOI 10.1016/S0013-7944(00)00055-2; Zhao YX, 2012, CORROS SCI, V55, P385, DOI 10.1016/j.corsci.2011.11.002; Zhao YX, 2011, CORROS SCI, V53, P3388, DOI 10.1016/j.corsci.2011.06.018	25	5	5	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54368	10.1371/journal.pone.0054368	http://dx.doi.org/10.1371/journal.pone.0054368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342140	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400155
J	Shain, AH; Pollack, JR				Shain, A. Hunter; Pollack, Jonathan R.			The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers	PLOS ONE			English	Article							IDENTIFIES FREQUENT MUTATION; SQUAMOUS-CELL CARCINOMA; REMODELING GENE ARID1A; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; INACTIVATING MUTATIONS; COMPLEX; EXPRESSION; LYMPHOMA; MELANOMA	SWI/SNF is a multi-subunit chromatin remodeling complex that uses the energy of ATP hydrolysis to reposition nucleosomes, thereby modulating gene expression. Accumulating evidence suggests that SWI/SNF functions as a tumor suppressor in some cancers. However, the spectrum of SWI/SNF mutations across human cancers has not been systematically investigated. Here, we mined whole-exome sequencing data from 24 published studies representing 669 cases from 18 neoplastic diagnoses. SWI/SNF mutations were widespread across diverse human cancers, with an excess of deleterious mutations, and an overall frequency approaching TP53 mutation. Mutations occurred most commonly in the SMARCA4 enzymatic subunit, and in subunits thought to confer functional specificity ( ARID1A, ARID1B, PBRM1, and ARID2). SWI/SNF mutations were not mutually-exclusive of other mutated cancer genes, including TP53 and EZH2 ( both previously linked to SWI/SNF). Our findings implicate SWI/SNF as an important but under-recognized tumor suppressor in diverse human cancers, and provide a key resource to guide future investigations.	[Shain, A. Hunter; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	pollack1@stanford.edu			NCI [R01CA112016]; NSF, Stanford Graduate Fellowship program; NSF, Cancer Biology program; NATIONAL CANCER INSTITUTE [R01CA112016] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF, Stanford Graduate Fellowship program; NSF, Cancer Biology program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by grants from the NCI: R01CA112016 (J.R.P.). A. H. S. was supported by fellowships from the NSF, Stanford Graduate Fellowship program, and Cancer Biology program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cornen S, 2012, ONCOGENE, V31, P4255, DOI 10.1038/onc.2011.598; Dal Molin M, 2012, HUM PATHOL, V43, P585, DOI 10.1016/j.humpath.2011.06.009; DelBove J, 2011, EPIGENETICS-US, V6, P1444, DOI 10.4161/epi.6.12.18492; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Medina PP, 2004, GENE CHROMOSOME CANC, V41, P170, DOI 10.1002/gcc.20068; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; NEIGEBORN L, 1984, GENETICS, V108, P845; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Nissenblatt M, 2011, NEW ENGL J MED, V364, P482, DOI 10.1056/NEJMc1012780; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	50	350	365	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e55119	10.1371/journal.pone.0055119	http://dx.doi.org/10.1371/journal.pone.0055119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355908	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500156
J	Yang, L; O'Neill, P; Martin, K; Maass, JC; Vassilev, V; Ladher, R; Groves, AK				Yang, Lu; O'Neill, Paul; Martin, Kareen; Maass, Juan C.; Vassilev, Vassil; Ladher, Raj; Groves, Andrew K.			Analysis of FGF-Dependent and FGF-Independent Pathways in Otic Placode Induction	PLOS ONE			English	Article							INNER-EAR; CHICK-EMBRYO; GENE-EXPRESSION; NEURAL CREST; MOUSE; GROWTH; CELL; WNT; IDENTIFICATION; SIGNALS	The inner ear develops from a patch of thickened cranial ectoderm adjacent to the hindbrain called the otic placode. Studies in a number of vertebrate species suggest that the initial steps in induction of the otic placode are regulated by members of the Fibroblast Growth Factor (FGF) family, and that inhibition of FGF signaling can prevent otic placode formation. To better understand the genetic pathways activated by FGF signaling during otic placode induction, we performed microarray experiments to estimate the proportion of chicken otic placode genes that can be up-regulated by the FGF pathway in a simple culture model of otic placode induction. Surprisingly, we find that FGF is only sufficient to induce about 15% of chick otic placode-specific genes in our experimental system. However, pharmacological blockade of the FGF pathway in cultured chick embryos showed that although FGF signaling was not sufficient to induce the majority of otic placode-specific genes, it was still necessary for their expression in vivo. These inhibitor experiments further suggest that the early steps in otic placode induction regulated by FGF signaling occur through the MAP kinase pathway. Although our work suggests that FGF signaling is necessary for otic placode induction, it demonstrates that other unidentified signaling pathways are required to co-operate with FGF signaling to induce the full otic placode program.	[Yang, Lu; Maass, Juan C.; Groves, Andrew K.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Yang, Lu; Maass, Juan C.; Groves, Andrew K.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Groves, Andrew K.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Martin, Kareen] House Res Inst, Div Cell Biol & Genet, Los Angeles, CA USA; [O'Neill, Paul; Vassilev, Vassil; Ladher, Raj] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan; [Maass, Juan C.] Univ Chile, Hosp Clin, Dept Otolaryngol, Santiago, Chile; [Maass, Juan C.] Univ Desarrollo, Fac Med Clin Alemana, Clin Alemana Santiago, Dept Otolaryngol, Santiago, Chile	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; RIKEN; Universidad de Chile; Clinica Alemana; Universidad del Desarrollo	Ladher, R (corresponding author), RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan.	raj-ladher@cdb.riken.jp; akgroves@bcm.edu		Yang, Lu/0000-0001-7965-2674; Maass, Juan/0000-0002-1586-4608; Groves, Andrew/0000-0002-0784-7998; Ladher, Raj/0000-0002-3613-9456	National Institutes of Health (NIH) [DC004675]; NIH [DC008692]; RIKEN FPR fellowship; RIKEN; MECESUP (Ministerio de Educacion, Gobierno de Chile) [UCH0603]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004675, R03DC008692] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN FPR fellowship; RIKEN; MECESUP (Ministerio de Educacion, Gobierno de Chile); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is funded by National Institutes of Health (NIH) DC004675 (A. K. G.), NIH DC008692 (K. M.), RIKEN FPR fellowship (P.O.), RIKEN intramural funding (P.O. and R.L.) and a fellowship from MECESUP (UCH0603, Ministerio de Educacion, Gobierno de Chile, J.C.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello G, 2007, MECH DEVELOP, V124, P631, DOI 10.1016/j.mod.2007.04.002; Adamska M, 2001, MECH DEVELOP, V109, P303, DOI 10.1016/S0925-4773(01)00550-0; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Betancur P, 2011, DEVELOPMENT, V138, P3689, DOI 10.1242/dev.057836; Bhattacharyya S, 2004, DEV BIOL, V271, P403, DOI 10.1016/j.ydbio.2004.04.010; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Freyer L, 2011, DEVELOPMENT, V138, P5403, DOI 10.1242/dev.069849; Grocott T, 2012, DEV BIOL, V370, P3, DOI 10.1016/j.ydbio.2012.06.028; Groves AK, 2005, SPR HDB AUD, V26, P10; Groves AK, 2000, DEVELOPMENT, V127, P3489; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Harduf H, 2005, DEV DYNAM, V233, P301, DOI 10.1002/dvdy.20364; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Herbrand H, 1998, DEVELOPMENT, V125, P645; Hidalgo-Sanchez M, 2000, MECH DEVELOP, V95, P225, DOI 10.1016/S0925-4773(00)00332-4; Ishihara T, 2008, GENE EXPR PATTERNS, V8, P357, DOI 10.1016/j.gep.2008.01.003; JACOBSON AG, 1966, SCIENCE, V152, P25, DOI 10.1126/science.152.3718.25; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Karabagli H, 2002, ANAT EMBRYOL, V205, P365, DOI 10.1007/s00429-002-0264-7; Kil SH, 2005, DEV BIOL, V285, P252, DOI 10.1016/j.ydbio.2005.05.044; Kurose H, 2004, GENE EXPR PATTERNS, V4, P687, DOI 10.1016/j.modgep.2004.04.005; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maroon H, 2002, DEVELOPMENT, V129, P2099; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; Matsumata M, 2005, DEV BIOL, V286, P601, DOI 10.1016/j.ydbio.2005.08.005; McKeown SJ, 2005, DEV DYNAM, V233, P430, DOI 10.1002/dvdy.20341; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Nagai H, 2011, GENESIS, V49, P46, DOI 10.1002/dvg.20690; Niss K, 1998, MECH DEVELOP, V76, P151, DOI 10.1016/S0925-4773(98)00103-8; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Ohyama T, 2007, INT J DEV BIOL, V51, P463, DOI 10.1387/ijdb.072320to; Padanad MS, 2011, DEV BIOL, V351, P90, DOI 10.1016/j.ydbio.2010.12.036; Park BY, 2008, DEV BIOL, V324, P108, DOI 10.1016/j.ydbio.2008.09.009; Paxton CN, 2010, GENE EXPR PATTERNS, V10, P31, DOI 10.1016/j.gep.2009.11.002; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Riley BB, 2003, DEV BIOL, V261, P289, DOI 10.1016/S0012-1606(03)00245-8; Rogers AAM, 2011, DEV BIOL, V353, P94, DOI 10.1016/j.ydbio.2011.02.022; Sai X, 2008, CURR BIOL, V18, P976, DOI 10.1016/j.cub.2008.05.049; Sato S, 2010, DEV BIOL, V344, P158, DOI 10.1016/j.ydbio.2010.04.029; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Sinkkonen ST, 2011, JARO-J ASSOC RES OTO, V12, P697, DOI 10.1007/s10162-011-0286-z; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Streit A, 2002, DEV BIOL, V249, P237, DOI 10.1006/dbio.2002.0739; Streit A, 2007, INT J DEV BIOL, V51, P447, DOI 10.1387/ijdb.072327as; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Urness LD, 2008, DEV DYNAM, V237, P163, DOI 10.1002/dvdy.21380; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; VONBARTHELD CS, 1991, DEVELOPMENT, V113, P455; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555; Xu H, 2008, DEV BIOL, V317, P174, DOI 10.1016/j.ydbio.2008.02.012; YAN MH, 1994, J BIOL CHEM, V269, P19067	69	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e55011	10.1371/journal.pone.0055011	http://dx.doi.org/10.1371/journal.pone.0055011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355906	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500153
J	Castanera, D; Vila, B; Razzolini, NL; Falkingham, PL; Canudo, JI; Manning, PL; Galobart, A				Castanera, Diego; Vila, Bernat; Razzolini, Novella L.; Falkingham, Peter L.; Canudo, Jose I.; Manning, Phillip L.; Galobart, Angel			Manus Track Preservation Bias as a Key Factor for Assessing Trackmaker Identity and Quadrupedalism in Basal Ornithopods	PLOS ONE			English	Article							DINOSAUR FOOTPRINTS; ORNITHISCHIA ORNITHOPODA; ICHNOLOGICAL EVIDENCE	Background: The Las Cerradicas site (Tithonian-Berriasian), Teruel, Spain, preserves at least seventeen dinosaur trackways, some of them formerly attributed to quadrupedal ornithopods, sauropods and theropods. The exposure of new track evidence allows a more detailed interpretation of the controversial tridactyl trackways as well as the modes of locomotion and taxonomic affinities of the trackmakers. Methodology/Principal Findings: Detailed stratigraphic analysis reveals four different levels where footprints have been preserved in different modes. Within the tridactyl trackways, manus tracks are mainly present in a specific horizon relative to surface tracks. The presence of manus tracks is interpreted as evidence of an ornithopod trackmaker. Cross-sections produced from photogrammetric digital models show different depths of the pes and manus, suggesting covariance in loading between the forelimbs and the hindlimbs. Conclusions/Significance: Several features (digital pads, length/width ratio, claw marks) of some ornithopod pes tracks from Las Cerradicas are reminiscent of theropod pedal morphology. This morphological convergence, combined with the shallow nature of the manus tracks, which reduces preservation potential, opens a new window into the interpretation of these tridactyl tracks. Thus, trackmaker assignations during the Jurassic-Cretaceous interval of purported theropod trackways may potentially represent ornithopods. Moreover, the Las Cerradicas trackways are further evidence for quadrupedalism among some basal small-to medium-sized ornithopods from this time interval.	[Castanera, Diego; Vila, Bernat; Canudo, Jose I.] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Vila, Bernat; Razzolini, Novella L.; Galobart, Angel] Inst Catala Paleontol Miquel Crusafont, Barcelona, Spain; [Falkingham, Peter L.] Univ London Royal Vet Coll, Dept Comparat Biomed Sci Struct & Mot Lab, London, England; [Falkingham, Peter L.] Brown Univ, Div Biol & Med, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Manning, Phillip L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Manning, Phillip L.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Zaragoza; Institut Catala de Paleontologia Miquel Crusafont (ICP); University of London; University of London Royal Veterinary College; Brown University; University of Manchester; University of Pennsylvania	Castanera, D (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain.	dcastanera@unizar.es	CASTANERA, DIEGO/AAH-5598-2019; VILA, BERNAT/AAA-7367-2021; Manning, Phillip/F-9966-2011; Falkingham, Peter/C-7656-2014; Galobart, Àngel À/H-5024-2011	CASTANERA, DIEGO/0000-0003-3950-1630; VILA, BERNAT/0000-0002-5935-1732; Manning, Phillip/0000-0002-7161-6246; Falkingham, Peter/0000-0003-1856-8377; Galobart, Àngel À/0000-0003-1508-4561; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155	FPU grant from the Spanish Ministry of Education [AP2008-01340]; Ministry of Science and Innovation (Subprograma Juan de la Cierva (MICINN-JDC)); Marie Curie International outgoing Fellowship within the 7th European Framework Programme	FPU grant from the Spanish Ministry of Education(German Research Foundation (DFG)); Ministry of Science and Innovation (Subprograma Juan de la Cierva (MICINN-JDC)); Marie Curie International outgoing Fellowship within the 7th European Framework Programme	DC was supported by a FPU grant from the Spanish Ministry of Education (AP2008-01340). BV acknowledges support from the Ministry of Science and Innovation (Subprograma Juan de la Cierva (MICINN-JDC) 2011). PLF was supported by a Marie Curie International outgoing Fellowship within the 7th European Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcal?, 2012, FUNDAMENTAL, P219; Alcal?, 2012, FUNDAMENTAL, P215; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Avanzini M, 2012, LETHAIA, V45, P238, DOI 10.1111/j.1502-3931.2011.00276.x; Barco Jose Luis, 2006, Ichnos, V13, P237, DOI 10.1080/10420940600843682; Barrett PM, 2011, SPEC PAP PALAEONTOL, P131, DOI 10.1111/j.1475-4983.2011.01076.x; Bates KT, 2008, J GEOL SOC LONDON, V165, P115, DOI 10.1144/0016-76492007-033; Canudo J.I., 2005, Geogaceta, V38, P39; Canudo JI, 2012, GEOL MAG, V149, P252, DOI 10.1017/S0016756811000732; Castanera D, J IBERIAN G IN PRESS; Castanera D, 2012, LETHAIA, V45, P476, DOI 10.1111/j.1502-3931.2012.00304.x; Castanera D, 2011, PALAEOGEOGR PALAEOCL, V310, P227, DOI 10.1016/j.palaeo.2011.07.015; Cobos A, 2011, THESIS U PAIS VASCO; D'Orazi Porchetti S., 2008, STUDI TRENTINI SCI N, V83, P277; Dall Vecchia Fabio M., 2000, Memorie di Scienze Geologiche, V52, P227; Diaz-Martinez I, 2012, FUNDAMENTAL, V20, P63; Diedrich Cajus, 2004, Ichnos, V11, P215, DOI 10.1080/10420940490444924; Falkingham PL, 2012, J GEOL SOC LONDON, V169, P365, DOI 10.1144/0016-76492011-019; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2011, BIOL LETTERS, V7, P142, DOI 10.1098/rsbl.2010.0403; Falkingham PL, 2010, PALAIOS, V25, P356, DOI 10.2110/palo.2009.p09-164r; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Farlow James O., 1993, Bulletin of the New Mexico Museum of Natural History and Science, V3, P123; Farlow James O., 1997, P519; FUENTES VIDARTE C., 1998, ESTUD GEOL-MADRID, V54, P147, DOI DOI 10.3989/EGEOL.98543-4213; HEINRICH RE, 1993, ZOOL J LINN SOC-LOND, V108, P179, DOI 10.1111/j.1096-3642.1993.tb00294.x; Hornung JJ, 2012, PALAEONTOL Z, V86, P231, DOI 10.1007/s12542-012-0131-7; Instituto de Estudios Turolenses, 2009, 2 JORN PAL GALV HOM, P85; Jackson SJ, 2009, PALAIOS, V24, P222, DOI 10.2110/palo.2007.p07-070r; Le Loeuff J, 2002, C R PALEVOL, V1, P287, DOI 10.1016/S1631-0683(02)00037-4; Leonardi G, 1997, REV SOC GEOLOGICA ES, V10, P341; Leonardi G., 1994, ANNOTATED ATLAS S AM; Lingham-Soliar T, 2003, NATURWISSENSCHAFTEN, V90, P572, DOI 10.1007/s00114-003-0477-5; LOCKLEY M. G, 1991, TRACKING DINOSAURS N; Lockley Martin, 1998, Modern Geology, V23, P317; Lockley Martin G., 2001, P428; Lockley MG, 2009, GEOL SOC SPEC PUBL, V315, P255, DOI 10.1144/SP315.18; Lockley MG, 2009, GEOL Q, V53, P415; Lockley Martin G., 2000, Gaia (Lisboa), V15, P339; LOCKLEY MG, 1986, GEOL SOC AM BULL, V97, P1163, DOI 10.1130/0016-7606(1986)97<1163:NALDTS>2.0.CO;2; Lockley MG, 1999, PALAEOGEOGR PALAEOCL, V150, P25, DOI 10.1016/S0031-0182(99)00005-X; Lockley MG, 2009, ACT 4 JORN INT PAL D, P121; Lockley MG, 2004, ICHNOS, V11, P262, DOI [DOI 10.1080/10420940490428805, 10.1080/10420940490428805]; Maidment SCR, ACTA PALEON IN PRESS; Maidment SCR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036904; Manning PL, 2004, GEOL SOC SPEC PUBL, V228, P93, DOI 10.1144/GSL.SP.2004.228.01.06; MARTY D., 2008, GEOFOCUS, V21, P1; Marty D, 2009, ICHNOS, V16, P127, DOI 10.1080/10420940802471027; Mateus Octavio, 2008, Oryctos, V8, P47; Matsukawa M, 1997, CRETACEOUS RES, V18, P603, DOI 10.1006/cres.1997.0075; Matsukawa Masaki, 2005, Ichnos, V12, P201, DOI 10.1080/10420940591009231; Meyer Christian A., 2003, Ichnos, V10, P221, DOI 10.1080/10420940390256186; Milan J, 2006, PALAEOGEOGR PALAEOCL, V231, P253, DOI 10.1016/j.palaeo.2004.12.022; Moratalla J.J., 1992, Journal of Vertebrate Paleontology, V12, P150; Moratalla J.J., 1997, REV ESPANOLA PALEONT, V12, P185; MORATALLA JJ, 1988, GEOBIOS-LYON, V21, P395, DOI 10.1016/S0016-6995(88)80042-1; Moratalla Jose J., 1994, Ichnos, V3, P89; Moreno K, 2007, J MORPHOL, V268, P50, DOI 10.1002/jmor.10498; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Olsen P.E., 1986, P61; Ortega F., 2006, Estudios Geologicos (Madrid), V62, P219; Pascual-Arribas Carlos, 2009, Studia Geologica Salmanticensia, V45, P105; Perez-Lorente Felix, 1997, Ichnos, V5, P109; Romilio A, 2011, CRETACEOUS RES, V32, P135, DOI 10.1016/j.cretres.2010.11.003; Royo-Torres R, 2009, PALAEONTOLOGY, V52, P1009, DOI 10.1111/j.1475-4983.2009.00898.x; Ruiz-Omenaca JI, 2011, ESTUD GEOL-MADRID, V67, P83, DOI 10.3989/egeol.40276.124; Sanchez-Hernandez B, 2007, PALAEOGEOGR PALAEOCL, V249, P180, DOI 10.1016/j.palaeo.2007.01.009; Santos VF, CRETACEOUS IN PRESS, P1; STERNBERG C.H., 1932, NATL MUSEUM CANADA B, P59; Taquet, 1984, ORME DINOSAURI, P165; Thulborn T., 1990, DINOSAUR TRACKS; Wright JL, 1999, SP PALAEONT, P209	72	40	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54177	10.1371/journal.pone.0054177	http://dx.doi.org/10.1371/journal.pone.0054177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349817	Green Accepted, Green Published, gold			2022-12-27	WOS:000314019100048
J	Eiler, A; Drakare, S; Bertilsson, S; Pernthaler, J; Peura, S; Rofner, C; Simek, K; Yang, Y; Znachor, P; Lindstrom, ES				Eiler, Alexander; Drakare, Stina; Bertilsson, Stefan; Pernthaler, Jakob; Peura, Sari; Rofner, Carina; Simek, Karel; Yang, Yang; Znachor, Petr; Lindstrom, Eva S.			Unveiling Distribution Patterns of Freshwater Phytoplankton by a Next Generation Sequencing Based Approach	PLOS ONE			English	Article							AUTOTROPHIC PICOPLANKTON; MICROBIAL DIVERSITY; RNA; MARINE; BACTERIAL; SEA; DNA; COMMUNITIES; ANABAENA; REVEALS	The recognition and discrimination of phytoplankton species is one of the foundations of freshwater biodiversity research and environmental monitoring. This step is frequently a bottleneck in the analytical chain from sampling to data analysis and subsequent environmental status evaluation. Here we present phytoplankton diversity data from 49 lakes including three seasonal surveys assessed by next generation sequencing (NGS) of 16S ribosomal RNA chloroplast and cyanobacterial gene amplicons and also compare part of these datasets with identification based on morphology. Direct comparison of NGS to microscopic data from three time-series showed that NGS was able to capture the seasonality in phytoplankton succession as observed by microscopy. Still, the PCR-based approach was only semi-quantitative, and detailed NGS and microscopy taxa lists had only low taxonomic correspondence. This is probably due to, both, methodological constraints and current discrepancies in taxonomic frameworks. Discrepancies included Euglenophyta and Heterokonta that were scarce in the NGS but frequently detected by microscopy and Cyanobacteria that were in general more abundant and classified with high resolution by NGS. A deep-branching taxonomically unclassified cluster was frequently detected by NGS but could not be linked to any group identified by microscopy. NGS derived phytoplankton composition differed significantly among lakes with different trophic status, showing that our approach can resolve phytoplankton communities at a level relevant for ecosystem management. The high reproducibility and potential for standardization and parallelization makes our NGS approach an excellent candidate for simultaneous monitoring of prokaryotic and eukaryotic phytoplankton in inland waters.	[Eiler, Alexander; Bertilsson, Stefan; Rofner, Carina; Lindstrom, Eva S.] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Drakare, Stina] Swedish Univ Agr Sci, Uppsala, Sweden; [Pernthaler, Jakob] Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland; [Peura, Sari] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Simek, Karel; Znachor, Petr] Acad Sci Czech Republ, Inst Hydrobiol, Vvi, Ctr Biol, Ceske Budejovice, Czech Republic; [Yang, Yang] Uppsala Univ, Erken Lab, Norrtalje, Sweden	Uppsala University; Swedish University of Agricultural Sciences; University of Jyvaskyla; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Uppsala University	Eiler, A (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	alexander.eiler@ebc.uu.se	Eiler, Alexander/V-9220-2017; LindstrÃm, Eva/H-5930-2016; Šimek, Karel/AAB-1956-2021; Drakare, Stina/D-4532-2016; Znachor, Petr/F-8901-2014; Znachor, Petr/AAH-5088-2020; Simek, Karel/F-8930-2014; Drakare, Stina/ABF-1259-2020; Znachor, Petr/AAC-2289-2021	Eiler, Alexander/0000-0001-9916-9567; LindstrÃm, Eva/0000-0001-8920-3071; Šimek, Karel/0000-0002-7058-9063; Drakare, Stina/0000-0002-7389-2105; Drakare, Stina/0000-0002-7389-2105; Znachor, Petr/0000-0002-9356-5996; Peura, Sari/0000-0003-3892-8157	Swedish foundation for strategic research; Swedish Research Council; Czech Grant Agency [206/08/0015]	Swedish foundation for strategic research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Czech Grant Agency(Grant Agency of the Czech Republic)	This work was supported by the Swedish foundation for strategic research (grant to AE), the Swedish Research Council (separate grants to ESL and SB) and the Czech Grant Agency (grant 206/08/0015 to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Bell T, 2001, LIMNOL OCEANOGR, V46, P1243, DOI 10.4319/lo.2001.46.5.1243; Bolhuis H, 2011, ISME J, V5, P1701, DOI [10.1038/Ismej.2011.52, 10.1038/ismej.2011.52]; Capblancq J., 1994, P9; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Galluzzi L, 2004, APPL ENVIRON MICROB, V70, P1199, DOI 10.1128/AEM.70.2.1199-1206.2004; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Gugger M, 2002, INT J SYST EVOL MICR, V52, P1867, DOI 10.1099/ijs.0.02270-0; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Joo S, 2010, J MICROBIOL METH, V81, P61, DOI 10.1016/j.mimet.2010.01.025; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Llewellyn CA, 2000, MAR ECOL PROG SER, V193, P33, DOI 10.3354/meps193033; Logares R, 2012, ISME J; Logares R, 2012, ISME J, V6, P1823, DOI 10.1038/ismej.2012.36; Logue JB, 2012, ISME J, V6, P1127, DOI 10.1038/ismej.2011.184; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; MALONE TC, 1971, LIMNOL OCEANOGR, V16, P633, DOI 10.4319/lo.1971.16.4.0633; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Martinez-Garcia M, 2012, ISME J, V6, P703, DOI 10.1038/ismej.2011.126; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Medlin LK, 2006, MICROB ECOL, V52, P53, DOI 10.1007/s00248-005-0062-x; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; NGANDO TS, 1991, ARCH PROTISTENKD, V140, P109, DOI 10.1016/S0003-9365(11)80179-X; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Olrik K, 1998, 4860 SWED EPA 1; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Peura S, 2012, ISME J, V6, P1640, DOI 10.1038/ismej.2012.21; Posch T, 2012, NATURE CLIMATE CHANG, V8, DOI 101038/nclimate1581; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Development Core Team, 2011, R LANG ENV STAT COMP, P2630; Schallenberg M, 2001, FRESHWATER BIOL, V46, P27, DOI 10.1046/j.1365-2427.2001.00647.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SOMMER U, 1985, LIMNOL OCEANOGR, V30, P335, DOI 10.4319/lo.1985.30.2.0335; STOCKNER JG, 1991, INT REV GES HYDROBIO, V76, P483, DOI 10.1002/iroh.19910760402; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Treusch AH, 2012, ISME J, V6, P481, DOI 10.1038/ismej.2011.117; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zapomelova E, 2009, J PHYCOL, V45, P1363, DOI 10.1111/j.1529-8817.2009.00758.x; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	55	81	88	2	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53516	10.1371/journal.pone.0053516	http://dx.doi.org/10.1371/journal.pone.0053516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349714	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000314019100023
J	Li, X; Florez, S; Wang, JB; Cao, HJ; Amendt, BA				Li, Xiao; Florez, Sergio; Wang, Jianbo; Cao, Huojun; Amendt, Brad A.			Dact2 Represses PITX2 Transcriptional Activation and Cell Proliferation through Wnt/beta-Catenin Signaling during Odontogenesis	PLOS ONE			English	Article							BETA-CATENIN; TOOTH DEVELOPMENT; GENE-EXPRESSION; WNT SIGNALS; CYCLIN D1; PROTEIN; MICE; HOMEODOMAIN; PATHWAY; MOUSE	Dact proteins belong to the Dapper/Frodo protein family and function as cytoplasmic attenuators in Wnt and TGF beta signaling. Previous studies show that Dact1 is a potent Wnt signaling inhibitor by promoting degradation of beta-catenin. We report a new mechanism for Dact2 function as an inhibitor of the canonical Wnt signaling pathway by interacting with PITX2. PITX2 is a downstream transcription factor in Wnt/beta-catenin signaling, and PITX2 synergizes with Lef-1 to activate downstream genes. Immunohistochemistry verified the expression of Dact2 in the tooth epithelium, which correlated with Pitx2 epithelial expression. Dact2 loss of function and PITX2 gain of function studies reveal a feedback mechanism for controlling Dact2 expression. Pitx2 endogenously activates Dact2 expression and Dact2 feeds back to repress Pitx2 transcriptional activity. A Topflash reporter system was employed showing PITX2 activation of Wnt signaling, which is attenuated by Dact2. Transient transfections demonstrate the inhibitory effect of Dact2 on critical dental epithelial differentiation factors during tooth development. Dact2 significantly inhibits PITX2 activation of the Dlx2 and amelogenin promoters. Multiple lines of evidence conclude the inhibition is achieved by the physical interaction between Dact2 and Pitx2 proteins. The loss of function of Dact2 also reveals increased cell proliferation due to up-regulated Wnt downstream genes, cyclinD1 and cyclinD2. In summary, we have identified a novel role for Dact2 as an inhibitor of the canonical Wnt pathway in embryonic tooth development through its regulation of cell proliferation and differentiation.	[Li, Xiao; Florez, Sergio; Wang, Jianbo; Cao, Huojun; Amendt, Brad A.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Iowa	Amendt, BA (corresponding author), Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	brad-amendt@uiowa.edu	cao, huojun/M-5431-2017; Li, Xiao/X-3429-2019	Li, Xiao/0000-0001-8527-4438; Cao, Huojun/0000-0003-4428-8686; Amendt, Brad A./0000-0001-6524-1006	National Institutes of Health grant [DE13941, DE18885]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941, R01DE018885] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health grants DE13941 and DE18885 to B.A.A. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Diamond E, 2006, NUCLEIC ACIDS RES, V34, P5951, DOI 10.1093/nar/gkl689; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Huang Y, 2010, CELL CYCLE, P9; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Kettunen P, 2010, GENE EXPR PATTERNS, V10, P140, DOI 10.1016/j.gep.2010.02.002; Kivimae S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-33; Lee WC, 2010, AM J PHYSIOL-RENAL, V299, pF740, DOI 10.1152/ajprenal.00148.2010; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Teran E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005522; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Venugopalan SR, 2011, J BIOL CHEM, V286, P21372, DOI 10.1074/jbc.M111.252031; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhang ZC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024608, 10.1371/journal.pone.0028817]	44	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54868	10.1371/journal.pone.0054868	http://dx.doi.org/10.1371/journal.pone.0054868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349981	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100104
J	Li, ZJ; Zhang, LL; Wang, AX; Xu, XY; Li, JF				Li, Zhenjun; Zhang, Lili; Wang, Aoxue; Xu, Xiangyang; Li, Jingfu			Ectopic Overexpression of SlHsfA3, a Heat Stress Transcription Factor from Tomato, Confers Increased Thermotolerance and Salt Hypersensitivity in Germination in Transgenic Arabidopsis	PLOS ONE			English	Article							FALSE DISCOVERY RATE; OXYGEN GENE NETWORK; SEED-GERMINATION; SHOCK PROTEINS; LOW-TEMPERATURE; DEVELOPMENTAL REGULATION; MOLECULAR CHAPERONES; ENDOTHELIAL-CELLS; ABIOTIC STRESS; THIONIN THI2.1	Plant heat stress transcription factors (Hsfs) are the critical components involved in mediating responses to various environmental stressors. However, the detailed roles of many plant Hsfs are far from fully understood. In this study, an Hsf (SlHsfA3) was isolated from the cultivated tomato (Solanum lycopersicum, Sl) and functionally characterized at the genetic and developmental levels. The nucleus-localized SlHsfA3 was basally and ubiquitously expressed in different plant organs. The expression of SlHsfA3 was induced dramatically by heat stress, moderately by high salinity, and slightly by drought, but was not induced by abscisic acid (ABA). The ectopic overexpression of SlHsfA3 conferred increased thermotolerance and late flowering phenotype to transgenic Arabidopsis plants. Moreover, SlHsfA3 played a negative role in controlling seed germination under salt stress. RNA-sequencing data demonstrated that a number of heat shock proteins (Hsps) and stress-associated genes were induced in Arabidopsis plants overexpressing SlHsfA3. A gel shift experiment and transient expression assays in Nicotiana benthamiana leaves demonstrated that SlHsfA3 directly activates the expression of SlHsp26.1-P and SlHsp21.5-ER. Taken together, our results suggest that SlHsfA3 behaves as a typical Hsf to contribute to plant thermotolerance. The late flowering and seed germination phenotypes and the RNA-seq data derived from SlHsfA3 overexpression lines lend more credence to the hypothesis that plant Hsfs participate in diverse physiological and biochemical processes related to adverse conditions.	[Li, Zhenjun; Zhang, Lili; Wang, Aoxue; Xu, Xiangyang; Li, Jingfu] NE Agr Univ, Coll Hort, Harbin, Heilongjiang, Peoples R China; [Zhang, Lili] NE Forestry Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Xu, Xiangyang; Li, Jingfu] Minist Agr, Key Lab Biol & Genet Improvement Hort Crops NE Re, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Northeast Forestry University - China; Ministry of Agriculture & Rural Affairs	Xu, XY (corresponding author), NE Agr Univ, Coll Hort, Harbin, Heilongjiang, Peoples R China.	xuxiangyang_neau@yahoo.com.cn; jfli_neau@yahoo.com.cn			National High Technology Research and Development Program of China [2007AA10Z178]; National Science and Technology Supporting Plan [2012BAD02B02]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science and Technology Supporting Plan	This research was supported by grants from the National High Technology Research and Development Program of China (No. 2007AA10Z178) and National Science and Technology Supporting Plan (No. No. 2012BAD02B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almoguera C, 2002, J BIOL CHEM, V277, P43866, DOI 10.1074/jbc.M207330200; Baniwal SK, 2007, J BIOL CHEM, V282, P3605, DOI 10.1074/jbc.M609545200; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; BARROS MD, 1992, PLANT MOL BIOL, V19, P665, DOI 10.1007/BF00026792; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bharti K, 2000, PLANT J, V22, P355, DOI 10.1046/j.1365-313x.2000.00746.x; Bharti K, 2004, PLANT CELL, V16, P1521, DOI 10.1105/tpc.019927; Birkenmeier GF, 1998, PLANT PHYSIOL, V117, P687, DOI 10.1104/pp.117.2.687; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Chen H, 2010, BIOCHEM BIOPH RES CO, V401, P238, DOI 10.1016/j.bbrc.2010.09.038; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; Czarnecka-Verner E, 2004, PLANT MOL BIOL, V56, P57, DOI 10.1007/s11103-004-2307-3; Czarnecka-Verner E, 2000, PLANT MOL BIOL, V43, P459, DOI 10.1023/A:1006448607740; Daszkowska-Golec A, 2011, OMICS, V15, P763, DOI 10.1089/omi.2011.0082; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Diaz-Martin J, 2005, PLANT PHYSIOL, V139, P1483, DOI 10.1104/pp.105.069963; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; El Oirdi M, 2011, PLANT CELL, V23, P2405, DOI 10.1105/tpc.111.083394; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Giorno F, 2010, J EXP BOT, V61, P453, DOI 10.1093/jxb/erp316; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Guo JK, 2008, J GENET GENOMICS, V35, P105, DOI 10.1016/S1673-8527(08)60016-8; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; JAKOB U, 1993, J BIOL CHEM, V268, P1517; JEFFERSON RA, 1987, EMBO J, V6, P3901; KAHN TL, 1993, PLANT PHYSIOL, V103, P597, DOI 10.1104/pp.103.2.597; Kazan K, 2012, TRENDS PLANT SCI, V17, P22, DOI 10.1016/j.tplants.2011.10.006; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kim DH, 2010, P NATL ACAD SCI USA, V107, P17029, DOI 10.1073/pnas.1010834107; Kotak S, 2007, PLANT CELL, V19, P182, DOI 10.1105/tpc.106.048165; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Loeza-Angeles H, 2008, BIOTECHNOL LETT, V30, P1713, DOI 10.1007/s10529-008-9756-8; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; NOVER L, 1987, ENZYME MICROB TECH, V9, P130, DOI 10.1016/0141-0229(87)90066-4; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Ochoa-Zarzosa A, 2008, VET MICROBIOL, V127, P425, DOI 10.1016/j.vetmic.2007.08.031; Ogawa D, 2007, J EXP BOT, V58, P3373, DOI 10.1093/jxb/erm184; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Prieto-Dapena P, 2008, PLANT J, V54, P1004, DOI 10.1111/j.1365-313X.2008.03465.x; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Rojas A, 1999, PLANT J, V20, P601, DOI 10.1046/j.1365-313X.1999.00635.x; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Scharf KD, 1998, MOL CELL BIOL, V18, P2240, DOI 10.1128/MCB.18.4.2240; Scharf KD, 2001, CELL STRESS CHAPERON, V6, P225, DOI 10.1379/1466-1268(2001)006<0225:TEFOAT>2.0.CO;2; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schmidt R, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls011; Schoffl F, 1998, PLANT PHYSIOL, V117, P1135, DOI 10.1104/pp.117.4.1135; Schramm F, 2006, PLANT MOL BIOL, V60, P759, DOI 10.1007/s11103-005-5750-x; Schramm F, 2008, PLANT J, V53, P264, DOI 10.1111/j.1365-313X.2007.03334.x; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; Storozhenko S, 1998, PLANT PHYSIOL, V118, P1005, DOI 10.1104/pp.118.3.1005; Sun JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002594; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Ward JM, 2006, PLANT CELL, V18, P29, DOI 10.1105/tpc.105.036707; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yamanouchi U, 2002, P NATL ACAD SCI USA, V99, P7530, DOI 10.1073/pnas.112209199; Yokotani N, 2008, PLANTA, V227, P957, DOI 10.1007/s00425-007-0670-4; Yoshida T, 2008, BIOCHEM BIOPH RES CO, V368, P515, DOI 10.1016/j.bbrc.2008.01.134; Yuan K, 2011, ACTA PHYSIOL PLANT, V33, P261, DOI 10.1007/s11738-010-0542-6; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhu Y, 2009, PLANT MOL BIOL, V71, P451, DOI 10.1007/s11103-009-9538-2	96	64	74	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54880	10.1371/journal.pone.0054880	http://dx.doi.org/10.1371/journal.pone.0054880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349984	Green Submitted, gold, Green Published			2022-12-27	WOS:000314019100107
J	Nobrega, C; Nascimento-Ferreira, I; Onofre, I; Albuquerque, D; Hirai, H; Deglon, N; de Almeida, LP				Nobrega, Clevio; Nascimento-Ferreira, Isabel; Onofre, Isabel; Albuquerque, David; Hirai, Hirokazu; Deglon, Nicole; de Almeida, Luis Pereira			Silencing Mutant Ataxin-3 Rescues Motor Deficits and Neuropathology in Machado-Joseph Disease Transgenic Mice	PLOS ONE			English	Article							POLYGLUTAMINE-INDUCED NEURODEGENERATION; SPINOCEREBELLAR ATAXIA; MOUSE MODEL; EXPANDED POLYGLUTAMINE; RAT MODEL; INTRANUCLEAR INCLUSIONS; CEREBELLAR DYSFUNCTION; NUCLEAR-LOCALIZATION; CAG REPEATS; IN-VITRO	Machado-Joseph disease (MJD) or spinocerebellar ataxia type 3 (SCA3) is an autosomal dominantly-inherited neurodegenerative disorder caused by the over-repetition of a CAG codon in the MJD1 gene. This expansion translates into a polyglutamine tract that confers a toxic gain-of-function to the mutant protein - ataxin-3, leading to neurodegeneration in specific brain regions, with particular severity in the cerebellum. No treatment able to modify the disease progression is available. However, gene silencing by RNA interference has shown promising results. Therefore, in this study we investigated whether lentiviral-mediated allele-specific silencing of the mutant ataxin-3 gene, after disease onset, would rescue the motor behavior deficits and neuropathological features in a severely impaired transgenic mouse model of MJD. For this purpose, we injected lentiviral vectors encoding allele-specific silencing-sequences (shAtx3) into the cerebellum of diseased transgenic mice expressing the targeted C-variant of mutant ataxin-3 present in 70% of MJD patients. This variation permits to discriminate between the wild-type and mutant forms, maintaining the normal function of the wild-type allele and silencing only the mutant form. Quantitative analysis of rotarod performance, footprint and activity patterns revealed significant and robust alleviation of gait, balance (average 3-fold increase of rotarod test time), locomotor and exploratory activity impairments in shAtx3-injected mice, as compared to control ones injected with shGFP. An important improvement of neuropathology was also observed, regarding the number of intranuclear inclusions, calbindin and DARPP-32 immunoreactivity, fluorojade B and Golgi staining and molecular and granular layers thickness. These data demonstrate for the first time the efficacy of gene silencing in blocking the MJD-associated motor-behavior and neuropathological abnormalities after the onset of the disease, supporting the use of this strategy for therapy of MJD.	[Nobrega, Clevio; Nascimento-Ferreira, Isabel; Onofre, Isabel; de Almeida, Luis Pereira] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Nascimento-Ferreira, Isabel; Onofre, Isabel; de Almeida, Luis Pereira] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Albuquerque, David] Univ Coimbra, Fac Sci & Technol, Coimbra, Portugal; [Hirai, Hirokazu] Gunma Univ, Grad Sch Med, Dept Neurophysiol, Maebashi, Gunma 371, Japan; [Deglon, Nicole] Univ Lausanne Hosp, Dept Clin Neurosci, Lab Cellular & Mol Neurotherapies, Lausanne, Switzerland	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Gunma University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	de Almeida, LP (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	luispa@ci.uc.pt	Deglon, Nicole/A-2265-2012; de Almeida, Luis Pereira/A-4605-2009; de Almeida, Luis Pereira/O-8196-2019; Nobrega, Clévio/M-6047-2013; Hirai, Hirokazu/ABP-1143-2022; Albuquerque, David/S-5586-2017	Deglon, Nicole/0000-0003-4475-9476; de Almeida, Luis Pereira/0000-0001-5831-3307; de Almeida, Luis Pereira/0000-0001-5831-3307; Nobrega, Clévio/0000-0002-8312-5292; Hirai, Hirokazu/0000-0002-0721-4293; Albuquerque, David/0000-0001-8899-9020; Onofre, Isabel/0000-0002-4937-448X	Portuguese Foundation for Science and Technology [PTDC/SAU-NEU/099307/2008, PTDC/SAU-FAR/116535/2010]; Center for Science and Technology of Madeira; National Ataxia Foundation; Richard Chin and Lily Lock Machado-Joseph disease Research Fund	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Center for Science and Technology of Madeira; National Ataxia Foundation; Richard Chin and Lily Lock Machado-Joseph disease Research Fund	This work was supported by the Portuguese Foundation for Science and Technology (grants PTDC/SAU-NEU/099307/2008 and PTDC/SAU-FAR/116535/2010 and fellowships to CN, INF, IO and DA), the Center for Science and Technology of Madeira (CN), the National Ataxia Foundation and the Richard Chin and Lily Lock Machado-Joseph disease Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2008, HUM MOL GENET, V17, P2071, DOI 10.1093/hmg/ddn106; Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Boy J, 2010, NEUROBIOL DIS, V37, P284, DOI 10.1016/j.nbd.2009.08.002; Boy J, 2009, HUM MOL GENET, V18, P4282, DOI 10.1093/hmg/ddp381; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Chen X, 2008, J NEUROSCI, V28, P12713, DOI 10.1523/JNEUROSCI.3909-08.2008; Chou AH, 2008, NEUROBIOL DIS, V31, P89, DOI 10.1016/j.nbd.2008.03.011; Clark HB, 1997, J NEUROSCI, V17, P7385; de Almeida LP, 2001, NEUROBIOL DIS, V8, P433, DOI 10.1006/nbdi.2001.0388; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; FOWLER HL, 1984, ARCH NEUROL-CHICAGO, V41, P921, DOI 10.1001/archneur.1984.04050200027013; Friedland DR, 2006, J NEUROSCI METH, V150, P90, DOI 10.1016/j.jneumeth.2005.06.004; Gaspar C, 1996, HUM GENET, V98, P620, DOI 10.1007/s004390050270; Gaspar C, 2001, AM J HUM GENET, V68, P523, DOI 10.1086/318184; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Hadj-Sahraoui N, 2001, DEV BRAIN RES, V126, P201, DOI 10.1016/S0165-3806(01)00095-5; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Ito M, 2002, ANN NY ACAD SCI, V978, P273, DOI 10.1111/j.1749-6632.2002.tb07574.x; Jardim LB, 2001, J NEUROL, V248, P870, DOI 10.1007/s004150170072; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Koeppen AH, 2005, CEREBELLUM, V4, P62, DOI 10.1080/14734220510007950; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Munoz E, 2002, J NEUROL SCI, V200, P19, DOI 10.1016/S0022-510X(02)00110-7; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047; Oue M, 2009, BRAIN RES, V1255, P9, DOI 10.1016/j.brainres.2008.12.014; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Rodrigues AJ, 2010, BBA-MOL CELL RES, V1803, P1154, DOI 10.1016/j.bbamcr.2010.07.004; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Scholefield J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007232; SCHOLS L, 1995, HUM MOL GENET, V4, P1001, DOI 10.1093/hmg/4.6.1001; Shakkottai VG, 2011, J NEUROSCI, V31, P13002, DOI 10.1523/JNEUROSCI.2789-11.2011; Silva-Fernandes A, 2010, NEUROBIOL DIS, V40, P163, DOI 10.1016/j.nbd.2010.05.021; Silveira I, 1998, AM J MED GENET, V81, P134, DOI 10.1002/(SICI)1096-8628(19980328)81:2<134::AID-AJMG3>3.0.CO;2-W; Simoes AT, 2012, BRAIN, V135, P2428, DOI 10.1093/brain/aws177; SUDARSKY L, 1995, CLIN NEUROSCI, V3, P17; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; van Alfen N, 2001, ANN NEUROL, V49, P805, DOI 10.1002/ana.1089; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Wullner U, 2005, ARCH NEUROL-CHICAGO, V62, P1280, DOI 10.1001/archneur.62.8.1280; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yoshizawa T, 2000, HUM MOL GENET, V9, P69, DOI 10.1093/hmg/9.1.69; Zhang CZ, 2006, J BIOSCIENCES, V31, P55, DOI 10.1007/BF02705235; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	55	85	86	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e52396	10.1371/journal.pone.0052396	http://dx.doi.org/10.1371/journal.pone.0052396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349684	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100011
J	Salati, S; Lisignoli, G; Manferdini, C; Pennucci, V; Zini, R; Bianchi, E; Norfo, R; Facchini, A; Ferrari, S; Manfredini, R				Salati, Simona; Lisignoli, Gina; Manferdini, Cristina; Pennucci, Valentina; Zini, Roberta; Bianchi, Elisa; Norfo, Ruggiero; Facchini, Andrea; Ferrari, Sergio; Manfredini, Rossella			Co-Culture of Hematopoietic Stem/Progenitor Cells with Human Osteblasts Favours Mono/Macrophage Differentiation at the Expense of the Erythroid Lineage	PLOS ONE			English	Article							STEM-CELL; BONE-MARROW; PROGENITOR CELLS; PERIPHERAL-BLOOD; SELF-RENEWAL; NICHE; TWIST; OSTEOBLASTS; PROLIFERATION; ENGRAFTMENT	Hematopoietic stem cells (HSCs) are located in the bone marrow in a specific microenvironment referred as the hematopoietic stem cell niche, where HSCs interact with a variety of stromal cells. Though several components of the stem cell niche have been identified, the regulatory mechanisms through which such components regulate the stem cell fate are still unknown. In order to address this issue, we investigated how osteoblasts (OBs) can affect the molecular and functional phenotype of Hematopoietic Stem/Progenitor Cells (HSPCs) and vice versa. For this purpose, human CD34+ cells were cultured in direct contact with primary human OBs. Our data showed that CD34+ cells cultured with OBs give rise to higher total cell numbers, produce more CFUs and maintain a higher percentage of CD34+CD38-cells compared to control culture. Moreover, clonogenic assay and long-term culture results showed that co-culture with OBs induces a strong increase in mono/macrophage precursors coupled to a decrease in the erythroid ones. Finally, gene expression profiling (GEP) allowed us to study which signalling pathways were activated in the hematopoietic cell fraction and in the stromal cell compartment after coculture. Such analysis allowed us to identify several cytokine-receptor networks, such as WNT pathway, and transcription factors, as TWIST1 and FOXC1, that could be activated by co-culture with OBs and could be responsible for the biological effects reported above. Altogether our results indicate that OBs are able to affect HPSCs on 2 different levels: on one side, they increase the immature progenitor pool in vitro, on the other side, they favor the expansion of the mono/macrophage precursors at the expense of the erythroid lineage.	[Salati, Simona; Pennucci, Valentina; Zini, Roberta; Bianchi, Elisa; Norfo, Ruggiero; Manfredini, Rossella] Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Modena, Italy; [Lisignoli, Gina; Manferdini, Cristina; Facchini, Andrea] Ist Ortoped Rizzoli, SC Lab Immunoreumatol & Rigeneraz Tissutale, Bologna, Italy; [Lisignoli, Gina; Manferdini, Cristina; Facchini, Andrea] Ist Ortoped Rizzoli, Lab RAMSES, Bologna, Italy; [Facchini, Andrea] Univ Bologna, Dipartimento Sci Med & Chirurg, Bologna, Italy; [Ferrari, Sergio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy	Universita di Modena e Reggio Emilia; IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; University of Bologna; Universita di Modena e Reggio Emilia	Manfredini, R (corresponding author), Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Modena, Italy.	rossella.manfredini@unimore.it	Lisignoli, Gina/K-4384-2016; Salati, Simona/J-2344-2012; Zini, Roberta/I-6734-2012; Manfredini, Rossella/C-5625-2015; Bianchi, Elisa/F-2242-2015; manferdini, cristina/K-2680-2018; Ferrari, Sergio/A-1110-2010	Lisignoli, Gina/0000-0003-2837-9967; Salati, Simona/0000-0002-8072-1128; Zini, Roberta/0000-0001-6657-0864; Manfredini, Rossella/0000-0003-0660-6110; Bianchi, Elisa/0000-0002-6110-5944; manferdini, cristina/0000-0002-6648-6061; Ferrari, Sergio/0000-0002-4822-2521; Norfo, Ruggiero/0000-0002-9485-6285	Italian Ministry of University Research [RBAP11CZLK_ 002]; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano); Special Program Molecular Clinical Oncology [10005, 561000]; AIRC project [12055]	Italian Ministry of University Research(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology; AIRC project(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Ministry of University & Research (FIRB Project 2011, project number #RBAP11CZLK_ 002, http://www.istruzione.it/web/ricerca/firb), Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano, http://www.airc.it/english/obiettivi-risultati-english.asp), project number #10005 "Special Program Molecular Clinical Oncology 561000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative, http://www.progettoagimm.it), AIRC project number #12055, and Project "Tecnopolo" (Regione Emilia Romagna, http://www.aster.it/tiki-index.php? page = TecnopoloMo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee DJ, 2011, VOX SANG, V100, P140, DOI 10.1111/j.1423-0410.2010.01388.x; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cashman JD, 1999, BLOOD, V93, P481, DOI 10.1182/blood.V93.2.481.402k20_481_487; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Dea V, 2004, BLOOD, V103, P3258; Dormady SP, 2000, P NATL ACAD SCI USA, V97, P12260, DOI 10.1073/pnas.97.22.12260; Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857; Hosokawa K, 2010, CELL STEM CELL, V6, P194, DOI 10.1016/j.stem.2009.04.013; Jung Y, 2005, CYTOKINE, V32, P155, DOI 10.1016/j.cyto.2005.09.001; Katoh M, 2004, INT J ONCOL, V25, P1495; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Li XA, 2010, BLOOD, V116, P2304, DOI 10.1182/blood-2009-09-242313; Lisignoli G, 2006, J CELL PHYSIOL, V206, P78, DOI 10.1002/jcp.20435; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; Manferdini C, J CELL PHYSL, V226, P2675; Manfredini R, 2005, STEM CELLS, V23, P496, DOI 10.1634/stemcells.2004-0265; MARUSIC A, 1993, J BONE MINER RES, V8, P617; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Nakata Y, 2006, BLOOD, V107, P4234, DOI 10.1182/blood-2005-08-3343; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ottersbach K, 2006, BLOOD, V107, P1284, DOI 10.1182/blood-2005-08-3112; Pelus LM, 2006, EXP HEMATOL, V34, P1010, DOI 10.1016/j.exphem.2006.04.004; Ross EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002338; Salati S, 2008, STEM CELLS, V26, P950, DOI 10.1634/stemcells.2007-0597; Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Terauchi M, 2007, CLIN EXP METASTAS, V24, P329, DOI 10.1007/s10585-007-9070-1; Weber JM, 2010, BONE, V46, P281, DOI 10.1016/j.bone.2009.08.007; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang XM, 2007, INT J CANCER, V120, P1891, DOI 10.1002/ijc.22489; Zhang YQ, 2007, PATHOLOGY, V39, P470, DOI 10.1080/00313020701570053	44	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53496	10.1371/journal.pone.0053496	http://dx.doi.org/10.1371/journal.pone.0053496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349713	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100022
J	Tang, HB; Ming, ZP; Liu, R; Xiong, T; Grevelding, CG; Dong, HF; Jiang, MS				Tang, Hongbin; Ming, Zhenping; Liu, Rong; Xiong, Tao; Grevelding, Christoph G.; Dong, Huifeng; Jiang, Mingsen			Development of Adult Worms and Granulomatous Pathology Are Collectively Regulated by T- and B-Cells in Mice Infected with Schistosoma japonicum	PLOS ONE			English	Article							HOST-PARASITE RELATIONSHIP; BLOOD FLUKE DEVELOPMENT; MURINE SCHISTOSOMIASIS; MANSONI; RESPONSES; IL-10; MODULATION; MOUSE; HYPERSENSITIVITY; INDUCTION	Schistosoma blood flukes, which cause schistosomiasis affecting 200 million people in the world, are dependent on signals from host CD4(+) T cells to facilitate parasite growth and development in the mammalian host and to induce Th2-biased inflammatory granulomas. B cells, however, are reported to down-regulate granulomatous pathology in schistosomiasis, but not to affect the development of blood flukes together with CD4(+) T lymphocytes. Thus it is not clear whether B cells mediate parasite development, reproduction and egg granuloma formation of schistosomes without the help of CD4(+) T lymphocytes. Using mice that have severe combined immunodeficiency (scid) and mice lacking T cells (nude), we found that the absence of B cells can more seriously hamper the development and paring of adult worms, but granuloma formation of Schistosoma japonicum in scid mice was not down-regulated comparing with that in nude mice. The level of IL-10 in the sera of nude mice was significantly higher than of scid mice at 43 days post infection (p.i.). Thus multiple mechanisms of immune modulation seem to be involved in parasite development and reproduction by helminth-induced regulatory B cells. Our findings have significance for understanding the molecular connections between schistosomes and T- and B-cells, indicating that more research is needed to develop efficient vaccine-based therapies for schistosomiasis.	[Tang, Hongbin] Wuhan Univ, Sch Med, Lab Anim Ctr, Wuhan 430072, Peoples R China; [Ming, Zhenping; Liu, Rong; Xiong, Tao; Dong, Huifeng; Jiang, Mingsen] Wuhan Univ, Sch Basic Med Sci, Dept Med Parasitol, Wuhan 430072, Peoples R China; [Grevelding, Christoph G.] Univ Giessen, Inst Parasitol, D-35390 Giessen, Germany	Wuhan University; Wuhan University; Justus Liebig University Giessen	Dong, HF (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Med Parasitol, Wuhan 430072, Peoples R China.	hfdong@whu.edu.cn; msjiang@whu.edu.cn	Liu, Rong/ABE-3102-2020	Liu, Rong/0000-0003-2561-348X	national natural science foundation of china [30872202]	national natural science foundation of china(National Natural Science Foundation of China (NSFC))	This work is financially supported by the national natural science foundation of china awarded #30872202. http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1984, J IMMUNOL, V132, P2084; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Blank RB, 2006, J INFECT DIS, V194, P1609, DOI 10.1086/508896; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Burdin N, 1997, METHODS, V11, P98, DOI 10.1006/meth.1996.0393; BYRAM JE, 1977, AM J TROP MED HYG, V26, P944, DOI 10.4269/ajtmh.1977.26.944; BYRAM JE, 1979, AM J TROP MED HYG, V28, P274, DOI 10.4269/ajtmh.1979.28.274; Cheever AW, 1999, INFECT IMMUN, V67, P2201, DOI 10.1128/IAI.67.5.2201-2208.1999; Chen PH, 1995, CULTIVATION IN VITRO, P277; Cheng YL, 2008, PARASITOL RES, V102, P1129, DOI 10.1007/s00436-008-0880-0; CHENSUE SW, 1981, J IMMUNOL, V127, P363; CHENSUE SW, 1993, J IMMUNOL, V151, P1391; CHENSUE SW, 1994, CLIN EXP IMMUNOL, V98, P395, DOI 10.1111/j.1365-2249.1994.tb05503.x; CUSTER RP, 1985, AM J PATHOL, V120, P464; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; DOENHOFF M, 1978, IMMUNOLOGY, V35, P771; DOENHOFF MJ, 1987, T ROY SOC TROP MED H, V81, P947, DOI 10.1016/0035-9203(87)90360-9; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Fairfax KC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002490; Falcao PL, 1998, PARASITE IMMUNOL, V20, P447, DOI 10.1046/j.1365-3024.1998.00166.x; FloresVillanueva PO, 1996, J IMMUNOL, V156, P3315; Harris N, 2011, TRENDS IMMUNOL, V32, P80, DOI 10.1016/j.it.2010.11.005; HARRISON RA, 1983, PARASITOLOGY, V86, P429, DOI 10.1017/S0031182000050629; Jankovic D, 1998, J EXP MED, V187, P619, DOI 10.1084/jem.187.4.619; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Lamb EW, 2007, INT J PARASITOL, V37, P405, DOI 10.1016/j.ijpara.2006.11.001; Lamb EW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000892; Mangan NE, 2004, J IMMUNOL, V173, P6346, DOI 10.4049/jimmunol.173.10.6346; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; MOLONEY NA, 1982, PARASITE IMMUNOL, V4, P431, DOI 10.1111/j.1365-3024.1982.tb00454.x; Montesano MA, 1997, J IMMUNOL, V158, P3800; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; PHILLIPS SM, 1977, J IMMUNOL, V118, P594; RUPPEL A, 1990, PARASITOLOGY, V101, P23, DOI 10.1017/S0031182000079701; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Velupillai P, 1997, J IMMUNOL, V158, P338; VELUPILLAI P, 1994, P NATL ACAD SCI USA, V91, P18, DOI 10.1073/pnas.91.1.18; VILLANUEVA POF, 1994, J IMMUNOL, V153, P5190; Wilson MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002171; Wolowczuk I, 1999, INFECT IMMUN, V67, P4183, DOI 10.1128/IAI.67.8.4183-4190.1999	42	25	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54432	10.1371/journal.pone.0054432	http://dx.doi.org/10.1371/journal.pone.0054432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349889	gold, Green Submitted, Green Published			2022-12-27	WOS:000314019100067
J	Yu, X; Lv, JJ; Zhu, YZ; Duan, LP; Ma, LQ				Yu, Xue; Lv, Jiajun; Zhu, Yunzhen; Duan, Liping; Ma, Lanqing			Homocysteine Inhibits Hepatocyte Proliferation via Endoplasmic Reticulum Stress	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; METHIONINE METABOLISM; MURINE MODEL; HYPERHOMOCYSTEINEMIA; APOPTOSIS; DEATH; LIVER; MICE; EXPRESSION; TRB3	Homocysteine is an independent risk factor for coronary, cerebral, and peripheral vascular diseases. Recent studies have shown that levels of homocysteine are elevated in patients with impaired hepatic function, but the precise role of homocysteine in the development of hepatic dysfunction is unclear. In this study, we examined the effect of homocysteine on hepatocyte proliferation in vitro. Our results demonstrated that homocysteine inhibited hepatocyte proliferation by up-regulating protein levels of p53 as well as mRNA and protein levels of p21(Cip1) in primary cultured hepatocytes. Homocysteine induced cell growth arrest in p53-positive hepatocarcinoma cell line HepG2, but not in p53-null hepatocarcinoma cell line Hep3B. A p53 inhibitor pifithrin-alpha inhibited the expression of p21(Cip1) and attenuated homocysteine-induced cell growth arrest. Homocysteine induced TRB3 expression via endoplasmic reticulum stress pathway, resulting in Akt dephosphorylation. Knock-down of endogenous TRB3 significantly suppressed the inhibitory effect of homocysteine on cell proliferation and the phosphorylation of Akt. LiCl reversed homocysteine-mediated cell growth arrest by inhibiting TRB3-mediated Akt dephosphorylation. These results demonstrate that both TRB3 and p21(Cip1) are critical molecules in the homocysteine signaling cascade and provide a mechanistic explanation for impairment of liver regeneration in hyperhomocysteinemia.	[Yu, Xue] Beijing Hosp, Minist Hlth, Dept Cardiol, Beijing, Peoples R China; [Lv, Jiajun; Zhu, Yunzhen; Duan, Liping; Ma, Lanqing] Kunming Med Univ, Affiliated Hosp 1, Dept Digest Dis, Kunming, Yunnan, Peoples R China	Beijing Hospital; Kunming Medical University	Ma, LQ (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Digest Dis, Kunming, Yunnan, Peoples R China.	mlq6006@yahoo.cn			National Natural Science Foundation of China [81160060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (81160060) from the National Natural Science Foundation of China (to LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2005, HEPATOLOGY, V41, P995, DOI 10.1002/hep.20664; Akasaka K, 2005, J VASC SURG, V41, P517, DOI 10.1016/j.jvs.2004.12.043; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Halsted CH, 2002, P NATL ACAD SCI USA, V99, P10072, DOI 10.1073/pnas.112336399; He L, 2007, MOL ENDOCRINOL, V21, P2541, DOI 10.1210/me.2007-0036; Ji C, 2005, ALCOHOL CLIN EXP RES, V29, P1496, DOI 10.1097/01.alc.0000174691.03751.11; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Liu WH, 2010, AM J PATHOL, V177, P2357, DOI 10.2353/ajpath.2010.091131; Liu WJ, 2011, AM J PATHOL, V178, P1489, DOI 10.1016/j.ajpath.2010.12.052; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mikael LG, 2006, CIRC RES, V98, P564, DOI 10.1161/01.RES.0000204825.66410.0b; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Sakuta H, 2005, ALCOHOL, V37, P73, DOI 10.1016/j.alcohol.2005.12.005; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Suhara T, 2004, HYPERTENSION, V43, P1208, DOI 10.1161/01.HYP.0000127914.94292.76; Thambyrajah J, 2000, EUR HEART J, V21, P967, DOI 10.1053/euhj.1999.1914; VARELAMOREIRAS G, 1995, HEPATOLOGY, V22, P1310, DOI 10.1016/0270-9139(95)90644-4; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu D, 2000, FEBS LETT, V470, P20, DOI 10.1016/S0014-5793(00)01278-3; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yu X, 2009, ACTA BIOCH BIOPH SIN, V41, P1027, DOI 10.1093/abbs/gmp097; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	42	11	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54265	10.1371/journal.pone.0054265	http://dx.doi.org/10.1371/journal.pone.0054265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349842	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100053
J	Egan, SP; Hood, GR; DeVela, G; Ott, JR				Egan, Scott P.; Hood, Glen R.; DeVela, Gabriel; Ott, James R.			Parallel Patterns of Morphological and Behavioral Variation among Host-Associated Populations of Two Gall Wasp Species	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; NATURAL-SELECTION; GENETIC DIFFERENTIATION; ECOLOGICAL SPECIATION; POSTMATING ISOLATION; PLANT ADAPTATION; SYMPATRIC RACES; BODY-SIZE; EVOLUTION; PREFERENCE	A powerful approach to address the general factors contributing to ecological speciation is to compare distantly related taxa that inhabit the same selective environments. In this design, similarities among taxa can elucidate general mechanisms of the process whereas differences may uncover specific factors important to the process for individual taxa. Herein, we present evidence of parallel patterns of morphological and behavioral variation among host-associated populations of two species of cynipid gall wasps, Belonocnema treatae and Disholcaspis quercusvirens, that each exhibit a life cycle intimately tied to the same two host plant environments, Quercus geminata and Q. virginiana. Across both gall-former species we find consistent differences in body size and gall morphology associated with host plant use, as well as strong differences in host plant preference, a measure of habitat isolation among populations. These consistent differences among taxa highlight the important role of host plant use in promoting reproductive isolation and morphological variation among herbivorous insect populations-a prerequisite for ecological speciation.	[Egan, Scott P.; Hood, Glen R.; DeVela, Gabriel] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Egan, Scott P.] Univ Notre Dame, Adv Diagnost & Therapeut Initiat, Notre Dame, IN 46556 USA; [Ott, James R.] Texas State Univ San Marcos, Populat & Conservat Biol Program, Dept Biol, San Marcos, TX USA	University of Notre Dame; University of Notre Dame; Texas State University System; Texas State University San Marcos	Egan, SP (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	scott.p.egan@nd.edu			University of Notre Dame - FRSP Initiation Grant	University of Notre Dame - FRSP Initiation Grant	The research was partially funded by a University of Notre Dame - FRSP Initiation Grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson W. G., 1997, EVOLUTIONARY ECOLOGY; Abrahamson WG, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P188; Ashmead J. M., 1896, Proceedings United States Museum, Vxix, P113; Ashmead W.H., 1885, T AM ENTOMOLOGICAL S, V12, P5; Ashmead W.H, 1881, TRANSACTION AM ENTOM, V9, P9; Barron AB, 2001, J INSECT BEHAV, V14, P725, DOI 10.1023/A:1013033332535; Bolnick DI, 2009, EVOLUTION, V63, P2004, DOI 10.1111/j.1558-5646.2009.00699.x; Cavender-Bares J, 2011, J BIOGEOGR, V38, P962, DOI 10.1111/j.1365-2699.2010.02451.x; Cavender-Bares J, 2009, AM J BOT, V96, P1690, DOI 10.3732/ajb.0800315; Coyne J.A., 2004, SPECIATION; Craig TP, 2001, EVOLUTION, V55, P773, DOI 10.1554/0014-3820(2001)055[0773:GEAHPP]2.0.CO;2; CRAIG TP, 1993, EVOLUTION, V47, P1696, DOI 10.1111/j.1558-5646.1993.tb01262.x; Dickey AM, 2010, J EVOLUTION BIOL, V23, P945, DOI 10.1111/j.1420-9101.2010.01962.x; Dobzhansky T., 1951, COPEIA; Edelaar P, 2008, EVOLUTION, V62, P2462, DOI 10.1111/j.1558-5646.2008.00459.x; Egan SP, 2011, J EVOLUTION BIOL, V24, P2217, DOI 10.1111/j.1420-9101.2011.02350.x; Egan S.P., 2012, INT J ECOL, V2012, DOI DOI 10.1155/2012/809897; Egan SP, 2012, BIOL LETTERS, V8, P605, DOI 10.1098/rsbl.2011.1205; Egan SP, 2009, P NATL ACAD SCI USA, V106, P19426, DOI 10.1073/pnas.0909424106; Feder JL, 2010, ECOL ENTOMOL, V35, P67, DOI 10.1111/j.1365-2311.2009.01144.x; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; Fitzpatrick BM, 2012, INT J ECOL, V2012, P1, DOI [rg/10.1155/2012/256017, DOI 10.1155/2012/256017]; Forbes AA, 2009, SCIENCE, V323, P776, DOI 10.1126/science.1166981; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hall MC, 2001, THESIS TEXAS STATE U; HAWKINS BA, 1990, J ANIM ECOL, V59, P57, DOI 10.2307/5158; Heard Stephen B., 2012, International Journal of Ecology, P1; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hood GR, 2010, OECOLOGIA, V162, P673, DOI 10.1007/s00442-009-1492-9; Horner JD, 2008, ENTOMOL EXP APPL, V128, P274, DOI 10.1111/j.1570-7458.2008.00728.x; Janz N, 2009, ECOL ENTOMOL, V34, P50, DOI 10.1111/j.1365-2311.2008.01041.x; KATAKURA H, 1989, EVOLUTION, V43, P1045, DOI 10.1111/j.1558-5646.1989.tb02549.x; KV Krombein, 1979, CATALOG HYMENOPTERA, VI; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Lowry DB, 2008, EVOLUTION, V62, P2196, DOI 10.1111/j.1558-5646.2008.00457.x; Lund JN, 1998, P ENTOMOL SOC WASH, V100, P755; MAYR E, 1947, EVOLUTION, V1, P263, DOI 10.2307/2405327; Mayr G.L., 1881, JAHRESBERICHTE COMMU, V20, P1; McBride CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000529; Melika George, 2002, P150; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2006, J EVOLUTION BIOL, V19, P929, DOI 10.1111/j.1420-9101.2005.01035.x; Nosil P, 2006, P ROY SOC B-BIOL SCI, V273, P991, DOI 10.1098/rspb.2005.3359; Nosil P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001907; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; PAPAJ DR, 1989, ANNU REV ENTOMOL, V34, P315, DOI 10.1146/annurev.en.34.010189.001531; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Platt JE, 2009, THESIS U FLORIDA US; Price PW, 2004, CONSERV BIOL, V18, P1405, DOI 10.1111/j.1523-1739.2004.00547.x; Rolan-Alvarez E, 1997, EVOLUTION, V51, P1838, DOI 10.1111/j.1558-5646.1997.tb05107.x; Rosenblum EB, 2011, EVOLUTION, V65, P946, DOI 10.1111/j.1558-5646.2010.01190.x; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Sandoval CP, 2005, EVOLUTION, V59, P2405; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; SMITH MA, 1979, ANIM BEHAV, V27, P365, DOI 10.1016/0003-3472(79)90170-2; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Stireman JO, 2005, EVOLUTION, V59, P2573, DOI 10.1554/05-222.1; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; vanEmden HF, 1996, PHYSIOL ENTOMOL, V21, P325, DOI 10.1111/j.1365-3032.1996.tb00873.x; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Vines TH, 2005, P R SOC B, V273, P911; WOOD TK, 1990, EVOLUTION, V44, P619, DOI 10.1111/j.1558-5646.1990.tb05942.x	68	23	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54690	10.1371/journal.pone.0054690	http://dx.doi.org/10.1371/journal.pone.0054690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349952	Green Published, gold, Green Submitted			2022-12-27	WOS:000313943000046
J	Colombara, DV; Cowgill, KD; Faruque, ASG				Colombara, Danny V.; Cowgill, Karen D.; Faruque, Abu S. G.			Risk Factors for Severe Cholera among Children under Five in Rural and Urban Bangladesh, 2000-2008: A Hospital-Based Surveillance Study	PLOS ONE			English	Article							BREAST-MILK; INFECTION; DIARRHEA; ANTIBODIES; INFANTS; DISEASE; TRIAL; DHAKA	Background: Children under five bear the largest cholera burden. We therefore sought to identify modifiable risk factors among Bangladeshi children. Methodology/Principal Findings: We used multivariate Poisson regression to assess risk factors for severe cholera among diarrheal patients presenting at hospitals in Matlab (rural) and Dhaka (urban), Bangladesh. Risk increased with age. Compared to those under one, rural and urban four-year-olds had adjusted risk ratios (aRR) of 4.17 (95% confidence interval (CI) 2.43-7.15) and 6.32 (95% CI: 4.63-8.63), respectively. Breastfeeding halved the risk in both rural (aRR = 0.49, 95% CI: 0.35-0.67) and urban (aRR = 0.51, 95% CI: 0.41-0.62) settings. Rural children's risk decreased with maternal education (P-trend: <0.001) and increased among those with a family member with diarrhea in the past week (aRR = 1.61, 95% CI: 1.22-2.14) and those with prior vitamin A supplementation (aRR = 1.65, 95% CI: 1.12-2.43). Urban children whose mothers daily (aRR = 0.41, 95% CI: 0.21-0.79) or occasionally (aRR = 0.55, 95% CI: 0.36-0.84) read a newspaper experienced reduced risk. Urban children from households with incomes between 34-84 USD/month had a 30% increased risk compared to those from households with incomes >84 USD/month. Conclusion/Significance: Increasing age, lower socioeconomic status, and lack of breastfeeding are key correlates of increased risk for cholera hospitalization among those under five in rural and urban Bangladesh. In addition, having a family member with diarrhea in the past week was associated with increased risk among rural children. Continued attention should be directed to the promotion of breastfeeding. Further research is needed to elucidate the relationship between maternal education and cholera risk. Renewed research regarding the use of chemoprophylaxis among family members of cholera cases may be warranted in rural endemic settings.	[Colombara, Danny V.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Cowgill, Karen D.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Cowgill, Karen D.] Seattle Univ, Coll Nursing, Seattle, WA 98122 USA; [Faruque, Abu S. G.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle University; International Centre for Diarrhoeal Disease Research (ICDDR)	Colombara, DV (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	dvc2@uw.edu	Colombara, Danny/H-7202-2015	Colombara, Danny/0000-0002-5237-1300; Cowgill, Karen/0000-0002-4188-3757	Washington Global Health Alliance travel grant; National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute; National Institute of Dental and Craniofacial Research; National Institute On Drug Abuse; National Institute of Mental Health; National Institute of Allergy and Infectious Diseases; National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; National Cancer Institute [R25 CA94880]; American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA094880] Funding Source: NIH RePORTER	Washington Global Health Alliance travel grant; National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute On Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Washington Global Health Alliance travel grant [2009 to DVC (http://www.wghalliance.org/)]; the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental and Craniofacial Research, National Institute On Drug Abuse, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, and National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [grant number R24 TW007988 to DVC (https://fogartyscholars.org/)]; the National Cancer Institute [grant number R25 CA94880 to DVC (http://www.cancer.gov/)]; and the American Relief and Recovery Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Ali M, 2011, J INFECT DIS, V204, P912, DOI 10.1093/infdis/jir416; BLAKE PA, 1993, J INFECT DIS, V167, P627, DOI 10.1093/infdis/167.3.627; Chowdhury F, 2008, PEDIATR INFECT DIS J, V27, P986, DOI 10.1097/INF.0b013e3181783adf; CLEMENS JD, 1990, AM J EPIDEMIOL, V131, P400, DOI 10.1093/oxfordjournals.aje.a115515; Giashuddin MS, 2004, INDIAN J MED RES, V119, P267; Giebultowicz S, 2011, HEALTH PLACE, V17, P490, DOI 10.1016/j.healthplace.2010.12.004; GLASS RI, 1986, ACTA PAEDIATR SCAND, V75, P713, DOI 10.1111/j.1651-2227.1986.tb10279.x; GLASS RI, 1983, NEW ENGL J MED, V308, P1389, DOI 10.1056/NEJM198306093082304; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; GLASS RI, 1982, AM J EPIDEMIOL, V116, P959, DOI 10.1093/oxfordjournals.aje.a113498; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; GUERRANT RL, 1983, J INFECT DIS, V148, P986, DOI 10.1093/infdis/148.6.986; GUNN RA, 1979, LANCET, V2, P730; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Harris JB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000221; Kay B, 1994, VIBRIO CHOLERAE CHOL, P3; LEVINE RJ, 1976, LANCET, V2, P86; Mccarthy N, 1999, CASE CASE COMP STUDY, P764; Mitra AK, 2000, J HEALTH POPUL NUTR, V18, P151; MOSLEY WH, 1968, B WORLD HEALTH ORGAN, V38, P335; O'Reilly CE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001256; PALMER DL, 1976, J INFECT DIS, V134, P8, DOI 10.1093/infdis/134.1.8; Qureshi K, 2006, PEDIATR INFECT DIS J, V25, P1163, DOI 10.1097/01.inf.0000246977.58697.a5; Rahman KM, 2009, J HEALTH POPUL NUTR, V27, P733; Reveiz L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027060; Rowe PC, 1994, EPIDEMIC ESCHERICHIA, P1; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008603.pub2; Strand TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036436; Weil AA, 2009, CLIN INFECT DIS, V49, P1473, DOI 10.1086/644779; WHO, 1987, PROGR CONTR DIARRH D; WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation, 2010, TYP DRINK WAT SOURC; Wilson Nick, 2008, Epidemiol Perspect Innov, V5, P6, DOI 10.1186/1742-5573-5-6; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54395	10.1371/journal.pone.0054395	http://dx.doi.org/10.1371/journal.pone.0054395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349875	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800049
J	Lang, R; Liu, GH; Shi, YG; Bharadwaj, S; Leng, XY; Zhou, XB; Liu, H; Atala, A; Zhang, YY				Lang, Ren; Liu, Guihua; Shi, Yingai; Bharadwaj, Shantaram; Leng, Xiaoyan; Zhou, Xiaobo; Liu, Hong; Atala, Anthony; Zhang, Yuanyuan			Self-Renewal and Differentiation Capacity of Urine-Derived Stem Cells after Urine Preservation for 24 Hours	PLOS ONE			English	Article							ORGAN PRESERVATION; TISSUE; CRYOPRESERVATION; BIOLOGY; GROWTH	Despite successful approaches to preserve organs, tissues, and isolated cells, the maintenance of stem cell viability and function in body fluids during storage for cell distribution and transportation remains unexplored. The aim of this study was to characterize urine-derived stem cells (USCs) after optimal preservation of urine specimens for up to 24 hours. A total of 415 urine specimens were collected from 12 healthy men (age range 20-54 years old). About 6x10(4) cells shed off from the urinary tract system in 24 hours. At least 100 USC clones were obtained from the stored urine specimens after 24 hours and maintained similar biological features to fresh USCs. The stored USCs had a "rice grain" shape in primary culture, and expressed mesenchymal stem cell surface markers, high telomerase activity, and normal karyotypes. Importantly, the preserved cells retained bipotent differentiation capacity. Differentiated USCs expressed myogenic specific proteins and contractile function when exposed to myogenic differentiation medium, and they expressed urothelial cell-specific markers and barrier function when exposed to urothelial differentiation medium. These data demonstrated that up to 75% of fresh USCs can be safely persevered in urine for 24 hours and that these cells stored in urine retain their original stem cell properties, indicating that preserved USCs could be available for potential use in cell-based therapy or clinical diagnosis.	[Lang, Ren] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Lang, Ren; Liu, Guihua; Shi, Yingai; Bharadwaj, Shantaram; Atala, Anthony; Zhang, Yuanyuan] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA; [Leng, Xiaoyan] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Zhou, Xiaobo] Methodist Hosp, Radiol Translat Biol Dept, Res Inst, Houston, TX 77030 USA; [Liu, Hong] Univ Oklahoma, Ctr Bioengn, Norman, OK 73019 USA; [Liu, Hong] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA	Capital Medical University; Wake Forest University; Wake Forest University; The Methodist Hospital System; The Methodist Hospital - Houston; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Zhang, YY (corresponding author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA.	yzhang@wakehealth.edu	zhang, yuanyuan/GYA-4428-2022; guihua, liu/B-1060-2012	Atala, Anthony/0000-0001-8186-2160				Bharadwaj S, 2009, J TISSUE ENG REGEN M, V6, pS293; Bharadwaj S, 2011, TISSUE ENG PT A, V17, P2123, DOI [10.1089/ten.TEA.2010.0637, 10.1089/ten.tea.2010.0637]; Bharadwaj S, 2010, J UROLOGY, V183, pE681, DOI 10.1016/j.juro.2010.02.1671; Bodin A, 2010, BIOMATERIALS, V31, P8889, DOI 10.1016/j.biomaterials.2010.07.108; DEBOER WI, 1994, J HISTOCHEM CYTOCHEM, V42, P277, DOI 10.1177/42.2.7507144; Fridell JA, 2009, CLIN TRANSPLANT, V23, P305, DOI 10.1111/j.1399-0012.2008.00952.x; Guibert EE, 2011, TRANSFUS MED HEMOTH, V38, P125, DOI 10.1159/000327033; Hoath SB, 2003, J INVEST DERMATOL, V121, P1440, DOI 10.1046/j.1523-1747.2003.12606.x; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Huss R, 2000, STEM CELLS, V18, P1, DOI 10.1634/stemcells.18-1-1; Isachenko E, 2003, EUR J OBSTET GYN R B, V108, P186, DOI 10.1016/S0301-2115(02)00465-7; Jiang SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003812; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kreft ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038509; Kropp BP, 1999, J UROLOGY, V162, P1779, DOI 10.1016/S0022-5347(05)68237-7; Luder Hans U, 2012, Methods Mol Biol, V887, P81, DOI 10.1007/978-1-61779-860-3_9; Muhlbacher F, 1999, TRANSPLANT P, V31, P2069, DOI 10.1016/S0041-1345(99)00265-1; Nakanishi W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042319; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Penny J, 2012, FRONT BIOSCI-LANDMRK, V17, P892, DOI 10.2741/3963; Poglio S, 2010, STEM CELLS, V28, P2065, DOI 10.1002/stem.523; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rubio D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001398; Tee JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005880; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001; WIGLEY CB, 1976, J CELL SCI, V20, P149; Wu SF, 2011, J UROLOGY, V186, P640, DOI 10.1016/j.juro.2011.03.152; Wu SF, 2011, BIOMATERIALS, V32, P1317, DOI 10.1016/j.biomaterials.2010.10.006; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; ZAHEER HA, 1994, STEM CELLS, V12, P180, DOI 10.1002/stem.5530120206; Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	34	82	96	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53980	10.1371/journal.pone.0053980	http://dx.doi.org/10.1371/journal.pone.0053980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349776	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800020
J	Sham, D; Wesley, UV; Hristova, M; van der Vliet, A				Sham, Derek; Wesley, Umadevi V.; Hristova, Milena; van der Vliet, Albert			ATP-Mediated Transactivation of the Epidermal Growth Factor Receptor in Airway Epithelial Cells Involves DUOX1-Dependent Oxidation of Src and ADAM17	PLOS ONE			English	Article							C-SRC; P2Y(2) RECEPTOR; TYROSINE KINASE; NADPH OXIDASES; WOUND REPAIR; ACTIVATION; REDOX; PHOSPHORYLATION; EXPRESSION; RESPONSES	The respiratory epithelium is subject to continuous environmental stress and its responses to injury or infection are largely mediated by transactivation of the epidermal growth factor receptor (EGFR) and downstream signaling cascades. Based on previous studies indicating involvement of ATP-dependent activation of the NADPH oxidase homolog DUOX1 in epithelial wound responses, the present studies were performed to elucidate the mechanisms by which DUOX1-derived H2O2 participates in ATP-dependent redox signaling and EGFR transactivation. ATP-mediated EGFR transactivation in airway epithelial cells was found to involve purinergic P2Y(2) receptor stimulation, and both ligand-dependent mechanisms as well as ligand-independent EGFR activation by the non-receptor tyrosine kinase Src. Activation of Src was also essential for ATP-dependent activation of the sheddase ADAM17, which is responsible for liberation and activation of EGFR ligands. Activation of P2Y(2)R results in recruitment of Src and DUOX1 into a signaling complex, and transient siRNA silencing or stable shRNA transfection established a critical role for DUOX1 in ATP-dependent activation of Src, ADAM17, EGFR, and downstream wound responses. Using thiol-specific biotin labeling strategies, we determined that ATP-dependent EGFR transactivation was associated with DUOX1-dependent oxidation of cysteine residues within Src as well as ADAM17. In aggregate, our findings demonstrate that DUOX1 plays a central role in overall epithelial defense responses to infection or injury, by mediating oxidative activation of Src and ADAM17 in response to ATP-dependent P2Y(2)R activation as a proximal step in EGFR transactivation and downstream signaling.	[Sham, Derek; Hristova, Milena; van der Vliet, Albert] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Wesley, Umadevi V.] Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT USA; [Wesley, Umadevi V.] Univ Vermont, Vermont Lung Ctr, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont	van der Vliet, A (corresponding author), Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA.	Albert.van-der-Vliet@uvm.edu			National Institutes of Health [R01 HL085646]; Department of Pathology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a research grant from the National Institutes of Health to AvdV (R01 HL085646), and by a Fellowship from the Department of Pathology to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2006, FREE RADICAL BIO MED, V41, P29, DOI 10.1016/j.freeradbiomed.2006.03.004; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Belete HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027469; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Block ER, 2011, CELL SIGNAL, V23, P2051, DOI 10.1016/j.cellsig.2011.07.021; Boots AW, 2009, J BIOL CHEM, V284, P17858, DOI 10.1074/jbc.M809761200; Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009; Boucher I, 2010, AM J PHYSIOL-CELL PH, V299, pC411, DOI 10.1152/ajpcell.00100.2009; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Davis FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023464; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; Douillet CD, 2006, AM J PHYSIOL-LUNG C, V291, pL734, DOI 10.1152/ajplung.00389.2005; Filosto S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023240; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Joo JH, 2012, ANTIOXID REDOX SIGN, V16, P57, DOI 10.1089/ars.2011.3898; Juarez MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002424; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Koff JL, 2008, AM J PHYSL LUNG CELL; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004; Linderholm AL, 2010, AM J PHYSIOL-LUNG C, V299, pL215, DOI 10.1152/ajplung.00015.2010; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Luxen S, 2009, J CELL SCI, V122, P1238, DOI 10.1242/jcs.044123; Maretzky T, 2011, ONCOGENE, V30, P611, DOI 10.1038/onc.2010.443; McCarthy SM, 2008, BIOCHEMISTRY-US, V47, P5832, DOI 10.1021/bi702496v; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Norambuena A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081166; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Peterson TS, 2010, MOL NEUROBIOL, V41, P356, DOI 10.1007/s12035-010-8115-7; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Ratchford AM, 2010, J BIOL CHEM, V285, P7545, DOI 10.1074/jbc.M109.078170; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Senga T, 2008, CANCER SCI, V99, P571, DOI 10.1111/j.1349-7006.2007.00714.x; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Vermeer PD, 2006, J BIOL CHEM, V281, P1725, DOI 10.1074/jbc.M506933200; Wang LF, 2011, AM J PHYSIOL-CELL PH, V301, pC171, DOI 10.1152/ajpcell.00363.2010; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Yu M, 2011, J IMMUNOL, V186, P1180, DOI 10.4049/jimmunol.1001499; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	74	57	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54391	10.1371/journal.pone.0054391	http://dx.doi.org/10.1371/journal.pone.0054391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349873	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872800048
J	Cuntz, U; Enck, P; Fruhauf, E; Lehnert, P; Riepl, RL; Fichter, MM; Otto, B				Cuntz, Ulrich; Enck, Paul; Fruehauf, Erich; Lehnert, Peter; Riepl, Rudolf L.; Fichter, Manfred M.; Otto, Baerbel			Cholecystokinin Revisited: CCK and the Hunger Trap in Anorexia Nervosa	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; EXOCRINE PANCREATIC-SECRETION; FOOD-INTAKE; PLASMA CHOLECYSTOKININ; GASTROINTESTINAL PEPTIDES; EATING-DISORDERS; BULIMIA-NERVOSA; BODY-WEIGHT; SATIETY; RELEASE	Objective: Despite a number of studies in the past decades, the role of Cholecystokinin (CCK) in anorexia nervosa (AN) has remained uncertain. In this study a highly specific assay for the biologically active part of CCK was used in patients with bulimic as well as with the restricting type of AN who were followed over the course of weight gain. Methods: Ten patients with restricting and 13 with bulimic AN were investigated upon admission (T0), after a weight gain of at least 2 kg on two consecutive weighting dates (T1), and during the last week before discharge (T2) from inpatient treatment in a specialized clinic. Blood samples were drawn under fasting conditions and 20 and 60 minutes following a standard meal (250 kcal). Data were compared to those of eight controls matched for sex and age. Gastrointestinal complaints of patients were measured by a questionnaire at each of the follow-up time points. Results: At admission, AN patients exhibited CCK-levels similar to controls both prior to and after a test meal. Pre and post-meal CCK levels increased significantly after an initial weight gain but decreased again with further weight improvement. CCK release was somewhat lower in bulimic than in restricting type AN but both subgroups showed a similar profile. There was no significant association of CCK release to either initial weight or BMI, or their changes, but CCK levels at admission predicted gastrointestinal symptom improvement during therapy. Conclusions: Normal CCK profiles in AN at admission indicates hormonal responses adapted to low food intake while change of eating habits and weight gain results in initially increased CCK release (counteracting the attempts to alter eating behavior) that returns towards normal levels with continuous therapy.	[Cuntz, Ulrich; Fruehauf, Erich; Fichter, Manfred M.] Klin Roseneck, Ctr Behav Med, Prien Am Chiemsee, Germany; [Cuntz, Ulrich] Paracelsus Med Univ, Salzburg, Austria; [Enck, Paul; Riepl, Rudolf L.] Univ Hosp, Dept Internal Med Psychosomat Med & Psychotherapy, Tubingen, Germany; [Lehnert, Peter; Otto, Baerbel] Univ Clin Munich, Med Dept Innenstadt, Munich, Germany	Paracelsus Private Medical University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich	Enck, P (corresponding author), Univ Hosp, Dept Internal Med Psychosomat Med & Psychotherapy, Tubingen, Germany.	paul.enck@uni-tuebingen.de		Cuntz, Ulrich/0000-0002-2394-9935				APA, 2000, DIAGN STAT MAN MENT; BALLINGER A, 1995, CLIN SCI, V89, P375, DOI 10.1042/cs0890375; BALLINGER AB, 1994, GASTROENTEROLOGY, V107, P1913, DOI 10.1016/0016-5085(94)90856-7; Baranowska B, 2000, DIABETES OBES METAB, V2, P99, DOI 10.1046/j.1463-1326.2000.00070.x; CHAMI TN, 1995, AM J GASTROENTEROL, V90, P88; Chowdhury P, 2001, ANN CLIN LAB SCI, V31, P376; de Krom M, 2006, PSYCHIAT GENET, V16, P239, DOI 10.1097/01.ypg.0000242197.59020.2e; Devlin MJ, 1997, AM J CLIN NUTR, V65, P114, DOI 10.1093/ajcn/65.1.114; Enck P, 2009, NEUROGASTROENT MOTIL, V21, P52, DOI 10.1111/j.1365-2982.2008.01182.x; Fujimoto S, 1997, BIOL PSYCHIAT, V41, P1068, DOI 10.1016/S0006-3223(97)00044-9; GERACIOTI TD, 1992, AM J PSYCHIAT, V149, P958; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GIBBS J, 1976, AM J PHYSIOL, V230, P15, DOI 10.1152/ajplegacy.1976.230.1.15; Giel KE, 2011, BIOL PSYCHIAT, V69, P661, DOI 10.1016/j.biopsych.2010.09.047; Giel KE, 2012, PSYCHIAT RE IN PRESS; GREEN GM, 1986, AM J PHYSIOL, V251, pG70, DOI 10.1152/ajpgi.1986.251.1.G70; HARTY RF, 1991, REGUL PEPTIDES, V36, P141, DOI 10.1016/0167-0115(91)90202-R; KANAYAMA S, 1991, GASTROENTEROLOGY, V100, P909, DOI 10.1016/0016-5085(91)90263-K; Keifer Ekaterina, 2010, Eat Disord, V18, P302, DOI 10.1080/10640266.2010.490120; Kopin AS, 1999, J CLIN INVEST, V103, P383, DOI 10.1172/JCI4901; LAMERS CBHW, 1995, BRIT J HOSP MED, V53, P113; Leibbrand R, 2002, INT J BEHAV MED, V9, P155, DOI 10.1207/S15327558IJBM0902_06; LIEVERSE RJ, 1993, INT J OBESITY, V17, P177; LIEVERSE RJ, 1994, GASTROENTEROLOGY, V106, P1451, DOI 10.1016/0016-5085(94)90397-2; MAOUYO D, 1995, AM J PHYSIOL-GASTR L, V268, pG251, DOI 10.1152/ajpgi.1995.268.2.G251; Matson CA, 2000, AM J PHYSIOL-REG I, V278, pR882, DOI 10.1152/ajpregu.2000.278.4.R882; Matson CA, 1997, PEPTIDES, V18, P1275, DOI 10.1016/S0196-9781(97)00138-1; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618; Munsch S, 2009, PHYSIOL BEHAV, V97, P14, DOI 10.1016/j.physbeh.2009.01.015; NIEDERAU C, 1992, GASTROENTEROLOGY, V102, P1889, DOI 10.1016/0016-5085(92)90310-U; PHILIPP E, 1991, LIFE SCI, V48, P2443, DOI 10.1016/0024-3205(91)90379-P; PIRKE KM, 1994, INT J EAT DISORDER, V15, P63, DOI 10.1002/1098-108X(199401)15:1&lt;63::AID-EAT2260150108&gt;3.0.CO;2-V; Probst M, 1996, BRIT J NUTR, V76, P639, DOI 10.1079/BJN19960072; Riepl R L, 1997, Eur J Med Res, V2, P23; Riepl RL, 1996, ITAL J GASTROENTEROL, V28, P421; Sjolund K, 1996, SCAND J GASTROENTERO, V31, P1110, DOI 10.3109/00365529609036895; Strum K, 2003, J CLIN ENDOCR METAB, V88, P3747, DOI 10.1210/jc.2002-021656; Tang TN, 1998, J PSYCHOSOM RES, V45, P171, DOI 10.1016/S0022-3999(97)00300-0; Tomasik PJ, 2004, J PEDIATR ENDOCR MET, V17, P1623; WALDHOLTZ BD, 1990, GASTROENTEROLOGY, V98, P1415, DOI 10.1016/0016-5085(90)91070-M; Wittorf A, 2012, COGN NEUROPSYCHIATRY, V17, P262, DOI 10.1080/13546805.2011.633749	42	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54457	10.1371/journal.pone.0054457	http://dx.doi.org/10.1371/journal.pone.0054457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349895	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900069
J	Dreschers, S; Gille, C; Haas, M; Grosse-Ophoff, J; Schneider, M; Leiber, A; Buhring, HJ; Orlikowsky, TW				Dreschers, Stephan; Gille, Christian; Haas, Martin; Grosse-Ophoff, Julia; Schneider, Marion; Leiber, Anja; Buehring, Hans-Joerg; Orlikowsky, Thorsten W.			Infection-induced Bystander-Apoptosis of Monocytes Is TNF-alpha-mediated	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CELL-DEATH; ESCHERICHIA-COLI; DENDRITIC CELLS; NEONATAL SEPSIS; CORD BLOOD; MACROPHAGES; PHAGOCYTOSIS; LIPOPOLYSACCHARIDE	Phagocytosis induced cell death (PICD) is crucial for controlling phagocyte effector cells, such as monocytes, at sites of infection, and essentially contributes to termination of inflammation. Here we tested the hypothesis, that during PICD bystander apoptosis of non-phagocyting monocytes occurs, that apoptosis induction is mediated via tumor necrosis factor-alpha (TNF-alpha and that TNF-alpha secretion and -signalling is causal. Monocytes were infected with Escherichia coli (E. coli), expressing green fluorescent protein (GFP), or a pH-sensitive Eos-fluorescent protein (EOS-FP). Monocyte phenotype, phagocytic activity, apoptosis, TNF-receptor (TNFR)-1, -2-expression and TNF-alpha production were analyzed. Apoptosis occured in phagocyting and non-phagocyting, bystander monocytes. Bacterial transport to the phagolysosome was no prerequisite for apoptosis induction, and desensitized monocytes from PICD, as confirmed by EOS-FP expressing E. coli. Co-cultivation with non-infected carboxyfluorescein-succinimidyl-ester- (CFSE-) labelled monocytes resulted in significant apoptotic cell death of non-infected bystander monocytes. This process required protein de-novo synthesis and still occurred in a diminished way in the absence of cell-cell contact. E. coli induced a robust TNF-alpha production, leading to TNF-mediated apoptosis in monocytes. Neutralization with an anti-TNF-alpha antibody reduced monocyte bystander apoptosis significantly. In contrast to TNFR2, the pro-apoptotic TNFR1 was down-regulated on the monocyte surface, internalized 30 min. p.i. and led to apoptosis predominantly in monocytes without phagocyting bacteria by themselves. Our results suggest, that apoptosis of bystander monocytes occurs after infection with E. coli via internalization of TNFR1, and indicate a relevant role for TNF-alpha. Modifying monocyte apoptosis in sepsis may be a future therapeutic option.	[Dreschers, Stephan; Haas, Martin; Grosse-Ophoff, Julia; Orlikowsky, Thorsten W.] Univ Childrens Hosp, Dept Neonatol, Aachen, Germany; [Gille, Christian; Leiber, Anja] Univ Childrens Hosp, Dept Neonatol, Tubingen, Germany; [Schneider, Marion] Univ Hosp, Dept Expt Anesthesiol, Ulm, Germany; [Buehring, Hans-Joerg] Univ Hosp, FACS Core Facil, Tubingen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Orlikowsky, TW (corresponding author), Univ Childrens Hosp, Dept Neonatol, Aachen, Germany.	torlikowsky@ukaachen.de	Gille, Christian/AAC-1883-2020					Brocklehurst P, 2011, NEW ENGL J MED, V365, P1201, DOI 10.1056/NEJMoa1100441; Cai BL, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/642462; Currie AJ, 2011, INFECT IMMUN, V79, P1588, DOI 10.1128/IAI.00535-10; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Dhiman R, 2008, BBA-GEN SUBJECTS, V1780, P733, DOI 10.1016/j.bbagen.2007.12.010; Ebach DR, 2005, SHOCK, V23, P311, DOI 10.1097/01.shk.0000157301.87051.77; Eissner G, 2000, J IMMUNOL, V164, P6193, DOI 10.4049/jimmunol.164.12.6193; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; Fortier A, 2009, INFECT IMMUN, V77, P4794, DOI 10.1128/IAI.01546-08; Frankenberg T, 2008, EUR J IMMUNOL, V38, P204, DOI 10.1002/eji.200737379; Garg AK, 2002, MOL IMMUNOL, V29, P497; Gille C, 2009, CYTOM PART B-CLIN CY, V76B, P271, DOI 10.1002/cyto.b.20474; Gille C, 2008, PEDIATR RES, V63, P33, DOI 10.1203/PDR.0b013e31815b8e9f; Gille C, 2007, J LIPID RES, V48, P307, DOI 10.1194/jlr.M600451-JLR200; Gille C, 2012, CYTOM PART B-CLIN CY, V82B, P26, DOI 10.1002/cyto.b.20609; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kapetanovic R, 2011, AM J PHYSIOL-CELL PH, V300, pC850, DOI 10.1152/ajpcell.00187.2010; Kirchner S, 2004, CYTOKINE, V28, P67, DOI 10.1016/j.cyto.2004.06.008; Kitamura M, 1999, EUR J IMMUNOL, V29, P1647; Morelli AE, 2010, APOPTOSIS, V15, P1083, DOI 10.1007/s10495-010-0469-9; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Quevedo-Diaz MA, 2010, J LEUKOCYTE BIOL, V88, P675, DOI 10.1189/jlb.1009674; Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Scherubl Christoph, 2005, J Inflamm (Lond), V2, P7, DOI 10.1186/1476-9255-2-7; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Spasojevic I, 2012, CRIT CARE, V16, DOI 10.1186/cc11183; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Volling K, 2011, CELL MICROBIOL; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Webster SJ, 2010, J IMMUNOL, V185, P2968, DOI 10.4049/jimmunol.1000805; Wiedenmann J, 2006, EXPERT REV PROTEOMIC, V3, P361, DOI 10.1586/14789450.3.3.361	40	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53589	10.1371/journal.pone.0053589	http://dx.doi.org/10.1371/journal.pone.0053589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349721	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900013
J	Casson, L; Howell, L; Mathews, LA; Ferrer, M; Southall, N; Guha, R; Keller, JM; Thomas, C; Siskind, LJ; Beverly, LJ				Casson, Lavona; Howell, Lauren; Mathews, Lesley A.; Ferrer, Marc; Southall, Noel; Guha, Rajarshi; Keller, Jonathan M.; Thomas, Craig; Siskind, Leah J.; Beverly, Levi J.			Inhibition of Ceramide Metabolism Sensitizes Human Leukemia Cells to Inhibition of BCL2-Like Proteins	PLOS ONE			English	Article							DAUNORUBICIN-INDUCED APOPTOSIS; BCL-2 FAMILY PROTEINS; BH3 MIMETIC ABT-737; GLUCOSYLCERAMIDE SYNTHASE; SPHINGOSINE KINASE; IN-VITRO; PATHWAY; BAX; RESISTANCE; EXPRESSION	The identification of novel combinations of effective cancer drugs is required for the successful treatment of cancer patients for a number of reasons. First, many "cancer specific" therapeutics display detrimental patient side-effects and second, there are almost no examples of single agent therapeutics that lead to cures. One strategy to decrease both the effective dose of individual drugs and the potential for therapeutic resistance is to combine drugs that regulate independent pathways that converge on cell death. BCL2-like family members are key proteins that regulate apoptosis. We conducted a screen to identify drugs that could be combined with an inhibitor of anti-apoptotic BCL2-like proteins, ABT-263, to kill human leukemia cells lines. We found that the combination of D,L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) hydrochloride, an inhibitor of glucosylceramide synthase, potently synergized with ABT-263 in the killing of multiple human leukemia cell lines. Treatment of cells with PDMP and ABT-263 led to dramatic elevation of two pro-apoptotic sphingolipids, namely ceramide and sphingosine. Furthermore, treatment of cells with the sphingosine kinase inhibitor, SKi-II, also dramatically synergized with ABT-263 to kill leukemia cells and similarly increased ceramides and sphingosine. Data suggest that synergism with ABT-263 requires accumulation of ceramides and sphingosine, as AMP-deoxynojirimycin, (an inhibitor of the glycosphingolipid pathway) did not elevate ceramides or sphingosine and importantly did not sensitize cells to ABT-263 treatment. Taken together, our data suggest that combining inhibitors of anti-apoptotic BCL2-like proteins with drugs that alter the balance of bioactive sphingolipids will be a powerful combination for the treatment of human cancers.	[Casson, Lavona; Beverly, Levi J.] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Div Hematol & Oncol, Louisville, KY 40292 USA; [Howell, Lauren; Siskind, Leah J.] Med Sch S Carolina, S Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Charleston, SC USA; [Mathews, Lesley A.; Ferrer, Marc; Southall, Noel; Guha, Rajarshi; Keller, Jonathan M.; Thomas, Craig] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Siskind, Leah J.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Beverly, Levi J.] NHGRI, Canc Biol & Genet Sect, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	University of Louisville; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Siskind, LJ (corresponding author), Med Sch S Carolina, S Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Charleston, SC USA.	Siskind@MUSC.edu; Levi.Beverly@Louisville.edu	Ferrer, Marta/C-4319-2016; Southall, Noel T/H-8991-2012	Ferrer, Marta/0000-0001-8495-1302; Southall, Noel T/0000-0003-4500-880X; Thomas, Craig/0000-0001-9386-9001; Siskind, Leah/0000-0001-5026-5187	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK093462]; Cancer Center Support Grant [P30 CA138313]; NIH/NCRR COBRE in Lipidomics and Pathobiology [P20 RR17677]; National Institutes of Health, Molecular Targets COBRE [8P20GM103482-10]; Wendy Will Case Cancer Fund [GB220413]; Kosair Pediatric Cancer Research Program award; NIH Common Fund Molecular Libraries and Imaging Program [U54 MH084681]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103482] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Center Support Grant; NIH/NCRR COBRE in Lipidomics and Pathobiology; National Institutes of Health, Molecular Targets COBRE; Wendy Will Case Cancer Fund; Kosair Pediatric Cancer Research Program award; NIH Common Fund Molecular Libraries and Imaging Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by: National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, R01DK093462 (to LJS), the Lipidomics Shared Resource of the Hollings Cancer Center at the Medical University of South Carolina supported by a Cancer Center Support Grant (P30 CA138313), pilot project (to LJS) from the NIH/NCRR P20 RR17677 COBRE in Lipidomics and Pathobiology, National Institutes of Health, Molecular Targets COBRE, 8P20GM103482-10 (to LJB), Wendy Will Case Cancer Fund, GB220413 (to LJB), Kosair Pediatric Cancer Research Program award (to LJB). This research was partly supported by the NIH Common Fund Molecular Libraries and Imaging Program, Grant U54 MH084681. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Allouche M, 1997, ONCOGENE, V14, P1837, DOI 10.1038/sj.onc.1201023; Alphonse G, 2004, ONCOGENE, V23, P2703, DOI 10.1038/sj.onc.1207357; Baran Y, 2011, J CANCER RES CLIN, V137, P1535, DOI 10.1007/s00432-011-1016-y; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Camgoz A, 2011, LEUKEMIA LYMPHOMA, V52, P1574, DOI 10.3109/10428194.2011.568653; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; El-Assaad W, 1998, BIOCHEM J, V336, P735, DOI 10.1042/bj3360735; Ganesan V, 2010, FEBS LETT, V584, P2128, DOI 10.1016/j.febslet.2010.02.032; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Geley S, 1997, FEBS LETT, V400, P15, DOI 10.1016/S0014-5793(96)01284-7; Giraldo P, 2009, HAEMATOL-HEMATOL J, V94, P1771, DOI 10.3324/haematol.2009.008078; Grazide S, 2004, J BIOL CHEM, V279, P18256, DOI 10.1074/jbc.M314105200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Horvitz HR, 1999, CANCER RES, V59, p1701S; Issuree PDA, 2009, FASEB J, V23, P2412, DOI 10.1096/fj.09-130542; Itoh M, 2003, CLIN CANCER RES, V9, P415; Kartal M, 2011, NUTR CANCER, V63, P637, DOI 10.1080/01635581.2011.538485; Kawatani M, 2003, EXP CELL RES, V286, P57, DOI 10.1016/S0014-4827(03)00098-3; Kim HJ, 2001, FEBS LETT, V505, P264, DOI 10.1016/S0014-5793(01)02836-8; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Lim KG, 2012, BRIT J PHARMACOL, V166, P1605, DOI 10.1111/j.1476-5381.2012.01862.x; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Messner MC, 2010, ADV EXP MED BIOL, V688, P156; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Perera MN, 2012, BIOCHEM J, V445, P81, DOI 10.1042/BJ20112103; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Sawada M, 2000, ONCOGENE, V19, P3508, DOI 10.1038/sj.onc.1203699; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Sinha UK, 2011, HEAD NECK-J SCI SPEC, V33, P178, DOI 10.1002/hed.21418; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Siskind LJ, 2008, J BIOL CHEM; Sobue S, 2008, INT J HEMATOL, V87, P266, DOI 10.1007/s12185-008-0052-0; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Taha TA, 2006, FEBS LETT, V580, P6047, DOI 10.1016/j.febslet.2006.09.070; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325	50	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54525	10.1371/journal.pone.0054525	http://dx.doi.org/10.1371/journal.pone.0054525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342165	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700122
J	Puiffe, ML; Lachaise, I; Molinier-Frenkel, V; Castellano, F				Puiffe, Marie-Line; Lachaise, Isabelle; Molinier-Frenkel, Valerie; Castellano, Flavia			Antibacterial Properties of the Mammalian L-Amino Acid Oxidase IL4I1	PLOS ONE			English	Article							DENDRITIC CELLS; SNAKE-VENOM; PROTEIN; PURIFICATION; MACROPHAGES	L-amino acid oxidases (LAAO) are flavoproteins that catalyze the oxidative deamination of L-amino acids to a keto-acid along with the production of H2O2 and ammonia. Interleukin 4 induced gene 1 (IL4I1) is a secreted LAAO expressed by macrophages and dendritic cells stimulated by microbial derived products or interferons, which is endowed with immunoregulatory properties. It is the first LAAO described in mammalian innate immune cells. In this work, we show that this enzyme blocks the in vitro and in vivo growth of Gram negative and Gram positive bacteria. This antibiotic effect is primarily mediated by H2O2 production but is amplified by basification of the medium due to the accumulation of ammonia. The depletion of phenylalanine (the primary amino acid catabolized by IL4I1) may also participate in the in vivo inhibition of staphylococci growth. Thus, IL4I1 plays a distinct role compared to other antibacterial enzymes produced by mononuclear phagocytes.	[Puiffe, Marie-Line; Molinier-Frenkel, Valerie; Castellano, Flavia] Hop Henri Mondor, INSERM, U955, IMRB,Equipe 09, F-94010 Creteil, France; [Puiffe, Marie-Line; Molinier-Frenkel, Valerie; Castellano, Flavia] Univ Paris Est, Fac Med, Creteil, France; [Molinier-Frenkel, Valerie; Castellano, Flavia] Hop H Mondor A Chenevier, AP HP, Serv Immunol Biol, Creteil, France; [Lachaise, Isabelle] ICMPE, Thiais, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Molinier-Frenkel, V (corresponding author), Hop Henri Mondor, INSERM, U955, IMRB,Equipe 09, F-94010 Creteil, France.	valerie.frenkel@inserm.fr; flavia.castellano@inserm.fr	Castellano, Flavia/Q-2847-2018; Molinier-Frenkel, Valérie/Q-2852-2018	Molinier-Frenkel, Valerie/0000-0002-7250-7295; Castellano, Flavia/0000-0001-9389-6704	Institut National de la Sante et de la Recherche Medicale (INSERM) [A1L9-SE]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grant A1L9-SE from Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Carbonnelle-Puscian A, 2009, LEUKEMIA, V23, P952, DOI 10.1038/leu.2008.380; Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Hughes AL, 2010, IMMUNOGENETICS, V62, P753, DOI 10.1007/s00251-010-0482-8; Jung SK, 2000, J IMMUNOL, V165, P1491, DOI 10.4049/jimmunol.165.3.1491; Kitani Y, 2007, FEBS J, V274, P125, DOI 10.1111/j.1742-4658.2006.05570.x; Lasoudris F, 2011, EUR J IMMUNOL, V41, P1629, DOI 10.1002/eji.201041119; Marquet J, 2010, EUR J IMMUNOL, V40, P2557, DOI 10.1002/eji.201040428; Nagaoka K, 2009, FASEB J, V23, P2514, DOI 10.1096/fj.08-126466; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Riemann M, 2005, J IMMUNOL, V175, P3560, DOI 10.4049/jimmunol.175.6.3560; Schmidt SK, 2009, EUR J IMMUNOL, V39, P2755, DOI 10.1002/eji.200939535; STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I; Wang FH, 2011, FISH SHELLFISH IMMUN, V30, P1095, DOI 10.1016/j.fsi.2011.02.004	16	34	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54589	10.1371/journal.pone.0054589	http://dx.doi.org/10.1371/journal.pone.0054589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355881	Green Published, gold			2022-12-27	WOS:000314021500091
J	Tran, DN; Thi, MHP; Ha, MT; Thi, TLT; Thi, KHD; Yoshida, LM; Okitsu, S; Hayakawa, S; Mizuguchi, M; Ushijima, H				Dinh Nguyen Tran; Thi Minh Hong Pham; Manh Tuan Ha; Thi Thu Loan Tran; Thi Kim Huyen Dang; Yoshida, Lay-Myint; Okitsu, Shoko; Hayakawa, Satoshi; Mizuguchi, Masashi; Ushijima, Hiroshi			Molecular Epidemiology and Disease Severity of Human Respiratory Syncytial Virus in Vietnam	PLOS ONE			English	Article							GROUP-A; SUBGROUP-A; GROUP-B; GENETIC-VARIABILITY; G-PROTEIN; CLINICAL CHARACTERISTICS; VIRAL PATHOGENS; INFECTION; INFANTS; CHILDREN	Respiratory syncytial virus (RSV) is a major cause of acute respiratory infections (ARIs) in children worldwide and can cause high mortality, especially in developing countries. However, information on the clinical and molecular characteristics of RSV infection in developing countries is limited. From April 2010 to May 2011, 1,082 nasopharyngeal swabs were collected from children with ARI admitted to the Children's Hospital 2, Ho Chi Minh City, Vietnam. Samples were screened for RSV and genotyped by reverse transcription-PCR and sequencing. Demographic and clinical data was also recorded. RSV was found in 23.8% (257/1,082) of samples. RSV A was the dominant subgroup, accounting for 91.4% (235/257), followed by RSV B, 5.1% (13/257), and 9 cases (3.5%) were mixed infection of these subgroups. The phylogenetic analysis revealed that all group A strains belonged to the GA2 genotype. All group B strains belonged to the recently identified BA genotype, and further clustered into 2 recently described subgenotypes BA9 and BA10. One GA2 genotype strain had a premature stop codon which shortened the G protein length. RSV infection was significantly associated with younger age and higher severity score than those without. Co-infection with other viruses did not affect disease severity. RSV A caused more severe disease than RSV B. The results from this study will not only contribute to the growing database on the molecular diversity of RSV circulating worldwide but may be also useful in clinical management and vaccine development.	[Dinh Nguyen Tran; Okitsu, Shoko; Mizuguchi, Masashi; Ushijima, Hiroshi] Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Dev Med Sci, Tokyo, Japan; [Dinh Nguyen Tran; Thi Minh Hong Pham] Univ Med & Pharm Ho Chi Minh City, Dept Pediat, Ho Chi Minh City, Vietnam; [Dinh Nguyen Tran; Manh Tuan Ha; Thi Thu Loan Tran; Thi Kim Huyen Dang] Childrens Hosp 2, Ho Chi Minh City, Vietnam; [Yoshida, Lay-Myint] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Okitsu, Shoko; Hayakawa, Satoshi; Ushijima, Hiroshi] Nihon Univ, Sch Med, Div Microbiol, Dept Pathol & Microbiol, Tokyo, Japan	University of Tokyo; Hochiminh City University of Medicine & Pharmacy; Nagasaki University; Nihon University	Ushijima, H (corresponding author), Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Dev Med Sci, Tokyo, Japan.	ushijima-hiroshi@jcom.home.ne.jp		YOSHIDA, LAYMYINT/0000-0002-7567-3248; Ha Manh, Tuan/0000-0002-4998-2581	Ministry of Education and Sciences; Ministry of Health, Labor and Welfare, Japan; Honjo International Scholarship Foundation	Ministry of Education and Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Honjo International Scholarship Foundation(Honjo International Scholarship Foundation)	This study was supported by Grants-in-Aid from the Ministry of Education and Sciences and the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We deeply thank Dr. Nguyen Tran Quynh Nhu and Ms. Pham Thi Ngoc Hue, Cardiovascular Department, Children's Hospital 2, Ho Chi Minh City for their help in patient counseling and sample collection. DNT is a recipient of the scholarship from the Honjo International Scholarship Foundation.	Bedoya VI, 1996, PEDIATR INFECT DIS J, V15, P1123, DOI 10.1097/00006454-199612000-00014; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Boonyasuppayakorn S, 2010, INFLUENZA OTHER RESP, V4, P313, DOI 10.1111/j.1750-2659.2010.00152.x; Brandenburg AH, 1997, J MED VIROL, V52, P97, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;97::AID-JMV16&gt;3.0.CO;2-Y; Brandenburg AH, 2000, J CLIN MICROBIOL, V38, P3849, DOI 10.1128/JCM.38.10.3849-3852.2000; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; Chan PKS, 1999, EPIDEMIOL INFECT, V123, P257, DOI 10.1017/S0950268899002824; CHERIAN T, 1990, AM J DIS CHILD, V144, P1026, DOI 10.1001/archpedi.1990.02150330086028; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Collins PL, 2007, FIELDS VIROLOGY, P1601; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Do Anh Ha Lien, 2011, PLoS One, V6, pe18176, DOI 10.1371/journal.pone.0018176; Ekalaksananan Tipaya, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P513; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; HALL CB, 1990, J INFECT DIS, V162, P1283, DOI 10.1093/infdis/162.6.1283; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAZLETT DTG, 1988, AM J TROP MED HYG, V39, P632, DOI 10.4269/ajtmh.1988.39.632; HEIKKINEN T, 1995, ACTA PAEDIATR, V84, P419, DOI 10.1111/j.1651-2227.1995.tb13663.x; HENDRY RM, 1986, J INFECT DIS, V153, P291, DOI 10.1093/infdis/153.2.291; Hornsleth A, 1998, PEDIATR INFECT DIS J, V17, P1114, DOI 10.1097/00006454-199812000-00003; Houben ML, 2010, J MED VIROL, V82, P1266, DOI 10.1002/jmv.21771; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Kneyber MCJ, 1996, ARCH DIS CHILD, V75, P137, DOI 10.1136/adc.75.2.137; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; MCCONNOCHIE KM, 1990, J PEDIATR-US, V117, P52, DOI 10.1016/S0022-3476(05)82443-6; MCINTOSH EDG, 1993, PEDIATR INFECT DIS J, V12, P815, DOI 10.1097/00006454-199310000-00004; MONTO AS, 1990, J INFECT DIS, V161, P781, DOI 10.1093/infdis/161.4.781; MUFSON MA, 1988, J INFECT DIS, V157, P143, DOI 10.1093/infdis/157.1.143; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Palomo C, 2000, J MED VIROL, V60, P468, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;468::AID-JMV16&gt;3.0.CO;2-E; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Roca A, 2001, J GEN VIROL, V82, P103, DOI 10.1099/0022-1317-82-1-103; RUSSI JC, 1989, LANCET, V2, P1039; SALOMON HE, 1991, J INFECT DIS, V163, P1167, DOI 10.1093/infdis/163.5.1167; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Scott PD, 2007, J MED VIROL, V79, P1943, DOI 10.1002/jmv.20999; Scott PD, 2004, J MED VIROL, V74, P344, DOI 10.1002/jmv.20183; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Straliotto S M, 1994, Rev Soc Bras Med Trop, V27, P1, DOI 10.1590/S0037-86821994000100001; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; TAYLOR CE, 1989, LANCET, V1, P777; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; TSUTSUMI H, 1991, SCAND J INFECT DIS, V23, P671, DOI 10.3109/00365549109024291; Viegas M, 2004, J INFECTION, V49, P222, DOI 10.1016/j.jinf.2003.10.006; Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976; WANG EEL, 1995, J PEDIATR-US, V126, P212, DOI 10.1016/S0022-3476(95)70547-3; Wang W, 2010, J CLIN VIROL, V49, P211, DOI 10.1016/j.jcv.2010.08.005; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Yoshida LM, 2010, PEDIATR INFECT DIS J, V29, P75, DOI 10.1097/INF.0b013e3181af61e9; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	58	42	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e45436	10.1371/journal.pone.0045436	http://dx.doi.org/10.1371/journal.pone.0045436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349659	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100002
J	Nerandzic, MM; Donskey, CJ				Nerandzic, Michelle M.; Donskey, Curtis J.			Activate to Eradicate: Inhibition of Clostridium difficile Spore Outgrowth by the Synergistic Effects of Osmotic Activation and Nisin	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION DEVICE; SUPERDORMANT SPORES; GERMINATING SPORES; VEGETATIVE CELLS; EFFICACY; DIARRHEA; DECONTAMINATION; DISINFECTION; INITIATION; MECHANISM	Background: Germination is the irreversible loss of spore-specific properties prior to outgrowth. Because germinating spores become more susceptible to killing by stressors, induction of germination has been proposed as a spore control strategy. However, this strategy is limited by superdormant spores that remain unaffected by germinants. Harsh chemicals and heat activation are effective for stimulating germination of superdormant spores but are impractical for use in a hospital setting, where Clostridium difficile spores present a challenge. Here, we tested whether osmotic activation solutes will provide a mild alternative for stimulation of superdormant C. difficile spores in the presence of germinants as previously demonstrated in several species of Bacillus. In addition, we tested the hypothesis that the limitations of superdormancy can be circumvented with a combined approach using nisin, a FDA-approved safe bacteriocin, to inhibit outgrowth of germinated spores and osmotic activation solutes to enhance outgrowth inhibition by stimulating superdormant spores. Principal Findings: Exposure to germination solutiontriggered similar to 1 log(10) colony forming units (CFU) of spores to germinate, and heat activation increased the spores that germinated to >2.5 log(10)CFU. Germinating spores, in contrast to dormant spores, became susceptible to inhibition by nisin. The presence of osmotic activation solutes did not stimulate germination of superdormant C. difficile spores exposed to germination solution. But, in the absence of germination solution, osmotic activation solutes enhanced nisin inhibition of superdormant spores to >3.5 log(10)CFU. The synergistic effects of osmotic activation solutes and nisin were associated with loss of membrane integrity. Conclusions: These findings suggest that the synergistic effects of osmotic activation and nisin bypass the limitations of germination as a spore control strategy, and might be a novel method to safely and effectively reduce the burden of C. difficile spores on skin and environmental surfaces.	[Nerandzic, Michelle M.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA	Geriatric Research Education & Clinical Center	Nerandzic, MM (corresponding author), Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA.	michellenerandzi@aim.com			Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This research was funded by a Merit Review grant from the Department of Veterans Affairs to CJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2009, FOOD MICROBIOL, V26, P272, DOI 10.1016/j.fm.2008.12.011; Alfa MJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-64; Barbut F, 2009, INFECT CONT HOSP EP, V30, P507, DOI 10.1086/597232; Bartoloni A, 2004, J CHEMOTHERAPY, V16, P119, DOI 10.1179/joc.2004.16.2.119; Brandes Ammann Andrea, 2011, Int J Microbiol, V2011, P435281, DOI 10.1155/2011/435281; Burns DA, 2010, J BACTERIOL, V192, P657, DOI 10.1128/JB.01209-09; DURBAN E, 1970, J BACTERIOL, V102, P590, DOI 10.1128/JB.102.2.590-592.1970; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; Garde S, 2011, INT J FOOD MICROBIOL, V150, P59, DOI 10.1016/j.ijfoodmicro.2011.07.018; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Ghosh S, 2010, J APPL MICROBIOL, V108, P582, DOI 10.1111/j.1365-2672.2009.04442.x; Ghosh S, 2012, J BACTERIOL, V194, P2221, DOI 10.1128/JB.00151-12; GOULD GW, 1968, J APPL BACTERIOL, V31, P357, DOI 10.1111/j.1365-2672.1968.tb00378.x; GOULD GW, 1970, J APPL BACTERIOL, V33, P34, DOI 10.1111/j.1365-2672.1970.tb05232.x; Gould GW, 1978, SPORES, P21; Gut IM, 2008, ANTIMICROB AGENTS CH, V52, P4281, DOI 10.1128/AAC.00625-08; Gut IM, 2011, ACS CHEM BIOL, V6, P744, DOI 10.1021/cb1004178; Hamouda T, 2002, LETT APPL MICROBIOL, V34, P86, DOI 10.1046/j.1472-765x.2002.01047.x; Heeg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032381; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Howerton A, 2011, J BACTERIOL, V193, P274, DOI 10.1128/JB.00980-10; Jury LA, 2011, INFECT CONT HOSP EP, V32, P181, DOI 10.1086/657911; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MUNAKATA N, 1974, J BACTERIOL, V120, P59, DOI 10.1128/JB.120.1.59-65.1974; Nerandzic MM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-120; Nerandzic MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012285; Nerandzic MM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-197; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Paidhungat M., 2002, BACILLUS SUBTILIS IT, P537, DOI DOI 10.1128/9781555817992.CH37; Pol IE, 2001, APPL ENVIRON MICROB, V67, P1693, DOI 10.1128/AEM.67.4.1693-1699.2001; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; PRESTON RA, 1984, J GEN MICROBIOL, V130, P1041; RAYMAN MK, 1981, APPL ENVIRON MICROB, V41, P375, DOI 10.1128/AEM.41.2.375-380.1981; Rutala WA, 2001, EMERG INFECT DIS, V7, P348, DOI 10.3201/eid0702.010241; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; STUY J. H., 1956, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V22, P337, DOI 10.1007/BF02538347; STUY JH, 1956, BIOCHIM BIOPHYS ACTA, V22, P241, DOI 10.1016/0006-3002(56)90146-9; Wei J, 2010, J BACTERIOL, V192, P1455, DOI 10.1128/JB.01497-09; Wheeldon LJ, 2008, J ANTIMICROB CHEMOTH, V62, P522, DOI 10.1093/jac/dkn219; Wheeldon LJ, 2011, J APPL MICROBIOL, V110, P987, DOI 10.1111/j.1365-2672.2011.04953.x; Wijnker JJ, 2011, FOOD MICROBIOL, V28, P974, DOI 10.1016/j.fm.2011.01.009; Xiao YH, 2011, FOOD MICROBIOL, V28, P266, DOI 10.1016/j.fm.2010.03.016	43	32	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54740	10.1371/journal.pone.0054740	http://dx.doi.org/10.1371/journal.pone.0054740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349961	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100094
J	Patel, JC; Oberstaller, J; Xayavong, M; Narayanan, J; DeBarry, JD; Srinivasamoorthy, G; Villegas, L; Escalante, AA; DaSilva, A; Peterson, DS; Barnwell, JW; Kissinger, JC; Udhayakumar, V; Lucchi, NW				Patel, Jaymin C.; Oberstaller, Jenna; Xayavong, Maniphet; Narayanan, Jothikumar; DeBarry, Jeremy D.; Srinivasamoorthy, Ganesh; Villegas, Leopoldo; Escalante, Ananias A.; DaSilva, Alexandre; Peterson, David S.; Barnwell, John W.; Kissinger, Jessica C.; Udhayakumar, Venkatachalam; Lucchi, Naomi W.			Real-Time Loop-Mediated Isothermal Amplification (RealAmp) for the Species-Specific Identification of Plasmodium vivax	PLOS ONE			English	Article							MALARIA INFECTIONS; DIAGNOSIS; LAMP; MICROSCOPY; GENOMICS; TARGETS; TESTS; BLOOD; PCR	Plasmodium vivax infections remain a major source of malaria-related morbidity and mortality. Early and accurate diagnosis is an integral component of effective malaria control programs. Conventional molecular diagnostic methods provide accurate results but are often resource-intensive, expensive, have a long turnaround time and are beyond the capacity of most malaria-endemic countries. Our laboratory has recently developed a new platform called RealAmp, which combines loop-mediated isothermal amplification (LAMP) with a portable tube scanner real-time isothermal instrument for the rapid detection of malaria parasites. Here we describe new primers for the detection of P. vivax using the RealAmp method. Three pairs of amplification primers required for this method were derived from a conserved DNA sequence unique to the P. vivax genome. The amplification was carried out at 64 degrees C using SYBR Green or SYTO-9 intercalating dyes for 90 minutes with the tube scanner set to collect fluorescence signals at 1-minute intervals. Clinical samples of P. vivax and other human-infecting malaria parasite species were used to determine the sensitivity and specificity of the primers by comparing with an 18S ribosomal RNA-based nested PCR as the gold standard. The new set of primers consistently detected laboratory-maintained isolates of P. vivax from different parts of the world. The primers detected P. vivax in the clinical samples with 94.59% sensitivity (95% CI: 87.48-98.26%) and 100% specificity (95% CI: 90.40-100%) compared to the gold standard nested-PCR method. The new primers also proved to be more sensitive than the published species-specific primers specifically developed for the LAMP method in detecting P. vivax.	[Patel, Jaymin C.; Xayavong, Maniphet; DaSilva, Alexandre; Barnwell, John W.; Udhayakumar, Venkatachalam; Lucchi, Naomi W.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Oberstaller, Jenna; Peterson, David S.; Kissinger, Jessica C.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Oberstaller, Jenna; DeBarry, Jeremy D.; Srinivasamoorthy, Ganesh; Peterson, David S.; Kissinger, Jessica C.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Narayanan, Jothikumar; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Villegas, Leopoldo] Asociac Civil Impacto Social, Tumeremo, Venezuela; [Escalante, Ananias A.] Arizona State Univ, Tempe, AZ USA; [Kissinger, Jessica C.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; Arizona State University; Arizona State University-Tempe; University System of Georgia; University of Georgia	Patel, JC (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.	jaymin86@gmail.com	Kissinger, Jessica C/E-9610-2010; Kissinger, Jessica/M-9920-2019	Kissinger, Jessica C/0000-0002-6413-1101; Kissinger, Jessica/0000-0002-6413-1101; Peterson, David/0000-0003-4394-6181; DeBarry, Jeremy/0000-0001-5718-2675; Escalante, Ananias/0000-0002-1532-3430; Lucchi, Naomi/0000-0001-8789-8041; Oberstaller, Jenna/0000-0002-3033-2212	CDC-UGA (OPHR) [8212]	CDC-UGA (OPHR)	This work was supported by a CDC-UGA seed grant (OPHR #8212) awarded to JCK and VU. This study was supported in part by resources and technical expertise from the University of Georgia Research Computing Center, a partnership between the Office of the Vice President for Research and the Office of the Chief Information Officer and CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chen JH, 2010, ACTA TROP, V113, P61, DOI 10.1016/j.actatropica.2009.09.007; Demas A, 2011, J CLIN MICROBIOL, V49, P2411, DOI 10.1128/JCM.02603-10; Eischeid Anne C, 2011, BMC Res Notes, V4, P263, DOI 10.1186/1756-0500-4-263; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Lau YL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-197; Lucchi NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031848; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; Mens P, 2007, TROP MED INT HEALTH, V12, P238, DOI 10.1111/j.1365-3165.2006.01779.x; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paris DH, 2007, AM J TROP MED HYG, V77, P972, DOI 10.4269/ajtmh.2007.77.972; Poschl B, 2010, AM J TROP MED HYG, V83, P56, DOI 10.4269/ajtmh.2010.09-0630; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Poon LLM, 2006, CLIN CHEM, V52, P303; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Tao ZY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-115; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2021, TOP 10 CAUS DEATH	29	52	55	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54986	10.1371/journal.pone.0054986	http://dx.doi.org/10.1371/journal.pone.0054986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349994	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100115
J	Rastrick, JMD; Stevenson, CS; Eltom, S; Grace, M; Davies, M; Kilty, I; Evans, SM; Pasparakis, M; Catley, MC; Lawrence, T; Adcock, IM; Belvisi, MG; Birrell, MA				Rastrick, Joseph M. D.; Stevenson, Christopher S.; Eltom, Suffwan; Grace, Megan; Davies, Meirion; Kilty, Iain; Evans, Steven M.; Pasparakis, Manolis; Catley, Matthew C.; Lawrence, Toby; Adcock, Ian M.; Belvisi, Maria G.; Birrell, Mark A.			Cigarette Smoke Induced Airway Inflammation Is Independent of NF-kappa B Signalling	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INDUCED LUNG INFLAMMATION; BETA-DEPENDENT GENES; IKK-BETA; MOUSE LUNG; CHRONIC-BRONCHITIS; INDUCED EMPHYSEMA; OXIDATIVE STRESS; EPITHELIAL-CELLS; FLOW LIMITATION	Rationale: COPD is an inflammatory lung disease largely associated with exposure to cigarette smoke (CS). The mechanism by which CS leads to the pathogenesis of COPD is currently unclear; it is known however that many of the inflammatory mediators present in the COPD lung can be produced via the actions of the transcription factor Nuclear Factor-kappaB (NF-kappa B) and its upstream signalling kinase, Inhibitor of kappa B kinase-2 (IKK-2). Therefore the NF-kappa B/IKK-2 signalling pathway may represent a therapeutic target to attenuate the inflammation associated with COPD. Aim: To use a range of assays, genetically modified animals and pharmacological tools to determine the role of NF-kappa B in CS-induced airway inflammation. Methods: NF-kappa B pathway activation was measured in pre-clinical models of CS-induced airway inflammation and in human lung tissue from COPD patients. This data was complemented by employing mice missing a functional NF-kappa B pathway in specific cell types (epithelial and myeloid cells) and with systemic inhibitors of IKK-2. Results: We showed in an airway inflammation model known to be NF-kappa B-dependent that the NF-kappa B pathway activity assays and modulators were functional in the mouse lung. Then, using the same methods, we demonstrated that the NF-kappa B pathway appears not to play an important role in the inflammation observed after exposure to CS. Furthermore, assaying human lung tissue revealed that in the clinical samples there was also no increase in NF-kappa B pathway activation in the COPD lung, suggesting that our pre-clinical data is translational to human disease. Conclusions: In this study we present compelling evidence that the IKK-2/NF-kappa B signalling pathway does not play a prominent role in the inflammatory response to CS exposure and that this pathway may not be important in COPD pathogenesis.	[Rastrick, Joseph M. D.; Stevenson, Christopher S.; Eltom, Suffwan; Grace, Megan; Davies, Meirion; Belvisi, Maria G.; Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England; [Stevenson, Christopher S.] Roche, Nutley, NJ USA; [Kilty, Iain; Evans, Steven M.] Pfizer Inc, Pfizer, Cambridge, MA USA; [Pasparakis, Manolis] Univ Cologne, D-50931 Cologne, Germany; [Catley, Matthew C.] AstraZeneca, Molndal, Sweden; [Lawrence, Toby] Ctr Immunol Marseille Luminy, Marseille, France; [Adcock, Ian M.] Imperial Coll London, London, England	Imperial College London; Roche Holding; Pfizer; University of Cologne; AstraZeneca; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London	Belvisi, MG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England.	m.belvisi@imperial.ac.uk	Lawrence, Toby/GLU-3895-2022; Adcock, Ian/L-3217-2019; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Grace, Megan/AAA-7285-2019	Lawrence, Toby/0000-0003-0967-6122; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Adcock, Ian/0000-0003-2101-8843	Medical Research Council (MRC), United Kingdom [G0800196]; MRC [G0800196, G0800195] Funding Source: UKRI; Medical Research Council [G0800195, G0800196] Funding Source: researchfish	Medical Research Council (MRC), United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JMDR was supported by a Medical Research Council (MRC), United Kingdom studentship and consumables support from UCB. CSS and MAB were funded by a project grant from the MRC, United Kingdom (G0800196). IKK-2 Delta Mye mice were obtained from Prof. Toby Lawrence and the IKK-2 Delta Epi mice were obtained from Pfizer. TPCA1 was a kind donation from GlaxoSmithKline. The human tissue experiments in this study were undertaken with the support of the National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield National Health Service Foundation Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2007, PLOS MED, V4, P779, DOI 10.1371/journal.pmed.0040112; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Birrell MA, 2006, MOL PHARMACOL, V69, P1791, DOI 10.1124/mol.105.019521; Broide DH, 2005, P NATL ACAD SCI USA, V102, P17723, DOI 10.1073/pnas.0509235102; Caramori G, 2003, THORAX, V58, P348, DOI 10.1136/thorax.58.4.348; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Culpitt SV, 1999, AM J RESP CRIT CARE, V160, P1635, DOI 10.1164/ajrccm.160.5.9811058; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; DiStefano A, 1996, AM J RESP CRIT CARE, V153, P629, DOI 10.1164/ajrccm.153.2.8564109; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Edwards MR, 2009, PHARMACOL THERAPEUT, V121, P1, DOI 10.1016/j.pharmthera.2008.09.003; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Gottipati KR, 2008, EXP DERMATOL, V17, P780, DOI 10.1111/j.1600-0625.2007.00685.x; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Lee SY, 2010, INT IMMUNOPHARMACOL, V10, P906, DOI 10.1016/j.intimp.2010.05.001; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-79; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Murata T, 2004, BIOORG MED CHEM LETT, V14, P4019, DOI 10.1016/j.bmcl.2004.05.041; Oliver KM, 2009, ANTIOXID REDOX SIGN, V11, P2057, DOI [10.1089/ars.2008.2400, 10.1089/ARS.2008.2400]; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Rajendrasozhan S, 2010, PULM PHARMACOL THER, V23, P172, DOI 10.1016/j.pupt.2010.01.002; Rajendrasozhan S, 2010, AM J PHYSIOL-LUNG C, V298, pL197, DOI 10.1152/ajplung.00265.2009; Saetta M, 1997, AM J RESP CRIT CARE, V156, P1633, DOI 10.1164/ajrccm.156.5.9701081; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tharappel JC, 2010, J TOXICOL ENV HEAL A, V73, P1288, DOI 10.1080/15287394.2010.484708; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Tudhope SJ, 2007, J IMMUNOL, V179, P6237, DOI 10.4049/jimmunol.179.9.6237; Valenca SS, 2006, INT J EXP PATHOL, V87, P373, DOI 10.1111/j.1365-2613.2006.00492.x; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; WHO, 2008, WORLD HLTH STAT; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Zeng LX, 2010, PULM PHARMACOL THER, V23, P411, DOI 10.1016/j.pupt.2010.05.004; Zhong CY, 2008, TOXICOL APPL PHARM, V230, P150, DOI 10.1016/j.taap.2008.02.005; Zhong CY, 2006, AM J RESP CRIT CARE, V174, P428, DOI 10.1164/rccm.200503-509OC	49	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54128	10.1371/journal.pone.0054128	http://dx.doi.org/10.1371/journal.pone.0054128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349803	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100047
J	Shatz, LF; De Groot, T				Shatz, Lisa F.; De Groot, Theodorus			The Frequency Response of the Vibrissae of Harp Seal, Pagophilus Groenlandicus, to Sound in Air and Water	PLOS ONE			English	Article							RAT VIBRISSAE; DISCRIMINATION; SIZE; WHISKERS; SHAPE	The motion of isolated seal vibrissae due to low frequency sound in air has been measured using a microscope with a video camera and modeled using an FEM method with good agreement between the measurements and the model; the model has also been used to predict the motion of seal vibrissae in water. The shape of the seal vibrissae is that of a tapered right rectangular prism, unlike that of the previously studied rat vibrissae which are conical in shape. Moreover, unlike rat vibrissae which oscillate in the direction of the sound stimulus, two different modes of vibration of seal vibrissae were observed - one corresponding to the wider side being stimulated and one with the narrow side stimulated. The tuning of the seal vibrissae was much sharper than those of rat vibrissae, with quality factors about three times as large as those of rat vibrissae. As shown by the model, this increased sharpness is caused by the larger cross-sectional areas (by more than a factor of ten) of the seal vibrissae. This increased sharpness may be necessary for seal vibrissae so that they can have tuning in water, where the drag more heavily dampens the tuning than in air. The results suggest that vibrissae tuning may be important in the seal's ability to track the wake of its prey.	[Shatz, Lisa F.] Suffolk Univ, Dept Elect & Comp Engn, Boston, MA 02114 USA; [De Groot, Theodorus] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	Suffolk University; University of Wisconsin System; University of Wisconsin Madison	Shatz, LF (corresponding author), Suffolk Univ, Dept Elect & Comp Engn, Boston, MA 02114 USA.	lshatz@suffolk.edu						BLECKMANN H, 1991, J COMP PHYSIOL A, V168, P749; Dehnhardt G, 1998, NATURE, V394, P235, DOI 10.1038/28303; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; DEHNHARDT G, 1994, J COMP PHYSIOL A, V175, P791; Dehnhardt G, 1996, ANIM LEARN BEHAV, V24, P366, DOI 10.3758/BF03199008; Dehnhardt G, 1995, J EXP BIOL, V201, P3023; Hanke W, 2010, J EXP BIOL, V213, P2665, DOI 10.1242/jeb.043216; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; HUMPHREY JAC, 1993, PHILOS T R SOC B, V340, P423, DOI 10.1098/rstb.1993.0083; Miersch L, 2011, PHILOS T R SOC B, V366, P3077, DOI 10.1098/rstb.2011.0155; Neimark MA, 2003, J NEUROSCI, V23, P6499; Schulte-Pelkum N, 2007, J EXP BIOL, V210, P781, DOI 10.1242/jeb.02708; Shatz LF, 2008, J ACOUST SOC AM, V123, P2918, DOI 10.1121/1.2902181; Shimozawa T, 1998, J COMP PHYSIOL A, V183, P171, DOI 10.1007/s003590050245; Stokes G. G., 1851, T CAMBRIDGE PHILOS S, DOI DOI 10.1017/CBO9780511702266.002; Weaver W., 1990, VIBRATION PROBLEMS E; Wieskotten S, 2011, J EXP BIOL, V214, P1922, DOI 10.1242/jeb.053926	17	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54876	10.1371/journal.pone.0054876	http://dx.doi.org/10.1371/journal.pone.0054876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349983	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100106
J	Tokarz, J; Norton, W; Moller, G; de Angelis, MH; Adamski, J				Tokarz, Janina; Norton, William; Moeller, Gabriele; de Angelis, Martin Hrabe; Adamski, Jerzy			Zebrafish 20 beta-Hydroxysteroid Dehydrogenase Type 2 Is Important for Glucocorticoid Catabolism in Stress Response	PLOS ONE			English	Article							DANIO-RERIO; RAINBOW-TROUT; ONCORHYNCHUS-MYKISS; MINERALOCORTICOID RECEPTOR; DISEASE RESISTANCE; FISH EMBRYOS; TELEOST FISH; CORTISOL; TISSUE; TARGET	Stress, the physiological reaction to a stressor, is initiated in teleost fish by hormone cascades along the hypothalamuspituitary-interrenal (HPI) axis. Cortisol is the major stress hormone and contributes to the appropriate stress response by regulating gene expression after binding to the glucocorticoid receptor. Cortisol is inactivated when 11 beta-hydroxysteroid dehydrogenase (HSD) type 2 catalyzes its oxidation to cortisone. In zebrafish, Danio rerio, cortisone can be further reduced to 20 beta-hydroxycortisone. This reaction is catalyzed by 20 beta-HSD type 2, recently discovered by us. Here, we substantiate the hypothesis that 20 beta-HSD type 2 is involved in cortisol catabolism and stress response. We found that hsd11b2 and hsd20b2 transcripts were up-regulated upon cortisol treatment. Moreover, a cortisol-independent, short-term physical stressor led to the up-regulation of hsd11b2 and hsd20b2 along with several HPI axis genes. The morpholino-induced knock down of hsd20b2 in zebrafish embryos revealed no developmental phenotype under normal culture conditions, but prominent effects were observed after a cortisol challenge. Reporter gene experiments demonstrated that 20 beta-hydroxycortisone was not a physiological ligand for the zebrafish glucocorticoid or mineralocorticoid receptor but was excreted into the fish holding water. Our experiments show that 20 beta-HSD type 2, together with 11 beta-HSD type 2, represents a short pathway in zebrafish to rapidly inactivate and excrete cortisol. Therefore, 20 beta-HSD type 2 is an important enzyme in stress response.	[Tokarz, Janina; Moeller, Gabriele; de Angelis, Martin Hrabe; Adamski, Jerzy] German Res Ctr Environm Hlth, Inst Expt Genet, Helmholtz Zentrum Munchen, Genome Anal Ctr, Neuherberg, Germany; [Norton, William] CNRS, Gif Sur Yvette, France; [de Angelis, Martin Hrabe; Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Technical University of Munich	Adamski, J (corresponding author), German Res Ctr Environm Hlth, Inst Expt Genet, Helmholtz Zentrum Munchen, Genome Anal Ctr, Neuherberg, Germany.	Adamski@helmholtz-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012; Tokarz, Janina/AAT-6675-2020	de Angelis, Martin Hrabe/0000-0002-7898-2353; Norton, William/0000-0002-3244-0145; Tokarz, Janina/0000-0003-4344-4149; Moller, Gabriele/0000-0002-2730-1351; Adamski, Jerzy/0000-0001-9259-0199	German Federal Ministry of Education and Research (BMBF); Deutsche Forschungsgemeinschaft [AD 127/10-1]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center Diabetes Research (DZD e.V.) and by a Deutsche Forschungsgemeinschaft grant to J.A. (AD 127/10-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman SL, 2009, GEN COMP ENDOCR, V164, P61, DOI 10.1016/j.ygcen.2009.04.007; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Alsop D, 2009, COMP BIOCHEM PHYS A, V153, P49, DOI 10.1016/j.cbpa.2008.12.008; Alsop D, 2009, GEN COMP ENDOCR, V161, P62, DOI 10.1016/j.ygcen.2008.09.011; Baker ME, 2004, FEBS LETT, V574, P167, DOI 10.1016/j.febslet.2004.08.023; Baker ME, 2010, BIOCHEM BIOPH RES CO, V399, P215, DOI 10.1016/j.bbrc.2010.07.057; Baker ME, 2010, FEBS LETT, V584, P2279, DOI 10.1016/j.febslet.2010.03.036; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bujalska O, 1997, STEROIDS, V62, P77, DOI 10.1016/S0039-128X(96)00163-8; Edwards CRW, 1996, STEROIDS, V61, P263, DOI 10.1016/0039-128X(96)00033-5; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Fuzzen MLM, 2010, ZEBRAFISH, V7, P349, DOI 10.1089/zeb.2010.0662; Hagedorn M, 1997, CRYOBIOLOGY, V34, P335, DOI 10.1006/cryo.1997.2014; HARVEY B, 1983, CRYOBIOLOGY, V20, P432, DOI 10.1016/0011-2240(83)90033-0; Hillegass JM, 2008, TOXICOL SCI, V102, P413, DOI 10.1093/toxsci/kfn010; Hillegass JM, 2007, TOXICOL SCI, V100, P168, DOI 10.1093/toxsci/kfm192; Jiang JQ, 1998, MOL CELL ENDOCRINOL, V146, P207, DOI 10.1016/S0303-7207(98)00147-6; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumai Y, 2012, MOL CELL ENDOCRINOL, V364, P113, DOI 10.1016/j.mce.2012.08.017; MAULE AG, 1989, J ENDOCRINOL, V120, P135, DOI 10.1677/joe.0.1200135; McCormick MI, 2002, J EXP ZOOL, V293, P456, DOI 10.1002/jez.10138; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; Metz JR, 2006, GEN COMP ENDOCR, V148, P150, DOI 10.1016/j.ygcen.2006.03.001; Meyer A, 2012, TOXICOLOGY, V301, P72, DOI 10.1016/j.tox.2012.07.001; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Nesan D, 2012, MOL CELL ENDOCRINOL, V363, P85, DOI 10.1016/j.mce.2012.07.010; Nesan D, 2012, ENDOCRINOLOGY, V153, P1288, DOI 10.1210/en.2011-1559; OLIVEREAU M, 1988, PEPTIDES, V9, P13, DOI 10.1016/0196-9781(88)90004-6; PAYNE DW, 1989, J STEROID BIOCHEM, V33, P289, DOI 10.1016/0022-4731(89)90307-5; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICKERING AD, 1992, AQUACULTURE, V100, P125, DOI 10.1016/0044-8486(92)90354-N; PICKERING AD, 1989, FISH PHYSIOL BIOCHEM, V7, P253, DOI 10.1007/BF00004714; Pikulkaew S, 2011, DEV DYNAM, V240, P874, DOI 10.1002/dvdy.22586; Pippal JB, 2011, MOL CELL ENDOCRINOL, V332, P58, DOI 10.1016/j.mce.2010.09.014; POTTINGER TG, 1992, FISH PHYSIOL BIOCHEM, V10, P55, DOI 10.1007/BF00004654; R Core Team, 2012, R LANG ENV STAT COMP; Rinaman L, 2007, FRONT NEUROENDOCRIN, V28, P50, DOI 10.1016/j.yfrne.2007.02.002; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Schreck CB, 2001, AQUACULTURE, V197, P3, DOI 10.1016/S0044-8486(01)00580-4; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Shimojo M, 1997, ENDOCRINOLOGY, V138, P1305, DOI 10.1210/en.138.3.1305; Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128; Tokarz J, 2012, MOL CELL ENDOCRINOL, V349, P202, DOI 10.1016/j.mce.2011.10.022; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; TRUSCOTT B, 1979, GEN COMP ENDOCR, V38, P196, DOI 10.1016/0016-6480(79)90207-7; Vermeirssen ELM, 1996, GEN COMP ENDOCR, V101, P180, DOI 10.1006/gcen.1996.0020; Vijayan MM, 1997, COMP BIOCHEM PHYS C, V116, P89, DOI 10.1016/S0742-8413(96)00124-7; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	51	37	39	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54851	10.1371/journal.pone.0054851	http://dx.doi.org/10.1371/journal.pone.0054851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349977	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100101
J	Zhang, C; Bai, DS; Huang, XY; Shi, GM; Ke, AW; Yang, LX; Yang, XR; Zhou, J; Fan, J				Zhang, Chi; Bai, Dou-Sheng; Huang, Xiao-Yong; Shi, Guo-Ming; Ke, Ai-Wu; Yang, Liu-Xiao; Yang, Xin-Rong; Zhou, Jian; Fan, Jia			Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							CALPAIN PROTEASES; SMALL-SUBUNIT; CELL; ADHESION; PROTEOLYSIS; CD151	Background: Calpain small subunit 1 (Capn4) has been shown to correlate with the metastasis/invasion of hepatocellular carcinoma. This study aimed to investigate the role of Capn4 in intrahepatic cholangiocarcinoma (ICC). Methods: Capn4 expression was measured in 33 ICC tissues by quantitative real-time polymerase chain reaction and western blot. The role of Capn4 in the migration, invasion and proliferation of ICC cells and matrix metalloproteinase 2 (MMP2) expression were assessed after Capn4 depletion by specific small interfering RNA. Capn4 expression was further examined by immunohistochemistry in a tissue microarray consisting of 140 ICC patients and 13 normal liver tissues, and the prognostic role of Capn4 in ICC was evaluated by Kaplan-Meier and Cox regression analyses. Results: Capn4 expression was significantly higher in the ICC tissues compared to the peritumor tissues. Capn4 down-regulation impaired the migration/invasion ability of HCCC-9810 and QBC939 cells in vitro and decreased MMP2 expression. Capn4 overexpression significantly correlated with the presence of lymphatic metastasis of ICC (p = 0.026) and the tumor-node-metastasis (TNM) stage (p = 0.009). The postoperative 2- and 5-year overall survivals in patients with Capn4(low) were higher than those in the Capn4(high) group. The cumulative recurrence rate in patients with Capn4(low) was much lower than in the Capn4(high) group. Multivariate analysis showed that Capn4 overexpression was an independent prognostic marker in ICC. Conclusions: Capn4 overexpression was implicated in ICC metastasis/invasion, and Capn4 overexpression may be used as a molecular therapeutic target for ICC.	[Zhang, Chi; Bai, Dou-Sheng] Yangzhou Univ, Clin Med Coll, Dept Hepatobiliary Surg, Yangzhou, Peoples R China; [Zhang, Chi; Huang, Xiao-Yong; Shi, Guo-Ming; Ke, Ai-Wu; Yang, Liu-Xiao; Yang, Xin-Rong; Zhou, Jian; Fan, Jia] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China; [Zhang, Chi; Huang, Xiao-Yong; Shi, Guo-Ming; Ke, Ai-Wu; Yang, Liu-Xiao; Yang, Xin-Rong; Zhou, Jian; Fan, Jia] Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai 200433, Peoples R China; [Fan, Jia] Fudan Univ, Ctr Canc, Inst Biomed Sci, Shanghai 200433, Peoples R China	Yangzhou University; Fudan University; Fudan University; Fudan University	Fan, J (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China.	jiafan99@yahoo.com	Fan, Jia/C-6689-2017	Zhou, Jian/0000-0002-7650-7540; Ke, Ai-Wu/0000-0002-7964-6909	Major Program of National Natural Science Foundation of China [81030038]; National Natural Science Foundation of China [81071741, 81172023]; National Natural Science Foundation of Jiangsu Province [BK2010300]; Ph.D. Programs Foundation of the Ministry of Education of China [20090071120025, 20110072120050]; Shanghai Municipal Natural Science Foundation [11ZR1428300, 114119a5000]	Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Shanghai Municipal Natural Science Foundation	This work was supported by the Major Program of National Natural Science Foundation of China (81030038), the National Natural Science Foundation of China (81071741 and 81172023,), the National Natural Science Foundation of Jiangsu Province (BK2010300), the Ph.D. Programs Foundation of the Ministry of Education of China (20090071120025, 20110072120050) and the Shanghai Municipal Natural Science Foundation (11ZR1428300, 114119a5000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; de Jong MC, 2011, J CLIN ONCOL, V29, P3140, DOI 10.1200/JCO.2011.35.6519; Dedieu S, 2004, EXP CELL RES, V292, P187, DOI 10.1016/j.yexcr.2003.08.014; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Huang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032775; Huang XY, 2010, CANCER-AM CANCER SOC, V116, P5440, DOI 10.1002/cncr.25485; Ishak KG, 1994, NONEPITHELIAL TUMORS; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Li SR, 2003, EUR SURG RES, V35, P327, DOI 10.1159/000070603; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Morise Z, 2010, WORLD J HEPATOL, V2, P58, DOI 10.4254/wjh.v2.i2.58; Ohtsuka M, 2002, BRIT J SURG, V89, P1525, DOI 10.1046/j.1365-2168.2002.02268.x; Okabayashi T, 2001, CANCER-AM CANCER SOC, V92, P2374, DOI 10.1002/1097-0142(20011101)92:9<2374::AID-CNCR1585>3.0.CO;2-L; Rosenberger G, 2005, J BIOL CHEM, V280, P6879, DOI 10.1074/jbc.M412119200; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Shi RY, 2013, CANCER-AM CANCER SOC, V119, P993, DOI 10.1002/cncr.27788; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Wittekind C, 2006, PATHOLOGE, V27, P289, DOI 10.1007/s00292-006-0834-1; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	30	32	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54619	10.1371/journal.pone.0054619	http://dx.doi.org/10.1371/journal.pone.0054619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349941	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100085
J	Elnagdy, S; Messing, S; Majerus, MEN				Elnagdy, Sherif; Messing, Susan; Majerus, Michael E. N.			Two Strains of Male-Killing Wolbachia in a Ladybird, Coccinella undecimpunctata, from a Hot Climate	PLOS ONE			English	Article							BIPUNCTATA LINNAEUS COLEOPTERA; ADALIA-BIPUNCTATA; INHERITED MICROORGANISMS; COLEOMEGILLA-MACULATA; SEX-RATIO; BEETLE; EVOLUTION; BACTERIA; AGENT; IDENTIFICATION	Ladybirds are a hot-spot for the invasion of male-killing bacteria. These maternally inherited endosymbionts cause the death of male host embryos, to the benefit of female sibling hosts and the bacteria that they contain. Previous studies have shown that high temperatures can eradicate male-killers from ladybirds, leaving the host free from infection. Here we report the discovery of two maternally inherited sex ratio distorters in populations of a coccinellid, Coccinella undecimpunctata, from a hot lowland region of the Middle East. DNA sequence analysis indicates that the male killing is the result of infection by Wolbachia, that the trait is tetracycline sensitive, and that two distinct strains of Wolbachia co-occur within one beetle population. We discuss the implications of these findings for theories of male-killing and suggest avenues for future fieldwork on this system.	[Elnagdy, Sherif; Majerus, Michael E. N.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Elnagdy, Sherif] Cairo Univ, Fac Sci, Dept Bot, Giza, Egypt; [Messing, Susan] Univ Rochester, Div Psychiat Stat, Dept Biostat & Computat Biol, Rochester, NY USA	University of Cambridge; Egyptian Knowledge Bank (EKB); Cairo University; University of Rochester	Elnagdy, S (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	sh.elnagdy@gmail.com		Elnagdy, Sherif/0000-0003-1331-8977	BP Egypt Trust; Cambridge Overseas Trust	BP Egypt Trust; Cambridge Overseas Trust	BP Egypt and Cambridge Overseas Trusts funded Sherif Elnagdy project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Dixon A.F.G., 2000, INSECT PREDATOR PREY; Dyson EA, 2002, HEREDITY, V88, P166, DOI 10.1038/sj.hdy.6800021; Elnagdy S, 2011, J EVOLUTION BIOL, V24, P2164, DOI 10.1111/j.1420-9101.2011.02346.x; Elnagdy S. E., 2008, THESIS U CAMBRIDGE C; Hurst CDD, 1997, INFLUENTIAL PASSENGERS, P125; Hurst GDD, 1997, GENET RES, V70, P1, DOI 10.1017/S0016672397002838; Hurst GDD, 1999, PARASITOLOGY, V118, P125, DOI 10.1017/S0031182098003655; HURST GDD, 1993, HEREDITY, V71, P81, DOI 10.1038/hdy.1993.110; HURST GDD, 1994, HEREDITY, V73, P309, DOI 10.1038/hdy.1994.138; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; HURST GDD, 1993, BIOL J LINN SOC, V49, P195, DOI 10.1111/j.1095-8312.1993.tb00898.x; Hurst GDD, 2003, CONT T ENT, P177; Hurst GDD, 1996, HEREDITY, V77, P177, DOI 10.1038/hdy.1996.122; HURST GDD, 1992, HEREDITY, V69, P84, DOI 10.1038/hdy.1992.97; Hurst GDD, 1999, INSECT MOL BIOL, V8, P133, DOI 10.1046/j.1365-2583.1999.810133.x; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Hurst GDD, 2000, GENETICS, V156, P699; HURST LD, 1991, P ROY SOC B-BIOL SCI, V244, P91, DOI 10.1098/rspb.1991.0056; Jiggins FM, 2000, PARASITOLOGY, V120, P439, DOI 10.1017/S0031182099005867; Jiggins FM, 2001, HEREDITY, V86, P161, DOI 10.1046/j.1365-2540.2001.00804.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Majerus M. E. N., 1989, NATURALISTS HDB, V10; Majerus M. E. N., 1999, EVOLUTION ECOLOGY AR, P777; Majerus M. E. N, 1994, NEW NATURALIST SERIE, V81; Majerus MEN, 2006, EUR J ENTOMOL, V103, P1, DOI 10.14411/eje.2006.001; MAJERUS MEN, 1989, J BIOL EDUC, V23, P85, DOI 10.1080/00219266.1989.9655039; Majerus MEN, 2000, ECOL ENTOMOL, V25, P234, DOI 10.1046/j.1365-2311.2000.00249.x; Majerus MEN, 1997, ENTOMOPHAGA, V42, P13, DOI 10.1007/BF02769875; Majerus MEN, 2000, HEREDITY, V84, P605, DOI 10.1046/j.1365-2540.2000.00710.x; Majerus Michael E.N., 1997, Bulletin of the Amateur Entomologists' Society, V56, P235; Majerus T. M. O., 2001, THESIS U CAMBRIDGE C; Majerus TMO, 2012, EVOL ECOL, V26, P207, DOI 10.1007/s10682-011-9490-x; Majerus TMO, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-37; Majerus TMO, 1998, HEREDITY, V81, P683, DOI 10.1046/j.1365-2540.1998.00438.x; Majerus TMO, 1999, INSECT MOL BIOL, V8, P551, DOI 10.1046/j.1365-2583.1999.00151.x; MALOGOLOWKIN C, 1958, GENETICS, V43, P274; Niijima K., 1981, B FAC AGR TAMAGAWA U, V21, P59; Randerson JP, 2000, HEREDITY, V84, P152, DOI 10.1046/j.1365-2540.2000.00645.x; SAKAGUCHI B, 1963, GENETICS, V48, P841; Schulenberg JHGvd, 2000, THESIS U CAMBRIDGE C; Schulenburg JHGV, 2001, APPL ENVIRON MICROB, V67, P270, DOI 10.1128/AEM.67.1.270-277.2001; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Tinsley MC, 2006, PARASITOLOGY, V132, P757, DOI 10.1017/S0031182005009789; Tinsley MC, 2003, THESIS U CAMBRIDGE C; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WERREN JH, 1994, J BACTERIOL, V176, P388, DOI 10.1128/JB.176.2.388-394.1994; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	50	2	3	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54218	10.1371/journal.pone.0054218	http://dx.doi.org/10.1371/journal.pone.0054218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349831	gold, Green Submitted, Green Published			2022-12-27	WOS:000313943000031
J	Mussulini, BM; Leite, CE; Zenki, KC; Moro, L; Baggio, S; Rico, EP; Rosemberg, DB; Dias, RD; Souza, TM; Calcagnotto, ME; Campos, MM; Battastini, AM; de Oliveira, DL				Mussulini, Ben Hur M.; Leite, Carlos E.; Zenki, Kamila C.; Moro, Luana; Baggio, Suelen; Rico, Eduardo P.; Rosemberg, Denis B.; Dias, Renato D.; Souza, Tadeu M.; Calcagnotto, Maria E.; Campos, Maria M.; Battastini, Ana M.; de Oliveira, Diogo L.			Seizures Induced by Pentylenetetrazole in the Adult Zebrafish: A Detailed Behavioral Characterization	PLOS ONE			English	Article							CURRENT ANIMAL-MODELS; BLOOD-BRAIN-BARRIER; GENE-EXPRESSION; DRUG-TREATMENT; EPILEPSY; ILAE; DISEASE; IDENTIFY; SCREEN; SERUM	Pentylenetetrazole (PTZ) is a common convulsant agent used in animal models to investigate the mechanisms of seizures. Although adult zebrafish have been recently used to study epileptic seizures, a thorough characterization of the PTZ-induced seizures in this animal model is missing. The goal of this study was to perform a detailed temporal behavior profile characterization of PTZ-induced seizure in adult zebrafish. The behavioral profile during 20 min of PTZ immersion (5, 7.5, 10, and 15 mM) was characterized by stages defined as scores: (0) short swim, (1) increased swimming activity and high frequency of opercular movement, (2) erratic movements, (3) circular movements, (4) clonic seizure-like behavior, (5) fall to the bottom of the tank and tonic seizure-like behavior, (6) death. Animals exposed to distinct PTZ concentrations presented different seizure profiles, intensities and latencies to reach all scores. Only animals immersed into 15 mM PTZ showed an increased time to return to the normal behavior (score 0), after exposure. Total mortality rate at 10 and 15 mM were 33% and 50%, respectively. Considering all behavioral parameters, 5, 7.5, 10, and 15 mM PTZ, induced seizures with low, intermediate, and high severity, respectively. Pretreatment with diazepam (DZP) significantly attenuated seizure severity. Finally, the brain PTZ levels in adult zebrafish immersed into the chemoconvulsant solution at 5 and 10 mM were comparable to those described for the rodent model, with a peak after a 20-min of exposure. The PTZ brain levels observed after 2.5-min PTZ exposure and after 60-min removal from exposure were similar. Altogether, our results showed a detailed temporal behavioral characterization of a PTZ epileptic seizure model in adult zebrafish. These behavioral analyses and the simple method for PTZ quantification could be considered as important tools for future investigations and translational research.	[Mussulini, Ben Hur M.; Zenki, Kamila C.; Moro, Luana; Baggio, Suelen; Rico, Eduardo P.; Rosemberg, Denis B.; Dias, Renato D.; Souza, Tadeu M.; Calcagnotto, Maria E.; Battastini, Ana M.; de Oliveira, Diogo L.] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil; [Leite, Carlos E.; Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Inst Toxicol & Farmacol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Mussulini, BM (corresponding author), Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil.	ben_hurmussulini@yahoo.com.br; losch@ufrgs.br	calcagnotto, maria elisa/B-1645-2013; Rosemberg, Denis B/E-5971-2016; Battastini, Ana M/E-2809-2012; Campos, Maria Martha M/J-8829-2015; CALCAGNOTTO, MARIA ELISA/AAU-7718-2020; Leite, Carlos Eduardo/U-4395-2017	calcagnotto, maria elisa/0000-0001-8196-0596; Battastini, Ana M/0000-0001-6068-3278; Campos, Maria Martha M/0000-0002-1153-3633; CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; Losch de Oliveira, Diogo/0000-0002-9028-6959; Rosemberg, Denis/0000-0003-2538-8761; Marins Mussulini, Ben Hur/0000-0003-4321-5709; Campos, Maria/0000-0001-7738-9892; Leite, Carlos Eduardo/0000-0002-6845-1612	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES); INCT para Excitotoxicidade e Neuroprotecao; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); FINEP [01.06.0842-00, 01.11.0014-00]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT para Excitotoxicidade e Neuroprotecao; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FINEP(Financiadora de Inovacao e Pesquisa (Finep))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), INCT para Excitotoxicidade e Neuroprotecao, Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and by FINEP research grants: "Rede Instituto Brasileiro de Neurociencia (IBN-Net)" #01.06.0842-00 and "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA) # 01.11.0014-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JM, 2011, EUR J NEUROSCI, V33, P1252, DOI 10.1111/j.1460-9568.2011.07622.x; Bachiega JC, 2008, EPILEPSY BEHAV, V13, P70, DOI 10.1016/j.yebeh.2008.02.010; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Berghmans S, 2007, EPILEPSY RES, V75, P18, DOI 10.1016/j.eplepsyres.2007.03.015; Blaser RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036931; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Chatterjee D, 2009, BEHAV BRAIN RES, V200, P208, DOI 10.1016/j.bbr.2009.01.016; Desmond D, 2012, ASSESSING EPILEPSY R; DiBella LM, 2009, HUM MOL GENET, V18, P595, DOI 10.1093/hmg/ddn384; Eliceiri BP, 2011, METHODS MOL BIOL, V686, P371, DOI 10.1007/978-1-60761-938-3_18; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; GOODMAN LS, 1953, J PHARMACOL EXP THER, V108, P168; Hortopan GA, 2010, J NEUROSCI, V30, P13718, DOI 10.1523/JNEUROSCI.1887-10.2010; Hortopan GA, 2010, DIS MODEL MECH, V3, P144, DOI 10.1242/dmm.002139; Ingham PW, 2009, HUM MOL GENET, V18, pR107, DOI 10.1093/hmg/ddp091; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lee Y, 2010, EUR J PHARMACOL, V643, P225, DOI 10.1016/j.ejphar.2010.06.041; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; LOSCHER W, 1984, METHOD FIND EXP CLIN, V6, P531; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Penberthy WT, 2002, FRONT BIOSCI-LANDMRK, V7, pD1439, DOI 10.2741/penber; Pineda R, 2012, DIS MODEL MECH; Pineda R, 2011, J NEUROSCI METH, V200, P20, DOI 10.1016/j.jneumeth.2011.06.001; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RAMZAN IM, 1985, J PHARMACOL EXP THER, V234, P624; Rico EP, 2007, TOXICOL LETT, V174, P25, DOI 10.1016/j.toxlet.2007.08.005; Rico EP, 2010, BRAIN RES BULL, V81, P517, DOI 10.1016/j.brainresbull.2009.11.011; Rosemberg DB, 2012, NEUROPHARMACOLOGY, V63, P613, DOI 10.1016/j.neuropharm.2012.05.009; Rosemberg DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019397; Rosemberg DB, 2008, COMP BIOCHEM PHYS B, V151, P96, DOI 10.1016/j.cbpb.2008.06.001; Sarkisian MR, 2001, EPILEPSY BEHAV, V2, P201, DOI 10.1006/ebeh.2001.0193; Shorvon SD, 2009, EPILEPSIA, V50, P93, DOI 10.1111/j.1528-1167.2009.02042.x; Shorvon SD, 2009, EPILEPSIA, V50, P69, DOI 10.1111/j.1528-1167.2009.02041.x; Siebel AM, 2011, BRAIN RES BULL, V86, P385, DOI 10.1016/j.brainresbull.2011.08.017; Sierra S, 2012, BRAIN RES BULL, V88, P467, DOI 10.1016/j.brainresbull.2012.04.007; SOTOOTERO R, 1987, ANAL BIOCHEM, V165, P331, DOI 10.1016/0003-2697(87)90277-6; Stewart AM, 2012, BRAIN RES BULL, V87, P135, DOI 10.1016/j.brainresbull.2011.11.020; Teng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024596; Teng Y, 2010, HUM MOL GENET, V19, P4409, DOI 10.1093/hmg/ddq364; Vermoesen K, 2011, EPILEPSY BEHAV, V22, P450, DOI 10.1016/j.yebeh.2011.08.016; Wong K, 2010, BRAIN RES, V1348, P209, DOI 10.1016/j.brainres.2010.06.012; YONEKAWA WD, 1980, J PHARMACOL EXP THER, V214, P589	49	76	77	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54515	10.1371/journal.pone.0054515	http://dx.doi.org/10.1371/journal.pone.0054515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349914	Green Published, Green Submitted, gold			2022-12-27	WOS:000313943000042
J	Singh, R				Singh, Raghvendra			Signal Oscillation Is Another Reason for Variability in Microarray-Based Gene Expression Quantification	PLOS ONE			English	Article							MOLECULAR CLASSIFICATION; ALZHEIMERS-DISEASE; CDNA MICROARRAY; MASTER-SWITCH; HYBRIDIZATION; REPRODUCIBILITY; CANCER; MODEL; DISCOVERY; DIFFUSION	Microarrays have been widely used for various biological applications, such as, gene expression profiling, determination of SNPs, and disease profiling. However, quantification and analysis of microarray data have been a challenge. Previously, by taking into account translational and rotational diffusion of the target DNA, we have shown that the rate of hybridization depends on its size. Here, by mathematical modeling of surface diffusion of transcript, we show that the dynamics of hybridization on DNA microarray surface is inherently oscillatory and the amplitude of oscillation depends on fluid velocity. We found that high fluid velocity enhances the signal without affecting the background, and reduces the oscillation, thereby reducing likelihood of inter-and intra-experiment variability. We further show that a strong probe reduces dependence of signal-to-noise ratio on probe strength, decreasing inter-microarray variability. On the other hand, weaker probes are required for SNP detection. Therefore, we recommend high fluid velocity and strong probes for all microarray applications except determination of SNPs. For SNP detection, we recommend high fluid velocity with weak probe on the spot. We also recommend a surface with high adsorption and desorption rates of transcripts.	Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Singh, R (corresponding author), Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.	raghvend@iitk.ac.in			Indian Institute of Technology Kanpur [IITK/CHE/20090282]	Indian Institute of Technology Kanpur	This work was supported by the Indian Institute of Technology Kanpur grant IITK/CHE/20090282 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey NB, 2002, ANAL CHEM, V74, P6413, DOI 10.1021/ac026082m; Amundson SA, 2002, CANCER BIOL THER, V1, P145, DOI 10.4161/cbt.59; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bryant PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019556; Budhraja V, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-1; Chan V, 1995, BIOPHYS J, V69, P2243, DOI 10.1016/S0006-3495(95)80095-0; Chan V, 1997, LANGMUIR, V13, P5514; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Dandy DS, 2007, P NATL ACAD SCI USA, V104, P8223, DOI 10.1073/pnas.0606054104; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Gadgil C, 2004, J BIOTECHNOL, V114, P31, DOI 10.1016/j.jbiotec.2004.05.008; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grunblatt E, 2001, J NEUROCHEM, V78, P1, DOI 10.1046/j.1471-4159.2001.00397.x; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Han T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S17; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; Jailwala P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006527; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Klevecz Robert R., 2000, Functional and Integrative Genomics, V1, P186, DOI 10.1007/s101420000027; Lawrence ND, 2004, BIOINFORMATICS, V20, P518, DOI 10.1093/bioinformatics/btg438; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Meyers JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000458; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Ptitsyn AA, 2007, PLOS COMPUT BIOL, V3, P1108, DOI 10.1371/journal.pcbi.0030120; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schaupp CJ, 2005, BIOTECHNIQUES, V38, P117, DOI 10.2144/05381MT01; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; Singh R, 2009, ANN BIOMED ENG, V37, P255, DOI 10.1007/s10439-008-9584-y; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spruill SE, 2002, BIOTECHNIQUES, V33, P916, DOI 10.2144/02334mt05; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tan JC, 2009, GENOMICS, V93, P543, DOI 10.1016/j.ygeno.2009.02.007; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang X, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.15.e75; Wong JSS, 2011, MACROMOLECULES, V44, P3073, DOI 10.1021/ma1024939; Workman C, 2002, GENOME BIOL, V3; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168	54	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54753	10.1371/journal.pone.0054753	http://dx.doi.org/10.1371/journal.pone.0054753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349963	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000049
J	Bythell-Douglas, R; Waters, MT; Scaffidi, A; Flematti, GR; Smith, SM; Bond, CS				Bythell-Douglas, Rohan; Waters, Mark T.; Scaffidi, Adrian; Flematti, Gavin R.; Smith, Steven M.; Bond, Charles S.			The Structure of the Karrikin-Insensitive Protein (KAI2) in Arabidopsis thaliana	PLOS ONE			English	Article							F-BOX PROTEIN; GERMINATION STIMULANT; SEED-GERMINATION; STRIGOLACTONES; INHIBITION; MECHANISM; RESPONSES; BOND	KARRIKIN INSENSITIVE 2 (KAI2) is an alpha/beta hydrolase involved in seed germination and seedling development. It is essential for plant responses to karrikins, a class of butenolide compounds derived from burnt plant material that are structurally similar to strigolactone plant hormones. The mechanistic basis for the function of KAI2 in plant development remains unclear. We have determined the crystal structure of Arabidopsis thaliana KAI2 in space groups P2(1) 2(1) 2(1) (a = 63.57 angstrom, b = 66.26 angstrom, c = 78.25 angstrom) and P2(1) (a = 50.20 angstrom, b = 56.04 angstrom, c = 52.43 angstrom, beta = 116.12 degrees) to 1.55 and 2.11 A respectively. The catalytic residues are positioned within a large hydrophobic pocket similar to that of DAD2, a protein required for strigolactone response in Petunia hybrida. KAI2 possesses a second solvent-accessible pocket, adjacent to the active site cavity, which offers the possibility of allosteric regulation. The structure of KAI2 is consistent with its designation as a serine hydrolase, as well as previous data implicating the protein in karrikin and strigolactone signalling.	[Bythell-Douglas, Rohan; Scaffidi, Adrian; Flematti, Gavin R.; Smith, Steven M.; Bond, Charles S.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Waters, Mark T.; Smith, Steven M.] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Bond, CS (corresponding author), Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia.	Charles.Bond@uwa.edu.au	Smith, Steven M/G-7183-2015; Flematti, Gavin R/J-2018-2012; Waters, Mark T/H-6054-2014; Bond, Charles S/B-4094-2011; Bond, Charles/AAF-9608-2020; Smith, Steven/HDM-9496-2022	Smith, Steven M/0000-0001-5661-9994; Waters, Mark T/0000-0001-5657-9005; Bond, Charles S/0000-0002-9584-6783; Bond, Charles/0000-0002-9584-6783; Bythell-Douglas, Rohan/0000-0002-3823-8749; Flematti, Gavin/0000-0003-2545-6939	Australian Research Council [DP1096717, LP0882775, FT110100304]	Australian Research Council(Australian Research Council)	The authors gratefully acknowledge the Australian Research Council (http://www.arc.gov.au/) for funding ( DP1096717, LP0882775, FT110100304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Ash EL, 2000, P NATL ACAD SCI USA, V97, P10371, DOI 10.1073/pnas.97.19.10371; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bricogne G, 2011, BUSTER VERSION 1 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; COOK CE, 1972, J AM CHEM SOC, V94, P6198, DOI 10.1021/ja00772a048; Cummins I, 2006, J MOL BIOL, V359, P422, DOI 10.1016/j.jmb.2006.03.048; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flematti GR, 2004, SCIENCE, V305, P977, DOI 10.1126/science.1099944; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goddard-Borger ED, 2007, EUR J ORG CHEM, V2007, P3925, DOI [10.1002/ejoe.200700334, 10.1002/ejoc.200700334]; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko T, 2005, PROTEIN SCI, V14, P558, DOI 10.1110/ps.041170005; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Mayzlish-Gati E, 2012, PLANT PHYSIOL, V160, P1329, DOI 10.1104/pp.112.202358; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nelson DC, 2012, ANNU REV PLANT BIOL, V63, P107, DOI 10.1146/annurev-arplant-042811-105545; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Peng Q, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-95; Rasmussen A, 2012, PLANT PHYSIOL, V158, P1976, DOI 10.1104/pp.111.187104; Scaffidi A, 2012, BIOORG MED CHEM LETT, V22, P3743, DOI 10.1016/j.bmcl.2012.04.016; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Waters MT, 2012, PLANT SIGNAL BEHAV, V7, P969, DOI 10.4161/psb.20977; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshida S, 2012, NEW PHYTOL, V196, P1208, DOI 10.1111/j.1469-8137.2012.04339.x	38	42	42	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54758	10.1371/journal.pone.0054758	http://dx.doi.org/10.1371/journal.pone.0054758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349965	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800075
J	Myers, RP; Shaheen, AAM; Faris, P; Aspinall, AI; Burak, KW				Myers, Robert P.; Shaheen, Abdel Aziz M.; Faris, Peter; Aspinall, Alexander I.; Burak, Kelly W.			Revision of MELD to Include Serum Albumin Improves Prediction of Mortality on the Liver Transplant Waiting List	PLOS ONE			English	Article							DYE-BINDING METHODS; DISEASE SCORE; PROGNOSTIC INDICATORS; ORGAN ALLOCATION; MODEL; SURVIVAL; RISK; CIRRHOSIS; SODIUM; FUTURE	Background: Allocation of donor livers for transplantation in most regions is based on the Model for End-Stage Liver Disease (MELD) or MELD-sodium (MELDNa). Our objective was to assess revisions to MELD and MELDNa that include serum albumin for predicting waiting list mortality. Methods: Adults registered for liver transplantation in the United States (2002-2007) were identified from the United Network for Organ Sharing (UNOS) database. Cox regression was used to determine the association between serum albumin and 3-month mortality, and to derive revised MELD and MELDNa scores incorporating albumin ('MELD-albumin' and '5-variable MELD [5vMELD]'). Results: Among 40,393 patients, 9% died and 24% underwent transplantation within 3 months of listing. For serum albumin concentrations between 1.0 and 4.0 g/dL, a linear, inverse relationship was observed between albumin and 3-month mortality (adjusted hazard ratio per 1 g/dL reduction in albumin: 1.44; 95% CI 1.35-1.54). The c-statistics for 3-month mortality of MELD-albumin and MELD were 0.913 and 0.896, respectively (P < 0.001); 5vMELD was superior to MELDNa (c-statistics 0.922 vs. 0.912, P < 0.001). The potential benefit of 5vMELD was greatest in patients with low MELD (<15). Among low MELD patients who died, 27% would have gained >= 10 points with 5vMELD over MELD versus only 4-7% among low MELD survivors and high MELD (>= 15) candidates (P < 0.0005). Conclusion: Modification of MELD and MELDNa to include serum albumin is associated with improved prediction of waiting list mortality. If validated and shown to be associated with reduced mortality, adoption of 5vMELD as the basis for liver allograft allocation may improve outcomes on the liver transplant waiting list.	[Myers, Robert P.; Shaheen, Abdel Aziz M.; Faris, Peter; Aspinall, Alexander I.; Burak, Kelly W.] Univ Calgary, Div Gastroenterol & Hepatol, Dept Med, Liver Unit, Calgary, AB, Canada	University of Calgary	Myers, RP (corresponding author), Univ Calgary, Div Gastroenterol & Hepatol, Dept Med, Liver Unit, Calgary, AB, Canada.	rpmyers@ucalgary.ca	Shaheen, Abdel Aziz/AAX-3773-2021; Faris, Peter/AAJ-3436-2020	Shaheen, Abdel Aziz/0000-0002-2940-897X; Faris, Peter/0000-0001-5208-817X; Aspinall, Alexander/0000-0001-5534-6146	Alberta Innovates - Health Solutions (AIHS); Canadian Institutes for Health Research (CIHR); AIHS; CIHR; Health Resources and Services Administration [231-00-0115]	Alberta Innovates - Health Solutions (AIHS); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); AIHS; CIHR(Canadian Institutes of Health Research (CIHR)); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Dr. Myers is supported by awards from Alberta Innovates - Health Solutions (AIHS) and the Canadian Institutes for Health Research (CIHR). This work was supported in part by grants from AIHS and CIHR, and Health Resources and Services Administration contract 231-00-0115, which funds data collection and management of the UNOS STAR database. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. government.	Bambha KM, 2008, CURR OPIN ORGAN TRAN, V13, P227, DOI 10.1097/MOT.0b013e3282ff84c7; Brown RS, 2005, AM J TRANSPLANT, V5, P203, DOI 10.1111/j.1600-6143.2005.00769.x; BUSH V, 1987, CLIN CHEM, V33, P821; Cholongitas E, 2007, LIVER TRANSPLANT, V13, P523, DOI 10.1002/lt.20994; College of American Pathologists, 2010, SURV 2010 CLIN CHEM; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; D'Agostino RB, 2004, HANDB STAT, V23, P1; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Doumas BT, 2009, CLIN CHEM, V55, P583, DOI 10.1373/clinchem.2008.112854; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Doumas BT, 1997, CLIN CHIM ACTA, V258, P3, DOI 10.1016/S0009-8981(96)06446-7; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Huo SC, 2007, TRANSPLANTATION, V84, P1406, DOI 10.1097/01.tp.0000282867.92367.d0; Huo TI, 2007, LIVER INT, V27, P498, DOI 10.1111/j.1478-3231.2007.01445.x; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kremers WK, 2007, CONCORDANCE SURVIVAL, V80; Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197; MAGUIRE GA, 1986, CLIN CHIM ACTA, V155, P83, DOI 10.1016/0009-8981(86)90102-6; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; McDiarmid SV, 2002, TRANSPLANTATION, V74, P173, DOI 10.1097/00007890-200207270-00006; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; MERKEL C, 1989, AM J GASTROENTEROL, V84, P717; Myers RP, 2011, J HEPATOL, V54, P462, DOI 10.1016/j.jhep.2010.07.015; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ravaioli M, 2007, TRANSPLANTATION, V83, P919, DOI 10.1097/01.tp.0000259251.92398.2a; REALDI G, 1994, J HEPATOL, V21, P656, DOI 10.1016/S0168-8278(94)80115-0; Schaubel DE, 2009, AM J TRANSPLANT, V9, P970, DOI 10.1111/j.1600-6143.2009.02571.x; Sharma P, 2008, GASTROENTEROLOGY, V135, P1575, DOI 10.1053/j.gastro.2008.08.004; Therneau T.M., 2000, MODELING SURVIVAL DA; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tripodi A, 2007, HEPATOLOGY, V46, P520, DOI 10.1002/hep.21732; Trotter JF, 2007, AM J TRANSPLANT, V7, P1624, DOI 10.1111/j.1600-6143.2007.01822.x; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; ZOLI M, 1991, AM J GASTROENTEROL, V86, P1508	44	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e51926	10.1371/journal.pone.0051926	http://dx.doi.org/10.1371/journal.pone.0051926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349678	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800003
J	Ploenes, T; Scholtes, B; Krohn, A; Burger, M; Passlick, B; Muller-Quernheim, J; Zissel, G				Ploenes, Till; Scholtes, Ben; Krohn, Alexander; Burger, Meike; Passlick, Bernward; Mueller-Quernheim, Joachim; Zissel, Gernot			CC-Chemokine Ligand 18 Induces Epithelial to Mesenchymal Transition in Lung Cancer A549 Cells and Elevates the Invasive Potential	PLOS ONE			English	Article							COLLAGEN PRODUCTION; PULMONARY-FIBROSIS; TUMOR PROGRESSION; PROTEIN S100A4; BREAST-CANCER; METASTASIS; EXPRESSION; CCL18; FIBROBLASTS; MACROPHAGES	Lung cancer is one of the leading causes of cancer related death worldwide with more than a million deaths per year. The poor prognosis is due to its high aggressiveness and its early metastasis. Although the exact mechanisms are still unknown, the process of epithelial to mesenchymal transition (EMT) seems to be involved in these neoplastic processes. We already demonstrated that serum levels of CCL18, a primate specific chemokine, are highly elevated in patients with lung cancer and correlate with their survival time of patients with adenocarcinoma of the lung. Therefore, we hypothesized that CCL18 may be directly involved in pathological processes of lung cancer, e. g. EMT. We investigated the effect of CCL18 on A549, an adenocarcinoma cell line of the lung, on EMT and other cell functions like proliferation, chemotaxis, invasion, chemoresistance and proliferation. Exposure of A549 lung cancer cells to CCL18 in various concentrations decreases the epithelial marker E-cadherin, whereas FSP-1, a marker of the mesenchymal phenotype increases. Accordingly, CCL18 induced the transcriptional EMT regulator SNAIL1 in a dose dependent fashion. In contrast, an increasing CCL18 concentration was associated with a decline of cell proliferation rate. In addition, CCL18 induced chemotaxis of these cells and increased their chemoresistance. Therefore, CCL18 may be an interesting therapeutic target for NSCLC.	[Ploenes, Till; Passlick, Bernward] Univ Freiburg, Med Ctr Freiburg, Div Thorac Surg, D-79106 Freiburg, Germany; [Scholtes, Ben; Mueller-Quernheim, Joachim; Zissel, Gernot] Univ Med Ctr Freiburg, Div Internal Med, Dept Pneumol, Freiburg, Germany; [Krohn, Alexander; Burger, Meike] Univ Med Ctr Freiburg, Div Internal Med, Dept Hematol & Oncol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Zissel, G (corresponding author), Univ Med Ctr Freiburg, Div Internal Med, Dept Pneumol, Freiburg, Germany.	gernot.zissel@uniklinik-freiburg.de	Zissel, Gernot/B-1208-2010; Plönes, Till/AAK-8208-2021	Zissel, Gernot/0000-0001-8021-9798; Plönes, Till/0000-0003-4839-2130	Albert-Ludwig University Freiburg (Stiftung Mattern)	Albert-Ludwig University Freiburg (Stiftung Mattern)	There are no current external funding sources for this study. T. P. is a recipient of a grant by the Albert-Ludwig University Freiburg (Stiftung Mattern). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Catusse J, 2010, J CELL PHYSIOL, V225, P792, DOI 10.1002/jcp.22284; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Guo J, 2008, J ALLERGY CLIN IMMUN, V122, P195, DOI 10.1016/j.jaci.2008.03.012; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hsu DSS, 2010, CLIN CANCER RES, V16, P4561, DOI 10.1158/1078-0432.CCR-10-0593; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Janssen-Heijnen MLG, 2003, LUNG CANCER-J IASLC, V41, P245, DOI 10.1016/S0169-5002(03)00230-7; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leung SY, 2004, GASTROENTEROLOGY, V127, P457, DOI 10.1053/j.gastro.2004.05.031; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Luzina IG, 2006, J CELL PHYSIOL, V206, P221, DOI 10.1002/jcp.20452; Miyazaki N, 2006, INT J ONCOL, V28, P1369; Osanai K, 1997, AM J RESP CRIT CARE, V155, pA750; Plones T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041746; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prasse A, 2007, ARTHRITIS RHEUM-US, V56, P1685, DOI 10.1002/art.22559; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Rudland PS, 2000, CANCER RES, V60, P1595; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Struyf S, 2003, AM J PATHOL, V163, P2065, DOI 10.1016/S0002-9440(10)63564-X; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wakelee HA, 2006, CANCER-AM CANCER SOC, V106, P2208, DOI 10.1002/cncr.21869; Yang CC, 2005, AM J PHYSIOL-CELL PH, V288, pC321, DOI 10.1152/ajpcell.00171.2004; Zissel G, 2011, AM J RESP CRIT CARE, V183, pA5574; Zissel G, 2011, AM J RESP CRIT CARE	33	41	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53068	10.1371/journal.pone.0053068	http://dx.doi.org/10.1371/journal.pone.0053068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349697	gold, Green Submitted, Green Published			2022-12-27	WOS:000313872800006
J	Missirlis, D; Teesalu, T; Black, M; Tirrell, M				Missirlis, Dimitris; Teesalu, Tambet; Black, Matthew; Tirrell, Matthew			The Non-Peptidic Part Determines the Internalization Mechanism and Intracellular Trafficking of Peptide Amphiphiles	PLOS ONE			English	Article							ANCHORED PROTEINS; PLASMA-MEMBRANE; CHOLERA-TOXIN; MICELLES; CELL; NANOPARTICLES; TUMORS; ENDOCYTOSIS; STABILITY; ALBUMIN	Background: Peptide amphiphiles (PAs) are a class of amphiphilic molecules able to self-assemble into nanomaterials that have shown efficient in vivo targeted delivery. Understanding the interactions of PAs with cells and the mechanisms of their internalization and intracellular trafficking is critical in their further development for therapeutic delivery applications. Methodology/Principal Findings: PAs of a novel, cell- and tissue-penetrating peptide were synthesized possessing two different lipophilic tail architectures and their interactions with prostate cancer cells were studied in vitro. Cell uptake of peptides was greatly enhanced post-modification. Internalization occurred via lipid-raft mediated endocytosis and was common for the two analogs studied. On the contrary, we identified the non-peptidic part as the determining factor of differences between intracellular trafficking and retention of PAs. PAs composed of di-stearyl lipid tails linked through poly(ethylene glycol) to the peptide exhibited higher exocytosis rates and employed different recycling pathways compared to ones consisting of di-palmitic-coupled peptides. As a result, cell association of the former PAs decreased with time. Conclusions/Significance: Control over peptide intracellular localization and retention is possible by appropriate modification with synthetic hydrophobic tails. We propose this as a strategy to design improved peptide-based delivery systems.	[Missirlis, Dimitris; Black, Matthew; Tirrell, Matthew] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Missirlis, Dimitris] Heidelberg Univ, Inst Phys Chem, Dept Biophys Chem, Heidelberg, Germany; [Missirlis, Dimitris] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Teesalu, Tambet] Univ Tartu, Canc Biol Lab, Inst Biomed, Ctr Excellence Translat Med, EE-50090 Tartu, Estonia; [Teesalu, Tambet] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA; [Tirrell, Matthew] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA	University of California System; University of California Berkeley; Ruprecht Karls University Heidelberg; Max Planck Society; University of Tartu; Sanford Burnham Prebys Medical Discovery Institute; University of Chicago	Missirlis, D (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	missirlis@uni-heidelberg.de	Missirlis, Dimitris/S-3798-2019; Teesalu, Tambet/J-1802-2015	Missirlis, Dimitris/0000-0003-1874-676X; 	College of Engineering at the University of California, Berkeley; Marie Curie International Incoming Fellowship; CellNetworks Postdoctoral fellowship; S. Komen for Cure Career Development Award; European Regional Development Fund; European Research Council	College of Engineering at the University of California, Berkeley; Marie Curie International Incoming Fellowship(European Commission); CellNetworks Postdoctoral fellowship; S. Komen for Cure Career Development Award; European Regional Development Fund(European Commission); European Research Council(European Research Council (ERC)European Commission)	This work was funded by the College of Engineering at the University of California, Berkeley (DM, MT), a Marie Curie International Incoming Fellowship to DM, a CellNetworks Postdoctoral fellowship to DM, the S. Komen for Cure Career Development Award to TT, the European Regional Development Fund grant to TT, the European Research Council starting grant to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019; Bhagatji P, 2009, J CELL BIOL, V186, P615, DOI 10.1083/jcb.200903102; Braun GB, 2009, ACS NANO, V3, P2007, DOI 10.1021/nn900469q; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328; Foerg C, 2008, J PHARM SCI-US, V97, P144, DOI 10.1002/jps.21117; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Karmali PP, 2009, NANOMED-NANOTECHNOL, V5, P73, DOI 10.1016/j.nano.2008.07.007; Kastantin M, 2010, J PHYS CHEM B, V114, P12632, DOI 10.1021/jp1001786; Kastantin M, 2009, LANGMUIR, V25, P7279, DOI 10.1021/la900310k; Lin BF, 2011, NANO LETT, V11, P3946, DOI 10.1021/nl202220q; Missirlis D, 2010, MOL PHARMACEUT, V7, P2173, DOI 10.1021/mp100193h; Missirlis D, 2009, BIOCHEMISTRY-US, V48, P3304, DOI 10.1021/bi802356k; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Peters D, 2009, P NATL ACAD SCI USA, V106, P9815, DOI 10.1073/pnas.0903369106; Ramprasad OG, 2007, CELL MOTIL CYTOSKEL, V64, P199, DOI 10.1002/cm.20176; Roth L, 2012, ONCOGENE, V31, P3754, DOI 10.1038/onc.2011.537; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SILVIUS JR, 1993, BIOCHEMISTRY-US, V32, P3153, DOI 10.1021/bi00063a030; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Teesalu T, 2012, METHOD ENZYMOL, V503, P35, DOI 10.1016/B978-0-12-396962-0.00002-1; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Torgersen ML, 2001, J CELL SCI, V114, P3737; Trent A, 2011, SOFT MATTER, V7, P9572, DOI 10.1039/c1sm05862b; Wang TY, 2005, J BIOL CHEM, V280, P22839, DOI 10.1074/jbc.M502920200; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	33	20	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54611	10.1371/journal.pone.0054611	http://dx.doi.org/10.1371/journal.pone.0054611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349939	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900081
J	Zhang, DC; Xiang, JB; Wang, LY; Xu, ZB; Sun, LD; Zhou, F; Zha, XL; Cai, D				Zhang, Diancai; Xiang, Jianbin; Wang, Liying; Xu, Zhibin; Sun, Lidong; Zhou, Feng; Zha, Xiliang; Cai, Duan			Comparative Proteomic Analysis of Gallbladder Bile Proteins Related to Cholesterol Gallstones	PLOS ONE			English	Article							SUPERSATURATED MODEL BILE; BILIARY PROTEINS; ELECTROPHORETIC ANALYSIS; ACCURATE SEPARATION; MICELLAR CARRIERS; CRYSTAL-FORMATION; GLYCATED ALBUMIN; CRYSTALLIZATION; ULTRACENTRIFUGATION; DISEASE	Background: Nucleation of cholesterol monohydrate crystals following the aggregation and fusion of cholesterol-enriched vesicles is a critical procedure in the formation of cholesterol gallstone. Biliary proteins play important roles in the process. It is inefficient to screen pro-nucleating or anti-nucleating proteins with routine physiochemical techniques, by which we discovered several pro-nucleating proteins. Methodology/Principal Findings: Based on comparative proteomic technologies, we investigated the differentially expressed proteins between the cholesterol gallstone and control groups, and between the vesicular phase and micellar phase. There are 401 +/- 75 spots detected on the cholesterol gallstone group and 389 +/- 94 spots on the control group gels, 120 +/- 24 spots detected on vesicular phase and 198 +/- 37 on micellar phase gels, and accordingly 22 and 8 differentially expressed proteins were identified successfully, respectively. Three of them, HSA, Profilin and Retinol Binding Protein, were validated by Western blot. Conclusion/Significance: Some of the identified proteins are in good agreement with proteins reported to be involved in the gallstone formation before. The information from this study might provide some important clues to uncover the key proteins involved in the formation of cholesterol gallstone.	[Zhang, Diancai] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Xiang, Jianbin; Cai, Duan] Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China; [Xiang, Jianbin; Cai, Duan] Fudan Univ, Shanghai Med Coll, Dept Surg, Shanghai 200433, Peoples R China; [Wang, Liying; Xu, Zhibin; Sun, Lidong; Zhou, Feng; Zha, Xiliang] Fudan Univ, Dept Biochem & Mol Biol, Minist Hlth, Key Lab Glycoconjugate Res, Shanghai 200433, Peoples R China	Nanjing Medical University; Fudan University; Fudan University; Fudan University	Xiang, JB (corresponding author), Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China.	tease@sohu.com; aroony@gmail.com			National Natural Science Foundation of China [30901443, 30772111]; 'Star of Century' Foundation of Fudan University; Opening Project of Institutes of Biomedical Sciences Fudan University; Opening Project of medical key disciplines in Jiangsu province [XK200703, XK03 200904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 'Star of Century' Foundation of Fudan University; Opening Project of Institutes of Biomedical Sciences Fudan University; Opening Project of medical key disciplines in Jiangsu province	This work was supported by grants from National Natural Science Foundation of China (30901443, 30772111), a grant from 'Star of Century' Foundation of Fudan University, a grant from Opening Project of Institutes of Biomedical Sciences Fudan University, and a grant from Opening Project of medical key disciplines(XK200703) in Jiangsu province(XK03 200904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEI M, 1993, J LIPID RES, V34, P1141; AMIGO L, 1990, J LIPID RES, V31, P341; BURNSTEIN MJ, 1983, GASTROENTEROLOGY, V85, P801; Cohen MP, 2003, ARCH BIOCHEM BIOPHYS, V419, P25, DOI 10.1016/j.abb.2003.08.012; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Donovan JM, 1998, HEPATOLOGY, V27, P641, DOI 10.1002/hep.510270301; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Grattagliano I, 2009, EUR J CLIN INVEST, V39, P986, DOI 10.1111/j.1365-2362.2009.02187.x; HARVEY PRC, 1991, J BIOL CHEM, V266, P13996; Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300; He C, 1997, J CHROMATOGR A, V776, P109, DOI 10.1016/S0021-9673(97)00560-8; He C, 1996, ELECTROPHORESIS, V17, P617, DOI 10.1002/elps.1150170334; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jirsa M, 2001, FRONT BIOSCI-LANDMRK, V6, pE154, DOI 10.2741/Jirsa; Keulemans YCA, 1998, HEPATOLOGY, V28, P11, DOI 10.1002/hep.510280103; KIBE A, 1984, SCIENCE, V225, P514, DOI 10.1126/science.6429856; Kristiansen TZ, 2004, MOL CELL PROTEOMICS, V3, P715, DOI 10.1074/mcp.M400015-MCP200; Marschall HU, 2007, J INTERN MED, V261, P529, DOI 10.1111/j.1365-2796.2007.01783.x; Maurer KJ, 2009, GASTROENTEROLOGY, V136, P425, DOI 10.1053/j.gastro.2008.12.031; Miquel JF, 2001, HEPATOLOGY, V33, P328, DOI 10.1053/jhep.2001.21550; MIQUEL JF, 1992, CLIN SCI, V82, P175, DOI 10.1042/cs0820175; Miquel JF, 1998, GASTROENTEROLOGY, V114, P1016, DOI 10.1016/S0016-5085(98)70322-1; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Moschetta A, 2001, BBA-MOL CELL BIOL L, V1532, P15, DOI 10.1016/S1388-1981(01)00110-X; OLEARY DP, 1995, J HEPATOL, V22, P239, DOI 10.1016/0168-8278(95)80435-8; Portincasa P, 2002, J LIPID RES, V43, P604; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; SOMJEN GJ, 1985, J LIPID RES, V26, P699; STRASBERG SM, 1990, HEPATOLOGY, V12, pS176; Venneman NG, 2004, EUR J CLIN INVEST, V34, P656, DOI 10.1111/j.1365-2362.2004.01409.x; Wang DQH, 1999, J LIPID RES, V40, P415; Wang HH, 2010, BBA-MOL CELL BIOL L, V1801, P138, DOI 10.1016/j.bbalip.2009.10.003; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Xu ZB, 2007, PROTEOMICS, V7, P2358, DOI 10.1002/pmic.200600041; YAMASHITA G, 1995, J LIPID RES, V36, P1325; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006; Yuet PK, 1996, HEPATOLOGY, V23, P896, DOI 10.1053/jhep.1996.v23.pm0008666347; Zhou H, 2005, RAPID COMMUN MASS SP, V19, P3569, DOI [10.1002/rcm.2207, 10.1007/rcm.2207]	39	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54489	10.1371/journal.pone.0054489	http://dx.doi.org/10.1371/journal.pone.0054489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349907	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900071
J	Zhang, Q; Zhou, C; Zhang, Q; Qian, HF; Liu, WP; Zhao, MR				Zhang, Qiong; Zhou, Cong; Zhang, Quan; Qian, Haifeng; Liu, Weiping; Zhao, Meirong			Stereoselective Phytotoxicity of HCH Mediated by Photosynthetic and Antioxidant Defense Systems in Arabidopsis thaliana	PLOS ONE			English	Article							OXIDATIVE STRESS; DELTA-HEXACHLOROCYCLOHEXANE; BETA-HEXACHLOROCYCLOHEXANE; SUPEROXIDE-DISMUTASE; ELECTRON-TRANSPORT; PHOTOSYSTEM-I; OXYGEN; SOIL; DDT; INHIBITION	Background: Hexachlorocyclohexane (HCH) has been used for plant protection and sanitation world-widely, and its isomers have been detected in water, soil, and air as well as in vegetation. As a sink for lipophilic pollutants, vegetation is very important for the degradation and fate of organic contamination; however, little was known about their phytotoxicity and mechanisms of toxic effect. In this study, the stereoselective phototoxicity of four isomers (alpha, beta, gamma, and delta) of HCHs mediated by independent as well as interconnecting systems of photosynthesis and enzymatic antioxidant defense system in Arabidopsis thaliana were assessed. Principal Findings: Our results revealed that all the HCHs not only stimulated the activities of catalase (CAT) and peroxidase (POD), but also inhibited the activity of superoxide dismutase (SOD). In photosynthesis system, the photosynthetic efficiency of PSI and PSII were all down regulated. Meanwhile, results from both systems showed that delta-HCH was the most toxic one, while alpha-HCH the least in Arabidopsis thaliana. Conclusions: For the first time, stereoselective effects of different isomers of HCH in plant were demonstrated. And the results suggest that it requires further research to fully elucidate the environmental toxicity and their mechanisms.	[Zhang, Qiong; Zhou, Cong; Zhang, Quan; Qian, Haifeng; Zhao, Meirong] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China; [Zhang, Quan; Liu, Weiping] Zhejiang Univ, Inst Environm Sci, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University of Technology; Zhejiang University	Liu, WP (corresponding author), Zhejiang Univ, Inst Environm Sci, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	wliu@zju.edu.cn; zhaomr@zjut.edu.cn	Liu, Weiping/E-9208-2010; Qian, Haifeng/A-7791-2012	Liu, Weiping/0000-0002-1173-892X; Qian, Haifeng/0000-0003-0807-9991	National Basic Research Program of China [2009CB421603]; Zhejiang Provincial Natural Science Foundation of China [LR12B07002]; National Natural Science Foundation of China [20837002]	National Basic Research Program of China(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (No. 2009CB421603), the Zhejiang Provincial Natural Science Foundation of China (LR12B07002) and the National Natural Science Foundation of China (No. 20837002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews J, 2000, PLANT CELL ENVIRON, V23, P415, DOI 10.1046/j.1365-3040.2000.00555.x; Anilakumar KR, 2006, PLANT FOOD HUM NUTR, V61, P169, DOI 10.1007/s11130-006-0027-3; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Babu GS, 2003, WATER AIR SOIL POLL, V144, P149, DOI 10.1023/A:1022929502510; BARRIE LA, 1992, SCI TOTAL ENVIRON, V122, P1, DOI 10.1016/0048-9697(92)90245-N; Bchanan BB, 2004, BIOCH MOL BIOL PLANT, P976; Bidlan R, 2004, CHEMOSPHERE, V56, P803, DOI 10.1016/j.chemosphere.2004.01.015; Bigsby RM, 1997, CANCER RES, V57, P865; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Pereira RC, 2006, ENVIRON POLLUT, V144, P210, DOI 10.1016/j.envpol.2005.12.030; Pereira RC, 2010, CHEMOSPHERE, V79, P326, DOI 10.1016/j.chemosphere.2010.01.035; del Rio LA, 1998, PLANT PHYSIOL, V116, P1195, DOI 10.1104/pp.116.4.1195; DeLorenzo ME, 2001, ENVIRON TOXICOL CHEM, V20, P84, DOI [10.1897/1551-5028(2001)020&lt;0084:TOPTAM&gt;2.0.CO;2, 10.1002/etc.5620200108]; Erhard P., 2008, PAM APPL NOTES, V1, P21; Feng K, 2004, ENVIRON GEOCHEM HLTH, V26, P253, DOI 10.1023/B:EGAH.0000039588.10092.37; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Gao S, 2011, PLANT CELL PHYSIOL, V52, P885, DOI 10.1093/pcp/pcr038; Golding AJ, 2003, PLANTA, V218, P107, DOI 10.1007/s00425-003-1077-5; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Huang W, 2010, PHOTOSYNTH RES, V103, P175, DOI 10.1007/s11120-010-9539-7; Kim SJ, 2001, PLANT CELL PHYSIOL, V42, P842, DOI 10.1093/pcp/pce109; KLUGHAMMER C, 1994, PLANTA, V192, P261, DOI 10.1007/BF01089043; Klughammer C., 2008, PAM APP NOTES, V1, P11, DOI DOI 10.1007/S00415-017-8571-3; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Kumar M, 2005, ENVIRON SCI TECHNOL, V39, P4005, DOI 10.1021/es048497q; Li YF, 1999, SCI TOTAL ENVIRON, V232, P121, DOI 10.1016/S0048-9697(99)00114-X; LINDENAU A, 1994, HUM REPROD, V9, P772, DOI 10.1093/oxfordjournals.humrep.a138595; Lu Y, 2010, BIOMED ENVIRON SCI, V23, P230, DOI 10.1016/S0895-3988(10)60057-8; Marco JAM, 2007, CHEMOSPHERE, V68, P832, DOI 10.1016/j.chemosphere.2007.02.026; Nagata K, 1996, BRAIN RES, V738, P131, DOI 10.1016/0006-8993(96)00775-5; Niewiadomska E, 2011, PLANTA, V233, P275, DOI 10.1007/s00425-010-1302-y; Ott T, 1999, PLANTA, V209, P250, DOI 10.1007/s004250050629; PATERSON S, 1994, ENVIRON SCI TECHNOL, V28, P2259, DOI 10.1021/es00062a009; PATTICHIS K, 1994, ANAL BIOCHEM, V221, P428, DOI 10.1006/abio.1994.1441; POMES A, 1993, DEV BRAIN RES, V73, P85, DOI 10.1016/0165-3806(93)90049-G; Ricking M, 2008, ENVIRON CHEM LETT, V6, P83, DOI 10.1007/s10311-007-0104-3; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1135, DOI 10.1111/j.1365-3040.2004.01219.x; Rugh CL, 2004, TRENDS BIOTECHNOL, V22, P496, DOI 10.1016/j.tibtech.2004.08.003; SAFE S, 1992, ENVIRON SCI TECHNOL, V26, P394, DOI 10.1021/es00026a023; Samanta L, 1999, ARCH TOXICOL, V73, P96, DOI 10.1007/s002040050593; SIMONICH SL, 1995, ENVIRON SCI TECHNOL, V29, P2905, DOI 10.1021/es00012a004; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Srivastava A, 2006, MOL CELL BIOCHEM, V286, P87, DOI 10.1007/s11010-005-9096-0; Srivastava A, 2010, CHEM-BIOL INTERACT, V183, P34, DOI 10.1016/j.cbi.2009.09.026; SUNDERMAN FW, 1985, ANN CLIN LAB SCI, V15, P229; Van Aken B, 2010, ENVIRON SCI TECHNOL, V44, P2767, DOI 10.1021/es902514d; Waliszewski SM, 2008, B ENVIRON CONTAM TOX, V81, P343, DOI 10.1007/s00128-008-9484-8; Wieczorek JK, 2007, ECOTOX ENVIRON SAFE, V66, P369, DOI 10.1016/j.ecoenv.2005.10.002; Willett KL, 1998, ENVIRON SCI TECHNOL, V32, P2197, DOI 10.1021/es9708530	51	9	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e51043	10.1371/journal.pone.0051043	http://dx.doi.org/10.1371/journal.pone.0051043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349669	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900001
J	Guan, Y; Du, QA; Zhu, W; Zou, C; Wu, D; Chen, L; Zhang, YA				Guan, Yunqian; Du, Qing-An; Zhu, Wanwan; Zou, Chunlin; Wu, Di; Chen, Ling; Zhang, Yu Alex			Function of Mouse Embryonic Stem Cell-Derived Supporting Cells in Neural Progenitor Cell Maturation and Long Term Cxpansion	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; ES CELLS; TERATOMA FORMATION; RAT MODEL; IN-VITRO; DIFFERENTIATION; TRANSPLANTATION; MIDBRAIN	Background: In the differentiation of mouse embryonic stem (ES) cells into neurons using the 5-stage method, cells in stage 4 are in general used as neural progenitors (NPs) because of their ability to give rise to neurons. The choice of stage 4 raises several questions about neural progenitors such as the type of cell types that are specifically considered to be neural progenitors, the exact time when these progenitors become capable of neurogenesis and whether neurogenesis is an independent and autonomous process or the result of an interaction between NP cells and the surrounding cells. Methodology/Principal Findings: In this study, we found that the confluent monolayer cells and neural sphere like cell clusters both appeared in the culture of the first 14 days and the subsequent 6 weeks. However, only the sphere cells are neural progenitors that give rise to neurons and astrocytes. The NP cells require 14 days to mature into neural lineages fully capable of differentiation. We also found that although the confluent monolayer cells do not undergo neurogenesis, they play a crucial role in the growth, differentiation, and apoptosis of the sphere cells, during the first 14 days and long term culture, by secreted factors and direct cell to cell contact. Conclusions/Significance: The sphere cells in stage 4 are more committed to developing into neural progenitors than monolayer cells. Interaction between the monolayer cells and sphere cells is important in the development of stage 4 cell characteristics.	[Guan, Yunqian; Du, Qing-An; Zhu, Wanwan; Zou, Chunlin; Wu, Di; Zhang, Yu Alex] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Cell Therapy Ctr, Beijing, Peoples R China; [Chen, Ling] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Chen, L (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China.	chlyz34@163.com; yaz@bjsap.org		ZOU, CHUNLIN/0000-0002-3308-5544	High Level Talent Fund of the Beijing Healthcare System [2009-2-14, 2011-3-093]; National Science Foundation of China [81272804, 30940039, 30970939]; National Science Foundation of Beijing [7102078]; Beijing Nova Program of Science and Technology [2009B22]; Youth Foundation of Capital Medical University; Science Foundation of the Ministry of Education in China [11120066]; Key Project of Chinese Ministry of Education [210003]	High Level Talent Fund of the Beijing Healthcare System; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Beijing; Beijing Nova Program of Science and Technology; Youth Foundation of Capital Medical University; Science Foundation of the Ministry of Education in China(Ministry of Education, China); Key Project of Chinese Ministry of Education(Ministry of Education, China)	This work was supported by a research grant from the High Level Talent Fund of the Beijing Healthcare System (Grant No: 2009-2-14, 2011-3-093), National Science Foundation of China (Grant No. 81272804; 30940039; 30970939), National Science Foundation of Beijing (Grant No. 7102078), Beijing Nova Program of Science and Technology (Grant No. 2009B22), Youth Foundation of Capital Medical University and Science Foundation of the Ministry of Education in China (Grant No. 11120066) and Key Project of Chinese Ministry of Education (Grant No. 210003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Boonman Z, 1999, EXP NEUROL, V156, P1, DOI 10.1006/exnr.1999.7056; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Brignier AC, 2010, J ALLERGY CLIN IMMUN, V125, pS336, DOI 10.1016/j.jaci.2009.09.032; Brustle O, 1996, CURR OPIN NEUROBIOL, V6, P688, DOI 10.1016/S0959-4388(96)80104-8; Buhnemann C, 2006, BRAIN, V129, P3238, DOI 10.1093/brain/awl261; Caldero J, 1998, J NEUROSCI, V18, P356; Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558; Chung S, 2011, P NATL ACAD SCI USA, V108, P9703, DOI 10.1073/pnas.1016443108; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Doi D, 2012, STEM CELLS, V30, P935, DOI 10.1002/stem.1060; Du QA, 2011, NEUROSCI LETT, V504, P285, DOI 10.1016/j.neulet.2011.09.048; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Hayashi MAF, 2010, TISSUE ENG PART C-ME, V16, P1493, DOI [10.1089/ten.tec.2009.0788, 10.1089/ten.TEC.2009.0788]; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Ringden O, 2003, TRANSPLANTATION, V76, P1011, DOI 10.1097/01.TP.0000090343.52309.CF; Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Solozobova V, 2012, STEM CELL REV REP, V8, P813, DOI 10.1007/s12015-012-9381-8; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Swistowska AM, 2010, STEM CELLS DEV, V19, P71, DOI 10.1089/scd.2009.0107; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vazin T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006606; Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	36	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54332	10.1371/journal.pone.0054332	http://dx.doi.org/10.1371/journal.pone.0054332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342136	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400151
J	Vermeulen, N				Vermeulen, Niki			From Darwin to the Census of Marine Life: Marine Biology as Big Science	PLOS ONE			English	Review								With the development of the Human Genome Project, a heated debate emerged on biology becoming 'big science'. However, biology already has a long tradition of collaboration, as natural historians were part of the first collective scientific efforts: exploring the variety of life on earth. Such mappings of life still continue today, and if field biology is gradually becoming an important subject of studies into big science, research into life in the world's oceans is not taken into account yet. This paper therefore explores marine biology as big science, presenting the historical development of marine research towards the international 'Census of Marine Life' (CoML) making an inventory of life in the world's oceans. Discussing various aspects of collaboration - including size, internationalisation, research practice, technological developments, application, and public communication - I will ask if CoML still resembles traditional collaborations to collect life. While showing both continuity and change, I will argue that marine biology is a form of natural history: a specific way of working together in biology that has transformed substantially in interaction with recent developments in the life sciences and society. As a result, the paper does not only give an overview of transformations towards large scale research in marine biology, but also shines a new light on big biology, suggesting new ways to deepen the understanding of collaboration in the life sciences by distinguishing between different 'collective ways of knowing'.	Univ Manchester, Ctr Hist Sci Technol & Med, Manchester, Lancs, England	University of Manchester	Vermeulen, N (corresponding author), Univ Manchester, Ctr Hist Sci Technol & Med, Manchester, Lancs, England.	niki.vermeulen@manchester.ac.uk		Vermeulen, Niki/0000-0001-8080-855X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The Wellcome Trust provided the funds to make this publication open-access. No other external funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, COMMUNICATION; Appleby P. Henson, 1945, BIG DEMOCRACY; Aronova E, 2010, HIST STUD NAT SCI, V40, P183, DOI 10.1525/hsns.2010.40.2.183; Ausubel J, 1997, CENSUS FISHES CONCEP; Ausubel J.H., 1999, OCEANOGRAPHY, V12, P4, DOI [10.5670/oceanog.1999.17, DOI 10.5670/OCEANOG.1999.17]; Ballard Robert D., 2000, ETERNAL DARKNESS PER; Barker R., 1964, BIG SCH SMALL SCH; Berman M., 1983, ALL IS SOLID MELTS A; Bocking, 1997, ECOLOGISTENV POLIT; Bowker GC, 2006, MEMORY PRACTICES SCI; CAPSHEW JH, 1992, OSIRIS, V7, P3, DOI 10.1086/368703; Check E, 2004, NATURE, V432, P546, DOI 10.1038/432546a; Darwin C, 1859, ORIGIN SPECIES MEANS; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; de Solla Price Derek J., 1986, LITTLE SCI BIG SCI; Drucker Peter Ferdinand, 1947, BIG BUSINESS; Dunbar MJ, 1971, GEOGR REV, V61, P161; Fernandez-Armesto Felipe, 2006, PATHFINDERS GLOBAL H; Galison Peter, 1992, BIG SCI GROWTH LARGE; Garfield Eugene, 1984, ESSAYS INFORM SCI, P213; Grassle JF, 1999, OCEANOGRAPHY, V12, P12, DOI [DOI 10.5670/, 10.5670/oceanog.1999.03, DOI 10.5670/OCEANOG.1999.03]; Hackett EJ, 2005, SOC STUD SCI, V35, P667, DOI 10.1177/0306312705057569; Heip C, 2006, COMMUNICATION; Hendrick B. J., 2002, AGE BIG BUSINESS CHR, V39; Hine C, 2006, SOC STUD SCI, V36, P269, DOI 10.1177/0306312706054047; Holmes B, 2004, NEW SCI, P31; Jungk Robert, 1968, BIG MACHINE; Kohler Robert E., 2002, LANDSCAPES LABSCAPES, P134; Kunzig R., 2000, MAPPING DEEP EXTRAOR; KWA C, 1987, SOC STUD SCI, V17, P413, DOI 10.1177/030631287017003002; Lamarck J. B., 1809, ZOOLOGICAL PHILOS EX; Lambright WH, 1998, PUBLIC ADMIN REV, V58, P259, DOI 10.2307/976566; Leslie M, 2002, SCIENCE, V298, P1685; MAIENSCHEIN J, 1993, J HIST BIOL, V26, P167, DOI 10.1007/BF01061964; McIntyre AD, 2005, MAR POLLUT BULL, V50, P791, DOI 10.1016/j.marpolbul.2005.05.012; Menard JW, 1969, OCEANIC QUEST INT DE; Nielsen WaldemarA., 1972, BIG FDN; Oreskes N, 2003, SOC STUD SCI, V33, P697, DOI 10.1177/0306312703335004; Parker J.N., 2010, COLLABORATION NEW LI; Pickstone J. V., 2000, WAYS KNOWING NEW HIS; Pierrot-Bults A, 2007, COMMUNICATION; Pusey MJ, 1945, BIG GOVERNMENT CAN W; Rip A, 2001, FUTURE SCI HUMANITIE; Roberts L, 2001, SCIENCE, V291, P1182; Rogers David, 1971, MANAGEMENT BIG CITIE; Schloegel Judith Johns, 2005, ECOLOGY ENV BIG SCI; Shrum W, 2007, STRUCTURES SCI COLLA; Sibuet M, 2006, COMMUNICATION; Sinclair M, 2006, COMMUNICATION; Snelgrove P, 1997, OCEANUS INT MAGAZINE, V38, P29; Stoeckle M, 2003, CENSUS MARINE DNA BA; Theberge A, 2006, HIST OCEAN EXPLORATI; Vermeulen N, 2010, EMBO REP, V11, P420, DOI 10.1038/embor.2010.67; Vermeulen Niki, 2009, SUPERSIZING SCI BUIL; Verne J, 1870, VINGT MILLE LIEUES M; Weinberg A. M., 1967, REFLECTIONS BIG SCI; Williams MJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000531; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	58	12	12	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54284	10.1371/journal.pone.0054284	http://dx.doi.org/10.1371/journal.pone.0054284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342119	Green Published, gold			2022-12-27	WOS:000314759400140
J	Real, R; Romero, D; Olivero, J; Estrada, A; Marquez, AL				Real, Raimundo; Romero, David; Olivero, Jesus; Estrada, Alba; Marquez, Ana L.			Estimating How Inflated or Obscured Effects of Climate Affect Forecasted Species Distribution	PLOS ONE			English	Article							DISTRIBUTION MODELS; ENVELOPE MODELS; GLOBAL CHANGE; RICHNESS; UNCERTAINTY; IMPACTS; SHIFT; PREDICTIONS; SCENARIOS; ABUNDANCE	Climate is one of the main drivers of species distribution. However, as different environmental factors tend to co-vary, the effect of climate cannot be taken at face value, as it may be either inflated or obscured by other correlated factors. We used the favourability models of four species (Alytes dickhilleni, Vipera latasti, Aquila fasciata and Capra pyrenaica) inhabiting Spanish mountains as case studies to evaluate the relative contribution of climate in their forecasted favourability by using variation partitioning and weighting the effect of climate in relation to non-climatic factors. By calculating the pure effect of the climatic factor, the pure effects of non-climatic factors, the shared climatic effect and the proportion of the pure effect of the climatic factor in relation to its apparent effect (rho), we assessed the apparent effect and the pure independent effect of climate. We then projected both types of effects when modelling the future favourability for each species and combination of AOGCM-SRES (two Atmosphere-Ocean General Circulation Models: CGCM2 and ECHAM4, and two Special Reports on Emission Scenarios (SRES): A2 and B2). The results show that the apparent effect of climate can be either inflated (overrated) or obscured (underrated) by other correlated factors. These differences were species-specific; the sum of favourable areas forecasted according to the pure climatic effect differed from that forecasted according to the apparent climatic effect by about 61% on average for one of the species analyzed, and by about 20% on average for each of the other species. The pure effect of future climate on species distributions can only be estimated by combining climate with other factors. Transferring the pure climatic effect and the apparent climatic effect to the future delimits the maximum and minimum favourable areas forecasted for each species in each climate change scenario.	[Real, Raimundo; Romero, David; Olivero, Jesus; Marquez, Ana L.] Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain; [Estrada, Alba] CSIC UCLM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain	Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Marquez, AL (corresponding author), Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain.	almarquez@uma.es	Real, Raimundo/E-6559-2010; Márquez, Ana Luz/K-8345-2014; Romero, David/H-7684-2015; Olivero, Jesús/K-8727-2014; ESTRADA, ALBA/A-9632-2018	Real, Raimundo/0000-0002-6642-1284; Márquez, Ana Luz/0000-0001-5586-9334; Romero, David/0000-0003-4540-6349; Olivero, Jesús/0000-0003-1714-0360; ESTRADA, ALBA/0000-0003-2727-1970	Ministerio de Ciencia e Innovacion of Spain; FEDER [CGL2009-11316/BOS]; Ministerio de Educacion y Ciencia [AP 2007-03633]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Ministerio de Educacion y Ciencia(Spanish Government)	The research was funded by the Ministerio de Ciencia e Innovacion of Spain and FEDER (project CGL2009-11316/BOS). D. Romero is a PhD student at the University of Malaga with a grant of the Ministerio de Educacion y Ciencia (AP 2007-03633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2012, GLOBAL CHANGE BIOL, V18, P1509, DOI 10.1111/j.1365-2486.2012.02655.x; Acevedo P, 2011, ECOL MODEL, V222, P814, DOI 10.1016/j.ecolmodel.2010.10.006; Aragon P, 2010, GLOBAL ECOL BIOGEOGR, V19, P40, DOI 10.1111/j.1466-8238.2009.00488.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Baer P, 2009, CLIMATIC CHANGE, V92, P31, DOI 10.1007/s10584-008-9529-3; Barbosa AM, 2010, CONSERV BIOL, V24, P1378, DOI 10.1111/j.1523-1739.2010.01517.x; Barbosa Ana Marcia, 2001, Diversity and Distributions, V7, P137, DOI 10.1046/j.1472-4642.2001.00104.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Borcard D, 1992, ECOLOGY, V87, P2614; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Dormann CF, 2008, ECOL LETT, V11, P235, DOI 10.1111/j.1461-0248.2007.01142.x; Dubey S, 2011, CLIMATIC CHANGE, V107, P531, DOI 10.1007/s10584-010-9963-x; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Galantinho A, 2009, ECOL RES, V24, P671, DOI 10.1007/s11284-008-0538-5; Garcia-Ortega E, 2007, ATMOS RES, V83, P225, DOI 10.1016/j.atmosres.2005.08.004; Gasner MR, 2010, BIOL CONSERV, V143, P1250, DOI 10.1016/j.biocon.2010.02.034; Godinho C, 2010, ECOL RES, V25, P283, DOI 10.1007/s11284-009-0655-9; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Jimenez-Valverde A, 2007, ECOL ENTOMOL, V32, P113, DOI 10.1111/j.1365-2311.2006.00848.x; Kharouba HM, 2009, ECOLOGY, V90, P2213, DOI 10.1890/08-1304.1; Klanderud K, 2003, HOLOCENE, V13, P1, DOI 10.1191/0959683603hl589ft; Lavergne S, 2005, J BIOGEOGR, V32, P799, DOI 10.1111/j.1365-2699.2005.01207.x; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Marquez AL, 2011, CLIMATIC CHANGE, V108, P135, DOI 10.1007/s10584-010-0010-8; Marquez AL, 2004, GLOBAL ECOL BIOGEOGR, V13, P295, DOI 10.1111/j.1466-822X.2004.00100.x; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Munoz-Diaz D, 2004, ANN GEOPHYS-GERMANY, V22, P1435, DOI 10.5194/angeo-22-1435-2004; Nielsen C, 2008, DIVERS DISTRIB, V14, P307, DOI 10.1111/j.1472-4642.2007.00456.x; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; PEREIRA JMC, 1991, PHOTOGRAMM ENG REM S, V57, P1475; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Randin CF, 2009, J VEG SCI, V20, P996, DOI 10.1111/j.1654-1103.2009.01098.x; Real R, 2008, DIVERS DISTRIB, V14, P364, DOI 10.1111/j.1472-4642.2007.00419.x; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Ritchie EG, 2009, J ANIM ECOL, V78, P724, DOI 10.1111/j.1365-2656.2008.01520.x; Rubidge EM, 2011, GLOBAL CHANGE BIOL, V17, P696, DOI 10.1111/j.1365-2486.2010.02297.x; Santos X, 2006, BIOL CONSERV, V130, P416, DOI 10.1016/j.biocon.2006.01.003; Stanton JC, 2012, METHODS ECOL EVOL, V3, P349, DOI 10.1111/j.2041-210X.2011.00157.x; Stefanescu C, 2004, J BIOGEOGR, V31, P905, DOI 10.1111/j.1365-2699.2004.01088.x; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; Trivino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029373; WallisDeVries MF, 2011, OECOLOGIA, V167, P559, DOI 10.1007/s00442-011-2007-z; Willis SG, 2009, ECOGRAPHY, V32, P5, DOI 10.1111/j.1600-0587.2008.05711.x; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	55	24	25	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53646	10.1371/journal.pone.0053646	http://dx.doi.org/10.1371/journal.pone.0053646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23349726	gold, Green Published			2022-12-27	WOS:000314705800066
J	Ambrosi, CM; Yamada, KA; Nerbonne, JM; Efimov, IR				Ambrosi, Christina M.; Yamada, Kathryn A.; Nerbonne, Jeanne M.; Efimov, Igor R.			Gender Differences in Electrophysiological Gene Expression in Failing and Non-Failing Human Hearts	PLOS ONE			English	Article							OUTWARD K+ CURRENT; HUMAN ATRIAL; CARDIAC-ARRHYTHMIAS; ION-CHANNEL; SEX-DIFFERENCES; RISK-FACTORS; FIBRILLATION; FAILURE; MECHANISMS; MOUSE	The increasing availability of human cardiac tissues for study are critically important in increasing our understanding of the impact of gender, age, and other parameters, such as medications and cardiac disease, on arrhythmia susceptibility. In this study, we aimed to compare the mRNA expression of 89 ion channel subunits, calcium handling proteins, and transcription factors important in cardiac conduction and arrhythmogenesis in the left atria (LA) and ventricles (LV) of failing and nonfailing human hearts of both genders. Total RNA samples, prepared from failing male (n = 9) and female (n = 7), and from nonfailing male (n = 9) and female (n = 9) hearts, were probed using custom-designed Taqman gene arrays. Analyses were performed to explore the relationships between gender, failure state, and chamber expression. Hierarchical cluster analysis revealed chamber specific expression patterns, but failed to identify disease-or gender-dependent clustering. Gender-specific analysis showed lower expression levels in transcripts encoding for K(v)4.3, KChIP2, K(v)1.5, and K(ir)3.1 in the failing female as compared with the male LA. Analysis of LV transcripts, however, did not reveal significant differences based on gender. Overall, our data highlight the differential expression and transcriptional remodeling of ion channel subunits in the human heart as a function of gender and cardiac disease. Furthermore, the availability of such data sets will allow for the development of disease-, gender-, and, most importantly, patient-specific cardiac models, with the ability to utilize such information as mRNA expression to predict cardiac phenotype.	[Ambrosi, Christina M.; Efimov, Igor R.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Yamada, Kathryn A.] Washington Univ Sch Med, Dept Med, St Louis, MO USA; [Nerbonne, Jeanne M.] Washington Univ Sch Med, Dept Dev Biol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Efimov, IR (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	igor@wustl.edu	Efimov, Igor/R-5544-2017; Efimov, Igor R/B-8040-2010; Efimov, Igor R./AAJ-3234-2021	Efimov, Igor/0000-0002-1483-5039; Efimov, Igor R/0000-0002-1483-5039; 	National Institutes of Health from the National Heart, Lung and Blood Institute [R01-HL114395, R01-HL085369]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085369, R01HL114395] Funding Source: NIH RePORTER	National Institutes of Health from the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by National Institutes of Health grants R01-HL114395 and R01-HL085369 from the National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Gerges N, 2004, FUND CLIN PHARMACOL, V18, P139, DOI 10.1111/j.1472-8206.2004.00230.x; Ahrens-Nicklas RC, 2009, BIOPHYS J, V97, P2684, DOI 10.1016/j.bpj.2009.09.002; Aiba T, 2010, CURR OPIN CARDIOL, V25, P29, DOI 10.1097/HCO.0b013e328333d3d6; Antzelevitch C, 2001, BASIC RES CARDIOL, V96, P517, DOI 10.1007/s003950170002; Antzelevitch C, 1999, J CARDIOVASC ELECTR, V10, P1124, DOI 10.1111/j.1540-8167.1999.tb00287.x; Antzelevitch C, 2007, HEART RHYTHM, V4, P964, DOI 10.1016/j.hrthm.2007.03.036; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Boheler KR, 2003, P NATL ACAD SCI USA, V100, P2754, DOI 10.1073/pnas.0436564100; Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Brandt MC, 2000, J MOL CELL CARDIOL, V32, P1885, DOI 10.1006/jmcc.2000.1221; Brundel BJJM, 2002, CARDIOVASC RES, V54, P315, DOI 10.1016/S0008-6363(02)00222-5; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Burke JH, 1996, AM J MED, V100, P537, DOI 10.1016/S0002-9343(96)00018-6; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Dhala A, 2002, CLIN CARDIOL, V25, P525, DOI 10.1002/clc.4960251109; Dobrev D, 2002, CARDIOVASC RES, V54, P397, DOI 10.1016/S0008-6363(01)00555-7; Ebert SN, 1998, J WOMENS HEALTH, V7, P547, DOI 10.1089/jwh.1998.7.547; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellinghaus P, 2005, J THORAC CARDIOV SUR, V129, P1383, DOI 10.1016/j.jtcvs.2004.08.031; Fedorov VV, 2011, J MOL CELL CARDIOL, V51, P215, DOI 10.1016/j.yjmcc.2011.04.016; Flagg TP, 2005, J MOL CELL CARDIOL, V39, P61, DOI 10.1016/j.yjmcc.2005.01.005; Gaborit N, 2005, CIRCULATION, V112, P471, DOI 10.1161/CIRCULATIONAHA.104.506857; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Gaborit N, 2010, J MOL CELL CARDIOL, V49, P639, DOI 10.1016/j.yjmcc.2010.06.005; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Glukhov AV, 2010, J MOL CELL CARDIOL, V48, P152, DOI 10.1016/j.yjmcc.2009.08.026; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gronich N, 2010, CHANNELS, V4, P101, DOI 10.4161/chan.4.2.10975; Hunt SA, 2005, J AM COLL CARDIOL, V46, P1; Iacobas DA, 2010, FUNCT INTEGR GENOMIC, V10, P73, DOI 10.1007/s10142-009-0137-8; James AF, 2007, PROG BIOPHYS MOL BIO, V94, P265, DOI 10.1016/j.pbiomolbio.2005.05.010; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; KANNEL WB, 1998, AM J CARDIOL, V0082; Kligfield P, 1996, J AM COLL CARDIOL, V28, P1547, DOI 10.1016/S0735-1097(96)00351-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locati EH, 1998, CIRCULATION, V97, P2237, DOI 10.1161/01.CIR.97.22.2237; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Nattel S, 2010, J MOL CELL CARDIOL, V48, P96, DOI 10.1016/j.yjmcc.2009.07.016; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Nerbonne JM, 2004, TRENDS CARDIOVAS MED, V14, P83, DOI 10.1016/j.tcm.2003.12.006; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Ramaekers D, 1998, EUR HEART J, V19, P1334, DOI 10.1053/euhj.1998.1084; Roden DM, 1999, CARDIOVASC RES, V42, P318, DOI 10.1016/S0008-6363(99)00063-2; Shanmugam M, 2011, BIOCHEM BIOPH RES CO, V410, P97, DOI 10.1016/j.bbrc.2011.05.113; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Tellez J, 2011, EXP PHYSL; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Van Wagoner DR, 2003, PACE, V26, P1572; VanWagoner DR, 1997, CIRC RES, V80, P772; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wolbrette D, 2002, CLIN CARDIOL, V25, P49, DOI 10.1002/clc.4950250203; Workman AJ, 2008, HEART RHYTHM, V5, pS1, DOI 10.1016/j.hrthm.2008.01.016; Workman AJ, 2010, N-S ARCH PHARMACOL, V381, P235, DOI 10.1007/s00210-009-0474-0; Yue LX, 1997, CIRC RES, V81, P512, DOI 10.1161/01.RES.81.4.512; Zicha S, 2004, J PHYSIOL-LONDON, V561, P735, DOI 10.1113/jphysiol.2004.075861	60	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54635	10.1371/journal.pone.0054635	http://dx.doi.org/10.1371/journal.pone.0054635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355885	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500099
J	Armbrecht, AS; Gibbons, H; Stahl, J				Armbrecht, Anne-Simone; Gibbons, Henning; Stahl, Jutta			Effects of Response Force Parameters on Medial-Frontal Negativity	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; ERROR-RELATED NEGATIVITY; MOTOR CONTROL; PRODUCTION TASK; COGNITIVE CONTROL; BRAIN POTENTIALS; CORRECT TRIALS; ERP COMPONENTS; NEURAL SYSTEM; PEAK FORCE	The response-related medial-frontal activity (MFN) is often supposed to reflect action-monitoring and error-processing activity. The present force-production task was designed to investigate the effects of two response parameters (i.e., peak response force and time-to-peak, TTP) on the MFN separately. In a 2 x 2 design (high vs. low target force and short vs. long TTP), 22 participants had to produce isometric force pulses to match one of four conditions (e.g., a high target force with a long TTP). Significant main effects of both target force and target TTP were revealed. As previously shown, the MFN amplitude was higher in the high target-force condition than in the low target-force condition. Contrary to the initial expectations, a long TTP had the effect of reducing the MFN amplitude. There was no error-specific effect on the MFN. The force-unit monitoring model (FUMM) is suggested to account for the force-and TTP-specific variations of MFN amplitude, latency and slope.	[Armbrecht, Anne-Simone; Stahl, Jutta] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany; [Gibbons, Henning] Univ Bonn, Inst Psychol, Bonn, Germany	University of Cologne; University of Bonn	Stahl, J (corresponding author), Univ Cologne, Dept Psychol, D-50931 Cologne, Germany.	jutta.stahl@uni-koeln.de		Stahl, Jutta/0000-0002-3252-180X	Deutsche Forschungsgemeinschaft (German Research Foundation) [STA 1035/2]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (German Research Foundation; STA 1035/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain S, 2004, CLIN NEUROPHYSIOL, V115, P2014, DOI 10.1016/j.clinph.2004.04.013; Allain S, 2004, PSYCHOPHYSIOLOGY, V41, P113, DOI 10.1111/j.1469-8986.2003.00136.x; Armbrecht AS, 2012, PSYCHOPHYSIOLOGY, V49, P56, DOI 10.1111/j.1469-8986.2011.01282.x; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Botzel K, 1997, EXP BRAIN RES, V114, P352, DOI 10.1007/PL00005643; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; de Bruijn ERA, 2003, PSYCHOPHYSIOLOGY, V40, P786, DOI 10.1111/1469-8986.00079; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Gallea C, 2008, BEHAV BRAIN RES, V193, P117, DOI 10.1016/j.bbr.2008.05.014; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; KANTOWITZ BH, 1973, J EXP PSYCHOL, V100, P302, DOI 10.1037/h0035780; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kristeva R, 1980, PROGR BRAIN RES, V54, P177; Maier M, 2008, J COGNITIVE NEUROSCI, V20, P2263, DOI 10.1162/jocn.2008.20159; Masaki H, 1998, EVOKED POTENTIAL, V108, P390, DOI 10.1016/S0168-5597(98)00019-7; Mattes S, 1997, PERCEPT PSYCHOPHYS, V59, P1089, DOI 10.3758/BF03205523; Mattes S, 1997, Q J EXP PSYCHOL-A, V50, P405, DOI 10.1080/027249897392152; NEWELL KM, 1985, J MOTOR BEHAV, V17, P230; NEWELL KM, 1988, J EXP PSYCHOL HUMAN, V14, P37; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; PERNIER J, 1988, ELECTROEN CLIN NEURO, V69, P385, DOI 10.1016/0013-4694(88)90009-0; PERRIN F, 1987, IEEE T BIO-MED ENG, V34, P283, DOI 10.1109/TBME.1987.326089; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; RABBITT P, 1978, ERGONOMICS, V21, P945, DOI 10.1080/00140137808931800; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rinkenauer G, 2001, J EXP PSYCHOL HUMAN, V27, P1485, DOI 10.1037/0096-1523.27.6.1485; Roger C, 2010, NEUROIMAGE, V51, P391, DOI 10.1016/j.neuroimage.2010.02.005; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Scheffers MK, 1996, PSYCHOPHYSIOLOGY, V33, P42, DOI 10.1111/j.1469-8986.1996.tb02107.x; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Slobounov SM, 1998, PSYCHOPHYSIOLOGY, V35, P537, DOI 10.1017/S0048577298970342; SOMMER W, 1994, PSYCHOPHYSIOLOGY, V31, P503, DOI 10.1111/j.1469-8986.1994.tb01054.x; Stahl J, 2005, ACTA PSYCHOL, V120, P1, DOI 10.1016/j.actpsy.2005.02.003; Stahl J, 2010, INT J PSYCHOPHYSIOL, V77, P43, DOI 10.1016/j.ijpsycho.2010.04.005; Stahl J, 2010, PSYCHOPHYSIOLOGY, V47, P43, DOI 10.1111/j.1469-8986.2009.00878.x; Suzuki K, 2011, NEUROREPORT, V22, P902, DOI 10.1097/WNR.0b013e32834cd736; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; ULRICH R, 1991, PSYCHOL REV, V98, P268, DOI 10.1037/0033-295X.98.2.268; ULRICH R, 1995, J EXP PSYCHOL HUMAN, V21, P1457, DOI 10.1037/0096-1523.21.6.1457; VANGALEN GP, 1995, HUM MOVEMENT SCI, V14, P539, DOI 10.1016/0167-9457(95)00027-3; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a	60	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54681	10.1371/journal.pone.0054681	http://dx.doi.org/10.1371/journal.pone.0054681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349950	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100090
J	Jones, MC; Dye, SR; Fernandes, JA; Frolicher, TL; Pinnegar, JK; Warren, R; Cheung, WWL				Jones, Miranda C.; Dye, Stephen R.; Fernandes, Jose A.; Froelicher, Thomas L.; Pinnegar, John K.; Warren, Rachel; Cheung, William W. L.			Predicting the Impact of Climate Change on Threatened Species in UK Waters	PLOS ONE			English	Article							POTENTIAL IMPACTS; FISH ASSEMBLAGE; MARINE FISHES; DISTRIBUTIONS; MODELS; AREAS; PROJECTIONS; FUTURE; SHIFTS; SCALE	Global climate change is affecting the distribution of marine species and is thought to represent a threat to biodiversity. Previous studies project expansion of species range for some species and local extinction elsewhere under climate change. Such range shifts raise concern for species whose long-term persistence is already threatened by other human disturbances such as fishing. However, few studies have attempted to assess the effects of future climate change on threatened vertebrate marine species using a multi-model approach. There has also been a recent surge of interest in climate change impacts on protected areas. This study applies three species distribution models and two sets of climate model projections to explore the potential impacts of climate change on marine species by 2050. A set of species in the North Sea, including seven threatened and ten major commercial species were used as a case study. Changes in habitat suitability in selected candidate protected areas around the UK under future climatic scenarios were assessed for these species. Moreover, change in the degree of overlap between commercial and threatened species ranges was calculated as a proxy of the potential threat posed by overfishing through bycatch. The ensemble projections suggest northward shifts in species at an average rate of 27 km per decade, resulting in small average changes in range overlap between threatened and commercially exploited species. Furthermore, the adverse consequences of climate change on the habitat suitability of protected areas were projected to be small. Although the models show large variation in the predicted consequences of climate change, the multi-model approach helps identify the potential risk of increased exposure to human stressors of critically endangered species such as common skate (Dipturus batis) and angelshark (Squatina squatina).	[Jones, Miranda C.; Fernandes, Jose A.; Warren, Rachel] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Jones, Miranda C.; Dye, Stephen R.; Pinnegar, John K.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Jones, Miranda C.; Warren, Rachel] Tyndall Ctr Climate Change Res, Norwich, Norfolk, England; [Froelicher, Thomas L.] Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; [Cheung, William W. L.] Univ British Columbia, Fisheries Ctr, Changing Ocean Res Unit, Vancouver, BC V5Z 1M9, Canada	University of East Anglia; Centre for Environment Fisheries & Aquaculture Science; University of East Anglia; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; University of British Columbia	Jones, MC (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.	miranda.jones@uea.ac.uk	Dye, Stephen R/C-9456-2011; Salvador, Jose Antonio Fernandes/AAH-7939-2019; Frölicher, Thomas L/E-5137-2015; Pinnegar, John K/C-4400-2012; Cheung, William/F-5104-2013; Froelicher, Thomas/AAG-9598-2019	Dye, Stephen R/0000-0002-4182-8475; Salvador, Jose Antonio Fernandes/0000-0003-4677-6077; Frölicher, Thomas L/0000-0003-2348-7854; Cheung, William/0000-0003-3626-1045; Froelicher, Thomas/0000-0003-2348-7854; Warren, Rachel/0000-0002-0122-1599; Pinnegar, John/0000-0001-5061-9520	UK Department for Environment, Food and Rural Affairs (DEFRA)/Centre for Environment, Fisheries and Aquaculture Science (CEFAS) [ME5102-ACME]; National Geographic Society; Natural Sciences and Engineering Research Council of Canada; NF-UBC Nereus Program; European project EURO-BASIN; EU; NERC [NE/F016107/1] Funding Source: UKRI; Natural Environment Research Council [NE/F016107/1] Funding Source: researchfish	UK Department for Environment, Food and Rural Affairs (DEFRA)/Centre for Environment, Fisheries and Aquaculture Science (CEFAS); National Geographic Society(National Geographic Society); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NF-UBC Nereus Program; European project EURO-BASIN; EU(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the UK Department for Environment, Food and Rural Affairs (DEFRA)/Centre for Environment, Fisheries and Aquaculture Science (CEFAS) under project ME5102-ACME. WWLC acknowledges funding support from the National Geographic Society and Natural Sciences and Engineering Research Council of Canada. The authors also thank the EU Vectors project for supporting time for JKP. TLF is partly supported by NF-UBC Nereus Program. JAF is funded by the European project EURO-BASIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy C, 2012, GLOBAL CHANGE BIOL, V18, P2995, DOI 10.1111/j.1365-2486.2012.02772.x; Almond S, 2011, UK SEA FISHERIES STA; [Anonymous], 1992, OFFICIAL J L, VL 206, P0007; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barange M, 2010, CURR OPIN ENV SUST, V2, P326, DOI 10.1016/j.cosust.2010.10.002; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; BRIG, 2007, REPORT ON THE SPECIE; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Cheung WWL, 2011, ICES J MAR SCI, V68, P1008, DOI 10.1093/icesjms/fsr012; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cheung WWL, 2005, BIOL CONSERV, V124, P97, DOI 10.1016/j.biocon.2005.01.017; Cheung WWL, 2008, FISHERIES CENTRE RES, V16; Cianfrani C, 2011, BIOL CONSERV, V144, P2068, DOI 10.1016/j.biocon.2011.03.027; Close Chris, 2006, University of British Columbia Fisheries Centre Research Reports, V14, P27; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Conroy MJ, 2011, BIOL CONSERV, V144, P1204, DOI 10.1016/j.biocon.2010.10.019; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; Dockerty T, 2003, GLOBAL ENVIRON CHANG, V13, P125, DOI 10.1016/S0959-3780(03)00010-4; Dulvy N, 2006, IUCN 2001 IUCN RED L; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Ellis J, 2009, IUCN 2001 IUCN RED L; Ellis J, 2005, IUCN 2001 IUCN RED L; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Froese R., 2011, FISHBASE WORLD WIDE; Fuller T, 2008, BIOL CONSERV, V141, P1547, DOI 10.1016/j.biocon.2008.03.021; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hagerman S, 2010, GLOBAL ENVIRON CHANG, V20, P192, DOI 10.1016/j.gloenvcha.2009.10.005; Harborne AR, 2011, CURR BIOL, V21, pR822, DOI 10.1016/j.cub.2011.08.043; Henderson PA, 2007, J MAR BIOL ASSOC UK, V87, P589, DOI 10.1017/S0025315407052447; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022873; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN, 2011, IUCN RED LIST OF THR; JNCC, 2012, MARINE SACS; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; LAWTON JH, 1994, PHILOS T ROY SOC B, V344, P61, DOI 10.1098/rstb.1994.0052; Lemieux CJ, 2011, LAND USE POLICY, V28, P928, DOI 10.1016/j.landusepol.2011.03.008; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MCEACHRAN JD, 1990, ELASMOBRANCHS LIVING, V90, P305; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; OSPAR, 2008, REFERENCE NUMBER 200; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Renkonen Olavi, 1938, ANN ZOOL SOC ZOOL BOT FENNICAE VANAMO, V6, P1; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rose NA, 2009, FOREST ECOL MANAG, V258, pS64, DOI 10.1016/j.foreco.2009.07.053; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P3593, DOI 10.5194/bg-7-3593-2010; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P759, DOI 10.1111/j.1365-2486.2006.01140.x; Toropova C., 2010, GLOBAL OCEAN PROTECT	78	93	94	2	244	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54216	10.1371/journal.pone.0054216	http://dx.doi.org/10.1371/journal.pone.0054216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349829	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000314019100051
J	Liu, SQ; Li, WS; Wu, YM; Chen, CM; Lei, JJ				Liu, Shaoqun; Li, Wanshun; Wu, Yimin; Chen, Changming; Lei, Jianjun			De Novo Transcriptome Assembly in Chili Pepper (Capsicum frutescens) to Identify Genes Involved in the Biosynthesis of Capsaicinoids	PLOS ONE			English	Article							PUNGENT PRINCIPLE; GENOME SEQUENCE; METABOLISM; MARKERS; FRUITS; PLACENTA; VARIETY; ANALOGS; RFLP; KAS	The capsaicinoids are a group of compounds produced by chili pepper fruits and are used widely in many fields, especially in medical purposes. The capsaicinoid biosynthetic pathway has not yet been established clearly. To understand more knowledge in biosynthesis of capsaicinoids, we applied RNA-seq for the mixture of placenta and pericarp of pungent pepper (Capsicum frutescens L.). We have assessed the effect of various assembly parameters using different assembly software, and obtained one of the best strategies for de novo assembly of transcriptome data. We obtained a total 54,045 high-quality unigenes (transcripts) using Trinity software. About 92.65% of unigenes showed similarity to the public protein sequences, genome of potato and tomato and pepper (C. annuum) ESTs databases. Our results predicted 3 new structural genes (DHAD, TD, PAT), which filled gaps of the capsaicinoid biosynthetic pathway predicted by Mazourek, and revealed new candidate genes involved in capsaicinoid biosynthesis based on KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis. A significant number of SSR (Simple Sequence Repeat) and SNP (Single Nucleotide Polymorphism) markers were predicted in C. frutescens and C. annuum sequences, which will be helpful in the identification of polymorphisms within chili pepper populations. These data will provide new insights to the pathway of capsaicinoid biosynthesis and subsequent research of chili peppers. In addition, our strategy of de novo transcriptome assembly is applicable to a wide range of similar studies.	[Liu, Shaoqun; Li, Wanshun; Wu, Yimin; Chen, Changming; Lei, Jianjun] S China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Lei, JJ (corresponding author), S China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China.	jjlei@scau.edu.cn			Natural Science Foundation of Guangdong Province [10151064201000056]; Principal Foundation of South China Agricultural University	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Principal Foundation of South China Agricultural University	This work was supported by the Natural Science Foundation of Guangdong Province (NO. 10151064201000056) and the Principal Foundation of South China Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru MR, 2003, J EXP BOT, V54, P1655, DOI 10.1093/jxb/erg176; Aza-Gonzalez C, 2011, PLANT CELL REP, V30, P695, DOI 10.1007/s00299-010-0968-8; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BENNETT DJ, 1968, J CHEM SOC C, P442, DOI 10.1039/j39680000442; Blum E, 2003, THEOR APPL GENET, V108, P79, DOI 10.1007/s00122-003-1405-y; CARMICHAEL JK, 1991, AM FAM PHYSICIAN, V44, P203; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Curry J, 1999, PLANT SCI, V148, P47, DOI 10.1016/S0168-9452(99)00118-1; Daood HG, 2002, J SUPERCRIT FLUID, V23, P143, DOI 10.1016/S0896-8446(02)00022-0; Abraham-Juarez MD, 2008, PLANTA, V227, P681, DOI 10.1007/s00425-007-0651-7; Deng MH, 2009, GENET RESOUR CROP EV, V56, P605, DOI 10.1007/s10722-009-9445-z; FUJIWAKE H, 1982, AGR BIOL CHEM TOKYO, V46, P2685, DOI 10.1080/00021369.1982.10865495; FUJIWAKE H, 1982, AGR BIOL CHEM TOKYO, V46, P2591, DOI 10.1080/00021369.1982.10865477; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gongora-Castillo E, 2012, BIOINFORMATION, V8, P43; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; HENRY CJK, 1986, HUM NUTR-CLIN NUTR, V40C, P165; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kim HJ, 2008, THEOR APPL GENET, V118, P15, DOI 10.1007/s00122-008-0873-5; Kim M, 2001, MOL CELLS, V11, P213; Lang YQ, 2006, BREEDING SCI, V56, P55, DOI 10.1270/jsbbs.56.55; Lee CJ, 2005, MOL CELLS, V19, P262; Lee HR, 2009, MOL CELLS, V27, P21, DOI 10.1007/s10059-009-0002-6; Lee R J, 1996, J Am Optom Assoc, V67, P548; LEETE E, 1968, J AM CHEM SOC, V90, P6837, DOI 10.1021/ja01026a049; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Lu FH, 2011, SCI HORTIC-AMSTERDAM, V129, P38, DOI 10.1016/j.scienta.2011.03.003; Luo XJ, 2011, EUR J PHARMACOL, V650, P1, DOI 10.1016/j.ejphar.2010.09.074; Malmstrom RR, 2010, PLOS ONE, P5; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mazourek M, 2009, PLANT PHYSIOL, V150, P1806, DOI 10.1104/pp.109.136549; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ochoa-Alejo N, 2001, IN VITRO CELL DEV-PL, V37, P701; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; SALGADOGARCIGLIA R, 1990, PLANT CELL REP, V8, P617, DOI 10.1007/BF00270067; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schulzeck S, 1997, SCHMERZ, V11, P345, DOI 10.1007/s004820050109; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Stewart C, 2005, PLANT J, V42, P675, DOI 10.1111/j.1365-313X.2005.02410.x; Stewart C, 2007, J EXP BOT, V58, P979, DOI 10.1093/jxb/erl243; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; SUKRASNO N, 1993, PHYTOCHEMISTRY, V32, P839, DOI 10.1016/0031-9422(93)85217-F; SUZUKI T, 1981, PLANT CELL PHYSIOL, V22, P23; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xue J, 2010, PLOS ONE, DOI [10.1371/journal.-pone.0014233, DOI 10.1371/JOURNAL.-PONE.0014233]; Yi GB, 2006, THEOR APPL GENET, V114, P113, DOI 10.1007/s00122-006-0415-y; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	53	103	113	2	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e48156	10.1371/journal.pone.0048156	http://dx.doi.org/10.1371/journal.pone.0048156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349661	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100003
J	Park, YM; Lee, WT; Bokara, KK; Seo, SK; Park, SH; Kim, JH; Yenari, MA; Park, KA; Eun, J				Park, Yu Mi; Lee, Won Taek; Bokara, Kiran Kumar; Seo, Su Kyoung; Park, Seung Hwa; Kim, Jae Hwan; Yenari, Midori A.; Park, Kyung Ah; Eun, Jong			The Multifaceted Effects of Agmatine on Functional Recovery after Spinal Cord Injury through Modulations of BMP-2/4/7 Expressions in Neurons and Glial Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; CLONIDINE-DISPLACING SUBSTANCE; PROGENITOR CELLS; BMP; DIFFERENTIATION; REMYELINATION; LOCOMOTION; PATHWAY; OLIGODENDROCYTES; PROLIFERATION	Presently, few treatments for spinal cord injury (SCI) are available and none have facilitated neural regeneration and/or significant functional improvement. Agmatine (Agm), a guanidinium compound formed from decarboxylation of L-arginine by arginine decarboxylase, is a neurotransmitter/neuromodulator and been reported to exert neuroprotective effects in central nervous system injury models including SCI. The purpose of this study was to demonstrate the multifaceted effects of Agm on functional recovery and remyelinating events following SCI. Compression SCI in mice was produced by placing a 15 g/mm(2) weight for 1 min at thoracic vertebra (Th) 9 segment. Mice that received an intraperitoneal (i.p.) injection of Agm (100 mg/kg/day) within 1 hour after SCI until 35 days showed improvement in locomotor recovery and bladder function. Emphasis was made on the analysis of remyelination events, neuronal cell preservation and ablation of glial scar area following SCI. Agm treatment significantly inhibited the demyelination events, neuronal loss and glial scar around the lesion site. In light of recent findings that expressions of bone morphogenetic proteins (BMPs) are modulated in the neuronal and glial cell population after SCI, we hypothesized whether Agm could modulate BMP- 2/4/7 expressions in neurons, astrocytes, oligodendrocytes and play key role in promoting the neuronal and glial cell survival in the injured spinal cord. The results from computer assisted stereological toolbox analysis (CAST) demonstrate that Agm treatment dramatically increased BMP-2/7 expressions in neurons and oligodendrocytes. On the other hand, BMP-4 expressions were significantly decreased in astrocytes and oligodendrocytes around the lesion site. Together, our results reveal that Agm treatment improved neurological and histological outcomes, induced oligodendrogenesis, protected neurons, and decreased glial scar formation through modulating the BMP-2/4/7 expressions following SCI.	[Park, Yu Mi; Lee, Won Taek; Bokara, Kiran Kumar; Seo, Su Kyoung; Kim, Jae Hwan; Park, Kyung Ah; Eun, Jong] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Park, Yu Mi; Seo, Su Kyoung; Eun, Jong] Yonsei Univ, Coll Med, BK Project Med Sci 21, Seoul, South Korea; [Park, Seung Hwa] Konkuk Univ, Coll Med, Dept Anat, Seoul, South Korea; [Yenari, Midori A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yenari, Midori A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Konkuk University; Konkuk University Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Eun, J (corresponding author), Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea.	jelee@yuhs.ac		Lee, Won Taek/0000-0001-7348-9562; Lee, Jong Eun/0000-0001-6203-7413	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2012-0002340]; National Institutes of Health [NS40516]; Veteran's Merit Award; Veterans Affairs Medical Center, San Francisco, California; Brain Korea 21 Project for Medical Science, Yonsei University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040516] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Merit Award; Veterans Affairs Medical Center, San Francisco, California; Brain Korea 21 Project for Medical Science, Yonsei University(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (2012-0002340) and National Institutes of Health (NS40516, to MY), the Veteran's Merit Award (to MY). Grants to MY were administered by the Northern California Institute for Research and Education, and supported by resources of the Veterans Affairs Medical Center, San Francisco, California. This work was also supported by the Brain Korea 21 Project for Medical Science, Yonsei University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; AUGUET M, 1995, JPN J PHARMACOL, V69, P285, DOI 10.1254/jjp.69.285; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Boido M, 2011, J NEUROSURG-SPINE, V15, P97, DOI 10.3171/2011.1.SPINE10607; Boulenguez P, 2009, CURR OPIN NEUROBIOL, V19, P587, DOI 10.1016/j.conb.2009.10.005; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; Butt SJB, 2002, J NEUROSCI, V22, P9961; Chalazonitis A, 2011, DEV BIOL, V350, P64, DOI 10.1016/j.ydbio.2010.11.017; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chang CF, 2003, STROKE, V34, P558, DOI 10.1161/01.STR.0000051507.64423.00; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; CHOI BH, 1986, J NEUROPATH EXP NEUR, V45, P513, DOI 10.1097/00005072-198609000-00003; Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cunha JD, 2007, WOUND REPAIR REGEN, V15, P134, DOI 10.1111/j.1524-475X.2006.00194.x; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; de Groat WC, 2006, PROG BRAIN RES, V152, P59, DOI 10.1016/S0079-6123(05)52005-3; Estores IM, 2003, J REHABIL RES DEV, V40, P93, DOI 10.1682/JRRD.2003.08.0093; Fairbanks CA, 2000, P NATL ACAD SCI USA, V97, P10584, DOI 10.1073/pnas.97.19.10584; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Galea E, 1996, BIOCHEM J, V316, P247, DOI 10.1042/bj3160247; Gambaro K, 2006, CELL DEATH DIFFER, V13, P1075, DOI 10.1038/sj.cdd.4401799; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Guertin Pierre A, 2008, Neuropsychiatr Dis Treat, V4, P759; Halaris A, 2007, CNS DRUGS, V21, P885, DOI 10.2165/00023210-200721110-00002; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Henriquez JP, 2011, INT J MOL SCI, V12, P8924, DOI 10.3390/ijms12128924; Hvid M, 2009, INT ARCH ALLERGY IMM, V149, P188, DOI 10.1159/000199714; Ille F, 2007, DEV BIOL, V304, P394, DOI 10.1016/j.ydbio.2006.12.045; Jacobs BL, 2002, BRAIN RES REV, V40, P45, DOI 10.1016/S0165-0173(02)00187-X; Jarjour AA, 2012, GLIA, V60, P1, DOI 10.1002/glia.21231; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Karimi-Abdolrezaee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037589; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kim JH, 2011, SPINE, V36, P2130, DOI 10.1097/BRS.0b013e318205e3f7; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Kulbatski I, 2007, J HISTOCHEM CYTOCHEM, V55, P209, DOI 10.1369/jhc.6A7020.2006; Lein PJ, 2002, J NEUROSCI, V22, P10377; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Lytle JM, 2007, EUR J NEUROSCI, V25, P1711, DOI 10.1111/j.1460-9568.2007.05390.x; Matsuura I, 2008, J NEUROCHEM, V105, P1471, DOI 10.1111/j.1471-4159.2008.05251.x; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; MURAYAMA T, 1993, BIOCHEMISTRY-US, V32, P561, DOI 10.1021/bi00053a022; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; NYGREN LG, 1974, BRAIN RES, V78, P377, DOI 10.1016/0006-8993(74)90922-6; Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008; Pajoohesh-Ganji A, 2010, NEUROSCI RES, V67, P117, DOI 10.1016/j.neures.2010.02.009; Parikh P, 2011, P NATL ACAD SCI USA, V108, pE99, DOI 10.1073/pnas.1100426108; PILETZ JE, 1995, J PHARMACOL EXP THER, V272, P581; Pisano JM, 2000, DEV BIOL, V227, P1, DOI 10.1006/dbio.2000.9876; Qi XA, 2010, EXP NEUROL, V221, P353, DOI 10.1016/j.expneurol.2009.12.003; Rasouli A, 2009, J ORTHOP RES, V27, P931, DOI 10.1002/jor.20793; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; Reiriz J, 1999, J NEUROBIOL, V38, P161, DOI 10.1002/(SICI)1097-4695(19990205)38:2<161::AID-NEU1>3.3.CO;2-V; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Saruhashi Y, 2009, ARCH ORTHOP TRAUM SU, V129, P1279, DOI 10.1007/s00402-008-0754-z; See J, 2007, MOL CELL NEUROSCI, V35, P171, DOI 10.1016/j.mcn.2007.02.012; Setoguchi T, 2004, EXP NEUROL, V189, P33, DOI 10.1016/j.expneurol.2003.12.007; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016; Shoichet Molly S., 2008, P221; Shunmugavel A, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-17; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsujii M, 2009, CLIN ORTHOP RELAT R, V467, P3183, DOI 10.1007/s11999-009-1009-1; Vaccari JPD, 2009, NEUROSCI LETT, V465, P226, DOI 10.1016/j.neulet.2009.09.013; White RE, 2008, RESTOR NEUROL NEUROS, V26, P197; Widerstrom-Noga E, 2004, J NEUROTRAUM, V21, P195, DOI 10.1089/089771504322778659; Wu B, 2009, J NEUROTRAUM, V26, P1847, DOI 10.1089/neu.2008.0551; Wu JF, 2010, GLIA, V58, P410, DOI 10.1002/glia.20932; Yoshimura N, 1999, PROG NEUROBIOL, V57, P583, DOI 10.1016/S0301-0082(98)00070-7; Yu CG, 2000, NEUROREPORT, V11, P3203, DOI 10.1097/00001756-200009280-00031	83	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53911	10.1371/journal.pone.0053911	http://dx.doi.org/10.1371/journal.pone.0053911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349763	Green Published, gold			2022-12-27	WOS:000313943000020
J	Gallacher, J; Collins, R; Elliott, P; Palmer, S; Burton, P; Mitchell, C; John, G; Lyons, R				Gallacher, John; Collins, Rory; Elliott, Paul; Palmer, Stephen; Burton, Paul; Mitchell, Clive; John, Gareth; Lyons, Ronan			A Platform for the Remote Conduct of Gene-Environment Interaction Studies	PLOS ONE			English	Article							WEB-BASED QUESTIONNAIRES; EPIDEMIOLOGY	Background: Gene-environment interaction studies offer the prospect of robust causal inference through both gene identification and instrumental variable approaches. As such they are a major and much needed development. However, conducting these studies using traditional methods, which require direct participant contact, is resource intensive. The ability to conduct gene-environment interaction studies remotely would reduce costs and increase capacity. Aim: To develop a platform for the remote conduct of gene-environment interaction studies. Methods: A random sample of 15,000 men and women aged 50+ years and living in Cardiff, South Wales, of whom 6,012 were estimated to have internet connectivity, were mailed inviting them to visit a web-site to join a study of successful ageing. Online consent was obtained for questionnaire completion, cognitive testing, re-contact, record linkage and genotyping. Cognitive testing was conducted using the Cardiff Cognitive Battery. Bio-sampling was randomised to blood spot, buccal cell or no request. Results: A heterogeneous sample of 663 (4.5% of mailed sample and 11% of internet connected sample) men and women (47% female) aged 50-87 years (median = 61 yrs) from diverse backgrounds (representing the full range of deprivation scores) was recruited. Bio-samples were donated by 70% of those agreeing to do so. Self report questionnaires and cognitive tests showed comparable distributions to those collected using face-to-face methods. Record linkage was achieved for 99.9% of participants. Conclusion: This study has demonstrated that remote methods are suitable for the conduct of gene-environment interaction studies. Up-scaling these methods provides the opportunity to increase capacity for large-scale gene-environment interaction studies.	[Gallacher, John; Palmer, Stephen; Mitchell, Clive] Cardiff Univ, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [Collins, Rory] Univ Oxford, Clin Trials Serv Unit, Oxford, England; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Burton, Paul] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [John, Gareth] NHS Wales Informat Serv, Cardiff, S Glam, Wales; [Lyons, Ronan] Swansea Univ, Inst Life Sci, Swansea, W Glam, Wales	Cardiff University; University of Oxford; Imperial College London; University of Leicester; Swansea University	Gallacher, J (corresponding author), Cardiff Univ, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales.	Gallacher@cf.ac.uk		Elliott, Paul/0000-0002-7511-5684	Welsh Assembly Government; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [MC_U137686860, G0801056, MR/K006525/1] Funding Source: UKRI; British Heart Foundation [SP/13/2/30111] Funding Source: researchfish; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0801056, MC_U137686860, MR/K006525/1, G0801056B] Funding Source: researchfish	Welsh Assembly Government; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Welsh Assembly Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2011, EUR J EPIDEMIOL, V26, P67, DOI 10.1007/s10654-010-9521-x; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Ekman A, 2006, EUR J EPIDEMIOL, V21, P103, DOI 10.1007/s10654-005-6030-4; Ekman A, 2007, EUROPEAN J EPIDEMIOL, V22, P281; Gallacher JEJ, 2007, EUR J PUBLIC HEALTH, V17, P548, DOI 10.1093/eurpub/ckm086; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Huybrechts KF, 2010, EUR J EPIDEMIOL, V25, P297, DOI 10.1007/s10654-010-9431-y; Kivimaki M, 2011, INT J EPIDEMIOL, V40, P845, DOI 10.1093/ije/dyr114; Klovning A, 2009, J CLIN EPIDEMIOL, V62, P1068, DOI 10.1016/j.jclinepi.2008.10.015; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Manolio TA, 2012, AM J EPIDEMIOL, V175, P859, DOI 10.1093/aje/kwr453; McCabe SE, 2006, ADDICT BEHAV, V31, P1619, DOI 10.1016/j.addbeh.2005.12.009; Mikkelsen EM, 2009, INT J EPIDEMIOL, V38, P938, DOI 10.1093/ije/dyn191; Reilly R, 2012, BJOG-INT J OBSTET GY, V119, P236, DOI 10.1111/j.1471-0528.2011.03052.x; Rothman KJ, 1997, EPIDEMIOLOGY, V8, P123; Smith B, 2007, AM J EPIDEMIOL, V166, P1345, DOI 10.1093/aje/kwm212; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Smith GD, 2011, EPIDEMIOLOGY, V22, P460, DOI 10.1097/EDE.0b013e31821d0426; Taverner N, 2010, INTERACTIVE J MED IN; Touvier M, 2010, EUR J EPIDEMIOL, V25, P287, DOI 10.1007/s10654-010-9433-9; van Gelder MMHJ, 2010, AM J EPIDEMIOL, V172, P1292, DOI 10.1093/aje/kwq291; Welsh Assembly Government, 2008, LIV WAL SURV 2007; Wood F, 2011, J MED ETHICS, V37, P487, DOI 10.1136/jme.2010.040352	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54331	10.1371/journal.pone.0054331	http://dx.doi.org/10.1371/journal.pone.0054331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349852	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000313872800040
J	Koreishi, M; Yu, S; Oda, M; Honjo, Y; Satoh, A				Koreishi, Mayuko; Yu, Sidney; Oda, Mayumi; Honjo, Yasuko; Satoh, Ayano			CK2 Phosphorylates Sec31 and Regulates ER-To-Golgi Trafficking	PLOS ONE			English	Article							RETICULUM EXIT SITES; COPII VESICLE COAT; PROTEIN-KINASE CK2; ENDOPLASMIC-RETICULUM; IN-VIVO; MAMMALIAN-CELLS; BINDING; TRANSPORT; COMPONENT; MEMBRANE	Protein export from the endoplasmic reticulum (ER) is an initial and rate-limiting step of molecular trafficking and secretion. This is mediated by coat protein II (COPII)-coated vesicles, whose formation requires small GTPase Sar1 and 6 Sec proteins including Sec23 and Sec31. Sec31 is a component of the outer layer of COPII coat and has been identified as a phosphoprotein. The initiation and promotion of COPII vesicle formation is regulated by Sar1; however, the mechanism regulating the completion of COPII vesicle formation followed by vesicle release is largely unknown. Hypothesizing that the Sec31 phosphorylation may be such a mechanism, we identified phosphorylation sites in the middle linker region of Sec31. Sec31 phosphorylation appeared to decrease its association with ER membranes and Sec23. Non-phosphorylatable mutant of Sec31 stayed longer at ER exit sites and bound more strongly to Sec23. We also found that CK2 is one of the kinases responsible for Sec31 phosphorylation because CK2 knockdown decreased Sec31 phosphorylation, whereas CK2 overexpression increased Sec31 phosphorylation. Furthermore, CK2 knockdown increased affinity of Sec31 for Sec23 and inhibited ER-to-Golgi trafficking. These results suggest that Sec31 phosphorylation by CK2 controls the duration of COPII vesicle formation, which regulates ER-to-Golgi trafficking.	[Koreishi, Mayuko; Oda, Mayumi; Satoh, Ayano] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Yu, Sidney] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, Sidney] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Honjo, Yasuko] Okayama Univ, Res Core Interdisciplinary Sci RCIS, Okayama 7008530, Japan	Okayama University; Chinese University of Hong Kong; Chinese University of Hong Kong; Okayama University	Satoh, A (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	ayano113@cc.okayama-u.ac.jp	Satoh, Ayano/B-2423-2011; Bin Sidney Yu, Siu/R-4936-2018; Oda, Mayumi/Z-2010-2019	Satoh, Ayano/0000-0003-3736-1283; Bin Sidney Yu, Siu/0000-0001-9643-2729; Oda, Mayumi/0000-0001-5102-7076	National Institute of Aging [R03 AG030101]; special Coordination Fund for Promoting Science and Technology of MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan); Hayashi Memorial Foundation for Female Natural Scientists; Ryobi Teien Memorial Foundation; Naito Foundation; Uehara Memorial Foundation; Kurata Memorial Hitachi Science and technology foundation; Kanae Foundation for the Promotion of Medical Science; NATIONAL INSTITUTE ON AGING [R03AG030101] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); special Coordination Fund for Promoting Science and Technology of MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Ryobi Teien Memorial Foundation(Ryobi Teien Memory Foundation); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Kurata Memorial Hitachi Science and technology foundation; Kanae Foundation for the Promotion of Medical Science; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded to AS by the National Institute of Aging (R03 AG030101), the special Coordination Fund for Promoting Science and Technology of MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan), Hayashi Memorial Foundation for Female Natural Scientists, Ryobi Teien Memorial Foundation, Naito Foundation, Uehara Memorial Foundation, Kurata Memorial Hitachi Science and technology foundation, and Kanae Foundation for the Promotion of Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 2003, EMBO REP, V4, P419, DOI 10.1038/sj.embor.embor812; Barlowe C, 2002, DEV CELL, V3, P467, DOI 10.1016/S1534-5807(02)00293-9; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Brandon E, 2006, MOL BIOL CELL, V17, P2996, DOI 10.1091/mbc.e05-09-0862; Buchanan R, 2010, TRAFFIC, V11, P1034, DOI 10.1111/j.1600-0854.2010.01080.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dirac-Svejstrup AB, 2000, J CELL BIOL, V150, P475, DOI 10.1083/jcb.150.3.475; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076; Franz-Wachtel M, 2012, MOL CELL PROTEOMICS, V11, P160, DOI 10.1074/mcp.M111.016014; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hanif IM, 2010, INT J BIOCHEM CELL B, V42, P1602, DOI 10.1016/j.biocel.2010.06.010; Ho HH, 2006, P NATL ACAD SCI USA, V103, P7676, DOI 10.1073/pnas.0602595103; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kung LF, 2012, EMBO J, V31, P1014, DOI 10.1038/emboj.2011.444; Lambert IH, 2011, CELL PHYSIOL BIOCHEM, V28, P1099, DOI 10.1159/000335846; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Maday S, 2008, TRAFFIC, V9, P1915, DOI 10.1111/j.1600-0854.2008.00805.x; Montegna EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031156; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong YS, 2010, J CELL BIOL, V190, P331, DOI 10.1083/jcb.201003005; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Rutz C, 2009, TRAFFIC, V10, P994, DOI 10.1111/j.1600-0854.2009.00934.x; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Scott GK, 2006, EMBO J, V25, P4423, DOI 10.1038/sj.emboj.7601336; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Shimoi W, 2005, J BIOL CHEM, V280, P10141, DOI 10.1074/jbc.M409673200; Shugrue CA, 1999, J CELL SCI, V112, P4547; Sohda M, 1998, J BIOL CHEM, V273, P5385, DOI 10.1074/jbc.273.9.5385; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stockli J, 2004, J BIOL CHEM, V279, P23542, DOI 10.1074/jbc.M313525200; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Whittle JRR, 2010, J CELL BIOL, V190, P347, DOI 10.1083/jcb.201003092; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yamasaki A, 2009, MOL BIOL CELL, V20, P4205, DOI 10.1091/mbc.E09-05-0387; Yorimitsu T, 2012, MOL BIOL CELL; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644	52	41	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54382	10.1371/journal.pone.0054382	http://dx.doi.org/10.1371/journal.pone.0054382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349870	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800046
J	Sabir, HJ; Nehlin, JO; Qanie, D; Harkness, L; Prokhorova, TA; Blagoev, B; Kassem, M; Isa, A; Barington, T				Sabir, Hardee J.; Nehlin, Jan O.; Qanie, Diyako; Harkness, Linda; Prokhorova, Tatyana A.; Blagoev, Blagoy; Kassem, Moustapha; Isa, Adiba; Barington, Torben			Separate Developmental Programs for HLA-A and -B Cell Surface Expression during Differentiation from Embryonic Stem Cells to Lymphocytes, Adipocytes and Osteoblasts	PLOS ONE			English	Article							MHC CLASS-I; COMPLEX CLASS-I; LANGERHANS CELLS; HEAVY-CHAINS; ANTIGENS; MOLECULES; TISSUE; GENES; LINES; KERATINOCYTES	A major problem of allogeneic stem cell therapy is immunologically mediated graft rejection. HLA class I A, B, and Cw antigens are crucial factors, but little is known of their respective expression on stem cells and their progenies. We have recently shown that locus-specific expression (HLA-A, but not -B) is seen on some multipotent stem cells, and this raises the question how this is in other stem cells and how it changes during differentiation. In this study, we have used flow cytometry to investigate the cell surface expression of HLA-A and -B on human embryonic stem cells (hESC), human hematopoietic stem cells (hHSC), human mesenchymal stem cells (hMSC) and their fully-differentiated progenies such as lymphocytes, adipocytes and osteoblasts. hESC showed extremely low levels of HLA-A and no -B. In contrast, multipotent hMSC and hHSC generally expressed higher levels of HLA-A and clearly HLA-B though at lower levels. IFN gamma induced HLA-A to very high levels on both hESC and hMSC and HLA-B on hMSC. Even on hESC, a low expression of HLA-B was achieved. Differentiation of hMSC to osteoblasts downregulated HLA-A expression (P = 0.017). Interestingly HLA class I on T lymphocytes differed between different compartments. Mature bone marrow CD4(+) and CD8(+) T cells expressed similar HLA-A and -B levels as hHSC, while in the peripheral blood they expressed significantly more HLA-B7 (P = 0.0007 and P = 0.004 for CD4(+) and CD8(+) T cells, respectively). Thus different HLA loci are differentially regulated during differentiation of stem cells.	[Sabir, Hardee J.; Nehlin, Jan O.; Isa, Adiba; Barington, Torben] Univ So Denmark, Dept Clin Immunol, Odense Univ Hosp, Odense, Denmark; [Sabir, Hardee J.; Nehlin, Jan O.; Isa, Adiba; Barington, Torben] Univ So Denmark, Inst Clin, Odense, Denmark; [Qanie, Diyako; Harkness, Linda; Kassem, Moustapha] Odense Univ Hosp, Mol Endocrinol Lab KMEB, Dept Endocrinol, DK-5000 Odense, Denmark; [Prokhorova, Tatyana A.; Blagoev, Blagoy] Univ So Denmark, Ctr Expt BioInformat, Dept Biochem & Mol Biol, Odense, Denmark; [Kassem, Moustapha] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; King Saud University	Barington, T (corresponding author), Univ So Denmark, Dept Clin Immunol, Odense Univ Hosp, Odense, Denmark.	barington@dadlnet.dk	Nehlin, Jan O./AAR-8721-2020; Barington, Torben/R-6841-2019; Harkness, Linda/A-5654-2017; Kassem, Moustapha/O-3819-2019; Barington, Torben/C-3922-2009	Nehlin, Jan O./0000-0001-6038-5027; Harkness, Linda/0000-0002-1648-9301; Kassem, Moustapha/0000-0003-1557-0869; Barington, Torben/0000-0001-6968-148X; Prokhorova, Tatyana/0000-0001-8768-8298; Blagoev, Blagoy/0000-0002-3596-0066	Danish Regions; Odense University Hospital; University of Southern Denmark; Else Poulsens Mindelegat; Horslev's Fund; Lundbeck Fund; Kurdistan Regional Government; Nanakaly Fund, Kurdistan, Iraq	Danish Regions; Odense University Hospital; University of Southern Denmark; Else Poulsens Mindelegat; Horslev's Fund; Lundbeck Fund(Lundbeckfonden); Kurdistan Regional Government; Nanakaly Fund, Kurdistan, Iraq	The present work was supported by funds from Danish Regions, Odense University Hospital, the University of Southern Denmark, Else Poulsens Mindelegat, the Horslev's Fund, Lundbeck Fund (BB) and a PhD fellowship from the Kurdistan Regional Government and Nanakaly Fund, Kurdistan, Iraq (to HJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2010, CELL MOL IMMUNOL, Vseventh, P109; AHMEDANSARI A, 1988, TRANSPLANTATION, V45, P972, DOI 10.1097/00007890-198805000-00027; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; BAKKER M, 1985, CURR EYE RES, V4, P599, DOI 10.3109/02713688508999991; Basak GW, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-27; Benevolo M, 2007, AM J SURG PATHOL, V31, P76, DOI 10.1097/01.pas.0000213343.55605.b9; Cabrera CM, 2007, CELL BIOL INT, V31, P1072, DOI 10.1016/j.cellbi.2007.03.015; COCKFIELD SM, 1989, TRANSPLANT P, V21, P630; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; CUNNINGHAM AC, 1994, J CELL SCI, V107, P443; DAAR AS, 1984, TRANSPLANTATION, V38, P287, DOI 10.1097/00007890-198409000-00018; DAVID-WATINE B, 1990, IMMUNOL TODAY, V11, P286, DOI 10.1016/0167-5699(90)90114-O; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Dutta N, 2005, HUM IMMUNOL, V66, P164, DOI 10.1016/j.humimm.2004.10.010; EBERLEINGONSKA M, 1989, VERH DEUT G, V73, P117; FLEMING KA, 1981, J CLIN PATHOL, V34, P779, DOI 10.1136/jcp.34.7.779; Foglieni C, 2008, AM J PHYSIOL-HEART C, V294, pH2831, DOI 10.1152/ajpheart.91428.2007; Friedrich D, 2011, JAIDS-J ACQ IMM DEF, V58, P248, DOI 10.1097/QAI.0b013e318228f992; Giacomini P, 1997, TISSUE ANTIGENS, V50, P555, DOI 10.1111/j.1399-0039.1997.tb02913.x; GIELEN V, 1988, ARCH DERMATOL RES, V280, P131, DOI 10.1007/BF00456841; Gono T, 2009, CLIN RHEUMATOL, V28, P873, DOI 10.1007/s10067-009-1172-5; Greene JM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-39; Harkness L, 2011, BONE, V48, P231, DOI 10.1016/j.bone.2010.09.023; Harkness L, 2010, IN VITRO CELL DEV-AN, V46, P259, DOI 10.1007/s11626-010-9281-7; Hobbs CGL, 2006, CLIN EXP IMMUNOL, V145, P365, DOI 10.1111/j.1365-2249.2006.03125.x; Horwitz MS, 1999, LAB INVEST, V79, P235; Isa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010900; Johnson DR, 2000, HUM IMMUNOL, V61, P389, DOI 10.1016/S0198-8859(99)00186-X; JONES RA, 1988, LEUKEMIA RES, V12, P799, DOI 10.1016/0145-2126(88)90032-X; Kaslow RA, 2001, J VIROL, V75, P8681, DOI 10.1128/JVI.75.18.8681-8689.2001; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Loyson SAJ, 1997, HISTOPATHOLOGY, V31, P412, DOI 10.1046/j.1365-2559.1997.2980886.x; Meunier L, 1996, CYTOMETRY, V26, P260, DOI 10.1002/(SICI)1097-0320(19961215)26:4<260::AID-CYTO4>3.3.CO;2-T; Parham P, 2009, IMMUNE SYSTEM, V3rd; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Prokhorova TA, 2009, MOL CELL PROTEOMICS, V8, P959, DOI 10.1074/mcp.M800287-MCP200; Roitt I., 2001, IMMUNOLOGY, V6th; Saenz-Lopez P, 2010, TISSUE ANTIGENS, V75, P110, DOI 10.1111/j.1399-0039.2009.01409.x; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; SUTTON R, 1987, TRANSPLANT P, V19, P220; Taipaleenmaki H, 2011, EXP CELL RES, V317, P745, DOI 10.1016/j.yexcr.2010.12.015; THEOBALD VA, 1993, TRANSPLANTATION, V55, P128, DOI 10.1097/00007890-199301000-00024; Wang EC, 2006, OTOLARYNG HEAD NECK, V134, P280, DOI 10.1016/j.otohns.2005.10.015; Wognum AW, 2003, ARCH MED RES, V34, P461, DOI 10.1016/j.arcmed.2003.09.008	49	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54366	10.1371/journal.pone.0054366	http://dx.doi.org/10.1371/journal.pone.0054366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349864	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800044
J	Shi, G; Sohn, KC; Li, Z; Choi, DK; Park, YM; Kim, JH; Fan, YM; Nam, YH; Kim, S; Im, M; Lee, Y; Seo, YJ; Kim, CD; Lee, JH				Shi, Ge; Sohn, Kyung-Cheol; Li, Zhengjun; Choi, Dae-Kyoung; Park, Young Min; Kim, Jin-Hwa; Fan, Yi-Ming; Nam, Yong Hee; Kim, Sooyeon; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon			Expression and Functional Role of Sox9 in Human Epidermal Keratinocytes	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; TRANSCRIPTION FACTOR; DIFFERENTIATION; PATHWAY; NOTCH; INVOLVEMENT; INITIATION; PROTEIN; GROWTH; GENES	In this study, we investigated the expression and putative role of Sox9 in epidermal keratinocyte. Immunohistochemical staining showed that Sox9 is predominantly expressed in the basal layer of normal human skin epidermis, and highly expressed in several skin diseases including psoriasis, basal cell carcinoma, keratoacanthoma and squamous cell carcinoma. In calcium-induced keratinocyte differentiation model, the expression of Sox9 was decreased in a time dependent manner. When Sox9 was overexpressed using a recombinant adenovirus, cell growth was enhanced, while the expression of differentiation-related genes such as loricrin and involucrin was markedly decreased. Similarly, when rat skin was intradermally injected with the adenovirus expressing Sox9, the epidermis was thickened with increase of PCNA positive cells, while the epidermal differentiation was decreased. Finally, UVB irradiation induced Sox9 expression in cultured human epidermal keratinocytes, and keratinocytes are protected from UVB-induced apoptosis by Sox9 overexpression. Together, these results suggest that Sox9 is an important regulator of epidermal keratinocytes with putative pro-proliferation and/or pro-survival functions, and may be related to several cutaneous diseases that are characterized by abnormal differentiation and hyperproliferation.	[Shi, Ge; Fan, Yi-Ming] Guangdong Med Coll, Dept Dermatol, Affiliated Hosp 1, Zhanjiang, Peoples R China; [Shi, Ge; Sohn, Kyung-Cheol; Li, Zhengjun; Choi, Dae-Kyoung; Nam, Yong Hee; Kim, Sooyeon; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Dept Dermatol, Sch Med, Taejon, South Korea; [Shi, Ge; Sohn, Kyung-Cheol; Li, Zhengjun; Choi, Dae-Kyoung; Nam, Yong Hee; Kim, Sooyeon; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Res Inst Med Sci, Sch Med, Taejon, South Korea; [Park, Young Min] Catholic Univ Korea, Dept Dermatol, Coll Med, Seoul, South Korea; [Kim, Jin-Hwa] SkinMED Corp, Taejon, South Korea	Guangdong Medical University; Chungnam National University; Chungnam National University; Catholic University of Korea	Lee, JH (corresponding author), Chungnam Natl Univ, Dept Dermatol, Sch Med, Taejon, South Korea.	jhoon@cnu.ac.kr	Fan, Yi-Ming/K-7567-2019; Fan, Yi-Ming/U-9192-2017	Fan, Yi-Ming/0000-0002-6206-1306; Fan, Yi-Ming/0000-0002-6206-1306; Seo, Young-Joon/0000-0002-4955-590X; Lee, Young/0000-0001-9205-1785; Kim, Chang Deok/0000-0001-9341-6491	National Research Foundation of Korea [KRF-2008-314-E00152]; Korea Health 21 R&D Project from the Korea Ministry of Health, Welfare and Family Affairs [01-PJ3-PG6-01GN12-0001]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health 21 R&D Project from the Korea Ministry of Health, Welfare and Family Affairs	This study was supported by a grant of the National Research Foundation of Korea (KRF-2008-314-E00152), and a grant of the Korea Health 21 R&D Project from the Korea Ministry of Health, Welfare and Family Affairs (01-PJ3-PG6-01GN12-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bikle DD, 2011, MOL CELL ENDOCRINOL, V347, P80, DOI 10.1016/j.mce.2011.05.017; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Chen W, 2006, J EUR ACAD DERMATOL, V20, P846, DOI 10.1111/j.1468-3083.2006.01663.x; Decker Patrice, 2002, Current Pharmaceutical Biotechnology, V3, P275, DOI 10.2174/1389201023378265; Dessinioti C, 2010, PHOTOCHEM PHOTOBIOL, V86, P481, DOI 10.1111/j.1751-1097.2010.00735.x; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Feldman SR, 2011, CUTIS, V87, P201; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Garcia-Borron JC, 2008, PIGM CELL MELANOMA R, V21, P3, DOI 10.1111/j.1755-148X.2007.00431.x; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Iwasaki JK, 2012, J AM ACAD DERMATOL, V66, pE167, DOI 10.1016/j.jaad.2010.06.054; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nishi K, 2009, J CELL BIOCHEM, V106, P63, DOI 10.1002/jcb.21978; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Piao MS, 2011, J DERMATOL SCI, V62, P147, DOI 10.1016/j.jdermsci.2011.02.003; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Seo EY, 2005, GENOMICS, V86, P528, DOI 10.1016/j.ygeno.2005.06.013; Shi G, 2011, ANN DERMATOL, V23, P138, DOI 10.5021/ad.2011.23.2.138; Shi G, 2010, EXP CELL RES, V316, P3263, DOI 10.1016/j.yexcr.2010.09.013; Shi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013216; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Tollefson Ann E, 2007, Methods Mol Med, V130, P223; Vidal VPI, 2008, J CUTAN PATHOL, V35, P373, DOI 10.1111/j.1600-0560.2007.00815.x; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Yoon HK, 2008, BIOCHEM BIOPH RES CO, V377, P662, DOI 10.1016/j.bbrc.2008.10.051	35	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54355	10.1371/journal.pone.0054355	http://dx.doi.org/10.1371/journal.pone.0054355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349860	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872800041
J	Abbott, SA; Haberland, NA; Mulenga, DM; Hewett, PC				Abbott, Sharon A.; Haberland, Nicole A.; Mulenga, Drosin M.; Hewett, Paul C.			Female Sex Workers, Male Circumcision and HIV: A Qualitative Study of Their Understanding, Experience, and HIV Risk in Zambia	PLOS ONE			English	Article							PREVENTION; BEHAVIOR; CONTEXT; KENYA; MEN	Several sub-Saharan African countries, including Zambia, have initiated national voluntary medical male circumcision (MC) programs to reduce HIV incidence. In-depth interviews were conducted with twenty female sex workers (FSWs) in Lusaka to examine their understanding of MC and experiences with circumcised clients. Knowledge of MC was derived primarily through informal sources, with very few FSWs reporting exposure to MC educational campaigns. MC was not widely believed to be protective against HIV, however it was viewed by some as protective against STIs. Three FSWs reported having sex with recently circumcised clients, and most reported that men often used their MC status to try to convince FSWs to forego condoms. Findings suggest that FSWs, already at high risk for HIV infection, may face additional pressure toward higher risk behavior as a result of MC. As MC services are expanded, programs should support FSWs' efforts to protect themselves by providing information about what MC can - and cannot - offer for HIV/STI infection prevention.	[Abbott, Sharon A.; Haberland, Nicole A.] Populat Council, New York, NY 10021 USA; [Mulenga, Drosin M.; Hewett, Paul C.] Populat Council, Lusaka, Zambia	Population Council	Abbott, SA (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.	sharonabbott@gmail.com			Population Services International (PSI) through the Male Circumcision Partnership; Bill & Melinda Gates Foundation	Population Services International (PSI) through the Male Circumcision Partnership; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was conducted under a subgrant from Population Services International (PSI) through the Male Circumcision Partnership, which is sponsored by PSI with support from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS Vaccine Advocacy Coalition, 2008, CIV SOC DIAL MAL CIR; [Anonymous], 2008, OPEN DEMOGRAPHY J, DOI [DOI 10.2174/1874918600801010001, 10.2174/1874918600801010001]; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Chipamaunga S, 2010, SAHARA J-J SOC ASP H, V7, P44, DOI 10.1080/17290376.2010.9724968; (CSO) CSO (MOH) MoH Zambia Uo Evaluation M, 2010, ZAMB SEX BEH SURV 20; Fitzgerald-Husek A, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-35; Gallo MF, 2011, J WOMENS HEALTH, V20, P733, DOI 10.1089/jwh.2010.2436; Gray RH, 2007, LANCET, V369; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Grund JM, 2012, AIDS CARE, V24, P245, DOI 10.1080/09540121.2011.596516; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Herman-Roloff A, 2011, AIDS BEHAV; Hewett PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036251; Hewett PC, 2012, AIDS, V26, P749, DOI 10.1097/QAD.0b013e32835097ff; Leclerc PM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005439; Londish GJ, 2008, INT J EPIDEMIOL, V37, P1246, DOI 10.1093/ije/dyn038; McClelland L, 2011, AIDS EDUC PREV, V23, P299, DOI 10.1521/aeap.2011.23.4.299; Ministry of Health (MOH), 2010, NAT MAL CIRC STRAT I; Ministry of Health (MOH) Zambia, 2012, COUNTR OP PLAN SCAL; Mulenga O, 2009, ZAMBIA HIV PREVENTIO; Munoz J, 2010, SAHARA J-J SOC ASP H, V7, P52, DOI 10.1080/17290376.2010.9724957; Ndubani P, 2005, BEHAV BIOL SURVEILLA; Ndubani P, 2009, FEMALE SEX WORKERS B; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3	29	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53809	10.1371/journal.pone.0053809	http://dx.doi.org/10.1371/journal.pone.0053809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	073JI	23349745	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900021
J	Lynch, T; Chong, P; Zhang, J; Hizon, R; Du, T; Graham, MR; Beniac, DR; Booth, TF; Kibsey, P; Miller, M; Gravel, D; Mulvey, MR				Lynch, Tarah; Chong, Patrick; Zhang, Jason; Hizon, Romeo; Du, Tim; Graham, Morag R.; Beniac, Daniel R.; Booth, Timothy F.; Kibsey, Pamela; Miller, Mark; Gravel, Denise; Mulvey, Michael R.		CNISP	Characterization of a Stable, Metronidazole-Resistant Clostridium difficile Clinical Isolate	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; HELICOBACTER-PYLORI; MULTIINSTITUTIONAL OUTBREAK; DIARRHEA; TOXIN; STRAINS; GENES; SUSCEPTIBILITY; VANCOMYCIN; EPIDEMIOLOGY	Background: Clostridium difficile are Gram-positive, spore forming anaerobic bacteria that are the leading cause of healthcare-associated diarrhea, usually associated with antibiotic usage. Metronidazole is currently the first-line treatment for mild to moderate C. difficile diarrhea however recurrence occurs at rates of 15-35%. There are few reports of C. difficile metronidazole resistance in the literature, and when observed, the phenotype has been transient and lost after storage or exposure of the bacteria to freeze/thaw cycles. Owing to the unstable nature of the resistance phenotype in the laboratory, clinical significance and understanding of the resistance mechanisms is lacking. Methodology/Principal Findings: Genotypic and phenotypic characterization was performed on a metronidazole resistant clinical isolate of C. difficile. Whole-genome sequencing was used to identify potential genetic contributions to the phenotypic variation observed with molecular and bacteriological techniques. Phenotypic observations of the metronidazole resistant strain revealed aberrant growth in broth and elongated cell morphology relative to a metronidazole-susceptible, wild type NAP1 strain. Comparative genomic analysis revealed single nucleotide polymorphism (SNP) level variation within genes affecting core metabolic pathways such as electron transport, iron utilization and energy production. Conclusions/Significance: This is the first characterization of stable, metronidazole resistance in a C. difficile isolate. The study provides an in-depth genomic and phenotypic analysis of this strain and provides a foundation for future studies to elucidate mechanisms conferring metronidazole resistance in C. difficile that have not been previously described.	[Lynch, Tarah; Chong, Patrick; Zhang, Jason; Hizon, Romeo; Du, Tim; Graham, Morag R.; Beniac, Daniel R.; Booth, Timothy F.; Mulvey, Michael R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Kibsey, Pamela] Victoria Gen Hosp, Victoria, BC, Canada; [Miller, Mark] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Gravel, Denise] Publ Hlth Agcy Canada, Ottawa, ON, Canada	Public Health Agency of Canada; University of Victoria; McGill University; Public Health Agency of Canada	Mulvey, MR (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Michael_mulvey@phac-aspc.gc.ca			Public Health Agency of Canada; National Science and Engineering Research Council of Canada	Public Health Agency of Canada; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	No external funding sources were received for this study. This project was funded solely by the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the National Science and Engineering Research Council of Canada's Visiting Fellowship in Canadian Government Laboratories Program; the Genomics, Bioinformatics and Media Core Facilities at the National Microbiology Laboratory for their expertise, hard work and technical support. Members of the Canadian Nosocomial Infection Surveillance Program are: David Boyd, National Microbiology Laboratory, Public Health Agency of Canada; Natalie Bridger, Eastern Health-HSC, St. John's, Nfld.; Elizabeth Bryce, Vancouver General Hospital, Vancouver, BC; John Conly, Foothills Medical Centre, Calgary, Alta.; Andre Dascal, SMBD-Jewish General Hospital, Montreal, Que.; Janice de Heer, Interior Health Authority, Kelowna, BC; John Embil, Health Sciences Centre, Winnipeg, Man.; Joanne Embree, Health Sciences Centre, Winnipeg, Man.; Gerald Evans, Kingston General Hospital, Kingston, Ont; Sarah Forgie, Stollery Children's Hospital, Edmonton, AB; Charles Frenette, McGill University Health Centre, Montreal, Que; David Haldane, Queen Elizabeth II Health Sciences Centre, Halifax, Nova ScotiaGregory German, Queen Elizabeth Hospital, Charlottetown, PEI; George Golding, National Microbiology Laboratory, Public Health Agency of Canada; Denise Gravel, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; Deanna Hembroff, University Hospital of Northern BC, Prince George, BC; Elizabeth Henderson, Alberta Health Services, Calgary, Alta.; Michael John, London Health Sciences Centre, London, Ont.; Lynn Johnston, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Kevin Katz, North York General Hospital, Toronto, ON; Pamela Kibsey, Victoria General Hospital, Victoria, BC; Magdalena Kuhn, South East Regional Health Authority, Moncton, NB; Joanne Langley, IWK. Health Centre, Halifax, NS; Camille Lemieux, University Health Network, Toronto, Ont.; Nicole Le Saux, Children's Hospital of Eastern Ontario, Ottawa, ON; Mark Loeb, Hamilton Health Sciences Corporation, Hamilton, Ont.; Susan Richardson, Hospital for Sick Children, Toronto, Ont.; Allison McGeer, Mount Sinai Hospital, Toronto, Ont.; Dominik Mertz, Hamilton Health Sciences Corporation, Hamilton, Ont; Mark Miller, SMBD-Jewish General Hospital, Montreal, Que.; Robyn Mitchell, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; Dorothy Moore, Montreal Children's Hospital, McGill University Health Centre, Montreal, Que.; Aboubakar Mounchili, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; Michael Mulvey, National Microbiology Laboratory, Public Health Agency of Canada; Suzanne Pelletier, Health Sciences North, Sudbury, ON; Linda Pelude, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; Caroline Quach, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec Virginia Roth, The Ottawa Hospital, Ottawa, Ont.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Alfa MJ, 2000, J CLIN MICROBIOL, V38, P2706, DOI 10.1128/JCM.38.7.2706-2714.2000; Baines SD, 2008, J ANTIMICROB CHEMOTH, V62, P1046, DOI 10.1093/jac/dkn313; Barbut F, 2000, J CLIN MICROBIOL, V38, P2386; BOLTON RP, 1986, GUT, V27, P1169, DOI 10.1136/gut.27.10.1169; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bourgault AM, 2006, ANTIMICROB AGENTS CH, V50, P3473, DOI 10.1128/AAC.00479-06; Brouwer MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023014; Burns DA, 2011, J MICROBIOL METH, V87, P133, DOI 10.1016/j.mimet.2011.07.017; Chang KC, 1997, BIOCHEM BIOPH RES CO, V236, P785, DOI 10.1006/bbrc.1997.7050; Chernak E., 2005, Morbidity and Mortality Weekly Report, V54, P1201; Choi SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018236; CLSI, 2007, M11A7 CLSI; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Diniz CG, 2004, J ANTIMICROB CHEMOTH, V54, P100, DOI 10.1093/jac/dkh256; EDWARDS DI, 1993, J ANTIMICROB CHEMOTH, V31, P9, DOI 10.1093/jac/31.1.9; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Gal M, 2004, J ANTIMICROB CHEMOTH, V54, P109, DOI 10.1093/jac/dkh296; Goodwin A, 1998, MOL MICROBIOL, V28, P383, DOI 10.1046/j.1365-2958.1998.00806.x; Gravel D, 2009, CLIN INFECT DIS, V48, P568, DOI 10.1086/596703; Grobner S, 2012, INT J MED MICROBIOL, V302, P40, DOI 10.1016/j.ijmm.2011.07.001; HAGGOUD A, 1994, ANTIMICROB AGENTS CH, V38, P1047, DOI 10.1128/AAC.38.5.1047; Helmann JD, 2003, J BACTERIOL, V185, P243, DOI 10.1128/JB.185.1.243-253.2003; Huang HH, 2009, INT J ANTIMICROB AG, V34, P516, DOI 10.1016/j.ijantimicag.2009.09.012; Indra A, 2008, J MED MICROBIOL, V57, P702, DOI 10.1099/jmm.0.47476-0; Jeong JY, 2000, J BACTERIOL, V182, P5082, DOI 10.1128/JB.182.18.5082-5090.2000; Johnson S, 1999, NEW ENGL J MED, V341, P1645, DOI 10.1056/NEJM199911253412203; Kaakoush NO, 2009, ANTIMICROB AGENTS CH, V53, P1884, DOI 10.1128/AAC.01449-08; Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin YC, 2011, ANTIMICROB AGENTS CH, V55, P1701, DOI 10.1128/AAC.01440-10; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Martin H, 2008, J CLIN MICROBIOL, V46, P2999, DOI 10.1128/JCM.02437-07; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Murray R., 2009, BMC Infectious Diseases, V9; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Oka K, 2012, J CLIN MICROBIOL, V50, P915, DOI 10.1128/JCM.05588-11; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Pelaez T, 1994, 34 INT C ANT AG CHEM; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; REYSSET G, 1993, CLIN INFECT DIS, V16, pS401, DOI 10.1093/clinids/16.Supplement_4.S401; Reysset G, 2012, MED MALADIES INFECT, V26, P213; Sakka V, 2008, CLIN MICROBIOL INFEC, V14, P14, DOI 10.1111/j.1469-0691.2007.01840.x; Sisson G, 2000, J BACTERIOL, V182, P5091, DOI 10.1128/JB.182.18.5091-5096.2000; Spigaglia P, 2004, J MED MICROBIOL, V53, P1129, DOI 10.1099/jmm.0.45682-0; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Spigaglia P, 2011, J ANTIMICROB CHEMOTH, V66, P2227, DOI 10.1093/jac/dkr292; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P2929, DOI 10.1128/AAC.00220-12; Tsugawa H, 2011, BIOCHEM BIOPH RES CO, V404, P656, DOI 10.1016/j.bbrc.2010.12.034; Tsugawa H, 2011, ANTIOXID REDOX SIGN, V14, P15, DOI 10.1089/ars.2010.3146; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2802, DOI 10.1128/JCM.00485-09; Yuan L, 2006, EVIDENCE REV COMMUNI; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	66	55	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53757	10.1371/journal.pone.0053757	http://dx.doi.org/10.1371/journal.pone.0053757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349739	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900020
J	Panagiotaropoulos, TI; Kapoor, V; Logothetis, NK; Deco, G				Panagiotaropoulos, Theofanis I.; Kapoor, Vishal; Logothetis, Nikos K.; Deco, Gustavo			A Common Neurodynamical Mechanism Could Mediate Externally Induced and Intrinsically Generated Transitions in Visual Awareness	PLOS ONE			English	Article							BINOCULAR-RIVALRY REVEALS; STOCHASTIC PROPERTIES; NETWORK MODEL; NEURAL MODEL; ADAPTATION; CORTEX; SUPPRESSION; DOMINANCE; DYNAMICS; CONSCIOUSNESS	The neural correlates of conscious visual perception are commonly studied in paradigms of perceptual multistability that allow multiple perceptual interpretations during unchanged sensory stimulation. What is the source of this multistability in the content of perception? From a theoretical perspective, a fine balance between deterministic and stochastic forces has been suggested to underlie the spontaneous, intrinsically driven perceptual transitions observed during multistable perception. Deterministic forces are represented by adaptation of feature-selective neuronal populations encoding the competing percepts while stochastic forces are modeled as noise-driven processes. Here, we used a unified neuronal competition model to study the dynamics of adaptation and noise processes in binocular flash suppression (BFS), a form of externally induced perceptual suppression, and compare it with the dynamics of intrinsically driven alternations in binocular rivalry (BR). For the first time, we use electrophysiological, biologically relevant data to constrain a model of perceptual rivalry. Specifically, we show that the mean population discharge pattern of a perceptually modulated neuronal population detected in electrophysiological recordings in the lateral prefrontal cortex (LPFC) during BFS, constrains the dynamical range of externally induced perceptual transitions to a region around the bifurcation separating a noise-driven attractor regime from an adaptation-driven oscillatory regime. Most interestingly, the dynamical range of intrinsically driven perceptual transitions during BR is located in the noise-driven attractor regime, where it overlaps with BFS. Our results suggest that the neurodynamical mechanisms of externally induced and spontaneously generated perceptual alternations overlap in a narrow, noise-driven region just before a bifurcation where the system becomes adaptation-driven.	[Panagiotaropoulos, Theofanis I.; Kapoor, Vishal; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, D-72076 Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Manchester, Lancs, England; [Deco, Gustavo] Univ Pompeu Fabra, ICREA, Dept Technol, Barcelona, Spain	Max Planck Society; University of Manchester; ICREA; Pompeu Fabra University	Panagiotaropoulos, TI (corresponding author), Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, Spemannstr 38, D-72076 Tubingen, Germany.	theofanis.panagiotaropoulos@tuebingen.mpg.de; gustavo.deco@upf.edu	Panagiotaropoulos, Theofanis/A-6053-2013; Logothetis, Nikos/U-9282-2019; DECO, GUSTAVO/A-6341-2008	Panagiotaropoulos, Theofanis/0000-0002-4621-1183; DECO, GUSTAVO/0000-0002-8995-7583	Max Planck Society; ICREA Funding Source: Custom	Max Planck Society(Max Planck SocietyFoundation CELLEX); ICREA(ICREA)	This study was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1994, J NEUROSCI, V14, P6435; BIALEK W, 1995, PHYS REV LETT, V74, P3077, DOI 10.1103/PhysRevLett.74.3077; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Dayan P, 1998, NEURAL COMPUT, V10, P1119, DOI 10.1162/089976698300017377; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; Hebb Donald O., 1949, ORG BEHAV; Hock HS, 1997, PERCEPT PSYCHOPHYS, V59, P509, DOI 10.3758/BF03211860; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kalarickal GJ, 2000, NEUROCOMPUTING, V32, P843, DOI 10.1016/S0925-2312(00)00252-6; Kanai R, 2005, PERCEPTION, V34, P803, DOI 10.1068/p5245; Keliris GA, 2010, J NEUROSCI, V30, P12353, DOI 10.1523/JNEUROSCI.0677-10.2010; Kim YJ, 2006, VISION RES, V46, P392, DOI 10.1016/j.visres.2005.08.009; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kreiman G, 2002, P NATL ACAD SCI USA, V99, P8378, DOI 10.1073/pnas.072194099; Lago-Fernandez LF, 2002, NEUROCOMPUTING, V44, P503, DOI 10.1016/S0925-2312(02)00408-3; Laing CR, 2002, J COMPUT NEUROSCI, V12, P39, DOI 10.1023/A:1014942129705; Lankheet MJM, 2006, J VISION, V6, P304, DOI 10.1167/6.4.1; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Levelt W. J. M., 1968, BINOCULAR RIVALRY; LEVELT WJM, 1967, BRIT J PSYCHOL, V58, P143, DOI 10.1111/j.2044-8295.1967.tb01068.x; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Lumer ED, 1998, CEREB CORTEX, V8, P553, DOI 10.1093/cercor/8.6.553; Mattia M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.052903; Mattia M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051917; MEENAN JP, 1994, NEUROPSYCHOLOGIA, V32, P1145, DOI 10.1016/0028-3932(94)90159-7; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; MUELLER TJ, 1989, BIOL CYBERN, V61, P223, DOI 10.1007/BF00198769; Panagiotaropoulos TI, 2012, NEURON, V74, P924, DOI 10.1016/j.neuron.2012.04.013; Renart A, 2004, MATH COMP BIOL SER, P431; RICCI C, 1990, NEUROPSYCHOLOGIA, V28, P1163, DOI 10.1016/0028-3932(90)90052-P; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Shpiro A, 2007, J NEUROPHYSIOL, V97, P462, DOI 10.1152/jn.00604.2006; Shpiro A, 2009, J COMPUT NEUROSCI, V27, P37, DOI 10.1007/s10827-008-0125-3; Theodoni P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00145; van Ee R, 2009, J OPT SOC AM A, V26, P2612, DOI 10.1364/JOSAA.26.002612; WALKER P, 1975, PERCEPT PSYCHOPHYS, V18, P467, DOI 10.3758/BF03204122; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Windmann S, 2006, J COGNITIVE NEUROSCI, V18, P456, DOI 10.1162/089892906775990570; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0; Zhou YH, 2004, BIOL CYBERN, V90, P256, DOI 10.1007/s00422-004-0472-8	49	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53833	10.1371/journal.pone.0053833	http://dx.doi.org/10.1371/journal.pone.0053833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349748	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900022
J	Sebban, S; Farago, M; Gashai, D; Ilan, L; Pikarsky, E; Ben-Porath, I; Katzav, S				Sebban, Shulamit; Farago, Marganit; Gashai, Dan; Ilan, Lena; Pikarsky, Eli; Ben-Porath, Ittai; Katzav, Shulamit			Vav1 Fine Tunes p53 Control of Apoptosis versus Proliferation in Breast Cancer	PLOS ONE			English	Article							SIGNAL TRANSDUCER VAV1; CELL-RECEPTOR SIGNALS; TYROSINE PHOSPHORYLATION; PROTOONCOGENE PRODUCT; NEGATIVE REGULATION; GROWTH-FACTOR; LUNG-CANCER; T-CELLS; CBL-B; ACTIVATION	Vav1 functions as a signal transducer protein in the hematopoietic system, where it is exclusively expressed. Vav1 was recently implicated in several human cancers, including lung, pancreatic and neuroblasoma. In this study, we analyzed the expression and function of Vav1 in human breast tumors and breast cancer cell lines. Immunohistochemical analysis of primary human breast carcinomas indicated that Vav1 is expressed in 62% of 65 tumors tested and is correlated positively with estrogen receptor expression. Based on published gene profiling of 50 breast cancer cell lines, several Vav1-expressing cell lines were identified. RT-PCR confirmed Vav1 mRNA expression in several of these cell lines, yet no detectable levels of Vav1 protein were observed due to cbl-c proteasomal degradation. We used two of these lines, MCF-7 (Vav1 mRNA negative) and AU565 (Vav1 mRNA positive), to explore the effect of Vav1 expression on breast cell phenotype and function. Vav1 expression had opposite effects on function in these two lines: it reduced proliferation and enhanced cell death in MCF-7 cells but enhanced proliferation in AU565 cells. Consistent with these findings, transcriptome analysis revealed an increase in expression of proliferation-related genes in Vav1-expressing AU565 cells compared to controls, and an increase in apoptosis-related genes in Vav1-expressing MCF-7 cells compared with controls. TUNEL and gamma-H2AX foci assays confirmed that expression of Vav1 increased apoptosis in MCF-7 cells but not AU565 cells and shRNA experiments revealed that p53 is required for this pro-apoptotic effect of Vav1 in these cells. These results highlight for the first time the potential role of Vav1 as an oncogenic stress activator in cancer and the p53 dependence of its pro-apoptotic effect in breast cells.	[Sebban, Shulamit; Farago, Marganit; Gashai, Dan; Ilan, Lena; Ben-Porath, Ittai; Katzav, Shulamit] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Immunol & Canc Res, IL-91010 Jerusalem, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Pathol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Katzav, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel.	shulamitk@ekmd.huji.ac.il	pikarsky, eli/GXV-7099-2022	Ilan, Lena/0000-0002-7300-4606; pikarsky, eli/0000-0003-4186-7105	Israel Academy of Sciences; Israel Cancer Research Foundation; Israeli Cancer Association; Hubert H. Humphrey Center for Experimental Medicine and Cancer Research	Israel Academy of Sciences; Israel Cancer Research Foundation; Israeli Cancer Association; Hubert H. Humphrey Center for Experimental Medicine and Cancer Research	This work was supported by grants from the Israel Academy of Sciences, and the Israel Cancer Research Foundation, The Israeli Cancer Association and the Hubert H. Humphrey Center for Experimental Medicine and Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogio C, 2008, CANCER RES, V68, P8899, DOI 10.1158/0008-5472.CAN-08-2568; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bertagnolo V, 2008, J PROTEOME RES, V7, P3729, DOI 10.1021/pr7008719; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; BROWER M, 1986, CANCER RES, V46, P798; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; CAMERON DJ, 1979, J CLIN INVEST, V63, P977, DOI 10.1172/JCI109398; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chiang J, 2011, PLOS ONE, V6; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; CLARK GM, 1984, J CLIN ONCOL, V2, P1102, DOI 10.1200/JCO.1984.2.10.1102; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Gjerstorff MF, 2006, INT J ONCOL, V28, P1327; Groysman M, 2002, J BIOL CHEM, V277, P50121, DOI 10.1074/jbc.M204299200; Gu Y, 2006, ONCOGENE, V25, P3963, DOI 10.1038/sj.onc.1209427; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Hornstein I, 2003, J PATHOL, V199, P526, DOI 10.1002/path.1314; Ilan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029939; Ishida M, 2010, TOXICOLOGY, V275, P72, DOI 10.1016/j.tox.2010.06.005; KATZAV S, 1989, ONCOGENE, V4, P1129; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Kim J, 2012, ONCOL LETT, V3, P607, DOI 10.3892/ol.2011.531; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Lane J, 2008, INT J ONCOL, V33, P585, DOI 10.3892/ijo_00000044; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Marengere LEM, 1997, J IMMUNOL, V159, P70; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MARTE BM, 1995, ONCOGENE, V10, P167; Melamed I, 1999, CELL IMMUNOL, V191, P83, DOI 10.1006/cimm.1998.1402; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Mondal B, 2011, INDIAN J EXP BIOL, V49, P574; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Prieto-Sanchez RM, 2006, BRIT J HAEMATOL, V133, P642, DOI 10.1111/j.1365-2141.2006.06094.x; Ramaswamy M, 2007, J IMMUNOL, V179, P6384, DOI 10.4049/jimmunol.179.10.6384; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vigorito E, 2005, BLOOD, V106, P2391, DOI 10.1182/blood-2004-12-4894; Villalba M, 2000, EUR J IMMUNOL, V30, P1587, DOI 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T; WEISS A, 1984, J IMMUNOL, V133, P123; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; WESTLEY B, 1979, BIOCHEM BIOPH RES CO, V90, P410, DOI 10.1016/0006-291X(79)91250-6; Wilsbacher Julie L, 2006, Cell Commun Signal, V4, P5, DOI 10.1186/1478-811X-4-5; Yin J, 2011, ACTA PHARMACOL SIN, V32, P99, DOI 10.1038/aps.2010.185	58	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54321	10.1371/journal.pone.0054321	http://dx.doi.org/10.1371/journal.pone.0054321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342133	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400148
J	Knoll, F; Ridgely, RC; Ortega, F; Sanz, JL; Witmer, LM				Knoll, Fabien; Ridgely, Ryan C.; Ortega, Francisco; Luis Sanz, Jose; Witmer, Lawrence M.			Neurocranial Osteology and Neuroanatomy of a Late Cretaceous Titanosaurian Sauropod from Spain (Ampelosaurus sp.)	PLOS ONE			English	Article							SEMICIRCULAR CANALS; DINOSAUR BRAINCASE; SAURISCHIA; AGILITY; ANATOMY; SKULL	Titanosaurians were a flourishing group of sauropod dinosaurs during Cretaceous times. Fossils of titanosaurians have been found on all continents and their remains are abundant in a number of Late Cretaceous sites. Nonetheless, the cranial anatomy of titanosaurians is still very poorly known. The Spanish latest Cretaceous locality of "Lo Hueco'' yielded a relatively well preserved, titanosaurian braincase, which shares a number of phylogenetically restricted characters with Ampelosaurus atacis from France such as a flat occipital region. However, it appears to differ from A. atacis in some traits such as the greater degree of dorsoventral compression and the presence of proatlas facets. The specimen is, therefore, provisionally identified as Ampelosaurus sp. It was CT scanned, and 3D renderings of the cranial endocast and inner-ear system were generated. Our investigation highlights that, although titanosaurs were derived sauropods with a successful evolutionary history, they present a remarkably modest level of paleoneurological organization. Compared with the condition in the basal titanosauriform Giraffatitan brancai, the labyrinth of Ampelosaurus sp. shows a reduced morphology. The latter feature is possibly related to a restricted range of head-turning movements.	[Knoll, Fabien] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Ridgely, Ryan C.; Witmer, Lawrence M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Ortega, Francisco] Univ Nacl Educ Distancia, Dept Fis Matemat & Fluidos, Fac Ciencias, E-28040 Madrid, Spain; [Luis Sanz, Jose] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University System of Ohio; Ohio University; Universidad Nacional de Educacion a Distancia (UNED); Autonomous University of Madrid	Knoll, F (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain.	knoll@mncn.csic.es	Ortega, Francisco/B-5760-2009; Knoll, Fabien/D-3812-2014; Sanz, Jose Luis/O-1421-2019; Ortega, Francisco/K-3255-2015	Ortega, Francisco/0000-0002-7431-354X; Knoll, Fabien/0000-0001-7822-8740; Ortega, Francisco/0000-0002-7431-354X; Sanz, Jose Luis/0000-0002-5214-5725; Witmer, Lawrence/0000-0002-7610-0118	Ministerio de Economia y Competitividad, Madrid [CGL2009-12143]; Ramon y Cajal Program; United States National Science Foundation [IBN-9601174, IBN-0343744, IOB-0517257, IOS-1050154]; Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputing Center; Division Of Integrative Organismal Systems [1050154] Funding Source: National Science Foundation	Ministerio de Economia y Competitividad, Madrid; Ramon y Cajal Program(Spanish Government); United States National Science Foundation(National Science Foundation (NSF)); Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputing Center; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This is a contribution to the research project CGL2009-12143 (Ministerio de Economia y Competitividad, Madrid), of which FK, who is currently supported by the Ramon y Cajal Program, is Principal Investigator. LMW and RCR acknowledge funding support from the United States National Science Foundation (IBN-9601174, IBN-0343744, IOB-0517257, IOS-1050154) and the Ohio University Heritage College of Osteopathic Medicine. The Ohio Supercomputing Center also provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 1998, THESIS U SCI TECHNIQ; Balanoff AM, 2010, AM MUS NOVIT, P1, DOI 10.1206/591.1; Barroso-Barcenilla F, 2009, CRETACEOUS RES, V30, P1268, DOI 10.1016/j.cretres.2009.07.010; BERMAN D S, 1982, Annals of Carnegie Museum, V51, P405; Carabajal AP, 2012, ANAT REC, V295, P2141, DOI 10.1002/ar.22572; Carpenter Kenneth, 1998, Modern Geology, V23, P69; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Cordier R., 1954, TRAITE ZOOLOGIE, V12, P202; Cox PG, 2010, J ANAT, V216, P37, DOI 10.1111/j.1469-7580.2009.01172.x; Diaz VD, 2012, P GEOLOGIST ASSOC, V123, P626, DOI 10.1016/j.pgeola.2012.04.002; Diaz VD, 2011, ACTA PALAEONTOL POL, V56, P521, DOI 10.4202/app.2010.0043; Franzosa J.W., 2004, THESIS U TEXAS AUSTI; Galton PM, 2006, GEOL MAG, V143, P905, DOI 10.1017/S0016756806002561; Gomani EM, 2005, PALAEONTOL ELECTRON, V8; Gray AA, 1907, LABYRINTH ANIMALS IN, V1; HADZISELIMOVIC H, 1964, ACTA ANAT, V57, P306; Huene F.V., 1933, MEMOIRS GEOLOGICAL S, V21, P1; Huene F. von, 1929, Anales del Museo de La Plata, V3, P1; Janensch W, 1935, PALAEONTOGRAPHICA S, V7, P145; Jeffery N, 2010, J ANAT, V216, P496, DOI 10.1111/j.1469-7580.2010.01211.x; Knoll F, 2006, GEOBIOS-LYON, V39, P215, DOI 10.1016/j.geobios.2004.11.005; Knoll F, 1999, B SOC GEOL FR, V170, P103; Knoll F, 1997, THESIS U SCI TECHNIQ; Knoll F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030060; Knoll F, 2009, ANN PALEONTOL, V95, P165, DOI 10.1016/j.annpal.2009.06.001; KURZANOV SM, 1983, PALEONTOL ZH, P90; Le Loeuff J, 2005, LIFE O PAST, P115; LELOEUFF J, 1989, CR ACAD SCI II, V309, P851; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; Madsen James H. Jr, 1995, Bulletin of Carnegie Museum of Natural History, V31, P1; Mannion PD, 2011, J SYST PALAEONTOL, V9, P355, DOI 10.1080/14772019.2010.527379; Martinelli Agustin G., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P257; Mohabey DM, 2005, GONDWANA GEOLOGICAL, P101; Nowinski A., 1971, Palaeontologia Polonica, VNo. 25, P57; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Paulina Carabajal A, 2007, AMEGHINIANA, V44, P109; Philip J., 2000, ATLAS PERITETHYS PAL; PLESKOT G., 1940, ZOOL JAHRB ABT ALLG ZOOL U PHYSIOL TIERE, V60, P13; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Retzius G., 1881, GEHORORGAN WIRBELTHI, V1; RETZIUS G, 1884, GEHORORGAN WIRBELTHI, V2; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Salgado L, 2005, ACTA PALAEONTOL POL, V50, P79; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Tidwell V, 2003, J VERTEBR PALEONTOL, V23, P176, DOI 10.1671/0272-4634(2003)23[176:BOAECT]2.0.CO;2; Weishampel DB, 2011, TRANSYLVANIAN DINOSAURS, P1; WEISHAMPEL DB, 1991, RES EXPLOR, V7, P196; Werner C., 1960, GEHORORGAN WIRBELTIE; Wilson J. A., 2009, Contributions from the Museum of Paleontology University of Michigan, V32, P17; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663	54	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54991	10.1371/journal.pone.0054991	http://dx.doi.org/10.1371/journal.pone.0054991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355905	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500152
J	Ohsawa, M; Kobayashi, T; Okura, H; Igarashi, T; Mizuguchi, M; Hino, O				Ohsawa, Maki; Kobayashi, Toshiyuki; Okura, Hidehiro; Igarashi, Takashi; Mizuguchi, Masashi; Hino, Okio			TSC1 Controls Distribution of Actin Fibers through Its Effect on Function of Rho Family of Small GTPases and Regulates Cell Migration and Polarity	PLOS ONE			English	Article							GENE-PRODUCT; MAMMALIAN TARGET; COMPLEX 2; ACTIVATION; HAMARTIN; TUBERIN; ADHESION; JUNCTIONS; ADHERENS; SUPPRESSION	The tumor-suppressor genes TSC1 and TSC2 are mutated in tuberous sclerosis, an autosomal dominant multisystem disorder. The gene products of TSC1 and TSC2 form a protein complex that inhibits the signaling of the mammalian target of rapamycin complex1 (mTORC1) pathway. mTORC1 is a crucial molecule in the regulation of cell growth, proliferation and survival. When the TSC1/TSC2 complex is not functional, uncontrolled mTORC1 activity accelerates the cell cycle and triggers tumorigenesis. Recent studies have suggested that TSC1 and TSC2 also regulate the activities of Rac1 and Rho, members of the Rho family of small GTPases, and thereby influence the ensuing actin cytoskeletal organization at focal adhesions. However, how TSC1 contributes to the establishment of cell polarity is not well understood. Here, the relationship between TSC1 and the formation of the actin cytoskeleton was analyzed in stable TSC1-expressing cell lines originally established from a Tsc1-deficient mouse renal tumor cell line. Our analyses showed that cell proliferation and migration were suppressed when TSC1 was expressed. Rac1 activity in these cells was also decreased as was formation of lamellipodia and filopodia. Furthermore, the number of basal actin stress fibers was reduced; by contrast, apical actin fibers, originating at the level of the tight junction formed a network in TSC1-expressing cells. Treatment with Rho-kinase (ROCK) inhibitor diminished the number of apical actin fibers, but rapamycin had no effect. Thus, the actin fibers were regulated by the Rho-ROCK pathway independently of mTOR. In addition, apical actin fibers appeared in TSC1-deficient cells after inhibition of Rac1 activity. These results suggest that TSC1 regulates cell polarity-associated formation of actin fibers through the spatial regulation of Rho family of small GTPases.	[Ohsawa, Maki; Igarashi, Takashi] Univ Tokyo, Dept Pediat, Grad Sch Med, Tokyo, Japan; [Ohsawa, Maki; Kobayashi, Toshiyuki; Okura, Hidehiro; Hino, Okio] Juntendo Univ Sch Med, Dept Pathol & Oncol, Tokyo, Japan; [Okura, Hidehiro] Juntendo Univ Sch Med, Dept Neurosurg, Tokyo, Japan; [Ohsawa, Maki; Mizuguchi, Masashi] Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Tokyo, Japan	University of Tokyo; Juntendo University; Juntendo University; University of Tokyo	Kobayashi, T (corresponding author), Juntendo Univ Sch Med, Dept Pathol & Oncol, Tokyo, Japan.	koba396@juntendo.ac.jp; ohino@juntendo.ac.jp			Ministry of Education, Science, Technology, Sports and Culture, Japan; Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare, Japan; Institute for Environmental and Gender-Specific Medicine; Juntendo University	Ministry of Education, Science, Technology, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Institute for Environmental and Gender-Specific Medicine; Juntendo University	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Technology, Sports and Culture, Japan, and Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science, and the Ministry of Health, Labour and Welfare, Japan. This work was also supported by the Institute for Environmental and Gender-Specific Medicine and a research project of Juntendo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukuda T, 2000, ANAL BIOCHEM, V285, P274, DOI 10.1006/abio.2000.4787; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Goncharova E, 2004, J CELL BIOL, V167, P1171, DOI 10.1083/jcb.200405130; Haddad LA, 2002, J BIOL CHEM, V277, P44180, DOI 10.1074/jbc.M207211200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Henry KW, 1998, J BIOL CHEM, V273, P20535, DOI 10.1074/jbc.273.32.20535; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Jin F, 1996, P NATL ACAD SCI USA, V93, P9154, DOI 10.1073/pnas.93.17.9154; Jones AC, 1997, HUM MOL GENET, V6, P2155, DOI 10.1093/hmg/6.12.2155; Kleymenova E, 2001, MOL CELL, V7, P823, DOI 10.1016/S1097-2765(01)00226-X; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Larson Y, 2010, J BIOL CHEM, V285, P24987, DOI 10.1074/jbc.M109.096917; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Mak BC, 2005, AM J PATHOL, V167, P107, DOI 10.1016/S0002-9440(10)62958-6; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Miloloza A, 2000, HUM MOL GENET, V9, P1721, DOI 10.1093/hmg/9.12.1721; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Orimoto K, 1996, BIOCHEM BIOPH RES CO, V219, P70, DOI 10.1006/bbrc.1996.0183; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Satake N, 1999, CANCER RES, V59, P849; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shiono M, 2008, ONCOGENE, V27, P6690, DOI 10.1038/onc.2008.283; Soucek T, 1998, ONCOGENE, V16, P2197, DOI 10.1038/sj.onc.1201743; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Tsuchiya H, 1996, CANCER RES, V56, P429; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; YONEMURA S, 1995, J CELL SCI, V108, P127; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhou J, 2011, GENE DEV, V25, P1595, DOI 10.1101/gad.16750211	55	11	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54503	10.1371/journal.pone.0054503	http://dx.doi.org/10.1371/journal.pone.0054503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355874	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500081
J	Hillert, L; Jovanovic, H; Ahs, F; Savic, I				Hillert, Lena; Jovanovic, Hristina; Ahs, Fredrik; Savic, Ivanka			Women with Multiple Chemical Sensitivity Have Increased Harm Avoidance and Reduced 5-HT1A Receptor Binding Potential in the Anterior Cingulate and Amygdala	PLOS ONE			English	Article							TRIDIMENSIONAL PERSONALITY QUESTIONNAIRE; EMISSION COMPUTED-TOMOGRAPHY; CHRONIC-FATIGUE-SYNDROME; SEROTONIN(2A) RECEPTORS; SUBJECTIVE HEALTH; PYRAMIDAL NEURONS; ALLELIC VARIATION; ODOR INTOLERANCE; NORMATIVE DATA; IN-VIVO	Multiple chemical sensitivity (MCS) is a common condition, characterized by somatic distress upon exposure to odors. As in other idiopathic environmental intolerances, the underlying mechanisms are unknown. Contrary to the expectations it was recently found that persons with MCS activate the odor-processing brain regions less than controls, while their activation of the anterior cingulate cortex (ACC) is increased. The present follow-up study was designed to test the hypotheses that MCS subjects have increased harm avoidance and deviations in the serotonin system, which could render them intolerant to environmental odors. Twelve MCS and 11 control subjects, age 22-44, all working or studying females, were included in a PET study where 5-HT1A receptor binding potential (BP) was assessed after bolus injection of [C-11]WAY100635. Psychological profiles were assessed by the Temperament and Character Inventory and the Swedish universities Scales of Personality. All MCS and 12 control subjects were also tested for emotional startle modulation in an acoustic startle test. MCS subjects exhibited significantly increased harm avoidance, and anxiety compared to controls. They also had a reduced 5-HT1A receptor BP in amygdala (p = 0.029), ACC (p = 0.005) (planned comparisons, significance level 0.05), and insular cortex (p = 0.003; significance level p<0.005 with Bonferroni correction), and showed an inverse correlation between degree of anxiety and the BP in the amygdala (planned comparison). No group by emotional category difference was found in the startle test. Increased harm avoidance and the observed changes in the 5-HT1A receptor BP in the regions processing harm avoidance provides a plausible pathophysiological ground for the symptoms described in MCS, and yields valuable information for our general understanding of idiopathic environmental intolerances.	[Hillert, Lena] Karolinska Inst, Dept Publ Hlth Sci, Div Occupat & Environm Med, Stockholm, Sweden; [Jovanovic, Hristina; Savic, Ivanka] Karolinska Inst, Stockholm Brain Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Ahs, Fredrik] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Karolinska Institutet; Karolinska Institutet; Duke University	Hillert, L (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Occupat & Environm Med, Stockholm, Sweden.	lena.hillert@ki.se		Ahs, Fredrik/0000-0002-6355-660X; Hillert, Lena/0000-0002-3459-9782	Swedish Council for Working Life and Social Research [2004-0674]; Swedish Research Council [2009-4925]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Contract Grant Sponsor: Swedish Council for Working Life and Social Research, Contract grant number: 2004-0674, http://www.fas.se/and Swedish Research Council, Contract grant number 2009-4925, http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amargos-Bosch M, 2004, CEREB CORTEX, V14, P281, DOI 10.1093/cercor/bhg128; Andine P, 1997, ACTA PSYCHIAT SCAND, V96, P82, DOI 10.1111/j.1600-0447.1997.tb09910.x; Aupperle Robin L, 2010, Dialogues Clin Neurosci, V12, P517; Bartha L, 1999, ARCH ENVIRON HEALTH, V54, P147; Berg ND, 2008, INT ARCH OCC ENV HEA, V81, P881, DOI 10.1007/s00420-007-0282-0; Bergdahl J, 2005, CLIN ORAL INVEST, V9, P251, DOI 10.1007/s00784-005-0015-2; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8; Brandstrom S, 1998, COMPR PSYCHIAT, V39, P122, DOI 10.1016/S0010-440X(98)90070-0; Carlsson F, 2005, PUBLIC HEALTH, V119, P568, DOI 10.1016/j.puhe.2004.07.011; Chiew KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017635; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Ciumas C, 2006, NEUROLOGY, V67, P683, DOI 10.1212/01.wnl.0000230171.23913.cf; Cleare AJ, 2005, BIOL PSYCHIAT, V57, P239, DOI 10.1016/j.biopsych.2004.10.031; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1987, J PSYCHIAT RES, V21, P457, DOI 10.1016/0022-3956(87)90094-X; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Conrad R, 2007, PAIN, V133, P197, DOI 10.1016/j.pain.2007.07.024; CULLEN MR, 1987, OCCUP MED, V2, P655; Dalton P, 1996, CHEM SENSES, V21, P447, DOI 10.1093/chemse/21.4.447; Enge S, 2011, BEHAV BRAIN RES, V216, P122, DOI 10.1016/j.bbr.2010.07.021; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Gustavsson JP, 2000, ACTA PSYCHIAT SCAND, V102, P217, DOI 10.1034/j.1600-0447.2000.102003217.x; HAMON M, 1990, NEUROPSYCHOPHARMACOL, V3, P349; Hansenne M, 1997, BIOL PSYCHIAT, V42, P959, DOI 10.1016/S0006-3223(97)00325-9; Hausteiner C, 2003, J NERV MENT DIS, V191, P50, DOI 10.1097/00005053-200301000-00009; HEUSER G, 1994, TOXICOL IND HEALTH, V10, P561; Hillert L, 2007, HUM BRAIN MAPP, V28, P172, DOI 10.1002/hbm.20266; Iidaka T, 2006, BRAIN RES, V1125, P85, DOI 10.1016/j.brainres.2006.09.015; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; Jacob CP, 2004, AM J PSYCHIAT, V161, P569, DOI 10.1176/appi.ajp.161.3.569; Johansson A, 2005, INT ARCH OCC ENV HEA, V78, P559, DOI 10.1007/s00420-005-0616-8; Jovanovic H, 2011, NEUROIMAGE, V55, P1178, DOI 10.1016/j.neuroimage.2010.12.060; Jovanovic H, 2008, NEUROIMAGE, V39, P1408, DOI 10.1016/j.neuroimage.2007.10.016; Kim HJ, 2009, NEUROSCI LETT, V464, P103, DOI 10.1016/j.neulet.2009.07.087; Kreutzer R, 1999, AM J EPIDEMIOL, V150, P1; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Lanzenberger RR, 2007, BIOL PSYCHIAT, V61, P1081, DOI 10.1016/j.biopsych.2006.05.022; Lavergne MR, 2010, CAN FAM PHYSICIAN, V56, pE57; Machado CJ, 2010, BEHAV NEUROSCI, V124, P761, DOI 10.1037/a0021560; Meggs WJ, 1996, ARCH ENVIRON HEALTH, V51, P275, DOI 10.1080/00039896.1996.9936026; Mohr C, 2008, PAIN, V139, P416, DOI 10.1016/j.pain.2008.05.020; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Ochsner KN, 2008, SOC COGN AFFECT NEUR, V3, P144, DOI 10.1093/scan/nsn006; Orriols R, 2009, J NEUROL SCI, V287, P72, DOI 10.1016/j.jns.2009.09.003; Osterberg K, 2007, HUM EXP TOXICOL, V26, P231, DOI 10.1177/0960327107070575; Peirson AR, 1999, PSYCHIAT RES, V89, P29, DOI 10.1016/S0165-1781(99)00079-7; Pissiota A, 2003, EUR J NEUROSCI, V18, P1325, DOI 10.1046/j.1460-9568.2003.02855.x; Puig MV, 2005, CEREB CORTEX, V15, P1, DOI 10.1093/cercor/bhh104; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Rabiner EA, 2002, NEUROIMAGE, V15, P620, DOI 10.1006/nimg.2001.0984; Ross GH, 1999, TOXICOL IND HEALTH, V15, P415, DOI 10.1191/074823399678846853; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Savic I, 2004, NEUROLOGY, V62, P1343, DOI 10.1212/01.WNL.0000123696.98166.AF; SIMON TR, 1994, TOXICOL IND HEALTH, V10, P573; Skovbjerg S, 2009, SCAND J PUBLIC HEALT, V37, P621, DOI 10.1177/1403494809105430; Slater P, 1998, J NEURAL TRANSM, V105, P305, DOI 10.1007/s007020050060; Stenn P, 1998, PSYCHOSOMATICS, V39, P547, DOI 10.1016/S0033-3182(98)71289-7; Strobel A, 2003, J NEURAL TRANSM, V110, P1445, DOI 10.1007/s00702-003-0072-0; Szarek MJ, 1997, J ENVIRON PSYCHOL, V17, P345, DOI 10.1006/jevp.1997.0071; Wiesbeck GA, 2004, WORLD J BIOL PSYCHIA, V5, P45, DOI 10.1080/15622970410029907; Yang TT, 2009, NEUROREPORT, V20, P19, DOI 10.1097/WNR.0b013e328317f3cb	66	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54781	10.1371/journal.pone.0054781	http://dx.doi.org/10.1371/journal.pone.0054781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349968	Green Published, gold			2022-12-27	WOS:000314019100096
J	Kareva, I				Kareva, Irina			Biological Stoichiometry in Tumor Micro-environments	PLOS ONE			English	Article							HIPPEL-LINDAU-DISEASE; EVOLUTIONARY BIOLOGY; CANCER; DORMANCY; ECOLOGY; GROWTH; HEMANGIOBLASTOMAS; ANGIOGENESIS; METASTASIS; DIVERSITY	Tumors can be viewed as evolving ecological systems, in which heterogeneous populations of cancer cells compete with each other and somatic cells for space and nutrients within the ecosystem of the human body. According to the growth rate hypothesis (GRH), increased phosphorus availability in an ecosystem, such as the tumor micro-environment, may promote selection within the tumor for a more proliferative and thus potentially more malignant phenotype. The applicability of the GRH to tumor growth is evaluated using a mathematical model, which suggests that limiting phosphorus availability might promote intercellular competition within a tumor, and thereby delay disease progression. It is also shown that a tumor can respond differently to changes in its micro-environment depending on the initial distribution of clones within the tumor, regardless of its initial size. This suggests that composition of the tumor as a whole needs to be evaluated in order to maximize the efficacy of therapy.	Tufts Univ, Sch Med, Ctr Canc Syst Biol, Steward St Elizabeths Med Ctr, Boston, MA 02111 USA	St. Elizabeth's Medical Center; Tufts University	Kareva, I (corresponding author), Tufts Univ, Sch Med, Ctr Canc Syst Biol, Steward St Elizabeths Med Ctr, Boston, MA 02111 USA.	Irina.Kareva@tufts.edu			National Science Foundation (NSF) [DMPS-0838705]; National Security Agency (NSA) [H98230-09-1-0104]; Alfred P. Sloan Foundation; Office of the Provost of Arizona State University	National Science Foundation (NSF)(National Science Foundation (NSF)); National Security Agency (NSA)(National Security Agency); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Office of the Provost of Arizona State University	This project has been partially supported by grants from the National Science Foundation (NSF - Grant DMPS-0838705), the National Security Agency (NSA - Grant H98230-09-1-0104), the Alfred P. Sloan Foundation, and the Office of the Provost of Arizona State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Ammerman JM, 2006, J NEUROSURG, V105, P248, DOI 10.3171/jns.2006.105.2.248; Asthagiri AR, 2010, NEURO-ONCOLOGY, V12, P80, DOI 10.1093/neuonc/nop018; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; Camalier CE, 2010, CANCER PREV RES, V3, P359, DOI 10.1158/1940-6207.CAPR-09-0068; Crespi B, 2005, TRENDS ECOL EVOL, V20, P545, DOI 10.1016/j.tree.2005.07.007; Croker AK, 2009, CANCER DRUG DISCOV D, P141, DOI 10.1007/978-1-60327-933-8_11; CUKIER RI, 1973, J CHEM PHYS, V59, P3873, DOI 10.1063/1.1680571; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; Elser J, 2006, AM NAT, V168, pS25, DOI 10.1086/509048; Elser JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001028; Elser JJ, 2003, BIOSCIENCE, V53, P1112, DOI 10.1641/0006-3568(2003)053[1112:BSAEPO]2.0.CO;2; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Kareva I, 2011, TRANSL ONCOL, V4, P266, DOI 10.1593/tlo.11154; Krakauer DC, 2009, AM NAT, V173, P26, DOI 10.1086/593707; LANGE K, 1992, MATH BIOSCI, V111, P261, DOI 10.1016/0025-5564(92)90074-7; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mulder C, 2009, GLOBAL CHANGE BIOL, V15, P2730, DOI 10.1111/j.1365-2486.2009.01899.x; Nagy JD, 2005, MATH BIOSCI ENG, V2, P381, DOI 10.3934/mbe.2005.2.381; Naumov GN, 2009, CLIN EXP METASTAS, V26, P51, DOI 10.1007/s10585-008-9176-0; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Rocken M, 2010, J CLIN INVEST, V120, P1800, DOI 10.1172/JCI43424; Song DK, 2008, J NEUROSURG-PEDIATR, V2, P397, DOI 10.3171/PED.2008.2.12.397; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Teng MWL, 2008, J LEUKOCYTE BIOL, V84, P988, DOI 10.1189/jlb.1107774; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Wood PA, 2005, MOL CANCER THER, V4, P1065, DOI 10.1158/1535-7163.MCT-05-0028	30	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e51844	10.1371/journal.pone.0051844	http://dx.doi.org/10.1371/journal.pone.0051844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349677	gold, Green Published			2022-12-27	WOS:000314019100010
J	Suman, SK; Ravindra, D; Sharma, Y; Mishra, A				Suman, Shashi Kumar; Ravindra, Daddali; Sharma, Yogendra; Mishra, Amita			Association Properties and Unfolding of a beta gamma-Crystallin Domain of a Vibrio-Specific Protein	PLOS ONE			English	Article							SPORE COAT PROTEIN; X-RAY-ANALYSIS; EYE LENS; MYXOCOCCUS-XANTHUS; STABILITY; BINDING; AGGREGATION; SINGLE; SUPERFAMILY; EVOLUTION	The beta gamma-crystallin superfamily possesses a large number of versatile members, of which only a few members other than lens beta gamma-crystallins have been studied. Understanding the non-crystallin functions as well as origin of crystallin-like properties of such proteins is possible by exploring novel members from diverse sources. We describe a novel beta gamma-crystallin domain with S-type (Spherulin 3a type) Greek key motifs in protein vibrillin from a pathogenic bacterium Vibrio cholerae. This domain is a part of a large Vibrio-specific protein prevalent in Vibrio species (found in at least fourteen different strains sequenced so far). The domain contains two canonical N/D-N/D-X-X-S/T-S Ca2+-binding motifs, and bind Ca2+. Unlike spherulin 3a and other microbial homologues studied so far, beta gamma-crystallin domain of vibrillin self-associates forming oligomers of various sizes including dimers. The fractionated dimers readily form octamers in concentration-dependent manner, suggesting an association between these two major forms. The domain associates/dissociates forming dimers at the cost of monomeric populations in the presence of Ca2+. No such effect of Ca2+ has been observed in oligomeric species. The equilibrium unfolding of both forms follows a similar pattern, with the formation of an unfolding intermediate at sub-molar concentrations of denaturant. These properties exhibited by this beta gamma-crystallin domain are not shown by any other domain studied so far, demonstrating the diversity in domain properties.	[Suman, Shashi Kumar; Ravindra, Daddali; Sharma, Yogendra; Mishra, Amita] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sharma, Y (corresponding author), CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad, Andhra Pradesh, India.	yogendra@ccmb.res.in; amita@ccmb.res.in		SUMAN, Shashi Kumar/0000-0002-7668-5515	Department of Biotechnology (DBT-PDF); Council of Scientific and Industrial Research (CSIR), Government of India; Department of Science and Technology (SERC, DST); DBT, Government of India	Department of Biotechnology (DBT-PDF); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (SERC, DST); DBT, Government of India(Department of Biotechnology (DBT) India)	AM is supported by a post-doctoral fellowship of the Department of Biotechnology (DBT-PDF), SKS is the recipient of senior research fellowship from the Council of Scientific and Industrial Research (CSIR), Government of India. This research was supported by a Department of Science and Technology (SERC, DST), and a DBT, Government of India, grants to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Sampson L, 2010, J MOL BIOL, V401, P134, DOI 10.1016/j.jmb.2010.05.067; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Aravind P, 2009, J MOL BIOL, V385, P163, DOI 10.1016/j.jmb.2008.10.035; BAGBY S, 1994, P NATL ACAD SCI USA, V91, P4308, DOI 10.1073/pnas.91.10.4308; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Bilecen K, 2009, ENVIRON MICROBIOL, V11, P2015, DOI 10.1111/j.1462-2920.2009.01923.x; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BLUNDELL T, 1981, NATURE, V289, P771, DOI 10.1038/289771a0; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; Clout NJ, 2000, J MOL BIOL, V304, P253, DOI 10.1006/jmbi.2000.4197; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Jobby MK, 2007, BIOCHEMISTRY-US, V46, P12298, DOI 10.1021/bi700843q; Jobby MK, 2005, J BIOL CHEM, V280, P1209, DOI 10.1074/jbc.M409253200; Kierek K, 2003, P NATL ACAD SCI USA, V100, P14357, DOI 10.1073/pnas.2334614100; Mayr EM, 1997, J MOL BIOL, V269, P260, DOI 10.1006/jmbi.1997.1033; Mishra A, 2012, J MOL BIOL, V415, P75, DOI 10.1016/j.jmb.2011.10.037; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Pace C N, 1986, Methods Enzymol, V131, P266; Rajini B, 2003, BIOCHEMISTRY-US, V42, P4552, DOI 10.1021/bi027384l; Shimeld SM, 2005, CURR BIOL, V15, P1684, DOI 10.1016/j.cub.2005.08.046; Srivastava AK, 2010, BIOCHEMISTRY-US, V49, P9746, DOI 10.1021/bi101000m; Suman SK, 2011, J BIOL CHEM, V286, P43891, DOI 10.1074/jbc.M111.247890; Talla V, 2006, INVEST OPHTH VIS SCI, V47, P5212, DOI 10.1167/iovs.06-0427; Vendra VPR, 2010, MOL VIS, V16, P2822; Wenk M, 1999, J MOL BIOL, V293, P117, DOI 10.1006/jmbi.1999.3146; WISTOW G, 1983, J MOL BIOL, V170, P175, DOI 10.1016/S0022-2836(83)80232-0; WISTOW G, 1990, J MOL EVOL, V30, P140, DOI 10.1007/BF02099940; WISTOW G, 1985, NATURE, V315, P771, DOI 10.1038/315771a0; Wistow G, 1995, MOL BIOL EVOLUTION C; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	31	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53610	10.1371/journal.pone.0053610	http://dx.doi.org/10.1371/journal.pone.0053610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349723	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100024
J	Chang, YS; Choi, SJ; Ahn, SY; Sung, DK; Sung, SI; Yoo, HS; Oh, WI; Park, WS				Chang, Yun Sil; Choi, Soo Jin; Ahn, So Yoon; Sung, Dong Kyung; Sung, Se In; Yoo, Hye Soo; Oh, Won Il; Park, Won Soon			Timing of Umbilical Cord Blood Derived Mesenchymal Stem Cells Transplantation Determines Therapeutic Efficacy in the Neonatal Hyperoxic Lung Injury	PLOS ONE			English	Article							NADPH OXIDASE COMPLEX; RETINOIC ACID; ALVEOLARIZATION; INFANTS; GROWTH	Intratracheal transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) attenuates the hyperoxia-induced neonatal lung injury. The aim of this study was to optimize the timing of MSCs transplantation. Newborn Sprague-Dawley rats were randomly exposed to hyperoxia (90% for 2 weeks and 60% for 1 week) or normoxia after birth for 21 days. Human UCB-derived MSCs (5x10(5) cells) were delivered intratracheally early at postnatal day (P) 3 (HT3), late at P10 (HT10) or combined early+late at P3+10 (HT3+10). Hyperoxia-induced increase in mortality, TUNEL positive cells, ED1 positive alveolar macrophages, myeloperoxidase activity and collagen levels, retarded growth and reduced alveolarization as evidenced by increased mean linear intercept and mean alveolar volume were significantly better attenuated in both HT3 and HT3+10 than in HT10. Hyperoxia-induced up-regulation of both cytosolic and membrane p47(phox) indicative of oxidative stress, and increased inflammatory markers such as tumor necrosis factor-alpha, interleukin (IL)-1 alpha, IL-1 beta, IL-6, and transforming growth factor-beta measured by ELISA, and tissue inhibitor of metalloproteinase-1, CXCL7, RANTES, L-selectin and soluble intercellular adhesion molecule-1 measured by protein array were consistently more attenuated in both HT3 and HT3+10 than in HT10. Hyperoxia-induced decrease in hepatocyte growth factor and vascular endothelial growth factor was significantly up-regulated in both HT3 and HT3+10, but not in HT10. In summary, intratracheal transplantation of human UCB derived MSCs time-dependently attenuated hyperoxia-induced lung injury in neonatal rats, showing significant protection only in the early but not in the late phase of inflammation. There were no synergies with combined early+late MSCs transplantation.	[Chang, Yun Sil; Ahn, So Yoon; Sung, Se In; Yoo, Hye Soo; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Chang, Yun Sil; Sung, Dong Kyung; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea; [Choi, Soo Jin; Oh, Won Il] MEDIPOST Co Ltd, Biomed Res Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; MEDIPOST	Park, WS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.	wonspark@skku.edu			Ministry for Health, Welfare & Family Affairs, Republic of Korea [A102136]; National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [S-2011-0317-000]; Samsung Biomedical Research Institute Grant [SBRI CB11271]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Samsung Biomedical Research Institute Grant(Samsung)	This work was supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A102136), by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (S-2011-0317-000), and by a Samsung Biomedical Research Institute Grant (#SBRI CB11271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; AVERY ME, 1987, PEDIATRICS, V79, P26; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BASTIAN NR, 1994, CURR OPIN IMMUNOL, V6, P131, DOI 10.1016/0952-7915(94)90044-2; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; BREGMAN J, 1992, CLIN PERINATOL, V19, P673, DOI 10.1016/S0095-5108(18)30451-2; Chang YS, 2011, CELL TRANSPLANT; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Cho SJ, 2005, AM J RESP CELL MOL, V33, P622, DOI 10.1165/rcmb.2005-0050OC; Choo-Wing R, 2007, AM J PHYSIOL-LUNG C, V293, pL142, DOI 10.1152/ajplung.00434.2006; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Gray KD, 2003, AM J SURG, V186, P526, DOI 10.1016/j.amjsurg.2003.07.010; Hohler B, 2000, HISTOCHEM CELL BIOL, V114, P29; Jang YK, 2006, ANN HEMATOL, V85, P212, DOI 10.1007/s00277-005-0047-3; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kunig AM, 2005, AM J PHYSIOL-LUNG C, V289, pL529, DOI 10.1152/ajplung.00336.2004; Lee JK, 2007, CELL TRANSPLANT, V16, P849, DOI 10.3727/000000007783465271; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; McGrath-Morrow SA, 2001, AM J RESP CELL MOL, V25, P150, DOI 10.1165/ajrcmb.25.2.4362; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P251, DOI 10.1006/jmcc.2001.1494; ROBINSON JM, 1995, HISTOCHEM CELL BIOL, V103, P163, DOI 10.1007/BF01454021; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Saugstad Ola Didrik, 2003, Semin Neonatol, V8, P39, DOI 10.1016/S1084-2756(02)00194-X; Snyder JM, 2005, PEDIATR RES, V57, P384, DOI 10.1203/01.PDR.0000151315.81106.D3; THURLBECK WM, 1982, THORAX, V37, P564, DOI 10.1136/thx.37.8.564; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041	36	155	160	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e52419	10.1371/journal.pone.0052419	http://dx.doi.org/10.1371/journal.pone.0052419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349686	Green Published, Green Submitted, gold			2022-12-27	WOS:000313943000008
J	Sainath, R; Granato, M				Sainath, Rajiv; Granato, Michael			Plexin A3 and Turnout Regulate Motor Axonal Branch Morphogenesis in Zebrafish	PLOS ONE			English	Article							DEVELOPMENTAL REGULATION; DIFFERENTIAL REQUIREMENT; IDENTIFIED MOTONEURONS; GROWTH; GENE; EXPRESSION; NEURONS; MUSCLE; SYNAPTOGENESIS; SEMAPHORINS	During embryogenesis motor axons navigate to their target muscles, where individual motor axons develop complex branch morphologies. The mechanisms that control axonal branching morphogenesis have been studied intensively, yet it still remains unclear when branches begin to form or how branch locations are determined. Live cell imaging of individual zebrafish motor axons reveals that the first axonal branches are generated at the ventral extent of the myotome via bifurcation of the growth cone. Subsequent branches are generated by collateral branching restricted to their synaptic target field along the distal portion of the axon. This precisely timed and spatially restricted branching process is disrupted in turnout mutants we identified in a forward genetic screen. Molecular genetic mapping positioned the turnout mutation within a 300 kb region encompassing eight annotated genes, however sequence analysis of all eight open reading frames failed to unambiguously identify the turnout mutation. Chimeric analysis and single cell labeling reveal that turnout function is required cell non-autonomously for intraspinal motor axon guidance and peripheral branch formation. turnout mutant motor axons form the first branch on time via growth cone bifurcation, but unlike wild-type they form collateral branches precociously, when the growth cone is still navigating towards the ventral myotome. These precocious collateral branches emerge along the proximal region of the axon shaft typically devoid of branches, and they develop into stable, permanent branches. Furthermore, we find that null mutants of the guidance receptor plexin A3 display identical motor axon branching defects, and time lapse analysis reveals that precocious branch formation in turnout and plexin A3 mutants is due to increased stability of otherwise short-lived axonal protrusions. Thus, plexin A3 dependent intrinsic and turnout dependent extrinsic mechanisms suppress collateral branch morphogenesis by destabilizing membrane protrusions before the growth cone completes navigation into the synaptic target field.	[Sainath, Rajiv; Granato, Michael] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Granato, M (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu			NIH [HD37975, MH092257]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by NIH grants HD37975 and MH092257 to M. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andlauer Till F M, 2012, Cold Spring Harb Protoc, V2012, P481, DOI 10.1101/pdb.prot068593; Appel B, 1995, DEVELOPMENT, V121, P4117; Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306; Barnes SH, 2010, DEVELOPMENT, V137, P805, DOI 10.1242/dev.042457; Birely J, 2005, DEV BIOL, V280, P162, DOI 10.1016/j.ydbio.2005.01.012; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Downes GB, 2004, DEV BIOL, V270, P232, DOI 10.1016/j.ydbio.2004.02.027; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Gallo G, 2011, DEV NEUROBIOL, V71, P201, DOI 10.1002/dneu.20852; Gibson DA, 2011, DEVELOPMENT, V138, P183, DOI 10.1242/dev.046441; Grider MH, 2009, J NEUROSCI RES, V87, P3033, DOI 10.1002/jnr.22140; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Knapik EW, 1996, DEVELOPMENT, V123, P451; Lefebvre JL, 2007, P NATL ACAD SCI USA, V104, P2483, DOI 10.1073/pnas.0610822104; Lichtman JW, 2003, J NEUROCYTOL, V32, P767, DOI 10.1023/B:NEUR.0000020622.58471.37; Liu DYT, 2008, J MICROSC-OXFORD, V231, P349, DOI 10.1111/j.1365-2818.2008.02068.x; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; Low LK, 2008, P NATL ACAD SCI USA, V105, P8136, DOI 10.1073/pnas.0803849105; Melancon E, 1997, J NEUROSCI, V17, P7796; Mould AP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-24; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Neufeld SQ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-15; Noda Y, 2012, P NATL ACAD SCI USA, V109, P1725, DOI 10.1073/pnas.1107808109; Palaisa KA, 2007, DEVELOPMENT, V134, P3251, DOI 10.1242/dev.007112; Panagiotaki N, 2010, DEVELOPMENT, V137, P4005, DOI 10.1242/dev.053173; Panzer JA, 2005, DEV BIOL, V285, P340, DOI 10.1016/j.ydbio.2005.06.027; Puschel AW, 2007, ADV EXP MED BIOL, V600, P12; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sato-Maeda M, 2006, DEVELOPMENT, V133, P937, DOI 10.1242/dev.02268; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TOMASELLI KJ, 1988, J NEUROSCI RES, V21, P275, DOI 10.1002/jnr.490210220; VARNUMFINNEY B, 1995, NEURON, V14, P1213, DOI 10.1016/0896-6273(95)90268-6; Waimey KE, 2006, NEUROSCIENTIST, V12, P398, DOI 10.1177/1073858406292631; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; WEAVER CD, 1995, J NEUROSCI, V15, P5275; Wyatt RM, 2003, J NEUROCYTOL, V32, P777, DOI 10.1023/B:NEUR.0000020623.62043.33; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; YU WQ, 1994, J NEUROSCI, V14, P5872; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54071	10.1371/journal.pone.0054071	http://dx.doi.org/10.1371/journal.pone.0054071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349787	Green Submitted, Green Published, gold			2022-12-27	WOS:000313943000025
J	Whang, YM; Jo, U; Sung, JS; Ju, HJ; Kim, HK; Park, KH; Lee, JW; Koh, IS; Kim, YH				Whang, Young Mi; Jo, Ukhyun; Sung, Jae Sook; Ju, Hyun Jung; Kim, Hyun Kyung; Park, Kyong Hwa; Lee, Jong Won; Koh, In Song; Kim, Yeul Hong			Wnt5a Is Associated with Cigarette Smoke-Related Lung Carcinogenesis via Protein Kinase C	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; TOBACCO-SMOKE; CANCER CELLS; EXPRESSION; TRANSFORMATION; PROLIFERATION; RELEASE; GROWTH; GENES; ALPHA	Wnt5a is overexpressed during the progression of human non-small cell lung cancer. However, the roles of Wnt5a during smoking-related lung carcinogenesis have not been clearly elucidated. We investigated the associations between Wnt5a and the early development of cigarette smoke related lung cancer using human bronchial epithelial (HBE) cells (NHBE, BEAS-2B, 1799, 1198 and 1170I) at different malignant stages established by exposure to cigarette smoke condensate (CSC). Abnormal up-regulation of Wnt5a mRNA and proteins was detected in CSC-exposed transformed 1198 and tumorigenic 1170I cells as compared with other non-CSC exposed HBE cells. Tumor tissues obtained from smokers showed higher Wnt5a expressions than matched normal tissues. In non-CSC exposed 1799 cells, treatment of recombinant Wnt5a caused the activations of PKC and Akt, and the blockage of Wnt5a and PKC significantly decreased the viabilities of CSC-transformed 1198 cells expressing high levels of Wnt5a. This reduced cell survival rate was associated with increased apoptosis via the down-regulation of Bcl2 and the induction of cleaved poly ADP-ribose polymerase. Moreover, CSC-treated 1799 cells showed induction of Wnt5a expression and enhanced colony-forming capacity. The CSC-induced colony forming efficiency was suppressed by the co-incubation with a PKC inhibitor. In conclusion, these results suggest that cigarette smoke induces Wnt5a-coupled PKC activity during lung carcinogenesis, which causes Akt activity and anti-apoptosis in lung cancer. Therefore, current study provides novel clues for the crucial role of Wnt5a in the smoking-related lung carcinogenesis.	[Whang, Young Mi; Jo, Ukhyun; Sung, Jae Sook; Ju, Hyun Jung; Kim, Hyun Kyung; Park, Kyong Hwa; Lee, Jong Won; Kim, Yeul Hong] Korea Univ, Coll Med, Anam Hosp, Dept Hematol Oncol, Seoul 136705, South Korea; [Whang, Young Mi; Jo, Ukhyun; Sung, Jae Sook; Ju, Hyun Jung; Kim, Hyun Kyung; Park, Kyong Hwa; Lee, Jong Won; Kim, Yeul Hong] Korea Univ, Coll Med, Anam Hosp, Brain Korea Project Biomed Sci 21, Seoul 136705, South Korea; [Koh, In Song] Hanyang Univ, Dept Physiol, Coll Med, Seoul 133791, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Hanyang University	Kim, YH (corresponding author), Korea Univ, Coll Med, Anam Hosp, Dept Hematol Oncol, Seoul 136705, South Korea.	yhk0215@korea.ac.kr	JO, Ukhyun/ABE-3019-2021	jo, ukhyun/0000-0002-2826-1355; PARK, KYONG HWA/0000-0002-2464-7920; Kim, Yeul Hong/0000-0002-2555-2333	National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea [A111218-11-GM04]; Seoul Research and Business Development Program [10574]	National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea; Seoul Research and Business Development Program(Seoul RBD program)	This study was supported by a grant from the National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea (A111218-11-GM04) and Seoul Research and Business Development Program (10574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Gao Zhi-qiang, 2010, Zhonghua Jie He He Hu Xi Za Zhi, V33, P284; HECHT SS, 1988, CARCINOGENESIS, V9, P875, DOI 10.1093/carcin/9.6.875; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Ikegami Y, 1996, JPN J PHARMACOL, V70, P65, DOI 10.1254/jjp.70.65; KLEINSZANTO AJP, 1992, P NATL ACAD SCI USA, V89, P6693, DOI 10.1073/pnas.89.15.6693; Lacroix L, 2006, CANCER BIOL THER, V5, P665, DOI 10.4161/cbt.5.6.2870; LEJEUNE S, 1995, CLIN CANCER RES, V1, P215; Lemjabbar H, 2003, J BIOL CHEM, V278, P26202, DOI 10.1074/jbc.M207018200; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; MacLeod RJ, 2007, AM J PHYSIOL-GASTR L, V293, pG403, DOI 10.1152/ajpgi.00119.2007; REDDEL RR, 1988, CANCER RES, V48, P1904; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; Schuller HM, 1999, CANCER RES, V59, P4510; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wen Jing, 2011, Chin J Cancer, V30, P551, DOI 10.5732/cjc.011.10059; Wyatt TA, 1999, AM J RESP CELL MOL, V21, P283, DOI 10.1165/ajrcmb.21.2.3636; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-0051OC	26	25	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53012	10.1371/journal.pone.0053012	http://dx.doi.org/10.1371/journal.pone.0053012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349696	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000010
J	Barben, J; Strippoli, MPF; Trachsel, D; Schiller, B; Hammer, J; Kuehni, CE				Barben, Juerg; Strippoli, Marie-Pierre F.; Trachsel, Daniel; Schiller, Barbara; Hammer, Juerg; Kuehni, Claudia E.			Effect of Mannitol Dry Powder Challenge on Exhaled Nitric Oxide in Children	PLOS ONE			English	Article							ASTHMA; METHACHOLINE; TESTS	Background: Fractional exhaled nitric oxide (FENO), a non-invasive marker of eosinophilic airway inflammation, is increasingly used for diagnostic and therapeutic decisions in adult and paediatric asthma. Standardized guidelines for the measurement of FENO recommend performing FENO measurements before rather than after bronchial provocation tests. Objective: To investigate whether FENO levels decrease after a Mannitol dry powder (MDP) challenge in a clinical setting, and whether the extent of the decrease is influenced by number of MDP manoeuvres, baseline FENO, atopy and doctor diagnosed asthma. Methods: Children aged 6-16 years, referred for possible reactive airway disease to a respiratory outpatient clinic, performed an MDP challenge (Aridol((R)), Pharmaxis, Australia). FENO was measured in doublets immediately before and after the challenge test using the portable NIOX MINO (R) device (Aerocrine, Stockholm, Sweden). We analysed the data using Kruskal-Wallis rank tests, Wilcoxon signed rank tests and multivariable linear regressions. Results: One hundred and seven children completed both tests (mean +/- SD age 11.5 +/- 2.8 years). Overall, median (interquartile range) FENO decreased slightly by -2.5 ppb (-7.0, -0.5), from 18.5 ppb (10.5, 45.5) before the MDP challenge to 16.5 ppb thereafter (8.5, 40.5;p < 0.001). In all participants, the change in FENO was smaller than one standard deviation of the baseline mean. The % fall in FENO was smaller in children with less MDP manoeuvres (e. g. higher bronchial responsiveness; p = 0.08) but was not influenced by levels of baseline FENO (p = 0.68), atopy (p = 0.84) or doctor diagnosed asthma (p = 0.93). Conclusion: MDP challenge test influences FENO values but differences are small and clinically barely relevant.	[Barben, Juerg; Schiller, Barbara] Childrens Hosp, Dept Paediat Pulmonol & Allergol, St Gallen, Switzerland; [Strippoli, Marie-Pierre F.; Kuehni, Claudia E.] Univ Bern, ISPM, Bern, Switzerland; [Trachsel, Daniel; Hammer, Juerg] Univ Childrens Hosp Basel, Dept Pulmonol & Intens Care, Basel, Switzerland	University of Bern; University of Basel	Barben, J (corresponding author), Childrens Hosp, Dept Paediat Pulmonol & Allergol, St Gallen, Switzerland.	juerg.barben@kispisg.ch	Strippoli, Marie-Pierre F/K-8164-2013	Strippoli, Marie-Pierre F/0000-0003-3053-484X; Hammer, Jurg/0000-0001-7404-2383; Kuehni, Claudia E./0000-0001-8957-2002	AstraZeneca (Switzerland); Lung Association St. Gallen; Schmidheiny Foundation (Heerbrugg, St. Gallen); Swiss National Science Foundation [3200B0-122341]	AstraZeneca (Switzerland)(AstraZeneca); Lung Association St. Gallen; Schmidheiny Foundation (Heerbrugg, St. Gallen); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by AstraZeneca (Switzerland), the Lung Association St. Gallen and the Schmidheiny Foundation (Heerbrugg, St. Gallen). Mannitol dry powder challenge tests were provided by Pharmaxis (New South Wales, Australia). MPS was supported by the Swiss National Science Foundation (grant 3200B0-122341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Anderson SD, 1997, AM J RESP CRIT CARE, V156, P758, DOI 10.1164/ajrccm.156.3.9701113; AVITAL A, 1995, THORAX, V50, P511, DOI 10.1136/thx.50.5.511; Barben J, 2003, PEDIATR PULM, V36, P490, DOI 10.1002/ppul.10378; Barben J, 2011, PEDIATR PULM, V46, P842, DOI 10.1002/ppul.21453; Barreto M, 2006, PEDIATR PULM, V41, P141, DOI 10.1002/ppul.20358; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Brannan JD, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-144; Braun-Fahrlander C, 1999, ALLERGOLOGIE, V22, P54; Decimo F, 2011, INT J IMMUNOPATH PH, V24, P1069, DOI 10.1177/039463201102400424; Gabriele C, 2005, PEDIAT ALLERG IMM-UK, V16, P243, DOI 10.1111/j.1399-3038.2005.00255.x; Kersten ETG, 2009, PEDIATR PULM, V44, P655, DOI 10.1002/ppul.21034; Menzies D, 2007, CHEST, V131, P410, DOI 10.1378/chest.06-1335; Schiller B, 2009, PEDIAT ALLERG IMM-UK, V20, P679, DOI 10.1111/j.1399-3038.2009.00853.x; SILVERMAN M, 1972, ARCH DIS CHILD, V47, P882, DOI 10.1136/adc.47.256.882; Subbarao P, 2000, PEDIATR PULM, V29, P291, DOI 10.1002/(SICI)1099-0496(200004)29:4<291::AID-PPUL9>3.0.CO;2-A; Taylor DR, 2006, THORAX, V61, P817, DOI 10.1136/thx.2005.056093	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54521	10.1371/journal.pone.0054521	http://dx.doi.org/10.1371/journal.pone.0054521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349918	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800060
J	Godugu, C; Patel, AR; Desai, U; Andey, T; Sams, A; Singh, M				Godugu, Chandraiah; Patel, Apurva R.; Desai, Utkarsh; Andey, Terrick; Sams, Alexandria; Singh, Mandip			AlgiMatrix (TM) Based 3D Cell Culture System as an In-Vitro Tumor Model for Anticancer Studies	PLOS ONE			English	Article							CANCER STEM-CELL; EXTRACELLULAR-MATRIX; DRUG-RESISTANCE; SOLID TUMORS; TISSUE; SCAFFOLDS; THERAPY; 3RD-DIMENSION; PENETRATION; SPHEROIDS	Background: Three-dimensional (3D) in-vitro cultures are recognized for recapitulating the physiological microenvironment and exhibiting high concordance with in-vivo conditions. Taking the advantages of 3D culture, we have developed the in-vitro tumor model for anticancer drug screening. Methods: Cancer cells grown in 6 and 96 well AlgiMatrix (TM) scaffolds resulted in the formation of multicellular spheroids in the size range of 100-300 mu m. Spheroids were grown in two weeks in cultures without compromising the growth characteristics. Different marketed anticancer drugs were screened by incubating them for 24 h at 7, 9 and 11 days in 3D cultures and cytotoxicity was measured by AlamarBlue (R) assay. Effectiveness of anticancer drug treatments were measured based on spheroid number and size distribution. Evaluation of apoptotic and anti-apoptotic markers was done by immunohistochemistry and RT-PCR. The 3D results were compared with the conventional 2D monolayer cultures. Cellular uptake studies for drug (Doxorubicin) and nanoparticle (NLC) were done using spheroids. Results: IC50 values for anticancer drugs were significantly higher in AlgiMatrix (TM) systems compared to 2D culture models. The cleaved caspase-3 expression was significantly decreased (2.09 and 2.47 folds respectively for 5-Fluorouracil and Camptothecin) in H460 spheroid cultures compared to 2D culture system. The cytotoxicity, spheroid size distribution, immunohistochemistry, RT-PCR and nanoparticle penetration data suggested that in vitro tumor models show higher resistance to anticancer drugs and supporting the fact that 3D culture is a better model for the cytotoxic evaluation of anticancer drugs in vitro. Conclusion: The results from our studies are useful to develop a high throughput in vitro tumor model to study the effect of various anticancer agents and various molecular pathways affected by the anticancer drugs and formulations.	[Godugu, Chandraiah; Patel, Apurva R.; Desai, Utkarsh; Andey, Terrick; Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Sams, Alexandria] Life Technol Corp, Cell Syst Div, Primary & Stem Cell Syst, Frederick, MA USA	State University System of Florida; Florida A&M University; Thermo Fisher Scientific	Singh, M (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	mandip.sachdeva@famu.edu	Godugu, Chandraiah/F-4741-2018	Godugu, Chandraiah/0000-0001-5904-3134; HYDERABAD, NIPER/0000-0001-7521-1150	NCMHD [P 20MD 006738-01]; SC-1 grant [1SC1CA161676-01A1]; National Institutes of Health (NIH) [SC1CA161676-01A1]; NATIONAL CANCER INSTITUTE [SC1CA161676] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007582, P20MD006738] Funding Source: NIH RePORTER	NCMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); SC-1 grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NCMHD grant P 20MD 006738-01 and SC-1 grant 1SC1CA161676-01A1. This work was also supported by National Institutes of Health (NIH) funding grant number SC1CA161676-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbone D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.58; Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Chitcholtan K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-38; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Dubrovska A, 2010, CLIN CANCER RES, V16, P5692, DOI 10.1158/1078-0432.CCR-10-1601; Duong HS, 2005, INT J EXP PATHOL, V86, P365, DOI 10.1111/j.0959-9673.2005.00441.x; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Howe GA, 2012, CELL ADHES MIGR, V6, P71, DOI 10.4161/cam.20077; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kim JW, 2011, ANTICANCER RES, V31, P3237; Kyle AH, 2004, CANCER RES, V64, P6304, DOI 10.1158/0008-5472.CAN-04-1099; Kyle AH, 2007, CLIN CANCER RES, V13, P2804, DOI 10.1158/1078-0432.CCR-06-1941; Labarbera DV, 2012, EXPERT OPIN DRUG DIS; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Mitra M, 2012, MOL VIS, V18, P1361; Ong SM, 2010, BIOMATERIALS, V31, P1180, DOI 10.1016/j.biomaterials.2009.10.049; Oshikata A, 2011, J BIOSCI BIOENG, V111, P590, DOI 10.1016/j.jbiosc.2011.01.006; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Patlolla RR, 2010, J CONTROL RELEASE, V144, P233, DOI 10.1016/j.jconrel.2010.02.006; Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542; Prestwich GD, 2008, ACCOUNTS CHEM RES, V41, P139, DOI 10.1021/ar7000827; Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jcb.21386; Sarkar B, 2009, CHEM REV, V109, P3200, DOI 10.1021/cr9000397; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001; Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev; Xiang XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014640; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Zschenker O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034279	39	164	166	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53708	10.1371/journal.pone.0053708	http://dx.doi.org/10.1371/journal.pone.0053708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349734	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800012
J	Johansson, J; Manneras-Holm, L; Shao, RJ; Olsson, A; Lonn, M; Billig, H; Stener-Victorin, E				Johansson, Julia; Manneras-Holm, Louise; Shao, Ruijin; Olsson, AnneLiese; Lonn, Malin; Billig, Hakan; Stener-Victorin, Elisabet			Electrical vs Manual Acupuncture Stimulation in a Rat Model of Polycystic Ovary Syndrome: Different Effects on Muscle and Fat Tissue Insulin Signaling	PLOS ONE			English	Article							LOW-FREQUENCY ELECTROACUPUNCTURE; MESSENGER-RNA EXPRESSION; BLOOD-FLOW RESPONSES; PHYSICAL-EXERCISE; ADIPOSE-TISSUE; GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; GENE-EXPRESSION; GROUP-III; WOMEN	In rats with dihydrotestosterone (DHT)-induced polycystic ovary syndrome (PCOS), repeated low-frequency electrical stimulation of acupuncture needles restores whole-body insulin sensitivity measured by euglycemic hyperinsulinemic clamp. We hypothesized that electrical stimulation causing muscle contractions and manual stimulation causing needle sensation have different effects on insulin sensitivity and related signaling pathways in skeletal muscle and adipose tissue, with electrical stimulation being more effective in DHT-induced PCOS rats. From age 70 days, rats received manual or low-frequency electrical stimulation of needles in abdominal and hind limb muscle five times/wk for 4-5 wks; controls were handled but untreated rats. Low-frequency electrical stimulation modified gene expression (decreased Tbc1d1 in soleus, increased Nr4a3 in mesenteric fat) and protein expression (increased pAS160/AS160, Nr4a3 and decreased GLUT4) by western blot and increased GLUT4 expression by immunohistochemistry in soleus muscle; glucose clearance during oral glucose tolerance tests was unaffected. Manual stimulation led to faster glucose clearance and modified mainly gene expression in mesenteric adipose tissue (increased Nr4a3, Mapk3/Erk, Adcy3, Gsk3b), but not protein expression to the same extent; however, Nr4a3 was reduced in soleus muscle. The novel finding is that electrical and manual muscle stimulation affect glucose homeostasis in DHT-induced PCOS rats through different mechanisms. Repeated electrical stimulation regulated key functional molecular pathways important for insulin sensitivity in soleus muscle and mesenteric adipose tissue to a larger extent than manual stimulation. Manual stimulation improved whole-body glucose tolerance, an effect not observed after electrical stimulation, but did not affect molecular signaling pathways to the same extent as electrical stimulation. Although more functional signaling pathways related to insulin sensitivity were affected by electrical stimulation, our findings suggest that manual stimulation of acupuncture needles has a greater effect on glucose tolerance. The underlying mechanism of the differential effects of the intermittent manual and the continuous electrical stimulation remains to be elucidated.	[Johansson, Julia; Manneras-Holm, Louise; Shao, Ruijin; Olsson, AnneLiese; Billig, Hakan; Stener-Victorin, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Lonn, Malin] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Stener-Victorin, Elisabet] Heilongjiang Univ Chinese Med, Dept Obstet & Gynecol, Affiliated Hosp 1, Harbin, Peoples R China	University of Gothenburg; University of Gothenburg; Heilongjiang University of Chinese Medicine	Stener-Victorin, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden.	elisabet.stener-victorin@neuro.gu.se	Billig, Hakan/E-8891-2011; Shao, Linus R/M-3134-2019; Stener-Victorin, Elisabet/W-6322-2018; Shao, Linus R/M-3059-2019	Billig, Hakan/0000-0001-6140-9182; Shao, Linus R/0000-0002-1339-9570; Stener-Victorin, Elisabet/0000-0002-3424-1502; Shao, Linus R/0000-0002-1339-9570	Genomics Core Facility at the Sahlgrenska Academy, University of Gothenburg; Knut and Alice Wallenberg Foundation	Genomics Core Facility at the Sahlgrenska Academy, University of Gothenburg; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	For the use of technical equipment and support we thank the Genomics Core Facility at the Sahlgrenska Academy, University of Gothenburg, which was funded by a grant from the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MI, 2008, HUM REPROD, V23, P2564, DOI 10.1093/humrep/den273; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chang SL, 2006, LIFE SCI, V79, P967, DOI 10.1016/j.lfs.2006.05.005; Ciaraldi TP, 2009, J CLIN ENDOCR METAB, V94, P157, DOI 10.1210/jc.2008-1492; CIARALDI TP, 1992, J CLIN ENDOCR METAB, V75, P577, DOI 10.1210/jc.75.2.577; Deshmukh AS, 2008, INT J OBESITY, V32, pS18, DOI 10.1038/ijo.2008.118; DUNAIF A, 1992, DIABETES, V41, P1257, DOI 10.2337/diabetes.41.10.1257; Dunaif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE392, DOI 10.1152/ajpendo.2001.281.2.E392; Feng Y, 2012, EXP PHYSL; Feng Y, 2012, EXP PHYSIOL, V97, P651, DOI 10.1113/expphysiol.2011.063131; Feng Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006638; Frosig C, 2009, OBESITY, V17, pS15, DOI 10.1038/oby.2009.383; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Han J. S., 1997, J ALTERN COMPLEME S1, V3, P101; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Higashimura Y, 2009, AUTON NEUROSCI-BASIC, V150, P100, DOI 10.1016/j.autneu.2009.06.003; Ishizaki N, 2009, METABOLISM, V58, P1372, DOI 10.1016/j.metabol.2009.05.001; Jedel E, 2011, AM J PHYSIOL-ENDOC M, V300, pE37, DOI 10.1152/ajpendo.00495.2010; Jensterle M, 2008, EUR J ENDOCRINOL, V158, P793, DOI 10.1530/EJE-07-0857; Johansson J, 2010, AM J PHYSIOL-ENDOC M, pE; Kagitani F, 2005, JPN J PHYSIOL, V55, P149, DOI 10.2170/jjphysiol.R2120; KAUFMAN MP, 1984, CARDIOVASC RES, V18, P663, DOI 10.1093/cvr/18.11.663; Kawasaki E, 2009, J APPL PHYSIOL, V106, P1826, DOI 10.1152/japplphysiol.90923.2008; Krook A, 2004, MED SCI SPORT EXER, V36, P1212, DOI 10.1249/01.MSS.0000132387.25853.3B; Lai Mao-Hua, 2010, Zhen Ci Yan Jiu, V35, P298; Liang FX, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/735297; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Manneras L, 2008, ENDOCRINOLOGY, V149, P3559, DOI 10.1210/en.2008-0053; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Manneras L, 2009, AM J PHYSIOL-REG I, V296, pR1124, DOI 10.1152/ajpregu.90947.2008; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Ohkura N, 1996, BBA-GENE STRUCT EXPR, V1308, P205, DOI 10.1016/0167-4781(96)00101-7; Padmanabhan V, 2011, SEMIN REPROD MED, V29, P173, DOI 10.1055/s-0031-1275519; Pastore LM, 2011, J CLIN ENDOCR METAB, V96, P3143, DOI 10.1210/jc.2011-1126; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; ROSENBAUM D, 1993, AM J PHYSIOL, V264, pE197, DOI 10.1152/ajpendo.1993.264.2.E197; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sato A, 2002, INT CONGR SER, V1238, P111, DOI 10.1016/S0531-5131(02)00418-1; Seow KM, 2007, HUM REPROD, V22, P1003, DOI 10.1093/humrep/del466; Shao RJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE147, DOI 10.1152/ajpendo.00101.2007; Stener-Victorin E, 2003, AUTON NEUROSCI-BASIC, V108, P50, DOI 10.1016/j.autneu.2003.08.006; Stener-Victorin E, 2006, J APPL PHYSIOL, V101, P84, DOI 10.1152/japplphysiol.01593.2005; Stener-Victorin E, 2012, FERTIL STERIL, V97, P501, DOI 10.1016/j.fertnstert.2011.11.010; Stener-Victorin E, 2009, AM J PHYSIOL-REG I, V297, pR387, DOI 10.1152/ajpregu.00197.2009; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Teede HJ, 2006, ENDOCRINE, V30, P45, DOI 10.1385/ENDO:30:1:45; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	54	25	26	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54357	10.1371/journal.pone.0054357	http://dx.doi.org/10.1371/journal.pone.0054357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349861	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800042
J	Wang, XD; Inzunza, H; Chang, H; Qi, ZH; Hu, BH; Malone, D; Cogswell, J				Wang, Xi-De; Inzunza, Hector; Chang, Han; Qi, Zhenhao; Hu, Beihong; Malone, Daniel; Cogswell, John			Mutations in the Hedgehog Pathway Genes SMO and PTCH1 in Human Gastric Tumors	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; HUMAN HOMOLOG; PATCHED GENE; CANCER; MEDULLOBLASTOMA; POLYMORPHISM; ACTIVATION; INHIBITOR; MEDICINE; DIFFUSE	The causal role of the hedgehog pathway in cancer has been best documented in basal cell carcinoma of the skin. To assess potential DNA alterations of the hedgehog pathway in gastric cancer, we sequenced SMO and PTCH1 genes in a set of 39 gastric tumors. Tumors were classified by histology based on the Lauren classification and Sanger sequencing was performed to obtain full length coding sequences. Genomic instability was evident in these tumors as a number of silent or missense mutations were found. In addition to those that are potential germline polymorphisms, we found three SMO missense mutations, and one PTCH1 frameshift mutation that are novel and have not been documented in basal cell carcinoma. Mutations were found in both intestinal and diffuse type gastric tumors as well as in tumors that exhibit both intestinal and diffuse features. mRNA expression of hedgehog pathway genes was also examined and their levels do not indicate unequivocal higher pathway activity in tumors with mutations than those without. In summary, SMO and/or PTCH1 mutations are present at low frequency in different histologic subtypes of gastric tumors and these do not appear to be driver mutations.	[Wang, Xi-De; Inzunza, Hector; Chang, Han; Qi, Zhenhao; Hu, Beihong; Malone, Daniel; Cogswell, John] Bristol Myers Squibb Co, Princeton, NJ USA	Bristol-Myers Squibb	Wang, XD (corresponding author), Bristol Myers Squibb Co, Princeton, NJ USA.	xi-de.wang@bms.com						Asplund A, 2005, BRIT J DERMATOL, V152, P868, DOI 10.1111/j.1365-2133.2005.06464.x; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Chang-Claude J, 2003, INT J CANCER, V103, P779, DOI 10.1002/ijc.10889; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Hafner C, 2007, HUM PATHOL, V38, P1496, DOI 10.1016/j.humpath.2007.02.015; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Holbrook JD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-119; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Ma XL, 2005, CARCINOGENESIS, V26, P1698, DOI 10.1093/carcin/bgi130; Maesawa C, 1998, GENE CHROMOSOME CANC, V21, P276, DOI 10.1002/(SICI)1098-2264(199803)21:3<276::AID-GCC15>3.3.CO;2-H; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Santos FPS, 2011, CANCER J, V17, P465, DOI 10.1097/PPO.0b013e31823dec8d; Vestergaard J, 2006, LUNG CANCER, V52, P281, DOI 10.1016/j.lungcan.2005.12.014; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Xie JW, 1997, CANCER RES, V57, P2369; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yan TQ, 2008, CLIN ORTHOP RELAT R, V466, P2184, DOI 10.1007/s11999-008-0332-2; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang JX, 2007, J UROLOGY, V177, P1179, DOI 10.1016/j.juro.2006.10.032	26	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54415	10.1371/journal.pone.0054415	http://dx.doi.org/10.1371/journal.pone.0054415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349881	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800051
J	Feng, YF; Liu, Y; Wang, L; Cai, XQ; Wang, DX; Wu, KM; Chen, HL; Li, J; Lei, W				Feng, Yafei; Liu, Yi; Wang, Lin; Cai, Xiaoqing; Wang, Dexin; Wu, Kaimin; Chen, Hongli; Li, Jia; Lei, Wei			Sustained Oxidative Stress Causes Late Acute Renal Failure via Duplex Regulation on p38 MAPK and Akt Phosphorylation in Severely Burned Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ACUTE KIDNEY INJURY; INDUCED APOPTOSIS; DYSFUNCTION; INHIBITION; ALPHA; GENERATION; MORTALITY; NECROSIS; DAMAGE	Background: Clinical evidence indicates that late acute renal failure (ARF) predicts high mortality in severely burned patients but the pathophysiology of late ARF remains undefined. This study was designed to test the hypothesis that sustained reactive oxygen species (ROS) induced late ARF in a severely burned rat model and to investigate the signaling mechanisms involved. Materials and Methods: Rats were exposed to 100 degrees C bath for 15 s to induce severe burn injury (40% of total body surface area). Renal function, ROS generation, tubular necrosis and apoptosis, and phosphorylation of MAPK and Akt were measured during 72 hours after burn. Results: Renal function as assessed by serum creatinine and blood urea nitrogen deteriorated significantly at 3 h after burn, alleviated at 6 h but worsened at 48 h and 72 h, indicating a late ARF was induced. Apoptotic cells and cleavage caspase-3 in the kidney went up slowly and turned into significant at 48 h and 72 h. Tubular cell ROS production shot up at 6 h and continuously rose during the 72-h experiment. Scavenging ROS with tempol markedly attenuated tubular apoptosis and renal dysfunction at 72 h after burn. Interestingly, renal p38 MAPK phosphorylation elevated in a time dependent manner whereas Akt phosphorylation increased during the first 24 h but decreased at 48 h after burn. The p38 MAPK specific inhibitor SB203580 alleviated whereas Akt inhibitor exacerbated burn-induced tubular apoptosis and renal dysfunction. Furthermore, tempol treatment exerted a duplex regulation through inhibiting p38 MAPK phosphorylation but further increasing Akt phosphorylation at 72 h postburn. Conclusions: These results demonstrate that sustained renal ROS overproduction induces continuous tubular cell apoptosis and thus a late ARF at 72 h after burn in severely burned rats, which may result from ROS-mediated activation of p38 MAPK but a late inhibition of Akt phosphorylation.	[Feng, Yafei; Wang, Lin; Lei, Wei] Fourth Mil Med Univ, Dept Orthoped Surg, Xijing Hosp, Xian 710032, Peoples R China; [Liu, Yi] Fourth Mil Med Univ, Dept Oral Implantol, Sch Stomatol, Xian 710032, Peoples R China; [Feng, Yafei; Liu, Yi; Cai, Xiaoqing; Li, Jia] Fourth Mil Med Univ, Dept Physiol, Sch Basic Med Sci, Xian 710032, Peoples R China; [Wang, Dexin; Wu, Kaimin] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Chen, Hongli] Fourth Mil Med Univ, Dept Toxicol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Li, J (corresponding author), Fourth Mil Med Univ, Dept Physiol, Sch Basic Med Sci, Xian 710032, Peoples R China.	jiali816@hotmail.com; leiwei@fmmu.edu.cn	; Wang, Lin/J-8805-2018	Lei, Wei/0000-0002-7346-6915; Wang, Lin/0000-0001-5937-6318	Research Fund for the National Natural Science Foundation of China [31170913/C1002]; XIJING ZHUTUI Foundation [XJZT10M07]	Research Fund for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); XIJING ZHUTUI Foundation	This work was supported by the Research Fund for the National Natural Science Foundation of China (No.31170913/C1002) and the Contract Grant Sponsor: XIJING ZHUTUI Foundation (XJZT10M07). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen M, 2006, REV MED CHILE, V134, P649; Bae EH, 2011, NEPHROL DIAL TRANSPL, V26, P3866, DOI 10.1093/ndt/gfr386; Brusselaers N, 2010, INTENS CARE MED, V36, P915, DOI 10.1007/s00134-010-1861-1; Calegari VC, 2011, J APPL PHYSL; Cao W, 2011, BASIC RES CARDIOL, V106, P1207, DOI 10.1007/s00395-011-0199-3; Chrysopoulo MT, 1999, J TRAUMA, V46, P141, DOI 10.1097/00005373-199901000-00024; Coca SG, 2007, AM J KIDNEY DIS, V49, P517, DOI 10.1053/j.ajkd.2006.12.018; Dagher PC, 2012, AM J PHYSIOL-RENAL, V302, pF284, DOI 10.1152/ajprenal.00317.2011; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Gao CJ, 2009, BURNS, V35, P547, DOI 10.1016/j.burns.2008.10.006; Gao F, 2002, CARDIOVASC RES, V53, P414, DOI 10.1016/S0008-6363(01)00488-6; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gravante G, 2007, APOPTOSIS, V12, P259, DOI 10.1007/s10495-006-0621-8; Guo R, 2005, PHARMACOL RES, V52, P192, DOI 10.1016/j.phrs.2005.03.001; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Holm C, 1999, BURNS, V25, P171, DOI 10.1016/S0305-4179(98)00144-2; Horton JW, 2003, TOXICOLOGY, V189, P75, DOI 10.1016/S0300-483X(03)00154-9; Huang TT, 1999, ANN NY ACAD SCI, V893, P95, DOI 10.1111/j.1749-6632.1999.tb07820.x; Kalia S, 2008, CHEM-BIOL INTERACT, V174, P193, DOI 10.1016/j.cbi.2008.06.004; Kim GH, 2003, AM J NEPHROL, V23, P55, DOI 10.1159/000066299; Kita T, 2004, SHOCK, V21, P535, DOI 10.1097/00024382-200406000-00007; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kou X, 2011, PHYTOTHER RES; Laatikainen LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024456; Li J, 2008, CRIT CARE MED, V36, P1551, DOI 10.1097/CCM.0b013e3181782335; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Liu CM, 2012, TOXICOL APPL PHARM, V258, P330, DOI 10.1016/j.taap.2011.11.015; Lv GF, 2011, J BURN CARE RES, V32, P591, DOI 10.1097/BCR.0b013e31822dc3f2; Mariano F, 2008, CRIT CARE, V12, DOI 10.1186/cc6848; Mosier MJ, 2010, J BURN CARE RES, V31, P83, DOI 10.1097/BCR.0b013e3181cb8c87; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Mustonen KM, 2008, J BURN CARE RES, V29, P227, DOI 10.1097/BCR.0b013e31815f3196; Orient A, 2007, NEPHROL DIAL TRANSPL, V22, P1281, DOI 10.1093/ndt/gfm077; Palma SA, 2011, ANASTH INTENSIV NOTF, V46, P12, DOI 10.1055/s-0030-1270554; Parajuli N, 2011, FREE RADICAL BIO MED, V51, P406, DOI 10.1016/j.freeradbiomed.2011.04.024; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Rana A, 2001, APOPTOSIS, V6, P83, DOI 10.1023/A:1009680229931; Sahu BD, 2011, FOOD CHEM TOXICOL, V49, P3090, DOI 10.1016/j.fct.2011.08.018; Sato H, 2005, SHOCK, V24, P488, DOI 10.1097/01.shk.0000176594.64626.7f; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Sener G, 2004, BURNS, V30, P557, DOI 10.1016/j.burns.2004.02.008; Shah SV, 2001, AM J KIDNEY DIS, V37, pS30, DOI 10.1053/ajkd.2001.20736; Shanu A, 2010, FREE RADICAL RES, V44, P843, DOI 10.3109/10715762.2010.485993; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Sousa LP, 2010, J LEUKOCYTE BIOL, V87, P895, DOI 10.1189/jlb.0809540; Tao L, 2005, AM J PHYSIOL-HEART C, V288, pH2811, DOI 10.1152/ajpheart.01252.2004; Tian W, 2000, AM J PHYSIOL-RENAL, V279, pF593, DOI 10.1152/ajprenal.2000.279.4.F593; Ueda N, 2000, AM J MED, V108, P403, DOI 10.1016/S0002-9343(00)00311-9; VERTEL RM, 1967, J AMER MED ASSOC, V200, P598, DOI 10.1001/jama.200.7.598; Wagener FADTG, 2009, APOPTOSIS, V14, P1451, DOI 10.1007/s10495-009-0359-1; Wen XY, 2011, CONTRIB NEPHROL, V174, P129, DOI 10.1159/000329382; Yang HY, 2011, TOXICOLOGY, V287, P38, DOI 10.1016/j.tox.2011.05.014; Yano T, 2007, APOPTOSIS, V12, P1901, DOI 10.1007/s10495-007-0110-8; Yuan L, 2011, AM J PHYSIOL-RENAL, V300, pF207, DOI 10.1152/ajprenal.00073.2010; Yuan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025811; Zang Q, 2007, J APPL PHYSIOL, V102, P103, DOI 10.1152/japplphysiol.00359.2006	58	19	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54593	10.1371/journal.pone.0054593	http://dx.doi.org/10.1371/journal.pone.0054593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349934	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900080
J	Chang, KH; Chen, CM; Chen, YC; Hsiao, YC; Huang, CC; Kuo, HC; Hsu, HC; Lee-Chen, GJ; Wu, YR				Chang, Kuo-Hsuan; Chen, Chiung-Mei; Chen, Yi-Chun; Hsiao, Ya-Chin; Huang, Chin-Chang; Kuo, Hung-Chou; Hsu, Hsuan-Chu; Lee-Chen, Guey-Jen; Wu, Yih-Ru			Association between GRN rs5848 Polymorphism and Parkinson's Disease in Taiwanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FRONTOTEMPORAL LOBAR DEGENERATION; RISK-FACTOR; GENE-EXPRESSION; COMMON VARIANTS; PROGRANULIN; LRRK2; LOCI; DEMENTIA; GENDER	A single nucleotide polymorphism GRN rs5848 (3'UTR+78 C > T) was reported to alter the risk for frontotemporal lobar degeneration. Herein, we investigated the effect of GRN rs5848 on the risk of Parkinson's disease (PD) by genotyping 573 Taiwanese patients with PD and 490 age-matched control subjects. Compared to subjects with CC genotype, those with TT genotype had a 1.58-fold increased risk of PD (95% CI: 1.77 similar to 2.34, P = 0.021). PD patients demonstrate a higher frequency of T allele (37.2%) than controls (32.2%; odds ratio [OR] = 1.24, 95% CI: 1.04 similar to 1.49, P = 0.017). This susceptibility was particularly observed in female subjects, in which TT genotype had a 2.16-fold increased risk of PD as compared with controls(95% CI: 1.24 similar to 3.78, P = 0.006). The frequency of T allele (39.3%) in female PD patients was higher than in female control subjects (31.1%; OR = 1.43, CI: 1.11 similar to 1.87, P = 0.007). No association was observed between GRN rs5848 and susceptibility in male subjects. These findings show that the GRN rs5848 TT genotype and T allele are risk factors for female Taiwanese patients with PD.	[Chang, Kuo-Hsuan; Chen, Chiung-Mei; Chen, Yi-Chun; Huang, Chin-Chang; Kuo, Hung-Chou; Wu, Yih-Ru] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan; [Hsiao, Ya-Chin; Hsu, Hsuan-Chu; Lee-Chen, Guey-Jen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan Normal University	Lee-Chen, GJ (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43019@ntnu.edu.tw; yihruwu@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		Chang Gung Memorial Hospital, Taipei, Taiwan [CMRPG3A0131]; National Science Council, Executive Yuan, Taiwan [NSC98-2628-B-182A-001-MY3]	Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital); National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This study was sponsored by Chang Gung Memorial Hospital, Taipei, Taiwan (CMRPG3A0131), and National Science Council, Executive Yuan, Taiwan (NSC98-2628-B-182A-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Baldereschi M, 2000, NEUROLOGY, V55, P1358, DOI 10.1212/WNL.55.9.1358; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; Biskup S, 2005, ANN NEUROL, V58, P905, DOI 10.1002/ana.20664; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Chen CC, 2009, NEUROEPIDEMIOLOGY, V33, P350, DOI 10.1159/000254572; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Farrer MJ, 2007, PARKINSONISM RELAT D, V13, P89, DOI 10.1016/j.parkreldis.2006.12.001; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Gillies GE, 2010, HORM BEHAV, V57, P23, DOI 10.1016/j.yhbeh.2009.06.002; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hsiung GYR, 2011, J NEUROL SCI, V300, P28, DOI 10.1016/j.jns.2010.10.009; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jasinska-Myga B, 2009, EUR J NEUROL, V16, P909, DOI 10.1111/j.1468-1331.2009.02621.x; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Liu XM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-104; Paisan-Ruiz C, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036889; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Rocca WA, 2008, NEUROLOGY, V70, P200, DOI 10.1212/01.wnl.0000280573.30975.6a; Ross OA, 2008, ANN NEUROL, V64, P88, DOI 10.1002/ana.21405; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Saunders-Pullman R, 2003, ENDOCRINE, V21, P81, DOI 10.1385/ENDO:21:1:81; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Simunovic F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008856; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Suzuki M, 2009, J REPROD DEVELOP, V55, P351, DOI 10.1262/jrd.20249; Tan EK, 2010, NEUROLOGY, V75, P508, DOI 10.1212/WNL.0b013e3181eccfcd; Tan EK, 2010, HUM MUTAT, V31, P561, DOI 10.1002/humu.21225; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54448	10.1371/journal.pone.0054448	http://dx.doi.org/10.1371/journal.pone.0054448			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342160	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700118
J	Baum, P; Petroff, D; Classen, J; Kiess, W; Bluher, S				Baum, Petra; Petroff, David; Classen, Joseph; Kiess, Wieland; Blueher, Susann			Dysfunction of Autonomic Nervous System in Childhood Obesity: A Cross-Sectional Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; IMPAIRED GLUCOSE-TOLERANCE; SYMPATHETIC SKIN-RESPONSE; PERIOD VARIABILITY; CHILDREN; ADOLESCENTS; PREVALENCE; MODULATION; PUPIL; BODY	Objective: To assess the distribution of autonomic nervous system (ANS) dysfunction in overweight and obese children. Methods: Parasympathetic and sympathetic ANS function was assessed in children and adolescents with no evidence of impaired glucose metabolism by analysis of heart rate variability (low frequency power ln(LF), high frequency power, ln(HF); ln(LF/HF) ratio, ratio of longest RR interval during expiration to shortest interval during inspiration (E/I ratio), root mean square of successive differences (RMSSD); sympathetic skin response (SSR); and quantitative pupillography (pupil diameter in darkness, light reflex amplitude, latency, constriction velocity, re-dilation velocity). The relationship of each ANS variable to the standard deviation score of body mass index (BMI-SDS) was assessed in a linear model considering age, gender and pubertal stage as co-variates and employing an F-statistic to compare the fit of nested models. Group comparisons between normal weight and obese children as well as an analysis of dependence on insulin resistance (as indexed by the Homeostasis Model Assessment of Insulin Resistance, HOMA-IR) were performed for parameters shown to correlate with BMI-SDS. Statistical significance was set at 5%. Results: Measurements were performed in 149 individuals (mean age 12.0 y; 90 obese 45 boys; 59 normal weight, 34 boys). E/I ratio (p = 0.003), ln(HF) (p = 0.03), pupil diameter in darkness (p = 0.01) were negatively correlated with BMI-SDS, whereas ln(LF/HF) was positively correlated (p = 0.05). Early re-dilation velocity was in trend negatively correlated to BMI-SDS (p = 0.08). None of the parameters that depended significantly on BMI-SDS was found to be significantly correlated with HOMA-IR. Conclusion: These findings demonstrate extended ANS dysfunction in obese children and adolescents, affecting several organ systems. Both parasympathetic activity and sympathetic activity are reduced. The conspicuous pattern of ANS dysfunction raises the possibility that obesity may give rise to dysfunction of the peripheral autonomic nerves resembling that observed in normal-weight diabetic children and adolescents.	[Baum, Petra; Classen, Joseph] Univ Leipzig, Dept Neurol, D-04109 Leipzig, Germany; [Petroff, David] Univ Leipzig, Clin Trial Ctr, D-04109 Leipzig, Germany; [Petroff, David; Kiess, Wieland; Blueher, Susann] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany; [Kiess, Wieland; Blueher, Susann] Univ Hosp Children & Adolescents, Dept Women & Child Hlth, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Bluher, S (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany.	susann.blueher@medizin.uni-leipzig.de		Weihrauch-Bluher, Susann/0000-0001-7399-223X; Classen, Joseph/0000-0001-7182-6967	German Diabetes Association; Federal Ministry of Education and Research, Germany [FKZ: 01E01001]; Saxonian Ministry of Social Affairs, Germany; Roland-Ernst-Stiftung fur Gesundheitsforschung, Germany; Nationales Aktionsforum Diabetes Mellitus	German Diabetes Association; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Saxonian Ministry of Social Affairs, Germany; Roland-Ernst-Stiftung fur Gesundheitsforschung, Germany; Nationales Aktionsforum Diabetes Mellitus	This work was supported by a grant from the German Diabetes Association (to SB and PB), by the Federal Ministry of Education and Research, Germany (Integrated Research and Treatment Center IFB "Adiposity Diseases'', FKZ: 01E01001; to SB, DP, WK), the Saxonian Ministry of Social Affairs, Germany (to SB), the Roland-Ernst-Stiftung fur Gesundheitsforschung, Germany (to SB) and the 'Nationales Aktionsforum Diabetes Mellitus' (to SB and WK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUNODAYA GR, 1995, J NEUROL SCI, V129, P81, DOI 10.1016/0022-510X(94)00265-P; Beijers HJBH, 2009, DIABETES CARE, V32, P1698, DOI 10.2337/dc08-1544; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; Boutcher SH, 1998, PSYCHOPHYSIOLOGY, V35, P16, DOI 10.1017/S0048577298951435; Camm AJ, 1996, CIRCULATION, V93, P1043; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Dutsch M, 2004, J NEUROL SCI, V222, P75, DOI 10.1016/j.jns.2004.04.008; Freeman R, 2005, LANCET, V365, P1259, DOI 10.1016/S0140-6736(05)74815-7; Guizar JM, 2005, INDIAN PEDIATR, V42, P464; Gutin B, 1997, J PEDIATR-US, V130, P938, DOI 10.1016/S0022-3476(97)70280-4; Gutin B, 2000, OBES RES, V8, P12, DOI 10.1038/oby.2000.3; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; HELLER PH, 1990, INVEST OPHTH VIS SCI, V31, P156; HOLM S, 1979, SCAND J STAT, V6, P65; Karachaliou F, 1997, DIABETIC MED, V14, P849, DOI 10.1002/(SICI)1096-9136(199710)14:10<849::AID-DIA470>3.0.CO;2-W; KARAVANAKI K, 1994, ARCH DIS CHILD, V71, P511, DOI 10.1136/adc.71.6.511; KARLSEN RL, 1979, ACTA OPHTHALMOL, V57, P41; Kaufman CL, 2007, OBESITY, V15, P1164, DOI 10.1038/oby.2007.619; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lambert E, 2010, HYPERTENSION, V56, P351, DOI 10.1161/HYPERTENSIONAHA.110.155663; LEVY DM, 1992, J NEUROL NEUROSUR PS, V55, P902, DOI 10.1136/jnnp.55.10.902; Lucini D, 2002, AM HEART J, V143, P977, DOI 10.1067/mhj.2002.123117; Vanderlei LCM, 2010, CLINICS, V65, P789, DOI 10.1590/S1807-59322010000800008; Vanderlei LCM, 2010, ARQ BRAS CARDIOL, V95, P35, DOI 10.1590/S0066-782X2010005000082; Martini G, 2001, CLIN AUTON RES, V11, P87, DOI 10.1007/BF02322051; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nagai N, 2004, INT J OBESITY, V28, P27, DOI 10.1038/sj.ijo.0802470; Nagai N, 2003, OBES RES, V11, P25, DOI 10.1038/oby.2003.6; O'Rahilly S, 2005, THE GENETICS OF OBES; Paschoal MA, 2009, ARQ BRAS CARDIOL, V93, P239, DOI 10.1590/S0066-782X2009000900007; PETERSON H R, 1988, New England Journal of Medicine, V318, P1077, DOI 10.1056/NEJM198804283181701; PFEIFER MA, 1984, DIABETES CARE, V7, P447, DOI 10.2337/diacare.7.5.447; Priano L, 2009, EUR J PAIN, V13, P829, DOI 10.1016/j.ejpain.2008.09.011; Rabbia F, 2003, OBES RES, V11, P541, DOI 10.1038/oby.2003.76; Rabbone Ivana, 2009, Acta Biomed, V80, P29; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; SMITH SA, 1983, BRIT J OPHTHALMOL, V67, P89, DOI 10.1136/bjo.67.2.89; Soares-Miranda L, 2011, PEDIATR CARDIOL, V32, P924, DOI 10.1007/s00246-011-0015-8; Straub RH, 1996, DIABETES CARE, V19, P960, DOI 10.2337/diacare.19.9.960; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tascilar ME, 2011, J CLIN RES PEDIATR E, V3, P60, DOI [10.4274/jcrpe.v3i2.131, 10.4274/jcrpe.v3i2.13]; Team RDC, 2010, R A LANGUAGE AND ENV; Tonhajzerova I, 2008, J PHYSIOL PHARMACOL, V59, P709; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; World Health Organization, 2011, OB OV FACT SHEET 311	46	59	64	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54546	10.1371/journal.pone.0054546	http://dx.doi.org/10.1371/journal.pone.0054546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358101	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600067
J	Toro, N; Martinez-Abarca, F				Toro, Nicolas; Martinez-Abarca, Francisco			Comprehensive Phylogenetic Analysis of Bacterial Group II Intron-Encoded ORFs Lacking the DNA Endonuclease Domain Reveals New Varieties	PLOS ONE			English	Article							RNA; MATURASE; ARCHAEA; REGION; LESS	Group II introns are self-splicing RNAs that act as mobile retroelements in the organelles of plants, fungi and protists. They are also widely distributed in bacteria, and are generally assumed to be the ancestors of nuclear spliceosomal introns. Most bacterial group II introns have a multifunctional intron-encoded protein (IEP) ORF within the ribozyme domain IV (DIV). This ORF encodes an N-terminal reverse transcriptase (RT) domain, followed by a putative RNA-binding domain with RNA splicing or maturase activity and, in some cases, a C-terminal DNA-binding (D) region followed by a DNA endonuclease (En) domain. In this study, we focused on bacterial group II intron ORF phylogenetic classes containing only reverse transcriptase/maturase open reading frames, with no recognizable D/En region (classes A, C, D, E, F and unclassified introns). On the basis of phylogenetic analyses of the maturase domain and its C-terminal extension, which appears to be a signature characteristic of ORF phylogenetic class, with support from the phylogeny inferred from the RT domain, we have revised the proposed new class F, defining new intron ORF varieties. Our results increase knowledge of the lineage of group II introns encoding proteins lacking the En-domain.	[Toro, Nicolas; Martinez-Abarca, Francisco] CSIC, Estn Expt Zaidin, Grp Ecol Genet, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Toro, N (corresponding author), CSIC, Estn Expt Zaidin, Grp Ecol Genet, Granada, Spain.	nicolas.toro@eez.csic.es	Toro, Nicolas/K-4909-2014; Martinez-Abarca, Francisco/K-9263-2014	Toro, Nicolas/0000-0002-3614-807X; Martinez-Abarca, Francisco/0000-0003-0417-6217	Spanish Ministerio de Ciencia e Innovacion [BIO2011-24401]; Consolider-Ingenio programme [CSD 2009-0006]; ERDF (European Regional Development Funds)	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consolider-Ingenio programme(Spanish Government); ERDF (European Regional Development Funds)(European Commission)	This work was supported by research grants BIO2011-24401 from the Spanish Ministerio de Ciencia e Innovacion, and CSD 2009-0006 of the Consolider-Ingenio programme including ERDF (European Regional Development Funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Candales MA, 2012, NUCLEIC ACIDS RES, V40, pD187, DOI 10.1093/nar/gkr1043; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Dai LX, 2003, RNA, V9, P14, DOI 10.1261/rna.2126203; Drummond AJ, 2010, GENEIOUS V5 1; Eickbush Thomas H., 1994, P121; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Michel F, 2009, TRENDS BIOCHEM SCI, V34, P189, DOI 10.1016/j.tibs.2008.12.007; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Molina-Sanchez MD, 2010, FEBS J, V277, P244, DOI 10.1111/j.1742-4658.2009.07478.x; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; Simon DM, 2008, RNA, V14, P1704, DOI 10.1261/rna.1056108; Simon DM, 2009, MOL BIOL EVOL, V26, P2795, DOI 10.1093/molbev/msp193; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toro N, 2003, ENVIRON MICROBIOL, V5, P143, DOI 10.1046/j.1462-2920.2003.00398.x; Toro N, 2007, FEMS MICROBIOL REV, V31, P342, DOI 10.1111/j.1574-6976.2007.00068.x; Zimmerly S, 2001, NUCLEIC ACIDS RES, V29, P1238, DOI 10.1093/nar/29.5.1238; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	25	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e55102	10.1371/journal.pone.0055102	http://dx.doi.org/10.1371/journal.pone.0055102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355907	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500155
J	Zhao, DX; Chen, DS; Ge, C; Gotoh, T; Hong, XY				Zhao, Dong-Xiao; Chen, Da-Song; Ge, Cheng; Gotoh, Tetsuo; Hong, Xiao-Yue			Multiple Infections with Cardinium and Two Strains of Wolbachia in The Spider Mite Tetranychus phaselus Ehara: Revealing New Forces Driving the Spread of Wolbachia	PLOS ONE			English	Article							CALLOSOBRUCHUS-CHINENSIS COLEOPTERA; INDUCED CYTOPLASMIC INCOMPATIBILITY; AEDES-ALBOPICTUS; ENDOSYMBIOTIC BACTERIUM; DROSOPHILA-SIMULANS; POPULATION-DYNAMICS; HOST GENOTYPE; RAPID SPREAD; ACARI; PHYLOGENY	Cytoplasmic incompatibility (CI) has been proposed as a major mechanism by which certain strains of Wolbachia to invade and persist in host populations. However, mechanisms that underlie the invasion and persistence of non-CI strains are less well understood. Here, we established a spider mite Tetranychus phaselus population multiply infected by Cardinium as well as two distinct lineages of Wolbachia, designated wCon and wOri, to study the forces driving the spread of the non-CI strain of Wolbachia wOri. Interestingly, we found that wOri provided a longevity advantage to its female hosts under ideal conditions, making wOri stay longer in this population, and then being transmitted to more offspring. Furthermore, the lifespan of uninfected females was reduced when mated with multiple-infected males. As a result, the uninfected population is attenuated by the multiple-infected males. Thus, we infer that the host age effects of multiple infection may represent sufficient forces driving the spread of wOri through the host population.	[Zhao, Dong-Xiao; Chen, Da-Song; Ge, Cheng; Hong, Xiao-Yue] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China; [Gotoh, Tetsuo] Ibaraki Univ, Fac Agr, Lab Appl Entomol & Zool, Ami, Ibaraki 30003, Japan	Nanjing Agricultural University; Ibaraki University	Hong, XY (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	xyhong@njau.edu.cn	Hong, Xiao-Yue/AAF-4759-2020	Ge, Cheng/0000-0002-0740-5428	Science and Technology Program of the National Public Welfare Professional Fund [201103020]; Ministry of Agriculture of China; National Basic Science Program of China (973 Program) [2009CB119202]; National Natural Science Foundation of China [31172131]	Science and Technology Program of the National Public Welfare Professional Fund; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Basic Science Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a Grant-in-Aid from the Science and Technology Program of the National Public Welfare Professional Fund (201103020) from the Ministry of Agriculture of China (www.moa.gov.cn), a Grant-in-Aid from the National Basic Science Program of China (973 Program, number 2009CB119202)(www.most.gov.cn), and a Grant-in-Aid for Scientific Research (number 31172131) from the National Natural Science Foundation of China (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bordenstein SR, 1998, GENETICS, V148, P1833; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Breeuwer JAJ, 1996, EXP APPL ACAROL, V20, P421, DOI 10.1007/BF00053306; Clark ME, 2002, MECH DEVELOP, V111, P3, DOI 10.1016/S0925-4773(01)00594-9; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Dobson SL, 2002, GENETICS, V160, P1087; Dobson SL, 2001, J MED ENTOMOL, V38, P382, DOI 10.1603/0022-2585-38.3.382; Goodacre SL, 2006, MOL ECOL, V15, P517, DOI 10.1111/j.1365-294X.2005.02802.x; Gotoh T, 2003, HEREDITY, V91, P208, DOI 10.1038/sj.hdy.6800329; Gotoh T, 2007, HEREDITY, V98, P13, DOI 10.1038/sj.hdy.6800881; Gotoh T, 2007, EXP APPL ACAROL, V42, P1, DOI 10.1007/s10493-007-9072-3; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1990, GENETICS, V126, P933; Hong XY, 2002, HEREDITY, V88, P190, DOI 10.1038/sj.hdy.6800026; Hurst LD, 1996, P ROY SOC B-BIOL SCI, V263, P97, DOI 10.1098/rspb.1996.0016; Ijichi N, 2002, APPL ENVIRON MICROB, V68, P4074, DOI 10.1128/AEM.68.8.4074-4080.2002; Kondo N, 2005, BIOL LETTERS, V1, P488, DOI 10.1098/rsbl.2005.0340; Kondo N, 2002, MOL ECOL, V11, P167, DOI 10.1046/j.0962-1083.2001.01432.x; Liu Y, 2006, J APPL ENTOMOL, V130, P523, DOI 10.1111/j.1439-0418.2006.01112.x; McGraw EA, 2001, P ROY SOC B-BIOL SCI, V268, P2565, DOI 10.1098/rspb.2001.1839; MERCOT H, 1995, GENETICS, V141, P1015; Mouton L, 2005, HEREDITY, V94, P187, DOI 10.1038/sj.hdy.6800596; Navajas M, 1996, B ENTOMOL RES, V86, P407, DOI 10.1017/S0007485300034994; PerrotMinnot MJ, 1996, GENETICS, V143, P961; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; Ros VID, 2009, HEREDITY, V102, P413, DOI 10.1038/hdy.2009.4; Rousset F, 1999, HEREDITY, V82, P620, DOI 10.1046/j.1365-2540.1999.00501.x; Rowley SM, 2004, CURR MICROBIOL, V49, P208, DOI 10.1007/s00284-004-4346-z; Ruang-areerate T, 2006, P NATL ACAD SCI USA, V103, P12534, DOI 10.1073/pnas.0508879103; SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; TURELLI M, 1995, GENETICS, V140, P1319; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Walker T, 2009, J HERED, V100, P192, DOI 10.1093/jhered/esn079; Watanabe M, 2011, HEREDITY, V106, P642, DOI 10.1038/hdy.2010.100; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430; Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zhang H, 2010, ENVIRON ENTOMOL, V39, P1801, DOI 10.1603/EN10051; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	48	26	29	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54964	10.1371/journal.pone.0054964	http://dx.doi.org/10.1371/journal.pone.0054964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355904	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500151
J	Boissiere, A; Gimonneau, G; Tchioffo, MT; Abate, L; Bayibeki, A; Awono-Ambene, PH; Nsango, SE; Morlais, I				Boissiere, Anne; Gimonneau, Geoffrey; Tchioffo, Majoline T.; Abate, Luc; Bayibeki, Albert; Awono-Ambene, Parfait H.; Nsango, Sandrine E.; Morlais, Isabelle			Application of a qPCR Assay in the Investigation of Susceptibility to Malaria Infection of the M and S Molecular Forms of An. gambiae s.s. in Cameroon	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SEQUENCE-BASED AMPLIFICATION; ANOPHELES-GAMBIAE; PLASMODIUM-FALCIPARUM; INSECTICIDE-RESISTANCE; CHROMOSOMAL FORMS; IMPORTED MALARIA; IDENTIFICATION; SPECIATION	Plasmodium falciparum is the causative agent of malaria, a disease that kills almost one million persons each year, mainly in sub-Saharan Africa. P. falciparum is transmitted to the human host by the bite of an Anopheles female mosquito, and Anopheles gambiae sensus stricto is the most tremendous malaria vector in Africa, widespread throughout the afro-tropical belt. An. gambiae s.s. is subdivided into two distinct molecular forms, namely M and S forms. The two molecular forms are morphologically identical but they are distinct genetically, and differ by their distribution and their ecological preferences. The epidemiological importance of the two molecular forms in malaria transmission has been poorly investigated so far and gave distinct results in different areas. We have developed a real-time quantitative PCR (qPCR) assay, and used it to detect P. falciparum at the oocyst stage in wild An. gambiae s.s. mosquitoes experimentally infected with natural isolates of parasites. Mosquitoes were collected at immature stages in sympatric and allopatric breeding sites and further infected at the adult stage. We next measured the infection prevalence and intensity in female mosquitoes using the qPCR assay and correlated the infection success with the mosquito molecular forms. Our results revealed different prevalence of infection between the M and S molecular forms of An. gambiae s.s. in Cameroon, for both sympatric and allopatric populations of mosquitoes. However, no difference in the infection intensity was observed. Thus, the distribution of the molecular forms of An. gambiae s.s. may impact on the malaria epidemiology, and it will be important to monitor the efficiency of malaria control interventions on the two M and S forms.	[Boissiere, Anne; Gimonneau, Geoffrey; Tchioffo, Majoline T.; Abate, Luc; Nsango, Sandrine E.; Morlais, Isabelle] Inst Rech Dev, Unite Mixte Rech MIVEGEC IRD CNRS UM1 UM2 224 529, Montpellier, France; [Gimonneau, Geoffrey; Tchioffo, Majoline T.; Abate, Luc; Bayibeki, Albert; Awono-Ambene, Parfait H.; Nsango, Sandrine E.; Morlais, Isabelle] Org Coordinat Lutte Endemies Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon	Institut de Recherche pour le Developpement (IRD)	Morlais, I (corresponding author), Inst Rech Dev, Unite Mixte Rech MIVEGEC IRD CNRS UM1 UM2 224 529, Montpellier, France.	isabelle.morlais@ird.fr	TSAPI, Majoline TCHIOFFO/S-3007-2019; Morlais, Isabelle/F-5078-2014; Gimonneau, Geoffrey/C-1681-2013; Morlais, Isabelle/Q-2171-2019; BOISSIERE, Anne/ABB-5669-2020	TSAPI, Majoline TCHIOFFO/0000-0001-9517-3665; Morlais, Isabelle/0000-0002-2962-7670; Morlais, Isabelle/0000-0002-2962-7670; BOISSIERE, Anne/0000-0003-3958-2602; Gimonneau, Geoffrey/0000-0002-0613-841X; abate, luc/0000-0003-3973-3036	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche [ANR-11-BSV7-009-01]; European Community [242095, 223601]	Institut de Recherche pour le Developpement (IRD); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community(European Commission)	This work was supported by funds from the Institut de Recherche pour le Developpement (IRD), the Agence Nationale de la Recherche (grant awarded to IM, ANR-11-BSV7-009-01) and the European Community's Seventh Framework Programme (FP7) (grant agreements No 242095, EviMalaR, and No 223601, MALVECBLOK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Arez AP, 2000, EXP PARASITOL, V94, P269, DOI 10.1006/expr.2000.4496; Babiker HA, 1999, MOL BIOCHEM PARASIT, V99, P143, DOI 10.1016/S0166-6851(98)00175-3; Bass C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-177; Bell AS, 2004, INT J PARASITOL, V34, P795, DOI 10.1016/j.ijpara.2004.03.008; Berry A, 2008, PARASITE, V15, P484, DOI 10.1051/parasite/2008153484; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Boissiere A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002742; Borenstein M, 2009, INTRO META ANAL; Boudin C, 2004, PARASITE IMMUNOL, V26, P105, DOI 10.1111/j.0141-9838.2004.00689.x; Bourgeois N, 2010, CLIN MICROBIOL INFEC, V16, P1305, DOI 10.1111/j.1469-0691.2009.02933.x; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Elsayed S, 2006, J CLIN MICROBIOL, V44, P622, DOI 10.1128/JCM.44.2.622-624.2006; Fabre R, 2004, PARASITOLOGY, V128, P15, DOI 10.1017/S0031182003004219; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Fryxell RTT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-133; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; GRAVES PM, 1980, T ROY SOC TROP MED H, V74, P738, DOI 10.1016/0035-9203(80)90189-3; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Kamdem C, 2012, PLOS ONE, V9; Krungkrai J, 2004, PARASITOLOGY, V129, P511, DOI 10.1017/S0031182004005888; Kudom AA, 2012, J VECTOR ECOL, V37, P77, DOI 10.1111/j.1948-7134.2012.00202.x; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Levashina EA, 2004, INSECT BIOCHEM MOLEC, V34, P673, DOI 10.1016/j.ibmb.2004.03.020; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; MCCUTCHAN TF, 1995, PARASITOL TODAY, V11, P134, DOI 10.1016/0169-4758(95)80132-4; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Mitri C, 2012, CURR OPIN MICROBIOL; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Morlais I, 2004, AM J TROP MED HYG, V71, P795, DOI 10.4269/ajtmh.2004.71.795; Ndiath MO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-269; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rao RU, 2009, T ROY SOC TROP MED H, V103, P365, DOI 10.1016/j.trstmh.2008.07.012; Riehle MM, 2011, SCIENCE, V331, P596, DOI 10.1126/science.1196759; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Schneider P, 2006, INT J PARASITOL, V36, P403, DOI 10.1016/j.ijpara.2006.01.002; Schoone GJ, 2000, J CLIN MICROBIOL, V38, P4072, DOI 10.1128/JCM.38.11.4072-4075.2000; Schwarzer G, 2012, META META ANALYSIS W; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Sinden RE, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P139; Sinden RE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-70; Slotman MA, 2005, AM J TROP MED HYG, V73, P326, DOI 10.4269/ajtmh.2005.73.326; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Stump AD, 2005, GENETICS, V169, P1509, DOI 10.1534/genetics.104.035303; Team RC, 2012, R LANG ENV STAT COMP; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; White BJ, 2011, P NATL ACAD SCI USA, V108, P244, DOI 10.1073/pnas.1013648108; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wondji C, 2002, INSECT MOL BIOL, V11, P11, DOI 10.1046/j.0962-1075.2001.00306.x; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2	71	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54820	10.1371/journal.pone.0054820	http://dx.doi.org/10.1371/journal.pone.0054820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349974	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100099
J	Brauer, L; Schicht, M; Worlitzsch, D; Bensel, T; Sawers, RG; Paulsen, F				Braeuer, Lars; Schicht, Martin; Worlitzsch, Dieter; Bensel, Tobias; Sawers, R. Gary; Paulsen, Friedrich			Staphylococcus aureus and Pseudomonas aeruginosa Express and Secrete Human Surfactant Proteins	PLOS ONE			English	Article							HUMAN TEAR FLUID; PULMONARY SURFACTANT; LUNG SURFACTANT; SP-B; BIOPHYSICAL ACTIVITY; CYSTIC-FIBROSIS; ACTIVE MATERIAL; SP-A; LOCALIZATION; INFLAMMATION	Surfactant proteins (SP), originally known from human lung surfactant, are essential to proper respiratory function in that they lower the surface tension of the alveoli. They are also important components of the innate immune system. The functional significance of these proteins is currently reflected by a very large and growing number of publications. The objective goal of this study was to elucidate whether Staphylococcus aureus and Pseudomonas aeruginosa is able to express surfactant proteins. 10 different strains of S. aureus and P. aeruginosa were analyzed by means of RT-PCR, Western blot analysis, ELISA, immunofluorescence microscopy and immunoelectron microscopy. The unexpected and surprising finding revealed in this study is that different strains of S. aureus and P. aeruginosa express and secrete proteins that react with currently commercially available antibodies to known human surfactant proteins. Our results strongly suggest that the bacteria are either able to express 'human-like' surfactant proteins on their own or that commercially available primers and antibodies to human surfactant proteins detect identical bacterial proteins and genes. The results may reflect the existence of a new group of bacterial surfactant proteins and DNA currently lacking in the relevant sequence and structure databases. At any rate, our knowledge of human surfactant proteins obtained from immunological and molecular biological studies may have been falsified by the presence of bacterial proteins and DNA and therefore requires critical reassessment.	[Braeuer, Lars; Schicht, Martin; Paulsen, Friedrich] Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany; [Worlitzsch, Dieter; Bensel, Tobias] Univ Halle Wittenberg, Dept Hyg, Fac Med, D-06108 Halle, Germany; [Sawers, R. Gary] Univ Halle Wittenberg, Inst Biol Microbiol, D-06108 Halle, Germany	University of Erlangen Nuremberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Brauer, L (corresponding author), Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany.	lars.braeuer@anatomie2.med.uni-erlangen.de		Schicht, Martin/0000-0001-5155-5477; Paulsen, Friedrich/0000-0002-0527-0953	German Research Foundation (DFG) [1329/12-1 BR, BR 3681/2-1]; Wilhelm Roux Program, Halle, Germany [FKZ 17/20]	German Research Foundation (DFG)(German Research Foundation (DFG)); Wilhelm Roux Program, Halle, Germany	The study was supported by the German Research Foundation (DFG, Program Grants 1329/12-1 BR and BR 3681/2-1) and the Wilhelm Roux Program, Halle, Germany (Program Grants FKZ 17/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; Alcorn JL, 2005, AM J PHYSIOL-LUNG C, V289, pL1113, DOI 10.1152/ajplung.00436.2004; Anderson Mark T, 2011, Mob Genet Elements, V1, P85; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Brauer L, 2007, CURR EYE RES, V32, P931, DOI 10.1080/02713680701694369; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Brauer L, 2009, HISTOCHEM CELL BIOL, V132, P331, DOI 10.1007/s00418-009-0609-x; Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296; FORSGREN A, 1966, J IMMUNOL, V97, P822; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Glasser JR, 2012, MICROBES INFECT, V14, P17, DOI 10.1016/j.micinf.2011.08.019; GLASSER SW, 1988, J BIOL CHEM, V263, P9; Haczku A, 2001, AM J RESP CELL MOL, V25, P45, DOI 10.1165/ajrcmb.25.1.4391; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hull J, 1997, AM J RESP CRIT CARE, V156, P161, DOI 10.1164/ajrccm.156.1.9609090; Kankavi O, 2003, ACTA BIOCHIM POL, V50, P1057; Kim JK, 2007, AM J PHYSIOL-LUNG C, V292, pL879, DOI 10.1152/ajplung.00156.2006; KING RJ, 1973, AM J PHYSIOL, V224, P788, DOI 10.1152/ajplegacy.1973.224.4.788; KLAUS MH, 1961, P NATL ACAD SCI USA, V47, P1858, DOI 10.1073/pnas.47.11.1858; KOBAYASHI T, 1991, J APPL PHYSIOL, V71, P530, DOI 10.1152/jappl.1991.71.2.530; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Lemos MP, 2011, INFECT IMMUN, V79, P1077, DOI 10.1128/IAI.00286-10; Leth-Larsen R, 2003, CLIN IMMUNOL, V108, P29, DOI 10.1016/S1521-6616(03)00042-1; LONGO ML, 1993, SCIENCE, V261, P453, DOI 10.1126/science.8332910; Mason RJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1, DOI 10.1152/ajplung.1998.275.1.L1; Mirani ZA, 2012, JCPSP-J COLL PHYSICI, V22, P10, DOI 01.2012/JCPSP.1014; Moyes RB, 2009, CURRENT PROTOCOLS IN; Ni M, 2005, INFECT IMMUN, V73, P2147, DOI 10.1128/IAI.73.4.2147-2156.2005; NOTTER RH, 1987, CHEM PHYS LIPIDS, V44, P1, DOI 10.1016/0009-3084(87)90002-8; Ohnishi H, 2002, AM J RESP CRIT CARE, V165, P378, DOI 10.1164/ajrccm.165.3.2107134; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEMISTRY-US, V30, P10965, DOI 10.1021/bi00109a022; Orgeig S, 2010, RESP PHYSIOL NEUROBI, V173, pS43, DOI 10.1016/j.resp.2010.04.023; Pandit Hrishikesh, 2012, Front Biosci (Elite Ed), V4, P651; PHIZACKERLEY PJR, 1979, BIOCHEM J, V183, P731, DOI 10.1042/bj1830731; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Sever-Chroneos Z, 2011, J BIOL CHEM, V286, P4854, DOI 10.1074/jbc.M110.125567; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; SPRAGG RG, 1994, CHEST, V105, P195, DOI 10.1378/chest.105.1.195; Stahlman MT, 2002, J HISTOCHEM CYTOCHEM, V50, P651, DOI 10.1177/002215540205000506; Stevens P, 2004, SURFACTANTTHERAPIE G, P11; Tagaram HRS, 2007, AM J PHYSIOL-LUNG C, V292, pL1052, DOI 10.1152/ajplung.00249.2006; ten Brinke A, 2002, BBA-MOL CELL BIOL L, V1583, P253, DOI 10.1016/S1388-1981(02)00248-2; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; VANIWAARDEN JF, 1994, BIOCHEM J, V303, P407, DOI 10.1042/bj3030407; Von Neergaard K., 1929, Z GES EXP MED, V66, P373; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; Vorbroker DK, 1995, AM J PHYSIOL-LUNG C, V269, pL727, DOI 10.1152/ajplung.1995.269.6.L727; WHITSETT JA, 1986, PEDIATR RES, V20, P460, DOI 10.1203/00006450-198605000-00016; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Woodworth BA, 2007, LARYNGOSCOPE, V117, P1296, DOI 10.1097/MLG.0b013e31805c9a28; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Xue HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020332; Yang L, 2010, J IMMUNOL, V184, P975, DOI 10.4049/jimmunol.0900650; YU SH, 1990, BIOCHIM BIOPHYS ACTA, V1046, P233, DOI 10.1016/0005-2760(90)90236-Q; Zhang SP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000564	59	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53705	10.1371/journal.pone.0053705	http://dx.doi.org/10.1371/journal.pone.0053705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349731	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100026
J	Gally, F; Chu, HW; Bowler, RP				Gally, Fabienne; Chu, Hong Wei; Bowler, Russell P.			Cigarette Smoke Decreases Airway Epithelial FABP5 Expression and Promotes Pseudomonas aeruginosa Infection	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ACTIVATED RECEPTOR-GAMMA; HUMAN BETA-DEFENSIN-2; ACUTE EXACERBATIONS; METABOLIC SYNDROME; INNATE IMMUNITY; INFLAMMATION; CELLS; MAL1; LUNG	Cigarette smoking is the primary cause of Chronic Obstructive Pulmonary Disease (COPD), which is characterized by chronic inflammation of the airways and destruction of lung parenchyma. Repeated and sustained bacterial infections are clearly linked to disease pathogenesis (e.g., exacerbations) and a huge burden on health care costs. The airway epithelium constitutes the first line of host defense against infection and our previous study indicated that Fatty Acid Binding Protein 5 (FABP5) is down regulated in airway epithelial cells of smokers with COPD as compared to smokers without COPD. We hypothesized that cigarette smoke (CS) exposure down regulates FABP5, thus, contributing to a more sustained inflammation in response to bacterial infection. In this report, we show that FABP5 is increased following bacterial infection but decreased following CS exposure of primary normal human bronchial epithelial (NHBE) cells. The goal of this study was to address FABP5 function by knocking down or overexpressing FABP5 in primary NHBE cells exposed to CS. Our data indicate that FABP5 down regulation results in increased P. aeruginosa bacterial load and inflammatory cytokine levels (e.g., IL-8) and decreased expression of the anti-bacterial peptide, beta defensin-2. On the contrary, FABP5 overexpression exerts a protective function in airway epithelial cells against P. aeruginosa infection by limiting the production of IL-8 and increasing the expression of beta defensin-2. Our study indicates that FABP5 exerts immunomodulatory functions in the airway epithelium against CS exposure and subsequent bacterial infection through its modulation of the nuclear receptor peroxisome proliferator-activated receptor (PPAR)-gamma activity. These findings support the development of FABP5/PPAR-gamma targeted therapeutic approach to prevent airway inflammation by restoring antimicrobial immunity during COPD exacerbations.	[Gally, Fabienne; Chu, Hong Wei; Bowler, Russell P.] Natl Jewish Hlth, Dept Med, Div Pulm, Denver, CO USA	National Jewish Health	Bowler, RP (corresponding author), Natl Jewish Hlth, Dept Med, Div Pulm, Denver, CO USA.	bowlerr@njhealth.org		Gally, Fabienne/0000-0003-0503-7411	Flight Attendant Medical Research Institute	Flight Attendant Medical Research Institute	This work was supported by the Young Clinical Scientist Award (F.G.) and Clinical Innovator Awards (H.W.C. and R.P.B.) from the Flight Attendant Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Babaev VR, 2011, ARTERIOSCL THROM VAS, V31, P1283, DOI 10.1161/ATVBAHA.111.225839; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Baqir M, 2008, RESP MED, V102, P1604, DOI 10.1016/j.rmed.2008.05.002; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Chu HW, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-155; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Eller J, 1998, CHEST, V113, P1542, DOI 10.1378/chest.113.6.1542; Fabbri LM, 2003, EUR RESPIR J, V22, P1, DOI 10.1183/09031936.03.00063703; Feingold KR, 2010, ATHEROSCLEROSIS, V209, P81, DOI 10.1016/j.atherosclerosis.2009.08.042; Green RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006860; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; HOLT PG, 1977, BACTERIOL REV, V41, P205, DOI 10.1128/MMBR.41.1.205-216.1977; Hong J, 2011, ATHEROSCLEROSIS, V217, P194, DOI 10.1016/j.atherosclerosis.2011.03.002; Janssens W, 2010, AM J RESP CRIT CARE, V182, P163, DOI 10.1164/rccm.200905-0767OC; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Lode H, 2007, INFECTION, V35, P143, DOI 10.1007/s15010-007-6078-z; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Martin Richard J, 2006, COPD, V3, P3, DOI 10.1080/15412550500493162; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Miravitlles M, 1999, CHEST, V116, P40, DOI 10.1378/chest.116.1.40; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Naveed B, 2012, AM J RESP CRIT CARE, V185, P392, DOI 10.1164/rccm.201109-1672OC; Parameswaran GI, 2009, DRUG AGING, V26, P985, DOI 10.2165/11315700-000000000-00000; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Phillips J, 2005, ATLA-ALTERN LAB ANIM, V33, P239, DOI 10.1177/026119290503300310; Polosukhin VV, 2011, AM J RESP CRIT CARE, V184, P317, DOI 10.1164/rccm.201010-1629OC; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; SIEGENTHALER G, 1994, BIOCHEM J, V302, P363, DOI 10.1042/bj3020363; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006; Yeung DCY, 2008, EUR HEART J, V29, P2156, DOI 10.1093/eurheartj/ehn295; Zimmerman AW, 2001, BIOCHEM J, V360, P159, DOI 10.1042/0264-6021:3600159	45	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e51784	10.1371/journal.pone.0051784	http://dx.doi.org/10.1371/journal.pone.0051784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349676	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100009
J	Gao, F; Shi, LL; Russin, J; Zeng, LY; Chang, X; He, SH; Chen, TC; Giannotta, SL; Weisenberger, DJ; Zada, G; Mack, WJ; Wang, K				Gao, Fan; Shi, Lingling; Russin, Jonathan; Zeng, Liyun; Chang, Xiao; He, Shuhan; Chen, Thomas C.; Giannotta, Steven L.; Weisenberger, Daniel J.; Zada, Gabriel; Mack, William J.; Wang, Kai			DNA Methylation in the Malignant Transformation of Meningiomas	PLOS ONE			English	Article							5-METHYLCYTOSINE CONTENT; GENE-EXPRESSION; HUMAN NEOPLASIA; CPG ISLANDS; CANCER; HYPERMETHYLATION; METHYLTRANSFERASES; PROGRESSION; GENOME; TUMORS	Meningiomas are central nervous system tumors that originate from the meningeal coverings of the brain and spinal cord. Most meningiomas are pathologically benign or atypical, but 3-5% display malignant features. Despite previous studies on benign and atypical meningiomas, the key molecular pathways involved in malignant transformation remain to be determined, as does the extent of epigenetic alteration in malignant meningiomas. In this study, we explored the landscape of DNA methylation in ten benign, five atypical and four malignant meningiomas. Compared to the benign tumors, the atypical and malignant meningiomas demonstrate increased global DNA hypomethylation. Clustering analysis readily separates malignant from atypical and benign tumors, implicating that DNA methylation patterns may serve as diagnostic biomarkers for malignancy. Genes with hypermethylated CpG islands in malignant meningiomas (such as HOXA6 and HOXA9) tend to coincide with the binding sites of polycomb repressive complexes (PRC) in early developmental stages. Most genes with hypermethylated CpG islands at promoters are suppressed in malignant and benign meningiomas, suggesting the switching of gene silencing machinery from PRC binding to DNA methylation in malignant meningiomas. One exception is the MAL2 gene that is highly expressed in benign group and silenced in malignant group, representing de novo gene silencing induced by DNA methylation. In summary, our results suggest that malignant meningiomas have distinct DNA methylation patterns compared to their benign and atypical counterparts, and that the differentially methylated genes may serve as diagnostic biomarkers or candidate causal genes for malignant transformation.	[Gao, Fan; Shi, Lingling; Zeng, Liyun; Chang, Xiao; Mack, William J.; Wang, Kai] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Russin, Jonathan; He, Shuhan; Chen, Thomas C.; Giannotta, Steven L.; Zada, Gabriel; Mack, William J.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Weisenberger, Daniel J.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Wang, Kai] Univ So Calif, Keck Sch Med, Dept Prevent Med, Div Bioinformat, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Mack, WJ (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	mackw@usc.edu; kaiwang@usc.edu	He, Shuhan/AAF-1764-2020; Weisenberger, Daniel/AAA-8314-2020; Xiao, Chang/AAO-9713-2020	He, Shuhan/0000-0002-9902-5077; Weisenberger, Daniel/0000-0001-8303-2603; Zeng, Liyun/0000-0001-5959-8295	American Cancer Society [IRG-58-007-51]; SC CTSI (NIH/NCRR/NCATS) [KL2RR031991]; National Institutes of Health through Southern California CTSI [KL2]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031991] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); SC CTSI (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health through Southern California CTSI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	WJM is supported by an National Institutes of Health KL2 grant through the Southern California CTSI. This project was supported in part by IRG-58-007-51 from the American Cancer Society, and in part by SC CTSI (NIH/NCRR/NCATS) through grant KL2RR031991. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RLP, 1993, FEBS LETT, V320, P243, DOI 10.1016/0014-5793(93)80595-L; ADAMS RLP, 1982, CRC CR REV BIOCH MOL, V13, P349, DOI 10.3109/10409238209108714; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; BAYLIN SB, 1991, CANCER CELL-MON REV, V3, P383; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BEDFORD MT, 1987, CANCER RES, V47, P5274; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brigati C, 2012, TRANSL RES; DEBUSTROS A, 1988, P NATL ACAD SCI USA, V85, P5693; DIALA ES, 1983, J NATL CANCER I, V71, P755; Dobbins SE, 2011, NAT GENET, V43, P825, DOI 10.1038/ng.879; FEINBERG AP, 1988, CANCER RES, V48, P1159; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Jones P A, 1990, Adv Cancer Res, V54, P1, DOI 10.1016/S0065-230X(08)60806-4; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kishida Y, 2012, CARCINOGENESIS, V33, P436, DOI 10.1093/carcin/bgr260; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lee Y, 2010, BRAIN PATHOL, V20, P751, DOI 10.1111/j.1750-3639.2009.00356.x; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; MAKOS M, 1993, CANCER RES, V53, P2715; MAKOS M, 1993, CANCER RES, V53, P2719; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Mimori K, 2003, ONCOGENE, V22, P3463, DOI 10.1038/sj.onc.1206378; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Perry A, 2004, J NEURO-ONCOL, V70, P183, DOI 10.1007/s11060-004-2749-0; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Ting AH, 2006, CANCER RES, V66, P729, DOI 10.1158/0008-5472.CAN-05-1537; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wrobel G, 2005, INT J CANCER, V114, P249, DOI 10.1002/ijc.20733; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631	42	77	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54114	10.1371/journal.pone.0054114	http://dx.doi.org/10.1371/journal.pone.0054114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349797	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100043
J	Grin'kina, NM; Abdel-Baki, SG; Bergold, PJ				Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.			Reversible Behavioral Deficits in Rats during a Cycle of Demyelination-Remyelination of the Fimbria	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; MORRIS WATER MAZE; COGNITIVE FUNCTION; HIPPOCAMPUS; MEMORY; NAVIGATION; PLACE; SEGREGATION; AVOIDANCE	Traumatic brain injury (TBI) selectively damages white matter. White matter damage does not produce deficits in many behavioral tests used to analyze experimental TBI. Rats were impaired on an active place avoidance task following inactivation of one hippocampal injection of tetrodotoxin. The need for both hippocampi suggests that acquisition of the active place avoidance task may require interhippocampal communication. The controlled cortical impact model of TBI demyelinates midline white matter and impairs rats on the active place avoidance task. One white matter region that is demyelinated is the fimbria that contains hippocampal commissural fibers. We therefore tested whether demyelination of the fimbria produces deficits in active place avoidance. Lysophosphatidylcholine (LPC) was injected stereotaxically to produce a cycle of demyelination-remyelination of the fimbria. At 4 days, myelin loss was observed in the fimbria of LPC-, but not saline-injected rats. Fourteen days after injection, myelin content increased in LPC-, but not saline-injected rats. Three days after injection, both saline- and LPC-injected rats had similar performance on an open field and passive place avoidance task in which the rat avoided a stationary shock zone on a stationary arena. The following day, on the active place avoidance task, LPC-injected rats had a significantly higher number of shock zone entrances suggesting learning was impaired. At 14 days after injection, saline- and LPC-injected rats had similar performance on open field and passive place avoidance. On active place avoidance, however, saline-and LPC-injected rats had a similar number of total entrances suggesting that the impairment seen at 4 days was no longer present at 14 days. These data suggest that active place avoidance is highly sensitive to white matter injury.	[Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.] Suny Downstate Med Ctr, Dept Physiol Pharmacol & Neurol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Bergold, Peter/0000-0002-6335-1380	United States Army Medical Research and Materiel Command [W81XWH-10-2-0171]	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by contract W81XWH-10-2-0171 from the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P., 2007, HIPPOCAMPUS BOOK; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Duarte FS, 2010, PSYCHOPHARMACOLOGY, V212, P653, DOI 10.1007/s00213-010-1985-6; Easton A, 2010, BEHAV BRAIN RES, V215, P310, DOI 10.1016/j.bbr.2009.10.019; FENTON AA, 1993, BEHAV NEUROSCI, V107, P552, DOI 10.1037/0735-7044.107.4.552; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Jean I, 2003, BRAIN RES, V972, P110, DOI 10.1016/S0006-8993(03)02510-1; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; OLTON DS, 1982, BRAIN RES, V233, P241, DOI 10.1016/0006-8993(82)91200-8; Olypher AV, 2006, J NEUROSCI, V26, P158, DOI 10.1523/JNEUROSCI.2064-05.2006; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Skelton RW, 1998, BEHAV BRAIN RES, V96, P13, DOI 10.1016/S0166-4328(97)00199-X; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L	27	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53775	10.1371/journal.pone.0053775	http://dx.doi.org/10.1371/journal.pone.0053775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349742	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100031
J	de la Ossa, DHP; Lorente, M; Gil-Alegre, ME; Torres, S; Garcia-Taboada, E; Aberturas, MD; Molpeceres, J; Velasco, G; Torres-Suarez, AI				Hernan Perez de la Ossa, Dolores; Lorente, Mar; Esther Gil-Alegre, Maria; Torres, Sofia; Garcia-Taboada, Elena; del Rosario Aberturas, Maria; Molpeceres, Jesus; Velasco, Guillermo; Isabel Torres-Suarez, Ana			Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme	PLOS ONE			English	Article							HUMAN GLIOMA-CELLS; DRUG-DELIVERY; IN-VITRO; HEPATOCELLULAR-CARCINOMA; ANTITUMOR-ACTIVITY; SUSTAINED-RELEASE; MICROSPHERES; CANNABIDIOL; CANCER; DOXORUBICIN	Cannabinoids, the active components of marijuana and their derivatives, are currently investigated due to their potential therapeutic application for the management of many different diseases, including cancer. Specifically, Delta(9)- Tetrahydrocannabinol (THC) and Cannabidiol (CBD) - the two major ingredients of marijuana - have been shown to inhibit tumor growth in a number of animal models of cancer, including glioma. Although there are several pharmaceutical preparations that permit the oral administration of THC or its analogue nabilone or the oromucosal delivery of a THC- and CBD- enriched cannabis extract, the systemic administration of cannabinoids has several limitations in part derived from the high lipophilicity exhibited by these compounds. In this work we analyzed CBD- and THC-loaded poly-epsilon- caprolactone microparticles as an alternative delivery system for long-term cannabinoid administration in a murine xenograft model of glioma. In vitro characterization of THC- and CBD-loaded microparticles showed that this method of microencapsulation facilitates a sustained release of the two cannabinoids for several days. Local administration of THC-, CBD- or a mixture (1:1 w:w) of THC- and CBD- loaded microparticles every 5 days to mice bearing glioma xenografts reduced tumour growth with the same efficacy than a daily local administration of the equivalent amount of those cannabinoids in solution. Moreover, treatment with cannabinoid-loaded microparticles enhanced apoptosis and decreased cell proliferation and angiogenesis in these tumours. Our findings support that THC- and CBD- loaded microparticles could be used as an alternative method of cannabinoid delivery in anticancer therapies.	[Hernan Perez de la Ossa, Dolores; Esther Gil-Alegre, Maria; Isabel Torres-Suarez, Ana] Univ Complutense, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-28040 Madrid, Spain; [Lorente, Mar; Torres, Sofia; Garcia-Taboada, Elena; Velasco, Guillermo] Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Lorente, Mar; Velasco, Guillermo] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [del Rosario Aberturas, Maria; Molpeceres, Jesus] Alcala Univ, Sch Pharm, Dept Pharm & Pharmaceut Technol, Madrid, Spain; [Esther Gil-Alegre, Maria; Isabel Torres-Suarez, Ana] Univ Complutense, Inst Farm Ind, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Hospital Clinico San Carlos; Universidad de Alcala; Complutense University of Madrid	Velasco, G (corresponding author), Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.	gvd@bbm1.ucm.es	Torres-Suárez, Ana I/N-4666-2013; Velasco, Guillermo/H-5260-2012; del Rosario Aberturas, María/AAA-9014-2019; Lorente, Mar/O-5106-2017; Torres-SuÃrez, Ana Isabel/AAR-9320-2020; /Y-9512-2019; Velasco, Guillermo/AAU-9189-2020; Lorente, Mar/K-2401-2014	Torres-Suárez, Ana I/0000-0003-2468-6177; Velasco, Guillermo/0000-0002-1994-2386; del Rosario Aberturas, María/0000-0001-7875-6009; Lorente, Mar/0000-0003-0982-0956; Torres-SuÃrez, Ana Isabel/0000-0003-2468-6177; /0000-0003-4201-0795; Velasco, Guillermo/0000-0002-1994-2386; GIL-ALEGRE, MARIA ESTHER/0000-0002-8313-8261; Torres, Sofia/0000-0002-9007-8105	Spanish Ministry of Science and Innovation (MICINN) [PS09/01401]; Comunidad Autonoma de Madrid [PR1/06-14474-B]; Complutense University [CCG07-UCM/BIO-2824]; Juan de la Cierva; Spanish Ministry of Education and Science; Comunidad de Madrid; GW Pharmaceuticals	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Complutense University; Juan de la Cierva(Instituto de Salud Carlos III); Spanish Ministry of Education and Science(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); GW Pharmaceuticals	This work was supported by grants from the Spanish Ministry of Science and Innovation (MICINN) (PS09/01401 to GV), Comunidad Autonoma de Madrid (PR1/06-14474-B to AITS) and Complutense University (CCG07-UCM/BIO-2824 to AITS). DH was recipient of a FPU fellowship from MICINN. ML was sequentially recipient of a "Juan de la Cierva'' contract, a postdoctoral contract from Spanish Ministry of Education and Science and a postdoctoral contract from Comunidad de Madrid. ST was recipient of a research training contract from Comunidad de Madrid. GW Pharmaceuticals funded part of the research that was performed in GV's laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ateh DD, 2011, BIOMATERIALS, V32, P8538, DOI 10.1016/j.biomaterials.2011.07.060; Benny O, 2009, CLIN CANCER RES, V15, P1222, DOI 10.1158/1078-0432.CCR-08-1316; Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Carracedo A, 2006, CANCER RES, V66, P6748, DOI 10.1158/0008-5472.CAN-06-0169; Chakravarthi SS, 2011, INT J PHARMACEUT, V409, P111, DOI 10.1016/j.ijpharm.2011.02.034; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Dubernet C, 2011, B CANCER, V98, P1363, DOI 10.1684/bdc.2011.1468; Gil-Alegre ME, 2008, J MICROENCAPSUL, V25, P561, DOI [10.1080/02652040802075799, 10.1080/02652040802075799 ]; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Freiberg S, 2004, INT J PHARMACEUT, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; GARRETT ER, 1974, J PHARM SCI-US, V63, P1056, DOI 10.1002/jps.2600630705; Guzman M, 2005, HANDB EXP PHARMACOL, V168, P627; Hillegass JM, 2011, INT J CANCER, V129, P233, DOI 10.1002/ijc.25666; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Kim I, 2012, BIOMATERIALS, V33, P5574, DOI 10.1016/j.biomaterials.2012.04.018; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Lin RY, 2005, BIOMATERIALS, V26, P4476, DOI 10.1016/j.biomaterials.2004.11.014; Marcu JP, 2010, MOL CANCER THER, V9, P180, DOI 10.1158/1535-7163.MCT-09-0407; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; Massi P, 2006, CELL MOL LIFE SCI, V63, P2057, DOI 10.1007/s00018-006-6156-x; McAllister SD, 2007, MOL CANCER THER, V6, P2921, DOI 10.1158/1535-7163.MCT-07-0371; McAllister SD, 2011, BREAST CANCER RES TR, V129, P37, DOI 10.1007/s10549-010-1177-4; Menei Philippe, 2005, Expert Opin Drug Deliv, V2, P363, DOI 10.1517/17425247.2.2.363; Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9; Nguyen TLU, 2007, J POLYM SCI POL CHEM, V45, P3256, DOI 10.1002/pola.22074; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; de la Ossa DHP, 2012, J CONTROL RELEASE, V161, P927, DOI 10.1016/j.jconrel.2012.05.003; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Sarfaraz S, 2008, CANCER RES, V68, P339, DOI 10.1158/0008-5472.CAN-07-2785; Sastre RL, 2004, DRUG DEVELOP RES, V63, P41, DOI 10.1002/ddr.10396; Soma CE, 2000, J CONTROL RELEASE, V68, P283, DOI 10.1016/S0168-3659(00)00269-8; Soma CE, 2000, BIOMATERIALS, V21, P1; Torelli-Souza RR, 2012, J APPL POLYM SCI, V126, pE408, DOI 10.1002/app.36928; Torres S, 2011, MOL CANCER THER, V10, P90, DOI 10.1158/1535-7163.MCT-10-0688; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247	41	58	61	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54795	10.1371/journal.pone.0054795	http://dx.doi.org/10.1371/journal.pone.0054795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349970	Green Published, gold			2022-12-27	WOS:000314019100098
J	Ke, PY; Chen, SSL				Ke, Po-Yuan; Chen, Steve S-L			Active RNA Replication of Hepatitis C Virus Downregulates CD81 Expression	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; INFECTION IN-VITRO; RECEPTOR SR-BI; SCAVENGER RECEPTOR; SUPERINFECTION EXCLUSION; HEPATOMA-CELLS; ENTRY FACTOR; PROTEIN; LIVER; HOST	So far how hepatitis C virus (HCV) replication modulates subsequent virus growth and propagation still remains largely unknown. Here we determine the impact of HCV replication status on the consequential virus growth by comparing normal and high levels of HCV RNA expression. We first engineered a full-length, HCV genotype 2a JFH1 genome containing a blasticidin-resistant cassette inserted at amino acid residue of 420 in nonstructural (NS) protein 5A, which allowed selection of human hepatoma Huh7 cells stably-expressing HCV. Short-term establishment of HCV stable cells attained a highly-replicating status, judged by higher expressions of viral RNA and protein as well as higher titer of viral infectivity as opposed to cells harboring the same genome without selection. Interestingly, maintenance of highly-replicating HCV stable cells led to decreased susceptibility to HCV pseudotyped particle (HCVpp) infection and downregulated cell surface level of CD81, a critical HCV entry (co) receptor. The decreased CD81 cell surface expression occurred through reduced total expression and cytoplasmic retention of CD81 within an endoplasmic reticulum -associated compartment. Moreover, productive viral RNA replication in cells harboring a JFH1 subgenomic replicon containing a similar blasticidin resistance gene cassette in NS5A and in cells robustly replicating full-length infectious genome also reduced permissiveness to HCVpp infection through decreasing the surface expression of CD81. The downregulation of CD81 surface level in HCV RNA highly-replicating cells thus interfered with reinfection and led to attenuated viral amplification. These findings together indicate that the HCV RNA replication status plays a crucial determinant in HCV growth by modulating the expression and intracellular localization of CD81.	[Ke, Po-Yuan; Chen, Steve S-L] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Ke, Po-Yuan] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Dept Biochem & Mol Biol, Tao Yuan, Taiwan; [Ke, Po-Yuan] Chang Gung Univ, Coll Med, Mol Med Res Ctr, Tao Yuan, Taiwan	Academia Sinica - Taiwan; Chang Gung University; Chang Gung University	Chen, SSL (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	schen@ibms.sinica.edu.tw	Ke, Po-Yuan/AAQ-6324-2021	Ke, Po-Yuan/0000-0002-0471-0806	National Health of Research Institute [NHRI-EX100-10051SI, NHRI-EX101-10051SI]; National Science Council [NSC99-2320-B-001-003-MY3, NSC101-2320-B-001-022-MY3]; Ministry of Education [EMRPD1B0161]; Chang Gung University [NMRPD1B12, CMRPD1B0461]; Foresight Research Grant [AS97FP-L15-1, AS98FP-L15-1, AS99FP-L15-1]; Academia Sinica; Liver Disease Prevention & Treatment Research Foundation	National Health of Research Institute; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education; Chang Gung University; Foresight Research Grant; Academia Sinica(Academia Sinica - Taiwan); Liver Disease Prevention & Treatment Research Foundation	This study was supported by research grants from the National Health of Research Institute (NHRI-EX100-10051SI and NHRI-EX101-10051SI), the National Science Council (NSC99-2320-B-001-003-MY3 and NSC101-2320-B-001-022-MY3), the Ministry of Education (EMRPD1B0161), Chang Gung University (NMRPD1B12 and CMRPD1B0461), and by Foresight Research Grants (AS97FP-L15-1, AS98FP-L15-1, and AS99FP-L15-1), Summit Project III from Academia Sinica, and the Liver Disease Prevention & Treatment Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Carloni V, 2004, ONCOGENE, V23, P1566, DOI 10.1038/sj.onc.1207287; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Farquhar MJ, 2012, J VIROL, V86, P4305, DOI 10.1128/JVI.06996-11; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Kato T, 2007, J VIROL, V81, P4405, DOI 10.1128/JVI.02334-06; Ke PY, 2012, VIRUSES-BASEL, V4, P2251, DOI 10.3390/v4102251; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Li HF, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-89; Lin KYK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001148; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lineberry N, 2008, J BIOL CHEM, V283, P28497, DOI 10.1074/jbc.M805092200; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044965; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Lopez D, 1999, ENDOCRINOLOGY, V140, P5669, DOI 10.1210/en.140.12.5669; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Masaki T, 2010, J VIROL, V84, P5824, DOI 10.1128/JVI.02397-09; Mazzocca A, 2008, GASTROENTEROLOGY, V135, P244, DOI 10.1053/j.gastro.2008.03.024; Meertens L, 2008, J VIROL, V82, P3555, DOI 10.1128/JVI.01977-07; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Wood P, 2011, J BIOL CHEM, V286, P23077, DOI 10.1074/jbc.M111.236398; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	46	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54866	10.1371/journal.pone.0054866	http://dx.doi.org/10.1371/journal.pone.0054866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349980	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100103
J	Lin, A; Bik, EM; Costello, EK; Dethlefsen, L; Haque, R; Relman, DA; Singh, U				Lin, Audrie; Bik, Elisabeth M.; Costello, Elizabeth K.; Dethlefsen, Les; Haque, Rashidul; Relman, David A.; Singh, Upinder			Distinct Distal Gut Microbiome Diversity and Composition in Healthy Children from Bangladesh and the United States	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; ACUTE DIARRHEA; INSIGHTS; BIODIVERSITY; ENVIRONMENT; ASSOCIATION; COMMUNITIES; ENTEROPATHY; EVOLUTION; ECOSYSTEM	Background: Our current understanding of the composition and stability of the human distal gut microbiota is based largely on studies of infants and adults living in developed countries. In contrast, little is known about the gut microbiota and its variation over time in older children and adolescents, especially in developing countries. Methodology/Principal Findings: We compared the diversity, composition, and temporal stability of the fecal microbiota of healthy children, ages 9 to 14 years, living in an urban slum in Bangladesh with that of children of the same age range in an upper-middle class suburban community in the United States. We analyzed >8,000 near full-length 16S rRNA gene sequences and over 845,000 pyrosequencing reads of the 16S rRNA V1-V3 region. The distal gut of Bangladeshi children harbored significantly greater bacterial diversity than that of U. S. children, including novel lineages from several bacterial phyla. Bangladeshi and U. S. children had distinct fecal bacterial community membership and structure; the microbiota of Bangladeshi children was enriched in Prevotella, Butyrivibrio, and Oscillospira and depleted in Bacteroides relative to U. S. children (although similar to Bangladeshi adults). Furthermore, community membership and structure in Bangladeshi children was significantly less stable month-to-month than U. S. children. Conclusions/Significance: Together, these results suggest that differing environmental or genetic factors may shape the microbiota of healthy children in the two countries. Further investigation is necessary to understand the mechanisms and factors that underlie these differences, and to incorporate these findings into new strategies for the prevention and treatment of childhood and adolescent diseases.	[Lin, Audrie; Bik, Elisabeth M.; Costello, Elizabeth K.; Dethlefsen, Les; Relman, David A.; Singh, Upinder] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Haque, Rashidul] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Relman, David A.; Singh, Upinder] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; International Centre for Diarrhoeal Disease Research (ICDDR); Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	relman@stanford.edu; usingh@stanford.edu	Bik, Elisabeth M/A-1204-2007; Dethlefsen, Les/R-2220-2018	Bik, Elisabeth M/0000-0001-5477-0324; Dethlefsen, Les/0000-0001-9622-1630; Relman, David A./0000-0001-8331-1354; Lin, Audrie/0000-0002-3877-3469; Singh, Upinder/0000-0003-0630-0306	Doris Duke Charitable Trust (DAR); National Institutes of Health Director's Pioneer Award [DP1OD000964]; NIH Clinical and Translational Science Award for the Stanford Center for Clinical and Translational Education and Research (Spectrum) (US) [1UL1 RR025744]; Lucile Packard Foundation for Children's Health; National Science Foundation Graduate Research Fellowship; Stanford Graduate Fellowship; Thomas C. and Joan M. Merigan Endowment at Stanford University; National Institutes of Health [AI 53724, AI 069382, 5R01AI043596]; Walter V. and Idun Berry Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043596, R01AI053724, R21AI069382] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER	Doris Duke Charitable Trust (DAR); National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Clinical and Translational Science Award for the Stanford Center for Clinical and Translational Education and Research (Spectrum) (US); Lucile Packard Foundation for Children's Health; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); Thomas C. and Joan M. Merigan Endowment at Stanford University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walter V. and Idun Berry Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Distinguished Clinical Scientist Award from the Doris Duke Charitable Trust (DAR), the National Institutes of Health Director's Pioneer Award DP1OD000964 (DAR), the NIH Clinical and Translational Science Award 1UL1 RR025744 for the Stanford Center for Clinical and Translational Education and Research (Spectrum) (US), and the Lucile Packard Foundation for Children's Health. AL was supported by a National Science Foundation Graduate Research Fellowship and a Stanford Graduate Fellowship. DAR is supported by the Thomas C. and Joan M. Merigan Endowment at Stanford University. US is supported by grants from the National Institutes of Health (AI 53724 and AI 069382). EKC is supported by a Walter V. and Idun Berry Postdoctoral Fellowship. R. H. and the longitudinal ICDDR,B child cohort study are supported by National Institutes of Health grant 5R01AI043596 to William A. Petri, Jr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; BERNET MF, 1994, GUT, V35, P483, DOI 10.1136/gut.35.4.483; Borruel N, 2002, GUT, V51, P659, DOI 10.1136/gut.51.5.659; Campbell DI, 2002, BRIT J NUTR, V88, P499, DOI 10.1079/BJN2002697; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chatterjee B, 2012, NATURE, V487, P39, DOI 10.1038/487039d; Clark KR., 2006, PRIMER V6 USER MANUA; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Haque R, 2003, AM J TROP MED HYG, V69, P398, DOI 10.4269/ajtmh.2003.69.398; Haque R, 2009, CLIN INFECT DIS, V48, P1191, DOI 10.1086/597580; Hayashi H, 2007, INT J SYST EVOL MICR, V57, P941, DOI 10.1099/ijs.0.64778-0; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mai V, 2006, J CLIN MICROBIOL, V44, P4550, DOI 10.1128/JCM.01542-06; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; Monira S, 2012, J HEALTH POPUL NUTR, V30, P250; Monira S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00228; Monteils V, 2008, FEMS MICROBIOL ECOL, V66, P620, DOI 10.1111/j.1574-6941.2008.00611.x; Murphy Stephen F, 2012, Curr Gastroenterol Rep, V14, P146, DOI 10.1007/s11894-012-0250-z; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; UNICEF, 2011, AD AG OPP; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	60	163	167	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53838	10.1371/journal.pone.0053838	http://dx.doi.org/10.1371/journal.pone.0053838			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349750	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100034
J	Yang, HY; Tan, YF; Zhang, TT; Tang, LJ; Wang, J; Ke, YH; Guo, ZB; Yang, XM; Yang, RF; Du, ZM				Yang, Huiying; Tan, Yafang; Zhang, Tingting; Tang, Liujun; Wang, Jian; Ke, Yuehua; Guo, Zhaobiao; Yang, Xiaoming; Yang, Ruifu; Du, Zongmin			Identification of Novel Protein-Protein Interactions of Yersinia pestis Type III Secretion System by Yeast Two Hybrid System	PLOS ONE			English	Article							YOP SECRETION; SUBSTRATE-SPECIFICITY; YSCC SECRETIN; ENTEROCOLITICA; TRANSLOCATION; EXPRESSION; CHAPERONE; 2-HYBRID; NEEDLE; REGULATOR	Type III secretion system (T3SS) of the plague bacterium Y. pestis encodes a syringe-like structure consisting of more than 20 proteins, which can inject virulence effectors into host cells to modulate the cellular functions. Here in this report, interactions among the possible components in T3SS of Yersinia pestis were identified using yeast mating technique. A total of 57 genes, including all the pCD1-encoded genes except those involved in plasmid replication and partition, pseudogenes, and the putative transposase genes, were subjected to yeast mating analysis. 21 pairs of interaction proteins were identified, among which 9 pairs had been previously reported and 12 novel pairs were identified in this study. Six of them were tested by GST pull down assay, and interaction pairs of YscG-SycD, YscG-TyeA, YscI-YscF, and YopN-YpCD1.09c were successfully validated, suggesting that these interactions might play potential roles in function of Yersinia T3SS. Several potential new interactions among T3SS components could help to understand the assembly and regulation of Yersinia T3SS.	[Yang, Huiying; Tan, Yafang; Ke, Yuehua; Guo, Zhaobiao; Yang, Ruifu; Du, Zongmin] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhang, Tingting] Sichuan Agr Univ, Coll Vet Med, Dept Clin Med, Yaan, Sichuan, Peoples R China; [Tang, Liujun; Wang, Jian; Yang, Xiaoming] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Sichuan Agricultural University; Academy of Military Medical Sciences - China	Yang, XM (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.	xmyang2@nic.bmi.ac.cn; ruifuyang@gmail.com; zongmindu@gmail.com	Yang, Ruifu/A-2273-2011	Yang, Ruifu/0000-0003-3219-7269	National Basic Research Program of China (973 Program) [2012CB518700]; National Natural Science Foundation of China [30970121, 31170122]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program, 2012CB518700) and National Natural Science Foundation of China (No. 30970121, 31170122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x; Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; ALLAOUI A, 1995, MOL MICROBIOL, V18, P343, DOI 10.1111/j.1365-2958.1995.mmi_18020343.x; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cambronne ED, 2004, J BACTERIOL, V186, P829, DOI 10.1128/JB.186.3.829-841.2004; Cattin Cedric, 2009, STOICHIOMETRY ANAL T; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Du ZM, 2009, INT J MED MICROBIOL, V299, P355, DOI 10.1016/j.ijmm.2008.10.003; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907; Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x; Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Matson JS, 2001, J BACTERIOL, V183, P5082, DOI 10.1128/JB.183.17.5082-5091.2001; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PLANO GV, 1991, J BACTERIOL, V173, P7293, DOI 10.1128/jb.173.22.7293-7303.1991; PLANO GV, 1993, J BACTERIOL, V175, P3536, DOI 10.1128/jb.175.11.3536-3545.1993; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva-Herzog E, 2008, MICROBIOL-SGM, V154, P593, DOI 10.1099/mic.0.2007/013045-0; SKRZYPEK E, 1993, J BACTERIOL, V175, P3520, DOI 10.1128/jb.175.11.3520-3528.1993; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Swietnicki W, 2004, J BIOL CHEM, V279, P38693, DOI 10.1074/jbc.M405217200; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Yang F, 2010, PLOS ONE, P5	47	15	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54121	10.1371/journal.pone.0054121	http://dx.doi.org/10.1371/journal.pone.0054121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349800	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100045
J	Benhamou, M; Baron, G; Dalichampt, M; Boutron, I; Alami, S; Rannou, F; Ravaud, P; Poiraudeau, S				Benhamou, Mathilde; Baron, Gabriel; Dalichampt, Marie; Boutron, Isabelle; Alami, Sophie; Rannou, Francois; Ravaud, Philippe; Poiraudeau, Serge			Development and Validation of a Questionnaire Assessing Fears and Beliefs of Patients with Knee Osteoarthritis: The Knee Osteoarthritis Fears and Beliefs Questionnaire (KOFBeQ)	PLOS ONE			English	Article							LOW-BACK-PAIN; QUALITY-OF-LIFE; AVOIDANCE BELIEFS; RHEUMATOID-ARTHRITIS; DISABILITY; ANXIETY; IMPACT; SCALE; HIP	Objective: We aimed to develop a questionnaire assessing fears and beliefs of patients with knee OA. Design: We sent a detailed document reporting on a qualitative analysis of interviews of patients with knee OA to experts, and a Delphi procedure was adopted for item generation. Then, 80 physicians recruited 566 patients with knee OA to test the provisional questionnaire. Items were reduced according to their metric properties and exploratory factor analysis. Reliability was tested by the Cronbach a coefficient. Construct validity was tested by divergent validity and confirmatory factor analysis. Test-retest reliability was assessed by the intra-class correlation coefficient (ICC) and the Bland and Altman technique. Results: 137 items were extracted from analysis of the interview data. Three Delphi rounds were needed to obtain consensus on a 25-item provisional questionnaire. The item-reduction process resulted in an 11-item questionnaire. Selected items represented fears and beliefs about daily living activities (3 items), fears and beliefs about physicians (4 items), fears and beliefs about the disease (2 items), and fears and beliefs about sports and leisure activities (2 items). The Cronbach a coefficient of global score was 0.85. We observed expected divergent validity. Confirmation factor analyses confirmed higher intra-factor than inter-factor correlations. Test-retest reliability was good, with an ICC of 0.81, and Bland and Altman analysis did not reveal a systematic trend. Conclusions: We propose an 11-item questionnaire assessing patients' fears and beliefs concerning knee OA with good content and construct validity.	[Benhamou, Mathilde; Rannou, Francois; Poiraudeau, Serge] AP HP, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, Paris, France; [Benhamou, Mathilde; Rannou, Francois; Poiraudeau, Serge] INSERM IFR 25 Handicap, Paris, France; [Baron, Gabriel; Dalichampt, Marie; Boutron, Isabelle; Ravaud, Philippe] AP HP, Ctr Epidemiol Clin, Paris, France; [Alami, Sophie] Univ Paris 05, Dept Sociol, Interlis, Paris, France; [Rannou, Francois] Sect Arthrose Soc Francaise Rhumatol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite	Poiraudeau, S (corresponding author), AP HP, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, Paris, France.	serge.poiraudeau@cch.aphp.fr	POIRAUDEAU, SERGE/P-5301-2016; ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241; , ALAMI/0000-0002-2999-8551; Poiraudeau, Serge/0000-0002-1988-9124	Pfizer	Pfizer(Pfizer)	This study was funded by an unlimited grant from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019634; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Askew C, 2007, BEHAV RES THER, V45, P2616, DOI 10.1016/j.brat.2007.06.008; BADLEY EM, 1994, J RHEUMATOL, V21, P505; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bellamy N, 2002, OSTEOARTHR CARTILAGE, V10, P855, DOI 10.1053/joca.2002.0837; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Benhamou M, 2012, ANN RHEUM DIS; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boersma K, 2006, CLIN J PAIN, V22, P160, DOI 10.1097/01.ajp.0000159582.37750.39; Boutron I, 2008, OSTEOARTHR CARTILAGE, V16, P1024, DOI 10.1016/j.joca.2008.01.001; Buchbinder R, 2004, BRIT MED J, V328, P321, DOI 10.1136/bmj.328.7435.321; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Dinno A, 2009, MULTIVAR BEHAV RES, V44, P362, DOI 10.1080/00273170902938969; DREISER RL, 1995, REV RHUM, V62, pS43; Duruoz MT, 1996, J RHEUMATOL, V23, P1167; Elfving B, 2007, PHYSIOTHER RES INT, V12, P14, DOI 10.1002/pri.355; FDA, 2009, CLIM MED, V74, P132; Field AP, 2003, BEHAV RES THER, V41, P1277, DOI 10.1016/S0005-7967(03)00034-2; Gheldof ELM, 2005, PAIN, V113, P71, DOI 10.1016/j.pain.2004.09.040; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hewlett S, 2001, ANN RHEUM DIS, V60, P928, DOI 10.1136/ard.60.10.928; LAPLANTE MP, 1991, MILBANK Q, V69, P55, DOI 10.2307/3350158; LEQUESNE MG, 1987, SCAND J RHEUMATOL, P85; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; RACHMAN S, 1977, BEHAV RES THER, V15, P375, DOI 10.1016/0005-7967(77)90041-9; Rainville J, 2011, SPINE J, V11, P895, DOI 10.1016/j.spinee.2011.08.006; Scopaz KA, 2009, ARCH PHYS MED REHAB, V90, P1866, DOI 10.1016/j.apmr.2009.06.012; Shelby RA, 2012, ARTHRIT CARE RES, V64, P862, DOI 10.1002/acr.21626; Somers TJ, 2009, J PAIN SYMPTOM MANAG, V37, P863, DOI 10.1016/j.jpainsymman.2008.05.009; Stewart J, 1999, BMJ-BRIT MED J, V319, P224, DOI 10.1136/bmj.319.7204.224; TUGWELL P, 1990, ARCH INTERN MED, V150, P59, DOI 10.1001/archinte.150.1.59; Turner JA, 2006, SPINE, V31, P682, DOI 10.1097/01.brs.0000202762.88787.af; van der Waal JM, 2005, QUAL LIFE RES, V14, P795, DOI 10.1007/s11136-004-0801-3; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P945, DOI 10.1016/S0895-4356(98)00085-7; Woby SR, 2004, BEHAV RES THER, V42, P761, DOI 10.1016/S0005-7967(03)00195-5; Wylde V, 2006, MUSCULOSKELET CARE, V4, P152, DOI 10.1002/msc.86	40	20	20	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53886	10.1371/journal.pone.0053886	http://dx.doi.org/10.1371/journal.pone.0053886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	076FX	23349757	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000019
J	Maddox, SA; Watts, CS; Doyere, V; Schafe, GE				Maddox, Stephanie A.; Watts, Casey S.; Doyere, Valerie; Schafe, Glenn E.			A Naturally-Occurring Histone Acetyltransferase Inhibitor Derived from Garcinia indica Impairs Newly Acquired and Reactivated Fear Memories	PLOS ONE			English	Article							LONG-TERM-MEMORY; POSTTRAUMATIC-STRESS-DISORDER; ESTRADIOL-INDUCED ENHANCEMENT; RUBINSTEIN-TAYBI-SYNDROME; PROTEIN-KINASE-A; LATERAL AMYGDALA; SYNAPTIC PLASTICITY; EPIGENETIC ALTERATIONS; MOLECULAR-MECHANISMS; OBJECT RECOGNITION	The study of the cellular and molecular mechanisms underlying the consolidation and reconsolidation of traumatic fear memories has progressed rapidly in recent years, yet few compounds have emerged that are readily useful in a clinical setting for the treatment of anxiety disorders such as post-traumatic stress disorder (PTSD). Here, we use a combination of biochemical, behavioral, and neurophysiological methods to systematically investigate the ability of garcinol, a naturally-occurring histone acetyltransferase (HAT) inhibitor derived from the rind of the fruit of the Kokum tree (Garcina indica), to disrupt the consolidation and reconsolidation of Pavlovian fear conditioning, a widely studied rodent model of PTSD. We show that local infusion of garcinol into the rat lateral amygdala (LA) impairs the training and retrieval-related acetylation of histone H3 in the LA. Further, we show that either intra-LA or systemic administration of garcinol within a narrow window after either fear conditioning or fear memory retrieval significantly impairs the consolidation and reconsolidation of a Pavlovian fear memory and associated neural plasticity in the LA. Our findings suggest that a naturally-occurring compound derived from the diet that regulates chromatin function may be useful in the treatment of newly acquired or recently reactivated traumatic memories.	[Maddox, Stephanie A.; Watts, Casey S.; Schafe, Glenn E.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Schafe, Glenn E.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Doyere, Valerie] Univ Paris 11, Ctr Neurosci Paris Sud, UMR 8195, Orsay, France; [Doyere, Valerie] CNRS, F-91405 Orsay, France	Yale University; Yale University; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS)	Schafe, GE (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	glenn.schafe@yale.edu	Maddox, Stephanie/AAD-6943-2022	Doyere, Valerie/0000-0002-3851-669X	National Institutes of Health [MH 073949]; Yale University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institutes of Health Grant MH 073949 (to G. E. S.) and by Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Arif M, 2009, J MED CHEM, V52, P267, DOI 10.1021/jm800657z; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; Bailey DJ, 1999, BEHAV NEUROSCI, V113, P276, DOI 10.1037/0735-7044.113.2.276; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Baliga MS, 2011, FOOD RES INT, V44, P1790, DOI 10.1016/j.foodres.2011.01.064; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; BOUTON ME, 1994, ANIM LEARN BEHAV, V22, P317, DOI 10.3758/BF03209840; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Bush DEA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00154; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Dal Piaz F, 2011, MOL DIVERS, V15, P401, DOI 10.1007/s11030-010-9299-5; Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; Duclot F, 2010, NEUROSCI LETT, V475, P179, DOI 10.1016/j.neulet.2010.03.077; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Duvarci S, 2008, LEARN MEMORY, V15, P747, DOI 10.1101/lm.1027208; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hawk JD, 2011, LEARN MEMORY, V18, P367, DOI 10.1101/lm.2097411; Hoge EA, 2012, CNS NEUROSCI THER, V18, P21, DOI 10.1111/j.1755-5949.2010.00227.x; Hsu CL, 2012, FOOD FUNCT, V3, P49, DOI 10.1039/c1fo10209e; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Koeberle A, 2009, BIOCHEM PHARMACOL, V77, P1513, DOI 10.1016/j.bcp.2009.02.005; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lopez-Atalaya JP, 2012, J MED GENET, V49, P66, DOI 10.1136/jmedgenet-2011-100354; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Maddox SA, 2011, J NEUROSCI, V31, P7073, DOI 10.1523/JNEUROSCI.1120-11.2011; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Manzo F, 2009, EXPERT OPIN THER PAT, V19, P761, DOI 10.1517/13543770902895727; Marek R, 2011, J NEUROSCI, V31, P7486, DOI 10.1523/JNEUROSCI.0133-11.2011; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Maurice T, 2008, NEUROPSYCHOPHARMACOL, V33, P1584, DOI 10.1038/sj.npp.1301551; McGhee LL, 2009, J BURN CARE RES, V30, P92, DOI 10.1097/BCR.0b013e3181921f51; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Milton AL, 2008, J NEUROSCI, V28, P8230, DOI 10.1523/JNEUROSCI.1723-08.2008; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Muravieva EV, 2010, LEARN MEMORY, V17, P306, DOI 10.1101/lm.1794710; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nugent NR, 2010, J TRAUMA STRESS, V23, P282, DOI 10.1002/jts.20517; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Oliveira AMM, 2011, LEARN MEMORY, V18, P161, DOI 10.1101/lm.1939811; Pavlov I.P., 1927, CONDITIONED REFLEXES; Penner MR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00009; Pitman R. K., 2000, NEW COGNITIVE NEUROS; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Stilling RM, 2011, NEUROBIOL LEARN MEM, V96, P19, DOI 10.1016/j.nlm.2011.04.002; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Tronson NC, 2006, NAT NEUROSCI, V9, P167, DOI 10.1038/nn1628; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Valor LM, 2011, J NEUROSCI, V31, P1652, DOI 10.1523/JNEUROSCI.4737-10.2011; Varga-Weisz PD, 1998, CURR OPIN CELL BIOL, V10, P346, DOI 10.1016/S0955-0674(98)80010-0; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wood MA, 2005, LEARN MEMORY, V12, P111, DOI 10.1101/lm.86605; Wood MA, 2006, LEARN MEMORY, V13, P609, DOI 10.1101/lm.213906; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoshida K, 2005, CANCER LETT, V221, P29, DOI 10.1016/j.canlet.2004.08.016; Zhao ZR, 2012, J NEUROSCI, V32, P2344, DOI 10.1523/JNEUROSCI.5819-11.2012; Zhao ZR, 2010, P NATL ACAD SCI USA, V107, P5605, DOI 10.1073/pnas.0910578107	94	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54463	10.1371/journal.pone.0054463	http://dx.doi.org/10.1371/journal.pone.0054463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349897	Green Published, gold			2022-12-27	WOS:000313943000039
J	Ruter, J; Sprekeler, H; Gerstner, W; Herzog, MH				Rueter, Johannes; Sprekeler, Henning; Gerstner, Wulfram; Herzog, Michael H.			The Silent Period of Evidence Integration in Fast Decision Making	PLOS ONE			English	Article							COMPELLED-RESPONSE TASK; PERCEPTUAL DECISION; TIME; MODELS; ACCUMULATION; PROBABILITY; INFORMATION; DYNAMICS; DURATION; JUDGMENT	In a typical experiment on decision making, one out of two possible stimuli is displayed and observers decide which one was presented. Recently, Stanford and colleagues (2010) introduced a new variant of this classical one-stimulus presentation paradigm to investigate the speed of decision making. They found evidence for "perceptual decision making in less than 30 ms". Here, we extended this one-stimulus compelled-response paradigm to a two-stimulus compelled-response paradigm in which a vernier was followed immediately by a second vernier with opposite offset direction. The two verniers and their offsets fuse. Only one vernier is perceived. When observers are asked to indicate the offset direction of the fused vernier, the offset of the second vernier dominates perception. Even for long vernier durations, the second vernier dominates decisions indicating that decision making can take substantial time. In accordance with previous studies, we suggest that our results are best explained with a two-stage model of decision making where a leaky evidence integration stage precedes a race-to-threshold process.	[Rueter, Johannes; Herzog, Michael H.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Psychophys, Lausanne EPFL, CH-1015 Lausanne, Switzerland; [Sprekeler, Henning; Gerstner, Wulfram] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Computat Neurosci, Lausanne EPFL, CH-1015 Lausanne, Switzerland; [Sprekeler, Henning; Gerstner, Wulfram] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne EPFL, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Ruter, J (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Psychophys, Lausanne EPFL, CH-1015 Lausanne, Switzerland.	johannes.rueter@gmail.com		Sprekeler, Henning/0000-0003-0690-3553; Herzog, Michael/0000-0001-5433-1030	Swiss National Science Foundation (SNF) [320030-119736]; SNF Sinergia project [CRSIK0-122697]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF Sinergia project	Johannes Ruter is funded by the Swiss National Science Foundation (SNF) project No. 320030-119736 "The dynamics of feature fusion". Michael H. Herzog and Wulfram Gerstner receive support from the SNF Sinergia project CRSIK0-122697 "State representation in reward based learning - from spiking neuron models to psychophysics". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Brown SD, 2008, COGNITIVE PSYCHOL, V57, P153, DOI 10.1016/j.cogpsych.2007.12.002; Carpenter RHS, 2009, J PHYSIOL-LONDON, V587, P4051, DOI 10.1113/jphysiol.2009.173955; Carpenter RHS, 2004, CURR BIOL, V14, P1576, DOI 10.1016/j.cub.2004.08.058; Deco G, 2009, PROG NEUROBIOL, V88, P1, DOI 10.1016/j.pneurobio.2009.01.006; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; EFRON R, 1967, ANN NY ACAD SCI, V138, P713, DOI 10.1111/j.1749-6632.1967.tb55017.x; EFRON R, 1973, PERCEPT PSYCHOPHYS, V14, P518, DOI 10.3758/BF03211193; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Herzog MH, 2003, VISION RES, V43, P1951, DOI 10.1016/S0042-6989(03)00278-5; Holmes P, 2005, IEICE T FUND ELECTR, VE88A, P2496, DOI [10.1093/ietfec/e88-a.10.2496, 10.1093/ietfec/e88.a.10.2496]; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Reddi BAJ, 2001, CURR BIOL, V11, pR603, DOI 10.1016/S0960-9822(01)00363-3; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Ruter J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002382; Salinas E, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00153; Salinas E, 2008, NEURON, V60, P946, DOI 10.1016/j.neuron.2008.12.011; Scharnowski F, 2007, VISION RES, V47, P2444, DOI 10.1016/j.visres.2007.05.004; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shankar S, 2011, J NEUROSCI, V31, P8406, DOI 10.1523/JNEUROSCI.1419-11.2011; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Wald A., 1947, SEQUENTIAL ANAL; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e46525	10.1371/journal.pone.0046525	http://dx.doi.org/10.1371/journal.pone.0046525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349660	Green Submitted, gold, Green Published			2022-12-27	WOS:000313943000001
J	Schiessl, IM; Bardehle, S; Castrop, H				Schiessl, Ina Maria; Bardehle, Sophia; Castrop, Hayo			Superficial Nephrons in BALB/c and C57BL/6 Mice Facilitate In Vivo Multiphoton Microscopy of the Kidney	PLOS ONE			English	Article							GLOMERULI; ALBUMIN; RAT; PROTEINURIA; FILTRATION; NUMBER; ANGIOTENSIN; MATURATION; INJURY	Multiphoton microscopy (MPM) offers a unique approach for addressing both the function and structure of an organ in near-real time in the live animal. The method however is limited by the tissue-specific penetration depth of the excitation laser. In the kidney, structures in the range of 100 mm from the surface are accessible for MPM. This limitation of MPM aggravates the investigation of the function of structures located deeper in the renal cortex, like the glomerulus and the juxtaglomerular apparatus. In view of the relevance of gene-targeted mice for investigating the function of these structures, we aimed to identify a mouse strain with a high percentage of superficially located glomeruli. The mean distance of the 30 most superficial glomeruli from the kidney surface was determined in 10 commonly used mouse strains. The mean depth of glomeruli was 118.4 +/- 3.4, 123.0 +/- 2.7, 133.7 +/- 3.0, 132.3 +/- 2.6, 141.0 +/- 4.0, 145.3 +/- 4.3, 148.9 +/- 4.2, 151.6 +/- 2.7, 167.7 +/- 3.9, and 207.8 +/- 3.2 mm in kidney sections from 4-week-old C3H/HeN, BALB/cAnN, SJL/J, C57BL/6N, DBA/2N, CD1 (CRI), 129S2/SvPas, CB6F1, FVB/N and NMRI (Han) mice, respectively (n = 5 animals from each strain). The mean distance from the kidney surface of the most superficial glomeruli was significantly lower in the strains C3H/HeN Crl, BALB/cAnN, DBA/2NCrl, and C57BL/6N when compared to a peer group consisting of all the other strains (p<.0001). In 10-week-old mice, the most superficial glomeruli were located deeper in the cortex when compared to 4-week-old animals, with BALB/cAnN and C57BL/6N being the strains with the highest percentage of superficial glomeruli (25% percentile 116.7 and 121.9 mm, respectively). In summary, due to significantly more superficial glomeruli compared to other commonly used strains, BALB/cAnN and C57BL/6N mice appear to be particularly suitable for the investigation of glomerular function using MPM.	[Schiessl, Ina Maria; Castrop, Hayo] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Bardehle, Sophia] Univ Munich, Inst Physiol, Dept Physiol Genom, D-80539 Munich, Germany; [Bardehle, Sophia] Helmholtz Zentrum, Inst Stem Cell Res, Munich, Germany	University of Regensburg; University of Munich; Helmholtz Association	Castrop, H (corresponding author), Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany.	hayo@castrop.com		Schiessl, Ina Maria/0000-0003-1613-2000	Uwe deVries; Institute of Anatomy; University of Regensburg; Deutsche Forschungsgemeinschaft [SFB699]	Uwe deVries; Institute of Anatomy; University of Regensburg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The expert support provided by Uwe deVries, Institute of Anatomy, University of Regensburg, is gratefully acknowledged. The microscope used in this study was financed in part by funding from the Deutsche Forschungsgemeinschaft (SFB699). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONVALET JP, 1977, J PHYSIOL-LONDON, V269, P627, DOI 10.1113/jphysiol.1977.sp011919; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; EISENBACH GM, 1975, KIDNEY INT, V8, P80, DOI 10.1038/ki.1975.83; FETTERMAN GH, 1965, PEDIATRICS, V35, P601; Forbes MS, 2011, AM J PHYSIOL-RENAL, V301, pF110, DOI 10.1152/ajprenal.00022.2011; HACKBARTH H, 1983, RENAL PHYSIOL BIOCH, V6, P63; HACKBARTH H, 1991, RENAL PHYSIOL BIOCH, V14, P246; HORSTER M, 1971, J CLIN INVEST, V50, P796, DOI 10.1172/JCI106550; Kobat D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646209; Kuligowski MP, 2006, J IMMUNOL, V176, P6991, DOI 10.4049/jimmunol.176.11.6991; Peti-Peterdi J, 2012, AM J PHYSIOL-RENAL, V302, pF227, DOI 10.1152/ajprenal.00561.2011; Peti-Peterdi J, 2010, J AM SOC NEPHROL, V21, P1835, DOI 10.1681/ASN.2010040378; REMUZZI A, 1988, KIDNEY INT, V34, P481, DOI 10.1038/ki.1988.206; REMUZZI A, 1990, J CLIN INVEST, V85, P541, DOI 10.1172/JCI114470; Rochefort NL, 2008, TRENDS MOL MED, V14, P389, DOI 10.1016/j.molmed.2008.07.005; ROVIRAHALBACH G, 1986, RENAL PHYSIOL BIOCH, V9, P317; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Sandoval RM, 2012, J AM SOC NEPHROL, V23, P447, DOI 10.1681/ASN.2011070666; Schulz A, 2002, J AM SOC NEPHROL, V13, P2706, DOI 10.1097/01.ASN.0000031803.55613.86; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tanner GA, 2009, AM J PHYSIOL-RENAL, V296, pF1258, DOI 10.1152/ajprenal.90638.2008; THURAU K, 1965, KLIN WOCHENSCHR, V43, P410, DOI 10.1007/BF01483845	22	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e52499	10.1371/journal.pone.0052499	http://dx.doi.org/10.1371/journal.pone.0052499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349687	Green Published, Green Submitted, gold			2022-12-27	WOS:000313943000009
J	Banerjee, S; Isaacman-Beck, J; Schneider, VA; Granato, M				Banerjee, Santanu; Isaacman-Beck, Jesse; Schneider, Valerie A.; Granato, Michael			A Novel Role for Lh3 Dependent ECM Modifications during Neural Crest Cell Migration in Zebrafish	PLOS ONE			English	Article							GROWTH CONE MIGRATION; XVIII COLLAGEN; LYSYL-HYDROXYLASE-3 LH3; AXON GUIDANCE; IN-VIVO; TRUNK; EMBRYO; EXPRESSION; PATTERN; SOMITE	During vertebrate development, trunk neural crest cells delaminate along the entire length of the dorsal neural tube and initially migrate as a non-segmented sheet. As they enter the somites, neural crest cells rearrange into spatially restricted segmental streams. Extracellular matrix components are likely to play critical roles in this transition from a sheet-like to a stream-like mode of migration, yet the extracellular matrix components and their modifying enzymes critical for this transition are largely unknown. Here, we identified the glycosyltransferase Lh3, known to modify extracellular matrix components, and its presumptive substrate Collagen18A1, to provide extrinsic signals critical for neural crest cells to transition from a sheet-like migration behavior to migrating as a segmental stream. Using live cell imaging we show that in lh3 null mutants, neural crest cells fail to transition from a sheet to a stream, and that they consequently enter the somites as multiple streams, or stall shortly after entering the somites. Moreover, we demonstrate that transgenic expression of lh3 in a small subset of somitic cells adjacent to where neural crest cells switch from sheet to stream migration restores segmental neural crest cell migration. Finally, we show that knockdown of the presumptive Lh3 substrate Collagen18A1 recapitulates the neural crest cell migration defects observed in lh3 mutants, consistent with the notion that Lh3 exerts its effect on neural crest cell migration by regulating post-translational modifications of Collagen18A1. Together these data suggest that Lh3-Collagen18A1 dependent ECM modifications regulate the transition of trunk neural crest cells from a non-segmental sheet like migration mode to a segmental stream migration mode.	[Banerjee, Santanu; Isaacman-Beck, Jesse; Schneider, Valerie A.; Granato, Michael] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Granato, M (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu		Isaacman-Beck, Jesse/0000-0002-0932-0962; Schneider, Valerie/0000-0002-3442-1888	United States National Institutes of Health [HD037975]; NSF [0920336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037975] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by United States National Institutes of Health grant HD037975 and by NSF grant 0920336 to M. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; BRONNERFRASER M, 1991, DEV BIOL, V143, P213, DOI 10.1016/0012-1606(91)90071-A; BRONNERFRASER M, 1994, FASEB J, V8, P699, DOI 10.1096/fasebj.8.10.8050668; EISEN JS, 1993, DEV BIOL, V159, P50, DOI 10.1006/dbio.1993.1220; Elamaa H, 2002, MECH DEVELOP, V114, P109, DOI 10.1016/S0925-4773(02)00014-X; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; ERICKSON CA, 1983, J EMBRYOL EXP MORPH, V74, P97; ERICKSON CA, 1985, DEV BIOL, V111, P138, DOI 10.1016/0012-1606(85)90442-7; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Glasgow E, 1998, MECH DEVELOP, V76, P175, DOI 10.1016/S0925-4773(98)00121-X; Halloran MC, 2003, DEV DYNAM, V228, P497, DOI 10.1002/dvdy.10374; Honjo Y, 2005, DEVELOPMENT, V132, P4461, DOI 10.1242/dev.02026; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; KALCHEIM C, 1989, DEVELOPMENT, V106, P85; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; Krull CE, 2010, CELL ADH MIGR, V4; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; McLennan R, 2002, GENE EXPRESSION, V10, P295, DOI 10.3727/000000002783992389; Meyer F, 2009, DEV GROWTH DIFFER, V51, P483, DOI 10.1111/j.1440-169X.2009.01111.x; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Perris R, 2000, MECH DEVELOP, V95, P3, DOI 10.1016/S0925-4773(00)00365-8; PIKE SH, 1992, DEVELOPMENT, V114, P825; RAIBLE DW, 1992, DEV DYNAM, V195, P29, DOI 10.1002/aja.1001950104; RICKMANN M, 1985, J EMBRYOL EXP MORPH, V90, P437; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; Roffers-Agarwal J, 2009, DEVELOPMENT, V136, P1879, DOI 10.1242/dev.032920; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Santiago A, 2002, DEVELOPMENT, V129, P3621; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Schwarz Q, 2009, DEVELOPMENT, V136, P1785, DOI 10.1242/dev.034322; Schwarz Q, 2009, P NATL ACAD SCI USA, V106, P6164, DOI 10.1073/pnas.0811521106; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Tucker RP, 1999, DEV DYNAM, V214, P312, DOI 10.1002/(SICI)1097-0177(199904)214:4<312::AID-AJA4>3.0.CO;2-A; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852	45	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54609	10.1371/journal.pone.0054609	http://dx.doi.org/10.1371/journal.pone.0054609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349938	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800066
J	Boldrin, L; Morgan, JE				Boldrin, Luisa; Morgan, Jennifer E.			Grafting of a Single Donor Myofibre Promotes Hypertrophy in Dystrophic Mouse Muscle	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SATELLITE CELLS; MYOSTATIN; MDX; GROWTH; REGENERATION; EXPRESSION; MUTATION; PATHWAY; MICE	Skeletal muscle has a remarkable capability of regeneration following injury. Satellite cells, the principal muscle stem cells, are responsible for this process. However, this regenerative capacity is reduced in muscular dystrophies or in old age: in both these situations, there is a net loss of muscle fibres. Promoting skeletal muscle muscle hypertrophy could therefore have potential applications for treating muscular dystrophies or sarcopenia. Here, we observed that muscles of dystrophic mdx nude host mice that had been acutely injured by myotoxin and grafted with a single myofibre derived from a normal donor mouse exhibited increased muscle area. Transplantation experiments revealed that the hypertrophic effect is mediated by the grafted fibre and does not require either an imposed injury to the host muscle, or the contribution of donor cells to the host muscle. These results suggest the presence of a crucial cross-talk between the donor fibre and the host muscle environment.	[Boldrin, Luisa; Morgan, Jennifer E.] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England	University of London; University College London	Boldrin, L (corresponding author), UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.	l.boldrin@ucl.ac.uk			Wellcome Trust University Award [08241/Z/07/Z]; Muscular Dystrophy Campaign [RA3/776]; Association Francaise contre les Myopathies [13948]; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish	Wellcome Trust University Award(Wellcome Trust); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by: Wellcome Trust University Award grant number: 08241/Z/07/Z (http://www.wellcome.ac.uk/); Muscular Dystrophy Campaign grant number: RA3/776 (http://www.muscular-dystrophy.org/); Association Francaise contre les Myopathies grant number: 13948 (http://www.afm-telethon.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Boldrin L, 2012, STEM CELLS; Boldrin L, 2012, STEM CELLS, V30, P1971, DOI 10.1002/stem.1158; Boldrin L, 2009, STEM CELLS, V27, P2478, DOI 10.1002/stem.162; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; KLEINOGUS C, 1983, CELL TISSUE RES, V230, P671, DOI 10.1007/BF00216210; Kota J, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000112; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Malerba A, 2009, HUM GENE THER, V20, P955, DOI 10.1089/hum.2008.157; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Morel BG, 2009, REGEN MED, V4, P293, DOI 10.2217/17460751.4.2.293; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; MUNTONI F, 1993, J NEUROL SCI, V120, P71, DOI 10.1016/0022-510X(93)90027-V; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Neal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037950; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; PASTORET C, 1995, MUSCLE NERVE, V18, P1147, DOI 10.1002/mus.880181011; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Stupka N, 2008, AM J PHYSIOL-REG I, V294, pR983, DOI 10.1152/ajpregu.00375.2007; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Yamamoto M, 2009, GENESIS, V47, P107, DOI 10.1002/dvg.20474; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	60	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54599	10.1371/journal.pone.0054599	http://dx.doi.org/10.1371/journal.pone.0054599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349935	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872800065
J	Vicidomini, G; Schonle, A; Ta, HS; Han, KY; Moneron, G; Eggeling, C; Hell, SW				Vicidomini, Giuseppe; Schoenle, Andreas; Ta, Haisen; Han, Kyu Young; Moneron, Gael; Eggeling, Christian; Hell, Stefan W.			STED Nanoscopy with Time-Gated Detection: Theoretical and Experimental Aspects	PLOS ONE			English	Article							GROUND-STATE-DEPLETION; STIMULATED-EMISSION; FLUORESCENCE MICROSCOPY; SINGLE-MOLECULE; RESOLUTION; BREAKING; LIGHT; EXCITATION; LIMIT	In a stimulated emission depletion (STED) microscope the region in which fluorescence markers can emit spontaneously shrinks with continued STED beam action after a singular excitation event. This fact has been recently used to substantially improve the effective spatial resolution in STED nanoscopy using time-gated detection, pulsed excitation and continuous wave (CW) STED beams. We present a theoretical framework and experimental data that characterize the time evolution of the effective point-spread-function of a STED microscope and illustrate the physical basis, the benefits, and the limitations of time-gated detection both for CW and pulsed STED lasers. While gating hardly improves the effective resolution in the all-pulsed modality, in the CW-STED modality gating strongly suppresses low spatial frequencies in the image. Gated CW-STED nanoscopy is in essence limited (only) by the reduction of the signal that is associated with gating. Time-gated detection also reduces/suppresses the influence of local variations of the fluorescence lifetime on STED microscopy resolution.	[Vicidomini, Giuseppe] Ist Italiano Tecnol, Genoa, Italy; [Vicidomini, Giuseppe; Schoenle, Andreas; Ta, Haisen; Han, Kyu Young; Moneron, Gael; Eggeling, Christian; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Moneron, Gael] Inst Pasteur, CNRS URA 2182, Dept Neurosci, Paris, France; [Eggeling, Christian] Univ Oxford, Weatherall Inst Mol Med, Oxford, England	Istituto Italiano di Tecnologia - IIT; Max Planck Society; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford	Vicidomini, G (corresponding author), Ist Italiano Tecnol, Genoa, Italy.	giuseppe.vicidomini@iit.it	Vicidomini, Giuseppe/C-8375-2011; Han, Kyu Young/F-8529-2011	Vicidomini, Giuseppe/0000-0002-3085-730X; 	BMBF (German Federal Ministry for Education and Science) under the project INVERS; MRC [MC_UU_12010/9, MR/K01577X/1] Funding Source: UKRI; Medical Research Council [MR/K01577X/1, MC_UU_12010/9] Funding Source: researchfish	BMBF (German Federal Ministry for Education and Science) under the project INVERS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported in part by BMBF (German Federal Ministry for Education and Science) under the project INVERS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; Auksorius E, 2008, OPT LETT, V33, P113, DOI 10.1364/OL.33.000113; Berning S, 2012, SCIENCE, V335, P551, DOI 10.1126/science.1215369; Bertero M, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123006; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Blom H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-16; Bretschneider S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218103; Dedecker P, 2007, OPT EXPRESS, V15, P3372, DOI 10.1364/OE.15.003372; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Dyba M, 2003, APPL OPTICS, V42, P5123, DOI 10.1364/AO.42.005123; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Fu CC, 2007, P NATL ACAD SCI USA, V104, P727, DOI 10.1073/pnas.0605409104; Galiani S, 2012, OPT EXPRESS, V20, P7362, DOI 10.1364/OE.20.007362; Grotjohann T, 2011, NATURE, V478, P204, DOI 10.1038/nature10497; Han KY, 2010, NANO LETT, V10, P3199, DOI 10.1021/nl102156m; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2003, APPL PHYS A-MATER, V77, P859, DOI 10.1007/s00339-003-2292-4; HELL SW, 1995, APPL PHYS B-LASERS O, V60, P495, DOI 10.1007/BF01081333; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Kolmakov K, 2010, CHEM-EUR J, V16, P158, DOI 10.1002/chem.200902309; Leutenegger M, 2006, OPT EXPRESS, V14, P11277, DOI 10.1364/OE.14.011277; Leutenegger M, 2010, OPT EXPRESS, V18, P26417, DOI 10.1364/OE.18.026417; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Luchowski R, 2008, CURR PHARM BIOTECHNO, V9, P411, DOI 10.2174/138920108785915094; Maus M, 2001, ANAL CHEM, V73, P2078, DOI 10.1021/ac000877g; Moffitt JR, 2011, OPT EXPRESS, V19, P4242, DOI 10.1364/OE.19.004242; Rankin BR, 2008, OPT LETT, V33, P2491, DOI 10.1364/OL.33.002491; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schrader M., 1995, Bioimaging, V3, P147, DOI 10.1002/1361-6374(199512)3:4<147::AID-BIO1>3.3.CO;2-8; SHERA EB, 1990, CHEM PHYS LETT, V174, P553, DOI 10.1016/0009-2614(90)85485-U; Smith BR, 2010, DIAM RELAT MATER, V19, P314, DOI 10.1016/j.diamond.2009.12.009; Vicidomini G, 2009, J MICROSC-OXFORD, V234, P47, DOI 10.1111/j.1365-2818.2009.03150.x; Vicidomini G, 2012, OPT EXPRESS, V20, P5225, DOI 10.1364/OE.20.005225; Vicidomini G, 2011, NAT METHODS, V8, P571, DOI [10.1038/NMETH.1624, 10.1038/nmeth.1624]; WEBER K, 1975, EXP CELL RES, V95, P111, DOI 10.1016/0014-4827(75)90615-1; Westphal V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.143903; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wurm CA, 2010, METHODS MOL BIOL, V591, P185, DOI 10.1007/978-1-60761-404-3_11	47	107	115	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54421	10.1371/journal.pone.0054421	http://dx.doi.org/10.1371/journal.pone.0054421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349884	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800053
J	Barr, MP; Gray, SG; Hoffmann, AC; Hilger, RA; Thomale, J; O'Flaherty, JD; Fennell, DA; Richard, D; O'Leary, JJ; O'Byrne, KJ				Barr, Martin P.; Gray, Steven G.; Hoffmann, Andreas C.; Hilger, Ralf A.; Thomale, Juergen; O'Flaherty, John D.; Fennell, Dean A.; Richard, Derek; O'Leary, John J.; O'Byrne, Kenneth J.			Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature	PLOS ONE			English	Article							OVARIAN-CANCER; IN-VITRO; DNA; SENSITIVITY; OVEREXPRESSION; IDENTIFICATION; PHARMACOLOGY; ARREST; AGENTS; COPPER	Introduction: Inherent and acquired cisplatin resistance reduces the effectiveness of this agent in the management of non-small cell lung cancer (NSCLC). Understanding the molecular mechanisms underlying this process may result in the development of novel agents to enhance the sensitivity of cisplatin. Methods: An isogenic model of cisplatin resistance was generated in a panel of NSCLC cell lines (A549, SKMES-1, MOR, H460). Over a period of twelve months, cisplatin resistant (CisR) cell lines were derived from original, age-matched parent cells (PT) and subsequently characterized. Proliferation (MTT) and clonogenic survival assays (crystal violet) were carried out between PT and CisR cells. Cellular response to cisplatin-induced apoptosis and cell cycle distribution were examined by FACS analysis. A panel of cancer stem cell and pluripotent markers was examined in addition to the EMT proteins, c-Met and beta-catenin. Cisplatin-DNA adduct formation, DNA damage (gamma H2AX) and cellular platinum uptake (ICP-MS) was also assessed. Results: Characterisation studies demonstrated a decreased proliferative capacity of lung tumour cells in response to cisplatin, increased resistance to cisplatin-induced cell death, accumulation of resistant cells in the G0/G1 phase of the cell cycle and enhanced clonogenic survival ability. Moreover, resistant cells displayed a putative stem-like signature with increased expression of CD133+/CD44+cells and increased ALDH activity relative to their corresponding parental cells. The stem cell markers, Nanog, Oct-4 and SOX-2, were significantly upregulated as were the EMT markers, c-Met and beta-catenin. While resistant sublines demonstrated decreased uptake of cisplatin in response to treatment, reduced cisplatin-GpG DNA adduct formation and significantly decreased gamma H2AX foci were observed compared to parental cell lines. Conclusion: Our results identified cisplatin resistant subpopulations of NSCLC cells with a putative stem-like signature, providing a further understanding of the cellular events associated with the cisplatin resistance phenotype in lung cancer.	[Barr, Martin P.; Gray, Steven G.; O'Flaherty, John D.; O'Byrne, Kenneth J.] St James Hosp, Trinity Ctr Hlth Sci, Inst Mol Med, Dublin, Ireland; [Barr, Martin P.; Gray, Steven G.; O'Flaherty, John D.; O'Leary, John J.; O'Byrne, Kenneth J.] Trinity Coll Dublin, Dublin, Ireland; [Hoffmann, Andreas C.; Hilger, Ralf A.] Univ Hosp Essen, W German Canc Ctr, Dept Med Oncol, Essen, Germany; [Thomale, Juergen] Univ Duisburg Essen, Dept Cell Biol Canc Res, Essen, Germany; [Fennell, Dean A.] Univ Leicester, Leicester, Leics, England; [Fennell, Dean A.] Leicester Univ Hosp, Leicester, Leics, England; [Richard, Derek] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [O'Leary, John J.] St James Hosp, Dept Histopathol, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; University of Duisburg Essen; University of Duisburg Essen; University of Leicester; University Hospitals of Leicester NHS Trust; Queensland University of Technology (QUT); Trinity College Dublin	Barr, MP (corresponding author), St James Hosp, Trinity Ctr Hlth Sci, Inst Mol Med, Dublin, Ireland.	mbarr@stjames.ie	Richard, Derek/J-1338-2012; Gray, Steven G./I-3081-2019	Richard, Derek/0000-0002-4839-8471; Gray, Steven G./0000-0002-5850-6392; Hoffmann, Andreas-Claudius/0000-0001-6609-4503; O'Leary, John/0000-0001-7311-9326; O'Byrne, Kenneth/0000-0002-6754-5633; Barr, Martin/0000-0001-5202-9655				AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Boulikas T, 2003, ONCOL REP, V10, P1663; Bunn PA, 1998, CLIN CANCER RES, V4, P1087; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Crawford N, 2011, APOPTOSIS, V16, P311, DOI 10.1007/s10495-010-0561-1; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; EISENHAUER E, 1990, CARBOPLATIN CURRENT, P133; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Furuta T, 2002, CANCER RES, V62, P4899; Giaccone G, 2000, DRUGS, V59, P9, DOI 10.2165/00003495-200059004-00002; Giaccone G, 1998, J CLIN ONCOL, V16, P2133, DOI 10.1200/JCO.1998.16.6.2133; GORE ME, 1989, BRIT J CANCER, V60, P767, DOI 10.1038/bjc.1989.356; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; HARPER JW, 1993, CELL, V75, P805; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Katano K, 2002, CANCER RES, V62, P6559; Kelland LR, 2000, DRUGS, V59, P37; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Liedert B, 2003, J INVEST DERMATOL, V121, P172, DOI 10.1046/j.1523-1747.2003.12313.x; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McDonald ES, 2005, NEUROBIOL DIS, V18, P305, DOI 10.1016/j.nbd.2004.09.013; Meijer C, 2000, INT J CANCER, V85, P777, DOI 10.1002/(SICI)1097-0215(20000315)85:6<777::AID-IJC6>3.0.CO;2-D; Moreb J, 1996, CANCER GENE THER, V3, P24; OZOLS RF, 1991, CANCER TREAT REV, V18, P77, DOI 10.1016/0305-7372(91)90027-W; OZOLS RF, 1992, HEMATOL ONCOL CLIN N, V6, P879; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patnaik SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022379; PRESTAYKO AW, 1979, CANCER TREAT REV, V6, P17, DOI 10.1016/S0305-7372(79)80057-2; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Samimi G, 2004, MOL PHARMACOL, V66, P25, DOI 10.1124/mol.66.1.25; Sekiguchi I, 1996, ONCOLOGY, V53, P19; SORENSON CM, 1990, JNCI-J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749; Sreerama L, 1997, ADV EXP MED BIOL, V414, P81; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Sullivan JP, 2010, CANCER METAST REV, V29, P61, DOI 10.1007/s10555-010-9216-5; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; TWENTYMAN PR, 1992, CANCER RES, V52, P5674; Vasey PA, 1996, MOL PHARMACOL, V50, P1536; Wang JR, 2010, ANTICANCER RES, V30, P3593; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338	46	179	186	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54193	10.1371/journal.pone.0054193	http://dx.doi.org/10.1371/journal.pone.0054193			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349823	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900051
J	Binkley, PF; Cooke, GE; Lesinski, A; Taylor, M; Chen, M; Laskowski, B; Waldman, WJ; Ariza, ME; Williams, MV; Knight, DA; Glaser, R				Binkley, Philip F.; Cooke, Glen E.; Lesinski, Amanda; Taylor, Mackenzie; Chen, Min; Laskowski, Bryon; Waldman, W. James; Ariza, Maria E.; Williams, Marshall V., Jr.; Knight, Deborah A.; Glaser, Ronald			Evidence for the Role of Epstein Barr Virus Infections in the Pathogenesis of Acute Coronary Events	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ACUTE MYOCARDIAL-INFARCTION; DEOXYURIDINE TRIPHOSPHATE NUCLEOTIDOHYDROLASE; CHRONIC-FATIGUE-SYNDROME; APPARENTLY HEALTHY-MEN; HERPES-SIMPLEX-VIRUS; CARDIOVASCULAR-DISEASE; HEART-DISEASE; ENDOTHELIAL-CELLS; ARTERY DISEASE	Background: The role of viral infections in the pathogenesis of atherosclerosis remains controversial largely due to inconsistent detection of the virus in atherosclerotic lesions. However, viral infections elicit a pro-inflammatory cascade known to be atherogenic and to precipitate acute ischemic events. We have published in vitro data that provide the foundation for a mechanism that reconciles these conflicting observations. To determine the relation between an early viral protein, deoxyuridine triphosphate nucleotidohydrolase (dUTPase), produced following reactivation of Epstein Barr Virus (EBV) to circulating pro-inflammatory cytokines, intercellular adhesion molecule-1 (ICAM-1) and acute coronary events. Methodology/Principal Findings: Blood samples were obtained from 299 patients undergoing percutaneous coronary intervention for stable angina (SA), unstable angina (UA), or acute myocardial infarction (AMI). Plasma concentrations of pro-inflammatory cytokines and neutralizing antibody against EBV-encoded dUTPase were compared in the three patient groups. AMI was associated with the highest measures of interleukin-6 (ANOVA p < 0.05; 4.6 +/- 2.6 pg/mL in patients with AMI vs. 3.2 +/- 2.3 pg/mL in SA). ICAM-1 was significantly higher in patients with AMI (ANOVA p < 0.05; 304 +/- 116 pg/mL in AMI vs. 265 +/- 86 pg/mL SA). The highest values of ICAM-1 were found in patients having an AMI and who were antibody positive for dUTPase (ANOVA p = 0.008; 369 +/- 183 pg/mL in AMI and positive for dUTPase vs. 249 +/- 70 pg/mL in SA negative for dUTPase antibody). Conclusions/Significance: These clinical data support a model, based on in vitro studies, by which EBV may precipitate AMI even under conditions of low viral load through the pro-inflammatory action of the early protein dUTPase that is produced even during incomplete viral replication. They further support the putative role of viral infections in the pathogenesis of atherosclerosis and coronary artery events.	[Binkley, Philip F.; Cooke, Glen E.; Lesinski, Amanda] Ohio State Univ, Coll Med, Div Cardiovasc Med, Columbus, OH 43210 USA; [Binkley, Philip F.; Cooke, Glen E.; Taylor, Mackenzie] Ohio State Univ, Coll Med, Dept Internal Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Ariza, Maria E.; Williams, Marshall V., Jr.; Knight, Deborah A.; Glaser, Ronald] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Chen, Min; Laskowski, Bryon; Glaser, Ronald] Ohio State Univ, Coll Med, Inst Behav Med Res, Columbus, OH 43210 USA; [Waldman, W. James] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Binkley, PF (corresponding author), Ohio State Univ, Coll Med, Div Cardiovasc Med, Columbus, OH 43210 USA.	Philip.Binkley@osumc.edu	Glaser, Ronald/E-3124-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084898] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI084898] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851; Bhattacharyya MR, 2007, PROG CARDIOVASC DIS, V49, P353, DOI 10.1016/j.pcad.2006.11.002; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Danesh J, 1998, Expert Opin Investig Drugs, V7, P691, DOI 10.1517/13543784.7.5.691; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Dvorakova A, 2004, ATHEROSCLEROSIS, V172, P391, DOI 10.1016/j.atherosclerosis.2003.09.005; Emani S, 2010, CIRC-HEART FAIL, V3, P715, DOI 10.1161/CIRCHEARTFAILURE.110.951509; Empana JP, 2008, EUR HEART J, V29, P1966, DOI 10.1093/eurheartj/ehn331; Fisman EZ, 2006, AM J CARDIOL, V98, P14, DOI 10.1016/j.amjcard.2006.01.045; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Gattone M, 2001, AM HEART J, V142, P633, DOI 10.1067/mhj.2001.118118; GLASER R, 1991, BRAIN BEHAV IMMUN, V5, P219, DOI 10.1016/0889-1591(91)90018-6; Glaser R, 2006, VIROLOGY, V346, P205, DOI 10.1016/j.virol.2005.10.034; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P91, DOI 10.1016/j.bbi.2004.09.001; Guan XR, 2008, INFLAMMATION, V31, P266, DOI 10.1007/s10753-008-9074-2; Haim M, 2002, J AM COLL CARDIOL, V39, P1133, DOI 10.1016/S0735-1097(02)01728-X; Horvath R, 2000, J CLIN VIROL, V16, P17, DOI 10.1016/S1386-6532(99)00064-5; Hwang SJ, 1997, CIRCULATION, V96, P4219; Ibrahim AI, 2005, J CLIN VIROL, V32, P29, DOI 10.1016/j.jcv.2004.06.010; JONES JF, 1988, ARCH INTERN MED, V148, P1957, DOI 10.1001/archinte.148.9.1957; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Lee KW, 2005, THROMB HAEMOSTASIS, V94, P1077, DOI 10.1160/TH05-03-0179; Lee KW, 2005, BLOOD, V105, P526, DOI 10.1182/blood-2004-03-1106; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P49, DOI 10.1055/s-0030-1248724; Morre SA, 2000, J CLIN PATHOL, V53, P647, DOI 10.1136/jcp.53.9.647; Padgett DA, 2004, J MED VIROL, V74, P442, DOI 10.1002/jmv.20196; Phrommintikul A, 2011, EUR HEART J, V32, P1730, DOI 10.1093/eurheartj/ehr004; Postadzhiyan AS, 2008, CLIN BIOCHEM, V41, P126, DOI 10.1016/j.clinbiochem.2007.09.001; Pretet JL, 2012, J AM COLL CARDIOL, V60, P81, DOI 10.1016/j.jacc.2012.02.049; PRINTSEVA OY, 1992, AM J PATHOL, V140, P889; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Rohde LEP, 1999, ARTERIOSCL THROM VAS, V19, P1595, DOI 10.1161/01.ATV.19.7.1595; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Stassen FR, 2006, J CLIN VIROL, V35, P349, DOI 10.1016/j.jcv.2005.11.007; Stassen FR, 2008, PHARMACOL REP, V60, P85; Vliegen I, 2005, ATHEROSCLEROSIS, V181, P39, DOI 10.1016/j.atherosclerosis.2004.12.035; Waldman WJ, 2008, BRAIN BEHAV IMMUN, V22, P215, DOI 10.1016/j.bbi.2007.07.007; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; WILLIAMS MV, 1987, VIROLOGY, V156, P282, DOI 10.1016/0042-6822(87)90408-9; WILLIAMS MV, 1985, VIROLOGY, V142, P326, DOI 10.1016/0042-6822(85)90341-1	44	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54008	10.1371/journal.pone.0054008	http://dx.doi.org/10.1371/journal.pone.0054008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349778	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900031
J	Li, XL; Wu, ZQ; Wang, Y; Mei, Q; Fu, XB; Han, WD				Li, Xiaolei; Wu, Zhiqiang; Wang, Yao; Mei, Qian; Fu, Xiaobing; Han, Weidong			Characterization of Adult alpha- and beta-Globin Elevated by Hydrogen Peroxide in Cervical Cancer Cells That Play A Cytoprotective Role Against Oxidative Insults	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; OXIDANT-ANTIOXIDANT STATUS; ALVEOLAR EPITHELIAL-CELLS; HEMOGLOBIN EXPRESSION; TUMOR PROGRESSION; STRESS; OXYGEN; IDENTIFICATION; NEURONS; FLAVOHEMOGLOBIN	Objectives: Hemoglobin (Hgb) is the main oxygen and carbon dioxide carrier in cells of erythroid lineage and is responsible for oxygen delivery to the respiring tissues of the body. However, Hgb is also expressed in nonerythroid cells. In the present study, the expression of Hgb in human uterine cervix carcinoma cells and its role in cervical cancer were investigated. Methodology: The expression level of Hgb in cervical cancer tissues was assessed by quantitative reverse transcriptase-PCR (qRT-PCR). We applied multiple methods, such as RT-PCR, immunoblotting, and immunohistochemical analysis, to confirm Hgb expression in cervical cancer cells. The effects of ectopic expression of Hgb and Hgb mutants on oxidative stress and cell viability were investigated by cellular reactive oxygen species (ROS) analysis and lactate dehydrogenase (LDH) array, respectively. Both Annexin V staining assay by flow cytometry and caspase-3 activity assay were used, respectively, to evaluate cell apoptosis. Results: qRT-PCR analysis showed that Hgb-alpha- (HBA1) and Hgb-beta-globin (HBB) gene expression was significantly higher in cervical carcinoma than in normal cervical tissues, whereas the expression of hematopoietic transcription factors and erythrocyte specific marker genes was not increased. Immunostaining experiments confirmed the expression of Hgb in cancer cells of the uterine cervix. Hgb mRNA and protein were also detected in the human cervical carcinoma cell lines SiHa and CaSki, and Hgb expression was up-regulated by hydrogen peroxide-induced oxidative stress. Importantly, ectopic expression of wild type HBA1/HBB or HBA1, rather than mutants HBA1(H88R)/HBBH93R unable to bind hemo, suppressed oxidative stress and improved cell viability. Conclusions: The present findings show for the first time that Hgb is expressed in cervical carcinoma cells and may act as an antioxidant, attenuating oxidative stress-induced damage in cervical cancer cells. These data provide a significant impact not only in globin biology but also in understanding of cervical cancer pathogenesis associated with oxidative stress.	[Li, Xiaolei; Wu, Zhiqiang; Mei, Qian; Fu, Xiaobing; Han, Weidong] Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Inst Basic Med, Dept Mol Biol, Beijing, Peoples R China; [Wang, Yao; Fu, Xiaobing; Han, Weidong] Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Inst Basic Med, Dept Immunol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Han, WD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Inst Basic Med, Dept Mol Biol, Beijing, Peoples R China.	hanwdrsw69@yahoo.com	Wang, Yao/GXV-3833-2022; May, Mere/HIK-1050-2022; li, Xiaolei/V-1383-2019	li, Xiaolei/0000-0002-2697-6496; Yao, Wang/0000-0002-9352-422X	National Natural Science Foundation of China [31201033, 31270820, 81230061, 81001184]; National Basic Science and Development Programme of China [2012CB518103, 2012CB518105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Science and Development Programme of China	This research was supported by the grants from the National Natural Science Foundation of China (website is http://www.nsfc.gov.cn/ Portal0/default124.htm) (No. 31201033, 31270820, 81230061 and 81001184) and was partially supported by the grants from National Basic Science and Development Programme of China (website is http://www.973.gov.cn/Default_3.aspx) (No. 2012CB518103 and 2012CB518105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2005, CANCER SCI, V96, P197, DOI 10.1111/j.1349-7006.2005.00029.x; Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891; Bhaskaran M, 2005, BIOCHEM BIOPH RES CO, V333, P1348, DOI 10.1016/j.bbrc.2005.06.042; Bignotti E, 2006, GYNECOL ONCOL, V103, P405, DOI 10.1016/j.ygyno.2006.03.056; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dassen H, 2008, HUM REPROD, V23, P635, DOI 10.1093/humrep/dem430; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gerber M, 1996, J NUTR, V126, pS1201, DOI 10.1093/jn/126.suppl_4.1201S; Gerber M, 1997, CANCER LETT, V114, P211, DOI 10.1016/S0304-3835(97)04665-X; Goldstein S, 2005, FREE RADICAL BIO MED, V39, P511, DOI 10.1016/j.freeradbiomed.2005.04.003; Grek CL, 2011, AM J RESP CELL MOL, V44, P439, DOI 10.1165/rcmb.2009-0307OC; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Han WD, 2009, NUCLEIC ACIDS RES, V37, P3996, DOI 10.1093/nar/gkp332; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Higuchi M, 1998, ONCOGENE, V17, P2753, DOI 10.1038/sj.onc.1202211; Karbownik M, 2003, NEUROENDOCRINOL LETT, V24, P293; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Lee RA, 2006, WORLD J GASTROENTERO, V12, P5644, DOI 10.3748/wjg.v12.i35.5644; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Liu W.S., 2011, PLOS ONE, V6; Lu G, 2012, ANTIOXID REDOX SIGN, V16, P217, DOI 10.1089/ars.2011.4112; Marcos-Almaraz MT, 2012, BIOCHEM J, V441, P843, DOI 10.1042/BJ20111640; Masuoka N, 2003, BBA-MOL BASIS DIS, V1637, P46, DOI 10.1016/S0925-4439(02)00213-2; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; McLaughlin-Drubin ME, 2011, P NATL ACAD SCI USA, V108, P2130, DOI 10.1073/pnas.1009933108; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Saintot M, 1996, CARCINOGENESIS, V17, P1267, DOI 10.1093/carcin/17.6.1267; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Smith MJ, 2009, BRIT J CANCER, V100, P1452, DOI 10.1038/sj.bjc.6604931; Smith MJ, 2008, ANN SURG ONCOL, V15, P2954, DOI 10.1245/s10434-008-0037-5; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P907, DOI 10.1167/iovs.09-4014; Tezel TH, 2009, INVEST OPHTH VIS SCI, V50, P1911, DOI 10.1167/iovs.07-1372; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Wang D, 2011, ENDOCR-RELAT CANCER, V18, P773, DOI 10.1530/ERC-11-0230; Widmer CC, 2010, ANTIOXID REDOX SIGN, V12, P185, DOI 10.1089/ars.2009.2826; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; Wu Z. Y., 2011, PLOS ONE, V6	49	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54342	10.1371/journal.pone.0054342	http://dx.doi.org/10.1371/journal.pone.0054342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349856	gold, Green Submitted, Green Published			2022-12-27	WOS:000313738900061
J	Masschelein, J; Mattheus, W; Gao, LJ; Moons, P; Van Houdt, R; Uytterhoeven, B; Lamberigts, C; Lescrinier, E; Rozenski, J; Herdewijn, P; Aertsen, A; Michiels, C; Lavigne, R				Masschelein, Joleen; Mattheus, Wesley; Gao, Ling-Jie; Moons, Pieter; Van Houdt, Rob; Uytterhoeven, Birgit; Lamberigts, Chris; Lescrinier, Eveline; Rozenski, Jef; Herdewijn, Piet; Aertsen, Abram; Michiels, Chris; Lavigne, Rob			A PKS/NRPS/FAS Hybrid Gene Cluster from Serratia plymuthica RVH1 Encoding the Biosynthesis of Three Broad Spectrum, Zeamine-Related Antibiotics	PLOS ONE			English	Article							PHOSPHOPANTETHEINYL TRANSFERASE GENE; POLYUNSATURATED FATTY-ACIDS; COMPLETE GENOME SEQUENCE; GRAM-NEGATIVE BACTERIA; EICOSAPENTAENOIC ACID; POLYKETIDE SYNTHASES; SUBSTRATE-SPECIFICITY; COMPONENT PRODUCTION; PEPTIDE SYNTHETASE; DOMAINS	Serratia plymuthica strain RVH1, initially isolated from an industrial food processing environment, displays potent antimicrobial activity towards a broad spectrum of Gram-positive and Gram-negative bacterial pathogens. Isolation and subsequent structure determination of bioactive molecules led to the identification of two polyamino antibiotics with the same molecular structure as zeamine and zeamine II as well as a third, closely related analogue, designated zeamine I. The gene cluster encoding the biosynthesis of the zeamine antibiotics was cloned and sequenced and shown to encode FAS, PKS as well as NRPS related enzymes in addition to putative tailoring and export enzymes. Interestingly, several genes show strong homology to the pfa cluster of genes involved in the biosynthesis of long chain polyunsaturated fatty acids in marine bacteria. We postulate that a mixed FAS/PKS and a hybrid NRPS/PKS assembly line each synthesize parts of the backbone that are linked together post-assembly in the case of zeamine and zeamine I. This interaction reflects a unique interplay between secondary lipid and secondary metabolite biosynthesis. Most likely, the zeamine antibiotics are produced as prodrugs that undergo activation in which a nonribosomal peptide sequence is cleaved off.	[Masschelein, Joleen; Mattheus, Wesley; Uytterhoeven, Birgit; Lamberigts, Chris; Lavigne, Rob] Katholieke Univ Leuven, Div Gene Technol, Heverlee, Belgium; [Masschelein, Joleen; Moons, Pieter; Van Houdt, Rob; Aertsen, Abram; Michiels, Chris] Katholieke Univ Leuven, Food Microbiol Lab, Heverlee, Belgium; [Gao, Ling-Jie; Herdewijn, Piet] Katholieke Univ Leuven, Louvain, Belgium; [Lescrinier, Eveline; Rozenski, Jef; Herdewijn, Piet] Catholic Univ Louvain, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; Universite Catholique Louvain	Lavigne, R (corresponding author), Katholieke Univ Leuven, Div Gene Technol, Heverlee, Belgium.	rob.lavigne@biw.kuleuven.be	Lescrinier, Eveline/G-9339-2016; Michiels, Chris/I-6847-2013; Van Houdt, Rob/B-8599-2011	Lescrinier, Eveline/0000-0001-7066-4329; Michiels, Chris/0000-0002-7710-6802; Van Houdt, Rob/0000-0002-7459-496X; Aertsen, Abram/0000-0002-1897-2305; Lavigne, Rob/0000-0001-7377-1314; moons, pieter/0000-0002-9830-0444; Lamberigts, Chris/0000-0002-7484-0059; Rozenski, Jef/0000-0001-9624-5536; Masschelein, Joleen/0000-0003-4366-3675; Herdewijn, Piet/0000-0003-3589-8503				Allen EE, 2002, MICROBIOL-SGM, V148, P1903, DOI 10.1099/00221287-148-6-1903; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; Aron ZD, 2005, J AM CHEM SOC, V127, P14986, DOI 10.1021/ja055247g; BARRETT AJ, 1992, BIOL CHEM H-S, V373, P353, DOI 10.1515/bchm3.1992.373.2.353; Blight Mark A., 1994, Current Opinion in Biotechnology, V5, P468, DOI 10.1016/0958-1669(94)90059-0; Borodovsky Mark, 2003, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0405s01; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; DAVIS AL, 1991, J MAGN RESON, V94, P637, DOI 10.1016/0022-2364(91)90154-L; DECRECYLAGARD V, 1995, CR ACAD SCI III-VIE, V318, P927; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fujii I, 2004, J BIOL CHEM, V279, P44613, DOI 10.1074/jbc.M406758200; Gaitatzis N, 2001, P NATL ACAD SCI USA, V98, P11136, DOI 10.1073/pnas.201167098; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hirota K, 2005, INT J SYST EVOL MICR, V55, P2355, DOI 10.1099/ijs.0.63804-0; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15513, DOI 10.1021/bi001651a; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15522, DOI 10.1021/bi0016523; Liu F, 2004, CHEM BIOL, V11, P1533, DOI 10.1016/j.chembiol.2004.08.017; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Marahiel MA, 2009, J PEPT SCI, V15, P799, DOI 10.1002/psc.1183; Mattheus W, 2010, CHEM BIOL, V17, P149, DOI 10.1016/j.chembiol.2010.01.014; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Moons P, 2008, THESIS KATHOLIEKE U; Moons P, 2006, APPL ENVIRON MICROB, V72, P7294, DOI 10.1128/AEM.01708-06; Moons P, 2011, APPL ENVIRON MICROB, V77, P3422, DOI 10.1128/AEM.02763-10; Moss SJ, 2004, NAT PROD REP, V21, P575, DOI 10.1039/b315020h; Neupane S, 2012, STAND GENOMIC SCI, V6, P165, DOI 10.4056/sigs.2705996; Neupane S, 2012, STAND GENOMIC SCI, V6, P54, DOI 10.4056/sigs.2595762; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Orikasa Y, 2006, FEBS LETT, V580, P4423, DOI 10.1016/j.febslet.2006.07.008; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Pace HC, 2001, GENOME BIOL, V2; Park SR, 2010, J ANTIBIOT, V63, P434, DOI 10.1038/ja.2010.71; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Reimer D, 2011, NAT CHEM BIOL, V7, P888, DOI [10.1038/NCHEMBIO.688, 10.1038/nchembio.688]; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; SATTLER M, 1995, J BIOMOL NMR, V6, P11, DOI 10.1007/BF00417487; SCHLUMBOHM W, 1991, J BIOL CHEM, V266, P23135; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Shulse CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020146; Silakowski B, 2000, EUR J BIOCHEM, V267, P6476, DOI 10.1046/j.1432-1327.2000.01740.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Sugihara S, 2008, BIOTECHNOL LETT, V30, P411, DOI 10.1007/s10529-007-9579-z; Sugihara S, 2010, FEMS MICROBIOL LETT, V307, P207, DOI 10.1111/j.1574-6968.2010.01987.x; Tanaka M, 1999, BIOTECHNOL LETT, V21, P939, DOI 10.1023/A:1005601606929; Van Houdt R, 2006, FEMS MICROBIOL LETT, V256, P83, DOI 10.1111/j.1574-6968.2006.00103.x; Van Houdt R, 2005, FEMS MICROBIOL LETT, V246, P265, DOI 10.1016/j.femsle.2005.04.016; Van Houdt R, 2004, J APPL MICROBIOL, V96, P177, DOI 10.1046/j.1365-2672.2003.02131.x; Van Houdt R, 2007, RES MICROBIOL, V158, P150, DOI 10.1016/j.resmic.2006.11.008; Van Houdt R, 2006, J BACTERIOL, V188, P4570, DOI 10.1128/JB.00144-06; Wilkinson B, 2000, CHEM BIOL, V7, P111, DOI 10.1016/S1074-5521(00)00076-4; Wu J, 2010, CHEM COMMUN, V46, P333, DOI 10.1039/b916307g; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095; Zhou JU, 2011, MOL PLANT MICROBE IN, V24, P1156, DOI 10.1094/MPMI-04-11-0087	62	52	52	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54143	10.1371/journal.pone.0054143	http://dx.doi.org/10.1371/journal.pone.0054143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349809	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900045
J	Polverino, G; Liao, JC; Porfiri, M				Polverino, Giovanni; Liao, Jian Cong; Porfiri, Maurizio			Mosquitofish (Gambusia affinis) Preference and Behavioral Response to Animated Images of Conspecifics Altered in Their Color, Aspect Ratio, and Swimming Depth	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; INVASIVE MOSQUITOFISH; SEXUAL-HARASSMENT; INTRODUCED MOSQUITOFISH; WESTERN MOSQUITOFISH; EASTERN MOSQUITOFISH; FEMALE PREFERENCE; MALE COMPETITION; VIDEO PLAYBACK; PLAGUE MINNOW	Mosquitofish (Gambusia affinis) is an example of a freshwater fish species whose remarkable diffusion outside its native range has led to it being placed on the list of the world's hundred worst invasive alien species (International Union for Conservation of Nature). Here, we investigate mosquitofish shoaling tendency using a dichotomous choice test in which computer-animated images of their conspecifics are altered in color, aspect ratio, and swimming level in the water column. Pairs of virtual stimuli are systematically presented to focal subjects to evaluate their attractiveness and the effect on fish behavior. Mosquitofish respond differentially to some of these stimuli showing preference for conspecifics with enhanced yellow pigmentation while exhibiting highly varying locomotory patterns. Our results suggest that computer-animated images can be used to understand the factors that regulate the social dynamics of shoals of Gambusia affinis. Such knowledge may inform the design of control plans and open new avenues in conservation and protection of endangered animal species.	[Polverino, Giovanni; Liao, Jian Cong; Porfiri, Maurizio] NYU, Polytech Inst, Dept Mech & Aerosp Engn, Brooklyn, NY USA	New York University; New York University Tandon School of Engineering	Porfiri, M (corresponding author), NYU, Polytech Inst, Dept Mech & Aerosp Engn, Brooklyn, NY USA.	mporfiri@poly.edu	Polverino, Giovanni/AAC-2556-2020; Porfiri, Maurizio/A-1712-2009	Polverino, Giovanni/0000-0001-9737-7995; Porfiri, Maurizio/0000-0002-1480-3539	National Science Foundation [CMMI-0745753, CMMI-1129820]	National Science Foundation(National Science Foundation (NSF))	Funding provided by National Science Foundation grants #CMMI-0745753 and #CMMI-1129820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2012, BEHAV BRAIN RES, V233, P545, DOI 10.1016/j.bbr.2012.05.047; Abaid N, 2012, BEHAV BRAIN RES, V232, P406, DOI 10.1016/j.bbr.2012.03.028; Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Alcaraz C, 2008, OECOLOGIA, V155, P205, DOI 10.1007/s00442-007-0899-4; Baldauf SA, 2009, J FISH BIOL, V75, P738, DOI 10.1111/j.1095-8649.2009.02347.x; Baldauf SA, 2008, ETHOLOGY, V114, P737, DOI 10.1111/j.1439-0310.2008.01520.x; Barrier R. F. G., 1994, Ecology of Freshwater Fish, V3, P93, DOI 10.1111/j.1600-0633.1994.tb00110.x; BELK MC, 1994, COPEIA, P296; Bisazza A, 2000, BEHAV GENET, V30, P207, DOI 10.1023/A:1001914208075; Brookhouse Nicola, 2010, Ecological Management & Restoration, V11, P226, DOI 10.1111/j.1442-8903.2010.00556.x; Butail S, 2012, J R SOC INTERFACE, V9, P77, DOI 10.1098/rsif.2011.0113; Butkowski T, 2011, JOVE-J VIS EXP, DOI 10.3791/2374; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Clark DL, 1999, ENVIRON BIOL FISH, V56, P317, DOI 10.1023/A:1007549721631; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Courtenay Walter R., 1997, P109; COURTENAY WR, 1993, BIOLOGICAL POLLUTION: THE CONTROL AND IMPACT OF INVASIVE EXOTIC SPECIES, P35; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; Dadda M, 2005, ANIM BEHAV, V70, P463, DOI 10.1016/j.anbehav.2004.12.010; Engeszer RE, 2008, P NATL ACAD SCI USA, V105, P929, DOI 10.1073/pnas.0708778105; Fleisch VC, 2006, ZEBRAFISH, V3, P191, DOI 10.1089/zeb.2006.3.191; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Green J, 2012, J NEUROSCI METH, V210, P266, DOI 10.1016/j.jneumeth.2012.07.017; Harcourt JL, 2009, ANIM BEHAV, V77, P1501, DOI 10.1016/j.anbehav.2009.03.004; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Keller K, 2008, J FISH BIOL, V73, P1714, DOI 10.1111/j.1095-8649.2008.02045.x; Komak S, 2000, WILDLIFE RES, V27, P185, DOI 10.1071/WR99028; KRUMHOLZ LA, 1948, ECOL MONOGR, V18, P1, DOI 10.2307/1948627; Kunzler R, 2001, BEHAV ECOL, V12, P681, DOI 10.1093/beheco/12.6.681; Laha M, 2007, ENVIRON BIOL FISH, V78, P1, DOI 10.1007/s10641-006-9040-5; Lambertini M, 2011, SCIENCE, V333, P404, DOI 10.1126/science.333.6041.404-b; LANZING WJR, 1982, CELL TISSUE RES, V223, P431, DOI 10.1007/BF01258500; Lawler SP, 1999, CONSERV BIOL, V13, P613, DOI 10.1046/j.1523-1739.1999.98075.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Lloyd L., 1986, ARBOVIRUSES RES AUST, P156; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Luca RM, 2012, BEHAV BRAIN RES, V226, P66, DOI 10.1016/j.bbr.2011.09.001; Mazzi D, 2003, BEHAV ECOL SOCIOBIOL, V54, P156, DOI 10.1007/s00265-003-0609-0; MCALISTER WH, 1958, ECOLOGY, V39, P477, DOI 10.2307/1931756; McRobert SP, 1998, ANIM BEHAV, V56, P611, DOI 10.1006/anbe.1998.0846; Meffe G.K., 1989, P13; Meffe G.K., 1983, North American Journal of Fisheries Management, V3, P315, DOI 10.1577/1548-8659(1983)3<315:ACROAA>2.0.CO;2; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Pather S, 2009, BEHAV BRAIN RES, V196, P323, DOI 10.1016/j.bbr.2008.09.013; Pilastro A, 2003, ANIM BEHAV, V65, P1161, DOI 10.1006/anbe.2003.2118; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Polverino G, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036019; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; Raven P.H., 1992, BIOLOGY; Rehage JS, 2005, BEHAV ECOL SOCIOBIOL, V57, P256, DOI 10.1007/s00265-004-0850-1; Robinson-Wolrath SI, 2006, ENVIRON BIOL FISH, V75, P409, DOI 10.1007/s10641-006-0024-2; Rosenthal GG, 2005, ANIM BEHAV, V70, P1063, DOI 10.1016/j.anbehav.2005.02.005; Rosenthal GG, 2002, ANIM BEHAV, V63, P37, DOI 10.1006/anbe.2001.1887; Rosenthal GG, 1999, ENVIRON BIOL FISH, V56, P307, DOI 10.1023/A:1007597604793; Rosenthal Gil G., 2000, Acta Ethologica, V3, P49, DOI 10.1007/s102110000024; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Simberloff D, 2011, NATURE, V475, P36, DOI 10.1038/475036a; Smith CC, 2006, ANIM BEHAV, V71, P401, DOI 10.1016/j.anbehav.2005.06.003; Smith CC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1349, DOI 10.1007/s00265-007-0365-7; Stein BA, 2000, PRECIOUS HERITAGE ST; Turnell ER, 2003, BIOL BULL-US, V205, P225, DOI 10.2307/1543265; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Ward AJW, 2010, BEHAV ECOL, V21, P1315, DOI 10.1093/beheco/arq152; Wittenberg R, 2011, INVASIVE ALIEN SPECI; Woo KL, 2011, BEHAV ECOL SOCIOBIOL, V65, P1671, DOI 10.1007/s00265-011-1226-y; Wright D, 2006, NAT PROTOC, V1, P1828, DOI 10.1038/nprot.2006.287	70	21	21	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54315	10.1371/journal.pone.0054315	http://dx.doi.org/10.1371/journal.pone.0054315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342131	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700107
J	Denisov, BP; Sakevich, VI; Jasilioniene, A				Denisov, Boris P.; Sakevich, Victoria I.; Jasilioniene, Aiva			Divergent Trends in Abortion and Birth Control Practices in Belarus, Russia and Ukraine	PLOS ONE			English	Article							CONTRACEPTIVE USE; WORLDWIDE; WOMEN; USSR	Context: The last decade witnessed growing differences in abortion dynamics in Belarus, Russia, and Ukraine despite demographic, social, and historical similarities of these nations. This paper investigates changes in birth control practices in the three countries and searches for an explanation of the diverging trends in abortion. Methods: Official abortion and contraceptive use statistics, provided by national statistical agencies, were analysed. Respective laws and other legal documents were examined and compared between the three countries. To disclose intercountry differences in prevalence of the modern methods of contraception and its association with major demographic and social factors, an analysis of data from national sample surveys was performed, including binary logistic regression. Results: The growing gap in abortion rate in Belarus, Russia, and Ukraine is a genuine phenomenon, not a statistical artefact. The examination of abortion and prevalence of contraception based on official statistics and three national sample surveys did not reveal any unambiguous factors that could explain differences in abortion dynamics in Belarus, Russia, and Ukraine. However, it is very likely that the cause of the inter-country discrepancies lies in contraceptive behavior itself, in adequacies of contraceptive knowledge and practices. Additionally, large differences in government policies, which are very important in shaping contraceptive practices of the population, were detected. Conclusion: Since the end of the 1990s, the Russian government switched to archaic ideology in the area of reproductive health and family planning and neglects evidence-based arguments. Such an extreme turn in the governmental position is not observed in Belarus or Ukraine. This is an important factor contributing to the slowdown in the decrease of abortion rates in Russia.	[Denisov, Boris P.] Moscow MV Lomonosov State Univ, Lab Populat Econ & Demog, Moscow, Russia; [Sakevich, Victoria I.] Natl Res Univ, Higher Sch Econ, Inst Demog, Moscow, Russia; [Jasilioniene, Aiva] Max Planck Inst Demog Res, Lab Demog Data, Rostock, Germany	Lomonosov Moscow State University; HSE University (National Research University Higher School of Economics); Max Planck Society	Denisov, BP (corresponding author), Moscow MV Lomonosov State Univ, Lab Populat Econ & Demog, Moscow, Russia.	denisov@demography.ru	Sakevich, Victoria/H-2315-2015	Sakevich, Victoria/0000-0002-4569-1760	National Research University Higher School of Economics [10-01-0076 2010/2011]	National Research University Higher School of Economics	This research was supported by the National Research University Higher School of Economics (grant No. 10-01-0076 2010/2011, awarded to Victoria Sakevich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian V, 2002, STUD FAMILY PLANN, V33, P237, DOI 10.1111/j.1728-4465.2002.00237.x; [Anonymous], EUROPEAN HEALTH FOR; [Anonymous], YEARBOOKS; Avdeev A., 1995, POPULATION ENGLISH S, V7, P39, DOI 10.2307/2949057; Bongaarts J, 2000, STUD FAMILY PLANN, V31, P193, DOI 10.1111/j.1728-4465.2000.00193.x; Centers for Disease Control and Prevention and ORC Macro, 2003, REPRODUCTIVE MATERNA; David HP, 1999, FROM ABORTION TO CON; Denisov BP, 2009, EVIDENCE BASED MEDIC, V1, P34; Denisov BP, 2011, DEMSOSCOPE WEEKLY, P465; Frost JJ, 2007, PERSPECT SEX REPRO H, V39, P48, DOI 10.1363/3904807; Goldberg HI, 2001, 24 GEN C INT UN SCI; Goldstein JR, 2009, POPUL DEV REV, V35, P663, DOI 10.1111/j.1728-4457.2009.00304.x; HENSHAW SK, 1986, FAM PLANN PERSPECT, V18, P250, DOI 10.2307/2134947; Kiev International Institute of Sociology (KIIS) Centers for Disease Control and Prevention (CDC) and United States Agency for International Development (USAID), 2001, 1999 UKRAINE REPRODU; Levchuk Nataliia, 2009, MPIDR WORKING PAPER; Ministry of Health of Ukraine WHO, 2008, REPORT AND RECOMMEND; Mogilevkina, 1996, ACTA OBSTETRICIA ET, V75, P908; Mogilevkina I, 2003, EUR J CONTRACEP REPR, V8, P185, DOI 10.1080/713604469; Perlman F, 2009, PERSPECT SEX REPRO H, V41, P40, DOI [10.1363/4104009, 10.1111/j.1931-2393.2009.4114009.x]; Philipov D, 2004, EUR J POPUL, V20, P95, DOI 10.1023/B:EUJP.0000034499.24658.7a; Pirozhkov Sergii, 2010, DEMOSCOPE WEEKLY, P405; POPOV AA, 1991, STUD FAMILY PLANN, V22, P368, DOI 10.2307/1966450; Population of Russia, 2009, ANNUAL DEMOGRAPHIC R, P136; Regushevskaya E, 2009, PERSPECT SEX REPRO H, V41, P51, DOI [10.1363/4105109, 10.1111/j.1931-2393.2009.04115109.x]; REMENNICK LI, 1991, SOC SCI MED, V33, P841, DOI 10.1016/0277-9536(91)90389-T; Sedgh G, 2011, INT PERSPECT SEX R H, V37, P84, DOI 10.1363/3708411; Shakhotko LP, 2009, THE MODEL OF DEMOGRA; Shakhotko LP, COMMUNICATION; Trussell J, 2004, CONTRACEPTIVE TECHNO; Ukrainian Center for Social Reforms (UCSR) State Statistical Committee (SSC) [Ukraine] Ministry of Health (MoH) [Ukraine] and Macro International Inc., 2008, UKRAINE DEMOGRAPHIC; UNFPA, 2004, NATIONAL POPULATION; UNFPA Ukrainian center of social reforms Institute of demography and social studies of the National Academy of Science of Ukraine State statistical committee of Ukraine, 2009, UKRAINE ON THE PATH; United Nations, 2009, WORLD CONTRACEPTIVE; Vishnevsky A.G., 2006, DEMOGRAPHIC MODERNIZ; Zakharov SV, 2011, DEMOSCOPE WEEKLY, P453; Zhilka H, 2001, REPRODUCTIVE HEALTH	36	16	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e49986	10.1371/journal.pone.0049986	http://dx.doi.org/10.1371/journal.pone.0049986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23349656	gold, Green Published, Green Submitted			2022-12-27	WOS:000312376100042
J	Roy, S; Bonfield, T; Tartakoff, AM				Roy, Sanhita; Bonfield, Tracey; Tartakoff, Alan M.			Non-Apoptotic Toxicity of Pseudomonas aeruginosa toward Murine Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RESPIRATORY EPITHELIAL-CELLS; PROTEIN SECRETION SYSTEMS; TOLL-LIKE RECEPTORS; CYSTIC-FIBROSIS; LIPOPOLYSACCHARIDE LPS; GAMMA-INTERFERON; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; INNATE IMMUNITY	Although P. aeruginosa is especially dangerous in cystic fibrosis (CF), there is no consensus as to how it kills representative cell types that are of key importance in the lung. This study concerns the acute toxicity of the sequenced strain, PAO1, toward a murine macrophage cell line (RAW 264.7). Toxicity requires brief contact with the target cell, but is then delayed for more than 12 h. None of the classical toxic effectors of this organism is required and cell death occurs without phagocytosis or acute perturbation of the actin cytoskeleton. Apoptosis is not required for toxicity toward either RAW 264.7 cells or for alveolar macrophages. Transcriptional profiling shows that encounter between PAO1 and RAW 264.7 cells elicits an early inflammatory response, followed by growth arrest. As an independent strategy to understand the mechanism of toxicity, we selected variant RAW 264.7 cells that resist PAO1. Upon exposure to P. aeruginosa, they are hyper-responsive with regard to classical inflammatory cytokine production and show transient downregulation of transcripts that are required for cell growth. They do not show obvious morphologic changes. Although they do not increase interferon transcripts, when exposed to PAO1 they dramatically upregulate a subset of the responses that are characteristic of exposure to g-interferon, including several guanylate-binding proteins. The present observations provide a novel foundation for learning how to equip cells with resistance to a complex challenge.	[Roy, Sanhita] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Bonfield, Tracey] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Tartakoff, Alan M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Tartakoff, Alan M.] Case Western Reserve Univ, Cell Biol Program, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Tartakoff, AM (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	amt10@case.edu		ROY, SANHITA/0000-0002-0407-8177	Cystic Fibrosis Foundation [R447-CR07]; Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Center for Research Resources (NCRR), National Institutes of Health (NIH) [UL1 RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Center for Research Resources (NCRR), National Institutes of Health (NIH); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported through a grant from the Cystic Fibrosis Foundation (www.cff.org/mobile/index.cfm?menu = 1&)(R447-CR07) and from the Case Western Reserve University/Cleveland Clinic CTSA Grant (no. UL1 RR024989) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Aiello D, 2010, ANTIMICROB AGENTS CH, V54, P1988, DOI 10.1128/AAC.01598-09; APODACA G, 1995, INFECT IMMUN, V63, P1541, DOI 10.1128/IAI.63.4.1541-1551.1995; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Baldwin MR, 2005, CURR TOP MICROBIOL, V291, P147; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Beutler B, 2007, WE SENSE MICROBES; Blum ES, 2012, SCIENCE, V335, P970, DOI 10.1126/science.1215156; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Cowell BA, 2005, FEMS MICROBIOL LETT, V250, P71, DOI 10.1016/j.femsle.2005.06.044; Delude RL, 1998, J IMMUNOL, V161, P3001; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P2861, DOI 10.1128/IAI.65.7.2861-2867.1997; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gomez MI, 2007, CURR OPIN PHARMACOL, V7, P244, DOI 10.1016/j.coph.2006.12.005; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Gorbacheva VY, 2002, J BIOL CHEM, V277, P6080, DOI 10.1074/jbc.M110542200; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Hasko G, 2002, J PHARMACOL EXP THER, V301, P103, DOI 10.1124/jpet.301.1.103; Ho PK, 2005, FEBS J, V272, P5436, DOI 10.1111/j.1742-4658.2005.04966.x; HORVAT RT, 1988, INFECT IMMUN, V56, P2925, DOI 10.1128/IAI.56.11.2925-2932.1988; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; JACOBS DM, 1977, J IMMUNOL, V118, P21; Jacquot J, 2008, INT J BIOCHEM CELL B, V40, P1703, DOI 10.1016/j.biocel.2008.02.002; Johansen HK, 1996, CLIN EXP IMMUNOL, V103, P212, DOI 10.1046/j.1365-2249.1996.d01-618.x; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Kierbel A, 2007, J CELL BIOL, V177, P21, DOI 10.1083/jcb.200605142; Kostyk AG, 2006, AM J PATHOL, V169, P12, DOI 10.2353/ajpath.2006.051042; Koulenti D, 2006, CURR OPIN PULM MED, V12, P198; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Li Y, 2003, AM J RESP CELL MOL, V29, P779, DOI 10.1165/rcmb.2003-0087RC; LONG JS, 2012, ONCOGENE; Ma QH, 2003, BBA-BIOMEMBRANES, V1611, P223, DOI 10.1016/S0005-2736(03)00059-2; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Murphey ED, 2004, INFECT IMMUN, V72, P6892, DOI 10.1128/IAI.72.12.6892-6901.2004; Nguyen TT, 2002, J INTERF CYTOK RES, V22, P899, DOI 10.1089/107999002760274926; NISHIJIMA M, 1994, J BIOCHEM-TOKYO, V116, P1082, DOI 10.1093/oxfordjournals.jbchem.a124631; Ohki K, 2001, IMMUNOL CELL BIOL, V79, P462, DOI 10.1046/j.1440-1711.2001.01037.x; Perez Aura, 2004, Journal of Structural and Functional Genomics, V5, P179, DOI 10.1023/B:JSFG.0000028982.59273.bd; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; Rajan S, 2000, AM J RESP CELL MOL, V23, P304, DOI 10.1165/ajrcmb.23.3.4098; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Rottner K, 2004, J PATHOL, V204, P396, DOI 10.1002/path.1638; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Schroder K, 2012, P NATL ACAD SCI US; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; SELLINS KS, 1987, J IMMUNOL, V139, P3199; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Skerrett SJ, 2007, AM J PHYSIOL-LUNG C, V292, pL312, DOI 10.1152/ajplung.00250.2006; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stotland PK, 2000, PEDIATR PULM, V30, P413, DOI 10.1002/1099-0496(200011)30:5<413::AID-PPUL8>3.0.CO;2-9; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Tart AH, 2008, CURR TOP MICROBIOL, V322, P193; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Wu W, 2011, CRIT REV ONCOL HEMAT; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	76	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54245	10.1371/journal.pone.0054245	http://dx.doi.org/10.1371/journal.pone.0054245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358229	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600041
J	Aizawa, S; Senda, M; Harada, A; Maruyama, N; Ishida, T; Aigaki, T; Ishigami, A; Senda, T				Aizawa, Shingo; Senda, Miki; Harada, Ayaka; Maruyama, Naoki; Ishida, Tetsuo; Aigaki, Toshiro; Ishigami, Akihito; Senda, Toshiya			Structural Basis of the gamma-Lactone-Ring Formation in Ascorbic Acid Biosynthesis by the Senescence Marker Protein-30/Gluconolactonase	PLOS ONE			English	Article							PROTEIN-30 SMP30; DIISOPROPYL PHOSPHOROFLUORIDATE; MOUSE-LIVER; RAT-LIVER; BINDING; PURIFICATION; FLUOROPHOSPHATASE; REGUCALCIN; MECHANISM; EVOLUTION	The senescence marker protein-30 (SMP30), which is also called regucalcin, exhibits gluconolactonase (GNL) activity. Biochemical and biological analyses revealed that SMP30/GNL catalyzes formation of the gamma-lactone-ring of L-gulonate in the ascorbic acid biosynthesis pathway. The molecular basis of the gamma-lactone formation, however, remains elusive due to the lack of structural information on SMP30/GNL in complex with its substrate. Here, we report the crystal structures of mouse SMP30/GNL and its complex with xylitol, a substrate analogue, and those with 1,5-anhydro-D-glucitol and D-glucose, product analogues. Comparison of the crystal structure of mouse SMP30/GNL with other related enzymes has revealed unique characteristics of mouse SMP30/GNL. First, the substrate-binding pocket of mouse SMP30/GNL is designed to specifically recognize monosaccharide molecules. The divalent metal ion in the active site and polar residues lining the substrate-binding cavity interact with hydroxyl groups of substrate/product analogues. Second, in mouse SMP30/GNL, a lid loop covering the substrate-binding cavity seems to hamper the binding of L-gulonate in an extended (or all-trans) conformation; L-gulonate seems to bind to the active site in a folded conformation. In contrast, the substrate-binding cavities of the other related enzymes are open to the solvent and do not have a cover. This structural feature of mouse SMP30/GNL seems to facilitate the gamma-lactone-ring formation.	[Aizawa, Shingo; Aigaki, Toshiro] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Hachioji, Tokyo, Japan; [Aizawa, Shingo; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan; [Aizawa, Shingo; Harada, Ayaka; Senda, Toshiya] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo, Japan; [Senda, Miki] JBIC, Dept Res & Dev, Koto Ku, Tokyo, Japan; [Harada, Ayaka] Tokyo Denki Univ, Adachi Ku, Tokyo 101, Japan; [Ishida, Tetsuo] Shiga Univ Med Sci, Dept Biochem & Mol Biol, Otsu, Shiga, Japan	Tokyo Metropolitan University; Tokyo Metropolitan Institute of Gerontology; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Denki University; Shiga University of Medical Science	Senda, T (corresponding author), Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo, Japan.	toshiya-senda@aist.go.jp		Harada, Ayaka/0000-0001-7976-8984; Senda, Toshiya/0000-0002-5153-928X; Ishigami, Akihito/0000-0001-7875-7482	Japan Society for the Promotion of Science [24380073, 23590441]; Ministry of Education, Science, and Culture, Japan [22121005]; New Energy and Industrial Technology Development Organization (NEDO) [P08005]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by Grant-in-Aid for Scientific Research (B) (24380073 AI), Grant-in-Aid for Scientific Research (C) (23590441 NM) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html), and Grant-in-Aid for Scientific Research on Innovative Areas (22121005 TS) from the Ministry of Education, Science, and Culture, Japan (http://www.mext.go.jp/english/). This work was also supported by the New Energy and Industrial Technology Development Organization (NEDO) (http://www.nedo.go.jp/english/index.html) (P08005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Belinskaya T, 2012, BBA-PROTEINS PROTEOM, V1824, P701, DOI 10.1016/j.bbapap.2012.02.007; Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4; Blum MM, 2006, J AM CHEM SOC, V128, P12750, DOI 10.1021/ja061887n; Blum MM, 2010, ACTA CRYSTALLOGR F, V66, P379, DOI 10.1107/S1744309110004318; Chakraborti S, 2010, BIOCHEMISTRY-US, V49, P3436, DOI 10.1021/bi9022297; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4; FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; HUCHO F, 1972, BIOCHIM BIOPHYS ACTA, V276, P176, DOI 10.1016/0005-2744(72)90018-6; Inai Y, 2003, J NUTR SCI VITAMINOL, V49, P315, DOI 10.3177/jnsv.49.315; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurentino SS, 2012, MOL HUM REPROD, V18, P161, DOI 10.1093/molehr/gar075; Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Tanaka Y, 2007, J BIOL CHEM, V282, P5770, DOI 10.1074/jbc.M607340200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; YAMAGUCHI M, 1978, CHEM PHARM BULL, V26, P1915; Yamaguchi M, 2011, MOL CELL BIOCHEM, V353, P101, DOI 10.1007/s11010-011-0779-4; Yu L, 2001, J BIOCHEM, V129, P411, DOI 10.1093/oxfordjournals.jbchem.a002872	32	13	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53706	10.1371/journal.pone.0053706	http://dx.doi.org/10.1371/journal.pone.0053706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349732	Green Submitted, gold, Green Published			2022-12-27	WOS:000314019100027
J	Henriques, MX; Catalao, MJ; Figueiredo, J; Gomes, JP; Filipe, SR				Henriques, Mafalda X.; Catalao, Maria Joao; Figueiredo, Joana; Gomes, Joao Paulo; Filipe, Sergio R.			Construction of Improved Tools for Protein Localization Studies in Streptococcus pneumoniae	PLOS ONE			English	Article							FLUORESCENT PROTEIN; CAPSULAR POLYSACCHARIDE; DIVISION; GENE; COMPETENCE; EXPRESSION; PLASMID	We have constructed a set of plasmids that allow efficient expression of both N- and C-terminal fusions of proteins of interest to fluorescent proteins mCherry, Citrine, CFP and GFP in the Gram-positive pathogen Streptococcus pneumoniae. In order to improve expression of the fluorescent fusions to levels that allow their detection by fluorescence microscopy, we have introduced a 10 amino acid tag, named i-tag, at the N-terminal end of the fluorescent proteins. This caused increased expression due to improved translation efficiency and did not interfere with the protein localization in pneumococcal bacteria. Localizing fluorescent derivatives of FtsZ, Wzd and Wze in dividing bacteria validated the developed tools. The availability of the new plasmids described in this work should greatly facilitate studies of protein localization in an important clinical pathogen.	[Henriques, Mafalda X.; Catalao, Maria Joao; Figueiredo, Joana; Filipe, Sergio R.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Surfaces & Pathogenesis, Oeiras, Portugal; [Gomes, Joao Paulo] Natl Inst Hlth, Dept Infect Dis, Lisbon, Portugal	Universidade Nova de Lisboa	Filipe, SR (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Surfaces & Pathogenesis, Oeiras, Portugal.	sfilipe@itqb.unl.pt	Filipe, Sergio Raposo/B-9167-2008; Catalao, Maria Joao/P-3248-2019; Catalão, Maria João/B-6731-2017; iMed.ULisboa, HPI/B-4239-2014; Figueiredo, Joana/T-9046-2017	Filipe, Sergio Raposo/0000-0002-4485-832X; Catalao, Maria Joao/0000-0002-3794-457X; Catalão, Maria João/0000-0002-3794-457X; iMed.ULisboa, HPI/0000-0001-5934-0198; Gomes, Joao Paulo/0000-0002-2697-2399; Henriques, Mafalda X./0000-0002-5665-2142; Figueiredo, Joana/0000-0002-6804-0522	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal [PTDC/SAU-MII/75696/2006, PTDC/BIA-MIC/100747/2008]; FCT [PEst-OE/EQB/LA0004/2011, SFRH/BD/43797/2008, SFRH/BPD/77758/2011]	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was funded by Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, through research grants PTDC/SAU-MII/75696/2006 and PTDC/BIA-MIC/100747/2008 awarded to SRF. The work performed at Instituto de Tecnologia Quimica e Biologica was supported additionally by FCT through grant PEst-OE/EQB/LA0004/2011. MXH and MJC were supported by FCT fellowships SFRH/BD/43797/2008 and SFRH/BPD/77758/2011, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Beilharz K, 2012, P NATL ACAD SCI USA, V109, pE905, DOI 10.1073/pnas.1119172109; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Eberhardt A, 2012, MICROB DRUG RESIST, V18, P240, DOI 10.1089/mdr.2011.0232; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; Fadda D, 2007, J BACTERIOL, V189, P1288, DOI 10.1128/JB.01168-06; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Halfmann A, 2007, FEMS MICROBIOL LETT, V268, P217, DOI 10.1111/j.1574-6968.2006.00584.x; Henriques MX, 2011, MOL MICROBIOL, V82, P515, DOI 10.1111/j.1365-2958.2011.07828.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; Lacks SA, 2000, MOL MICROBIOL, V35, P1089, DOI 10.1046/j.1365-2958.2000.01777.x; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Mellroth P, 2012, J BIOL CHEM, V287, P11018, DOI 10.1074/jbc.M111.318584; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Morlot C, 2003, MOL MICROBIOL, V50, P845, DOI 10.1046/j.1365-2958.2003.03767.x; Morlot C, 2004, MOL MICROBIOL, V51, P1641, DOI 10.1046/j.1365-2958.2003.03953.x; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; Pereira PM, 2010, APPL ENVIRON MICROB, V76, P4346, DOI 10.1128/AEM.00359-10; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509	27	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e55049	10.1371/journal.pone.0055049	http://dx.doi.org/10.1371/journal.pone.0055049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349996	Green Published, gold			2022-12-27	WOS:000314019100117
J	Rivera, C; Simonson, SJS; Yamben, IF; Shatadal, S; Nguyen, MM; Beurg, M; Lambert, PF; Griep, AE				Rivera, Charlene; Simonson, Sara J. S.; Yamben, Idella F.; Shatadal, Shalini; Nguyen, Minh M.; Beurg, Maryline; Lambert, Paul F.; Griep, Anne E.			Requirement for Dlgh-1 in Planar Cell Polarity and Skeletogenesis during Vertebrate Development	PLOS ONE			English	Article							LARGE TUMOR-SUPPRESSOR; NEURAL-TUBE DEFECTS; DISCS-LARGE; HUMAN HOMOLOG; CAENORHABDITIS-ELEGANS; LOOP-TAIL; CRANIOFACIAL DEVELOPMENT; COOPERATIVE REGULATION; CONVERGENT EXTENSION; CONTAINING PROTEINS	The development of specialized organs is tightly linked to the regulation of cell growth, orientation, migration and adhesion during embryogenesis. In addition, the directed movements of cells and their orientation within the plane of a tissue, termed planar cell polarity (PCP), appear to be crucial for the proper formation of the body plan. In Drosophila embryogenesis, Discs large (dlg) plays a critical role in apical-basal cell polarity, cell adhesion and cell proliferation. Craniofacial defects in mice carrying an insertional mutation in Dlgh-1 suggest that Dlgh-1 is required for vertebrate development. To determine what roles Dlgh-1 plays in vertebrate development, we generated mice carrying a null mutation in Dlgh-1. We found that deletion of Dlgh-1 caused open eyelids, open neural tube, and misorientation of cochlear hair cell stereociliary bundles, indicative of defects in planar cell polarity (PCP). Deletion of Dlgh-1 also caused skeletal defects throughout the embryo. These findings identify novel roles for Dlgh-1 in vertebrates that differ from its well-characterized roles in invertebrates and suggest that the Dlgh-1 null mouse may be a useful animal model to study certain human congenital birth defects.	[Rivera, Charlene; Yamben, Idella F.; Shatadal, Shalini; Nguyen, Minh M.; Griep, Anne E.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Simonson, Sara J. S.; Lambert, Paul F.] Univ Wisconsin, Dept Oncol, Madison, WI USA; [Beurg, Maryline] Hop Pellegrin, INSERM, F-33076 Bordeaux, France	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Griep, AE (corresponding author), Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.	aegriep@wisc.edu	Griep, Anne/ABA-9636-2020	Beurg, Maryline/0000-0003-3069-267X	NIH [EY09091, CA908428]; University of Wisconsin Carbone Cancer Center [P30 CA14520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009091] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Carbone Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants EY09091 (AEG), CA908428 (PFL/AEG). The University of Wisconsin Carbone Cancer Center (P30 CA14520) provided shared service support for the project. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barrow JR, 2011, ORGANOGENESIS, V7, P260, DOI 10.4161/org.7.4.19049; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bekman E, 2002, MECH DEVELOP, V119, pS77, DOI 10.1016/S0925-4773(03)00095-9; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bilder D, 2001, TRENDS GENET, V17, P511, DOI 10.1016/S0168-9525(01)02407-6; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; Brault V, 2001, DEVELOPMENT, V128, P1253; Caruana G, 2002, INT J DEV BIOL, V46, P511; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Feng W, 2004, NAT STRUCT MOL BIOL, V11, P475, DOI 10.1038/nsmb751; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Hering H, 2002, FEBS LETT, V521, P185, DOI 10.1016/S0014-5793(02)02831-4; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hirata A, 2004, VIROLOGY, V318, P327, DOI 10.1016/j.virol.2003.10.006; Iizuka-Kogo A, 2007, DEVELOPMENT, V134, P1799, DOI 10.1242/dev.02830; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Laprise P, 2004, J BIOL CHEM, V279, P10157, DOI 10.1074/jbc.M309843200; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Lin LH, 1997, BBA-MOL BASIS DIS, V1362, P1, DOI 10.1016/S0925-4439(97)00059-8; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; McMahon L, 2001, J CELL SCI, V114, P2265; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Naim E, 2005, KIDNEY INT, V68, P955, DOI 10.1111/j.1523-1755.2005.00489.x; Nguyen MM, 2005, MOL VIS, V11, P1183; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Rachel RA, 2000, GENESIS, V27, P32, DOI 10.1002/1526-968X(200005)27:1<32::AID-GENE50>3.0.CO;2-T; Rafael JA, 1998, NEUROREPORT, V9, P2121, DOI 10.1097/00001756-199806220-00039; Rivera C, 2009, DEV DYNAM, V238, P2292, DOI 10.1002/dvdy.22036; Romereim SM, 2011, ORGANOGENESIS, V7, P217, DOI 10.4161/org.7.3.18583; Sasaki T, 2006, DEVELOPMENT, V133, P371, DOI 10.1242/dev.02200; Segbert C, 2004, DEV BIOL, V266, P17, DOI 10.1016/j.ydbio.2003.10.019; Shai A, 2007, CANCER RES, V67, P1626, DOI 10.1158/0008-5472.CAN-06-3344; Simonson SJS, 2005, CANCER RES, V65, P8266, DOI 10.1158/0008-5472.CAN-05-1651; Suzuki T, 1999, ONCOGENE, V18, P5967, DOI 10.1038/sj.onc.1203008; Thomas U, 1997, MECH DEVELOP, V62, P161, DOI 10.1016/S0925-4773(97)00658-8; Topczewski J, 2011, ORGANOGENESIS, V7, P255, DOI 10.4161/org.7.4.18797; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Trokovic N, 2003, GENE DEV, V17, P141, DOI 10.1101/gad.250703; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; Wang B, 2011, HUM MOL GENET, V20, P271, DOI 10.1093/hmg/ddq462; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wawrzak D, 2009, ADV ENZYME REGUL, V49, P98, DOI 10.1016/j.advenzreg.2009.01.002; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wyngaarden LA, 2010, DEVELOPMENT, V137, P2551, DOI 10.1242/dev.046987; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto Y, 2004, ONCOGENE, V23, P3889, DOI 10.1038/sj.onc.1207495; Yao R, 2004, ONCOGENE, V23, P6023, DOI 10.1038/sj.onc.1207817	82	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54410	10.1371/journal.pone.0054410	http://dx.doi.org/10.1371/journal.pone.0054410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349879	gold, Green Submitted, Green Published			2022-12-27	WOS:000314019100065
J	Srivastava, G; Mehrotra, RC				Srivastava, Gaurav; Mehrotra, Rakesh C.			First Fossil Record of Alphonsea Hk. f. & T. (Annonaceae) from the Late Oligocene Sediments of Assam, India and Comments on Its Phytogeography	PLOS ONE			English	Article							MAKUM COALFIELD; TERTIARY; DIVERSIFICATION; CRYPTERONIACEAE; DISPERSAL; PETROLOGY; ORIGIN; FLORA; LEAF	A new fossil leaf impression of Alphonsea Hk. f. & T. of the family Annonaceae is described from the Late Oligocene sediments of Makum Coalfield, Assam, India. This is the first authentic record of the fossil of Alphonsea from the Tertiary rocks of South Asia. The Late Oligocene was the time of the last significant globally warm climate and the fossil locality was at 10 degrees-15 degrees N palaeolatitude. The known palaeoflora and sedimentological studies indicate a fluvio-marine deltaic environment with a mosaic of mangrove, fluvial, mire and lacustrine depositional environments. During the depositional period the suturing between the Indian and Eurasian plates was not complete to facilitate the plant migration. The suturing was over by the end of the Late Oligocene/beginning of Early Miocene resulting in the migration of the genus to Southeast Asia where it is growing profusely at present. The present study is in congruence with the earlier published palaeofloral and molecular phylogenetic data. The study also suggests that the Indian plate was not only a biotic ferry during its northward voyage from Gondwana to Asia but also a place for the origin of several plant taxa.	[Srivastava, Gaurav; Mehrotra, Rakesh C.] Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India	Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP)	Srivastava, G (corresponding author), Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India.	gaurav_jan10@yahoo.co.in	Srivastava, Gaurav/A-1384-2019	Srivastava, Gaurav/0000-0001-7498-4338				Ahmed M, 1996, INT J COAL GEOL, V30, P319, DOI 10.1016/0166-5162(95)00051-8; BANDE M B, 1973, Botanique (Nagpur), V4, P41; BANDE MB, 1986, REV PALAEOBOT PALYNO, V49, P203, DOI 10.1016/0034-6667(86)90028-X; Bonde S. D., 1993, J INDIAN BOT SOC, V72, P251; Bossuyt F, 2001, SCIENCE, V292, P93, DOI 10.1126/science.1058875; Burnham RJ, 2004, PHILOS T R SOC B, V359, P1595, DOI 10.1098/rstb.2004.1531; Carter HJ, 1852, J BOMBAY BRCH R ASIA, V5, P179; Chatterjee S, 1999, P INDIAN NATL SCI A, V65, P397; Chester K. I. M., 1955, ANN MAGAZINE NATURAL, V8, P498, DOI DOI 10.1080/00222935508655660; Conti E, 2002, EVOLUTION, V56, P1931; Couvreur TLP, 2011, J BIOGEOGR, V38, P664, DOI 10.1111/j.1365-2699.2010.02434.x; DEPORTA NS, 1971, STUD GEOL SALAMANCA, V2, P133; DILCHER DL, 1974, BOT REV, V40, P1, DOI 10.1007/BF02860067; DOYLE JA, 1994, ACTA BOT GALLICA, V141, P149, DOI 10.1080/12538078.1994.10515148; Gamble J., 1990, MANUAL INDIAN TIMBER, P143; GENTRY AH, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P500; GULERIA J.S., 1999, PALEOBOTANIST, V47, P68; Hably L., 2006, Studia Botanica Hungarica, V37, P41; HICKEY LJ, 1973, AM J BOT, V60, P17, DOI 10.2307/2441319; Kress JW, 2006, ALISO, V22, P619; Kumar M, 2012, PALAEOGEOGR PALAEOCL, V342, P143, DOI 10.1016/j.palaeo.2012.05.001; LAKHANPAL R N, 1983, Geophytology, V13, P46; Lakhanpal RN, 1976, CATALOGUE INDIAN FOS, P1; Mabberley D. J., 1997, PLANT BOOK PORTABLE; MEHROTRA R C, 1990, Phytomorphology, V40, P169; Mehrotra R. C., 1998, Phytomorphology, V48, P91; Mehrotra R.C., 2000, PALAEOBOTANIST, V49, P255; Mehrotra RC, 2003, GEOBIOS-LYON, V36, P83, DOI 10.1016/S0016-6995(02)00107-9; Mishra HK, 1996, INT J COAL GEOL, V30, P65, DOI 10.1016/0166-5162(95)00038-0; Misra BK, 1992, PALEOBOTANIST, V39, P309; Molnar P, 2009, TECTONICS, V28; Morley RJ, 2003, AM J BOT, V90, P1638, DOI 10.3732/ajb.90.11.1638; Punyasena SW, 2008, J BIOGEOGR, V35, P117, DOI 10.1111/j.1365-2699.2007.01773.x; QIU YL, 1993, ANN MO BOT GARD, V80, P587, DOI 10.2307/2399848; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Rutschmann F, 2004, INT J PLANT SCI, V165, pS69, DOI 10.1086/383335; Srivastava G.A., 2010, MEMOIR GEOLOGICAL SO, V75, P123; Srivastava G, 2012, PALAEOGEOGR PALAEOCL, V342, P130, DOI 10.1016/j.palaeo.2012.05.002; Srivastava G, 2012, CURR SCI INDIA, V102, P398; Srivastava G, 2010, J GEOL SOC INDIA, V75, P820, DOI 10.1007/s12594-010-0069-x; Srivastava R, 1991, CATALOGUE FOSSIL PLA, P1; Srivastava R, 2005, CATALOGUE CENOZOIC T, P1; STEENIS C. G. G. J. VAN., 1962, Blumea, V11, P235; Su YCF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-153; Takahashi M, 2008, INT J PLANT SCI, V169, P908, DOI 10.1086/589693; Tchouto MGP, 2006, BIODIVERS CONSERV, V15, P1353, DOI 10.1007/s10531-005-5394-9; Tomlinson PB, 1990, STRUCTURAL BIOL PLAN; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x	50	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53177	10.1371/journal.pone.0053177	http://dx.doi.org/10.1371/journal.pone.0053177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349701	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100017
J	Xu, P; Zhang, AL; Jiang, RC; Qiu, MZ; Kang, CS; Jia, ZF; Wang, GX; Han, L; Fan, X; Pu, PY				Xu, Peng; Zhang, Anling; Jiang, Rongcai; Qiu, Mingzhe; Kang, Chunsheng; Jia, Zhifan; Wang, Guangxiu; Han, Lei; Fan, Xing; Pu, Peiyu			The Different Role of Notch1 and Notch2 in Astrocytic Gliomas	PLOS ONE			English	Article							CELL-CYCLE ARREST; SIGNALING PATHWAY; SONIC-HEDGEHOG; BRAIN-DEVELOPMENT; DOWN-REGULATION; CANCER CELLS; STEM-CELLS; ACTIVATION; GROWTH; PROLIFERATION	It is well known that Notch signaling plays either oncogenic or tumor suppressive role in a variety of tumors, depending on the cellular context. However, in our previous study, we found that Notch1 was overexpressed while Notch2 downregulated in the majority of astrocytic gliomas with different grades as well as in glioblastoma cell lines U251 and A172. We had knocked down Notch1 by siRNA in glioblastoma cells, and identified that the cell growth and invasion were inhibited, whereas cell apoptosis was induced either in vitro or in vivo. For further clarification of the role of Notch2 in pathogenesis of gliomas, enforced overexpression of Notch2 was carried out with transfection of Notch2 expression plasmid in glioma cells and the cell growth, invasion and apoptosis were examined in vitro and in vivo in the present study, and siRNA targeting Notch1 was used as a positive control in vivo. The results showed that upregulating Notch2 had the effect of suppressing cell growth and invasion as well as inducing apoptosis, just the same as the results of knocking down Notch1. Meanwhile, the activity of core signaling pathway-EGFR/PI3K/AKT in astrocytic glioma cells was repressed. Thus, the present study reveals, for the first time, that Notch1 and Notch2 play different roles in the biological processes of astrocytic gliomas. Knocking down the Notch1 or enforced overexpression of Notch2 both modulate the astrocytic glioma phenotype, and the mechanism by which Notch1 and 2 play different roles in the glioma growth should be further investigated.	[Xu, Peng; Zhang, Anling; Jiang, Rongcai; Qiu, Mingzhe; Kang, Chunsheng; Jia, Zhifan; Wang, Guangxiu; Han, Lei; Pu, Peiyu] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Xu, Peng; Zhang, Anling; Jiang, Rongcai; Qiu, Mingzhe; Kang, Chunsheng; Jia, Zhifan; Wang, Guangxiu; Han, Lei; Pu, Peiyu] Tianjin Neurol Inst, Tianjin, Peoples R China; [Xu, Peng; Zhang, Anling; Jiang, Rongcai; Qiu, Mingzhe; Kang, Chunsheng; Jia, Zhifan; Wang, Guangxiu; Han, Lei; Pu, Peiyu] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Xu, Peng; Zhang, Anling; Jiang, Rongcai; Qiu, Mingzhe; Kang, Chunsheng; Jia, Zhifan; Wang, Guangxiu; Han, Lei; Pu, Peiyu] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Fan, Xing] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI 48109 USA	Tianjin Medical University; University of Michigan System; University of Michigan	Fan, X (corresponding author), Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI 48109 USA.	xingf@med.umich.edu; pupeiyu33@hotmail.com	Kang, Chunsheng/AAM-5979-2021; Zhang, An/GRS-5852-2022	Kang, Chunsheng/0000-0002-3255-3369; 	China National Natural Scientific Fund [30300365]; NATIONAL CANCER INSTITUTE [R01CA163737, R01CA148621] Funding Source: NIH RePORTER	China National Natural Scientific Fund(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The China National Natural Scientific Fund (30300365). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelson H, 2004, SEMIN CANCER BIOL, V14, P317, DOI 10.1016/j.semcancer.2004.04.010; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Chiaramonte R, 2005, CANCER LETT, V219, P113, DOI 10.1016/j.canlet.2004.07.022; Cuevas IC, 2005, CANCER RES, V65, P5070, DOI 10.1158/0008-5472.CAN-05-0240; Dakubo GD, 2006, J NEURO-ONCOL, V79, P221, DOI 10.1007/s11060-006-9132-2; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fitzgerald K, 2000, ONCOGENE, V19, P4191, DOI 10.1038/sj.onc.1203766; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Guentchev M, 2006, EUR J NEUROSCI, V23, P2289, DOI 10.1111/j.1460-9568.2006.04766.x; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Irvin DK, 2001, J COMP NEUROL, V436, P167, DOI 10.1002/cne.1059.abs; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Lasky JL, 2005, PEDIATR RES, V57, p104R, DOI 10.1203/01.PDR.0000159632.70510.3D; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; NYE JS, 1994, DEVELOPMENT, V120, P2421; Pahlman S, 2004, SEMIN CANCER BIOL, V14, P365, DOI 10.1016/j.semcancer.2004.04.016; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pu PY, 2006, TECHNOL CANCER RES T, V5, P271, DOI 10.1177/153303460600500308; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Qi RZ, 2003, CANCER RES, V63, P8323; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ramdass B, 2007, GYNECOL ONCOL, V104, P352, DOI 10.1016/j.ygyno.2006.08.054; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Sriuranpong V, 2001, CANCER RES, V61, P3200; Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Tanaka M, 1999, J NEUROBIOL, V41, P524, DOI 10.1002/(SICI)1097-4695(199912)41:4<524::AID-NEU8>3.3.CO;2-9; Wang SL, 2000, NEURON, V27, P197, DOI 10.1016/S0896-6273(00)00028-3; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Xu P, 2010, J NEURO-ONCOL, V97, P41, DOI 10.1007/s11060-009-0007-1; Xu P, 2009, PATHOL ONCOL RES, V15, P703, DOI 10.1007/s12253-009-9173-x	47	24	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53654	10.1371/journal.pone.0053654	http://dx.doi.org/10.1371/journal.pone.0053654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349727	Green Published, gold			2022-12-27	WOS:000313943000015
J	Callis, M; Serrano, S; Benito, A; Laurents, DV; Vilanova, M; Bruix, M; Ribo, M				Callis, Mariona; Serrano, Soraya; Benito, Antoni; Laurents, Douglas V.; Vilanova, Maria; Bruix, Marta; Ribo, Marc			Towards Tricking a Pathogen's Protease into Fighting Infection: The 3D Structure of a Stable Circularly Permuted Onconase Variant Cleavedby HIV-1 Protease	PLOS ONE			English	Article							AMPHIBIAN RIBONUCLEASE; CONFORMATIONAL STABILITY; CYTOTOXIC RIBONUCLEASE; MOLECULAR-DYNAMICS; RANA-CATESBEIANA; DISULFIDE BOND; P-30 PROTEIN; INHIBITOR; OOCYTES; ZYMOGEN	Onconase((R)) is a highly cytotoxic amphibian homolog of Ribonuclease A. Here, we describe the construction of circularly permuted Onconase((R)) variants by connecting the N- and C-termini of this enzyme with amino acid residues that are recognized and cleaved by the human immunodeficiency virus protease. Uncleaved circularly permuted Onconase((R)) variants are unusually stable, non-cytotoxic and can internalize in human T-lymphocyte Jurkat cells. The structure, stability and dynamics of an intact and a cleaved circularly permuted Onconase((R)) variant were determined by Nuclear Magnetic Resonance spectroscopy and provide valuable insight into the changes in catalytic efficiency caused by the cleavage. The understanding of the structural environment and the dynamics of the activation process represents a first step toward the development of more effective drugs for the treatment of diseases related to pathogens expressing a specific protease. By taking advantage of the protease's activity to initiate a cytotoxic cascade, this approach is thought to be less susceptible to known resistance mechanisms.	[Callis, Mariona; Benito, Antoni; Vilanova, Maria; Ribo, Marc] Univ Girona, Dept Biol, Lab Engn Prot, Girona, Spain; [Callis, Mariona; Benito, Antoni; Vilanova, Maria; Ribo, Marc] Inst Invest Biomed Girona Dr Josep Trueta, Girona, Spain; [Serrano, Soraya; Laurents, Douglas V.; Bruix, Marta] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Universitat de Girona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Ribo, M (corresponding author), Univ Girona, Dept Biol, Lab Engn Prot, Girona, Spain.	marc.ribo@udg.edu	Bruix, Marta/H-4161-2011; Ribó, Marc/R-5704-2019; Ribó, Marc/M-4514-2013; Vilanova, Maria/ABG-5767-2020; Benito, Antoni/D-8537-2011; Ribo, Marc/ABG-3202-2021; Laurents, Douglas V/E-7527-2015; Vilanova, Maria/D-9525-2011	Bruix, Marta/0000-0002-0096-3558; Ribó, Marc/0000-0001-6944-6383; Ribó, Marc/0000-0001-6944-6383; Vilanova, Maria/0000-0003-0523-815X; Benito, Antoni/0000-0002-9776-1003; Ribo, Marc/0000-0001-9242-043X; Laurents, Douglas V/0000-0002-4187-165X; Vilanova, Maria/0000-0003-0523-815X	MICINN (Spain) [CTQ2008-0080, CTQ2010-21567-C02-02, BFU2009-06935/BMC]; Universitat de Girona [PUG2008A]; Ministerio de Educacion y Ciencia; Ministerio de Ciencia e Innovacion	MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universitat de Girona; Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Work was supported by grants [CTQ2008-0080, CTQ2010-21567-C02-02 and BFU2009-06935/BMC] from MICINN (Spain) and PUG2008A from the Universitat de Girona. MC and SS acknowledge their fellowships from the Ministerio de Educacion y Ciencia and Ministerio de Ciencia e Innovacion, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDELT W, 1991, J BIOL CHEM, V266, P245; Arnold U, 2006, BIOTECHNOL LETT, V28, P1615, DOI 10.1007/s10529-006-9145-0; Beck ZQ, 2000, VIROLOGY, V274, P391, DOI 10.1006/viro.2000.0420; Boix E, 1996, J MOL BIOL, V257, P992, DOI 10.1006/jmbi.1996.0218; Bosch M, 2004, BIOCHEMISTRY-US, V43, P2167, DOI 10.1021/bi035729+; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang CF, 1998, J MOL BIOL, V283, P231, DOI 10.1006/jmbi.1998.2082; Costanzi J, 2005, CANCER INVEST, V23, P643, DOI 10.1080/07357900500283143; DARZYNKIEWICZ Z, 1988, CELL TISSUE KINET, V21, P169, DOI 10.1111/j.1365-2184.1988.tb00855.x; Dauer Brenda, 2005, J HIV Ther, V10, P72; DEBOUCK C, 1992, AIDS RES HUM RETROV, V8, P153, DOI 10.1089/aid.1992.8.153; Gorbatyuk VY, 2004, J BIOL CHEM, V279, P5772, DOI 10.1074/jbc.M311233200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holloway DE, 2011, FEBS J, V278, P4136, DOI 10.1111/j.1742-4658.2011.08320.x; Hsu CH, 2003, J MOL BIOL, V326, P1189, DOI 10.1016/S0022-2836(02)01472-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson RJ, 2006, FEBS J, V273, P5457, DOI 10.1111/j.1742-4658.2006.05536.x; Kelemen BR, 1999, BIOCHEMISTRY-US, V38, P5302, DOI 10.1021/bi990325w; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laurents DV, 2009, BIOPOLYMERS, V91, P1018, DOI 10.1002/bip.21152; Lee JE, 2008, J MOL BIOL, V375, P165, DOI 10.1016/j.jmb.2007.09.089; Lee JE, 2003, BIOCHEMISTRY-US, V42, P11443, DOI 10.1021/bi035147s; Leland PA, 2000, FEBS LETT, V477, P203, DOI 10.1016/S0014-5793(00)01804-4; Liao YD, 2003, NUCLEIC ACIDS RES, V31, P5247, DOI 10.1093/nar/gkg746; Merlino A, 2005, J BIOL CHEM, V280, P17953, DOI 10.1074/jbc.M501339200; Mikulski SM, 2002, J CLIN ONCOL, V20, P274, DOI 10.1200/JCO.20.1.274; MOSIMANN SC, 1994, J MOL BIOL, V236, P1141, DOI 10.1016/0022-2836(94)90017-5; Neira JL, 1999, J MOL BIOL, V285, P627, DOI 10.1006/jmbi.1998.2365; Notomista E, 2001, BIOCHEMISTRY-US, V40, P9097, DOI 10.1021/bi010741s; Notomista E, 2000, BIOCHEMISTRY-US, V39, P8711, DOI 10.1021/bi000415x; Park C, 2001, METHOD ENZYMOL, V341, P81, DOI 10.1016/S0076-6879(01)41146-3; Plainkum P, 2003, NAT STRUCT BIOL, V10, P115, DOI 10.1038/nsb884; Ribo M, 2004, EUR J BIOCHEM, V271, P1163, DOI 10.1111/j.1432-1033.2004.04020.x; Rodriguez M, 2007, J CELL SCI, V120, P1405, DOI 10.1242/jcs.03427; Rutkoski TJ, 2008, CURR PHARM BIOTECHNO, V9, P185, DOI 10.2174/138920108784567344; Saxena SK, 1996, J BIOL CHEM, V271, P20783, DOI 10.1074/jbc.271.34.20783; Schulenburg C, 2010, CHEMBIOCHEM, V11, P978, DOI 10.1002/cbic.200900773; Serrano S, 2012, BIOMOL NMR ASSIGN IN; Tomasselli AG, 2000, BBA-PROTEIN STRUCT M, V1477, P189, DOI 10.1016/S0167-4838(99)00273-3; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Turcotte RF, 2008, AIDS RES HUM RETROV, V24, P1357, DOI 10.1089/aid.2008.0146; Von Der Helm K, 2000, PROTEASES AS TARGETS; WU YN, 1993, J BIOL CHEM, V268, P10686	43	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54568	10.1371/journal.pone.0054568	http://dx.doi.org/10.1371/journal.pone.0054568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349931	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800063
J	Wei, XL; Zou, GY; Yin, J; Walley, J; Zhou, BA; Yu, YX; Tian, LW; Chen, K				Wei, Xiaolin; Zou, Guanyang; Yin, Jia; Walley, John; Zhou, Biao; Yu, Yunxian; Tian, Linwei; Chen, Kun			Characteristics of High Risk People with Cardiovascular Disease in Chinese Rural Areas: Clinical Indictors, Disease Patterns and Drug Treatment	PLOS ONE			English	Article							PRIMARY PREVENTION; BLOOD-PRESSURE; HEART-DISEASE; MIDDLE-INCOME; DOUBLE-BLIND; STROKE; HYPERTENSION; INDIVIDUALS; CHOLESTEROL; POLYPILL	Background and Aims: Current cardiovascular disease (CVD) prevention is based on diagnosis and treatment of specific disease. Little is known for high risk people with CVD at the community level. In rural China, health records of all residents were established after the recent health reforms. This study aims to describe the characters of the rural population with high CVD risk regarding their clinical indicators, disease patterns, drug treatment and adherence. Methods and Results: 17042 (87%) of all the 19500 rural residents in the two townships had valid health records in 2009. We employed a validated tool, the Asian Equation, to screen 8182 (48%) resident health records of those aged between 40-75 years in 2010. Those who were identified with a CVD risk of 20% or higher were selected for a face-to-face questionnaire survey regarding their diagnosed disease and drug treatment. 453 individuals were identified as high risk of CVD, with an average age of 53 years, 62% males, 50% smoking rate and average systolic blood pressure of 161 mmHg. 386 (85%) participated in the survey, while 294 (76%) were diagnosed with and 88 (23%) were suspects of CVD, hypertension, diabetes or hyperlipidaemia. 75 (19%) took drug regularly and 125 (32%) either stopped treatment or missed drugs. The most often used drugs were calcium channel blockers (20%). Only 2% used aspirins and 0.8% used statins. The median costs of drugs were 17 RMB (USD2.66) per month. Conclusion: The majority of the high risk population in our setting of rural China had already been diagnosed with a CVD related disease, but very few took any drugs, and less still took highly effective drugs to prevent CVD. A holistic strategy focused on population with high risk CVD and based on the current China public health reform is suggested in the context of primary care.	[Wei, Xiaolin; Tian, Linwei] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Zou, Guanyang; Yin, Jia; Walley, John] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Zhou, Biao; Yu, Yunxian; Chen, Kun] Zhejiang Univ, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Chinese University of Hong Kong; University of Leeds; Zhejiang University	Chen, K (corresponding author), Zhejiang Univ, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn	Walley, John D/AAY-1375-2021; Tian, Linwei/A-9736-2009; Wei, Xiaolin/H-5364-2013	Walley, John D/0000-0001-7290-0989; Tian, Linwei/0000-0002-4739-1534; Tian, Linwei/0000-0003-2240-8886	World Universities Network Fund for international research collaborations [dvnuid374700]	World Universities Network Fund for international research collaborations	This work was supported by the World Universities Network Fund for international research collaborations, grant number: dvnuid374700. However, the sponsor of this study has no role in research design, data collection and result interpretation. The authors take full responsibility of views expressed in this manuscript.	Baker S, 2000, BMJ-BRIT MED J, V320, P680, DOI 10.1136/bmj.320.7236.680; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Fan FF, 2010, J ZHEJIANG UNIV-SC B, V11, P583, DOI 10.1631/jzus.B1001003; Hu Da-yi, 2008, Zhonghua Nei Ke Za Zhi, V47, P976; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Liu LS, 2010, CHINESE J HYPERTENS, V18, P11; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; National Center for Cardiovascular Dseases C, 2011, ENCY CHIN PUBL HOUS; National Centre for Cardiovascular Disease, 2007, REP CARD DIS CHIN 20; NICE, 2008, CLIN GUID EV REV LIP; NICE, 2010, NICE IND GUID QOF CA; Tang JL, 2010, INT J EPIDEMIOL, V39, P244, DOI 10.1093/ije/dyp213; The World Bank, 2011, HLTH HARM LIF CHIN S; Volmink J, 2006, COCHRANE DATABASE SY, P2; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Walley J, 2012, B WORLD HEALTH ORGAN, V90, P402, DOI 10.2471/BLT.12.106674; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wei XL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-260; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Xiao JZ, 2010, NEW ENGL J MED, V362, P2426; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C	33	25	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54169	10.1371/journal.pone.0054169	http://dx.doi.org/10.1371/journal.pone.0054169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349814	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800029
J	Miranda, JJ; Herrera, VM; Chirinos, JA; Gomez, LF; Perel, P; Pichardo, R; Gonzalez, A; Sanchez, JR; Ferreccio, C; Aguilera, X; Silva, E; Orostegui, M; Medina-Lezama, J; Perez, CM; Suarez, E; Ortiz, AP; Rosero, L; Schapochnik, N; Ortiz, Z; Ferrante, D; Casas, JP; Bautista, LE				Jaime Miranda, J.; Herrera, Victor M.; Chirinos, Julio A.; Gomez, Luis F.; Perel, Pablo; Pichardo, Rafael; Gonzalez, Angel; Sanchez, Jose R.; Ferreccio, Catterina; Aguilera, Ximena; Silva, Egle; Orostegui, Myriam; Medina-Lezama, Josefina; Perez, Cynthia M.; Suarez, Erick; Ortiz, Ana P.; Rosero, Luis; Schapochnik, Noberto; Ortiz, Zulma; Ferrante, Daniel; Casas, Juan P.; Bautista, Leonelo E.			Major Cardiovascular Risk Factors in Latin America: A Comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO)	PLOS ONE			English	Article							BLOOD-PRESSURE DETERMINATION; PERUVIAN ANDEAN HISPANICS; METABOLIC SYNDROME; GLOBAL BURDEN; PREVALENCE; HYPERTENSION; MORTALITY; DISEASE	Background: Limited knowledge on the prevalence and distribution of risk factors impairs the planning and implementation of cardiovascular prevention programs in the Latin American and Caribbean (LAC) region. Methods and Findings: Prevalence of hypertension, diabetes mellitus, abnormal lipoprotein levels, obesity, and smoking were estimated from individual-level patient data pooled from population-based surveys (1998-2007, n = 31,009) from eight LAC countries and from a national survey of the United States (US) population (1999-2004) Age and gender specific prevalence were estimated and age-gender adjusted comparisons between both populations were conducted. Prevalence of diabetes mellitus, hypertension, and low high-density lipoprotein (HDL)-cholesterol in LAC were 5% (95% confidence interval [95% CI]: 3.4, 7.9), 20.2% (95% CI: 12.5, 31), and 53.3% (95% CI: 47, 63.4), respectively. Compared to LAC region's average, the prevalence of each risk factor tended to be lower in Peru and higher in Chile. LAC women had higher prevalence of obesity and low HDL-cholesterol than men. Obesity, hypercholesterolemia, and hypertriglyceridemia were more prevalent in the US population than in LAC population (31 vs. 16.1%, 16.8 vs. 8.9%, and 36.2 vs. 26.5%, respectively). However, the prevalence of low HDL-cholesterol was higher in LAC than in the US (53.3 vs. 33.7%). Conclusions: Major cardiovascular risk factors are highly prevalent in LAC region, in particular low HDL-cholesterol. In addition, marked differences do exist in this prevalence profile between LAC and the US. The observed patterns of obesity-related risk factors and their current and future impact on the burden of cardiovascular diseases remain to be explained.	[Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Dept Med, Sch Med, Lima, Peru; [Herrera, Victor M.; Bautista, Leonelo E.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA; [Herrera, Victor M.] Univ Autonoma Bucaramanga, Bucaramanga, Colombia; [Chirinos, Julio A.] Univ Penn, Philadelphia, PA 19104 USA; [Chirinos, Julio A.] Philadelphia VAMC, Philadelphia, PA 19104 USA; [Gomez, Luis F.] Pontificia Univ Javeriana, Bogota, Colombia; [Perel, Pablo; Casas, Juan P.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Pichardo, Rafael; Gonzalez, Angel] Inst Dominicano Cardiol, Santo Domingo, Dominican Rep; [Sanchez, Jose R.] Ctr Nacl Alimentac & Nutr, Inst Nacl Salud, Lima, Peru; [Ferreccio, Catterina] Pontificia Univ Catolica Chile, Dept Salud Publ, Santiago, Chile; [Aguilera, Ximena] Minist Salud Chile, Santiago, Chile; [Silva, Egle] Univ Zulia, Fac Med, Inst Invest & Estudios Enfermedades Cardiovasc, Maracaibo 4011, Venezuela; [Orostegui, Myriam] Univ Ind Santander, Epidemiol Res Ctr, Cardiovasc Dis Epidemiol Observ, Bucaramanga, Colombia; [Medina-Lezama, Josefina] Santa Maria Catholic Univ, Sch Med, Arequipa, Peru; [Medina-Lezama, Josefina] Santa Maria Res Inst, Arequipa, Peru; [Perez, Cynthia M.; Suarez, Erick; Ortiz, Ana P.] Univ Puerto Rico, Dept Biostat & Epidemiol, Grad Sch Publ Hlth, San Juan, PR 00936 USA; [Rosero, Luis] Univ Costa Rica, Ctr Ctr Amer Poblac, San Jose, Costa Rica; [Schapochnik, Noberto] Minist Salud Prov Tierra del Fuego, Ushuaia, Argentina; [Ortiz, Zulma] Inst Invest Epidemiol Acad Nacl Med, Buenos Aires, DF, Argentina; [Ferrante, Daniel] Minist Salud & Ambiente, Buenos Aires, DF, Argentina; [Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania; Pontificia Universidad Javeriana; University of London; London School of Hygiene & Tropical Medicine; Instituto Nacional de Salud - Peru; Pontificia Universidad Catolica de Chile; Universidad Industrial de Santander; Universidad Catolica de Santa Maria; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Universidad Costa Rica; Buenos Aires National Academy of Medicine; IIE - Instituto de Investigaciones Epidemiologicas; University of London; University College London	Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	Jaime.Miranda@upch.pe; lebautista@wisc.edu	Herrera, Víctor/ABB-4480-2020; Aguilera, Ximena Paz/D-9861-2014; aguilera, ximena/P-7682-2019	Herrera, Víctor/0000-0002-6295-1640; Aguilera, Ximena Paz/0000-0002-8153-6733; aguilera, ximena/0000-0002-8153-6733; ferreccio, catterina/0000-0001-6331-5534; Gomez Gutierrez, Luis Fernando/0000-0003-1834-3012; Miranda, J. Jaime/0000-0002-4738-5468; Bautista, Leonelo/0000-0002-9151-6920; /0000-0002-2342-301X	Ministerio de Salud de la Republica Argentina; Gobierno de la Provincia de Tierra del Fuego, Antartida e Islas del Atlantico Sur, Argentina; Ministerio de Salud, Chile; Secretaria Distrital de Salud de Bogota, Colombia; Secretaria de Salud Municipal de Bucaramanga; Secretaria Departamental de Salud de Santander, Colombia; The Wellcome Trust Foundation [072406]; Sociedad Dominicana de Cardiologia; Brystol Myers Squibb; Warners Lambert (Pfizer); Novartis; Instituto Nacional de Salud, Lima, Peru; Wellcome Trust [GR074833MA]; National Heart, Lung and Blood Institute (NHLBI); National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; Santa Maria Research Institute, Arequipa, Peru; The National Institutes of Health [RO1-HL080076]; American Heart Association [0885031N]; Merck Sharp & Dohme Corporation; National Institutes of Health/National Center for Research Resources (NCRR/NIH) [G12RR03051, U54RR026139-01A1]; Fondo Nacional de Ciencia, Tecnologia e Innovacion (FONACIT); Fundacion Venezolana de Hipertension Arterial (FUNDAHIPERTENSION); Estudio de Factores de Riesgo Cardiovascular en la Republica Dominicana (EFRICARD); Merck Sharp Dohme; Magnachen International; British Heart Foundation [PG/09/022/26739] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026139, G12RR003051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080076] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	Ministerio de Salud de la Republica Argentina; Gobierno de la Provincia de Tierra del Fuego, Antartida e Islas del Atlantico Sur, Argentina; Ministerio de Salud, Chile; Secretaria Distrital de Salud de Bogota, Colombia; Secretaria de Salud Municipal de Bucaramanga; Secretaria Departamental de Salud de Santander, Colombia; The Wellcome Trust Foundation; Sociedad Dominicana de Cardiologia; Brystol Myers Squibb; Warners Lambert (Pfizer)(Pfizer); Novartis(Novartis); Instituto Nacional de Salud, Lima, Peru; Wellcome Trust(Wellcome TrustEuropean Commission); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Santa Maria Research Institute, Arequipa, Peru; The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Merck Sharp & Dohme Corporation; National Institutes of Health/National Center for Research Resources (NCRR/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Fondo Nacional de Ciencia, Tecnologia e Innovacion (FONACIT); Fundacion Venezolana de Hipertension Arterial (FUNDAHIPERTENSION); Estudio de Factores de Riesgo Cardiovascular en la Republica Dominicana (EFRICARD); Merck Sharp Dohme(Merck & Company); Magnachen International; British Heart Foundation(British Heart Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by several sources. The 'Prueba de Validacion de la Encuesta Nacional de Factores de Riesgo' was funded by the Ministerio de Salud de la Republica Argentina and the Gobierno de la Provincia de Tierra del Fuego, Antartida e Islas del Atlantico Sur, Argentina. The 'Encuesta Nacional de Factores de Riesgo' was funded by the Ministerio de Salud de la Republica Argentina. The 'Encuesta Nacional de Salud 2003' was funded by the Ministerio de Salud, Chile. The 'Estudio CARMEN Santa Fe' was funded by the Secretaria Distrital de Salud de Bogota, Colombia. CARMEN-Bucaramanga was funded by the Secretaria de Salud Municipal de Bucaramanga and the Secretaria Departamental de Salud de Santander, Colombia. The 'Costa Rica: Estudio de Longevidad y Envejecimeinto Saludable (CRELES)' was funded by The Wellcome Trust Foundation [grant 072406]. The 'Estudio de Factores de Riesgo Cardiovascular en la Republica Dominicana (EFRICARD)' was funded by the Sociedad Dominicana de Cardiologia, Brystol Myers Squibb, Warners Lambert (Pfizer), Novartis, Merck Sharp Dohme and Magnachen International. The 'Encuesta Nacional de Indicadores Nutricionales, Bioquimicos, Socioeconomicos y Culturales Relacionados con las Enfermedades Cronico Degenerativas (ENINBSC-ECNT)' was funded by the Instituto Nacional de Salud, Lima, Peru. The 'PERU MIGRANT study' was funded by the Wellcome Trust [GR074833MA] and JJM is further supported by the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services [contract No HHSN268200900033C]. The 'PREVENCION study' was supported by the Santa Maria Research Institute, Arequipa, Peru. The National Institutes of Health [grant RO1-HL080076] and American Heart Association [grant 0885031N] contributed with additional support to JAC. The study of the 'Prevalence of Metabolic Syndrome and its Individual Components in the adult population of the San Juan Metropolitan Area in Puerto Rico' was funded by an unrestricted grant from Merck Sharp & Dohme Corporation with additional support from the National Institutes of Health/National Center for Research Resources (NCRR/NIH) awards [grant G12RR03051 and U54RR026139-01A1]. The 'Zulia Coronary Heart Disease Risk Factor Study' was funded by the Fondo Nacional de Ciencia, Tecnologia e Innovacion (FONACIT) and the Fundacion Venezolana de Hipertension Arterial (FUNDAHIPERTENSION). Some studies received funding from commercial sources (The 'Estudio de Factores de Riesgo Cardiovascular en la Republica Dominicana (EFRICARD)' was funded by the Sociedad Dominicana de Cardiologia, Brystol Myers Squibb, Warners Lambert (Pfizer), Novartis, Merck Sharp Dohme and Magnachen International and the study of the 'Prevalence of Metabolic Syndrome and its Individual Components in the adult population of the San Juan Metropolitan Area in Puerto Rico' was funded by an unrestricted grant from Merck Sharp & Dohme Corporation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Bautista LE, 2009, OBES REV, V10, P364, DOI 10.1111/j.1467-789X.2009.00591.x; Bautista LE, 2006, EUR J CARDIOV PREV R, V13, P769, DOI 10.1097/01.hjr.0000219113.40662.dd; Bautista LE, 2006, ANN EPIDEMIOL, V16, P675, DOI 10.1016/j.annepidem.2006.02.001; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2006, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2002, NAT HLTH NUTR EX SUR; Centro Nacional de Alimentacion y Nutricion Instituto Nacional de Salud, 2006, ENC NAC IND NUTR BIO; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Florez H, 2005, DIABETES RES CLIN PR, V69, P63, DOI 10.1016/j.diabres.2004.11.018; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; FROHLICH ED, 1988, ANN INTERN MED, V109, P612, DOI 10.7326/0003-4819-109-8-612; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gomez LF, 2004, INVESTIGACIONES SEGU, V6, P9; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Herrera VM, 2009, INT J OBESITY, V33, P568, DOI 10.1038/ijo.2009.35; Institute of Medicine, 2010, PROM CARD HLTH DEV W; International Diabetes Federation, 2011, IDF DIAB ATL; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Korn E. L., 1999, ANAL HLTH SURVEYS; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Medina-Lezama J, 2007, DIABETES RES CLIN PR, V78, P270, DOI 10.1016/j.diabres.2007.04.004; Medina-Lezama J, 2007, J AM SOC HYPERTENS, V1, P216, DOI 10.1016/j.jash.2007.02.003; Ministerio de Salud de Chile, 2003, ENC NAC SAL CHIL 200; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Perel P, 2006, PLOS MED, V3, P1448, DOI 10.1371/journal.pmed.0030344; Perez CM, 2008, ETHNIC DIS, V18, P434; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Pichardo R, 1998, ARCH DOMINICANOS CAR, V2, P3; Rubin DB., 2004, MULTIPLE IMPUTATION; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; WHO, 2011, GLOB STAT REP NONC D; World Health Organization, 1997, WHO PUBL, VWHO/NUT/NCD/98.1	39	87	99	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54056	10.1371/journal.pone.0054056	http://dx.doi.org/10.1371/journal.pone.0054056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349785	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000313738900034
J	Jovicic, A; Jolissaint, JFZ; Moser, R; Santos, MDS; Luthi-Carter, R				Jovicic, Ana; Jolissaint, Julien Francisco Zaldivar; Moser, Roger; Santos, Mariana de Fatima Silva; Luthi-Carter, Ruth			MicroRNA-22 (miR-22) Overexpression Is Neuroprotective via General Anti-Apoptotic Effects and May also Target Specific Huntington's Disease-Related Mechanisms	PLOS ONE			English	Article							3-NITROPROPIONIC ACID; EXPRESSION; BRAIN; MODELS; NEURODEGENERATION; NEURONS; CULTURE; DEATH	Background: Whereas many causes and mechanisms of neurodegenerative diseases have been identified, very few therapeutic strategies have emerged in parallel. One possible explanation is that successful treatment strategy may require simultaneous targeting of more than one molecule of pathway. A new therapeutic approach to have emerged recently is the engagement of microRNAs (miRNAs), which affords the opportunity to target multiple cellular pathways simultaneously using a single sequence. Methodology/Principal Findings: We identified miR-22 as a potentially neuroprotective miRNA based on its predicted regulation of several targets implicated in Huntington's disease (histone deacetylase 4 (HDAC4), REST corepresor 1 (Rcor1) and regulator of G-protein signaling 2 (Rgs2)) and its diminished expression in Huntington's and Alzheimer's disease brains. We then tested the hypothesis that increasing cellular levels of miRNA-22 would achieve neuroprotection in in vitro models of neurodegeneration. As predicted, overexpression of miR-22 inhibited neurodegeneration in primary striatal and cortical cultures exposed to a mutated human huntingtin fragment (Htt171-82Q). Overexpression of miR-22 also decreased neurodegeneration in primary neuronal cultures exposed to 3-nitropropionic acid (3-NP), a mitochondrial complex II/III inhibitor. In addition, miR-22 improved neuronal viability in an in vitro model of brain aging. The mechanisms underlying the effects of miR-22 included a reduction in caspase activation, consistent with miR-22's targeting the pro-apoptotic activities of mitogen-activated protein kinase 14/p38 (MAPK14/p38) and tumor protein p53-inducible nuclear protein 1 (Tp53inp1). Moreover, HD-specific effects comprised not only targeting HDAC4, Rcor1 and Rgs2 mRNAs, but also decreasing focal accumulation of mutant Htt-positive foci, which occurred via an unknown mechanism. Conclusions: These data show that miR-22 has multipartite anti-neurodegenerative activities including the inhibition of apoptosis and the targeting of mRNAs implicated in the etiology of HD. These results motivate additional studies to evaluate the feasibility and therapeutic efficacy of manipulating miR-22 in vivo.	[Jovicic, Ana; Jolissaint, Julien Francisco Zaldivar; Moser, Roger; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Vaud, Switzerland; [Santos, Mariana de Fatima Silva; Luthi-Carter, Ruth] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Leicester	Luthi-Carter, R (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Vaud, Switzerland.	relc3@leicester.ac.uk			Swiss National Science Foundation; Roche Foundation; Ecole Polytechnique Federale de Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Foundation; Ecole Polytechnique Federale de Lausanne	This work was supported by the Swiss National Science Foundation, the Roche Foundation and the Ecole Polytechnique Federale de Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BEAL MF, 1993, J NEUROSCI, V13, P4181; Cao J, 2004, J BIOL CHEM, V279, P35903, DOI 10.1074/jbc.M402353200; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fink SL, 1996, EXP NEUROL, V138, P298, DOI 10.1006/exnr.1996.0068; Gambazzi L, 2010, J PHARMACOL EXP THER, V335, P13, DOI 10.1124/jpet.110.167551; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; LUDOLPH AC, 1991, CAN J NEUROL SCI, V18, P492, DOI 10.1017/S0317167100032212; LUTHICARTER R, 2007, DRUG DISCOV TODAY DI, V4, P111; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Rudinskiy N, 2009, J NEUROCHEM, V111, P460, DOI 10.1111/j.1471-4159.2009.06344.x; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Savas JN, 2008, P NATL ACAD SCI USA, V105, P10820, DOI 10.1073/pnas.0800658105; Seredenina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022231; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	30	124	129	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54222	10.1371/journal.pone.0054222	http://dx.doi.org/10.1371/journal.pone.0054222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349832	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900054
J	Morley, CG; Winder, L				Morley, Craig G.; Winder, Linton			The Effect of the Small Indian Mongoose (Urva auropunctatus), Island Quality and Habitat on the Distribution of Native and Endemic Birds on Small Islands within Fiji	PLOS ONE			English	Article							HERPESTES-AUROPUNCTATUS; JAVANICUS; CARNIVORA; MAMMALS; IMPACT; GENUS; DIET; AVES	This study investigated the effect of the presence of introduced mongoose, environmental quality and habitat on the distribution of native and endemic birds on 16 small islands within Fiji. In total, 9055 birds representing 45 species were observed within four key habitats (forest, villages, crop land and coastal vegetation) on the 16 islands, half of which had mongoose present. Previous studies attribute bird declines and extirpation anecdotally to the mongoose. The presence of mongoose, environmental quality and habitat type had a measurable influence on observed extant native and endemic bird communities. We conclude that three ground birds; Gallirallus phillipensis, Anas supericiliosa and Porphyrio porhyrio were negatively influenced by the presence of mongoose and that Ptilinopus perousii, Phigys solitarius, Chrysoenas victor, Ducula latrans, Clytorhyrchus vitiensis, Pachycephala pectoralis, Prospeia tabunesis, and Foulehaio carunculata were particularly dependent on good quality forest habitat. Conservation priorities in relation to protecting Fiji's endemic birds from the effect of mongoose are discussed and preventative measures suggested.	[Morley, Craig G.] Waiariki Inst Technol, Sch Forestry & Primary Ind, Rotorua, New Zealand; [Winder, Linton] Unitec Inst Technol, Fac Social & Hlth Sci, Dept Nat Sci, Auckland, New Zealand	Waiariki Institute of Technology; Unitec NZ	Morley, CG (corresponding author), Waiariki Inst Technol, Sch Forestry & Primary Ind, Rotorua, New Zealand.	craig.morley@waiariki.ac.nz	Morley, CRaig/R-9163-2019	Morley, Craig/0000-0001-7149-4915	University of the South Pacific	University of the South Pacific	This work was funded by a research grant from the University of the South Pacific. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Glover M., 1911, Bulletin of the Museum of Comparative Zoology at Harvard College, V54; Allison N.A., 1980, Sea Swallow, V29, P10; Atkinson IAE, 2006, ECOL STU AN, V186, P49; Bahr PH, 1912, IBIS, V6, P282; Baker J.K., 1979, Elepaio, V40, P51; BALDWIN PH, 1952, J MAMMAL, V33, P335, DOI 10.2307/1375771; Barun A, 2010, ANIM CONSERV, V13, P549, DOI 10.1111/j.1469-1795.2010.00374.x; Barun A., 2011, ISLAND INVASIVES ERA; Beckon W, 1988, DISTRIBUTION L UNPUB; BirdLife International, 2008, STAT WORLDS BIRDS IN; BLACKBURN A, 1971, Notornis, V18, P147; Blackburn TM, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P85; CAVALLINI P, 1995, J MAMMAL, V76, P569, DOI 10.2307/1382365; Cheke A.S., 1987, P5, DOI 10.1017/CBO9780511735769.003; Clunie F, 1984, BIRDS FIJI BUSH; Clunie F, 1972, FIJI MUSEUM ED SERIE; COLLINGS DF, 1984, NEW ZEAL VET J, V32, P21, DOI 10.1080/00480169.1984.35050; Finch O, 1877, P ZOOL SOC LOND, P723; Franklin J, 2010, PLOS ONE, V5, P1; GORMAN ML, 1975, J ZOOL, V175, P273, DOI 10.1111/j.1469-7998.1975.tb01401.x; GORMAN ML, 1975, IBIS, V117, P152, DOI 10.1111/j.1474-919X.1975.tb04202.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Griffiths R, 2011, TURNING TIDE ERADICA; Hartlaub G., 1864, Ibis, P232; Hays WST, 2003, PAC SCI, V61, P3; Hedges SB, 2012, ZOOTAXA, P1; Holdaway Richard N., 1999, P189; HOLYOAK DT, 1979, EMU, V79, P7, DOI 10.1071/MU9790007; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Innes J, 2011, TURNING TIDE ERADICA; KAMI HARRY T., 1964, ZOONOSES RES, V3, P165; KING WARREN B., 1967, LIVING BIRD, V6, P163; Layard E. L., 1876, P137; Leps J, 2003, MULTIVARIATE ANAL EC; Lorvelec O, 2004, REV ECOL-TERRE VIE, V59, P293; MAC ARTHUR ROBERT H., 1967; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martin AH, 1938, T FIJI SOC SCI IND, P4; Martin P.S., 1999, EXTINCTIONS NEAR TIM, P17, DOI DOI 10.1007/978-1-4757-5202-1_2; Mercer R, 1970, FIJI MUSEUM SPECIAL; Moors P. J., 1985, INT COUNCIL BIRD PRE, VPublication No. 3, P35; Morley CG, 2004, ORYX, V38, P457, DOI 10.1017/S0030605304000857; Morley Craig G., 2004, Proceedings of the Vertebrate Pest Conference, V21, P37; Nellis DW, 1983, BIOL MONGOOSE CARIBB; NELLIS DW, 1983, STUD FAUNA CURACAO, V64, P1; Patou ML, 2009, MOL PHYLOGENET EVOL, V53, P69, DOI 10.1016/j.ympev.2009.05.038; PERNETTA JC, 1978, PAC SCI, V32, P223; Peters D, 2011, ISLAND INVASIVES ERA; PIMENTEL DAVID, 1955, JOUR MAMMAL, V36, P62, DOI 10.2307/1375723; Quinn JH, 2005, J ZOOL, V267, P339, DOI 10.1017/S0952836905007491; Rimmer A., 2009, TIRITIRI MATANGI MOD; Roy S.S., 2002, Occasional Papers of the IUCN Species Survival Commission, V27, P266; Ryan P.A., 2000, FIJIS NATURAL HERITA; Seaman G. A., 1962, Journal of Mammalogy, V43, P544, DOI 10.2307/1376922; Seaman G. A., 1952, T N AM WILDL C, V17, P188; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Simberloff D, 2011, ENCY BIOL INVASIONS; SPREP, 2003, ACT STRAT NAT CONS P; Steadman David W., 1999, Ecotropica, V5, P13; Steadman DW, 2006, EXTINCTION BIOGEOGRA; Stone C. P., 1994, ELEPAIO, V54, P73; Stratford JMC, 2000, PALAEOGEOGR PALAEOCL, V162, P137, DOI 10.1016/S0031-0182(00)00109-7; Swinnerton K, 2006, PRELIMINARY RE UNPUB; TARBURTON M K, 1992, Bulletin of the British Ornithologists' Club, V112, P34; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Thaman R. R., 2005, Pacific Science, V59, P193, DOI 10.1353/psc.2005.0027; Trevino HS, 2007, CONSERV BIOL, V21, P125, DOI 10.1111/j.1523-1739.2006.00581.x; Urich J. W., 1931, TROPICAL AGR, V8, P95; Veitch C. R., 2011, ISLAND INVASIVES ERA; Veron G, 2007, ZOOL SCR, V36, P1, DOI 10.1111/j.1463-6409.2006.00261.x; Vilella Francisco J., 1993, Caribbean Journal of Science, V29, P24; Watling D., 1985, Bulletin of the British Ornithologists' Club, V105, P96; Watling D, 2001, GUIDE BIRDS FIJI W P; WILLIAMS C. B., 1918, Bull. Dep. Agric. Trinidad and Tobago, V17, P167; Wood C. A., 1925, Ibis, V1925, P814; Worthy T, 2001, B BRIT ORNITHOLOGIST, V123, P90; Worthy TH, 2004, J ROY SOC NEW ZEAL, V34, P295, DOI 10.1080/03014223.2004.9517768; Worthy TH, 2000, J ROY SOC NEW ZEAL, V30, P337, DOI 10.1080/03014223.2000.9517627; Yamada F, 2002, TURNING TIDE ERADICA, P389	79	6	8	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53842	10.1371/journal.pone.0053842	http://dx.doi.org/10.1371/journal.pone.0053842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349751	Green Published, gold			2022-12-27	WOS:000313738900023
J	Ding, YM; Zhang, RY; Zhang, KN; Lv, XY; Chen, YA; Li, AQ; Wang, LL; Zhang, X; Xia, Q				Ding, Yuemin; Zhang, Ruyi; Zhang, Kena; Lv, Xinyou; Chen, Yanan; Li, Aiqing; Wang, Linlin; Zhang, Xiong; Xia, Qiang			Nischarin Is Differentially Expressed in Rat Brain and Regulates Neuronal Migration	PLOS ONE			English	Article							RHO-GTPASES; CELL-MIGRATION; MENTAL-RETARDATION; AXONAL GROWTH; CDNA-CLONE; INVASION; PHOSPHORYLATION; ANTISERA; SUBUNIT; PROTEIN	Nischarin is a protein known to inhibit breast cancer cell motility by regulating the signaling of the Rho GTPase family. However, little is known about its location and function in the nervous system. The aim of the present study was to investigate the regional and cellular expression and functions of Nischarin in the adult rodent brain. As assessed by real-time PCR, Western blot analysis and immunostaining, we found that Nischarin was widely distributed throughout the brain, with a higher expression in the cerebral cortex and hippocampus. Double-labeling showed that Nischarin was expressed in neurons and was mainly located in the perinuclear region and F-actin-rich protrusions. The expression pattern of Nischarin in the brain was thought to be closely associated with its function. This was verified by our findings from cell migration assays that Nischarin regulated neuronal migration. These results provide a preliminary survey of the distribution of Nischarin in different regions and cell types in the rat brain. This might help to elucidate its physiological roles, and to evaluate its potential clinical implications.	[Ding, Yuemin; Zhang, Ruyi; Zhang, Kena; Wang, Linlin; Zhang, Xiong; Xia, Qiang] Zhejiang Univ, Sch Med, Dept Physiol, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Yuemin; Zhang, Ruyi] Zhejiang Univ City Coll, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Lv, Xinyou] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Yanan] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Aiqing] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Gastroenterol Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University City College; Zhejiang University; Hangzhou Normal University; Zhejiang University	Xia, Q (corresponding author), Zhejiang Univ, Sch Med, Dept Physiol, Hangzhou 310003, Zhejiang, Peoples R China.	xiaqiang@zju.edu.cn			National Natural Science Foundation of China [81000535]; Natural Science Foundation of Zhejiang Province [Y2100508]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (No. 81000535) and the Natural Science Foundation of Zhejiang Province (No. Y2100508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Alahari SK, 2003, EXP CELL RES, V288, P415, DOI 10.1016/S0014-4827(03)00233-7; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Antoine-Bertrand J, 2011, CURR DRUG TARGETS, V12, P1202, DOI 10.2174/138945011795906543; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Baranwal S, 2011, J NATL CANCER I, V103, P1513, DOI 10.1093/jnci/djr350; Benarroch EE, 2007, NEUROLOGY, V68, P1315, DOI 10.1212/01.wnl.0000259588.97409.8f; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042413; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Fournier AE, 2000, METHOD ENZYMOL, V325, P473; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Guerrini R, 2010, NEUROBIOL DIS, V38, P154, DOI 10.1016/j.nbd.2009.02.008; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ivanov TR, 1998, J AUTONOM NERV SYST, V72, P98, DOI 10.1016/S0165-1838(98)00094-0; Khalil BD, 2012, J NEURO-ONCOL, V108, P333, DOI 10.1007/s11060-012-0866-8; Li AQ, 2010, ONCOL REP, V23, P1247, DOI 10.3892/or_00000757; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Piletz JE, 1999, ANN NY ACAD SCI, V881, P1, DOI 10.1111/j.1749-6632.1999.tb09335.x; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Reddig PJ, 2005, J BIOL CHEM, V280, P30994, DOI 10.1074/jbc.M502546200; Tashiro A, 2008, METHOD ENZYMOL, V439, P285, DOI 10.1016/S0076-6879(07)00421-1; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Verrotti A, 2010, EUR J PAEDIATR NEURO, V14, P1, DOI 10.1016/j.ejpn.2009.01.005; Wang XY, 2012, J ZHEJIANG UNIV-SC B, V13, P356, DOI 10.1631/jzus.B1100386	28	21	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54563	10.1371/journal.pone.0054563	http://dx.doi.org/10.1371/journal.pone.0054563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342172	Green Submitted, gold, Green Published			2022-12-27	WOS:000313682700127
J	Sunyakumthorn, P; Paris, DH; Chan, TC; Jones, M; Luce-Fedrow, A; Chattopadhyay, S; Jiang, J; Anantatat, T; Turner, GDH; Day, NPJ; Richards, AL				Sunyakumthorn, Piyanate; Paris, Daniel H.; Chan, Teik-Chye; Jones, Margaret; Luce-Fedrow, Alison; Chattopadhyay, Suchismita; Jiang, Ju; Anantatat, Tippawan; Turner, Gareth D. H.; Day, Nicholas P. J.; Richards, Allen L.			An Intradermal Inoculation Model of Scrub Typhus in Swiss CD-1 Mice Demonstrates More Rapid Dissemination of Virulent Strains of Orientia tsutsugamushi	PLOS ONE			English	Article							HOST DEFENSES; RICKETTSIAL INFECTIONS; CYNOMOLGUS MONKEYS; VACCINE CANDIDATE; IMMUNE-RESPONSES; DENDRITIC CELLS; MACROPHAGES; RESISTANCE; JAPAN; EPIDEMIOLOGY	Scrub typhus is an important endemic disease of the Asia-Pacific region caused by Orientia tsutsugamushi. To develop an effective vaccine to prevent scrub typhus infection, a better understanding of the initial host-pathogen interaction is needed. The objective of this study was to investigate early bacterial dissemination in a CD-1 Swiss outbred mouse model after intradermal injection of O. tsutsugamushi. Three human pathogenic strains of O. tsutsugamushi (Karp, Gilliam, and Woods) were chosen to investigate the early infection characteristics associated with bacterial virulence. Tissue biopsies of the intradermal injection site and draining lymph nodes were examined using histology and immunohistochemistry to characterize bacterial dissemination, and correlated with quantitative real-time PCR for O. tsutsugamushi in blood and tissue from major organs. Soluble adhesion molecules were measured to examine cellular activation in response to infection. No eschar formation was seen at the inoculation site and no clinical disease developed within the 7 day period of observation. However, O. tsutsugamushi was localized at the injection site and in the draining lymph nodes by day 7 post inoculation. Evidence of leukocyte and endothelial activation was present by day 7 with significantly raised levels of sL-selectin, sICAM-1 and sVCAM-1. Infection with the Karp strain was associated with earlier and higher bacterial loads and more extensive dissemination in various tissues than the less pathogenic Gilliam and Woods strains. The bacterial loads of O. tsutsugamushi were highest in the lungs and spleens of mice inoculated with Karp and Gilliam, but not Woods strains. Strains of higher virulence resulted in more rapid systemic infection and dissemination in this model. The CD-1 mouse intradermal inoculation model demonstrates features relevant to early scrub typhus infection in humans, including the development of regional lymphadenopathy, leukocyte activation and distant organ dissemination after low-dose intradermal injection with O. tsutsugamushi.	[Sunyakumthorn, Piyanate; Chan, Teik-Chye; Luce-Fedrow, Alison; Chattopadhyay, Suchismita; Jiang, Ju; Richards, Allen L.] USN, Viral & Rickettsial Dis Dept, Med Res Ctr, Silver Spring, MD USA; [Sunyakumthorn, Piyanate; Paris, Daniel H.; Anantatat, Tippawan; Turner, Gareth D. H.; Day, Nicholas P. J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Jones, Margaret; Turner, Gareth D. H.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Richards, Allen L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	United States Department of Defense; United States Navy; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Uniformed Services University of the Health Sciences - USA	Richards, AL (corresponding author), USN, Viral & Rickettsial Dis Dept, Med Res Ctr, Silver Spring, MD USA.	Allen.Richards@med.navy.mil	Paris, Daniel/GLN-7566-2022; Paris, Daniel/AFV-4762-2022	PARIS, Daniel/0000-0003-4743-5987	U.S. Military Infectious Diseases Research Program [A0310]; Wellcome Trust of Great Britain [089275/Z/09/Z]	U.S. Military Infectious Diseases Research Program; Wellcome Trust of Great Britain(Wellcome Trust)	This work was funded by the U.S. Military Infectious Diseases Research Program, work unit number A0310, and by the Wellcome Trust of Great Britain, grant 089275/Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ACC, 1945, AM J PATHOL, P603; CATANZARO PJ, 1976, INFECT IMMUN, V13, P861, DOI 10.1128/IAI.13.3.861-875.1976; Chan TC, 2003, VACCINE, V21, P4550, DOI 10.1016/S0264-410X(03)00505-X; Chattopadhyay S, 2005, INFECT IMMUN, V73, P5039, DOI 10.1128/IAI.73.8.5039-5047.2005; Chattopadhyay S, 2007, HUM VACCINES, V3, P73, DOI 10.4161/hv.3.3.4009; Fukuhara M, 2005, MICROB PATHOGENESIS, V39, P177, DOI 10.1016/j.micpath.2005.08.004; GROVES MG, 1978, INFECT IMMUN, V19, P583, DOI 10.1128/IAI.19.2.583-588.1978; Guinet F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001688; JERRELLS TR, 1983, INFECT IMMUN, V41, P666, DOI 10.1128/IAI.41.2.666-674.1983; JERRELLS TR, 1982, INFECT IMMUN, V37, P1066, DOI 10.1128/IAI.37.3.1066-1073.1982; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; KAWAMURA A, 1988, JPN J EXP MED, V58, P169; Kawamura A., 1995, TSUTSUGAMUSHI DIS; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Lee YS, 2006, JPN J INFECT DIS, V59, P235; Lerdthusnee K, 2006, ANN NY ACAD SCI, V1078, P607, DOI 10.1196/annals.1374.121; Lurchachaiwong W, 2012, EXP APPL ACAROL, V58, P23, DOI 10.1007/s10493-012-9563-8; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Mwangi W, 2005, J LEUKOCYTE BIOL, V78, P401, DOI 10.1189/jlb.1204722; Mwangi W, 2002, J IMMUNOL, V169, P3837, DOI 10.4049/jimmunol.169.7.3837; NACY CA, 1981, INFECT IMMUN, V31, P1239, DOI 10.1128/IAI.31.3.1239-1250.1981; Nagano I, 1996, MICROBIOL IMMUNOL, V40, P743, DOI 10.1111/j.1348-0421.1996.tb01135.x; Ogawa M, 2002, AM J TROP MED HYG, V67, P162, DOI 10.4269/ajtmh.2002.67.162; Paris DH, 2008, CLIN EXP IMMUNOL, V153, P63, DOI 10.1111/j.1365-2249.2008.03673.x; Paris DH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001466; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; RIDGWAY RL, 1986, LAB ANIM SCI, V36, P481; SHIRAI A, 1976, INFECT IMMUN, V14, P39, DOI 10.1128/IAI.14.1.39-46.1976; Tay ST, 2000, T ROY SOC TROP MED H, V94, P280, DOI 10.1016/S0035-9203(00)90322-5; Walsh DS, 2007, VECTOR-BORNE ZOONOT, V7, P547, DOI 10.1089/vbz.2006.0642; Xu GA, 2005, ANN NY ACAD SCI, V1063, P266, DOI 10.1196/annals.1355.043	31	29	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54570	10.1371/journal.pone.0054570	http://dx.doi.org/10.1371/journal.pone.0054570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342173	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700128
J	Oliveira, AF; Yasuda, R				Oliveira, Ana F.; Yasuda, Ryohei			An Improved Ras Sensor for Highly Sensitive and Quantitative FRET-FLIM Imaging	PLOS ONE			English	Article							GROWTH-FACTOR; RHO GTPASES; ACTIVATION; PROTEINS; TRAFFICKING; PLASTICITY; TARGETS; BINDING	Ras is a signaling protein involved in a variety of cellular processes. Hence, studying Ras signaling with high spatiotemporal resolution is crucial to understanding the roles of Ras in many important cellular functions. Previously, fluorescence lifetime imaging (FLIM) of fluorescent resonance energy transfer (FRET)-based Ras activity sensors, FRas and FRas-F, have been demonstrated to be useful for measuring the spatiotemporal dynamics of Ras signaling in subcellular micro-compartments. However the predominantly nuclear localization of the sensors' acceptor has limited its sensitivity. Here, we have overcome this limitation and developed two variants of the existing FRas sensor with different affinities: FRas2-F (K-d similar to 1.7 mu M) and FRas2-M (K-d similar to 0.5 mu M). We demonstrate that, under 2-photon fluorescence lifetime imaging microscopy, FRas2 sensors provide higher sensitivity compared to previous sensors in 293T cells and neurons.	[Oliveira, Ana F.; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Oliveira, Ana F.] Univ Coimbra, Ctr Neurosci & Cell Biol, Doctoral Program Biomed & Expt Biol, Coimbra, Portugal; [Yasuda, Ryohei] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Yasuda, Ryohei] Max Planck Florida Inst, Jupiter, FL USA	Duke University; Universidade de Coimbra; Duke University; Howard Hughes Medical Institute; Max Planck Society	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	Ryohei.Yasuda@mpfi.org		Yasuda, Ryohei/0000-0001-6263-9297; Oliveira, Ana/0000-0002-0330-3643	National Institute of Health [R01MH080047, R01NS068410]; Portuguese Foundation for Science and Technology [SFRH/BD/15226/2004]; Children's Tumor Foundation [2009-01-014]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068410] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Children's Tumor Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study is funded by National Institute of Health (R01MH080047, R01NS068410), the Pre-Doctoral Fellowship from the Portuguese Foundation for Science and Technology (SFRH/BD/15226/2004) and Young Investigator Award, Children's Tumor Foundation (YIA # 2009-01-014). and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Habas A, 2006, J NEUROCHEM, V96, P335, DOI 10.1111/j.1471-4159.2005.03543.x; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Hetman M, 2002, J BIOL CHEM, V277, P49577, DOI 10.1074/jbc.M111227200; Jaitner BK, 1997, J BIOL CHEM, V272, P29927, DOI 10.1074/jbc.272.47.29927; LACOWICZ JR, 2006, PRINCIPLES FLUORESCE; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; MEDEMA RH, 1993, MOL CELL BIOL, V13, P155, DOI 10.1128/MCB.13.1.155; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stornetta RL, 2011, NEUROSCIENTIST, V17, P54, DOI 10.1177/1073858410365562; Szatmari E, 2007, J NEUROSCI, V27, P11389, DOI 10.1523/JNEUROSCI.3473-07.2007; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wimmer R, 2010, TRENDS BIOCHEM SCI, V35, P660, DOI 10.1016/j.tibs.2010.06.001; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Ye XJ, 2010, NEURON, V68, P340, DOI 10.1016/j.neuron.2010.09.013; Zhao J, 2002, BIOCHEM BIOPH RES CO, V297, P653, DOI 10.1016/S0006-291X(02)02257-X; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	28	21	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52874	10.1371/journal.pone.0052874	http://dx.doi.org/10.1371/journal.pone.0052874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23349692	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400025
J	Stozer, A; Dolensek, J; Rupnik, MS				Stozer, Andraz; Dolensek, Jurij; Rupnik, Marjan Slak			Glucose-Stimulated Calcium Dynamics in Islets of Langerhans in Acute Mouse Pancreas Tissue Slices	PLOS ONE			English	Article							CYTOPLASMIC CA2+ CONCENTRATION; BURSTING ELECTRICAL-ACTIVITY; RECORDED IN-VIVO; BETA-CELLS; INSULIN-RELEASE; INTACT ISLETS; INDUCED OSCILLATIONS; IDENTIFIED ALPHA; CHROMAFFIN CELLS; DELTA-CELLS	In endocrine cells within islets of Langerhans calcium ions couple cell stimulation to hormone secretion. Since the advent of modern fluorimetry, numerous in vitro studies employing primarily isolated mouse islets have investigated the effects of various secretagogues on cytoplasmic calcium, predominantly in insulin-secreting beta cells. Due to technical limitations, insights of these studies are inherently limited to a rather small subpopulation of outermost cells. The results also seem to depend on various factors, like culture conditions and duration, and are not always easily reconcilable with findings in vivo. The main controversies regard the types of calcium oscillations, presence of calcium waves, and the level of synchronized activity. Here, we set out to combine the in situ acute mouse pancreas tissue slice preparation with noninvasive fluorescent calcium labeling and subsequent confocal laser scanning microscopy to shed new light on the existing controversies utilizing an innovative approach enabling the characterization of responses in many cells from all layers of islets. Our experiments reproducibly showed stable fast calcium oscillations on a sustained plateau rather than slow oscillations as the predominant type of response in acute tissue slices, and that calcium waves are the mechanistic substrate for synchronization of oscillations. We also found indirect evidence that even a large amplitude calcium signal was not sufficient and that metabolic activation was necessary to ensure cell synchronization upon stimulation with glucose. Our novel method helped resolve existing controversies and showed the potential to help answer important physiological questions, making it one of the methods of choice for the foreseeable future.	[Stozer, Andraz; Dolensek, Jurij; Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia; [Rupnik, Marjan Slak] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Maribor	Rupnik, MS (corresponding author), Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia.	marjan.rupnik@uni-mb.si	Rupnik, Marjan Slak/R-4738-2019; Slak Rupnik, Marjan/E-6246-2015	Rupnik, Marjan Slak/0000-0002-3744-4882; Slak Rupnik, Marjan/0000-0002-3744-4882	Slovenian Research Agency [P3-0310-2334]; MPG Partner Group Program [J3-2290-2334]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); MPG Partner Group Program	This work was supported by the Slovenian Research Agency Program P3-0310-2334 (http://www.arrs.gov.si/en/dobrodoslica.asp), and Grant J3-2290-2334, MPG Partner Group Program (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada N, 1998, DIABETES, V47, P751, DOI 10.2337/diabetes.47.5.751; Aslanidi OV, 2001, BIOPHYS J, V80, P1195, DOI 10.1016/S0006-3495(01)76096-1; Beauvois MC, 2006, AM J PHYSIOL-CELL PH, V290, pC1503, DOI 10.1152/ajpcell.00400.2005; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; BERGSTEN P, 1993, BIOCHEM BIOPH RES CO, V192, P1182, DOI 10.1006/bbrc.1993.1541; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; BERGSTEN P, 1995, AM J PHYSIOL-ENDOC M, V268, pE282, DOI 10.1152/ajpendo.1995.268.2.E282; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bertuzzi F, 1999, DIABETES, V48, P1971, DOI 10.2337/diabetes.48.10.1971; Bosco D, 2007, J ENDOCRINOL, V194, P21, DOI 10.1677/JOE-06-0169; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; EDDLESTONE GT, 1984, J MEMBRANE BIOL, V77, P1, DOI 10.1007/BF01871095; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fernandez J, 2000, FEBS LETT, V477, P33, DOI 10.1016/S0014-5793(00)01631-8; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GILON P, 1993, J BIOL CHEM, V268, P22265; GILON P, 1994, DIABETOLOGIA, V37, P1007, DOI 10.1007/BF00400464; GILON P, 1992, J BIOL CHEM, V267, P20713; GRAPENGIESSER E, 1988, BIOCHEM BIOPH RES CO, V151, P1299, DOI 10.1016/S0006-291X(88)80503-5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heller RS, 2010, ADV EXP MED BIOL, V654, P21, DOI 10.1007/978-90-481-3271-3_2; HELLMAN B, 1992, BIOCHIM BIOPHYS ACTA, V1113, P295, DOI 10.1016/0304-4157(92)90003-S; Hodson DJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1612; Huang YC, 2011, J PHYSIOL-LONDON, V589, P395, DOI 10.1113/jphysiol.2010.200345; Katsuta H, 2010, DIABETOLOGIA, V53, P128, DOI 10.1007/s00125-009-1570-x; Liu YJ, 1998, J PHYSIOL-LONDON, V508, P471, DOI 10.1111/j.1469-7793.1998.471bq.x; MEISSNER HP, 1976, NATURE, V262, P502, DOI 10.1038/262502a0; Milton F, 1937, J AM STAT ASSOC, V32, P675; Moser T, 1997, J NEUROSCI, V17, P2314; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Palti Y, 1996, DIABETES, V45, P595, DOI 10.2337/diabetes.45.5.595; POOLE CA, 1993, J CELL SCI, V106, P685; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; Ravier MA, 2002, DIABETOLOGIA, V45, P1154, DOI 10.1007/s00125-002-0883-9; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Rozzo A, 2009, ANN NY ACAD SCI, V1152, P53, DOI 10.1111/j.1749-6632.2008.04003.x; Rupnik M, 2009, ACTA PHYSIOL, V195, P123, DOI 10.1111/j.1748-1716.2008.01927.x; Sanchez-Cardenas C, 2010, NEUROENDOCRINOLOGY, V91, P239, DOI 10.1159/000274493; SANCHEZANDRES JV, 1995, J PHYSIOL-LONDON, V486, P223, DOI 10.1113/jphysiol.1995.sp020804; SANTOS RM, 1991, PFLUG ARCH EUR J PHY, V418, P417, DOI 10.1007/BF00550880; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Sedej S, 2005, J PHYSIOL-LONDON, V567, P799, DOI 10.1113/jphysiol.2005.090381; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Takahashi N, 2002, DIABETES, V51, pS25, DOI 10.2337/diabetes.51.2007.S25; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Valdeolmillos M, 1996, J PHYSIOL-LONDON, V493, P9, DOI 10.1113/jphysiol.1996.sp021361; VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X; Zhang Q, 2008, PHILOS T R SOC A, V366, P3503, DOI 10.1098/rsta.2008.0110	51	55	55	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54638	10.1371/journal.pone.0054638	http://dx.doi.org/10.1371/journal.pone.0054638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358454	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600083
J	Finsterwald, C; Carrard, A; Martin, JL				Finsterwald, Charles; Carrard, Anthony; Martin, Jean-Luc			Role of Salt-Inducible Kinase 1 in the Activation of MEF2-Dependent Transcription by BDNF	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CREB COACTIVATOR TORC2; HISTONE DEACETYLASES; GENE-EXPRESSION; DENDRITIC DEVELOPMENT; NEURONAL SURVIVAL; SIGNALING CASCADE; CORTICAL-NEURONS; KEY REGULATOR; CLASS IIHDAC	Substantial evidence supports a role for myocyte enhancer factor 2 (MEF2)-mediated transcription in neuronal survival, differentiation and synaptic function. In developing neurons, it has been shown that MEF2-dependent transcription is regulated by neurotrophins. Despite these observations, little is known about the cellular mechanisms by which neurotrophins activate MEF2 transcriptional activity. In this study, we examined the role of salt-inducible kinase 1 (SIK1), a member of the AMP-activated protein kinase (AMPK) family, in the regulation of MEF2-mediated transcription by the neurotrophin brain-derived neurotrophic factor (BDNF). We show that BDNF increases the expression of SIK1 in primary cultures of rat cortical neurons through the extracellular signal-regulated kinase 1/2 (ERK1/2)-signaling pathway. In addition to inducing SIK1 expression, BDNF triggers the phosphorylation of SIK1 at Thr182 and its translocation from the cytoplasm to the nucleus of cortical neurons. The effects of BDNF on the expression, phosphorylation and, translocation of SIK1 are followed by the phosphorylation and nuclear export of histone deacetylase 5 (HDAC5). Blockade of SIK activity with a low concentration of staurosporine abolished BDNF-induced phosphorylation and nuclear export of HDAC5 in cortical neurons. Importantly, stimulation of HDAC5 phosphorylation and nuclear export by BDNF is accompanied by the activation of MEF2-mediated transcription, an effect that is suppressed by staurosporine. Consistent with these data, BDNF induces the expression of the MEF2 target genes Arc and Nur77, in a staurosporine-sensitive manner. In further support of the role of SIK1 in the regulation of MEF2-dependent transcription by BDNF, we found that expression of wild-type SIK1 or S577A SIK1, a mutated form of SIK1 which is retained in the nucleus of transfected cells, is sufficient to enhance MEF2 transcriptional activity in cortical neurons. Together, these data identify a previously unrecognized mechanism by which SIK1 mediates the activation of MEF2-dependent transcription by BDNF.	[Finsterwald, Charles; Carrard, Anthony; Martin, Jean-Luc] CHUV, Dept Psychiat, Ctr Psychiat Neurosci, Prilly, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Martin, JL (corresponding author), CHUV, Dept Psychiat, Ctr Psychiat Neurosci, Prilly, Switzerland.	jean-luc.martin@unil.ch	Carrard, Anthony/C-2206-2013	Carrard, Anthony/0000-0003-0610-8680; Martin, Jean-Luc/0000-0002-5082-4687	Swiss National Science Foundation [31003A-124783]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, grant 31003A-124783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Dietrich JB, 2012, SYNAPSE, V66, P61, DOI 10.1002/syn.20988; Feldman JD, 2000, J NEUROCHEM, V74, P2227, DOI 10.1046/j.1471-4159.2000.0742227.x; Finsterwald C, 2011, EUR J NEUROSCI, V34, P1053, DOI 10.1111/j.1460-9568.2011.07839.x; Finsterwald C, 2010, J BIOL CHEM, V285, P28587, DOI 10.1074/jbc.M110.125740; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Heidenreich KA, 2004, MOL NEUROBIOL, V29, P155, DOI 10.1385/MN:29:2:155; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Kanyo R, 2009, ENDOCRINOLOGY, V150, P4221, DOI 10.1210/en.2009-0275; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kumagai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026148; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Liu Y, 2012, ENDOCRINOLOGY, V153, P223, DOI 10.1210/en.2011-1404; Liu YW, 2005, J CELL BIOL, V168, P887, DOI 10.1083/jcb.200408128; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Popov S, 2012, AM J PHYSL HEART CIR; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi A, 2003, J NEUROSCI, V23, P7326; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Uebi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037803; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Wang YP, 2007, J NEUROCHEM, V102, P957, DOI 10.1111/j.1471-4159.2007.04606.x; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5	51	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54545	10.1371/journal.pone.0054545	http://dx.doi.org/10.1371/journal.pone.0054545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349925	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100079
J	Rath, BH; Fair, JM; Jamal, M; Camphausen, K; Tofilon, PJ				Rath, Barbara H.; Fair, Joshlean M.; Jamal, Muhammad; Camphausen, Kevin; Tofilon, Philip J.			Astrocytes Enhance the Invasion Potential of Glioblastoma Stem-Like Cells	PLOS ONE			English	Article							GLIOMA-CELLS; BRAIN; EXPRESSION; GROWTH; PROTEIN; ALPHA; METALLOPROTEINASES; IDENTIFICATION; INVASIVENESS; INHIBITORS	Glioblastomas (GBMs) are characterized as highly invasive; the contribution of GBM stem-like cells (GSCs) to the invasive phenotype, however, has not been completely defined. Towards this end, we have defined the invasion potential of CD133+ GSCs and their differentiated CD133- counterparts grown under standard in vitro conditions and in co-culture with astrocytes. Using a trans-well assay, astrocytes or astrocyte conditioned media in the bottom chamber significantly increased the invasion of GSCs yet had no effect on CD133- cells. In addition, a monolayer invasion assay showed that the GSCs invaded farther into an astrocyte monolayer than their differentiated progeny. Gene expression profiles were generated from two GSC lines grown in trans-well culture with astrocytes in the bottom chamber or directly in contact with astrocyte monolayers. In each co-culture model, genes whose expression was commonly increased in both GSC lines involved cell movement and included a number of genes that have been previously associated with tumor cell invasion. Similar gene expression modifications were not detected in CD133- cells co-cultured under the same conditions with astrocytes. Finally, evaluation of the secretome of astrocytes grown in monolayer identified a number of chemokines and cytokines associated with tumor cell invasion. These data suggest that astrocytes enhance the invasion of CD133+ GSCs and provide additional support for a critical role of brain microenvironment in the regulation of GBM biology.	[Rath, Barbara H.; Fair, Joshlean M.; Jamal, Muhammad; Camphausen, Kevin; Tofilon, Philip J.] NCI, Radiat Oncol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tofilon, PJ (corresponding author), NCI, Radiat Oncol Branch, Bldg 10, Bethesda, MD 20892 USA.	tofilonp@mail.nih.gov			Division of Basic Sciences of the National Cancer Institute [1 Z1A BC011372 01]; NATIONAL CANCER INSTITUTE [ZIABC011372] Funding Source: NIH RePORTER	Division of Basic Sciences of the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the the Division of Basic Sciences of the National Cancer Institute (1 Z1A BC011372 01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg-Jessen C, 2009, J NEURO-ONCOL, V95, P117, DOI 10.1007/s11060-009-9910-8; ALOISI F, 1995, INT J DEV NEUROSCI, V13, P265, DOI 10.1016/0736-5748(94)00071-A; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Ehtesham M, 2006, ONCOGENE, V25, P2801, DOI 10.1038/sj.onc.1209302; Esencay M, 2010, J NEURO-ONCOL, V99, P33, DOI 10.1007/s11060-010-0111-2; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Garcia-Segura LM, 2004, ENDOCRINOLOGY, V145, P1082, DOI 10.1210/en.2003-1383; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Hong X, 2006, CANCER LETT, V236, P39, DOI 10.1016/j.canlet.2005.05.011; Jan HJ, 2010, NEURO-ONCOLOGY, V12, P58, DOI 10.1093/neuonc/nop013; Jones TS, 2011, ONCOGENE; Kim SJ, 2011, NEOPLASIA, V13, P286, DOI 10.1593/neo.11112; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Liang Y, 2008, J NEURO-ONCOL, V86, P153, DOI 10.1007/s11060-007-9463-7; Lin QT, 2010, NEOPLASIA, V12, P748, DOI 10.1593/neo.10602; Liu QL, 2010, J NEURO-ONCOL, V100, P165, DOI 10.1007/s11060-010-0158-0; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; McCord AM, 2009, CLIN CANCER RES, V15, P5145, DOI 10.1158/1078-0432.CCR-09-0263; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; MOHANAM S, 1995, CLIN EXP METASTAS, V13, P57, DOI 10.1007/BF00144019; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rodrigues-Ferreira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035667; Seike T, 2011, CLIN EXP METASTAS, V28, P13, DOI 10.1007/s10585-010-9354-8; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shaw Leslie M., 2004, V294, P97; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Song SW, 2003, P NATL ACAD SCI USA, V100, P13970, DOI 10.1073/pnas.2332186100; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tatenhorst L, 2006, NEUROPATH APPL NEURO, V32, P271, DOI 10.1111/j.1365-2990.2006.00720.x; TOWER DB, 1973, J NEUROCHEM, V20, P269, DOI 10.1111/j.1471-4159.1973.tb12126.x; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Wang DY, 2000, ONCOGENE, V19, P5801, DOI 10.1038/sj.onc.1203917; Wick W, 2001, J NEUROSCI, V21, P3360, DOI 10.1523/JNEUROSCI.21-10-03360.2001	50	79	81	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54752	10.1371/journal.pone.0054752	http://dx.doi.org/10.1371/journal.pone.0054752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349962	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100095
J	Silvagno, F; Consiglio, M; Foglizzo, V; Destefanis, M; Pescarmona, G				Silvagno, Francesca; Consiglio, Marco; Foglizzo, Valentina; Destefanis, Michele; Pescarmona, Gianpiero			Mitochondrial Translocation of Vitamin D Receptor Is Mediated by the Permeability Transition Pore in Human Keratinocyte Cell Line	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; LOCALIZATION; INVOLVEMENT; METABOLISM; ACTIVATION; BINDING; GROWTH; VDR; P53	Background: Vitamin D receptor (VDR) is a well known transcriptional regulator, active as heterodimer in association with coactivators and corepressors. In addition it has been described the extranuclear distribution of the receptor and in particular the recently reported mitochondrial localization in platelets and megakaryocytes is intriguing because it appears to be a common feature of steroid receptors. Whereas for other members of the steroid receptor family the mitochondrial function has been explored, up to now nothing is known about a mitochondrial form of VDR in human proliferating cells. Methodology/Principal Findings: In this study we characterized for the first time the mitochondrial localization of VDR in the human keratinocyte cell line HaCaT. In proliferating HaCaT cells VDR was abundantly expressed in mitochondria in association with its binding partner RXR alpha and the import was ligand-independent. By immunoprecipitation studies we demonstrated the interaction of VDR with proteins of the permeability transition pore (PTP), VDAC and StAR. We then adopted different pharmacological and silencing approaches with the aim of hampering PTP function, either affecting PTP opening or abating the expression of the complex member StAR. By all means the impairment of pore function led to a reduction of mitochondrial levels of VDR. Conclusions: The results reported here demonstrate a ligand-independent mitochondrial import of VDR through the permeability transition pore, and open interesting new perspectives on PTP function as transporter and on VDR role in mitochondria.	[Silvagno, Francesca; Consiglio, Marco; Foglizzo, Valentina; Destefanis, Michele; Pescarmona, Gianpiero] Univ Turin, Dept Oncol, Turin, Italy; [Foglizzo, Valentina] S Giovanni Battista Hosp, Ctr Expt Res & Med Studies, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Silvagno, F (corresponding author), Univ Turin, Dept Oncol, Turin, Italy.	francesca.silvagno@unito.it		PESCARMONA, GIAN PIERO/0000-0003-2143-8901; Foglizzo, Valentina/0000-0001-5059-3279	Ministero dell'Istruzione Universita e Ricerca	Ministero dell'Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione Universita e Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsony J, 1997, J BIOL CHEM, V272, P5774, DOI 10.1074/jbc.272.9.5774; Bikle DD, 2011, MOL CELL ENDOCRINOL, V347, P80, DOI 10.1016/j.mce.2011.05.017; Boopathi E, 2008, MOL CELL, V32, P32, DOI 10.1016/j.molcel.2008.09.008; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Capiati D, 2002, J CELL BIOCHEM, V86, P128, DOI 10.1002/jcb.10191; Carito V, 2012, BBA-GEN SUBJECTS, V1820, P96, DOI 10.1016/j.bbagen.2011.10.015; Casas F, 2003, FASEB J, V17, P426, DOI 10.1096/fj.02-0732com; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Costet P, 2000, J BIOL CHEM, V275, P28240; CROMPTON M, 1988, BIOCHEM J, V255, P357; FUJIKI M, 1993, J BIOL CHEM, V268, P1914; Gavrilova-Jordan LP, 2007, SEMIN REPROD MED, V25, P154, DOI 10.1055/s-2007-973428; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Ling XL, 2010, INT J BIOL SCI, V6, P773; Liu JF, 2008, FEBS LETT, V582, P1319, DOI 10.1016/j.febslet.2008.03.013; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; Matsuda H, 1996, BBA-LIPID LIPID MET, V1301, P76, DOI 10.1016/0005-2760(96)00020-3; MATSUMOTO K, 1991, BIOCHIM BIOPHYS ACTA, V1092, P311, DOI 10.1016/S0167-4889(97)90006-9; Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Morrish F, 2006, MITOCHONDRION, V6, P143, DOI 10.1016/j.mito.2006.04.002; Oda Y, 2007, J STEROID BIOCHEM, V103, P776, DOI 10.1016/j.jsbmb.2006.12.069; Pardo VG, 2008, BIOGERONTOLOGY, V9, P109, DOI 10.1007/s10522-007-9118-2; Psarra AMG, 2009, BBA-BIOENERGETICS, V1787, P431, DOI 10.1016/j.bbabio.2008.11.011; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; Silvagno F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008670; Thorne JL, 2011, NUCLEIC ACIDS RES, V39, P2045, DOI 10.1093/nar/gkq875; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067; Xiao YC, 2010, J ANDROL, V31, P365, DOI 10.2164/jandrol.109.009019	32	47	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54716	10.1371/journal.pone.0054716	http://dx.doi.org/10.1371/journal.pone.0054716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349955	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100092
J	Singh, AP; Sarkar, S; Tripathi, M; Rajender, S				Singh, Akhand Pratap; Sarkar, Saumya; Tripathi, Muktanand; Rajender, Singh			Mucuna pruriens and Its Major Constituent L-DOPA Recover Spermatogenic Loss by Combating ROS, Loss of Mitochondrial Membrane Potential and Apoptosis	PLOS ONE			English	Article							OXIDATIVE STRESS; ESTRADIOL TREATMENT; MALE-INFERTILITY; SPERM MOTILITY; ADULT-RAT; DAMAGE; UPDATE; TESTIS	Background: The Ayurvedic medicinal system claims Mucuna pruriens (MP) to possess pro-male fertility, aphrodisiac and adaptogenic properties. Some scientific evidence also supports its pro-male fertility properties; however, the mechanism of its action is not yet clear. The present study aimed at demonstrating spermatogenic restorative efficacy of MP and its major constituent L-DOPA (LD), and finding the possible mechanism of action thereof in a rat model. Methodology/Findings: Ethinyl estradiol (EE) was administered at a rate of 3 mg/kg body weight (BW)/day for a period of 14 days to generate a rat model with compromised spermatogenesis. MP and LD were administered in two separate groups of these animals starting 15th day for a period of 56 days, and the results were compared with an auto-recovery (AR) group. Sperm count and motility, testis histo-architecture, level of reactive oxygen species (ROS), mitochondrial membrane potential (MMP), apoptosis, peripheral hormone levels and testicular germ cell populations were analysed, in all experimental groups. We observed efficient and quick recovery of spermatogenesis in MP and LD groups in comparison to the auto-recovery group. The treatment regulated ROS level, apoptosis, and mitochondrial membrane potential (MMP), recovered the hypothalamic-pituitary-gonadal axis and the number of testicular germ cells, ultimately leading to increased sperm count and motility. Conclusion/Significance: M. pruriens efficiently recovers the spermatogenic loss induced due to EE administration. The recovery is mediated by reduction in ROS level, restoration of MMP, regulation of apoptosis and eventual increase in the number of germ cells and regulation of apoptosis. The present study simplified the complexity of mechanism involved and provided meaningful insights into MP/LD mediated correction of spermatogenic impairment caused by estrogens exposure. This is the first study demonstrating that L-DOPA largely accounts for pro-spermatogenic properties of M. pruriens. The manuscript bears CDRI communication number 8374.	[Singh, Akhand Pratap; Sarkar, Saumya; Tripathi, Muktanand; Rajender, Singh] Council Sci & Ind Res Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Rajender, S (corresponding author), Council Sci & Ind Res Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	rajender_singh@cdri.res.in	Singh, Rajender/ABE-3512-2020	Rajender, Singh/0000-0002-4592-6566; Sarkar, Saumya/0000-0003-2247-8796	Ministry of Health and Family Welfare, Government of India	Ministry of Health and Family Welfare, Government of India	This study was supported by financial grant from Ministry of Health and Family Welfare, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x; Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x; Ahmad MK, 2008, FERTIL STERIL, V90, P627, DOI 10.1016/j.fertnstert.2007.07.1314; [Anonymous], 1962, RAW MAT, V6, P47; [Anonymous], 1962, RAW MAT, V6, P337; [Anonymous], 1962, RAW MAT, V6, P220; [Anonymous], 1962, RAW MAT, V6, P439; Atanassova N, 1999, ENDOCRINOLOGY, V140, P5364, DOI 10.1210/en.140.11.5364; Atessahin A, 2006, REPROD TOXICOL, V21, P42, DOI 10.1016/j.reprotox.2005.05.003; Baumber J, 2000, J ANDROL, V21, P895; BlancoRodriguez J, 1997, J REPROD FERTIL, V110, P61, DOI 10.1530/jrf.0.1100061; BlancoRodriguez J, 1996, INT J ANDROL, V19, P237, DOI 10.1111/j.1365-2605.1996.tb00468.x; Carole M, 2002, HUM REPROD, V17, P1257; Chaki SP, 2006, APOPTOSIS, V11, P1427, DOI 10.1007/s10495-006-8761-4; Dama MS, 2011, J ANDROL; Daniel B, 1998, COVER CROPS HILLSIDE; Eduardo RP, 1998, CLIN CHEM, V44, P1616; GHOSAL S, 1971, PLANTA MED, V19, P279, DOI 10.1055/s-0028-1099642; Gow-Chin Yen, 1997, Bioscience, Biotechnology, and Biochemistry, V61, P1646; Gulcin I, 2007, AMINO ACIDS, V32, P431, DOI 10.1007/s00726-006-0379-x; Gupta N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022277; Iida Shigeru, 1997, Journal of Toxicological Sciences, V22, P397; Kasai T, 2002, ASIAN J ANDROL, V4, P97; Kazuki K, 2000, J AGR FOOD CHEM, V48, P844; King SR, 1992, DISCOVERY, V45, P23; Madhukar D, 2009, J ANDROL, V30, P95, DOI 10.2164/jandrol.108.005694; Masako K, 1999, REPROD TOXICOL, V13, P279; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; MEHTA JC, 1994, INDIAN J PHARM SCI, V6, P92; Nadzialek S, 2010, ENVIRON TOXICOL CHEM, V29, P881, DOI 10.1002/etc.100; Newbold RR, 2006, ENDOCRINOLOGY, V147, pS11, DOI 10.1210/en.2005-1164; PANIKKAR KR, 1987, PLANTA MED, P503, DOI 10.1055/s-2006-962789; Peter S, 2001, J CELL SCI, V114, P1665; Prakash D, 2001, INT J FOOD SCI NUTR, V52, P79, DOI 10.1080/09637480020027264; Sharma BK, 2012, NOVEL SCI INT J PHAR, V1, P308; Shukla KK, 2011, REPROD BIOMED ONLINE, V22, P421, DOI 10.1016/j.rbmo.2011.01.010; Shukla KK, 2009, FERTIL STERIL, V92, P1934, DOI 10.1016/j.fertnstert.2008.09.045; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Suresh S, 2010, J SEX MED; Suresh S, 2010, INT J ANDROL, V33, P22, DOI 10.1111/j.1365-2605.2008.00949.x; Suresh S, 2009, J ETHNOPHARMACOL, V122, P497, DOI 10.1016/j.jep.2009.01.032; Toshiko K, 2000, J TOXICOL SCI, V25, P43; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Volpe S, 2009, REPROD DOMEST ANIM, V44, P275, DOI 10.1111/j.1439-0531.2009.01457.x	44	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54655	10.1371/journal.pone.0054655	http://dx.doi.org/10.1371/journal.pone.0054655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349947	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100087
J	Zuo, H; Shi, ZM; Yuan, BJ; Dai, Y; Wu, GL; Hussain, A				Zuo, Hui; Shi, Zumin; Yuan, Baojun; Dai, Yue; Wu, Gaolin; Hussain, Akhtar			Association between Serum Leptin Concentrations and Insulin Resistance: A Population-Based Study from China	PLOS ONE			English	Article							BODY-MASS INDEX; PLASMA LEPTIN; WAIST CIRCUMFERENCE; FAT DISTRIBUTION; OBESITY; ADIPOSITY; WOMEN; ADIPONECTIN; DISEASE; WEIGHT	Background: Insulin resistance contributes to the cardio-metabolic risk. The effect of leptin in obese and overweight population on insulin resistance was seldom reported. Methods: A total of 1234 subjects (572 men and 662 women) aged >= 18 y was sampled by the procedure. Adiposity measures included BMI, waist circumference, hip circumference, WHR, upper arm circumference, triceps skinfold and body fat percentage. Serum leptin concentrations were measured by an ELISA method. The homeostasis model (HOMA-IR) was applied to estimate insulin resistance. Results: In men, BMI was the variable which was most strongly correlated with leptin, whereas triceps skinfold was most sensitive for women. More importantly, serum leptin levels among insulin resistant subjects were almost double compared to the subjects who had normal insulin sensitivity at the same level of adiposity in both men and women, after controlling for potential confounders. In addition, HOMA-IR increased significantly across leptin quintiles after adjustment for age, BMI, total energy intake, physical activity and smoking status in both men and women (p for trend <0.0001). Conclusions: There was a significant association between HOMA-IR and serum leptin concentrations in Chinese men and women, independently of adiposity levels. This may suggest that serum leptin concentration is an important predictor of insulin resistance and other metabolic risks irrespective of obesity levels. Furthermore, leptin levels may be used to identify the cardio-metabolic risk in obese and overweight population.	[Zuo, Hui; Yuan, Baojun; Dai, Yue; Wu, Gaolin] Jiangsu Prov Ctr Dis Control & Prevent, Dept Nutr & Food Hyg, Nanjing, Jiangsu, Peoples R China; [Zuo, Hui; Hussain, Akhtar] Univ Oslo, Fac Med, Inst Hlth & Soc, Dept Community Med, Oslo, Norway; [Shi, Zumin] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	Jiangsu Provincial Center for Disease Control & Prevention; University of Oslo; University of Adelaide	Zuo, H (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Nutr & Food Hyg, Nanjing, Jiangsu, Peoples R China.	huizuo97@gmail.com	Shi, Zumin/A-1093-2009; Zuo, Hui/G-4611-2011	Shi, Zumin/0000-0002-3099-3299; Zuo, Hui/0000-0003-3918-5754	Norwegian Research Council, Norway	Norwegian Research Council, Norway(Research Council of Norway)	This work was funded by the Norwegian Research Council, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Ceddia RB, 2002, FASEB J, V16, DOI 10.1096/fj.02-0158rev; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; Esteghamati A, 2010, METABOLISM, V59, P1730, DOI 10.1016/j.metabol.2010.04.016; Esteghamati A, 2009, METAB SYNDR RELAT D, V7, P447, DOI 10.1089/met.2008.0100; Haapala I, 2002, CLIN PHYSIOL FUNCT I, V22, P383, DOI 10.1046/j.1475-097X.2002.00447.x; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hu FB, 2001, INT J OBESITY, V25, P121, DOI 10.1038/sj.ijo.0801480; Huang KC, 2004, INT J OBESITY, V28, P470, DOI 10.1038/sj.ijo.0802531; Laddu D, 2011, NUTR CLIN PRACT, V26, P512, DOI 10.1177/0884533611418335; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; Mahabir S, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-3; Mally K, 2011, EUR J APPL PHYSIOL, V111, P1879, DOI 10.1007/s00421-010-1795-x; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mente A, 2010, DIABETES CARE, V33, P1629, DOI 10.2337/dc09-1392; Meyer MR, 2011, ACTA PHYSIOL, V203, P259, DOI 10.1111/j.1748-1716.2010.02237.x; Monti V, 2006, J AM DIET ASSOC, V106, P822, DOI 10.1016/j.jada.2006.03.015; Nakhjavani M, 2011, GYNECOL ENDOCRINOL, V27, P14, DOI 10.3109/09513590.2010.487583; Panahloo A, 1997, DIABETES, V46, P1340; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Reseland JE, 2005, PROSTAG LEUKOTR ESS, V73, P43, DOI 10.1016/j.plefa.2005.04.006; Ruhl CE, 2001, AM J CLIN NUTR, V74, P295; Ruige JB, 1999, DIABETES CARE, V22, P1097, DOI 10.2337/diacare.22.7.1097; Wang ZQ, 2010, DIABETES-METAB RES, V26, P109, DOI 10.1002/dmrr.1060; Yang Y, 2005, CHINESE FOOD COMPOSI; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao W, 2006, PUBLIC HEALTH NUTR, V5, P829; Zuo H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-247	33	63	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54615	10.1371/journal.pone.0054615	http://dx.doi.org/10.1371/journal.pone.0054615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349940	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100084
J	Jiang, ZY; Applegate, TJ; Lossie, AC				Jiang, Zhengyu; Applegate, Todd J.; Lossie, Amy C.			Cloning, Annotation and Developmental Expression of the Chicken Intestinal MUC2 Gene	PLOS ONE			English	Article							MOLECULAR-CLONING; C-TERMINUS; SEQUENCE; LAYERS; DOMAIN; DATABASE; COLITIS; CELLS; GLYCOSYLATION; COLLECTION	Intestinal mucin 2 (MUC2) encodes a heavily glycosylated, gel-forming mucin, which creates an important protective mucosal layer along the gastrointestinal tract in humans and other species. This first line of defense guards against attacks from microorganisms and is integral to the innate immune system. As a first step towards characterizing the innate immune response of MUC2 in different species, we report the cloning of a full-length, 11,359 bp chicken MUC2 cDNA, and describe the genomic organization and functional annotation of this complex, 74.5 kb locus. MUC2 contains 64 exons and demonstrates distinct spatiotemporal expression profiles throughout development in the gastrointestinal tract; expression increases with gestational age and from anterior to posterior along the gut. The chicken protein has a similar domain organization as the human orthologue, with a signal peptide and several von Willebrand domains in the N-terminus and the characteristic cystine knot at the C-terminus. The PTS domain of the chicken MUC2 protein spans similar to 1600 amino acids and is interspersed with four CysD motifs. However, the PTS domain in the chicken diverges significantly from the human orthologue; although the chicken domain is shorter, the repetitive unit is 69 amino acids in length, which is three times longer than the human. The amino acid composition shows very little similarity to the human motif, which potentially contributes to differences in the innate immune response between species, as glycosylation across this rapidly evolving domain provides much of the musical barrier. Future studies of the function of MUC2 in the innate immune response system in chicken could provide an important model organism to increase our understanding of the biological significance of MUC2 in host defense and highlight the potential of the chicken for creating new immune-based therapies.	[Jiang, Zhengyu; Applegate, Todd J.; Lossie, Amy C.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Lossie, Amy C.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington	Lossie, AC (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	alossie@purdue.edu	Lossie, Amy/D-2480-2009	Lossie, Amy/0000-0001-5078-7743; Applegate, Todd/0000-0002-2406-5058	Biomin Research Center, (Tulln, Austria); BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [MR/K001744/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish	Biomin Research Center, (Tulln, Austria); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded through state and federal funds appropriated to Purdue University, as well as through gift funds from Biomin Research Center, (Tulln, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Ambort D, 2011, BIOCHEM J, V436, P61, DOI 10.1042/BJ20102066; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Buisine MP, 1998, GUT, V43, P519, DOI 10.1136/gut.43.4.519; Burger-van Paassen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038798; Burger-van Paassen N, 2011, AM J PHYSIOL-GASTR L, V301, pG667, DOI 10.1152/ajpgi.00199.2010; Byrne CM, 2007, MICROBIOL-SGM, V153, P561, DOI 10.1099/mic.0.2006/000711-0; CHAMBERS JA, 1994, J CELL SCI, V107, P413; Collier CT, 2008, VET IMMUNOL IMMUNOP, V122, P104, DOI 10.1016/j.vetimm.2007.10.014; Desseyn JL, 2008, GENE, V410, P215, DOI 10.1016/j.gene.2007.12.014; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Escande F, 2004, BBA-GENE STRUCT EXPR, V1676, P240, DOI 10.1016/j.bbaexp.2004.01.001; Galperin MY, 2009, NUCLEIC ACIDS RES, V37, pD1, DOI 10.1093/nar/gkn942; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; GUM JR, 1989, J BIOL CHEM, V264, P6480; GUM JR, 1994, J BIOL CHEM, V269, P2440; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hoorens PR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-140; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jeong YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001163; Jiang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022691; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Karcher DM, 2009, GROWTH HORM IGF RES, V19, P31, DOI 10.1016/j.ghir.2008.05.003; Karlsson NG, 1996, GLYCOCONJUGATE J, V13, P823, DOI 10.1007/BF00702346; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lang TG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-197; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; Lu P, 2011, INFLAMM BOWEL DIS, V17, P2047, DOI 10.1002/ibd.21592; Matsuoka Y, 1999, BBA-GENE STRUCT EXPR, V1489, P336, DOI 10.1016/S0167-4781(99)00186-4; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sternberg LR, 2004, ARCH BIOCHEM BIOPHYS, V421, P21, DOI 10.1016/j.abb.2003.10.002; TAM PY, 1981, NATURE, V292, P340, DOI 10.1038/292340a0; Uni Z, 2003, POULTRY SCI, V82, P320, DOI 10.1093/ps/82.2.320; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; Watanabe K, 2004, DNA SEQUENCE, V15, P251, DOI 10.1080/10425170410001723921; Xu GQ, 2000, EUR J BIOCHEM, V267, P2998, DOI 10.1046/j.1432-1327.2000.01319.x	51	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53781	10.1371/journal.pone.0053781	http://dx.doi.org/10.1371/journal.pone.0053781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349743	Green Published, Green Submitted, gold			2022-12-27	WOS:000313943000017
J	Munang'andu, HM; Sandtro, A; Mutoloki, S; Brudeseth, BE; Santi, N; Evensen, O				Munang'andu, Hetron M.; Sandtro, Ane; Mutoloki, Stephen; Brudeseth, Bjorn E.; Santi, Nina; Evensen, Oystein			Immunogenicity and Cross Protective Ability of the Central VP2 Amino Acids of Infectious Pancreatic Necrosis Virus in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; BROOK TROUT; AQUATIC BIRNAVIRUSES; CARRIER STATE; PROTEIN VP2; VIRULENCE; VACCINE; CHALLENGE; STRAIN; IPNV	Infectious pancreatic necrosis virus (IPNV) is a member of the family Birnaviridae that has been linked to high mortalities in juvenile salmonids and postsmolt stages of Atlantic salmon (Salmo salar L.) after transfer to seawater. IPN vaccines have been available for a long time but their efficacy has been variable. The reason for the varying immune response to these vaccines has not well defined and studies on the importance of using vaccine trains homologous to the virulent field strain has not been conclusive. In this study we prepared one vaccine identical to the virulent Norwegian Sp strain NVI-015 (NCBI: 379740) (T(217)A(221)T(247) of VP2) and three other vaccine strains developed using the same genomic backbone altered by reverse genetics at three residues yielding variants, T217T221T247, P(217)A(221)A(24)7, P(217)T(221)A(247). These 4 strains, differing in these three positions only, were used as inactivated, oil-adjuvanted vaccines while two strains, T(217)A(221)T(247) and P(217)T(221)A(247), were used as live vaccines. The results show that these three residues of the VP2 capsid play a key role for immunogenicity of IPNV vaccines. The virulent strain for inactivated vaccines elicited the highest level of virus neutralization (VN) titers and ELISA antibodies. Interestingly, differences in immunogenicity were not reflected in differences in post challenge survival percentages (PCSP) for oil-adjuvanted, inactivated vaccines but clearly so for live vaccines (TAT and PTA). Further post challenge viral carrier state correlated inversely with VN titers at challenge for inactivated vaccines and prevalence of pathology in target organs inversely correlated with protection for live vaccines. Overall, our findings show that a few residues localized on the VP2-capsid are important for immunogenicity of IPNV vaccines.	[Munang'andu, Hetron M.; Sandtro, Ane; Mutoloki, Stephen; Evensen, Oystein] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Brudeseth, Bjorn E.] PHARMAQ AS, Oslo, Norway; [Santi, Nina] AquaGen, Trondheim, Norway	Norwegian University of Life Sciences	Evensen, O (corresponding author), Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	oystein.evensen@nvh.no	Munang'andu, Hetron Mweemba/C-5926-2014; Evensen, Øystein/O-3011-2015	Munang'andu, Hetron Mweemba/0000-0002-1021-6396; Evensen, Øystein/0000-0002-4856-3043	Research Council of Norway [183204]	Research Council of Norway(Research Council of Norway)	This work was performed with financial support from the Research Council of Norway, project no. 183204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audibert F, 2003, INT IMMUNOPHARMACOL, V3, P1187, DOI 10.1016/S1567-5769(03)00011-0; Bain N, 2008, J FISH DIS, V31, P37, DOI 10.1111/j.1365-2761.2007.00864.x; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Biering E, 2005, DEV BIOLOGICALS, V121, P97; BOOTLAND LM, 1991, DIS AQUAT ORGAN, V10, P13, DOI 10.3354/dao010013; BOOTLAND LM, 1986, VET IMMUNOL IMMUNOP, V12, P365, DOI 10.1016/0165-2427(86)90142-X; BROOME C V, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P219; Bruslind LD, 2000, J AQUAT ANIM HEALTH, V12, P301, DOI 10.1577/1548-8667(2000)012&lt;0301:VCOTBS&gt;2.0.CO;2; Calhoun K, 2011, ARCH PATHOL LAB MED, V135, P207, DOI 10.1043/1543-2165-135.2.207; CASWELLRENO P, 1989, J CLIN MICROBIOL, V27, P1924, DOI 10.1128/JCM.27.9.1924-1929.1989; Coulibaly F, 2010, J VIROL, V84, P1792, DOI 10.1128/JVI.01536-09; DAVIES JR, 1989, EPIDEMIOL INFECT, V102, P325, DOI 10.1017/S0950268800030004; DOBOS P, 1977, J VIROL, V24, P805, DOI 10.1128/JVI.24.3.805-820.1977; DOBOS P, 1976, NUCLEIC ACIDS RES, V3, P1903, DOI 10.1093/nar/3.8.1903; DOBOS P, 1983, CAN J MICROBIOL, V29, P377, DOI 10.1139/m83-062; DOMINGUEZ J, 1990, DIS AQUAT ORGAN, V8, P157, DOI 10.3354/dao008157; Evensen O, 1990, J Vet Diagn Invest, V2, P288; Evensen O., 2008, ENCY VIROLOGY, P83, DOI DOI 10.1016/B978-012374410-4.00772-X; FROST P, 1995, J GEN VIROL, V76, P1165, DOI 10.1099/0022-1317-76-5-1165; Gomez-Casado E, 2011, VACCINE, V29, P2657, DOI 10.1016/j.vaccine.2011.01.097; GOODEVE A, 1983, J HYG-CAMBRIDGE, V90, P107, DOI 10.1017/S0022172400063907; Gudding R, 1999, VET IMMUNOL IMMUNOP, V72, P203, DOI 10.1016/S0165-2427(99)00133-6; HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019; HEPPELL J, 1995, VIROLOGY, V214, P40, DOI 10.1006/viro.1995.9956; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; LIAO L, 1995, VIROLOGY, V209, P684, DOI 10.1006/viro.1995.1304; MASUREL N, 1984, J HYG-CAMBRIDGE, V92, P263, DOI 10.1017/S0022172400064500; MEIKLEJOHN G, 1952, AM J HYG, V55, P12, DOI 10.1093/oxfordjournals.aje.a119500; MELBY HP, 1994, J FISH DIS, V17, P409, DOI 10.1111/j.1365-2761.1994.tb00236.x; Melby HP, 1995, J FISH DIS, V18, P579, DOI 10.1111/j.1365-2761.1995.tb00362.x; Munang'andu HM, 2012, VACCINE, V30, P4007, DOI 10.1016/j.vaccine.2012.04.039; Mutoloki S, 2011, J GEN VIROL, V92, P1721, DOI 10.1099/vir.0.030270-0; Santi N, 2005, VIROLOGY, V342, P13, DOI 10.1016/j.virol.2005.07.028; Santi N, 2005, J VIROL, V79, P9206, DOI 10.1128/JVI.79.14.9206-9216.2005; Santi N, 2004, VIROLOGY, V322, P31, DOI 10.1016/j.virol.2003.12.016; Skjesol A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-396; Song HC, 2005, J VIROL, V79, P10289, DOI 10.1128/JVI.79.16.10289-10299.2005; TARRAB E, 1993, J GEN VIROL, V74, P2025, DOI 10.1099/0022-1317-74-9-2025; TARRAB E, 1995, J GEN VIROL, V76, P551, DOI 10.1099/0022-1317-76-3-551; WOLSKI SC, 1986, VET IMMUNOL IMMUNOP, V12, P373, DOI 10.1016/0165-2427(86)90143-1; Yao K, 1998, J VIROL, V72, P8913, DOI 10.1128/JVI.72.11.8913-8920.1998	42	27	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54263	10.1371/journal.pone.0054263	http://dx.doi.org/10.1371/journal.pone.0054263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349841	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000033
J	Rish, I; Cecchi, G; Thyreau, B; Thirion, B; Plaze, M; Paillere-Martinot, ML; Martelli, C; Martinot, JL; Poline, JB				Rish, Irina; Cecchi, Guillermo; Thyreau, Benjamin; Thirion, Bertrand; Plaze, Marion; Paillere-Martinot, Marie Laure; Martelli, Catherine; Martinot, Jean-Luc; Poline, Jean-Baptiste			Schizophrenia as a Network Disease: Disruption of Emergent Brain Function in Patients with Auditory Hallucinations	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; CONNECTIVITY	Schizophrenia is a psychiatric disorder that has eluded characterization in terms of local abnormalities of brain activity, and is hypothesized to affect the collective, "emergent" working of the brain. Indeed, several recent publications have demonstrated that functional networks in the schizophrenic brain display disrupted topological properties. However, is it possible to explain such abnormalities just by alteration of local activation patterns? This work suggests a negative answer to this question, demonstrating that significant disruption of the topological and spatial structure of functional MRI networks in schizophrenia (a) cannot be explained by a disruption to area-based task-dependent responses, i.e. indeed relates to the emergent properties, (b) is global in nature, affecting most dramatically long-distance correlations, and (c) can be leveraged to achieve high classification accuracy (93%) when discriminating between schizophrenic vs control subjects based just on a single fMRI experiment using a simple auditory task. While the prior work on schizophrenia networks has been primarily focused on discovering statistically significant differences in network properties, this work extends the prior art by exploring the generalization (prediction) ability of network models for schizophrenia, which is not necessarily captured by such significance tests.	[Rish, Irina; Cecchi, Guillermo] IBM Corp, TJ Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA; [Thyreau, Benjamin; Thirion, Bertrand; Poline, Jean-Baptiste] CEA Saclay, Neurospin, Saclay, France; [Thirion, Bertrand] INRIA Saclay Ile de France, EPI Parietal, Saclay, France; [Plaze, Marion; Martinot, Jean-Luc] Univ Paris Sud, INSERM, CEA, U797 Neuroimaging & Psychiat SHFJ, Orsay, France; [Plaze, Marion; Martinot, Jean-Luc] Neurospin, Orsay, France; [Paillere-Martinot, Marie Laure] Univ Paris 05, Cochin Hosp, AP HP, Adolescent Psychopathol & Med Dept Maison de Sole, Paris, France; [Martelli, Catherine] Ctr Hosp Paul Brousse, Dept Psychiat & Addictol, Villejuif, France	International Business Machines (IBM); CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Rish, I (corresponding author), IBM Corp, TJ Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA.	rish@us.ibm.com	Martinot, Jean-Luc/N-3704-2018	Plaze, Marion/0000-0001-9022-4945	INSERM [RBM 01-26]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We would like to thank Rahul Garg for his help with the data preprocessing and many stimulating discussions that contributed to the ideas of this paper, and Drs. Andre Galinowski, Thierry Gallarda, and Frank Bellivier who recruited and clinically rated the patients. We also would like to thank INSERM as promotor of the MR data acquired (project RBM 01-26).	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Banerjee O, 2008, J MACH LEARN RES, V9, P485; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Benedetti F, 2010, GENES BRAIN BEHAV, V9, P365, DOI 10.1111/j.1601-183X.2010.00566.x; Bleuler E., 1911, DEMENTIA PRAECOX GRO; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Braun P, 2008, P NATL ACAD SCI USA, V105, P9849, DOI 10.1073/pnas.0805644105; Burkard TR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-17; Cecchi G, 2009, P NIPS 09; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garg R, 2011, NEUROIMAGE, V58, P416, DOI 10.1016/j.neuroimage.2011.02.074; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Haken H., 2002, BRAIN DYNAMICS; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kircher TTJ, 2005, BRIT J PSYCHIAT, V186, P209, DOI 10.1192/bjp.186.3.209; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Mandl RCW, 2010, SCHIZOPHRENIA BULL, V36, P778, DOI 10.1093/schbul/sbn161; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Plaze M, 2006, SCHIZOPHR RES, V87, P109, DOI 10.1016/j.schres.2006.05.005; Rish I, 2012, P SPIE MED IM 2012; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Storkey A. J., 2007, ADV NEURAL INFORM PR, V19, P1329; Thirion B, 2006, HUM BRAIN MAPP, V27, P678, DOI 10.1002/hbm.20210; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; WERNICKE C, 1906, GRUNDRISSE PSYCHIAT; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Yu QB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025423; Zhang L., 2006, ADV NEURAL INF PROCE, V18, P1593; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	37	23	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e50625	10.1371/journal.pone.0050625	http://dx.doi.org/10.1371/journal.pone.0050625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349665	Green Submitted, Green Published, gold			2022-12-27	WOS:000313943000002
J	Dong, B; Wang, AX; Yuan, LH; Chen, LS; Pu, KF; Duan, W; Yan, XY; Zhu, YM				Dong, Bing; Wang, Anxin; Yuan, Lihua; Chen, Lisha; Pu, Kefeng; Duan, Wei; Yan, Xiyun; Zhu, Yimin			Peptide-Fluorescent Bacteria Complex as Luminescent Reagents for Cancer Diagnosis	PLOS ONE			English	Article							FROZEN-SECTION; THERAPY; EXPRESSION; DELIVERY; CELLS	Currently in clinic, people use hematoxylin and eosin stain (H&E stain) and immunohistochemistry methods to identify the generation and genre of cancers for human pathological samples. Since these methods are inaccurate and time consuming, developing a rapid and accurate method to detect cancer is urgently demanded. In our study, binding peptides for lung cancer cell line A549 were identified using bacteria surface display method. With those binding peptides for A549 cells on the surface, the fluorescent bacteria (Escherichia coli with stably expressed green fluorescent protein) were served as specific detecting reagents for the diagnosis of cancers. The binding activity of peptide-fluorescent bacteria complex was confirmed by detached cancer cells, attached cancer cells and mice tumor xenograft samples. A unique fixation method was developed for peptide-bacteria complex in order to make this complex more feasible for the clinic use. This peptide-fluorescent bacteria complex has great potential to become a new diagnostic tool for clinical application.	[Dong, Bing; Wang, Anxin; Yuan, Lihua; Chen, Lisha; Pu, Kefeng; Zhu, Yimin] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed, Suzhou Key Lab Nanobiomed, Suzhou, Jiangsu, Peoples R China; [Dong, Bing; Wang, Anxin; Chen, Lisha; Pu, Kefeng; Yan, Xiyun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Duan, Wei] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia	Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Deakin University	Zhu, YM (corresponding author), Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed, Suzhou Key Lab Nanobiomed, Suzhou, Jiangsu, Peoples R China.	ymzhu2008@sinano.ac.cn	Duan, Wei/A-5181-2015; Wang, Anxin/AAF-6657-2019; Chen, Lisha/HGC-6247-2022	Duan, Wei/0000-0001-5782-9184; 	National Natural Science Foundation of China [30870683, 81171451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China( No.30870683 and 81171451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshirpour Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031881; Bessette PH, 2004, PROTEIN ENG DES SEL, V17, P731, DOI 10.1093/protein/gzh084; Bidwell GL, 2012, THER DELIV, V3, P609, DOI 10.4155/TDE.12.37; Bonaccorsi Silvia, 2011, Cold Spring Harb Protoc, V2011, P1270, DOI 10.1101/pdb.prot065763; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; Brown MV, 2012, GENOME MED, V4, DOI 10.1186/gm332; Cronin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030940; Dane KY, 2006, J IMMUNOL METHODS, V309, P120, DOI 10.1016/j.jim.2005.11.021; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Esposito CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024071; Feng SP, 2011, NUCLEIC ACIDS RES, V39, P6669, DOI 10.1093/nar/gkr232; FRANCISCO JA, 1993, P NATL ACAD SCI USA, V90, P10444, DOI 10.1073/pnas.90.22.10444; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Gao YZ, 2009, CARCINOGENESIS, V30, P2064, DOI 10.1093/carcin/bgp283; Graham MM, 2011, J NUCL MED, V52, p56S, DOI 10.2967/jnumed.110.085746; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heatley MK, 2012, INT J GYNECOL PATHOL, V31, P111, DOI 10.1097/PGP.0b013e318226043b; Liu GJ, 2010, BIOMATERIALS, V31, P7575, DOI 10.1016/j.biomaterials.2010.06.021; Mace E, 2011, NAT METHODS, V8, P662, DOI [10.1038/nmeth.1641, 10.1038/NMETH.1641]; Pichler BJ, 2010, J NUCL MED, V51, P333, DOI 10.2967/jnumed.109.061853; PUCHTLER H, 1986, HISTOCHEMISTRY, V85, P353, DOI 10.1007/BF00982665; Qu DZ, 2011, ANAL BIOCHEM, V417, P112, DOI 10.1016/j.ab.2011.05.037; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shi H, 2011, P NATL ACAD SCI USA, V108, P3900, DOI 10.1073/pnas.1016197108; Singh B, 2011, ORAL ONCOL, V47, pS70, DOI 10.1016/j.oraloncology.2011.06.235; Stahl S, 1997, TRENDS BIOTECHNOL, V15, P185, DOI 10.1016/S0167-7799(97)01034-2; Suzuki Y, 2008, MAGN RESON MED, V60, P1269, DOI 10.1002/mrm.21816; van Essen HF, 2010, J CLIN PATHOL, V63, P1090, DOI 10.1136/jcp.2010.079905; Wang F, 2010, ANALYST, V135, P1839, DOI 10.1039/c0an00144a; Wernerus H, 2004, BIOTECHNOL APPL BIOC, V40, P209; Xu RX, 2010, EXPERT REV MED DEVIC, V7, P303, DOI [10.1586/erd.10.9, 10.1586/ERD.10.9]; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yildiz-Aktas IZ, 2012, AM J CLIN PATHOL, V137, P691, DOI 10.1309/AJCPQRAG67GJRPMT	34	11	11	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54467	10.1371/journal.pone.0054467	http://dx.doi.org/10.1371/journal.pone.0054467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349898	gold, Green Submitted, Green Published			2022-12-27	WOS:000313872800056
J	Kits, JH; Marshall, SA; Skevington, JH				Kits, Joel H.; Marshall, Stephen A.; Skevington, Jeffrey H.			Phylogeny of the Archiborborinae (Diptera: Sphaeroceridae) Based on Combined Morphological and Molecular Analysis	PLOS ONE			English	Article							NORTH-AMERICA; INFERENCE; MRBAYES; GENUS; AMPLIFICATION; EVOLUTION; APTILOTUS; PRIMERS; INSECTA; UTILITY	The Archiborborinae is a diverse Neotropical subfamily of Sphaeroceridae, with many undescribed species. The existing generic classification includes three genera consisting of brachypterous species, with all other species placed in the genus Archiborborus. We present the first phylogenetic hypothesis for the subfamily based on morphological, molecular, and combined datasets. Morphological data include 53 characters and cover all valid described taxa (33 species in 4 genera) in the subfamily, as well as 83 undescribed species. Molecular data for five genes (mitochondrial 12S rDNA, cytochrome c oxidase subunit I, and cytochrome B, and nuclear alanyl-tRNA synthetase and 28S rDNA) were obtained for 21 ingroup taxa. Data support the separation of the Archiborborinae from the Copromyzinae, with which they were formerly combined. Analyses support consistent groups within the subfamily, but relationships between groups are poorly resolved. The validity of the brachypterous genera Penola Richards and Frutillaria Richards is supported. The former genus Archiborborus Duda is paraphyletic, and will be divided into monophyletic genera on the basis of this work. Aptery and brachyptery have evolved multiple times in the subfamily. Antrops Enderlein, previously including a single brachypterous species, is a senior synonym of Archiborborus.	[Kits, Joel H.; Marshall, Stephen A.] Univ Guelph, Sch Environm Sci, Insect Collect & Insect Systemat Lab, Guelph, ON N1G 2W1, Canada; [Skevington, Jeffrey H.] Agr & Agri Food Canada, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Skevington, Jeffrey H.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of Guelph; Agriculture & Agri Food Canada; Carleton University	Kits, JH (corresponding author), Univ Guelph, Sch Environm Sci, Insect Collect & Insect Systemat Lab, Guelph, ON N1G 2W1, Canada.	joel.kits@gmail.com			NSERC; Dipterology Fund; Agriculture and Agri-Food Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dipterology Fund; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	Funding was provided by NSERC (http://www.nserc-crsng.gc.ca/) discovery grants to S. A. M., O. G. S. (http://www.tcu.gov.on.ca/) and NSERC postgraduate scholarships to J. H. K., and a grant from the Dipterology Fund (http://www.nadsdiptera.org/DipFund/Fundhome.htm) to J. H. K. Sequencing was supported by funding to J. H. S. by Agriculture and Agri-Food Canada (http://www.agr.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2012, SYSTEMATIC IN PRESS; Bertone MA, 2008, SYST ENTOMOL, V33, P668, DOI 10.1111/j.1365-3113.2008.00437.x; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Drummond A.J., 2007, TRACER VERSION 15; Fan Y, 2011, MOL BIOL EVOL, V28, P523, DOI 10.1093/molbev/msq224; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibson JF, 2011, ANN ENTOMOL SOC AM, V104, P976, DOI 10.1603/AN10153; Gibson JF, 2010, MOL PHYLOGENET EVOL, V56, P1126, DOI 10.1016/j.ympev.2010.05.005; Gibson JF, 2010, MOL PHYLOGENET EVOL, V56, P91, DOI 10.1016/j.ympev.2010.03.026; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; HACKMAN W, 1969, Notulae Entomologicae, V49, P193; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han HY, 2005, MOL PHYLOGENET EVOL, V34, P416, DOI 10.1016/j.ympev.2004.10.017; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kits JH, 2011, ZOOTAXA, P1; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lewis PO, 2010, PHYCAS SOFTWARE PHYL; MARSHALL SA, 1990, CAN J ZOOL, V68, P2338, DOI 10.1139/z90-325; MARSHALL SA, 1983, CAN J ZOOL, V61, P1910, DOI 10.1139/z83-248; Marshall SA, 1997, P ENTOMOL SOC WASH, V99, P279; Marshall Steve A., 1996, Studia Dipterologica, V3, P283; McAlpine DK, 2007, RECORDS AUSTR MUSEUM, V59, P1; Miller M.A., 2010, P GAT COMP ENV WORKS; NORRBOM AL, 1985, SYST ENTOMOL, V10, P167, DOI 10.1111/j.1365-3113.1985.tb00527.x; NORRBOM AL, 1984, P ENTOMOL SOC WASH, V86, P305; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richards O. W., 1961, Proceedings of the Royal Entomological Society of London (B), V30, P57; Richards O. W., 1941, BRIT MUS [NAT HIST] BRIT GRAHAM LAND EXPED 1934 37 SCI REPTS, V1, P323; ROHACEK J, 2001, WORLD CATALOGUE SPHA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065; Winkler IS, 2010, MOL PHYLOGENET EVOL, V54, P746, DOI 10.1016/j.ympev.2009.12.016	40	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e51190	10.1371/journal.pone.0051190	http://dx.doi.org/10.1371/journal.pone.0051190			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349671	gold, Green Published			2022-12-27	WOS:000313872800002
J	Wu, YY; Wang, K; Karapetyan, A; Fernando, WA; Simkin, J; Han, MJ; Rugg, EL; Muneoka, K				Wu, Yuanyuan; Wang, Karen; Karapetyan, Adrine; Fernando, Warnakulusuriya Akash; Simkin, Jennifer; Han, Manjong; Rugg, Elizabeth L.; Muneoka, Ken			Connective Tissue Fibroblast Properties Are Position-Dependent during Mouse Digit Tip Regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LIMB REGENERATION; COLLAGEN-MATRIX; FOOT SCALES; EXPRESSION; AMPUTATION; DIFFERENTIATION; MORPHOGENESIS; CONTRACTION; FINGER	A key factor that contributes to the regenerative ability of regeneration-competent animals such as the salamander is their use of innate positional cues that guide the regeneration process. The limbs of mammals has severe regenerative limitations, however the distal most portion of the terminal phalange is regeneration competent. This regenerative ability of the adult mouse digit is level dependent: amputation through the distal half of the terminal phalanx (P3) leads to successful regeneration, whereas amputation through a more proximal location, e. g. the subterminal phalangeal element (P2), fails to regenerate. Do the connective tissue cells of the mammalian digit play a role similar to that of the salamander limb in controlling the regenerative response? To begin to address this question, we isolated and cultured cells of the connective tissue surrounding the phalangeal bones of regeneration competent (P3) and incompetent (P2) levels. Despite their close proximity and localization, these cells show very distinctive profiles when characterized in vitro and in vivo. In vitro studies comparing their proliferation and position-specific interactions reveal that cells isolated from the P3 and P2 are both capable of organizing and differentiating epithelial progenitors, but with different outcomes. The difference in interactions are further characterized with three-dimension cultures, in which P3 regenerative cells are shown to lack a contractile response that is seen in other fibroblast cultures, including the P2 cultures. In in vivo engraftment studies, the difference between these two cell lines is made more apparent. While both P2 and P3 cells participated in the regeneration of the terminal phalanx, their survival and proliferative indices were distinct, thus suggesting a key difference in their ability to interact within a regeneration permissive environment. These studies are the first to demonstrate distinct positional characteristics of connective tissue cells that are associated with their regenerative capabilities.	[Wu, Yuanyuan; Wang, Karen; Fernando, Warnakulusuriya Akash; Simkin, Jennifer; Han, Manjong; Muneoka, Ken] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Karapetyan, Adrine; Rugg, Elizabeth L.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA	Tulane University; University of California System; University of California Irvine	Muneoka, K (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	kmuneoka@tulane.edu		Simkin, Jennifer/0000-0002-6122-4222; Muneoka, Ken/0000-0002-7520-6869	United States National Institutes of Health [(NIH)-R01HD043277]; Tulane University;  [DARPA-W911NF-06-1-0161];  [ARO-W911NF0910305]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043277] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding was provided by United States National Institutes of Health (NIH)-R01HD043277, DARPA-W911NF-06-1-0161, ARO-W911NF0910305 and the John L. and Mary Wright Ebaugh Endowment Fund at Tulane University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Bryant SV, 2002, INT J DEV BIOL, V46, P887; Carlson MA, 2004, WOUND REPAIR REGEN, V12, P134, DOI 10.1111/j.1067-1927.2004.012208.x; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Civin CI, 1996, BLOOD, V88, P4102, DOI 10.1182/blood.V88.11.4102.bloodjournal88114102; DHOUAILLY D, 1980, J EMBRYOL EXP MORPH, V58, P63; DOUGLAS BS, 1972, AUST PAEDIATR J, V8, P86; DUNIS DA, 1977, DEV BIOL, V56, P97, DOI 10.1016/0012-1606(77)90157-9; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Gardiner DM, 2005, REJUV RES, V8, P141, DOI 10.1089/rej.2005.8.141; GARDINER DM, 1986, DEV BIOL, V118, P488, DOI 10.1016/0012-1606(86)90020-5; Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Han Manjong, 2005, Anatomical Record Part B:The New Anatomist, V287, P14, DOI 10.1002/ar.b.20082; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Ide H, 2012, DEV DYNAM, V241, P435, DOI 10.1002/dvdy.23728; ILLINGWORTH CM, 1974, J PEDIATR SURG, V9, P853, DOI 10.1016/S0022-3468(74)80220-4; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kanzler B, 1997, DEV DYNAM, V210, P274, DOI 10.1002/(SICI)1097-0177(199711)210:3<274::AID-AJA8>3.0.CO;2-D; Kaur P, 2000, J INVEST DERMATOL, V114, P413, DOI 10.1046/j.1523-1747.2000.00884.x; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; Margulis A, 2004, METH MOL B, V289, P61; Masaki H, 2007, DEV GROWTH DIFFER, V49, P89, DOI 10.1111/j.1440-169X.2007.00909.x; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Montel V, 2005, AM J PATHOL, V166, P1565, DOI 10.1016/S0002-9440(10)62372-3; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Muller TL, 1999, SEMIN CELL DEV BIOL, V10, P405, DOI 10.1006/scdb.1999.0327; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Muneoka Ken, 2008, Birth Defects Research, V84, P265, DOI 10.1002/bdrc.20137; NAMENWIRTH M, 1974, DEV BIOL, V41, P42, DOI 10.1016/0012-1606(74)90281-4; Neufeld Daniel A., 1995, Wound Repair and Regeneration, V3, P461, DOI 10.1046/j.1524-475X.1995.30410.x; Ngo P, 2006, METH MOL B, V341, P103; Ngo-Muller V, 2000, METH MOL B, V135, P481; Ngo-Muller V, 2000, DEV BIOL, V219, P224, DOI 10.1006/dbio.2000.9612; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okamoto H, 2006, J DERMATOL SCI, V44, P175, DOI 10.1016/j.jdermsci.2006.08.006; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; REVARDEL JL, 1987, CAN J ZOOL, V65, P3166, DOI 10.1139/z87-475; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; SINGER M, 1987, ANAT EMBRYOL, V177, P29, DOI 10.1007/BF00325287; Skalli O, 1988, MOL CELLULAR BIOL WO, P373; Stark Hans-Jurgen, 2004, Biol Proced Online, V6, P55, DOI 10.1251/bpo72; Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x; Stocum DL, 2008, DEV DYNAM, V237, P3648, DOI 10.1002/dvdy.21774; Stocum DL, 2004, CURR TOP MICROBIOL, V280, P1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Turksen K, 2005, EPIDERMAL CELLS; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; Widelitz RB, 2000, DEV BIOL, V219, P98, DOI 10.1006/dbio.1999.9580; Yamaguchi Y, 2001, J DERMATOL, V28, P521, DOI 10.1111/j.1346-8138.2001.tb00025.x; Yamaguchi Y, 2001, ARCH DERMATOL, V137, P621; Yamaguchi Y, 2005, J DERMATOL SCI, V40, P1, DOI 10.1016/j.jdermsci.2005.04.006; Yamaguchi Y, 1999, J INVEST DERMATOL, V112, P483, DOI 10.1046/j.1523-1747.1999.00544.x; Yu L, 2012, DEV BIOL; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424	65	48	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54764	10.1371/journal.pone.0054764	http://dx.doi.org/10.1371/journal.pone.0054764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349966	Green Published, gold			2022-12-27	WOS:000313872800076
J	Chen, XL; Shen, YP; Gao, YH; Zhao, HZ; Sheng, XM; Zou, JZ; Lip, V; Xie, H; Guo, J; Shao, H; Bao, YH; Shen, JL; Niu, B; Gusella, JF; Wu, BL; Zhang, T				Chen, Xiaoli; Shen, Yiping; Gao, Yonghui; Zhao, Huizhi; Sheng, Xiaoming; Zou, Jizhen; Lip, Va; Xie, Hua; Guo, Jin; Shao, Hong; Bao, Yihua; Shen, Jianliang; Niu, Bo; Gusella, James F.; Wu, Bai-Lin; Zhang, Ting			Detection of Copy Number Variants Reveals Association of Cilia Genes with Neural Tube Defects	PLOS ONE			English	Article							CELL POLARITY GENE; HIGH-RISK AREA; SHANXI PROVINCE; HIGH PREVALENCE; ARRAY CGH; MUTATIONS; POLYMORPHISMS; AUTOPSY; SUSCEPTIBILITY; IDENTIFICATION	Background: Neural tube defects (NTDs) are one of the most common birth defects caused by a combination of genetic and environmental factors. Currently, little is known about the genetic basis of NTDs although up to 70% of human NTDs were reported to be attributed to genetic factors. Here we performed genome-wide copy number variants (CNVs) detection in a cohort of Chinese NTD patients in order to exam the potential role of CNVs in the pathogenesis of NTDs. Methods: The genomic DNA from eighty-five NTD cases and seventy-five matched normal controls were subjected for whole genome CNVs analysis. Non-DGV (the Database of Genomic Variants) CNVs from each group were further analyzed for their associations with NTDs. Gene content in non-DGV CNVs as well as participating pathways were examined. Results: Fifty-five and twenty-six non-DGV CNVs were detected in cases and controls respectively. Among them, forty and nineteen CNVs involve genes (genic CNV). Significantly more non-DGV CNVs and non-DGV genic CNVs were detected in NTD patients than in control (41.2% vs. 25.3%, p<0.05 and 37.6% vs. 20%, p<0.05). Non-DGV genic CNVs are associated with a 2.65-fold increased risk for NTDs (95% CI: 1.24-5.87). Interestingly, there are 41 cilia genes involved in non-DGV CNVs from NTD patients which is significantly enriched in cases compared with that in controls (24.7% vs. 9.3%, p<0.05), corresponding with a 3.19-fold increased risk for NTDs (95% CI: 1.27-8.01). Pathway analyses further suggested that two ciliogenesis pathways, tight junction and protein kinase A signaling, are top canonical pathways implicated in NTD-specific CNVs, and these two novel pathways interact with known NTD pathways. Conclusions: Evidence from the genome-wide CNV study suggests that genic CNVs, particularly ciliogenic CNVs are associated with NTDs and two ciliogenesis pathways, tight junction and protein kinase A signaling, are potential pathways involved in NTD pathogenesis.	[Chen, Xiaoli; Gao, Yonghui; Zhao, Huizhi; Xie, Hua; Guo, Jin; Bao, Yihua; Zhang, Ting] Capital Inst Pediat, Beijing, Peoples R China; [Chen, Xiaoli; Shen, Yiping; Sheng, Xiaoming; Lip, Va; Shao, Hong; Wu, Bai-Lin] Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA; [Chen, Xiaoli; Shen, Yiping; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Shen, Yiping] Jiao Tong Univ, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China; [Shen, Yiping; Gusella, James F.; Wu, Bai-Lin] Harvard Univ, Sch Med, Boston, MA USA; [Gao, Yonghui] China Acad Chinese Med Sci, Inst Acumoxibust, Beijing, Peoples R China; [Zou, Jizhen] Capital Inst Pediat, Dept Pathol, Beijing, Peoples R China; [Shen, Jianliang] Navy Gen Hosp PLA, Dept Hematol, Beijing, Peoples R China; [Niu, Bo] Capital Inst Pediat, Dept Biotechnol, Beijing, Peoples R China; [Wu, Bai-Lin] Fudan Univ, Shanghai Med Coll, Childrens Hosp, Shanghai 200433, Peoples R China; [Wu, Bai-Lin] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Capital Institute of Pediatrics (CIP); Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Shanghai Jiao Tong University; Harvard University; Harvard Medical School; China Academy of Chinese Medical Sciences; Capital Institute of Pediatrics (CIP); Sixth Medical Center of Chinese PLA General Hospital; Capital Institute of Pediatrics (CIP); Fudan University; Fudan University	Wu, BL (corresponding author), Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA.	Bai-Lin.Wu@childrens.harvard.edu; zhangtingcv@yahoo.com.cn			Ministry of Science and Technology of P. R. China; National "973" Program on Population and Health [2013CB945404, 2010CB529601]; National Nature Science Fund [81100841]; Beijing Excellent Scientist Fund [20061A0303200108]; Chinese Returned Oversea Scientist Fund; Beijing Science and Technology; Shanghai Science Fund [09JC1402400, 09ZR1404500]	Ministry of Science and Technology of P. R. China(Ministry of Science and Technology, China); National "973" Program on Population and Health; National Nature Science Fund(National Natural Science Foundation of China (NSFC)); Beijing Excellent Scientist Fund; Chinese Returned Oversea Scientist Fund; Beijing Science and Technology; Shanghai Science Fund	This work was jointly supported by the Ministry of Science and Technology of P. R. China, the National "973" Program on Population and Health (2013CB945404 to TZ; 2010CB529601 to BLW), the National Nature Science Fund (81100841 to XLC), the Beijing Excellent Scientist Fund (20061A0303200108 to XLC), Chinese Returned Oversea Scientist Fund to XLC by Beijing Science and Technology, and the Shanghai Science Fund (09JC1402400 and 09ZR1404500 to BLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allache R, 2012, BIRTH DEFECTS RES A, V94, P176, DOI 10.1002/bdra.23002; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Bosoi CM, 2011, HUM MUTAT, V32, P1371, DOI 10.1002/humu.21589; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Boyles AL, 2005, AM J MED GENET C, V135C, P9, DOI 10.1002/ajmg.c.30048; Cameron M, 2009, PRENATAL DIAG, V29, P402, DOI 10.1002/pd.2250; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chen CP, 2008, TAIWAN J OBSTET GYNE, V47, P131, DOI 10.1016/S1028-4559(08)60070-4; Chen XL, 2010, BIRTH DEFECTS RES A, V88, P575, DOI 10.1002/bdra.20670; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; De Marco P, 2012, HUM MUTAT, V33, P384, DOI 10.1002/humu.21643; Dheen ST, 2009, CURR MED CHEM, V16, P2345, DOI 10.2174/092986709788453069; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feuchtbaum LB, 1999, GENET TEST, V3, P265, DOI 10.1089/109065799316572; Gao YH, 2012, REPROD SCI, V19, P764, DOI 10.1177/1933719111433886; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Gu X, 2007, BIRTH DEFECTS RES A, V79, P702, DOI 10.1002/bdra.20397; Guo J, 2012, GENES NUTR; Harris MJ, 2007, BIRTH DEFECTS RES A, V79, P187, DOI 10.1002/bdra.20333; Hong E, 2010, DEV BIOL, V341, P335, DOI 10.1016/j.ydbio.2010.01.034; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Hume RF, 1996, AM J MED GENET, V61, P171, DOI 10.1002/(SICI)1096-8628(19960111)61:2<171::AID-AJMG14>3.3.CO;2-X; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Ionita-Laza I, 2009, GENOMICS, V93, P22, DOI 10.1016/j.ygeno.2008.08.012; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kanit H, 2011, CLIN DYSMORPHOL, V20, P190, DOI 10.1097/MCD.0b013e328348d99d; Kennedy D, 1998, AM J MED GENET, V77, P317, DOI 10.1002/(SICI)1096-8628(19980526)77:4<317::AID-AJMG13>3.0.CO;2-L; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; Kibar Z, 2011, CLIN GENET, V80, P76, DOI 10.1111/j.1399-0004.2010.01515.x; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kibar Z, 2009, HUM MUTAT, V30, pE706, DOI 10.1002/humu.21026; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Li ZW, 2006, BIRTH DEFECTS RES A, V76, P237, DOI 10.1002/bdra.20248; Lin CH, 2009, GENOMICS, V94, P241, DOI 10.1016/j.ygeno.2009.06.004; Mazzitelli N, 2002, TERATOLOGY, V66, P105, DOI 10.1002/tera.10053; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Nielsen LAG, 2006, APMIS, V114, P239, DOI 10.1111/j.1600-0463.2006.apm_325.x; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Pinar H, 1998, PEDIATR DEVEL PATHOL, V1, P42, DOI 10.1007/s100249900005; Rajcan-Separovic E, 2010, MOL HUM REPROD, V16, P125, DOI 10.1093/molehr/gap083; Rampersaud E, 2006, NEURAL TUBE DEFECTS; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robinson A, 2012, HUM MUTAT, V33, P440, DOI 10.1002/humu.21662; Salonen R, 2011, EUR J HUM GENET, V19, DOI 10.1038/ejhg.2010.255; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Sepulveda W, 2004, ULTRASOUND OBST GYN, V23, P352, DOI 10.1002/uog.964; Shang YL, 2008, BIRTH DEFECTS RES A, V82, P3, DOI 10.1002/bdra.20416; Shen YP, 2009, CLIN CHEM, V55, P659, DOI 10.1373/clinchem.2008.112821; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Taha D, 2003, AM J MED GENET A, V122A, P269, DOI 10.1002/ajmg.a.20267; Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722; Wang JH, 2011, REPROD SCI, V18, P556, DOI 10.1177/1933719110393026; Xiao K Z, 1989, Zhonghua Yi Xue Za Zhi, V69, P189; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Zhang T, 2009, PUBLIC HEALTH NUTR, V12, P680, DOI 10.1017/S1368980008002735; Zhao HZ, 2012, GENE, V505, P340, DOI 10.1016/j.gene.2012.05.035	67	16	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54492	10.1371/journal.pone.0054492	http://dx.doi.org/10.1371/journal.pone.0054492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349908	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900072
J	Miles, DC; Wakeling, SI; Stringer, JM; van den Bergen, JA; Wilhelm, D; Sinclair, AH; Western, PS				Miles, Denise C.; Wakeling, Stephanie I.; Stringer, Jessica M.; van den Bergen, Jocelyn A.; Wilhelm, Dagmar; Sinclair, Andrew H.; Western, Patrick S.			Signaling through the TGF Beta-Activin Receptors ALK4/5/7 Regulates Testis Formation and Male Germ Cell Development	PLOS ONE			English	Article							FEMALE SEX-REVERSAL; MEIOTIC INITIATION; RETINOIC ACID; OVARIAN DEVELOPMENT; NANOG EXPRESSION; MAMMALIAN OVARY; GENE-EXPRESSION; MOUSE EMBRYOS; FETAL TESTIS; STEM-CELLS	The developing testis provides an environment that nurtures germ cell development, ultimately ensuring spermatogenesis and fertility. Impacts on this environment are considered to underlie aberrant germ cell development and formation of germ cell tumour precursors. The signaling events involved in testis formation and male fetal germ cell development remain largely unknown. Analysis of knockout mice lacking single Tgf beta family members has indicated that Tgf beta's are not required for sex determination. However, due to functional redundancy, it is possible that additional functions for these ligands in gonad development remain to be discovered. Using FACS purified gonadal cells, in this study we show that the genes encoding Activin's, TGF beta's, Nodal and their respective receptors, are expressed in sex and cell type specific patterns suggesting particular roles in testis and germ cell development. Inhibition of signaling through the receptors ALK4, ALK5 and ALK7, and ALK5 alone, demonstrated that TGF beta signaling is required for testis cord formation during the critical testis-determining period. We also show that signaling through the Activin/NODAL receptors, ALK4 and ALK7 is required for promoting differentiation of male germ cells and their entry into mitotic arrest. Finally, our data demonstrate that Nodal is specifically expressed in male germ cells and expression of the key pluripotency gene, Nanog was significantly reduced when signaling through ALK4/5/7 was blocked. Our strategy of inhibiting multiple Activin/NODAL/TGF beta receptors reduces the functional redundancy between these signaling pathways, thereby revealing new and essential roles for TGF beta and Activin signaling during testis formation and male germ cell development.	[Miles, Denise C.; Wakeling, Stephanie I.; Stringer, Jessica M.; Western, Patrick S.] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [van den Bergen, Jocelyn A.; Sinclair, Andrew H.] Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Wilhelm, Dagmar] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University	Western, PS (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia.	patrick.western@monash.edu	Sinclair, Andrew H/A-3598-2010; Wilhelm, Dagmar/B-6915-2009; Stringer, Jessica/I-5525-2013	Sinclair, Andrew H/0000-0003-2741-7992; Wilhelm, Dagmar/0000-0002-7757-4075; Stringer, Jessica/0000-0003-4729-3026; Western, Patrick/0000-0002-7587-8227	Monash University Faculty of Medicine, Nursing and Health Sciences; Victorian Government's Operational Infrastructure Support Program; ARC Centre of Excellence for Biotechnology and Development; Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council Victoria; ARC Future Fellowship	Monash University Faculty of Medicine, Nursing and Health Sciences(Monash University); Victorian Government's Operational Infrastructure Support Program; ARC Centre of Excellence for Biotechnology and Development(Australian Research Council); Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); ARC Future Fellowship(Australian Research Council)	This work was supported by funding from the Monash University Faculty of Medicine, Nursing and Health Sciences funding granted to PW, and the Victorian Government's Operational Infrastructure Support Program and ARC Centre of Excellence for Biotechnology and Development awarded to AHS. DM was supported by a Sydney Parker Smith Postdoctoral Research Fellowship from the Cancer Council Victoria. DW is supported by an ARC Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2002, DEVELOPMENT, V129, P1155; Archambeault DR, 2010, P NATL ACAD SCI USA, V107, P10526, DOI 10.1073/pnas.1000318107; Bagheri-Fam S, 2008, DEV BIOL, V314, P71, DOI 10.1016/j.ydbio.2007.11.010; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Barrios F, 2010, J CELL SCI, V123, P871, DOI 10.1242/jcs.057968; BEHRINGER RR, 1994, CELL, V79, P415, DOI 10.1016/0092-8674(94)90251-8; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Brown CW, 2000, NAT GENET, V25, P453, DOI 10.1038/78140; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Combes AN, 2009, DEV BIOL, V326, P112, DOI 10.1016/j.ydbio.2008.10.040; Cook MS, 2009, DEV BIOL, V328, P377, DOI 10.1016/j.ydbio.2009.01.041; Daggag H, 2008, BIOL REPROD, V79, P468, DOI 10.1095/biolreprod.107.067348; DiNapoli L, 2006, DEVELOPMENT, V133, P1519, DOI 10.1242/dev.02303; Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Guerquin MJ, 2010, DEV BIOL, V346, P320, DOI 10.1016/j.ydbio.2010.08.002; Hueng DY, 2011, J NEURO-ONCOL, V104, P21, DOI 10.1007/s11060-010-0467-3; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Memon MA, 2008, MOL CELL ENDOCRINOL, V294, P70, DOI 10.1016/j.mce.2008.08.017; Mendis SHS, 2011, BIOL REPROD, V84, P379, DOI 10.1095/biolreprod.110.086231; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Miles DC, 2012, DEV BIOL, V365, P101, DOI 10.1016/j.ydbio.2012.02.014; Miles DC, 2012, HISTOL HISTOPATHOL, V27, P445, DOI 10.14670/HH-27.445; Miles DC, 2010, CELL CYCLE, V9, P408, DOI 10.4161/cc.9.2.10691; Mithraprabhu S, 2010, BIOL REPROD, V82, P980, DOI 10.1095/biolreprod.109.079855; Moreno SG, 2010, DEV BIOL, V342, P74, DOI 10.1016/j.ydbio.2010.03.007; Morizane A, 2011, J NEUROSCI RES, V89, P117, DOI 10.1002/jnr.22547; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Sarraj MA, 2010, BIOL REPROD, V82, P153, DOI 10.1095/biolreprod.109.078766; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; Spiller CM, 2010, BIOL REPROD, V82, P433, DOI 10.1095/biolreprod.109.078691; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; van den Bergen JA, 2009, BIOL REPROD, V81, P362, DOI 10.1095/biolreprod.109.076224; Western P, 2009, INT J DEV BIOL, V53, P393, DOI 10.1387/ijdb.082671pw; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Western PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020736; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yao HHC, 2006, BIOL REPROD, V74, P978, DOI 10.1095/biolreprod.105.050286	66	65	69	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54606	10.1371/journal.pone.0054606	http://dx.doi.org/10.1371/journal.pone.0054606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342175	gold, Green Published			2022-12-27	WOS:000313682700130
J	Mielnik-Sikorska, M; Daca, P; Malyarchuk, B; Derenko, M; Skonieczna, K; Perkova, M; Dobosz, T; Grzybowski, T				Mielnik-Sikorska, Marta; Daca, Patrycja; Malyarchuk, Boris; Derenko, Miroslava; Skonieczna, Katarzyna; Perkova, Maria; Dobosz, Tadeusz; Grzybowski, Tomasz			The History of Slavs Inferred from Complete Mitochondrial Genome Sequences	PLOS ONE			English	Article							MTDNA HAPLOGROUP-H; DNA VARIABILITY; CZECH POPULATION; PHYLOGENY; EASTERN; DIVERSITY; REGION; DISSECTION; SELECTION; EUROPE	To shed more light on the processes leading to crystallization of a Slavic identity, we investigated variability of complete mitochondrial genomes belonging to haplogroups H5 and H6 (63 mtDNA genomes) from the populations of Eastern and Western Slavs, including new samples of Poles, Ukrainians and Czechs presented here. Molecular dating implies formation of H5 approximately 11.5-16 thousand years ago (kya) in the areas of southern Europe. Within ancient haplogroup H6, dated at around 15-28 kya, there is a subhaplogroup H6c, which probably survived the last glaciation in Europe and has undergone expansion only 3-4 kya, together with the ancestors of some European groups, including the Slavs, because H6c has been detected in Czechs, Poles and Slovaks. Detailed analysis of complete mtDNAs allowed us to identify a number of lineages that seem specific for Central and Eastern Europe (H5a1f, H5a2, H5a1r, H5a1s, H5b4, H5e1a, H5u1, some subbranches of H5a1a and H6a1a9). Some of them could possibly be traced back to at least,4 kya, which indicates that some of the ancestors of today's Slavs (Poles, Czechs, Slovaks, Ukrainians and Russians) inhabited areas of Central and Eastern Europe much earlier than it was estimated on the basis of archaeological and historical data. We also sequenced entire mitochondrial genomes of several non-European lineages (A, C, D, G, L) found in contemporary populations of Poland and Ukraine. The analysis of these haplogroups confirms the presence of Siberian (C5c1, A8a1) and Ashkenazi-specific (L2a1l2a) mtDNA lineages in Slavic populations. Moreover, we were able to pinpoint some lineages which could possibly reflect the relatively recent contacts of Slavs with nomadic Altaic peoples (C4a1a, G2a, D5a2a1a1).	[Mielnik-Sikorska, Marta; Daca, Patrycja; Skonieczna, Katarzyna; Grzybowski, Tomasz] Nicolaus Copernicus Univ, Ludwik Rydygier Coll Med, Inst Forens Med, Dept Mol & Forens Genet, Bydgoszcz, Poland; [Malyarchuk, Boris; Derenko, Miroslava; Perkova, Maria] Russian Acad Sci, Inst Biol Problems N, Far E Branch, Magadan, Russia; [Dobosz, Tadeusz] Wroclaw Med Univ, Dept Forens Med, Wroclaw, Poland	Nicolaus Copernicus University; Institute of Biological Problems of the North; Russian Academy of Sciences; Wroclaw Medical University	Grzybowski, T (corresponding author), Nicolaus Copernicus Univ, Ludwik Rydygier Coll Med, Inst Forens Med, Dept Mol & Forens Genet, Bydgoszcz, Poland.	tgrzyb@cm.umk.pl	Skonieczna, Katarzyna/AAT-7176-2021; Dobosz, Tadeusz/ABE-9988-2021; Skonieczna, Katarzyna/E-1178-2014; Malyarchuk, Boris/D-5783-2018; Derenko, Miroslava/J-1495-2018; Grzybowski, Tomasz/A-1676-2015; Dobosz, Tadeusz/T-8250-2018	Malyarchuk, Boris/0000-0002-0304-0652; Derenko, Miroslava/0000-0002-1849-784X; Grzybowski, Tomasz/0000-0001-6228-6460; Skonieczna, Katarzyna/0000-0001-5788-9398; Dobosz, Tadeusz/0000-0003-0413-9109; Daca-Roszak, Patrycja/0000-0003-1094-1333	Polish Ministry of Science and Higher Education [N N301 075839, N N303 307737]; Program of Presidium of Russian Academy of Sciences "Biodiversity" [12-I-P30-12]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Program of Presidium of Russian Academy of Sciences "Biodiversity"	This study was partially supported by the Polish Ministry of Science and Higher Education grants (nos. N N301 075839 and N N303 307737) and the Program of Presidium of Russian Academy of Sciences "Biodiversity" (grant no. 12-I-P30-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alekseeva TI, 2002, ESTERN SLAVS ANTHR E; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Barford P. M., 2001, EARLY SLAVS CULTURE; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Behar DM, 2004, EUR J HUM GENET, V12, P355, DOI 10.1038/sj.ejhg.5201156; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Belyaeva O, 2003, HUM BIOL, V75, P647, DOI 10.1353/hub.2003.0069; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Branicki W, 2005, J FORENSIC SCI, V50, P732; Buko A, 2006, POLISH ARCHEOLOGY EA; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Curta F, 2001, CAMBRIDGE STUDIES ME, V52, pxxv; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; Godlowski K, 2000, 1 SETTLEMENTS SLAVS; Golab Z., 1992, ORIGINS SLAVS LINGUI; Greenspan, 2008, FAMILY TREE DNA PROJ; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Kaczanowski P, 2005, ARCH OR SLAVS P C CR; Karachanak S, 2012, INT J LEGAL MED, V126, P497, DOI 10.1007/s00414-011-0589-y; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kostrzewski J, 1965, PREHISTORY POLAND; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Mallory J. P., 1989, SEARCH INDOEUROPEANS; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; Malyarchuk BA, 2003, ANN HUM GENET, V67, P412, DOI 10.1046/j.1469-1809.2003.00042.x; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Malyarchuk B, 2010, MOL BIOL EVOL, V27, P2220, DOI 10.1093/molbev/msq065; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Malyarchuk BA, 2008, EUR J HUM GENET, V16, P1091, DOI 10.1038/ejhg.2008.70; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; Malyarchuk BA, 2006, HUM BIOL, V78, P681, DOI 10.1353/hub.2007.0014; Metspalu M, 2006, NUCL ACID M, V18, P181; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Orekhov V, 1999, FEBS LETT, V445, P197, DOI 10.1016/S0014-5793(99)00115-5; Pajnic IZ, 2004, INT J LEGAL MED, V118, P1, DOI 10.1007/s00414-003-0394-3; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pereira L, 2006, FORENSIC SCI INT, V159, P43, DOI 10.1016/j.forsciint.2005.06.008; Piechota J, 2004, ACTA BIOCHIM POL, V51, P883; Piontek J, 2006, SLAVIA ANTIQUA, V47, P161; Piontek J, 2008, CENTURY JAGIELLONIAN, P175; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; SEDOV VV, 1979, ORIGIN EARLY HIST SL; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vanecek T, 2004, INT J LEGAL MED, V118, P14, DOI 10.1007/s00414-003-0407-2	66	48	49	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54360	10.1371/journal.pone.0054360	http://dx.doi.org/10.1371/journal.pone.0054360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342138	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400153
J	Neeves, KB; Onasoga, AA; Hansen, RR; Lilly, JJ; Venckunaite, D; Sumner, MB; Irish, AT; Brodsky, G; Manco-Johnson, MJ; Di Paola, JA				Neeves, Keith B.; Onasoga, Abimbola A.; Hansen, Ryan R.; Lilly, Jessica J.; Venckunaite, Diana; Sumner, Meghan B.; Irish, Andrew T.; Brodsky, Gary; Manco-Johnson, Marilyn J.; Di Paola, Jorge A.			Sources of Variability in Platelet Accumulation on Type 1 Fibrillar Collagen in Microfluidic Flow Assays	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; MEASURE THROMBUS FORMATION; BLOOD-FLOW; VONWILLEBRAND-FACTOR; FACTOR-VIII; THIN-FILMS; SHEAR RATE; ADHESION; AGGREGATION; SEX	Microfluidic flow assays (MFA) that measure shear dependent platelet function have potential clinical applications in the diagnosis and treatment of bleeding and thrombotic disorders. As a step towards clinical application, the objective of this study was to measure how phenotypic and genetic factors, as well as experimental conditions, affect the variability of platelet accumulation on type 1 collagen within a MFA. Whole blood was perfused over type 1 fibrillar collagen at wall shear rates of 150, 300, 750 and 1500 s(-1) through four independent channels with a height of 50 mu m and a width of 500 mu m. The accumulation of platelets was characterized by the lag time to 1% platelet surface coverage (Lag(T)), the rate of platelet accumulation (V-PLT), and platelet surface coverage (SC). A cohort of normal donors was tested and the results were correlated to plasma von Willebrand factor (VWF) levels, platelet count, hematocrit, sex, and collagen receptors genotypes. VWF levels were the strongest determinant of platelet accumulation. VWF levels were positively correlated to V-PLT and SC at all wall shear rates. A longer Lag(T) for platelet accumulation at arterial shear rates compared to venous shear rates was attributed to the time required for plasma proteins to adsorb to collagen. There was no association between platelet accumulation and hematocrit or platelet count. Individuals with the AG genotype of the GP6 gene had lower platelet accumulation than individuals with the AA genotype at 150 s(-1) and 300 s(-1). Recalcified blood collected into sodium citrate and corn trypsin inhibitor (CTI) resulted in diminished platelet accumulation compared to CTI alone, suggesting that citrate irreversibly diminishes platelet function. This study the largest association study of MFA in healthy donors (n = 104) and will likely set up the basis for the determination of the normal range of platelet responses in this type of assay.	[Neeves, Keith B.; Onasoga, Abimbola A.; Hansen, Ryan R.; Irish, Andrew T.] Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA; [Neeves, Keith B.; Lilly, Jessica J.; Venckunaite, Diana; Sumner, Meghan B.; Brodsky, Gary; Manco-Johnson, Marilyn J.; Di Paola, Jorge A.] Univ Colorado Denver, Dept Pediat, Hemophilia & Thrombosis Ctr, Aurora, CO USA	Colorado School of Mines; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Neeves, KB (corresponding author), Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA.	kneeves@mines.edu; jorge.dipaola@ucdenver.edu	Neeves, Keith/J-9494-2019	Neeves, Keith/0000-0001-7546-4588	American Heart Association; National Heart, Lung, and Blood Institute [HL100333]; Postle Family Chair; Colorado Office of Economic Development and International Trade; Boettcher Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084086, RC1HL100333] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Postle Family Chair; Colorado Office of Economic Development and International Trade; Boettcher Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Scientist Development Grant (K.B.N.) and a Postdoctoral Fellowship (R. R. H.) from the American Heart Association, the National Heart, Lung, and Blood Institute (HL100333), the Postle Family Chair (J.D.P.), the Colorado Office of Economic Development and International Trade, and the Boettcher Foundation's Webb-Waring Biomedical Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADIMON L, 1989, BLOOD, V73, P961; Bar J, 1996, CLIN LAB HAEMATOL, V18, P281; Bernardo A, 2004, J THROMB HAEMOST, V2, P660, DOI 10.1111/j.1538-7836.2004.00661.x; Bonnefoy A, 2006, J THROMB HAEMOST, V4, P2151, DOI 10.1111/j.1538-7836.2006.02111.x; Brill A, 2011, BLOOD, V117, P1106, DOI [10.1182/blood-2010-11-315879, DOI 10.1182/BLOOD-2010-11-315879]; Chauhan AK, 2007, BLOOD, V109, P2424, DOI 10.1182/blood-2006-06-028241; Colace T, 2011, ANN BIOMED ENG, V39, P922, DOI 10.1007/s10439-010-0182-4; Conant CG, 2011, BIOTECHNOL BIOENG, V108, P2978, DOI 10.1002/bit.23243; Cosemans JMEM, 2011, BLOOD, V117, P651, DOI 10.1182/blood-2010-01-262683; Di Paola J, 2005, J THROMB HAEMOST, V3, P1511, DOI 10.1111/j.1538-7836.2005.01273.x; DUARTE APT, 1986, THROMB RES, V43, P33, DOI 10.1016/0049-3848(86)90042-3; Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r; Eshel-Green T, 2009, THROMB HAEMOSTASIS, V102, P958, DOI 10.1160/TH08-09-0624; Farndale RW, 2004, J THROMB HAEMOST, V2, P561, DOI 10.1111/j.1538-7836.2004.00665.x; Flood VH, 2010, BLOOD, V116, P280, DOI 10.1182/blood-2009-10-249102; Fuchs TA, 2012, ARTERIOSCL THROM VAS, V32, P1777, DOI 10.1161/ATVBAHA.111.242859; Gutierrez E, 2008, LAB CHIP, V8, P1486, DOI 10.1039/b804795b; Hansen RR, 2013, ANN BIOMED ENG, V41, P250, DOI 10.1007/s10439-012-0658-5; Hansen RR, 2011, LANGMUIR, V27, P13648, DOI 10.1021/la2023727; Heemskerk JWM, 2011, J THROMB HAEMOST, V9, P856, DOI 10.1111/j.1538-7836.2011.04230.x; HOUDIJK WPM, 1985, J CLIN INVEST, V75, P531, DOI 10.1172/JCI111729; JOHNSON M, 1975, NATURE, V253, P355, DOI 10.1038/253355a0; Joutsi-Korhonen L, 2003, BLOOD, V101, P4372, DOI 10.1182/blood-2002-08-2591; Kulkarni S, 2000, J CLIN INVEST, V105, P783, DOI 10.1172/JCI7569; Kunicki TJ, 2010, BLOOD, V116, P2627, DOI 10.1182/blood-2010-04-262048; Kunicki TJ, 2004, BLOOD, V104, P2359, DOI 10.1182/blood-2004-01-0349; Lisman T, 2005, J THROMB HAEMOST, V3, P742, DOI 10.1111/j.1538-7836.2005.01227.x; Maloney SF, 2010, INTEGR BIOL-UK, V2, P183, DOI 10.1039/b919728a; Mann KG, 2007, J THROMB HAEMOST, V5, P2055, DOI 10.1111/j.1538-7836.2007.02710.x; Mendolicchio GL, 2011, J THROMB HAEMOST, V9, P373, DOI 10.1111/j.1538-7836.2010.04144.x; Nalayanda DD, 2007, BIOMED MICRODEVICES, V9, P207, DOI 10.1007/s10544-006-9022-6; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Neeves KB, 2010, BIOPHYS J, V98, P1344, DOI 10.1016/j.bpj.2009.12.4275; Okorie UM, 2006, BIOPHYS J, V91, P3474, DOI 10.1529/biophysj.106.083287; Otahbachi M, 2010, J THROMB THROMBOLYS, V30, P184, DOI 10.1007/s11239-009-0436-x; Philipose S, 2010, ARTERIOSCL THROM VAS, V30, P2416, DOI 10.1161/ATVBAHA.110.216374; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; Pugh N, 2010, BLOOD, V115, P5069, DOI 10.1182/blood-2010-01-260778; Roest M, 2000, BLOOD, V96, P1433, DOI 10.1182/blood.V96.4.1433.h8001433_1433_1437; Roest M, 2011, J THROMB HAEMOST, V9, P2322, DOI 10.1111/j.1538-7836.2011.04492.x; Sarvepalli DP, 2009, ANN BIOMED ENG, V37, P1331, DOI 10.1007/s10439-009-9708-z; Savage B, 1996, CELL; Shulman Z. P., 1995, Journal of Engineering Physics and Thermophysics, V68, P353, DOI 10.1007/BF00859048; TURITTO VT, 1980, SCIENCE, V207, P541, DOI 10.1126/science.7352265; VANBREUGEL HHFI, 1988, ARTERIOSCLEROSIS, V8, P332, DOI 10.1161/01.ATV.8.3.332; Varon D, 1997, THROMB RES, V85, P283, DOI 10.1016/S0049-3848(97)00014-5; Yee DL, 2005, BLOOD, V106, P2723, DOI 10.1182/blood-2005-03-1290; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhao XM, 2008, THROMB RES, V121, P821, DOI 10.1016/j.thromres.2007.07.013; Zwaginga JJ, 2007, J THROMB HAEMOST, V5, P2547, DOI 10.1111/j.1538-7836.2007.02807.x	52	55	56	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54680	10.1371/journal.pone.0054680	http://dx.doi.org/10.1371/journal.pone.0054680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355889	gold, Green Submitted, Green Published			2022-12-27	WOS:000314021500104
J	Loken-Amsrud, KI; Myhr, KM; Bakke, SJ; Beiske, AG; Bjerve, KS; Bjornara, BT; Hovdal, H; Lilleas, F; Midgard, R; Pedersen, T; Benth, JS; Torkildsen, O; Wergeland, S; Holmoy, T				Loken-Amsrud, Kristin I.; Myhr, Kjell-Morten; Bakke, Soren J.; Beiske, Antonie G.; Bjerve, Kristian S.; Bjornara, Bard T.; Hovdal, Harald; Lilleas, Finn; Midgard, Rune; Pedersen, Tom; Benth, Jurate Saltyte; Torkildsen, Oivind; Wergeland, Stig; Holmoy, Trygve			Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction	PLOS ONE			English	Article							VITAMIN-E; CAROTENOIDS; LIPIDS; BLOOD; RISK; DNA	Objective: Alpha-tocopherol is the main vitamin E compound in humans, and has important antioxidative and immunomodulatory properties. The aim of this study was to study alpha-tocopherol concentrations and their relationship to disease activity in Norwegian multiple sclerosis (MS) patients. Methods: Prospective cohort study in 88 relapsing-remitting MS (RRMS) patients, originally included in a randomised placebo-controlled trial of omega-3 fatty acids (the OFAMS study), before and during treatment with interferon beta. The patients were followed for two years with repeated 12 magnetic resonance imaging (MRI) scans and nine serum measurements of alpha-tocopherol. Results: During interferon beta (IFNB) treatment, each 10 mu mol/L increase in alpha-tocopherol reduced the odds (CI 95%) for simultaneous new T2 lesions by 36.8 (0.5-59.8) %, p = 0.048, and for combined unique activity by 35.4 (1.6-57.7) %, p = 0.042, in a hierarchical regression model. These associations were not significant prior to IFNB treatment, and were not noticeably changed by gender, age, body mass index, HLA-DRB1*15, treatment group, compliance, or the concentrations of 25-hydroxyvitamin D, retinol, neutralising antibodies against IFNB, or the omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid. The corresponding odds for having new T1 gadolinium enhancing lesions two months later was reduced by 65.4 (16.5-85.7) %, p = 0.019, and for new T2 lesions by 61.0 (12.4-82.6) %, p = 0.023. Conclusion: During treatment with IFNB, increasing serum concentrations of alpha-tocopherol were associated with reduced odds for simultaneous and subsequent MRI disease activity in RRMS patients.	[Loken-Amsrud, Kristin I.] Innlandet Hosp Trust, Dept Neurol, Lillehammer, Norway; [Loken-Amsrud, Kristin I.; Benth, Jurate Saltyte; Holmoy, Trygve] Univ Oslo, Inst Clin Med, Oslo, Norway; [Myhr, Kjell-Morten; Torkildsen, Oivind; Wergeland, Stig] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway; [Myhr, Kjell-Morten] Univ Bergen, Dept Clin Med, Bergen, Norway; [Myhr, Kjell-Morten] Univ Bergen, Kristian Gerhard Jebsen Multiple Sclerosis Res Ct, Bergen, Norway; [Bakke, Soren J.] Oslo Univ Hosp, Dept Neuroradiol, Oslo, Norway; [Beiske, Antonie G.] Multiple Sclerosis Ctr Hakadal, Hakadal, Norway; [Bjerve, Kristian S.] Univ Trondheim Hosp, St Olavs Hosp, Dept Med Biochem, Trondheim, Norway; [Bjerve, Kristian S.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway; [Bjornara, Bard T.] Helsehuset Kongsberg, Kongsberg, Norway; [Hovdal, Harald] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurol, Trondheim, Norway; [Lilleas, Finn] Curato Oslo, Oslo, Norway; [Midgard, Rune] Molde Hosp, Dept Neurol, Molde, Norway; [Midgard, Rune] Norwegian Univ Sci & Technol, Unit Appl Clin Res, N-7034 Trondheim, Norway; [Pedersen, Tom] Unilabs Drammen, Drammen, Norway; [Benth, Jurate Saltyte] Akershus Univ Hosp, Helse Sor Ost Hlth Serv Res Ctr, Lorenskog, Norway; [Holmoy, Trygve] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway	Innlandet Hospital Trust; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo	Holmoy, T (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	trygve.holmoy@medisin.uio.no	Torkildsen, Øivind/A-1606-2008; Myhr, Kjell-Morten/H-1528-2018	Torkildsen, Øivind/0000-0001-5294-2866; Myhr, Kjell-Morten/0000-0002-0980-510X; Midgard, Rune/0000-0002-6096-726X	Merck-Serono; Pronova Biocare; Bayer Schering; Innlandet Hospital Trust [150164]; Western Norway Regional Health Authority; Odd Fellow Research Foundation for multiple sclerosis; Kare Waerner's Legacy; Norwegian MS Society; Biogen Idec; Novartis; Sanofi Aventis; Merck Serono	Merck-Serono(Merck & Company); Pronova Biocare; Bayer Schering(Bayer AG); Innlandet Hospital Trust; Western Norway Regional Health Authority; Odd Fellow Research Foundation for multiple sclerosis; Kare Waerner's Legacy; Norwegian MS Society; Biogen Idec(Biogen); Novartis(Novartis); Sanofi Aventis(Sanofi-Aventis); Merck Serono(Merck & Company)	The study was supported by Merck-Serono, Pronova Biocare, Bayer Schering, Innlandet Hospital Trust (Grant number 150164), The Western Norway Regional Health Authority, Odd Fellow Research Foundation for multiple sclerosis, Kare Waerner's Legacy and The Norwegian MS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was partly supported by Merck-Serono, Pronova Biocare and Bayer Schering. Bard T. Bjornara is employed by Helsehuset Kongsberg, Finn Lilleas by Curato Oslo and Tom Pedersen by Unilabs. Kristin I. Loken-Amsrud has received travel support and an unrestricted research grant from Biogen Idec and travel support from Merck Serono. Kjell-Morten Myhr has received honoraria for lecturing, participation in pharmaceutical company sponsored clinical trials, and travel support from Bayer Schering, Biogen Idec, Novartis, Merck-Serono and Sanofi Aventis. Harald Hovdal has participated in pharmaceutical company sponsored clinical trials and received travel support from Merck Serono, Biogen Idec and Bayer Schering. Rune Midgard has received honoraria for lecturing, participation in pharmaceutical company sponsored clinical trials, and travel support from Bayer Schering, Biogen Idec, Novartis, Merck-Serono and Sanofi Aventis. Stig Wergeland has received speaker honoraria and travel support from Sanofi Aventis, Biogen Idec, Bayer Schering and Novartis. Trygve Holmoy has received speaker honoraria and travel support from Sanofi Aventis, Biogen Idec, Bayer Schering, Novartis and Merck Serono. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Azemi MK, 2009, REPROD BIOMED ONLINE, V19, P583, DOI 10.1016/j.rbmo.2009.05.005; Becker W., 2004, Scandinavian Journal of Nutrition, V48, P178, DOI 10.1080/1102680410003794; Besler HT, 2002, NUTR NEUROSCI, V5, P215, DOI 10.1080/10284150290029205; BJORNSON LK, 1976, J LIPID RES, V17, P343; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Garcia-Closas R, 2004, BRIT J NUTR, V91, P1005, DOI 10.1079/BJN20041130; Goudarzvand M, 2010, CELL MOL NEUROBIOL, V30, P289, DOI 10.1007/s10571-009-9451-x; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Heppner FL, 1998, GLIA, V22, P180, DOI 10.1002/(SICI)1098-1136(199802)22:2<180::AID-GLIA9>3.0.CO;2-B; Hsieh CC, 2005, NUTRITION, V21, P940, DOI 10.1016/j.nut.2004.11.021; JARVINEN R, 1995, INT J VITAM NUTR RES, V65, P24; Jimenez-Jimenez FJ, 1998, NEUROSCI LETT, V249, P65, DOI 10.1016/S0304-3940(98)00370-X; Karg E, 2003, EUR NEUROL, V50, P215, DOI 10.1159/000073862; Karg E, 1999, J NEUROL, V246, P533, DOI 10.1007/s004150050399; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Loken-Amsrud KI, 2013, MULT SCLER J, V19, P451, DOI 10.1177/1352458512457843; Loken-Amsrud KI, 2012, NEUROLOGY, V79, P267, DOI 10.1212/WNL.0b013e31825fdf01; Lucas M, 2003, NEUROCHEM INT, V42, P67, DOI 10.1016/S0197-0186(02)00057-8; Mehta LR, 2009, NAT CLIN PRACT NEURO, V5, P82, DOI 10.1038/ncpneuro1009; Pekmezci D, 2011, VITAM HORM, V86, P179, DOI 10.1016/B978-0-12-386960-9.00008-3; RUULS SR, 1995, J NEUROIMMUNOL, V56, P207, DOI 10.1016/0165-5728(94)00154-G; Saarela J, 2006, PLOS GENET, V2, P364, DOI 10.1371/journal.pgen.0020042; Salemi G, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-19; Sheridan PA, 2009, FREE RADICAL BIO MED, V46, P1581, DOI 10.1016/j.freeradbiomed.2009.03.010; Simpson JL, 2011, J MATERN-FETAL NEO M, V24, P1, DOI 10.3109/14767051003678226; Torkildsen O, 2012, ARCH NEUROL-CHICAGO, V69, P1044, DOI 10.1001/archneurol.2012.283; Venkatraman JT, 1999, J AM COLL NUTR, V18, P602, DOI 10.1080/07315724.1999.10718895; Vladimirova O, 1998, MULT SCLER, V4, P413, DOI 10.1191/135245898678919456; Vladimirova O, 1999, INFLAMM RES, V48, P412, DOI 10.1007/s000110050480; Weinstock-Guttman B, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-127; Zhang SM, 2001, NEUROLOGY, V57, P75, DOI 10.1212/WNL.57.1.75; Zingg JM, 2004, CURR MED CHEM, V11, P1113, DOI 10.2174/0929867043365332	32	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54417	10.1371/journal.pone.0054417	http://dx.doi.org/10.1371/journal.pone.0054417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349882	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100066
J	Brioude, F; Bouligand, J; Francou, B; Fagart, J; Roussel, R; Viengchareun, S; Combettes, L; Brailly-Tabard, S; Lombes, M; Young, J; Guiochon-Mantel, A				Brioude, Frederic; Bouligand, Jerome; Francou, Bruno; Fagart, Jerome; Roussel, Ronan; Viengchareun, Say; Combettes, Laurent; Brailly-Tabard, Sylvie; Lombes, Marc; Young, Jacques; Guiochon-Mantel, Anne			Two Families with Normosmic Congenital Hypogonadotropic Hypogonadism and Biallelic Mutations in KISS1R (KISS1 Receptor): Clinical Evaluation and Molecular Characterization of a Novel Mutation	PLOS ONE			English	Article							GNRH RECEPTOR; NEUROKININ B; GENE; PATIENT; NEUROENDOCRINE; KISSPEPTIN; EXPRESSION; ROLES; LOOP	Context: KISS1R mutations have been reported in few patients with normosmic congenital hypogonadotropic hypogonadism (nCHH) (OMIM # 146110). Objective: To describe in detail nCHH patients with biallelic KISS1R mutations belonging to 2 unrelated families, and to functionally characterize a novel KISS1R mutation. Results: An original mutant, p.Tyr313His, was found in the homozygous state in 3 affected kindred (2 females and 1 male) from a consanguineous Portuguese family. This mutation, located in the seventh transmembrane domain, affects a highly conserved amino acid, perturbs the conformation of the transmembrane segment, and impairs MAP kinase signaling and intracellular calcium release. In the second family, a French Caucasian male patient with nCHH was found to carry two recurrent mutations in the compound heterozygous state (p.Leu102Pro/Stop399Arg). In this man, pulsatile GnRH (Gonadotropin Releasing Hormone) administration restored pulsatile LH (Luteinizing Hormone) secretion and testicular hormone secretion. Later, long-term combined gonadotropin therapy induced spermatogenesis, enabling 3 successive pregnancies that resulted in 2 miscarriages and the birth of a healthy boy. Conclusion: We show that a novel loss-of-function mutation (p.Tyr313His) in the KISS1R gene can cause familial nCHH, revealing the crucial role of this amino acid in KISS1R function. The observed restoration of gonadotropin secretion by exogenous GnRH administration further supports, in humans, the hypothalamic origin of the gonadotropin deficiency in this genetic form of nCHH.	[Brioude, Frederic; Bouligand, Jerome; Francou, Bruno; Fagart, Jerome; Viengchareun, Say; Brailly-Tabard, Sylvie; Lombes, Marc; Young, Jacques; Guiochon-Mantel, Anne] Univ Paris Sud, Fac Med Paris Sud, UMR S693, F-94275 Le Kremlin Bicetre, France; [Brioude, Frederic; Bouligand, Jerome; Francou, Bruno; Fagart, Jerome; Viengchareun, Say; Brailly-Tabard, Sylvie; Lombes, Marc; Young, Jacques; Guiochon-Mantel, Anne] INSERM, IFR93, U693, F-94275 Le Kremlin Bicetre, France; [Bouligand, Jerome; Francou, Bruno; Brailly-Tabard, Sylvie; Guiochon-Mantel, Anne] Hop Bicetre, Assistance Publ Hop Paris, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Roussel, Ronan] Univ Paris 07, Paris, France; [Roussel, Ronan] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Dept Endocrinol Diabetol & Nutr, F-75877 Paris, France; [Combettes, Laurent] Univ Paris Sud, Fac Sci, INSERM, UMR S757, Orsay, France; [Lombes, Marc; Young, Jacques] Hop Bicetre, Assistance Publ Hop Paris, Serv Endocrinol & Malad Reprod, Paris, France; [Lombes, Marc; Young, Jacques] Hop Bicetre, Assistance Publ Hop Paris, Ctr Reference Malad Endocriniennes Rares Croissan, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay	Young, J (corresponding author), Univ Paris Sud, Fac Med Paris Sud, UMR S693, F-94275 Le Kremlin Bicetre, France.	jacques.young@bct.aphp.fr; anne.mantel@bct.aphp.fr	Combettes, Laurent/L-1842-2013; Young, Jacques/N-5251-2019; Viengchareun, Say/M-6612-2017; Brioude, Frédéric/H-7898-2014; Lombes, Marc/L-5933-2018; Francou, Bruno/B-8156-2015; Viengchareun, Say/GOV-6812-2022; Young, Jacques/T-2976-2018; Francou, Bruno/AAX-7301-2020; Guiochon-Mantel, Anne S/S-8408-2018; Fagart, Jerome/S-4581-2018; BOULIGAND, Jérôme/S-5716-2018	Combettes, Laurent/0000-0002-1376-4574; Young, Jacques/0000-0001-9286-5631; Brioude, Frédéric/0000-0001-8122-760X; Lombes, Marc/0000-0003-3189-023X; Young, Jacques/0000-0001-9286-5631; Francou, Bruno/0000-0002-3903-2320; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Fagart, Jerome/0000-0002-7965-0553; viengchareun, say/0000-0003-4280-3250	Paris-Sud University (Bonus Qualite Recherche); INSERM [KalGenopath 09-GENO-017]; PHRC HYPOPROTEO [P081212]; Agence Francaise de lutte contre le Dopage (AFLD); BMBS intergovernmental framework for European Cooperation in Science and Technology (COST) Action [BM1105]	Paris-Sud University (Bonus Qualite Recherche); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); PHRC HYPOPROTEO; Agence Francaise de lutte contre le Dopage (AFLD); BMBS intergovernmental framework for European Cooperation in Science and Technology (COST) Action	Paris-Sud University (Bonus Qualite Recherche 2009), INSERM KalGenopath 09-GENO-017, PHRC HYPOPROTEO P081212, Agence Francaise de lutte contre le Dopage (AFLD) and BMBS intergovernmental framework for European Cooperation in Science and Technology (COST) Action BM1105: GnRH deficiency: Elucidation of the neuroendocrine control of human reproduction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; Breuer O, 2012, EUR J ENDOCRINOL, V167, P209, DOI 10.1530/EJE-12-0127; Brioude F, 2010, EUR J ENDOCRINOL, V162, P835, DOI 10.1530/EJE-10-0083; Bry-Gauillard H, 2010, ANN ENDOCRINOL-PARIS, V71, P158, DOI 10.1016/j.ando.2010.02.024; Chan YM, 2009, P NATL ACAD SCI USA, V106, P11703, DOI 10.1073/pnas.0903449106; Chevrier L, 2011, MOL CELL ENDOCRINOL, V346, P21, DOI 10.1016/j.mce.2011.04.018; Clair C, 2001, J CELL SCI, V114, P1999; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; De Roux N, 1999, J CLIN ENDOCR METAB, V84, P567, DOI 10.1210/jc.84.2.567; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Eloit Corinne, 1994, Rhinology (Utrecht), V32, P57; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Francou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025614; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Goze C, 2010, EUR J PHARMACOL, V643, P153, DOI 10.1016/j.ejphar.2010.06.018; Guran T, 2009, J CLIN ENDOCR METAB, V94, P3633, DOI 10.1210/jc.2009-0551; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lanfranco F, 2005, EUR J ENDOCRINOL, V153, P845, DOI 10.1530/eje.1.02031; Layman LC, 1998, NAT GENET, V18, P14, DOI 10.1038/ng0198-14; Lovell S.C., 2003, PROTEINS STRUCT FUNC, V50, P437, DOI [10.1002/prot.10286, DOI 10.1002/PROT.10286]; Mitchell AL, 2011, TRENDS ENDOCRIN MET, V22, P249, DOI 10.1016/j.tem.2011.03.002; Nimri R, 2011, J CLIN ENDOCR METAB, V96, pE536, DOI 10.1210/jc.2010-1676; Noel SD, 2011, MOL CELL ENDOCRINOL, V346, P91, DOI 10.1016/j.mce.2011.06.022; Pallais JC, 2006, MOL CELL ENDOCRINOL, V254, P70, DOI 10.1016/j.mce.2006.04.019; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Ramaswamy S, 2009, J NEUROENDOCRINOL, V21, P795, DOI 10.1111/j.1365-2826.2009.01905.x; Sarfati J, 2010, J CLIN ENDOCR METAB, V95, P659, DOI 10.1210/jc.2009-0843; Schmidlin F, 2003, AM J PHYSIOL-CELL PH, V285, pC945, DOI 10.1152/ajpcell.00541.2002; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Semple RK, 2005, J CLIN ENDOCR METAB, V90, P1849, DOI 10.1210/jc.2004-1418; Shaw ND, 2011, J CLIN ENDOCR METAB, V96, pE566, DOI 10.1210/jc.2010-2292; SIMONIN F, 1995, P NATL ACAD SCI USA, V92, P7006, DOI 10.1073/pnas.92.15.7006; Szereszewski JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012964; Teles MG, 2010, EUR J ENDOCRINOL, V163, P29, DOI 10.1530/EJE-10-0012; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Tello JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038456; Tenenbaum-Rakover Y, 2007, J CLIN ENDOCR METAB, V92, P1137, DOI 10.1210/jc.2006-2147; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Trabado S, 2011, FERTIL STERIL, V95, P2324, DOI 10.1016/j.fertnstert.2011.03.091; Wahab F, 2011, MOL CELL ENDOCRINOL, V346, P29, DOI 10.1016/j.mce.2011.05.043; Young J, 2012, J CLIN ENDOCR METAB, V97, P707, DOI 10.1210/jc.2011-1664; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600	45	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53896	10.1371/journal.pone.0053896	http://dx.doi.org/10.1371/journal.pone.0053896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349759	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800018
J	Granja, C; Povoa, P; Lobo, C; Teixeira-Pinto, A; Carneiro, A; Costa-Pereira, A				Granja, Cristina; Povoa, Pedro; Lobo, Cristina; Teixeira-Pinto, Armando; Carneiro, Antonio; Costa-Pereira, Altamiro			The Predisposition, Infection, Response and Organ Failure (Piro) Sepsis Classification System: Results of Hospital Mortality Using a Novel Concept and Methodological Approach	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; INTENSIVE-CARE-UNIT; PRACTICE GUIDELINES; EPIDEMIOLOGY; MANAGEMENT; SCORE; DYSFUNCTION; ENGLAND; STATES; WALES	Introduction: PIRO is a conceptual classification system in which a number of demographic, clinical, biological and laboratory variables are used to stratify patients with sepsis in categories with different outcomes, including mortality rates. Objectives: To identify variables to be included in each component of PIRO aiming to improve the hospital mortality prediction. Methods: Patients were selected from the Portuguese ICU-admitted community-acquired sepsis study (SACiUCI). Variables concerning the R and O component included repeated measurements along the first five days in ICU stay. The trends of these variables were summarized as the initial value at day 1 (D1) and the slope of the tendency during the five days, using a linear mixed model. Logistic regression models were built to assess the best set of covariates that predicted hospital mortality. Results: A total of 891 patients (age 60 +/- 17 years, 64% men, 38% hospital mortality) were studied. Factors significantly associated with mortality for P component were gender, age, chronic liver failure, chronic renal failure and metastatic cancer; for I component were positive blood cultures, guideline concordant antibiotic therapy and health-care associated sepsis; for R component were C-reactive protein slope, D1 heart rate, heart rate slope, D1 neutrophils and neutrophils slope; for O component were D1 serum lactate, serum lactate slope, D1 SOFA and SOFA slope. The relative weight of each component of PIRO was calculated. The combination of these four results into a single-value predictor of hospital mortality presented an AUC-ROC 0.84 (IC95%: 0.81-0.87) and a test of goodness-of-fit (Hosmer and Lemeshow) of p = 0.368. Conclusions: We identified specific variables associated with each of the four components of PIRO, including biomarkers and a dynamic view of the patient daily clinical course. This novel approach to PIRO concept and overall score can be a better predictor of mortality for patients with community-acquired sepsis admitted to ICUs.	[Granja, Cristina; Teixeira-Pinto, Armando; Costa-Pereira, Altamiro] Fac Med Porto, Dept Hlth Informat & Decis Sci, Oporto, Portugal; [Granja, Cristina; Lobo, Cristina; Teixeira-Pinto, Armando; Costa-Pereira, Altamiro] Fac Med Porto, CINTESIS Ctr Res Hlth Technol & Hlth Syst, Oporto, Portugal; [Povoa, Pedro] Sao Francisco Xavier Hosp CHLO, Polyvalent Intens Care Unit, Lisbon, Portugal; [Povoa, Pedro] Univ Nova Lisboa, Fac Med Sci, CEDOC, Lisbon, Portugal; [Teixeira-Pinto, Armando] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Carneiro, Antonio] Hosp Arrabida, Intens Care Unit, Vila Nova De Gaia, Portugal	Universidade do Porto; Universidade do Porto; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade Nova de Lisboa; University of Sydney	Granja, C (corresponding author), Fac Med Porto, Dept Hlth Informat & Decis Sci, Oporto, Portugal.	cristinagranja@hotmail.com	Povoa, Pedro/I-1669-2013; Costa-Pereira, Altamiro/I-5987-2012; Granja, Cristina/ABG-6861-2020; Granja, Cristina/H-8146-2013; Teixeira-Pinto, Armando/H-7947-2013; , CINTESIS/C-6631-2014	Costa-Pereira, Altamiro/0000-0001-8467-6398; Granja, Cristina/0000-0002-5503-051X; Teixeira-Pinto, Armando/0000-0002-9389-2516; Povoa, Pedro/0000-0002-7069-7304; , CINTESIS/0000-0001-7248-2086	Fundacao para a Ciencia e Tecnologia [PIC/IC/83312/2007]; Fundação para a Ciência e a Tecnologia [PIC/IC/83312/2007, 2021.06067.BD] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	Cristina Lobo was financially supported by the Grant from Fundacao para a Ciencia e Tecnologia (PIC/IC/83312/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Cardoso T, 2010, CRIT CARE, V14, DOI 10.1186/cc9008; Chalupka AN, 2012, CRIT CARE CLIN, V28, P57, DOI 10.1016/j.ccc.2011.09.003; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Howell MD, 2011, CRIT CARE MED, V39, P322, DOI 10.1097/CCM.0b013e3182037a8e; Hutt E, 2002, J FAM PRACTICE, V51, P709; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2005, CRIT CARE MED, V33, P2194, DOI 10.1097/01.CCM.0000182798.39709.84; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lisboa T, 2008, CHEST, V134, P1208, DOI 10.1378/chest.08-1106; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Menendez R, 2005, AM J RESP CRIT CARE, V172, P757, DOI 10.1164/rccm.200411-1444OC; Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Moreno RP, 2008, INTENS CARE MED, V34, P496, DOI 10.1007/s00134-007-0943-1; Mylotte JM, 2002, CLIN INFECT DIS, V35, P1205, DOI 10.1086/344281; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Ferreira AMP, 2011, SEMIN RESP CRIT CARE, V32, P543, DOI 10.1055/s-0031-1287862; Povoa P, 2008, CURR OPIN INFECT DIS, V21, P157, DOI 10.1097/QCO.0b013e3282f47c32; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10313; Povoa PR, 2009, CRIT CARE MED, V37, P410, DOI 10.1097/CCM.0b013e3181958b1c; Rello J, 2009, CRIT CARE MED, V37, P456, DOI 10.1097/CCM.0b013e318194b021; Rivers EP, 2007, CRIT CARE MED, V35, P2016, DOI 10.1097/01.CCM.0000281637.08984.6E; Rubulotta F, 2009, CRIT CARE MED, V37, P1329, DOI 10.1097/CCM.0b013e31819d5db1; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Soares M, 2011, CRIT CARE MED, V39, P408, DOI 10.1097/CCM.0b013e3181f17a04; Solomkin JS, 2003, CLIN INFECT DIS, V37, P997, DOI 10.1086/378702; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vincent JL, 2003, CRIT CARE MED, V31, P834, DOI 10.1097/01.CCM.0000051515.56179.E1; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427	38	26	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53885	10.1371/journal.pone.0053885	http://dx.doi.org/10.1371/journal.pone.0053885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349756	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800017
J	Pongor, LS; Pinter, F; Petak, I				Pongor, Lorinc S.; Pinter, Ferenc; Petak, Istvan			HeurAA: Accurate and Fast Detection of Genetic Variations with a Novel Heuristic Amplicon Aligner Program for Next Generation Sequencing	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG CANCERS; MOLECULAR DIAGNOSTICS; SOMATIC MUTATIONS; READ ALIGNMENT; COPY NUMBER; GEFITINIB; PROTEIN; CATALOG; SEARCH	Next generation sequencing (NGS) of PCR amplicons is a standard approach to detect genetic variations in personalized medicine such as cancer diagnostics. Computer programs used in the NGS community often miss insertions and deletions (indels) that constitute a large part of known human mutations. We have developed HeurAA, an open source, heuristic amplicon aligner program. We tested the program on simulated datasets as well as experimental data from multiplex sequencing of 40 amplicons in 12 oncogenes collected on a 454 Genome Sequencer from lung cancer cell lines. We found that HeurAA can accurately detect all indels, and is more than an order of magnitude faster than previous programs. HeurAA can compare reads and reference sequences up to several thousand base pairs in length, and it can evaluate data from complex mixtures containing reads of different gene-segments from different samples. HeurAA is written in C and Perl for Linux operating systems, the code and the documentation are available for research applications at http://sourceforge.net/projects/heuraa/	[Pongor, Lorinc S.; Pinter, Ferenc; Petak, Istvan] KPS Med Biotechnol & Healthcare Serv Ltd, Budapest, Hungary		Pongor, LS (corresponding author), KPS Med Biotechnol & Healthcare Serv Ltd, Budapest, Hungary.	pongorlorinc@gmail.com; petak@kps.hu	Pongor, Lorinc/AAA-9835-2021; Petak, Istvan/X-3656-2019	Pongor, Lorinc/0000-0001-5917-4628; 	Hungarian National Development Agency [TECH_08_A2 STEMKILL OM-107/2008]	Hungarian National Development Agency	This work was supported by a research grant from the Hungarian National Development Agency (TECH_08_A2 STEMKILL OM-107/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Croes EA, 2004, J NEUROL NEUROSUR PS, V75, P1166, DOI 10.1136/jnnp.2003.020198; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Ferragina P, 2000, EXPT STUDY OPPORTUNI, P390; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; GOLDFARB LG, 1993, NEUROLOGY, V43, P2392, DOI 10.1212/WNL.43.11.2392; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; Kris NG, 2011, ASCOS BLUEPRINT TRAN; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Oliver GR, 2012, F1000 RES, V1, P1; Petak I, 2010, NAT REV DRUG DISCOV, V9, P523, DOI 10.1038/nrd3135; Pinter F, 2008, J MOL DIAGN, V10, P160, DOI 10.2353/jmoldx.2008.070125; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schwab R, 2005, J CLIN ONCOL, V23, P7736, DOI 10.1200/JCO.2005.02.4760; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stenson Peter D, 2009, Hum Genomics, V4, P69	27	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54294	10.1371/journal.pone.0054294	http://dx.doi.org/10.1371/journal.pone.0054294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349847	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800037
J	Sharma, P; Gaur, SN; Arora, N				Sharma, Prerna; Gaur, Shailendra Nath; Arora, Naveen			In silico Identification of IgE-Binding Epitopes of Osmotin Protein	PLOS ONE			English	Article							HYPOALLERGENIC MUTANTS; POLLEN ALLERGEN; TOBACCO OSMOTIN; CELL EPITOPES; EXPRESSION	The identification of B-cell epitopes is an important step to study the antigen-antibody interactions for diagnosis and therapy. The present study aimed to identify B-cell epitopes of osmotin using bioinformatic tools and further modify these regions to study the allergenic property. B-cell epitopes were predicted based on amino acid physicochemical properties. Three single point mutations M1, M2, and M3 and a multiple point mutant (M123) were selected to disrupt the IgE binding. These mutants were cloned, expressed and proteins purified to homogeneity. The IgE binding of the purified proteins was evaluated by ELISA and ELISA inhibition with patients' sera. Three regions of osmotin M1 (57-70 aa), M2 (72-85 aa) and M3 (147-165 aa) were identified as potential antibody recognition sites using in silico tools. The sequence similarity search of the predicted epitopes of osmotin using Structural Database of Allergenic proteins (SDAP) showed similarity with known allergens from tomato, kiwifruit, bell pepper, apple, mountain cedar and cypress. Mutants M1, M2 and M3 showed up to 72%, 60% and 76% reduction, respectively in IgE binding whereas M123 showed up to 90% reduction with patients' sera. The immunoblot of M123 mutant showed 40% reduction in spot density as compared to osmotin. All mutants showed decreased inhibition potency with M123 exhibiting lowest potency of 32% with osmotin positive pooled patients' sera. The three B-cell epitopes of osmotin predicted by in silico method correlated with the experimental approach. The mutant M123 showed a reduction of 90% in IgE binding. The present method may be employed for prediction of B-cell epitopes of allergenic proteins.	[Sharma, Prerna; Arora, Naveen] CSIR Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India; [Gaur, Shailendra Nath] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Resp Med, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi	Arora, N (corresponding author), CSIR Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India.	naveen@igib.res.in			Council for Scientific and Industrial Reasearch (CSIR)	Council for Scientific and Industrial Reasearch (CSIR)	The work covered in this manuscript was funded by the Council for Scientific and Industrial Reasearch (CSIR). The URL for the funder's website is "http://rdpp.csir.res.in/csir_acsir/Home.aspx''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad LR, 1996, PLANT SCI, V118, P11, DOI 10.1016/0168-9452(96)04420-2; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Ayuso R, 2002, INT ARCH ALLERGY IMM, V127, P27, DOI 10.1159/000048166; Bannon GA, 2004, CURR ALLERGY ASTHM R, V4, P43, DOI 10.1007/s11882-004-0042-0; Barthakur S, 2001, J PLANT BIOCHEM BIOT, V10, P31, DOI 10.1007/BF03263103; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bolhaar STHP, 2005, CLIN EXP ALLERGY, V35, P1638, DOI 10.1111/j.1365-2222.2005.02390.x; Busse PJ, 2002, INT ARCH ALLERGY IMM, V129, P93, DOI 10.1159/000065178; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Cianferoni Antonella, 2009, Allergology International, V58, P457, DOI 10.2332/allergolint.09-RAI-0138; CORNELISSEN BJC, 1986, NATURE, V321, P531, DOI 10.1038/321531a0; Das M, 2011, TRANSGENIC RES, V20, P231, DOI 10.1007/s11248-010-9405-6; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; Garcia-Casado G, 2003, J ALLERGY CLIN IMMUN, V112, P599, DOI 10.1037/mai.2003.1638; Goel D, 2010, PROTOPLASMA, V245, P133, DOI 10.1007/s00709-010-0158-0; Herman EM, 2003, J EXP BOT, V54, P1317, DOI 10.1093/jxb/erg164; Husaini AM, 2008, INDIAN J BIOTECHNOL, V7, P465; Jaervinen KM, 2007, ALLERGY, V62, P758, DOI 10.1111/j.1398-9995.2007.01332.x; King N, 2005, MOL NUTR FOOD RES, V49, P963, DOI 10.1002/mnfr.200500073; Maleki SJ, 2011, ALLERGY, V66, P1522, DOI 10.1111/j.1398-9995.2011.02692.x; Marazuela EG, 2007, CLIN EXP ALLERGY, V37, P251, DOI 10.1111/j.1365-2222.2006.02632.x; Nair S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020020; Nelson HS, 1997, J ALLERGY CLIN IMMUN, V99, P744, DOI 10.1016/S0091-6749(97)80006-1; Noori SAS, 2008, RUSS J PLANT PHYSL+, V55, P256, DOI 10.1134/S1021443708020143; Okada T, 1998, FEBS LETT, V434, P255, DOI 10.1016/S0014-5793(98)00992-2; Parkhi V, 2009, MOL BREEDING, V23, P625, DOI 10.1007/s11032-009-9261-3; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Reese G, 2005, J IMMUNOL, V175, P8354, DOI 10.4049/jimmunol.175.12.8354; Sharma P, 2011, J AGR FOOD CHEM, V59, P9990, DOI 10.1021/jf202265d; Sharma V, 2009, J PROTEOME RES, V8, P2650, DOI 10.1021/pr800784q; Sicherer SH, 2007, J ALLERGY CLIN IMMUN, V120, P491, DOI 10.1016/j.jaci.2007.07.015; Srivastava D, 2009, INFLAMM RES, V58, P523, DOI 10.1007/s00011-009-0033-7; Thalhamer T, 2010, J ALLERGY CLIN IMMUN, V125, P926, DOI 10.1016/j.jaci.2010.01.031; Toda M, 2011, J ALLERGY CLIN IMMUN, V128, P1022, DOI 10.1016/j.jaci.2011.04.020; Valenta R, 2007, J ALLERGY CLIN IMMUN, V119, P826, DOI 10.1016/j.jaci.2007.01.025; Vrtala S, 2008, ALLERGY, V63, P299, DOI 10.1111/j.1398-9995.2007.01609.x; Wang HW, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432830; Xiao Y, 2001, IMMUNOL LETT, V77, P3, DOI 10.1016/S0165-2478(01)00187-0	38	23	23	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54755	10.1371/journal.pone.0054755	http://dx.doi.org/10.1371/journal.pone.0054755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349964	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872800074
J	Joseph, HSSL; Liversedge, SP				Joseph, Holly S. S. L.; Liversedge, Simon P.			Children's and Adults' On-Line Processing of Syntactically Ambiguous Sentences during Reading	PLOS ONE			English	Article							Z-READER MODEL; EYE-MOVEMENTS; SACCADE GENERATION; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; SPOKEN LANGUAGE; DYNAMICAL MODEL; WORKING-MEMORY; LEXICAL-BIASES; INFORMATION	While there has been a fair amount of research investigating children's syntactic processing during spoken language comprehension, and a wealth of research examining adults' syntactic processing during reading, as yet very little research has focused on syntactic processing during text reading in children. In two experiments, children and adults read sentences containing a temporary syntactic ambiguity while their eye movements were monitored. In Experiment 1, participants read sentences such as, 'The boy poked the elephant with the long stick/trunk from outside the cage' in which the attachment of a prepositional phrase was manipulated. In Experiment 2, participants read sentences such as, 'I think I'll wear the new skirt I bought tomorrow/yesterday. It's really nice' in which the attachment of an adverbial phrase was manipulated. Results showed that adults and children exhibited similar processing preferences, but that children were delayed relative to adults in their detection of initial syntactic misanalysis. It is concluded that children and adults have the same sentence-parsing mechanism in place, but that it operates with a slightly different time course. In addition, the data support the hypothesis that the visual processing system develops at a different rate than the linguistic processing system in children.	[Joseph, Holly S. S. L.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Liversedge, Simon P.] Univ Southampton, Sch Psychol, Southampton, Hants, England	University of Oxford; University of Southampton	Joseph, HSSL (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	holly.joseph@psy.ox.ac.uk		Joseph, Holly/0000-0003-4325-4628	ESRC studentship [PTA-026-27-1912]; Leverhulme Trust [F/00128/AB F/00 180/AN]; ESRC [ES/I032398/1]; Economic and Social Research Council [ES/F040725/1, ES/I032398/1] Funding Source: researchfish; ESRC [ES/F040725/1] Funding Source: UKRI	ESRC studentship(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme Trust(Leverhulme Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by an ESRC studentship (PTA-026-27-1912) to the first author. The second author acknowledges support from the Leverhulme Trust (Grants F/00128/AB & F/00 180/AN) and the ESRC (ES/I032398/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN G, 1988, COGNITION, V30, P191, DOI 10.1016/0010-0277(88)90020-0; Altmann GTM, 1998, J MEM LANG, V38, P459, DOI 10.1006/jmla.1997.2562; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; [Anonymous], 1992, EYE MOVEMENTS VISUAL; Arnold JE, 2007, LANG COGNITIVE PROC, V22, P527, DOI 10.1080/01690960600845950; Bates E, 1989, CROSS LINGUISTIC STU; Blythe H. I., 2011, OXFORD HDB EYE MOVEM, P643, DOI [10.1093/oxfordhb/9780199539789.013.0036, DOI 10.1093/OXFORDHB/9780199539789.013.0036]; Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; Blythe HI, 2011, VISION RES, V51, P84, DOI 10.1016/j.visres.2010.10.003; Blythe HI, 2009, VISION RES, V49, P1583, DOI 10.1016/j.visres.2009.03.015; BOWEY JA, 1986, J PSYCHOLINGUIST RES, V15, P285, DOI 10.1007/BF01067676; Choi Y, 2011, ARCH MECH LANG PROC; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; CRAIN S, 1985, NATURAL LANGUAGE PAR, P320, DOI DOI 10.1017/CBO9780511597855.011; Crocker MW, 2000, J PSYCHOLINGUIST RES, V29, P647, DOI 10.1023/A:1026560822390; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Engbert R, 2002, VISION RES, V42, P621, DOI 10.1016/S0042-6989(01)00301-7; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; Frazier Lyn, 1978, THESIS U CONNECTICUT; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Haikio T, 2009, J EXP CHILD PSYCHOL, V102, P167, DOI 10.1016/j.jecp.2008.04.002; Hale J, 2001, 2ND MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P159; Huestegge L, 2009, VISION RES, V49, P2948, DOI 10.1016/j.visres.2009.09.012; Hurewitz F, 2000, J PSYCHOLINGUIST RES, V29, P597, DOI 10.1023/A:1026468209238; Hyona J, 2002, J EDUC PSYCHOL, V94, P44, DOI 10.1037//0022-0663.94.1.44; HYONA J, 1995, J EXP PSYCHOL LEARN, V21, P1430, DOI 10.1037/0278-7393.21.6.1430; Inhoff AW, 2005, MEM COGNITION, V33, P447, DOI 10.3758/BF03193062; Joseph HSSL, 2008, Q J EXP PSYCHOL, V61, P708, DOI 10.1080/17470210701400657; Joseph HSSL, 2009, VISION RES, V49, P2078, DOI 10.1016/j.visres.2009.05.015; Jurafsky D, 1996, COGNITIVE SCI, V20, P137, DOI 10.1207/s15516709cog2002_1; KENNEDY A, 1987, Q J EXP PSYCHOL-A, V39, P649, DOI 10.1080/14640748708401807; KIDD E, 2007, 1 LANGUAGE, V0027; Kidd E, 2012, DEV PSYCHOL, V48, P171, DOI 10.1037/a0025405; Kidd E, 2011, J CHILD LANG, V38, P222, DOI 10.1017/S0305000909990316; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Liu YP, 2010, COGNITION IN FLUX, P1136; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; MACDONALD MC, 1994, LANG COGNITIVE PROC, V9, P157, DOI 10.1080/01690969408402115; McConkie G.W., 1991, VISION VISUAL DYSLEX; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; Mitchell DC, 2008, J MEM LANG, V59, P266, DOI 10.1016/j.jml.2008.06.002; MORGAN JL, 1987, COGNITIVE PSYCHOL, V19, P498, DOI 10.1016/0010-0285(87)90017-X; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; O'Regan J K, 1990, Rev Oculomot Res, V4, P395; OREGAN JK, 1987, ATTENTION PERFORM, P363; Palladino P, 2001, MEM COGNITION, V29, P344, DOI 10.3758/BF03194929; Parviainen T, 2006, J NEUROSCI, V26, P6052, DOI 10.1523/JNEUROSCI.0673-06.2006; Pickering M.J., 2006, HDB PSYCHOLINGUISTIC, V2nd ed., P455; Pollatsek A, 2006, COGNITIVE PSYCHOL, V52, P1, DOI 10.1016/j.cogpsych.2005.06.001; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1983, J VERB LEARN VERB BE, V22, P358, DOI 10.1016/S0022-5371(83)90236-0; RAYNER K, 1986, J EXP CHILD PSYCHOL, V41, P211, DOI 10.1016/0022-0965(86)90037-8; Reichle ED, 2006, PSYCHOL REV, V113, P390, DOI 10.1037/0033-295X.113.2.390; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; Reichle ED, 2012, DEV REV IN PRESS; Rust J, 1993, WECHSLER OBJECTIVE R; Saffran JR, 2001, P NATL ACAD SCI USA, V98, P12874, DOI 10.1073/pnas.231498898; Sekerina IA, 2004, J CHILD LANG, V31, P123, DOI 10.1017/S0305000903005890; Snedeker J, 2004, COGNITIVE PSYCHOL, V49, P238, DOI 10.1016/j.cogpsych.2004.03.001; Snedeker J, 2001, P 23 ANN C COGN SCI, P964; SPIVEYKNOWLTON M, 1995, COGNITION, V55, P227, DOI 10.1016/0010-0277(94)00647-4; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; TARABAN R, 1988, J MEM LANG, V27, P597, DOI 10.1016/0749-596X(88)90011-3; TAYLOR SE, 1965, AM EDUC RES J, V2, P187, DOI 10.2307/1161646; Tomasello M, 2000, TRENDS COGN SCI, V4, P156, DOI 10.1016/S1364-6613(00)01462-5; Traxler MJ, 1998, J MEM LANG, V39, P558, DOI 10.1006/jmla.1998.2600; Trueswell J, 1999, COGNITION, P73; TRUESWELL JC, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P155; TRUESWELL JC, 1994, J MEM LANG, V33, P285, DOI 10.1006/jmla.1994.1014; van Gompel RPG, 2005, J MEM LANG, V52, P284, DOI 10.1016/j.jml.2004.11.003; van Gompel RPG, 2001, J MEM LANG, V45, P225, DOI 10.1006/jmla.2001.2773; Weger UW, 2007, MEM COGNITION, V35, P1293, DOI 10.3758/BF03193602; Weighall AR, 2008, J EXP CHILD PSYCHOL, V99, P75, DOI 10.1016/j.jecp.2007.10.004; WILLOWS DM, 1986, READ RES QUART, V21, P253, DOI 10.2307/747708; WILLOWS DM, 1981, J EDUC PSYCHOL, V73, P607, DOI 10.1037/0022-0663.73.5.607; Yang SN, 2004, EUR J COGN PSYCHOL, V16, P226, DOI 10.1080/09541440340000231; Yang SN, 2001, VISION RES, V41, P3567, DOI 10.1016/S0042-6989(01)00025-6; Zang G, 2012, J EXP PSYCH IN PRESS	81	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54141	10.1371/journal.pone.0054141	http://dx.doi.org/10.1371/journal.pone.0054141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	073JI	23349807	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000313738900043
J	Namjoshi, DR; Martin, G; Donkin, J; Wilkinson, A; Stukas, S; Fan, JJ; Carr, M; Tabarestani, S; Wuerth, K; Hancock, REW; Wellington, CL				Namjoshi, Dhananjay R.; Martin, Georgina; Donkin, James; Wilkinson, Anna; Stukas, Sophie; Fan, Jianjia; Carr, Michael; Tabarestani, Sepideh; Wuerth, Kelli; Hancock, Robert E. W.; Wellington, Cheryl L.			The Liver X Receptor Agonist GW3965 Improves Recovery from Mild Repetitive Traumatic Brain Injury in Mice Partly through Apolipoprotein E	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; E-DEFICIENT MICE; ALZHEIMERS-DISEASE; AXONAL INJURY; HEAD-INJURY; AMYLOID DEPOSITION; E POLYMORPHISM; MOUSE MODEL; LIPOPROTEIN PARTICLES; APP23 MICE	Traumatic brain injury (TBI) increases Alzheimer's disease (AD) risk and leads to the deposition of neurofibrillary tangles and amyloid deposits similar to those found in AD. Agonists of Liver X receptors (LXRs), which regulate the expression of many genes involved in lipid homeostasis and inflammation, improve cognition and reduce neuropathology in AD mice. One pathway by which LXR agonists exert their beneficial effects is through ATP-binding cassette transporter A1 (ABCA1)-mediated lipid transport onto apolipoprotein E (apoE). To test the therapeutic utility of this pathway for TBI, we subjected male wild-type (WT) and apoE(-/-) mice to mild repetitive traumatic brain injury (mrTBI) followed by treatment with vehicle or the LXR agonist GW3965 at 15 mg/kg/day. GW3965 treatment restored impaired novel object recognition memory in WT but not apoE(-/-) mice. GW3965 did not significantly enhance the spontaneous recovery of motor deficits observed in all groups. Total soluble A beta(40) and A beta(42) levels were significantly elevated in WT and apoE(-/-) mice after injury, a response that was suppressed by GW3965 in both genotypes. WT mice showed mild but significant axonal damage at 2 d post-mrTBI, which was suppressed by GW3965. In contrast, apoE(-/-) mice showed severe axonal damage from 2 to 14 d after mrTBI that was unresponsive to GW3965. Because our mrTBI model does not produce significant inflammation, the beneficial effects of GW3965 we observed are unlikely to be related to reduced inflammation. Rather, our results suggest that both apoE-dependent and apoE-independent pathways contribute to the ability of GW3965 to promote recovery from mrTBI.	[Namjoshi, Dhananjay R.; Martin, Georgina; Donkin, James; Wilkinson, Anna; Stukas, Sophie; Fan, Jianjia; Carr, Michael; Tabarestani, Sepideh; Wellington, Cheryl L.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Wuerth, Kelli; Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Wellington, CL (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	cheryl@cmmt.ubc.ca	Stukas, Sophie/GQO-7639-2022; Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Stukas, Sophie/0000-0001-8819-8821; Wuerth, Kelli/0000-0001-5260-9166; Namjoshi, Dhananjay/0000-0003-1753-5581	operating grant from the Canadian Institutes of Health Research (CIHR) [MOP 67088]; Alzheimer Society Research Program (ASRP, Alzheimer Society of Canada) doctoral award; ASRP post-doctoral award; CIHR Vanier studentship; Child & Family Research Institute studentship	operating grant from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Research Program (ASRP, Alzheimer Society of Canada) doctoral award; ASRP post-doctoral award; CIHR Vanier studentship(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute studentship	This work was supported by an operating grant (MOP 67088) to C.L.W. from the Canadian Institutes of Health Research (CIHR). D.R.N. was supported by Alzheimer Society Research Program (ASRP, Alzheimer Society of Canada) doctoral award. J.D. was supported by an ASRP post-doctoral award. S.S. was supported by a CIHR Vanier studentship. J.F. was supported by a Child & Family Research Institute studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goldstein LE, 2012, SCI TRANSL MED, V4; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Jamroz-Wisniewska Anna, 2007, Postepy Hig Med Dosw (Online), V61, P760; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jiang Y, 2008, ACTA NEUROCHIR SUPPL, V105, P233; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; LaDu MJ, 2000, ANN NY ACAD SCI, V903, P167, DOI 10.1111/j.1749-6632.2000.tb06365.x; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; May S, 2011, J NEUROLOGY NEUROSCI, V2, P1; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petit-Turcotte C, 2007, NEUROSCIENCE, V150, P58, DOI 10.1016/j.neuroscience.2007.05.021; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	68	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53529	10.1371/journal.pone.0053529	http://dx.doi.org/10.1371/journal.pone.0053529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349715	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900009
J	Zheng, WL; Xu, HY; Lam, SH; Luo, HE; Karuturi, RKM; Gong, ZY				Zheng, Weiling; Xu, Hongyan; Lam, Siew Hong; Luo, Huaien; Karuturi, R. Krishna Murthy; Gong, Zhiyuan			Transcriptomic Analyses of Sexual Dimorphism of the Zebrafish Liver and the Effect of Sex Hormones	PLOS ONE			English	Article							HEPATIC GENE-EXPRESSION; DANIO-RERIO; TRANSGENIC ZEBRAFISH; HEPATOCELLULAR-CARCINOMA; ESTROGENIC COMPOUNDS; VITELLOGENIN GENES; ENRICHED GENES; METABOLISM; RECEPTOR; EXPOSURE	The liver is one of the most sex-dimorphic organs in both oviparous and viviparous animals. In order to understand the molecular basis of the difference between male and female livers, high-throughput RNA-SAGE (serial analysis of gene expression) sequencing was performed for zebrafish livers of both sexes and their transcriptomes were compared. Both sexes had abundantly expressed genes involved in translation, coagulation and lipid metabolism, consistent with the general function of the liver. For sex-biased transcripts, from in addition to the high enrichment of vitellogenin transcripts in spawning female livers, which constituted nearly 80% of total mRNA, it is apparent that the female-biased genes were mostly involved in ribosome/translation, estrogen pathway, lipid transport, etc, while the male-biased genes were enriched for oxidation reduction, carbohydrate metabolism, coagulation, protein transport and localization, etc. Sexual dimorphism on xenobiotic metabolism and anti-oxidation was also noted and it is likely that retinol x receptor (RXR) and liver x receptor (LXR) play central roles in regulating the sexual differences of lipid and cholesterol metabolisms. Consistent with high ribosomal/translational activities in the female liver, female-biased genes were significantly regulated by two important transcription factors, Myc and Mycn. In contrast, Male livers showed activation of transcription factors Ppargc1b, Hnf4a, and Stat4, which regulate lipid and glucose metabolisms and various cellular activities. The transcriptomic responses to sex hormones, 17 beta-estradiol (E2) or 11-keto testosterone (KT11), were also investigated in both male and female livers and we found that female livers were relatively insensitive to sex hormone disturbance, while the male livers were readily affected. E2 feminized male liver by up-regulating female-biased transcripts and down-regulating male-biased transcripts. The information obtained in this study provides comprehensive insights into the sexual dimorphism of zebrafish liver transcriptome and will facilitate further development of the zebrafish as a human liver disease model.	[Zheng, Weiling; Xu, Hongyan; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Luo, Huaien; Karuturi, R. Krishna Murthy] Genome Inst Singapore, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Lam, Siew Hong/H-8483-2012; Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme [R-154-000-328-272]	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Pham CH, 2011, AQUAT TOXICOL, V105, P569, DOI 10.1016/j.aquatox.2011.08.019; Cinaroglu A, 2011, HEPATOLOGY; Correale J, 2011, MULT SCLER J, V17, P521, DOI 10.1177/1352458510392619; Curado S, 2010, SEMIN LIVER DIS, V30, P288, DOI 10.1055/s-0030-1255357; Curado S, 2010, DIS MODEL MECH, V3, P486, DOI 10.1242/dmm.004390; Davis LK, 2008, GEN COMP ENDOCR, V156, P544, DOI 10.1016/j.ygcen.2008.03.002; Deaciuc IV, 2004, J HEPATOL, V40, P219, DOI 10.1016/j.jhep.2003.10.021; Dell H, 1999, J BIOL CHEM, V274, P9013, DOI 10.1074/jbc.274.13.9013; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Gao MH, 2011, BBA-MOL CELL RES, V1813, P1239, DOI 10.1016/j.bbamcr.2011.03.017; Goetz FW, 2009, PHYSIOL GENOMICS, V38, P261, DOI 10.1152/physiolgenomics.00069.2009; Groh KJ, 2011, FISH PHYSIOL BIOCHEM, V37, P619, DOI 10.1007/s10695-010-9464-x; Hallare A, 2006, ECOTOX ENVIRON SAFE, V63, P378, DOI 10.1016/j.ecoenv.2005.07.006; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hashimoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004108; Hoffmann JL, 2008, AQUAT TOXICOL, V87, P69, DOI 10.1016/j.aquatox.2008.01.012; Holth TF, 2008, AQUAT TOXICOL, V90, P277, DOI 10.1016/j.aquatox.2008.08.020; Hook SE, 2006, AQUAT TOXICOL, V77, P372, DOI 10.1016/j.aquatox.2006.01.007; Howarth DL, 2011, ALCOHOL CLIN EXP RES, V35, P826, DOI 10.1111/j.1530-0277.2010.01407.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kausch U, 2008, ENVIRON TOXICOL, V23, P15, DOI 10.1002/tox.20306; Kling P, 2008, ECOTOX ENVIRON SAFE, V71, P319, DOI 10.1016/j.ecoenv.2007.12.010; Knoll-Gellida A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-46; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Lam SH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-41; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Levi L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-141; Li Y, 2004, COMP FUNCT GENOM, V5, P403, DOI 10.1002/cfg.418; Li Z, 2012, DIS MODELS MECH; Li ZJ, 2009, MOL IMMUNOL, V46, P3232, DOI 10.1016/j.molimm.2009.08.006; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Liu XJ, 2006, BIOL REPROD, V74, P1016, DOI 10.1095/biolreprod.105.049403; Liu YF, 2011, J BREAST CANCER, V14, P20, DOI 10.4048/jbc.2011.14.1.20; Mode A, 2006, DRUG METAB REV, V38, P197, DOI 10.1080/03602530600570057; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robison BD, 2008, COMP BIOCHEM PHYS D, V3, P141, DOI 10.1016/j.cbd.2008.01.001; Rogers AB, 2004, TOXICOL PATHOL, V32, P668, DOI 10.1080/01926230490524247; Rogers AB, 2007, CANCER RES, V67, P11536, DOI 10.1158/0008-5472.CAN-07-1479; ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345; Ruggeri B, 2008, GEN COMP ENDOCR, V158, P138, DOI 10.1016/j.ygcen.2008.05.012; Santos EM, 2008, COMP BIOCHEM PHYS A, V149, P314, DOI 10.1016/j.cbpa.2008.01.010; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Small CM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-579; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; STERNBERG EM, 1992, ANN INTERN MED, V117, P854, DOI 10.7326/0003-4819-117-10-854; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Taboada X, 2012, GENE, V492, P250, DOI 10.1016/j.gene.2011.10.020; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Tong Y, 2004, GENE, V328, P25, DOI 10.1016/j.gene.2003.12.001; Troxel CM, 1997, TOXICOL APPL PHARM, V143, P213, DOI 10.1006/taap.1996.8058; Ung CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-212; Ung CY, 2009, ZEBRAFISH, V6, P425, DOI 10.1089/zeb.2009.0608; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Wang-Buhler JL, 2005, COMP BIOCHEM PHYS C, V140, P207, DOI 10.1016/j.cca.2005.02.002; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wen CM, 2005, DEV DYNAM, V232, P171, DOI 10.1002/dvdy.20210; Weng Y, 2005, J BIOL CHEM, V280, P31686, DOI 10.1074/jbc.M504447200; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zeng S, 2002, GENE, V294, P45, DOI 10.1016/S0378-1119(02)00791-6; Zhang W, 2012, ENVIRON SCI TECHNOL, V46, P5175, DOI 10.1021/es300147w; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271; Zhao S, 2012, BIOCHEM CELL BIOL, V90, P142, DOI [10.1139/O11-079, 10.1139/o11-079]	78	52	53	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53562	10.1371/journal.pone.0053562	http://dx.doi.org/10.1371/journal.pone.0053562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349717	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900011
J	Sen, A; Damm, VT; Cox, RT				Sen, Aditya; Damm, Vanessa T.; Cox, Rachel T.			Drosophila Clueless Is Highly Expressed in Larval Neuroblasts, Affects Mitochondrial Localization and Suppresses Mitochondrial Oxidative Damage	PLOS ONE			English	Article							SELF-RENEWAL; MORPHOLOGY; DYNAMICS; PATTERNS; MUTATION; FISSION; FUSION; GENES; ROLES; BRAIN	Mitochondria are critical for neuronal function due to the high demand of ATP in these cell types. During Drosophila development, neuroblasts in the larval brain divide asymmetrically to populate the adult central nervous system. While many of the proteins responsible for maintaining neuroblast cell fate and asymmetric cell divisions are known, little is know about the role of metabolism and mitochondria in neuroblast division and maintenance. The gene clueless (clu) has been previously shown to be important for mitochondrial function. clu mutant adults have severely shortened lifespans and are highly uncoordinated. Part of their lack of coordination is due to defects in muscle, however, in this study we have identified high levels of Clu expression in larval neuroblasts and other regions of the dividing larval brain. We show while mitochondria in clu mutant neuroblasts are mislocalized during the cell cycle, surprisingly, overall brain morphology appears to be normal. This is explained by our observation that clu mutant larvae have normal levels of ATP and do not suffer oxidative damage, in sharp contrast to clu mutant adults. Mutations in two other genes encoding mitochondrial proteins, technical knockout and stress sensitive B, do not cause neuroblast mitochondrial mislocalization, even though technical knockout mutant larvae suffer oxidative damage. These results suggest Clu functions upstream of electron transport and oxidative phosphorylation, has a role in suppressing oxidative damage in the cell, and that lack of Clu's specific function causes mitochondria to mislocalize. These results also support the previous observation that larval development relies on aerobic glycolysis, rather than oxidative phosphorylation. Thus Clu's role in mitochondrial function is not critical during larval development, but is important for pupae and adults.	[Sen, Aditya; Damm, Vanessa T.; Cox, Rachel T.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD USA; [Damm, Vanessa T.; Cox, Rachel T.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Cox, RT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD USA.	rachel.cox@usuhs.edu			USUHS [CO71IQ]; Center for Neuroscience and Regeneration [G171JA]; NICHD	USUHS; Center for Neuroscience and Regeneration; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by USUHS start-up grant CO71IQ and the Center for Neuroscience and Regeneration grant G171JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Cheng-Yu Lee for the aur<SUP>14641</SUP> stock, Dr. Chris Doe for the anti-Mir antibody, Dr. Michael Pallandino for the ATP6<SUP>1</SUP>; sesB<SUP>1</SUP> stock, and Dr. Chun-Fang Wu for the tko<SUP>25t</SUP> stock. We would also like to thank Xin Xiang for helpful discussions and Allan Spradling, in whose lab we first observed Clu labeling in neuroblasts. The anti-tubulin antibodies AA4.3, AA12.1, and E7, developed by Drs. Charles Walsh and Michael Klymkowsky, respectfully, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. We also thank the members of the USUHS Biomedical Instrumentation Core for imaging support.	Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Chai PC, 2012, WIRES DEV BIOL, V1, P307, DOI 10.1002/wdev.27; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159; Cox RT, 2006, DEVELOPMENT, V133, P3371, DOI 10.1242/dev.02514; Cox RT, 2009, DIS MODEL MECH, V2, P490, DOI 10.1242/dmm.002378; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Duttaroy A, 2003, GENETICS, V165, P2295; Fergestad Tim, 2006, Genetics, V173, P1357, DOI 10.1534/genetics.106.057463; Fields SD, 1998, J CELL SCI, V111, P1717; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hayden MA, 2007, DEV BIOL, V305, P358, DOI 10.1016/j.ydbio.2007.02.018; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; JUDD BH, 1972, GENETICS, V71, P139; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kumar S, 2011, BIOINFORMATICS, V27, P3319, DOI 10.1093/bioinformatics/btr567; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Logan DC, 2003, PLANT J, V36, P500, DOI 10.1046/j.1365-313X.2003.01894.x; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; Zhang YQ, 1999, GENETICS, V153, P891; Zhu QL, 1997, P NATL ACAD SCI USA, V94, P7308, DOI 10.1073/pnas.94.14.7308	37	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54283	10.1371/journal.pone.0054283	http://dx.doi.org/10.1371/journal.pone.0054283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342118	Green Submitted, gold, Green Published			2022-12-27	WOS:000313682700102
J	Crooke, AK; Fuller, JR; Obrist, MW; Tomkovich, SE; Vitko, NP; Richardson, AR				Crooke, Adrianne K.; Fuller, James R.; Obrist, Markus W.; Tomkovich, Sarah E.; Vitko, Nicholas P.; Richardson, Anthony R.			CcpA-Independent Glucose Regulation of Lactate Dehydrogenase 1 in Staphylococcus aureus	PLOS ONE			English	Article							NITRIC-OXIDE; BACILLUS-SUBTILIS; INNATE IMMUNITY; METABOLISM; RESISTANCE; GENE; INFECTIONS; EXPRESSION; REPRESSOR; REGULON	Lactate Dehydrogenase 1 (Ldh1) is a key enzyme involved in Staphylococcus aureus NO-resistance. Full ldh1-induction requires the presence of glucose, and mutants lacking the Carbon-Catabolite Protein (CcpA) exhibit decreased ldh1 transcription and diminished Ldh1 activity. The redox-regulator Rex represses ldh1 directly by binding to Rex-sites within the ldh1 promoter (P-ldh1). In the absence of Rex, neither glucose nor CcpA affect ldh1 expression implying that glucose/CcpA-mediated activation requires Rex activity. Rex-mediated repression of ldh1 depends on cellular redox status and is maximal when NADH levels are low. However, compared to WT cells, the Delta ccpA mutant exhibited impaired redox balance with relatively high NADH levels, yet ldh1 was still poorly expressed. Furthermore, CcpA did not drastically alter Rex transcript levels, nor did glucose or CcpA affect the expression of other Rex-regulated genes indicating that the glucose/CcpA effect is specific for P-ldh1. A putative catabolite response element (CRE) is located similar to 30 bp upstream of the promoter-distal Rex-binding site in P-ldh1. However, CcpA had no affinity for P-ldh1 in vitro and a genomic mutation of CRE upstream of P-ldh1 in S. aureus had no affect on Ldh1 expression in vivo. In contrast to WT, Delta ccpA S. aureus preferentially consumes non-glycolytic carbon sources. However when grown in defined medium with glucose as the primary carbon source, Delta ccpA mutants express high levels of Ldh1 compared to growth in media devoid of glucose. Thus, the actual consumption of glucose stimulates Ldh1 expression rather than direct CcpA interaction at P-ldh1.	[Crooke, Adrianne K.; Fuller, James R.; Obrist, Markus W.; Tomkovich, Sarah E.; Vitko, Nicholas P.; Richardson, Anthony R.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Richardson, AR (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	anthony_richardson@med.unc.edu	Tomkovich, Sarah/ABF-7952-2020	Tomkovich, Sarah/0000-0003-1638-5307	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [AI093613]; Pew Charitable Trusts (Pew Scholars Program in the Biomedical Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093613] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pew Charitable Trusts (Pew Scholars Program in the Biomedical Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) (AI093613 to ARR) and the Pew Charitable Trusts (Pew Scholars Program in the Biomedical Sciences). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2011, J BIOCHEM, V150, P579, DOI 10.1093/jb/mvr100; Brown GC, 1997, BIOCHEM SOC T, V25, P901, DOI 10.1042/bst0250901; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; DYKE KGH, 1969, J MED MICROBIOL, V2, P261, DOI 10.1099/00222615-2-3-261; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fuller JR, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00019; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lambert M, 2011, AM FAM PHYSICIAN, V84, P455; Li CL, 2010, J BACTERIOL, V192, P3883, DOI 10.1128/JB.00237-10; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Makhlin J, 2007, J BACTERIOL, V189, P5976, DOI 10.1128/JB.00592-07; Marciniak BC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-401; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Richardson AR, 2011, CELL HOST MICROBE, V10, P33, DOI 10.1016/j.chom.2011.06.004; SABATH LD, 1972, ANTIMICROB AGENTS CH, V22, P350, DOI 10.1128/AAC.2.5.350; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Titgemeyer F, 2002, ANTON LEEUW INT J G, V82, P59, DOI 10.1023/A:1020628909429; Toledo JC, 2012, CHEM RES TOXICOL, V25, P975, DOI 10.1021/tx300042g; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; Yang SJ, 2006, MOL MICROBIOL, V60, P458, DOI 10.1111/j.1365-2958.2006.05105.x	26	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54293	10.1371/journal.pone.0054293	http://dx.doi.org/10.1371/journal.pone.0054293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342123	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400143
J	Matsuzaki, Y; Hosokai, H; Mizuguchi, Y; Fukamachi, S; Shimizu, A; Saya, H				Matsuzaki, Yuriko; Hosokai, Haru; Mizuguchi, Yukiyo; Fukamachi, Shoji; Shimizu, Atsushi; Saya, Hideyuki			Establishment of HRAS(G12V) Transgenic Medaka as a Stable Tumor Model for In Vivo Screening of Anticancer Drugs	PLOS ONE			English	Article							ZEBRAFISH MODEL; ORYZIAS-LATIPES; MELANOMA; PROGRESSION; EXPRESSION; RATIONALE; PATHWAYS; CELLS; GENE	Most targeted anticancer drugs have been identified by screening at the molecular or cellular level in vitro. However, many compounds selected by such costly and time-consuming screening do not prove effective against tumors in vivo. The development of anticancer drugs would thus be facilitated by the availability of an in vivo screening system based on a multicellular organism. We have now established a transgenic line of the freshwater fish medaka in which melanophores (melanocytes) proliferate in a manner dependent on heat shock-induced signaling by a human RAS oncoprotein. The human HRAS(G12V) oncogene was expressed under the control of a melanophore-specific gene promoter in order to allow visualization of tumor growth in live fish maintained in a water tank. The expression of HRAS(G12V) was induced as a result of Cre-mediated recombination by exposure of the fish to a temperature of 37 degrees C for 30 min, given that the Cre gene was placed under the control of a medaka heat shock promoter. One of the stable transgenic lines developed abnormal pigment cell proliferation in the eyes and epidermis with 100% penetrance by 6 months postfertilization. Sorafenib, an inhibitor of RAS signaling, was administered to the transgenic fish and was found both to reduce the extent of melanophore proliferation and to improve survival. The transgenic medaka established here thus represents a promising in vivo system with which to screen potential anticancer drugs that target RAS signaling, and this system can readily be adapted for the screening of agents that target other oncogenes.	[Matsuzaki, Yuriko; Mizuguchi, Yukiyo; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Hosokai, Haru] Japan Womens Univ, Div Mat & Biol Sci, Tokyo 112, Japan; [Fukamachi, Shoji] Japan Womens Univ, Dept Chem & Biol Sci, Lab Evolutionary Genet, Tokyo 112, Japan; [Shimizu, Atsushi] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan; [Saya, Hideyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	Keio University; Japan Womens University; Japan Womens University; Keio University; Japan Science & Technology Agency (JST)	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan.	hsaya@a5.keio.jp	Matsuzaki, Yuriko/L-5309-2013; Saya, Hideyuki/J-4325-2013	Fukamachi, Shoji/0000-0001-7967-1883; Saya, Hideyuki/0000-0001-6610-1902	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology; Grants-in-Aid for Scientific Research [24591633] Funding Source: KAKEN	Japan Science and Technology Agency, Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by Japan Science and Technology Agency, Core Research for Evolutional Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Hawkins William E., 2003, Toxicologic Pathology, V31, P88; INAGAKI H, 1994, GENE, V150, P319, DOI 10.1016/0378-1119(94)90445-6; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; Klaunig J E, 1984, Natl Cancer Inst Monogr, V65, P155; Kobayashi Y, 2011, AM J PATHOL, V179, P1471, DOI 10.1016/j.ajpath.2011.05.019; Larue L, 2007, PIGM CELL RES, V20, P485, DOI 10.1111/j.1600-0749.2007.00411.x; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Maruyama K, 2002, J BIOCHEM, V132, P581, DOI 10.1093/oxfordjournals.jbchem.a003260; Michailidou C, 2009, DIS MODEL MECH, V2, P399, DOI 10.1242/dmm.001149; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Santoriello C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015170; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443	22	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54424	10.1371/journal.pone.0054424	http://dx.doi.org/10.1371/journal.pone.0054424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342156	gold, Green Submitted, Green Published			2022-12-27	WOS:000314759400165
J	Salinas, RY; Baker, SA; Gospe, SM; Arshavsky, VY				Salinas, Raquel Y.; Baker, Sheila A.; Gospe, Sidney M., III; Arshavsky, Vadim Y.			A Single Valine Residue Plays an Essential Role in Peripherin/rds Targeting to Photoreceptor Outer Segments	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; TRANSGENIC XENOPUS-LAEVIS; PROTEIN-COUPLED-RECEPTORS; DEGENERATION SLOW RDS; RETINAL DEGENERATION; ROD PHOTORECEPTORS; C-TERMINUS; DISK MEMBRANES; MUTANT MICE; LOCALIZATION	Peripherin/retinal degeneration slow (rds) is an integral membrane protein specifically localized to the light-sensing organelle of the photoreceptor cell, the outer segment. Within the outer segment, peripherin is found at the edges of photoreceptor discs, where it plays a critical role in disc morphogenesis and maintenance. Peripherin loss or mutations are often associated with severe forms of visual impairments. Like all other resident outer segment proteins, peripherin is synthesized in the photoreceptor cell body and subsequently transported to the outer segment. In an effort to further examine peripherin's delivery to outer segments, we undertook a careful examination of its targeting sequence. Using a fluorescently labeled reporter expressed in the rods of transgenic tadpoles, we narrowed peripherin's targeting sequence to ten amino acids within its C-terminal tail. This small stretch of amino acid residues is both necessary and sufficient for outer segment targeting. We also conducted alanine scanning of all residues within this sequence and found that only a single residue, valine at position 332, is essential for outer segment targeting. This valine is conserved in all species and its mutation is sufficient to completely abrogate the targeting of full-length peripherin in mouse rods.	[Salinas, Raquel Y.; Gospe, Sidney M., III; Arshavsky, Vadim Y.] Duke Univ Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Baker, Sheila A.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gospe, Sidney M., III; Arshavsky, Vadim Y.] Duke Univ Med Ctr, Dept Ophthalmol, Durham, NC USA	Duke University; University of Iowa; Duke University	Arshavsky, VY (corresponding author), Duke Univ Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA.	vadim.arshavsky@duke.edu		Gospe III, Sidney/0000-0003-2838-7983; Salinas, Raquel/0000-0002-3119-7737; Baker, Sheila/0000-0002-0259-0652	National Institutes of Health (NIH) grant [EY12859]; IH Core Grant for Vision Research [EY05722]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [F31EY022862, P30EY005722, R01EY012859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IH Core Grant for Vision Research; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grant EY12859 (VYA), the NIH Core Grant for Vision Research EY05722, and an unrestricted grant from Research to Prevent Blindness to Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Berson EL, 2002, INVEST OPHTH VIS SCI, V43, P3027; Bessant D A, 1999, Hum Mutat, V13, P83, DOI 10.1002/(SICI)1098-1004(1999)13:1<83::AID-HUMU12>3.0.CO;2-5; Boesze-Battaglia K, 2003, EXP EYE RES, V77, P505, DOI 10.1016/S0014-4835(03)00151-9; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boesze-Battaglia K, 2002, INT REV CYTOL, V217, P183; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; Deretic D, 2012, VISION RES; Edrington TC, 2007, BIOCHEMISTRY-US, V46, P3605, DOI 10.1021/bi061820c; FARISS RN, 1992, MOL BIOL CELL, V3, pA56; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; GOLDBERG AFX, 1995, BIOCHEMISTRY-US, V34, P14213, DOI 10.1021/bi00043a028; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; Grover S, 2002, OPHTHALMOLOGY, V109, P1110, DOI 10.1016/S0161-6420(02)01029-1; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; Luo WQ, 2004, J NEUROSCI, V24, P2623, DOI 10.1523/JNEUROSCI.5302-03.2004; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MOLDAY LL, 1992, INVEST OPHTH VIS SCI, V33, P740; Nour M, 2004, MOL THER, V9, pS89; Nour M, 2008, ADV EXP MED BIOL, V613, P129, DOI 10.1007/978-0-387-74904-4_14; Pandey KN, 2010, CURR OPIN BIOTECH, V21, P611, DOI 10.1016/j.copbio.2010.08.007; PETERS KR, 1983, J CELL BIOL, V96, P265, DOI 10.1083/jcb.96.1.265; Ritter LM, 2004, J BIOL CHEM, V279, P39958, DOI 10.1074/jbc.M403943200; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Zhang L, 2005, BIOCHEMISTRY-US, V44, P14509, DOI 10.1021/bi051386z	47	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54292	10.1371/journal.pone.0054292	http://dx.doi.org/10.1371/journal.pone.0054292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342122	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400142
J	Xie, Q; Yang, Y; Huang, J; Ninkovic, J; Walcher, T; Wolf, L; Vitenzon, A; Zheng, DY; Gotz, M; Beebe, DC; Zavadil, J; Cvekl, A				Xie, Qing; Yang, Ying; Huang, Jie; Ninkovic, Jovica; Walcher, Tessa; Wolf, Louise; Vitenzon, Ariel; Zheng, Deyou; Goetz, Magdalena; Beebe, David C.; Zavadil, Jiri; Cvekl, Ales			Pax6 Interactions with Chromatin and Identification of Its Novel Direct Target Genes in Lens and Forebrain	PLOS ONE			English	Article							ALPHA-A-CRYSTALLIN; TRANSCRIPTION FACTOR PAX6; EMBRYONIC STEM-CELLS; REGULATORY NETWORKS; EYE DEVELOPMENT; HIGH-RESOLUTION; PAIRED DOMAIN; MOUSE MODEL; DNA-BINDING; C-MAF	Pax6 encodes a specific DNA-binding transcription factor that regulates the development of multiple organs, including the eye, brain and pancreas. Previous studies have shown that Pax6 regulates the entire process of ocular lens development. In the developing forebrain, Pax6 is expressed in ventricular zone precursor cells and in specific populations of neurons; absence of Pax6 results in disrupted cell proliferation and cell fate specification in telencephalon. In the pancreas, Pax6 is essential for the differentiation of alpha-, beta- and delta-islet cells. To elucidate molecular roles of Pax6, chromatin immunoprecipitation experiments combined with high-density oligonucleotide array hybridizations (ChIP-chip) were performed using three distinct sources of chromatin (lens, forebrain and beta-cells). ChIP-chip studies, performed as biological triplicates, identified a total of 5,260 promoters occupied by Pax6. 1,001 (133) of these promoter regions were shared between at least two (three) distinct chromatin sources, respectively. In lens chromatin, 2,335 promoters were bound by Pax6. RNA expression profiling from Pax6(+/-) lenses combined with in vivo Pax6-binding data yielded 76 putative Pax6-direct targets, including the Gaa, Isl1, Kif1b, Mtmr2, Pcsk1n, and Snca genes. RNA and ChIP data were validated for all these genes. In lens cells, reporter assays established Kib1b and Snca as Pax6 activated and repressed genes, respectively. In situ hybridization revealed reduced expression of these genes in E14 cerebral cortex. Moreover, we examined differentially expressed transcripts between E9.5 wild type and Pax6(-/-) lens placodes that suggested Efnb2, Fat4, Has2, Nav1, and Trpm3 as novel Pax6-direct targets. Collectively, the present studies, through the identification of Pax6-direct target genes, provide novel insights into the molecular mechanisms of Pax6 gene control during mouse embryonic development. In addition, the present data demonstrate that Pax6 interacts preferentially with promoter regions in a tissue-specific fashion. Nevertheless, nearly 20% of the regions identified are accessible to Pax6 in multiple tissues.	[Xie, Qing; Yang, Ying; Zheng, Deyou; Cvekl, Ales] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Wolf, Louise; Vitenzon, Ariel; Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Huang, Jie; Beebe, David C.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Ninkovic, Jovica; Walcher, Tessa; Goetz, Magdalena] Helmholtz Zentrum Munchen, Inst Stem Cell Res, Neuherberg, Germany; [Ninkovic, Jovica; Walcher, Tessa; Goetz, Magdalena] Univ Munich, Inst Physiol, Dept Physiol Genom, Munich Ctr Integrated Prot Sci CiPS, D-80539 Munich, Germany; [Zavadil, Jiri] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; New York University; NYU Langone Medical Center	Cvekl, A (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	ales.cvekl@einstein.yu.edu	Ninkovic, Jovica/AAH-5220-2019; Huang, Jie/D-7728-2014; Zavadil, Jiri/ABG-1780-2020	Ninkovic, Jovica/0000-0002-4381-0041; Zavadil, Jiri/0000-0003-0640-5562; Zheng, Deyou/0000-0003-4354-5337	National Institutes of Health [R01 EY012200, R21 EY017296, EY04853]; Research to Prevent Blindness; Washington University; NATIONAL EYE INSTITUTE [R01EY004853, R21EY017296, R01EY012200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Washington University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants R01 EY012200 and R21 EY017296 to AC and EY04853 to DCB, and unrestricted grants from Research to Prevent Blindness to the Departments of Ophthalmology and Visual Sciences at Albert Einstein and Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Baulmann DC, 2002, MECH DEVELOP, V118, P3, DOI 10.1016/S0925-4773(02)00260-5; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bijvoet AGA, 1998, HUM MOL GENET, V7, P53, DOI 10.1093/hmg/7.1.53; Bolino A, 2004, J CELL BIOL, V167, P711, DOI 10.1083/jcb.200407010; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chauhan BK, 2004, INVEST OPHTH VIS SCI, V45, P385, DOI 10.1167/iovs.03-0968; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028147; Collinson JM, 2001, P NATL ACAD SCI USA, V98, P9688, DOI 10.1073/pnas.161144098; Coutinho P, 2011, GENOME RES, V21, P1349, DOI 10.1101/gr.124115.111; Cvekl A, 2004, INT J DEV BIOL, V48, P829, DOI 10.1387/ijdb.041866ac; Cvekl A, 2010, HEREDITY, V105, P135, DOI 10.1038/hdy.2010.16; CVEKL A, 1995, MOL CELL BIOL, V15, P653; Cvekl A, 1996, BIOESSAYS, V18, P621, DOI 10.1002/bies.950180805; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; D'Elia AV, 2006, EUR J HUM GENET, V14, P744, DOI 10.1038/sj.ejhg.5201579; Dames P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-39; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; DAVIS A, 1993, HUM MOL GENET, V2, P2093, DOI 10.1093/hmg/2.12.2093; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; DeRuisseau LR, 2009, P NATL ACAD SCI USA, V106, P9419, DOI 10.1073/pnas.0902534106; Dohrmann C, 2000, MECH DEVELOP, V92, P47, DOI 10.1016/S0925-4773(99)00324-X; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; EFRAT S, 1991, J BIOL CHEM, V266, P11141; Erclik T, 2009, DEV BIOL, V332, P70, DOI 10.1016/j.ydbio.2009.05.565; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; He SY, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-21; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2011, DEV BIOL, V355, P32, DOI 10.1016/j.ydbio.2011.04.008; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jonasova K, 2008, SEMIN CELL DEV BIOL, V19, P71, DOI 10.1016/j.semcdb.2007.10.005; Kiselev Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031915; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kokhan VS, 2012, BEHAV BRAIN RES; Kuracha MR, 2011, INVEST OPHTH VIS SCI, V52, P6887, DOI 10.1167/iovs.11-7531; Laakso M, 2009, DIABETOLOGIA, V52, P381, DOI 10.1007/s00125-008-1251-1; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; Leonard M, 2008, DEV BIOL, V319, P298, DOI 10.1016/j.ydbio.2008.04.036; Liu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046934; Lyons DA, 2009, NAT GENET, V41, P854, DOI 10.1038/ng.376; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; Madhavan M, 2006, P NATL ACAD SCI USA, V103, P14848, DOI 10.1073/pnas.0601949103; Maekawa M, 2009, NEUROSCI LETT, V462, P267, DOI 10.1016/j.neulet.2009.07.021; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Martinez-Lopez MJ, 2005, MOL CELL NEUROSCI, V28, P599, DOI 10.1016/j.mcn.2004.09.016; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100; Molotkov A, 2006, DEVELOPMENT, V133, P1901, DOI 10.1242/dev.02328; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nasonkin IO, 2011, J COMP NEUROL, V519, P1914, DOI 10.1002/cne.22613; Nfonsam LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044583; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Nomura T, 2007, DEV GROWTH DIFFER, V49, P683, DOI 10.1111/j.1440-169x.2007.00965.x; Numayama-Tsuruta K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-6; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Ostrin EJ, 2006, GENOME RES, V16, P466, DOI 10.1101/gr.4673006; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Pinto LW, 2008, VIRCHOWS ARCH, V452, P481, DOI 10.1007/s00428-007-0562-9; POKORNY KS, 1982, INVEST OPHTH VIS SCI, V22, P25; Rodgers LS, 2006, CIRC RES, V99, P583, DOI 10.1161/01.RES.0000242561.95978.43; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Sander T, 1999, EPILEPSY RES, V36, P61, DOI 10.1016/S0920-1211(99)00024-8; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Secker GA, 2008, STEM CELL REV, V4, P159, DOI 10.1007/s12015-008-9029-x; Senturk A, 2011, NATURE, V472, P356, DOI 10.1038/nature09874; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/NMETH.1626, 10.1038/nmeth.1626]; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Smith AN, 2010, DEV BIOL, V337, P195, DOI 10.1016/j.ydbio.2009.11.009; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107; Sugiyama Y, 2011, ORGANOGENESIS, V7, P191, DOI 10.4161/org.7.3.18421; Thaung C, 2002, HUM MOL GENET, V11, P755, DOI 10.1093/hmg/11.7.755; Thompson PJ, 2004, NEUROLOGY, V62, P1216, DOI 10.1212/01.WNL.0000118298.81140.62; Tien JYL, 2005, DEV DYNAM, V233, P130, DOI 10.1002/dvdy.20328; Tong YR, 2009, NEURON, V64, P771, DOI 10.1016/j.neuron.2009.12.017; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; van Raamsdonk CD, 2000, DEVELOPMENT, V127, P5439; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wolf LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004159; Xie Q, 2011, J BIOL CHEM, V286, P43259, DOI 10.1074/jbc.M111.264580; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Yamaguchi Y, 1997, GENES CELLS, V2, P255, DOI 10.1046/j.1365-2443.1997.1170315.x; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	125	51	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54507	10.1371/journal.pone.0054507	http://dx.doi.org/10.1371/journal.pone.0054507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342162	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400166
J	Shao, HJ; Scott, SG; Nakata, C; Hamad, AR; Chakravarti, S				Shao, Hanjuan; Scott, Sherri-Gae; Nakata, Chiaki; Hamad, Abdel R.; Chakravarti, Shukti			Extracellular Matrix Protein Lumican Promotes Clearance and Resolution of Pseudomonas aeruginosa Keratitis in a Mouse Model	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; PHOTOREFRACTIVE KERATECTOMY; NEUTROPHIL INFILTRATION; INFECTIOUS KERATITIS; CORNEAL INFLAMMATION; IMMUNE PRIVILEGE; IN-VIVO; INNATE; TLR4; EXPRESSION	Lumican is an extracellular protein that associates with CD14 on the surface of macrophages and neutrophils, and promotes CD14-TLR4 mediated response to bacterial lipopolysaccharides (LPS). Lumican-deficient (Lum(-/-)) mice and macrophages are impaired in TLR4 signals; raising the possibility that lumican may regulate host response to live bacterial infections. In a recent study we showed that in vitro Lum(-/-) macrophages are impaired in phagocytosis of gram-negative bacteria and in a lung infection model the Lum(-/-) mice showed poor survival. The cornea is an immune privileged barrier tissue that relies primarily on innate immunity to protect against ocular infections. Lumican is a major component of the cornea, yet its role in counteracting live bacteria in the cornea remains poorly understood. Here we investigated Pseudomonas aeruginosa infections of the cornea in Lum(-/-) mice. By flow cytometry we found that 24 hours after infection macrophage and neutrophil counts were lower in the cornea of Lum(-/-) mice compared to wild types. Infected Lum(-/-) corneas showed lower levels of the leukocyte chemoattractant CXCL1 by 24-48 hours of infection, and increased bacterial counts up to 5 days after infection, compared to Lum(+/-) mice. The pro-inflammatory cytokine TNF-alpha was comparably low 24 hours after infection, but significantly higher in the Lum(-/-) compared to Lum(+/-) infected corneas by 2-5 days after infection. Taken together, the results indicate that lumican facilitates development of an innate immune response at the earlier stages of infection and lumican deficiency leads to poor bacterial clearance and resolution of corneal inflammation at a later stage.	[Shao, Hanjuan; Scott, Sherri-Gae; Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Nakata, Chiaki; Hamad, Abdel R.] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD USA; [Chakravarti, Shukti] Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Chakravarti, S (corresponding author), Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA.	schakra1@jhmi.edu			NIH [EY11654]; NATIONAL EYE INSTITUTE [R56EY011654, R01EY011654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant EY11654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Carlson EC, 2010, J LEUKOCYTE BIOL, V88, P517, DOI 10.1189/jlb.0310134; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Cole N, 2005, IMMUNOL CELL BIOL, V83, P301, DOI 10.1111/j.1440-1711.2005.01324.x; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Fleiszig Suzanne M J, 2002, Clin Exp Optom, V85, P271; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Hazlett LD, 2005, OCUL IMMUNOL INFLAMM, V13, P133, DOI 10.1080/09273940490912362; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Hazlett LD, 2002, INVEST OPHTH VIS SCI, V43, P419; Hazlett LD, 2010, OCUL IMMUNOL INFLAMM, V18, P237, DOI 10.3109/09273948.2010.501946; Huang X, 2005, INVEST OPHTH VIS SCI, V46, P4209, DOI 10.1167/iovs.05-0185; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Jeng BH, 2003, BRIT J OPHTHALMOL, V87, P805, DOI 10.1136/bjo.87.7.805; Johnson AC, 2005, INVEST OPHTH VIS SCI, V46, P589, DOI 10.1167/iovs.04-1077; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Karimian F, 2007, J REFRACT SURG, V23, P312; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khatri S, 2002, INVEST OPHTH VIS SCI, V43, P2278; Kumar A, 2008, INFECT IMMUN, V76, P89, DOI 10.1128/IAI.01232-07; Kumar A, 2010, MICROBES INFECT, V12, P978, DOI 10.1016/j.micinf.2010.06.007; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P5220, DOI 10.1167/iovs.03-0229; Lee S, 2009, J BIOL CHEM, V284, P23662, DOI 10.1074/jbc.M109.026229; Lin M, 2007, J LEUKOCYTE BIOL, V81, P786, DOI 10.1189/jlb.0806502; OCallaghan RJ, 1996, INVEST OPHTH VIS SCI, V37, P534; Robertson DM, 2008, CLIN OPHTHALMOL, V2, P907; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Shao H, 2012, J BIOL CHEM; Spandau UHM, 2003, ARCH OPHTHALMOL-CHIC, V121, P825, DOI 10.1001/archopht.121.6.825; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Vajpayee RB, 2007, SURV OPHTHALMOL, V52, P1, DOI 10.1016/j.survophthal.2006.10.001; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Wroblewski KJ, 2006, OPHTHALMOLOGY, V113, P520, DOI 10.1016/j.ophtha.2005.09.038; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Zaidi TS, 2010, INVEST OPHTH VIS SCI, V51, P2085, DOI 10.1167/iovs.09-4139	42	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54765	10.1371/journal.pone.0054765	http://dx.doi.org/10.1371/journal.pone.0054765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358433	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600106
J	Hameed, A; Bennett, E; Ciani, B; Hoebers, LPC; Milner, R; Lawrie, A; Francis, SE; Grierson, AJ				Hameed, Abdul; Bennett, Ellen; Ciani, Barbara; Hoebers, Loes P. C.; Milner, Roy; Lawrie, Allan; Francis, Sheila E.; Grierson, Andrew J.			No Evidence for Cardiac Dysfunction in Kif6 Mutant Mice	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; KINESIN-LIKE PROTEIN-6; TRP719ARG POLYMORPHISM; MYOCARDIAL-INFARCTION; GENE VARIANTS; RISK; ASSOCIATION; SUPERFAMILY; TRANSPORT; EFFICACY	A KIF6 variant in man has been reported to be associated with adverse cardiovascular outcomes after myocardial infarction. No clear biological or physiological data exist for Kif6. We sought to investigate the impact of a deleterious KIF6 mutation on cardiac function in mice. Kif6 mutant mice were generated and verified. Cardiac function was assessed by serial echocardiography at baseline, after ageing and after exercise. Lipid levels were also measured. No discernable adverse lipid or cardiac phenotype was detected in Kif6 mutant mice. These data suggest that dysfunction of Kif6 is linked to other more complex biological/biochemical parameters or is unlikely to be of material consequence in cardiac function.	[Hameed, Abdul; Lawrie, Allan; Francis, Sheila E.] Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Bennett, Ellen; Hoebers, Loes P. C.; Milner, Roy; Grierson, Andrew J.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Ciani, Barbara] Univ Sheffield, Dept Chem, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Francis, SE (corresponding author), Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	s.francis@sheffield.ac.uk	Ciani, Barbara/A-1679-2012; Lawrie, Allan/A-2708-2012; Grierson, Andy/A-5067-2009; Hameed, Abdul/O-1782-2019	Ciani, Barbara/0000-0001-7223-4154; Lawrie, Allan/0000-0003-4192-9505; Grierson, Andy/0000-0001-7039-6731; Hameed, Abdul/0000-0002-2128-2081; Bennett, Ellen/0000-0002-9818-827X; Francis, Sheila/0000-0001-6552-0339	University of Sheffield; MRC [G0800318] Funding Source: UKRI; Medical Research Council [G0800318] Funding Source: researchfish	University of Sheffield; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Research and Innovation Fund, University of Sheffield. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao H, 2012, ATHEROSCLEROSIS, V220, P456, DOI 10.1016/j.atherosclerosis.2011.11.037; Arsenault BJ, 2012, CIRC-CARDIOVASC GENE, V5, P51, DOI 10.1161/CIRCGENETICS.111.960252; Assimes TL, 2010, J AM COLL CARDIOL, V56, P1552, DOI 10.1016/j.jacc.2010.06.022; Bare LA, 2007, GENET MED, V9, P682, DOI 10.1097/GIM.0b013e318156fb62; Davani S, 2010, ATHEROSCLEROSIS, V210, P48, DOI 10.1016/j.atherosclerosis.2009.11.041; Ference BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028834; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoffmann MM, 2011, ATHEROSCLEROSIS, V219, P659, DOI 10.1016/j.atherosclerosis.2011.07.126; Hopewell JC, 2011, J AM COLL CARDIOL, V57, P2000, DOI 10.1016/j.jacc.2011.02.015; Iakoubova OA, 2008, J AM COLL CARDIOL, V51, P435, DOI 10.1016/j.jacc.2007.05.057; Iakoubova OA, 2010, EUR J CARDIOV PREV R, V17, P455, DOI 10.1097/HJR.0b013e328336a0dd; Kasher PR, 2009, J NEUROCHEM, V110, P34, DOI 10.1111/j.1471-4159.2009.06104.x; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Li YH, 2010, AM J CARDIOL, V106, P994, DOI 10.1016/j.amjcard.2010.05.033; Marian AJ, 2008, J AM COLL CARDIOL, V51, P456, DOI 10.1016/j.jacc.2007.10.020; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Ridker PM, 2011, CIRC-CARDIOVASC GENE, V4, P312, DOI 10.1161/CIRCGENETICS.110.959353; Shiffman D, 2008, J AM COLL CARDIOL, V51, P444, DOI 10.1016/j.jacc.2007.09.044; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Shiffman D, 2010, AM J CARDIOL, V105, P1300, DOI 10.1016/j.amjcard.2009.12.049; Topol EJ, 2010, J AM COLL CARDIOL, V56, P1564, DOI 10.1016/j.jacc.2010.06.023	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54636	10.1371/journal.pone.0054636	http://dx.doi.org/10.1371/journal.pone.0054636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355886	Green Published, Green Accepted, gold			2022-12-27	WOS:000314021500100
J	Bryan, N; Lewis, FC; Bond, D; Stanley, C; Hunt, JA				Bryan, Nicholas; Lewis, Fiona C.; Bond, Damian; Stanley, Christopher; Hunt, John A.			Evaluation of a Novel Non-Destructive Catch and Release Technology for Harvesting Autologous Adult Stem Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; ADIPOSE-TISSUE; PROTEIN-A; IN-VITRO; DIFFERENTIATION; IMMUNOGLOBULINS; CHROMATOGRAPHY; PURIFICATION; LIGANDS	Background: Cell based therapies are required now to meet the critical care needs of paediatrics and healthy ageing in an increasingly long-lived human population. Repair of compromised tissue by supporting autologous regeneration is a life changing objective uniting the fields of medical science and engineering. Adipose stem cells (adSCs) are a compelling candidate for use in cell based medicine due to their plasticity and residence in numerous tissues. Adipose found in all animals contains a relatively high concentration of stem cells and is easily isolated by a minimally invasive clinical intervention; such as liposuction. Methods: This study utilised primary rat adipose to validate a novel strategy for selecting adult stem cells. Experiments explored the use of large, very dense cell-specific antibody loaded isolation beads (diameter 5x-10x greater than target cells) which overcome the problem of endocytosis and have proved to be very effective in cell isolation from minimally processed primary tissue. The technique also benefited from pH mediated release, which enabled elution of captured cells using a simple pH shift. Results: Large beads successfully captured and released adSCs from rat adipose, which were characterised using a combination of microscopy, flow cytometry and PCR. The resultant purified cell population retains minimal capture artefact facilitating autologous reperfusion or application in in vitro models. Conclusion: Although evidenced here for adSCs, this approach provides a technological advance at a platform level; whereby it can be applied to isolate any cell population for which there is a characterised surface antigen.	[Bryan, Nicholas; Lewis, Fiona C.; Hunt, John A.] Univ Liverpool, Inst Ageing & Chron Dis, United Kingdom Ctr Tissue Engn, Liverpool L69 3BX, Merseyside, England; [Bond, Damian; Stanley, Christopher] CellCap Technol Ltd, Todmorden, Bacup, England	University of Liverpool	Bryan, N (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, United Kingdom Ctr Tissue Engn, Liverpool L69 3BX, Merseyside, England.	n.bryan@liv.ac.uk	Hunt, John Alan/S-2347-2019; Hunt, John A/G-6366-2012; Lewis-McDougall, Fiona/AAI-7771-2021	Hunt, John Alan/0000-0002-5168-4778; Hunt, John A/0000-0002-5168-4778; Lewis-McDougall, Fiona/0000-0001-7273-639X	Strategic Projects to Access Research and Knowledge (SPARK), United Kingdom	Strategic Projects to Access Research and Knowledge (SPARK), United Kingdom	This research was funded by Strategic Projects to Access Research and Knowledge (SPARK), United Kingdom (grant number not available)(SPARK is a specific funding call offered by Knowledge Transfer Network) United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979; Balmayor ER, 2011, J R SOC INTERFACE, V8, P896, DOI 10.1098/rsif.2010.0531; Banas A, 2007, DEV DYNAM, V236, P3228, DOI 10.1002/dvdy.21330; Dvorakova J, 2008, CELL BIOL INT, V32, P1116, DOI 10.1016/j.cellbi.2008.04.024; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Flake AW, 2004, BLOOD CELL MOL DIS, V32, P58, DOI 10.1016/j.bcmd.2003.09.015; Francesco FD, 2009, PLOS ONE, V4, pe6537; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Handley ME, 2005, J IMMUNOL METHODS, V297, P27, DOI 10.1016/j.jim.2004.11.009; Huang AHC, 2008, J ORAL PATHOL MED, V37, P571, DOI 10.1111/j.1600-0714.2008.00654.x; Ishimura D, 2008, TOHOKU J EXP MED, V216, P149, DOI 10.1620/tjem.216.149; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kestendjieva S, 2008, CELL BIOL INT, V32, P724, DOI 10.1016/j.cellbi.2008.02.002; KNUDSEN KL, 1992, ANAL BIOCHEM, V201, P170, DOI 10.1016/0003-2697(92)90191-9; Kruse C, 2006, ANN ANAT, V188, P503, DOI 10.1016/j.aanat.2006.07.012; LINDMARK R, 1983, J IMMUNOL METHODS, V62, P1, DOI 10.1016/0022-1759(83)90104-7; McKenzie KP, 2012, J CELL BIOCH; Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027; Modder UI, 2012, BONE, V50, P804, DOI 10.1016/j.bone.2011.12.014; Musina RA, 2005, B EXP BIOL MED+, V139, P504, DOI 10.1007/s10517-005-0331-1; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8; Qiao C, 2008, CELL BIOL INT, V32, P8, DOI 10.1016/j.cellbi.2007.08.002; RODBELL M, 1966, J BIOL CHEM, V241, P140; Romanov YA, 2005, B EXP BIOL MED+, V140, P138, DOI 10.1007/s10517-005-0430-z; Ujam LB, 2003, BIOTECHNOL BIOENG, V83, P554, DOI 10.1002/bit.10703; Willoughby N, 2009, J CHEM TECHNOL BIOT, V84, P145, DOI 10.1002/jctb.2020; Zhao GF, 2009, J BIOTECHNOL, V144, P3, DOI 10.1016/j.jbiotec.2009.04.009; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	33	3	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53933	10.1371/journal.pone.0053933	http://dx.doi.org/10.1371/journal.pone.0053933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349768	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100039
J	Svensson, MND; Andersson, SEM; Erlandsson, MC; Jonsson, IM; Ekwall, AKH; Andersson, KME; Nilsson, A; Bian, L; Brisslert, M; Bokarewa, MI				Svensson, Mattias N. D.; Andersson, Sofia E. M.; Erlandsson, Malin C.; Jonsson, Ing-Marie; Ekwall, Anna-Karin H.; Andersson, Karin M. E.; Nilsson, Anders; Bian, Li; Brisslert, Mikael; Bokarewa, Maria I.			Fms-Like Tyrosine Kinase 3 Ligand Controls Formation of Regulatory T Cells in Autoimmune Arthritis	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; COLLAGEN-INDUCED ARTHRITIS; ANTIGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; IN-VIVO; HOMEOSTASIS; BLIMP-1; MICE; ATHEROSCLEROSIS; LYMPHOCYTES	Fms-like tyrosine kinase 3 ligand (Flt3L) is known as the primary differentiation and survival factor for dendritic cells (DCs). Furthermore, Flt3L is involved in the homeostatic feedback loop between DCs and regulatory T cell (Treg). We have previously shown that Flt3L accumulates in the synovial fluid in rheumatoid arthritis (RA) and that local exposure to Flt3L aggravates arthritis in mice, suggesting a possible involvement in RA pathogenesis. In the present study we investigated the role of Flt3L on DC populations, Tregs as well as inflammatory responses in experimental antigen-induced arthritis. Arthritis was induced in mBSA-immunized mice by local knee injection of mBSA and Flt3L was provided by daily intraperitoneal injections. Flow cytometry analysis of spleen and lymph nodes revealed an increased formation of DCs and subsequently Tregs in mice treated with Flt3L. Flt3L-treatment was also associated with a reduced production of mBSA specific antibodies and reduced levels of the pro-inflammatory cytokines IL-6 and TNF-alpha. Morphological evaluation of mBSA injected joints revealed reduced joint destruction in Flt3L treated mice. The role of DCs in mBSA arthritis was further challenged in an adoptive transfer experiment. Transfer of DCs in combination with T-cells from mBSA immunized mice, predisposed naive recipients for arthritis and production of mBSA specific antibodies. We provide experimental evidence that Flt3L has potent immunoregulatory properties. Flt3L facilitates formation of Treg cells and by this mechanism reduces severity of antigen-induced arthritis in mice. We suggest that high systemic levels of Flt3L have potential to modulate autoreactivity and autoimmunity.	[Svensson, Mattias N. D.; Andersson, Sofia E. M.; Erlandsson, Malin C.; Jonsson, Ing-Marie; Ekwall, Anna-Karin H.; Andersson, Karin M. E.; Bian, Li; Brisslert, Mikael; Bokarewa, Maria I.] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden; [Nilsson, Anders] Univ Gothenburg, Dept Hand Surg, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Svensson, MND (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden.	mattias.svensson@rheuma.gu.se	Bokarewa, Maria I/A-8114-2019; Svensson, Mattias N.D./A-9827-2012	Bokarewa, Maria I/0000-0001-9424-5145; Svensson, Mattias N.D./0000-0001-8077-9824; Andersson, Sofia/0000-0003-2933-7339; Andersson, Karin/0000-0002-9475-3040; Ekwall, Anna-Karin/0000-0001-8236-6089; Brisslert, Mikael/0000-0002-1412-5600; Erlandsson, Malin/0000-0003-1100-7577	Medical Society of Gothenburg; Swedish Association against Rheumatism; King Gustaf V:s 80-year Anniversary Foundation; Swedish Research Council; EU Commission; Professor's Nanna Swartz Foundation; AME Wolff Foundation; Rune and Ulla Amlovs Trust; Swedish Research Agency for Innovation Systems (VINNOVA); Torsten Soderbergs Foundation; Ingabritt and Arne Lundberg's Foundation; Swedish Foundation; Magnus Bergwall foundation; pharmacist Hedberg foundation; University of Gothenburg; Family Tholen and Kristlers Foundation; Regional agreement on medical training and clinical research between the Western Gotaland county council; University of Goteborg (LUA/ALF)	Medical Society of Gothenburg; Swedish Association against Rheumatism; King Gustaf V:s 80-year Anniversary Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU Commission(European CommissionEuropean Commission Joint Research Centre); Professor's Nanna Swartz Foundation; AME Wolff Foundation; Rune and Ulla Amlovs Trust; Swedish Research Agency for Innovation Systems (VINNOVA)(Vinnova); Torsten Soderbergs Foundation; Ingabritt and Arne Lundberg's Foundation; Swedish Foundation; Magnus Bergwall foundation; pharmacist Hedberg foundation; University of Gothenburg; Family Tholen and Kristlers Foundation; Regional agreement on medical training and clinical research between the Western Gotaland county council; University of Goteborg (LUA/ALF)	This study was supported by grants from the Medical Society of Gothenburg, the Swedish Association against Rheumatism, the King Gustaf V:s 80-year Anniversary Foundation, the Swedish Research Council, the EU Commission (FP7-HEALTH), Professor's Nanna Swartz Foundation, AME Wolff Foundation, Rune and Ulla Amlovs Trust, the Swedish Research Agency for Innovation Systems (VINNOVA), Torsten Soderbergs Foundation, Ingabritt and Arne Lundberg's Foundation, the Swedish Foundation for Strategic Research, Magnus Bergwall foundation, the pharmacist Hedberg foundation, and the University of Gothenburg, the Family Tholen and Kristlers Foundation, the Regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Goteborg (LUA/ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bostrom EA, 2011, ARTHRITIS RHEUM-US, V63, P2894, DOI 10.1002/art.30527; Brand DD, 2004, METH MOLEC MED, V102, P295; Cavanagh LL, 2005, ARTHRITIS RES THER, V7, pR230, DOI 10.1186/ar1467; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Collins CB, 2011, GUT; Daissormont ITMN, 2011, CIRC RES, V109, P1387, DOI 10.1161/CIRCRESAHA.111.256529; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Dehlin M, 2011, J LEUKOCYTE BIOL, V90, P811, DOI 10.1189/jlb.1110640; Dehlin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003633; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Frey O, 2005, ARTHRITIS RES THER, V7, pR291, DOI 10.1186/ar1484; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Heltemes-Harris LM, 2011, ANN NY ACAD SCI, V1217, P18, DOI 10.1111/j.1749-6632.2010.05907.x; Ibarra JM, 2011, IMMUNOBIOLOGY, V216, P971, DOI 10.1016/j.imbio.2011.03.012; Irla M, 2010, J EXP MED, V207, P1891, DOI 10.1084/jem.20092627; Jaen O, 2009, IMMUNOLOGY, V126, P35, DOI 10.1111/j.1365-2567.2008.02875.x; Jongbloed SL, 2009, J IMMUNOL, V182, P963, DOI 10.4049/jimmunol.182.2.963; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kavousanaki M, 2010, ARTHRITIS RHEUM-US, V62, P53, DOI 10.1002/art.25037; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Lebre MC, 2009, HUM IMMUNOL, V70, P321, DOI 10.1016/j.humimm.2009.02.006; Lindblad SS, 2011, NEUROSIGNALS; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Martin E, 2007, ARTHRITIS RHEUM-US, V56, P2255, DOI 10.1002/art.22655; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Raghavan S, 2009, ANN RHEUM DIS, V68, P1908, DOI 10.1136/ard.2008.100768; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Sadhu C, 2007, J LEUKOCYTE BIOL, V81, P1395, DOI 10.1189/jlb.1106680; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Swee LK, 2009, BLOOD, V113, P6277, DOI 10.1182/blood-2008-06-161026; Teshima T, 2002, BLOOD, V99, P1825, DOI 10.1182/blood.V99.5.1825; van den Berg Wim B., 2007, V136, P243; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923	50	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54884	10.1371/journal.pone.0054884	http://dx.doi.org/10.1371/journal.pone.0054884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349985	Green Published, gold, Green Submitted			2022-12-27	WOS:000313943000052
J	Jensen, TH; Bech, M; Binderup, T; Bottiger, A; David, C; Weitkamp, T; Zanette, I; Reznikova, E; Mohr, J; Rank, F; Feidenhans'l, R; Kjaer, A; Hojgaard, L; Pfeiffer, F				Jensen, Torben Haugaard; Bech, Martin; Binderup, Tina; Boettiger, Arvid; David, Christian; Weitkamp, Timm; Zanette, Irene; Reznikova, Elena; Mohr, Juergen; Rank, Fritz; Feidenhans'l, Robert; Kjaer, Andreas; Hojgaard, Liselotte; Pfeiffer, Franz			Imaging of Metastatic Lymph Nodes by X-ray Phase-Contrast Micro-Tomography	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; GRATING INTERFEROMETER; TALBOT INTERFEROMETRY; BIOPSY; CT; DISSECTION	Invasive cancer causes a change in density in the affected tissue, which can be visualized by x-ray phase-contrast tomography. However, the diagnostic value of this method has so far not been investigated in detail. Therefore, the purpose of this study was, in a blinded manner, to investigate whether malignancy could be revealed by non-invasive x-ray phase-contrast tomography in lymph nodes from breast cancer patients. Seventeen formalin-fixed paraffin-embedded lymph nodes from 10 female patients (age range 37-83 years) diagnosed with invasive ductal carcinomas were analyzed by X-ray phase-contrast tomography. Ten lymph nodes had metastatic deposits and 7 were benign. The phase-contrast images were analyzed according to standards for conventional CT images looking for characteristics usually only visible by pathological examinations. Histopathology was used as reference. The result of this study was that the diagnostic sensitivity of the image analysis for detecting malignancy was 100% and the specificity was 87%. The positive predictive value was 91% for detecting malignancy and the negative predictive value was 100%. We conclude that x-ray phase-contrast imaging can accurately detect density variations to obtain information regarding lymph node involvement previously inaccessible with standard absorption x-ray imaging.	[Jensen, Torben Haugaard; Boettiger, Arvid; Feidenhans'l, Robert] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Bech, Martin; Zanette, Irene; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, D-80290 Munich, Germany; [Bech, Martin] Lund Univ, Lund, Sweden; [Binderup, Tina; Rank, Fritz; Kjaer, Andreas; Hojgaard, Liselotte] Rigshosp, Dept Clin Physiol, DK-2100 Copenhagen, Denmark; [Binderup, Tina; Kjaer, Andreas; Hojgaard, Liselotte] Univ Copenhagen, Copenhagen, Denmark; [David, Christian] Paul Scherrer Inst, Villigen, Switzerland; [Weitkamp, Timm] Synchrotron Soleil, Gif Sur Yvette, France; [Weitkamp, Timm; Zanette, Irene] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Reznikova, Elena; Mohr, Juergen] Karlsruhe Inst Technol, Inst Microstruct Technol, D-76021 Karlsruhe, Germany	University of Copenhagen; Niels Bohr Institute; Technical University of Munich; University of Munich; Lund University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; SOLEIL Synchrotron; European Synchrotron Radiation Facility (ESRF); Helmholtz Association; Karlsruhe Institute of Technology	Bech, M (corresponding author), Tech Univ Munich, Dept Phys, D-80290 Munich, Germany.	martin.bech@tum.de	Weitkamp, Timm/A-8975-2012; Bech, Martin/K-4331-2012; Højgaard, Liselotte/AAK-8329-2020; Kjaer, Andreas/E-8932-2015	Weitkamp, Timm/0000-0002-0374-0472; Bech, Martin/0000-0001-9109-7175; Zanette, Irene/0000-0001-6096-6059; Kjaer, Andreas/0000-0002-2706-5547; Feidenhansl, Robert/0000-0002-7963-3649; Reznikova, Elena/0000-0002-7277-6858	Faculty of Science and Health at the University of Copenhagen, through the European Synchrotron Radiation Facility (ESRF); Faculties of Science and Health through the DFG Cluster of Excellence Munich-Center for Advanced Photonics [DFG EXC-158]; European Research Council [24012]	Faculty of Science and Health at the University of Copenhagen, through the European Synchrotron Radiation Facility (ESRF); Faculties of Science and Health through the DFG Cluster of Excellence Munich-Center for Advanced Photonics; European Research Council(European Research Council (ERC)European Commission)	Financial support is given through Faculties of Science and Health at the University of Copenhagen, through the European Synchrotron Radiation Facility (ESRF), and through the DFG Cluster of Excellence Munich-Center for Advanced Photonics (DFG EXC-158) and the European Research Council (FP7, Starting Grant No. 24012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Benjamin O, 2003, J Natl Compr Canc Netw, V1 Suppl 1, pS64; David C, 2007, SPECTROCHIM ACTA B, V62, P626, DOI 10.1016/j.sab.2007.03.001; David C, 2002, APPL PHYS LETT, V81, P3287, DOI 10.1063/1.1516611; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fuster D, 2008, J CLIN ONCOL, V26, P4746, DOI 10.1200/JCO.2008.17.1496; Heusner TA, 2009, EUR J NUCL MED MOL I, V36, P1543, DOI 10.1007/s00259-009-1145-6; Hsiang DJ, 2007, ARCH SURG-CHICAGO, V142, P855, DOI 10.1001/archsurg.142.9.855; Lang S, 2012, MICROVASC RES, V84, P314, DOI 10.1016/j.mvr.2012.07.002; McDonald SA, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012043; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Momose A, 2006, JPN J APPL PHYS 1, V45, P5254, DOI 10.1143/JJAP.45.5254; Momose A, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012044; Muller B, 2010, PROC SPIE, V7804, DOI 10.1117/12.859052; Peintinger F, 2003, BRIT J CANCER, V89, P648, DOI 10.1038/sj.bjc.6601150; Pfeiffer F, 2007, PHYS MED BIOL, V52, P6923, DOI 10.1088/0031-9155/52/23/010; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Qi ZH, 2010, PHYS MED BIOL, V55, P2669, DOI 10.1088/0031-9155/55/9/016; Reintgen D, 2002, CANCER J, V8, pS15; Reznikova E, 2008, MICROSYST TECHNOL, V14, P1683, DOI 10.1007/s00542-007-0507-x; Samphao S, 2008, ANN SURG ONCOL, V15, P1282, DOI 10.1245/s10434-008-9863-8; Schulz G, 2010, J R SOC INTERFACE, V7, P1665, DOI 10.1098/rsif.2010.0281; Schulze T, 2006, J SURG ONCOL, V93, P109, DOI 10.1002/jso.20406; Shien T, 2008, INT J CLIN ONCOL, V13, P314, DOI 10.1007/s10147-007-0753-z; Stampanoni M, 2011, INVEST RADIOL, V46, P801, DOI 10.1097/RLI.0b013e31822a585f; Stutman D, 2011, PHYS MED BIOL, V56, P5697, DOI 10.1088/0031-9155/56/17/015; Takei H, 2010, BREAST CANCER-TOKYO, V17, P9, DOI 10.1007/s12282-009-0154-4; Tapfer A, 2012, P NATL ACAD SCI USA, V109, P15691, DOI 10.1073/pnas.1207503109; Tapfer A, 2011, MED PHYS, V38, P5910, DOI 10.1118/1.3644844; Taras AR, 2010, AM J SURG, V199, P625, DOI 10.1016/j.amjsurg.2010.01.009; Veronesi U, 2006, LANCET ONCOL, V7, P983, DOI 10.1016/S1470-2045(06)70947-0; Wang ZL, 2011, J ELECTRON SPECTROSC, V184, P342, DOI 10.1016/j.elspec.2010.12.009; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Weitkamp T, 2010, PROC SPIE, V7804, DOI 10.1117/12.860203; Weitkamp T, 2010, AIP CONF PROC, V1221, P33, DOI 10.1063/1.3399253; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109	36	10	10	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54047	10.1371/journal.pone.0054047	http://dx.doi.org/10.1371/journal.pone.0054047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349784	Green Published, gold			2022-12-27	WOS:000313872800023
J	Clark, EL; Hadjimichael, C; Temperley, R; Barnard, A; Fuller-Pace, FV; Robson, CN				Clark, Emma L.; Hadjimichael, Christiana; Temperley, Richard; Barnard, Amy; Fuller-Pace, Frances V.; Robson, Craig N.			p68/DdX5 Supports beta-Catenin & RNAP II during Androgen Receptor Mediated Transcription in Prostate Cancer	PLOS ONE			English	Article							WNT SIGNALING PATHWAYS; HISTONE DEACETYLASE-1; HELICASE P68; MULTIFUNCTIONAL PROTEINS; NUCLEAR TRANSLOCATION; WNT/BETA-CATENIN; COLON-CANCER; COACTIVATOR; EXPRESSION; GROWTH	The DEAD box RNA helicase p68 (Ddx5) is an important androgen receptor (AR) transcriptional co-activator in prostate cancer (PCa) and is over-expressed in late stage disease. beta-Catenin is a multifunctional protein with important structural and signalling functions which is up-regulated in PCa and similar to p68, interacts with the AR to co-activate expression of AR target genes. Importantly, p68 forms complexes with nuclear beta-Catenin and promotes gene transcription in colon cancer indicating a functional interplay between these two proteins in cancer progression. In this study, we explore the relationship of p68 and beta-Catenin in PCa to assess their potential co-operation in AR-dependent gene expression, which may be of importance in the development of castrate resistant prostate cancer (CRPCa). We use immunoprecipitation to demonstrate a novel interaction between p68 and beta-Catenin in the nucleus of PCa cells, which is androgen dependent in LNCaP cells but androgen independent in a hormone refractory derivative of the same cell line (representative of the CRPCa disease type). Enhanced AR activity is seen in androgen-dependent luciferase reporter assays upon transient co-transfection of p68 and beta-Catenin as an additive effect, and p68-depleted Chromatin-Immunoprecipitation (ChIP) showed a decrease in the recruitment of the AR and beta-Catenin to androgen responsive promoter regions. In addition, we found p68 immunoprecipitated with the processive and non-processive form of RNA polymerase II (RNAP II) and show p68 recruited to elongating regions of the AR mediated PSA gene, suggesting a role for p68 in facilitating RNAP II transcription of AR mediated genes. These results suggest p68 is important in facilitating beta-Catenin and AR transcriptional activity in PCa cells.	[Clark, Emma L.; Temperley, Richard; Barnard, Amy; Robson, Craig N.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hadjimichael, Christiana] Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Fuller-Pace, Frances V.] Univ Dundee, Ninewells Hosp & Med Sch, Div Canc Res, Dundee DD1 9SY, Scotland	Newcastle University - UK; University of Dundee	Robson, CN (corresponding author), Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	c.n.robson@ncl.ac.uk			Prostate Action Charity [PCRF9/07]; Medical Research Council, Cancer Research UK; Department of Health Prostate cancer Mechanisms of Progression and Treatment (ProMPT) collaboration [G0100100/64424]; MRC [G0900871] Funding Source: UKRI; Medical Research Council [G0900871] Funding Source: researchfish	Prostate Action Charity; Medical Research Council, Cancer Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Cancer Research UK); Department of Health Prostate cancer Mechanisms of Progression and Treatment (ProMPT) collaboration; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Prostate Action Charity [PCRF9/07 to CNR & ELC]; and the Medical Research Council, Cancer Research UK, and Department of Health Prostate cancer Mechanisms of Progression and Treatment (ProMPT) collaboration [G0100100/64424 to CNR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Buszczak M, 2006, GENE DEV, V20, P977, DOI 10.1101/gad.1396306; Caretti G, 2007, CELL CYCLE, V6, P1172, DOI 10.4161/cc.6.10.4228; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Clark EL, 2008, BIOCHEM SOC T, V36, P546, DOI 10.1042/BST0360546; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Germann S, 2012, ONCOGENE, P1; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Honig A, 2002, MOL CELL BIOL, V22, P5698, DOI 10.1128/MCB.22.16.5698-5707.2002; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; Liu S, 2008, ONCOGENE, V27, P499, DOI 10.1038/sj.onc.1210671; Liu XH, 2007, CANCER RES, V67, P5747, DOI 10.1158/0008-5472.CAN-07-0478; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Nieto M, 2007, INT J BIOCHEM CELL B, V39, P1562, DOI 10.1016/j.biocel.2007.01.005; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Saporita AJ, 2011, CANCER RES, V71, P6708, DOI 10.1158/0008-5472.CAN-11-1472; Schweizer L, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-4; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Stucke VM, 2008, CELL CYCLE, V7, P830, DOI 10.4161/cc.7.6.5614; Terry S, 2006, J CELL BIOCHEM, V99, P402, DOI 10.1002/jcb.20983; Truica CI, 2000, CANCER RES, V60, P4709; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Wang HZ, 2009, CELL RES, V19, P1388, DOI 10.1038/cr.2009.113; Whitaker HC, 2008, PROSTATE, V68, P1196, DOI 10.1002/pros.20780; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Yang LQ, 2007, J BIOL CHEM, V282, P16811, DOI 10.1074/jbc.M610488200; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794	45	30	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54150	10.1371/journal.pone.0054150	http://dx.doi.org/10.1371/journal.pone.0054150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349811	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900046
J	Connor, TMF; Oygar, DD; Gale, DP; Steenkamp, R; Nitsch, D; Neild, GH; Maxwell, PH				Connor, Thomas M. F.; Oygar, D. Deren; Gale, Daniel P.; Steenkamp, Retha; Nitsch, Dorothea; Neild, Guy H.; Maxwell, Patrick H.			Incidence of End-Stage Renal Disease in the Turkish-Cypriot Population of Northern Cyprus: A Population Based Study	PLOS ONE			English	Article							REPLACEMENT THERAPY; KIDNEY-DISEASE; FAILURE; MUTATIONS; PREVALENCE; IDENTIFICATION; THALASSEMIA; OVERWEIGHT; DIAGNOSIS; DIALYSIS	Background: This is the first report of the incidence and causes of end-stage renal disease (ESRD) of the Turkish-Cypriot population in Northern Cyprus. Methods: Data were collected over eight consecutive years (2004-2011) from all those starting renal replacement therapy (RRT) in this population. Crude and age-standardised incidence at 90 days was calculated and comparisons made with other national registries. We collected DNA from the entire prevalent population. As an initial experiment we looked for two genetic causes of ESRD that have been reported in Greek Cypriots. Results: Crude and age-standardised incidence at 90 days was 234 and 327 per million population (pmp) per year, respectively. The mean age was 63, and 62% were male. The age-adjusted prevalence of RRT in Turkish-Cypriots was 1543 pmp on 01/01/2011. The incidence of RRT is higher than other countries reporting to the European Renal Association European Dialysis and Transplant Association, with the exception of Turkey. Diabetes is a major cause of ESRD in those under 65, accounting for 36% of incident cases followed by 30% with uncertain aetiology. 18% of the incident population had a family history of ESRD. We identified two families with thin basement membrane nephropathy caused by a mutation in COL4A3, but no new cases of CFHR5 nephropathy. Conclusions: This study provides the first estimate of RRT incidence in the Turkish-Cypriot population, describes the contribution of different underlying diagnoses to ESRD, and provides a basis for healthcare policy planning.	[Connor, Thomas M. F.; Gale, Daniel P.; Neild, Guy H.; Maxwell, Patrick H.] UCL, UCL Div Med, London, England; [Connor, Thomas M. F.; Gale, Daniel P.; Neild, Guy H.; Maxwell, Patrick H.] UCL, Ctr Nephrol, London, England; [Oygar, D. Deren] Burhan Nalbantoglu Gen Hosp, Nicosia State Hosp, Nicosia, Cyprus; [Steenkamp, Retha] Southmead Hosp, UK Renal Registry, Bristol, Avon, England; [Nitsch, Dorothea] London Sch Hyg & Trop Med, London WC1, England	University of London; University College London; University of London; University College London; Southmead Hospital; University of London; London School of Hygiene & Tropical Medicine	Connor, TMF (corresponding author), UCL, UCL Div Med, London, England.	t.connor@ucl.ac.uk	Neild, Guy/K-2513-2013; Maxwell, Patrick H/C-5557-2008; Gale, Daniel/D-5594-2013	Maxwell, Patrick H/0000-0002-0338-2679; Gale, Daniel/0000-0002-9170-1579; Connor, Thomas/0000-0002-5896-7084; Nitsch, Dorothea/0000-0001-5767-248X	Clinical Research Training Fellowship from the Medical Research Council; St Peter's Trust for Kidney, Bladder and Prostate Research; Medical Research Council [G0802266] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish; MRC [G0802266] Funding Source: UKRI	Clinical Research Training Fellowship from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); St Peter's Trust for Kidney, Bladder and Prostate Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Clinical Research Training Fellowship to TMFC from the Medical Research Council (http://www.mrc.ac.uk/index.htm) and a grant from the St Peter's Trust for Kidney, Bladder and Prostate Research (http://www.stpeterstrust.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agodoa L, 2007, SEMIN DIALYSIS, V20, P577, DOI 10.1111/j.1525-139X.2007.00350.x; Alves TP, 2010, CLIN NEPHROL, V74, pS72; BAYSAL E, 1995, BRIT J HAEMATOL, V89, P496, DOI 10.1111/j.1365-2141.1995.tb08354.x; BAYSAL E, 1992, BRIT J HAEMATOL, V81, P607, DOI 10.1111/j.1365-2141.1992.tb03000.x; Boddana Preetham, 2009, Nephron Clin Pract, V111 Suppl 1, pc269, DOI 10.1159/000210003; Byrne C, 2010, NEPHRON CLIN PRACT, V115, pC9, DOI 10.1159/000299800; Caskey FJ, 2011, NEPHROL DIAL TRANSPL, V26, P2604, DOI 10.1093/ndt/gfq781; Census, 2006, FIN RES TRNC GEN POP; Deltas CC, 2002, GENET TEST, V6, P15, DOI 10.1089/109065702760093861; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; ERA, 2008, ERA EDTA REG ANN REP; Eurostat, 2010, EUR COMM POP STAT; Freedman BI, 2005, AM J NEPHROL, V25, P529, DOI 10.1159/000088491; Gale DP, 2011, J ROY SOC MED, V104, P186, DOI 10.1258/jrsm.2011.11k013; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Institute TS, 2008, MID POP PROJ AG GROU; Irwin J, 2008, INT J LEGAL MED, V122, P87, DOI 10.1007/s00414-007-0173-7; Lemley KV, 2008, PEDIATR NEPHROL, V23, P1933, DOI 10.1007/s00467-008-0763-8; Loizou T, 2006, DIABETES CARE, V29, P1714, DOI 10.2337/dc06-0696; Lubensky IA, 1999, AM J PATHOL, V155, P517, DOI 10.1016/S0002-9440(10)65147-4; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Neild GH, 2011, SAUDI J KIDNEY DIS T, V22, P651; Neild GH, 2009, PEDIATR NEPHROL, V24, P1913, DOI 10.1007/s00467-008-1108-3; Nephrology TSo, 2008, REG NEPHR DIAL TRANS; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; [ONS Statistics Ofn], 2011, MID YEAR POP EST 200; PERNEGER TV, 1995, AM J EPIDEMIOL, V141, P10, DOI 10.1093/oxfordjournals.aje.a117338; Rosansky SJ, 2009, KIDNEY INT, V76, P257, DOI 10.1038/ki.2009.161; Savva SC, 2008, INT J PEDIATR OBES, V3, P186, DOI 10.1080/17477160701705451; Shaheen FAM, 2005, KIDNEY INT, V68, pS37, DOI 10.1111/j.1523-1755.2005.09807.x; Stavrou C, 2002, KIDNEY INT, V62, P1385, DOI 10.1111/j.1523-1755.2002.kid581.x; Stewart JH, 2007, NEPHROLOGY, V12, P520, DOI 10.1111/j.1440-1797.2007.00830.x; Suleymanlar G, 2011, NEPHROL DIAL TRANSPL, V26, P1862, DOI 10.1093/ndt/gfq656; Suleymanlar G, 2011, AM J KIDNEY DIS, V57, P456, DOI 10.1053/j.ajkd.2010.12.007; USRDS. U.S. Renal Data System, 2011, US REN DAT SYST USRD; van Dijk PCW, 2007, KIDNEY INT, V71, P53, DOI 10.1038/sj.ki.5002008; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Wikipedia editor, 2011, NO CYPRUS; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88	42	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54394	10.1371/journal.pone.0054394	http://dx.doi.org/10.1371/journal.pone.0054394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349874	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900063
J	Los, FCO; Ha, C; Aroian, RV				Los, Ferdinand C. O.; Ha, Christine; Aroian, Raffi V.			Neuronal Go alpha and CAPS Regulate Behavioral and Immune Responses to Bacterial Pore-Forming Toxins	PLOS ONE			English	Article							PLASMA-MEMBRANE REPAIR; CAENORHABDITIS-ELEGANS; C-ELEGANS; INNATE IMMUNITY; SIGNALING NETWORK; BACILLUS-THURINGIENSIS; CRYSTAL PROTEINS; NERVOUS-SYSTEM; UNC-31 CAPS; PATHWAY	Pore-forming toxins (PFTs) are abundant bacterial virulence factors that attack host cell plasma membranes. Host defense mechanisms against PFTs described to date all function in the host tissue that is directly attacked by the PFT. Here we characterize a rapid and fully penetrant cessation of feeding of Caenorhabditis elegans in response to PFT attack. We demonstrate via analyses of C. elegans mutants that inhibition of feeding by PFT requires the neuronal G protein Go alpha subunit goa-1, and that maintenance of this response requires neuronally expressed calcium activator for protein secretion (CAPS) homolog unc-31. Independently from their role in feeding cessation, we find that goa-1 and unc-31 are additionally required for immune protection against PFTs. We thus demonstrate that the behavioral and immune responses to bacterial PFT attack involve the cross-talk between the nervous system and the cells directly under attack.	[Los, Ferdinand C. O.; Ha, Christine; Aroian, Raffi V.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Aroian, RV (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	raroian@ucsd.edu			National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [R01GM071603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071603] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) grant R01GM071603 to RVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; Anyanful A, 2009, CELL HOST MICROBE, V5, P450, DOI 10.1016/j.chom.2009.04.012; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avery Leon, 1993, Genetics, V134, P455; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof Larry J., 2006, V351, P139; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; Corrotte M, 2012, TRAFFIC, V13, P483, DOI 10.1111/j.1600-0854.2011.01323.x; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Dutta S, 2010, J BACTERIOL, V192, P169, DOI 10.1128/JB.00930-09; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Goehler LE, 2007, BRAIN BEHAV IMMUN, V21, P721, DOI 10.1016/j.bbi.2007.02.005; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hasshoff M, 2007, FASEB J, V21, P1801, DOI 10.1096/fj.06-6551com; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Jacob TC, 2003, J NEUROSCI, V23, P2122; Jiang MS, 2001, P NATL ACAD SCI USA, V98, P3577, DOI 10.1073/pnas.051632598; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Kawli T, 2010, P NATL ACAD SCI USA, V107, P13788, DOI 10.1073/pnas.0914715107; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Los FCO, 2011, CELL HOST MICROBE, V9, P147, DOI 10.1016/j.chom.2011.01.005; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; RAIZEN DM, 1995, GENETICS, V141, P1365; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Robatzek M, 2000, GENETICS, V156, P1069; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van Swinderen B, 2001, GENETICS, V158, P643; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	54	15	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54528	10.1371/journal.pone.0054528	http://dx.doi.org/10.1371/journal.pone.0054528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349920	Green Submitted, gold, Green Published			2022-12-27	WOS:000313738900075
J	Steelandt, S; Broihanne, MH; Romain, A; Thierry, B; Dufour, V				Steelandt, Sophie; Broihanne, Marie-Helene; Romain, Amelie; Thierry, Bernard; Dufour, Valerie			Decision-Making under Risk of Loss in Children	PLOS ONE			English	Article							PROBABILITY; PREFERENCES; GRATIFICATION; UNCERTAINTY; PSYCHOLOGY; JUDGMENTS; GAINS; DELAY; AGE	In human adults, judgment errors are known to often lead to irrational decision-making in risky contexts. While these errors can affect the accuracy of profit evaluation, they may have once enhanced survival in dangerous contexts following a "better be safe than sorry" rule of thumb. Such a rule can be critical for children, and it could develop early on. Here, we investigated the rationality of choices and the possible occurrence of judgment errors in children aged 3 to 9 years when exposed to a risky trade. Children were allocated with a piece of cookie that they could either keep or risk in exchange of the content of one cup among 6, visible in front of them. In the cups, cookies could be of larger, equal or smaller sizes than the initial allocation. Chances of losing or winning were manipulated by presenting different combinations of cookie sizes in the cups (for example 3 large, 2 equal and 1 small cookie). We investigated the rationality of children's response using the theoretical models of Expected Utility Theory (EUT) and Cumulative Prospect Theory. Children aged 3 to 4 years old were unable to discriminate the profitability of exchanging in the different combinations. From 5 years, children were better at maximizing their benefit in each combination, their decisions were negatively induced by the probability of losing, and they exhibited a framing effect, a judgment error found in adults. Confronting data to the EUT indicated that children aged over 5 were risk-seekers but also revealed inconsistencies in their choices. According to a complementary model, the Cumulative Prospect Theory (CPT), they exhibited loss aversion, a pattern also found in adults. These findings confirm that adult-like judgment errors occur in children, which suggests that they possess a survival value.	[Steelandt, Sophie; Romain, Amelie; Thierry, Bernard; Dufour, Valerie] Ctr Natl Rech Sci, Dept Ecol Physiol & Ethol, Strasbourg, France; [Steelandt, Sophie; Romain, Amelie; Thierry, Bernard; Dufour, Valerie] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Broihanne, Marie-Helene] Univ Strasbourg, EM Strasbourg Business Sch, Lab Rech Gest & Econ, Strasbourg, France; [Dufour, Valerie] Univ St Andrews, Sch Psychol, Scottish Primate Res Grp, SPRG,Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of St Andrews	Dufour, V (corresponding author), Ctr Natl Rech Sci, Dept Ecol Physiol & Ethol, Strasbourg, France.	valerie.dufour@iphc.cnrs.fr		Broihanne, Marie-Helene/0000-0002-3651-2740	Agence Nationale de la Recherche [ANR-08-412 BLAN-0042-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	The research was supported by a grant from the Agence Nationale de la Recherche (ANR-08-412 BLAN-0042-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NH, 1991, CONTRIB INFORMATION, P83; Barberis N, 2008, AM ECON REV, V98, P2066, DOI 10.1257/aer.98.5.2066; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; CAMERER CF, 1994, J RISK UNCERTAINTY, V8, P167, DOI 10.1007/BF01065371; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Cauffman E, 2010, DEV PSYCHOL, V46, P193, DOI 10.1037/a0016128; Clearfield MW, 1999, PSYCHOL SCI, V10, P408, DOI 10.1111/1467-9280.00177; Daniel K, 1998, J FINANC, V53, P1839, DOI 10.1111/0022-1082.00077; DELONG JB, 1990, J POLIT ECON, V98, P703, DOI 10.1086/261703; Denison S, 2006, P 28 ANN C COGN SCI, P1216; Feldman T, 2011, ALGORITHMIC FIN IN P; Gigerenzer G., 2001, BOUNDED RATIONALITY; Gonzalez R, 1999, COGNITIVE PSYCHOL, V38, P129, DOI 10.1006/cogp.1998.0710; Griffiths M, 1995, ADOLESCENT GAMBLING; Griffiths M D, 1990, J Gambl Stud, V6, P31, DOI 10.1007/BF01015747; Harbaugh WT, 2002, EXP ECON, V5, P53, DOI 10.1023/A:1016316725855; Holt C., 2008, HDB EXPT EC RESULTS; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kessler EH, 1996, J ECON BEHAV ORGAN, V30, P241, DOI 10.1016/S0167-2681(96)00860-8; Knight, 1933, RISK UNCERTAINTY PRO; Lambos C, 2007, REPORT PREPARED FOR; Levin IP, 2003, J BEHAV DECIS MAKING, V16, P397, DOI 10.1002/bdm.453; Levy-Garboua L, 2011, EXP ECON IN PRESS; LINVILLE PW, 1991, J PERS SOC PSYCHOL, V60, P5, DOI 10.1037/0022-3514.60.1.5; Mas-Colell A., 1995, MICROECONOMIC THEORY; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Mix KS, 2002, QUANTITATIVE DEVELOP; Murnighan JK, 1998, J ECON PSYCHOL, V19, P415, DOI 10.1016/S0167-4870(98)00017-8; Nofsinger JR, 2005, THE PSYCHOLOGY OF IN; Odean T, 1998, J FINANC, V53, P1775, DOI 10.1111/0022-1082.00072; Pange J, 2003, ZDM INT J MATH ED, V35, P182; REYNA VF, 1994, PSYCHOL SCI, V5, P275, DOI 10.1111/j.1467-9280.1994.tb00625.x; Reyna VF, 1994, SUBJECTIVE PROBABILI, P239; SCHLOTTMANN A, 1994, DEV PSYCHOL, V30, P56, DOI 10.1037/0012-1649.30.1.56; Schlottmann A, 2001, CHILD DEV, V72, P103, DOI 10.1111/1467-8624.00268; Schlottmann A, 2000, J BEHAV DECIS MAKING, V13, P77, DOI 10.1002/(SICI)1099-0771(200001/03)13:1<77::AID-BDM344>3.0.CO;2-Y; Shiller RJ, 2002, J PSYCHOL FINANCIAL, V3, P87; SHLEIFER A, 1990, J ECON PERSPECT, V4, P19, DOI 10.1257/jep.4.2.19; Steelandt S, 2012, COGNITION, V122, P416, DOI 10.1016/j.cognition.2011.11.009; Stich S, 1990, THE FRAGMENTATION OF; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Van Leijenhorst L, 2008, DEV NEUROPSYCHOL, V33, P179, DOI 10.1080/87565640701884287; Wang XT, 2009, EVOL HUM BEHAV, V30, P77, DOI 10.1016/j.evolhumbehav.2008.09.006; Wang XB, 1996, J MOL STRUCT, V385, P1, DOI 10.1016/S0022-2860(96)09397-0; Wu G, 1996, MANAGE SCI, V42, P1676, DOI 10.1287/mnsc.42.12.1676	51	9	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52316	10.1371/journal.pone.0052316	http://dx.doi.org/10.1371/journal.pone.0052316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23349682	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500011
J	Zhu, Y; Carido, M; Meinhardt, A; Kurth, T; Karl, MO; Ader, M; Tanaka, EM				Zhu, Yu; Carido, Madalena; Meinhardt, Andrea; Kurth, Thomas; Karl, Mike O.; Ader, Marius; Tanaka, Elly M.			Three-Dimensional Neuroepithelial Culture from Human Embryonic Stem Cells and Its Use for Quantitative Conversion to Retinal Pigment Epithelium	PLOS ONE			English	Article							NEURAL DIFFERENTIATION; OPTIC VESICLE; IPS CELLS; IN-VITRO; HUMAN ES; GENERATION; NEURONS; DISEASE; MOUSE; RPE	A goal in human embryonic stem cell (hESC) research is the faithful differentiation to given cell types such as neural lineages. During embryonic development, a basement membrane surrounds the neural plate that forms a tight, apico-basolaterally polarized epithelium before closing to form a neural tube with a single lumen. Here we show that the three-dimensional epithelial cyst culture of hESCs in Matrigel combined with neural induction results in a quantitative conversion into neuroepithelial cysts containing a single lumen. Cells attain a defined neuroepithelial identity by 5 days. The neuroepithelial cysts naturally generate retinal epithelium, in part due to IGF-1/insulin signaling. We demonstrate the utility of this epithelial culture approach by achieving a quantitative production of retinal pigment epithelial (RPE) cells from hESCs within 30 days. Direct transplantation of this RPE into a rat model of retinal degeneration without any selection or expansion of the cells results in the formation of a donor-derived RPE monolayer that rescues photoreceptor cells. The cyst method for neuroepithelial differentiation of pluripotent stem cells is not only of importance for RPE generation but will also be relevant to the production of other neuronal cell types and for reconstituting complex patterning events from three-dimensional neuroepithelia.	[Zhu, Yu; Carido, Madalena; Meinhardt, Andrea; Kurth, Thomas; Karl, Mike O.; Ader, Marius; Tanaka, Elly M.] Tech Univ Dresden, Ctr Regenerat Therapies, D-01062 Dresden, Germany	Technische Universitat Dresden	Tanaka, EM (corresponding author), Tech Univ Dresden, Ctr Regenerat Therapies, D-01062 Dresden, Germany.	elly.tanaka@crt-dresden.de	Karl, Mike O./E-7246-2010; Ader, Marius/E-7535-2010; Meinhardt, Andrea/P-6161-2014; Tanaka, Elly M/F-8572-2010	Karl, Mike O./0000-0002-0926-6556; Ader, Marius/0000-0001-9467-7677; Meinhardt, Andrea/0000-0003-3833-8210; Tanaka, Elly/0000-0003-4240-2158; Carido, Madalena/0000-0001-8969-0877; Kurth, Thomas/0000-0001-5624-1717	Deutsche Forschungsgemeinschaft (DFG), Center for Regenerative Therapies Dresden, Cluster of Excellence [FZT 111]; DIGS-BB Graduate Program; Fundacao para a Ciencia e Tecnologia	Deutsche Forschungsgemeinschaft (DFG), Center for Regenerative Therapies Dresden, Cluster of Excellence(German Research Foundation (DFG)); DIGS-BB Graduate Program; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the FZT 111 (Deutsche Forschungsgemeinschaft (DFG), Center for Regenerative Therapies Dresden, Cluster of Excellence), the DIGS-BB Graduate Program and the Fundacao para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Carr AJ, 2009, MOL VIS, V15, P283; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; FRAMBACH DA, 1990, INVEST OPHTH VIS SCI, V31, P1767; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391; Haruta M, 2004, INVEST OPHTH VIS SCI, V45, P1020, DOI 10.1167/iovs.03-1034; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu Q, 2010, STEM CELLS; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Inman Jamie L, 2010, J Biol, V9, P2, DOI 10.1186/jbiol213; Jin ZB, 2012, STEM CELL TRANSL MED, V1, P503, DOI 10.5966/sctm.2012-0005; Jin ZB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017084; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Krohne TU, 2012, STEM CELL TRANSL MED, V1, P96, DOI 10.5966/sctm.2011-0057; LACOUR M, 1994, INVEST OPHTH VIS SCI, V35, P434; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Okamoto S, 2011, INVEST OPHTH VIS SCI, V52, P8785, DOI 10.1167/iovs.11-8129; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pollard SM, 2006, METHOD ENZYMOL, V418, P151, DOI 10.1016/S0076-6879(06)18010-6; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; SCHWARTZ SD, 2012, LANCET; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	46	71	76	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54552	10.1371/journal.pone.0054552	http://dx.doi.org/10.1371/journal.pone.0054552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358448	Green Published, gold			2022-12-27	WOS:000314023600068
J	Dai, J; Shen, DF; Bian, ZY; Zhou, H; Gan, HW; Zong, J; Deng, W; Yuan, Y; Li, FF; Wu, QQ; Gao, L; Zhang, R; Ma, ZG; Li, HL; Tang, QZ				Dai, Jia; Shen, Di-Fei; Bian, Zhou-Yan; Zhou, Heng; Gan, Hua-Wen; Zong, Jing; Deng, Wei; Yuan, Yuan; Li, FangFang; Wu, Qing-Qing; Gao, Lu; Zhang, Rui; Ma, Zhen-Guo; Li, Hong-Liang; Tang, Qi-Zhu			IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED CARDIOMYOCYTE HYPERTROPHY; HEART-FAILURE; SIGNALING PATHWAY; PULMONARY INFLAMMATION; TASK-FORCE; TNF-ALPHA; EPSILON; GENE; INVOLVEMENT	The inducible I kappa B kinase (IKKi/IKK epsilon) is a recently described serine-threonine IKK-related kinase. Previous studies have reported the role of IKKi in infectious diseases and cancer. However, its role in the cardiac response to pressure overload remains elusive. In this study, we investigated the effects of IKKi deficiency on the development of pathological cardiac hypertrophy using in vitro and in vivo models. First, we developed mouse models of pressure overload cardiac hypertrophy induced by pressure overload using aortic banding (AB). Four weeks after AB, cardiac function was then assessed through echocardiographic and hemodynamic measurements. Western blotting, real-time PCR and histological analyses were used to assess the pathological and molecular mechanisms. We observed that IKKi-deficient mice showed significantly enhanced cardiac hypertrophy, cardiac dysfunction, apoptosis and fibrosis compared with WT mice. Furthermore, we recently revealed that the IKKi-deficient mice spontaneously develop cardiac hypertrophy. Moreover, in vivo experiments showed that IKKi deficiency-induced cardiac hypertrophy was associated with the activation of the AKT and NF-kappa B signaling pathway in response to AB. In cultured cells, IKKi overexpression suppressed the activation of this pathway. In conclusion, we demonstrate that IKKi deficiency exacerbates cardiac hypertrophy by regulating the AKT and NF-kappa B signaling pathway.	[Dai, Jia; Shen, Di-Fei; Bian, Zhou-Yan; Zhou, Heng; Gan, Hua-Wen; Zong, Jing; Deng, Wei; Yuan, Yuan; Li, FangFang; Wu, Qing-Qing; Zhang, Rui; Ma, Zhen-Guo; Li, Hong-Liang; Tang, Qi-Zhu] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China; [Dai, Jia; Shen, Di-Fei; Bian, Zhou-Yan; Zhou, Heng; Gan, Hua-Wen; Zong, Jing; Deng, Wei; Yuan, Yuan; Li, FangFang; Wu, Qing-Qing; Zhang, Rui; Ma, Zhen-Guo; Li, Hong-Liang; Tang, Qi-Zhu] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China; [Gao, Lu] Huazhong Univ Sci & Technol, Dept Cardiol, Inst Cardiovasc Dis, Union Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China	Wuhan University; Wuhan University; Huazhong University of Science & Technology	Tang, QZ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China.	qztang@whu.edu.cn			National Natural Science Foundation of China [30901628, 81000036]; Fundamental Research Funds for the Central Universities of China [201130202020007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (30901628 and 81000036) (http://www.nsfc.gov.cn/Portal0/default106.htm) and the Fundamental Research Funds for the Central Universities of China (No. 201130202020007) (http://www.gs.whu.edu.cn/newscenter/Readews.asp?NewsID=728). The funders had the role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar N, 2009, FRONT BIOSCI-LANDMRK, V14, P3168, DOI 10.2741/3443; Bian ZY, 2012, J MOL MED BERL; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; De Boer RA, 2003, MICROCIRCULATION, V10, P113, DOI 10.1038/sj.mn.7800188; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gaspar-Pereira S, 2012, AM J PATHOL, V180, P929, DOI 10.1016/j.ajpath.2011.11.007; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Higuchi Y, 2006, AM J PHYSIOL-HEART C, V290, pH590, DOI 10.1152/ajpheart.00379.2005; Higuchi Y, 2002, J MOL CELL CARDIOL, V34, P233, DOI 10.1006/jmcc.2001.1505; Hikoso S, 2009, CIRC RES, V105, P70, DOI 10.1161/CIRCRESAHA.108.193318; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Iemitsu M, 2001, AM J PHYSIOL-REG I, V281, pR2029, DOI 10.1152/ajpregu.2001.281.6.R2029; Joung SM, 2011, J IMMUNOL, V186, P499, DOI 10.4049/jimmunol.0903534; Koop A, 2011, EUR J IMMUNOL, V41, P224, DOI 10.1002/eji.201040814; Kravchenko VV, 2003, J BIOL CHEM, V278, P26612, DOI 10.1074/jbc.M303001200; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pazos-Lopez P, 2011, VASC HEALTH RISK MAN, V7, P237, DOI 10.2147/VHRM.S10669; Peant B, 2011, PROSTATE, V71, P1131, DOI 10.1002/pros.21329; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Sambandam N, 2004, EUR J BIOCHEM, V271, P2831, DOI 10.1111/j.1432-1033.2004.04218.x; Shembade N, 2011, CELL MOL IMMUNOL, V8, P447, DOI 10.1038/cmi.2011.44; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Sun HZ, 2010, J ENDOCRINOL, V204, P311, DOI 10.1677/JOE-09-0270; Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Wang NZ, 2005, GENE, V353, P118, DOI 10.1016/j.gene.2005.04.013; Yamazaki T, 2012, HYPERTENS RES, V35, P34, DOI 10.1038/hr.2011.139; Yan L, 2011, CARDIOVASC RES, V92, P85, DOI 10.1093/cvr/cvr159; Zelarayan L, 2009, CARDIOVASC RES, V84, P416, DOI 10.1093/cvr/cvp237; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744	38	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53412	10.1371/journal.pone.0053412	http://dx.doi.org/10.1371/journal.pone.0053412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349709	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100020
J	McMahon, SJ; Butterworth, KT; Trainor, C; McGarry, CK; O'Sullivan, JM; Schettino, G; Hounsell, AR; Prise, KM				McMahon, Stephen J.; Butterworth, Karl T.; Trainor, Colman; McGarry, Conor K.; O'Sullivan, Joe M.; Schettino, Giuseppe; Hounsell, Alan R.; Prise, Kevin M.			A Kinetic-Based Model of Radiation-Induced Intercellular Signalling	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; X-RAYS; CELLULAR-RESPONSE; BYSTANDER; CELLS; FIELDS; IRRADIATION; SURVIVAL; INDUCTION; TISSUES	It is now widely accepted that intercellular communication can cause significant variations in cellular responses to genotoxic stress. The radiation-induced bystander effect is a prime example of this effect, where cells shielded from radiation exposure see a significant reduction in survival when cultured with irradiated cells. However, there is a lack of robust, quantitative models of this effect which are widely applicable. In this work, we present a novel mathematical model of radiation- induced intercellular signalling which incorporates signal production and response kinetics together with the effects of direct irradiation, and test it against published data sets, including modulated field exposures. This model suggests that these so-called "bystander'' effects play a significant role in determining cellular survival, even in directly irradiated populations, meaning that the inclusion of intercellular communication may be essential to produce robust models of radio-biological outcomes in clinically relevant in vivo situations.	[McMahon, Stephen J.; Butterworth, Karl T.; Trainor, Colman; McGarry, Conor K.; O'Sullivan, Joe M.; Schettino, Giuseppe; Hounsell, Alan R.; Prise, Kevin M.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [McGarry, Conor K.; O'Sullivan, Joe M.; Hounsell, Alan R.] Belfast Hlth & Social Care Trust, No Ireland Canc Ctr, Belfast, Antrim, North Ireland	Queens University Belfast	McMahon, SJ (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	stephen.mcmahon@qub.ac.uk	Schettino, Giuseppe/X-1983-2018; Prise, Kevin/N-7872-2015; Butterworth, Karl/I-7476-2019	Schettino, Giuseppe/0000-0003-3284-3953; Prise, Kevin/0000-0001-6134-7946; Butterworth, Karl/0000-0001-7170-6789; McGarry, Conor/0000-0001-6396-2184; McMahon, Stephen/0000-0001-5980-6728; O'Sullivan, Joe/0000-0001-6999-2739	Cancer Research United Kingdom [C1513/A7047, C212/A11342]; Health and Social Care Research and Development of the Public Health Agency training fellowship award; DEL studentship	Cancer Research United Kingdom(Cancer Research UK); Health and Social Care Research and Development of the Public Health Agency training fellowship award; DEL studentship	This work was supported by grants from Cancer Research United Kingdom (Grant no. C1513/A7047 to KMP, and C212/A11342 for SMM and ARH). CKM is supported by a Health and Social Care Research and Development of the Public Health Agency training fellowship award. CT is supported by a DEL studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asur RS, 2009, MUTAT RES-GEN TOX EN, V676, P11, DOI 10.1016/j.mrgentox.2009.02.012; Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; Banerjee G, 2005, CANCER LETT, V223, P275, DOI 10.1016/j.canlet.2004.09.035; Belyakov OV, 2005, P NATL ACAD SCI USA, V102, P14203, DOI 10.1073/pnas.0505020102; Blyth BJ, 2011, RADIAT RES, V176, P139, DOI 10.1667/RR2548.1; Botchway SW, 1997, RADIAT RES, V148, P317, DOI 10.2307/3579516; Brenner DJ, 2001, RADIAT RES, V155, P402, DOI 10.1667/0033-7587(2001)155[0402:TBEIRO]2.0.CO;2; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Butterworth KT, 2012, PHYS MED BIOL, V57, P3197, DOI 10.1088/0031-9155/57/10/3197; Butterworth KT, 2011, INT J RADIAT ONCOL, V79, P1516, DOI 10.1016/j.ijrobp.2010.11.034; Butterworth KT, 2010, PHYS MED BIOL, V55, P1607, DOI 10.1088/0031-9155/55/6/005; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Ebert MA, 2010, ACTA ONCOL, V49, P1334, DOI 10.3109/0284186X.2010.487874; Fakir H, 2009, RADIAT RES, V171, P320, DOI 10.1667/RR1293.1; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Little MP, 2001, RADIAT RES, V156, P695, DOI 10.1667/0033-7587(2001)156[0695:TBEICC]2.0.CO;2; Little MP, 2005, J THEOR BIOL, V232, P329, DOI 10.1016/j.jtbi.2004.08.016; Mackonis EC, 2007, PHYS MED BIOL, V52, P5469, DOI 10.1088/0031-9155/52/18/001; MASTRO AM, 1984, P NATL ACAD SCI-BIOL, V81, P3414, DOI 10.1073/pnas.81.11.3414; McMahon SJ, 2012, INT J RADIAT ONCOL, V84, P250, DOI 10.1016/j.ijrobp.2011.10.058; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 1998, RADIAT RES, V149, P256, DOI 10.2307/3579958; Mothersill C, 2001, RADIAT RES, V155, P759, DOI 10.1667/0033-7587(2001)155[0759:RIBEPH]2.0.CO;2; Nikjoo H, 2003, INT J RADIAT BIOL, V79, P43, DOI 10.1080/0955300021000034701; Partridge M, 2008, PHYS MED BIOL, V53, P3595, DOI 10.1088/0031-9155/53/13/014; Ponnaiya B, 2004, RADIAT RES, V162, P426, DOI 10.1667/RR3236; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Przybyszewski WM, 2004, CANCER LETT, V214, P91, DOI 10.1016/j.canlet.2004.03.046; Purschke M, 2010, J INVEST DERMATOL, V130, P86, DOI 10.1038/jid.2009.205; Ryan LA, 2008, RADIAT RES, V169, P188, DOI 10.1667/RR1141.1; Schettino G, 2005, RADIAT RES, V163, P332, DOI 10.1667/RR3319; Schettino G, 2003, RADIAT RES, V160, P505, DOI 10.1667/RR3060; Shuryak I, 2007, RADIAT RES, V168, P741, DOI 10.1667/RR1117.1; Stewart RD, 2006, RADIAT RES, V165, P460, DOI 10.1667/RR3520.1; Suchowerska N, 2005, PHYS MED BIOL, V50, P3041, DOI 10.1088/0031-9155/50/13/005; Trainor C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043326; Vines AM, 2008, INT J RADIAT BIOL, V84, P83, DOI 10.1080/09553000701797062; Wang HC, 2001, ONCOGENE, V20, P2212, DOI 10.1038/sj.onc.1204350; Zhang Y, 2009, MUTAT RES-FUND MOL M, V671, P20, DOI 10.1016/j.mrfmmm.2009.08.006	40	49	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54526	10.1371/journal.pone.0054526	http://dx.doi.org/10.1371/journal.pone.0054526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349919	gold, Green Published			2022-12-27	WOS:000314019100077
J	Wang, NK; Lai, CC; Chou, CL; Chen, YP; Chuang, LH; Chao, AN; Tseng, HJ; Chang, CJ; Wu, WC; Chen, KJ; Tsang, SH				Wang, Nan-Kai; Lai, Chi-Chun; Chou, Chai Lin; Chen, Yen-Po; Chuang, Lan-Hsin; Chao, An-Ning; Tseng, Hsiao-Jung; Chang, Chee-Jen; Wu, Wei-Chi; Chen, Kuan-Jen; Tsang, Stephen H.			Choroidal Thickness and Biometric Markers for the Screening of Lacquer Cracks in Patients with High Myopia	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGICAL MYOPIA; VISUAL IMPAIRMENT; PREVALENCE; NEOVASCULARIZATION; EYE; POPULATION; BLINDNESS; REPRODUCIBILITY; PROGRESSION	Objective: Validation of choroidal thickness and other biometrics measured by spectral domain optical coherence tomography (SD-OCT) in predicting lacquer cracks formation in highly myopic eyes. Methods: Patients with a refractive error worse than -8 diopters and moderate myopic maculopathy were recruited into two groups based on the presence or absence of lacquer cracks (36 eyes without and 33 eyes with lacquer cracks). Choroidal thickness, refractive error, and axial length were measured and subjected to receiver operating characteristic curve analysis to identify the optimal cutoff values at predicting lacquer crack formation. The width of the retinal pigment epithelium (RPE), RPE to the inner segment/outer segment line, RPE to the external limiting membrane were also measured and compared to the subfoveal choroidal thickness to assess their relationships as potential markers of lacquer crack formation. Results: Lacquer crack is associated with decreased choroidal thickness, lower best-corrected visual acuity, longer axial length and higher refractive errors. Choroidal thickness has the strongest association with lacquer crack formation versus axial length and refractive error. In eyes with lacquer cracks, stellate lacquer cracks are associated with thinner choroidal thickness compared to eyes with linear lacquer cracks. Subfoveal choroidal thickness less than the width of the retinal pigment epithelium to the inner segment/outer segment line is also associated with lacquer crack formation (sensitivity 78.8%, specificity 88.3%, and accuracy 81.2%). Conclusions: This study suggests that choroidal thickness and other SD-OCT measurements could be employed clinically to predict the development and severity of lacquer cracks in patients with high myopia.	[Wang, Nan-Kai; Lai, Chi-Chun; Chen, Yen-Po; Chuang, Lan-Hsin; Chao, An-Ning; Wu, Wei-Chi; Chen, Kuan-Jen] Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan; [Wang, Nan-Kai; Lai, Chi-Chun; Chen, Yen-Po; Chao, An-Ning; Wu, Wei-Chi; Chen, Kuan-Jen] Chang Gung Mem Hosp, Dept Ophthalmol, Linkuo Med Ctr, Tao Yuan, Taiwan; [Chou, Chai Lin] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Chuang, Lan-Hsin] Chang Gung Mem Hosp, Dept Ophthalmol, Keelung, Taiwan; [Tseng, Hsiao-Jung; Chang, Chee-Jen] Chang Gung Mem Hosp, Biostat Ctr Clin Res, Tao Yuan, Taiwan; Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Tao Yuan, Taiwan; [Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, Dept Pathol & Cell Biol, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Edward S Harkness Eye Inst, New York, NY USA	Chang Gung University; Chang Gung Memorial Hospital; University of British Columbia; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Columbia University; Columbia University	Wang, NK (corresponding author), Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan.	wang.nankai@gmail.com	Wang, Nan-Kai/AAO-6559-2020; Wang, Nan-Kai/D-6608-2011; Chou, Chai Lin/C-2331-2008	Wang, Nan-Kai/0000-0002-6277-9879; Wang, Nan-Kai/0000-0002-6277-9879; Chou, Chai Lin/0000-0003-4754-0488; Lai, Chi-Chun/0000-0001-9547-7212; Chao, An-Ning/0000-0002-4761-9244; Chang, Chee Jen/0000-0002-7725-7555; Chen, Kuan-Jen/0000-0002-4994-8391	Taiwan National Science Council, Taiwan [NSC-99-2314-B-182A-029-MY3]; Chang Gung Memorial Hospital, Linkou, Taiwan [381561similar to381563, 391801similar to391802]; National Eye Institute/National Institutes of Health (Bethesda, Maryland) [EY018213, P30EY019007]; Research to Prevent Blindness (New York, New York); NATIONAL EYE INSTITUTE [P30EY019007, R01EY018213] Funding Source: NIH RePORTER	Taiwan National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital); National Eye Institute/National Institutes of Health (Bethesda, Maryland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (New York, New York)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by research grant NSC-99-2314-B-182A-029-MY3 from the Taiwan National Science Council, Taiwan, and CMRPG 381561 similar to 381563 and 391801 similar to 391802 from Chang Gung Memorial Hospital, Linkou, Taiwan, National Eye Institute/National Institutes of Health (Bethesda, Maryland) EY018213 (SHT), P30EY019007 (Core Support for Vision Research; Columbia University), Foundation Fighting Blindness (Owings Mills, Maryland), and unrestricted funds from Research to Prevent Blindness (New York, New York). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA MP, 1984, OPHTHALMOLOGY, V91, P1573; Axer-Siegez R, 2004, OPHTHAL SURG LAS IM, V35, P139, DOI 10.3928/1542-8877-20040301-09; Branchini L, 2012, OPHTHALMOLOGY, V119, P119, DOI 10.1016/j.ophtha.2011.07.002; Curtin BJ, 1971, AM J OPHTHALMOL, V1, P42; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; Hsu WM, 2004, OPHTHALMOLOGY, V111, P62, DOI 10.1016/j.ophtha.2003.05.011; Ikuno Y, 2008, RETINA-J RET VIT DIS, V28, P1124, DOI 10.1097/IAE.0b013e318174417a; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Johnson DA, 1998, RETINA-J RET VIT DIS, V18, P118, DOI 10.1097/00006982-199818020-00004; KLEIN RM, 1975, AM J OPHTHALMOL, V79, P386, DOI 10.1016/0002-9394(75)90611-X; Leske MC, 2002, OPHTHALMOLOGY, V109, P1303, DOI 10.1016/S0161-6420(02)01094-1; Lim R, 1999, INVEST OPHTH VIS SCI, V40, P3021; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Liu J H, 2001, Ophthalmic Epidemiol, V8, P339; Michon JJ, 2002, BRIT J OPHTHALMOL, V86, P133, DOI 10.1136/bjo.86.2.133; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Ohno-Matsui K, 2003, BRIT J OPHTHALMOL, V87, P570, DOI 10.1136/bjo.87.5.570; Ohno-Matsui K, 1998, JPN J OPHTHALMOL, V42, P293, DOI 10.1016/S0021-5155(98)00008-2; OhnoMatsui K, 1996, RETINA-J RET VIT DIS, V16, P29, DOI 10.1097/00006982-199616010-00006; Quaranta M, 1996, AM J OPHTHALMOL, V122, P663, DOI 10.1016/S0002-9394(14)70484-2; RABB M F, 1981, International Ophthalmology Clinics, V21, P51, DOI 10.1097/00004397-198102130-00006; Salzmann M, 1902, ARCH OPHTHALMOL-CHIC, V31, P41; Sato A, 2010, BRIT J OPHTHALMOL, V94, P1624, DOI 10.1136/bjo.2009.165472; Soubrane G CG, 2005, RETINA, P1136; Tokoro T., 1998, ATLAS POSTERIOR FUND; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; Wang NK, 2012, AM J OPHTHALMOL, V153, P669, DOI 10.1016/j.ajo.2011.08.039; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1449; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035	33	46	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53660	10.1371/journal.pone.0053660	http://dx.doi.org/10.1371/journal.pone.0053660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349728	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100025
J	Chan, YS; Ng, TB				Chan, Yau Sang; Ng, Tzi Bun			A Lectin with Highly Potent Inhibitory Activity toward Breast Cancer Cells from Edible Tubers of Dioscorea opposita cv. Nagaimo	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; FRENCH BEAN LEGUMES; ANTIFUNGAL ACTIVITY; PLANT-LECTINS; ANTITUMOR; PURIFICATION; PROTEINS; HEMAGGLUTININ; APOPTOSIS; GALECTINS	A 70-kDa galactose-specific lectin was purified from the tubers of Dioscorea opposita cv. nagaimo. The purification involved three chromatographic steps: anion exchange chromatography on a Q-Sepharose column, FPLC-anion exchange chromatography on a Mono Q column, and FPLC-gel filtration on a Superdex 75 column. The purified nagaimo lectin presented as a single 35-kDa band in reducing SDS-PAGE while it exhibited a 70-kDa single band in non-reducing SDS-PAGE suggesting its dimeric nature. Nagaimo lectin displayed moderate thermostability, retaining full hemagglutinating activity after heating up to 62 degrees C for 30 minutes. It also manifested stability over a wide pH range from pH 2 to 13. Nagaimo lectin was a galactose-specific lectin, as evidenced by binding with galactose and galactose-containing sugars such as lactose and raffinose. The minimum concentration of galactose, lactose and raffinose required to exert an inhibitory effect on hemagglutinating activity of nagaimo lectin was 20 mM, 5 mM and 40 mM, respectively. Nagaimo lectin inhibited the growth of some cancer cell lines including breast cancer MCF7 cells, hepatoma HepG2 cells and nasopharyngeal carcinoma CNE2 cells, with IC50 values of 3.71 mu M, 7.12 mu M and 19.79 mu M, respectively, after 24 hour treatment with nagaimo lectin. The induction of phosphatidylserine externalization and mitochondrial depolarization indicated that nagaimo lectin evoked apoptosis in MCF7 cells. However, the anti-proliferative activity of nagaimo lectin was not blocked by application of galactose, signifying that the activity was not related to the carbohydrate binding specificity of the lectin.	[Chan, Yau Sang; Ng, Tzi Bun] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ng, TB (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	b021770@mailserv.cuhk.edu.hk						Amano K, 2012, BIOSCI BIOTECH BIOCH, V76, P967, DOI 10.1271/bbb.110982; Angata T, 2002, BBA-GEN SUBJECTS, V1572, P294, DOI 10.1016/S0304-4165(02)00316-1; Ashraf GM, 2011, PROTEIN J, V30, P39, DOI 10.1007/s10930-010-9300-2; Bhandari MR, 2005, PLANT FOOD HUM NUTR, V60, P129, DOI 10.1007/s11130-005-6841-1; Cardoso MRD, 2011, VACCINE, V29, P9183, DOI 10.1016/j.vaccine.2011.09.136; Carvalho FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027892; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Fang EF, 2011, CURR MED CHEM, V18, P4410; Fang EF, 2010, J AGR FOOD CHEM, V58, P2221, DOI 10.1021/jf903964u; Feng L, 2010, FASEB J, V24, P3861, DOI 10.1096/fj.10-159111; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Gaidamashvili M, 2004, J BIOL CHEM, V279, P26028, DOI 10.1074/jbc.M402139200; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; He XC, 2011, FISH SHELLFISH IMMUN, V31, P1247, DOI 10.1016/j.fsi.2011.08.021; Hsu HC, 1999, BIOCHEM J, V323, P557; Kaur M, 2006, ARCH BIOCHEM BIOPHYS, V445, P156, DOI 10.1016/j.abb.2005.10.021; Kheeree N, 2010, APPL BIOCHEM BIOTECH, V162, P912, DOI 10.1007/s12010-009-8804-8; Kobayashi T, 2010, LEUKEMIA, V24, P843, DOI 10.1038/leu.2010.25; KOIKE T, 1995, J BIOCHEM-TOKYO, V118, P1205, DOI 10.1093/oxfordjournals.jbchem.a125008; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lam SK, 2010, BIOSCIENCE REP, V30, P307, DOI 10.1042/BSR20090059; Lannoo N, 2010, BBA-GEN SUBJECTS, V1800, P190, DOI 10.1016/j.bbagen.2009.07.021; Lee CH, 2009, INT IMMUNOPHARMACOL, V9, P1555, DOI 10.1016/j.intimp.2009.09.011; Li T, 2010, ACTA BIOCH BIOPH SIN, V44, P606; McAnuff MA, 2005, PLANT FOOD HUM NUTR, V60, P93, DOI 10.1007/s11130-005-5105-0; Naeem A, 2007, BIOCHEMISTRY-MOSCOW+, V72, P44, DOI 10.1134/S0006297907010051; Nakagawa R, 1996, BIOSCI BIOTECH BIOCH, V60, P259, DOI 10.1271/bbb.60.259; Nawrot R, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-78; Ohizumi Y, 2009, J AGR FOOD CHEM, V57, P2896, DOI 10.1021/jf8040269; Ola MS, 2007, CELL BIOL INT, V31, P578, DOI 10.1016/j.cellbi.2006.11.032; Omokawa Y, 2010, INT J PHARMACEUT, V389, P157, DOI 10.1016/j.ijpharm.2010.01.033; Peumans WJ, 1998, CRIT REV BIOCHEM MOL, V33, P209; Poon TYC, 2011, J DIABETES, V3, P184, DOI 10.1111/j.1753-0407.2011.00130.x; Saekoo J, 2010, J MED ASS THAI S7, V93, P277; Salatino M, 2011, METHODS MOL BIOL, V677, P355, DOI 10.1007/978-1-60761-869-0_23; Sharma A, 2010, PROTEIN PEPTIDE LETT, V17, P221, DOI 10.2174/092986610790226067; She QB, 1998, BIOCHEM BIOPH RES CO, V247, P106, DOI 10.1006/bbrc.1998.8744; Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084; Subramanyam S, 2008, PLANT PHYSIOL, V147, P1412, DOI 10.1104/pp.108.116145; Toledo RG, 2010, MOL IMMUNOL, V48, P26, DOI 10.1016/j.molimm.2010.09.015; Tsivileva OM, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1154, DOI 10.1134/S0006297908100131; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Wojcikowsi K, 2008, FOOD CHEM TOXICOL, V46, P3122, DOI 10.1016/j.fct.2008.06.090; Wong JH, 2005, ARCH BIOCHEM BIOPHYS, V439, P91, DOI 10.1016/j.abb.2005.05.004; Xia LX, 2006, J CHROMATOGR B, V844, P213, DOI 10.1016/j.jchromb.2006.07.042; Xia LX, 2005, PEPTIDES, V26, P2397, DOI 10.1016/j.peptides.2005.06.003; Xu ZT, 2011, AM J CHINESE MED, V39, P579, DOI 10.1142/S0192415X11009044; Yagi F, 2002, EUR J BIOCHEM, V269, P4335, DOI 10.1046/j.1432-1033.2002.03127.x; Yan QJ, 2009, PHYTOMEDICINE, V16, P586, DOI 10.1016/j.phymed.2008.12.024; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang Y, 2011, PHYTOMEDICINE, V18, P748, DOI 10.1016/j.phymed.2010.11.001; Ye XY, 2002, LIFE SCI, V71, P1667, DOI 10.1016/S0024-3205(02)01925-2; Ye XY, 1999, BIOCHEM BIOPH RES CO, V263, P130, DOI 10.1006/bbrc.1999.1166; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	57	29	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54212	10.1371/journal.pone.0054212	http://dx.doi.org/10.1371/journal.pone.0054212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349827	gold, Green Published			2022-12-27	WOS:000313943000030
J	Lim, S; Kawamura, E; Fielding, AB; Maydan, M; Dedhar, S				Lim, Simin; Kawamura, Eiko; Fielding, Andrew B.; Maydan, Mykola; Dedhar, Shoukat			Integrin-Linked Kinase Regulates Interphase and Mitotic Microtubule Dynamics	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; PROTEIN-KINASE; CELL-PROLIFERATION; BETA-CATENIN; CANCER-CELLS; INDIVIDUAL MICROTUBULES; SUPPRESSES DYNAMICS; THERAPEUTIC TARGET; VINCA ALKALOIDS; INHIBITION	Integrin-linked kinase (ILK) localizes to both focal adhesions and centrosomes in distinct multiprotein complexes. Its dual function as a kinase and scaffolding protein has been well characterized at focal adhesions, where it regulates integrin-mediated cell adhesion, spreading, migration and signaling. At the centrosomes, ILK regulates mitotic spindle organization and centrosome clustering. Our previous study showed various spindle defects after ILK knockdown or inhibition that suggested alteration in microtubule dynamics. Since ILK expression is frequently elevated in many cancer types, we investigated the effects of ILK overexpression on microtubule dynamics. We show here that overexpressing ILK in HeLa cells was associated with a shorter duration of mitosis and decreased sensitivity to paclitaxel, a chemotherapeutic agent that suppresses microtubule dynamics. Measurement of interphase microtubule dynamics revealed that ILK overexpression favored microtubule depolymerization, suggesting that microtubule destabilization could be the mechanism behind the decreased sensitivity to paclitaxel, which is known to stabilize microtubules. Conversely, the use of a small molecule inhibitor selective against ILK, QLT-0267, resulted in suppressed microtubule dynamics, demonstrating a new mechanism of action for this compound. We further show that treatment of HeLa cells with QLT-0267 resulted in higher inter-centromere tension in aligned chromosomes during mitosis, slower microtubule regrowth after cold depolymerization and the presence of a more stable population of spindle microtubules. These results demonstrate that ILK regulates microtubule dynamics in both interphase and mitotic cells.	[Lim, Simin; Kawamura, Eiko; Fielding, Andrew B.; Maydan, Mykola; Dedhar, Shoukat] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Lim, Simin] Univ British Columbia, Fac Grad Studies, Vancouver, BC V5Z 1M9, Canada; [Fielding, Andrew B.] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Dedhar, Shoukat] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; University of Liverpool; University of British Columbia	Dedhar, S (corresponding author), British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada.	sdedhar@bccrc.ca		Dedhar, Shoukat/0000-0003-4355-1657; Fielding, Andrew/0000-0002-3170-9966	Canadian Institutes of Health Research [199901]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number: 199901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andreassen Paul R, 2004, Methods Mol Biol, V281, P213; Barr AR, 2008, MOL CELL BIOL, V28, P7199, DOI 10.1128/MCB.01040-08; Cassimeris L, 2009, CELL MOTIL CYTOSKEL, V66, P535, DOI 10.1002/cm.20359; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; DHAMODHARAN R, 1995, MOL BIOL CELL, V6, P1215, DOI 10.1091/mbc.6.9.1215; Dobreva I, 2008, J PROTEOME RES, V7, P1740, DOI 10.1021/pr700852r; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hu LM, 2002, CANCER RES, V62, P1087; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; JORDAN MA, 1991, CANCER RES, V51, P2212; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kalra J, 2011, CANCER BIOL THER, V11, P826, DOI 10.4161/cbt.11.9.15183; Kalra J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2252; Kamath K, 2010, METHOD CELL BIOL, V97, P1, DOI 10.1016/S0091-679X(10)97001-5; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Kelling J, 2003, CANCER RES, V63, P2794; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Muranyi AL, 2009, EXP HEMATOL, V37, P450, DOI 10.1016/j.exphem.2009.01.002; Ngan VK, 2001, MOL PHARMACOL, V60, P225, DOI 10.1124/mol.60.1.225; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Rowinsky EK, 1997, ANNU REV MED, V48, P353; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Waters JC, 1996, J CELL SCI, V109, P2823; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; WILSON PJ, 1994, J CELL SCI, V107, P3015; Wu CY, 1998, J BIOL CHEM, V273, P528, DOI 10.1074/jbc.273.1.528; Younes MN, 2005, MOL CANCER THER, V4, P1146, DOI 10.1158/1535-7163.MCT-05-0078; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	41	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53702	10.1371/journal.pone.0053702	http://dx.doi.org/10.1371/journal.pone.0053702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349730	Green Submitted, Green Published, gold			2022-12-27	WOS:000313943000016
J	Risse, B; Thomas, S; Otto, N; Lopmeier, T; Valkov, D; Jiang, XY; Klambt, C				Risse, Benjamin; Thomas, Silke; Otto, Nils; Loepmeier, Tim; Valkov, Dimitar; Jiang, Xiaoyi; Klaembt, Christian			FIM, a Novel FTIR-Based Imaging Method for High Throughput Locomotion Analysis	PLOS ONE			English	Article							DROSOPHILA LARVAL; DECISION-MAKING; FRUIT-FLY; TRACKING; SYSTEM; BEHAVIOR; LEVEL; CELLS; MICE	We designed a novel imaging technique based on frustrated total internal reflection (FTIR) to obtain high resolution and high contrast movies. This FTIR-based Imaging Method (FIM) is suitable for a wide range of biological applications and a wide range of organisms. It operates at all wavelengths permitting the in vivo detection of fluorescent proteins. To demonstrate the benefits of FIM, we analyzed large groups of crawling Drosophila larvae. The number of analyzable locomotion tracks was increased by implementing a new software module capable of preserving larval identity during most collision events. This module is integrated in our new tracking program named FIMTrack which subsequently extracts a number of features required for the analysis of complex locomotion phenotypes. FIM enables high throughput screening for even subtle behavioral phenotypes. We tested this newly developed setup by analyzing locomotion deficits caused by the glial knockdown of several genes. Suppression of kinesin heavy chain (khc) or rab30 function led to contraction pattern or head sweeping defects, which escaped in previous analysis. Thus, FIM permits forward genetic screens aimed to unravel the neural basis of behavior.	[Risse, Benjamin; Thomas, Silke; Otto, Nils; Klaembt, Christian] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany; [Risse, Benjamin; Loepmeier, Tim; Valkov, Dimitar; Jiang, Xiaoyi] Univ Munster, Inst Comp Sci, D-48149 Munster, Germany	University of Munster; University of Munster	Klambt, C (corresponding author), Univ Munster, Inst Neurobiol, D-48149 Munster, Germany.	klaembt@uni-muenster.de	Jiang, Xiaoyi/AAA-3532-2022	Jiang, Xiaoyi/0000-0001-7678-9528; Rodrigues, Silke/0000-0003-0407-0615; Otto, Nils/0000-0001-9713-4088	Boehringer Ingelheim Fonds	Boehringer Ingelheim Fonds(Boehringer Ingelheim)	ST acknowledges a predoctoral fellowship of the Boehringer Ingelheim Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRIGAN D, 1995, J INSECT PHYSIOL, V41, P329, DOI 10.1016/0022-1910(94)00113-U; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Duda RO, 2001, PATTERN CLASSICATION; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Frye MA, 2004, CURR OPIN NEUROBIOL, V14, P729, DOI 10.1016/j.conb.2004.10.004; Gershow M, 2012, NAT METHODS, V9, P290, DOI [10.1038/NMETH.1853, 10.1038/nmeth.1853]; Glassner A. S., 1993, GRAPHICS GEMS; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gomez-Marin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041642; Gomez-Marin A, 2012, CURR OPIN NEUROBIOL, V22, P208, DOI 10.1016/j.conb.2011.11.008; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Heckscher ES, 2012, J NEUROSCI, V32, P12460, DOI 10.1523/JNEUROSCI.0222-12.2012; Inada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029019; Keene AC, 2012, TRENDS NEUROSCI, V35, P104, DOI 10.1016/j.tins.2011.11.003; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015259; Lahiri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023180; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pistori H, 2010, PATTERN RECOGN LETT, V31, P337, DOI 10.1016/j.patrec.2009.05.015; Scantlebury N, 2007, BEHAV GENET, V37, P513, DOI 10.1007/s10519-007-9146-3; Schmidt I, 2012, J NEUROSCI, V32, P7466, DOI 10.1523/JNEUROSCI.0349-12.2012; Sinadinos C, 2012, J NEUROSCI METH, V203, P325, DOI 10.1016/j.jneumeth.2011.08.037; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Suzuki S, 1985, COMPUTER VISION; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Yemini E, 2011, COLD SPRING HARBOR P, V2011	30	70	70	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53963	10.1371/journal.pone.0053963	http://dx.doi.org/10.1371/journal.pone.0053963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349775	Green Published, Green Submitted, gold			2022-12-27	WOS:000313943000022
J	Schwenke, M; Knofler, M; Velicky, P; Weimar, CHE; Kruse, M; Samalecos, A; Wolf, A; Macklon, NS; Bamberger, AM; Gellersen, B				Schwenke, Maren; Knoefler, Martin; Velicky, Philipp; Weimar, Charlotte H. E.; Kruse, Michelle; Samalecos, Annemarie; Wolf, Anja; Macklon, Nick S.; Bamberger, Ana-Maria; Gellersen, Birgit			Control of Human Endometrial Stromal Cell Motility by PDGF-BB, HB-EGF and Trophoblast-Secreted Factors	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SIGNALING PATHWAYS; FACTOR RECEPTOR; EMBRYO IMPLANTATION; EXPRESSION; PREGNANCY; INVASION; ROLES; DECIDUALIZATION; MIGRATION	Human implantation involves extensive tissue remodeling at the fetal-maternal interface. It is becoming increasingly evident that not only trophoblast, but also decidualizing endometrial stromal cells are inherently motile and invasive, and likely contribute to the highly dynamic processes at the implantation site. The present study was undertaken to further characterize the mechanisms involved in the regulation of endometrial stromal cell motility and to identify trophoblast-derived factors that modulate migration. Among local growth factors known to be present at the time of implantation, heparin-binding epidermal growth factor-like growth factor (HB-EGF) triggered chemotaxis (directed locomotion), whereas platelet-derived growth factor (PDGF)-BB elicited both chemotaxis and chemokinesis (non-directed locomotion) of endometrial stromal cells. Supernatants of the trophoblast cell line AC-1M88 and of first trimester villous explant cultures stimulated chemotaxis but not chemokinesis. Proteome profiling for cytokines and angiogenesis factors revealed neither PDGF-BB nor HB-EGF in conditioned media from trophoblast cells or villous explants, while placental growth factor, vascular endothelial growth factor and PDGF-AA were identified as prominent secretory products. Among these, only PDGF-AA triggered endometrial stromal cell chemotaxis. Neutralization of PDGF-AA in trophoblast conditioned media, however, did not diminish chemoattractant activity, suggesting the presence of additional trophoblast-derived chemotactic factors. Pathway inhibitor studies revealed ERK1/2, PI3 kinase/Akt and p38 signaling as relevant for chemotactic motility, whereas chemokinesis depended primarily on PI3 kinase/Akt activation. Both chemotaxis and chemokinesis were stimulated upon inhibition of Rho-associated, coiled-coil containing protein kinase. The chemotactic response to trophoblast secretions was not blunted by inhibition of isolated signaling cascades, indicating activation of overlapping pathways in trophoblast-endometrial communication. In conclusion, trophoblast signals attract endometrial stromal cells, while PDGF-BB and HB-EGF, although not identified as trophoblast-derived, are local growth factors that may serve to fine-tune directed and non-directed migration at the implantation site.	[Schwenke, Maren; Kruse, Michelle; Samalecos, Annemarie; Wolf, Anja; Gellersen, Birgit] Endokrinologikum Hamburg, Hamburg, Germany; [Knoefler, Martin; Velicky, Philipp] Med Univ Vienna, Dept Obstet & Fetal Maternal Med, Reprod Biol Unit, Vienna, Austria; [Weimar, Charlotte H. E.; Macklon, Nick S.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis NIDOD, Utrecht, Netherlands; [Macklon, Nick S.] Univ Southampton, Princess Anne Hosp, Fac Med, Southampton, Hants, England; [Bamberger, Ana-Maria] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany	Medical University of Vienna; Utrecht University; Utrecht University Medical Center; University of Southampton; University of Hamburg; University Medical Center Hamburg-Eppendorf	Gellersen, B (corresponding author), Endokrinologikum Hamburg, Hamburg, Germany.	gellersen@endokrinologikum.com		Velicky, Philipp/0000-0002-2340-7431	Deutsche Forschungsgemeinschaft [DFG-GE 748/11-2]; Austrian Science Funds, Vienna, Austria [P-22687-B13]; Foundation "De Drie Lichten" in the Netherlands; Alexandre-Suermann scholarship from the University Medical Center Utrecht, The Netherlands; Austrian Science Fund (FWF) [P 22687] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Funds, Vienna, Austria(Austrian Science Fund (FWF)); Foundation "De Drie Lichten" in the Netherlands; Alexandre-Suermann scholarship from the University Medical Center Utrecht, The Netherlands; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft grant DFG-GE 748/11-2 (to B. G. and A. M. B). P. V. was supported by grant P-22687-B13 of the Austrian Science Funds, Vienna, Austria. This project was further supported by Foundation "De Drie Lichten" in the Netherlands and the Alexandre-Suermann scholarship from the University Medical Center Utrecht, The Netherlands (to C. H. E. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Baulida J, 1996, J BIOL CHEM, V271, P5251; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bilban M, 2009, ENDOCRINOLOGY, V150, P1000, DOI 10.1210/en.2008-0456; Boomsma CM, 2010, FERTIL STERIL, V94, P1764, DOI 10.1016/j.fertnstert.2009.10.044; Brahmbhatt AA, 2003, J BIOL CHEM, V278, P13016, DOI 10.1074/jbc.M211873200; Brar AK, 2001, PHYSIOL GENOMICS, V7, P135, DOI 10.1152/physiolgenomics.00061.2001; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brosens JJ, 2010, ULTRASOUND OBST GYN, V36, P1, DOI 10.1002/uog.7714; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chobotova K, 2005, J CLIN ENDOCR METAB, V90, P913, DOI 10.1210/jc.2004-0476; Clark DE, 1998, J ENDOCRINOL, V159, P459, DOI 10.1677/joe.0.1590459; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Fazleabas AT, 2004, PLACENTA, V25, pS26, DOI 10.1016/j.placenta.2004.01.014; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Funayama H., 1997, PLACENTA, V18, P191; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gaus G, 1997, PLACENTA S2, V18, P181, DOI DOI 10.1016/S0143-4004(97)80088-4; Gellersen B, 2010, HUM REPROD, V25, P862, DOI 10.1093/humrep/dep468; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gentilini D, 2007, MOL HUM REPROD, V13, P317, DOI 10.1093/molehr/gam001; Gentilini D, 2010, FERTIL STERIL, V93, P2588, DOI 10.1016/j.fertnstert.2010.02.006; Gonzalez M, 2011, MOL HUM REPROD, V17, P421, DOI 10.1093/molehr/gar015; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Grewal S, 2010, BIOL REPROD, V83, P75, DOI 10.1095/biolreprod.109.080630; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Haouzi D, 2011, HUM REPROD, V26, P1440, DOI 10.1093/humrep/der075; Ihnatovych I, 2007, ENDOCRINOLOGY, V148, P3176, DOI 10.1210/en.2006-1673; Jessmon P, 2010, BIOL REPROD, V82, P921, DOI 10.1095/biolreprod.109.082305; Jessmon P, 2009, MOL REPROD DEV, V76, P1116, DOI 10.1002/mrd.21066; Jiang Y, 2011, BIOCHEM BIOPH RES CO, V404, P628, DOI 10.1016/j.bbrc.2010.12.027; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Knofler M, 2012, PLACENTA, V33, pS55, DOI 10.1016/j.placenta.2011.09.019; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Lash GE, 2003, PLACENTA, V24, P549, DOI 10.1053/plac.2002.0923; Lash GE, 2012, HUM REPROD, V27, P183, DOI 10.1093/humrep/der376; Leach RE, 1999, J CLIN ENDOCR METAB, V84, P3355, DOI 10.1210/jc.84.9.3355; Leach RE, 2004, DEV BIOL, V266, P223, DOI 10.1016/j.ydbio.2003.09.026; Leach RE, 2012, HUM REPROD, V27, P814, DOI 10.1093/humrep/der436; Lessey BA, 2002, MOL REPROD DEV, V62, P446, DOI 10.1002/mrd.10129; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Llorens F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-326; Lyall F, 2005, PLACENTA, V26, pS31, DOI 10.1016/j.placenta.2005.02.010; Maijenburg MW, 2012, STEM CELLS DEV, V21, P228, DOI 10.1089/scd.2011.0076; Matsumoto H, 2005, J CLIN ENDOCR METAB, V90, P3560, DOI 10.1210/jc.2004-1918; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Samalecos A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-76; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Stavreus-Evers A, 2002, MOL HUM REPROD, V8, P765, DOI 10.1093/molehr/8.8.765; Teklenburg G, 2010, MOL HUM REPROD, V16, P886, DOI 10.1093/molehr/gaq079; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Thomas CP, 2009, J CLIN ENDOCR METAB, V94, P2524, DOI 10.1210/jc.2009-0017; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Weimar CHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041424; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3; Yoo HJ, 1997, DEV GENET, V21, P102, DOI 10.1002/(SICI)1520-6408(1997)21:1<102::AID-DVG12>3.0.CO;2-C; Yotova IY, 2011, HUM REPROD, V26, P885, DOI 10.1093/humrep/der010; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	76	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54336	10.1371/journal.pone.0054336	http://dx.doi.org/10.1371/journal.pone.0054336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349855	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000313943000034
J	Chang, H; Xie, Q; Zhang, QY; Peng, XL; Zhu, JD; Mi, MT				Chang Hui; Xie Qi; Zhang Qianyong; Peng Xiaoli; Zhu Jundong; Mi Mantian			Flavonoids, Flavonoid Subclasses and Breast Cancer Risk: A Meta-Analysis of Epidemiologic Studies	PLOS ONE			English	Article							DIETARY FLAVONOIDS; LUNG-CANCER; POSTMENOPAUSAL WOMEN; URINARY POLYPHENOLS; RICH FOODS; CONSUMPTION; INHIBITION; FRUIT	Background: Studies have suggested the chemopreventive effects of flavonoids on carcinogenesis. Yet numbers of epidemiologic studies assessing dietary flavonoids and breast cancer risk have yielded inconsistent results. The association between flavonoids, flavonoid subclasses (flavonols, flavan-3-ols, etc.) and the risk of breast cancer lacks systematic analysis. Objective: We aimed to examine the association between flavonoids, each flavonoid subclass (except isoflavones) and the risk of breast cancer by conducting a meta-analysis. Design: We searched for all relevant studies with a prospective cohort or case-control study design published before July 1st, 2012, using Cochrane library, MEDLINE, EMBASE and PUBMED. Summary relative risks (RR) were calculated using fixed- or random-effects models. All analyses were performed using STATA version 10.0. Results: Twelve studies were included, involving 9 513 cases and 181 906 controls, six of which were prospective cohort studies, and six were case-control studies. We calculated the summary RRs of breast cancer risk for the highest vs lowest categories of each flavonoid subclass respectively. The risk of breast cancer significantly decreased in women with high intake of flavonols (RR = 0.88, 95% CI 0.80-0.98) and flavones (RR = 0.83, 95% CI: 0.76-0.91) compared with that in those with low intake of flavonols and flavones. However, no significant association of flavan-3-ols (RR = 0.93, 95% CI: 0.84-1.02), flavanones (summary RR = 0.95, 95% CI: 0.88-1.03), anthocyanins (summary RR = 0.97, 95% CI: 0.87-1.08) or total flavonoids (summary RR = 0.98, 95% CI: 0.86-1.12) intake with breast cancer risk was observed. Furthermore, summary RRs of 3 case-control studies stratified by menopausal status suggested flavonols, flavones or flavan-3-ols intake is associated with a significant reduced risk of breast cancer in post-menopausal while not in pre-menopausal women. Conclusions: The present study suggests the intake of flavonols and flavones, but not other flavonoid subclasses or total flavonoids, is associated with a decreased risk of breast cancer, especially among post-menopausal women.	[Chang Hui; Xie Qi; Zhang Qianyong; Zhu Jundong; Mi Mantian] Third Mil Med Univ, Res Ctr Nutr & Food Safety, Chongqing Key Lab Nutr & Food Safety, Chongqing, Peoples R China; [Peng Xiaoli] Chengdu Med Coll, Sch Preclin Med, Dept Publ Hlth, Chengdu, Sichuan, Peoples R China	Army Medical University; Chengdu Medical College	Zhu, JD (corresponding author), Third Mil Med Univ, Res Ctr Nutr & Food Safety, Chongqing Key Lab Nutr & Food Safety, Chongqing, Peoples R China.	zhujd68@126.com; mimt2007@126.com			National Natural Science Foundation of China [30901194]; Youth Innovation Foundation of Third Military Medical University [2009XQN14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Foundation of Third Military Medical University	This work was supported by the research grant from National Natural Science Foundation of China (30901194) and Youth Innovation Foundation of Third Military Medical University (2009XQN14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebamowo CA, 2005, INT J CANCER, V114, P628, DOI 10.1002/ijc.20741; American Institute for Cancer Research (AICR) and World Cancer Research Fund (WCRF), 2009, POLICY AND ACTION FO; [Anonymous], 2007, AMERICAN CANCER SOCI; Arts ICW, 2002, CANCER CAUSE CONTROL, V13, P373, DOI 10.1023/A:1015290131096; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Aune D, 2012, BREAST CANCER RES TR, V134, P479, DOI 10.1007/s10549-012-2118-1; Aune D, 2011, GASTROENTEROLOGY, V141, P106, DOI 10.1053/j.gastro.2011.04.013; Beecher GR, 2003, J NUTR, V133, p3248S; Berger A, 2012, J NUTR BIOCH; Bosetti C, 2005, CANCER EPIDEM BIOMAR, V14, P805, DOI 10.1158/1055-9965.EPI-04-0838; Butler LM, 2010, AM J CLIN NUTR, V91, P1013, DOI 10.3945/ajcn.2009.28572; CASSIDY A, 1994, AM J CLIN NUTR, V60, P333, DOI 10.1093/ajcn/60.3.333; Chang H, 2010, NUTR CANC, V62, P1; Chang H, 2012, BREAST CANCER RES, V14, pR80; Cho YA, 2010, EUR J CLIN NUTR, V64, P924, DOI 10.1038/ejcn.2010.95; Christensen KY, 2012, NUTR CANCER, V64, P964, DOI 10.1080/01635581.2012.717677; Chun Ock K., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P190, DOI 10.1080/21551197.2012.702530; Cutler GJ, 2008, INT J CANCER, V123, P664, DOI 10.1002/ijc.23564; Dai Q, 2002, CANCER EPIDEM BIOMAR, V11, P815; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong JY, 2011, BREAST CANCER RES TR, V125, P315, DOI 10.1007/s10549-010-1270-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, IARC CANCERBASE VERS; Fink BN, 2007, AM J EPIDEMIOL, V165, P514, DOI 10.1093/aje/kwk033; Goldbohm RA, 1998, EUR COMMISS SCI RES, P159; Guha N, 2009, BREAST CANCER RES TR, V118, P395, DOI 10.1007/s10549-009-0321-5; Hooper L, 2008, AM J CLIN NUTR, V88, P38, DOI 10.1093/ajcn/88.1.38; Jennings A, 2012, AM J CLIN NUTR, V96, P781, DOI 10.3945/ajcn.112.042036; Kim KK, 2012, INT J ONCOL, V40, P227, DOI 10.3892/ijo.2011.1198; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Knekt P, 1997, AM J EPIDEMIOL, V146, P223, DOI 10.1093/oxfordjournals.aje.a009257; Lu LJW, 1996, CANCER EPIDEM BIOMAR, V5, P63; Luo JF, 2012, MOL CARCINOGEN, V51, P379, DOI 10.1002/mc.20799; Luo JF, 2010, BREAST CANCER RES TR, V120, P693, DOI 10.1007/s10549-009-0487-x; National Cancer Institute (NCI) US Department of Health and Human Services, 2006, THE NCI STRATEGIC PL; Neuhouser ML, 2004, NUTR CANCER, V50, P1, DOI 10.1207/s15327914nc5001_1; Ni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038802; Peterson J, 2003, BRIT J CANCER, V89, P1255, DOI 10.1038/sj.bjc.6601271; Reiss R, 2012, FOOD CHEM TOXICOL, V50, P4421, DOI 10.1016/j.fct.2012.08.055; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Tang NP, 2009, JPN J CLIN ONCOL, V39, P352, DOI 10.1093/jjco/hyp028; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039806; Toledo AC, 2012, BR J PHARM; Torres-Sanchez L, 2009, PUBLIC HEALTH NUTR, V12, P825, DOI 10.1017/S136898000800325X; Touvier M, 2012, BREAST CANC RES TREA; Wang L, 2009, AM J CLIN NUTR, V89, P905, DOI 10.3945/ajcn.2008.26913; Wang W, 2011, BRIT J PHARMACOL, V162, P1364, DOI 10.1111/j.1476-5381.2010.01143.x; Yang PM, 2012, INT J ONCOL, V40, P469, DOI 10.3892/ijo.2011.1203; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007; Zhang CX, 2009, INT J CANCER, V125, P181, DOI 10.1002/ijc.24358; Zhang SZ, 2005, BIOCHEM PHARMACOL, V70, P627, DOI 10.1016/j.bcp.2005.05.017	52	119	124	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54318	10.1371/journal.pone.0054318	http://dx.doi.org/10.1371/journal.pone.0054318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349849	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800039
J	Fang, ZD; Du, RF; Edwards, A; Flemington, EK; Zhang, K				Fang, Zhide; Du, Ruofei; Edwards, Andrea; Flemington, Erik K.; Zhang, Kun			The Sequence Structures of Human MicroRNA Molecules and Their Implications	PLOS ONE			English	Article							BREAST-CANCER; EVOLUTION; TARGETS; GENES; RNA; ANNOTATION; EXPRESSION; PREDICTION; MIRBASE; ELEGANS	The count of the nucleotides in a cloned, short genomic sequence has become an important criterion to annotate such a sequence as a miRNA molecule. While the majority of human mature miRNA sequences consist of 22 nucleotides, there exists discrepancy in the characteristic lengths of the miRNA sequences. There is also a lack of systematic studies on such length distribution and on the biological factors that are related to or may affect this length. In this paper, we intend to fill this gap by investigating the sequence structure of human miRNA molecules using statistics tools. We demonstrate that the traditional discrete probability distributions do not model the length distribution of the human mature miRNAs well, and we obtain the statistical distribution model with a decent fit. We observe that the four nucleotide bases in a miRNA sequence are not randomly distributed, implying that possible structural patterns such as dinucleotide (trinucleotide or higher order) may exist. Furthermore, we study the relationships of this length distribution to multiple important factors such as evolutionary conservation, tumorigenesis, the length of precursor loop structures, and the number of predicted targets. The association between the miRNA sequence length and the distributions of target site counts in corresponding predicted genes is also presented. This study results in several novel findings worthy of further investigation that include: (1) rapid evolution introduces variation to the miRNA sequence length distribution; (2) miRNAs with extreme sequence lengths are unlikely to be cancer-related; and (3) the miRNA sequence length is positively correlated to the precursor length and the number of predicted target genes.	[Fang, Zhide; Du, Ruofei] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Biostat Program, New Orleans, LA USA; [Edwards, Andrea; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA; [Flemington, Erik K.] Tulane Univ, Sch Med, Dept Pathol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Xavier University of Louisiana; Tulane University	Flemington, EK (corresponding author), Tulane Univ, Sch Med, Dept Pathol, New Orleans, LA 70112 USA.	eflemin@tulane.edu; kzhang@xula.edu	Du, Ruofei/Q-6245-2017	Du, Ruofei/0000-0002-4006-7416	National Institutes of Health [NIGMS P20GM103424, NCRR-RCMI 5G12RR026260-04]; US Department of Army [W911NF-12-1-0066]; NSF [EPS-1006891]; NATIONAL CANCER INSTITUTE [R01CA138268] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR026260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Army; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research reported in this publication was supported by National Institutes of Health grants (NIGMS P20GM103424, NCRR-RCMI 5G12RR026260-04), an US Department of Army grant (W911NF-12-1-0066) and an NSF grant (EPS-1006891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; HOAGLIN DC, 1980, AM STAT, V34, P146, DOI 10.2307/2683871; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kotz S, 2002, ANN I STAT MATH, V54, P816, DOI 10.1023/A:1022467519537; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Park SY, 2009, J ECONOMETRICS, V150, P219, DOI 10.1016/j.jeconom.2008.12.014; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; QUESENBERRY CP, 1964, TECHNOMETRICS, V6, P191, DOI 10.2307/1266151; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang Q, 2008, NATURE P; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	47	41	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54215	10.1371/journal.pone.0054215	http://dx.doi.org/10.1371/journal.pone.0054215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349828	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800032
J	Ramaseshadri, P; Segers, G; Flannagan, R; Wiggins, E; Clinton, W; Ilagan, O; McNulty, B; Clark, T; Bolognesi, R				Ramaseshadri, Parthasarathy; Segers, Gerrit; Flannagan, Ronald; Wiggins, Elizabeth; Clinton, William; Ilagan, Oliver; McNulty, Brian; Clark, Thomas; Bolognesi, Renata			Physiological and Cellular Responses Caused by RNAi-Mediated Suppression of Snf7 Orthologue in Western Corn Rootworm (Diabrotica virgifera virgifera) Larvae	PLOS ONE			English	Article							ESCRT MACHINERY; MULTIVESICULAR BODIES; AUTOPHAGIC CLEARANCE; FAT-BODY; DROSOPHILA; PROTEIN; TRAFFICKING; ENDOCYTOSIS; COMPLEXES; ENDOSOME	Ingestion of double stranded RNA (dsRNA) has been previously demonstrated to be effective in triggering RNA interference (RNAi) in western corn rootworm (WCR, Diabrotica virgifera virgifera LeConte), providing potential novel opportunities for insect pest control. The putative Snf7 homolog of WCR (DvSnf7) has previously been shown to be an effective RNAi target for insect control, as DvSnf7 RNAi leads to lethality of WCR larvae. Snf7 functions as a part of the ESCRT (Endosomal Sorting Complex Required for Transport) pathway which plays a crucial role in cellular housekeeping by internalization, transport, sorting and lysosomal degradation of transmembrane proteins. To understand the effects that lead to death of WCR larvae by DvSnf7 RNAi, we examined some of the distinct cellular processes associated with ESCRT functions such as de-ubiquitination of proteins and autophagy. Our data indicate that ubiquitinated proteins accumulate in DvSnf7 dsRNA-fed larval tissues and that the autophagy process seems to be impaired. These findings suggest that the malfunctioning of these cellular processes in both midgut and fat body tissues triggered by DvSnf7 RNAi were the main effects leading to the death of WCR. This study also illustrates that Snf7 is an essential gene in WCR and its functions are consistent with biological functions described for other eukaryotes.	[Ramaseshadri, Parthasarathy; Segers, Gerrit; Flannagan, Ronald; Wiggins, Elizabeth; Clinton, William; Ilagan, Oliver; McNulty, Brian; Clark, Thomas; Bolognesi, Renata] Monsanto Co, Dept Biotechnol, Chesterfield, MO USA	Monsanto	Bolognesi, R (corresponding author), Monsanto Co, Dept Biotechnol, Chesterfield, MO USA.	renata.bolognesi@monsanto.com			Monsanto Creative Services (St. Louis); In silico Analytics Team (Monsanto Research Center, Bangalore)	Monsanto Creative Services (St. Louis); In silico Analytics Team (Monsanto Research Center, Bangalore)	We thank Monsanto Creative Services (St. Louis) and In silico Analytics Team (Monsanto Research Center, Bangalore) for their support.	Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Bolognesi R, 2012, PLOS ONE; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Caballe A, 2011, TRAFFIC, V12, P1318, DOI 10.1111/j.1600-0854.2011.01244.x; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim DW, 2011, MOL CELLS, V31, P585, DOI 10.1007/s10059-011-1045-z; Lee JA, 2008, AUTOPHAGY, V4, P230, DOI 10.4161/auto.5384; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lone M, 2010, J CELL SCI, V123, P2369, DOI 10.1242/jcs.060582; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Michelet X, 2010, BIOL CELL, V102, P191, DOI 10.1042/BC20090145; Neufeld TP, 2003, CURR TOP MICROBIOL, V279, P139; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Peck JW, 2004, BIOCHEM J, V377, P693, DOI 10.1042/bj20031347; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren XF, 2011, TRAFFIC, V12, P1282, DOI 10.1111/j.1600-0854.2011.01208.x; Roxrud I, 2010, BIOL CELL, V102, P293, DOI 10.1042/BC20090161; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Rusten TE, 2008, CELL CYCLE, V7, P1166, DOI 10.4161/cc.7.9.5784; Rusten TE, 2008, AUTOPHAGY, V4, P233, DOI 10.4161/auto.5396; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Sambrook J, 2001, MOL CLONING LAB MANU, V1, P33; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; TU JL, 1993, GENETICS, V135, P17; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Wegner CS, 2011, TRAFFIC, V12, P1291, DOI 10.1111/j.1600-0854.2011.01210.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504	50	72	74	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54270	10.1371/journal.pone.0054270	http://dx.doi.org/10.1371/journal.pone.0054270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349844	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800035
J	Baharnoori, M; Bhardwaj, SK; Srivastava, LK				Baharnoori, Moogeh; Bhardwaj, Sanjeev K.; Srivastava, Lalit K.			Effect of Maternal Lipopolysaccharide Administration on the Development of Dopaminergic Receptors and Transporter in the Rat Offspring	PLOS ONE			English	Article							PRENATAL IMMUNE ACTIVATION; MEDIAL PREFRONTAL CORTEX; GAMMA-AMINOBUTYRIC-ACID; WORKING-MEMORY; HIPPOCAMPAL NEUROGENESIS; CORTICAL INTERNEURONS; COGNITIVE IMPAIRMENT; BACTERIAL-ENDOTOXIN; ANIMAL-MODELS; SCHIZOPHRENIA	Epidemiological evidence supports that maternal infection during gestation are notable risk factors for developmental mental illnesses including schizophrenia and autism. In prenatal lipopolysaccharide (LPS) model of immune activation in rats, the offspring exhibit significant impairments in behaviors mediated by central dopamine (DA) system. This study aimed to examine the temporal and regional pattern of postnatal DA development in the male offspring of pregnant Sprague-Dawley rats administered with 100 mu g/kg LPS or saline at gestational days 15/16. Using ligand autoradiography, D1 and D2 dopamine receptors (D1R, D2R) and dopamine transporter (DAT) binding levels were measured in the prefrontal cortex (PFC) and sub cortical regions (dorsal striatum and nucleus accumbens core and shell) at pre pubertal (P35) and post pubertal ages (P60). We found a significant decrease in D2R ligand [H-3] YM-90151-2 binding in the medial PFC (mPFC) in prenatal LPS-treated animals at P35 and P60 compared to respective saline groups. The decrease in D2R levels was not observed in the striatum or accumbens of maternal LPS-treated animals. No significant changes were observed in [H-3] SCH23390 binding to D1R. However, the level of [I-125] RTI-121 binding to DAT was selectively reduced in the nucleus accumbens core and shell at P35 in the prenatal LPS group. Immunohistochemical analysis showed that number of D2R immunopositive cells in infralimbic/prelimbic (IL/PL) part of mPFC was significantly reduced in the LPS group at P60. Prenatal LPS treatment did not significantly affect either the total number of mature neurons or parvalbumin (PV)- immunopositive interneurons in this region. However the number of PV and D2R co-labeled neurons was significantly reduced in the IL/PL subregion of PFC of LPS treated animals. Our data suggests D2R deficit in the PFC and PV interneurons may be relevant to understanding mechanisms of cortical dysfunctions described in prenatal infection animal models as well as schizophrenia.	[Srivastava, Lalit K.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; McGill University	Srivastava, LK (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	lalit.srivastava@mcgill.ca		Srivastava, Lalit/0000-0002-1222-3223	Canadian Institute of Health Research [ELA 80228]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by team grant from Canadian Institute of Health Research # ELA 80228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Baharnoori M, 2009, SCHIZOPHR RES, V107, P99, DOI 10.1016/j.schres.2008.10.003; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bitanihirwe BKY, 2010, INT J NEUROPSYCHOPH, V13, P981, DOI 10.1017/S1461145710000192; Boksa P, 2008, J PSYCHIATR NEUROSCI, V33, P183; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8; BOUNDY VA, 1993, MOL PHARMACOL, V43, P666; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Cui K, 2009, SCHIZOPHR RES, V113, P288, DOI 10.1016/j.schres.2009.05.003; Dick Danielle M, 2010, Dialogues Clin Neurosci, V12, P7; Druzin MY, 2000, BEHAV BRAIN RES, V109, P99, DOI 10.1016/S0166-4328(99)00166-7; Ducharme G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029754; Ernst M, 1997, LANCET, V350, P638, DOI 10.1016/S0140-6736(05)63326-0; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; Flores G, 1998, BRAIN RES, V814, P34, DOI 10.1016/S0006-8993(98)01011-7; Flores G, 1996, J NEUROSCI, V16, P7366; Fortier ME, 2007, BEHAV BRAIN RES, V181, P270, DOI 10.1016/j.bbr.2007.04.016; Fortier ME, 2004, J PSYCHIATR RES, V38, P335, DOI 10.1016/j.jpsychires.2003.10.001; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Leviel V, 2011, J NEUROCHEM, V118, P475, DOI 10.1111/j.1471-4159.2011.07335.x; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Mendez P, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/976856; Mengual E, 2002, SYNAPSE, V43, P151, DOI 10.1002/syn.10033; Meyer U, 2008, NEUROSCIENCE, V154, P701, DOI 10.1016/j.neuroscience.2008.04.031; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Meyer U, 2008, NEUROPSYCHOPHARMACOL, V33, P441, DOI 10.1038/sj.npp.1301413; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Muly EC, 1998, J NEUROSCI, V18, P10553; Nakamura K, 2010, ARCH GEN PSYCHIAT, V67, P59, DOI 10.1001/archgenpsychiatry.2009.137; Nouel D, 2012, EUR NEUROPSYCHOPHARM, V22, P300, DOI 10.1016/j.euroneuro.2011.08.001; O'Donnell P, 2010, NEUROTOX RES, V18, P306, DOI 10.1007/s12640-010-9157-3; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Piontkewitz Y, 2012, BRAIN BEHAV IMMUN, V26, P353, DOI 10.1016/j.bbi.2011.11.004; Riley B, 2011, SCHIZOPHRENIA, P245; Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Sesack SR, 1998, J NEUROSCI, V18, P2697; Sorensen HJ, 2009, SCHIZOPHRENIA BULL, V35, P631, DOI 10.1093/schbul/sbn121; Tseng KY, 2008, J NEUROSCI, V28, P12691, DOI 10.1523/JNEUROSCI.4166-08.2008; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; VINCENT SL, 1993, J NEUROSCI, V13, P2551, DOI 10.1523/JNEUROSCI.13-06-02551.1993; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Zuckerman L, 2005, J PSYCHIATR RES, V39, P311, DOI 10.1016/j.jpsychires.2004.08.008	56	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54439	10.1371/journal.pone.0054439	http://dx.doi.org/10.1371/journal.pone.0054439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349891	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900068
J	Elizaga, ML; Vasan, S; Marovich, MA; Sato, AH; Lawrence, DN; Chaitman, BR; Frey, SE; Keefer, MC				Elizaga, Marnie L.; Vasan, Sandhya; Marovich, Mary A.; Sato, Alicia H.; Lawrence, Dale N.; Chaitman, Bernard R.; Frey, Sharon E.; Keefer, Michael C.		MVA Cardiac Safety Working Grp	Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic Review	PLOS ONE			English	Article							T-CELL RESPONSES; PHASE-I TRIAL; SMALLPOX VACCINATION; UNITED-STATES; VIRUS; SAFETY; IMMUNOGENICITY; MVA; HIV-1; DNA	Background: Vaccinia-associated myo/pericarditis was observed during the US smallpox vaccination (DryVax) campaign initiated in 2002. A highly-attenuated vaccinia strain, modified vaccinia Ankara (MVA) has been evaluated in clinical trials as a safer alternative to DryVax and as a vector for recombinant vaccines. Due to the lack of prospectively collected cardiac safety data, the US Food and Drug Administration required cardiac screening and surveillance in all clinical trials of MVA since 2004. Here, we report cardiac safety surveillance from 6 phase I trials of MVA vaccines. Methods: Four clinical research organizations contributed cardiac safety data using common surveillance methods in trials administering MVA or recombinant MVA vaccines to healthy participants. 'Routine cardiac investigations' (ECGs and cardiac enzymes obtained 2 weeks after injections of MVA or MVA-HIV recombinants, or placebo-controls), and 'Symptom-driven cardiac investigations' are reported. The outcome measure is the number of participants who met the CDC-case definition for vaccinia-related myo/pericarditis or who experienced cardiac adverse events from an MVA vaccine. Results: Four hundred twenty-five study participants had post-vaccination safety data analyzed, 382 received at least one MVA-containing vaccine and 43 received placebo; 717 routine ECGs and 930 cardiac troponin assays were performed. Forty-five MVA recipients (12%) had additional cardiac testing performed; 22 for cardiac symptoms, 19 for ECG/laboratory changes, and 4 for cardiac symptoms with an ECG/laboratory change. No participant had evidence of symptomatic or asymptomatic myo/pericarditis meeting the CDC-case definition and judged to be related to an MVA vaccine. Conclusions: Prospective surveillance of MVA recipients for myo/pericarditis did not detect cardiac adverse reactions in 382 study participants.	[Elizaga, Marnie L.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Vasan, Sandhya] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Marovich, Mary A.] Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD USA; [Sato, Alicia H.] Fred Hutchinson Canc Res Ctr, SCHARP, Seattle, WA 98104 USA; [Lawrence, Dale N.] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Chaitman, Bernard R.] St Louis Univ, Sch Med, Div Cardiol, St Louis, MO USA; [Frey, Sharon E.] St Louis Univ, Sch Med, Clin Res Div Infect Dis Allergy & Immunol, St Louis, MO USA; [Keefer, Michael C.] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA	Fred Hutchinson Cancer Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Saint Louis University; Saint Louis University; University of Rochester	Keefer, MC (corresponding author), Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.	Michael_Keefer@URMC.Rochester.edu			National Institutes of Health [N01 AI25464, UM1 AI069511, UM1 AI068614, UM1 AI046747, UM1 AIO68614, UM1 AI068635]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046747, UM1AI069511, UM1AI068614, N01AI025464, UM1AI068635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant numbers N01 AI25464, UM1 AI069511, UM1 AI068614, UM1 AI046747, UM1 AIO68614, UM1 AI068635. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart PA, 2008, VACCINE, V26, P3153, DOI 10.1016/j.vaccine.2008.03.083; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Cassimatis DC, 2004, J AM COLL CARDIOL, V43, P1503, DOI 10.1016/j.jacc.2003.11.053; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P492; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P248; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Eckart RE, 2004, J AM COLL CARDIOL, V44, P201, DOI 10.1016/j.jacc.2004.05.004; Fenner F., 1988, SMALLPOX ITS ERADICA; Fortescue EB, 2007, ANN EMERG MED, V49, P137, DOI 10.1016/j.annemergmed.2006.09.024; Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Gorse GJ, 2012, CLIN VACCINE IMMUNOL; Guimaraes-Walker A, 2008, VACCINE, V26, P6671, DOI 10.1016/j.vaccine.2008.09.016; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; MACKETT M, 1982, P NATL ACAD SCI-BIOL, V79, P7415, DOI 10.1073/pnas.79.23.7415; Mayr A, 1978, Dev Biol Stand, V41, P225; Mayr A., 1975, INFECTION, V3, P6, DOI [10.1007/BF01641272, DOI 10.1007/BF01641272]; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McCurdy LH, 2004, CLIN INFECT DIS, V38, P1749, DOI 10.1086/421266; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Morgan J, 2008, CLIN INFECT DIS, V46, pS242, DOI 10.1086/524747; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; Parrino J, 2007, VACCINE, V25, P1513, DOI 10.1016/j.vaccine.2006.10.047; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; PIALOUX G, 1995, AIDS RES HUM RETROV, V11, P373, DOI 10.1089/aid.1995.11.373; Poland GA, 2005, VACCINE, V23, P2078, DOI 10.1016/j.vaccine.2005.01.012; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Sano J, 2009, AM J MED, V122, P79, DOI 10.1016/j.amjmed.2008.07.025; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; Stittelaar KJ, 2001, VACCINE, V19, P3700, DOI 10.1016/S0264-410X(01)00075-5; US FDA, 2007, FOOD DRUG ADM ACAMBI; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008816; WALLACK MK, 1986, AM SURGEON, V52, P148; ZAGURY D, 1988, NATURE, V332, P728, DOI 10.1038/332728a0	39	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54407	10.1371/journal.pone.0054407	http://dx.doi.org/10.1371/journal.pone.0054407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349878	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900066
J	Fabricius, KE; Cseke, S; Humphrey, C; De'ath, G				Fabricius, Katharina E.; Cseke, Szilvia; Humphrey, Craig; De'ath, Glenn			Does Trophic Status Enhance or Reduce the Thermal Tolerance of Scleractinian Corals? A Review, Experiment and Conceptual Framework	PLOS ONE			English	Review							GREAT-BARRIER-REEF; WATER-QUALITY; STYLOPHORA-PISTILLATA; MORTALITY RISK; CLIMATE-CHANGE; GROWTH; TEMPERATURE; HETEROTROPHY; ENERGETICS; SEDIMENTS	Global warming, and nutrient and sediment runoff from coastal development, both exert increasing pressures on coastal coral reefs. The objective of this study was to resolve the question of whether coastal eutrophication may protect corals from thermal stress by improving their nutritional status, or rather diminish their thermal tolerance through the synergy of dual stressors. A review of previous studies on the topic of combined trophic status and heat exposure on the thermal tolerance of corals reveals a broad range of outcomes, including synergistic, additive and antagonistic effects. We conducted a 90-day long experiment exposing corals to realistic levels of elevated nutrients and sediments, and heat stress. Colonies of two common scleractinian corals (Acropora millepora and Montipora tuberculosa) were kept in coastal seawater, or coastal seawater that was further organically and nutrient enriched (OE), and/or enriched with nitrate. Batches of OE were created daily, facilitating nutrient uptake, plankton succession and organic enrichment as observed in coastal waters. After 10 days of acclimation, 67% of the colonies had their temperature gradually increased from 27 degrees to 31.2 degrees C. After 3-7 weeks of heat stress, colonies of both species had significantly greater reductions in fluorescence yields and lower survival in OE than without addition of OE. Furthermore, photophysiological recovery was incomplete 31-38 days after ending the heat stress only in the OE treatments. Nitrate alone had no measurable effect on survival, bleaching and recovery in either species. Skeletal growth rates were reduced by 45% in heat-stressed A. millepora and by 24% in OE-exposed M. tuberculosa. We propose a conceptual trophic framework that resolves some of the apparently contradictory outcomes revealed by the review. Our study shows that management actions to reduce coastal eutrophication can improve the resistance and resilience of vulnerable coastal coral reefs to warming temperatures.	[Fabricius, Katharina E.; Cseke, Szilvia; Humphrey, Craig; De'ath, Glenn] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Cseke, Szilvia] Leibniz Ctr Trop Marine Ecol, Bremen, Germany	Australian Institute of Marine Science; Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Fabricius, KE (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	k.fabricius@aims.gov.au	Fabricius, Katharina E/F-1759-2010	Fabricius, Katharina E/0000-0001-7671-4358; Humphrey, Craig/0000-0002-1303-036X	Australian Institute of Marine Science; Australian Government's Marine and Tropical Sciences Research Facility; Australian Government's National Environmental Research Program	Australian Institute of Marine Science; Australian Government's Marine and Tropical Sciences Research Facility(Australian Government); Australian Government's National Environmental Research Program(Australian Government)	This study was jointly funded by the Australian Institute of Marine Science, the Australian Government's Marine and Tropical Sciences Research Facility, and the Australian Government's National Environmental Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2004, OECOLOGIA, V141, P373, DOI 10.1007/s00442-004-1647-7; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; Borell EM, 2008, OECOLOGIA, V157, P593, DOI 10.1007/s00442-008-1102-2; Brodie J, 2010, MAR FRESHWATER RES, V61, P651, DOI 10.1071/MF08030; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, MAR POLLUT BULL, V58, P1835, DOI 10.1016/j.marpolbul.2009.07.024; Connolly SR, 2012, CORAL REEFS IN PRESS; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; DAVIES PS, 1989, MAR BIOL, V101, P389; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DUBINSKY Z, 1990, PROC R SOC SER B-BIO, V239, P231, DOI 10.1098/rspb.1990.0015; Fabricius K, 2012, ESTUARINE COASTAL SH; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fabricius KE, 2012, MAR POLLUT BULL, V65, P320, DOI 10.1016/j.marpolbul.2011.09.004; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fabricius KE, 2006, LIMNOL OCEANOGR, V51, P30, DOI 10.4319/lo.2006.51.1.0030; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2004, ECOL APPL, V14, P1448, DOI 10.1890/03-5320; Fabricius KE, 2003, ESTUAR COAST SHELF S, V57, P613, DOI 10.1016/S0272-7714(02)00400-6; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Ferrier-Pages C, 2001, J EXP MAR BIOL ECOL, V259, P249, DOI 10.1016/S0022-0981(01)00241-6; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Fussel HM, 2009, CLIMATIC CHANGE, V97, P469, DOI 10.1007/s10584-009-9648-5; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoogenboom MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030167; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Jimenez IM, 2008, LIMNOL OCEANOGR, V53, P1548, DOI 10.4319/lo.2008.53.4.1548; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Lough JM, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002050; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McCullagh P, 1989, GEN LINEAR MODELS; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Nordemar I, 2003, MAR BIOL, V142, P669, DOI 10.1007/s00227-002-0989-0; R Development Core Team, 2012, R LANG ENV STAT COMP; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Robertson AI, 1998, ESTUAR COAST SHELF S, V46, P319, DOI 10.1006/ecss.1997.0270; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Secretariat of the Convention on Biological Diversity, 2010, COP 10 DEC X 2 STRAT; Shick JM, 2011, LIMNOL OCEANOGR, V56, P813, DOI 10.4319/lo.2011.56.3.0813; State of Queensland, 2009, REEF WAT QUAL PROT P; van Oppen Madeleine J. H., 2009, V205, P83; Wagner DE, 2010, MAR ECOL PROG SER, V408, P65, DOI 10.3354/meps08584; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8; Weber M, 2006, J EXP MAR BIOL ECOL, V336, P18, DOI 10.1016/j.jembe.2006.04.007; Weber M, 2012, P NATL ACAD SCI USA, V109, pE1558, DOI 10.1073/pnas.1100715109; West J, 2003, COMMENTARY, V115, P17; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013	65	37	37	3	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54399	10.1371/journal.pone.0054399	http://dx.doi.org/10.1371/journal.pone.0054399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349876	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900064
J	Githinji, S; Kigen, S; Memusi, D; Nyandigisi, A; Mbithi, AM; Wamari, A; Muturi, AN; Jagoe, G; Barrington, J; Snow, RW; Zurovac, D				Githinji, Sophie; Kigen, Samwel; Memusi, Dorothy; Nyandigisi, Andrew; Mbithi, Agneta M.; Wamari, Andrew; Muturi, Alex N.; Jagoe, George; Barrington, Jim; Snow, Robert W.; Zurovac, Dejan			Reducing Stock-Outs of Life Saving Malaria Commodities Using Mobile Phone Text-Messaging: SMS for Life Study in Kenya	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; CHALLENGES; MADAGASCAR; MARKET; ZAMBIA; POLICY	Background: Health facility stock-outs of life saving malaria medicines are common across Africa. Innovative ways of addressing this problem are urgently required. We evaluated whether SMS based reporting of stocks of artemether-lumefantrine (AL) and rapid diagnostic tests (RDT) can result in reduction of stock-outs at peripheral facilities in Kenya. Methods/Findings: All 87 public health facilities in five Kenyan districts were included in a 26 week project. Weekly facility stock counts of four AL packs and RDTs were sent via structured incentivized SMS communication process from health workers' personal mobile phones to a web-based system accessed by district managers. The mean health facility response rate was 97% with a mean formatting error rate of 3%. Accuracy of stock count reports was 79% while accuracy of stock-out reports was 93%. District managers accessed the system 1,037 times at an average of eight times per week. The system was accessed in 82% of the study weeks. Comparing weeks 1 and 26, stock-out of one or more AL packs declined by 38 percentage-points. Total AL stock-out declined by 5 percentage-points and was eliminated by the end of the project. Stock-out declines of individual AL packs ranged from 14 to 32 percentage-points while decline in RDT stock-outs was 24 percentage-points. District managers responded to 44% of AL and 73% of RDT stock-out signals by redistributing commodities between facilities. In comparison with national trends, stock-out declines in study areas were greater, sharper and more sustained. Conclusions: Use of simple SMS technology ensured high reporting rates of reasonably accurate, real-time facility stock data that were used by district managers to undertake corrective actions to reduce stock-outs. Future work on stock monitoring via SMS should focus on assessing response rates without use of incentives and demonstrating effectiveness of such interventions on a larger scale.	[Githinji, Sophie; Snow, Robert W.; Zurovac, Dejan] KEMRI Wellcome Trust Univ Oxford Collaborat Progr, Nairobi, Kenya; [Kigen, Samwel; Memusi, Dorothy; Nyandigisi, Andrew; Mbithi, Agneta M.; Wamari, Andrew] Minist Publ Hlth & Sanitat, Div Malaria Control, Nairobi, Kenya; [Muturi, Alex N.] Management Sci Hlth, Nairobi, Kenya; [Jagoe, George] Med Malaria Venture, Geneva, Switzerland; [Barrington, Jim] Novartis AG, SMS Life, Basel, Switzerland; [Snow, Robert W.; Zurovac, Dejan] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Zurovac, Dejan] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA	Novartis; University of Oxford; Boston University	Githinji, S (corresponding author), KEMRI Wellcome Trust Univ Oxford Collaborat Progr, Nairobi, Kenya.	sgithinji@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Novartis Pharma AG; The United States President's Malaria Initiative/USAID, through Management Sciences for Health/Health Commodities and Services Management Program; Medicines for Malaria Venture [AD 09/10]; Wellcome Trust [079080, 092654]	Novartis Pharma AG; The United States President's Malaria Initiative/USAID, through Management Sciences for Health/Health Commodities and Services Management Program(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Medicines for Malaria Venture; Wellcome Trust(Wellcome TrustEuropean Commission)	Novartis Pharma AG provided support for the technical development of the SMS for Life project, development of training materials and funded the operational costs during the six months of the pilot. The United States President's Malaria Initiative/USAID, through Management Sciences for Health/Health Commodities and Services Management Program, provided support for health workers training. Medicines for Malaria Venture provided support for evaluation component of the project. RWS is supported by the Wellcome Trust as a Principal Research Fellow (#079080). SG and DZ acknowledge the support of Medicines for Malaria Venture (A&D 09/10). SG, DZ and RWS acknowledge the support of the Wellcome Trust to the Kenyan Major Overseas Programme (#092654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: the authors confirm that commercial source (Novartis Pharma AG), funded part of the project. They also confirm that JB is an employee of Novartis Pharma AG and that DZ and RWS have received a fee for speaking at a meeting organized by Novartis Pharma AG. Finally, the authors also state that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Asiimwe C, 2011, AM J TROP MED HYG, V85, P26, DOI 10.4269/ajtmh.2011.10-0528; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Davis RG, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-260; Diap G, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S1-S1; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Kamanga A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-96; Mechael P., 2010, BARRIERS GAPS AFFECT; Ministry of Public Health and Sanitation, 2009, KEN MAL MON EV PLAN; Ministry of Public Health and Sanitation, 2009, NAT MAL STRAT 2009 2; Ministry of Public Health and Sanitation M.o.M.S., 2010, GUID DET REG PROC GE; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Quick JD, 1997, DC2018020003 DEP EN; Rajatonirina S, 2012, B WORLD HEALTH ORGAN, V90, P385, DOI 10.2471/BLT.11.097816; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Sudoi RK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-37; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; World Health Organization, 2011, MHEALTHNEW HOR HLTH, V3; Zurovac D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001176	20	52	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54066	10.1371/journal.pone.0054066	http://dx.doi.org/10.1371/journal.pone.0054066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349786	Green Submitted, gold, Green Published			2022-12-27	WOS:000313738900035
J	Ilinsky, Y				Ilinsky, Yury			Coevolution of Drosophila melanogaster mtDNA and Wolbachia Genotypes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; CYTOPLASMIC INCOMPATIBILITY; NATURAL-POPULATIONS; GENETIC-VARIATION; GENIC VARIATION; INFECTION; SELECTION; HISTORY; VIRULENT; SEQUENCE	Maternally inherited microorganisms can influence the mtDNA pattern of variation in hosts. This influence is driven by selection among symbionts and can cause the frequency of mitochondrial variants in the population to eventually increase or decrease. Wolbachia infection is common and widespread in Drosophila melanogaster populations. We compared genetic variability of D. melanogaster mitotypes with Wolbachia genotypes among isofemale lines associated with different geographic locations and time intervals to study coevolution of the mtDNA and Wolbachia. Phylogenetic analysis of D. melanogaster mtDNA revealed two clades diverged in Africa, each associated with one of the two Wolbachia genotype groups. No evidence of horizontal transmission of Wolbachia between maternal lineages has been found. All the mtDNA variants that occur in infected isofemale lines are found in uninfected isofemale lines and vice versa, which is indicative of a recent loss of infection from some maternal fly lineages and confirms a significant role of Wolbachia in the D. melanogaster mtDNA pattern of variation. Finally, we present a comparative analysis of biogeographic distribution of D. melanogaster mitotypes all over the world.	[Ilinsky, Yury] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Lab Populat Genet, Novosibirsk, Russia; [Ilinsky, Yury] Novosibirsk State Univ, Dept Cytol & Genet, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Ilinsky, Y (corresponding author), Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Lab Populat Genet, Novosibirsk, Russia.	paulee@bionet.nsc.ru	Ilinsky, Yury Y/A-1326-2017	Ilinsky, Yury/0000-0002-2691-3241	Russian Foundation for Basic Research [12-04-01319-a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grant number 12-04-01319-a from the Russian Foundation for Basic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azou Y, 2001, HEREDITY, V86, P110, DOI 10.1046/j.1365-2540.2001.00814.x; Baldo L, 2008, MOL ECOL, V17, P557, DOI 10.1111/j.1365-294X.2007.03608.x; Ballard JWO, 2000, J MOL EVOL, V51, P48, DOI 10.1007/s002390010066; Bourtzis K., 1994, Insect Molecular Biology, V3, P131, DOI 10.1111/j.1365-2583.1994.tb00160.x; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Clancy DJ, 2008, AGING CELL, V7, P795, DOI 10.1111/j.1474-9726.2008.00428.x; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; DEBRUIJN MHL, 1983, NATURE, V304, P234, DOI 10.1038/304234a0; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GARESSE R, 1988, GENETICS, V118, P649; Gleason JM, 1997, EVOLUTION, V51, P433, DOI 10.1111/j.1558-5646.1997.tb02430.x; Glinka S, 2003, GENETICS, V165, P1269; Glinka S, 2006, MOL BIOL EVOL, V23, P1869, DOI 10.1093/molbev/msl069; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; HALE LR, 1991, GENETICS, V129, P103; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1998, GENETICS, V148, P221; HOLDEN PR, 1993, GENET RES, V62, P23, DOI 10.1017/S0016672300031529; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Hutter S, 2009, GENETICS, V181, P1699; Ilinsky YY, 2007, RUSS J GENET+, V43, P748, DOI 10.1134/S102279540707006X; Ilinsky Yu.Yu., 2007, DOKL BIOL SCI, V413, P166, DOI [10.1134/S0012496607020238, DOI 10.1134/S0012496607020238]; Ilinsky YY, 2006, DROS INF SERV, V89, P89; Jensen JD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000198; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Nunes MDS, 2008, MOL BIOL EVOL, V25, P2493, DOI 10.1093/molbev/msn199; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Palumbi Stephen R., 1996, P205; Parsch J, 2009, MOL BIOL EVOL, V26, P691, DOI 10.1093/molbev/msn297; Pool JE, 2012, POPULATION GENOMICS; Pool JE, 2006, GENETICS, V174, P915, DOI 10.1534/genetics.106.058693; RAND DM, 1994, GENETICS, V138, P741; Reynolds KT, 2003, GENETICS, V164, P1027; Richardson MF, 2012, POPULATION GENOMICS; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Rodriguero MS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-340; Schofl G, 2005, GENETICS, V170, P1701, DOI 10.1534/genetics.104.037507; SINGH RS, 1987, GENETICS, V115, P313; SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461; Stephan W, 2007, HEREDITY, V98, P65, DOI 10.1038/sj.hdy.6800901; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verspoor RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026318; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zhukova MV, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S15	55	40	47	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54373	10.1371/journal.pone.0054373	http://dx.doi.org/10.1371/journal.pone.0054373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349865	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900062
J	Li, XL; Tai, HH				Li, Xiuling; Tai, Hsin-Hsiung			Activation of Thromboxane A(2) Receptor (TP) Increases the Expression of Monocyte Chemoattractant Protein-1 (MCP-1)/Chemokine (C-C motif) Ligand 2 (CCL2) and Recruits Macrophages to Promote Invasion of Lung Cancer Cells	PLOS ONE			English	Article							MULTIPLE SIGNALING PATHWAYS; NF-KAPPA-B; PROSTATE-CANCER; GENE-EXPRESSION; BLADDER-CANCER; IN-VIVO; ENDOTHELIAL-CELLS; ASTROCYTOMA-CELLS; TUMOR-METASTASIS; CARCINOMA CELLS	Thromboxane synthase (TXAS) and thromboxane A(2) receptor (TP), two critical components for thromboxane A(2) (TXA(2)) signaling, have been suggested to be involved in cancer invasion and metastasis. However, the mechanisms by which TXA(2) promotes these processes are still unclear. Here we show that TXA(2) mimetic, I-BOP, induced monocyte chemoattractant protein -1(MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) expression at both mRNA and protein levels in human lung adenocarcinoma A549 cells stably over-expressing TP receptor alpha isoform (A549-TP alpha). The induction of MCP-1 was also found in other lung cancer cells H157 and H460 that express relatively high levels of endogenous TP. Using specific inhibitors of several signaling molecules and promoter/luciferase assay, we identified that transcription factor SP1 mediates I-BOP-induced MCP-1 expression. Furthermore, supernatants from I-BOP-treated A549-TP alpha cells enhanced MCP-1-dependent migration of RAW 264.7 macrophages. Moreover, co-culture of A549 cells with RAW 264.7 macrophages induced expression of MMPs, VEGF and MCP-1 genes, and increased the invasive potential in A549 cells. These findings suggest that TXA(2) may stimulate invasion of cancer cells through MCP-1-mediated macrophage recruitment.	[Li, Xiuling; Tai, Hsin-Hsiung] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA	University of Kentucky	Tai, HH (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA.	htai1@email.uky.edu	li, xiu/GXV-1745-2022		University of Kentucky	University of Kentucky	University of Kentucky supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenberg DA, 2000, CANCER IMMUNOL IMMUN, V49, P63, DOI 10.1007/s002620050603; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Cai Z, 2009, NEOPLASIA, V11, P228, DOI 10.1593/neo.81282; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Chiu HY, 2012, CYTOKINE, V59, P423, DOI 10.1016/j.cyto.2012.04.017; Coursey TG, 2011, CANCER RES, V71, P2445, DOI 10.1158/0008-5472.CAN-10-2628; Ekambaram P, 2011, CANC METASTASIS REV; Ferrero E, 1998, EUR J IMMUNOL, V28, P2530, DOI 10.1002/(SICI)1521-4141(199808)28:08<2530::AID-IMMU2530>3.0.CO;2-6; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Giese A, 1999, Neuro Oncol, V1, P3, DOI 10.1093/neuonc/1.1.3; Gu LY, 2006, NEPHROL DIAL TRANSPL, V21, P299, DOI 10.1093/ndt/gfi210; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; HEPPNER GH, 1984, CANCER RES, V44, P2259; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Hung JJ, 2005, J BIOL CHEM, V280, P36283, DOI 10.1074/jbc.M504904200; Ishitsuka Y, 2009, J PHARMACOL SCI, V111, P211, DOI 10.1254/jphs.09128SC; Ishizuka T, 2000, CLIN EXP IMMUNOL, V120, P71, DOI 10.1046/j.1365-2249.2000.01169.x; Joshi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004208; Keelan JA, 2000, J SOC GYNECOL INVEST, V7, P37, DOI 10.1016/S1071-5576(99)00065-9; Koide N, 2004, AM J GASTROENTEROL, V99, P1667, DOI 10.1111/j.1572-0241.2004.30733.x; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Li XL, 2012, CURR CANCER DRUG TAR, V12, P703, DOI 10.2174/156800912801784884; Li XL, 2009, CARCINOGENESIS, V30, P1606, DOI 10.1093/carcin/bgp161; Lim JH, 2009, EXP MOL MED, V41, P757, DOI 10.3858/emm.2009.41.10.082; Lin CW, 2010, CARCINOGENESIS, V31, P2039, DOI 10.1093/carcin/bgq172; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; McDonough W, 1998, J NEUROPATH EXP NEUR, V57, P449, DOI 10.1097/00005072-199805000-00008; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Moussa O, 2008, CANCER RES, V68, P4097, DOI 10.1158/0008-5472.CAN-07-6560; Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226; NEEDLEMAN P, 1976, NATURE, V261, P558, DOI 10.1038/261558a0; Nie DT, 2000, BIOCHEM BIOPH RES CO, V267, P245, DOI 10.1006/bbrc.1999.1840; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ping DS, 1996, IMMUNITY, V4, P455, DOI 10.1016/S1074-7613(00)80412-4; Ping DS, 1999, J BIOL CHEM, V274, P31909, DOI 10.1074/jbc.274.45.31909; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Toomey D, 2003, INT J CANCER, V103, P408, DOI 10.1002/ijc.10836; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wei J, 2007, BIOCHEM PHARMACOL, V74, P787, DOI 10.1016/j.bcp.2007.06.008; Wei JY, 2010, LUNG CANCER, V69, P26, DOI 10.1016/j.lungcan.2009.09.009; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Yan WL, 2006, J PHARMACOL EXP THER, V317, P267, DOI 10.1124/jpet.105.096826; Yao Y, 2010, J BIOL CHEM, V285, P31509, DOI 10.1074/jbc.M110.124891; Yoshimoto A, 2005, ONCOL REP, V13, P1049; Zeni E, 2007, EUR RESPIR J, V30, P627, DOI 10.1183/09031936.00129306; Zhang JH, 2011, AM J PATHOL, V178, P382, DOI 10.1016/j.ajpath.2010.11.017; Zhou ZHL, 1998, J IMMUNOL, V160, P3908	58	25	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54073	10.1371/journal.pone.0054073	http://dx.doi.org/10.1371/journal.pone.0054073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349788	Green Published, gold			2022-12-27	WOS:000313738900036
J	Ondrusova, L; Vachtenheim, J; Reda, J; Zakova, P; Benkova, K				Ondrusova, Lubica; Vachtenheim, Jiri; Reda, Jiri; Zakova, Petra; Benkova, Kamila			MITF-Independent Pro-Survival Role of BRG1-Containing SWI/SNF Complex in Melanoma Cells	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEXES; TRANSCRIPTION FACTOR MITF; LUNG-CANCER; INCREASED EXPRESSION; CUTANEOUS MELANOMA; MASTER REGULATOR; XIII COLLAGEN; TARGET GENES; BRG1; BRM	Metastasized malignant melanoma has a poor prognosis because of its intrinsic resistance to chemotherapy and radiotherapy. The central role in the melanoma transcriptional network has the transcription factor MITF (microphthalmia-associated transcription factor). It has been shown recently that the expression of MITF and some of its target genes require the SWI/SNF chromatin remodeling complex. Here we demonstrate that survival of melanoma cells requires functional SWI/SNF complex not only by supporting expression of MITF and its targets and but also by activating expression of prosurvival proteins not directly regulated by MITF. Microarray analysis revealed that besides the MITF-driven genes, expression of proteins like osteopontin, IGF1, TGF beta 2 and survivin, the factors known to be generally associated with progression of tumors and the antiapoptotic properties, were reduced in acute BRG1-depleted 501mel cells. Western blots and RT-PCR confirmed the microarray findings. These proteins have been verified to be expressed independently of MITF, because MITF depletion did not impair their expression. Because these genes are not regulated by MITF, the data suggests that loss of BRG1-based SWI/SNF complexes negatively affects survival pathways beyond the MITF cascade. Immunohistochemistry showed high expression of both BRM and BRG1 in primary melanomas. Exogenous CDK2, osteopontin, or IGF1 each alone partly relieved the block of proliferation imposed by BRG1 depletion, implicating that more factors, besides the MITF target genes, are involved in melanoma cell survival. Together these results demonstrate an essential role of SWI/SNF for the expression of MITF-dependent and MITF-independent prosurvival factors in melanoma cells and suggest that SWI/SNF may be a potential and effective target in melanoma therapy.	[Ondrusova, Lubica; Vachtenheim, Jiri; Reda, Jiri; Zakova, Petra] Charles Univ Prague, Fac Med 1, Inst Med Biochem, Lab Transcript & Cell Signaling, Prague, Czech Republic; [Ondrusova, Lubica; Vachtenheim, Jiri; Reda, Jiri; Zakova, Petra] Charles Univ Prague, Fac Med 1, Diagnost Lab, Prague, Czech Republic; [Benkova, Kamila] Hosp Bulovka, Dept Pathol, Prague, Czech Republic	Charles University Prague; Charles University Prague; Bulovka University Hospital	Vachtenheim, J (corresponding author), Charles Univ Prague, Fac Med 1, Inst Med Biochem, Lab Transcript & Cell Signaling, Prague, Czech Republic.	jiri.vachtenheim@lf1.cuni.cz	Žáková, Petra/J-3270-2017; Réda, Jiří/I-7023-2017; Vachtenheim, Jiri/I-6232-2017; Ondrušová, Lubica/HII-2979-2022	Žáková, Petra/0000-0002-8172-6115; Réda, Jiří/0000-0002-4455-4756; Vachtenheim, Jiri/0000-0002-4923-9296; 	Internal Granting Agency, Ministry of Health, Czech Rep [NT/11229-3]	Internal Granting Agency, Ministry of Health, Czech Rep	This work was supported by a grant no. NT/11229-3 (to JV) from the Internal Granting Agency, Ministry of Health (www.mzcr.cz), Czech Rep. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; Bartlett C, 2011, J CELL PHYSIOL, V226, P1989, DOI 10.1002/jcp.22533; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Das S, 2009, J BIOL CHEM; de la Serna IL, 2006, J BIOL CHEM, V281, P20233, DOI 10.1074/jbc.M512052200; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Goding CR, 2000, GENE DEV, V14, P1712; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Halliday GM, 2009, INT J BIOCHEM CELL B, V41, P725, DOI 10.1016/j.biocel.2008.04.026; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Keenen B, 2010, ONCOGENE, V29, P81, DOI 10.1038/onc.2009.304; Kido K, 2009, CANCER SCI, V100, P1863, DOI 10.1111/j.1349-7006.2009.01266.x; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Liu T, 2004, ONCOGENE, V23, P39, DOI 10.1038/sj.onc.1206978; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Peltonen S, 1999, J INVEST DERMATOL, V113, P635, DOI 10.1046/j.1523-1747.1999.00736.x; Pierrat M.J., 2012, J BIOL CHEM; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2003, CANCER RES, V63, P560; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Saladi SV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-280; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Shen H, 2008, CANCER RES, V68, P10154, DOI 10.1158/0008-5472.CAN-08-1794; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Vachtenheim J, 2004, PIGM CELL RES, V17, P43, DOI 10.1046/j.1600-0749.2003.00108.x; Vachtenheim J, 2001, J INVEST DERMATOL, V117, P1505, DOI 10.1046/j.0022-202x.2001.01563.x; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Vachtenheim J, 2010, BIOCHEM BIOPH RES CO, V392, P454, DOI 10.1016/j.bbrc.2010.01.048; Vaisanen T, 2005, J PATHOL, V207, P324, DOI 10.1002/path.1836; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vinod Saladi Srinivas, 2010, Epigenetics, V5, P469; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601; Zhang CY, 2009, CANCER RES, V69, P828, DOI 10.1158/0008-5472.CAN-08-2588; Zhou YW, 2005, J INVEST DERMATOL, V124, P1044, DOI 10.1111/j.0022-202X.2005.23680.x	56	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54110	10.1371/journal.pone.0054110	http://dx.doi.org/10.1371/journal.pone.0054110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349796	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900040
J	Huh, JE; Ko, R; Jung, HJ; Lee, SY				Huh, Jeong-Eun; Ko, Ryeojin; Jung, Hyun Ju; Lee, Soo Young			Glycogen Synthase Kinase 3 beta Promotes Osteogenic Differentiation of Murine Adipose-Derived Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; BETA-CATENIN; BONE-MARROW; CHONDROGENIC DIFFERENTIATION; WNT; PROLIFERATION; TISSUE; EXPANSION; INACTIVATION	Although the role of glycogen synthase kinase 3 beta (GSK3 beta) in osteogenic differentiation of bone marrow-derived mesenchymal stromal cells (BMSCs) is well-characterized as a negative regulator of beta-catenin, its effect on osteogenesis of adipose-derived stromal cells (ADSCs) is poorly understood. Here, we show that GSK3 beta positively regulates osteogenic differentiation of murine ADSCs. Gain-of-function studies showed that GSK3 beta promotes in vitro osteogenesis of ADSCs. Regulation of GSK3 beta activity in ADSCs, either by small interfering RNA (siRNA)-mediated GSK3 beta silencing or by pharmacological inhibitors, blunted osteogenesis and the expression of osteogenic markers. Importantly, we demonstrated that transgenic mice, engineered to overexpress the constitutively active GSK3 beta (GSK3 beta-S9A) mutant, exhibited a marked increase in osteogenesis, whereas expression of the catalytically inactive GSK3 beta (GSK3 beta-K85A) in mice inhibits osteogenic differentiation. Molecular analyses showed that the enhanced osteoblast differentiation induced by GSK3 beta was mediated by downregulation of beta-catenin. Remarkably, beta-catenin silencing enhances osteogenesis and osteoblast marker gene expression such as alkaline phosphatase (ALP) and osterix. Taken together, these findings demonstrate a novel role for GSK3 beta in the regulation of osteogenic differentiation in ADSCs.	[Huh, Jeong-Eun; Ko, Ryeojin; Jung, Hyun Ju; Lee, Soo Young] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Lee, Soo Young] Ewha Womans Univ, Dept Life Sci, Dept Bioinspired Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Lee, SY (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	leesy@ewha.ac.kr			National Research Foundation of Korea (NRF) grant; Korea Government (MEST) [R0A-2008-000-20001-0, R31-2008-000-10010-0, 2012-0000952, 2010-0020577]; Brain Korea 21 Project; LG Yonam Foundation	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); LG Yonam Foundation	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST; R0A-2008-000-20001-0; R31-2008-000-10010-0; No. 2012-0000952; No. 2010-0020577). JEH and RK were supported by the second stage of the Brain Korea 21 Project. SYL is grateful for LG Yonam Foundation for the visiting scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Davis LA, 2008, CELL MOL LIFE SCI, V65, P2658, DOI 10.1007/s00018-008-8042-1; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Gregory CA, 2006, DRUG NEWS PERSPECT, V19, P445, DOI 10.1358/dnp.2006.19.8.1043960; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Ito T, 2008, CYTOTECHNOLOGY, V56, P1, DOI 10.1007/s10616-007-9092-1; Jang HD, 2011, J BIOL CHEM, V286, P39043, DOI 10.1074/jbc.M111.256768; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Krause U, 2010, P NATL ACAD SCI USA, V107, P4147, DOI 10.1073/pnas.0914360107; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Liu N, 2011, J BONE MINER RES, V26, P2082, DOI 10.1002/jbmr.440; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; Ogawa R, 2004, BIOCHEM BIOPH RES CO, V319, P511, DOI 10.1016/j.bbrc.2004.05.021; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Rich JT, 2008, BIOCHEM BIOPH RES CO, V372, P230, DOI 10.1016/j.bbrc.2008.05.022; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	45	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54551	10.1371/journal.pone.0054551	http://dx.doi.org/10.1371/journal.pone.0054551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342170	Green Submitted, gold, Green Published			2022-12-27	WOS:000313682700125
J	Yan, P; Sun, B; Shi, HM; Zhu, W; Zhou, Q; Jiang, YW; Zhu, H; Huang, GQ				Yan, Ping; Sun, Bin; Shi, Haiming; Zhu, Wen; Zhou, Qing; Jiang, Yuwen; Zhu, Hui; Huang, Guoqian			Left Atrial and Right Atrial Deformation in Patients with Coronary Artery Disease: A Velocity Vector Imaging-Based Study	PLOS ONE			English	Article							SPECKLE-TRACKING ECHOCARDIOGRAPHY; VENTRICULAR DIASTOLIC FUNCTION; STRAIN-RATE ECHOCARDIOGRAPHY; 2-DIMENSIONAL STRAIN; DOPPLER-ECHOCARDIOGRAPHY; MYOCARDIAL-FUNCTION; FILLING PRESSURES; SYSTOLIC FUNCTION; CLINICAL UTILITY; ISCHEMIA	Background: Impaired left ventricular (LV) function has been shown by strain rate (SR) imaging in patients with coronary artery disease (CAD). Our aim was to investigate global and regional, systolic and diastolic left atrial (LA) and right atrial (RA) longitudinal deformation in CAD using velocity vector imaging. Methods: Echocardiographic and velocity vector imaging studies were performed in 20 patients with mild CAD, 40 patients with severe CAD and 25 controls. Maximal atrial volume, peak atrial longitudinal strain (epsilon(s)) and SR during LV systole (SRs), SR during early LV filling (SRe) and late LV filling (SRa) were measured. Longitudinal strain during atrial contraction (epsilon(a)) was obtained at the onset of P-wave on electrocardiography, and epsilon(a)/epsilon(s) was calculated. Results: Longitudinal peak epsilon(s) and SRs of LA showed decreased trend among CAD patients. The global and lateral LA SRe were prominently lower, while RA epsilon(a), SRa and epsilon(a)/epsilon(s) were prominently higher in 2 CAD groups than control group (P value<0.05). As compared with controls and patients with other single-vessel disease, LA SRa and epsilon(a)/epsilon(s) ratio were significantly increased among patients with exclusively left anterior descending coronary artery (LAD) stenosis (SRa 1.14 +/- 0.38 s(-1), 1.10 +/- 0.41 s(-1), 1.45 +/- 0.46 s(-1), P value<0.05; epsilon(a)/epsilon(s) 0.44 +/- 0.11, 0.44 +/- 0.20, 0.57 +/- 0.12, P value<0.01). Conclusions: Apparently decreased SRe of LA and increased epsilon(a), SRa and epsilon(a)/epsilon(s) of RA were found in CAD patients with preserved LVEF and E/E' in gray zone. SRa and epsilon(a)/epsilon(s) of LA were found to significantly increase in those with LAD stenosis.	[Yan, Ping; Sun, Bin; Shi, Haiming; Zhu, Wen; Zhou, Qing; Jiang, Yuwen; Zhu, Hui; Huang, Guoqian] Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University	Huang, GQ (corresponding author), Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China.	guoqian_huang@yahoo.com.cn	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454				Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; BONOW RO, 1981, CIRCULATION, V64, P315, DOI 10.1161/01.CIR.64.2.315; Dattilo G, 2010, INT J CARDIOL, V145, pE6, DOI 10.1016/j.ijcard.2008.12.100; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dokainish H, 2010, J AM SOC ECHOCARDIOG, V23, P156, DOI 10.1016/j.echo.2009.11.015; Guan ZQ, 2010, CLIN CARDIOL, V33, P643, DOI 10.1002/clc.20784; Gurbel PA, 2008, AM HEART J, V155, P56, DOI 10.1016/j.ahj.2007.08.021; Her AY, 2012, CAN J CARDIOL; Hoit BD, 2011, CIRC-CARDIOVASC IMAG, V4, P179, DOI 10.1161/CIRCIMAGING.110.959817; Kalay N, 2011, ECHOCARDIOGR-J CARD, V28, P203, DOI 10.1111/j.1540-8175.2010.01298.x; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Kim DG, 2009, ECHOCARDIOGR-J CARD, V26, P1179, DOI 10.1111/j.1540-8175.2009.00955.x; Kimura K, 2011, J CARDIOL; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee KW, 2005, AM HEART J, V150, P756, DOI 10.1016/j.ahj.2004.11.019; Leung DY, 2010, HEART LUNG CIRC, V19, P161, DOI 10.1016/j.hlc.2009.11.006; Leung DY, 2008, AM HEART J, V156, P1056, DOI 10.1016/j.ahj.2008.07.021; Liu YY, 2011, ECHOCARDIOGR-J CARD, V28, P1095, DOI 10.1111/j.1540-8175.2011.01513.x; Min PK, 2007, AM J CARDIOL, V100, P326, DOI 10.1016/j.amjcard.2007.02.102; MITCHELL JH, 1962, AM J CARDIOL, V9, P237, DOI 10.1016/0002-9149(62)90043-7; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Motoki H, 2012, J AM SOC ECHOCARDIOG, V25, P428, DOI 10.1016/j.echo.2011.12.020; Nesbitt GC, 2009, INT J CARDIOVAS IMAG, V25, P9, DOI 10.1007/s10554-008-9414-1; NISHIMURA RA, 1985, MAYO CLIN PROC, V60, P321, DOI 10.1016/S0025-6196(12)60540-0; Ommen SR, 2000, CIRCULATION, V102, P1788; Paulus WJ, 2010, HEART, V96, P1147, DOI 10.1136/hrt.2009.169052; Perk G, 2009, ECHOCARDIOGR-J CARD, V26, P299, DOI 10.1111/j.1540-8175.2008.00863.x; Pirat B, 2008, J AM COLL CARDIOL, V51, P651, DOI 10.1016/j.jacc.2007.10.029; Psaty BM, 1997, CIRCULATION, V96, P2455; Russo C, 2012, HEART, V98, P813, DOI 10.1136/heartjnl-2011-301388; SIGWART U, 1990, AM J CARDIOL, V65, P282, DOI 10.1016/0002-9149(90)90288-C; Stefanadis C, 1999, J AM COLL CARDIOL, V33, P687, DOI 10.1016/S0735-1097(98)00623-8; STEWART JT, 1992, BRIT HEART J, V68, P377; Stolker JM, 2010, J INVASIVE CARDIOL, V22, P107; Sun Tao, 2010, Clin Cardiol, V33, pE1, DOI 10.1002/clc.20698; Tanaka H, 2007, CIRC J, V71, P517, DOI 10.1253/circj.71.517; Tsai WC, 2010, J AM SOC ECHOCARDIOG, V23, P1183, DOI 10.1016/j.echo.2010.08.011; Vianna-Pinton R, 2009, J AM SOC ECHOCARDIOG, V22, P299, DOI 10.1016/j.echo.2008.12.017; Yan P, 2011, NEPHRON CLIN PRACT, V118, pC232, DOI 10.1159/000321383	39	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e51204	10.1371/journal.pone.0051204	http://dx.doi.org/10.1371/journal.pone.0051204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23349657	Green Published, Green Submitted, gold			2022-12-27	WOS:000312108500050
J	Goodwin, PR; Juo, P				Goodwin, Patricia R.; Juo, Peter			The Scaffolding Protein SYD-2/Liprin-alpha Regulates the Mobility and Polarized Distribution of Dense-Core Vesicles in C. elegans Motor Neurons	PLOS ONE			English	Article							ACTIVE ZONE; LIPRIN-ALPHA; PRESYNAPTIC COMPONENTS; NERVOUS-SYSTEM; SAD-1 KINASE; TRANSPORT; RELEASE; TRAFFICKING; MATURATION; SECRETION	The polarized trafficking of axonal and dendritic components is essential for the development and maintenance of neuronal structure and function. Neuropeptide-containing dense-core (DCVs) vesicles are trafficked in a polarized manner from the cell body to their sites of release; however, the molecules involved in this process are not well defined. Here we show that the scaffolding protein SYD-2/Liprin-alpha is required for the normal polarized localization of Venus-tagged neuropeptides to axons of cholinergic motor neurons in C. elegans. In syd-2 loss of function mutants, the normal polarized localization of INS-22 neuropeptide-containing DCVs in motor neurons is disrupted, and DCVs accumulate in the cell body and dendrites. Time-lapse microscopy and kymograph analysis of mobile DCVs revealed that syd-2 mutants exhibit decreased numbers of DCVs moving in both anterograde and retrograde directions, and a corresponding increase in stationary DCVs in both axon commissures and dendrites. In addition, DCV run lengths and velocities were decreased in both axon commissures and dendrites of syd-2 mutants. This study shows that SYD-2 promotes bi-directional mobility of DCVs and identifies SYD-2 as a novel regulator of DCV trafficking and polarized distribution.	[Goodwin, Patricia R.; Juo, Peter] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA; [Goodwin, Patricia R.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Grad Program Neurosci, Boston, MA 02111 USA	Tufts University; Tufts University	Juo, P (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA.	peter.juo@tufts.edu	Juo, Peter/CJY-3695-2022	Juo, Peter/0000-0002-3039-2266	National Institutes of Health (NIH) [NS059953]; Basil O'Connor March of Dimes Scholar Award; Tufts Center for Neuroscience Research [P30 NS047243]; Synapse Neurobiology Training Program [T32 NS061764]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243, R56NS059953, R01NS059953, T32NS061764] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basil O'Connor March of Dimes Scholar Award(March of Dimes); Tufts Center for Neuroscience Research; Synapse Neurobiology Training Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a grant from the National Institutes of Health (NIH) to PJ (NS059953), a Basil O'Connor March of Dimes Scholar Award to PJ, and the Tufts Center for Neuroscience Research (P30 NS047243). PRG was supported by a Dean's Fellowship and the Synapse Neurobiology Training Program (T32 NS061764). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astigarraga S, 2010, J NEUROSCI, V30, P15358, DOI 10.1523/JNEUROSCI.1862-10.2010; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; BRENNER S, 1974, GENETICS, V77, P71; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Ch'ng Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000283; Chia PH, 2012, NAT NEUROSCI, V15, P234, DOI 10.1038/nn.2991; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Edwards SL, 2009, J CELL BIOL, V186, P881, DOI 10.1083/jcb.200902095; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Goodwin PR, 2012, J NEUROSCI, V32, P8158, DOI 10.1523/JNEUROSCI.0251-12.2012; Hammarlund M, 2008, J CELL BIOL, V180, P483, DOI 10.1083/jcb.200708018; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hannemann M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002722; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Hsu CC, 2011, NEUROSCIENCE, V176, P39, DOI 10.1016/j.neuroscience.2010.12.044; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Ko J, 2003, J NEUROSCI, V23, P1667; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; Lessmann V, 2009, NEUROSCI RES, V65, P11, DOI 10.1016/j.neures.2009.06.004; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Park J, 2009, J MOL NEUROSCI, V37, P151, DOI 10.1007/s12031-008-9098-y; Park JJ, 2008, MOL ENDOCRINOL, V22, P2583, DOI 10.1210/me.2008-0209; Park M, 2011, NEURON, V70, P742, DOI 10.1016/j.neuron.2011.04.002; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Patel MR, 2009, SCIENCE, V323, P1500, DOI 10.1126/science.1169025; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Shakiryanova D, 2006, NAT NEUROSCI, V9, P896, DOI 10.1038/nn1719; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Stigloher C, 2011, J NEUROSCI, V31, P4388, DOI 10.1523/JNEUROSCI.6164-10.2011; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sumakovic M, 2009, J CELL BIOL, V186, P897, DOI 10.1083/jcb.200902096; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; Taru H, 2011, J NEUROSCI, V31, P16261, DOI 10.1523/JNEUROSCI.0002-11.2011; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Wagner OI, 2009, P NATL ACAD SCI USA, V106, P19605, DOI 10.1073/pnas.0902949106; West AE, 1997, J CELL BIOL, V139, P917, DOI 10.1083/jcb.139.4.917; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wong MY, 2009, J MOL NEUROSCI, V37, P146, DOI 10.1007/s12031-008-9080-8; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	59	13	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54763	10.1371/journal.pone.0054763	http://dx.doi.org/10.1371/journal.pone.0054763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358451	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600105
J	Hwang, BF; Young, LH; Tsai, CH; Tung, KY; Wang, PC; Su, MW; Lee, YLL				Hwang, Bing-Fang; Young, Li-Hao; Tsai, Ching-Hui; Tung, Kuan-Yen; Wang, Pei-Chuan; Su, Ming-Wei; Lee, Yungling Leo			Fine Particle, Ozone Exposure, and Asthma/Wheezing: Effect Modification by Glutathione S-transferase P1 Polymorphisms	PLOS ONE			English	Article							AIR-POLLUTION; CHILDHOOD ASTHMA; OXIDATIVE STRESS; CHILDREN; HEALTH; COHORT; GSTM1	Background: There are limited studies on the role of interaction between exposure to ambient air pollution and glutathione-S-transferase (GST) P1 on the risk of asthma/wheezing among children, which provided suggestive, but inconclusive results. Methods: To assess the joint effect of air pollutants and GSTP1 on asthma/wheezing, we conducted a nationwide cross-sectional study of 3,825 children in Taiwan Children Health Study. The studied determinants were three GSTP1 Ile105Val (rs 1695) genotypes (Ile-Ile; Ile-Val and Val-Val) and expoure to ambient air pollutants. We used routine air-pollution monitoring data for ozone (O-3) and particles with an aerodynamic diameter of 2.5 mu m or less (PM2.5). The effect estimates were presented as odds ratios (ORs) per interquartile changes for PM2.5 and O-3. Findings: In a two-stage hierarchical model adjusting for confounding, the risk of asthma was negatively associated with PM2.5 (adjusted odds ratio (OR) 0.60; 95% confidence interval (CI) 0.45, 0.82) and O-3 (OR 0.74; 95% CI 0.60, 0.90) among Ile105 homozygotes, but positively associated with PM2.5 (OR 1.52; 95% CI 1.01, 2.27) and O-3 (OR 1.19; 95% CI 0.91, 1.57) among those with at least one val105 allele (interaction p value = 0.001 and 0.03, respectively). A similar tendency of effect modification between PM2.5 and O-3 and GSTP1 on wheezing was found. Conclusion: Children who carried Ile105 variant allele and exposed to PM2.5 and O-3 may be less likely to occurrence of asthma/wheezing.	[Hwang, Bing-Fang; Young, Li-Hao] China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Heath, Taichung, Taiwan; [Hwang, Bing-Fang; Young, Li-Hao] China Med Univ, Coll Publ Hlth, Grad Program, Taichung, Taiwan; [Tsai, Ching-Hui; Tung, Kuan-Yen; Wang, Pei-Chuan; Su, Ming-Wei; Lee, Yungling Leo] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	China Medical University Taiwan; China Medical University Taiwan; National Taiwan University	Lee, YLL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	leolee@ntu.edu.tw	Young, Li-Hao/AAG-4311-2020; Hwang, Bing-Fang/O-2709-2015; LEE, YUNG-LING/S-7011-2018	Hwang, Bing-Fang/0000-0002-5951-9662; Young, Li-Hao/0000-0002-3328-8181; LEE, YUNG-LING/0000-0002-2234-9479	Taiwan National Science Council [96-2314-B-039-019, 96-2314-B-006-053, 98-2314-B-002-138-MY3, 99-2314-B-039-021-MY3, 101-2314-B-002-113-MY3]; grant CMU from China Medical University [100-AWARD-07]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); grant CMU from China Medical University	This study was supported by grant #96-2314-B-039-019, #96-2314-B-006-053, #98-2314-B-002-138-MY3, #99-2314-B-039-021-MY3 and #101-2314-B-002-113-MY3 from the Taiwan National Science Council. BFH was supported by grant CMU# 100-AWARD-07 from China Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	41st World Medical Assembly, 1990, B PAN AM HLTH ORG, V24, P606; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Avissar NE, 2000, AM J RESP CRIT CARE, V162, P1342, DOI 10.1164/ajrccm.162.4.9912041; Braback L, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-17; Dellinger B, 2001, CHEM RES TOXICOL, V14, P1371, DOI 10.1021/tx010050x; Dominici F, 2002, AM J EPIDEMIOL, V155, P11, DOI 10.1093/aje/155.1.11; Donaldson K, 2003, FREE RADICAL BIO MED, V34, P1369, DOI 10.1016/S0891-5849(03)00150-3; Ercan H, 2006, J ALLERGY CLIN IMMUN, V118, P1097, DOI 10.1016/j.jaci.2006.08.012; Greenland S, 2000, INT J EPIDEMIOL, V29, P158, DOI 10.1093/ije/29.1.158; Hwang BF, 2010, CHEST, V138, P956, DOI 10.1378/chest.09-2600; Islam T, 2009, THORAX, V64, P197, DOI 10.1136/thx.2008.099366; Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612; Korytina GF, 2005, J MOL MED, V83, P700, DOI 10.1007/s00109-005-0660-6; Lee YL, 2004, CLIN EXP ALLERGY, V34, P1707, DOI 10.1111/j.1365-2222.2004.02099.x; Melen E, 2008, ENVIRON HEALTH PERSP, V116, P1077, DOI 10.1289/ehp.11117; Nel A E, 2001, Curr Opin Pulm Med, V7, P20, DOI 10.1097/00063198-200101000-00004; Ohtoshi T, 1998, J ALLERGY CLIN IMMUN, V101, P778, DOI 10.1016/S0091-6749(98)70307-0; Romieu I, 2006, EUR RESPIR J, V28, P953, DOI 10.1183/09031936.06.00114905; Schroer KT, 2009, J PEDIATR-US, V154, P401, DOI 10.1016/j.jpeds.2008.08.040; See SW, 2007, ENVIRON RES, V103, P317, DOI 10.1016/j.envres.2006.08.012; Tung KY, 2011, CHEST, V139, P839, DOI 10.1378/chest.10-2479; Witte JS, 2000, EPIDEMIOLOGY, V11, P684, DOI 10.1097/00001648-200011000-00012; Yang IA, 2008, THORAX, V63, P555, DOI 10.1136/thx.2007.079426	23	16	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e52715	10.1371/journal.pone.0052715	http://dx.doi.org/10.1371/journal.pone.0052715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23357926	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600008
J	de Haas, B; Cecere, R; Cullen, H; Driver, J; Romei, V				de Haas, Benjamin; Cecere, Roberto; Cullen, Harriet; Driver, Jon; Romei, Vincenzo			The Duration of a Co-Occurring Sound Modulates Visual Detection Performance in Humans	PLOS ONE			English	Article							PERCEPTION; VISION; ENHANCEMENT; INTEGRATION; CORTEX	Background: The duration of sounds can affect the perceived duration of co-occurring visual stimuli. However, it is unclear whether this is limited to amodal processes of duration perception or affects other non-temporal qualities of visual perception. Methodology/Principal Findings: Here, we tested the hypothesis that visual sensitivity - rather than only the perceived duration of visual stimuli - can be affected by the duration of co-occurring sounds. We found that visual detection sensitivity (d') for unimodal stimuli was higher for stimuli of longer duration. Crucially, in a cross-modal condition, we replicated previous unimodal findings, observing that visual sensitivity was shaped by the duration of co-occurring sounds. When short visual stimuli (similar to 24 ms) were accompanied by sounds of matching duration, visual sensitivity was decreased relative to the unimodal visual condition. However, when the same visual stimuli were accompanied by longer auditory stimuli (, 6096 ms), visual sensitivity was increased relative to the performance for similar to 24 ms auditory stimuli. Across participants, this sensitivity enhancement was observed within a critical time window of similar to 60-96 ms. Moreover, the amplitude of this effect correlated with visual sensitivity enhancement found for longer lasting visual stimuli across participants. Conclusions/Significance: Our findings show that the duration of co-occurring sounds affects visual perception; it changes visual sensitivity in a similar way as altering the (actual) duration of the visual stimuli does.	[de Haas, Benjamin; Driver, Jon; Romei, Vincenzo] UCL, Wellcome Trust Ctr Neuroimaging UCL, London, England; [de Haas, Benjamin; Cecere, Roberto; Cullen, Harriet; Driver, Jon; Romei, Vincenzo] UCL, UCL Inst Cognit Neurosci, London, England; [Cecere, Roberto] Univ Bologna, Ctr Studi Ric Neurosci Cognit, Bologna, Italy	University of London; University College London; University of London; University College London; University of Bologna	de Haas, B (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging UCL, London, England.	benjamin.haas.09@ucl.ac.uk; v.romei@ucl.ac.uk	de Haas, Benjamin/E-8400-2012; Romei, Vincenzo/AAT-5755-2021	de Haas, Benjamin/0000-0003-1722-7757; Romei, Vincenzo/0000-0003-1214-2316; Cecere, Roberto/0000-0002-5922-5787	Wellcome Trust; National Institute for Health Research [ACF-2011-21-009] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	BDH, VR and JD were supported by the Wellcome Trust. JD (recently deceased) was a Royal Society Anniversary Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolognini N, 2005, EXP BRAIN RES, V160, P273, DOI 10.1007/s00221-004-2005-z; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; Cappe C, 2010, J NEUROSCI, V30, P12572, DOI 10.1523/JNEUROSCI.1099-10.2010; Chen KM, 2009, ACTA PSYCHOL, V130, P225, DOI 10.1016/j.actpsy.2008.12.008; Chen YC, 2011, SEEING PERCEIVING, V24, P623, DOI 10.1163/187847611X603765; de Haas B, 2012, P BIOL SCI ROYAL SOC; Donovan CL, 2004, BRAIN COGNITION, V56, P1, DOI 10.1016/j.bandc.2004.02.019; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Kim R, 2012, PSYCHOL SCI, V23, P6, DOI 10.1177/0956797611420662; Kleiner M, 2007, PERCEPTION, V36, P14; Klink PC, 2011, ATTEN PERCEPT PSYCHO, V73, P219, DOI 10.3758/s13414-010-0010-9; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Leo F, 2011, EXP BRAIN RES, V213, P193, DOI 10.1007/s00221-011-2742-8; Macmillan N. A., 2004, DETECTION THEORY USE; Macmillan NA, 1997, SPATIAL VISION, V11, P141; Murray M.M., 2012, NEW HDB MULTISENSORY; Nath AR, 2012, NEUROIMAGE, V59, P781, DOI 10.1016/j.neuroimage.2011.07.024; Noesselt T, 2010, J NEUROSCI, V30, P13609, DOI 10.1523/JNEUROSCI.4524-09.2010; Romei V, 2011, FRONTIERS PSYCHOL, V2, P8; Romei V, 2007, J NEUROSCI, V27, P11465, DOI 10.1523/JNEUROSCI.2827-07.2007; Romei V, 2012, CURR BIOL, V22, P807, DOI 10.1016/j.cub.2012.03.025; Romei V, 2009, CURR BIOL, V19, P1799, DOI 10.1016/j.cub.2009.09.027; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Spence C., 2004, CROSSMODAL SPACE CRO; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Vroomen J, 2009, ACTA PSYCHOL, V130, P58, DOI 10.1016/j.actpsy.2008.10.001; Wada Y, 2003, INT J PSYCHOPHYSIOL, V50, P117, DOI 10.1016/S0167-8760(03)00128-4; WALKER JT, 1981, J EXP PSYCHOL HUMAN, V7, P1327, DOI 10.1037/0096-1523.7.6.1327; Wang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-79	38	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54789	10.1371/journal.pone.0054789	http://dx.doi.org/10.1371/journal.pone.0054789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355900	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000314021500127
J	Chou, J; Ito, T; Bishop, D; Otsuka, M; Ben-Nissan, B; Milthorpe, B				Chou, Joshua; Ito, Tomoko; Bishop, David; Otsuka, Makoto; Ben-Nissan, Besim; Milthorpe, Bruce			Controlled Release of Simvastatin from Biomimetic beta-TCP Drug Delivery System	PLOS ONE			English	Article							BONE-FORMATION	Simvastatin have been shown to induce bone formation and there is currently a urgent need to develop an appropriate delivery system to sustain the release of the drug to increase therapeutic efficacy whilst reducing side effects. In this study, a novel drug delivery system for simvastatin by means of hydrothermally converting marine exoskeletons to biocompatible beta-tricalcium phosphate was investigated. Furthermore, the release of simvastatin was controlled by the addition of an outer apatite coating layer. The samples were characterized by x-ray diffraction analysis, fourier transform infrared spectroscopy, scanning electron microscopy and mass spectroscopy confirming the conversion process. The in-vitro dissolution of key chemical compositional elements and the release of simvastatin were measured in simulated body fluid solution showing controlled release with reduction of approximately 25% compared with un-coated samples. This study shows the potential applications of marine structures as a drug delivery system for simvastatin.	[Chou, Joshua] Univ Technol Sydney, Sch Med & Mol Sci, Adv Tissue Regenerat & Drug Delivery Grp, Sydney, NSW 2007, Australia; [Ito, Tomoko; Otsuka, Makoto] Musashino Univ, Pharmaceut Sci Res Inst, Fac Pharm, Nishi Tokyo, Japan; [Bishop, David; Ben-Nissan, Besim] Univ Technol Sydney, Sch Chem & Forens Sci, Sydney, NSW 2007, Australia; [Milthorpe, Bruce] Univ Technol Sydney, Fac Sci, Sydney, NSW 2007, Australia	University of Technology Sydney; University of Technology Sydney; University of Technology Sydney	Chou, J (corresponding author), Univ Technol Sydney, Sch Med & Mol Sci, Adv Tissue Regenerat & Drug Delivery Grp, Sydney, NSW 2007, Australia.	Joshua.chou@uts.edu.au	Milthorpe, Bruce/Z-1153-2019; Milthorpe, Bruce K/A-7014-2008; Bishop, David P/F-2891-2019; Ben-Nissan, Besim/AAR-4445-2020; Chou, Joshua/G-7746-2013	Milthorpe, Bruce/0000-0002-0867-9586; Bishop, David P/0000-0002-6533-4410; Ben-Nissan, Besim/0000-0003-0433-3593; Chou, Joshua/0000-0002-7472-8016	University of Technology Sydney Chancellor Postdoctoral Fellowship; Australia Endeavour Cheung Kuong Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057083, R01AR048756] Funding Source: NIH RePORTER	University of Technology Sydney Chancellor Postdoctoral Fellowship; Australia Endeavour Cheung Kuong Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the University of Technology Sydney Chancellor Postdoctoral Fellowship and the Australia Endeavour Cheung Kuong Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayukawa Y, 2004, CLIN ORAL IMPLAN RES, V404, P343; Du ZB, 2009, CLIN ORAL IMPLAN RES, V20, P145, DOI 10.1111/j.1600-0501.2008.01630.x; Guyton JR, 2006, AM J CARDIOL, V97, p95C, DOI 10.1016/j.amjcard.2005.12.016; Junqueira Juliana C, 2002, J Oral Sci, V44, P117; Kiliccoglu SS, 2007, J TRAUMA, V63, P187, DOI 10.1097/01.TA.0000240974.07999.bc; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Lee YJ, 2008, BIOMATERIALS, V29, P1940, DOI 10.1016/j.biomaterials.2007.12.045; LeGeros RZ, 1996, ADV DENT RES, V10, P252; Maeda T, 2003, ENDOCRINOLOGY, V144, P681, DOI 10.1210/en.2002-220682; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nyan M, 2007, J PHARMACOL SCI, V104, P384, DOI 10.1254/jphs.SC0070184; Pytlik M, 2003, POL J PHARMACOL, V55, P63; Rizzoli R, 2005, J Endocrinol Invest, V28, P50; Skoglund B, 2002, J BONE MINER RES, V17, P2004, DOI 10.1359/jbmr.2002.17.11.2004; Stein D, 2005, J PERIODONTOL, V76, P1861, DOI 10.1902/jop.2005.76.11.1861; Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697; Wong RWK, 2003, BRIT J ORAL MAX SURG, V41, P244, DOI 10.1016/S0266-4356(03)00081-0	17	35	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54676	10.1371/journal.pone.0054676	http://dx.doi.org/10.1371/journal.pone.0054676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349949	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800070
J	Lind, O; Karlsson, S; Kelber, A				Lind, Olle; Karlsson, Sandra; Kelber, Almut			Brightness Discrimination in Budgerigars (Melopsittacus undulatus)	PLOS ONE			English	Article							SPATIAL CONTRAST SENSITIVITY; VISION	Birds have excellent spatial acuity and colour vision compared to other vertebrates while spatial contrast sensitivity is relatively poor for unknown reasons. Contrast sensitivity describes the detection of gratings of varying spatial frequency. It is unclear whether bird brightness discrimination between large uniform fields is poor as well. Here we show that budgerigars (Melopsittacus undulatus) need a Michelson contrast of 0.09 to discriminate between large spatially separated achromatic fields in bright light conditions. This is similar to the peak contrast sensitivity of 10.2 (0.098 Michelson contrast) for achromatic grating stimuli established in earlier studies. The brightness discrimination threshold described in Weber fractions is 0.18, which is modest compared to other vertebrates.	[Lind, Olle; Karlsson, Sandra; Kelber, Almut] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Lind, O (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	olle.lind@biol.lu.se	Chaib, Sandra/G-4671-2016; Kelber, Almut/H-6216-2014	Chaib, Sandra/0000-0001-5098-1634; Kelber, Almut/0000-0003-3937-2808	Royal Physiographic Society in Lund; Royal Swedish Academy of Sciences; Swedish Research Council, Stockholm [2006-4510, 2009-5683]	Royal Physiographic Society in Lund; Royal Swedish Academy of Sciences; Swedish Research Council, Stockholm(Swedish Research Council)	This work was supported by the Royal Physiographic Society in Lund (http://www.fysiografen.se/), the Royal Swedish Academy of Sciences (http://www.kva.se/en/), and the Swedish Research Council, Stockholm (Grant Numbers 2006-4510 and 2009-5683) (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett ATD, 2007, AM NAT, V169, pS1, DOI 10.1086/510163; Coletta NJ, 2003, OPTOMETRY VISION SCI, V80, P50, DOI 10.1097/00006324-200301000-00008; DeValois RL, 1990, SPATIAL VISION; Geisbauer G, 2004, CAN J ZOOL, V82, P660, DOI [10.1139/z04-026, 10.1139/Z04-026]; Ghim MM, 2006, J COMP PHYSIOL A, V192, P523, DOI 10.1007/s00359-005-0090-5; Griebel U, 1997, J EXP BIOL, V200, P1587; Harmening WM, 2007, VISION RES, V47, P2934, DOI 10.1016/j.visres.2007.08.001; Harmening WM, 2009, J VISION, V9, DOI 10.1167/9.7.13; HODOS W, 1985, VISION RES, V25, P1525, DOI 10.1016/0042-6989(85)90231-7; Hodos William, 1993, P63; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; Johnsen S, 2006, J EXP BIOL, V209, P789, DOI 10.1242/jeb.02053; Lind O, 2012, J COMP PHYSIOL A, V198, P69, DOI 10.1007/s00359-011-0689-7; Lind O, 2011, J VISION, V11, DOI 10.1167/11.7.2; Scholtyssek C, 2012, THESIS U ROSTOCK ROS; Scholtyssek C, 2008, VISION RES, V48, P96, DOI 10.1016/j.visres.2007.10.012; Stone CP, 1921, J COMP PSYCHOL, V1, P413, DOI 10.1037/h0072941; VONCAMPENHAUSE C, 1986, NATURWISSENSCHAFTEN, V73, P674; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	19	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54650	10.1371/journal.pone.0054650	http://dx.doi.org/10.1371/journal.pone.0054650			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349946	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800069
J	Sikora, D; Zhang, DJ; Bojic, T; Beeharry, Y; Tanara, A; Pelchat, M				Sikora, Dorota; Zhang, Dajiang; Bojic, Teodora; Beeharry, Yasnee; Tanara, Ali; Pelchat, Martin			Identification of a Binding Site for ASF/SF2 on an RNA Fragment Derived from the Hepatitis delta Virus Genome	PLOS ONE			English	Article							SPLICING FACTOR ASF/SF2; C-TERMINAL DOMAIN; MESSENGER-RNA; POLYMERASE-II; SR PROTEINS; RECOGNITION MOTIF; GENE-EXPRESSION; AMINO-ACIDS; IN-VITRO; B-VIRUS	The hepatitis delta virus (HDV) is a small (similar to 1700 nucleotides) RNA pathogen which encodes only one open reading frame. Consequently, HDV is dependent on host proteins to replicate its RNA genome. Recently, we reported that ASF/SF2 binds directly and specifically to an HDV-derived RNA fragment which has RNA polymerase II promoter activity. Here, we localized the binding site of ASF/SF2 on the HDV RNA fragment by performing binding experiments using purified recombinant ASF/SF2 combined with deletion analysis and site-directed mutagenesis. In addition, we investigated the requirement of ASF/SF2 for HDV RNA replication using RNAi-mediated knock-down of ASF/SF2 in 293 cells replicating HDV RNA. Overall, our results indicate that ASF/SF2 binds to a purine-rich region distant from both the previously published initiation site of HDV mRNA transcription and binding site of RNAP II, and suggest that this protein is not involved in HDV replication in the cellular system used.	[Sikora, Dorota; Zhang, Dajiang; Bojic, Teodora; Beeharry, Yasnee; Tanara, Ali; Pelchat, Martin] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Pelchat, M (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	mpelchat@uottawa.ca	Beeharry, Y./V-3167-2019	Beeharry, Y./0000-0001-9074-3008	Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute of Health Research (CIHR) to M. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahem A, 2008, NUCLEIC ACIDS RES, V36, P5201, DOI 10.1093/nar/gkn501; Allain FHT, 1996, NATURE, V380, P646, DOI 10.1038/380646a0; Beard MR, 1996, J VIROL, V70, P4986, DOI 10.1128/JVI.70.8.4986-4995.1996; Benzaghou I, 2006, FEBS LETT, V580, P867, DOI 10.1016/j.febslet.2006.01.006; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Bougie I, 2004, BIOCHEM J, V384, P411, DOI 10.1042/BJ20041112; Bougie I, 2007, YEAST, V24, P431, DOI 10.1002/yea.1482; BRUN F, 1975, BIOCHEMISTRY-US, V14, P558, DOI 10.1021/bi00674a015; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Casey JL, 2012, CURR TOP MICROBIOL, V353, P123, DOI 10.1007/82_2011_146; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; Chang JH, 2005, J VIROL, V79, P8182, DOI 10.1128/JVI.79.13.8182-8188.2005; Chang JH, 2008, J VIROL, V82, P1118, DOI 10.1128/JVI.01758-07; CHAO M, 1990, J VIROL, V64, P5066, DOI 10.1128/JVI.64.10.5066-5069.1990; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; Flowers S, 2003, BIOCHEMISTRY-US, V42, P1910, DOI 10.1021/bi025992v; FU TB, 1993, J VIROL, V67, P6965, DOI 10.1128/JVI.67.12.6965-6972.1993; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Greco-Stewart V, 2010, VIRUSES-BASEL, V2, P189, DOI 10.3390/v2010189; Greco-Stewart VS, 2007, VIROLOGY, V357, P68, DOI 10.1016/j.virol.2006.08.010; Greco-Stewart VS, 2009, VIROLOGY, V386, P12, DOI 10.1016/j.virol.2009.02.007; Gudima S, 1999, J VIROL, V73, P6533, DOI 10.1128/JVI.73.8.6533-6539.1999; Gudima S, 2000, J VIROL, V74, P7204, DOI 10.1128/JVI.74.16.7204-7210.2000; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; JESSEN TH, 1991, EMBO J, V10, P3447, DOI 10.1002/j.1460-2075.1991.tb04909.x; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; KUO MYP, 1989, J VIROL, V63, P1945, DOI 10.1128/JVI.63.5.1945-1950.1989; LEE CZ, 1995, J VIROL, V69, P5332, DOI 10.1128/JVI.69.9.5332-5336.1995; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Millhouse S, 2005, MOL CELL BIOL, V25, P533, DOI 10.1128/MCB.25.2.533-544.2005; Misteli T, 1999, CURR BIOL, V9, pR198, DOI 10.1016/S0960-9822(99)80128-6; Moraleda G, 2001, J VIROL, V75, P10161, DOI 10.1128/JVI.75.21.10161-10169.2001; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Petrik J, 1999, J GEN VIROL, V80, P3109, DOI 10.1099/0022-1317-80-12-3109; RIZZETTO M, 1977, GUT, V18, P997, DOI 10.1136/gut.18.12.997; Rocheleau L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-24; RYU WS, 1992, J VIROL, V66, P2310, DOI 10.1128/JVI.66.4.2310-2315.1992; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Showalter SA, 2004, J MOL BIOL, V335, P465, DOI 10.1016/j.jmb.2003.10.055; Sikora D, 2009, VIROLOGY, V390, P71, DOI 10.1016/j.virol.2009.04.022; Sinha R, 2010, MOL CELL BIOL, V30, P2762, DOI 10.1128/MCB.01270-09; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Souliere MF, 2008, NUCLEIC ACIDS RES, V36, P451, DOI 10.1093/nar/gkm1067; SUREAU C, 1992, J VIROL, V66, P1241, DOI 10.1128/JVI.66.2.1241-1245.1992; Taylor JM, 2009, ADV VIRUS RES, V74, P103, DOI 10.1016/S0065-3527(09)74003-5; TEALE FWJ, 1957, BIOCHEM J, V65, P476, DOI 10.1042/bj0650476; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tintaru AM, 2007, EMBO REP, V8, P756, DOI 10.1038/sj.embor.7401031; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1075, P181, DOI 10.1016/0304-4165(91)90249-G; Wang X, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S8; Wu TT, 1997, J VIROL, V71, P5408, DOI 10.1128/JVI.71.7.5408-5414.1997; Yamaguchi Y, 2001, SCIENCE, V293, P124, DOI 10.1126/science.1057925; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799	69	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54832	10.1371/journal.pone.0054832	http://dx.doi.org/10.1371/journal.pone.0054832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349975	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872800078
J	Tikkanen, O; Haakana, P; Pesola, AJ; Hakkinen, K; Rantalainen, T; Havu, M; Pullinen, T; Finni, T				Tikkanen, Olli; Haakana, Piia; Pesola, Arto J.; Hakkinen, Keijo; Rantalainen, Timo; Havu, Marko; Pullinen, Teemu; Finni, Taija			Muscle Activity and Inactivity Periods during Normal Daily Life	PLOS ONE			English	Article							TIME PHYSICAL-ACTIVITY; TYPE-2 DIABETES-MELLITUS; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; SEDENTARY BEHAVIORS; ENERGY-EXPENDITURE; SEASONAL-VARIATION; ADULTS; RISK; OBESITY	Recent findings suggest that not only the lack of physical activity, but also prolonged times of sedentary behaviour where major locomotor muscles are inactive, significantly increase the risk of chronic diseases. The purpose of this study was to provide details of quadriceps and hamstring muscle inactivity and activity during normal daily life of ordinary people. Eighty-four volunteers (44 females, 40 males, 44.1 +/- 17.3 years, 172.3 +/- 6.1 cm, 70.1 +/- 10.2 kg) were measured during normal daily life using shorts measuring muscle electromyographic (EMG) activity (recording time 11.3 +/- 2.0 hours). EMG was normalized to isometric MVC (EMG(MVC)) during knee flexion and extension, and inactivity threshold of each muscle group was defined as 90% of EMG activity during standing (2.5 +/- 1.7% of EMG(MVC)). During normal daily life the average EMG amplitude was 4.0 +/- 2.6% and average activity burst amplitude was 5.8 +/- 3.4% of EMG(MVC) (mean duration of 1.4 +/- 1.4 s) which is below the EMG level required for walking (5 km/h corresponding to EMG level of about 10% of EMG(MVC)). Using the proposed individual inactivity threshold, thigh muscles were inactive 67.5 +/- 11.9% of the total recording time and the longest inactivity periods lasted for 13.9 +/- 7.3 min (2.5-38.3 min). Women had more activity bursts and spent more time at intensities above 40% EMG(MVC) than men (p < 0.05). In conclusion, during normal daily life the locomotor muscles are inactive about 7.5 hours, and only a small fraction of muscle's maximal voluntary activation capacity is used averaging only 4% of the maximal recruitment of the thigh muscles. Some daily non-exercise activities such as stair climbing produce much higher muscle activity levels than brisk walking, and replacing sitting by standing can considerably increase cumulative daily muscle activity.	[Tikkanen, Olli; Haakana, Piia; Pesola, Arto J.; Hakkinen, Keijo; Havu, Marko; Pullinen, Teemu; Finni, Taija] Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, SF-40100 Jyvaskyla, Finland; [Rantalainen, Timo] Univ Jyvaskyla, Dept Hlth Sci, SF-40100 Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Tikkanen, O (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, SF-40100 Jyvaskyla, Finland.	olli.tikkanen@megaemg.com	Finni, Taija/F-6544-2014; Havu, Marko/AAJ-9720-2020; Pesola, Arto/AAF-2800-2020; Finni, Taija/AAV-9073-2020; Havu, Marko/Q-6259-2016	Finni, Taija/0000-0002-7697-2813; Havu, Marko/0000-0002-4109-6593; Pesola, Arto/0000-0002-2984-9847; Havu, Marko/0000-0002-4109-6593; Haakana, Piia/0000-0003-0005-3834; Rantalainen, Timo/0000-0001-6977-4782	Academy of Finland [128643]; Ministry of Education [42/627/2010]; Urheiluopistosaatio	Academy of Finland(Academy of Finland); Ministry of Education; Urheiluopistosaatio	This study was funded by Academy of Finland (# 128643/Finni), Ministry of Education (42/627/2010/Finni) and Urheiluopistosaatio (Tikkanen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Buchowski MS, 2009, J PHYS ACT HEALTH, V6, P252, DOI 10.1123/jpah.6.2.252; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; De Luca CJ, 2010, J NEUROPHYSIOL, V104, P1034, DOI 10.1152/jn.01018.2009; Desmedt J, 1977, J PHYSL, V234, P723; Dunstan DW, 2007, DIABETES CARE, V30, P516, DOI 10.2337/dc06-1996; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Dunstan DW, 2004, DIABETES CARE, V27, P2603, DOI 10.2337/diacare.27.11.2603; Edgerton VR, 2001, J EXP BIOL, V204, P3217; Finni T, 2007, PHYSIOL MEAS, V28, P1405, DOI 10.1088/0967-3334/28/11/007; Finni T, 2014, SCAND J MED SCI SPOR, V24, P211, DOI 10.1111/j.1600-0838.2012.01456.x; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hirvensalo M, 2011, SCAND J PUBLIC HEALT, V39, P669, DOI 10.1177/1403494811420324; Howe TE, 2009, J ELECTROMYOGR KINES, V19, pE78, DOI 10.1016/j.jelekin.2007.10.005; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Kern DS, 2001, J APPL PHYSIOL, V91, P2224, DOI 10.1152/jappl.2001.91.5.2224; Klein CS, 2010, J APPL PHYSIOL, V108, P655, DOI 10.1152/japplphysiol.00757.2009; Kraemer WJ HK, 2002, STRENGTH TRAINING SP; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Masakado Yoshihisa, 1994, Keio Journal of Medicine, V43, P137; Matthews CE, 2001, AM J EPIDEMIOL, V153, P172, DOI 10.1093/aje/153.2.172; MONSTER AW, 1978, SCIENCE, V200, P314, DOI 10.1126/science.635587; Ochia RS, 2007, J ELECTROMYOGR KINES, V17, P365, DOI 10.1016/j.jelekin.2006.01.003; Pivarnik JM, 2003, MED SCI SPORT EXER, V35, P1004, DOI 10.1249/01.MSS.0000069747.55950.B1; Powell KE, 2011, ANNU REV PUBL HEALTH, V32, P349, DOI 10.1146/annurev-publhealth-031210-101151; Rassier DE, 1999, J APPL PHYSIOL, V86, P1445, DOI 10.1152/jappl.1999.86.5.1445; Scilingo EP, 2005, IEEE T INF TECHNOL B, V9, P345, DOI 10.1109/TITB.2005.854506; Stephens BR, 2011, METABOLISM, V60, P941, DOI 10.1016/j.metabol.2010.08.014; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2	34	85	85	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e52228	10.1371/journal.pone.0052228	http://dx.doi.org/10.1371/journal.pone.0052228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349681	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800004
J	Bastin, P; Bastard, M; Rossel, L; Melgar, P; Jones, A; Antierens, A				Bastin, Pierre; Bastard, Mathieu; Rossel, Ludovic; Melgar, Pablo; Jones, Alison; Antierens, Annick			Description and Predictive Factors of Individual Outcomes in a Refugee Camp Based Mental Health Intervention (Beirut, Lebanon)	PLOS ONE			English	Article								Background: There is little evidence on the effectiveness of services for the care of people with mental disorders among refugee populations. Medecins sans Frontieres (MSF) has established a mental health centre in a mixed urban-refugee population in Beirut to respond to the significant burden of mental health problems. Patients received comprehensive care through a multidisciplinary team. A cohort of people with common and severe mental disorders has been analysed between December 2008 and June 2011 to evaluate individual outcomes of treatment in terms of functionality. Methods: All patients diagnosed with mental disorders were included in the study. The Global Assessment of Functioning (GAF) and the Self Reporting Questionnaire-20 items (SRQ 20) were used as tools for baseline assessment, monitoring and evaluation of patients. Predictors of evolution of SRQ20 and GAF over visits were explored using a linear mixed model. Results: Up to June 2011, 1144 patients were followed, 63.7% of them Lebanese, 31.8% Palestinians and 1.2% Iraqis. Females represented 64.2% of the patient population. Mean age was 39.2 years (28.5-46.5). The most frequent primary diagnoses were depressive disorders (28.8%), anxiety disorders (15.6%) and psychosis (11.5%). A lower baseline SRQ20 score/higher baseline GAF score (indicators of severity), being diagnosed with anxiety (compared to being diagnosed with depression or psychosis) and a higher level of education were associated with better outcomes. Discussion: In this MSF program, we observed a significant decrease of SRQ20 individual scores and a significant increase of individual GAF scores. This corresponded to an improvement in the functionality of our patients. Analysis of the predictors of this positive evolution indicates that we need to adapt our model for the more severe and less educated patients. It also makes us reflect on the length of the individual follow-up. Further research could include a qualitative evaluation of the intervention. Results of this study have been presented at the World Congress of the World Federation for Mental Health in Cape Town, October 2011.	[Bastin, Pierre; Rossel, Ludovic; Melgar, Pablo; Jones, Alison; Antierens, Annick] Med Sans Frontieres, Geneva, Switzerland; [Bastard, Mathieu] Epicentre, Paris, France	Doctors Without Borders	Bastin, P (corresponding author), Med Sans Frontieres, Geneva, Switzerland.	pierre_bastin75@hotmail.com						[Anonymous], 2000, DIAGN STAT MAN MENT; [Anonymous], 2001, WORLD HLTH REP MENT; Hijazi Z, 2011, LEBANON INTERVENTION, V9, P265; Karam EG, 2006, LANCET, V367, P1000, DOI 10.1016/S0140-6736(06)68427-4; McDougal L, 2011, DISASTERS, V35, P87, DOI 10.1111/j.1467-7717.2010.01194.x; Medecins sans Frontieres Operational Centre of Amsterdam, 2011, AN ROUT PROGR DAT MS; Medecins sans Frontieres Operational Centre of Geneva, 2008, ASS REP LEB NOV 2007; Medecins sans Frontieres Operational Centre of Geneva, 2012, MENT HLTH POL; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Tol WA, GLOBAL MENTAL HLTH P; WHO, 2009, IMPR HLTH SYST SERV; WHO, 2022, GLOB BURD DIS 2004 U; World Health Organization, 1994, USERS GUIDE SELF REP; World Health Organization (WHO), 2010, MENT HLTH DEV TARG P	14	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54107	10.1371/journal.pone.0054107	http://dx.doi.org/10.1371/journal.pone.0054107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	073JI	23349795	gold, Green Submitted, Green Published			2022-12-27	WOS:000313738900039
J	Pericacho, M; Velasco, S; Prieto, M; Llano, E; Lopez-Novoa, JM; Rodriguez-Barbero, A				Pericacho, Miguel; Velasco, Soraya; Prieto, Marta; Llano, Elena; Lopez-Novoa, Jose M.; Rodriguez-Barbero, Alicia			Endoglin Haploinsufficiency Promotes Fibroblast Accumulation during Wound Healing through Akt Activation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; UP-REGULATION; TRANSFORMING GROWTH-FACTOR-BETA-1; CELLULAR-RESPONSES; BINDING PROTEIN; MESANGIAL CELLS; EXPRESSION; RECEPTOR; ANGIOGENESIS; FIBROSIS	Accurate regulation of dermal fibroblast function plays a crucial role in wound healing. Many fibrotic diseases are characterized by a failure to conclude normal tissue repair and the persistence of fibroblasts inside lesions. In the present study we demonstrate that endoglin haploinsufficiency promotes fibroblast accumulation during wound healing. Moreover, scars from endoglin-heterozygous (Eng(+/-)) mice show persisting fibroblasts 12 days after wounding, which could lead to a fibrotic scar. Endoglin haploinsufficiency results in increased proliferation and migration of primary cultured murine dermal fibroblasts (MDFs). Moreover, Eng(+/-) MDF have diminished responses to apoptotic signals compared with control cells. Altogether, these modifications could explain the augmented presence of fibroblasts in Eng(+/-) mice wounds. We demonstrate that endoglin expression regulates Akt phosphorylation and that PI3K inhibition abolishes the differences in proliferation between endoglin haploinsufficient and control cells. Finally, persistent fibroblasts in Eng(+/-) mice wound co-localize with a greater degree of Akt phosphorylation. Thus, endoglin haploinsufficiency seems to promote fibroblast accumulation during wound healing through the activation of the PI3K/Akt pathway. These studies open new non-Smad signaling pathway for endoglin regulating fibroblast cell function during wound healing, as new therapeutic opportunities for the treatment of fibrotic wounds.	[Pericacho, Miguel; Velasco, Soraya; Prieto, Marta; Llano, Elena; Lopez-Novoa, Jose M.; Rodriguez-Barbero, Alicia] Univ Salamanca, Renal & Cardiovasc Physiopathol Unit, Inst Reina Sofia Invest Nefrol, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain; [Lopez-Novoa, Jose M.; Rodriguez-Barbero, Alicia] Biomed Res Inst Salamanca, Salamanca, Spain	University of Salamanca	Rodriguez-Barbero, A (corresponding author), Univ Salamanca, Renal & Cardiovasc Physiopathol Unit, Inst Reina Sofia Invest Nefrol, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain.	barberoa@usal.es	Pericacho, Miguel/H-1786-2016; Rodriguez-Barbero, Alicia/A-7583-2017; Lopez-Novoa, Jose M/A-3672-2008; Llano, Elena/K-1723-2014; Llano, Elena/AAS-5517-2021; Prieto, Marta/A-5445-2016	Pericacho, Miguel/0000-0003-0226-482X; Rodriguez-Barbero, Alicia/0000-0002-6774-7147; Llano, Elena/0000-0002-2626-5723; Llano, Elena/0000-0002-2626-5723; Lopez-Novoa, Jose M./0000-0002-6211-7269; Pendas, Alberto M/0000-0001-9264-3721; Prieto, Marta/0000-0002-2540-4461	Junta de Castilla y Leon [SA052A06, SA029A09, SA001/C05]; Ministerio de Ciencia e Innovacion [BFU2004-00285/BFI, SAF2007-63893]; Instituto de Salud Carlos III [RETIC RedInRen RD/0016]; Spanish Ministerio de Educacion y Ciencia	Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by grants from the Junta de Castilla y Leon (SA052A06 and SA029A09) to ARB and SA001/C05 to JMLN, and Ministerio de Ciencia e Innovacion (BFU2004-00285/BFI, and SAF2007-63893 to JMLN) and the Instituto de Salud Carlos III, (RETIC RedInRen RD/0016). MP was a holder of a fellowship from the Junta de Castilla y Leon, and SV was a fellowship holder of the Spanish Ministerio de Educacion y Ciencia. The Renal and Cardiovascular Physiology Unit is an Excellence Research Group awarded by Junta de Castilla y Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Burke JP, 2010, BRIT J SURG, V97, P892, DOI 10.1002/bjs.6996; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Clemente M, 2006, J VIRAL HEPATITIS, V13, P625, DOI 10.1111/j.1365-2893.2006.00733.x; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Cudmore MJ, 2012, EUR HEART J, V33, P1150, DOI 10.1093/eurheartj/ehr065; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Diez-Marques L, 2002, BBA-MOL BASIS DIS, V1587, P36, DOI 10.1016/S0925-4439(02)00051-0; Docherty NG, 2006, NEPHROL DIAL TRANSPL, V21, P2106, DOI 10.1093/ndt/gfl179; Duwel A, 2007, TUMOR BIOL, V28, P1, DOI 10.1159/000097040; Feutz AC, 2008, J CELL SCI, V121, P1435, DOI 10.1242/jcs.018689; Fujita D, 2010, J ENDOCRINOL, V206, P131, DOI 10.1677/JOE-10-0027; GE AZ, 1994, GENE, V138, P201, DOI 10.1016/0378-1119(94)90808-7; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Institute of Laboratory Animal Resources (U.S.), 1996, GUID CAR US LAB AN, Vxii; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Jerkic M, 2006, CIRC RES, V99, P248, DOI 10.1161/01.RES.0000236755.98627.69; Kapoor M, 2008, J CLIN INVEST, V118, P3279, DOI 10.1172/JCI35381; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Leask A, 2002, ARTHRITIS RHEUM-US, V46, P1857, DOI 10.1002/art.10333; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Lee NY, 2012, MOL BIOL CELL; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Meurer SK, 2011, CELL SIGNAL, V23, P683, DOI 10.1016/j.cellsig.2010.12.002; Morris E, 2011, J CELL PHYSIOL, V226, P3340, DOI 10.1002/jcp.22690; Mouta-Bellum C, 2009, DEV DYNAM, V238, P2670, DOI 10.1002/dvdy.22078; Obreo J, 2004, CELL PHYSIOL BIOCHEM, V14, P301, DOI 10.1159/000080340; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Perez-Gomez E, 2005, ONCOGENE, V24, P4450, DOI 10.1038/sj.onc.1208644; Perez-Gomez E, 2007, CANCER RES, V67, P10268, DOI 10.1158/0008-5472.CAN-07-1348; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Robledo MM, 1998, BRIT J HAEMATOL, V102, P804, DOI 10.1046/j.1365-2141.1998.00820.x; Rodriguez-Barbero A, 2001, BIOCHEM BIOPH RES CO, V282, P142, DOI 10.1006/bbrc.2001.4526; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Rodriguez-Pena A, 2001, NEPHROL DIAL TRANSPL, V16, P34, DOI 10.1093/ndt/16.suppl_1.34; Rodriguez-Pena A, 2002, HYPERTENSION, V40, P713, DOI 10.1161/01.HYP.0000037429.73954.27; RoyChaudhury P, 1997, EXP NEPHROL, V5, P55; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scharpfenecker M, 2009, RADIOTHER ONCOL, V92, P484, DOI 10.1016/j.radonc.2009.06.013; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Shyu KG, 2010, EUR J HEART FAIL, V12, P219, DOI 10.1093/eurjhf/hfq011; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Subramaniam V, 2010, ANTI-CANCER DRUG, V21, P351, DOI 10.1097/CAD.0b013e328334992c; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Torsney E, 2002, INFLAMM RES, V51, P464, DOI 10.1007/PL00012413; Valluru M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00089; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Velasco S, 2008, J CELL SCI, V121, P913, DOI 10.1242/jcs.023283; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241	72	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54687	10.1371/journal.pone.0054687	http://dx.doi.org/10.1371/journal.pone.0054687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349951	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900083
J	Su, D; Cheng, Y; Liu, M; Liu, DZ; Cui, H; Zhang, BL; Zhou, SY; Yang, TH; Mei, QB				Su, Dan; Cheng, Ying; Liu, Miao; Liu, Daozhou; Cui, Han; Zhang, Bangle; Zhou, Siyuan; Yang, Tiehong; Mei, Qibing			Comparision of Piceid and Resveratrol in Antioxidation and Antiproliferation Activities In Vitro	PLOS ONE			English	Article							BREAST-CANCER CELLS; TRANS-RESVERATROL; OXIDATIVE STRESS; GROWTH-INHIBITION; WINE POLYPHENOLS; S-PHASE; BIOAVAILABILITY; METABOLISM; APOPTOSIS; ABSORPTION	Background: The clinic therapeutic effect of resveratrol is limited due to its low oral bioavailability. Piceid, a precursor of resveratrol, is the most abundant form of resveratrol in nature. A number of studies have hypothesized that piceid may have the same bioactivities like those of resveratrol. The aim of this work is to compare piceid with resveratrol in antioxidation and antiproliferation activities in vitro. Methods: The antioxidative effects of resveratrol and piceid were evaluated by phenanthroline-Fe2+ method and H2O2-induced oxidative injury cell model. The antiproliferation effects were determined by MTT method in human liver tumor HepG2 cells, human breast cancer MDA-MB-231 cells and MCF-7 cells. The effects of resveratrol and piceid on the cell cycle and the apoptosis were evaluated by flow cytometry. Additionally, the uptake profiles of resveratrol and piceid in cancer cells were observed using fluorescence microscopy and clarified by LC-MS/MS. Conclusion: Piceid exhibited higher scavenging activity against hydroxyl radicals than resveratrol in vitro. Resveratrol showed a significant protective effect against H2O2-induced cell damage. What is more, resveratrol had biphasic effects on tumor cells. Resveratrol and piceid only showed significant cytotoxicity on tumor cells at high concentration (>= 50 mu mol/L), while low concentration of resveratrol (<30 mu mol/L) increased the cell viability. The principal effect of resveratrol and piceid on the viability of tumor cells was caused by the cell cycle arrest, while the effect on apoptosis was relatively minor. The reason that piceid showed lower biological activity than resveratrol at the same concentration was probably because piceid was more difficult in being uptaken by cells.	[Su, Dan; Cheng, Ying; Liu, Miao; Liu, Daozhou; Cui, Han; Zhang, Bangle; Zhou, Siyuan] Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China; [Yang, Tiehong; Mei, Qibing] Fourth Mil Med Univ, Sch Pharm, Natl Key Lab Gastrointestinal Pharmacol Chinese M, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhou, SY (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China.	zhousy@fmmu.edu.cn; yangziyi@fmmu.edu.cn; qbmei@fmmu.edu.cn	su, dan/GYJ-1940-2022	Zhang, Bang-Le/0000-0001-9008-5391; Liu, Miao/0000-0002-7975-6702	Collaborative Innovation Center for Chinese Medicine in Qinba Mountains; National Nature Science Foundation [81072671]	Collaborative Innovation Center for Chinese Medicine in Qinba Mountains; National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported in part by Collaborative Innovation Center for Chinese Medicine in Qinba Mountains and National Nature Science Foundation (NO.81072671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Alfaras I, 2010, J AGR FOOD CHEM, V58, P4523, DOI 10.1021/jf9042858; Alkhalaf M, 2007, EUR J CANCER PREV, V16, P334, DOI 10.1097/01.cej.0000228413.06471.4c; Appeldoorn MM, 2009, J AGR FOOD CHEM, V57, P7693, DOI 10.1021/jf901381x; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Brohan M, 2011, J AGR FOOD CHEM, V59, P4088, DOI 10.1021/jf1047755; Chen Liang-Wei, 2007, CNS & Neurological Disorders-Drug Targets, V6, P273; CHUNG MI, 1992, PLANTA MED, V58, P274, DOI 10.1055/s-2006-961453; Das Samarjit, 2007, Recent Pat Cardiovasc Drug Discov, V2, P133; de la Monte SM, 2000, LAB INVEST, V80, P1323, DOI 10.1038/labinvest.3780140; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Delmas D, 2006, CURR DRUG TARGETS, V7, P423, DOI 10.2174/138945006776359331; Delmas D, 2011, MOL NUTR FOOD RES, V55, P1142, DOI 10.1002/mnfr.201100065; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; Esterbauer H, 1996, REV PHYSIOL BIOCH P, V127, P31, DOI 10.1007/BFb0048264; Goldberg DA, 2003, CLIN BIOCHEM, V36, P79, DOI 10.1016/S0009-9120(02)00397-1; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kaldas MI, 2003, J PHARM PHARMACOL, V55, P307, DOI 10.1211/002235702612; Kuwajerwala N, 2002, CANCER RES, V62, P2488; Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013; Lancon A, 2004, BIOCHEM BIOPH RES CO, V316, P1132, DOI 10.1016/j.bbrc.2004.02.164; Lancon A, 2007, DRUG METAB DISPOS, V35, P699, DOI 10.1124/dmd.106.013664; Lanzilli G, 2012, INFLAMMATION, V35, P240, DOI 10.1007/s10753-011-9310-z; Lee KW, 2006, MECH AGEING DEV, V127, P424, DOI 10.1016/j.mad.2006.01.021; Maeda R, 2008, HYPERTENS RES, V31, P141, DOI 10.1291/hypres.31.141; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Martowicz A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-501; Ming J, 1996, PROG BIOCHEM BIOPHYS, V23, P553; Mukherjee S, 2010, DOSE-RESPONSE, V8, P478, DOI 10.2203/dose-response.09-015.Mukherjee; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Orsini F, 1997, J NAT PROD, V60, P1082, DOI 10.1021/np970069t; Osmond GW, 2012, J SURG RES, V172, P109, DOI 10.1016/j.jss.2010.07.033; Osmond GW, 2012, J SURG RES; Paulo M, 2009, MENOPAUSE, V16, P539, DOI 10.1097/gme.0b013e31818d6349; Pintea A, 2011, J OCUL PHARMACOL TH, V27, P315, DOI 10.1089/jop.2010.0144; Pozo-Guisado E, 2005, INT J CANCER, V115, P74, DOI 10.1002/ijc.20856; Rathel TR, 2007, J HYPERTENS, V25, P541, DOI 10.1097/HJH.0b013e328013e805; Regev-Shoshani G, 2003, BIOCHEM J, V374, P157, DOI 10.1042/BJ20030141; Russo GL, 2007, BIOCHEM PHARMACOL, V74, P533, DOI 10.1016/j.bcp.2007.02.014; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Soleas GJ, 2001, CLIN BIOCHEM, V34, P415, DOI 10.1016/S0009-9120(01)00246-6; Stocco B, 2012, MATURITAS, V72, P72, DOI 10.1016/j.maturitas.2012.02.004; SX L, 2009, CHINESE TRADITIONAL, V3, P469; Szende B, 2000, EXP MOL MED, V32, P88, DOI 10.1038/emm.2000.16; van de Wetering K, 2009, MOL PHARMACOL, V75, P876, DOI 10.1124/mol.108.052019; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; Wang YC, 2011, J NEUROL SCI, V304, P29, DOI 10.1016/j.jns.2011.02.025; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P472, DOI 10.1002/mnfr.200500010; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P482, DOI 10.1002/mnfr.200500003; Zhai L, 2011, PHARMACOL REP, V63, P1469, DOI 10.1016/S1734-1140(11)70711-3; Zhou SY, 2009, J AGR FOOD CHEM, V57, P4572, DOI 10.1021/jf803948g	57	109	110	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54505	10.1371/journal.pone.0054505	http://dx.doi.org/10.1371/journal.pone.0054505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342161	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700119
J	Tang, J; Pecka, JL; Fritzsch, B; Beisel, KW; He, DZZ				Tang, Jie; Pecka, Jason L.; Fritzsch, Bernd; Beisel, Kirk W.; He, David Z. Z.			Lizard and Frog Prestin: Evolutionary Insight into Functional Changes	PLOS ONE			English	Article							OUTER HAIR CELL; SPONTANEOUS OTOACOUSTIC EMISSIONS; MOTOR PROTEIN; ANION TRANSPORTER; ECHOLOCATING BATS; CHARGE MOVEMENT; BOBTAIL LIZARD; ELECTROMOTILITY; SENSITIVITY; ZEBRAFISH	The plasma membrane of mammalian cochlear outer hair cells contains prestin, a unique motor protein. Prestin is the fifth member of the solute carrier protein 26A family. Orthologs of prestin are also found in the ear of non-mammalian vertebrates such as zebrafish and chicken. However, these orthologs are electrogenic anion exchangers/transporters with no motor function. Amphibian and reptilian lineages represent phylogenic branches in the evolution of tetrapods and subsequent amniotes. Comparison of the peptide sequences and functional properties of these prestin orthologs offer new insights into prestin evolution. With the recent availability of the lizard and frog genome sequences, we examined amino acid sequence and function of lizard and frog prestins to determine how they are functionally and structurally different from prestins of mammals and other non-mammals. Somatic motility, voltage-dependent nonlinear capacitance (NLC), the two hallmarks of prestin function, and transport capability were measured in transfected human embryonic kidney cells using voltage-clamp and radioisotope techniques. We demonstrated that while the transport capability of lizard and frog prestin was compatible to that of chicken prestin, the NLC of lizard prestin was more robust than that of chicken's and was close to that of platypus. However, unlike platypus prestin which has acquired motor capability, lizard or frog prestin did not demonstrate motor capability. Lizard and frog prestins do not possess the same 11-amino-acid motif that is likely the structural adaptation for motor function in mammals. Thus, lizard and frog prestins appear to be functionally more advanced than that of chicken prestin, although motor capability is not yet acquired.	[Tang, Jie; Pecka, Jason L.; Beisel, Kirk W.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Tang, Jie] So Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou, Guangdong, Peoples R China; [Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	Creighton University; Southern Medical University - China; University of Iowa	Beisel, KW (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	beisel@creighton.edu; hed@creighton.edu	Tang, Jie/GNW-2318-2022	He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Tang, Jie/0000-0001-7882-4462; Fritzsch, Bernd/0000-0002-4882-8398	National Institutes of Health [R01 DC008649, R01 DC004696]; NIH from the NCRR [2P20 RR 18788]; NCRR, NIH [C06 RR17417-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417, P20RR018788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008649, R01DC004696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the NCRR; NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work has been supported by the National Institutes of Health grants R01 DC008649 to KB and R01 DC004696 to DH. JT was supported by the NIH grant 2P20 RR 18788 from the NCRR. The Integrated Biological Imaging Facility, supported by the Creighton University School of Medicine, was constructed with support from C06 Grant RR17417-01 from the NCRR, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Ashmore J. F., 1989, COCHLEAR MECH, P107; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; Elgoyhen AB, 2011, HEARING RES, V273, P100, DOI 10.1016/j.heares.2009.12.028; Bergevin C, 2008, J COMP PHYSIOL A, V194, P665, DOI 10.1007/s00359-008-0338-y; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dossena S, 2009, J MOL ENDOCRINOL, V43, P93, DOI 10.1677/JME-08-0175; EVANS BN, 1991, HEARING RES, V52, P288, DOI 10.1016/0378-5955(91)90019-6; Franchini LF, 2006, MOL PHYLOGENET EVOL, V41, P622, DOI 10.1016/j.ympev.2006.05.042; He DZZ, 2006, J MEMBRANE BIOL, V209, P119, DOI 10.1007/s00232-005-0833-9; He DZZ, 2003, J PHYSIOL-LONDON, V546, P511, DOI 10.1113/jphysiol.2002.026070; He DZZ, 1997, J NEUROSCI, V17, P3634; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; Homma K, 2011, J BIOL CHEM, V286, P2297, DOI 10.1074/jbc.M110.185694; Jia SP, 2005, NAT NEUROSCI, V8, P1028, DOI 10.1038/nn1509; KOPPL C, 1994, HEARING RES, V72, P159, DOI 10.1016/0378-5955(94)90215-1; KOPPL C, 1993, HEARING RES, V71, P157, DOI 10.1016/0378-5955(93)90031-U; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Liu Z, 2012, MOL BIOL EVOL, V29, P2187, DOI 10.1093/molbev/mss087; Manley GA, 2001, P NATL ACAD SCI USA, V98, P2826, DOI 10.1073/pnas.041604998; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Manley GA, 2011, HEARING RES, V273, P1, DOI 10.1016/j.heares.2011.01.005; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Muallem D, 2006, BIOPHYS J, V90, P4035, DOI 10.1529/biophysj.105.073254; Okoruwa OE, 2008, EVOL DEV, V10, P300, DOI 10.1111/j.1525-142X.2008.00239.x; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; SANTOS-SACCHI J, 1989, J NEUROSCI, V9, P2954; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Tan XD, 2012, J CELL SCI, V125, P1039, DOI 10.1242/jcs.097337; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Tang J, 2011, J BIOL CHEM, V286, P31014, DOI 10.1074/jbc.M111.259564; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDIJK P, 1987, J ACOUST SOC AM, V82, P2147, DOI 10.1121/1.395660; vanDijk P, 1996, HEARING RES, V101, P102, DOI 10.1016/S0378-5955(96)00140-2; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2005, J CELL SCI, V118, P2987, DOI 10.1242/jcs.02431; Zheng J, 2002, AUDIOL NEURO-OTOL, V7, P9, DOI 10.1159/000046855	51	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54388	10.1371/journal.pone.0054388	http://dx.doi.org/10.1371/journal.pone.0054388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342145	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700110
J	Wang, Y; Yang, J; Li, HS; Wang, X; Zhu, LL; Fan, M; Wang, XM				Wang, Yue; Yang, Jian; Li, Haisheng; Wang, Xuan; Zhu, Lingling; Fan, Ming; Wang, Xiaomin			Hypoxia Promotes Dopaminergic Differentiation of Mesenchymal Stem Cells and Shows Benefits for Transplantation in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							NEURAL PRECURSOR CELLS; P38 MAP KINASE; ACTIVATED PROTEIN-KINASE; INDUCIBLE FACTOR 1-ALPHA; MARROW STROMAL CELLS; BONE-MARROW; NEURONAL DIFFERENTIATION; EFFICIENT GENERATION; SIGNALING PATHWAYS; PROGENITOR CELLS	Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into dopaminergic (DAergic) neurons, which is one of the major cell types damaged in Parkinson's disease (PD). For this reason, MSCs are considered a potential cell source for PD therapy. It has been proved that hypoxia is involved in the proliferation and differentiation of stem cells. In this study, we investigated the effect of hypoxia on MSC proliferation and DAergic neuronal differentiation. Our results demonstrate that 3% O-2 treatment can enhance rat MSC proliferation by upregulation of phosphorylated p38 MAPK and subsequent nuclear translocation of hypoxia inducible factor (HIF)-1 alpha. During neural differentiation, 3% O-2 treatment increases the expression of HIF-1 alpha, phosphorylated ERK and p38 MAPK. These changes are followed by promotion of neurosphere formation and further DAergic neuronal differentiation. Furthermore, we explored the physiological function of hypoxia-induced DAergic neurons from human fetal MSCs by transplanting them into parkinsonian rats. Grafts induced with hypoxia display more survival of DAergic neurons and greater amelioration of behavioral impairments. Altogether, these results suggest that hypoxia can promote MSC proliferation and DAergic neuronal differentiation, and benefit for intrastriatal transplantation. Therefore, this study may provide new perspectives in application of MSCs to clinical PD therapy.	[Yang, Jian; Wang, Xuan; Wang, Xiaomin] Capital Med Univ, Educ Minist, Key Lab Neurodegenerat Dis, Dept Physiol & Neurobiol, Beijing, Peoples R China; [Wang, Yue] Peking Univ, Key Lab Neurosci PKU, Hlth Sci Ctr, Neurosci Res Inst,Minist Educ, Beijing 100871, Peoples R China; [Yang, Jian] Beijing An Ding Hosp, Beijing, Peoples R China; [Li, Haisheng; Zhu, Lingling; Fan, Ming] Beijing Inst Basic Med Sci, Dept Brain Protect, Beijing, Peoples R China	Capital Medical University; Peking University; Academy of Military Medical Sciences - China	Fan, M (corresponding author), Beijing Inst Basic Med Sci, Dept Brain Protect, Beijing, Peoples R China.	fanmingchina@126.com; xmwang@ccmu.edu.cn	Yang, Kevin/GRE-7923-2022		Chinese National Basic Research 973 Program [2011CB504100, 2010CB944801, 2011CB910800, 2012CB518200]; National Science Foundation of Beijing [5102010, 90919025]	Chinese National Basic Research 973 Program(National Basic Research Program of China); National Science Foundation of Beijing	This work was supported by grants from the Chinese National Basic Research 973 Program (2011CB504100, 2010CB944801, 2011CB910800, 2012CB518200) and National Science Foundation of Beijing (5102010, 90919025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cho MS, 2008, NAT PROTOC, V3, P1888, DOI 10.1038/nprot.2008.188; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Hur E, 2001, MOL PHARMACOL, V59, P1216, DOI 10.1124/mol.59.5.1216; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim TS, 2008, J NEUROSCI RES, V86, P2353, DOI 10.1002/jnr.21687; Kubo M, 2009, J CELL PHYSIOL, V220, P508, DOI 10.1002/jcp.21803; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Le Belle JE, 2002, BIODRUGS, V16, P389, DOI 10.2165/00063030-200216060-00001; Lee SH, 2008, J CELL BIOCHEM, V104, P1598, DOI 10.1002/jcb.21657; Lee SH, 2010, AM J PHYSIOL-CELL PH, V298, pC847, DOI 10.1152/ajpcell.00418.2009; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Mortimer HJ, 2007, PULM PHARMACOL THER, V20, P718, DOI 10.1016/j.pupt.2006.08.007; Neumeister B, 2009, STEM CELLS, V27, P714, DOI 10.1634/stemcells.2008-0985; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Pacary E, 2007, MOL CELL NEUROSCI, V35, P409, DOI 10.1016/j.mcn.2007.04.002; Pacary E, 2006, J CELL SCI, V119, P2667, DOI 10.1242/jcs.03004; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren HX, 2010, P NATL ACAD SCI USA, V107, P5857, DOI 10.1073/pnas.0909570107; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Schnell PO, 2003, J NEUROCHEM, V85, P483, DOI 10.1046/j.1471-4159.2003.01696.x; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Stacpoole SRL, 2011, NAT PROTOC, V6, P1229, DOI 10.1038/nprot.2011.380; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Studer L, 2000, J NEUROSCI, V20, P7377; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Trzaska KA, 2011, METHODS MOL BIOL, V698, P295, DOI 10.1007/978-1-60761-999-4_22; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang X, 2004, INT J DEV NEUROSCI, V22, P175, DOI 10.1016/j.ijdevneu.2004.05.008; Wang X, 2004, NEUROSCI LETT, V362, P117, DOI 10.1016/j.neulet.2004.03.007; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Welsh DJ, 2006, PULM PHARMACOL THER, V19, P128, DOI 10.1016/j.pupt.2005.04.008; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu L, 2004, CLIN CANCER RES, V10, P701, DOI 10.1158/1078-0432.CCR-0953-03; Zhang CL, 2010, BIOCHEM BIOPH RES CO, V394, P976, DOI 10.1016/j.bbrc.2010.03.102	53	31	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54296	10.1371/journal.pone.0054296	http://dx.doi.org/10.1371/journal.pone.0054296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342124	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700104
J	Chellan, B; Koroleva, EP; Sontag, TJ; Tumanov, AV; Fu, YX; Getz, GS; Reardon, CA				Chellan, Bijoy; Koroleva, Ekaterina P.; Sontag, Timothy J.; Tumanov, Alexei V.; Fu, Yang-Xin; Getz, Godfrey S.; Reardon, Catherine A.			LIGHT/TNFSR14 Can Regulate Hepatic Lipase Expression by Hepatocytes Independent of T Cells and Kupffer Cells	PLOS ONE			English	Article							LYMPHOTOXIN BETA-RECEPTOR; TRIGLYCERIDE LIPASE; LIVER; LIGHT; ACTIVATION; INTERLEUKIN-1; ALPHA; PATHOGENESIS; LYMPHOCYTES; METABOLISM	LIGHT/TNFSF14 is a costimulatory molecule expressed on activated T cells for activation and maintenance of T cell homeostasis. LIGHT over expressed in T cells also down regulates hepatic lipase levels in mice through lymphotoxin beta receptor (LT beta R) signaling. It is unclear whether LIGHT regulates hepatic lipase directly by interacting with LT beta R expressing cells in the liver or indirectly by activation of T cells, and whether Kupffer cells, a major cell populations in the liver that expresses the LT beta R, are required. Here we report that LIGHT expression via an adenoviral vector (Ad-LIGHT) is sufficient to down regulate hepatic lipase expression in mice. Depletion of Kupffer cells using clodronate liposomes had no effect on LIGHT-mediated down regulation of hepatic lipase. LIGHT-mediated regulation of hepatic lipase is also independent of LIGHT expression by T cells or activation of T cells. This is demonstrated by the decreased hepatic lipase expression in the liver of Ad-LIGHT infected recombination activating gene deficient mice that lack mature T cells and by the Ad-LIGHT infection of primary hepatocytes. Hepatic lipase expression was not responsive to LIGHT when mice lacking LT beta R globally or only on hepatocytes were infected with Ad-LIGHT. Therefore, our data argues that interaction of LIGHT with LT beta R on hepatocytes, but not Kupffer cells, is sufficient to down regulate hepatic lipase expression and that this effect can be independent of LIGHT's costimulatory function.	[Chellan, Bijoy; Sontag, Timothy J.; Fu, Yang-Xin; Getz, Godfrey S.; Reardon, Catherine A.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Koroleva, Ekaterina P.; Tumanov, Alexei V.] Trudeau Inst Inc, Saranac Lake, NY USA	University of Chicago; Trudeau Institute	Fu, YX (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yfu@uchicago.edu; reardon@uchicago.edu	Tumanov, Alexei/AAR-1607-2021	Tumanov, Alexei/0000-0001-6042-0152; fu, yang-xin/0000-0001-8441-6617	National Institutes of Health [HL85516, HL86675]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086675, R01HL085516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by National Institutes of Health grants HL85516 and HL86675. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083; Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Annema W, 2011, CURR ATHEROSCLER REP, V13, P257, DOI 10.1007/s11883-011-0175-2; Bertolino P, 1999, INT IMMUNOL, V11, P1225, DOI 10.1093/intimm/11.8.1225; Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.3.CO;2-6; BOGERS WMJM, 1991, CLIN EXP IMMUNOL, V85, P128; Brunzell JD, 2011, BIOCHIM BIOPHYS ACTA, P365, DOI [DOI 10.1016/J.BBALIP.2011.09.008), 10.1016/j.bbalip.2011.09.008]; Cartmell T, 1999, J NEUROSCI, V19, P1517; Cohen JI, 2011, J DIGEST DIS, V12, P3, DOI 10.1111/j.1751-2980.2010.00468.x; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Dahl CP, 2008, EUR J HEART FAIL, V10, P352, DOI 10.1016/j.ejheart.2008.02.010; Feingold KR, 1999, ATHEROSCLEROSIS, V142, P379, DOI 10.1016/S0021-9150(98)00265-2; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gregory SH, 1998, J IMMUNOL, V160, P6056; Jansen Hans, 2004, Curr Atheroscler Rep, V6, P343, DOI 10.1007/s11883-004-0044-3; Jin WJ, 2003, CIRC RES, V92, P644, DOI 10.1161/01.RES.0000064502.47539.6D; KAWAKAMI M, 1986, MICROBIOL IMMUNOL, V30, P849, DOI 10.1111/j.1348-0421.1986.tb03012.x; Lee CM, 2005, J GASTROEN HEPATOL, V20, P1762, DOI 10.1111/j.1440-1746.2005.04065.x; Lee WH, 2001, ARTERIOSCL THROM VAS, V21, P2004, DOI 10.1161/hq1201.098945; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Li W, 2003, IMMUNOLOGY, V109, P336, DOI 10.1046/j.1365-2567.2003.01658.x; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; MAGILAVY DB, 1993, BIOCHEM J, V292, P249, DOI 10.1042/bj2920249; MERAIHI Z, 1991, NUTRITION, V7, P93; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MORAHAN G, 1989, P NATL ACAD SCI USA, V86, P3782, DOI 10.1073/pnas.86.10.3782; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Otterdal K, 2008, AM J RESP CRIT CARE, V177, P202, DOI 10.1164/rccm.200703-506OC; Perret B, 2002, J LIPID RES, V43, P1163, DOI 10.1194/jlr.R100020-JLR200; Perry BC, 2011, J INVEST SURG, V24, P178, DOI 10.3109/08941939.2011.568594; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Reardon CA, 2003, ARTERIOSCL THROM VAS, V23, P1449, DOI 10.1161/01.ATV.0000079793.58054.2E; Remouchamps C, 2011, CYTOKINE GROWTH F R, V22, P301, DOI 10.1016/j.cytogfr.2011.11.007; Rufibach LE, 2006, J LIPID RES, V47, P1463, DOI 10.1194/jlr.M600082-JLR200; Sacci John B Jr, 2002, Methods Mol Med, V72, P503, DOI 10.1385/1-59259-271-6:503; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Scholz H, 2005, CIRCULATION, V112, P2121, DOI 10.1161/CIRCULATIONAHA.105.544676; SCHONRICH G, 1992, INT IMMUNOL, V4, P581, DOI 10.1093/intimm/4.5.581; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Wang J, 2001, J CLIN INVEST, V108, P1771, DOI 10.1172/JCI200113827; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wimmer N, 2012, J IMMUNOL, V188, P3426, DOI 10.4049/jimmunol.1103324; Xu YH, 2007, IMMUNOL RES, V37, P17, DOI 10.1007/BF02686093; Yu P, 2007, J IMMUNOL, V179, P1960, DOI 10.4049/jimmunol.179.3.1960; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010	49	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54719	10.1371/journal.pone.0054719	http://dx.doi.org/10.1371/journal.pone.0054719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355893	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500116
J	Kim, HR; Choi, HJ; Kim, YK; Kim, HJ; Shin, JH; Suh, SP; Ryang, DW; Shin, MG				Kim, Hye-Ran; Choi, Hyun-Jung; Kim, Yeo-Kyeoung; Kim, Hyeoung-Joon; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun			Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms	PLOS ONE			English	Article							DISORDERS; PREVALENCE; DIAGNOSIS; CRITERIA; GENE; PCR	The discovery of a single point mutation in the JAK2 gene in patients with BCR/ABL-negative myeloproliferative neoplasms (MPNs) has not only brought new insights and pathogenesis, but also has made the diagnosis of MPNs much easier. Although, to date, several mechanisms for the contribution of single JAK2V617F point mutation to phenotypic diversity of MPNs have been suggested in multiple studies, but it is not clear how a unique mutation can cause the phenotypic diversity of MPNs. In this study, our results show that allelic expression imbalance of JAK2 V617F mutant frequently occurs and contributes to phenotypic diversity of BCR-ABL-negative MPNs. The proportion of JAK2 V617F mutant allele was significantly augmented in RNA levels as compared with genomic DNA differently by distinct MPNs subtypes. In detail, preferential expression of JAK2 mutant allele showed threefold increase from the cDNA compared with the genomic DNA from patients with essential thrombocythemia and twofold increase in polycythemia vera. In conclusion, allelic expression imbalance of JAK2 V617F mutant proposes another plausible mechanism for the contribution of single JAK2 point mutation to phenotypic diversity of MPNs.	[Kim, Hye-Ran] Chonnam Natl Univ, Ctr Biomed Human Resources, Brain Korea Project 21, Kwangju, South Korea; [Choi, Hyun-Jung; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun] Chonnam Natl Univ, Sch Med, Dept Lab Med, Hwasun, South Korea; [Choi, Hyun-Jung; Shin, Jong-Hee; Suh, Soon-Pal; Ryang, Dong-Wook; Shin, Myung-Geun] Chonnam Natl Univ, Hwasun Hosp, Dept Lab Med, Hwasun, South Korea; [Kim, Yeo-Kyeoung; Kim, Hyeoung-Joon] Chonnam Natl Univ, Sch Med, Dept Hematol, Hwasun, South Korea; [Kim, Yeo-Kyeoung; Kim, Hyeoung-Joon] Chonnam Natl Univ, Sch Med, Genome Res Ctr Hematopoiet Dis, Hwasun, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Shin, MG (corresponding author), Chonnam Natl Univ, Sch Med, Dept Lab Med, Hwasun, South Korea.	mgshin@chonnam.ac.kr			Leading Foreign Research Institute Recruitment Program through National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2011-0030034, 2010-0024326]; NRF; Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea [A110367]	Leading Foreign Research Institute Recruitment Program through National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF; Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea	This work was supported by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (2011-0030034), Basic Science Research Program through NRF funded by the MEST (No. 2010-0024326) and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, and Republic of Korea (A110367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; Chae H, 2009, KOREAN J LAB MED, V29, P243, DOI 10.3343/kjlm.2009.29.3.243; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Haferlach T, 2008, ANN HEMATOL, V87, P1, DOI 10.1007/s00277-007-0403-6; James Chloe, 2008, Hematology Am Soc Hematol Educ Program, P69, DOI 10.1182/asheducation-2008.1.69; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kondo T, 2008, LEUKEMIA LYMPHOMA, V49, P1784, DOI 10.1080/10428190802258972; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Larsen TS, 2007, BRIT J HAEMATOL, V136, P745, DOI 10.1111/j.1365-2141.2007.06497.x; Lippert E, 2009, HAEMATOL-HEMATOL J, V94, P38, DOI 10.3324/haematol.13486; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Poodt J, 2006, HEMATOL ONCOL, V24, P227, DOI 10.1002/hon.800; Sazawal S, 2010, INDIAN J MED RES, V132, P423; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Thoennissen NH, 2010, BLOOD, V115, P2882, DOI 10.1182/blood-2009-07-235119; Vannucchi AM, 2008, LEUKEMIA, V22, pCP5, DOI 10.1038/leu.2008.113; Vilaine M, 2011, BLOOD, V118, P6468, DOI 10.1182/blood-2011-08-372813; Wang DX, 2006, AAPS J, V8, pE515, DOI 10.1208/aapsj080361	20	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e52518	10.1371/journal.pone.0052518	http://dx.doi.org/10.1371/journal.pone.0052518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349688	Green Submitted, gold, Green Published			2022-12-27	WOS:000314019100012
J	Mita-Mendoza, NK; van de Hoef, DL; Lopera-Mesa, TM; Doumbia, S; Konate, D; Doumbouya, M; Gu, WJ; Anderson, JM; Santos-Argumedo, L; Rodriguez, A; Fay, MP; Diakite, M; Long, CA; Fairhurst, RM				Mita-Mendoza, Neida K.; van de Hoef, Diana L.; Lopera-Mesa, Tatiana M.; Doumbia, Saibou; Konate, Drissa; Doumbouya, Mory; Gu, Wenjuan; Anderson, Jennifer M.; Santos-Argumedo, Leopoldo; Rodriguez, Ana; Fay, Michael P.; Diakite, Mahamadou; Long, Carole A.; Fairhurst, Rick M.			A Potential Role for Plasma Uric Acid in the Endothelial Pathology of Plasmodium falciparum malaria	PLOS ONE			English	Article							NITRIC-OXIDE; OXIDATIVE STRESS; CEREBRAL MALARIA; HYPERURICEMIA; INFLAMMATION; ASSOCIATION; COAGULATION; ACTIVATION; EXPRESSION; PLATELETS	Background: Inflammatory cytokinemia and systemic activation of the microvascular endothelium are central to the pathogenesis of Plasmodium falciparum malaria. Recently, 'parasite-derived' uric acid (UA) was shown to activate human immune cells in vitro, and plasma UA levels were associated with inflammatory cytokine levels and disease severity in Malian children with malaria. Since UA is associated with endothelial inflammation in non-malaria diseases, we hypothesized that elevated UA levels contribute to the endothelial pathology of P. falciparum malaria. Methodology/Principal Findings: We measured levels of UA and soluble forms of intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), E-selectin (sE-Selectin), thrombomodulin (sTM), tissue factor (sTF) and vascular endothelial growth factor (VEGF) in the plasma of Malian children aged 0.5-17 years with uncomplicated malaria (UM, n = 487) and non-cerebral severe malaria (NCSM, n = 68). In 69 of these children, we measured these same factors once when they experienced a malaria episode and twice when they were healthy (i.e., before and after the malaria transmission season). We found that levels of UA, sICAM-1, sVCAM-1, sE-Selectin and sTM increase during a malaria episode and return to basal levels at the end of the transmission season (p < 0.0001). Plasma levels of UA and these four endothelial biomarkers correlate with parasite density and disease severity. In children with UM, UA levels correlate with parasite density (r = 0.092, p = 0.043), sICAM-1 (r = 0.255, p < 0.0001) and sTM (r = 0.175, p = 0.0001) levels. After adjusting for parasite density, UA levels predict sTM levels. Conclusions/Significance: Elevated UA levels may contribute to malaria pathogenesis by damaging endothelium and promoting a procoagulant state. The correlation between UA levels and parasite densities suggests that parasitized erythrocytes are one possible source of excess UA. UA-induced shedding of endothelial TM may represent a novel mechanism of malaria pathogenesis, in which activated thrombin induces fibrin deposition and platelet aggregation in microvessels. This protocol is registered at clinicaltrials.gov (NCT00669084).	[Mita-Mendoza, Neida K.; Lopera-Mesa, Tatiana M.; Anderson, Jennifer M.; Long, Carole A.; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Mita-Mendoza, Neida K.; Santos-Argumedo, Leopoldo] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [van de Hoef, Diana L.; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA; [Doumbia, Saibou; Konate, Drissa; Doumbouya, Mory; Diakite, Mahamadou] Univ Bamako, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali; [Gu, Wenjuan; Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; New York University; University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fairhurst, RM (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	rfairhurst@niaid.nih.gov	Rodríguez, Ana/GQR-0554-2022; Fay, Michael P/A-2974-2008	Fay, Michael P/0000-0002-8643-9625; Santos-Argumedo, Leopoldo/0000-0002-4772-0713; Rodriguez, Ana/0000-0002-0060-3405	NIAID, National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, ZIAAI001000, ZIAAI001062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NIAID, National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the NIAID, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Atoh Y, 2011, VIOPOINTS 1 D SCATTE; Barbier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019651; Combes V, 2006, INT J PARASITOL, V36, P541, DOI 10.1016/j.ijpara.2006.02.005; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Feig DI, 2006, CURR HYPERTENS REP, V8, P111, DOI 10.1007/s11906-006-0005-z; Filiopoulos V, 2012, RENAL FAILURE, V34, P510, DOI 10.3109/0886022X.2011.653753; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Furuta T, 2010, AM J TROP MED HYG, V82, P136, DOI 10.4269/ajtmh.2010.09-0203; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hong Q, 2012, CELL CALCIUM, V51, P402, DOI 10.1016/j.ceca.2012.01.003; Hsieh MS, 2003, J CELL BIOCHEM, V89, P791, DOI 10.1002/jcb.10530; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Kawai T, 2012, HYPERTENS RES; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kim H, 2011, CURR OPIN HEMATOL, V18, P177, DOI 10.1097/MOH.0b013e328345a4cf; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lopera-Mesa TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046424; Nakagawa T, 2006, KIDNEY INT, V69, P1722, DOI 10.1038/sj.ki.5000391; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Orengo JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005194; Panoulas VF, 2007, RHEUMATOLOGY, V46, P1466, DOI 10.1093/rheumatology/kem159; Pasalic D, 2012, BIOCHEM MEDICA, V22, P63; Prato M, 2011, CELL MICROBIOL, V13, P1275, DOI 10.1111/j.1462-5822.2011.01620.x; Price KL, 2006, J AM SOC NEPHROL, V17, P1791, DOI 10.1681/ASN.2006030264; Puddu P, 2012, J CARDIOL, V59, P235, DOI 10.1016/j.jjcc.2012.01.013; Shyu, 1992, STAT MODELS; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Sobolewski P, 2005, TRENDS PARASITOL, V21, P415, DOI 10.1016/j.pt.2005.07.002; Strazzullo P, 2007, NUTR METAB CARDIOVAS, V17, P409, DOI 10.1016/j.numecd.2007.02.011; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Tomiyama H, 2011, AM J HYPERTENS, V24, P770, DOI 10.1038/ajh.2011.55; Turner GDH, 1998, AM J PATHOL, V152, P1477; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Wu HL, 2008, BIOCHEM BIOPH RES CO, V367, P162, DOI 10.1016/j.bbrc.2007.12.135; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641	47	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54481	10.1371/journal.pone.0054481	http://dx.doi.org/10.1371/journal.pone.0054481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349902	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100073
J	Nikaido, M; Law, EWP; Kelsh, RN				Nikaido, Masataka; Law, Edward W. P.; Kelsh, Robert N.			A Systematic Survey of Expression and Function of Zebrafish frizzled Genes	PLOS ONE			English	Article							CONVERGENT EXTENSION MOVEMENTS; NEURAL CREST DEVELOPMENT; WNT SIGNALING PATHWAY; CELL-MIGRATION; GASTRULATION MOVEMENTS; WNT/BETA-CATENIN; BETA-CATENIN; EMBRYONIC-DEVELOPMENT; VENTRICULAR SEPTUM; SPEMANN ORGANIZER	Wnt signaling is crucial for the regulation of numerous processes in development. Consistent with this, the gene families for both the ligands (Wnts) and receptors (Frizzleds) are very large. Surprisingly, while we have a reasonable understanding of the Wnt ligands likely to mediate specific Wnt-dependent processes, the corresponding receptors usually remain to be elucidated. Taking advantage of the zebrafish model's excellent genomic and genetic properties, we undertook a comprehensive analysis of the expression patterns of frizzled (fzd) genes in zebrafish. To explore their functions, we focused on testing their requirement in several developmental events known to be regulated by Wnt signaling, convergent extension movements of gastrulation, neural crest induction, and melanocyte specification. We found fourteen distinct fzd genes in the zebrafish genome. Systematic analysis of their expression patterns between 1-somite and 30 hours post-fertilization revealed complex, dynamic and overlapping expression patterns. This analysis demonstrated that only fzd3a, fzd9b, and fzd10 are expressed in the dorsal neural tube at stages corresponding to the timing of melanocyte specification. Surprisingly, however, morpholino knockdown of these, alone or in combination, gave no indication of reduction of melanocytes, suggesting the important involvement of untested fzds or another type of Wnt receptor in this process. Likewise, we found only fzd7b and fzd10 expressed at the border of the neural plate at stages appropriate for neural crest induction. However, neural crest markers were not reduced by knockdown of these receptors. Instead, these morpholino knockdown studies showed that fzd7a and fzd7b work co-operatively to regulate convergent extension movement during gastrulation. Furthermore, we show that the two fzd7 genes function together with fzd10 to regulate epiboly movements and mesoderm differentiation.	[Nikaido, Masataka; Law, Edward W. P.; Kelsh, Robert N.] Univ Bath, Dept Biol & Biochem, Claverton Down, England	University of Bath	Kelsh, RN (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, England.	bssrnk@bath.ac.uk	Kelsh, Robert/B-6445-2008	Kelsh, Robert/0000-0002-9381-0066; Law, Edward/0000-0001-5089-6341	Uehara Memorial Foundation; University of Bath	Uehara Memorial Foundation(Uehara Memorial Foundation); University of Bath	This work was supported by a Uehara Memorial Foundation research fellowship (MN) and the University of Bath. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elmagd M, 2006, DEV BIOL, V298, P285, DOI 10.1016/j.ydbio.2006.06.037; Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306; Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Borello U, 1999, MECH DEVELOP, V89, P173, DOI 10.1016/S0925-4773(99)00205-1; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Conway SJ, 1997, DEVELOPMENT, V124, P505; Djiane A, 2000, DEVELOPMENT, V127, P3091; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dorsky RI, 2000, BIOESSAYS, V22, P708, DOI 10.1002/1521-1878(200008)22:8<708::AID-BIES4>3.3.CO;2-E; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dorsky RI, 2000, GENE DEV, V14, P158; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; FoerstPotts L, 1997, DEV DYNAM, V209, P70, DOI 10.1002/(SICI)1097-0177(199705)209:1<70::AID-AJA7>3.0.CO;2-U; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; Forrester WC, 2004, GENETICS, V168, P1951, DOI 10.1534/genetics.104.031781; Fukukawa C, 2009, ONCOGENE, V28, P1110, DOI 10.1038/onc.2008.467; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Granato M, 1996, DEVELOPMENT, V123, P399; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Hari L, 2012, DEVELOPMENT, V139, P2107, DOI 10.1242/dev.073064; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 2002, SEMIN CELL DEV BIOL, V13, P471, DOI 10.1016/S1084952102001003; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Inoue T, 2007, DEV BIOL, V306, P669, DOI 10.1016/j.ydbio.2007.04.003; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEVELOPMENT, V127, P515; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Lamoreux ML., 2010, COLORS MICE MODEL GE; Le Douarin NM, 1999, NEURAL CREST, V2; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Lister JA, 1999, DEVELOPMENT, V126, P3757; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; McGraw HF, 2011, DEVELOPMENT, V138, P3921, DOI 10.1242/dev.062554; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Momoi A, 2003, MECH DEVELOP, V120, P477, DOI 10.1016/S0925-4773(03)00003-0; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; PARR BA, 1993, DEVELOPMENT, V119, P247; Raible DW, 2006, CURR OPIN CELL BIOL, V18, P698, DOI 10.1016/j.ceb.2006.09.003; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Sisson BE, 2009, GENE EXPR PATTERNS, V9, P520, DOI 10.1016/j.gep.2009.07.003; Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Sumanas S, 2001, GENESIS, V30, P114, DOI 10.1002/gene.1043; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Takahashi K, 2001, DEV DYNAM, V222, P252, DOI 10.1002/dvdy.1185; Thisse B, 2004, ZFIN DIRECT DATA SUB; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van de Water S, 2001, DEVELOPMENT, V128, P3877; Wada H, 2006, DEVELOPMENT, V133, P4749, DOI 10.1242/dev.02665; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang YF, 2003, BIOESSAYS, V25, P317, DOI 10.1002/bies.10255; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yamamoto A, 1998, DEVELOPMENT, V125, P3389; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026533	92	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54833	10.1371/journal.pone.0054833	http://dx.doi.org/10.1371/journal.pone.0054833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349976	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100100
J	Wang, BY; Doan, D; Petersen, YR; Alvarado, E; Alvarado, G; Bhandari, A; Mohanty, A; Mohanty, S; Nissen, RM				Wang, Bingyan; Doan, Diana; Petersen, Yanett Roman; Alvarado, Estibaliz; Alvarado, Gregory; Bhandari, Ajay; Mohanty, Aditya; Mohanty, Sudipta; Nissen, Robert M.			Wdr68 Requires Nuclear Access for Craniofacial Development	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; MEDIATES CELL-SURVIVAL; MIRK PROTEIN-KINASE; HISTONE DEACETYLASES; PANCREATIC-CANCER; MIRK/DYRK1B; ZEBRAFISH; ACTIVATION; REPRESSION; GENES	Wdr68 is a highly conserved scaffolding protein required for craniofacial development and left-right asymmetry. A Ras-Map3k-Wdr68-Dyrk1 signaling relay may mediate these and other diverse signaling events important in development and disease. While the sub-cellular localization of Wdr68 has been shown to be dependent on that of its interaction partners, it is not clear where Wdr68 activity is required during development. Here we show that while a GFP-Wdr68 fusion functionally substituted for craniofacial development in the zebrafish, that a Nuclear Export Signal (NES) fusion protein (GFPNESWdr68) failed to support craniofacial development. As control for NES activity, we show that while GFP-Wdr68 exhibited a pan-cellular distribution in C2C12 cells, the GFPNESWdr68 fusion predominantly localized to the cell cytoplasm, as expected. Interestingly, while GFP-Wdr68 and RFP-Dyrk1a co-localized to the cell nucleus as expected based on the known sub-cellular localization for Dyrk1a, we found that the GFPNESWdr68 fusion redistributed RFP-Dyrk1a to the cell cytoplasm potentially disconnecting the Ras/Dyrk1 signal relay from further downstream targets. Consistent with a nuclear role in gene regulation, we also found that while a transcriptional activation domain fusion, CebpFlagWdr68, functionally substituted for endogenous Wdr68 for craniofacial development, that a transcriptional repression domain fusion, MadFlagWdr68, failed to support craniofacial development. Dyrk1b is required for myogenin (myog) expression in differentiating mouse C2C12 cells and here we report that wdr68 is also important for myog expression in differentiating C2C12 cells. Using a C2C12 cell myog promoter-reporter system, we found that Wdr68 overexpression increased reporter activity while moderate expression levels of MadFlagWdr68 interfered with reporter activity. Taken together, these findings support a nuclear role for Wdr68-containing complexes.	[Wang, Bingyan; Doan, Diana; Petersen, Yanett Roman; Alvarado, Estibaliz; Alvarado, Gregory; Bhandari, Ajay; Mohanty, Aditya; Mohanty, Sudipta; Nissen, Robert M.] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	California State University System; California State University Los Angeles	Nissen, RM (corresponding author), Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA.	rnissen@calstatela.edu	Wang, Bingyan/AAB-3883-2019	Wang, Bingyan/0000-0002-3522-2848; Nissen, Robert/0000-0002-0591-1167	United States National Science Foundation [IOS-0744454]; California State University Program for Education and Research in Biotechnology (CSUPERB); Division Of Graduate Education [0742426] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); California State University Program for Education and Research in Biotechnology (CSUPERB); Division Of Graduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This study was funded by the United States National Science Foundation (IOS-0744454) and the California State University Program for Education and Research in Biotechnology (CSUPERB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Deng XB, 2006, CANCER RES, V66, P4149, DOI 10.1158/0008-5472.CAN-05-3089; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; Deng XB, 2003, J BIOL CHEM, V278, P41347, DOI 10.1074/jbc.M306780200; Deng XB, 2009, CANCER RES, V69, P3317, DOI 10.1158/0008-5472.CAN-08-2903; deVetten N, 1997, GENE DEV, V11, P1422, DOI 10.1101/gad.11.11.1422; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Jin K, 2007, CANCER RES, V67, P7247, DOI 10.1158/0008-5472.can-06-4099; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee K, 2000, CANCER RES, V60, P3631; Lim S, 2002, J BIOL CHEM, V277, P25040, DOI 10.1074/jbc.M203257200; Lyons SE, 2001, GENE, V281, P43, DOI 10.1016/S0378-1119(01)00774-0; Mazmanian G, 2010, GENESIS, V48, P20, DOI 10.1002/dvg.20578; Mercer SE, 2005, J BIOL CHEM, V280, P25788, DOI 10.1074/jbc.M413594200; Mercer SE, 2006, CANCER RES, V66, P5143, DOI 10.1158/0008-5472.CAN-05-1539; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Miller CT, 2007, DEV BIOL, V308, P144, DOI 10.1016/j.ydbio.2007.05.018; Miyata Y, 2011, BBA-MOL CELL RES, V1813, P1728, DOI 10.1016/j.bbamcr.2011.06.023; Nissen RM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-28; Ritterhoff S, 2010, EMBO J, V29, P3750, DOI 10.1038/emboj.2010.251; RUSSELL M, 1995, J BIOL CHEM, V270, P11757, DOI 10.1074/jbc.270.20.11757; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Wang Y, 2011, PLANT CELL, V23, P486, DOI 10.1105/tpc.110.081661; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Williamson EA, 1998, J BIOL CHEM, V273, P14796, DOI 10.1074/jbc.273.24.14796; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697	35	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54363	10.1371/journal.pone.0054363	http://dx.doi.org/10.1371/journal.pone.0054363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349862	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100060
J	Wang, H; Chan, YL; Li, TL; Bauer, BA; Hsia, SM; Wang, CH; Huang, JS; Wang, HM; Yeh, KY; Huang, TH; Wu, GJ; Wu, CJ				Wang, Hang; Chan, Yi-Lin; Li, Tsung-Lin; Bauer, Brent A.; Hsia, Simon; Wang, Cheng-Hsu; Huang, Jen-Seng; Wang, Hung-Ming; Yeh, Kun-Yun; Huang, Tse-Hung; Wu, Gwo-Jang; Wu, Chang-Jer			Reduction of Splenic Immunosuppressive Cells and Enhancement of Anti-Tumor Immunity by Synergy of Fish Oil and Selenium Yeast	PLOS ONE			English	Article							IMMATURE MYELOID CELLS; REGULATORY T-CELLS; TUMOR-BEARING MICE; NUTRITIONAL-STATUS; SUPPRESSOR-CELLS; CANCER-PATIENTS; LUNG-CANCER; FATTY-ACIDS; CACHEXIA; INHIBITION	Growing evidence has shown that regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) abnormally increase in cancer cachectic patients. Suppressions of Tregs and MDSCs may enhance anti-tumor immunity for cancer patients. Fish oil and selenium have been known to have many biological activities such as anti-inflammation and anti-oxidation. Whether fish oil and/or selenium have an additional effect on population of immunosuppressive cells in tumor-bearing hosts remained elusive and controversial. To gain insights into their roles on anti-tumor immunity, we studied the fish oil- and/or selenium-mediated tumor suppression and immunity on lung carcinoma, whereof cachexia develops. Advancement of cachexia in a murine lung cancer model manifested with such indicative symptoms as weight loss, chronic inflammation and disturbed immune functionality. The elevation of Tregs and MDSCs in spleens of tumor-bearing mice was positively correlated with tumor burdens. Consumption of either fish oil or selenium had little or no effect on the levels of Tregs and MDSCs. However, consumption of both fish oil and selenium together presented a synergistic effect-The population of Tregs and MDSCs decreased as opposed to increase of anti-tumor immunity when both fish oil and selenium were supplemented simultaneously, whereby losses of body weight and muscle/fat mass were alleviated significantly.	[Wang, Hang; Wu, Chang-Jer] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan; [Wang, Hang; Wu, Chang-Jer] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung, Taiwan; [Chan, Yi-Lin; Wu, Gwo-Jang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Li, Tsung-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Bauer, Brent A.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Hsia, Simon] Hung Kuang Univ, Inst Biomed Nutr, Taichung, Taiwan; [Wang, Cheng-Hsu; Huang, Jen-Seng; Yeh, Kun-Yun] Chang Gung Mem Hosp, Dept Internal Med, Div Hematooncol, Keelung, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Dept Internal Med, Div Hematooncol, Kweishan, Taiwan; [Huang, Tse-Hung] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Kweishan, Taiwan; [Huang, Tse-Hung] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Kaohsiung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University; National Defense Medical Center; Academia Sinica - Taiwan; Mayo Clinic; Hungkuang University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Wu, CJ (corresponding author), Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan.	wuchangjer@yahoo.com.tw	Huang, Tse-Hung/N-5989-2019	Huang, Tse-Hung/0000-0002-5231-9932; Wu, Tsung-Han/0000-0001-8455-8009				Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; BALDIE G, 1993, BIOCHIM BIOPHYS ACTA, V1179, P125, DOI 10.1016/0167-4889(93)90133-A; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; BECK SA, 1987, CANCER RES, V47, P5919; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Burns CP, 2004, CANCER, V101, P370, DOI 10.1002/cncr.20362; Cohen AC, 2006, J IMMUNOL, V177, P2770, DOI 10.4049/jimmunol.177.5.2770; DeLong P, 2003, CANCER RES, V63, P7845; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Elkabets M, 2010, EUR J IMMUNOL, V40, P3347, DOI 10.1002/eji.201041037; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Evans C, 2006, ALIMENT PHARM THER, V24, P1163, DOI 10.1111/j.1365-2036.2006.03075.x; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Faber J, 2009, ONCOL REP, V22, P1403, DOI 10.3892/or_00000581; Furukawa K, 1999, ANN SURG, V229, P255, DOI 10.1097/00000658-199902000-00014; Herber DL, 2007, CANCER RES, V67, P5067, DOI 10.1158/0008-5472.CAN-07-0897; Hoffmann PR, 2007, ARCH IMMUNOL THER EX, V55, P289, DOI 10.1007/s00005-007-0036-4; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Kiremidjian-Schumacher L, 2001, BIOFACTORS, V14, P161, DOI 10.1002/biof.5520140121; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Markowska J., 1995, European Journal of Gynaecological Oncology, V16, P54; Martin F, 1999, CYTOKINE, V11, P80, DOI 10.1006/cyto.1998.0398; McCarthy Donna O, 2003, Biol Res Nurs, V5, P3, DOI 10.1177/1099800403005001001; Moon PD, 2011, AMINO ACIDS; Ren J, 2007, J AGR FOOD CHEM, V55, P5073, DOI 10.1021/jf0702693; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Roth MJ, 2006, EUR J CANCER PREV, V15, P548, DOI 10.1097/01.cej.0000220632.93104.2d; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SEVCIKOVA L, 1992, NEOPLASMA, V39, P219; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Takagi K, 2001, NUTRITION, V17, P478, DOI 10.1016/S0899-9007(01)00557-3; Takekoshi K, 2004, LIFE SCI, V74, P863, DOI 10.1016/J.lfs.2003.07.036; Tatsuta T, 1996, J IMMUNOL, V157, P3949; Ueha S, 2011, INT IMMUNOPHARMACOL, V11, P783, DOI 10.1016/j.intimp.2011.03.003; Van Cutsem Eric, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS51, DOI 10.1016/j.ejon.2005.09.007; van der Meij BS, 2010, J NUTR, V140, P1774, DOI 10.3945/jn.110.121202; Xia S, 2011, J BIOL CHEM; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; YUHAS JM, 1974, CANCER RES, V34, P722; Zeng JH, 2009, J NUTR BIOCHEM, V20, P530, DOI 10.1016/j.jnutbio.2008.05.012	44	18	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e52912	10.1371/journal.pone.0052912	http://dx.doi.org/10.1371/journal.pone.0052912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349693	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100014
J	Ylosmaki, E; Lavilla-Alonso, S; Jaamaa, S; Vaha-Koskela, M; af Hallstrom, T; Hemminki, A; Arola, J; Makisalo, H; Saksela, K				Ylosmaki, Erkko; Lavilla-Alonso, Sergio; Jaamaa, Sari; Vaha-Koskela, Markus; af Hallstrom, Taija; Hemminki, Akseli; Arola, Johanna; Makisalo, Heikki; Saksela, Kalle			MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver	PLOS ONE			English	Article							GENE-TRANSFER; VIRUS-INFECTION; IN-VITRO; EXPRESSION; CANCER; ROLES; MOUSE; IDENTIFICATION; HEPATOCYTES; VIROTHERAPY	MicroRNAs (miRNAs) are important and ubiquitous regulators of gene expression that can suppress their target genes by translational inhibition as well as mRNA destruction. Cell type-specific miRNA expression patterns have been successfully exploited for targeting the expression of experimental and therapeutic gene constructs, for example to reduce pathogenic effects of cancer virotherapy in normal tissues. In order to avoid liver damage associated with systemic or intrahepatic delivery of oncolytic adenoviruses we have introduced the concept of suppressing adenovirus replication in hepatic cells by inserting target elements for the liver-specific miR122 into the viral genome. Here we show using ex vivo cultured tissue specimens that six perfectly complementary miR122 target sites in the 39 untranslated region of the viral E1A gene are sufficient in the absence of any other genetic modifications to prevent productive replication of serotype 5 adenovirus (Ad5) in normal human liver. This modification did not compromise the replicative capacity of the modified virus in cancer tissue derived from a colon carcinoma liver metastasis or its oncolytic potency in a human lung cancer xenograft mouse model. Unlike wild-type Ad5, the modified virus did not result in increased serum levels of liver enzymes in infected mice. These results provide a strong preclinical proof of concept for the use of miR122 target sites for reducing the risk of liver damage caused by oncolytic adenoviruses, and suggest that ectopic miR122 target elements should be considered as an additional safety measure included in any therapeutic virus or viral vector posing potential hazard to the liver.	[Ylosmaki, Erkko; Lavilla-Alonso, Sergio; Jaamaa, Sari; Saksela, Kalle] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Ylosmaki, Erkko; Lavilla-Alonso, Sergio; Jaamaa, Sari; Arola, Johanna; Saksela, Kalle] Helsinki Univ Cent Hosp, HUSLAB, Helsinki, Finland; [Jaamaa, Sari] Univ Helsinki, Biomedicum Helsinki, Mol Canc Biol Program, Helsinki, Finland; [Vaha-Koskela, Markus; Hemminki, Akseli] Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program, Helsinki, Finland; [Vaha-Koskela, Markus; Hemminki, Akseli] Univ Helsinki, Transplantat Lab, Helsinki, Finland; [af Hallstrom, Taija] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Arola, Johanna] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland; [Makisalo, Heikki] Helsinki Univ Cent Hosp, Dept Gastrointestinal Surg, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Saksela, K (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	kalle.saksela@helsinki.fi		Vaha-Koskela, Markus/0000-0001-7764-7820; Saksela, Kalle/0000-0003-0827-122X	Academy of Finland [127197]; Helsinki University Central Hospital Research Council [TYH2008307]; Sigrid Juselius Foundation; Jenny and Antti Wihuri Foundation; Helsinki Biomedical Graduate School	Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Council; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jenny and Antti Wihuri Foundation; Helsinki Biomedical Graduate School	This study was supported by grants from the Academy of Finland (127197), Helsinki University Central Hospital Research Council (TYH2008307), and the Sigrid Juselius Foundation to KS, and from Jenny and Antti Wihuri Foundation to EY. SLA and EY were supported in part by Helsinki Biomedical Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Cawood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016152; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Cody JJ, 2009, CANCER GENE THER, V16, P473, DOI 10.1038/cgt.2009.3; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; de Kanter R, 1999, TOXICOL IN VITRO, V13, P737, DOI 10.1016/S0887-2333(99)00047-8; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; DUNCAN SJ, 1978, J GEN VIROL, V40, P45, DOI 10.1099/0022-1317-40-1-45; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Habib NA, 2001, HUM GENE THER, V12, P219, DOI 10.1089/10430340150218369; Hamid O, 2003, J CLIN ONCOL, V21, P1498, DOI 10.1200/JCO.2003.09.114; Hamilton MA, 1977, ENV SCI TECHNOL, V11; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Heise C, 2000, J CLIN INVEST, V105, P847, DOI 10.1172/JCI9762; HITT MM, 1990, VIROLOGY, V179, P667, DOI 10.1016/0042-6822(90)90134-D; IKEDA T, 1989, EXP CELL RES, V185, P292, DOI 10.1016/0014-4827(89)90058-X; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Jogler C, 2006, J VIROL, V80, P3549, DOI 10.1128/JVI.80.7.3549-3558.2006; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Leja J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008916; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Loyer P, 1996, J BIOL CHEM, V271, P11484, DOI 10.1074/jbc.271.19.11484; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Olinga P, 1997, J PHARMACOL TOXICOL, V38, P59, DOI 10.1016/S1056-8719(97)00060-9; Pesonen S, 2011, MOL PHARMACEUT, V8, P12, DOI 10.1021/mp100219n; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Russo A, 2011, FEBS LETT, V585, P2551, DOI 10.1016/j.febslet.2011.07.015; Sullivan DE, 1997, HUM GENE THER, V8, P1195, DOI 10.1089/hum.1997.8.10-1195; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Yamamoto M, 2010, MOL THER, V18, P243, DOI 10.1038/mt.2009.266; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08; Yu SL, 2007, DNA CELL BIOL, V26, P283, DOI 10.1089/dna.2006.0555	54	22	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54506	10.1371/journal.pone.0054506	http://dx.doi.org/10.1371/journal.pone.0054506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349911	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100076
J	Munoz, A; Harries, E; Contreras-Valenzuela, A; Carmona, L; Read, ND; Marcos, JF				Munoz, Alberto; Harries, Eleonora; Contreras-Valenzuela, Adriana; Carmona, Lourdes; Read, Nick D.; Marcos, Jose F.			Two Functional Motifs Define the Interaction, Internalization and Toxicity of the Cell-Penetrating Antifungal Peptide PAF26 on Fungal Cells	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; HEXAPEPTIDE PAF26; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ANTIBACTERIAL ACTIVITY; PHYTOPATHOGENIC FUNGI; NEUROSPORA-CRASSA	The synthetic, cell penetrating hexapeptide PAF26 (RKKWFW) is antifungal at low micromolar concentrations and has been proposed as a model for cationic, cell-penetrating antifungal peptides. Its short amino acid sequence facilitates the analysis of its structure-activity relationships using the fungal models Neurospora crassa and Saccharomyces cerevisiae, and human and plant pathogens Aspergillus fumigatus and Penicillium digitatum, respectively. Previously, PAF26 at low fungicidal concentrations was shown to be endocytically internalized, accumulated in vacuoles and then actively transported into the cytoplasm where it exerts its antifungal activity. In the present study, two PAF26 derivatives, PAF95 (AAAWFW) and PAF96 (RKKAAA), were designed to characterize the roles of the N-terminal cationic and the C-terminal hydrophobic motifs in PAF26's mode-of-action. PAF95 and PAF96 exhibited substantially reduced antifungal activity against all the fungi analyzed. PAF96 localized to fungal cell envelopes and was not internalized by the fungi. In contrast, PAF95 was taken up into vacuoles of N. crassa, wherein it accumulated and was trapped without toxic effects. Also, the PAF26 resistant Delta arg1 strain of S. cerevisiae exhibited increased PAF26 accumulation in vacuoles. Live-cell imaging of GFP-labelled nuclei in A. fumigatus showed that transport of PAF26 from the vacuole to the cytoplasm was followed by nuclear breakdown and dissolution. This work demonstrates that the amphipathic PAF26 possesses two distinct motifs that allow three stages in its antifungal action to be defined: (i) its interaction with the cell envelope; (ii) its internalization and transport to vacuoles mediated by the aromatic hydrophobic domain; and (iii) its transport from vacuoles to the cytoplasm. Significantly, cationic residues in PAF26 are important not only for the electrostatic attraction and interaction with the fungal cell but also for transport from the vacuole to the cytoplasm, which coincides with cell death. Peptide containment within vacuoles preserves fungal cells from peptide toxicity.	[Munoz, Alberto; Harries, Eleonora; Contreras-Valenzuela, Adriana; Read, Nick D.] Univ Edinburgh, Fungal Cell Biol Grp, Inst Cell Biol, Edinburgh, Midlothian, Scotland; [Harries, Eleonora; Carmona, Lourdes; Marcos, Jose F.] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Food Sci, E-46010 Valencia, Spain	University of Edinburgh; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Read, ND (corresponding author), Univ Edinburgh, Fungal Cell Biol Grp, Inst Cell Biol, Edinburgh, Midlothian, Scotland.	Nick.Read@ed.ac.uk; jmarcos@iata.csic.es	Carmona López, Lourdes/M-8661-2014; Marcos, Jose F./A-7121-2011	Marcos, Jose F./0000-0003-3339-2584; Munoz, Alberto/0000-0002-1622-5074; Read, Nick/0000-0002-2286-2862	Ministerio de Ciencia e Innovacion (MICINN, Spain); Consejo Superior de Investigaciones Cientificas (CSIC, Spain); Consejo Nacional de Ciencia y Tecnologia (CONACYT, MExico); Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) [BB/E010741/1]; Wellcome Trust [093596/B/10Z]; MICINN (Spain) [BIO2009-12919]; Generalitat Valenciana, Valencia, Spain [ACOMP2012-018]; Biotechnology and Biological Sciences Research Council [BB/E010741/1] Funding Source: researchfish; BBSRC [BB/E010741/1] Funding Source: UKRI	Ministerio de Ciencia e Innovacion (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC, Spain); Consejo Nacional de Ciencia y Tecnologia (CONACYT, MExico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biotechnology and Biological Sciences Research Council (BBSRC, U.K.)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana, Valencia, Spain(Center for Forestry Research & Experimentation (CIEF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AM was funded by the Postdoctoral Mobility Program of Ministerio de Ciencia e Innovacion (MICINN, Spain). EH fellowship and short stay at the University of Edinburgh were funded by the JAE-PREDOC Program of Consejo Superior de Investigaciones Cientificas (CSIC, Spain). ACV was funded by the Consejo Nacional de Ciencia y Tecnologia (CONACYT, MExico). The work was supported by research grants BB/E010741/1 from Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) and grant #093596/B/10Z from the Wellcome Trust to NDR, and BIO2009-12919 from MICINN (Spain) and ACOMP2012-018 (Generalitat Valenciana, Valencia, Spain) to JFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2010, EXPERT REV ANTI-INFE, V8, P359, DOI [10.1586/eri.10.13, 10.1586/ERI.10.13]; Alekseeva L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-33; Bignell E, 2005, MOL MICROBIOL, V55, P1072, DOI 10.1111/j.1365-2958.2004.04472.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Carmona L, 2012, BIOCHEM BIOPH RES CO, V417, P56, DOI 10.1016/j.bbrc.2011.11.050; Castle M, 1999, J BIOL CHEM, V274, P32555, DOI 10.1074/jbc.274.46.32555; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Gupte M, 2002, APPL MICROBIOL BIOT, V58, P46, DOI 10.1007/s002530100822; Gyurko C, 2001, ANTON LEEUW INT J G, V79, P297, DOI 10.1023/A:1012070600340; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Helmerhorst EJ, 1999, ANTIMICROB AGENTS CH, V43, P702, DOI 10.1128/AAC.43.3.702; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Jang WS, 2008, ANTIMICROB AGENTS CH, V52, P497, DOI 10.1128/AAC.01199-07; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Jung HJ, 2006, BIOCHEM BIOPH RES CO, V345, P222, DOI 10.1016/j.bbrc.2006.04.059; Kragol G, 2002, EUR J BIOCHEM, V269, P4226, DOI 10.1046/j.1432-1033.2002.03119.x; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lopez-Garcia B, 2002, APPL ENVIRON MICROB, V68, P2453, DOI 10.1128/AEM.68.5.2453-2460.2002; Lopez-Garcia B, 2000, MOL PLANT MICROBE IN, V13, P837, DOI 10.1094/MPMI.2000.13.8.837; Lopez-Garcia B, 2007, BIOCHEM BIOPH RES CO, V356, P107, DOI 10.1016/j.bbrc.2007.02.093; Lopez-Garcia B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-289; Lupetti A, 2008, EUR J CLIN MICROBIOL, V27, P1125, DOI 10.1007/s10096-008-0553-z; Mania D, 2010, APPL ENVIRON MICROB, V76, P7102, DOI 10.1128/AEM.01560-10; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Marcos JF, 2009, EXPERT OPIN DRUG DIS, V4, P659, DOI 10.1517/17460440902992888; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; Munoz A, 2007, BIOCHEM BIOPH RES CO, V354, P172, DOI 10.1016/j.bbrc.2006.12.173; Munoz A, 2006, ANTIMICROB AGENTS CH, V50, P3847, DOI 10.1128/AAC.00650-06; Munoz A, 2012, MOL MICROBIOL, V85, P89, DOI 10.1111/j.1365-2958.2012.08091.x; Narasimhan ML, 2003, PLANT J, V36, P390, DOI 10.1046/j.1365-313X.2003.01886.x; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Otvos L, 2005, J PEPT SCI, V11, P697, DOI 10.1002/psc.698; Palm C, 2006, PEPTIDES, V27, P1710, DOI 10.1016/j.peptides.2006.01.006; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Powers JPS, 2006, ANTIMICROB AGENTS CH, V50, P1522, DOI 10.1128/AAC.50.4.1522-1524.2006; Roilides E, 1999, INFECT IMMUN, V67, P3047, DOI 10.1128/IAI.67.6.3047-3050.1999; Schibli DJ, 1999, FEBS LETT, V446, P213, DOI 10.1016/S0014-5793(99)00214-8; Schmidtchen A, 2011, BBA-BIOMEMBRANES, V1808, P1081, DOI 10.1016/j.bbamem.2010.12.020; Strom MB, 2000, J PEPT RES, V56, P265, DOI 10.1034/j.1399-3011.2000.00770.x; Sun JNN, 2008, MOL MICROBIOL, V70, P1246, DOI 10.1111/j.1365-2958.2008.06480.x; Vallon-Eberhard A, 2008, ANTIMICROB AGENTS CH, V52, P3118, DOI 10.1128/AAC.00526-08; van der Kraan MIA, 2005, PEPTIDES, V26, P1537, DOI 10.1016/j.peptides.2005.02.011; van der Weerden NL, 2010, J BIOL CHEM, V285, P37513, DOI 10.1074/jbc.M110.134882; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; Yun DJ, 1997, P NATL ACAD SCI USA, V94, P7082, DOI 10.1073/pnas.94.13.7082; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	54	30	31	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54813	10.1371/journal.pone.0054813	http://dx.doi.org/10.1371/journal.pone.0054813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349973	Green Submitted, Green Published, gold			2022-12-27	WOS:000313943000051
J	Shabaik, YH; Millard, M; Neamati, N				Shabaik, Yumna H.; Millard, Melissa; Neamati, Nouri			Mechanistic Evaluation of a Novel Small Molecule Targeting Mitochondria in Pancreatic Cancer Cells	PLOS ONE			English	Article							ALPHA-TOCOPHERYL SUCCINATE; DUCTAL ADENOCARCINOMA; LIPOPHILIC CATIONS; SUPEROXIDE-DISMUTASE; TUMOR ANGIOGENESIS; KINASE; AUTOPHAGY; DEATH; ACTIVATION; THERAPY	Background: Pancreatic cancer is one of the deadliest cancers with a 5-year survival rate of 6%. Therapeutic options are very limited and there is an unmet medical need for safe and efficacious treatments. Cancer cell metabolism and mitochondria provide unexplored targets for this disease. We recently identified a novel class of triphenylphosphonium salts, TP compounds, with broad-spectrum anticancer properties. We examined the ability of our prototypical compound TP421-chosen for its fluorescent properties - to inhibit the growth of pancreatic cancer cells and further investigated the molecular mechanisms by which it exerts its anticancer effects. Methodology/Principal Findings: TP421 exhibited sub-micromolar IC50 values in all the pancreatic cancer cell lines tested using MTT and colony formation assays. TP421 localized predominantly to mitochondria and induced G(0)/G(1) arrest, ROS accumulation, and activation of several stress-regulated kinases. Caspase and PARP-1 cleavage were observed indicating an apoptotic response while LC3B-II and p62 were accumulated indicating inhibition of autophagy. Furthermore, TP421 induced de-phosphorylation of key signaling molecules involved in FAK mediated adhesion that correlated with inhibition of cell migration. Conclusions/Significance: TP421 is a representative compound of a new promising class of mitochondrial-targeted agents useful for pancreatic cancer treatment. Because of their unique mechanism of action and efficacy further development is warranted.	[Shabaik, Yumna H.; Millard, Melissa; Neamati, Nouri] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	University of Southern California	Neamati, N (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	neamati@usc.edu			Congressionally Directed Medical Research Program Breast Cancer Concept Award; Sharon and William Cockrell Endowed Cancer Research Fund	Congressionally Directed Medical Research Program Breast Cancer Concept Award; Sharon and William Cockrell Endowed Cancer Research Fund	This study was supported in part by funds from the Congressionally Directed Medical Research Program Breast Cancer Concept Award and the Sharon and William Cockrell Endowed Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2012, CANC FACTS FIG 2012; Bartz RR, 2010, CRIT CARE, V14, DOI 10.1186/cc9185; BERROZPE G, 1994, INT J CANCER, V58, P185, DOI 10.1002/ijc.2910580207; Biasutto L, 2008, BIOORG MED CHEM LETT, V18, P5594, DOI 10.1016/j.bmcl.2008.08.100; Biswas S, 2012, J CONTROL RELEASE, V159, P393, DOI 10.1016/j.jconrel.2012.01.009; Biswas S, 2012, BIOMATERIALS, V33, P4773, DOI 10.1016/j.biomaterials.2012.03.032; Bold RJ, 1999, ANN SURG ONCOL, V6, P279, DOI 10.1007/s10434-999-0279-x; Bose JK, 2011, J BIOL CHEM, V286, P44441, DOI 10.1074/jbc.M111.237115; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; BURNS RJ, 1995, ARCH BIOCHEM BIOPHYS, V322, P60, DOI 10.1006/abbi.1995.1436; Cagnol S, 2006, APOPTOSIS, V11, P337, DOI 10.1007/s10495-006-4065-y; Cassel JA, 2012, BIOCHIMIE; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chatzizacharias NA, 2010, PANCREAS, V39, P930, DOI 10.1097/MPA.0b013e3181d7abcc; Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x; Cocheme HM, 2007, MITOCHONDRION, V7, pS94, DOI 10.1016/j.mito.2007.02.007; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Cullen JJ, 2003, CANCER RES, V63, P1297; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dong LF, 2011, FREE RADICAL BIO MED, V50, P1546, DOI 10.1016/j.freeradbiomed.2011.02.032; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Fulda S, 2011, ANTIOXID REDOX SIGN, V15, P2937, DOI 10.1089/ars.2011.4078; Galli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002379; Gogvadze V, 2011, CURR PHARM DESIGN, V17, P4034, DOI 10.2174/138161211798764933; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Hsiao PW, 2007, TOXICOL APPL PHARM, V222, P97, DOI 10.1016/j.taap.2007.04.007; Hung SW, 2012, CANCER LETT, V320, P138, DOI 10.1016/j.canlet.2012.03.007; Ischenko Ivan, 2007, Angiogenesis, V10, P167, DOI 10.1007/s10456-007-9071-3; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kulich SM, 2007, FREE RADICAL BIO MED, V43, P372, DOI 10.1016/j.freeradbiomed.2007.04.028; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lim PLK, 2008, TOXICOL SCI, V101, P341, DOI 10.1093/toxsci/kfm273; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Liu BB, 2011, WORLD J CLIN ONCOL, V2, P164, DOI 10.5306/wjco.v2.i3.164; Liu HF, 2010, CHEM-BIOL INTERACT, V188, P535, DOI 10.1016/j.cbi.2010.08.001; Madar I, 2007, EUR J NUCL MED MOL I, V34, P2057, DOI 10.1007/s00259-007-0500-8; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Malhi SS, 2012, INT J PHARMACEUT, V432, P63, DOI 10.1016/j.ijpharm.2012.04.030; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Millard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013131; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Mohri D, 2012, J GASTROENTEROL, V47, P203, DOI 10.1007/s00535-011-0482-y; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Nagaraj NS, 2010, MOL CANCER THER, V9, P2322, DOI 10.1158/1535-7163.MCT-09-1212; Nezis IP, 2012, ANTIOXID REDOX SIGNA; Nowak G, 2006, AM J PHYSIOL-RENAL, V291, pF840, DOI 10.1152/ajprenal.00219.2005; OBERLEY LW, 1988, MOL CELL BIOCHEM, V84, P147, DOI 10.1007/BF00421049; OBERLEY LW, 1979, CANCER RES, V39, P1141; Plunkett W, 1995, ANTI-CANCER DRUG, V6, P7, DOI 10.1097/00001813-199512006-00002; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2923, DOI 10.1089/ars.2011.4192; Senderowicz AM, 2007, ONCOLOGY-NY, V21, P1696; Sheikh R, 2010, EXPERT REV ANTICANC, V10, P1647, DOI [10.1586/era.10.148, 10.1586/ERA.10.148]; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Wang XX, 2011, BIOMATERIALS, V32, P5673, DOI 10.1016/j.biomaterials.2011.04.029; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	69	15	17	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54346	10.1371/journal.pone.0054346	http://dx.doi.org/10.1371/journal.pone.0054346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349858	Green Submitted, gold, Green Published			2022-12-27	WOS:000313943000035
J	Tseng, TS; Cheng, CS; Hsu, STD; Shih, MF; He, PL; Lyu, PC				Tseng, Tien-Sheng; Cheng, Chao-Sheng; Hsu, Shang-Te Danny; Shih, Min-Fang; He, Pei-Lin; Lyu, Ping-Chiang			Residue-Specific Annotation of Disorder-to-Order Transition and Cathepsin Inhibition of a Propeptide-Like Crammer from D. melanogaster	PLOS ONE			English	Article							BOMBYX CYSTEINE PROTEINASE; STRUCTURE-BASED DESIGN; LONG-TERM-MEMORY; CRYSTAL-STRUCTURE; SELECTIVE INHIBITOR; ALZHEIMERS-DISEASE; STRUCTURAL BASIS; PROTEASES; REVEALS; REGIONS	Drosophila melanogaster crammer is a novel cathepsin inhibitor involved in long-term memory formation. A molten globule-to-ordered structure transition is required for cathepsin inhibition. This study reports the use of alanine scanning to probe the critical residues in the two hydrophobic cores and the salt bridges of crammer in the context of disorder-to-order transition and cathepsin inhibition. Alanine substitution of the aromatic residues W9, Y12, F16, Y20, Y32, and W53 within the hydrophobic cores, and charged residues E8, R28, R29, and E67 in the salt bridges considerably decrease the ability of crammer to inhibit Drosophila cathepsin B (CTSB). Far-UV circular dichroism (CD), intrinsic fluorescence, and nuclear magnetic resonance (NMR) spectroscopies show that removing most of the aromatic and charged side-chains substantially reduces thermostability, alters pH-dependent helix formation, and disrupts the molten globule-to-ordered structure transition. Molecular modeling indicates that W53 in the hydrophobic Core 2 is essential for the interaction between crammer and the prosegment binding loop (PBL) of CTSB; the salt bridge between R28 and E67 is critical for the appropriate alignment of the alpha-helix 4 toward the CTSB active cleft. The results of this study show detailed residue-specific dissection of folding transition and functional contributions of the hydrophobic cores and salt bridges in crammer, which have hitherto not been characterized for cathepsin inhibition by propeptide-like cysteine protease inhibitors. Because of the involvements of cathepsin inhibitors in neurodegenerative diseases, these structural insights can serve as a template for further development of therapeutic inhibitors against human cathepsins.	[Tseng, Tien-Sheng; Cheng, Chao-Sheng; Shih, Min-Fang; He, Pei-Lin; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Hsu, Shang-Te Danny] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lyu, Ping-Chiang] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; China Medical University Taiwan	Lyu, PC (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	lslpc@life.nthu.edu.tw	Hsu, Shang-Te Danny/L-2826-2014; Hsu, Shang-Te Danny/B-2324-2009; Tseng, Tien-Sheng Emerson/ABB-1352-2021; Tseng, Tien-Sheng Emerson/ABB-1365-2021	Hsu, Shang-Te Danny/0000-0002-7231-0185; Tseng, Tien-Sheng Emerson/0000-0002-2344-0485; Tseng, Tien-Sheng Emerson/0000-0003-0515-1855	National Science Council, Taiwan [NSC 99-2811-M-007-073, 99-3112-B-007-003, 99-2627-B-007-010, NSC 101-2321- B-007-005-MY2, 100-2113-M-001-031-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan (Grant numbers: NSC 99-2811-M-007-073, 99-3112-B-007-003, 99-2627-B-007-010, NSC 101-2321- B-007-005-MY2, and 100-2113-M-001-031-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn NG, 2005, SCIENCE, V308, P1266, DOI 10.1126/science.1113707; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Buhling F, 2000, ADV EXP MED BIOL, V477, P241; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Chen YM, 1996, FEBS LETT, V393, P24, DOI 10.1016/0014-5793(96)00847-2; Cheng CS, 2008, PROTEINS, V70, P695, DOI 10.1002/prot.21520; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELARIA K, 1994, J BIOL CHEM, V269, P25172; DENIZOT F, 1989, EUR J IMMUNOL, V19, P631, DOI 10.1002/eji.1830190409; Deshapriya RMC, 2010, J BIOCHEM, V147, P393, DOI 10.1093/jb/mvp188; Deshapriya RMC, 2007, ZOOL SCI, V24, P21, DOI 10.2108/zsj.24.21; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Groves MR, 1998, PROTEINS, V32, P504, DOI 10.1002/(SICI)1097-0134(19980901)32:4<504::AID-PROT8>3.0.CO;2-F; Gutierrez-Gonzalez LH, 2006, ARCH BIOCHEM BIOPHYS, V446, P151, DOI 10.1016/j.abb.2005.12.005; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Huo SH, 2002, J MED CHEM, V45, P1412, DOI 10.1021/jm010338j; II K, 1993, VIRCHOWS ARCH A, V423, P185, DOI 10.1007/BF01614769; Inui T, 1997, J BIOL CHEM, V272, P8109, DOI 10.1074/jbc.272.13.8109; Jerala R, 1998, J BIOL CHEM, V273, P11498, DOI 10.1074/jbc.273.19.11498; Jilkova A, 2011, J BIOL CHEM, V286, P35770, DOI 10.1074/jbc.M111.271304; Katunuma N, 2002, ARCH BIOCHEM BIOPHYS, V397, P305, DOI 10.1006/abbi.2001.2709; Kaulmann G, 2003, ACTA CRYSTALLOGR D, V59, P1243, DOI 10.1107/S0907444903008801; Kaulmann G, 2006, PROTEIN SCI, V15, P2619, DOI 10.1110/ps.062401806; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Kurata M, 2003, PROTEIN EXPRES PURIF, V32, P119, DOI 10.1016/S1046-5928(03)00222-5; Kurata M, 2001, J BIOCHEM, V130, P857, DOI 10.1093/oxfordjournals.jbchem.a003058; LaLonde JM, 1999, BIOCHEMISTRY-US, V38, P862, DOI 10.1021/bi9822271; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu YN, 2007, BIOCHEM J, V403, P21, DOI 10.1042/BJ20061312; MANTLE D, 1995, J NEUROL SCI, V131, P65, DOI 10.1016/0022-510X(95)00035-Z; Markt P, 2008, J CHEM INF MODEL, V48, P1693, DOI 10.1021/ci800101j; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MASON RW, 1987, BIOCHEM J, V248, P449, DOI 10.1042/bj2480449; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; MORT JS, 1984, ARTHRITIS RHEUM, V27, P509, DOI 10.1002/art.1780270505; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Ravikumar M, 2008, CHEM BIOL DRUG DES, V72, P79, DOI 10.1111/j.1747-0285.2008.00667.x; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Roche L, 1999, MOL BIOCHEM PARASIT, V98, P271, DOI 10.1016/S0166-6851(98)00164-9; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sivaraman J, 1999, PROTEIN SCI, V8, P283; Teles RCL, 2005, BIOPHYS J, V88, P3509, DOI 10.1529/biophysj.104.045682; Thompson SK, 1999, BIOORGAN MED CHEM, V7, P599, DOI 10.1016/S0968-0896(99)00010-3; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tseng TS, 2012, BIOCHEM J, V442, P563, DOI 10.1042/BJ20111360; Tseng TS, 2011, BIOCH J; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiederanders B, 2000, ADV EXP MED BIOL, V477, P261; WL D, 2002, PYMOL MOL GRAPHICS S; Yamamoto Y, 1999, FEBS LETT, V448, P257, DOI 10.1016/S0014-5793(99)00382-8; Zhang LS, 2009, ACTA BIOCH BIOPH SIN, V41, P437, DOI 10.1093/abbs/gmp031	66	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54187	10.1371/journal.pone.0054187	http://dx.doi.org/10.1371/journal.pone.0054187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349821	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000028
J	Zhou, HQ; Chen, ZN; Shi, HB; Wu, YQ; Yin, SK				Zhou, Huiqun; Chen, Zhengnong; Shi, Haibo; Wu, Yaqin; Yin, Shankai			Categories of Auditory Performance and Speech Intelligibility Ratings of Early-Implanted Children without Speech Training	PLOS ONE			English	Article							PEDIATRIC COCHLEAR IMPLANTATION; LANGUAGE-DEVELOPMENT; DEAFENED PATIENTS; PERCEPTION; AGE	Objective: To assess whether speech therapy can lead to better results for early cochlear implantation (CI) children. Patients: A cohort of thirty-four congenitally profoundly deaf children who underwent CI before the age of 18 months at the Sixth Hospital affiliated with Shanghai Jiaotong University from January 2005 to July 2008 were included. Nineteen children received speech therapy in rehabilitation centers (ST), whereas the remaining fifteen cases did not (NST), but were exposed to the real world, as are normal hearing children. Methods: All children were assessed before surgery and at 6, 12, and 24 months after surgery with the Categories of Auditory Performance test (CAP) and the Speech Intelligibility Rating (SIR). Each assessment was given by the same therapist who was blind to the situation of the child at each observation interval. CAP and SIR scores of the groups were compared at each time point. Results: Our study showed that the auditory performance and speech intelligibility of trained children were almost the same as to those of untrained children with early implantation. The CAP and SIR scores of both groups increased with increased time of implant use during the follow-up period, and at each time point, the median scores of the two groups were about equal. Conclusions: These results indicate that great communication benefits are achieved by early implantation (, 18 months) without routine speech therapy. The results exemplify the importance of enhanced social environments provided by everyday life experience for human brain development and reassure parents considering cochlear implants where speech training is unavailable.	[Zhou, Huiqun; Chen, Zhengnong; Shi, Haibo; Wu, Yaqin; Yin, Shankai] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Otolaryngol, Shanghai 200030, Peoples R China; [Zhou, Huiqun; Chen, Zhengnong; Shi, Haibo; Wu, Yaqin; Yin, Shankai] Shanghai Jiao Tong Univ, Otolaryngol Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, ZN (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Otolaryngol, Shanghai 200030, Peoples R China.	jassey@126.com; yinshankai@china.com		Shi, Haibo/0000-0002-2920-0183	Ministry of Health Sector Fund [201202001]; joint research projects of Shanghai municipal hospitals [SHDC12010119]	Ministry of Health Sector Fund; joint research projects of Shanghai municipal hospitals	This work was supported by the Ministry of Health Sector Fund (grant no. 201202001) and the joint research projects of Shanghai municipal hospitals (grant no. SHDC12010119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2001, OTOL NEUROTOL, V22, P631, DOI 10.1097/00129492-200109000-00012; Allen MC, 1998, AM J OTOL, V19, P742; Archbold S, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P312; BUSBY P A, 1991, British Journal of Audiology, V25, P291, DOI 10.3109/03005369109076601; Dawson PW, 1997, EAR HEARING, V18, P488, DOI 10.1097/00003446-199712000-00007; Dettman SJ, 2007, EAR HEARING, V28, p11S, DOI 10.1097/AUD.0b013e31803153f8; FryaufBertschy H, 1997, J SPEECH LANG HEAR R, V40, P183, DOI 10.1044/jslhr.4001.183; Fu QJ, 2008, HEARING RES, V242, P198, DOI 10.1016/j.heares.2007.11.010; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; Geers AE, 2004, ARCH OTOLARYNGOL, V130, P634, DOI 10.1001/archotol.130.5.634; Geers Ann E, 2007, Audiol Med, V5, P262, DOI 10.1080/16513860701659404; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Govaerts PJ, 2002, OTOL NEUROTOL, V23, P885, DOI 10.1097/00129492-200211000-00013; Hiraumi H, 2007, ACTA OTO-LARYNGOL, V127, P17, DOI 10.1080/03655230601065225; Houston DM, 2010, OTOL NEUROTOL, V31, P1248, DOI 10.1097/MAO.0b013e3181f1cc6a; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; O'Neill C, 2002, OTOL NEUROTOL, V23, P44, DOI 10.1097/00129492-200201000-00011; Pyman B, 2000, AM J OTOL, V21, P57, DOI 10.1016/S0196-0709(00)80076-9; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Snik AFM, 1997, INT J PEDIATR OTORHI, V41, P121, DOI 10.1016/S0165-5876(97)00058-X; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Wu JL, 2007, AUDIOL NEURO-OTOL, V12, P307, DOI 10.1159/000103211; Yucel E, 2009, INT J PEDIATR OTORHI, V73, P1043, DOI 10.1016/j.ijporl.2009.04.009	23	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53852	10.1371/journal.pone.0053852	http://dx.doi.org/10.1371/journal.pone.0053852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349752	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000018
J	Kanoksil, M; Jatapai, A; Peacock, SJ; Limmathurotsakul, D				Kanoksil, Manas; Jatapai, Anchalee; Peacock, Sharon J.; Limmathurotsakul, Direk			Epidemiology, Microbiology and Mortality Associated with Community-Acquired Bacteremia in Northeast Thailand: A Multicenter Surveillance Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; ESCHERICHIA-COLI BACTEREMIA; POPULATION-BASED COHORT; ANTIBIOTIC-RESISTANCE; TYPHOID-FEVER; MELIOIDOSIS; IMPACT	Background: National statistics in developing countries are likely to underestimate deaths due to bacterial infections. Here, we calculated mortality associated with community-acquired bacteremia (CAB) in a developing country using routinely available databases. Methods/Principal Findings: Information was obtained from the microbiology and hospital database of 10 provincial hospitals in northeast Thailand, and compared with the national death registry from the Ministry of Interior, Thailand for the period between 2004 and 2010. CAB was defined in patients who had pathogenic organisms isolated from blood taken within 2 days of hospital admission without a prior inpatient episode in the preceding 30 days. A total of 15,251 CAB patients identified, of which 5,722 (37.5%) died within 30 days of admission. The incidence rate of CAB between 2004 and 2010 increased from 16.7 to 38.1 per 100,000 people per year, and the mortality rate associated with CAB increased from 6.9 to 13.7 per 100,000 people per year. In 2010, the mortality rate associated with CAB was lower than that from respiratory tract infection, but higher than HIV disease or tuberculosis. The most common causes of CAB were Escherichia coli (23.1%), Burkholderia pseudomallei (19.3%), and Staphylococcus aureus (8.2%). There was an increase in the proportion of Extended-Spectrum Beta-Lactamases (ESBL) producing E. coli and Klebsiella pneumoniae over time. Conclusions: This study has demonstrated that national statistics on causes of death in developing countries could be improved by integrating information from readily available databases. CAB is neglected as an important cause of death, and specific prevention and intervention is urgently required to reduce its incidence and mortality.	[Kanoksil, Manas] Sappasithiprasong Hosp, Dept Pediat, Ubon Ratchathani, Thailand; [Jatapai, Anchalee; Peacock, Sharon J.; Limmathurotsakul, Direk] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Peacock, Sharon J.] Mahidol Univ, Dept Microbiol & Immunol, Bangkok 10700, Thailand; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; Mahidol University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Limmathurotsakul, D (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	direk@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020	Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782	Wellcome Trust [090219/Z/09/Z]; Wellcome Trust; NIHR Cambridge Biomedical Research Center; UKCRC TIRI; Health Protection Agency	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cambridge Biomedical Research Center; UKCRC TIRI; Health Protection Agency	The study was funded by the Wellcome Trust (090219/Z/09/Z). Sharon Peacock receives funding from the Wellcome Trust, the NIHR Cambridge Biomedical Research Center, the UKCRC TIRI, and the Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhengsri S, 2011, AM J TROP MED HYG, V85, P117, DOI 10.4269/ajtmh.2011.11-0070; BODHIDATTA L, 1987, REV INFECT DIS, V9, P841; Bureau of Policy and Strategy Ministry of Public Health Thailand, THAIL HLTH PROF 2008; DANCE DAB, 1988, LANCET, V1, P994; Deen J, 2012, LANCET INFECT DIS, V12, P480, DOI 10.1016/S1473-3099(12)70028-2; Department of Provincial Administration Thailand, THAIL DEM; Douglas MW, 2004, TROP MED INT HEALTH, V9, P795, DOI 10.1111/j.1365-3156.2004.01269.x; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Heron Melonie, 2012, Natl Vital Stat Rep, V60, P1; Laupland KB, 2007, EPIDEMIOL INFECT, V135, P1037, DOI 10.1017/S0950268806007631; Laupland KB, 2012, EPIDEMIOL INFECT, P1; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Melzer M, 2012, LANCET INFECT DIS, V12, P103, DOI 10.1016/S1473-3099(11)70356-5; Ministry of Publich Health Thailand, 1998, PUBL HLTH STAT A D; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Pedersen G, 2003, CLIN MICROBIOL INFEC, V9, P793, DOI 10.1046/j.1469-0691.2003.00599.x; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Reacher MH, 2000, BMJ-BRIT MED J, V320, P213, DOI 10.1136/bmj.320.7229.213; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Savard P, 2012, CURR OPIN INFECT DIS, V25, P371, DOI 10.1097/QCO.0b013e3283558c17; Siegman-Igra Y, 2002, CLIN INFECT DIS, V34, P1431, DOI 10.1086/339809; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Skogberg K, 2008, EPIDEMIOL INFECT, V136, P108, DOI 10.1017/S0950268807008138; Skrlin J, 2011, J CHEMOTHERAPY, V23, P341; Sogaard M, 2011, CLIN INFECT DIS, V52, P61, DOI 10.1093/cid/ciq069; Statistics Canada, LEAD CAUS DEATH CAN; Taylor DN, 1999, J INFECT DIS, V180, P2089, DOI 10.1086/315159; Underwood J, 2011, J HOSP INFECT, V79, P364, DOI 10.1016/j.jhin.2011.07.005; Uslan DZ, 2007, ARCH INTERN MED, V167, P834, DOI 10.1001/archinte.167.8.834; *WHO, 1999, REP INF DIS	33	62	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54714	10.1371/journal.pone.0054714	http://dx.doi.org/10.1371/journal.pone.0054714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349954	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800071
J	McLaughlin, MF; Woodward, J; Boll, RA; Wall, JS; Rondinone, AJ; Kennel, SJ; Mirzadeh, S; Robertson, JD				McLaughlin, Mark F.; Woodward, Jonathan; Boll, Rose A.; Wall, Jonathan S.; Rondinone, Adam J.; Kennel, Stephen J.; Mirzadeh, Saed; Robertson, J. David			Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy	PLOS ONE			English	Article							RADIOIMMUNOTHERAPY; THERAPY; FATE	Targeted radiotherapies maximize cytotoxicty to cancer cells. In vivo a-generator targeted radiotherapies can deliver multiple alpha particles to a receptor site dramatically amplifying the radiation dose delivered to the target. The major challenge with alpha-generator radiotherapies is that traditional chelating moieties are unable to sequester the radioactive daughters in the bioconjugate which is critical to minimize toxicity to healthy, non-target tissue. The recoil energy of the Ac-225 daughters following alpha decay will sever any metal-ligand bond used to form the bioconjugate. This work demonstrates that an engineered multilayered nanoparticle-antibody conjugate can deliver multiple alpha radiations and contain the decay daughters of Ac-225 while targeting biologically relevant receptors in a female BALB/c mouse model. These multi-shell nanoparticles combine the radiation resistance of lanthanide phosphate to contain Ac-225 and its radioactive decay daughters, the magnetic properties of gadolinium phosphate for easy separation, and established gold chemistry for attachment of targeting moieties.	[McLaughlin, Mark F.; Robertson, J. David] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [McLaughlin, Mark F.; Robertson, J. David] Univ Missouri, Univ Missouri Res Reactor, Columbia, MO USA; [McLaughlin, Mark F.; Woodward, Jonathan; Boll, Rose A.; Rondinone, Adam J.; Mirzadeh, Saed] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Wall, Jonathan S.; Kennel, Stephen J.] Univ Tennessee, Grad Sch Med, Knoxville, TN USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Health Science Center	Robertson, JD (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	robertsonjo@missouri.edu	Rondinone, Adam J/F-6489-2013; Boll, Rose/C-4138-2016	Rondinone, Adam J/0000-0003-0020-4612; Boll, Rose/0000-0003-2507-4834; Robertson, John/0000-0002-6675-8469; Wall, Jonathan/0000-0002-5516-8578	Isotope Production/Distribution Program; Office of Nuclear Physics of the U. S. Department of Energy (DOE); DOE Nuclear Energy University Program Graduate Fellowship; University of Tennessee; Graduate School of Medicine; Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Office of Basic Energy Sciences, U.S. Department of Energy; ORNL is managed by UT-Battelle, LLC, for the U.S. Department of energy [DE-AC05-00OR22725]	Isotope Production/Distribution Program; Office of Nuclear Physics of the U. S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE Nuclear Energy University Program Graduate Fellowship; University of Tennessee; Graduate School of Medicine; Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Office of Basic Energy Sciences, U.S. Department of Energy; ORNL is managed by UT-Battelle, LLC, for the U.S. Department of energy(United States Department of Energy (DOE))	Research supported in part by the Isotope Production/Distribution Program, Office of Nuclear Physics of the U. S. Department of Energy (DOE), and under a DOE Nuclear Energy University Program Graduate Fellowship. The work was also supported by the University of Tennessee, Graduate School of Medicine through funding of the cancer imaging and tracer development program. A portion of this research was conducted at the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Office of Basic Energy Sciences, U.S. Department of Energy. ORNL is managed by UT-Battelle, LLC, for the U.S. Department of energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, FDA GRANTS FAST TRAC; Bruland OS, 2006, CLIN CANCER RES, V12, p6250S, DOI 10.1158/1078-0432.CCR-06-0841; Buissette V, 2006, J MATER CHEM, V16, P529, DOI 10.1039/b508656f; Burdick M.J., 2010, DRUG DISC TODAY THER, V7, P23; Essler M, 2012, EUR J NUCL MED MOL I, V39, P602, DOI 10.1007/s00259-011-2023-6; EWING RC, 1975, AM MINERAL, V60, P728; Gadbois DM, 1996, RADIAT RES, V146, P414, DOI 10.2307/3579303; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hifumi H, 2009, J MATER CHEM, V19, P6393, DOI 10.1039/b902134e; HUMM JL, 1986, J NUCL MED, V27, P1490; Jacene HA, 2007, J NUCL MED, V48, P1767, DOI 10.2967/jnumed.107.043489; Jaggi JS, 2005, CANCER RES, V65, P4888; KAMPF G, 1988, Radiobiologia Radiotherapia, V29, P631; KARIORIS FG, 1981, RADIAT EFF LETT, V58, P1, DOI 10.1080/01422448108226520; Kennel SJ, 2008, NUCL MED BIOL, V35, P501, DOI 10.1016/j.nucmedbio.2008.02.001; Kennel Stephen J., 2010, Current Drug Delivery, V7, P428; Kim YS, 2012, TUMOR BIOL, V33, P573, DOI 10.1007/s13277-011-0286-y; KOLSKY KL, 1993, APPL RADIAT ISOTOPES, V44, P553, DOI 10.1016/0969-8043(93)90169-B; Lasbury ME, 2006, J IMMUNOL, V176, P6443, DOI 10.4049/jimmunol.176.11.6443; McDevitt MR, 1998, EUR J NUCL MED, V25, P1341, DOI 10.1007/s002590050306; McDevitt MR, 2001, SCIENCE, V294, P1537, DOI 10.1126/science.1064126; Meiser F, 2004, ANGEW CHEM INT EDIT, V43, P5954, DOI 10.1002/anie.200460856; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; MIRZADEH S, 1993, RADIOCHIM ACTA, V60, P1; Mulford DA, 2005, J NUCL MED, V46, p199S; Schwartz J, 2011, PHYS MED BIOL, V56, P721, DOI 10.1088/0031-9155/56/3/012; Sofou S, 2004, J NUCL MED, V45, P253; Song H, 2009, CANCER RES, V69, P8941, DOI 10.1158/0008-5472.CAN-09-1828; TABUTEAU A, 1988, J MATER SCI LETT, V7, P1315, DOI 10.1007/BF00719969; van Vlerken LE, 2007, PHARM RES-DORDR, V24, P1405, DOI 10.1007/s11095-007-9284-6; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Woodward J, 2011, BIOCONJUGATE CHEM, V22, P766, DOI 10.1021/bc100574f; Woodward JD, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/17/175103; Zalutsky MR, 2004, Q J NUCL MED MOL IM, V48, P289	34	94	97	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54531	10.1371/journal.pone.0054531	http://dx.doi.org/10.1371/journal.pone.0054531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349921	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800061
J	Dietz, MW; Rogers, KG; Piersma, T				Dietz, Maurine W.; Rogers, Ken G.; Piersma, Theunis			When the Seasons Don't Fit: Speedy Molt as a Routine Carry-Over Cost of Reproduction	PLOS ONE			English	Article							KNOTS CALIDRIS-CANUTUS; PLOVERS PLUVIALIS-SQUATAROLA; AVIAN PRIMARY MOLT; RED KNOTS; MIGRATION STRATEGIES; SOUTHWARD MIGRATION; FEATHER QUALITY; ANNUAL CYCLE; HABITAT USE; LIFE-CYCLE	The failure of animals to fit all life-cycle stages into an annual cycle could reduce the chances of successful breeding. In some cases, non-optimal strategies will be adopted in order to maintain the life-cycle within the scope of one year. We studied trade-offs made by a High Arctic migrant shorebird, the red knot Calidris canutus islandica, between reproduction and wing feather molt carried out in the non-breeding period in the Dutch Wadden Sea. We compared primary molt duration between birds undertaking the full migratory and breeding schedule with birds that forego breeding because they are young or are maintained in captivity. Molt duration was ca. 71 days in breeding adults, which was achieved by an accelerated feather replacement strategy. Second-year birds and captive adults took ca. 22% and 27% longer, respectively. Second-year birds start molt in late June, more than four weeks before captive adults, and almost seven weeks before adults that return from breeding in late July-August. Adults finish molt in October when steeply increasing thermostatic costs and reductions in food availability occur. Primary molt duration was longer in female than in male knots (all ages), which was accordance with the somewhat larger body size of females. Since fast growth leads to lower quality feathers, the speedy wing molt shown by Arctic-breeding birds may represent a time constraint that is an unavoidable and routine cost of reproduction. So far it was hypothesized that only birds over 1 kg would have difficulty fitting molt within a year. Here we show that in birds an order of magnitude smaller, temporal imperatives may impose the adoption of non-optimal life-cycle routines in the entire actively breeding population.	[Dietz, Maurine W.; Piersma, Theunis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Piersma, Theunis] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Texel, Netherlands	University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Dietz, MW (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands.	M.W.Dietz@rug.nl	Dietz, Maurine W./F-2614-2013; Piersma, Theunis/D-1871-2012	Dietz, Maurine W./0000-0001-9022-3790; Piersma, Theunis/0000-0001-9668-466X	NIOZ Royal Netherlands Institute for Sea Research; NWO-PIONIER grant; Waddenfonds (programme Metawad)	NIOZ Royal Netherlands Institute for Sea Research; NWO-PIONIER grant; Waddenfonds (programme Metawad)	This research was funded by operational grants from the NIOZ Royal Netherlands Institute for Sea Research. NWO-PIONIER grant to Theunis Piersma and funding from the Waddenfonds (programme Metawad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1990, BIRD MIGRATION; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Baker AJ, 1999, CONDOR, V101, P887, DOI 10.2307/1370083; Battley PF, 2006, BIOL LETTERS, V2, P517, DOI 10.1098/rsbl.2006.0535; Blomqvist S, 2002, OECOLOGIA, V133, P146, DOI 10.1007/s00442-002-1017-2; BOERE GC, 1976, ARDEA, V64, P210; Bridge ES, 2011, CONDOR, V113, P1, DOI 10.1525/cond.2011.100228; Broggi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024942; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; DAVIDSON NC, 1992, WADER STUDY GROUP S, V64, P39; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2004, IBIS, V146, P493, DOI 10.1111/j.1474-919x.2004.00290.x; de la Hera I, 2010, J AVIAN BIOL, V41, P342, DOI 10.1111/j.1600-048X.2009.04835.x; de la Hera I, 2009, BIOL J LINN SOC, V97, P98, DOI 10.1111/j.1095-8312.2008.01189.x; Dietz MW, 2010, CONDOR, V112, P48, DOI 10.1525/cond.2010.090139; Dietz MW, 1999, J EXP BIOL, V202, P2831; Erni B, 2012, J STAT SOFT IN PRESS; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; Ginn HB, 2007, BTO GUIDE; Hall KSS, 2000, J AVIAN BIOL, V31, P583, DOI 10.1034/j.1600-048X.2000.310419.x; Hedenstrom A, 2003, J AVIAN BIOL, V34, P324, DOI 10.1111/j.0908-8857.2003.03324.x; Hedenstrom A, 2006, ARDEA, V94, P399; Helseth A, 2005, ARDEA, V93, P213; Hout P.J. van den, 2009, LIMOSA, V82, P122; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; Jenni L., 1994, BIOL MOULT BIRDS; Kjellen Nils, 1994, Ornis Svecica, V4, P1; Lank DB, 2003, OIKOS, V103, P303, DOI 10.1034/j.1600-0706.2003.12314.x; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; Mitchell GW, 2012, IBIS, V154, P325, DOI 10.1111/j.1474-919X.2012.01212.x; Nebel S, 2000, ARDEA, V88, P165; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; PIERSMA T, 1993, NETH J SEA RES, V31, P331, DOI 10.1016/0077-7579(93)90052-T; Piersma T, 1998, J AVIAN BIOL, V29, P97, DOI 10.2307/3677186; Piersma T, 2000, GEN COMP ENDOCR, V120, P118, DOI 10.1006/gcen.2000.7543; PIERSMA T, 1995, J COMP PHYSIOL B, V165, P37, DOI 10.1007/BF00264684; Piersma T, 2007, J ORNITHOL, V148, pS45, DOI 10.1007/s10336-007-0240-3; Piersma Theunis, 2005, P262; Prater A.J., 1979, GUIDE IDENTIFICATION; Quaintenne G, 2011, P ROY SOC B-BIOL SCI, V278, P2728, DOI 10.1098/rspb.2011.0026; Quinn JL, 2006, P R SOC B, V273, P2521, DOI 10.1098/rspb.2006.3612; Remisiewicz Magdalena, 2011, Wader Study Group Bulletin, V118, P163; Rohwer S, 2011, CONDOR, V113, P61, DOI 10.1525/cond.2011.100092; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; Serra L, 2006, IBIS, V148, P292, DOI 10.1111/j.1474-919X.2006.00532.x; Serra L, 2001, J AVIAN BIOL, V32, P377, DOI 10.1111/j.0908-8857.2001.320415.x; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Summers RW, 2010, IBIS, V152, P127, DOI 10.1111/j.1474-919X.2009.00972.x; Tomkovich P.S., 1992, WADER STUDY GROUP S, V64, P17; Tomkovich PS, 1996, ARDEA, V84, P85; Underhill L.G., 1993, Wader Study Group Bulletin, V71, P29; UNDERHILL LG, 1990, IBIS, V132, P118, DOI 10.1111/j.1474-919X.1990.tb01024.x; UNDERHILL LG, 1988, IBIS, V130, P358, DOI 10.1111/j.1474-919X.1988.tb00993.x; Vagasi CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040651; Vagasi CI, 2011, ARDEA, V99, P53, DOI 10.5253/078.099.0107; Vagasi CI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014215; Van Den Hout PJ, 2008, IBIS, V150, P219, DOI 10.1111/j.1474-919X.2008.00785.x; van den Hout PJ, 2010, BEHAV ECOL, V21, P16, DOI 10.1093/beheco/arp146; van Gils JA, 2003, J EXP BIOL, V206, P3369, DOI 10.1242/jeb.00546; Vezina F, 2009, PHYSIOL BIOCHEM ZOOL, V82, P129, DOI 10.1086/596512; WHITFIELD DP, 1991, IBIS, V133, P246, DOI 10.1111/j.1474-919X.1991.tb04566.x; WIERSMA P, 1994, CONDOR, V96, P257, DOI 10.2307/1369313; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149	63	26	28	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53890	10.1371/journal.pone.0053890	http://dx.doi.org/10.1371/journal.pone.0053890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349758	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900024
J	Donald, DB; Bogard, MJ; Finlay, K; Bunting, L; Leavitt, PR				Donald, Derek B.; Bogard, Matthew J.; Finlay, Kerri; Bunting, Lynda; Leavitt, Peter R.			Phytoplankton-Specific Response to Enrichment of Phosphorus-Rich Surface Waters with Ammonium, Nitrate, and Urea	PLOS ONE			English	Article							EXPERIMENTAL LAKES AREA; FRESH-WATER; COMMUNITY COMPOSITION; MICROCYSTIS-AERUGINOSA; OSCILLATORIA-AGARDHII; NITROGEN ASSIMILATION; TEMPORAL VARIABILITY; SUPPLY RATIOS; CHLOROPHYLL-A; ALGAL GROWTH	Supply of anthropogenic nitrogen (N) to the biosphere has tripled since 1960; however, little is known of how in situ response to N fertilisation differs among phytoplankton, whether species response varies with the chemical form of N, or how interpretation of N effects is influenced by the method of analysis (microscopy, pigment biomarkers). To address these issues, we conducted two 21-day in situ mesocosm (3140 L) experiments to quantify the species- and genus-specific responses of phytoplankton to fertilisation of P-rich lake waters with ammonium (NH4+), nitrate (NO3-), and urea ([NH2](2)CO). Phytoplankton abundance was estimated using both microscopic enumeration of cell densities and high performance liquid chromatographic (HPLC) analysis of algal pigments. We found that total algal biomass increased 200% and 350% following fertilisation with NO3- and chemically-reduced N (NH4+, urea), respectively, although 144 individual taxa exhibited distinctive responses to N, including compound-specific stimulation (Planktothrix agardhii and NH4+), increased biomass with chemically-reduced N alone (Scenedesmus spp., Coelastrum astroideum) and no response (Aphanizomenon flos-aquae, Ceratium hirundinella). Principle components analyses (PCA) captured 53.2-69.9% of variation in experimental assemblages irrespective of the degree of taxonomic resolution of analysis. PCA of species-level data revealed that congeneric taxa exhibited common responses to fertilisation regimes (e.g., Microcystis aeruginosa, M. flos-aquae, M. botrys), whereas genera within the same division had widely divergent responses to added N (e.g., Anabaena, Planktothrix, Microcystis). Least-squares regression analysis demonstrated that changes in phytoplankton biomass determined by microscopy were correlated significantly (p<0.005) with variations in HPLC-derived concentrations of biomarker pigments (r(2) = 0.13-0.64) from all major algal groups, although HPLC tended to underestimate the relative abundance of cyanobacteria. Together, these findings show that while fertilisation of P-rich lakes with N can increase algal biomass, there is substantial variation in responses of genera and divisions to specific chemical forms of added N.	[Donald, Derek B.; Bogard, Matthew J.; Bunting, Lynda; Leavitt, Peter R.] Univ Regina, Dept Biol, Limnol Lab, Regina, SK S4S 0A2, Canada	University of Regina	Leavitt, PR (corresponding author), Univ Regina, Dept Biol, Limnol Lab, Regina, SK S4S 0A2, Canada.	Peter.Leavitt@uregina.ca	Bunting, Lynda/K-2039-2013; Leavitt, Peter R/A-1048-2013	Leavitt, Peter R/0000-0001-9805-9307	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Research Chairs, Canada Foundation for Innovation; Province of Saskatchewan; University of Regina	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs, Canada Foundation for Innovation(Canada Foundation for InnovationCanada Research Chairs); Province of Saskatchewan; University of Regina	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant (PRL) and Graduate Scholarships (DBD), Canada Research Chairs, Canada Foundation for Innovation, the Province of Saskatchewan, and the University of Regina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN RJ, 1980, ENVIRON POLLUT B, V1, P217, DOI 10.1016/0143-148X(80)90012-9; [Anonymous], 2002, TRACKING ENV CHANGE, DOI DOI 10.1007/0-306-47668-1_15; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; BARICA J, 1980, CAN J FISH AQUAT SCI, V37, P1175, DOI 10.1139/f80-150; Berg GM, 2003, AQUAT MICROB ECOL, V30, P263, DOI 10.3354/ame030263; Berman T, 1999, J PLANKTON RES, V21, P1423, DOI 10.1093/plankt/21.8.1423; BLOMQVIST P, 1994, ARCH HYDROBIOL, V132, P141; Bruggeman J, 2011, J PHYCOL, V47, P52, DOI 10.1111/j.1529-8817.2010.00946.x; Bunting L, 2007, LIMNOL OCEANOGR, V52, P354, DOI 10.4319/lo.2007.52.1.0354; Burger DF, 2007, FUND APPL LIMNOL, V169, P57, DOI 10.1127/1863-9135/2007/0169-0057; Carneiro FM, 2010, ECOL INDIC, V10, P249, DOI 10.1016/j.ecolind.2009.05.004; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Collier JL, 2012, J PHYCOL, V48, P106, DOI 10.1111/j.1529-8817.2011.01100.x; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Dolman AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038757; Donald DB, 2011, LIMNOL OCEANOGR, V56, P2161, DOI 10.4319/lo.2011.56.6.2161; Droscher I, 2009, LIMNOL OCEANOGR, V54, P2469, DOI 10.4319/lo.2009.54.6_part_2.2469; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Edwards KF, 2011, ECOLOGY, V92, P2085, DOI 10.1890/11-0395.1; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fastner J, 1999, ARCH HYDROBIOL, V145, P147; Fernandez E, 2007, J EXP BOT, V58, P2279, DOI 10.1093/jxb/erm106; Finlay K, 2009, LIMNOL OCEANOGR, V54, P2553, DOI 10.4319/lo.2009.54.6_part_2.2553; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1213, DOI 10.4319/lo.2010.55.3.1213; Flores E, 2005, BIOCHEM SOC T, V33, P164, DOI 10.1042/BST0330164; FOY RH, 1995, WATER RES, V29, P1051, DOI 10.1016/0043-1354(94)00259-A; FOY RH, 1987, FRESHWATER BIOL, V17, P237, DOI 10.1111/j.1365-2427.1987.tb01045.x; Fujimoto N, 1997, LIMNOL OCEANOGR, V42, P250, DOI 10.4319/lo.1997.42.2.0250; Giani A, 2005, CAN J FISH AQUAT SCI, V62, P2100, DOI 10.1139/F05-124; Ginn HP, 2010, APPL ENVIRON MICROB, V76, P4362, DOI 10.1128/AEM.01862-09; Grover JP, 1999, ARCH HYDROBIOL, V145, P1; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; HOLMGREN SK, 1984, INT REV GES HYDROBIO, V69, P781, DOI 10.1002/iroh.19840690603; Hyenstrand P, 2000, HYDROBIOLOGIA, V435, P91, DOI 10.1023/A:1004008721373; James C, 2003, ARCH HYDROBIOL, V158, P249, DOI 10.1127/0003-9136/2003/0158-0249; Jeffrey S.W., 2003, PHYTOPLANKTON PIGMEN; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JENSEN JP, 1994, CAN J FISH AQUAT SCI, V51, P1692, DOI 10.1139/f94-170; John D., 2002, FRESHWATER ALGAE FLO; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; KLEMER AR, 1976, ARCH HYDROBIOL, V78, P343; Kruk C, 2011, LIMNOL OCEANOGR, V56, P110, DOI 10.4319/lo.2011.56.1.0110; LATHROP RC, 1988, CAN J FISH AQUAT SCI, V45, P2061, DOI 10.1139/f88-240; Leavitt PR, 2006, LIMNOL OCEANOGR, V51, P2262, DOI 10.4319/lo.2006.51.5.2262; LEAVITT PR, 1994, CAN J FISH AQUAT SCI, V51, P2286, DOI 10.1139/f94-232; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; Levine SN, 1999, CAN J FISH AQUAT SCI, V56, P451, DOI 10.1139/cjfas-56-3-451; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lomas MW, 1999, LIMNOL OCEANOGR, V44, P556, DOI 10.4319/lo.1999.44.3.0556; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; McCarthy MJ, 2009, LIMNOLOGY, V10, P215, DOI 10.1007/s10201-009-0277-5; McGowan S, 2005, ECOSYSTEMS, V8, P694, DOI 10.1007/s10021-003-0152-x; Millennium Ecosystem Assessment, 2005, MILL ASS SER, V1; MILLIE DF, 1993, CAN J FISH AQUAT SCI, V50, P2513, DOI 10.1139/f93-275; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Patoine A, 2008, INT VER THEOR ANGEW, V30, P366; Patoine A, 2006, LIMNOL OCEANOGR, V51, P1665, DOI 10.4319/lo.2006.51.4.1665; PEREZMARTINEZ C, 1995, FRESHWATER BIOL, V33, P193, DOI 10.1111/j.1365-2427.1995.tb01160.x; Pham SV, 2009, LIMNOL OCEANOGR, V54, P101, DOI 10.4319/lo.2009.54.1.0101; PRESCOTT GW, 1982, ALGAE W GREAT LAKES; Revilla M, 2005, LIMNOL OCEANOGR-METH, V3, P290, DOI 10.4319/lom.2005.3.290; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; Sanderson MP, 2008, AQUAT MICROB ECOL, V51, P153, DOI 10.3354/ame01178; Sandgren C.D., 1988, GROWTH REPROD STRATE; Scheffer M, 1997, ECOLOGY, V78, P272; Schindler DW, 2006, LIMNOL OCEANOGR, V51, P356, DOI 10.4319/lo.2006.51.1_part_2.0356; Schindler DW, 2009, SCIENCE, V324, P721, DOI 10.1126/science.324_721b; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Schwaderer AS, 2011, LIMNOL OCEANOGR, V56, P589, DOI 10.4319/lo.2011.56.2.0589; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith Val H., 1995, Archiv fuer Hydrobiologie Supplementband, V107, P71; Solomon CM, 2010, AQUAT MICROB ECOL, V59, P67, DOI 10.3354/ame01390; SOMMER U, 1989, LIMNOL OCEANOGR, V34, P1162, DOI 10.4319/lo.1989.34.7.1162; Staehr PA, 2002, MAR ECOL PROG SER, V238, P47, DOI 10.3354/meps238047; Stainton MP, 1977, CANADIAN FISHERIES M, V25; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; TAKAMURA N, 1987, J PLANKTON RES, V9, P151, DOI 10.1093/plankt/9.1.151; TILMAN D, 1986, ARCH HYDROBIOL, V106, P473; TURPIN DH, 1985, PLANT PHYSIOL, V78, P746, DOI 10.1104/pp.78.4.746; United States Environmental Protection Agency, 2007, EPA823R07002 OFF WAT; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Valladares A, 2002, MOL MICROBIOL, V43, P703, DOI 10.1046/j.1365-2958.2002.02778.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Waiser MJ, 2011, ENVIRON TOXICOL CHEM, V30, P496, DOI 10.1002/etc.399; Wehr J. D., 2003, FRESHWATER ALGAE N A; ZEVENBOOM W, 1982, LIMNOL OCEANOGR, V27, P39, DOI 10.4319/lo.1982.27.1.0039	94	102	105	2	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53277	10.1371/journal.pone.0053277	http://dx.doi.org/10.1371/journal.pone.0053277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349705	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900008
J	Higuchi, Y; Sumiyoshi, T; Seo, T; Miyanishi, T; Kawasaki, Y; Suzuki, M				Higuchi, Yuko; Sumiyoshi, Tomiki; Seo, Tomonori; Miyanishi, Tomohiro; Kawasaki, Yasuhiro; Suzuki, Michio			Mismatch Negativity and Cognitive Performance for the Prediction of Psychosis in Subjects with At-Risk Mental State	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; FOLLOW-UP; 1ST-EPISODE SCHIZOPHRENIA; UNTREATED PSYCHOSIS; LORETA ANALYSIS; P300 AMPLITUDE; 1ST EPISODE; DURATION; MMN; REDUCTION	Background: A shorter duration of untreated psychosis has been associated with better prognosis in schizophrenia. In this study, we measured the duration mismatch negativity (dMMN), an event-related potential, and cognitive performance in subjects with at-risk mental state (ARMS), patients with first-episode or chronic schizophrenia, and healthy volunteers. The main interest was to determine if these neurocognitive measures predict progression to overt schizophrenia in ARMS subjects. Methodology/Principal Findings: Seventeen ARMS subjects, meeting the criteria of the Comprehensive Assessment of At-Risk Mental State, 31 schizophrenia patients (20 first-episode and 11 chronic) and healthy controls (N = 20) participated in the study. dMMN was measured by an auditory odd-ball paradigm at baseline. Neuropsychological performance was evaluated by the Japanese version of the Brief assessment of cognitive function of schizophrenia (BACS-J). The first-episode schizophrenia group showed significantly smaller amplitudes at frontal electrodes than did control subjects whereas chronic patients elicited smaller amplitudes at frontal and central electrodes, consistent with previous reports. During the follow-up period, 4 out of the 17 ARMS subjects transitioned to schizophrenia (converters) while 13 did not (non-converters). Specifically, dMMN amplitudes of non-converters did not differ from those of healthy controls, while converters showed significantly smaller dMMN amplitudes at some electrodes compared to control subjects. Converters performed significantly worse on tests of working memory, verbal fluency, and attention/information processing than did non-converters. There was a significant positive correlation between dMMN amplitudes at the frontal electrodes and verbal fluency, as measured by the BACS, in the AMRS subjects as a whole. Conclusions/Significance: ARMS subjects who later developed schizophrenia elicited smaller dMMN amplitudes to begin with, compared to non-converters. Notably, we have provided the first evidence for the ability of verbal fluency to predict dMMN amplitudes in ARMS subjects. These findings are expected to add to the efforts for early diagnosis and intervention of schizophrenia.	[Higuchi, Yuko; Sumiyoshi, Tomiki; Seo, Tomonori; Miyanishi, Tomohiro; Suzuki, Michio] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neuropsychiat, Toyama 930, Japan; [Kawasaki, Yasuhiro] Kanazawa Med Univ, Dept Neuropsychiat, Uchinada, Ishikawa 92002, Japan	University of Toyama; Kanazawa Medical University	Sumiyoshi, T (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neuropsychiat, Toyama 930, Japan.	tomikisumiyoshi840@hotmail.com	Sumiyoshi, Tomiki/K-4507-2019		Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare, Japan; SENSHIN Medical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This work was supported by grants-in-aid for Scientific Research from Japan Society for the Promotion of Science, grants-in-aid from the Ministry of Health, Labour and Welfare, Japan, and SENSHIN Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2005, BRIT J PSYCHIAT, V187, pS120, DOI 10.1192/bjp.187.48.s120; Andreasen N C, 1990, Mod Probl Pharmacopsychiatry, V24, P73; Atkinson RJ, 2012, BIOL PSYCHIAT, V71, P98, DOI 10.1016/j.biopsych.2011.08.023; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Bruder GE, 1998, PSYCHOPHYSIOLOGY, V35, P54, DOI 10.1111/1469-8986.3510054; Brzustowicz LM, 2004, AM J HUM GENET, V74, P1057, DOI 10.1086/420774; Carrion RE, 2011, AM J PSYCHIAT, V168, P806, DOI 10.1176/appi.ajp.2011.10081209; Chang WC, 2011, SCHIZOPHR RES, V133, P22, DOI 10.1016/j.schres.2011.09.006; Edwards J, 1999, SCHIZOPHR RES, V40, P147, DOI 10.1016/S0920-9964(99)00043-2; Eriksson J, 2005, BIOSYSTEMS, V79, P207, DOI 10.1016/j.biosystems.2004.09.017; Frommann I, 2011, SCHIZOPHRENIA BULL, V37, P861, DOI 10.1093/schbul/sbp155; Galderisi S, 2012, EUR NEUROPSYCHOPHARM; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 1996, AM J PSYCHIAT, V153, P321; Green MF, 2008, AM J PSYCHIAT, V165, P221, DOI 10.1176/appi.ajp.2007.07010089; Harvey PD, 2004, J CLIN PSYCHIAT, V65, P361; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Higuchi Y, 2008, SCHIZOPHR RES, V101, P320, DOI 10.1016/j.schres.2008.01.020; Higuchi Y, 2010, J CLIN PSYCHOPHARM, V30, P732, DOI 10.1097/JCP.0b013e3181faa57d; Ikezawa S, 2008, INT J PSYCHOPHYSIOL, V68, P41, DOI 10.1016/j.ijpsycho.2008.01.006; Itoh T, 2011, NEUROSCI RES, V70, P442, DOI 10.1016/j.neures.2011.05.003; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Kaneda Y, 2008, SEISHINIGAKU, V50, P913; Kaneda Y, 2007, PSYCHIAT CLIN NEUROS, V61, P602, DOI 10.1111/j.1440-1819.2007.01725.x; Kasai K, 2002, CLIN NEUROPHYSIOL, V113, P141, DOI 10.1016/S1388-2457(01)00710-6; Kaur M, 2011, SCHIZOPHR RES, V130, P203, DOI 10.1016/j.schres.2011.03.025; Kawasaki Y, 1997, SCHIZOPHR RES, V26, P107, DOI 10.1016/S0920-9964(97)00055-8; Kawasaki Y, 2007, SCHIZOPHR RES, V94, P164, DOI 10.1016/j.schres.2007.04.015; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Leung S, 2007, PSYCHOPHARMACOLOGY, V194, P443, DOI 10.1007/s00213-007-0865-1; Lin YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034454; LOEBEL AD, 1992, AM J PSYCHIAT, V149, P1183; Malla AK, 2004, J NERV MENT DIS, V192, P455, DOI 10.1097/01.nmd.0000131804.34977.c1; Matsubayashi J, 2008, BRAIN RES, V1236, P159, DOI 10.1016/j.brainres.2008.07.120; McGorry PD, 2009, J CLIN PSYCHIAT, V70, P1206, DOI 10.4088/JCP.08r04472; Melle I, 2008, ARCH GEN PSYCHIAT, V65, P634, DOI 10.1001/archpsyc.65.6.634; Meltzer HY, 2003, BIOL PSYCHIAT, V53, P265, DOI 10.1016/S0006-3223(02)01790-0; Michie PT, 2000, CLIN NEUROPHYSIOL, V111, P1054, DOI 10.1016/S1388-2457(00)00275-3; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Nakamura K, 2004, SCHIZOPHRENIA BULL, V30, P393, DOI 10.1093/oxfordjournals.schbul.a007087; Ozgurdal S, 2008, SCHIZOPHR RES, V105, P272, DOI 10.1016/j.schres.2008.05.017; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785; ROTH WT, 1980, ELECTROEN CLIN NEURO, V49, P497, DOI 10.1016/0013-4694(80)90392-2; Salisbury DF, 2002, ARCH GEN PSYCHIAT, V59, P686, DOI 10.1001/archpsyc.59.8.686; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Shaikh M, 2012, SCHIZOPHR RES, V134, P42, DOI 10.1016/j.schres.2011.09.022; Stone JM, 2009, BIOL PSYCHIAT, V66, P533, DOI 10.1016/j.biopsych.2009.05.006; Sumiyoshi T, 2003, SCHIZOPHR RES, V59, P7, DOI 10.1016/S0920-9964(01)00329-2; Sumiyoshi T, 2006, PROG NEURO-PSYCHOPH, V30, P1299, DOI 10.1016/j.pnpbp.2006.04.028; Sumiyoshi T, 2009, PSYCHIAT RES-NEUROIM, V172, P180, DOI 10.1016/j.pscychresns.2008.07.005; Takahashi T, 2011, PROG NEURO-PSYCHOPH, V35, P1957, DOI 10.1016/j.pnpbp.2011.07.009; Takayanagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021047; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Umbricht D, 1998, BIOL PSYCHIAT, V44, P716, DOI 10.1016/S0006-3223(97)00524-6; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Yamazawa R, 2008, AUST NZ J PSYCHIAT, V42, P159, DOI 10.1080/00048670701787537; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x; Yung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6	67	66	67	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54080	10.1371/journal.pone.0054080	http://dx.doi.org/10.1371/journal.pone.0054080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349791	Green Submitted, gold, Green Published			2022-12-27	WOS:000313738900037
J	Law, SP; Fung, R; Kung, C				Law, Sam-Po; Fung, Roxana; Kung, Carmen			An ERP Study of Good Production vis-a-vis Poor Perception of Tones in Cantonese: Implications for Top-Down Speech Processing	PLOS ONE			English	Article							PURE WORD DEAFNESS; MISMATCH NEGATIVITY; MEMORY TRACES; MOTOR THEORY; P300; ORGANIZATION; LATENCY; SOUNDS; SPOKEN; INTERFACE	This study investigated a theoretically challenging dissociation between good production and poor perception of tones among neurologically unimpaired native speakers of Cantonese. The dissociation is referred to as the near-merger phenomenon in sociolinguistic studies of sound change. In a passive oddball paradigm, lexical and nonlexical syllables of the T1/T6 and T4/T6 contrasts were presented to elicit the mismatch negativity (MMN) and P3a from two groups of participants, those who could produce and distinguish all tones in the language (Control) and those who could produce all tones but specifically failed to distinguish between T4 and T6 in perception (Dissociation). The presence of MMN to T1/T6 and null response to T4/T6 of lexical syllables in the dissociation group confirmed the near-merger phenomenon. The observation that the control participants exhibited a statistically reliable MMN to lexical syllables of T1/T6, weaker responses to nonlexical syllables of T1/T6 and lexical syllables of T4/T6, and finally null response to nonlexical syllables of T4/T6, suggests the involvement of top-down processing in speech perception. Furthermore, the stronger P3a response of the control group, compared with the dissociation group in the same experimental conditions, may be taken to indicate higher cognitive capability in attention switching, auditory attention or memory in the control participants. This cognitive difference, together with our speculation that constant top-down predictions without complete bottom-up analysis of acoustic signals in speech recognition may reduce one's sensitivity to small acoustic contrasts, account for the occurrence of dissociation in some individuals but not others.	[Law, Sam-Po] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Fung, Roxana] Hong Kong Polytech Univ, Hong Kong, Hong Kong, Peoples R China; [Kung, Carmen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	University of Hong Kong; Hong Kong Polytechnic University; Radboud University Nijmegen	Law, SP (corresponding author), Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.	splaw@hku.hk		Kung, Carmen/0000-0003-3981-6990	Hong Kong Polytechnic University [Z448F]; University of Hong Kong [10401150.14304.10010.323.01]	Hong Kong Polytechnic University(Hong Kong Polytechnic University); University of Hong Kong(University of Hong Kong)	This research was supported by the Hong Kong Polytechnic University (Project no. Z448F, http://www.polyu.edu.hk/cpa/polyu/index.php) and the University of Hong Kong (Project no. 10401150.14304.10010.323.01, http://www.hku.hk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2011, PLOS ONE, V6, P1; Atienza M, 2012, LEARN MEMORY, V9, P138; Auberbach SH, 1982, BRAIN, V105, P271; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Bishop DVM, 2011, DEVELOPMENTAL SCI, V14, P402, DOI 10.1111/j.1467-7687.2010.00990.x; Bishop DVM, 2010, J NEUROSCI, V30, P15578, DOI 10.1523/JNEUROSCI.2217-10.2010; BLUMSTEIN SE, 1977, NEUROPSYCHOLOGIA, V15, P19, DOI 10.1016/0028-3932(77)90111-7; Buchsbaum BR, 2001, COGNITIVE SCI, V25, P663, DOI 10.1207/s15516709cog2505_2; Chandrasekaran B, 2007, BRAIN RES, V1128, P148, DOI 10.1016/j.brainres.2006.10.064; Chen Y., 2011, P PSYCHOLINGUISTICS, P38; Davis MH, 2007, HEARING RES, V229, P132, DOI 10.1016/j.heares.2007.01.014; Dell GS, 1997, PSYCHOL REV, V104, P801, DOI 10.1037/0033-295X.104.4.801; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Fodor J. A, 1983, MODULARITY MIND; Fung RSY, 2010, TON INT 4 STOCKH SWE, V4; Fung RSY, 2010, 15 INT C YUE DIAL MA; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; GANONG WF, 1980, J EXP PSYCHOL HUMAN, V6, P110, DOI 10.1037/0096-1523.6.1.110; GARCIALARREA L, 1992, NEUROPSYCHOLOGIA, V30, P723, DOI 10.1016/0028-3932(92)90042-K; Gaskell MG, 1997, LANG COGNITIVE PROC, V12, P613, DOI 10.1080/016909697386646; GOODGLASS H, 1976, BRAIN LANG, V3, P359, DOI 10.1016/0093-934X(76)90032-8; GROSJEAN F, 1980, PERCEPT PSYCHOPHYS, V28, P267, DOI 10.3758/BF03204386; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2001, J PSYCHOLINGUIST RES, V30, P225, DOI 10.1023/A:1010486816667; Hickok G., 2009, COGNITIVE NEUROSCIEN, P767; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2010, LANG COGNITIVE PROC, V25, P749, DOI 10.1080/01690961003595572; Hillis AE, 1999, NEUROLOGY, V53, P1813, DOI 10.1212/WNL.53.8.1813; Horvath J, 2008, BIOL PSYCHOL, V39, P179; Houlihan M, 1998, INTELLIGENCE, V26, P9, DOI 10.1016/S0160-2896(99)80049-X; JOHNSON R, 1985, PSYCHOPHYSIOLOGY, V22, P497, DOI 10.1111/j.1469-8986.1985.tb01639.x; Karen M., 1991, LANG VAR CHANGE, V3, P33, DOI 10.1017/S0954394500000442; Labov W., 1994, PRINCIPLES LINGUISTI, V1; Law SP, 2009, LANG COGNITIVE PROC, V24, P983, DOI 10.1080/01690960802193696; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; MICELI G, 1982, NEUROPSYCHOLOGIA, V20, P5, DOI 10.1016/0028-3932(82)90083-5; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; NOVAK G, 1992, PSYCHOPHYSIOLOGY, V29, P398, DOI 10.1111/j.1469-8986.1992.tb01713.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Peelle JE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00051; Poeppel D, 2001, COGNITIVE SCI, V25, P679, DOI 10.1207/s15516709cog2505_3; Poeppel D., 2011, LEXICAL REPRESENTATI, P171; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; POLICH J, 1983, PSYCHOPHYSIOLOGY, V20, P665, DOI 10.1111/j.1469-8986.1983.tb00936.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; PORT RF, 1985, J PHONETICS, V13, P455, DOI 10.1016/S0095-4470(19)30797-1; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; Pulvermuller F, 2004, PSYCHOPHYSIOLOGY, V41, P106, DOI 10.1111/j.1469-8986.2003.00135.x; Rapp B, 1997, BRAIN LANG, V56, P248, DOI 10.1006/brln.1997.1735; Rapp B, 2000, PSYCHOL REV, V107, P460, DOI 10.1037/0033-295X.107.3.460; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; Rinne T, 2006, BRAIN RES, V1077, P135, DOI 10.1016/j.brainres.2006.01.043; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Shtyrov Y, 2002, NEUROREPORT, V13, P521, DOI 10.1097/00001756-200203250-00033; Sohoglu E, 2012, J NEUROSCI, V32, P8443, DOI 10.1523/JNEUROSCI.5069-11.2012; Stefanatos GA, 2005, J INT NEUROPSYCH SOC, V11, P456, DOI 10.1017/S1355617705050538; Sussman E, 2003, PSYCHON B REV, V10, P630, DOI 10.3758/BF03196525; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Tsang YK, 2011, NEUROSCI LETT, V487, P268, DOI 10.1016/j.neulet.2010.10.035; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; WARREN RM, 1970, SCI AM, V223, P30, DOI 10.1038/scientificamerican1270-30; Yaeger Malcah, 1972, QUANTITATIVE STUDY S; Yu A.C., 2007, PHONOLOGY, V24, P187, DOI [10.1017/s0952675707001157, DOI 10.1017/S0952675707001157]; Yuan JH, J CHINESE L IN PRESS, V41	70	23	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54396	10.1371/journal.pone.0054396	http://dx.doi.org/10.1371/journal.pone.0054396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342146	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700111
J	Chatterjee, A; Saranath, D; Bhatter, P; Mistry, N				Chatterjee, Anirvan; Saranath, Dhananjaya; Bhatter, Purva; Mistry, Nerges			Global Transcriptional Profiling of Longitudinal Clinical Isolates of Mycobacterium tuberculosis Exhibiting Rapid Accumulation of Drug Resistance	PLOS ONE			English	Article							EFFLUX PUMP; GENE-EXPRESSION; PULMONARY TUBERCULOSIS; POPULATION-GENETICS; TREATMENT-FAILURE; INDIA; MULTIDRUG; EPIDEMIOLOGY; BACTERIA; HOST	The identification of multidrug resistant (MDR), extensively and totally drug resistant Mycobacterium tuberculosis (Mtb), in vulnerable sites such as Mumbai, is a grave threat to the control of tuberculosis. The current study aimed at explaining the rapid expression of MDR in Directly Observed Treatment Short Course (DOTS) compliant patients, represents the first study comparing global transcriptional profiles of 3 pairs of clinical Mtb isolates, collected longitudinally at initiation and completion of DOTS. While the isolates were drug susceptible (DS) at onset and MDR at completion of DOTS, they exhibited identical DNA fingerprints at both points of collection. The whole genome transcriptional analysis was performed using total RNA from H37Rv and 3 locally predominant spoligotypes viz. MANU1, CAS and Beijing, hybridized on MTBv3 (BuG@S) microarray, and yielded 36, 98 and 45 differentially expressed genes respectively. Genes encoding transcription factors (sig, rpoB), cell wall biosynthesis (emb genes), protein synthesis (rpl) and additional central metabolic pathways (ppdK, pknH, pfkB) were found to be down regulated in the MDR isolates as compared to the DS isolate of the same genotype. Up regulation of drug efflux pumps, ABC transporters, trans-membrane proteins and stress response transcriptional factors (whiB) in the MDR isolates was observed. The data indicated that Mtb, without specific mutations in drug target genes may persist in the host due to additional mechanisms like drug efflux pumps and lowered rate of metabolism. Furthermore this population of Mtb, which also showed reduced DNA repair activity, would result in selection and stabilization of spontaneous mutations in drug target genes, causing selection of a MDR strain in the presence of drug pressures. Efflux pump such as drrA may play a significant role in increasing fitness of low level drug resistant cells and assist in survival of Mtb till acquisition of drug resistant mutations with least fitness cost.	[Chatterjee, Anirvan; Saranath, Dhananjaya; Bhatter, Purva; Mistry, Nerges] Fdn Med Res, Dept TB, Bombay, Maharashtra, India		Mistry, N (corresponding author), Fdn Med Res, Dept TB, Bombay, Maharashtra, India.	fmr@fmrindia.org		Chatterjee, Anirvan/0000-0002-7113-9718	Department of Biotechnology, Government of India, Center of Excellence Grant [BT/01/COE/05/06/01]	Department of Biotechnology, Government of India, Center of Excellence Grant	The study was supported by Department of Biotechnology, Government of India, Center of Excellence Grant BT/01/COE/05/06/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Arora J, 2009, INFECT GENET EVOL, V9, P832, DOI 10.1016/j.meegid.2009.05.008; Balganesh M, 2010, ANTIMICROB AGENTS CH, V54, P5167, DOI 10.1128/AAC.00610-10; Beisiegel M, 2009, EUR J IMMUNOL, V39, P3369, DOI 10.1002/eji.200939615; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatter P, 2011, TUBERCULOSIS EDINB; Bhatter P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033507; Brites D, 2011, INFECT GENET EVOL; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chatterjee A, 2010, J CLIN MICROBIOL, V48, P3593, DOI 10.1128/JCM.00430-10; Chen LC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-5; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; De Rossi E, 1998, J BACTERIOL, V180, P6068, DOI 10.1128/JB.180.22.6068-6071.1998; Dhar N, 2010, P NATL ACAD SCI USA, V107, P12275, DOI 10.1073/pnas.1003219107; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Jiang X, 2008, MICROB DRUG RESIST, V14, P7, DOI 10.1089/mdr.2008.0772; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kubica GP, 1972, INT J SYSTEMATIC BAC, V22, P8; Levin BR, 2000, GENETICS, V154, P985; Machado D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034538; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Mangan JA, 1997, NUCLEIC ACIDS RES, V25, P675, DOI 10.1093/nar/25.3.675; McCarthy AJ, 2011, GENOME BIOL EVOL, V3, P1164, DOI 10.1093/gbe/evr092; Mistry NF, 2002, J CLIN MICROBIOL, V40, P2677, DOI 10.1128/JCM.40.7.2677-2680.2002; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mollenkopf HJ, 2004, INFECT IMMUN, V72, P6471, DOI 10.1128/IAI.72.11.6471-6479.2004; Mostowy S, 2004, TUBERCULOSIS, V84, P197, DOI 10.1016/j.tube.2004.02.002; Oda Shinya, 2007, Gan To Kagaku Ryoho, V34, P347; Pasipanodya JG, 2011, CURR OPIN PHARMACOL, V11, P457, DOI 10.1016/j.coph.2011.07.001; Pleban K, 2005, ACTA BIOCHIM POL, V52, P737; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Saier MH, 1998, FASEB J, V12, P265, DOI 10.1096/fasebj.12.3.265; Singh M, 2011, INDIAN J MED RES, V133, P535; Singh UB, 2007, INFECT GENET EVOL, V7, P441, DOI 10.1016/j.meegid.2007.01.003; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; WHO, 2011, WHO GLOBAL TUBERCULO	45	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54717	10.1371/journal.pone.0054717	http://dx.doi.org/10.1371/journal.pone.0054717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355892	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500115
J	Blamires, SJ; Tso, IM				Blamires, Sean J.; Tso, I-Min			Nutrient-Mediated Architectural Plasticity of a Predatory Trap	PLOS ONE			English	Article							SPIDER SILK; DRAGLINE SILK; MECHANICAL-PROPERTIES; ARGIOPE-KEYSERLINGI; NEPHILA-CLAVIPES; PREY VARIATION; ORB WEBS; ARANEIDAE; ARANEAE; PROTEIN	Background: Nutrients such as protein may be actively sought by foraging animals. Many predators exhibit foraging plasticity, but how their foraging strategies are affected when faced with nutrient deprivation is largely unknown. In spiders, the assimilation of protein into silk may be in conflict with somatic processes so we predicted web building to be affected under protein depletion. Methodology/Principal Findings: To assess the influence of protein intake on foraging plasticity we fed the orb-web spiders Argiope aemula and Cyclosa mulmeinensis high, low or no protein solutions over 10 days and allowed them to build webs. We compared post-feeding web architectural components and major ampullate (MA) silk amino acid compositions. We found that the number of radii in webs increased in both species when fed high protein solutions. Mesh size increased in A. aemula when fed a high protein solution. MA silk proline and alanine compositions varied in each species with contrasting variations in alanine between the two species. Glycine compositions only varied in C. mulmeinensis silk. No spiders significantly lost or gained mass on any feeding treatment, so they did not sacrifice somatic maintenance for amino acid investment in silk. Conclusions/Significance: Our results show that the amount of protein taken in significantly affects the foraging decisions of trap-building predators, such as orb web spiders. Nevertheless, the subtle differences found between species in the association between protein intake, the amino acids invested in silk and web architectural plasticity show that the influence of protein deprivation on specific foraging strategies differs among different spiders.	[Blamires, Sean J.; Tso, I-Min] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Tso, I-Min] Tunghai Univ, Ctr Trop Ecol & Biodivers, Taichung 40704, Taiwan	Tunghai University; Tunghai University	Tso, IM (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	spider@thu.edu.tw			National Science Council (NSC) [NSC-98-2811-B-029-002]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	The study was assisted financially by a National Science Council (NSC)postdoctoral fellowship (NSC-98-2811-B-029-002) to SJB and an NSC grant to IMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; Blackledge TA, 2007, ANIM BEHAV, V73, P855, DOI 10.1016/j.anbehav.2006.10.014; Blamires SJ, 2012, J R SOC INTERFACE, V9, P2479, DOI 10.1098/rsif.2012.0277; Blamires SJ, 2012, BIOL J LINN SOC, V106, P580, DOI 10.1111/j.1095-8312.2012.01884.x; Blamires SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031626; Blamires SJ, 2011, AUSTRAL ECOL, V36, P389, DOI 10.1111/j.1442-9993.2010.02161.x; Blamires SJ, 2011, ANIM BEHAV, V81, P955, DOI 10.1016/j.anbehav.2011.01.022; Blamires SJ, 2010, ANIM BEHAV, V80, P947, DOI 10.1016/j.anbehav.2010.09.011; Blamires SJ, 2010, J EXP BIOL, V213, P3207, DOI 10.1242/jeb.045583; Blamires SJ, 2009, ECOL ENTOMOL, V34, P545, DOI 10.1111/j.1365-2311.2009.01095.x; Cheng RC, 2007, BEHAV ECOL, V18, P1085, DOI 10.1093/beheco/arm081; Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292; Craig CL, 2003, SPIDERWEBS SILK TRAC; Creager MS, 2010, BIOMACROMOLECULES, V11, P2039, DOI 10.1021/bm100399x; Denno RF, 2004, ECOL ENTOMOL, V29, P566, DOI 10.1111/j.0307-6946.2004.00628.x; Gan WJ, 2011, J NAT HIST, V45, P35, DOI 10.1080/00222933.2010.512398; Gregoric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026847; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Herberstein ME, 2000, J ARACHNOL, V28, P180, DOI 10.1636/0161-8202(2000)028[0180:EOFTET]2.0.CO;2; Herberstein ME, 2000, EVOL ECOL RES, V2, P69; Herberstein ME, 2000, BIOL REV, V75, P649, DOI 10.1111/j.1469-185X.2000.tb00056.x; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Jensen K, 2012, P ROY SOC B-BIOL SCI, V279, P2212, DOI 10.1098/rspb.2011.2410; Jensen K, 2011, ANIM BEHAV, V81, P993, DOI 10.1016/j.anbehav.2011.01.035; Krebs J.R., 1987, BEHAV ECOL, Vsecond; Lee KP, 2006, J EXP BIOL, V209, P2076, DOI 10.1242/jeb.02253; Liao CP, 2009, BEHAV ECOL, V20, P1194, DOI 10.1093/beheco/arp119; Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174; MASTERS WM, 1984, BEHAV ECOL SOCIOBIOL, V15, P217, DOI 10.1007/BF00292978; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mayntz D, 2009, BIOL LETTERS, V5, P735, DOI 10.1098/rsbl.2009.0431; Moyes CD, 2008, PRINCIPALS ANIMAL PH; Nakata K, 2007, NATURWISSENSCHAFTEN, V94, P853, DOI 10.1007/s00114-007-0264-9; Nakata K, 2009, ANIM BEHAV, V78, P1255, DOI 10.1016/j.anbehav.2009.08.012; Phillips BL, 2006, P ROY SOC B-BIOL SCI, V273, P1545, DOI 10.1098/rspb.2006.3479; Salomon M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1191, DOI 10.1007/s00265-010-1132-8; Scharf I, 2011, BIOL REV, V86, P626, DOI 10.1111/j.1469-185X.2010.00163.x; Seah WK, 2002, J ZOOL, V258, P531, DOI 10.1017/S0952836902001693; SIMPSON SJ, 1995, J INSECT PHYSIOL, V41, P545, DOI 10.1016/0022-1910(95)00006-G; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Simpson SJ, 2011, AUST J ZOOL, V59, P350, DOI 10.1071/ZO11068; Sokal RR, 1995, BIOMETRY; Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998; Tan EJ, 2009, J EXP BIOL, V212, P1832, DOI 10.1242/jeb.030502; Toft S, 2010, PHYSIOL ENTOMOL, V35, P317, DOI 10.1111/j.1365-3032.2010.00746.x; TOWNLEY MA, 1988, J ARACHNOL, V16, P303; Tseng L, 2009, ANIM BEHAV, V78, P425, DOI 10.1016/j.anbehav.2009.05.017; Tso IM, 2007, ETHOLOGY, V113, P324, DOI 10.1111/j.1439-0310.2007.01318.x; Tso IM, 2005, J EXP BIOL, V208, P1053, DOI 10.1242/jeb.01437; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Walter A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1909, DOI 10.1007/s00265-011-1200-8; WORK RW, 1987, J ARACHNOL, V15, P65; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zax DB, 2004, BIOMACROMOLECULES, V5, P732, DOI 10.1021/bm034309x	54	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54558	10.1371/journal.pone.0054558	http://dx.doi.org/10.1371/journal.pone.0054558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349928	gold, Green Published			2022-12-27	WOS:000314019100081
J	Lemes, P; Loyola, RD				Lemes, Priscila; Loyola, Rafael Dias			Accommodating Species Climate-Forced Dispersal and Uncertainties in Spatial Conservation Planning	PLOS ONE			English	Article							HABITAT SUITABILITY MODELS; BRAZILIAN ATLANTIC FOREST; RESERVE NETWORKS; PROTECTED AREAS; BIODIVERSITY; FACE; DISTRIBUTIONS; EXTINCTIONS; PREDICTION; MANAGEMENT	Spatial conservation prioritization should seek to anticipate climate change impacts on biodiversity and to mitigate these impacts through the development of dynamic conservation plans. Here, we defined spatial priorities for the conservation of amphibians inhabiting the Atlantic Forest Biodiversity Hotspot that overcome the likely impacts of climate change on the distribution of this imperiled fauna. First, we built ecological niche models (ENMs) for 431 amphibian species both for current time and for the mid-point of a 30-year period spanning 2071-2099 (i.e. 2080). For modeling species' niches, we combined six modeling methods and three different climate models. We also quantified and mapped model uncertainties. Our consensus models forecasted range shifts that culminate with high species richness in central and eastern Atlantic Forest, both for current time and for 2080. Most species had a significant range contraction (up to 72%) and 12% of species were projected to be regionally extinct. Most species would need to disperse because suitable climatic sites will change. Therefore, we identified a network of priority sites for conservation that minimizes the distance a given species would need to disperse because of changes in future habitat suitability (i.e. climate-forced dispersal) as well as uncertainties associated to ENMs. This network also maximized complementary species representation across currently established protected areas. Priority sites already include possible dispersal corridors linking current and future suitable habitats for amphibians. Although we used the a top-ranked Biodiversity Hotspot and amphibians as a case study for illustrating our approach, our study may help developing more effective conservation strategies under climate change, especially when applied at different spatial scales, geographic regions, and taxonomic groups.	[Lemes, Priscila] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [Loyola, Rafael Dias] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Loyola, RD (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.	rdiasloyola@gmail.com	Lemes, Priscila/I-5877-2013; Loyola, Rafael/S-3978-2019; Loyola, Rafael/A-4425-2008	Lemes, Priscila/0000-0002-0918-5158; Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735	CNPq [147345/2010-3]; CAPES-FCT Program (Brazil-Portugal); Brazilian Research Network on Global Climate Change (Rede CLIMA)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-FCT Program (Brazil-Portugal); Brazilian Research Network on Global Climate Change (Rede CLIMA)	P.L. received a CNPq doctoral scholarship (project # 147345/2010-3). R.D.L. research is funded by CAPES-FCT Program (Brazil-Portugal) and by the Brazilian Research Network on Global Climate Change (Rede CLIMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; ARAUJO MB, 2009, SPATIAL CONSERVATION, P172; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Arponen A, 2005, CONSERV BIOL, V21, P527; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Bush Mark B., 2005, P125; Cabeza M, 2006, BIOL CONSERV, V132, P336, DOI 10.1016/j.biocon.2006.04.025; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Franklin J, 2009, MAPPING SPECIES DIST; Game ET, 2011, GLOBAL CHANGE BIOL, V17, P3150, DOI 10.1111/j.1365-2486.2011.02457.x; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hole DG, 2011, CONSERV BIOL, V25, P305, DOI 10.1111/j.1523-1739.2010.01633.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kamino Luciana H Y, 2012, Biol Lett, V8, P324, DOI 10.1098/rsbl.2011.0942; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Lawler JJ, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P271, DOI 10.1007/978-1-4419-7390-0_14; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lemes P, 2011, NAT CONSERVACAO, V9, P240, DOI 10.4322/natcon.2011.032; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loyola RD, 2008, DIVERS DISTRIB, V14, P949, DOI 10.1111/j.1472-4642.2008.00508.x; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McCarthy MA, 2011, ECOL LETT, V14, P470, DOI 10.1111/j.1461-0248.2011.01608.x; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Mittermeier R, 2010, NAT CONSERVACAO, V8, P197, DOI 10.4322/natcon.00802017; Mittermeier Russell A., 2004, P1; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A, 2009, SPATIAL CONSERVATION; Moilanen A, 2008, ZONATION SOFTWARE SP; Moilanen A, 2006, ECOL MODEL, V199, P115, DOI 10.1016/j.ecolmodel.2006.07.004; Munoz J, 2004, J VEG SCI, V15, P285, DOI 10.1111/j.1654-1103.2004.tb02263.x; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nicholson E, 2007, ECOL APPL, V17, P251, DOI 10.1890/1051-0761(2007)017[0251:MCDUUF]2.0.CO;2; Nori J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025718; Parry ML, 2007, CLIMATE CHANGE 2007; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2011, MONOGRAPHS POPULATIO, P328, DOI [DOI 10.5860/CHOICE.49-6266, 10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Rayfield B, 2009, ECOL MODEL, V220, P725, DOI 10.1016/j.ecolmodel.2008.11.016; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rondinini C, 2005, CONSERV BIOL, V19, P1488, DOI 10.1111/j.1523-1739.2005.00204.x; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Sokal R. H., 1995, BIOMETRY PRINCIPLES; SOS Mata Atlantica Instituto Nacional de Pesquisas Espaciais, 2008, ATL REM FLOR MAT ATL; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; UNEP-WCMC, 2010, DAT STAND WORLD DAT; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838; Wilson KA, 2010, NAT CONSERVACAO, V8, P145, DOI 10.4322/natcon.00802007; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170	71	68	68	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54323	10.1371/journal.pone.0054323	http://dx.doi.org/10.1371/journal.pone.0054323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349850	gold, Green Submitted, Green Published			2022-12-27	WOS:000314019100055
J	Qian, W; Deng, L; Lu, DS; Xu, SH				Qian, Wei; Deng, Lian; Lu, Dongsheng; Xu, Shuhua			Genome-Wide Landscapes of Human Local Adaptation in Asia	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; NATURAL-SELECTION; LINKAGE DISEQUILIBRIUM; GENETIC DIVERSITY; SIGNATURES; SIGNALS; AFRICA; PIGMENTATION; EVOLUTION; VARIANTS	Genetic studies of human local adaptation have been facilitated greatly by recent advances in high-throughput genotyping and sequencing technologies. However, few studies have investigated local adaptation in Asian populations on a genome-wide scale and with a high geographic resolution. In this study, taking advantage of the dense population coverage in Southeast Asia, which is the part of the world least studied in term of natural selection, we depicted genome-wide landscapes of local adaptations in 63 Asian populations representing the majority of linguistic and ethnic groups in Asia. Using genome-wide data analysis, we discovered many genes showing signs of local adaptation or natural selection. Notable examples, such as FOXQ1, MAST2, and CDH4, were found to play a role in hair follicle development and human cancer, signal transduction, and tumor repression, respectively. These showed strong indications of natural selection in Philippine Negritos, a group of aboriginal hunter-gatherers living in the Philippines. MTTP, which has associations with metabolic syndrome, body mass index, and insulin regulation, showed a strong signature of selection in Southeast Asians, including Indonesians. Functional annotation analysis revealed that genes and genetic variants underlying natural selections were generally enriched in the functional category of alternative splicing. Specifically, many genes showing significant difference with respect to allele frequency between northern and southern Asian populations were found to be associated with human height and growth and various immune pathways. In summary, this study contributes to the overall understanding of human local adaptation in Asia and has identified both known and novel signatures of natural selection in the human genome.	[Xu, Shuhua] Chinese Acad Sci, Max Planck Independent Res Grp Populat Genom, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Soc CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Xu, SH (corresponding author), Chinese Acad Sci, Max Planck Independent Res Grp Populat Genom, Shanghai, Peoples R China.	xushua@picb.ac.cn	Xu, Shuhua/AAH-7620-2020; XU, SHUHUA/D-5345-2009	Xu, Shuhua/0000-0002-1975-1002; XU, SHUHUA/0000-0002-1975-1002	National Science Foundation of China [30971577, 31171218]; Shanghai Rising-Star Program [11QA1407600]; Science Foundation of the Chinese Academy of Sciences [KSCX2-EW-Q-1-11, KSCX2-EW-R-01-05, KSCX2-EW-J-15-05]; Ministry of Science and Technology (MoST) International Cooperation Base of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Science Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology (MoST) International Cooperation Base of China	SX was supported by the National Science Foundation of China (30971577; 31171218), Shanghai Rising-Star Program (11QA1407600), and Science Foundation of the Chinese Academy of Sciences (KSCX2-EW-Q-1-11; KSCX2-EW-R-01-05; KSCX2-EW-J-15-05). This research was supported in part by the Ministry of Science and Technology (MoST) International Cooperation Base of China. SX is Max-Planck Independent Junior Research Group Leader and member of CAS Youth Innovation Promotion Association. SX also gratefully acknowledges the support of the K.C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Diaz-Perales A, 2005, J BIOL CHEM, V280, P30367, DOI 10.1074/jbc.M504533200; Evseeva I, 2010, EUR J HUM GENET, V18, P924, DOI 10.1038/ejhg.2010.32; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; Jin WF, 2012, GENOME RES, V22, P519, DOI 10.1101/gr.124784.111; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Ledmyr H, 2002, J LIPID RES, V43, P51; Li JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002578; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Magalon H, 2008, EUR J HUM GENET, V16, P243, DOI 10.1038/sj.ejhg.5201963; Mothe I, 1997, MOL ENDOCRINOL, V11, P1911, DOI 10.1210/me.11.13.1911; Ngamphiw C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021451; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; O'Reilly PF, 2007, GENET EPIDEMIOL, V31, P611; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Ohashi J, 2011, MOL BIOL EVOL, V28, P849, DOI 10.1093/molbev/msq264; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Tennessen JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002127; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wilder JA, 2009, J HUM GENET, V54, P182, DOI 10.1038/jhg.2009.12; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825	54	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54224	10.1371/journal.pone.0054224	http://dx.doi.org/10.1371/journal.pone.0054224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349834	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100052
J	Salzman, J; Klass, DM; Brown, PO				Salzman, Julia; Klass, Daniel M.; Brown, Patrick O.			Improved Discovery of Molecular Interactions in Genome-Scale Data with Adaptive Model-Based Normalization	PLOS ONE			English	Article							MICROARRAY DATA; WIDE ANALYSIS; SPECIFICITY; EXPRESSION; BINDING	Background: High throughput molecular-interaction studies using immunoprecipitations (IP) or affinity purifications are powerful and widely used in biology research. One of many important applications of this method is to identify the set of RNAs that interact with a particular RNA-binding protein (RBP). Here, the unique statistical challenge presented is to delineate a specific set of RNAs that are enriched in one sample relative to another, typically a specific IP compared to a nonspecific control to model background. The choice of normalization procedure critically impacts the number of RNAs that will be identified as interacting with an RBP at a given significance threshold - yet existing normalization methods make assumptions that are often fundamentally inaccurate when applied to IP enrichment data. Methods: In this paper, we present a new normalization methodology that is specifically designed for identifying enriched RNA or DNA sequences in an IP. The normalization (called adaptive or AD normalization) uses a basic model of the IP experiment and is not a variant of mean, quantile, or other methodology previously proposed. The approach is evaluated statistically and tested with simulated and empirical data. Results and Conclusions: The adaptive (AD) normalization method results in a greatly increased range in the number of enriched RNAs identified, fewer false positives, and overall better concordance with independent biological evidence, for the RBPs we analyzed, compared to median normalization. The approach is also applicable to the study of pairwise RNA, DNA and protein interactions such as the analysis of transcription factors via chromatin immunoprecipitation (ChIP) or any other experiments where samples from two conditions, one of which contains an enriched subset of the other, are studied.	[Salzman, Julia; Klass, Daniel M.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Salzman, Julia; Klass, Daniel M.; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Salzman, Julia] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Salzman, J (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	julia.salzman@stanford.edu; pbrown@stanford.edu			Howard Hughes Medical Institute; National Institutes of Health [NIH RO1 CA77097]; National Science Foundation [NSF-DMS 0940077]; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported mainly by the Howard Hughes Medical Institute and by a grant from the National Institutes of Health to POB (NIH RO1 CA77097). POB is an investigator for the Howard Hughes Medical Institute. DMK was also partially supported by a National Science Foundation pre-doctoral fellowship. JS was supported by National Science Foundation Mathematical Sciences Grant (NSF-DMS 0940077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Duttagupta R, 2005, MOL CELL BIOL, V25, P5499, DOI 10.1128/MCB.25.13.5499-5513.2005; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Mann HB, 1943, ANN MATH STAT, V14, P217, DOI 10.1214/aoms/1177731415; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Ni TT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-505; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53930	10.1371/journal.pone.0053930	http://dx.doi.org/10.1371/journal.pone.0053930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349766	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100038
J	Brandt, KM; Mellmann, A; Ballhausen, B; Jenke, C; van der Wolf, PJ; Broens, EM; Becker, K; Kock, R				Brandt, Karin M.; Mellmann, Alexander; Ballhausen, Britta; Jenke, Christian; van der Wolf, Peter J.; Broens, Els M.; Becker, Karsten; Koeck, Robin			Evaluation of Multiple-Locus Variable Number of Tandem Repeats Analysis for Typing Livestock-Associated Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; MRSA CC398; NASAL COLONIZATION; PREVALENCE; STRAINS; PIGS; ST398; BURP; FOOD	Background: The increasing occurrence of livestock-associated (LA) methicillin-resistant Staphylococcus aureus (MRSA) associated with the clonal complex (CC) 398 within the past years shows the importance of standardized and comparable typing methods for the purposes of molecular surveillance and outbreak detection. Multiple-locus variable number of tandem repeats analysis (MLVA) has recently been described as an alternative and highly discriminative tool for S. aureus. However, until now the applicability of MLVA for the typing of LA-MRSA isolates from different geographic origin has not been investigated in detail. We therefore compared MLVA and S. aureus protein A (spa) typing for characterizing porcine MRSA from distinct Dutch and German farms. Methodology/Principal Findings: Overall, 134 MRSA isolates originating from 21 different pig-farms in the Netherlands and 36 farms in Germany comprising 21 different spa types were subjected to MLVA-typing. Amplification and subsequent automated fragment sizing of the tandem repeat loci on a capillary sequencer differentiated these 134 isolates into 20 distinct MLVA types. Whereas overall MLVA and spa typing showed the same discriminatory power to type LA-MRSA (p = 0.102), MLVA was more discriminatory than spa typing for isolates associated with the prevalent spa types t011 and t034 (Simpson's Index of Diversity 0.564 vs. 0.429, respectively; p<0.001). Conclusion: Although the applied MLVA scheme was not more discriminatory than spa typing in general, it added valuable information to spa typing results for specific spa types (t011, t034) which are highly prevalent in the study area, i.e. Dutch-German border area. Thus, both methods may complement each other to increase the discriminatory power to resolute highly conserved clones such as CC398 (spa types t011, t034) for the detection of outbreaks and molecular surveillance of zoonotic MRSA.	[Brandt, Karin M.; Mellmann, Alexander; Jenke, Christian; Koeck, Robin] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Ballhausen, Britta; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [van der Wolf, Peter J.] Anim Hlth Serv, Pig Hlth Dept, Deventer, Netherlands; [Broens, Els M.] Univ Utrecht, Fac Vet Med, Vet Microbiol Diagnost Ctr, Dept Infect Dis & Immunol, Utrecht, Netherlands	University of Munster; University of Munster; Utrecht University	Kock, R (corresponding author), Univ Hosp Munster, Inst Hyg, Munster, Germany.	robin.koeck@ukmuenster.de	Köck, Robin/AAC-1552-2019; Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341; Mellmann, Alexander/0000-0002-0649-5185; van der Wolf, Peter/0000-0001-7893-5971	Bundesministerium fur Bildung und Forschung (BMBF), Germany [01KI1014A]; INTERREG IVa project SafeGuard (MRSA vet-net) [III-2-03 = 025]; BMBF [01KI1020]; Medical Faculty Munster [BD9817044]	Bundesministerium fur Bildung und Forschung (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); INTERREG IVa project SafeGuard (MRSA vet-net); BMBF(Federal Ministry of Education & Research (BMBF)); Medical Faculty Munster	This work was supported in part by grants from the Bundesministerium fur Bildung und Forschung (BMBF, http://www.bmbf.de/), Germany "Interdisciplinary Research Network MedVet-Staph" to R. K. and K. B. (01KI1014A), by the INTERREG IVa project SafeGuard (MRSA vet-net) to R. K., P.v.d.W. and K. B. (III-2-03 = 025) and by the BMBF (01KI1020) and the Medical Faculty Munster (BD9817044) to A. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PHILOS T R SOC B, V367, P860, DOI 10.1098/rstb.2011.0303; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Argudin MA, 2010, LETT APPL MICROBIOL, V50, P127, DOI 10.1111/j.1472-765X.2009.02742.x; Bens CCPM, 2006, J CLIN MICROBIOL, V44, P1875, DOI 10.1128/JCM.44.5.1875-1876.2006; Bosch T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-40; Broens EM, 2011, PREV VET MED, V98, P182, DOI 10.1016/j.prevetmed.2010.10.010; Cuny C, 2008, MICROB DRUG RESIST, V14, P307, DOI 10.1089/mdr.2008.0845; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Espinosa-Gongora C, 2012, VET REC, V170, DOI 10.1136/vr.100704; Fanoy E, 2009, EUROSURVEILLANCE, V14; Fessler AT, 2011, APPL ENVIRON MICROB, V77, P7151, DOI 10.1128/AEM.00561-11; FRENAY HME, 1994, J CLIN MICROBIOL, V32, P846; Furuya D, 2010, JPN J INFECT DIS, V63, P364; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Holmes A, 2010, J CLIN MICROBIOL, V48, P3600, DOI 10.1128/JCM.01039-10; Holmes MA, 2011, J MAMMARY GLAND BIOL, V16, P373, DOI 10.1007/s10911-011-9237-x; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; HUIJSDENS XW, 2009, EURO SURVEILL, V14; Kock R, 2011, J HOSP INFECT, V79, P292, DOI 10.1016/j.jhin.2011.08.011; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Malachowa N, 2005, J CLIN MICROBIOL, V43, P3095, DOI 10.1128/JCM.43.7.3095-3100.2005; Meemken D, 2010, ZOONOSES PUBLIC HLTH, V57, pE143, DOI 10.1111/j.1863-2378.2009.01313.x; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Mellmann A, 2008, J CLIN MICROBIOL, V46, P2805, DOI 10.1128/JCM.00071-08; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Pourcel C, 2009, J CLIN MICROBIOL, V47, P3121, DOI 10.1128/JCM.00267-09; Sabat A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Sobral D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033967; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Tenover FC, 2007, J CLIN MICROBIOL, V45, P2215, DOI 10.1128/JCM.02451-06; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van der Wolf PJ, 2012, VET MICROBIOL, V158, P136, DOI 10.1016/j.vetmic.2012.01.025; van Rijen MML, 2009, J HOSP INFECT, V72, P299, DOI 10.1016/j.jhin.2009.05.006; Vanderhaeghen W, 2010, EPIDEMIOL INFECT, V138, P606, DOI 10.1017/S0950268809991567; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wulf M. W., 2008, EURO SURVEILL, V13; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z; Wulf M, 2006, EMERG INFECT DIS, V12, P1939	45	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54425	10.1371/journal.pone.0054425	http://dx.doi.org/10.1371/journal.pone.0054425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349886	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000037
J	Listl, S; Jansen, L; Stenzinger, A; Freier, K; Emrich, K; Holleczek, B; Katalinic, A; Gondos, A; Brenner, H				Listl, Stefan; Jansen, Lina; Stenzinger, Albrecht; Freier, Kolja; Emrich, Katharina; Holleczek, Bernd; Katalinic, Alexander; Gondos, Adam; Brenner, Hermann		GEKID Canc Survival Working Grp	Survival of Patients with Oral Cavity Cancer in Germany	PLOS ONE			English	Article							UP-TO-DATE; PERIOD ANALYSIS; QUALITY-CONTROL; UNITED-STATES; POPULATION; EUROPE; TRENDS; 21ST-CENTURY; EXPERIENCE; CARCINOMA	The purpose of the present study was to describe the survival of patients diagnosed with oral cavity cancer in Germany. The analyses relied on data from eleven population-based cancer registries in Germany covering a population of 33 million inhabitants. Patients with a diagnosis of oral cavity cancer (ICD-10: C00-06) between 1997 and 2006 are included. Period analysis for 2002-2006 was applied to estimate five-year age-standardized relative survival, taking into account patients' sex as well as grade and tumor stage. Overall five-year relative survival for oral cavity cancer patients was 54.6%. According to tumor localization, five-year survival was 86.5% for lip cancer, 48.1% for tongue cancer and 51.7% for other regions of the oral cavity. Differences in survival were identified with respect to age, sex, tumor grade and stage. The present study is the first to provide a comprehensive overview on survival of oral cavity cancer patients in Germany.	[Listl, Stefan] Univ Heidelberg Hosp, Dept Conservat Dent, Heidelberg, Germany; [Listl, Stefan] Max Planck Inst Social Law & Social Policy, Munich Ctr Econ Aging, Munich, Germany; [Jansen, Lina; Gondos, Adam; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Stenzinger, Albrecht] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Freier, Kolja] Univ Heidelberg Hosp, Dept Oral & Maxillofacial Surg, Heidelberg, Germany; [Emrich, Katharina] Johannes Gutenberg Univ Mainz, Canc Registry Rhineland Palatine, Inst Med Biostat Epidemiol & Informat, Univ Med Ctr, D-55122 Mainz, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Katalinic, Alexander] Inst Clin Epidemiol, Lubeck, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Listl, S (corresponding author), Univ Heidelberg Hosp, Dept Conservat Dent, Heidelberg, Germany.	stefan.listl@med.uni-heidelberg.de	Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Listl, Stefan/S-7600-2017; Katalinic, Alexander/D-2512-2010; Jansen, Lina/D-7255-2016	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Listl, Stefan/0000-0002-8176-3397; Katalinic, Alexander/0000-0003-0490-1554; Jansen, Lina/0000-0001-8004-4940	Medical Faculty of the University of Heidelberg; German Cancer Aid (Deutsche Krebshilfe) [108257]	Medical Faculty of the University of Heidelberg; German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	SL and AS are fully funded through a Postdoctoral Fellowship by the Medical Faculty of the University of Heidelberg. LJ, KF, KE, BH, AK, AG and HB were funded through their institutions. The study itself was funded by the German Cancer Aid (Deutsche Krebshilfe), grant number 108257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrino F, 1998, EUR J CANCER, V34, P2154, DOI 10.1016/S0959-8049(98)00328-1; BLOT WJ, 1988, CANCER RES, V48, P3282; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Brenner H, 2002, EUR J CANCER, V38, P690, DOI 10.1016/S0959-8049(02)00003-5; Brenner H, 2002, AM J EPIDEMIOL, V156, P566, DOI 10.1093/aje/kwf071; Brenner H, 2006, AM J EPIDEMIOL, V164, P689, DOI 10.1093/aje/kwj243; Brenner H, 2011, CANCER EPIDEM BIOMAR, V20, P2480, DOI 10.1158/1055-9965.EPI-11-0697; Brenner H, 2009, EUR J CANCER, V45, P1028, DOI 10.1016/j.ejca.2008.11.005; Cancela MD, 2010, CANCER EPIDEMIOL, V34, P501, DOI 10.1016/j.canep.2010.04.012; Capocaccia R, 2003, ANN ONCOL, V14, pV14, DOI 10.1093/annonc/mdg751; CEREZO L, 1993, RADIOTHER ONCOL, V28, P142, DOI 10.1016/0167-8140(93)90006-T; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; da Silva SD, 2011, ORAL ONCOL, V47, P783, DOI 10.1016/j.oraloncology.2011.07.004; De Angelis R, 2009, EUR J CANCER, V45, P909, DOI 10.1016/j.ejca.2008.11.003; Deng H, 2011, AUST DENT J, V56, P244, DOI 10.1111/j.1834-7819.2011.01349.x; Ederer F., 1959, INSTRUCTIONS IBM 650; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Ferlay J, 2005, 42 IARC; Ferlito A, 2006, ORAL ONCOL, V42, P14, DOI 10.1016/j.oraloncology.2005.03.009; Gondos A, 2009, ANN ONCOL, V20, P564, DOI 10.1093/annonc/mdn639; Gondos A, 2007, INT J CANCER, V121, P395, DOI 10.1002/ijc.22683; HENSON DE, 1995, CANCER-AM CANCER SOC, V76, P1687, DOI 10.1002/1097-0142(19951115)76:10<1687::AID-CNCR2820761002>3.0.CO;2-I; Hiripi E, 2012, ANN ONCOL, V23, P472, DOI 10.1093/annonc/mdr131; Howlader N, 2011, SEER CANC STAT REV 1; Mehrotra R, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-33; MOLNAR L, 1974, ONCOLOGY-BASEL, V29, P101, DOI 10.1159/000224893; Petersen PE, 2005, COMMUNITY DENT ORAL, V33, P397, DOI 10.1111/j.1600-0528.2005.00251.x; *R KOCH I, 2010, CANC GERM 2005 2006; Shiboski CH, 2000, COMMUNITY DENT ORAL, V28, P249, DOI 10.1034/j.1600-0528.2000.280402.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Zigon G, 2011, ANN ONCOL, V22, P165, DOI 10.1093/annonc/mdq306	33	59	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53415	10.1371/journal.pone.0053415	http://dx.doi.org/10.1371/journal.pone.0053415			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349710	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800009
J	Pooran, A; Pieterson, E; Davids, M; Theron, G; Dheda, K				Pooran, Anil; Pieterson, Elize; Davids, Malika; Theron, Grant; Dheda, Keertan			What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?	PLOS ONE			English	Article							PREVALENCE; EPIDEMIOLOGY; HIV; FEASIBILITY; STRATEGIES; COMMUNITY; COHORT; IMPACT; TB	Background: Drug-resistant tuberculosis (DR-TB) is undermining TB control in South Africa. However, there are hardly any data about the cost of treating DR-TB in high burden settings despite such information being quintessential for the rational planning and allocation of resources by policy-makers, and to inform future cost-effectiveness analyses. Methodology: We analysed the comparative 2011 United States dollar ($) cost of diagnosis and treatment of drug sensitive TB (DS-TB), MDR-TB and XDR-TB, based on National South African TB guidelines, from the perspective of the National TB Program using published clinical outcome data. Principal Findings: Assuming adherence to national DR-TB management guidelines, the per patient cost of XDR-TB was $ 26,392, four times greater than MDR-TB ($ 6772), and 103 times greater than drug-sensitive TB ($ 257). Despite DR-TB comprising only 2.2% of the case burden, it consumed,similar to 32% of the total estimated 2011 national TB budget of US $ 218 million. 45% and 25% of the DR-TB costs were attributed to anti-TB drugs and hospitalization, respectively. XDR-TB consumed 28% of the total DR-TB diagnosis and treatment costs. Laboratory testing and anti-TB drugs comprised the majority (71%) of MDR-TB costs while hospitalization and anti-TB drug costs comprised the majority (92%) of XDR-TB costs. A decentralized XDR-TB treatment programme could potentially reduce costs by $ 6930 (26%) per case and reduce the total amount spent on DR-TB by,similar to 7%. Conclusion/Significance: Although DR-TB forms a very small proportion of the total case burden it consumes a disproportionate and substantial amount of South Africa's total annual TB budget. These data inform rational resource allocation and selection of management strategies for DR-TB in high burden settings.	[Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Dheda, K (corresponding author), Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Theron, Grant/ABB-1167-2020	Theron, Grant/0000-0002-9216-2415	European Union Seventh Framework Programme (TBsusgent); South African National Research Foundation Research Chairs Initiative (SARChI); European and Developing Countries Clinical Trials Partnership (EDCTP); National Research Foundation (NRF); Claude Leon Foundation	European Union Seventh Framework Programme (TBsusgent); South African National Research Foundation Research Chairs Initiative (SARChI); European and Developing Countries Clinical Trials Partnership (EDCTP); National Research Foundation (NRF); Claude Leon Foundation	This work was funded by the European Union Seventh Framework Programme (TBsusgent) and the South African National Research Foundation Research Chairs Initiative (SARChI). GT is supported by the the European and Developing Countries Clinical Trials Partnership (EDCTP), National Research Foundation (NRF) and Claude Leon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO REP 2011 GLOB TU; Arbex MA, 2010, J BRAS PNEUMOL, V36, P641, DOI 10.1590/S1806-37132010000500017; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Dheda K, 2012, LANCET, V379, P773, DOI 10.1016/S0140-6736(11)61062-3; Dheda K, 2010, INFECT DIS CLIN N AM, V24, P705, DOI 10.1016/j.idc.2010.05.001; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Iddriss A, 2011, JOINT M 19 ASCVTS 21; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Kvasnovsky CL, 2011, JAIDS-J ACQ IMM DEF, V57, P146, DOI 10.1097/QAI.0b013e31821190a3; Mehta U, 2008, BRIT J CLIN PHARMACO, V65, P396, DOI 10.1111/j.1365-2125.2007.03034.x; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; Oxlade O, 2012, EUR RESPIR J, V39, P626, DOI 10.1183/09031936.00065311; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Schaaf HS, 2009, CLIN CHEST MED, V30, P667, DOI 10.1016/j.ccm.2009.08.019; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; South Africa Department of Health, 2007, TUB STRAT PLAN S AFR; South Africa Dept. of Health, 2009, NAT TUB MAN GUID 200; South African Department of Health, 2011, MAN DRUG RES TUB POL; Statistics South Africa, 2012, STAT REL P0141 CONS; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Suh DC, 2000, ANN PHARMACOTHER, V34, P1373, DOI 10.1345/aph.10094; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; UN, 2011, UN MILL DEV GOALS RE; United Nations, 2011, OP RAT EXCH; White VLC, 2000, THORAX, V55, P962, DOI 10.1136/thorax.55.11.962; *WHO, 2005, WHOHTMTB2004343; WHO, 2002, GUID COST COST EFF A; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2011, TUB COUNTR PROF S AF; World Health Organization, 2006, GUID PROGR MAN DRUG	43	123	124	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54587	10.1371/journal.pone.0054587	http://dx.doi.org/10.1371/journal.pone.0054587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349933	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800064
J	Prates, RA; Fuchs, BB; Mizuno, K; Naqvi, Q; Kato, IT; Ribeiro, MS; Mylonakis, E; Tegos, GP; Hamblin, MR				Prates, Renato A.; Fuchs, Beth Burgwyn; Mizuno, Kazue; Naqvi, Qurat; Kato, Ilka T.; Ribeiro, Martha S.; Mylonakis, Eleftherios; Tegos, George P.; Hamblin, Michael R.			Effect of Virulence Factors on the Photodynamic Inactivation of Cryptococcus neoformans	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIFUNGAL AGENTS; IN-VITRO; OXIDATIVE STRESS; THERAPY; SUSCEPTIBILITY; PHOTOSENSITIZERS; MELANIZATION; MECHANISMS; POLYSACCHARIDE	Opportunistic fungal pathogens may cause an array of superficial infections or serious invasive infections, especially in immunocompromised patients. Cryptococcus neoformans is a pathogen causing cryptococcosis in HIV/AIDS patients, but treatment is limited due to the relative lack of potent antifungal agents. Photodynamic inactivation (PDI) uses the combination of non-toxic dyes called photosensitizers and harmless visible light, which produces singlet oxygen and other reactive oxygen species that produce cell inactivation and death. We report the use of five structurally unrelated photosensitizers (methylene blue, Rose Bengal, selenium derivative of a Nile blue dye, a cationic fullerene and a conjugate between poly-L-lysine and chlorin(e6)) combined with appropriate wavelengths of light to inactivate C. neoformans. Mutants lacking capsule and laccase, and culture conditions that favoured melanin production were used to probe the mechanisms of PDI and the effect of virulence factors. The presence of cell wall, laccase and melanin tended to protect against PDI, but the choice of the appropriate photosensitizers and dosimetry was able to overcome this resistance.	[Prates, Renato A.; Kato, Ilka T.; Ribeiro, Martha S.] Nucl & Energy Res Inst, Ctr Lasers & Applicat, Sao Paulo, Brazil; [Prates, Renato A.] Univ Nove Julho, Sch Dent, Dept Hlth, Sao Paulo, Brazil; [Fuchs, Beth Burgwyn; Mylonakis, Eleftherios] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Prates, Renato A.; Mizuno, Kazue; Naqvi, Qurat; Tegos, George P.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Prates, Renato A.; Mizuno, Kazue; Tegos, George P.; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Tegos, George P.] Univ New Mexico, Dept Pathol, Sch Med, Albuquerque, NM 87131 USA; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade Nove de Julho; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of New Mexico; Harvard University; Massachusetts Institute of Technology (MIT)	Tegos, GP (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	GTegos@salud.unm.edu; Hamblin@helix.mgh.harvard.edu	Ribeiro, Martha Simões/G-3517-2012; Prates, Renato A/F-8235-2014; Hamblin, Michael R/H-2758-2019; Kato, Ilka Tiemy/X-5821-2019; Hamblin, Mike/AAB-2511-2022; Kato, Ilka/G-7644-2012	Ribeiro, Martha Simões/0000-0002-4203-1134; Prates, Renato A/0000-0002-8115-9237; Hamblin, Michael R/0000-0001-6431-4605; 	FAPESP [2010/13313 9]; Brazilian National Commission on Research (CNPq) [501499/2011 3]; United States National Institutes of Health (NIH) [R01A1050875, R01CA137108]; US Air Force MFEL Program [FA9550-04-1-0079]; NIH [5U54MH084690-02]; DTRA [HDTRA1-13-C-0005]; NATIONAL CANCER INSTITUTE [R01CA137108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Commission on Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Air Force MFEL Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DTRA(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by FAPESP (2010/13313 9) and Brazilian National Commission on Research (CNPq grant 501499/2011 3). Research in the Hamblin laboratory was supported by United States National Institutes of Health (NIH) grants (R01A1050875 to MRH and R01CA137108 to Long Y. Chiang) and US Air Force MFEL Program (FA9550-04-1-0079). George P. Tegos was supported by the NIH (grant 5U54MH084690-02) and DTRA (contract HDTRA1-13-C-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanio A, 2011, MBIO, V2, DOI 10.1128/mBio.00158-11; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; CASADEVALL A, 1994, CLIN INFECT DIS, V19, P951, DOI 10.1093/clinids/19.5.951; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Castano AP, 2004, PHOTODIAGN PHOTODYN, V1, P279, DOI 10.1016/S1572-1000(05)00007-4; Chang YC, 1999, J BACTERIOL, V181, P5636, DOI 10.1128/JB.181.18.5636-5643.1999; Cowen LE, 2002, ANNU REV MICROBIOL, V56, P139, DOI 10.1146/annurev.micro.56.012302.160907; Cruess AF, 2009, ACTA OPHTHALMOL, V87, P118, DOI 10.1111/j.1755-3768.2008.01218.x; da Silva EG, 2006, J MED MICROBIOL, V55, P139, DOI 10.1099/jmm.0.46206-0; Dai TH, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00120, 10.3389/fmicb.2012.00417]; Dai TH, 2010, LASER SURG MED, V42, P38, DOI 10.1002/lsm.20887; Dai T, 2009, PHOTODIAGN PHOTODYN, V6, P170, DOI 10.1016/j.pdpdt.2009.10.008; Demidova TN, 2005, ANTIMICROB AGENTS CH, V49, P2329, DOI 10.1128/AAC.49.6.2329-2335.2005; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Espinel-Ingroff A, 2009, REV IBEROAM MICOL, V26, P15, DOI 10.1016/S1130-1406(09)70004-X; Foley JW, 2006, J MED CHEM, V49, P5291, DOI 10.1021/JM060153i; Fuchs BB, 2007, ANTIMICROB AGENTS CH, V51, P2929, DOI 10.1128/AAC.00121-07; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001; Garcia-Rivera J, 2001, MED MYCOL, V39, P353, DOI 10.1080/mmy.39.4.353.357; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; Harris F, 2005, CURR DRUG TARGETS, V6, P615, DOI 10.2174/1389450054545962; HAY RJ, 1991, J ANTIMICROB CHEMOTH, V28, P17, DOI 10.1093/jac/28.suppl_B.17; Huang LY, 2012, LASER SURG MED, V44, P490, DOI 10.1002/lsm.22045; Huang L, 2010, ANTIMICROB AGENTS CH, V54, P3834, DOI 10.1128/AAC.00125-10; Huang LY, 2010, NANOMED-NANOTECHNOL, V6, P442, DOI 10.1016/j.nano.2009.10.005; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Khajo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025092; Konan YN, 2002, J PHOTOCH PHOTOBIO B, V66, P89, DOI 10.1016/S1011-1344(01)00267-6; Lam M, 2011, PHOTOCHEM PHOTOBIOL, V87, P904, DOI 10.1111/j.1751-1097.2011.00938.x; Li Q, 2008, FREE RADICAL BIO MED, V44, P394, DOI 10.1016/j.freeradbiomed.2007.09.019; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Mizuno Kazue, 2011, J Nanomed Nanotechnol, V2, P1; Moan J, 2003, ANTICANCER RES, V23, P3591; Monfrecola G, 2004, PHOTOCH PHOTOBIO SCI, V3, P419, DOI 10.1039/b315629j; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; Nelson RT, 2001, GENETICS, V157, P935; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x; PFALLER MA, 1988, J CLIN MICROBIOL, V26, P1437, DOI 10.1128/JCM.26.8.1437-1441.1988; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Prates RA, 2011, J ANTIMICROB CHEMOTH, V66, P1525, DOI 10.1093/jac/dkr160; Prates RA, 2009, LASER PHYS, V19, P1038, DOI 10.1134/S1054660X09050284; Prates RA, 2007, J PHOTOCH PHOTOBIO B, V86, P70, DOI 10.1016/j.jphotobiol.2006.07.010; Rodrigues GB, 2012, PHOTOCHEM PHOTOBIOL, V88, P440, DOI 10.1111/j.1751-1097.2011.01055.x; Rosas AL, 1997, FEMS MICROBIOL LETT, V153, P265, DOI 10.1016/S0378-1097(97)00239-5; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0; Schafer M, 2000, PHOTOCHEM PHOTOBIOL, V71, P514, DOI 10.1562/0031-8655(2000)071<0514:SSOPIT>2.0.CO;2; Seaton RA, 1997, J MED VET MYCOL, V35, P7; Soares BM, 2011, PHOTOCHEM PHOTOBIOL, V87, P357, DOI 10.1111/j.1751-1097.2010.00868.x; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Steinbach WJ, 2005, CURR OPIN INFECT DIS, V18, P484, DOI 10.1097/01.qco.0000185986.64759.9a; Tegos GP, 2005, CHEM BIOL, V12, P1127, DOI 10.1016/j.chembiol.2005.08.014; van Duin D, 2002, ANTIMICROB AGENTS CH, V46, P3394, DOI 10.1128/AAC.46.11.3394-3400.2002; Vecchiarelli A, 2000, MED MYCOL, V38, P407, DOI 10.1080/mmy.38.6.407.417; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; Wainwright M, 2006, J PHOTOCH PHOTOBIO B, V84, P227, DOI 10.1016/j.jphotobiol.2006.03.002; WANG YL, 1994, INFECT IMMUN, V62, P3004, DOI 10.1128/IAI.62.7.3004-3007.1994; Williamson PR, 1998, J BACTERIOL, V180, P1570, DOI 10.1128/JB.180.6.1570-1572.1998; Wilson M, 2004, PHOTOCH PHOTOBIO SCI, V3, P412, DOI 10.1039/b211266c; WILSON M, 1995, J MED MICROBIOL, V42, P62, DOI 10.1099/00222615-42-1-62; Zaragoza O, 2006, FEMS YEAST RES, V6, P662, DOI 10.1111/j.1567-1364.2006.00070.x; Zhu XD, 2001, INFECT IMMUN, V69, P5589, DOI 10.1128/IAI.69.9.5589-5596.2001	68	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54387	10.1371/journal.pone.0054387	http://dx.doi.org/10.1371/journal.pone.0054387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349872	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800047
J	Bonthoux, S; Baselga, A; Balent, G				Bonthoux, Sebastien; Baselga, Andres; Balent, Gerard			Assessing Community-Level and Single-Species Models Predictions of Species Distributions and Assemblage Composition after 25 Years of Land Cover Change	PLOS ONE			English	Article							BIRD DISTRIBUTIONS; BIOCLIMATIC MODELS; HABITAT USE; CLIMATE; BIODIVERSITY; LANDSCAPE; PATTERNS; DIVERSITY; CHALLENGES; ACCURACY	To predict the impact of environmental change on species distributions, it has been hypothesized that community-level models could give some benefits compared to species-level models. In this study we have assessed the performance of these two approaches. We surveyed 256 bird communities in an agricultural landscape in southwest France at the same locations in 1982 and 2007. We compared the ability of CQO (canonical quadratic ordination; a method of community-level GLM) and GLMs (generalized linear models) to i) explain species distributions in 1982 and ii) predict species distributions, community composition and species richness in 2007, after land cover change. Our results show that models accounting for shared patterns between species (CQO) slightly better explain the distribution of rare species than models that ignore them (GLMs). Conversely, the predictive performances were better for GLMs than for CQO. At the assemblage level, both CQO and GLMs overestimated species richness, compared with that actually observed in 2007, and projected community composition was only moderately similar to that observed in 2007. Species richness projections tended to be more accurate in sites where land cover change was more marked. In contrast, the composition projections tended to be less accurate in those sites. Both modelling approaches showed a similar but limited ability to predict species distribution and assemblage composition under conditions of land cover change. Our study supports the idea that our community-level model can improve understanding of rare species patterns but that species-level models can provide slightly more accurate predictions of species distributions. At the community level, the similar performance of both approaches for predicting patterns of assemblage variation suggests that species tend to respond individualistically or, alternatively, that our community model was unable to effectively account for the emergent community patterns.	[Bonthoux, Sebastien; Balent, Gerard] INRA, UMR1201, DYNAFOR, F-31326 Castanet Tolosan, France; [Bonthoux, Sebastien] ENSNP, UMR CITERES 7324, Blois, France; [Baselga, Andres] Univ Santiago de Compostela, Dept Zool, Fac Biol, Santiago De Compostela, Spain	INRAE; Universidade de Santiago de Compostela	Bonthoux, S (corresponding author), INRA, UMR1201, DYNAFOR, F-31326 Castanet Tolosan, France.	bonthoux.sebastien@gmail.com	Baselga, Andres/A-6740-2008	Baselga, Andres/0000-0001-7914-7109	INRA-SAD Research Department; INRA-Midi-Pyrenees Region PSDR project CHAPAY; National Research Agency grant BIODIVAGRIM [ANR-07-BDIV-002]; Spanish Ministry of Science and Innovation [CGL2009-10111]	INRA-SAD Research Department; INRA-Midi-Pyrenees Region PSDR project CHAPAY(Region Occitanie); National Research Agency grant BIODIVAGRIM; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by INRA-SAD Research Department, and INRA-Midi-Pyrenees Region PSDR project CHAPAY. Sebastien Bonthoux was funded through the National Research Agency grant BIODIVAGRIM (ANR-07-BDIV-002)_Conserving biodiversity in agro-ecosystems: a spatially explicit landscape modeling approach. Andres Baselga is funded by the Spanish Ministry of Science and Innovation (grant CGL2009-10111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; BALENT G, 1992, LANDSCAPE ECOL, V6, P195; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2012, J BIOGEOGR, V39, P760, DOI 10.1111/j.1365-2699.2011.02612.x; Baselga A, 2010, J BIOGEOGR, V37, P1842, DOI 10.1111/j.1365-2699.2010.02341.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Baselga A, 2009, ECOGRAPHY, V32, P55, DOI 10.1111/j.1600-0587.2009.05856.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Berg A, 2002, BIRD STUDY, V49, P153, DOI 10.1080/00063650209461260; Bonthoux S, 2012, J ORNITHOL, V153, P491, DOI 10.1007/s10336-011-0766-2; Campbell SP, 2010, ECOL MONOGR, V80, P287, DOI 10.1890/08-2366.1; Chapman DS, 2011, J BIOGEOGR, V38, P1524, DOI 10.1111/j.1365-2699.2011.02517.x; Choisis JP, 2010, CAH AGRIC, V19, P97, DOI 10.1684/agr.2010.0375; Cody M.L, 1974, COMPETITION STRUCTUR; Concepcion ED, 2011, AGR ECOSYST ENVIRON, V142, P303, DOI 10.1016/j.agee.2011.05.028; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dubuis A, 2011, DIVERS DISTRIB, V17, P1122, DOI 10.1111/j.1472-4642.2011.00792.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Gotelli NJ, 2010, P NATL ACAD SCI USA, V107, P5030, DOI 10.1073/pnas.0914089107; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kissling W.D., 2012, Journal of Biogeography, V39, P2163; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Merckx T, 2010, AGR ECOSYST ENVIRON, V138, P147, DOI 10.1016/j.agee.2010.04.010; Morales MB, 2012, ECOL RES, V27, P691, DOI 10.1007/s11284-012-0946-4; Newbold T, 2010, OIKOS, V119, P1326, DOI 10.1111/j.1600-0706.2009.18295.x; ORIANS GH, 1964, ECOLOGY, V45, P736, DOI 10.2307/1934921; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pelosi C, 2010, AGR ECOSYST ENVIRON, V139, P455, DOI 10.1016/j.agee.2010.09.004; Perkins AJ, 2000, BIOL CONSERV, V95, P279, DOI 10.1016/S0006-3207(00)00042-2; ROBINSON SK, 1995, J ANIM ECOL, V64, P1, DOI 10.2307/5822; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Siriwardena GM, 2000, ECOGRAPHY, V23, P702, DOI 10.1034/j.1600-0587.2000.230608.x; Soderstrom B, 2000, CONSERV BIOL, V14, P522, DOI 10.1046/j.1523-1739.2000.98564.x; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tingley R, 2009, J BIOGEOGR, V36, P1656, DOI 10.1111/j.1365-2699.2009.02117.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Vallecillo S, 2009, ECOL APPL, V19, P538, DOI 10.1890/08-0348.1; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Yee TW, 2004, ECOL MONOGR, V74, P685, DOI 10.1890/03-0078	58	13	13	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54179	10.1371/journal.pone.0054179	http://dx.doi.org/10.1371/journal.pone.0054179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349818	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900050
J	Delaspre, F; Massumi, M; Salido, M; Soria, B; Ravassard, P; Savatier, P; Skoudy, A				Delaspre, Fabien; Massumi, Mohammad; Salido, Marta; Soria, Bernat; Ravassard, Philippe; Savatier, Pierre; Skoudy, Anouchka			Directed Pancreatic Acinar Differentiation of Mouse Embryonic Stem Cells via Embryonic Signalling Molecules and Exocrine Transcription Factors	PLOS ONE			English	Article							LOOP-HELIX COMPLEX; GENE-EXPRESSION; IN-VITRO; DEFINITIVE ENDODERM; ENDOCRINE PANCREAS; VISCERAL ENDODERM; DNA-BINDING; ES CELLS; PROGENITORS; INDUCTION	Pluripotent embryonic stem cells (ESC) are a promising cellular system for generating an unlimited source of tissue for the treatment of chronic diseases and valuable in vitro differentiation models for drug testing. Our aim was to direct differentiation of mouse ESC into pancreatic acinar cells, which play key roles in pancreatitis and pancreatic cancer. To that end, ESC were first differentiated as embryoid bodies and sequentially incubated with activin A, inhibitors of Sonic hedgehog (Shh) and bone morphogenetic protein (BMP) pathways, fibroblast growth factors (FGF) and retinoic acid (RA) in order to achieve a stepwise increase in the expression of mRNA transcripts encoding for endodermal and pancreatic progenitor markers. Subsequent plating in Matrigel (R) and concomitant modulation of FGF, glucocorticoid, and folllistatin signalling pathways involved in exocrine differentiation resulted in a significant increase of mRNAs encoding secretory enzymes and in the number of cells co-expressing their protein products. Also, pancreatic endocrine marker expression was down-regulated and accompanied by a significant reduction in the number of hormone-expressing cells with a limited presence of hepatic marker expressing-cells. These findings suggest a selective activation of the acinar differentiation program. The newly differentiated cells were able to release alpha-amylase and this feature was greatly improved by lentiviral-mediated expression of Rbpjl and Ptf1a, two transcription factors involved in the maximal production of digestive enzymes. This study provides a novel method to produce functional pancreatic exocrine cells from ESC.	[Delaspre, Fabien; Massumi, Mohammad; Salido, Marta; Skoudy, Anouchka] Inst Hosp Mar Invest Med IMIM, Canc Res Program, Barcelona, Spain; [Soria, Bernat] CABIMER, Seville, Spain; [Soria, Bernat] Inst Salud Carlos III, CIBERDEM, Madrid, Spain; [Ravassard, Philippe] ICM, Paris, France; [Savatier, Pierre] Stem Cells & Brain Res Inst, Bron, France; [Savatier, Pierre] Univ Lyon, Lyon, France	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Skoudy, A (corresponding author), Inst Hosp Mar Invest Med IMIM, Canc Res Program, Biomed Res Pk, Barcelona, Spain.	askoudy@imim.es	SAVATIER, Pierre/J-4663-2014; DELASPRE, FABIEN/M-3654-2015; , Bernat/AAL-6470-2021	DELASPRE, FABIEN/0000-0001-7815-5537; Massumi, Mohammad/0000-0001-8291-9798; ravassard, philippe/0000-0002-0393-9262; Soria, Bernat/0000-0002-2356-0380	Instituto de Salud Carlos III (ISCIII)-FEDER [PI052738, PI080511, PI100094]; Tercel [RD06/0010/0025]; ISCIII; Health Department of the Generalitat de Catalunya; Generalitat de Catalunya	Instituto de Salud Carlos III (ISCIII)-FEDER(Instituto de Salud Carlos IIIEuropean Commission); Tercel; ISCIII(Instituto de Salud Carlos III); Health Department of the Generalitat de Catalunya(Generalitat de Catalunya); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII)-FEDER (PI052738 and PI080511 to A.S.; PI100094 and Tercel RD06/0010/0025 to B.S.). A.S. was supported by ISCIII and the Health Department of the Generalitat de Catalunya; F.D. was the recipient of a Graduate Fellowship from ISCIII and was also supported by Tercel; M.M. was the recipient of a Graduate Fellowship from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bernardo AS, 2009, STEM CELLS, V27, P341, DOI 10.1634/stemcells.2008-0310; Bhushan A, 2001, DEVELOPMENT, V128, P5109; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Decker K, 2006, DEV BIOL, V298, P415, DOI 10.1016/j.ydbio.2006.06.046; Fukuda A, 2008, DIABETES, V57, P2421, DOI 10.2337/db07-1558; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Ledda-Columbano GM, 2005, J ENDOCRINOL, V185, P393, DOI 10.1677/joe.1.06110; LEE JT, 1991, PANCREAS, V6, P96, DOI 10.1097/00006676-199101000-00013; Liu Y, 2001, J BIOL CHEM, V276, P17985, DOI 10.1074/jbc.M100678200; LOGSDON CD, 1985, J CELL BIOL, V100, P1200, DOI 10.1083/jcb.100.4.1200; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Masui T, 2007, GENE DEV, V21, P2629, DOI 10.1101/gad.1575207; Masui T, 2010, GASTROENTEROLOGY, V139, P270, DOI 10.1053/j.gastro.2010.04.003; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Miralles F, 1998, DEVELOPMENT, V125, P1017; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakanishi M, 2007, DIFFERENTIATION, V75, P1, DOI 10.1111/j.1432-0436.2006.00109.x; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pin CL, 2000, ANAT REC, V259, P157, DOI 10.1002/(SICI)1097-0185(20000601)259:2<157::AID-AR6>3.0.CO;2-0; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Ravassard P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004731; Ren M, 2009, ACTA PHARMACOL SIN, V30, P1289, DOI 10.1038/aps.2009.115; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Rovira M, 2008, GASTROENTEROLOGY, V135, P1301, DOI 10.1053/j.gastro.2008.06.049; Rovira M, 2007, CLONING STEM CELLS, V9, P327, DOI 10.1089/clo.2006.0064; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Serafimidis I, 2008, STEM CELLS, V26, P3, DOI 10.1634/stemcells.2007-0194; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shirasawa S, 2011, BIOCHEM BIOPH RES CO, V410, P608, DOI 10.1016/j.bbrc.2011.06.036; Shirasawa S, 2011, STEM CELLS DEV, V20, P1071, DOI 10.1089/scd.2010.0185; Skoudy A, 2004, BIOCHEM J, V379, P749, DOI 10.1042/BJ20031784; Sphyris N, 2005, PANCREAS, V30, P148, DOI 10.1097/01.mpa.0000147086.15867.ab; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Sulzbacher S, 2009, STEM CELL REV REP, V5, P159, DOI 10.1007/s12015-009-9061-5; Tosh D, 2002, BIOCHEM SOC T, V30, P51, DOI 10.1042/BST0300051; VILA MR, 1994, LAB INVEST, V71, P423; Vincent RK, 2009, DIFFERENTIATION, V78, P24, DOI 10.1016/j.diff.2009.03.006; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	53	8	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54243	10.1371/journal.pone.0054243	http://dx.doi.org/10.1371/journal.pone.0054243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349836	Green Published, gold			2022-12-27	WOS:000313738900056
J	Kamran, N; Takai, Y; Miyoshi, J; Biswas, SK; Wong, JSB; Gasser, S				Kamran, Neha; Takai, Yoshimi; Miyoshi, Jun; Biswas, Subhra K.; Wong, Justin S. B.; Gasser, Stephan			Toll-Like Receptor Ligands Induce Expression of the Costimulatory Molecule CD155 on Antigen-Presenting Cells	PLOS ONE			English	Article							NF-KAPPA-B; NECTIN-2 CD112; TRANSCRIPTIONAL ACTIVATION; IMMUNE-RESPONSE; DENDRITIC CELLS; DISTINCT ROLES; CUTTING EDGE; PVR CD155; DNAM-1; GENE	Genotoxic stress and RAS induce the expression of CD155, a ligand for the immune receptors DNAM-1, CD96 and TIGIT. Here we show that antigen-presenting cells upregulate CD155 expression in response to Toll-like receptor activation. Induction of CD155 by Toll-like receptors depended on MYD88, TRIF and NF-kappa B. In addition, IRF3, but not IRF7, modulated CD155 upregulation in response to TLR3 signals. Immunization of CD155-deficient mice with OVA and the TLR9 agonist CpG resulted in increased OVA-specific IgG2a/c titers when compared to wild type mice. Splenocytes of immunized CD155-deficient mice secreted lower levels of IL-4 and fewer IL-4 and GATA-3 expressing CD4(+) T cells were present in the spleen of Cd155(-/-) mice. Our data suggest that CD155 regulates T(h)2 differentiation. Targeting of CD155 in immunization protocols using peptides may represent a promising new approach to boost protective humoral immunity in viral vaccines.	[Kamran, Neha; Wong, Justin S. B.; Gasser, Stephan] Natl Univ Singapore, Dept Microbiol, Immunol Programme, Singapore 117548, Singapore; [Kamran, Neha; Gasser, Stephan] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 657, Japan; [Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan; [Biswas, Subhra K.] Singapore Immunol Network, Singapore, Singapore	National University of Singapore; National University of Singapore; Kobe University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Gasser, S (corresponding author), Natl Univ Singapore, Dept Microbiol, Immunol Programme, Singapore 117548, Singapore.	micsg@nus.edu.sg		Gasser, Stephan/0000-0002-5616-0914	NRF grant HUJ-CREATE - Cellular and Molecular Mechanisms of Inflammation; NMRC grant [NMRC/1158/2008]	NRF grant HUJ-CREATE - Cellular and Molecular Mechanisms of Inflammation; NMRC grant(National Medical Research Council, Singapore)	This work was supported by the NRF grant HUJ-CREATE - Cellular and Molecular Mechanisms of Inflammation (http://www.nrf.gov.sg/nrf/default.aspx) and the NMRC grant NMRC/1158/2008 (http://www.nmrc.gov.sg/content/nmrc_internet/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2009, J PATHOL, V217, P42, DOI 10.1002/path.2431; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Barton GM, 2002, CURR OPIN IMMUNOL, V14, P380, DOI 10.1016/S0952-7915(02)00343-6; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; CHADENEAU C, 1994, J BIOL CHEM, V269, P15601; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; De Becker G, 1998, EUR J IMMUNOL, V28, P3161, DOI 10.1002/(SICI)1521-4141(199810)28:10<3161::AID-IMMU3161>3.3.CO;2-H; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hirota T, 2005, ONCOGENE, V24, P2229, DOI 10.1038/sj.onc.1208409; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JOUVINMARCHE E, 1989, IMMUNOGENETICS, V29, P92, DOI 10.1007/BF00395856; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Klinman DM, 2006, INT REV IMMUNOL, V25, P135, DOI 10.1080/08830180600743057; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Krieg AM, 2000, CURR OPIN IMMUNOL, V12, P35, DOI 10.1016/S0952-7915(99)00048-5; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; Lin L, 2004, EUR J IMMUNOL, V34, P1483, DOI 10.1002/eji.200324736; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pende D, 2005, MOL IMMUNOL, V42, P463, DOI 10.1016/j.molimm.2004.07.028; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Schmitz F, 2004, EUR J IMMUNOL, V34, P2863, DOI 10.1002/eji.200425228; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Seth S, 2007, BIOCH BIOPHYS RES CO; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; THOMPSON CB, 1995, CELL, V81, P979, DOI 10.1016/S0092-8674(05)80001-7; WANG PL, 1992, J IMMUNOL, V148, P2600; Xu H, 1997, J IMMUNOL, V159, P4217; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003	61	52	56	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54406	10.1371/journal.pone.0054406	http://dx.doi.org/10.1371/journal.pone.0054406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349877	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900065
J	Thakur, K; Chawla, V; Bhatti, S; Swarnkar, MK; Kaur, J; Shankar, R; Jha, G				Thakur, Karnika; Chawla, Vandna; Bhatti, Shammi; Swarnkar, Mohit Kumar; Kaur, Jagdeep; Shankar, Ravi; Jha, Gopaljee			De Novo Transcriptome Sequencing and Analysis for Venturia inaequalis, the Devastating Apple Scab Pathogen	PLOS ONE			English	Article							MAGNAPORTHE-GRISEA; GENOME SEQUENCE; GENE; RESISTANCE; PROTEIN; DATABASE; IDENTIFICATION; EFFECTORS; BIOLOGY; ENZYME	Venturia inaequalis is the causal agent of apple scab, one of the most devastating diseases of apple. Due to several distinct features, it has emerged as a model fungal pathogen to study various aspects of hemibiotrophic plant pathogen interactions. The present study reports de novo assembling, annotation and characterization of the transcriptome of V. inaequalis. Venturia transcripts expressed during its growth on laboratory medium and that expressed during its biotrophic stage of infection on apple were sequenced using Illumina RNAseq technology. A total of 94,350,055 reads (50 bp read length) specific to Venturia were obtained after filtering. The reads were assembled into 62,061 contigs representing 24,571 unique genes. GO analysis suggested prevalence of genes associated with biological process categories like metabolism, transport and response to stimulus. Genes associated with molecular function like binding, catalytic activities and transferase activities were found in majority. EC and KEGG pathway analyses suggested prevalence of genes encoding kinases, proteases, glycoside hydrolases, cutinases, cytochrome P450 and transcription factors. The study has identified several putative pathogenicity determinants and candidate effectors in V. inaequalis. A large number of transcripts encoding membrane transporters were identified and comparative analysis revealed that the number of transporters encoded by Venturia is significantly more as compared to that encoded by several other important plant fungal pathogens. Phylogenomics analysis indicated that V. inaequalis is closely related to Pyrenophora tritici-repentis (the causal organism of tan spot of wheat). In conclusion, the findings from this study provide a better understanding of the biology of the apple scab pathogen and have identified candidate genes/functions required for its pathogenesis. This work lays the foundation for facilitating further research towards understanding this host-pathogen interaction.	[Thakur, Karnika; Bhatti, Shammi; Swarnkar, Mohit Kumar; Shankar, Ravi; Jha, Gopaljee] CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India; [Thakur, Karnika; Kaur, Jagdeep] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Panjab University	Shankar, R (corresponding author), CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India.	ravish@ihbt.res.in; jmsgopal@ihbt.res.in	Jha, Gopaljee/Y-8411-2018; thakur, karnika/ABD-6440-2021	Jha, Gopaljee/0000-0002-3965-3135; thakur, karnika/0000-0003-3859-4783; Kaur, Jagdeep/0000-0002-2252-2489; SWARNKAR, MOHIT KUMAR/0000-0002-7033-2364	Department of Biotechnology (Government of India); Council of Scientific and Industrial Research, (CSIR) Government of India [MLP0031, MLP0062];  [MLP0037]	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, (CSIR) Government of India(Council of Scientific & Industrial Research (CSIR) - India); 	The authors acknowledge the financial support provided by Department of Biotechnology (Government of India) under sub-program I (Enhancing productivity of apple through understanding the molecular basis of host-pathogen interactions) of network project entitled "Improvement of Apple through Biotechnological Interventions'' and in-house projects (MLP0031 and MLP0062) of Council of Scientific and Industrial Research, (CSIR) Government of India, that support the GJ lab research initiatives to unravel the molecular basis of fungal pathogenesis on apple. The computational part of this study was supported by MLP0037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benaouf G, 2000, PHYTOPATHOLOGY, V90, P236, DOI 10.1094/PHYTO.2000.90.3.236; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bouwmeester K, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00075; Bowen JK, 2011, MOL PLANT PATHOL, V12, P105, DOI 10.1111/j.1364-3703.2010.00656.x; Bowen JK, 2009, MOL PLANT PATHOL, V10, P431, DOI [10.1111/j.1364-3703.2009.00543.x, 10.1111/J.1364-3703.2009.00543.X]; Broggini GAL, 2007, FUNGAL GENET BIOL, V44, P44, DOI 10.1016/j.fgb.2006.07.001; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Bus VGM, 2011, ANNU REV PHYTOPATHOL, V49, P391, DOI 10.1146/annurev-phyto-072910-095339; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Celton JM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-155; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; DAY PR, 1956, AM J BOT, V43, P835, DOI 10.2307/2438999; de Jonge R, 2011, CURR OPIN PLANT BIOL, V14, P400, DOI 10.1016/j.pbi.2011.03.005; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; De Leeuw Jan, 1973, P 2 INT S INF THEOR, P267; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Elliot MA, 2004, CURR OPIN MICROBIOL, V7, P594, DOI 10.1016/j.mib.2004.10.013; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Gessler C, 2006, CRIT REV PLANT SCI, V25, P473, DOI 10.1080/07352680601015975; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; Gladieux P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001455; Guerin F, 2004, PHYTOPATHOLOGY, V94, P364, DOI 10.1094/PHYTO.2004.94.4.364; GUPTA G K, 1985, Pesticides (Bombay), V19, P19; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jha G, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/680160; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joshi SG, 2011, PLANT MOL BIOL, V75, P579, DOI 10.1007/s11103-011-9749-1; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kim Y, 2007, TRENDS BIOTECHNOL, V25, P395, DOI 10.1016/j.tibtech.2007.07.008; King BC, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-4; Koller W, 2004, PLANT DIS, V88, P537, DOI 10.1094/PDIS.2004.88.5.537; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MacHardy W.E, 1996, APPLE SCAB BIOL EPID; Malnoy M, 2007, MOL PLANT MICROBE IN, V20, P1568, DOI 10.1094/MPMI-20-12-1568; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marine SC, 2007, PLANT HLTH PROGR, DOI [10.1094/PHP-2007-1113-01-RS, DOI 10.1094/PHP-2007-1113-01-RS]; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliva R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/j.1462-5822.2010.01471.x; Palani PV, 1999, MYCOL RES, V103, P1157, DOI 10.1017/S0953756299008321; PARISI L, 1993, PHYTOPATHOLOGY, V83, P533, DOI 10.1094/Phyto-83-533; Park J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-402; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rees DJG, 2009, PLANT AN GEN 17 C; Reimann S, 2005, APPL ENVIRON MICROB, V71, P3269, DOI 10.1128/AEM.71.6.3269-3275.2005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robbertse B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1213; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Schomburg D, 2010, METHODS MOL BIOL, V609, P113, DOI 10.1007/978-1-60327-241-4_7; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Van Dongen S, 2000, THESIS U UTRECHT NET; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Win J, 2003, PHYSIOL MOL PLANT P, V62, P193, DOI 10.1016/S0885-5765(03)00061-4; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Wu SC, 2006, APPL ENVIRON MICROB, V72, P986, DOI 10.1128/AEM.72.2.986-993.2006; Xu Xiangming, 2009, BMC Res Notes, V2, P163, DOI 10.1186/1756-0500-2-163; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	92	25	26	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53937	10.1371/journal.pone.0053937	http://dx.doi.org/10.1371/journal.pone.0053937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349770	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900028
J	Zhang, XB; Shen, YF; Ding, GT; Tian, Y; Liu, ZP; Li, B; Wang, Y; Jiang, CZ				Zhang, Xiaobai; Shen, Yuefeng; Ding, Guitao; Tian, Yi; Liu, Zhenping; Li, Bing; Wang, Yun; Jiang, Cizhong			TFPP: An SVM-Based Tool for Recognizing Flagellar Proteins in Trypanosoma brucei	PLOS ONE			English	Article							PREDICTING SUBCELLULAR-LOCALIZATION; WEB SERVER; CELL-DIVISION; SEQUENCE; CYTOKINESIS; MOTILITY; DATABASE	Trypanosoma brucei is a unicellular flagellated eukaryotic parasite that causes African trypanosomiasis in human and domestic animals with devastating health and economic consequences. Recent studies have revealed the important roles of the single flagellum of T. brucei in many aspects, especially that the flagellar motility is required for the viability of the bloodstream form T. brucei, suggesting that impairment of the flagellar function may provide a promising cure for African sleeping sickness. Knowing the flagellum proteome is crucial to study the molecular mechanism of the flagellar functions. Here we present a novel computational method for identifying flagellar proteins in T. brucei, called trypanosome flagellar protein predictor (TFPP). TFPP was developed based on a list of selected discriminating features derived from protein sequences, and could predict flagellar proteins with similar to 92% specificity at a similar to 84% sensitivity rate. Applied to the whole T. brucei proteome, TFPP reveals 811 more flagellar proteins with high confidence, suggesting that the flagellar proteome covers similar to 10% of the whole proteome. Comparison of the expression profiles of the whole T. brucei proteome at three typical life cycle stages found that similar to 45% of the flagellar proteins were significantly changed in expression levels between the three life cycle stages, indicating life cycle stage-specific regulation of flagellar functions in T. brucei. Overall, our study demonstrated that TFPP is highly effective in identifying flagellar proteins and could provide opportunities to study the trypanosome flagellar proteome systematically. Furthermore, the web server for TFPP can be freely accessed at http:/wukong.tongji.edu.cn/tfpp.	[Zhang, Xiaobai; Shen, Yuefeng; Ding, Guitao; Tian, Yi; Liu, Zhenping; Li, Bing; Wang, Yun; Jiang, Cizhong] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China	Tongji University	Zhang, XB (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China.	zhangxb@tongji.edu.cn; czjiang@tongji.edu.cn			National Natural Science Foundation of China [31200952]; New Century Talent Project of Ministry of Education of China [NCET-10-0600]; Aurora Talent Project of Shanghai [10SG24]; Pujiang Talent Project of Shanghai [10PJ1409500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Talent Project of Ministry of Education of China; Aurora Talent Project of Shanghai; Pujiang Talent Project of Shanghai	This work was supported by the National Natural Science Foundation of China [31200952 to X.Z.]; New Century Talent Project of Ministry of Education of China to [NCET-10-0600 to C.J.]; Aurora Talent Project of Shanghai [10SG24 to C.J.]; and Pujiang Talent Project of Shanghai [10PJ1409500 to C.J.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Benz C, 2007, MOL BIOCHEM PARASIT, V156, P217, DOI 10.1016/j.molbiopara.2007.08.005; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bloodgood RA, 2000, CELL BIOL INT, V24, P857, DOI 10.1006/cbir.2000.0598; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Garrow AG, 2005, NUCLEIC ACIDS RES, V33, pW188, DOI 10.1093/nar/gki384; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Hart SR, 2009, J AM SOC MASS SPECTR, V20, P167, DOI 10.1016/j.jasms.2008.08.014; Hill KL, 2010, CURR OPIN MICROBIOL, V13, P459, DOI 10.1016/j.mib.2010.05.015; Hong CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016875; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ruiz-Postigo JA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001541; Schneider A, 1997, J CELL SCI, V110, P431; Sharma R, 2008, PROTIST, V159, P137, DOI 10.1016/j.protis.2007.07.004; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; Vaughan S, 2010, CURR OPIN MICROBIOL, V13, P453, DOI 10.1016/j.mib.2010.05.006; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang XB, 2010, NUCLEIC ACIDS RES, V38, P7378, DOI 10.1093/nar/gkq618; Zhao N, 2011, PROTEOMICS, V11, P4321, DOI 10.1002/pmic.201100217	42	1	1	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54032	10.1371/journal.pone.0054032	http://dx.doi.org/10.1371/journal.pone.0054032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349782	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900033
J	Wood, S; Pithadia, R; Rehman, T; Zhang, LJ; Plichta, J; Radek, KA; Forsyth, C; Keshavarzian, A; Shafikhani, SH				Wood, Stephen; Pithadia, Ravi; Rehman, Tooba; Zhang, Lijuan; Plichta, Jennifer; Radek, Katherine A.; Forsyth, Christopher; Keshavarzian, Ali; Shafikhani, Sasha H.			Chronic Alcohol Exposure Renders Epithelial Cells Vulnerable to Bacterial Infection	PLOS ONE			English	Article							SECRETED TOXIN EXOT; PSEUDOMONAS-AERUGINOSA; INTESTINAL PERMEABILITY; MESENCHYMAL TRANSITION; BARRIER DYSFUNCTION; LIVER-DISEASE; ETHANOL; MICROFLORA; APOPTOSIS; GROWTH	Despite two centuries of reports linking alcohol consumption with enhanced susceptibility to bacterial infections and in particular gut-derived bacteria, there have been no studies or model systems to assess the impact of long-term alcohol exposure on the ability of the epithelial barrier to withstand bacterial infection. It is well established that acute alcohol exposure leads to reduction in tight and adherens junctions, which in turn leads to increases in epithelial cellular permeability to bacterial products, leading to endotoxemia and a variety of deleterious effects in both rodents and human. We hypothesized that reduced fortification at junctional structures should also reduce the epithelial barrier's capacity to maintain its integrity in the face of bacterial challenge thus rendering epithelial cells more vulnerable to infection. In this study, we established a cell-culture based model system for long-term alcohol exposure to assess the impact of chronic alcohol exposure on the ability of Caco-2 intestinal epithelial cells to withstand infection when facing pathogenic bacteria under the intact or wounded conditions. We report that daily treatment with 0.2% ethanol for two months rendered Caco-2 cells far more susceptible to wound damage and cytotoxicity caused by most but not all bacterial pathogens tested in our studies. Consistent with acute alcohol exposure, long-term ethanol exposure also adversely impacted tight junction structures, but in contrast, it did not affect the adherens junction. Finally, alcohol-treated cells partially regained their ability to withstand infection when ethanol treatment was ceased for two weeks, indicating that alcohol's deleterious effects on cells may be reversible.	[Wood, Stephen; Pithadia, Ravi; Rehman, Tooba; Shafikhani, Sasha H.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Plichta, Jennifer; Radek, Katherine A.] Loyola Univ Chicago, Dept Surg, Burn & Shock Trauma Inst, Maywood, IL USA; [Zhang, Lijuan; Forsyth, Christopher; Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA	Rush University; Loyola University Chicago; Rush University	Shafikhani, SH (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	Sasha_Shafikhani@rush.edu	Plichta, Jennifer K/L-5450-2016; Shafikhani, Sasha/AAM-3460-2021	Plichta, Jennifer K/0000-0002-7411-0558; Wood, Stephen/0000-0002-1306-1027; Shafikhani, Sasha/0000-0003-1755-9997	Rush Startup funds;  [AA020216]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020216] Funding Source: NIH RePORTER	Rush Startup funds; ; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported in part by grant AA020216 (AK, CBF) and by Rush Startup funds to S. H. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Banan A, 1999, J PHARMACOL EXP THER, V291, P1075; BODE JC, 1984, HEPATO-GASTROENTEROL, V31, P30; Bode JC, 2001, ALCOHOL IN HEALTH AND DISEASE, P369; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Elamin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035008; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Forsyth CB, 2011, ALCOHOL CLIN EXP RES, V35, P1635, DOI 10.1111/j.1530-0277.2011.01510.x; Forsyth CB, 2010, ALCOHOL CLIN EXP RES, V34, P19, DOI 10.1111/j.1530-0277.2009.01061.x; Gao LY, 2000, MICROBES INFECT, V2, P1705, DOI 10.1016/S1286-4579(00)01326-5; GARCIA JMA, 1984, REV CLIN ESP, V174, P85; Garrity-Ryan L, 2004, INFECT IMMUN, V72, P546, DOI 10.1128/IAI.72.1.546-558.2004; Hauser AR, 1999, INFECT IMMUN, V67, P5530, DOI 10.1128/IAI.67.10.5530-5537.1999; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Huang DB, 2004, J TRAVEL MED, V11, P143, DOI 10.2310/7060.2004.18560; Jones Stuart G, 2004, Int J Low Extrem Wounds, V3, P201, DOI 10.1177/1534734604271810; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kazmierczak BI, 2001, ANNU REV MICROBIOL, V55, P407, DOI 10.1146/annurev.micro.55.1.407; KESHAVARZIAN A, 1994, AM J GASTROENTEROL, V89, P2205; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; KOLB D, 1982, DRUG ALCOHOL DEPEN, V9, P181, DOI 10.1016/0376-8716(82)90043-6; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lerner A M, 1968, Mich Med, V67, P35; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; Murdoch EL, 2011, SHOCK, V35, P403, DOI 10.1097/SHK.0b013e31820217c9; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; NOLAN JP, 1965, AM J MED SCI, V249, P135; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Robson MC, 1997, SURG CLIN N AM, V77, P637, DOI 10.1016/S0039-6109(05)70572-7; Rush B, 1814, AN INQUIRY INTO THE, P321; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shafikhani SH, 2008, CELL MICROBIOL, V10, P994, DOI 10.1111/j.1462-5822.2007.01102.x; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Simet SM, 2012, ALCOHOL CLIN EXP RES, V36, P432, DOI 10.1111/j.1530-0277.2011.01640.x; SMITH FE, 1976, J CHRON DIS, V29, P35, DOI 10.1016/0021-9681(76)90066-7; SPACH DH, 1995, NEW ENGL J MED, V332, P424, DOI 10.1056/NEJM199502163320703; Stephens P, 2003, BRIT J DERMATOL, V148, P456, DOI 10.1046/j.1365-2133.2003.05232.x; Swanson G, 2011, ALCOHOL CLIN EXP RES, V35, P1305, DOI 10.1111/j.1530-0277.2011.01466.x; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; TILLOTSON JR, 1966, MEDICINE, V45, P65, DOI 10.1097/00005792-196601000-00003; Wood S, 2011, CELL CYCLE, V10, P648, DOI 10.4161/cc.10.4.14813	46	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54646	10.1371/journal.pone.0054646	http://dx.doi.org/10.1371/journal.pone.0054646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358457	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600085
J	Diaz-Villasenor, A; Cruz, L; Cebrian, A; Hernandez-Ramirez, RU; Hiriart, M; Garcia-Vargas, G; Bassol, S; Sordo, M; Gandolfi, AJ; Klimecki, WT; Lopez-Carillo, L; Cebrian, ME; Ostrosky-Wegman, P				Diaz-Villasenor, Andrea; Cruz, Laura; Cebrian, Arturo; Hernandez-Ramirez, Raul U.; Hiriart, Marcia; Garcia-Vargas, Gonzalo; Bassol, Susana; Sordo, Monserrat; Gandolfi, A. Jay; Klimecki, Walter T.; Lopez-Carillo, Lizbeth; Cebrian, Mariano E.; Ostrosky-Wegman, Patricia			Arsenic Exposure and Calpain-10 Polymorphisms Impair the Function of Pancreatic Beta-Cells in Humans: A Pilot Study of Risk Factors for T2DM	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; STIMULATED GLUCOSE-UPTAKE; INSULIN-RESISTANCE; DRINKING-WATER; GENE; ASSOCIATION; PREVALENCE; SECRETION; INVOLVEMENT; HOMEOSTASIS	The incidence of type 2 diabetes mellitus (T2DM) is increasing worldwide and diverse environmental and genetic risk factors are well recognized. Single nucleotide polymorphisms (SNPs) in the calpain-10 gene (CAPN-10), which encodes a protein involved in the secretion and action of insulin, and chronic exposure to inorganic arsenic (iAs) through drinking water have been independently associated with an increase in the risk for T2DM. In the present work we evaluated if CAPN-10 SNPs and iAs exposure jointly contribute to the outcome of T2DM. Insulin secretion (beta-cell function) and insulin sensitivity were evaluated indirectly through validated indexes (HOMA2) in subjects with and without T2DM who have been exposed to a gradient of iAs in their drinking water in northern Mexico. The results were analyzed taking into account the presence of the risk factor SNPs SNP-43 and -44 in CAPN-10. Subjects with T2DM had significantly lower beta-cell function and insulin sensitivity. An inverse association was found between beta-cell function and iAs exposure, the association being more pronounced in subjects with T2DM. Subjects without T2DM who were carriers of the at-risk genotype SNP-43 or -44, also had significantly lower beta-cell function. The association of SNP-43 with beta-cell function was dependent on iAs exposure, age, gender and BMI, whereas the association with SNP-44 was independent of all of these factors. Chronic exposure to iAs seems to be a risk factor for T2DM in humans through the reduction of beta-cell function, with an enhanced effect seen in the presence of the at-risk genotype of SNP-43 in CAPN-10. Carriers of CAPN-10 SNP-44 have also shown reduced beta-cell function.	[Diaz-Villasenor, Andrea; Sordo, Monserrat; Ostrosky-Wegman, Patricia] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico; [Cruz, Laura; Bassol, Susana] Univ Autonoma Coahuila, Fac Med, Torreon, Coahuila, Mexico; [Cebrian, Arturo; Garcia-Vargas, Gonzalo] Univ Juarez Estado Durango, Fac Med, Gomez Palacio, Durango, Mexico; [Hernandez-Ramirez, Raul U.; Lopez-Carillo, Lizbeth] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Morelos, Mexico; [Hiriart, Marcia] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico; [Gandolfi, A. Jay; Klimecki, Walter T.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Cebrian, Mariano E.] IPN CINVESTAV, Ctr Invest & Estudios Avanzados, Secc Externa Toxicol, Mexico City, DF, Mexico; [Diaz-Villasenor, Andrea] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Coahuila; Universidad Juarez del Estado de Durango; Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; University of Arizona; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Ostrosky-Wegman, P (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico.	ostrosky@biomedicas.unam.mx	Hiriart, Marcia/A-3988-2008	Hiriart, Marcia/0000-0001-5711-8868; Garcia Vargas, Gonzalo/0000-0003-1680-5236; Diaz-Villasenor, Andrea/0000-0003-1222-2615; ostrosky-wegman, patricia/0000-0002-8564-3472	CONACYT; DGAPA-PAPIIT (UNAM); Dean Carter Binational Center for Environmental Health Sciences; NIEHS [NIH ES-04940]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004940, P30ES006694] Funding Source: NIH RePORTER	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT (UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Dean Carter Binational Center for Environmental Health Sciences; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was partially supported by CONACYT, DGAPA-PAPIIT (UNAM) and by the Dean Carter Binational Center for Environmental Health Sciences. The analyses for arsenic determination in water and urine samples were performed by the Analytical Section of the Hazard Identification Core from the NIEHS-supported Superfund Basic Research Program Grant (NIH ES-04940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganna E, 2006, J ENDOCRINOL, V190, pR1, DOI 10.1677/joe.1.06737; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Brown AE, 2007, MOL GENET METAB, V91, P318, DOI 10.1016/j.ymgme.2007.05.001; Coronado-Gonzalez JA, 2007, ENVIRON RES, V104, P383, DOI 10.1016/j.envres.2007.03.004; Day C., 2011, BR J DIABETES VASC D, V11, P55; del Bosque-Plata L, 2004, MOL GENET METAB, V81, P122, DOI 10.1016/j.ymgme.2003.10.005; Del Razo LM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-73; DelRazo LM, 1997, ARCH TOXICOL, V71, P211; Diaz-Villasenor A, 2008, TOXICOL APPL PHARM; Diaz-Villasenor A, 2006, TOXICOL APPL PHARM, V214, P30, DOI 10.1016/j.taap.2005.11.015; Emoto M, 1999, DIABETES CARE, V22, P818, DOI 10.2337/diacare.22.5.818; Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P1059, DOI 10.1289/ehp0800533; Fu JQ, 2010, ENVIRON HEALTH PERSP, V118, P864, DOI 10.1289/ehp.0901608; Hoffstedt J, 2002, DIABETOLOGIA, V45, P276, DOI 10.1007/s00125-001-0732-2; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Izquierdo-Vega JA, 2006, TOXICOL LETT, V160, P135, DOI 10.1016/j.toxlet.2005.06.018; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; LAI MS, 1994, AM J EPIDEMIOL, V139, P484, DOI 10.1093/oxfordjournals.aje.a117031; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Logie LJ, 2005, MOL GENET METAB, V85, P54, DOI 10.1016/j.ymgme.2005.01.003; Lu TH, 2011, TOXICOL LETT, V201, P15, DOI 10.1016/j.toxlet.2010.11.019; Lyssenko V, 2009, CURR OPIN LIPIDOL, V20, P87, DOI 10.1097/MOL.0b013e32832923af; Makaji E, 2011, INT J TOXICOL, V30, P410, DOI 10.1177/1091581811405544; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meza MM, 2005, ENVIRON HEALTH PERSP, V113, P775, DOI 10.1289/ehp.7780; Meza MM, 2004, ENVIRON RES, V96, P119, DOI 10.1016/j.envres.2003.08.010; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Orho-Melander M, 2002, DIABETES, V51, P2658, DOI 10.2337/diabetes.51.8.2658; Paul DS, 2008, METAL IONS BIOL MED, V10, P1; Paul DS, 2007, TOXICOL APPL PHARM, V222, P305, DOI 10.1016/j.taap.2007.01.010; Paul DS, 2007, ENVIRON HEALTH PERSP, V115, P734, DOI 10.1289/ehp.9867; Paul DS, 2011, ENVIRON HEALTH PERSP, V119, P1104, DOI 10.1289/ehp.1003324; Paul DS, 2003, BIOCHEM J, V376, P625, DOI 10.1042/BJ20030681; Rahman M, 1999, OCCUP ENVIRON MED, V56, P277, DOI 10.1136/oem.56.4.277; Rahman M, 1998, AM J EPIDEMIOL, V148, P198, DOI 10.1093/oxfordjournals.aje.a009624; Shore AC, 2002, DIABETOLOGIA, V45, P899, DOI 10.1007/s00125-002-0847-0; Smeester L, 2011, CHEM RES TOXICOL, V24, P165, DOI 10.1021/tx1004419; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stumvoll M, 2001, DIABETES, V50, P2161, DOI 10.2337/diabetes.50.9.2161; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Tschritter O, 2003, DIABETES CARE, V26, P1026, DOI 10.2337/diacare.26.4.1026; Tseng CH, 2000, ENVIRON HEALTH PERSP, V108, P847, DOI 10.2307/3434992; Turner MD, 2007, BIOCHEM BIOPH RES CO, V352, P650, DOI 10.1016/j.bbrc.2006.11.077; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang SL, 2003, ENVIRON HEALTH PERSP, V111, P155, DOI 10.1289/ehp.5457; Weedon MN, 2003, AM J HUM GENET, V73, P1208, DOI 10.1086/379285; Xue P, 2011, BIOCHEM BIOPH RES CO, V407, P360, DOI 10.1016/j.bbrc.2011.03.024	52	26	27	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e51642	10.1371/journal.pone.0051642	http://dx.doi.org/10.1371/journal.pone.0051642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349674	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100007
J	Nguyen, THT; Lam, PK; Huynh, TLD; Ngoc, TV; Phan, TTH; Nguyen, TTK; Simmons, C; Wolbers, M; Wills, B				Nguyen Thi Hanh Tien; Phung Khanh Lam; Huynh Thi Le Duyen; Tran Van Ngoc; Phan Thi Thanh Ha; Nguyen Tan Thanh Kieu; Simmons, Cameron; Wolbers, Marcel; Wills, Bridget			Assessment of Microalbuminuria for Early Diagnosis and Risk Prediction in Dengue Infections	PLOS ONE			English	Article							URINARY ALBUMIN EXCRETION; DIFFERENTIATE DENGUE; FEBRILE ILLNESSES; CREATININE RATIO; SHOCK SYNDROME; CHILDREN; CLASSIFICATION; VARIABILITY; PROTEINURIA; FEATURES	Background: Dengue is the most important arboviral infection of humans. Following an initial febrile period, a small proportion of infected patients develop a vasculopathy, with children at particular risk for severe vascular leakage and shock. Differentiation between dengue and other common childhood illnesses is difficult during the early febrile phase, and risk prediction for development of shock is poor. The presence of microalbuminuria is recognized as a useful early predictor for subsequent complications in a number of other disorders with vascular involvement. Significant proteinuria occurs in association with dengue shock syndrome and it is possible that early-phase microalbuminuria may be helpful both for diagnosis of dengue and for identification of patients likely to develop severe disease. Methodology/Principal Findings: We measured formal urine albumin to creatinine ratios (UACRs) in daily samples obtained from a large cohort of children with suspected dengue recruited at two outpatient clinics in Ho Chi Minh City, Vietnam. Although UACRs were increased in the 465 confirmed dengue patients, with a significant time trend showing peak values around the critical period for dengue-associated plasma leakage, urine albumin excretion was also increased in the comparison group of 391 patients with other febrile illnesses (OFI). The dengue patients generally had higher UACRs than the OFI patients, but microalbuminuria, using the conventional cutoff of 30 mg albumin/g creatinine discriminated poorly between the two diagnostic groups in the early febrile phase. Secondly UACRs did not prove useful in predicting either development of warning signs for severe dengue or need for hospitalization. Conclusion/Significance: Low-level albuminuria is common, even in relatively mild dengue infections, but is also present in many OFIs. Simple point-of-care UACR tests are unlikely to be useful for early diagnosis or risk prediction in dengue endemic areas.	[Nguyen Thi Hanh Tien; Phung Khanh Lam; Huynh Thi Le Duyen; Nguyen Tan Thanh Kieu; Simmons, Cameron; Wolbers, Marcel; Wills, Bridget] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Simmons, Cameron; Wolbers, Marcel; Wills, Bridget] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Phan Thi Thanh Ha] Dist 8 Hosp, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Wills, B (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Dist 5, Ho Chi Minh City, Vietnam.	bwills@oucru.org	Simmons, Cameron P/ABA-3896-2021; Lam, Phung/AAW-4108-2020	Simmons, Cameron P/0000-0002-9039-7392; Lam, Phung/0000-0001-7968-473X; Wills, Bridget/0000-0001-9086-8804	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by the Wellcome Trust, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AJ, 1999, DIABETES CARE, V22, P307, DOI 10.2337/diacare.22.2.307; Bates D, 2012, LME4 LINEAR MIXED EF; Biswas HH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001562; Cardosa MJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-9; Chau NP, 2000, DIABETES METAB, V26, P36; Daoussis D, 2011, CLIN RHEUMATOL, V30, P477, DOI 10.1007/s10067-010-1446-y; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Drumheller BC, 2012, ACAD EMERG MED, V19, P259, DOI 10.1111/j.1553-2712.2011.01266.x; Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014; Carvalho JF, 2007, J CLIN IMMUNOL, V27, P246, DOI 10.1007/s10875-007-9083-1; Garcia S, 1995, Bol Asoc Med P R, V87, P2; Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400; Gregory CJ, 2010, AM J TROP MED HYG, V82, P922, DOI 10.4269/ajtmh.2010.09-0552; Incerti J, 2005, NEPHROL DIAL TRANSPL, V20, P2402, DOI 10.1093/ndt/gfi074; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Phuong CXT, 2004, TROP MED INT HEALTH, V9, P573, DOI 10.1111/j.1365-3156.2004.01232.x; Potts JA, 2010, AM J TROP MED HYG, V83, P781, DOI 10.4269/ajtmh.2010.10-0135; Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709; Pugia MJ, 1999, CLIN CHEM LAB MED, V37, P149, DOI 10.1515/CCLM.1999.027; R Core Team, 2012, R LANG ENV STAT COMP; Rademacher ER, 2009, CURR OPIN NEPHROL HY, V18, P246, DOI 10.1097/MNH.0b013e3283294b98; Rein P, 2011, AM J CARDIOL, V107, P1144, DOI 10.1016/j.amjcard.2010.12.011; ROWE DJF, 1985, BMJ-BRIT MED J, V291, P693, DOI 10.1136/bmj.291.6497.693; Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003; Smink PA, 2012, AM J KIDNEY DIS; Smulders YM, 1998, J LAB CLIN MED, V132, P39, DOI 10.1016/S0022-2143(98)90023-3; Thorevska N, 2003, CRIT CARE MED, V31, P1075, DOI 10.1097/01.CCM.0000059316.90804.0B; Trachtenberg F, 2007, AM J KIDNEY DIS, V50, P938, DOI 10.1053/j.ajkd.2007.08.014; Vasanwala FF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-212; Wills BA, 2004, J INFECT DIS, V190, P810, DOI 10.1086/422754; World Health Organization, 2009, DENGUE GUIDELINES DI; Younes N, 2010, CLIN J AM SOC NEPHRO, V5, P1235, DOI 10.2215/CJN.07901109	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54538	10.1371/journal.pone.0054538	http://dx.doi.org/10.1371/journal.pone.0054538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349922	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100078
J	Lennen, RM; Pfleger, BF				Lennen, Rebecca M.; Pfleger, Brian F.			Modulating Membrane Composition Alters Free Fatty Acid Tolerance in Escherichia coli	PLOS ONE			English	Article							CARRIER PROTEIN THIOESTERASE; P-BAD PROMOTER; ACP THIOESTERASE; EXPRESSION; OVERPRODUCTION; BIOSYNTHESIS; SPECIFICITY; CHEMICALS; VECTORS; BINDING	Microbial synthesis of free fatty acids (FFA) is a promising strategy for converting renewable sugars to advanced biofuels and oleochemicals. Unfortunately, FFA production negatively impacts membrane integrity and cell viability in Escherichia coli, the dominant host in which FFA production has been studied. These negative effects provide a selective pressure against FFA production that could lead to genetic instability at industrial scale. In prior work, an engineered E. coli strain harboring an expression plasmid for the Umbellularia californica acyl-acyl carrier protein (ACP) thioesterase was shown to have highly elevated levels of unsaturated fatty acids in the cell membrane. The change in membrane content was hypothesized to be one underlying cause of the negative physiological effects associated with FFA production. In this work, a connection between the regulator of unsaturated fatty acid biosynthesis in E. coli, FabR, thioesterase expression, and unsaturated membrane content was established. A strategy for restoring normal membrane saturation levels and increasing tolerance towards endogenous production of FFAs was implemented by modulating acyl-ACP pools with a second thioesterase (from Geobacillus sp. Y412MC10) that primarily targets medium chain length, unsaturated acyl-ACPs. The strategy succeeded in restoring membrane content and improving viability in FFA producing E. coli while maintaining FFA titers. However, the restored fitness did not increase FFA productivity, indicating the existence of additional metabolic or regulatory barriers.	[Lennen, Rebecca M.; Pfleger, Brian F.] Univ Wisconsin Madison, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Lennen, Rebecca M.; Pfleger, Brian F.] Univ Wisconsin Madison, US DOE, Great Lakes Bioenergy Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Pfleger, BF (corresponding author), Univ Wisconsin Madison, Dept Chem & Biol Engn, Madison, WI 53706 USA.	pfleger@engr.wisc.edu	Pfleger, Brian Frederick/AAA-2559-2022	Pfleger, Brian Frederick/0000-0002-9232-9959	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Sciences) [DE-FC02-07ER64494]; Department of Chemical and Biological Engineering Dahlke-Hougen Fellowship	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Sciences)(United States Department of Energy (DOE)); Department of Chemical and Biological Engineering Dahlke-Hougen Fellowship	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Sciences DE-FC02-07ER64494). R. M. L. was supported as a trainee in the Chemistry-Biology Interface Training Program (NIH) and by the Department of Chemical and Biological Engineering Dahlke-Hougen Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DE, 2012, METAB ENG, V14, P705, DOI 10.1016/j.ymben.2012.08.003; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; [Anonymous], 2003, LIPID ANAL; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; CHO HS, 1995, J BIOL CHEM, V270, P4216, DOI 10.1074/jbc.270.9.4216; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Feng YJ, 2011, MOL MICROBIOL, V80, P195, DOI 10.1111/j.1365-2958.2011.07564.x; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; Goh EB, 2012, APPL ENVIRON MICROB, V78, P70, DOI 10.1128/AEM.06785-11; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Huffer S, 2012, TRENDS BIOTECHNOL; Jing FY, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-44; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Lennen RM, 2012, TRENDS BIOTECHNOLOGY; Lennen RM, 2012, J BACTERIOLOGY; Lennen RM, 2011, APPL ENV MICROBIOL; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Maki-Arvela P, 2007, ENERG FUEL, V21, P30, DOI 10.1021/ef060455v; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Serrano-Vega MJ, 2005, PLANTA, V221, P868, DOI 10.1007/s00425-005-1502-z; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; VOELKER TA, 1994, J BACTERIOL, V176, P7320, DOI 10.1128/JB.176.23.7320-7327.1994; YUAN L, 1995, P NATL ACAD SCI USA, V92, P10639, DOI 10.1073/pnas.92.23.10639; Yuan L, 1996, J BIOL CHEM, V271, P3417; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Zhu K, 2009, J BIOL CHEM, V284, P34880, DOI 10.1074/jbc.M109.068239	33	54	58	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54031	10.1371/journal.pone.0054031	http://dx.doi.org/10.1371/journal.pone.0054031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349781	Green Published, Green Submitted, gold			2022-12-27	WOS:000313943000024
J	Obiero, W; Young, MR; Bailey, RC				Obiero, Walter; Young, Marisa R.; Bailey, Robert C.			The PrePex Device Is Unlikely to Achieve Cost-Savings Compared to the Forceps-Guided Method in Male Circumcision Programs in Sub-Saharan Africa	PLOS ONE			English	Article							HIV PREVENTION; IMPACT; MEN	Background: Male circumcision (MC) reduces the risk of heterosexual HIV acquisition in men by approximately 60%. MC programs for HIV prevention are currently being scaled-up in fourteen countries in sub-Saharan Africa. The current standard surgical technique for MC in many sub-Saharan African countries is the forceps-guided male circumcision (FGMC) method. The PrePex male circumcision (PMC) method could replace FGMC and potentially reduce MC programming costs. We compared the potential costs of introducing the PrePex device into MC programming to the cost of the forceps-guided method. Methods: Data were obtained from the Nyanza Reproductive Health Society (NRHS), an MC service delivery organization in Kenya, and from the Kenya Ministry of Health. Analyses are based on 48,265 MC procedures performed in four Districts in western Kenya from 2009 through 2011. Data were entered into the WHO/UNAIDS Decision Makers Program Planning Tool. The tool assesses direct and indirect costs of MC programming. Various sensitivity analyses were performed. Costs were discounted at an annual rate of 6% and are presented in United States Dollars. Results: Not including the costs of the PrePex device or referral costs for men with phimosis/tight foreskin, the costs of one MC surgery were $44.54-$49.02 and $54.52-$55.29 for PMC and FGMC, respectively. Conclusion: The PrePex device is unlikely to result in significant cost-savings in comparison to the forceps-guided method. MC programmers should target other aspects of the male circumcision minimum package for improved cost efficiency.	[Obiero, Walter; Bailey, Robert C.] Nyanza Reprod Hlth Soc, Kisumu, Kenya; [Young, Marisa R.; Bailey, Robert C.] Univ Illinois, Chicago Sch Publ Hlth, Dept Epidemiol & Biostat, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Obiero, W (corresponding author), Nyanza Reprod Hlth Soc, Kisumu, Kenya.	wobiero@unimkenya.org	Young, Marisa/GXH-4437-2022		CDC/PEPFAR; University of Illinois at Chicago; Chicago Developmental Center for AIDS Research (D-CFAR); NIH [P30 AI 082151]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI082151] Funding Source: NIH RePORTER	CDC/PEPFAR; University of Illinois at Chicago; Chicago Developmental Center for AIDS Research (D-CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Nyanza Reproductive Health Society (NRHS), in partnership with the Kenyan MOH, is supported by CDC/PEPFARin carrying out provision of male circumcision services for HIV prevention. WO is supported in part by CDC/PEPFAR. MRY is supported by the University of Illinois at Chicago. RCB is supported in part by the Chicago Developmental Center for AIDS Research (D-CFAR), an NIH funded program (P30 AI 082151). The results and opinions presented in this paper are those of the authors and do not necessarily reflect the views of NRHS, CDC/PEPFAR, or the Kenyan MOH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2012, 19 INT AIDS C JUL 22; AVAC, 2012, PROGR VMMC SCAL UP P; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barone MA, 2012, J ACQUIR IMMUNE DEFI; Barone MA, 2011, JAIDS-J ACQ IMM DEF, V57, pE7, DOI 10.1097/QAI.0b013e3182158967; Bertrand JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027562; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Bitega JP, 2011, 18 C RETR OPP INF FE; Bollinger L, 2009, MALE CIRCUMCISION DE; Curran K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001129; Dickson KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001133; Edgil D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001128; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hargreave T, 2010, ASIAN J ANDROL, V12, P628, DOI 10.1038/aja.2010.59; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018299; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kioko U, 2010, ESTIMATING COSTS IMP; Lagarde E, 2009, SAMJ S AFR MED J, V99, P163; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Mutabazi V, 2012, J ACQUIR IMMUNE DEFI; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; National AIDS/STI Control Programme Ministry of Health Republic of Kenya, 2008, NAT GUID VOL MED MAL; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Odeny TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043832; Republic of Kenya Ministry of Health, 2011, RAR CONS DISTR HLTH; Republic of Kenya Ministry of Public Health and Sanitation, 2009, CLIN MAN MAL CIRC LO; Schmitz RF, 2001, TROP DOCT, V31, P152, DOI 10.1177/004947550103100312; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Westercamp N, 2012, 19 INT AIDS C JUL 22; WHO, 2012, US DEV AD MAL CIRC P; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; World Health Organization Joint United Nations Program on HIV / AIDS, 2007, NEW DAT MAL CIRC HIV	35	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53380	10.1371/journal.pone.0053380	http://dx.doi.org/10.1371/journal.pone.0053380			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349708	Green Published, gold, Green Submitted			2022-12-27	WOS:000313943000012
J	Smee, MR; Pauchet, Y; Wilkinson, P; Wee, B; Singer, MC; Ffrench-Constant, RH; Hodgson, DJ; Mikheyev, AS				Smee, Melanie R.; Pauchet, Yannick; Wilkinson, Paul; Wee, Brian; Singer, Michael C.; Ffrench-Constant, Richard H.; Hodgson, David J.; Mikheyev, Alexander S.			Microsatellites for the Marsh Fritillary Butterfly: De Novo Transcriptome Sequencing, and a Comparison with Amplified Fragment Length Polymorphism (AFLP) Markers	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; LONG-DISTANCE DISPERSAL; PARNASSIUS-APOLLO; EUPHYDRYAS-EDITHA; HARDY-WEINBERG; LEPIDOPTERA; LOCI; CONSERVATION; DNA; CONSTRUCTION	Background: Until recently the isolation of microsatellite markers from Lepidoptera has proved troublesome, expensive and time-consuming. Following on from a previous study of Edith's checkerspot butterfly, Euphydryas editha, we developed novel microsatellite markers for the vulnerable marsh fritillary butterfly, E. aurinia. Our goal was to optimize the process in order to reduce both time and cost relative to prevailing techniques. This was accomplished by using a combination of previously developed techniques: in silico mining of a de novo assembled transcriptome sequence, and genotyping the microsatellites found there using an economic method of fluorescently labelling primers. Principal Findings: In total, we screened nine polymorphic microsatellite markers, two of which were previously published, and seven that were isolated de novo. These markers were able to amplify across geographically isolated populations throughout Continental Europe and the UK. Significant deviations from Hardy-Weinberg equilibrium were evident in some populations, most likely due to the presence of null alleles. However, we used an F-st outlier approach to show that these markers are likely selectively neutral. Furthermore, using a set of 128 individuals from 11 populations, we demonstrate consistency in population differentiation estimates with previously developed amplified fragment length polymorphism (AFLP) markers (r = 0.68, p<0.001). Significance: Rapid development of microsatellite markers for difficult taxa such as Lepidoptera, and concordant results with other putatively neutral molecular markers, demonstrate the potential of de novo transcriptional sequencing for future studies of population structure and gene flow that are desperately needed for declining species across fragmented landscapes.	[Smee, Melanie R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Smee, Melanie R.; Pauchet, Yannick; Wilkinson, Paul; Ffrench-Constant, Richard H.; Hodgson, David J.] Univ Exeter, Ctr Ecol & Conservat, Sch Biosci, Penryn, Cornwall, England; [Pauchet, Yannick] Max Planck Inst Chem Ecol, Jena, Germany; [Wilkinson, Paul] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Wee, Brian] Natl Ecol Observ Network Inc, Washington, DC USA; [Singer, Michael C.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Mikheyev, Alexander S.] Okinawa Inst Sci & Technol, Onna Son, Okinawa, Japan	University of York - UK; University of Exeter; Max Planck Society; University of Bristol; University of Texas System; University of Texas Austin; Okinawa Institute of Science & Technology Graduate University	Smee, MR (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	melaniesmee@gmail.com	Wee, Brian Peck-Sheng/P-3240-2019; Mikheyev, Alexander/E-7999-2013; Pauchet, Yannick/AAU-9751-2021; Wee, Brian Peck-Sheng/B-8774-2016; Smee, Melanie/K-4201-2015	Wee, Brian Peck-Sheng/0000-0002-0038-9381; Mikheyev, Alexander/0000-0003-4369-1019; Pauchet, Yannick/0000-0002-2918-8946; Wee, Brian Peck-Sheng/0000-0002-0038-9381; Smee, Melanie/0000-0002-6973-0365; ffrench-Constant, Richard/0000-0001-5385-9888	BBSRC CASE studentship; Okinawa Institute for Science and Technology (OIST)	BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Okinawa Institute for Science and Technology (OIST)(Okinawa Institute of Science & Technology Graduate University)	This work was funded by a BBSRC CASE studentship awarded to RHffC. ASM is supported by funding from the Okinawa Institute for Science and Technology (OIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; ASHER J, 2001, MILLENIUM ATLAS BUTT; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BEAUMONT MA, 1999, MICROSATELLITES EVOL, P165; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EHRLICH PR, 1965, EVOLUTION, V19, P327, DOI 10.2307/2406442; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ford HD, 1930, T ROYAL ENTOMOLOGICA, V78, P345; Fox R, 2010, INSECT CONSERVATION; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hanski I., 1999, METAPOPULATION ECOLO; HARRISON S, 1989, ECOLOGY, V70, P1236, DOI 10.2307/1938181; Ji Ya-Jie, 2004, Acta Zoologica Sinica, V50, P608; Ji YJ, 2003, MOL ECOL NOTES, V3, P102, DOI 10.1046/j.1471-8286.2003.00366.x; KANDPAL RP, 1994, P NATL ACAD SCI USA, V91, P88, DOI 10.1073/pnas.91.1.88; Keyghobadi N, 1999, MOL ECOL, V8, P1481, DOI 10.1046/j.1365-294x.1999.00726.x; Kong LF, 2008, MOL ECOL RESOUR, V8, P152, DOI 10.1111/j.1471-8286.2007.01906.x; LOUIS EJ, 1987, BIOMETRICS, V43, P805, DOI 10.2307/2531534; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Meglecz E, 1998, HEREDITAS, V128, P179, DOI 10.1111/j.1601-5223.1998.00179.x; Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x; Metzger C, 2011, CONSERVATION GENETIC; Mikheyev AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011212; Neve G, 2000, TRENDS ECOL EVOL, V15, P376, DOI 10.1016/S0169-5347(00)01921-2; OSTRANDER EA, 1992, P NATL ACAD SCI USA, V89, P3419, DOI 10.1073/pnas.89.8.3419; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Petenian F, 2005, MOL ECOL NOTES, V5, P243, DOI 10.1111/j.1471-8286.2005.00891.x; PORTER K, 1982, OIKOS, V38, P308, DOI 10.2307/3544670; Porter K, 1981, THESIS OXFORD U OXFO; Prasad MD, 2005, GENETICS, V169, P197, DOI 10.1534/genetics.104.031005; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schtickzelle N, 2005, BIOL CONSERV, V126, P569, DOI 10.1016/j.biocon.2005.06.030; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sigaard P, 2008, BIOL J LINN SOC, V95, P677, DOI 10.1111/j.1095-8312.2008.01078.x; Sinama M, 2011, EUR J ENTOMOL, V108, P261, DOI 10.14411/eje.2011.035; THURSTON MI, 2005, MSATFINDER DETECTION; Van't Hof AE, 2007, HEREDITY, V98, P320, DOI 10.1038/sj.hdy.6800944; van't Hof AE, 2005, MOL ECOL NOTES, V5, P169, DOI 10.1111/j.1471-8286.2004.00870.x; Varshney RK, 2007, PLANT SCI, V173, P638, DOI 10.1016/j.plantsci.2007.08.010; Vila M, 2009, EUR J ENTOMOL, V106, P485, DOI 10.14411/eje.2009.061; Wee P-S, 2004, THESIS U TEXAS AUSTI; Woodhead M, 2005, MOL ECOL, V14, P1681, DOI 10.1111/j.1365-294X.2005.02543.x; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zimmermann K, 2011, ECOL ENTOMOL, V36, P499, DOI 10.1111/j.1365-2311.2011.01293.x	52	9	9	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54721	10.1371/journal.pone.0054721	http://dx.doi.org/10.1371/journal.pone.0054721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349956	Green Published, gold, Green Submitted			2022-12-27	WOS:000313943000047
J	Bellucci, L; Dalvai, M; Kocanova, S; Moutahir, F; Bystricky, K				Bellucci, Luca; Dalvai, Mathieu; Kocanova, Silvia; Moutahir, Fatima; Bystricky, Kerstin			Activation of p21 by HDAC Inhibitors Requires Acetylation of H2A.Z	PLOS ONE			English	Article							BREAST-CANCER CELLS; HISTONE DEACETYLASE; ESTROGEN; RECEPTOR; GENE; TRANSCRIPTION; TRICHOSTATIN; SP1; P53; EXPRESSION	Differential positioning of the histone variant H2A.Z in a p53 dependent manner was shown to regulate p21 transcription. Whether H2A.Z is involved in p21 activity in the absence of p53 is not known. The p21 gene is repressed in estrogen receptor (ER) negative cell lines that are p53-/- and hormone independent for their growth. Here we demonstrate that class I and II pan Histone deacetylase inhibitors (HDACi) induce p21 transcription and reduce cell proliferation of MDA-MB231, an ER alpha-negative mammary tumor cell line, in a H2A.Z dependent manner. H2A.Z is associated with the transcription start site (TSS) of the repressed p21 gene. Depleting H2A.Z did not lead to transcription of p21 but annihilated the stimulating effect of HDACi on this gene. Acetylation of H2A.Z but not of H3K9 at the p21 promoter correlated with p21 activation. We further show that HDACi treatment reduced the presence of the p400 chromatin remodeler at the p21 TSS. We propose a model in which association of p400 negatively affects p21 transcription by interfering with acetylation of H2A.Z.	[Bellucci, Luca; Dalvai, Mathieu; Kocanova, Silvia; Moutahir, Fatima; Bystricky, Kerstin] Univ Toulouse, Lab Biol Mol Eucaryote, Toulouse, France; [Bellucci, Luca; Dalvai, Mathieu; Kocanova, Silvia; Moutahir, Fatima; Bystricky, Kerstin] CNRS, LBME, UMR5099, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bystricky, K (corresponding author), Univ Toulouse, Lab Biol Mol Eucaryote, Toulouse, France.	kerstin@biotoul.fr	BYSTRICKY, Kerstin/B-8670-2009; Bystricky, Kerstin/AAA-3003-2020	BYSTRICKY, Kerstin/0000-0001-6717-3721; Bystricky, Kerstin/0000-0001-6717-3721	Ligue Nationale Contre le Cancer; Institut National du Cancer (INCa) [34696]; Fondation pour la Recherche Medicale (FRM)	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Ligue Nationale Contre le Cancer (fellowship to LB), the Institut National du Cancer (INCa grant #34696) and the Fondation pour la Recherche Medicale (FRM, fellowship to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bowman TA, 2011, INT J CELL BIOL, V2011; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Dalvai M, 2010, J MAMMARY GLAND BIOL, V15, P19, DOI 10.1007/s10911-010-9167-z; Fleury L, 2008, ONCOGENE, V27, P4075, DOI 10.1038/onc.2008.41; Fortunati N, 2010, BREAST CANCER RES TR, V124, P667, DOI 10.1007/s10549-010-0789-z; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Lavigne A.C., 2012, ONCOGENE IN PRESS; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Love IM, 2012, CELL CYCLE, V11, P2458, DOI 10.4161/cc.20864; Mattera L, 2009, ONCOGENE, V28, P1506, DOI 10.1038/onc.2008.499; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Park JH, 2010, MOL CELL BIOL, V30, P2750, DOI 10.1128/MCB.00804-09; Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Suzuki T, 2000, INT J CANCER, V88, P992, DOI 10.1002/1097-0215(20001215)88:6<992::AID-IJC24>3.0.CO;2-9; TOUITOU I, 1991, J STEROID BIOCHEM, V40, P231, DOI 10.1016/0960-0760(91)90187-A; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Valdes-Mora F, 2012, GENOME RES, V22, P307, DOI 10.1101/gr.118919.110; Wharton W, 2000, J BIOL CHEM, V275, P33981, DOI 10.1074/jbc.M005600200; Yang XW, 2000, CANCER RES, V60, P6890; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	35	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54102	10.1371/journal.pone.0054102	http://dx.doi.org/10.1371/journal.pone.0054102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349794	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800025
J	Chan, YS; Huen, DS; Glauert, R; Whiteway, E; Russell, S				Chan, Yuk-Sang; Huen, David S.; Glauert, Ruth; Whiteway, Eleanor; Russell, Steven			Optimising Homing Endonuclease Gene Drive Performance in a Semi-Refractory Species: The Drosophila melanogaster Experience	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; SITE; EXPRESSION; VECTOR; SYSTEM	Homing endonuclease gene (HEG) drive is a promising insect population control technique that employs meganucleases to impair the fitness of pest populations. Our previous studies showed that HEG drive was more difficult to achieve in Drosophila melanogaster than Anopheles gambiae and we therefore investigated ways of improving homing performance in Drosophila. We show that homing in Drosophila responds to increased expression of HEGs specifically during the spermatogonia stage and this could be achieved through improved construct design. We found that 39-UTR choice was important to maximise expression levels, with HEG activity increasing as we employed Hsp70, SV40, vasa and beta Tub56D derived UTRs. We also searched for spermatogonium-specific promoters and found that the Rcd-1r promoter was able to drive specific expression at this stage. Since Rcd-1 is a regulator of differentiation in other species, it suggests that Rcd-1r may serve a similar role during spermatogonial differentiation in Drosophila. Contrary to expectations, a fragment containing the entire region between the TBPH gene and the bgcn translational start drove strong HEG expression only during late spermatogenesis rather than in the germline stem cells and spermatogonia as expected. We also observed that the fraction of targets undergoing homing was temperature-sensitive, falling nearly four-fold when the temperature was lowered to 18 degrees C. Taken together, this study demonstrates how a few simple measures can lead to substantial improvements in the HEG-based gene drive strategy and reinforce the idea that the HEG approach may be widely applicable to a variety of insect control programs.	[Chan, Yuk-Sang; Huen, David S.; Glauert, Ruth; Whiteway, Eleanor; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Russell, Steven] Cambridge Syst Biol Ctr, Cambridge, England	University of Cambridge; University of Cambridge	Huen, DS (corresponding author), Wolverhampton Univ, Sch Appl Sci, Wolverhampton WV1 1DJ, W Midlands, England.	david.s.huen@googlemail.com	Huen, David/F-3676-2014; Russell, Steve/A-4072-2011	Huen, David/0000-0002-9900-2297; Russell, Steve/0000-0003-0546-3031	FNIH grant; Bill & Melinda Gates Foundation	FNIH grant; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded via a FNIH grant to Austin Burt (Imperial College). The FNIH funding originated from the generous support of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birnbaum RY, 2012, GENOME RES, V22, P1059, DOI 10.1101/gr.133546.111; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; BUTTGEREIT D, 1993, MOL GEN GENET, V241, P263, DOI 10.1007/BF00284677; Chan YS, 2011, GENETICS, V188, P33, DOI 10.1534/genetics.111.127506; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; Duncker BP, 1997, MOL GEN GENET, V254, P291, DOI 10.1007/s004380050418; Gonczy P, 1997, DEVELOPMENT, V124, P4361; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Jeongsil KH, 1999, MOL CELL BIOL, V19, P2505; John B., 2005, MEIOSIS; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; McQuilton P, 2011, NUCLEIC ACIDS RES, V40, P1; Metzger MJ, 2011, NUCLEIC ACIDS RES, V39, P926, DOI 10.1093/nar/gkq826; Morris CA, 2009, NAT PROTOC, V4, P1807, DOI 10.1038/nprot.2009.192; Niu Y, 2008, J MOL BIOL, V382, P188, DOI 10.1016/j.jmb.2008.07.010; PETERSEN R, 1988, GENE, V72, P161, DOI 10.1016/0378-1119(88)90138-2; Quezada-Diaz JE, 2010, GENETICA, V138, P925, DOI 10.1007/s10709-010-9474-8; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2003, GENETICS, V165, P1831; Rorth P, 1998, DEVELOPMENT, V125, P1049; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Ulge UY, 2011, NUCLEIC ACIDS RES, V39, P4330, DOI 10.1093/nar/gkr022; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	35	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54130	10.1371/journal.pone.0054130	http://dx.doi.org/10.1371/journal.pone.0054130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349805	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800026
J	Matar, RNB; Klein, JD; Sands, JM				Matar, Raed N. Bou; Klein, Janet D.; Sands, Jeff M.			Erlotinib Preserves Renal Function and Prevents Salt Retention in Doxorubicin Treated Nephrotic Rats	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNELS; CELL LUNG-CANCER; GROWTH-FACTOR; INCREASED EXPRESSION; ENAC SUBUNITS; BINDING; INHIBITION; TRANSPORTERS; NEPHROPATHY; PLASMIN	Nephrotic syndrome is associated with up-regulation of the heparin-binding epidermal growth factor (HB-EGF). Erlotinib blocks the activation of the epidermal growth factor receptor (EGFR) in response to HB-EGF. This study investigates the effect of Erlotinib on the progression of proteinuria, renal dysfunction, and salt retention in doxorubicin treated nephrotic rats. Male rats were divided into 3 pair-fed groups (n = 13/group) as follows: Control rats (Ctrl); rats receiving intravenous doxorubicin (Dox); and rats receiving intravenous doxorubicin followed by daily oral Erlotinib (Dox + Erl). Upon establishment of high grade proteinuria, urine sodium and creatinine clearance were measured. Kidney tissue was dissected and analyzed for gamma-epithelial sodium channel (gamma ENaC), sodium-potassium -chloride co-transporter 2 (NKCC2), sodium chloride co-transporter (NCC), aquaporin 2 (AQP2), and EGFR abundances using western blot. Creatinine clearance was preserved in the Dox + Erl rats as compared to the Dox group (in ml/min: Ctrl: 5.2 +/-.5, Dox: 1.9 +/- 0.3, Dox + Erl: 3.6 +/- 0.5). Despite a minimal effect on the degree of proteinuria, Erlotinib prevented salt retention (Urinary Na in mEq/d: Ctrl: 2.2 +/- 0.2, Dox: 1.8 +/- 0.3, Dox + Erl: 2.2 +/- 0.2). The cleaved/uncleaved gamma ENaC ratio was increased by 41 +/- 16% in the Dox group but unchanged in the Dox + Erl group when compared to Ctrl. The phosphorylated EGFR/total EGFR ratio was reduced by 74 +/- 7% in the Dox group and by 77 +/- 4% in the Dox + Erl group. In conclusion, Erlotinib preserved renal function and prevented salt retention in nephrotic rats. The observed effects do not appear to be mediated by direct blockade of EGFR.	[Matar, Raed N. Bou] Emory Univ, Dept Pediat Med, Atlanta, GA 30322 USA; [Matar, Raed N. Bou] Emory Univ, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Klein, Janet D.; Sands, Jeff M.] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Klein, Janet D.; Sands, Jeff M.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; Emory University	Sands, JM (corresponding author), Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA.	jeff.sands@emory.edu			National Institutes of Health (NIH) [R01-DK41707, R01-DK89828, R21-DK91147]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK091147, R01DK041707, R01DK089828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants R01-DK41707, R01-DK89828, and R21-DK91147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2011, NEPHROLOGY, V16, P573, DOI 10.1111/j.1440-1797.2011.01451.x; Agarwal R, 2000, J AM SOC NEPHROL, V11, P1100, DOI 10.1681/ASN.V1161100; Apostol E, 1997, J AM SOC NEPHROL, V8, P15; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Braun N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003233.pub2; Cohen MH, 2010, ONCOLOGIST, V15, P1344, DOI 10.1634/theoncologist.2010-0257; Ecelbarger CA, 2001, EXP NEUROL, V171, P227, DOI 10.1006/exnr.2001.7775; Feng LL, 2000, J CLIN INVEST, V105, P341, DOI 10.1172/JCI2869; Fernandez-Llama P, 1998, KIDNEY INT, V53, P1244, DOI 10.1046/j.1523-1755.1998.00878.x; Fernandez-Llama P, 1998, KIDNEY INT, V54, P170, DOI 10.1046/j.1523-1755.1998.00984.x; Khong TF, 2000, KIDNEY INT, V58, P1098, DOI 10.1046/j.1523-1755.2000.00267.x; Kim D, 2003, AM J PHYSIOL-RENAL, V285, pF303, DOI 10.1152/ajprenal.00438.2002; Kim SW, 2006, AM J PHYSIOL-RENAL, V290, pF674, DOI 10.1152/ajprenal.00084.2005; Kim SW, 2004, AM J PHYSIOL-RENAL, V286, pF922, DOI 10.1152/ajprenal.00277.2003; Kitiyakara C, 2003, SEMIN NEPHROL, V23, P172, DOI 10.1053/snep.2003.50025; LEE YJ, 1995, BIOCHEM BIOPH RES CO, V207, P216, DOI 10.1006/bbrc.1995.1175; Liu L, 2009, AM J PHYSIOL-RENAL, V296, pF1417, DOI 10.1152/ajprenal.90337.2008; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Matar RNB, 2012, AM J PHYSIOL-RENAL, V302, pF1545, DOI 10.1152/ajprenal.00686.2011; Mok TSK, 2009, J CLIN ONCOL, V27, P5080, DOI 10.1200/JCO.2008.21.5541; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; Orcutt KP, 2011, CANCER RES, V71, P3932, DOI 10.1158/0008-5472.CAN-10-3425; Paizis K, 1998, KIDNEY INT, V53, P1162, DOI 10.1046/j.1523-1755.1998.00846.x; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Raymond E, 2000, DRUGS, V60, P15, DOI 10.2165/00003495-200060001-00002; Sakai M, 1997, J CLIN INVEST, V99, P2128, DOI 10.1172/JCI119386; Svenningsen P, 2009, AM J PHYSIOL-REG I, V297, pR1733, DOI 10.1152/ajpregu.00321.2009; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Troiani T, 2012, CURR DRUG TARGETS, V13, P802, DOI 10.2174/138945012800564158; Wassef L, 2004, KIDNEY INT, V66, P1805, DOI 10.1111/j.1523-1755.2004.00955.x	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54738	10.1371/journal.pone.0054738	http://dx.doi.org/10.1371/journal.pone.0054738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349960	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800073
J	Raynes, R; Pombier, KM; Nguyen, K; Brunquell, J; Mendez, JE; Westerheide, SD				Raynes, Rachel; Pombier, Kathleen M.; Nguyen, Kevin; Brunquell, Jessica; Mendez, Jamie E.; Westerheide, Sandy D.			The SIRT1 Modulators AROS and DBC1 Regulate HSF1 Activity and the Heat Shock Response	PLOS ONE			English	Article							YEAST LIFE-SPAN; CALORIE RESTRICTION; DEACETYLASE SIRT1; TRANSCRIPTION FACTORS; CELL-SURVIVAL; STRESS; P53; FACTOR-1; PHOSPHORYLATION; PGC-1-ALPHA	The heat shock response, the cellular response to protein damaging stress, is critical in maintaining proteostasis. The heat shock response is regulated by the transcription factor HSF1, which is activated upon heat shock and other stresses to induce the expression of molecular chaperones. SIRT1 has previously been shown to activate HSF1 by deacetylating it, leading to increased DNA binding ability. We have investigated how the heat shock response may be controlled by factors influencing SIRT1 activity. We found that heat shock results in an increase in the cellular NAD(+)/NADH ratio and an increase in recruitment of SIRT1 to the hsp70 promoter. Furthermore, we found that the SIRT1 modulators AROS and DBC1 have an impact on hsp70 transcription, HSF1 acetylation status, and HSF1 recruitment to the hsp70 promoter. Therefore, AROS and DBC1 are now two new targets available for therapeutic regulation of the heat shock response.	[Raynes, Rachel; Pombier, Kathleen M.; Nguyen, Kevin; Brunquell, Jessica; Mendez, Jamie E.; Westerheide, Sandy D.] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Westerheide, SD (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	swesterheide@usf.edu			Cell Biology, Microbiology and Molecular Biology Department at the University of South Florida	Cell Biology, Microbiology and Molecular Biology Department at the University of South Florida	This work was supported by a departmental start-up grant from the Cell Biology, Microbiology and Molecular Biology Department at the University of South Florida to S.D.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cotto JJ, 1997, J CELL SCI, V110, P2925; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Ethridge RT, 1998, GASTROENTEROLOGY, V115, P1454, DOI 10.1016/S0016-5085(98)70024-1; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Morimoto RI, 2009, HDB CELL SIGNALING, P2231; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Rahat O, 2011, J GERONTOL A-BIOL, V66, P163, DOI 10.1093/gerona/glq165; Raynes R, 2012, J BIOL CHEM; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Senawong T, 2005, ARCH BIOCHEM BIOPHYS, V434, P316, DOI 10.1016/j.abb.2004.10.028; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zschoernig B, 2008, BIOCHEM BIOPH RES CO, V376, P251, DOI 10.1016/j.bbrc.2008.08.137	42	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54364	10.1371/journal.pone.0054364	http://dx.doi.org/10.1371/journal.pone.0054364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349863	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800043
J	Mkrtchyan, HV; Russell, CA; Wang, N; Cutler, RR				Mkrtchyan, Hermine V.; Russell, Charlotte A.; Wang, Nan; Cutler, Ronald R.			Could Public Restrooms Be an Environment for Bacterial Resistomes?	PLOS ONE			English	Article							LASER-DESORPTION IONIZATION; FLIGHT MASS-SPECTROMETRY; STAPHYLOCOCCUS-HAEMOLYTICUS; RAPID IDENTIFICATION; RESISTANCE; COMMUNITY; TOILETS; CHALLENGES; PATHOGENS; CARRIAGE	Antibiotic resistance in bacteria remains a major problem and environments that help to maintain such resistance, represent a significant problem to infection control in the community. Restrooms have always been regarded as potential sources of infectious diseases and we suggest they have the potential to sustain bacterial "resistomes". Recent studies have demonstrated the wide range of different bacterial phyla that can be found in non-healthcare restrooms. In our study we focused on the Staphylococci. These species are often skin contaminants on man and have been reported as common restroom isolates in recent molecular studies. We collected samples from 18 toilets sited in 4 different public buildings. Using MALDI-TOF-MS and other techniques, we identified a wide range of antibiotic resistant Staphylococci and other bacteria from our samples. We identified 19 different Staphylococcal species within our isolates and 37.8% of the isolates were drug resistant. We also identified different Staphylococcal species with the same antibiograms inhabiting the same restrooms. Bacterial "resistomes" are communities of bacteria often localised in specific areas and within these environments drug resistance determinants may be freely transferred. Our study shows that non-healthcare restrooms are a source of antibiotic resistant bacteria where a collection of antibiotic resistance genes in pathogenic and non-pathogenic bacteria could form a resistome containing a "nexus of genetic diversity"	[Mkrtchyan, Hermine V.; Wang, Nan; Cutler, Ronald R.] Queen Mary Univ London, Sch Biol & Chem Sci, Preclin Drug Discovery Grp, London, England; [Russell, Charlotte A.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Wang, Nan] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	University of London; Queen Mary University London; University of London; Queen Mary University London; University of Electronic Science & Technology of China	Cutler, RR (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Preclin Drug Discovery Grp, London, England.	r.cutler@qmul.ac.uk		Mkrtchyan, Hermine/0000-0001-7339-7297				Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Barker J, 2000, J APPL MICROBIOL, V89, P137, DOI 10.1046/j.1365-2672.2000.01091.x; Benagli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016424; Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x; Bocher S, 2010, CLIN MICROBIOL INFEC, V16, P1427, DOI [10.1111/j.1469-0691.2010.03137.x, 10.1111/j.1469-0691.2009.03137.x]; Carbonnelle E, 2007, J CLIN MICROBIOL, V45, P2156, DOI 10.1128/JCM.02405-06; Cizman M, 2003, INT J ANTIMICROB AG, V21, P297, DOI 10.1016/S0924-8579(02)00394-1; Edern A, 2012, NEPHROL THER; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Fox K, 2011, J MICROBIOL METH, V84, P243, DOI 10.1016/j.mimet.2010.12.007; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Gardner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000752; GERBA CP, 1975, APPL MICROBIOL, V30, P229, DOI 10.1128/AEM.30.2.229-237.1975; Goto H, 2009, J INFECT CHEMOTHER, V15, P347, DOI 10.1007/s10156-009-0719-3; Karakulska J, 2012, J MICROBIOL, V50, P444, DOI 10.1007/s12275-012-1550-6; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Kliem M, 2012, CURR OPIN MICROBIOL, V15, P397, DOI 10.1016/j.mib.2012.02.006; Koksal F, 2009, MICROBIOL RES, V164, P404, DOI 10.1016/j.micres.2007.03.004; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Marshall B., 2009, MICROBE WASH 600, V4, P231, DOI [DOI 10.1128/MICROBE.4.231.1, 10.1128/microbe.4.231.1]; MENDES MF, 1976, J HYG-CAMBRIDGE, V76, P183, DOI 10.1017/S002217240005508X; Miller YW, 1996, J ANTIMICROB CHEMOTH, V38, P829; Miyakis S, 2011, CLIN INFECT DIS, V53, P177, DOI 10.1093/cid/cir323; Nakib Al M, 2012, DIAGN MICROBIOL INFE, V72, P193, DOI [10.1016/j.diagmicrobio.2011.10.004, DOI 10.1016/J.DIAGMICROBIO.2011.10.004]; Nathwani D, 2008, J ANTIMICROB CHEMOTH, V61, P976, DOI 10.1093/jac/dkn096; Nelson L, 2006, EMERG INFECT DIS, V12, P172, DOI 10.3201/eid1201.050279; OVERMAN TL, 1985, J CLIN MICROBIOL, V21, P542, DOI 10.1128/JCM.21.4.542-545.1985; Park JY, 2011, VET MICROBIOL, V147, P142, DOI 10.1016/j.vetmic.2010.06.020; Rahman A, 2012, Mymensingh Med J, V21, P195; SCOTT E, 1982, J HYG-CAMBRIDGE, V89, P279, DOI 10.1017/S0022172400070819; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vickers AA, 2007, ANTIMICROB AGENTS CH, V51, P4484, DOI 10.1128/AAC.00708-07; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005	37	37	40	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54223	10.1371/journal.pone.0054223	http://dx.doi.org/10.1371/journal.pone.0054223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349833	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000313738900055
J	Mushaben, EM; Brandt, EB; Hershey, GKK; Le Cras, TD				Mushaben, Elizabeth M.; Brandt, Eric B.; Hershey, Gurjit K. Khurana; Le Cras, Timothy D.			Differential Effects of Rapamycin and Dexamethasone in Mouse Models of Established Allergic Asthma	PLOS ONE			English	Article							REGULATORY T-CELLS; AIRWAY INFLAMMATION; GOBLET CELLS; HOUSE-DUST; B-CELLS; MTOR; HYPERREACTIVITY; DISEASE; PROTEIN; INNATE	The mammalian target of rapamycin (mTOR) plays an important role in cell growth/differentiation, integrating environmental cues, and regulating immune responses. Our lab previously demonstrated that inhibition of mTOR with rapamycin prevented house dust mite (HDM)-induced allergic asthma in mice. Here, we utilized two treatment protocols to investigate whether rapamycin, compared to the steroid, dexamethasone, could inhibit allergic responses during the later stages of the disease process, namely allergen re-exposure and/or during progression of chronic allergic disease. In protocol 1, BALB/c mice were sensitized to HDM (three i.p. injections) and administered two intranasal HDM exposures. After 6 weeks of rest/recovery, mice were re-exposed to HDM while being treated with rapamycin or dexamethasone. In protocol 2, mice were exposed to HDM for 3 or 6 weeks and treated with rapamycin or dexamethasone during weeks 4-6. Characteristic features of allergic asthma, including IgE, goblet cells, airway hyperreactivity (AHR), inflammatory cells, cytokines/chemokines, and T cell responses were assessed. In protocol 1, both rapamycin and dexamethasone suppressed goblet cells and total CD4(+) T cells including activated, effector, and regulatory T cells in the lung tissue, with no effect on AHR or total inflammatory cell numbers in the bronchoalveolar lavage fluid. Rapamycin also suppressed IgE, although IL-4 and eotaxin 1 levels were augmented. In protocol 2, both drugs suppressed total CD4+ T cells, including activated, effector, and regulatory T cells and IgE levels. IL-4, eotaxin, and inflammatory cell numbers were increased after rapamycin and no effect on AHR was observed. Dexamethasone suppressed inflammatory cell numbers, especially eosinophils, but had limited effects on AHR. We conclude that while mTOR signaling is critical during the early phases of allergic asthma, its role is much more limited once disease is established.	[Mushaben, Elizabeth M.; Le Cras, Timothy D.] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp, Div Pulm Biol,Dept Pediat, Cincinnati, OH 45221 USA; [Brandt, Eric B.; Hershey, Gurjit K. Khurana] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp, Div Asthma Res,Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Le Cras, TD (corresponding author), Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp, Div Pulm Biol,Dept Pediat, Cincinnati, OH 45221 USA.	tim.lecras@cchmc.org		Brandt, Eric/0000-0003-0617-4100; Le Cras, Timothy/0000-0001-8538-2703	National Institutes of Health [U19A170235, HL097135]; NIEHS [T32 ES010957]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES010957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by National Institutes of Health Grants U19A170235 (GKH), HL097135 (TDLC and GKH), and NIEHS T32 ES010957 (EBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre-Alcazar MA, 2007, DEV DYNAM, V236, P2825, DOI 10.1002/dvdy.21293; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Benhamron S, 2011, EUR J IMMUNOL, V41, P2390, DOI 10.1002/eji.201041336; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; de Kluijver J, 2002, AM J RESP CRIT CARE, V166, P294, DOI 10.1164/rccm.2112097; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dumont F J, 1996, Life Sci, V58, P373; Fredriksson K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033984; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Heidt S, 2008, TRANSPLANTATION, V86, P1292, DOI 10.1097/TP.0b013e3181874a36; Hesselmar B, 2000, PEDIATR ALLERGY IMMU, V11, P74, DOI 10.1034/j.1399-3038.2000.00070.x; Holgate ST, 2005, AM J RESP CRIT CARE, V172, P941, DOI 10.1164/rccm.2507007; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Jungsuwadee P, 2004, CLIN IMMUNOL, V110, P13, DOI 10.1016/j.clim.2003.09.003; Kay AB, 2006, CHEM IMMUNOL ALLERGY, V91, P59; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim J, 2004, AM J PHYSIOL-LUNG C, V287, pL503, DOI 10.1152/ajplung.00433.2003; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Kramer EL, 2011, J APPL PHYSIOL, V111, P1760, DOI 10.1152/japplphysiol.00737.2011; Kramer EL, 2009, AM J RESP CELL MOL, V41, P415, DOI 10.1165/rcmb.2008-0470OC; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Le Cras TD, 2004, AM J PHYSIOL-LUNG C, V287, pL718, DOI 10.1152/ajplung.00084.2004; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Ma JX, 2011, J ALLERGY CLIN IMMUN, V127, P1447, DOI 10.1016/j.jaci.2011.01.032; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Martin P, 2010, J ALLERGY CLIN IMMUN, V126, P355, DOI 10.1016/j.jaci.2010.05.010; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Miki-Hosokawa T, 2009, J IMMUNOL, V183, P8203, DOI 10.4049/jimmunol.0900646; Mushaben EM, 2011, J IMMUNOL, V187, P5756, DOI 10.4049/jimmunol.1102133; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; Perkins C, 2011, J EXP MED, V208, P853, DOI 10.1084/jem.20100023; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Siegle JS, 2006, AM J RESP CELL MOL, V35, P565, DOI 10.1165/rcmb.2006-0135OC; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Taams LS, 2006, IMMUNOLOGY, V118, P1, DOI 10.1111/j.1365-2567.2006.02348.x; Ulrich K, 2008, PULM PHARMACOL THER, V21, P637, DOI 10.1016/j.pupt.2008.02.006; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhang X, 2009, J IMMUNOL, V182, P5123, DOI 10.4049/jimmunol.0804276	56	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54426	10.1371/journal.pone.0054426	http://dx.doi.org/10.1371/journal.pone.0054426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349887	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900067
J	Wang, LF; Li, J; Ruan, YY; Lu, TL; Liu, CX; Jia, MX; Yue, WH; Liu, J; Bourgeron, T; Zhang, D				Wang, Lifang; Li, Jun; Ruan, Yanyan; Lu, Tianlan; Liu, Chenxing; Jia, Meixiang; Yue, Weihua; Liu, Jing; Bourgeron, Thomas; Zhang, Dai			Sequencing ASMT Identifies Rare Mutations in Chinese Han Patients with Autism	PLOS ONE			English	Article							DE-NOVO MUTATIONS; SPECTRUM DISORDERS; MELATONIN SYNTHESIS; PROTEIN FUNCTION; MOOD DISORDERS; GENE; PATHWAY; ASSOCIATION; CHILDREN; INSOMNIA	Melatonin is involved in the regulation of circadian and seasonal rhythms and immune function. Prior research reported low melatonin levels in autism spectrum disorders (ASD). ASMT located in pseudo-autosomal region 1 encodes the last enzyme of the melatonin biosynthesis pathway. A previous study reported an association between ASD and single nucleotide polymorphisms (SNPs) rs4446909 and rs5989681 located in the promoter of ASMT. Furthermore, rare deleterious mutations were identified in a subset of patients. To investigate the association between ASMT and autism, we sequenced all ASMT exons and its neighboring region in 398 Chinese Han individuals with autism and 437 healthy controls. Although our study did not detect significant differences of genotypic distribution and allele frequencies of the common SNPs in ASMT between patients with autism and healthy controls, we identified new rare coding mutations of ASMT. Among these rare variants, 4 were exclusively detected in patients with autism including a stop mutation (p.R115W, p.V166I, p.V179G, and p.W257X). These four coding variants were observed in 6 of 398 (1.51%) patients with autism and none in 437 controls (Chi-Square test, Continuity Correction p = 0.032, two-sided). Functional prediction of impact of amino acid showed that p.R115W might affect protein function. These results indicate that ASMT might be a susceptibility gene for autism. Further studies in larger samples are needed to better understand the degree of variation in this gene as well as to understand the biochemical and clinical impacts of ASMT/melatonin deficiency.	[Wang, Lifang; Li, Jun; Ruan, Yanyan; Lu, Tianlan; Liu, Chenxing; Jia, Meixiang; Yue, Weihua; Liu, Jing; Zhang, Dai] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China; [Wang, Lifang; Li, Jun; Ruan, Yanyan; Lu, Tianlan; Liu, Chenxing; Yue, Weihua; Zhang, Dai] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Zhang, Dai] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Bourgeron, Thomas] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, Paris, France; [Bourgeron, Thomas] Univ Paris Diderot, Paris, France	Peking University; Peking University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Wang, LF (corresponding author), Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China.	lifangwang@bjmu.edu.cn; daizhang@bjmu.edu.cn	Jia, Mei/GXZ-9967-2022	Bourgeron, Thomas/0000-0001-8164-9220	National Basic Research Development Program of China (973 program) [2010CB833905]; National Natural Science Foundation [30870897, 81071110]; Beijing Natural Science Foundation [7081005]	National Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by research grants from the National Basic Research Development Program of China (973 program 2010CB833905), National Natural Science Foundation (grant number 30870897 and 81071110), and Beijing Natural Science Foundation (grant number: 7081005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agez L, 2009, J PINEAL RES, V46, P95, DOI 10.1111/j.1600-079X.2008.00636.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Botros HG, 2012, J PINEAL RES; Cai GQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-50; Chaste P, 2011, J PINEAL RES, V51, P394, DOI 10.1111/j.1600-079X.2011.00902.x; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Etain B, 2012, HUM MOL GENET, V21, P4030, DOI 10.1093/hmg/dds227; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galecki P, 2010, J PINEAL RES, V48, P311, DOI 10.1111/j.1600-079X.2010.00754.x; HALLIWELL B, 1992, ANN NEUROL, V32, pS10, DOI 10.1002/ana.410320704; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jimenez-Jorge S, 2007, J PINEAL RES, V42, P240, DOI 10.1111/j.1600-079X.2006.00411.x; Jonsson L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-10; Kripke Daniel F, 2011, J Circadian Rhythms, V9, P8, DOI 10.1186/1740-3391-9-8; Kulman G, 2000, NEUROENDOCRINOL LETT, V21, P31; Kumar PNS, 2007, J CLIN PSYCHIAT, V68, P237, DOI 10.4088/JCP.v68n0208; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LAM RW, 1990, PSYCHIAT RES, V33, P129, DOI 10.1016/0165-1781(90)90066-E; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Melke J, 2008, MOL PSYCHIATR, V13, P90, DOI 10.1038/sj.mp.4002016; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nir I, 1995, J AUTISM DEV DISORD, V25, P641, DOI 10.1007/BF02178193; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pagan C, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-17; Park HJ, 2011, J MOL NEUROSCI, V45, P304, DOI 10.1007/s12031-011-9522-6; Perlis ML, 1997, J AFFECT DISORDERS, V42, P209, DOI 10.1016/S0165-0327(96)01411-5; Rutter M, 2000, J ABNORM CHILD PSYCH, V28, P3, DOI 10.1023/A:1005113900068; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Srinivasan V, 2008, NEUROIMMUNOMODULAT, V15, P93, DOI 10.1159/000148191; Srinivasan V, 2006, WORLD J BIOL PSYCHIA, V7, P138, DOI 10.1080/15622970600571822; Taupin Philippe, 2008, Int J Med Sci, V5, P127; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Toma C, 2007, MOL PSYCHIATR, V12, P977, DOI 10.1038/sj.mp.4002069; Tordjman S, 2005, BIOL PSYCHIAT, V57, P134, DOI 10.1016/j.biopsych.2004.11.003; Veenstra-Vanderweele J, 2003, J AM ACAD CHILD PSY, V42, P116, DOI 10.1097/00004583-200301000-00018; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016	44	20	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53727	10.1371/journal.pone.0053727	http://dx.doi.org/10.1371/journal.pone.0053727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349736	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900018
J	Branton, WG; Ellestad, KK; Maingat, F; Wheatley, BM; Rud, E; Warren, RL; Holt, RA; Surette, MG; Power, C				Branton, William G.; Ellestad, Kristofor K.; Maingat, Ferdinand; Wheatley, B. Matt; Rud, Erling; Warren, Rene L.; Holt, Robert A.; Surette, Michael G.; Power, Christopher			Brain Microbial Populations in HIV/AIDS: alpha-Proteobacteria Predominate Independent of Host Immune Status	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; NOVOSPHINGOBIUM-AROMATICIVORANS; ACHROMOBACTER-XYLOSOXIDANS; NERVOUS-SYSTEM; PCR ASSAYS; INFECTION; GUT; BACTERIA; BLOOD; NEUROINFLAMMATION	The brain is assumed to be a sterile organ in the absence of disease although the impact of immune disruption is uncertain in terms of brain microbial diversity or quantity. To investigate microbial diversity and quantity in the brain, the profile of infectious agents was examined in pathologically normal and abnormal brains from persons with HIV/AIDS [HIV] (n = 12), other disease controls [ODC] (n = 14) and in cerebral surgical resections for epilepsy [SURG] (n = 6). Deep sequencing of cerebral white matter-derived RNA from the HIV (n = 4) and ODC (n = 4) patients and SURG (n = 2) groups revealed bacterially-encoded 16 s RNA sequences in all brain specimens with alpha-proteobacteria representing over 70% of bacterial sequences while the other 30% of bacterial classes varied widely. Bacterial rRNA was detected in white matter glial cells by in situ hybridization and peptidoglycan immunoreactivity was also localized principally in glia in human brains. Analyses of amplified bacterial 16 s rRNA sequences disclosed that Proteobacteria was the principal bacterial phylum in all human brain samples with similar bacterial rRNA quantities in HIV and ODC groups despite increased host neuroimmune responses in the HIV group. Exogenous viruses including bacteriophage and human herpes viruses-4, - 5 and - 6 were detected variably in autopsied brains from both clinical groups. Brains from SIV- and SHIV-infected macaques displayed a profile of bacterial phyla also dominated by Proteobacteria but bacterial sequences were not detected in experimentally FIV-infected cat or RAG1(-/-) mouse brains. Intracerebral implantation of human brain homogenates into RAG1(-/-) mice revealed a preponderance of alpha-proteobacteria 16 s RNA sequences in the brains of recipient mice at 7 weeks post-implantation, which was abrogated by prior heat-treatment of the brain homogenate. Thus, alpha-proteobacteria represented the major bacterial component of the primate brain's microbiome regardless of underlying immune status, which could be transferred into naive hosts leading to microbial persistence in the brain.	[Branton, William G.; Maingat, Ferdinand; Power, Christopher] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Ellestad, Kristofor K.; Power, Christopher] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Wheatley, B. Matt] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Rud, Erling] Hlth Canada, Natl Lab HIV Pathogenesis, Ottawa, ON K1A 0L2, Canada; [Warren, Rene L.; Holt, Robert A.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Surette, Michael G.] McMaster Univ, Dept Med, Hamilton, ON, Canada	University of Alberta; University of Alberta; University of Alberta; Health Canada; British Columbia Cancer Agency; McMaster University	Power, C (corresponding author), Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada.	chris.power@ualberta.ca	Surette, Michael G/AAE-8825-2020; Holt, Robert A/C-3303-2009; Rud, Erling/P-5359-2016; Power, Christopher/C-7181-2013; Warren, Rene/R-7681-2016	Holt, Robert A/0000-0002-7259-1247; Rud, Erling/0000-0001-8615-0277; Warren, Rene/0000-0002-9890-2293; Branton, William/0000-0002-3259-2544; Power, Christopher/0000-0002-5131-9711	Canadian Institutes of Health Research [G118160525]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	These studies were supported by the Canadian Institutes of Health Research (G118160525). CP holds a Canada Research Chair (CRC) (Tier 1) in Neurological Infection and Immunity and is an Alberta Innovates-Health Solutions Senior Scholar. MS holds a Canada Research Chair CRC (Tier 1) in Interdisciplinary Microbiome Research. None of the authors have commercial interests or activities related to the contents of the present manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2010, FASEB J, V24, P4343, DOI 10.1096/fj.10-162313; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Al Masalma M, 2012, CLIN INFECT DIS, V54, P202, DOI 10.1093/cid/cir797; Almuzara MN, 2010, J CLIN MICROBIOL, V48, P660, DOI 10.1128/JCM.01849-09; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Arbour N, 2000, J VIROL, V74, P8913, DOI 10.1128/JVI.74.19.8913-8921.2000; Arck P, 2010, EXP DERMATOL, V19, P401, DOI 10.1111/j.1600-0625.2009.01060.x; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Benndorf D, 2002, MICROBIOL-SGM, V148, P2883, DOI 10.1099/00221287-148-9-2883; Bienenstock J, 2010, CLIN EXP IMMUNOL, V160, P85, DOI 10.1111/j.1365-2249.2010.04124.x; Bruls T, 2011, HUM MOL GENET, V20, pR142, DOI 10.1093/hmg/ddr353; CASTAGNOLA E, 1994, CLIN INFECT DIS, V19, P559, DOI 10.1093/clinids/19.3.559-a; Cho BJ, 2002, ARCH OPHTHALMOL-CHIC, V120, P1091; da Silva RM, 2006, J VASC SURG, V44, P1055, DOI 10.1016/j.jvs.2006.07.021; DECRE D, 1992, J ANTIMICROB CHEMOTH, V30, P769, DOI 10.1093/jac/30.6.769; del Mar Ojeda-Vargas Maria, 1999, Clin Microbiol Infect, V5, P443; Dimmitt RA, 2010, J PEDIATR GASTR NUTR, V51, P262, DOI 10.1097/MPG.0b013e3181e1a114; Ellestad KK, 2009, J IMMUNOL, V183, P298, DOI 10.4049/jimmunol.0803576; Ellis CL, 2011, JAIDS-J ACQ IMM DEF, V57, P363, DOI 10.1097/QAI.0b013e31821a603c; Espinoza-Gomez F, 2007, BRAZ J INFECT DIS, V11, P603, DOI 10.1590/S1413-86702007000600015; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; HEARN YR, 1991, AM J CLIN PATHOL, V96, P211, DOI 10.1093/ajcp/96.2.211; Hill JE, 2010, APPL ENVIRON MICROB, V76, P4550, DOI 10.1128/AEM.01510-09; HOROWITZ H, 1990, J CLIN MICROBIOL, V28, P143, DOI 10.1128/JCM.28.1.143-145.1990; Jarchum I, 2011, CURR OPIN IMMUNOL, V23, P353, DOI 10.1016/j.coi.2011.03.001; Jebbink J, 2003, J MOL DIAGN, V5, P15, DOI 10.1016/S1525-1578(10)60446-1; Johnston JB, 2001, CURR BIOL, V11, P1109, DOI 10.1016/S0960-9822(01)00350-5; Kaplan MM, 2004, AM J GASTROENTEROL, V99, P2147, DOI 10.1111/j.1572-0241.2004.41121.x; Kawahara K, 2002, FEMS MICROBIOL LETT, V214, P289; Kawamura I, 2011, J INFECT CHEMOTHER, V17, P111, DOI 10.1007/s10156-010-0089-x; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Maingat F, 2009, J NEUROSCI, V29, P8429, DOI 10.1523/JNEUROSCI.5818-08.2009; Malek-Marin T, 2009, CLIN NEPHROL, V72, P405, DOI 10.5414/cnp72405; MANJRA AI, 1989, S AFR MED J, V76, P571; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Moehario LH, 2009, J INFECT DEV COUNTR, V3, P843, DOI 10.3855/jidc.85; Moore RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019838; Noorbakhsh F, 2005, J IMMUNOL, V174, P7320, DOI 10.4049/jimmunol.174.11.7320; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Ochoa-Reparaz J, 2011, ANN NEUROL, V69, P240, DOI 10.1002/ana.22344; Padgett KA, 2005, J AUTOIMMUN, V24, P209, DOI 10.1016/j.jaut.2005.01.012; PEDERSEN MM, 1970, AM J CLIN PATHOL, V54, P178; POWER C, 1993, ANN NEUROL, V34, P339, DOI 10.1002/ana.410340307; Reinke SN, 2013, J INFECT DIS, V207, P1451, DOI 10.1093/infdis/jis479; Salha MD, 2008, VIROLOGY, V377, P239, DOI 10.1016/j.virol.2008.04.031; Schrijver IA, 2001, BRAIN, V124, P1544, DOI 10.1093/brain/124.8.1544; SHIGETA S, 1978, J CLIN PATHOL, V31, P156, DOI 10.1136/jcp.31.2.156; Sibley CD, 2012, EUR J CLIN MICROBIOL, V31, P2679, DOI 10.1007/s10096-012-1614-x; Strazza M, 2011, BRAIN RES, V1399, P96, DOI 10.1016/j.brainres.2011.05.015; Visser L, 2006, AM J PATHOL, V169, P1671, DOI 10.2353/ajpath.2006.060143; Vivithanaporn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012856; Vogel TU, 1998, J MED PRIMATOL, V27, P65, DOI 10.1111/j.1600-0684.1998.tb00228.x; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	59	86	87	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54673	10.1371/journal.pone.0054673	http://dx.doi.org/10.1371/journal.pone.0054673			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355888	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500103
J	Ellis, RJ; Bruce, KD; Jenkins, C; Stothard, JR; Ajarova, L; Mugisha, L; Viney, ME				Ellis, Richard J.; Bruce, Kenneth D.; Jenkins, Claire; Stothard, J. Russell; Ajarova, Lilly; Mugisha, Lawrence; Viney, Mark E.			Comparison of the Distal Gut Microbiota from People and Animals in Africa	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; FECAL MICROBIOTA; DIVERSITY; EVOLUTION; SEQUENCES; SOFTWARE; OBESITY; HEALTH; DIET; TOOL	The gut microbiota plays a key role in the maintenance of healthy gut function as well as many other aspects of health. High-throughput sequence analyses have revealed the composition of the gut microbiota, showing that there is a core signature to the human gut microbiota, as well as variation in its composition between people. The gut microbiota of animals is also being investigated. We are interested in the relationship between bacterial taxa of the human gut microbiota and those in the gut microbiota of domestic and semi-wild animals. While it is clear that some human gut bacterial pathogens come from animals (showing that human - animal transmission occurs), the extent to which the usually nonpathogenic commensal taxa are shared between humans and animals has not been explored. To investigate this we compared the distal gut microbiota of humans, cattle and semi-captive chimpanzees in communities that are geographically sympatric in Uganda. The gut microbiotas of these three host species could be distinguished by the different proportions of bacterial taxa present. We defined multiple operational taxonomic units (OTUs) by sequence similarity and found evidence that some OTUs were common between human, cattle and chimpanzees, with the largest number of shared OTUs occurring between chimpanzees and humans, as might be expected with their close physiological similarity. These results show the potential for the sharing of usually commensal bacterial taxa between humans and other animals. This suggests that further investigation of this phenomenon is needed to fully understand how it drives the composition of human and animal gut microbiotas.	[Ellis, Richard J.] Anim Hlth & Vet Labs Agcy, Specialist Sci Support Dept, Addlestone, Surrey, England; [Bruce, Kenneth D.] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England; [Jenkins, Claire] Hlth Protect Agcy, Lab Gastrointestinal Pathogens, London, England; [Stothard, J. Russell] Univ Liverpool, Liverpool Sch Trop Med, Dis Control Strategy Grp, Liverpool L3 5QA, Merseyside, England; [Ajarova, Lilly] Chimpanzee Sanctuary & Wildlife Conservat Trust, Entebbe, Uganda; [Mugisha, Lawrence] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda; [Mugisha, Lawrence] Conservat & Ecosyst Hlth Alliance, Kampala, Uganda; [Viney, Mark E.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	Veterinary Laboratories Agency; University of London; King's College London; Health Protection Agency; Liverpool School of Tropical Medicine; University of Liverpool; Makerere University; University of Bristol	Ellis, RJ (corresponding author), Anim Hlth & Vet Labs Agcy, Specialist Sci Support Dept, Addlestone, Surrey, England.	richard.ellis@ahvla.gsi.gov.uk	Mugisha, Lawrence/N-4916-2017; Ellis, Richard/A-9176-2008; Stothard, John Russell/AAK-4829-2021	Mugisha, Lawrence/0000-0003-4932-3356; Ellis, Richard/0000-0002-2690-9090; Stothard, John Russell/0000-0002-9370-3420	UK Medical Research Council (MRC) Environmental and Social Ecology of Human Infectious Diseases (ESEI) catalyst grant [G0902447]; Medical Research Council [G0902447] Funding Source: researchfish; MRC [G0902447] Funding Source: UKRI	UK Medical Research Council (MRC) Environmental and Social Ecology of Human Infectious Diseases (ESEI) catalyst grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was from a UK Medical Research Council (MRC) Environmental and Social Ecology of Human Infectious Diseases (ESEI) catalyst grant (http://www.mrc.ac.uk/Fundingopportunities/Calls/ESEI/index.htm) to MV (G0902447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraclough TG, 2012, EVOL BIOL, V39, P148, DOI 10.1007/s11692-012-9181-8; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Brugman Sylvia, 2010, J Mol Med (Berl), V88, P881, DOI 10.1007/s00109-010-0639-9; Candela M, 2010, INT J FOOD MICROBIOL, V140, P93, DOI 10.1016/j.ijfoodmicro.2010.04.017; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chung HC, 2010, CURR OPIN IMMUNOL, V22, P455, DOI 10.1016/j.coi.2010.06.008; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JE, 2011, ISME J, V5, P362, DOI 10.1038/ismej.2010.120; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Marchesi JR, 2010, ADV APPL MICROBIOL, V72, P43, DOI 10.1016/S0065-2164(10)72002-5; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Mugisha L., 2010, Open Veterinary Science Journal, V4, P6, DOI 10.2174/1874318801004010006; Noor Samah O, 2010, BMC Gastroenterol, V10, P134, DOI 10.1186/1471-230X-10-134; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4	51	47	48	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54783	10.1371/journal.pone.0054783	http://dx.doi.org/10.1371/journal.pone.0054783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355898	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000314021500125
J	Zhang, LP; Shao, HB; Long, XH; Liu, ZP				Zhang Liping; Shao Hongbo; Long Xiaohua; Liu Zhaopu			Gene Regulation of Iron-Deficiency Responses Is Associated with Carbon Monoxide and Heme Oxydase 1 in Chlamydomonas reinhardtii	PLOS ONE			English	Article							PHYTOCHROME-CHROMOPHORE BIOSYNTHESIS; METAL TRANSPORTER; EFFECTOR MOLECULES; CHELATE REDUCTASE; ARABIDOPSIS; METABOLISM; EXPRESSION; ACCUMULATION; FOX1; CO	Carbon monoxide (CO) as an endogenous gaseous molecule regulates a variety of biological processes in animals. However, CO regulating nutrient stress responses in green alga is largely unknown. On the other hand, heme oxydase (HO1 as a rate-limiting enzyme of the first step for heme degration and to catalyze heme into biliverdin (BV), which is concomitant with releasing of CO and ferrous ions, probably participates in the process of CO-regulating response to nutrient stress in green alga. In this paper, we described an observation that CO could regulate iron-homeostasis in iron-starving Chlamydomonas reinhardtii. Exogenous CO at 8 mu M was able to prevent the iron deficient-inducing chlorosis and improve chlorophyll accumulation. Expression pattern of FOX1, FTR1 and ferredoxin was up-regulated by CO exposure in iron-deficient mediam. treatment with external CO increasing iron accumulation in iron-deficient C. reinhardtii. Moreover, to get insights into the regulatory role of HO1, we constructed a transgenic alga overexpressing HO1 and HO1 knock-out mutants. The results show that there was no significant influence on chlorosis with HO1 overexpression of C. reinhardtii under iron-deficiency and the chlorophyll accumulation, and gene expression associated with iron deficiency of mutant were greatly improved. Otherwise, those results from HO1 knock-out mutants were opposite to HO1 overexpression mutants. Finally, CO exposure induced NO accumulation in cells. However, such an action could be blocked by NO scavenger cPTIO. These results indicate that CO/HO1 may play an important role in improving green algae adaptation to iron deficiency or cross-talking with NO under the iron deficiency.	[Zhang Liping; Shao Hongbo; Long Xiaohua; Liu Zhaopu] Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China; [Zhang Liping; Shao Hongbo] Chinese Acad Sci, Yantai Inst Costal Zone Res YIC, Key Lab Coastal Biol & Bioresources Utilizat, Yantai, Peoples R China; [Shao Hongbo] Qingdao Univ Sci & Technol, Inst Life Sci, Qingdao, Peoples R China	Nanjing Agricultural University; Chinese Academy of Sciences; Qingdao University of Science & Technology	Shao, HB (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China.	shaohongbochu@126.com; longxiaohua@njau.edu.cn; sea@njau.edu.cn			National Key Project of Scientific and Technical Supporting Programs [2011BAD13B09]; Jiangsu Provincial Key Project of Scientific and Technical Supporting Programs [BE2010305, BE2011368]; Fundamental Research Funds for the Central Universities [Y0201100249]; New Teachers' Fund for Doctor Stations, Ministry of Education [20100097120016]; Project of Special Fund for Public Welfare Industrial (Agriculture) Research of China [200903001-5]; National Natural Science Foundation of China [31201692]; One Hundred-Talent Plan of Chinese Academy of Sciences (CAS); CAS/SAFEA International Partnership Program for Creative Research Teams; Yantai Science & Technology Development Project [2011016, 2010245]; Yantai Double-hundred Talent Plan [XY-003-02]; 135 Plan Development Plan of YIC-CAS	National Key Project of Scientific and Technical Supporting Programs; Jiangsu Provincial Key Project of Scientific and Technical Supporting Programs; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); New Teachers' Fund for Doctor Stations, Ministry of Education; Project of Special Fund for Public Welfare Industrial (Agriculture) Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred-Talent Plan of Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Yantai Science & Technology Development Project; Yantai Double-hundred Talent Plan; 135 Plan Development Plan of YIC-CAS	This work has been supported jointly by the National Key Project of Scientific and Technical Supporting Programs (No. 2011BAD13B09), Jiangsu Provincial Key Project of Scientific and Technical Supporting Programs (Nos. BE2010305; BE2011368), the Fundamental Research Funds for the Central Universities (No. Y0201100249), the New Teachers' Fund for Doctor Stations, Ministry of Education (No. 20100097120016), the Project of Special Fund for Public Welfare Industrial (Agriculture) Research of China (No. 200903001-5), the National Natural Science Foundation of China (No. 31201692), One Hundred-Talent Plan of Chinese Academy of Sciences (CAS), the CAS/SAFEA International Partnership Program for Creative Research Teams, Yantai Science & Technology Development Project (No. 2011016; 2010245), Yantai Double-hundred Talent Plan (XY-003-02), and 135 Plan Development Plan of YIC-CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Chen J, 2009, ECOTOXICOLOGY, V18, P110, DOI 10.1007/s10646-008-0264-3; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; Deng X, 2007, EUKARYOT CELL, V6, P2163, DOI 10.1128/EC.00324-07; Eckhardt U, 1998, J EXP BOT, V49, P1219, DOI 10.1093/jexbot/49.324.1219; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Graziano M, 2007, PLANT J, V52, P949, DOI 10.1111/j.1365-313X.2007.03283.x; Guo K, 2008, J EXP BOT, V59, P3443, DOI 10.1093/jxb/ern194; Hartsfield CL, 2002, ANTIOXID REDOX SIGN, V4, P301, DOI 10.1089/152308602753666352; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; Kong WW, 2010, PLANT BIOTECHNOL J, V8, P88, DOI 10.1111/j.1467-7652.2009.00469.x; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Li LH, 2004, PLANT MOL BIOL, V54, P125, DOI 10.1023/B:PLAN.0000028774.82782.16; Lu Y, 2012, PLOS ONE, V7; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Murgia I, 2002, PLANT J, V30, P521, DOI 10.1046/j.1365-313X.2002.01312.x; Paz Y, 2007, J BIOL CHEM, V282, P8658, DOI 10.1074/jbc.M609756200; Piantadosi CA, 2002, ANTIOXID REDOX SIGN, V4, P259, DOI 10.1089/152308602753666316; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Schmidt W, 1999, NEW PHYTOL, V141, P1, DOI 10.1046/j.1469-8137.1999.00331.x; SIEGEL SM, 1962, SCIENCE, V137, P683, DOI 10.1126/science.137.3531.683; STOCKING CR, 1975, PLANT PHYSIOL, V55, P626, DOI 10.1104/pp.55.4.626; Thom SR, 1997, CHEM RES TOXICOL, V10, P1023, DOI 10.1021/tx970041h; Wang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052436; Watts RN, 2004, BBA-MOL CELL RES, V1692, P1, DOI 10.1016/j.bbamcr.2004.02.004; Watts RN, 2003, BIOCHEM J, V369, P429, DOI 10.1042/BJ20021302; WINDER TL, 1995, PLANT PHYSIOL, V108, P1487, DOI 10.1104/pp.108.4.1487; Wu HL, 2005, PLANT CELL PHYSIOL, V46, P1505, DOI 10.1093/pcp/pci163; Xie YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049800; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017	36	2	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53835	10.1371/journal.pone.0053835	http://dx.doi.org/10.1371/journal.pone.0053835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349749	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100033
J	Dmochewitz, L; Fortsch, C; Zwerger, C; Vaeth, M; Felder, E; Huber-Lang, M; Barth, H				Dmochewitz, Lydia; Foertsch, Christina; Zwerger, Christian; Vaeth, Martin; Felder, Edward; Huber-Lang, Markus; Barth, Holger			A Recombinant Fusion Toxin Based on Enzymatic Inactive C3bot1 Selectively Targets Macrophages	PLOS ONE			English	Article							BOTULINUM C2 TOXIN; ADP-RIBOSYLATING TOXINS; CLOSTRIDIUM-BOTULINUM; MAMMALIAN-CELLS; MEMBRANE TRANSLOCATION; BACTERIAL TOXINS; ACTIN-FILAMENTS; CELLULAR UPTAKE; RIBOSYLTRANSFERASE; C3	Background: The C3bot1 protein (similar to 23 kDa) from Clostridium botulinum ADP-ribosylates and thereby inactivates Rho. C3bot1 is selectively taken up into the cytosol of monocytes/macrophages but not of other cell types such as epithelial cells or fibroblasts. Most likely, the internalization occurs by a specific endocytotic pathway via acidified endosomes. Methodology/Principal Findings: Here, we tested whether enzymatic inactive C3bot1E174Q serves as a macrophage-selective transport system for delivery of enzymatic active proteins into the cytosol of such cells. Having confirmed that C3bot1E174Q does not induce macrophage activation, we used the actin ADP-ribosylating C2I (similar to 50 kDa) from Clostridium botulinum as a reporter enzyme for C3bot1E174Q-mediated delivery into macrophages. The recombinant C3bot1E174Q-C2I fusion toxin was cloned and expressed as GST-protein in Escherichia coli. Purified C3bot1E174Q-C2I was recognized by antibodies against C2I and C3bot and showed C2I-specific enzyme activity in vitro. When applied to cultured cells C3bot1E174Q-C2I ADP-ribosylated actin in the cytosol of macrophages including J774A.1 and RAW264.7 cell lines as well as primary cultured human macrophages but not of epithelial cells. Together with confocal fluorescence microscopy experiments, the biochemical data indicate the selective uptake of a recombinant C3-fusion toxin into the cytosol of macrophages. Conclusions/Significance: In summary, we demonstrated that C3bot1E174Q can be used as a delivery system for fast, selective and specific transport of enzymes into the cytosol of living macrophages. Therefore, C3-based fusion toxins can represent valuable molecular tools in experimental macrophage pharmacology and cell biology as well as attractive candidates to develop new therapeutic approaches against macrophage-associated diseases.	[Dmochewitz, Lydia; Foertsch, Christina; Zwerger, Christian; Barth, Holger] Univ Ulm, Inst Pharmacol & Toxicol, Med Ctr, D-89069 Ulm, Germany; [Vaeth, Martin] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Felder, Edward] Univ Ulm, Inst Gen Physiol, D-89069 Ulm, Germany; [Huber-Lang, Markus] Univ Ulm, Med Ctr, Inst Traumatol Hand & Reconstruct Surg, D-89069 Ulm, Germany	Ulm University; University of Wurzburg; Ulm University; Ulm University	Barth, H (corresponding author), Univ Ulm, Inst Pharmacol & Toxicol, Med Ctr, D-89069 Ulm, Germany.	holger.barth@uni-ulm.de	Barth, Holger/E-7920-2013; Huber-Lang, Markus/AAJ-2209-2020	Vaeth, Martin/0000-0001-8974-7052	Deutsche Forschungsgemeinschaft via the International Graduate School in Molecular Medicine Ulm	Deutsche Forschungsgemeinschaft via the International Graduate School in Molecular Medicine Ulm	This work was financially supported by the Deutsche Forschungsgemeinschaft via the International Graduate School in Molecular Medicine Ulm by a fellowship for Lydia Dmochewitz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1987, BIOCHEM J, V247, P363, DOI 10.1042/bj2470363; AKTORIES K, 1995, BIOCHIMIE, V77, P326, DOI 10.1016/0300-9084(96)88142-9; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; ALON R, 1990, BIOCHEM BIOPH RES CO, V170, P1236, DOI 10.1016/0006-291X(90)90526-S; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 1998, J BIOL CHEM, V273, P29506, DOI 10.1074/jbc.273.45.29506; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Barth H, 2008, CURR MED CHEM, V15, P459, DOI 10.2174/092986708783503195; Barth H, 2011, EUR J CELL BIOL, V90, P944, DOI 10.1016/j.ejcb.2010.11.007; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, BIOCHEMISTRY-US, V42, P5368, DOI 10.1021/bi034199e; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Fahrer J, 2010, CELL MICROBIOL, V12, P233, DOI 10.1111/j.1462-5822.2009.01393.x; Fujii N, 1996, BIOCHEM BIOPH RES CO, V220, P353, DOI 10.1006/bbrc.1996.0409; Haug G, 2003, BIOCHEMISTRY-US, V42, P15284, DOI 10.1021/bi0354278; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; JUST I, 1992, J BIOL CHEM, V267, P10274; Kaiser E, 2006, BIOCHEMISTRY-US, V45, P13361, DOI 10.1021/bi061459u; Kaiser E, 2012, CELL MICROBIOL, V14, P1193, DOI 10.1111/j.1462-5822.2012.01788.x; Kaiser E, 2009, CELL MICROBIOL, V11, P780, DOI 10.1111/j.1462-5822.2009.01291.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lillich M, 2012, BIOCONJUGATE CHEM, V23, P1426, DOI 10.1021/bc300041z; MONTECUCCO C, 1994, FEBS LETT, V346, P92, DOI 10.1016/0014-5793(94)00449-8; Nagahama M, 2009, INFECT IMMUN, V77, P5139, DOI 10.1128/IAI.00638-09; OHISHI I, 1980, INFECT IMMUN, V30, P668; Olsnes S, 2000, HANDB EXP PHARM, V145, P1; Pautsch A, 2005, EMBO J, V24, P3670, DOI 10.1038/sj.emboj.7600813; Pust S, 2010, CELL MICROBIOL, V12, P1809, DOI 10.1111/j.1462-5822.2010.01512.x; Rohrbeck A, 2012, FEBS J, V279, P2657, DOI 10.1111/j.1742-4658.2012.08645.x; Sandvig K, 1984, Acta Histochem Suppl, V29, P79; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stiles BG, 2002, TOXICON, V40, P1135, DOI 10.1016/S0041-0101(02)00113-7; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; WEGNER A, 1988, J BIOL CHEM, V263, P13739; WEIGT C, 1989, FEBS LETT, V246, P181, DOI 10.1016/0014-5793(89)80279-0; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237	42	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54517	10.1371/journal.pone.0054517	http://dx.doi.org/10.1371/journal.pone.0054517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349915	Green Published, gold, Green Submitted			2022-12-27	WOS:000313943000043
J	Nikam, C; Jagannath, M; Narayanan, MM; Ramanabhiraman, V; Kazi, M; Shetty, A; Rodrigues, C				Nikam, Chaitali; Jagannath, Manjula; Narayanan, Manoj Mulakkapurath; Ramanabhiraman, Vinaya; Kazi, Mubin; Shetty, Anjali; Rodrigues, Camilla			Rapid Diagnosis of Mycobacterium tuberculosis with Truenat MTB: A Near-Care Approach	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CLINICAL SPECIMENS; SPUTUM SEDIMENTS; PCR ASSAY; DNA	Background: Control of the global Tuberculosis (TB) burden is hindered by the lack of a simple and effective diagnostic test that can be utilized in resource-limited settings. Methods: We evaluated the performance of Truenat MTB (TM), a chip-based nucleic acid amplification test in the detection of Mycobacterium tuberculosis (MTB) in clinical sputum specimens from 226 patients with suspected pulmonary tuberculosis (TB). The test involved sputum processing using Trueprep-MAG (TM) (nanoparticle-based protocol run on a battery-operated device) and real-time PCR performed on the Truelab Uno (TM) analyzer (handheld, battery-operated thermal cycler). Specimens were also examined for presence of MTB using smear microscopy, liquid culture and an in-house nested PCR protocol. Results were assessed in comparison to a composite reference standard (CRS) consisting of smear and culture results, clinical treatment and follow-up, and radiology findings. Results: Based on the CRS, 191 patients had "Clinical-TB" (Definite and Probable-TB). Of which 154 patients are already on treatment, and 37 were treatment naive cases. Remaining 35 were confirmed "Non-TB" cases which are treatment naive cases. The Truenat MTB test was found to have sensitivity and specificity of 91.1% (CI: 86.1-94.7) and 100% (CI: 90.0-100) respectively, in comparison to 90.58% (CI: 85.5-94.3) and 91.43% (CI: 76.9-98.2) respectively for the in-house nested PCR protocol. Conclusion: This preliminary study shows that the Truenat MTB test allows detection of TB in approximately one hour and can be utilized in near-care settings to provide quick and accurate diagnosis.	[Nikam, Chaitali; Kazi, Mubin; Shetty, Anjali; Rodrigues, Camilla] PD Hinduja Hosp & Med Res Ctr, Dept Microbiol, Bombay, Maharashtra, India; [Jagannath, Manjula; Narayanan, Manoj Mulakkapurath; Ramanabhiraman, Vinaya] Bigtec Pvt Ltd, BigtecLabs, Bangalore, Karnataka, India		Rodrigues, C (corresponding author), PD Hinduja Hosp & Med Res Ctr, Dept Microbiol, Bombay, Maharashtra, India.	dr_crodrigues@hindujahospital.com		Mulakkapurath Narayanan, Manoj/0000-0003-0886-0980; Nikam, Chaitali/0000-0002-3834-3936	Bigtec Laboratories, Bangalore, India	Bigtec Laboratories, Bangalore, India	Bigtec Laboratories, Bangalore, India, has funded the study but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baevis KG, 1995, J CLIN MICROBIOL, V33, P2582; BEIGE J, 1995, J CLIN MICROBIOL, V33, P90, DOI 10.1128/JCM.33.1.90-95.1995; Bennedsen J, 1996, J CLIN MICROBIOL, V34, P1407, DOI 10.1128/JCM.34.6.1407-1411.1996; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; Brisson-Noel A, 1989, J GERONTOL B-PSYCHOL, V335, P1069; CLARRIDGE JE, 1993, J CLIN MICROBIOL, V31, P2049, DOI 10.1128/JCM.31.8.2049-2056.1993; Deshmukh M, 2012, INDIAN J TUBER UNPUB; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; EISENACH KD, 1991, AM REV RESPIR DIS, V144, P1160, DOI 10.1164/ajrccm/144.5.1160; HERMANS PWM, 1990, J CLIN MICROBIOL, V28, P1204, DOI 10.1128/JCM.28.6.1204-1213.1990; JONAS V, 1993, J CLIN MICROBIOL, V31, P2410, DOI 10.1128/JCM.31.9.2410-2416.1993; KELLOGG DE, 1994, BIOTECHNIQUES, V16, P1134; Kent PT, 1985, PUBLIC HLTH MYCOBACT, P36; KHANDEKAR P, 1994, INDIAN J MED RES, V100, P167; Kumar KK, 2009, PCT Pub., Patent No. [WO/2009/047805, 2009047805]; Kumar KK, 2009, PCT Pub., Patent No. [WO/2009/047804, 2009047804]; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; MILLER N, 1994, J CLIN MICROBIOL, V32, P393, DOI 10.1128/JCM.32.2.393-397.1994; Pfyffer GE, 1996, J CLIN MICROBIOL, V34, P834, DOI 10.1128/JCM.34.4.834-841.1996; REDDI PP, 1993, INT J LEPROSY, V61, P227; SHAH JS, 1995, J CLIN MICROBIOL, V33, P1435, DOI 10.1128/JCM.33.6.1435-1441.1995; SJOBRING U, 1990, J CLIN MICROBIOL, V28, P2200; Traore H, 2006, J CLIN MICROBIOL, V44, P4384, DOI 10.1128/JCM.01332-06; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; WILLIAMS DL, 1995, J CLIN MICROBIOL, V33, P1558, DOI 10.1128/JCM.33.6.1558-1561.1995; World Health Organization, 2012, FACT SHEET 104 TUB; World Health Organization, 2004, WORLD HLTH REP 2004; YAJKO DM, 1995, J CLIN MICROBIOL, V33, P1944, DOI 10.1128/JCM.33.7.1944-1947.1995	29	57	58	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e51121	10.1371/journal.pone.0051121	http://dx.doi.org/10.1371/journal.pone.0051121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349670	Green Submitted, gold, Green Published			2022-12-27	WOS:000313943000005
J	Holtermann, A; Marott, JL; Gyntelberg, F; Sogaard, K; Suadicani, P; Mortensen, OS; Prescott, E; Schnohr, P				Holtermann, Andreas; Marott, Jacob Louis; Gyntelberg, Finn; Sogaard, Karen; Suadicani, Poul; Mortensen, Ole Steen; Prescott, Eva; Schnohr, Peter			Does the Benefit on Survival from Leisure Time Physical Activity Depend on Physical Activity at Work? A Prospective Cohort Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK; MEN; DEMANDS	Purpose: To investigate if persons with high physical activity at work have the same benefits from leisure time physical activity as persons with sedentary work. Methods: In the Copenhagen City Heart Study, a prospective cohort of 7,411 males and 8,916 females aged 25-66 years without known cardiovascular disease at entry in 1976-78, 1981-83, 1991-94, or 2001-03, the authors analyzed with sex-stratified multivariate Cox proportional hazards regression the association between leisure time physical activity and cardiovascular and all-cause mortality among individuals with different levels of occupational physical activity. Results: During a median follow-up of 22.4 years, 4,003 individuals died from cardiovascular disease and 8,935 from all-causes. Irrespective of level of occupational physical activity, a consistently lower risk with increasing leisure time physical activity was found for both cardiovascular and all-cause mortality among both men and women. Compared to low leisure time physical activity, the survival benefit ranged from 1.5-3.6 years for moderate and 2.6-4.7 years for high leisure time physical activity among the different levels of occupational physical activity. Conclusion: Public campaigns and initiatives for increasing physical activity in the working population should target everybody, irrespective of physical activity at work.	[Holtermann, Andreas; Mortensen, Ole Steen] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Marott, Jacob Louis; Prescott, Eva; Schnohr, Peter] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Gyntelberg, Finn; Suadicani, Poul; Mortensen, Ole Steen] Bispebjerg Hosp, Copenhagen Male Study, Epidemiol Res Unit, Dept Occupat & Environm Med, Copenhagen, Denmark; [Sogaard, Karen] Univ So Denmark, Inst Sport Sci & Clin Biomech, Odense, Denmark; [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark	National Research Centre for the Working Environment; Aarhus University; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Copenhagen; Bispebjerg Hospital	Holtermann, A (corresponding author), Natl Res Ctr Working Environm, Copenhagen, Denmark.	aho@nrcwe.dk	Søgaard, Karen/B-7933-2008; Prescott, Eva/AAJ-7441-2020	Søgaard, Karen/0000-0003-3968-6364; Prescott, Eva/0000-0002-4134-0349; Mortensen, Ole Steen/0000-0002-4655-8048	Danish Working Environment Research Foundation	Danish Working Environment Research Foundation	The study is a part of the Physical Work Demands and Fitness Project, financed by the Danish Working Environment Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard M, 1984, SCANDINAVIAN J SOCIA; Clays E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1002; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Holtermann A, 2012, BMJ OPEN, V13, P2; Holtermann A, 2012, INT ARCH OCC ENV HEA, V85, P305, DOI 10.1007/s00420-011-0668-x; Holtermann A, 2011, J OCCUP ENVIRON MED, V53, P1221, DOI 10.1097/JOM.0b013e318233865f; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P357, DOI 10.5271/sjweh.2913; Holtermann A, 2009, SCAND J WORK ENV HEA, V35, P466, DOI 10.5271/sjweh.1357; Jans MP, 2007, AM J PREV MED, V33, P450, DOI 10.1016/j.amepre.2007.07.033; Karlqvist LK, 2003, SCAND J WORK ENV HEA, V29, P363, DOI 10.5271/sjweh.743; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Krause N, 2007, SCAND J WORK ENV HEA, V33, P405, DOI 10.5271/sjweh.1171; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; MORRIS JN, 1980, LANCET, V2, P1207; MORRIS JN, 1953, LANCET, V265, P1111; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e	22	41	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54548	10.1371/journal.pone.0054548	http://dx.doi.org/10.1371/journal.pone.0054548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349926	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900077
J	Kobayashi, T; Yan, HM; Kurahashi, Y; Ito, Y; Maeda, H; Tada, T; Hongo, K; Nakayama, J				Kobayashi, Tatsuya; Yan, Huimin; Kurahashi, Yasuhiro; Ito, Yuki; Maeda, Hiroshi; Tada, Tsuyoshi; Hongo, Kazuhiro; Nakayama, Jun			Role of GalNAc4S-6ST in Astrocytic Tumor Progression	PLOS ONE			English	Article							ACETYLGALACTOSAMINE 4-SULFATE 6-O-SULFOTRANSFERASE; CHONDROITIN SULFATE-E; TYROSINE-PHOSPHATASE-ZETA; P-SELECTIN; CANCER; GLYCOSAMINOGLYCANS; MIDKINE; BINDING; PROTEIN	N-Acetylgalactosamine 4-sulfate 6-O-sulfotransferase (GalNAc4S-6ST) is the sulfotransferase responsible for biosynthesis of highly sulfated chondroitin sulfate CS-E. Although involvements of CS-E in neuronal cell functions have been extensively analyzed, the role of GalNAc4S-6ST in astrocytic tumor progression remains unknown. Here, we reveal that GalNAc4S-6ST transcripts were detected in astrocytic tumors derived from all 30 patients examined using quantitative reverse transcription-PCR analysis. Patients with high GalNAc4S-6ST mRNA expression had significantly worse outcome compared with patients with low expression, and multivariate survival analysis disclosed that GalNAc4S-6ST is an independent poor prognostic factor for astrocytic tumors. We then tested whether CS-E enhanced haptotaxic migration of glioblastoma U251-MG cells that endogenously express both the CS-E's scaffold tyrosine phosphatase xi (PTP xi) and GalNAc4S-6ST, in the presence of CS-E's preferred ligands, pleiotrophin (PTN) or midkine (MK), using a modified Boyden chamber method. Haptotaxic stimulation of cell migration by PTN was most robust on control siRNA-transfected U251-MG cells, while that enhancing effect was cancelled following transduction of GalNAc4S-6ST siRNA. Similar results were obtained using MK, suggesting that both PTN and MK enhance migration of U251-MG cells by binding to CS-E. We also found that PTP xi as well as PTN and MK were frequently expressed in astrocytic tumor cells. Thus, our findings indicate that GalNAc4S-6ST mRNA expressed by astrocytic tumor cells is associated with poor patient prognosis likely by enhancing CS-E-mediated tumor cell motility in the presence of PTN and/or MK.	[Kobayashi, Tatsuya; Yan, Huimin; Ito, Yuki; Nakayama, Jun] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 390, Japan; [Kobayashi, Tatsuya; Hongo, Kazuhiro] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 390, Japan; [Tada, Tsuyoshi] Shinshu Univ, Sch Med, Dept Med Educ, Matsumoto, Nagano 390, Japan; [Kurahashi, Yasuhiro; Maeda, Hiroshi] Seikagaku Corp, Cent Res Labs, Higashiyamato, Japan	Shinshu University; Shinshu University; Shinshu University; Seikagaku Corporation	Nakayama, J (corresponding author), Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 390, Japan.	jnaka@shinshu-u.ac.jp			Japan Society for the Promotion of Science [18390113]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research 18390113 from the Japan Society for the Promotion of Science (to J.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Ito Y, 2000, J BIOL CHEM, V275, P34728, DOI 10.1074/jbc.M909633199; Ito Y, 2007, ACTA HISTOCHEM CYTOC, V40, P53, DOI 10.1267/ahc.07004; Karumbaiah L, 2011, GLIA, V59, P981, DOI 10.1002/glia.21170; Kato Y, 2008, BIOCHEM BIOPH RES CO, V369, P1041, DOI 10.1016/j.bbrc.2008.02.130; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kobayashi T, 2007, CLIN CANCER RES, V13, P3868, DOI 10.1158/1078-0432.CCR-06-2730; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Machida E, 2001, CANCER RES, V61, P2226; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Ohtake-Niimi S, 2010, J BIOL CHEM, V285, P20793, DOI 10.1074/jbc.M109.084749; Sato Y, 2008, J NEUROCHEM, V104, P1565, DOI 10.1111/j.1471-4159.2007.05107.x; SHINMEI M, 1992, ARTHRITIS RHEUM, V35, P1304, DOI 10.1002/art.1780351110; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; The WHO, 2020, CLASSIFICATION TUMOU; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Ulbricht U, 2006, J NEUROCHEM, V98, P1497, DOI 10.1111/j.1471-4159.2006.04022.x; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59; YOSHIDA J, 1990, J NEURO-ONCOL, V8, P221; Zou P, 2003, GLYCOBIOLOGY, V13, P35, DOI 10.1093/glycob/cwg001	29	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54278	10.1371/journal.pone.0054278	http://dx.doi.org/10.1371/journal.pone.0054278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349846	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900059
J	Ma, YL; Yang, YZ; Wang, F; Zhang, P; Shi, CZ; Zou, Y; Qin, HL				Ma, Yanlei; Yang, Yongzhi; Wang, Feng; Zhang, Peng; Shi, Chenzhang; Zou, Yang; Qin, Huanlong			Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies	PLOS ONE			English	Review							BODY-MASS-INDEX; GROWTH-FACTOR (IGF)-I; COLON-CANCER; RECTAL-CANCER; PHYSICAL-ACTIVITY; WEIGHT CHANGE; WAIST CIRCUMFERENCE; SIZE; INSULIN; METAANALYSIS	Background: Mounting evidence indicates that obesity may be associated with the risk of colorectal cancer (CRC). To conduct a systematic review of prospective studies assessing the association of obesity with the risk of CRC using meta-analysis. Methodology/Principal Findings: Relevant studies were identified by a search of MEDLINE and EMBASE databases before January 2012, with no restrictions. We also reviewed reference lists from retrieved articles. We included prospective studies that reported relative risk (RR) estimates with 95% confidence intervals (CIs) for the association between general obesity [measured using body mass index (BMI)] or central obesity [measured using waist circumference (WC)] and the risk of colorectal, colon, or rectal cancer. Approximately 9, 000, 000 participants from several countries were included in this analysis. 41 studies on general obesity and 13 studies on central obesity were included in the meta-analysis. The pooled RRs of CRC for the obese vs. normal category of BMI were 1.334 (95% CI, 1.253-1.420), and the highest vs. lowest category of WC were 1.455 (95% CI, 1.327-1.596). There was heterogeneity among studies of BMI (P<0.001) but not among studies of WC (P = 0.323). Conclusions: Both of general and central obesity were positively associated with the risk of CRC in this meta-analysis.	[Ma, Yanlei; Wang, Feng; Zhang, Peng; Qin, Huanlong] Tongji Univ, Dept Surg, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Yang, Yongzhi; Shi, Chenzhang; Zou, Yang; Qin, Huanlong] Shanghai Jiao Tong Univ, Dept Surg, Peoples Hosp 6, Shanghai 200030, Peoples R China	Tongji University; Shanghai Jiao Tong University	Ma, YL (corresponding author), Tongji Univ, Dept Surg, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	yanleima@live.cn; hl-qin@hotmail.com	huanlong, Qin/B-3844-2015		Shanghai Rising-Star Program [11QA1404800]; National Natural Science Foundation of China [81001069]; Shanghai Science and Technology Development Fund [12140902300, 12410707400]	Shanghai Rising-Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Fund	This work was financially sponsored by the Shanghai Rising-Star Program (No. 11QA1404800), the Grants from the National Natural Science Foundation of China (No. 81001069), and Shanghai Science and Technology Development Fund (No. 12140902300 and No. 12410707400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2007, AM J EPIDEMIOL, V166, P36, DOI 10.1093/aje/kwm049; Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; Bassett JK, 2010, CANCER EPIDEM BIOMAR, V19, P2978, DOI 10.1158/1055-9965.EPI-10-0543; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725; Bowers K, 2006, AM J EPIDEMIOL, V164, P652, DOI 10.1093/aje/kwj253; Chung YW, 2006, DIGEST LIVER DIS, V38, P668, DOI 10.1016/j.dld.2006.05.014; Chyou PH, 1996, ANN EPIDEMIOL, V6, P276, DOI 10.1016/S1047-2797(96)00047-6; Clayton PE, 2011, NAT REV ENDOCRINOL, V7, P11, DOI 10.1038/nrendo.2010.171; Dai Z, 2007, WORLD J GASTROENTERO, V13, P4199, DOI 10.3748/wjg.v13.i31.4199; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engeland A, 2005, CANCER CAUSE CONTROL, V16, P987, DOI 10.1007/s10552-005-3638-3; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ford ES, 1999, AM J EPIDEMIOL, V150, P390; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hughes LAE, 2011, AM J EPIDEMIOL, V174, P1127, DOI 10.1093/aje/kwr247; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Kuriyama S, 2005, INT J CANCER, V113, P148, DOI 10.1002/ijc.20529; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2006, EUR J CANCER, V42, P2590, DOI 10.1016/j.ejca.2006.04.015; LEE IM, 1992, J NATL CANCER I, V84, P1326, DOI 10.1093/jnci/84.17.1326; Levi Z, 2011, CANCER EPIDEM BIOMAR, V20, P2524, DOI 10.1158/1055-9965.EPI-11-0531; Lin J, 2004, CANCER CAUSE CONTROL, V15, P581, DOI 10.1023/B:CACO.0000036168.23351.f1; Lukanova A, 2006, INT J CANCER, V118, P458, DOI 10.1002/ijc.21354; Lundqvist E, 2007, INT J CANCER, V121, P810, DOI 10.1002/ijc.22746; MacInnis RJ, 2006, INT J CANCER, V118, P1496, DOI 10.1002/ijc.21508; MacInnis RJ, 2004, CANCER EPIDEM BIOMAR, V13, P553; MacInnis RJ, 2006, CANCER CAUSE CONTROL, V17, P1291, DOI 10.1007/s10552-006-0074-y; Martinez ME, 1997, J NATL CANCER I, V89, P948, DOI 10.1093/jnci/89.13.948; Matsuo K, 2011, ANN ONCOL; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Moore LL, 2004, INT J OBESITY, V28, P559, DOI 10.1038/sj.ijo.0802606; Odegaard AO, 2011, CANCER-AM CANCER SOC, V117, P3841, DOI 10.1002/cncr.25936; Ogino S, 2007, HUM PATHOL, V38, P842, DOI 10.1016/j.humpath.2006.11.018; Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726; Otani T, 2005, CANCER CAUSE CONTROL, V16, P839, DOI 10.1007/s10552-005-4573-z; Oxentenko AS, 2010, CANCER PREV RES, V3, P1608, DOI 10.1158/1940-6207.CAPR-10-0116; Park JY, 2011, INT J OBES LOND; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Rapp K, 2008, ANN ONCOL, V19, P641, DOI 10.1093/annonc/mdm549; Rapp K, 2005, BRIT J CANCER, V93, P1062, DOI 10.1038/sj.bjc.6602819; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Renehan AG, 2001, BRIT J SURG, V88, P107, DOI 10.1046/j.1365-2168.2001.01645.x; Renehan Andrew G., 2008, Archives of Physiology and Biochemistry, V114, P71, DOI [10.1080/13813450801954303, 10.1080/13813450801954303 ]; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Schoen RE, 1999, JNCI-J NATL CANCER I, V91, P1147, DOI 10.1093/jnci/91.13.1147; Shimizu N, 2003, BRIT J CANCER, V88, P1038, DOI 10.1038/sj.bjc.6600845; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stattin P, 2004, INT J CANCER, V109, P149, DOI 10.1002/ijc.11668; Stattin P, 2003, ONCOL REP, V10, P2015; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; Terry P, 2001, BRIT J CANCER, V85, P346, DOI 10.1054/bjoc.2001.1894; Terry PD, 2002, GUT, V51, P191, DOI 10.1136/gut.51.2.191; Thygesen LC, 2008, INT J CANCER, V123, P1160, DOI 10.1002/ijc.23612; Wang Y, 2008, CANCER CAUSE CONTROL, V19, P783, DOI 10.1007/s10552-008-9141-x; Wang YT, 2007, CANCER CAUSE CONTROL, V18, P793, DOI 10.1007/s10552-007-9009-5; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Yin L, 2009, ALIMENT PHARM THER, V30, P113, DOI 10.1111/j.1365-2036.2009.04022.x	69	355	373	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53916	10.1371/journal.pone.0053916	http://dx.doi.org/10.1371/journal.pone.0053916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349764	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900027
J	Xu, LX; Xue, HL; Song, MJ; Zhao, QH; Dong, JP; Liu, J; Guo, Y; Xu, TQ; Cao, XP; Wang, FS; Wang, SQ; Hao, SS; Yang, HF; Zhang, ZB				Xu, Laixiang; Xue, Huiliang; Song, Mingjing; Zhao, Qinghua; Dong, Jingping; Liu, Juan; Guo, Yu; Xu, Tongqin; Cao, Xiaoping; Wang, Fusheng; Wang, Shuqing; Hao, Shushen; Yang, Hefang; Zhang, Zhibin			Variation of Genetic Diversity in a Rapidly Expanding Population of the Greater Long-Tailed Hamster (Tscherskia triton) as Revealed by Microsatellites	PLOS ONE			English	Article							ARVICOLA-TERRESTRIS; DISPERSAL; TIME; FLOW	Genetic diversity is essential for persistence of animal populations over both the short- and long-term. Previous studies suggest that genetic diversity may decrease with population decline due to genetic drift or inbreeding of small populations. For oscillating populations, there are some studies on the relationship between population density and genetic diversity, but these studies were based on short- term observation or in low-density phases. Evidence from rapidly expanding populations is lacking. In this study, genetic diversity of a rapidly expanding population of the Greater long-tailed hamsters during 1984-1990, in the Raoyang County of the North China Plain was studied using DNA microsatellite markers. Results show that genetic diversity was positively correlated with population density (as measured by % trap success), and the increase in population density was correlated with a decrease of genetic differentiation between the sub-population A and B. The genetic diversity tended to be higher in spring than in autumn. Variation in population density and genetic diversity are consistent between sub-population A and B. Such results suggest that dispersal is density- and season-dependent in a rapidly expanding population of the Greater long-tailed hamster. For typically solitary species, increasing population density can increase intra-specific attack, which is a driving force for dispersal. This situation is counterbalanced by decreasing population density caused by genetic drift or inbreeding as the result of small population size. Season is a major factor influencing population density and genetic diversity. Meanwhile, roads, used to be considered as geographical isolation, have less effect on genetic differentiation in a rapidly expanding population. Evidences suggest that gene flow (Nm) is positively correlated with population density, and it is significant higher in spring than that in autumn.	[Xu, Laixiang; Xue, Huiliang; Zhao, Qinghua; Liu, Juan; Guo, Yu] Qufu Normal Univ, Coll Life Sci, Qufu, Shandong, Peoples R China; [Song, Mingjing; Dong, Jingping; Cao, Xiaoping; Wang, Fusheng; Wang, Shuqing; Hao, Shushen; Yang, Hefang; Zhang, Zhibin] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Song, Mingjing] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Song, Mingjing] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China; [Xu, Tongqin] Wugong Stn Pest Monitoring & Forecasting, Raoyang Cty, Hebei Province, Peoples R China	Qufu Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, LX (corresponding author), Qufu Normal Univ, Coll Life Sci, Qufu, Shandong, Peoples R China.	xulx@mail.qfnu.edu.cn			Ministry of Science and Technology [2007BC109104]; National Natural Science Foundation of China [31070332]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Ministry of Science and Technology (2007BC109104) and National Natural Science Foundation of China (31070332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aars J, 2006, MOL ECOL, V15, P1455, DOI 10.1111/j.1365-294X.2006.02889.x; Andreassen HP, 2001, ECOLOGY, V82, P2911, DOI 10.2307/2679970; Aspi J, 2006, MOL ECOL, V15, P1561, DOI 10.1111/j.1365-294X.2006.02877.x; Berthier K, 2005, MOL ECOL, V14, P2861, DOI 10.1111/j.1365-294X.2005.02636.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Cena CJ, 2006, MOL ECOL, V15, P303, DOI 10.1111/j.1365-294X.2005.02637.x; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; Clobert Jean, 2004, P307, DOI 10.1016/B978-012323448-3/50015-5; Cote SD, 2002, MOL ECOL, V11, P1923, DOI 10.1046/j.1365-294X.2002.01582.x; Dong JP, 2010, J MAMMAL, V91, P200, DOI 10.1644/09-MAMM-A-098R1.1; Estoup A, 1998, NATO ADV SCI I A-LIF, V306, P55; Francis C.Y., 1999, POPGENE VERSION 1 31; Hanski I., 1999, METAPOPULATION ECOLO; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Ims RA, 2005, P ROY SOC B-BIOL SCI, V272, P913, DOI 10.1098/rspb.2004.3025; Ims Rolf A., 2001, P203; Keller I, 2003, P ROY SOC B-BIOL SCI, V270, P417, DOI 10.1098/rspb.2002.2247; KIMURA M, 1964, GENETICS, V49, P725; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Lin YTK, 2001, ECOL MONOGR, V71, P245, DOI 10.1890/0012-9615(2001)071[0245:TIOHQO]2.0.CO;2; MADER HJ, 1984, BIOL CONSERV, V29, P81, DOI 10.1016/0006-3207(84)90015-6; Nielsen EE, 1999, EVOLUTION, V53, P261, DOI [10.2307/2640938, 10.1111/j.1558-5646.1999.tb05351.x]; North A, 2011, EVOLUTION, V65, P1739, DOI 10.1111/j.1558-5646.2011.01254.x; Nowicki P, 2011, OECOLOGIA, V167, P657, DOI 10.1007/s00442-011-2025-x; Parn H, 2012, P ROY SOC B-BIOL SCI, V279, P144, DOI 10.1098/rspb.2011.0673; Planes S, 2002, MOL ECOL, V11, P1515, DOI 10.1046/j.1365-294X.2002.01521.x; Ranta E, 2008, P ROY SOC B-BIOL SCI, V275, P435, DOI 10.1098/rspb.2007.1546; Shikano T, 2001, HEREDITY, V86, P153, DOI 10.1046/j.1365-2540.2001.00792.x; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Song MJ, 2005, CAN J ZOOL, V83, P773, DOI 10.1139/Z05-060; Stenson AG, 2002, MOL ECOL, V11, P1679, DOI 10.1046/j.1365-294X.2002.01564.x; Wang M, 2001, HEREDITY, V86, P703, DOI 10.1046/j.1365-2540.2001.00889.x; Wang YQ, 2002, CHINESE SCI BULL, V47, P201, DOI 10.1360/02tb9048; Waser PM, 2006, MOL ECOL, V15, P1929, DOI 10.1111/j.1365-294X.2006.02893.x; Xie JY, 2006, INTEGR ZOOL, V1, P188, DOI 10.1111/j.1749-4877.2006.00035.x; Xu Lai-Xiang, 2002, Acta Zoologica Sinica, V48, P264; Xu LX, 2007, MOL ECOL NOTES, V7, P617, DOI 10.1111/j.1471-8286.2006.01651.x; Zhang Z., 1998, ECOLOGY MANAGEMENT R	40	7	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54171	10.1371/journal.pone.0054171	http://dx.doi.org/10.1371/journal.pone.0054171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349815	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900048
J	Xu, SS; Chen, GD; Chen, CJ; Sun, C; Zhang, DY; Murbach, M; Kuster, N; Zeng, QL; Xu, ZP				Xu, Shanshan; Chen, Guangdi; Chen, Chunjing; Sun, Chuan; Zhang, Danying; Murbach, Manuel; Kuster, Niels; Zeng, Qunli; Xu, Zhengping			Cell Type-Dependent Induction of DNA Damage by 1800 MHz Radiofrequency Electromagnetic Fields Does Not Result in Significant Cellular Dysfunctions	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; RAT-BRAIN CELLS; HUMAN-LYMPHOCYTES; PROTEIN EXPRESSION; EPITHELIAL-CELLS; IN-VITRO; RADIATION; GAMMA-H2AX; MICROWAVES; EXPOSURE	Background: Although IARC clarifies radiofrequency electromagnetic fields (RF-EMF) as possible human carcinogen, the debate on its health impact continues due to the inconsistent results. Genotoxic effect has been considered as a golden standard to determine if an environmental factor is a carcinogen, but the currently available data for RF-EMF remain controversial. As an environmental stimulus, the effect of RF-EMF on cellular DNA may be subtle. Therefore, more sensitive method and systematic research strategy are warranted to evaluate its genotoxicity. Objectives: To determine whether RF-EMF does induce DNA damage and if the effect is cell-type dependent by adopting a more sensitive method gamma H2AX foci formation; and to investigate the biological consequences if RF-EMF does increase gamma H2AX foci formation. Methods: Six different types of cells were intermittently exposed to GSM 1800 MHz RF-EMF at a specific absorption rate of 3.0 W/kg for 1 h or 24 h, then subjected to immunostaining with anti-gamma H2AX antibody. The biological consequences in gamma H2AX-elevated cell type were further explored with comet and TUNEL assays, flow cytometry, and cell growth assay. Results: Exposure to RF-EMF for 24 h significantly induced gamma H2AX foci formation in Chinese hamster lung cells and Human skin fibroblasts (HSFs), but not the other cells. However, RF-EMF-elevated gamma H2AX foci formation in HSF cells did not result in detectable DNA fragmentation, sustainable cell cycle arrest, cell proliferation or viability change. RF-EMF exposure slightly but not significantly increased the cellular ROS level. Conclusions: RF-EMF induces DNA damage in a cell type-dependent manner, but the elevated gamma H2AX foci formation in HSF cells does not result in significant cellular dysfunctions.	[Xu, Shanshan; Chen, Guangdi; Chen, Chunjing; Sun, Chuan; Zeng, Qunli; Xu, Zhengping] Zhejiang Univ, Sch Med, Bioelectromagnet Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Danying] Guangdong Prevent & Treatment Ctr Occupat Dis, Inst Occupat Hlth Assessment, Guangzhou, Guangdong, Peoples R China; [Murbach, Manuel; Kuster, Niels] Swiss Fed Inst Technol, Fdn Res Informat Technol Soc, Zurich, Switzerland	Zhejiang University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zeng, QL (corresponding author), Zhejiang Univ, Sch Med, Bioelectromagnet Lab, Hangzhou 310003, Zhejiang, Peoples R China.	zengql@zju.edu.cn; zpxu@zju.edu.cn		Kuster, Niels/0000-0002-5827-3728	Ministry of Science and Technology [2011CB503702]; Natural Science Foundation of China [81102094, 30872082]; Natural Science Foundation of Zhejiang Province [5Y205458]; Research Fund for the Doctoral Program of Higher Education of China [20110101120100]; Fundamental Research Funds for the Central Universities of China [2011QNA7018, 2012QNA7019, 2012FZA7019]; Program for New Century Excellent Talents in University of China; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Technology Foundation for Excellent Overseas Chinese Scholar, Zhejiang Province Human Resources and Social Security Bureau	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Technology Foundation for Excellent Overseas Chinese Scholar, Zhejiang Province Human Resources and Social Security Bureau	This work was supported by grants from the Ministry of Science and Technology (2011CB503702), the Natural Science Foundation of China (81102094&30872082), the Natural Science Foundation of Zhejiang Province (5Y205458), the Research Fund for the Doctoral Program of Higher Education of China (20110101120100), and the Fundamental Research Funds for the Central Universities of China (2011QNA7018, 2012QNA7019, 2012FZA7019). Z. Xu is sponsored by the Program for New Century Excellent Talents in University of China and the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents. G. Chen is supported by Technology Foundation for Excellent Overseas Chinese Scholar, Zhejiang Province Human Resources and Social Security Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; Belyaev IY, 2009, BIOELECTROMAGNETICS, V30, P129, DOI 10.1002/bem.20445; Bonner WM, 2003, P NATL ACAD SCI USA, V100, P4973, DOI 10.1073/pnas.1031538100; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Chauhan V, 2007, RADIAT RES, V167, P87, DOI 10.1667/RR0662.1; Dickey JS, 2009, CHROMOSOMA, V118, P683, DOI 10.1007/s00412-009-0234-4; Focke F, 2010, MUTAT RES-FUND MOL M, V683, P74, DOI 10.1016/j.mrfmmm.2009.10.012; Franzellitti S, 2010, MUTAT RES-FUND MOL M, V683, P35, DOI 10.1016/j.mrfmmm.2009.10.004; Huang X, 2004, CURR PROTOC CYTOM; ICNIRP, 2009, EXP HIGH FREQ EL FIE, P98; International Telecommunication Union, 2011, WORLD 2011 ICT FACTS; Ismail IH, 2008, ENVIRON MOL MUTAGEN, V49, P73, DOI 10.1002/em.20358; Ismail IH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1169; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Konca K, 2004, CASP COM ASS SOFTW P; Kundi M, 2009, ENVIRON HEALTH PERSP, V117, P316, DOI 10.1289/ehp.11902; Lai H, 2004, ENVIRON HEALTH PERSP, V112, P687, DOI 10.1289/ehp.6355; Lai H, 1997, BIOELECTROMAGNETICS, V18, P446, DOI 10.1002/(SICI)1521-186X(1997)18:6<446::AID-BEM7>3.0.CO;2-2; Lai H, 1997, J PINEAL RES, V22, P152, DOI 10.1111/j.1600-079X.1997.tb00317.x; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; Markova E, 2005, ENVIRON HEALTH PERSP, V113, P1172, DOI 10.1289/ehp.7561; Markova E, 2010, ENVIRON HEALTH PERSP, V118, P394, DOI 10.1289/ehp.0900781; Nylund R, 2006, PROTEOMICS, V6, P4769, DOI 10.1002/pmic.200600076; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Phillips J L, 2009, Pathophysiology, V16, P79, DOI 10.1016/j.pathophys.2008.11.005; Remondini D, 2006, PROTEOMICS, V6, P4745, DOI 10.1002/pmic.200500896; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruediger Hugo W, 2009, Pathophysiology, V16, P89, DOI 10.1016/j.pathophys.2008.11.004; Schuderer J, 2004, IEEE T MICROW THEORY, V52, P2057, DOI 10.1109/TMTT.2004.832009; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Simko M, 2007, CURR MED CHEM, V14, P1141, DOI 10.2174/092986707780362835; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Suder P, 2009, J PROTEOME RES, V8, P4633, DOI 10.1021/pr900443r; Vijayalaxmi, 2004, RADIAT RES, V162, P481, DOI 10.1667/RR3252; Vijayalaxmi, 2008, RADIAT RES, V169, P561, DOI 10.1667/RR0987.1; Yang J, 2002, INFECT IMMUN, V70, P3649, DOI 10.1128/IAI.70.7.3649-3655.2002; Yao K, 2008, MOL VIS, V14, P964; Zeng QL, 2006, PROTEOMICS, V6, P4732, DOI 10.1002/pmic.200600234; Zeni O, 2003, RADIAT RES, V160, P152, DOI 10.1667/RR3014; Zhang Dan-ying, 2006, Zhonghua Yufang Yixue Zazhi, V40, P149	42	35	38	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54906	10.1371/journal.pone.0054906	http://dx.doi.org/10.1371/journal.pone.0054906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355902	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500139
J	Andrade, JM; Pobre, V; Arraiano, CM				Andrade, Jose Marques; Pobre, Vania; Arraiano, Cecilia Maria			Small RNA Modules Confer Different Stabilities and Interact Differently with Multiple Targets	PLOS ONE			English	Article							SMALL REGULATORY RNA; RHO-INDEPENDENT TERMINATOR; MESSENGER-RNA; ESCHERICHIA-COLI; TRANSCRIPTION TERMINATION; RIBONUCLEASE-III; PROTEIN HFQ; KEY PLAYER; OXYS RNA; BINDING	Bacterial Hfq-associated small regulatory RNAs (sRNAs) parallel animal microRNAs in their ability to control multiple target mRNAs. The small non-coding MicA RNA represses the expression of several genes, including major outer membrane proteins such as ompA, tsx and ecnB. In this study, we have characterised the RNA determinants involved in the stability of MicA and analysed how they influence the expression of its targets. Site- directed mutagenesis was used to construct MicA mutated forms. The 5'linear domain, the structured region with two stem-loops, the A/U-rich sequence or the 3' poly(U) tail were altered without affecting the overall secondary structure of MicA. The stability and the target regulation abilities of the wild-type and the different mutated forms of MicA were then compared. The 5' domain impacted MicA stability through an RNase III-mediated pathway. The two stem-loops showed different roles and disruption of stem-loop 2 was the one that mostly affected MicA stability and abundance. Moreover, STEM2 was found to be more important for the in vivo repression of both ompA and ecnB mRNAs while STEM1 was critical for regulation of tsx mRNA levels. The A/U-rich linear sequence is not the only Hfq-binding site present in MicA and the 3' poly(U) sequence was critical for sRNA stability. PNPase was shown to be an important exoribonuclease involved in sRNA degradation. In addition to the 5' domain of MicA, the stem-loops and the 3' poly(U) tail are also shown to affect target-binding. Disruption of the 3'U-rich sequence greatly affects all targets analysed. In conclusion, our results have shown that it is important to understand the "sRNA anatomy'' in order to modulate its stability. Furthermore, we have demonstrated that MicA RNA can use different modules to regulate its targets. This knowledge can allow for the engineering of non-coding RNAs that interact differently with multiple targets.	[Andrade, Jose Marques; Pobre, Vania; Arraiano, Cecilia Maria] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade Nova de Lisboa	Arraiano, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ, Oeiras, Portugal.	cecilia@itqb.unl.pt	Pobre, Vânia SF/M-4115-2013	Pobre, Vânia SF/0000-0002-4339-8472; Arraiano, Cecilia/0000-0003-1934-9301; Andrade, Jose/0000-0002-3716-2615	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PEst-OE/EQB/LA0004/2011]; European Commission [FP7-KBBE-2011-1-289326]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal (including grant PEst-OE/EQB/LA0004/2011) and by grant FP7-KBBE-2011-1-289326 from European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1996, BIOCHIMIE, V78, P1035, DOI 10.1016/S0300-9084(97)86727-2; Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Amarasinghe AK, 2001, METHOD ENZYMOL, V342, P143, DOI 10.1016/S0076-6879(01)42542-0; Andrade JM, 2008, RNA, V14, P543, DOI 10.1261/rna.683308; Andrade JM, 2012, RNA, V18, P844, DOI 10.1261/rna.029413.111; Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Argaman L, 2000, J MOL BIOL, V300, P1101, DOI 10.1006/jmbi.2000.3942; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; ARRAIANO CM, 1988, J BACTERIOL, V170, P4625, DOI 10.1128/jb.170.10.4625-4633.1988; BABITZKE P, 1993, J BACTERIOL, V175, P229, DOI 10.1128/JB.175.1.229-239.1993; Balbontin R, 2010, MOL MICROBIOL, V78, P380, DOI 10.1111/j.1365-2958.2010.07342.x; Beisel CL, 2012, EMBO J, V31, P1961, DOI 10.1038/emboj.2012.52; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Benito Y, 2000, RNA, V6, P668, DOI 10.1017/S1355838200992550; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bossi L, 2007, MOL MICROBIOL, V65, P799, DOI 10.1111/j.1365-2958.2007.05829.x; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brunel C, 2000, METHOD ENZYMOL, V318, P3; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coornaert A, 2010, MOL MICROBIOL, V76, P467, DOI 10.1111/j.1365-2958.2010.07115.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidson EA, 2005, TRENDS BIOTECHNOL, V23, P109, DOI 10.1016/j.tibtech.2005.01.006; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Durand S, 2010, MOL MICROBIOL, V75, P1215, DOI 10.1111/j.1365-2958.2010.07044.x; Ferrara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036553; Folichon M, 2003, NUCLEIC ACIDS RES, V31, P7302, DOI 10.1093/nar/gkg915; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Guillier M, 2008, NUCLEIC ACIDS RES, V36, P6781, DOI 10.1093/nar/gkn742; Hajnsdorf E, 2012, BIOCHIMIE, V94, P1544, DOI 10.1016/j.biochi.2012.02.010; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Le Derout J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-17; Liang JC, 2011, MOL CELL, V43, P915, DOI 10.1016/j.molcel.2011.08.023; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Lioliou E, 2010, NEW BIOTECHNOL, V27, P222, DOI 10.1016/j.nbt.2010.03.002; Liu JM, 2010, CURR OPIN MICROBIOL, V13, P18, DOI 10.1016/j.mib.2009.11.004; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Olejniczak M, 2011, BIOCHEMISTRY-US, V50, P4427, DOI 10.1021/bi102043f; Otaka H, 2011, P NATL ACAD SCI USA, V108, P13059, DOI 10.1073/pnas.1107050108; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; Peer A, 2011, J BACTERIOL, V193, P1690, DOI 10.1128/JB.01419-10; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; Regnier P, 2009, PROG MOL BIOL TRANSL, V85, P137, DOI 10.1016/S0079-6603(08)00804-0; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; REYNOLDS R, 1992, J MOL BIOL, V224, P53, DOI 10.1016/0022-2836(92)90575-5; Rice JB, 2011, NUCLEIC ACIDS RES, V39, P3806, DOI 10.1093/nar/gkq1219; Salvail H, 2010, P NATL ACAD SCI USA, V107, P15223, DOI 10.1073/pnas.1007805107; Sauer E, 2011, P NATL ACAD SCI US; Sauer E, 2012, P NATL ACAD SCI USA, V109, P9396, DOI 10.1073/pnas.1202521109; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Shinhara A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-428; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; Udekwu KI, 2007, NUCLEIC ACIDS RES, V35, P1279, DOI 10.1093/nar/gkl1154; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Viegas SC, 2011, NUCLEIC ACIDS RES, V39, P2918, DOI 10.1093/nar/gkq1239; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Ziolkowska K, 2006, NUCLEIC ACIDS RES, V34, P709, DOI 10.1093/nar/gkj464; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	26	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e52866	10.1371/journal.pone.0052866	http://dx.doi.org/10.1371/journal.pone.0052866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349691	Green Published, gold			2022-12-27	WOS:000314019100013
J	Auld, AF; Mbofana, F; Shiraishi, RW; Alfredo, C; Sanchez, M; Ellerbrock, TV; Nelson, LJ				Auld, Andrew F.; Mbofana, Francisco; Shiraishi, Ray W.; Alfredo, Charity; Sanchez, Mauro; Ellerbrock, Tedd V.; Nelson, Lisa J.			Incidence and Determinants of Tuberculosis among Adults Initiating Antiretroviral Therapy - Mozambique, 2004-2008	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; HIV-ASSOCIATED TUBERCULOSIS; RESOURCE-LIMITED SETTINGS; RISK-FACTORS; MULTIPLE IMPUTATION; POSITIVE PATIENTS; MISSING VALUES; SOUTH-AFRICA; TERM; ADHERENCE	Background: In Mozambique, tuberculosis (TB) is thought to be the most common cause of death among antiretroviral therapy (ART) enrollees. Monitoring proportions of enrollees screened for TB, and incidence and determinants of TB during ART can help clinicians and program managers identify program improvement opportunities. Methodology/Principal Findings: We conducted a retrospective cohort study among a nationally representative sample of the 79,500 adults (>14 years old) initiating ART during 2004-2007 to estimate clinician compliance with TB screening guidelines, factors associated with active TB at ART initiation, and incidence and predictors of documented TB during ART follow-up. Of 94 sites enrolling >= 50 adults on ART, 30 were selected using probability-proportional-to-size sampling; 2,596 medical records at these sites were randomly selected for abstraction and analysis. At ART initiation, median age of patients was 34, 62% were female, median baseline CD4(+) T-cell count was 153/mu L, and 11% were taking TB treatment. Proportions of records with TB screening documentation before ART initiation improved from 31% to 66% during 2004-2007 (p<0.001). TB screening compliance varied widely by ART clinic [n = 30, 2%-98% (p<0.001)] and supporting non-Governmental Organization (NGO) [n = 7, 27%-83% (p<0.001)]. Receiving TB treatment at ART enrollment was associated with male sex (p<0.001), weight <45 kg (p<0.001) and CD4<50/mu L (p=0.001). Isoniazid preventive therapy (IPT) was prescribed to <1% of ART enrollees not taking TB treatment. TB incidence during ART was 2.32 cases per 100 person-years. Factors associated with TB incidence included adherence to ART<95% (AHR 2.06; 95% CI, 1.32-3.21). Conclusion: Variations in TB screening by clinic and NGO may reflect differing investments in TB screening activities. Future scale-up should target under-performing clinics. Scale-up of TB screening at ART initiation, IPT, and ART adherence interventions could significantly reduce incident TB during ART.	[Auld, Andrew F.; Shiraishi, Ray W.; Ellerbrock, Tedd V.] Ctr Dis Control & Prevent, DGHA, CGH, Atlanta, GA 30333 USA; [Mbofana, Francisco] Minist Hlth, Insituto Nacl Saude, Maputo, Mozambique; [Alfredo, Charity] Ctr Dis Control & Prevent, DGHA, CGH, Maputo, Mozambique; [Sanchez, Mauro] Univ Brasilia, Sch Hlth Sci, Dept Publ Hlth, Brasilia, DF, Brazil	Centers for Disease Control & Prevention - USA; Universidade de Brasilia	Auld, AF (corresponding author), Ctr Dis Control & Prevent, DGHA, CGH, Atlanta, GA 30333 USA.	aauld@cdc.gov	Sanchez, Mauro/AAU-2404-2020	Sanchez, Mauro/0000-0002-0472-1804; Auld, Andrew/0000-0001-5089-9163; Shiraishi, Ray/0000-0001-7640-0666	United States (U.S.) President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	United States (U.S.) President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	All parts of the study were funded by the United States (U.S.) President's Emergency Plan for AIDS Relief (PEPFAR) (http://www.pepfar.gov/) through the U.S. Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/). Authors Auld, Shiraishi, Alfredo, Nelson, and Ellerbrock are employed by the CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], GUID INT TUB CAS FIN; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Dembele M, 2010, INT J TUBERC LUNG D, V14, P318; Fairley CK, 2005, HIV MED, V6, P366, DOI 10.1111/j.1468-1293.2005.00322.x; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Nachega J, 2011, 6 INT AIDS SOC C ROM; Namuwenge PM, 2012, T ROY SOC TROP MED H, V106, P84, DOI 10.1016/j.trstmh.2011.10.015; Prasso JE, 2010, 18 INT AIDS C 18 23; Rana F, 1997, J ACQ IMMUN DEF SYND, V14, P83, DOI 10.1097/00042560-199701010-00017; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB, 2004, MULTIPLE IMPUTATION; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UNAIDS, 2012, GLOB REP GLOB AIDS E; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; World Health Organization, 2006, ANT THER HIV INF AD	42	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54665	10.1371/journal.pone.0054665	http://dx.doi.org/10.1371/journal.pone.0054665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349948	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100089
J	Brydges, NM; Whalley, HC; Jansen, MA; Merrifield, GD; Wood, ER; Lawrie, SM; Wynne, SM; Day, M; Fleetwood-Walker, S; Steele, D; Marshall, I; Hall, J; Holmes, MC				Brydges, Nichola M.; Whalley, Heather C.; Jansen, Maurits A.; Merrifield, Gavin D.; Wood, Emma R.; Lawrie, Stephen M.; Wynne, Sara-Madge; Day, Mark; Fleetwood-Walker, Sue; Steele, Douglas; Marshall, Ian; Hall, Jeremy; Holmes, Megan C.			Imaging Conditioned Fear Circuitry Using Awake Rodent fMRI	PLOS ONE			English	Article							JUVENILE STRESS; BRAIN; RATS; CONSEQUENCES; ACTIVATION; DISORDERS; CHILDHOOD; AMYGDALA; STIMULI; MEMORY	Functional magnetic resonance imaging (fMRI) is a powerful method for exploring emotional and cognitive brain responses in humans. However rodent fMRI has not previously been applied to the analysis of learned behaviour in awake animals, limiting its use as a translational tool. Here we have developed a novel paradigm for studying brain activation in awake rats responding to conditioned stimuli using fMRI. Using this method we show activation of the amygdala and related fear circuitry in response to a fear-conditioned stimulus and demonstrate that the magnitude of fear circuitry activation is increased following early life stress, a rodent model of affective disorders. This technique provides a new translatable method for testing environmental, genetic and pharmacological manipulations on emotional and cognitive processes in awake rodent models.	[Brydges, Nichola M.; Jansen, Maurits A.; Hall, Jeremy; Holmes, Megan C.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Wood, Emma R.] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh, Midlothian, Scotland; [Day, Mark] Bristol Myers Squibb Co, Strateg Transact Grp, Wallingford, CT 06492 USA; [Steele, Douglas] Univ Dundee, Med Res Inst, Dundee, Scotland	University of Edinburgh; University of Edinburgh; Bristol-Myers Squibb; University of Dundee	Holmes, MC (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	megan.holmes@ed.ac.uk	Jansen, Maurits/B-3913-2012; Lawrie, Stephen MacGregor/AAD-1607-2021; Steele, Douglas/AAB-9889-2019; Whalley, Heather C/N-1886-2019	Jansen, Maurits/0000-0002-7077-0188; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Steele, Douglas/0000-0002-9822-8753; Whalley, Heather C/0000-0002-4505-8869; Brydges, Nichola/0000-0003-0485-4639; Hall, Jeremy/0000-0002-0403-3278; Merrifield, Gavin/0000-0003-4652-6625	Wyeth-TMRC grant [NS-EU-136]; Scottish Senior Clinical Fellowship; University of Edinburgh Centre for Cognitive Aging and Cognitive Epidemiology, cross council Lifelong Health and Wellbeing Initiative [G0700704/84698]; Pfizer; Medical Research Council [G0801418B, MR/K026992/1, G0700704] Funding Source: researchfish; MRC [G0700704] Funding Source: UKRI	Wyeth-TMRC grant; Scottish Senior Clinical Fellowship; University of Edinburgh Centre for Cognitive Aging and Cognitive Epidemiology, cross council Lifelong Health and Wellbeing Initiative; Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wyeth-TMRC grant NS-EU-136 (IM, SF-W, MCH, JH, ERW, SML, MAJ). JH is supported by a Scottish Senior Clinical Fellowship. Further support was provided by the Dr Mortimer and Theresa Sackler Foundation JH) and the University of Edinburgh Centre for Cognitive Aging and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698)(MCG, IM and ERW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared that no competing interests exist. Wyeth (now Pfizer) contributed to the funding for setting up this technique, MD was previously employed by Abbott Pharmaceuticals and is now employed by Bristol-Myers Squib but there are no competing financial interests in respect to the acquisition, analysis or interpretation of the results. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Becerra L, 2011, NEUROIMAGE, V54, P1355, DOI 10.1016/j.neuroimage.2010.08.056; Bremner JD, 2001, DEV PSYCHOPATHOL, V13, P473, DOI 10.1017/S0954579401003042; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Chin CL, 2011, J PHARMACOL EXP THER, V336, P709, DOI 10.1124/jpet.110.173880; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Ferris CF, 2005, J NEUROSCI, V25, P149, DOI 10.1523/JNEUROSCI.3156-04.2005; Governo RJM, 2008, BRIT J PHARMACOL, V153, P1558, DOI 10.1038/bjp.2008.27; Jacobson-Pick S, 2010, BEHAV BRAIN RES, V214, P268, DOI 10.1016/j.bbr.2010.05.036; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Kim T, 2010, NEUROIMAGE, V52, P224, DOI 10.1016/j.neuroimage.2010.03.064; King JA, 2005, J NEUROSCI METH, V148, P154, DOI 10.1016/j.jneumeth.2005.04.011; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Meewisse ML, 2011, J TRAUMA STRESS, V24, P405, DOI 10.1002/jts.20663; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Romaniuk L, 2010, ARCH GEN PSYCHIAT, V67, P1246, DOI 10.1001/archgenpsychiatry.2010.169; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Toledo-Rodriguez Maria, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/71203; Weich S, 2009, BRIT J PSYCHIAT, V194, P392, DOI 10.1192/bjp.bp.107.042515; Yaniv D, 2004, BRAIN RES REV, V44, P179, DOI 10.1016/j.brainresrev.2003.08.008; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	26	34	34	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54197	10.1371/journal.pone.0054197	http://dx.doi.org/10.1371/journal.pone.0054197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349824	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000314019100049
J	McKenzie, DJ; Estivales, G; Svendsen, JC; Steffensen, JF; Agnese, JF				McKenzie, David J.; Estivales, Guillan; Svendsen, Jon C.; Steffensen, John F.; Agnese, Jean-Francois			Local Adaptation to Altitude Underlies Divergent Thermal Physiology in Tropical Killifishes of the Genus Aphyosemion	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCES; EUROPEAN SEA BASS; METABOLIC-RATE; CLIMATE-CHANGE; PHYLOGENETIC-RELATIONSHIPS; FUNDULUS-HETEROCLITUS; SWIMMING PERFORMANCE; INTRINSIC GROWTH; DYNAMIC ACTION; PASSAGE TIME	In watersheds of equatorial West Africa, monophyletic groups of killifish species (genus Aphyosemion) occur in discrete altitudinal ranges, low altitude species (LA, sea level to similar to 350 m) or high altitude species (HA, 350 to 900 m). We investigated the hypothesis that local adaptation to altitude by the LA and HA species would be revealed as divergent effects of temperature on their physiological energetics. Two species from each group (mass similar to 350 mg) were acclimated to 19, 25 and 28 degrees C, with 19 and 28 degrees C estimated to be outside the thermal envelope for LA or HA, respectively, in the wild. Wild-caught animals (F0 generation) were compared with animals raised in captivity at 25 degrees C (F1 generation) to investigate the contribution of adaptation versus plasticity. Temperature significantly increased routine metabolic rate in all groups and generations. However, LA and HA species differed in the effects of temperature on their ability to process a meal. At 25 degrees C, the specific dynamic action (SDA) response was completed within 8 h in all groups, but acclimation to temperatures beyond the thermal envelope caused profound declines in SDA performance. At 19 degrees C, the LA required similar to 14 h to complete the SDA, whereas the HA required only similar to 7 h. The opposite effect was observed at 28 degrees C. This effect was evident in both F0 and F1. Reaction norms for effects of temperature on SDA therefore revealed a trade-off, with superior performance at warmer temperatures by LA being associated with inferior performance at cooler temperatures, and vice-versa in HA. The data indicate that divergent physiological responses to temperature in the LA and HA species reflect local adaptation to the thermal regime in their habitat, and that local adaptation to one thermal environment trades off against performance in another.	[McKenzie, David J.; Estivales, Guillan; Agnese, Jean-Francois] Univ Montpellier 2, Inst Sci Evolut, UMR5554, Montpellier, France; [McKenzie, David J.] Univ Montpellier 2, UMR5119 Ecol Syst Marins Cotiers, Montpellier, France; [Svendsen, Jon C.; Steffensen, John F.] Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; University of Copenhagen	McKenzie, DJ (corresponding author), Univ Montpellier 2, Inst Sci Evolut, UMR5554, Montpellier, France.	david.mckenzie@univ-montp2.fr	McKenzie, David/AAA-5179-2021; Steffensen, John F/F-6778-2010; Svendsen, Jon/J-2716-2013; Agnèse, jean-François/J-8302-2016; McKenzie, David J./K-3090-2012	McKenzie, David/0000-0003-0961-9101; Steffensen, John F/0000-0002-4477-8039; Svendsen, Jon/0000-0002-0273-0985; Agnèse, jean-François/0000-0002-6883-551X; McKenzie, David J./0000-0003-0961-9101	Centre National pour la Recherche Scientifique; Universite Montpellier 2; Ambassade de France in Copenhagen	Centre National pour la Recherche Scientifique; Universite Montpellier 2; Ambassade de France in Copenhagen	This research was funded by the Centre National pour la Recherche Scientifique, the Universite Montpellier 2 and the Ambassade de France in Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese JF, 2006, MOL PHYLOGENET EVOL, V40, P332, DOI 10.1016/j.ympev.2006.03.018; Agnese JF, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2045.1.4; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; AVERY HW, 1993, PHYSIOL ZOOL, V66, P902, DOI 10.1086/physzool.66.6.30163746; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bennett WA, 1997, T AM FISH SOC, V126, P841, DOI 10.1577/1548-8659(1997)126<0841:CTAPOO>2.3.CO;2; Billerbeck JM, 2001, EVOLUTION, V55, P1863; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; BRATTSTROM BH, 1979, AM ZOOL, V19, P345; Damme R, 1989, OECOLOGIA, V80, P516; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Dupont-Prinet A, 2010, J EXP BIOL, V213, P1143, DOI 10.1242/jeb.037812; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Fangue NA, 2008, PHYSIOL BIOCHEM ZOOL, V81, P389, DOI 10.1086/589109; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Fangue NA, 2009, PHYSIOL BIOCHEM ZOOL, V82, P776, DOI 10.1086/606030; Fraser KPP, 2007, ADV MAR BIOL, V52, P267, DOI 10.1016/S0065-2881(06)52003-6; Fry FEJ, 1971, FISH PHYSIOL, VVI, P1, DOI DOI 10.1016/S1546-5098(08)60146-6; Gomes ARC, 2005, FISH PHYSIOL, V21, P443; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; HUEY RB, 1993, AM NAT, V142, pS21, DOI 10.1086/285521; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jordan AD, 2007, PHYSIOL BIOCHEM ZOOL, V80, P178, DOI 10.1086/510565; Killen SS, 2011, J ANIM ECOL, V80, P1024, DOI 10.1111/j.1365-2656.2011.01844.x; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; McKenzie DJ, 2007, AQUACULTURE, V263, P280, DOI 10.1016/j.aquaculture.2006.10.022; Millidine KJ, 2009, P ROY SOC B-BIOL SCI, V276, P2103, DOI 10.1098/rspb.2009.0080; Murphy WJ, 1999, MOL PHYLOGENET EVOL, V11, P351, DOI 10.1006/mpev.1998.0566; Nespolo RF, 2007, J EXP BIOL, V210, P2000, DOI 10.1242/jeb.02780; NICIEZA AG, 1994, OECOLOGIA, V99, P243, DOI 10.1007/BF00627736; Norin T, 2011, J EXP BIOL, V214, P1668, DOI 10.1242/jeb.054205; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Olivry J.C., 1986, COLLECTION MONOGRAPH, V9; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Powers DA, 1998, J EXP ZOOL, V282, P71; Schulte PM, 2011, INTEGR COMP BIOL, V51, P691, DOI 10.1093/icb/icr097; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Somero George N., 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-1; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; WALDSCHMIDT SR, 1986, PHYSIOL ZOOL, V59, P376, DOI 10.1086/physzool.59.3.30156109; Wendelaar BSE, 1997, PHYSIOL REV, V77, P591	47	23	23	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54345	10.1371/journal.pone.0054345	http://dx.doi.org/10.1371/journal.pone.0054345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349857	gold, Green Submitted, Green Published			2022-12-27	WOS:000314019100058
J	Vera, E; de Jesus, BB; Foronda, M; Flores, JM; Blasco, MA				Vera, Elsa; Bernardes de Jesus, Bruno; Foronda, Miguel; Flores, Juana M.; Blasco, Maria A.			Telomerase Reverse Transcriptase Synergizes with Calorie Restriction to Increase Health Span and Extend Mouse Longevity	PLOS ONE			English	Article							LIFE-SPAN; DIETARY RESTRICTION; CELLULAR SENESCENCE; OXIDATIVE STRESS; HUMAN-DISEASE; CANCER; LENGTH; MICE; GROWTH; AGE	Caloric restriction (CR), a reduction of food intake while avoiding malnutrition, can delay the onset of cancer and age-related diseases in several species, including mice. In addition, depending of the genetic background, CR can also increase or decrease mouse longevity. This has highlighted the importance of identifying the molecular pathways that interplay with CR in modulating longevity. Significant lifespan extension in mice has been recently achieved through over-expression of the catalytic subunit of mouse telomerase (mTERT) in a cancer protective background. Given the CR cancer-protective effects in rodents, we set to address here whether CR impacts on telomere length and synergizes with mTERT to extend mouse longevity. CR significantly decreased tumor incidence in TERT transgenic (TgTERT) mice and extended their lifespan compared to wild-type (WT) controls under the same diet, indicating a synergy between TgTERT and CR in increasing mouse longevity. In addition, longitudinal telomere length measurements in peripheral blood leukocytes from individual mice showed that CR resulted in maintenance and/or elongation telomeres in a percentage of WT mice, a situation that mimics telomere dynamics in TgTERT cohorts. These results demonstrate that CR attenuates telomere erosion associated to aging and that synergizes with TERT over-expression in increasing "health span'' and extending mouse longevity.	[Vera, Elsa; Bernardes de Jesus, Bruno; Foronda, Miguel; Blasco, Maria A.] Spanish Natl Canc Res Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid, Spain; [Flores, Juana M.] Univ Complutense Madrid, Fac Vet, Anim Surg & Med Dept, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Complutense University of Madrid	Blasco, MA (corresponding author), Spanish Natl Canc Res Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, Madrid, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014; Bernardes de Jesus, Bruno/GLQ-7625-2022	Blasco, Maria A./0000-0002-4211-233X; Bernardes de Jesus, Bruno/0000-0002-6407-3466; Foronda, Miguel/0000-0001-9590-9281; Nobrega-Pereira, Sandrina/0000-0002-9652-1382	Spanish Ministry of Science and Innovation; European Union; European Research Council; Fundacion Botin; Fundacion Lilly	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Fundacion Botin; Fundacion Lilly	Blasco lab is funded by Spanish Ministry of Science and Innovation, European Union (GENICA and TELOMARKER), European Research Council Advanced Grant, Fundacion Botin and Fundacion Lilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Argentino DP, 2005, EXP GERONTOL, V40, P27, DOI 10.1016/j.exger.2004.09.005; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dunn SE, 1997, CANCER RES, V57, P4667; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gonzalez-Suarez E, 2005, ONCOGENE, V24, P2256, DOI 10.1038/sj.onc.1208413; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hamrick MW, 2008, J BONE MINER RES, V23, P870, DOI [10.1359/jbmr.080213, 10.1359/JBMR.080213]; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hempenstall S, 2010, MECH AGEING DEV, V131, P111, DOI 10.1016/j.mad.2009.12.008; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; INGRAM DK, 1986, EXP AGING RES, V12, P155; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McIlrath J, 2001, CANCER RES, V61, P912; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	61	63	66	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53760	10.1371/journal.pone.0053760	http://dx.doi.org/10.1371/journal.pone.0053760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349740	gold, Green Published			2022-12-27	WOS:000314019100029
J	Ruuska, M; Sahlberg, AS; Granfors, K; Penttinen, MA				Ruuska, Marja; Sahlberg, Anna S.; Granfors, Kaisa; Penttinen, Markus A.			Phosphorylation of STAT-1 Serine 727 Is Prolonged in HLA-B27-Expressing Human Monocytic Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; REACTIVE ARTHRITIS; TRANSGENIC RATS; KINASE PKR; B-POCKET; ANKYLOSING-SPONDYLITIS; SALMONELLA-ENTERITIDIS; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; YERSINIA ANTIGENS	A tissue antigen, HLA-B27, is strongly associated with a group of rheumatic diseases called spondyloarthritides. Despite the intensive research, the exact role of HLA-B27 in the pathogenesis of these diseases is still unclear. Here we studied whether HLA-B27 modulates the phosphorylation of signal transducer and activator of transcription 1 (STAT-1) serine 727 residue and the localization of STAT-1 in Salmonella-infected human monocytic cells. In addition, we studied the role of signaling molecule double-stranded RNA activated protein kinase (PKR) in these modulatory effects. U937 human monocytic cell transfectants stably expressing wild type HLA-B27 or mutated HLA-B27 heavy chains with amino acid substitutions in the B pocket were prepared. The PMA-differentiated cells were infected with S. enteritidis. Western blotting was used to detect the phosphorylation of STAT-1, and to visualize the localization of STAT-1 in the cells confocal microscopy was used. Specific inhibitors were employed to study the role of PKR in STAT-1 phosphorylation. We discovered that the phosphorylation of STAT-1 serine 727 is prolonged in cells expressing misfolding forms of HLA-B27 after S. enteritidis infection, whereas in mock cells and in cells expressing mutated, non-misfolding HLA-B27 the phosphorylation of serine 727 is transient. Interestingly, STAT-1 serine 727 phosphorylation is partly dependent on PKR. In addition, more STAT-1 is localized in the nucleus of HLA-B27-expressing cells, even before an external trigger, when compared to mock cells. In conclusion, our results show that the phosphorylation of STAT-1 serine 727 residue is prolonged in HLA-B27-expressing monocyte-macrophage U937 cells after bacterial infection. This is of interest since the phosphorylation of serine 727 on STAT-1 is suggested to contribute to macrophage activation and promote inflammatory responses. Therefore, our results provide a mechanism which explains how the expression of an HLA-B27 molecule can impact the course of Salmonella infection and reactive arthritis.	[Ruuska, Marja; Sahlberg, Anna S.; Penttinen, Markus A.] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Ruuska, Marja; Sahlberg, Anna S.; Granfors, Kaisa] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland	University of Turku; Finland National Institute for Health & Welfare	Ruuska, M (corresponding author), Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland.	marja.ruuska@utu.fi			Academy of Finland; Sigrid Juselius Foundation; Finnish Cultural Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This study was supported by grants from the Academy of Finland (http://www.aka.fi/en-GB/A/), the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation/foundation/) and the Finnish Cultural Foundation (http://www.skr.fi/default.asp?docId = 12256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbuch D, 2011, PEDIATR INFECT DIS J, V30, P352, DOI 10.1097/INF.0b013e3181fdff4a; Colbert RA, 2004, CURR MOL MED, V4, P21, DOI 10.2174/1566524043479293; COLBERT RA, 1993, P NATL ACAD SCI USA, V90, P6879, DOI 10.1073/pnas.90.14.6879; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; Dangoria NS, 2002, J BIOL CHEM, V277, P23459, DOI 10.1074/jbc.M110336200; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Ekman P, 2000, ARTHRITIS RHEUM-US, V43, P1527, DOI 10.1002/1529-0131(200007)43:7<1527::AID-ANR17>3.3.CO;2-7; Gaston JSH, 1999, ARTHRITIS RHEUM, V42, P2239; GRANFORS K, 1989, NEW ENGL J MED, V320, P216, DOI 10.1056/NEJM198901263200404; Granfors K, 1998, ARTHRITIS RHEUM, V41, P855, DOI 10.1002/1529-0131(199805)41:5<855::AID-ART12>3.0.CO;2-J; GRANFORS K, 1990, LANCET, V335, P685, DOI 10.1016/0140-6736(90)90804-E; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Laitio P, 1997, EUR J IMMUNOL, V27, P1331, DOI 10.1002/eji.1830270606; LEIRISALO M, 1982, ARTHRITIS RHEUM, V25, P249, DOI 10.1002/art.1780250302; Mear JP, 1999, J IMMUNOL, V163, P6665; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Najjar I, 2010, BIOCHIMIE, V92, P425, DOI 10.1016/j.biochi.2010.02.009; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Paradowska-Gorycka A, 2010, SCAND J IMMUNOL, V71, P134, DOI 10.1111/j.1365-3083.2009.02361.x; Penttinen MA, 2004, ARTHRITIS RHEUM, V50, P2255, DOI 10.1002/art.20336; Penttinen Markus A, 2002, Curr Rheumatol Rep, V4, P518, DOI 10.1007/s11926-002-0060-7; Ruuska M, 2012, ARTHRITIS RHEUM-US, V64, P772, DOI 10.1002/art.33391; Sahlberg AS, 2012, SCAND J IMMUNOL, V75, P184, DOI 10.1111/j.1365-3083.2011.02648.x; Sahlberg AS, 2007, ARTHRITIS RHEUM, V56, P2652, DOI 10.1002/art.22746; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; SIEPER J, 1995, ARTHRITIS RHEUM, V38, P1547, DOI 10.1002/art.1780381105; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TAUROG JD, 1988, J IMMUNOL, V141, P4020; Turner MJ, 2007, ARTHRITIS RHEUM, V56, P215, DOI 10.1002/art.22295; Turner MJ, 2005, J IMMUNOL, V175, P2438, DOI 10.4049/jimmunol.175.4.2438; Vahamiko S, 2005, ARTHRITIS RES THER, V7, P136, DOI 10.1186/ar1762; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Zeng L, 2011, ARTHRITIS RHEUM-US, V63, P3807, DOI 10.1002/art.30593	39	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e50684	10.1371/journal.pone.0050684	http://dx.doi.org/10.1371/journal.pone.0050684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349666	Green Published, gold, Green Submitted			2022-12-27	WOS:000313943000003
J	Chu, CP; Jin, WZ; Bing, YH; Jin, QH; Kannan, H; Qiu, DL				Chu, Chun-Ping; Jin, Wen-Zhe; Bing, Yan-Hua; Jin, Qing-Hua; Kannan, Hiroshi; Qiu, De-Lai			Effects of Stresscopin on Rat Hypothalamic Paraventricular Nucleus Neurons In Vitro	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CENTRAL-NERVOUS-SYSTEM; RECTIFIER K+ CHANNELS; FACTOR-RECEPTOR; MESSENGER-RNA; MAGNOCELLULAR NEURONS; SUPRAOPTIC NUCLEI; PYRAMIDAL CELLS; UROCORTIN-III; CRF2 RECEPTOR	The effects of stresscopin (SCP) on rat paraventricular nucleus (PVN) neurons were examined using whole-cell patch-clamp recordings and single-cell reverse-transcription multiplex polymerase chain reaction (SC-RT-mPCR) techniques. Under current-clamp conditions, bath application of SCP (100 nM) induced inhibition in 35.2% (37/105) of putative magnocellular neurons and 24.7% (20/81) of putative parvocellular neurons, and excitation in 5.7% (6/105) of putative magnocellular neurons and 18.5% (15/81) of putative parvocellular neurons. SCP-induced inhibition persisted in the presence of a mixture of TTX, a voltage-gated Na+ channel blocker, CNQX, an AMPA/kainate receptor antagonist and bicuculline, a GABA(A) receptor antagonist, whereas SCP-induced excitation of PVN neurons was reversed by the mixture. The SCP-induced inhibition of PVN neurons was abolished by bath application of antisauvagine-30, a selective CRF receptor 2 (CRF-R2) antagonist. Under voltage-clamp conditions, SCP evoked outward currents at the holding potential (-60 mV), which reversed near the potassium equilibrium potential. The SCP-evoked membrane currents were completely blocked by bath application of tertiapin-Q, a selective blocker of G protein-activated inwardly rectifying potassium (GIRK) channels. SC-RT-mPCR analysis indicated that all the SCP-sensitive PVN neurons (57 SCP-inhibited neurons, 21 SCP-excited neurons) expressed CRF-R1 and CRF-R2 mRNAs. Among SCP-hyperpolarized PVN neurons, oxytocin (OT) mRNA was detected in 91.8% of putative magnocellular neurons and 45.0% of putative parvocellular neurons. OT mRNA was also detected in 26.6% of SCP-depolarized parvocellular neurons, but not in SCP-depolarized magnocellular neurons. These results indicate that SCP inhibits a subpopulation of PVN neurons, especially OTergic magnocellular neurons, by enhancing the activity of GIRK channels via CRF-R2.	[Chu, Chun-Ping; Jin, Wen-Zhe; Bing, Yan-Hua; Qiu, De-Lai] Yanbian Univ, Cellular Funct Res Ctr, Yanji, Jilin Province, Peoples R China; [Jin, Wen-Zhe; Bing, Yan-Hua; Jin, Qing-Hua; Qiu, De-Lai] Yanbian Univ, Dept Physiol & Pathophysiol, Coll Med, Yanji, Jilin Province, Peoples R China; [Jin, Wen-Zhe] Yanbian Univ, Dept Pain, Affiliated Hosp, Yanji, Jilin Province, Peoples R China; [Kannan, Hiroshi] Kyushu Womens Univ, Fac Home Econ, Dept Nutr, Kitakyushu, Fukuoka, Japan	Yanbian University; Yanbian University; Yanbian University	Qiu, DL (corresponding author), Yanbian Univ, Cellular Funct Res Ctr, Yanji, Jilin Province, Peoples R China.	dlqiu@ybu.edu.cn			National Natural Science Foundations of China [31060138, 81260208]; Ministry of Education, Culture, Sports, Science and Technology, Japan [14370024]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the National Natural Science Foundations of China (31060138; 81260208), and in part by a Grant-in-Aid for Science Research (14370024) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blume A, 2008, EUR J NEUROSCI, V27, P1947, DOI 10.1111/j.1460-9568.2008.06184.x; Chao HX, 2012, ENDOCRINOLOGY, V153, P166, DOI 10.1210/en.2011-1312; Chen PL, 2010, AM J PHYSIOL-ENDOC M, V298, pE337, DOI 10.1152/ajpendo.00402.2009; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Chu CP, 2012, NEUROSCI LETT, V511, P79, DOI 10.1016/j.neulet.2012.01.035; Chu CP, 2004, REGUL PEPTIDES, V119, P53, DOI 10.1016/j.regpep.2003.12.007; Csaki A, 2000, NEUROSCIENCE, V101, P637, DOI 10.1016/S0306-4522(00)00411-5; DESOUZA EB, 1987, J NEUROSCI, V7, P88; Fekete EM, 2007, NEUROPSYCHOPHARMACOL, V32, P1052, DOI 10.1038/sj.npp.1301214; Frank MD, 2002, TRENDS PHARMACOL SCI, V23, P71; Giesbrecht CJ, 2010, J NEUROSCI, V30, P16970, DOI 10.1523/JNEUROSCI.2306-10.2010; Hashimoto K, 2004, PEPTIDES, V25, P1711, DOI 10.1016/j.peptides.2004.05.024; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Jamieson PM, 2006, ENDOCRINOLOGY, V147, P4578, DOI 10.1210/en.2006-0545; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; KANNAN H, 1989, AM J PHYSIOL, V256, pR1325, DOI 10.1152/ajpregu.1989.256.6.R1325; Lawrence AJ, 2002, BRIT J PHARMACOL, V136, P896, DOI 10.1038/sj.bjp.0704783; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li C, 2002, J NEUROSCI, V22, P991, DOI 10.1523/JNEUROSCI.22-03-00991.2002; Li X, 2010, AUTON NEUROSCI-BASIC, V154, P108, DOI 10.1016/j.autneu.2009.12.004; LOVENBERG TW, 1995, ENDOCRINOLOGY, V136, P4139, DOI 10.1210/en.136.9.4139; Luther JA, 2000, J NEUROPHYSIOL, V84, P1814, DOI 10.1152/jn.2000.84.4.1814; MARTIN DS, 1991, HYPERTENSION, V18, P48, DOI 10.1161/01.HYP.18.1.48; Neumann ID, 2002, PROG BRAIN RES, V139, P147; Nicolas N, 2011, CURRENT NEUROPHARMAC, V9, P262; Nishioka T, 1998, BRAIN RES, V781, P57, DOI 10.1016/S0006-8993(97)01159-1; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; Ohata H, 2004, PEPTIDES, V25, P1703, DOI 10.1016/j.peptides.2004.05.023; Park JB, 2005, FASEB J, V19, pA599; Qiu DL, 2005, J NEUROPHYSIOL, V94, P226, DOI 10.1152/jn.01325.2004; Qiu DL, 2005, NEUROSCI LETT, V374, P69, DOI 10.1016/j.neulet.2004.10.033; SAWCHENKO PE, 1983, BRAIN RES, V277, P355, DOI 10.1016/0006-8993(83)90945-9; Shirasaka T, 2007, ANESTHESIOLOGY, V107, P605, DOI 10.1097/01.anes.0000281916.65365.4e; Slugg RM, 2003, J PHYSIOL-LONDON, V551, P295, DOI 10.1113/jphysiol.2003.041319; Sun QQ, 2002, J NEUROSCI, V22, P5374; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takigawa T, 2003, J NEUROPHYSIOL, V89, P2238, DOI 10.1152/jn.00957.2002; Takigawa T, 2002, J PHYSIOL-LONDON, V539, P67, DOI 10.1113/jphysiol.2001.012883; TASKER JG, 1993, J PHYSIOL-LONDON, V469, P179, DOI 10.1113/jphysiol.1993.sp019810; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; WEISS ML, 1990, BRAIN RES BULL, V24, P231, DOI 10.1016/0361-9230(90)90210-Q; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829; WONG ML, 1994, ENDOCRINOLOGY, V135, P2275, DOI 10.1210/en.135.5.2275; Wotjak CT, 2001, EUR J NEUROSCI, V13, P2273, DOI 10.1046/j.0953-816x.2001.01613.x; Zheng J, 2010, AM J PHYSIOL-GASTR L, V299, pG946, DOI 10.1152/ajpgi.00483.2009	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53863	10.1371/journal.pone.0053863	http://dx.doi.org/10.1371/journal.pone.0053863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349753	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800015
J	Moussa, M; De Jonckheere, JF; Guerlotte, J; Richard, V; Bastaraud, A; Romana, M; Talarmin, A				Moussa, Mirna; De Jonckheere, Johan F.; Guerlotte, Jerome; Richard, Vincent; Bastaraud, Alexandra; Romana, Marc; Talarmin, Antoine			Survey of Naegleria fowleri in Geothermal Recreational Waters of Guadeloupe (French West Indies)	PLOS ONE			English	Article							FREE-LIVING AMEBAS; MENINGOENCEPHALITIS; IDENTIFICATION	In 2008 a fatal case of primary amoebic meningoencephalitis, due to the amoeboflagellate Naegleria fowleri, occurred in Guadeloupe, French West Indies, after a child swam in a bath fed with geothermal water. In order to improve the knowledge on free-living amoebae in this tropical part of France, we investigated on a monthly basis, the presence of Naegleria spp. in the recreational baths, and stream waters which feed them. A total of 73 water samples, 48 sediments and 54 swabs samples were collected from 6 sampling points between June 2011 and July 2012. The water samples were filtered and the filters transferred to non-nutrient agar plates seeded with a heat-killed suspension of Escherichia coli while sediment and swab samples were placed directly on these plates. The plates were incubated at 44 degrees C for the selective isolation of thermophilic Naegleria. To identify the Naegleria isolates the internal transcribed spacers, including the 5.8S rDNA, were amplified by polymerase chain reaction and the sequence of the PCR products was determined. Thermophilic amoebae were present at nearly all collection sites. The pathogenic N. fowleri was the most frequently encountered thermophilic species followed by N. lovaniensis. The concentration of N. fowleri was rather low in most water samples, ranging from 0 to 22 per liter. Sequencing revealed that all N. fowleri isolates belonged to a common Euro-American genotype, the same as detected in the human case in Guadeloupe. These investigations need to be continued in order to counsel the health authorities about prevention measures, because these recreational thermal baths are used daily by local people and tourists.	[Moussa, Mirna; Guerlotte, Jerome; Bastaraud, Alexandra; Talarmin, Antoine] Inst Pasteur Guadeloupe, Unite Environm Sante, Les Abymes, Guadeloupe, France; [De Jonckheere, Johan F.] De Duve Inst, Brussels, Belgium; [De Jonckheere, Johan F.] Sci Inst Publ Hlth, Brussels, Belgium; [Guerlotte, Jerome] Univ Antilles Guyane, Pointe A Pitre, Guadeloupe, France; [Guerlotte, Jerome] Museum Natl Hist Nat, CNRS, UMR MNHN 7205, Paris, France; [Richard, Vincent] Inst Pasteur, Dakar, Senegal; [Romana, Marc] INSERM, U665, Pointe A Pitre, Guadeloupe, France	Universite des Antilles; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Talarmin, A (corresponding author), Inst Pasteur Guadeloupe, Unite Environm Sante, Les Abymes, Guadeloupe, France.	atalarmin@pasteur-guadeloupe.fr	Romana, Marc/K-6442-2017	Romana, Marc/0000-0002-8715-9836; Vincent, RICHARD/0000-0002-6961-1753	ACIP from the Institut Pasteur, Paris [A-01-2011]; Agence Regionale de la Sante (ARS Guadeloupe)	ACIP from the Institut Pasteur, Paris; Agence Regionale de la Sante (ARS Guadeloupe)	This research was supported by a grant ACIP (A-01-2011) from the Institut Pasteur, Paris. The authors are also grateful to the Agence Regionale de la Sante (ARS Guadeloupe) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFNOR, 2001, T90007 AFNOR NF; AFNOR, 1995, 8467 AFNOR NF EN ISO; AFNOR, 1996, 99631 AFNOR NF EN IS; AFNOR, 2009, 103041 AFNOR NF EN I; AFNOR, 2000, 7027 AFNOR NF EN ISO; AFNOR, 1996, 13395 AFNOR NF EN IS; AFNOR, 2005, 11732 AFNOR NF EN IS; AFNOR, 1997, 1484 AFNOR NF EN; AFNOR, 1984, T90003 AFNOR NF; [Anonymous], 1988, NEW KEY FRESHWATER S; [Anonymous], 1999, 14911 AFNOR NF EN; Behets J, 2007, PARASITOL RES, V100, P1249, DOI 10.1007/s00436-006-0399-1; BROWN TJ, 1983, NEW ZEAL J MAR FRESH, V17, P59, DOI 10.1080/00288330.1983.9515987; Cabanes PA, 2001, APPL ENVIRON MICROB, V67, P2927, DOI 10.1128/AEM.67.7.2927-2931.2001; CARTER RF, 1970, J PATHOL, V100, P217, DOI 10.1002/path.1711000402; CARTER SA, 1978, INT J ENVIRON STUD, V12, P199, DOI 10.1080/00207237808709782; CASSELLS JM, 1995, WATER SCI TECHNOL, V31, P119, DOI 10.1016/0273-1223(95)00251-H; CHANG SL, 1978, APPL ENVIRON MICROB, V35, P368, DOI 10.1128/AEM.35.2.368-375.1978; CURSONS RTM, 1980, APPL ENVIRON MICROB, V40, P62, DOI 10.1128/AEM.40.1.62-66.1980; De Jonckheere JF, 2002, ACTA PROTOZOOL, V41, P309; De Jonckheere JF, 1998, PROTIST, V149, P221, DOI 10.1016/S1434-4610(98)70030-6; De Jonckheere JF, 2012, EUR J PROTISTOL, V48, P178, DOI 10.1016/j.ejop.2012.01.009; De Jonckheere JF, 2011, INFECT GENET EVOL, V11, P1520, DOI 10.1016/j.meegid.2011.07.023; De Jonckheerea JF, 2005, PROTIST, V156, P89, DOI 10.1016/j.protis.2004.11.001; DEJONCKHEERE J, 1975, J HYG-CAMBRIDGE, V75, P7, DOI 10.1017/S0022172400047021; Edagawa A, 2009, PARASITOL RES, V105, P1109, DOI 10.1007/s00436-009-1528-4; Eddyani M, 2008, APPL ENVIRON MICROB, V74, P6547, DOI 10.1128/AEM.01066-08; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; GRIFFIN JL, 1983, J PROTOZOOL, V30, P403, DOI 10.1111/j.1550-7408.1983.tb02939.x; Hugo ER, 1992, PROTOCOLS PROTOZOOLO; JOHN DT, 1995, PARASITOL RES, V81, P193; LEGRAND L, 1981, EQUILIBRES CARBONIQU; MARCIANOCABRAL F, 1988, MICROBIOL REV, V52, P114, DOI 10.1128/MMBR.52.1.114-133.1988; Martinez AJ, 1997, BRAIN PATHOL, V7, P583, DOI 10.1111/j.1750-3639.1997.tb01076.x; Nicolas M, 2010, Bull Soc Pathol Exot, V103, P14, DOI 10.1007/s13149-009-0028-1; Pernin P, 1998, APPL ENVIRON MICROB, V64, P955; Schuster FL, 2004, DRUG RESIST UPDATE, V7, P41, DOI 10.1016/j.drup.2004.01.002; Sheehan KB, 2003, APPL ENVIRON MICROB, V69, P5914, DOI 10.1128/AEM.69.10.5914-5918.2003; STEVENS AR, 1980, INT J PARASITOL, V10, P51, DOI 10.1016/0020-7519(80)90064-8; TYNDALL RL, 1989, APPL ENVIRON MICROB, V55, P722, DOI 10.1128/AEM.55.3.722-732.1989; TYNDALL RL, 1984, CRIT REV ENV CONTR, V13, P195, DOI 10.1080/10643388409381707; Tyndall RL, 1985, MICROBIAL PROCESSES, P135	42	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54414	10.1371/journal.pone.0054414	http://dx.doi.org/10.1371/journal.pone.0054414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349880	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800050
J	Pan-ngum, W; Blacksell, SD; Lubell, Y; Pukrittayakamee, S; Bailey, MS; de Silva, HJ; Lalloo, DG; Day, NPJ; White, LJ; Limmathurotsakul, D				Pan-ngum, Wirichada; Blacksell, Stuart D.; Lubell, Yoel; Pukrittayakamee, Sasithon; Bailey, Mark S.; de Silva, H. Janaka; Lalloo, David G.; Day, Nicholas P. J.; White, Lisa J.; Limmathurotsakul, Direk			Estimating the True Accuracy of Diagnostic Tests for Dengue Infection Using Bayesian Latent Class Models	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; RAPID IMMUNOCHROMATOGRAPHIC ASSAYS; JAPANESE ENCEPHALITIS; VIRUS-INFECTION; NS1 ANTIGEN; ANTIBODIES; GOLD; IGM	Background: Accuracy of rapid diagnostic tests for dengue infection has been repeatedly estimated by comparing those tests with reference assays. We hypothesized that those estimates might be inaccurate if the accuracy of the reference assays is not perfect. Here, we investigated this using statistical modeling. Methods/Principal Findings: Data from a cohort study of 549 patients suspected of dengue infection presenting at Colombo North Teaching Hospital, Ragama, Sri Lanka, that described the application of our reference assay (a combination of Dengue IgM antibody capture ELISA and IgG antibody capture ELISA) and of three rapid diagnostic tests (Panbio NS1 antigen, IgM antibody and IgG antibody rapid immunochromatographic cassette tests) were re-evaluated using Bayesian latent class models (LCMs). The estimated sensitivity and specificity of the reference assay were 62.0% and 99.6%, respectively. Prevalence of dengue infection (24.3%), and sensitivities and specificities of the Panbio NS1 (45.9% and 97.9%), IgM (54.5% and 95.5%) and IgG (62.1% and 84.5%) estimated by Bayesian LCMs were significantly different from those estimated by assuming that the reference assay was perfect. Sensitivity, specificity, PPV and NPV for a combination of NS1, IgM and IgG cassette tests on admission samples were 87.0%, 82.8%, 62.0% and 95.2%, respectively. Conclusions: Our reference assay is an imperfect gold standard. In our setting, the combination of NS1, IgM and IgG rapid diagnostic tests could be used on admission to rule out dengue infection with a high level of accuracy (NPV 95.2%). Further evaluation of rapid diagnostic tests for dengue infection should include the use of appropriate statistical models.	[Pan-ngum, Wirichada; Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Pan-ngum, Wirichada; Blacksell, Stuart D.; Lubell, Yoel; Day, Nicholas P. J.; White, Lisa J.; Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Blacksell, Stuart D.; Day, Nicholas P. J.; White, Lisa J.] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Bailey, Mark S.] Royal Ctr Def Med, Dept Mil Med, Birmingham, W Midlands, England; [de Silva, H. Janaka] Univ Kelaniya, Fac Med, Dept Med, Ragama, Sri Lanka; [Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; University of Oxford; Royal Centre for Defence Medicine; University Kelaniya; Liverpool School of Tropical Medicine; University of Liverpool	Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand.	direk@tropmedres.ac	White, Lisa/AAC-9396-2020; Blacksell, Stuart/D-5530-2018; Bailey, Mark S./D-3854-2013	White, Lisa/0000-0002-6523-185X; Blacksell, Stuart/0000-0001-6576-726X; Bailey, Mark S./0000-0003-4840-5093; Lalloo, David/0000-0001-7680-2200; Lubell, Yoel/0000-0002-0237-1070; pan-ngum, wirichada/0000-0002-9839-5359; Limmathurotsakul, Direk/0000-0001-7240-5320	Thailand Research Fund, Faculty of Tropical Medicine, Mahidol University [TRG5380004]; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme; Wellcome Trust of Great Britain	Thailand Research Fund, Faculty of Tropical Medicine, Mahidol University; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme(Wellcome Trust); Wellcome Trust of Great Britain(Wellcome Trust)	This study is supported by the Thailand Research Fund (TRG5380004), Faculty of Tropical Medicine, Mahidol University and the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banoo S, 2006, NAT REV MICROBIOL, pS20, DOI 10.1038/nrmicro1570; Bernatsky S, 2011, RHEUMATOL INT, V31, P549, DOI 10.1007/s00296-010-1591-2; Blacksell SD, 2006, CLIN INFECT DIS, V42, P1127, DOI 10.1086/501358; Blacksell SD, 2008, DIAGN MICR INFEC DIS, V60, P43, DOI 10.1016/j.diagmicrobio.2007.07.011; Blacksell SD, 2007, CLIN VACCINE IMMUNOL, V14, P1458, DOI 10.1128/CVI.00482-06; Blacksell SD, 2006, T ROY SOC TROP MED H, V100, P775, DOI 10.1016/j.trstmh.2005.10.018; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Ellis RD, 2006, AM J TROP MED HYG, V74, P108, DOI 10.4269/ajtmh.2006.74.108; Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199; Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Lam SK, 1998, WHO DENGUE B, V22; Limmathurotsakul D, 2012, CLIN INFECT DIS, V55, P322, DOI 10.1093/cid/cis403; Limmathurotsakul D, 2011, CLIN INFECT DIS, V52, P1024, DOI 10.1093/cid/cir080; Limmathurotsakul D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012485; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Speybroeck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016705; Spiegelhalter D. J., 2004, STAT PRACTICE; Spiegelhalter DJ, 2004, STAT SCI, V19, P156, DOI 10.1214/088342304000000080; Strickman D, 2000, AM J TROP MED HYG, V63, P27, DOI 10.4269/ajtmh.2000.63.27; Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461; Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693; Wang SM, 2010, J CLIN MICROBIOL, V48, P2793, DOI 10.1128/JCM.02142-09; Zhou X, 2008, STAT METHODS DIAGNOS	28	30	33	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e50765	10.1371/journal.pone.0050765	http://dx.doi.org/10.1371/journal.pone.0050765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349667	Green Published, Green Accepted, gold			2022-12-27	WOS:000313872800001
J	Saito, K; Horiuchi, K; Kimura, T; Mizuno, S; Yoda, M; Morioka, H; Akiyama, H; Threadgill, D; Okada, Y; Toyama, Y; Sato, K				Saito, Kenta; Horiuchi, Keisuke; Kimura, Tokuhiro; Mizuno, Sakiko; Yoda, Masaki; Morioka, Hideo; Akiyama, Haruhiko; Threadgill, David; Okada, Yasunori; Toyama, Yoshiaki; Sato, Kazuki			Conditional Inactivation of TNF alpha-Converting Enzyme in Chondrocytes Results in an Elongated Growth Plate and Shorter Long Bones	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RECEPTOR-DEFICIENT MICE; EGF-RECEPTOR; ENDOCHONDRAL OSSIFICATION; METALLOPROTEINASE; ADAM17; ROLES; TACE; DIFFERENTIATION; MACROPHAGES	TNF alpha-converting enzyme (TACE) is a membrane-bound proteolytic enzyme with essential roles in the functional regulation of TNF alpha and epidermal growth factor receptor (EGFR) ligands. Previous studies have demonstrated critical roles for TACE in vivo, including epidermal development, immune response, and pathological neoangiogenesis, among others. However, the potential contribution of TACE to skeletal development is still unclear. In the present study, we generated a Tace mutant mouse in which Tace is conditionally disrupted in chondrocytes under the control of the Col2a1 promoter. These mutant mice were fertile and viable but all exhibited long bones that were approximately 10% shorter compared to those of wildtype animals. Histological analyses revealed that Tace mutant mice exhibited a longer hypertrophic zone in the growth plate, and there were fewer osteoclasts at the chondro-osseous junction in the Tace mutant mice than in their wild-type littermates. Of note, we found an increase in osteoprotegerin transcripts and a reduction in Rankl and Mmp-13 transcripts in the TACE-deficient cartilage, indicating that dysregulation of these genes is causally related to the skeletal defects in the Tace mutant mice. Furthermore, we also found that phosphorylation of EGFR was significantly reduced in the cartilage tissue lacking TACE, and that suppression of EGFR signaling increases osteoprotegerin transcripts and reduces Rankl and Mmp-13 transcripts in primary chondrocytes. In accordance, chondrocyte-specific abrogation of Egfr in vivo resulted in skeletal defects nearly identical to those observed in the Tace mutant mice. Taken together, these data suggest that TACE-EGFR signaling in chondrocytes is involved in the turnover of the growth plate during postnatal development via the transcriptional regulation of osteoprotegerin, Rankl, and Mmp-13.	[Saito, Kenta; Horiuchi, Keisuke; Mizuno, Sakiko; Morioka, Hideo; Toyama, Yoshiaki; Sato, Kazuki] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Horiuchi, Keisuke; Yoda, Masaki] Keio Univ, Sch Med, Dept Antiaging Orthoped Res, Tokyo, Japan; [Kimura, Tokuhiro; Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Akiyama, Haruhiko] Kyoto Univ, Dept Orthoped, Kyoto, Japan; [Threadgill, David] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	Keio University; Keio University; Keio University; Kyoto University; University of North Carolina; North Carolina State University	Horiuchi, K (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan.	horiuchi@z3.keio.jp	Horiuchi, Keisuke/L-2277-2013; Threadgill, David W/N-4425-2013; Sato, Kazuki/AAL-2166-2021; Toyama, Yoshiaki/K-5743-2013; Okada, Yasunori/B-5550-2014	Horiuchi, Keisuke/0000-0001-7063-9609; Threadgill, David W/0000-0003-3538-1635; Okada, Yasunori/0000-0001-9208-4755; Mizuno, Sakiko/0000-0003-4081-3973	Keio University Kanrinmaru project; MEXT KAKENHI [30327564]	Keio University Kanrinmaru project; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Keio University Kanrinmaru project, and MEXT KAKENHI (30327564). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dreymueller D, 2011, EUR J CELL BIOL; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hakozaki A, 2010, J IMMUNOL, V184, P2442, DOI 10.4049/jimmunol.0901188; Harari PM, 2007, J CLIN ONCOL, V25, P4057, DOI 10.1200/JCO.2007.11.8984; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Horiuchi K, 2009, J IMMUNOL, V182, P2093, DOI 10.4049/jimmunol.0802491; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Isshiki H, 2011, J ORTHOP SCI, V16, P670, DOI 10.1007/s00776-011-0119-2; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawaguchi N, 2007, J CELL SCI, V120, P943, DOI 10.1242/jcs.03403; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peschon JJ, 1998, J IMMUNOL, V160, P943; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Usmani SE, 2012, BONE, V51, P131, DOI 10.1016/j.bone.2012.04.012; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang K, 2004, J BIOL CHEM, V279, P53848, DOI 10.1074/jbc.M403114200; Yi T, 2008, J CELL PHYSIOL, V217, P409, DOI 10.1002/jcp.21511; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang XR, 2011, J BONE MINER RES, V26, P2622, DOI 10.1002/jbmr.502; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295	39	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54853	10.1371/journal.pone.0054853	http://dx.doi.org/10.1371/journal.pone.0054853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349978	Green Published, gold			2022-12-27	WOS:000313872800079
J	Friedman, J; Alm, EJ; Shapiro, BJ				Friedman, Jonathan; Alm, Eric J.; Shapiro, B. Jesse			Sympatric Speciation: When Is It Possible in Bacteria?	PLOS ONE			English	Article							THREESPINE STICKLEBACKS; ECOLOGICAL SPECIATION; BENEFICIAL MUTATIONS; POPULATION GENOMICS; ANOPHELES-GAMBIAE; MULTILOCUS MODEL; GENE-FLOW; DIVERGENCE; RECOMBINATION; DIVERSITY	According to theory, sympatric speciation in sexual eukaryotes is favored when relatively few loci in the genome are sufficient for reproductive isolation and adaptation to different niches. Here we show a similar result for clonally reproducing bacteria, but which comes about for different reasons. In simulated microbial populations, there is an evolutionary tradeoff between early and late stages of niche adaptation, which is resolved when relatively few loci are required for adaptation. At early stages, recombination accelerates adaptation to new niches (ecological speciation) by combining multiple adaptive alleles into a single genome. Later on, without assortative mating or other barriers to gene flow, recombination generates unfit intermediate genotypes and homogenizes incipient species. The solution to this tradeoff may be simply to reduce the number of loci required for speciation, or to reduce recombination between species over time. Both solutions appear to be relevant in natural microbial populations, allowing them to diverge into ecological species under similar constraints as sexual eukaryotes, despite differences in their life histories.	[Friedman, Jonathan; Alm, Eric J.; Shapiro, B. Jesse] MIT, Program Computat & Syst Biol, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alm, Eric J.; Shapiro, B. Jesse] Broad Inst, Cambridge, MA USA; [Shapiro, B. Jesse] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Shapiro, B. Jesse] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Alm, EJ (corresponding author), MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu; bshapiro@fas.harvard.edu	Friedman, Jonathan/I-6930-2019; Shapiro, B. Jesse/U-9337-2019	Friedman, Jonathan/0000-0001-8476-8030; Shapiro, B. Jesse/0000-0001-6819-8699	National Science Foundation (NSF Grant) [DEB-0918333]; NSF Grant [0821391]; NSERC Canada Graduate Scholarship; Harvard MIDAS Center for Communicable Disease Dynamics postdoctoral fellowship; Merck-MIT fellowship	National Science Foundation (NSF Grant)(National Science Foundation (NSF)); NSF Grant(National Science Foundation (NSF)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Harvard MIDAS Center for Communicable Disease Dynamics postdoctoral fellowship; Merck-MIT fellowship	Funding for this work was provided by the National Science Foundation (NSF Grant DEB-0918333). Computational resources were provided by NSF Grant 0821391. B.J.S. was supported by an NSERC Canada Graduate Scholarship and a Harvard MIDAS Center for Communicable Disease Dynamics postdoctoral fellowship; J.F. by a Merck-MIT fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSH GL, 1994, TRENDS ECOL EVOL, V9, P285, DOI 10.1016/0169-5347(94)90031-0; Cadillo-Quiroz H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001265; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; Cornejo OE, 2010, MOL BIOL EVOL, V27, P694, DOI 10.1093/molbev/msp287; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Denef VJ, 2010, ISME J, V4, P599, DOI 10.1038/ismej.2009.158; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Eppley JM, 2007, GENETICS, V177, P407, DOI 10.1534/genetics.107.072892; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Haldane JB., 1990, CAUSES EVOLUTION; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; KONDRASHOV AS, 1986, THEOR POPUL BIOL, V29, P1, DOI 10.1016/0040-5809(86)90002-X; KONDRASHOV AS, 1986, BIOL J LINN SOC, V27, P201, DOI 10.1111/j.1095-8312.1986.tb01734.x; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; KONDRASHOV AS, 1983, THEOR POPUL BIOL, V24, P121, DOI 10.1016/0040-5809(83)90036-9; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Levin BR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000601; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; Mallet J, 2009, J EVOLUTION BIOL, V22, P2332, DOI 10.1111/j.1420-9101.2009.01816.x; Mallet J, 2006, TRENDS ECOL EVOL, V21, P386, DOI 10.1016/j.tree.2006.05.004; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Mayr E, 1942, SYSTEMATICS ORIGIN S; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Preheim SP, 2011, ENVIRON MICROBIOL, V13, P265, DOI 10.1111/j.1462-2920.2010.02328.x; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Shapiro BJ, 2009, TRENDS MICROBIOL, V17, P196, DOI 10.1016/j.tim.2009.02.002; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Vos M, 2011, TRENDS MICROBIOL, V19, P1, DOI 10.1016/j.tim.2010.10.003; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Wylie CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001108	50	27	29	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53539	10.1371/journal.pone.0053539	http://dx.doi.org/10.1371/journal.pone.0053539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349716	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900010
J	Mei, YW; Xu, L; Kramer, HF; Tomberlin, GH; Townsend, C; Meissner, G				Mei, Yingwu; Xu, Le; Kramer, Henning F.; Tomberlin, Ginger H.; Townsend, Claire; Meissner, Gerhard			Stabilization of the Skeletal Muscle Ryanodine Receptor Ion Channel-FKBP12 Complex by the 1,4-Benzothiazepine Derivative S107	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; CA2+ RELEASE; SARCOPLASMIC-RETICULUM; S-NITROSYLATION; DEFECTIVE REGULATION; CALMODULIN-BINDING; FKBP12 BINDING; NITRIC-OXIDE; REDOX SENSOR; PHOSPHORYLATION	Activation of the skeletal muscle ryanodine receptor (RyR1) complex results in the rapid release of Ca2+ from the sarcoplasmic reticulum and muscle contraction. Dissociation of the small FK506 binding protein 12 subunit (FKBP12) increases RyR1 activity and impairs muscle function. The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex. Here, we report a high degree of nonspecific and specific low affinity [H-3]S107 binding to SR vesicles. SR vesicles enriched in RyR1 bound similar to 48 [H-3]S107 per RyR1 tetramer with EC50 similar to 52 mu M and Hillslope similar to 2. The effects of S107 and FKBP12 on RyR1 were examined under conditions that altered the redox state of RyR1. S107 increased FKBP12 binding to RyR1 in SR vesicles in the presence of reduced glutathione and the NO-donor NOC12, with no effect in the presence of oxidized glutathione. Addition of 0.15 mu M FKBP12 to SR vesicles prevented FKBP12 dissociation; however, in the presence of oxidized glutathione and NOC12, FKBP12 dissociation was observed in skeletal muscle homogenates that contained 0.43 mu M myoplasmic FKBP12 and was attenuated by S107. In single channel measurements with FKBP12-depleted RyR1s, in the absence and presence of NOC12, S107 augmented the FKBP12-mediated decrease in channel activity. The data suggest that S107 can reverse the harmful effects of redox active species on SR Ca2+ release in skeletal muscle by binding to RyR1 low affinity sites.	[Mei, Yingwu; Xu, Le; Meissner, Gerhard] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Kramer, Henning F.; Tomberlin, Ginger H.; Townsend, Claire] GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; GlaxoSmithKline	Meissner, G (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu			National Institutes of Health Grant [AR018687]; GlaxoSmithKline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded with support of the National Institutes of Health Grant AR018687 and GlaxoSmithKline. No other external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors HK, GT and CT are employed by GlaxoSmithKline Research and Development. This study was partly funded by GlaxoSmithKline. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahern GP, 1997, BIOPHYS J, V72, P146, DOI 10.1016/S0006-3495(97)78654-5; ANDERSON K, 1994, AM J PHYSIOL, V266, pC462, DOI 10.1152/ajpcell.1994.266.2.C462; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Aracena P, 2005, ANTIOXID REDOX SIGN, V7, P870, DOI 10.1089/ars.2005.7.870; Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Balshaw DM, 2001, J BIOL CHEM, V276, P20144, DOI 10.1074/jbc.M010771200; Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Capes EM, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-18; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Eu JP, 2003, P NATL ACAD SCI USA, V100, P15229, DOI 10.1073/pnas.2433468100; Fauconnier J, 2011, P NATL ACAD SCI USA, V108, P13258, DOI 10.1073/pnas.1100286108; Fauconnier J, 2010, P NATL ACAD SCI USA, V107, P1559, DOI 10.1073/pnas.0908540107; Feng W, 2000, J BIOL CHEM, V275, P35902, DOI 10.1074/jbc.C000523200; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Kakizawa S, 2012, EMBO J, V31, P417, DOI 10.1038/emboj.2011.386; LAM E, 1995, J BIOL CHEM, V270, P26511, DOI 10.1074/jbc.270.44.26511; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Li YX, 2002, CIRC RES, V90, P309, DOI 10.1161/hh0302.105660; Ma JJ, 1995, BIOPHYS J, V69, P2398, DOI 10.1016/S0006-3495(95)80109-8; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; MEISSNER G, 1983, MOL CELL BIOCHEM, V55, P65; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Petrotchenko EV, 2011, RES REP BIOL, V2, P13, DOI 10.2147/RRB.S15776; Reid MB, 1996, NEWS PHYSIOL SCI, V11, P114, DOI 10.1152/physiologyonline.1996.11.3.114; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; Sun JH, 2003, J BIOL CHEM, V278, P8184, DOI 10.1074/jbc.M211940200; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Sutko JL, 1997, PHARMACOL REV, V49, P53; Tang W, 2004, FASEB J, V18, P1597, DOI 10.1096/fj.04-1587fje; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; TIMERMAN AP, 1995, J BIOL CHEM, V270, P2451, DOI 10.1074/jbc.270.6.2451; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; Ward CW, 2003, FASEB J, V17, P1517, DOI 10.1096/fj.02-1083fje; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Xia RH, 2000, J BIOL CHEM, V275, P36556, DOI 10.1074/jbc.M007613200; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Xiao JM, 2007, J BIOL CHEM, V282, P34828, DOI 10.1074/jbc.M707423200; Xu L, 1999, J BIOL CHEM, V274, P32680, DOI 10.1074/jbc.274.46.32680; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Zable AC, 1997, J BIOL CHEM, V272, P7069, DOI 10.1074/jbc.272.11.7069; Zissimopoulos S, 2007, J BIOL CHEM, V282, P6976, DOI 10.1074/jbc.M607590200	56	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54208	10.1371/journal.pone.0054208	http://dx.doi.org/10.1371/journal.pone.0054208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349825	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900052
J	Wu, DD; Chen, Y; Xu, C; Wang, K; Wang, HJ; Zheng, FY; Ma, D; Wang, GM				Wu, Dandan; Chen, Yang; Xu, Chen; Wang, Ke; Wang, Huijun; Zheng, Fengyun; Ma, Duan; Wang, Guomin			Characteristic Face: A Key Indicator for Direct Diagnosis of 22q11.2 Deletions in Chinese Velocardiofacial Syndrome Patients	PLOS ONE			English	Article							CARDIO-FACIAL SYNDROME; CHROMOSOME 22Q11.2; MICRODUPLICATION 22Q11.2; PHENOTYPE CORRELATION; CLINICAL-FEATURES; DIGEORGE-SYNDROME; CLEFT-PALATE; TBX1; ANOMALIES; SPECTRUM	Velocardiofacial syndrome (VCFS) is a disease in human with an expansive phenotypic spectrum and diverse genetic mechanisms mainly associated with copy number variations (CNVs) on 22q11.2 or other chromosomes. However, the correlations between CNVs and phenotypes remain ambiguous. This study aims to analyze the types and sizes of CNVs in VCFS patients, to define whether correlations exist between CNVs and clinical manifestations in Chinese VCFS patients. In total, 55 clinically suspected Chinese VCFS patients and 100 normal controls were detected by multiplex ligation-dependent probe amplification (MLPA). The data from MLPA and all the detailed clinical features of the objects were documented and analyzed. A total of 44 patients (80.0%) were diagnosed with CNVs on 22q11.2. Among them, 43 (78.2%) presented with 22q11.2 heterozygous deletions, of whom 40 (93.0%) had typical 3-Mb deletion, and 3 (7.0%) exhibited proximal 1.5-Mb deletion; no patient was found with atypical deletion on 22q11.2. One patient (1.8%) presented with a 3-Mb duplication mapping to the typical 3-Mb region on 22q11.2, while none of the chromosomal abnormalities in the MLPA kit were found in the other 11 patients and 100 normal controls. All the 43 patients with 22q11.2 deletions displayed characteristic face and palatal anomalies; 37 of them (86.0%) had cognitive or behavioral disorders, and 23 (53.5%) suffered from immune deficiencies; 10 patients (23.3%) manifested congenital heart diseases. Interestingly, all patients with the characteristic face had 22q11.2 heterozygous deletions, but no difference in phenotypic spectrum was observed between 3-Mb and 1.5-Mb deletions. Our data suggest that the characteristic face can be used as a key indicator for direct diagnosis of 22q11.2 deletions in Chinese VCFS patients.	[Wu, Dandan; Chen, Yang; Xu, Chen; Wang, Guomin] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Dept Oral & Craniomaxillofacial Sci, Shanghai Peoples Hosp 9,Coll Stomatol,Sch Med, Shanghai 200030, Peoples R China; [Wang, Ke] Qingdao Univ, Sch Med, Affiliated Hosp, Dept Oral & Maxillofacial Surg, Qingdao 266071, Peoples R China; [Wang, Huijun; Ma, Duan] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Zheng, Fengyun; Ma, Duan] Fudan Univ, Shanghai Med Coll, Inst Med Sci,Key Lab Mol Med, Dept Biochem & Mol Biol,Minist Educ, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Qingdao University; Fudan University; Fudan University	Ma, D (corresponding author), Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China.	duanma@yahoo.cn; guomin@sh163.net	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022; Ma, Duan/I-8330-2014		National Natural Science Foundation of China [81070813]; Nation Science Supporting Plan [2006BAI5A09]; Hospital Foundation of Shanghai Ninth People's Hospital [201212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nation Science Supporting Plan; Hospital Foundation of Shanghai Ninth People's Hospital	This study was supported by the funds from National Natural Science Foundation of China (No. 81070813), Nation Science Supporting Plan (No. 2006BAI5A09), and Hospital Foundation of Shanghai Ninth People's Hospital (No. 201212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Conti E, 2003, EUR J HUM GENET, V11, P349, DOI 10.1038/sj.ejhg.5200956; Devriendt K, 1995, ANN GENET-PARIS, V38, P228; Driscoll DA, 2006, CLEFT PALATE-CRAN J, V43, P435; Emanuel BS, 2008, DEV DISABIL RES REV, V14, P11, DOI 10.1002/ddrr.3; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Fernandez L, 2008, AM J MED GENET A, V146A, P1134, DOI 10.1002/ajmg.a.32256; Friedman MA, 2011, INT J PEDIATR OTORHI, V75, P1167, DOI 10.1016/j.ijporl.2011.06.013; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Gothelf D, 2009, J MENT HEALTH RES IN, V2, P149, DOI 10.1080/19315860902756136; GREENBERG F, 1988, AM J MED GENET, V31, P1, DOI 10.1002/ajmg.1320310102; Jalali GR, 2008, HUM MUTAT, V29, P433, DOI 10.1002/humu.20640; Kitsiou-Tzeli S, 2004, IN VIVO, V18, P603; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; LIPSON AH, 1991, J MED GENET, V28, P596, DOI 10.1136/jmg.28.9.596; Looman WS, 2010, CLEFT PALATE-CRAN J, V47, P273, DOI [10.1597/09-009.1, 10.5555/09-009.1]; Lundin J, 2010, EUR J MED GENET, V53, P61, DOI 10.1016/j.ejmg.2009.11.004; McDonald-McGinn DM, 2005, AM J MED GENET A, V134A, P242, DOI 10.1002/ajmg.a.30069; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; Oh AK, 2007, CLEFT PALATE-CRAN J, V44, P62, DOI 10.1597/05-192; Ou Z, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31816b64c2; Paylor R, 2006, BIOL PSYCHIAT, V59, P1172, DOI 10.1016/j.biopsych.2006.01.018; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Portnoi MF, 2009, EUR J MED GENET, V52, P88, DOI 10.1016/j.ejmg.2009.02.008; Rauch A, 2005, J MED GENET, V42, P871, DOI 10.1136/jmg.2004.030619; Robin NH, 2005, J PEDIATR-US, V147, P90, DOI 10.1016/j.jpeds.2005.03.007; Sandrin-Garcia P, 2007, MOL CELL BIOCHEM, V303, P9, DOI 10.1007/s11010-007-9450-5; Sandrin-Garcia P, 2007, GENET MOL BIOL, V30, P21, DOI 10.1590/S1415-47572007000100006; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Shprintzen RJ, 2000, MENT RETARD DEV D R, V6, P142, DOI 10.1002/1098-2779(2000)6:2<142::AID-MRDD9>3.0.CO;2-H; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Shprintzen RJ, 2008, DEV DISABIL RES REV, V14, P3, DOI 10.1002/ddrr.2; Tsai CH, 1999, AM J MED GENET, V82, P336, DOI 10.1002/(SICI)1096-8628(19990212)82:4<336::AID-AJMG11>3.3.CO;2-9; Van Esch H, 1999, GENET COUNSEL, V10, P59; Vorstman JAS, 2006, HUM MUTAT, V27, P814, DOI 10.1002/humu.20330; Wentzel C, 2008, EUR J MED GENET, V51, P501, DOI 10.1016/j.ejmg.2008.07.005; Xu YJ, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-169; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yatsenko SA, 2004, CLIN GENET, V66, P128, DOI 10.1111/j.1399-0004.2004.00290.x; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993	40	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54404	10.1371/journal.pone.0054404	http://dx.doi.org/10.1371/journal.pone.0054404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342150	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700114
J	Dauplais, M; Lazard, M; Blanquet, S; Plateau, P				Dauplais, Marc; Lazard, Myriam; Blanquet, Sylvain; Plateau, Pierre			Neutralization by Metal Ions of the Toxicity of Sodium Selenide	PLOS ONE			English	Article							RAT PLASMA INVIVO; POSSIBLE MECHANISM; INORGANIC MERCURY; HYDROGEN-SULFIDE; CADMIUM; OXIDATION; CANCER; DETOXIFICATION; METHYLMERCURY; PREVENTION	Inert metal-selenide colloids are found in animals. They are believed to afford cross-protection against the toxicities of both metals and selenocompounds. Here, the toxicities of metal salt and sodium selenide mixtures were systematically studied using the death rate of Saccharomyces cerevisiae cells as an indicator. In parallel, the abilities of these mixtures to produce colloids were assessed. Studied metal cations could be classified in three groups: (i) metal ions that protect cells against selenium toxicity and form insoluble colloids with selenide (Ag+, Cd2+, Cu2+, Hg2+, Pb2+ and Zn2+), (ii) metal ions which protect cells by producing insoluble metal-selenide complexes and by catalyzing hydrogen selenide oxidation in the presence of dioxygen (Co2+ and Ni2+) and, finally, (iii) metal ions which do not afford protection and do not interact (Ca2+, Mg2+, Mn2+) or weakly interact (Fe2+) with selenide under the assayed conditions. When occurring, the insoluble complexes formed from divalent metal ions and selenide contained equimolar amounts of metal and selenium atoms. With the monovalent silver ion, the complex contained two silver atoms per selenium atom. Next, because selenides are compounds prone to oxidation, the stabilities of the above colloids were evaluated under oxidizing conditions. 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), the reduction of which can be optically followed, was used to promote selenide oxidation. Complexes with cadmium, copper, lead, mercury or silver resisted dissolution by DTNB treatment over several hours. With nickel and cobalt, partial oxidation by DTNB occurred. On the other hand, when starting from ZnSe or FeSe complexes, full decompositions were obtained within a few tens of minutes. The above properties possibly explain why ZnSe and FeSe nanoparticles were not detected in animals exposed to selenocompounds.	[Dauplais, Marc; Lazard, Myriam; Blanquet, Sylvain; Plateau, Pierre] Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris	Plateau, P (corresponding author), Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France.	pierre.plateau@polytechnique.edu		Lazard, Myriam/0000-0002-7154-1352	CNRS; Ecole polytechnique	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole polytechnique	This study was funded by the CNRS and the Ecole polytechnique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASETH J, 1981, SCAND J CLIN LAB INV, V41, P247, DOI 10.3109/00365518109092041; Arai T, 2004, ENVIRON SCI TECHNOL, V38, P6468, DOI 10.1021/es040367u; BLEEHEN SS, 1981, BRIT J DERMATOL, V104, P19, DOI 10.1111/j.1365-2133.1981.tb01706.x; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; CHABEREK S, 1952, J AM CHEM SOC, V74, P6228, DOI 10.1021/ja01144a022; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; CHEN KY, 1972, J SANIT ENG DIV ASCE, V98, P215; CHEN RW, 1975, BIOINORG CHEM, V4, P125, DOI 10.1016/S0006-3061(00)81021-2; ESAKI N, 1982, J BIOL CHEM, V257, P4386; FRIEDEN E, 1985, J CHEM EDUC, V62, P917, DOI 10.1021/ed062p917; Gailer J, 2000, CHEM RES TOXICOL, V13, P1135, DOI 10.1021/tx000050h; Gailer J, 2012, J INORG BIOCHEM, V108, P128, DOI 10.1016/j.jinorgbio.2011.12.001; GASIEWICZ TA, 1976, BIOCHIM BIOPHYS ACTA, V428, P113, DOI 10.1016/0304-4165(76)90113-6; GASIEWICZ TA, 1978, CHEM-BIOL INTERACT, V23, P171, DOI 10.1016/0009-2797(78)90004-2; Glattre E, 2012, J TRACE ELEM MED BIO, V26, P168, DOI 10.1016/j.jtemb.2012.04.021; Gueldry O, 2003, EUR J BIOCHEM, V270, P2486, DOI 10.1046/j.1432-1033.2003.03620.x; HILL CH, 1975, FED PROC, V34, P2096; HILL CH, 1974, J NUTR, V104, P593, DOI 10.1093/jn/104.5.593; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; JENSEN LS, 1975, J NUTR, V105, P769, DOI 10.1093/jn/105.6.769; Khan MAK, 2010, CHEM RES TOXICOL, V23, P1202, DOI 10.1021/tx100080s; Kobayashi Y, 2001, J CHROMATOGR B, V760, P73, DOI 10.1016/S0378-4347(01)00252-3; KOEMAN JH, 1973, NATURE, V245, P385, DOI 10.1038/245385a0; KOSTA L, 1975, NATURE, V254, P238, DOI 10.1038/254238a0; Kungolos A, 1999, ECOTOX ENVIRON SAFE, V43, P149, DOI 10.1006/eesa.1999.1767; Lailson-Brito J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042162; Letavayova L, 2008, MUTAT RES-GEN TOX EN, V652, P198, DOI 10.1016/j.mrgentox.2008.03.001; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; Manikova D, 2012, CHEM RES TOXICOL, V25, P1598, DOI 10.1021/tx300061n; MARTOJA R, 1977, CR ACAD SCI D NAT, V285, P109; MATSUMURA T, 1992, Journal of Dermatology (Tokyo), V19, P87; Muecke R, 2010, INTEGR CANCER THER, V9, P136, DOI 10.1177/1534735410367648; NAGANUMA A, 1983, TOXICOLOGY, V29, P77, DOI 10.1016/0300-483X(83)90040-9; Nakazawa E, 2011, METALLOMICS, V3, P719, DOI 10.1039/c0mt00106f; Nakazawa E, 2011, J ENVIRON MONITOR, V13, P1678, DOI 10.1039/c1em10115c; NASHEF AS, 1977, ANAL BIOCHEM, V79, P394, DOI 10.1016/0003-2697(77)90413-4; Nigro M, 1996, MAR ECOL PROG SER, V135, P137, DOI 10.3354/meps135137; NIGRO M, 1994, J MAR BIOL ASSOC UK, V74, P975, DOI 10.1017/S0025315400090226; NUTTALL KL, 1984, INORG CHIM A-BIOINOR, V91, P243, DOI 10.1016/S0020-1693(00)81844-7; NUTTALL KL, 1987, MED HYPOTHESES, V24, P217, DOI 10.1016/0306-9877(87)90107-1; Odian G, 1981, PRINCIPLES POLYM, P282; Perego P, 1997, TOXICOL APPL PHARM, V147, P312, DOI 10.1006/taap.1997.8271; Peyroche G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036343; Ralston NVC, 2010, TOXICOLOGY, V278, P112, DOI 10.1016/j.tox.2010.06.004; RAWSON AJ, 1995, ECOTOX ENVIRON SAFE, V30, P309, DOI 10.1006/eesa.1995.1035; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Richman EL, 2012, AM J CLIN NUTR, V96, P1, DOI 10.3945/ajcn.112.042119; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10; Sanmartin C, 2012, INT J MOL SCI, V13, P9649, DOI 10.3390/ijms13089649; Sasakura C, 1998, J INORG BIOCHEM, V71, P159, DOI 10.1016/S0162-0134(98)10048-X; Seby F, 2001, CHEM GEOL, V171, P173, DOI 10.1016/S0009-2541(00)00246-1; Seko Y, 1997, BIOMED ENVIRON SCI, V10, P333; Selenius M, 2010, ANTIOXID REDOX SIGN, V12, P867, DOI 10.1089/ars.2009.2884; Sigel A, 2009, METALLOTHIONEINS REL; Singh VP, 2005, METAL TOXICITY TOLER; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Tarze A, 2007, J BIOL CHEM, V282, P8759, DOI 10.1074/jbc.M610078200; Tatum L, 2000, BIOL TRACE ELEM RES, V77, P241, DOI 10.1385/BTER:77:3:241; Wang L, 1997, COLLOID POLYM SCI, V275, P593, DOI 10.1007/s003960050123; WERES O, 1985, CORROSION, V41, P307, DOI 10.5006/1.3582010; WHANGER PD, 1985, ADV NUTR RES, V7, P221; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Yoneda S, 1997, BIOCHEM BIOPH RES CO, V231, P7, DOI 10.1006/bbrc.1996.6036	65	22	22	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54353	10.1371/journal.pone.0054353	http://dx.doi.org/10.1371/journal.pone.0054353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342137	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400152
J	Leszczynska, D; Matuszewska, E; Kuczynska-Wisnik, D; Furmanek-Blaszk, B; Laskowska, E				Leszczynska, Daria; Matuszewska, Ewelina; Kuczynska-Wisnik, Dorota; Furmanek-Blaszk, Beata; Laskowska, Ewa			The Formation of Persister Cells in Stationary-Phase Cultures of Escherichia Coli Is Associated with the Aggregation of Endogenous Proteins	PLOS ONE			English	Article							BACTERIAL PERSISTENCE; MULTIPLE ANTIBIOTICS; MULTIDRUG TOLERANCE; GLYCINE-BETAINE; IN-VITRO; CHAPERONES; MECHANISM; FREQUENCY; STRESSES; GROWTH	Persister cells (persisters) are transiently tolerant to antibiotics and usually constitute a small part of bacterial populations. Persisters remain dormant but are able to re-grow after antibiotic treatment. In this study we found that the frequency of persisters correlated to the level of protein aggregates accumulated in E. coli stationary-phase cultures. When 3-(N-morpholino) propanesulfonic acid or an osmolyte (trehalose, betaine, glycerol or glucose) were added to the growth medium at low concentrations, proteins were prevented from aggregation and persister formation was inhibited. On the other hand, acetate or high concentrations of osmolytes enhanced protein aggregation and the generation of persisters. We demonstrated that in the E. coli stationary-phase cultures supplemented with MOPS or a selected osmolyte, the level of protein aggregates and persister frequency were not correlated with such physiological parameters as the extent of protein oxidation, culturability, ATP level or membrane integrity. The results described here may help to understand the mechanisms underlying persister formation.	[Leszczynska, Daria; Matuszewska, Ewelina; Kuczynska-Wisnik, Dorota; Laskowska, Ewa] Univ Gdansk, Fac Biol, Dept Biochem, PL-80952 Gdansk, Poland; [Furmanek-Blaszk, Beata] Univ Gdansk, Fac Biol, Dept Microbiol, PL-80952 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Laskowska, E (corresponding author), Univ Gdansk, Fac Biol, Dept Biochem, PL-80952 Gdansk, Poland.	lasko@biotech.ug.gda.pl		Furmanek-Blaszk, Beata/0000-0002-9104-4177; Laskowska, Ewa/0000-0002-7138-1125; Kuczynska-Wisnik, Dorota/0000-0002-3678-2660	Polish Ministry of Science and Higher Education [0923/B/P01/2009/36]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grant 0923/B/P01/2009/36 from the Polish Ministry of Science and Higher Education (www.nauka.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Caldas T, 1999, MICROBIOL-SGM, V145, P2543, DOI 10.1099/00221287-145-9-2543; CAYLEY S, 1989, J BACTERIOL, V171, P3597, DOI 10.1128/jb.171.7.3597-3602.1989; Cecarini V, 2007, BBA-MOL CELL RES, V1773, P93, DOI 10.1016/j.bbamcr.2006.08.039; Chien AC, 2012, CURR BIOL, V22, pR340, DOI 10.1016/j.cub.2012.02.032; De Spiegeleer P, 2004, J APPL MICROBIOL, V97, P124, DOI 10.1111/j.1365-2672.2004.02285.x; Diamant S, 2003, MOL MICROBIOL, V49, P401, DOI 10.1046/j.1365-2958.2003.03553.x; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hong SH, 2012, MICROB BIOTECHNOL, V5, P509, DOI 10.1111/j.1751-7915.2011.00327.x; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim JS, 2011, BIOCHEM BIOPH RES CO, V413, P105, DOI 10.1016/j.bbrc.2011.08.063; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kitko RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010078; Klapper I, 2007, MICROBIOL-SGM, V153, P3623, DOI 10.1099/mic.0.2007/006734-0; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Ksiazek K, 2010, BIOGERONTOLOGY, V11, P717, DOI 10.1007/s10522-010-9278-3; KUCHARCZYK K, 1991, MOL MICROBIOL, V5, P2935, DOI 10.1111/j.1365-2958.1991.tb01853.x; Kwiatkowska J, 2008, RES MICROBIOL, V159, P651, DOI 10.1016/j.resmic.2008.09.008; Laskowska E, 1996, MOL MICROBIOL, V22, P555, DOI 10.1046/j.1365-2958.1996.1231493.x; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li YF, 2007, ANTIMICROB AGENTS CH, V51, P2092, DOI 10.1128/AAC.00052-07; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Luidalepp H, 2011, J BACTERIOL, V193, P3598, DOI 10.1128/JB.00085-11; Ma C, 2010, FEMS MICROBIOL LETT, V303, P33, DOI 10.1111/j.1574-6968.2009.01857.x; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samuel D, 2000, PROTEIN SCI, V9, P344; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Singh LR, 2011, LIFE SCI, V88, P117, DOI 10.1016/j.lfs.2010.10.020; Spoering AL, 2006, J BACTERIOL, V188, P5136, DOI 10.1128/JB.00369-06; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	49	49	49	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54737	10.1371/journal.pone.0054737	http://dx.doi.org/10.1371/journal.pone.0054737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358116	Green Submitted, gold, Green Published			2022-12-27	WOS:000314023600100
J	Saito, S; Yamamoto, H; Mukaisho, K; Sato, S; Higo, T; Hattori, T; Yamamoto, G; Sugihara, H				Saito, Shota; Yamamoto, Hiroto; Mukaisho, Ken-ichi; Sato, Sho; Higo, Tomoki; Hattori, Takanori; Yamamoto, Gaku; Sugihara, Hiroyuki			Mechanisms Underlying Cancer Progression Caused by Ezrin Overexpression in Tongue Squamous Cell Carcinoma	PLOS ONE			English	Article							CADHERIN/BETA-CATENIN COMPLEX; MESENCHYMAL TRANSITION; ERM PROTEINS; IMMUNOHISTOCHEMICAL EXPRESSION; PROGNOSTIC-SIGNIFICANCE; ORGANIZER EZRIN; LINKER EZRIN; RHO-GTPASES; HIGH-GRADE; INVASION	Background: Ezrin is a member of the ezrin, radixin, and moesin family that provides a functional link between the plasma membrane and the cortical actin cytoskeleton. A correlation between ezrin overexpression and aggressive cancer behavior has been recently reported in various tumor types. However, its roles in the mechanisms underlying progression of tongue squamous cell carcinoma (SCC) are unclear. Method: We used human tongue SCC and noncancerous tissue microarrays to immunohistochemically analyze the ezrin expression level and its relationship with proliferative activity. The human tongue SCC cell line HSC-3 was used to determine the effects of ezrin RNA interference (RNAi) on cancer cells during MTT; wound healing and invasion assays; immunofluorescence of the actin cytoskeleton; and western blotting of E-cadherin, N-cadherin, beta-catenin, and the active and total RhoA/Rac1/cdc42. Results: Ezrin was overexpressed in 46.4% of the tumors examined in human tongue SCC tissue microarrays. Ezrin expression was correlated with the Ki-67 index. Ezrin depletion by RNAi in the HSC-3 cells significantly reduced cell proliferation, migration, and invasiveness and disturbed actin reorganization during podia formation. Its effects on RhoA/Rac1/cdc42 expression were not significant, whereas it enhanced E-cadherin and b-catenin expression and decreased N-cadherin expression. Conclusions: Ezrin is often overexpressed in primary tongue SCCs and may have an important role in their growth, migration, and invasiveness possibly via its relationship with the E-cadherin/beta-catenin complex and the cadherin switch. Thus, ezrin could be a therapeutic target in tongue SCC.	[Saito, Shota; Yamamoto, Hiroto; Mukaisho, Ken-ichi; Sato, Sho; Higo, Tomoki; Hattori, Takanori; Sugihara, Hiroyuki] Shiga Univ Med Sci, Dept Pathol, Div Mol Diagnost Pathol, Otsu, Shiga 52021, Japan; [Saito, Shota; Sato, Sho; Higo, Tomoki; Yamamoto, Gaku] Shiga Univ Med Sci, Dept Oral & Maxillofacial Surg, Otsu, Shiga 52021, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Mukaisho, K (corresponding author), Shiga Univ Med Sci, Dept Pathol, Div Mol Diagnost Pathol, Otsu, Shiga 52021, Japan.	mukaisho@belle.shiga-med.ac.jp	Mukaisho, Ken-ichi/AAI-7262-2020					Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Chandler K, 2011, HEAD NECK PATHOL, V5, P359, DOI 10.1007/s12105-011-0296-5; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Ferrari S, 2008, PEDIATR BLOOD CANCER, V50, P752, DOI 10.1002/pbc.21360; Fischer CA, 2011, HEAD NECK-J SCI SPEC, V33, P267, DOI 10.1002/hed.21440; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ilmonen S, 2005, MODERN PATHOL, V18, P503, DOI 10.1038/modpathol.3800300; Japan Society for Head and Neck Cancer Cancer Registry Committee, 2002, JPN J HEAD NECK CA S, V32, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang HB, 2010, J CANCER RES CLIN, V136, P1295, DOI 10.1007/s00432-010-0780-4; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kobel M, 2006, INT J GYNECOL PATHOL, V25, P121, DOI 10.1097/01.pgp.0000185410.39050.ac; Kocher HM, 2009, GUT, V58, P271, DOI 10.1136/gut.2008.159871; Kruaysawat Watcharin, 2010, Journal of the Medical Association of Thailand, V93, P278; Kurokawa H, 2005, J ORAL PATHOL MED, V34, P602, DOI 10.1111/j.1600-0714.2005.00358.x; Li Q, 2008, CANCER LETT, V261, P55, DOI 10.1016/j.canlet.2007.11.018; Ling ZQ, 2010, CANCER SCI, V101, P624, DOI 10.1111/j.1349-7006.2009.01470.x; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Liu SS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-58; Madan R, 2006, HEAD NECK-J SCI SPEC, V28, P1018, DOI 10.1002/hed.20435; Mahomed F, 2007, ORAL DIS, V13, P386, DOI 10.1111/j.1601-0825.2006.01295.x; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Musial Jacek, 2007, Polish Journal of Pathology, V58, P235; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Ohtani K, 1999, CANCER LETT, V147, P31, DOI 10.1016/S0304-3835(99)00272-4; Park HR, 2006, PATHOL RES PRACT, V202, P509, DOI 10.1016/j.prp.2006.01.015; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Schlecht NF, 2012, HEAD NECK PATHOL; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Shen Zhi-Hua, 2008, Ai Zheng, V27, P165; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Sun Chuan-zheng, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P650; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Vaheri A, 1997, CURR OPIN CELL BIOL, V9, P659, DOI 10.1016/S0955-0674(97)80119-6; Wang HJ, 2009, J DIGEST DIS, V10, P258, DOI 10.1111/j.1751-2980.2009.00394.x; Wang YH, 2011, MED ONCOL, V28, pS360, DOI 10.1007/s12032-010-9737-3; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548; Wick W, 2001, J NEUROSCI, V21, P3360, DOI 10.1523/JNEUROSCI.21-10-03360.2001; Xie JJ, 2009, INT J CANCER, V124, P2549, DOI 10.1002/ijc.24216; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yang SM, 2009, BBA-BIOMEMBRANES, V1788, P1458, DOI 10.1016/j.bbamem.2009.03.022; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang Y, 2006, J CANCER RES CLIN, V132, P685, DOI 10.1007/s00432-006-0117-5; Ziober BL, 2001, CRIT REV ORAL BIOL M, V12, P499, DOI 10.1177/10454411010120060401	57	34	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54881	10.1371/journal.pone.0054881	http://dx.doi.org/10.1371/journal.pone.0054881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23357878	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600127
J	Cuconati, A; Mills, C; Goddard, C; Zhang, XC; Yu, WQ; Guo, HT; Xu, XD; Block, TM				Cuconati, Andrea; Mills, Courtney; Goddard, Cally; Zhang, Xianchao; Yu, Wenquan; Guo, Haitao; Xu, Xiaodong; Block, Timothy M.			Suppression of AKT Anti-Apoptotic Signaling by a Novel Drug Candidate Results in Growth Arrest and Apoptosis of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HEPATITIS-B; DISCOVERY; SURVIVAL; PATHWAY; CANCER; LIVER; LINES; GENE; SORAFENIB; MUTATIONS	Hepatocellular carcinoma (HCC) is the third most common cause of cancer fatalities worldwide, with limited treatment options and five year survival rates of between <5 and 15%. To address this medical need, we conducted a screen of a drug-like small molecule library for HCC-selective cytotoxins. We report here the identification of a disubstituted aminothiazole termed HBF-0079, with remarkable selective toxicity for HCC-derived cell lines versus non-HCC liver lines and most other cancer lines. HBF-0079 caused irreversible growth arrest and apoptosis of the HCC lines Huh7, Hep3B, HepaRG as well as the hepatoblastoma line HepG2, with CC50 values from similar to 0.7-7.7 mu M, while more than 45 mu M was needed to achieve CC50 values for the immortalized normal hepatocyte lines THLE-2 and PH5CH. Of the sixty cancer lines from the National Cancer Institute panel, only five exhibited >50% growth inhibition by HBF-0079. In Huh7 cells, HBF-0079 induced cell cycle arrest in G1 and concomitant apoptosis, and its effects were irreversible after removal of the compound. These observations corroborate a loss of AKT phosphorylation at the mTORC2-targeted residue S473, with concurrent loss of phosphorylation of the mTORC1 targets SK6 and 4EBP1 in Huh7 but not PH5CH cells. Finally, growth of Hep3B-derived tumors in a murine xenograft model was significantly repressed by the compound through either systemic or intratumoral administration of formulated HBF-0079. The potential for development of this drug candidate is discussed.	[Cuconati, Andrea; Mills, Courtney; Goddard, Cally; Yu, Wenquan; Xu, Xiaodong; Block, Timothy M.] Hepatitis B Fdn, Inst Hepatitis & Virus Res, Doylestown, PA USA; [Zhang, Xianchao; Guo, Haitao; Block, Timothy M.] Drexel Univ Coll Med, Drexel Inst Biotechnol & Virol Res, Doylestown, PA USA; [Xu, Xiaodong] Enantigen Therapeut Inc, Doylestown, PA USA; [Yu, Wenquan] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China	Drexel University; Tianjin University	Cuconati, A (corresponding author), Hepatitis B Fdn, Inst Hepatitis & Virus Res, Doylestown, PA USA.	acuconati.research@hepb.org; Timothy.Block@drexelmed.edu	Yu, Wenquan/S-7342-2017; Cuconati, Andrea/AAI-7533-2020; Sharma, Ashwani/AAK-3879-2020; Cuconati, Andrea/GWV-4662-2022	Yu, Wenquan/0000-0002-3711-0006; Sharma, Ashwani/0000-0001-9835-1973; Cuconati, Andrea/0000-0001-5123-0381	Hepatitis B Foundation; Pennsylvania Commonwealth Institute; Enantigen, Inc.	Hepatitis B Foundation; Pennsylvania Commonwealth Institute; Enantigen, Inc.	Funding for this study was provided by the Hepatitis B Foundation, the Pennsylvania Commonwealth Institute, and Enantigen, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Cagatay T, 2002, ONCOGENE, V21, P7971, DOI 10.1038/sj.onc.1205919; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gallardo-Godoy A, 2011, J MED CHEM, V54, P1010, DOI 10.1021/jm101250y; Gentles RG, 2008, BIOORG MED CHEM LETT, V18, P5316, DOI 10.1016/j.bmcl.2008.08.023; Ghaemmaghami S, 2010, J VIROL, V84, P3408, DOI 10.1128/JVI.02145-09; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hay MP, 2010, J MED CHEM, V53, P787, DOI 10.1021/jm901457w; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kew M, 2006, SLEISENGER FORDTRANS; Kew MC, 1996, CLIN LAB MED, V16, P395, DOI 10.1016/S0272-2712(18)30276-2; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Lazo JS, 2007, MOL PHARMACOL, V72, P1, DOI 10.1124/mol.107.035113; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Noguchi M, 1996, IN VITRO CELL DEV-AN, V32, P135; PFEIFER AMA, 1993, P NATL ACAD SCI USA, V90, P5123, DOI 10.1073/pnas.90.11.5123; Ries LAG, 2008, SEER CANC STAT REV; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Tang TC, 2010, NEOPLASIA, V12, P928, DOI 10.1593/neo.10804; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; WESTLEY B, 1979, BIOCHEM BIOPH RES CO, V90, P410, DOI 10.1016/0006-291X(79)91250-6; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350	50	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54595	10.1371/journal.pone.0054595	http://dx.doi.org/10.1371/journal.pone.0054595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355882	gold, Green Submitted, Green Published			2022-12-27	WOS:000314021500092
J	Gu, Y; Shimada, T; Yasui, Y; Tada, Y; Kaku, M; Okabe, N				Gu, Yoshiaki; Shimada, Tomoe; Yasui, Yoshinori; Tada, Yuki; Kaku, Mitsuo; Okabe, Nobuhiko			National Surveillance of Influenza-Associated Encephalopathy in Japan over Six Years, before and during the 2009-2010 Influenza Pandemic	PLOS ONE			English	Article							ACUTE NECROTIZING ENCEPHALOPATHY; NEUROLOGIC COMPLICATIONS; ENCEPHALITIS; CHILDREN; SYSTEM	Influenza-associated encephalopathy (IAE) is a serious complication of influenza and is reported most frequently in Japan. This paper presents an assessment of the epidemiological characteristics of influenza A (H1N1) 2009-associated encephalopathy in comparison to seasonal IAE, based on Japanese national surveillance data of influenza-like illness (ILI) and IAE during flu seasons from 2004-2005 through 2009-2010. In each season before the pandemic, 34-55 IAE cases (mean 47.8; 95% confidence interval: 36.1-59.4) were reported, and these cases increased drastically to 331 during the 2009 pandemic (6.9-fold the previous seasons). Of the 331 IAE cases, 322 cases were reported as influenza A (H1N1) 2009-associated encephalopathy. The peaks of IAE were consistent with the peaks of the influenza epidemics and pandemics. A total of 570 cases of IAE (seasonal A, 170; seasonal B, 50; influenza A (H1N1) 2009, 322; unknown, 28) were reported over six seasons. The case fatality rate (CFR) ranged from 4.8 to 18.2% before the pandemic seasons and 3.6% in the 2009 pandemic season. The CFR of pandemic-IAE was 3.7%, which is lower than that of influenza A-/B-associated encephalopathy (12.9%, p<0.001; 14.0%, p = 0.002; respectively). The median age of IAE was 7 years during the pandemic, which is higher than that of influenza A-/B-associated encephalopathy (4, p<0.001; 4.5, p = 0.006; respectively). However, the number of pandemic-IAE cases per estimated ILI outpatients peaked in the 0-4-year age group and data both before and during the pandemic season showed a U-shape pattern. This suggests that the high incidence of influenza infection in the 0-4 year age group may lead to a high incidence of IAE in the same age group in a future influenza season. Further studies should include epidemiologic case definitions and clinical details of IAE to gain a more accurate understanding of the epidemiologic status of IAE.	[Gu, Yoshiaki] Tohoku Univ, Grad Sch Med, Dept Reg Cooperat Infect Dis, Sendai, Miyagi 980, Japan; [Gu, Yoshiaki] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Field Epidemiol Training Program Japan, Tokyo, Japan; [Kaku, Mitsuo] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Sendai, Miyagi 980, Japan; [Okabe, Nobuhiko] Kawasaki City Inst Publ Hlth, Kawasaki, Kanagawa 2100834, Japan	Tohoku University; National Institute of Infectious Diseases (NIID); Tohoku University	Gu, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Reg Cooperat Infect Dis, Sendai, Miyagi 980, Japan.	ygu@med.tohoku.ac.jp	Kaku, Mitsuo/E-5811-2017		Study Group of Influenza-Associated Encephalopathy under the Health Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare of Japan [H23-Shinkou-10]	Study Group of Influenza-Associated Encephalopathy under the Health Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare of Japan	This work was supported by the Study Group of Influenza-Associated Encephalopathy (H23-Shinkou-10) under the Health Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins PT, 2010, NEUROCRIT CARE, V13, P396, DOI 10.1007/s12028-010-9436-0; Amin R, 2008, PEDIATR INFECT DIS J, V27, P390, DOI 10.1097/INF.0b013e31816507b2; [Anonymous], 2010, IASR, V31, P248; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fujii H, 2002, JPN J INFECT DIS, V55, P23; Gejyo F, 2005, KIDNEY INT, V68, P188, DOI 10.1111/j.1523-1755.2005.00393.x; Gonzalez BE, 2009, CLIN INFECT DIS, V49, P1966, DOI 10.1086/649014; Hashimoto S, 2003, J EPIDEMIOL, V13, P136, DOI 10.2188/jea.13.136; Hjalmarsson A, 2009, EUR NEUROL, V61, P289, DOI 10.1159/000206854; Infectious Disease Surveillance Center, IS DET VIR REP PREF; Kamigaki T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1139; Kawashima H, 2012, J MED VIROL, V84, P1151, DOI 10.1002/jmv.23317; Kwong KL, 2009, J PAEDIATR CHILD H, V45, P660, DOI 10.1111/j.1440-1754.2009.01591.x; Lee N, 2010, EMERG INFECT DIS, V16, P139, DOI [10.3201/eid1601.090077, 10.3201/eid1601.090007]; Lyon JB, 2010, PEDIATR RADIOL, V40, P200, DOI 10.1007/s00247-009-1487-z; Maricich SM, 2004, PEDIATRICS, V114, pE626, DOI 10.1542/peds.2004-0143; Martin A, 2010, CLIN INFECT DIS, V50, pE50, DOI 10.1086/651501; *MIN HLTH LAB WELF, 2007, INFECT AGENTS SURVEI, V28, P311; Ministry of Education Culture Sports Science and Technology Ministry of Health Labour and Welfare of Japan, 2002, ETH GUID EP RES; Ministry of Health Labour and Welfare, 2009, RES BAS RES OS WORK; Ministry of Health Labour and Welfare, 2010, EST NUMB VACC PERS R; Ministry of Health Labour and Welfare, 2001, INFECT AGENTS SURVEI, V22, P309; Ministry of Health Labour and Welfare, 2009, RES CLIN RES OS WORK; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2010, INFL A H1N1 PDM ASS; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2010, INF DIS WEEKL REP 50; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2008, INECT AGENTS SURVEIL, V29, P297; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2009, INFECT AGENTS SURVEI, V30, P285; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2005, INFECT AGENTS SURVEI, V26, P287; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2009, INFL A H1N1 PDM ASS; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2000, WEEKL REP INFL VIR I; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2006, INFECT AGENTS SURVEI, V27, P293; Ministry of Health Labour and Welfare National Institute of Infectious Diseases, 2007, INFECT AGENTS SURVEI, V28, P339; Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Morishima Tsuneo, 2009, Virus (Nagoya), V59, P59; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Okabe N, 2000, PEDIATR INT, V42, P187, DOI 10.1046/j.1442-200x.2000.01206.x; Okamoto S, 2005, PEDIATR INFECT DIS J, V24, P575, DOI 10.1097/01.inf.0000164799.33635.fe; Okumura A, 2011, EMERG INFECT DIS, V17, P1993, DOI 10.3201/eid1711.110649; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Statistics Bureau, RES POP EST; Steininger C, 2003, CLIN INFECT DIS, V36, P567, DOI 10.1086/367623; The Study Group of Influenza-Associated Encephalopathy, 2009, GUID DIAGN TREATM IN; The Study Group of Influenza-Associated Encephalopathy, 2005, GUID DIAGN TREATM IN; Toovey S, 2012, ADV THER, V29, P826, DOI 10.1007/s12325-012-0050-8; Wada T, 2009, MICROBIOL IMMUNOL, V53, P83, DOI 10.1111/j.1348-0421.2008.00100.x; Wang GF, 2010, CURR OPIN NEUROL, V23, P305, DOI 10.1097/WCO.0b013e328338f6c9; Yamada Shinichiro, 2012, Rinsho Shinkeigaku, V52, P480	50	28	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54786	10.1371/journal.pone.0054786	http://dx.doi.org/10.1371/journal.pone.0054786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355899	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500126
J	Varotto, L; Domeneghetti, S; Rosani, U; Manfrin, C; Cajaraville, MP; Raccanelli, S; Pallavicini, A; Venier, P				Varotto, Laura; Domeneghetti, Stefania; Rosani, Umberto; Manfrin, Chiara; Cajaraville, Miren P.; Raccanelli, Stefano; Pallavicini, Alberto; Venier, Paola			DNA Damage and Transcriptional Changes in the Gills of Mytilus galloprovincialis Exposed to Nanomolar Doses of Combined Metal Salts (Cd, Cu, Hg)	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GENE-EXPRESSION; OXIDATIVE STRESS; HEAVY-METALS; METALLOTHIONEIN GENES; QUANTITATIVE PCR; DIGESTIVE GLAND; BLUE MUSSEL; MERCURY; CADMIUM	Aiming at an integrated and mechanistic view of the early biological effects of selected metals in the marine sentinel organism Mytilus galloprovincialis, we exposed mussels for 48 hours to 50, 100 and 200 nM solutions of equimolar Cd, Cu and Hg salts and measured cytological and molecular biomarkers in parallel. Focusing on the mussel gills, first target of toxic water contaminants and actively proliferating tissue, we detected significant dose-related increases of cells with micronuclei and other nuclear abnormalities in the treated mussels, with differences in the bioconcentration of the three metals determined in the mussel flesh by atomic absorption spectrometry. Gene expression profiles, determined in the same individual gills in parallel, revealed some transcriptional changes at the 50 nM dose, and substantial increases of differentially expressed genes at the 100 and 200 nM doses, with roughly similar amounts of up-and down-regulated genes. The functional annotation of gill transcripts with consistent expression trends and significantly altered at least in one dose point disclosed the complexity of the induced cell response. The most evident transcriptional changes concerned protein synthesis and turnover, ion homeostasis, cell cycle regulation and apoptosis, and intracellular trafficking (transcript sequences denoting heat shock proteins, metal binding thioneins, sequestosome 1 and proteasome subunits, and GADD45 exemplify up-regulated genes while transcript sequences denoting actin, tubulins and the apoptosis inhibitor 1 exemplify down-regulated genes). Overall, nanomolar doses of co-occurring free metal ions have induced significant structural and functional changes in the mussel gills: the intensity of response to the stimulus measured in laboratory supports the additional validation of molecular markers of metal exposure to be used in Mussel Watch programs.	[Varotto, Laura; Domeneghetti, Stefania; Rosani, Umberto; Venier, Paola] Univ Padua, Dept Biol, Padua, Italy; [Manfrin, Chiara; Pallavicini, Alberto] Univ Trieste, Dept Life Sci, Trieste, Italy; [Cajaraville, Miren P.] Univ Basque Country UPV EHU, Dept Zool & Cell Biol, Bilbao, Basque Country, Spain; [Raccanelli, Stefano] Consorzio INCA Marghera, Venice, Italy	University of Padua; University of Trieste; University of Basque Country	Venier, P (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	paola.venier@unipd.it	Venier, Paola/J-6302-2019; Pallavicini, Alberto/H-9281-2019; Pallavicini, Alberto/J-4158-2012; Cajaraville, Miren P/I-4757-2015; rosani, umbero/I-6007-2019	Venier, Paola/0000-0001-9634-3662; Pallavicini, Alberto/0000-0001-7174-4603; Pallavicini, Alberto/0000-0001-7174-4603; Cajaraville, Miren P/0000-0001-6527-6137; rosani, umbero/0000-0003-0685-1618	MIUR; Co.Ri.La.; Basque Government [GIC07/26-IT-393-07]; University of the Basque Country [11/37]; UE 7th FP [CP-FP 214478-2]; Spanish Ministry of Science and Innovation [CTM2009-13477];  [FP7-KBBE-2010-4-266157 Bivalife]	MIUR(Ministry of Education, Universities and Research (MIUR)); Co.Ri.La.(Keygene N.V.); Basque Government(Basque Government); University of the Basque Country; UE 7th FP; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	Work granted by MIUR and Co.Ri.La. to PV. LV is currently supported by the FP7-KBBE-2010-4-266157 Bivalife project. Work in the laboratory of MPC is funded by grants to consolidated research groups (ref GIC07/26-IT-393-07, Basque Government), and to the unit of formation and research (UFI ref 11/37, University of the Basque Country) and projects Nanoretox (ref CP-FP 214478-2, UE 7th FP) and Nanocancer (ref CTM2009-13477, Spanish Ministry of Science and Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada PB, 2012, MOL PHARMACOL, V82, P510, DOI 10.1124/mol.112.079822; Aceto S, 2011, MAR GENOM, V4, P61, DOI 10.1016/j.margen.2011.01.001; Ahmad I, 2011, CHEMOSPHERE, V82, P1541, DOI 10.1016/j.chemosphere.2010.11.064; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auffret M, 2006, ECOTOX ENVIRON SAFE, V63, P393, DOI 10.1016/j.ecoenv.2005.10.016; Ba LA, 2009, METALLOMICS, V1, P292, DOI 10.1039/b904533c; Balshaw S., 2007, Reviews on Environmental Health, V22, P91; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Besada V, 2002, SCI TOTAL ENVIRON, V288, P239, DOI 10.1016/S0048-9697(01)01010-5; Bolognesi C, 1999, ENVIRON MOL MUTAGEN, V33, P287, DOI 10.1002/(SICI)1098-2280(1999)33:4<287::AID-EM5>3.0.CO;2-G; Bolognesi C, 2011, MUTAGENESIS, V26, P205, DOI 10.1093/mutage/geq073; Bury NR, 2003, J EXP BIOL, V206, P11, DOI 10.1242/jeb.00068; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; Campos A, 2012, J PROTEOMICS, V75, P4346, DOI 10.1016/j.jprot.2012.04.027; Chapman PM, 2008, HUM ECOL RISK ASSESS, V14, P5, DOI 10.1080/10807030701790272; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Comuzzi C, 2011, J HAZARD MATER, V193, P177, DOI 10.1016/j.jhazmat.2011.07.047; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Connor KM, 2011, P NATL ACAD SCI USA, V108, P16110, DOI 10.1073/pnas.1111076108; Cosson RP, 2008, MAR ENVIRON RES, V65, P405, DOI 10.1016/j.marenvres.2008.01.005; Dimitriadis VK, 2003, ENVIRON POLLUT, V125, P345, DOI 10.1016/S0269-7491(03)00122-2; Dolcetti L, 2002, MAR ENVIRON RES, V54, P487, DOI 10.1016/S0141-1136(02)00142-3; Domeneghetti S, 2011, ISJ-INVERT SURVIV J, V8, P179; Domouhtsidou GP, 2000, ARCH ENVIRON CON TOX, V38, P472, DOI 10.1007/s002449910062; Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031; Durrnagel S, 2012, J GEN PHYSIOL, V140, P391, DOI 10.1085/jgp.201210798; Duffus JH, 2002, PURE APPL CHEM, V74, P793, DOI 10.1351/pac200274050793; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Fasulo S, 2008, AQUAT TOXICOL, V88, P62, DOI 10.1016/j.aquatox.2008.03.009; Fernandez B, 2011, ENVIRON MOL MUTAGEN, V52, P479, DOI 10.1002/em.20646; Fields PA, 2012, J EXP BIOL, V215, P1106, DOI 10.1242/jeb.062273; Flora SJS, 2008, INDIAN J MED RES, V128, P501; FUNK AE, 1987, COMP BIOCHEM PHYS C, V86, P1, DOI 10.1016/0742-8413(87)90133-2; Gallo LI, 2011, J BIOL CHEM, V286, P30152, DOI 10.1074/jbc.M111.256610; Goldberg E. D, 1975, MAR POLLUT B, V6, P111, DOI [10.1016/0025-326X(75)90271-4, DOI 10.1016/0025-326X(75)90271-4]; Gomez-Mendikute A, 2005, CELL TISSUE RES, V321, P131, DOI 10.1007/s00441-005-1093-9; Gomez-Mendikute A, 2003, TOXICOL IN VITRO, V17, P539, DOI 10.1016/S0887-2333(03)00093-6; Greenough MA, 2012, NEUROCHEM I IN PRESS; Gueguen M, 2011, REV ENVIRON CONTAM T, V213, P55, DOI 10.1007/978-1-4419-9860-6_3; Gutierrez AJ, 2006, J FOOD PROTECT, V69, P2237, DOI 10.4315/0362-028X-69.9.2237; Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kadar E, 2006, ENVIRON RES, V101, P221, DOI 10.1016/j.envres.2005.08.010; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kimbrough K.L, 2008, 74 NOAA NOS NCCOS, P105; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Li J, 2012, FISH SHELLFISH IMMUN, V32, P368, DOI 10.1016/j.fsi.2011.10.030; Lin Y, 2012, ENVIRON TOXICOL CHEM, V31, P2431, DOI 10.1002/etc.1980; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QY, 2012, BIOMATERIALS, V33, P1903, DOI 10.1016/j.biomaterials.2011.11.021; Lyons BP, 2010, MAR POLLUT BULL, V60, P1647, DOI 10.1016/j.marpolbul.2010.06.005; Manfrin C, 2010, ENVIRON SCI TECHNOL, V44, P8276, DOI 10.1021/es102213f; Marchi B, 2004, AQUAT TOXICOL, V66, P197, DOI 10.1016/j.aquatox.2003.09.003; Maret W, 2012, METALLOMICS, V4, P1017, DOI 10.1039/c2mt90041f; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; Moore MN, 2007, AQUAT TOXICOL, V84, P80, DOI 10.1016/j.aquatox.2007.06.007; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; Neser G, 2012, MAR POLLUT BULL, V64, P882, DOI 10.1016/j.marpolbul.2012.02.006; Nguyen TTT, 2011, J ANIM BREED GENET, V128, P482, DOI 10.1111/j.1439-0388.2011.00948.x; NIEBOER E, 1980, ENVIRON POLLUT B, V1, P3, DOI 10.1016/0143-148X(80)90017-8; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091; Place SP, 2012, FUNCT ECOL, V26, P144, DOI 10.1111/j.1365-2435.2011.01924.x; Potrykus J, 2009, OCEANOLOGIA, V51, P525, DOI 10.5697/oc.51-4.525; Pytharopoulou S, 2011, AQUAT TOXICOL, V105, P157, DOI 10.1016/j.aquatox.2011.06.007; Raftopoulou EK, 2011, CHEMOSPHERE, V83, P1155, DOI 10.1016/j.chemosphere.2011.01.003; Sakellari A, 2012, ENV MONIT A IN PRESS; Sen Arpita, 2012, Biomol Concepts, V3, P117; Shaw JP, 2011, MAR ENVIRON RES, V72, P13, DOI 10.1016/j.marenvres.2011.05.003; Singh BK, 2011, MOL CELL BIOCHEM, V357, P373, DOI 10.1007/s11010-011-0908-0; Sinicropi MS, 2010, ARCH TOXICOL, V84, P501, DOI 10.1007/s00204-010-0544-6; Soundararajan R, 2012, CRIT REV BIOCHEM MOL, V47, P349, DOI 10.3109/10409238.2012.678285; Storey John D, 2003, Methods Mol Biol, V224, P149; Strogyloudi E, 2012, ENVIRON MONIT ASSESS, V184, P7189, DOI 10.1007/s10661-011-2490-z; Syversen T, 2012, J TRACE ELEM MED BIO, V26, P215, DOI 10.1016/j.jtemb.2012.02.004; Szefer P, 2006, ENVIRON POLLUT, V139, P70, DOI 10.1016/j.envpol.2005.04.031; Takahashi S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-41; Thevenod F, 2010, BIOMETALS, V23, P857, DOI 10.1007/s10534-010-9309-1; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueki T, 2011, BBA-GEN SUBJECTS, V1810, P457, DOI 10.1016/j.bbagen.2010.12.006; van Kolck M, 2008, ENVIRON TOXICOL CHEM, V27, P272, DOI 10.1897/07-224R.1; Veltman K, 2008, ENVIRON SCI TECHNOL, V42, P852, DOI 10.1021/es071331f; Veltman K, 2010, ENVIRON SCI TECHNOL, V44, P5022, DOI 10.1021/es903697c; Venier P, 2005, ENVIRON INT, V31, P1053, DOI 10.1016/j.envint.2005.05.016; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Vergani L, 2007, ARCH BIOCHEM BIOPHYS, V465, P247, DOI 10.1016/j.abb.2007.05.023; Voulgaridou GP, 2011, MUTAT RES-FUND MOL M, V711, P13, DOI 10.1016/j.mrfmmm.2011.03.006; Wang WX, 2010, COMP BIOCHEM PHYS C, V152, P1, DOI 10.1016/j.cbpc.2010.02.015; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Zorita I, 2007, TOXICOL APPL PHARM, V220, P186, DOI 10.1016/j.taap.2007.01.003; Zorita I, 2006, AQUAT TOXICOL, V78, pS109, DOI 10.1016/j.aquatox.2006.02.032	93	53	56	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54602	10.1371/journal.pone.0054602	http://dx.doi.org/10.1371/journal.pone.0054602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355883	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500094
J	Aranda, A; Campo, P; Palacin, A; Dona, I; Gomez-Casado, C; Galindo, L; Diaz-Perales, A; Blanca, M				Aranda, Ana; Campo, Paloma; Palacin, Arantxa; Dona, Inmaculada; Gomez-Casado, Cristina; Galindo, Luisa; Diaz-Perales, Araceli; Blanca, Miguel			Antigenic Proteins Involved in Occupational Rhinitis and Asthma Caused by Obeche Wood (Triplochiton Scleroxylon)	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEINS; CROSS-REACTIVITY; DUST EXPOSURE; IGE; IDENTIFICATION; ALLERGEN; WORKERS; POLLEN; SENSITIZATION; DETERMINANTS	Background: Obeche wood dust is a known cause of occupational asthma where an IgE-mediated mechanism has been demonstrated. Objective: To characterize the allergenic profile of obeche wood dust and evaluate the reactivity of the proteins by in vitro, ex vivo and in vivo assays in carpenters with confirmed rhinitis and/or asthma Materials and methods: An in-house obeche extract was obtained, and two IgE binding bands were purified (24 and 12 kDa) and sequenced by N-terminal identity. Specific IgE and IgG, basophil activation tests and skin prick tests (SPTs) were performed with whole extract and purified proteins. CCD binding was analyzed by ELISA inhibition studies. Results: Sixty-two subjects participated: 12 with confirmed occupational asthma/rhinitis (ORA+), 40 asymptomatic exposed (ORA-), and 10 controls. Of the confirmed subjects, 83% had a positive SPT to obeche. There was a 100% recognition by ELISA in symptomatic subjects vs. 30% and 10% in asymptomatic exposed subjects and controls respectively (p < 0.05). Two new proteins were purified, a 24 kDa protein identified as a putative thaumatin-like protein and a 12 kDa gamma-expansin. Both showed allergenic activity in vitro, with the putative thaumatin being the most active, with 92% recognition by ELISA and 100% by basophil activation test in ORA+ subjects. Cross-reactivity due to CCD was ruled out in 82% of cases. Conclusions: Two proteins of obeche wood were identified and were recognized by a high percentage of symptomatic subjects and by a small proportion of asymptomatic exposed subjects. Further studies are required to evaluate cross reactivity with other plant allergens.	[Aranda, Ana] Carlos Haya Hosp, Allergy Res Lab, Malaga, Spain; [Campo, Paloma; Dona, Inmaculada; Galindo, Luisa; Blanca, Miguel] Carlos Haya Hosp, Unidad Gest Clin Allergy, Malaga, Spain; [Palacin, Arantxa; Gomez-Casado, Cristina; Diaz-Perales, Araceli] Ctr Plant Biotechnol & Genom, Dept Biotechnol, Madrid, Spain	Hospital Carlos Haya; Hospital Carlos Haya; Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP)	Campo, P (corresponding author), Carlos Haya Hosp, Unidad Gest Clin Allergy, Malaga, Spain.	campomozo@yahoo.com	Gomez-Casado, Cristina/AAE-4826-2021; Díaz-Perales, Araceli/D-8433-2016; Gomez-Casado, Cristina/K-4031-2016	Díaz-Perales, Araceli/0000-0002-1093-3627; Gomez-Casado, Cristina/0000-0002-7707-6367	Ministry of Health grant [FIS/PI071175]; Andalusian Health Division grants [PI-0182/2008]; Spanish Society of Allergy, Ministry of Science and Innovation-DGI, Spain [BIO2009-07050]; Thematic Network FIS-RIRAAF [RD07/0064]	Ministry of Health grant; Andalusian Health Division grants; Spanish Society of Allergy, Ministry of Science and Innovation-DGI, Spain; Thematic Network FIS-RIRAAF	Financial Support: Ministry of Health grant FIS/PI071175; Andalusian Health Division grants PI-0182/2008; grant from the Spanish Society of Allergy, Ministry of Science and Innovation-DGI, Spain (grant BIO2009-07050); and Thematic Network FIS-RIRAAF (RD07/0064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiteneder H, 2004, ALLERGY, V59, P479, DOI 10.1046/j.1398-9995.2003.00421.x; BURNEY PGJ, 1989, EUR RESPIR J, V2, P940; Campo P, 2010, ANN ALLERG ASTHMA IM, V105, P24, DOI 10.1016/j.anai.2010.05.002; Ceccardi TL, 1998, PLANT MOL BIOL, V38, P775, DOI 10.1023/A:1006039016393; Chan-Yeung M, 2006, ASTHMA WORKPLACE, P505; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Diaz-Perales A, 2000, CLIN EXP ALLERGY, V30, P1403, DOI 10.1046/j.1365-2222.2000.00909.x; DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x; Fernandez-Nieto M, 2006, INT ARCH OCC ENV HEA, V79, P483, DOI 10.1007/s00420-005-0078-z; Fernandez-Rivas M, 2006, J ALLERGY CLIN IMMUN, V118, P481, DOI 10.1016/j.jaci.2006.05.012; Ferrer A, 2001, J INVEST ALLERG CLIN, V11, P199; Gavrovic-Jankulovic M, 2002, J ALLERGY CLIN IMMUN, V110, P805, DOI 10.1067/mai.2002.128947; HINOJOSA M, 1986, CLIN ALLERGY, V16, P145, DOI 10.1111/j.1365-2222.1986.tb00758.x; Kauppinen T, 2006, ANN OCCUP HYG, V50, P549, DOI [10.1093/annhyg/mel013, 10.1093/annhyg/me1013]; Kespohl S, 2005, ALLERGY, V60, P808, DOI 10.1111/j.1398-9995.2005.00794.x; Kespohl S, 2010, CLIN EXP ALLERGY, V40, P1099, DOI 10.1111/j.1365-2222.2010.03514.x; Kespohl S, 2008, SCAND J WORK ENV HEA, V34, P387, DOI 10.5271/sjweh.1285; Kespohl S, 2012, INT ARCH ALLERGY IMM, V157, P202, DOI 10.1159/000324953; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Malmberg PO, 1996, AM J RESP CRIT CARE, V153, P948, DOI 10.1164/ajrccm.153.3.8630578; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Palacin A, 2010, CLIN EXP ALLERGY, V40, P1422, DOI 10.1111/j.1365-2222.2010.03578.x; Perez-Rios M, 2010, ALLERGY, V65, P467, DOI 10.1111/j.1398-9995.2009.02166.x; Quirce S, 2000, J ALLERGY CLIN IMMUN, V106, P400, DOI 10.1067/mai.2000.107601; Quirce S, 2004, J ALLERGY CLIN IMMUN, V113, P361, DOI 10.1016/j.jaci.2003.11.018; REIJULA K, 1994, THORAX, V49, P622, DOI 10.1136/thx.49.6.622; Rondon C, 2007, J ALLERGY CLIN IMMUN, V119, P899, DOI 10.1016/j.jaci.2007.01.006; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Schlunssen V, 2008, ANN OCCUP HYG, V52, P227, DOI 10.1093/annhyg/men012; Skovsted TA, 2003, ALLERGY, V58, P772, DOI 10.1034/j.1398-9995.2003.00127.x; Torres MJ, 2004, CLIN EXP ALLERGY, V34, P1768, DOI 10.1111/j.1365-2222.2004.02110.x; TSE KS, 1982, CLIN ALLERGY, V12, P249, DOI 10.1111/j.1365-2222.1982.tb02525.x; Venturini M, 2004, ALLERGY, V59, P225, DOI 10.1046/j.13989995.2003.00137.x; Vidal C, 2006, ANN ALLERG ASTHMA IM, V96, P870, DOI 10.1016/S1081-1206(10)61352-X	35	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53926	10.1371/journal.pone.0053926	http://dx.doi.org/10.1371/journal.pone.0053926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349765	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100037
J	Li, L; Zhang, ZG; Lei, H; Wang, C; Wu, LP; Wang, JY; Fu, FY; Zhu, WG; Wu, LL				Li, Li; Zhang, Zhi-Guo; Lei, Hong; Wang, Cheng; Wu, Li-Peng; Wang, Jin-Yu; Fu, Feng-Ying; Zhu, Wei-Guo; Wu, Li-Ling			Angiotensin II Reduces Cardiac AdipoR1 Expression through AT1 Receptor/ROS/ERK1/2/c-Myc Pathway	PLOS ONE			English	Article							ADIPONECTIN RECEPTOR EXPRESSION; LEFT-VENTRICULAR HYPERTROPHY; PLASMA ADIPONECTIN; NADPH OXIDASES; RAT CARDIOMYOCYTES; INFARCTED HEART; GENE-EXPRESSION; C-MYC; HYPERTENSION; INSULIN	Adiponectin, an abundant adipose tissue-derived protein, exerts protective effect against cardiovascular disease. Adiponectin receptors (AdipoR1 and AdipoR2) mediate the beneficial effects of adiponectin on the cardiovascular system. However, the alteration of AdipoRs in cardiac remodeling is not fully elucidated. Here, we investigated the effect of angiotensin II (AngII) on cardiac AdipoRs expression and explored the possible molecular mechanism. AngII infusion into rats induced cardiac hypertrophy, reduced AdipoR1 but not AdipoR2 expression, and attenuated the phosphorylations of adenosine monophosphate-activated protein kinase and acetyl coenzyme A carboxylase, and those effects were all reversed by losartan, an AngII type 1 (AT1) receptor blocker. AngII reduced expression of AdipoR1 mRNA and protein in cultured neonatal rat cardiomyocytes, which was abolished by losartan, but not by PD123319, an AT2 receptor antagonist. The antioxidants including reactive oxygen species (ROS) scavenger NAC, NADPH oxidase inhibitor apocynin, Nox2 inhibitor peptide gp91 ds-tat, and mitochondrial electron transport chain complex I inhibitor rotenone attenuated AngII-induced production of ROS and phosphorylation of extracellular signal-regulated kinase (ERK) 1/2. AngII-reduced AdipoR1 expression was reversed by pretreatment with NAC, apocynin, gp91 ds-tat, rotenone, and an ERK1/2 inhibitor PD98059. Chromatin immunoprecipitation assay demonstrated that AngII provoked the recruitment of c-Myc onto the promoter region of AdipoR1, which was attenuated by PD98059. Moreover, AngII-induced DNA binding activity of c-Myc was inhibited by losartan, NAC, apocynin, gp91 ds-tat, rotenone, and PD98059. c-Myc small interfering RNA abolished the inhibitory effect of AngII on AdipoR1 expression. Our results suggest that AngII inhibits cardiac AdipoR1 expression in vivo and in vitro and AT1 receptor/ROS/ERK1/2/c-Myc pathway is required for the downregulation of AdipoR1 induced by AngII.	[Li, Li; Zhang, Zhi-Guo; Lei, Hong; Wang, Cheng; Wang, Jin-Yu; Wu, Li-Ling] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Li, Li; Zhang, Zhi-Guo; Lei, Hong; Wang, Cheng; Wang, Jin-Yu; Wu, Li-Ling] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Wu, Li-Peng; Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Fu, Feng-Ying] Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Beijing, Peoples R China	Peking University; Peking University	Wu, LL (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	pathophy@bjmu.edu.cn	zhu, wei-guo/E-1334-2012	Zhu, Wei-Guo/0000-0001-8385-6581	National Nature Science Foundation of China [30871014, 30973316]; National Basic Research Program of China (973 Program) [2007CB512004]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Nature Science Foundation of China (Nos. 30871014 and 30973316) and the National Basic Research Program of China (973 Program 2007CB512004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Afanas'ev I, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/293769; Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Brandes RP, 2010, FREE RADICAL BIO MED, V49, P687, DOI 10.1016/j.freeradbiomed.2010.04.030; Chang SP, 2006, EUR J APPL PHYSIOL, V97, P189, DOI 10.1007/s00421-006-0163-3; Cui XB, 2012, CARDIOVASC RES, V93, P69, DOI 10.1093/cvr/cvr273; De Giusti VC, 2009, J MOL CELL CARDIOL, V47, P716, DOI 10.1016/j.yjmcc.2009.07.023; Delaney J, 2008, NEUROCHEM RES, V33, P545, DOI 10.1007/s11064-007-9474-y; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Fang X, 2005, J MOL ENDOCRINOL, V35, P465, DOI 10.1677/jme.1.01877; Fu L, 2008, EUR J PHARMACOL, V584, P202, DOI 10.1016/j.ejphar.2008.01.028; Fujioka D, 2006, AM J PHYSIOL-HEART C, V290, pH2409, DOI 10.1152/ajpheart.00987.2005; Furuhashi M, 2003, HYPERTENSION, V42, P76, DOI 10.1161/01.HYP.0000078490.59735.6E; Guo ZX, 2011, J PHARM PHARMACOL, V63, P87, DOI 10.1111/j.2042-7158.2010.01157.x; Hong SJ, 2004, BLOOD PRESSURE, V13, P236, DOI 10.1080/08037050410021397; Hopkins TA, 2007, CARDIOVASC RES, V74, P11, DOI 10.1016/j.cardiores.2006.10.009; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kozakova M, 2008, J CLIN ENDOCR METAB, V93, P2811, DOI 10.1210/jc.2007-2580; Laskowski A, 2006, CARDIOVASC RES, V72, P112, DOI 10.1016/j.cardiores.2006.07.006; Li L, 2007, REGUL PEPTIDES, V139, P72, DOI 10.1016/j.regpep.2006.10.007; Li R, 2010, J MOL CELL CARDIOL, V49, P508, DOI 10.1016/j.yjmcc.2010.03.002; Liu S, 2011, EUR J PHARMACOL, V650, P384, DOI 10.1016/j.ejphar.2010.09.082; Looi YH, 2008, HYPERTENSION, V51, P319, DOI 10.1161/HYPERTENSIONAHA.107.101980; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; McWhinney CD, 1998, J MOL CELL CARDIOL, V30, P751, DOI 10.1006/jmcc.1998.0639; Mitsuhashi H, 2007, HYPERTENSION, V49, P1448, DOI 10.1161/HYPERTENSIONAHA.106.079509; Paakko T, 2010, ANN MED, V42, P131, DOI 10.3109/07853890903449827; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023211; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Ran JM, 2006, METABOLISM, V55, P478, DOI 10.1016/j.metabol.2005.10.009; Rasmussen MS, 2006, OBESITY, V14, P28, DOI 10.1038/oby.2006.5; Gonzalez CR, 2010, PHYSIOL BEHAV, V99, P91, DOI 10.1016/j.physbeh.2009.10.015; Saito Y, 2007, AM J PHYSIOL-HEART C, V293, pH3490, DOI 10.1152/ajpheart.00310.2007; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Schauwienold D, 2003, HYPERTENSION, V41, P546, DOI 10.1161/01.HYP.0000054213.37471.84; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Sun XL, 2008, FEBS LETT, V582, P3401, DOI 10.1016/j.febslet.2008.08.037; Toyz RM, 2002, BRAZ J MED BIOL RES, V35, P1001, DOI 10.1590/S0100-879X2002000900001; Tsuchida A, 2004, J BIOL CHEM, V279, P30817, DOI 10.1074/jbc.M402367200; Unger T, 2002, AM J CARDIOL, V89, p3A; Wade TE, 2009, J SURG RES, V154, P78, DOI 10.1016/j.jss.2008.05.006; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07; Xiao GS, 2001, CIRC RES, V89, P1122, DOI 10.1161/hh2401.100742; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhang M, 2012, ANTIOXID REDOX SIGNA; Zhao YL, 2005, REGUL PEPTIDES, V128, P43, DOI 10.1016/j.regpep.2004.12.012; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252	52	13	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e49915	10.1371/journal.pone.0049915	http://dx.doi.org/10.1371/journal.pone.0049915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349663	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100005
J	Parruti, G; Vadini, F; Sozio, F; Mazzott, E; Ursini, T; Polill, E; Di Stefano, P; Tontodonati, M; Verrocchio, MC; Fulcheri, M; Calella, G; Santilli, F; Manzoli, L				Parruti, Giustino; Vadini, Francesco; Sozio, Federica; Mazzott, Elena; Ursini, Tamara; Polill, Ennio; Di Stefano, Paola; Tontodonati, Monica; Verrocchio, Maria C.; Fulcheri, Mario; Calella, Giulio; Santilli, Francesca; Manzoli, Lamberto			Psychological Factors, Including Alexithymia, in the Prediction of Cardiovascular Risk in HIV Infected Patients: Results of a Cohort Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; ACTIVE ANTIRETROVIRAL THERAPY; D PERSONALITY; NEGATIVE AFFECTIVITY; PLATELET ACTIVATION; EMOTION REGULATION; METABOLIC SYNDROME; SOCIAL INHIBITION	Background: Psychological factors are known predictors of cardiovascular disease in many clinical settings, but data are lacking for HIV infection. We carried out a prospective cohort study to evaluate potential psychological predictors of preclinical and clinical vascular disease in HIV patients. Methodology/Principal Findings: HIV patients were consecutively enrolled. Demographics, viral and immune parameters and traditional cardiovascular predictors were considered; Intima-Media Thickness (c-IMT, continuous measure) and Carotid Plaques (CPs, focal thickening >= 1.5 mm) were investigated by B-mode ultrasonography; depressive symptoms by the Beck Depression Inventory (BDI-II), Type D personality (Distressed Personality or Type D) by the DS14, alexithymia by the Toronto Alexithymia Scale (TAS-20). Vascular outcomes included transient ischemic attacks or stroke, acute coronary syndrome, myocardial or other organ infarction. We enrolled 232 HIV subjects, 73.9% males, aged 44.5 +/- 9.9 y, 38.2% with AIDS diagnosis, 18.3% untreated. Mean Nadir CD4 T-cell counts were 237.5 +/- 186.2/mmc. Of them, 224 (96.5%) attended IMT measurements; 201 (86.6%) attended both IMT assessment and psychological profiling. Mean follow-up was 782 +/- 308 days. Fifty-nine patients (29.4%) had CPs at baseline. Nineteen patients (9.5%) had >= 1 vascular event; 12 (6.0%) died due to such events (n = 4) or any cause. At baseline cross-sectional multivariate analysis, increasing age, total cholesterol, current smoking and Alexithymia score >= 50 were significantly associated with both increased cIMT (linear regression) and CPs (logistic regression). At follow-up analysis, log-rank tests and Cox's regression revealed that only older age (p = 0.001), current smoking (p = 0.019) and alexithymia score >= 50 (p = 0.013) were independently associated with vascular events. Conclusions/Significance: In HIV-infected subjects, the Alexithymic trait emerges as a strong predictor of increased IMT, presence of CPs and vascular events. Such results are preliminary and require confirmation from studies with larger sample size and longer follow-up.	[Parruti, Giustino; Vadini, Francesco; Sozio, Federica; Mazzott, Elena; Ursini, Tamara; Polill, Ennio; Di Stefano, Paola; Tontodonati, Monica; Calella, Giulio] Pescara Gen Hosp, Infect Dis Unit, Pescara, Italy; [Verrocchio, Maria C.; Fulcheri, Mario] Univ G dAnnunzio, Clin Psychol Div, Chieti, Italy; [Santilli, Francesca] Univ G dAnnunzio, Dept Med & Aging, Chieti, Italy; [Manzoli, Lamberto] Univ G dAnnunzio, Sect Hyg Epidemiol Pharmacol & Legal Med, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Parruti, G (corresponding author), Pescara Gen Hosp, Infect Dis Unit, Pescara, Italy.	parruti@tin.it	Ursini, Tamara/AAB-3891-2019; Santilli, Francesca/ABC-6243-2021; Manzoli, Lamberto/K-1895-2018; Verrocchio, Maria Cristina/S-5080-2019	Ursini, Tamara/0000-0002-6012-0667; Santilli, Francesca/0000-0002-4593-905X; Manzoli, Lamberto/0000-0002-8129-9344; Verrocchio, Maria Cristina/0000-0003-2549-1152; Verrocchio, Maria Cristina/0000-0003-0326-619X; Fulcheri, Mario/0000-0002-2389-9800	"Fondazione onlus Camillo De Lellis Per l'Innovazione e la Ricerca in Medicina'', Pescara, Italy	"Fondazione onlus Camillo De Lellis Per l'Innovazione e la Ricerca in Medicina'', Pescara, Italy	This work was partly supported by a grant by the "Fondazione onlus Camillo De Lellis Per l'Innovazione e la Ricerca in Medicina'', Pescara, Italy. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Bermond B, 2010, INT J PSYCHOPHYSIOL, V75, P227, DOI 10.1016/j.ijpsycho.2009.11.004; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Bogdanova Y, 2010, NEUROPSYCHOLOGIA, V48, P1295, DOI 10.1016/j.neuropsychologia.2009.12.033; Carney RM, 2005, PSYCHOSOM MED, V67, pS29, DOI 10.1097/01.psy.0000162254.61556.d5; Chatzi L, 2009, J PSYCHOSOM RES, V67, P307, DOI 10.1016/j.jpsychores.2009.04.011; Clark US, 2010, J INT NEUROPSYCH SOC, V16, P1127, DOI 10.1017/S1355617710001037; Dahlof Bjorn, 2010, Am J Cardiol, V105, p3A, DOI 10.1016/j.amjcard.2009.10.007; Davidson KW, 2009, AM J CARDIOL, V103, P755, DOI 10.1016/j.amjcard.2008.11.035; Denollet J, 2000, CIRCULATION, V102, P630, DOI 10.1161/01.CIR.102.6.630; Denollet J, 2006, AM J CARDIOL, V97, P970, DOI 10.1016/j.amjcard.2005.10.035; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2000, J PSYCHOSOM RES, V49, P255, DOI 10.1016/S0022-3999(00)00177-X; Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Grabe HJ, 2010, J PSYCHOSOM RES, V68, P139, DOI 10.1016/j.jpsychores.2009.07.015; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Grynberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042429; Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057; Hausteiner C, 2010, PSYCHOSOM MED, V72, P163, DOI 10.1097/PSY.0b013e3181cb8bae; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Joukamaa M, 2007, J PSYCHOSOM RES, V63, P373, DOI 10.1016/j.jpsychores.2007.01.018; Jula A, 1999, HYPERTENSION, V33, P1057, DOI 10.1161/01.HYP.33.4.1057; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; Karmochkine M, 1998, THROMB HAEMOSTASIS, V80, P208; Lavoie KL, 2010, PSYCHOSOM MED, V72, P20, DOI 10.1097/PSY.0b013e3181c2d6b8; Lorenz MW, 2008, ATHEROSCLEROSIS, V196, P720, DOI 10.1016/j.atherosclerosis.2006.12.022; Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290; McComsey GA, 2007, AIDS, V21, P921, DOI 10.1097/QAD.0b013e328133f29c; Mommersteeg PMC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-714; Needham BL, 2010, AM J PUBLIC HEALTH, V100, P1040, DOI 10.2105/AJPH.2009.172809; O'Leary DH, 2002, AM J CARDIOL, V90, p18L, DOI 10.1016/S0002-9149(02)02957-0; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Oyefeso A, 2008, DRUG ALCOHOL DEPEN, V98, P227, DOI 10.1016/j.drugalcdep.2008.06.004; Pao V, 2008, CURR ATHEROSCLER REP, V10, P61, DOI 10.1007/s11883-008-0010-6; Parker JDA, 2003, J PSYCHOSOM RES, V55, P269, DOI 10.1016/S0022-3999(02)00578-0; Pedersen SS, 2004, J AM COLL CARDIOL, V44, P997, DOI 10.1016/j.jacc.2004.05.064; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pizzi C, 2010, ATHEROSCLEROSIS, V212, P292, DOI 10.1016/j.atherosclerosis.2010.04.038; Plante GE, 2005, METABOLISM, V54, P45, DOI 10.1016/j.metabol.2005.01.013; Pollatos O, 2011, J PSYCHOSOM RES, V70, P525, DOI 10.1016/j.jpsychores.2010.12.003; Reich J, 2010, J PSYCHIATR RES, V44, P1017, DOI 10.1016/j.jpsychires.2010.03.016; Reid GJ, 2009, PSYCHOSOM MED, V71, P438, DOI 10.1097/PSY.0b013e31819cc751; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; Serrano CV, 2011, VASC HEALTH RISK MAN, V7, P159, DOI 10.2147/VHRM.S10783; Shen YMP, 2004, CLIN APPL THROMB-HEM, V10, P277, DOI 10.1177/107602960401000311; Stansfeld SA, 2002, INT J EPIDEMIOL, V31, P248, DOI 10.1093/ije/31.1.248; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Steptoe A, 2003, ATHEROSCLEROSIS, V168, P57, DOI 10.1016/S0021-9150(02)00453-7; Swart M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005751; TAYLOR GJ, 1991, PSYCHOSOMATICS, V32, P153, DOI 10.1016/S0033-3182(91)72086-0; Taylor SF, 2007, TRENDS COGN SCI, V11, P413, DOI 10.1016/j.tics.2007.08.006; Thiebaut F, 2005, AIDS, V19, P729, DOI 10.1097/01.aids.0000166097.46940.35; Tolmunen T, 2011, COMPR PSYCHIAT, V52, P536, DOI 10.1016/j.comppsych.2010.09.007; Tolmunen T, 2010, PSYCHOSOM MED, V72, P187, DOI 10.1097/PSY.0b013e3181c65d00; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Troll JG, 2011, CURR ATHEROSCLER REP, V13, P51, DOI 10.1007/s11883-010-0152-1; Vella EJ, 2009, INT J PSYCHOPHYSIOL, V72, P253, DOI 10.1016/j.ijpsycho.2009.01.003; Vogelzangs N, 2008, ARCH GEN PSYCHIAT, V65, P1386, DOI 10.1001/archpsyc.65.12.1386; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Wright EJ, 2010, NEUROLOGY, V75, P864, DOI 10.1212/WNL.0b013e3181f11bd8	73	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54555	10.1371/journal.pone.0054555	http://dx.doi.org/10.1371/journal.pone.0054555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349927	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100080
J	Kim, H; Lee, SA; Kim, DW; Lee, SH; Kim, BJ				Kim, Hong; Lee, Seoung-Ae; Kim, Dong-Won; Lee, Sueng-Hyun; Kim, Bum-Joon			Naturally Occurring Mutations in Large Surface Genes Related to Occult Infection of Hepatitis B Virus Genotype C	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; KOREAN PATIENTS; HBV INFECTION; DNA; RISK; PREVALENCE; ANTIBODIES; STRESS; GENOME	Molecular mechanisms related to occult hepatitis B virus (HBV) infection, particularly those based on genotype C infection, have rarely been determined thus far in the ongoing efforts to determine infection mechanisms. Therefore, we aim to elucidate the mutation patterns in the surface open reading frame (S ORF) underlying occult infections of HBV genotype C in the present study. Nested PCRs were applied to 624 HBV surface antigen (HBsAg) negative Korean subjects. Cloning and sequencing of the S ORF gene was applied to 41 occult cases and 40 control chronic carriers. Forty-one (6.6%) of the 624 Korean adults with HBsAg-negative serostatus were found to be positive for DNA according to nested PCR tests. Mutation frequencies in the three regions labeled here as preS1, preS2, and S were significantly higher in the occult subjects compared to the carriers in all cases. A total of two types of deletions, preS1 deletions in the start codon and preS2 deletions as well as nine types of point mutations were significantly implicated in the occult infection cases. Mutations within the "a'' determinant region in HBsAg were found more frequently in the occult subjects than in the carriers. Mutations leading to premature termination of S ORF were found in 16 occult subjects (39.0%) but only in one subject from among the carriers (2.5%). In conclusion, our data suggest that preS deletions, the premature termination of S ORF, and "a'' determinant mutations are associated with occult infections of HBV genotype C among a HBsAg-negative population. The novel mutation patterns related to occult infection introduced in the present study can help to broaden our understanding of HBV occult infections.	[Kim, Hong; Lee, Seoung-Ae; Kim, Dong-Won; Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Microbiol & Immunol,Liver Res Inst, Seoul, South Korea; [Kim, Hong; Lee, Seoung-Ae; Kim, Dong-Won; Kim, Bum-Joon] Seoul Natl Univ, Coll Med, SNUMRC, Seoul, South Korea; [Lee, Sueng-Hyun] Konkuk Univ, Sch Med, Dept Microbiol Family Med & Internal Med, Chungju, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Konkuk University; Konkuk University Medical Center	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Microbiol & Immunol,Liver Res Inst, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/AGY-4274-2022; Kim, Bum Joon/J-2739-2012	Kim, Bum Joon/0000-0003-0085-6709; Kim, Hong/0000-0003-1383-6803	National Research Foundation of Korea (NRF); Korea government (MEST, the Korean Ministry of Education, Science, and Technology) [2010-0014269]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST, the Korean Ministry of Education, Science, and Technology)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST, the Korean Ministry of Education, Science, and Technology) (No. 2010-0014269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Bavil-Olyaee S, 2010, J VIROL, V84, P1026, DOI 10.1128/JVI.01796-09; Banerjee A, 2007, J CLIN VIROL, V40, P312, DOI 10.1016/j.jcv.2007.08.009; Brechot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016; BRECHOT C, 1981, P NATL ACAD SCI-BIOL, V78, P3906, DOI 10.1073/pnas.78.6.3906; Bruss V, 2002, HEPATOLOGY, V36, P1327, DOI 10.1053/jhep.2002.37351; Chaudhuri V, 2004, GASTROENTEROLOGY, V127, P1356, DOI 10.1053/j.gastro.2004.08.003; Chemin I, 2001, J HEPATOL, V34, P447, DOI 10.1016/S0168-8278(00)00100-8; Conjeevaram H, 2001, HEPATOLOGY, V34, P204, DOI 10.1053/jhep.2001.25225; Cooreman MP, 2001, J BIOMED SCI, V8, P237, DOI 10.1007/BF02256597; De Maria N, 2000, AM J GASTROENTEROL, V95, P3529, DOI 10.1111/j.1572-0241.2000.03371.x; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Hunt CM, 2000, HEPATOLOGY, V31, P1037, DOI 10.1053/he.2000.6709; Jeantet D, 2002, HEPATOLOGY, V35, P1215, DOI 10.1053/jhep.2002.32710; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim H, 2007, INTERVIROLOGY, V50, P52, DOI 10.1159/000096313; Kim HJ, 2008, J MED VIROL, V80, P1337, DOI 10.1002/jmv.21219; Koike K, 1998, J MED VIROL, V54, P249, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;249::AID-JMV3&gt;3.0.CO;2-4; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lee DH, 2002, J KOREAN MED SCI, V17, P457, DOI 10.3346/jkms.2002.17.4.457; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; LIANG TJ, 1991, HEPATOLOGY, V13, P1044, DOI 10.1002/hep.1840130607; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Mu SC, 2009, J HEPATOL, V50, P264, DOI 10.1016/j.jhep.2008.09.017; Mun HS, 2008, J MED VIROL, V80, P1189, DOI 10.1002/jmv.21208; Mun HS, 2011, J VIROL, V85, P123, DOI 10.1128/JVI.01524-10; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; Park NH, 2010, INTERVIROLOGY, V53, P20, DOI 10.1159/000252780; Pollicino T, 2007, HEPATOLOGY, V45, P277, DOI 10.1002/hep.21529; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Sagnelli E, 2001, J MED VIROL, V64, P350, DOI 10.1002/jmv.1057; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHAFRITZ DA, 1981, NEW ENGL J MED, V305, P1067, DOI 10.1056/NEJM198110293051807; Song BC, 2005, J MED VIROL, V76, P194, DOI 10.1002/jmv.20354; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Yao JDC, 2003, HEPATOLOGY, V38, p718A; ZHANG YY, 1993, HEPATOLOGY, V17, P538, DOI 10.1002/hep.1840170403	41	96	106	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54486	10.1371/journal.pone.0054486	http://dx.doi.org/10.1371/journal.pone.0054486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349904	Green Submitted, gold, Green Published			2022-12-27	WOS:000313872800057
J	Miyagawa, T; Kawamura, H; Obuchi, M; Ikesaki, A; Ozaki, A; Tokunaga, K; Inoue, Y; Honda, M				Miyagawa, Taku; Kawamura, Hiromi; Obuchi, Mariko; Ikesaki, Asuka; Ozaki, Akiko; Tokunaga, Katsushi; Inoue, Yuichi; Honda, Makoto			Effects of Oral L-Carnitine Administration in Narcolepsy Patients: A Randomized, Double-Blind, Cross-Over and Placebo-Controlled Trial	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; EPWORTH SLEEPINESS SCALE; ACETYL-L-CARNITINE; LATENCY TEST MSLT; BODY-MASS INDEX; SERUM ACYLCARNITINE; OREXIN NEURONS; DEFICIENCY; MICE; FREQUENCY	Narcolepsy is a sleep disorder characterized by excessive daytime sleepiness, cataplexy, and rapid eye movement (REM) sleep abnormalities. A genome-wide association study (GWAS) identified a novel narcolepsy-related single nucleotide polymorphism (SNP), which is located adjacent to the carnitine palmitoyltransferase 1B (CPT1B) gene encoding an enzyme involved in beta-oxidation of long-chain fatty acids. The mRNA expression levels of CPT1B were associated with this SNP. In addition, we recently reported that acylcarnitine levels were abnormally low in narcolepsy patients. To assess the efficacy of oral L-carnitine for the treatment of narcolepsy, we performed a clinical trial administering L-carnitine (510 mg/day) to patients with the disease. The study design was a randomized, double-blind, cross-over and placebo-controlled trial. Thirty narcolepsy patients were enrolled in our study. Two patients were withdrawn and 28 patients were included in the statistical analysis (15 males and 13 females, all with HLA-DQB1*06:02). L-carnitine treatment significantly improved the total time for dozing off during the daytime, calculated from the sleep logs, compared with that of placebo-treated periods. L-carnitine efficiently increased serum acylcarnitine levels, and reduced serum triglycerides concentration. Differences in the Japanese version of the Epworth Sleepiness Scale (ESS) and the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) vitality and mental health subscales did not reach statistical significance between L-carnitine and placebo. This study suggests that oral L-carnitine can be effective in reducing excessive daytime sleepiness in narcolepsy patients.	[Miyagawa, Taku; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Kawamura, Hiromi; Obuchi, Mariko; Ikesaki, Asuka] Site Support Inst Co Ltd SSI, Clin Trial Operat Div, Tokyo, Japan; [Ozaki, Akiko] Toho Univ, Fac Nursing, Sch Nursing, Tokyo, Japan; [Inoue, Yuichi; Honda, Makoto] Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan; [Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan; [Honda, Makoto] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Sleep Disorders Project, Tokyo 113, Japan	University of Tokyo; Toho University; Tokyo Medical University; Tokyo Metropolitan Institute of Medical Science	Honda, M (corresponding author), Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan.	honda-mk@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23689022, 22133008]; Takeda Science Foundation; SENSHIN Medical Research Foundation; Kowa Life Science Foundation; Grants-in-Aid for Scientific Research [23689022, 22133008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Kowa Life Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Young Scientists (A) (23689022) and Scientific Research on Innovative Areas (22133008) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Grants-in-Aid from "Takeda Science Foundation", "SENSHIN Medical Research Foundation" and "Kowa Life Science Foundation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dahmen N, 2001, EUR ARCH PSY CLIN N, V251, P85, DOI 10.1007/s004060170057; Dauvilliers Y, 2011, SLEEP MED, V12, P572, DOI 10.1016/j.sleep.2011.01.010; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fortuyn HAD, 2012, J SLEEP RES, V21, P163, DOI 10.1111/j.1365-2869.2011.00943.x; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; HONDA Y, 1986, SLEEP, V9, P254, DOI 10.1093/sleep/9.1.254; Hutton B, 2004, AM J CLIN NUTR, V80, P1461, DOI 10.1093/ajcn/80.6.1461; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Kido Y, 2001, J NEUROCHEM, V79, P959, DOI 10.1046/j.1471-4159.2001.00621.x; Kok SW, 2003, OBES RES, V11, P1147, DOI 10.1038/oby.2003.156; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Kuratsune H, 1998, INT J MOL MED, V2, P51; KURATSUNE H, 1994, CLIN INFECT DIS, V18, pS62, DOI 10.1093/clinids/18.Supplement_1.S62; Kuwajima M, 2007, ENDOCR J; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Miyagawa T, 2011, SLEEP, V34, P349, DOI 10.1093/sleep/34.3.349; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; PLIOPLYS AV, 1995, NEUROPSYCHOBIOLOGY, V32, P132, DOI 10.1159/000119226; Plioplys AV, 1997, NEUROPSYCHOBIOLOGY, V35, P16, DOI 10.1159/000119325; Poli F, 2009, SLEEP, V32, P1491, DOI 10.1093/sleep/32.11.1491; Rao KVR, 1997, CAN J PHYSIOL PHARM, V75, P423, DOI 10.1139/cjpp-75-5-423; Schneider C, 2004, J SLEEP RES, V13, P373, DOI 10.1111/j.1365-2869.2004.00427.x; Schuld A, 2000, LANCET, V355, P1274, DOI 10.1016/S0140-6736(05)74704-8; Schuld Andreas, 2002, Sleep Med, V3, P335, DOI 10.1016/S1389-9457(02)00012-6; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Takegami M, 2009, SLEEP MED, V10, P556, DOI 10.1016/j.sleep.2008.04.015; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Yoshida G, 2006, NEUROSCI RES, V55, P78, DOI 10.1016/j.neures.2006.02.003	42	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53707	10.1371/journal.pone.0053707	http://dx.doi.org/10.1371/journal.pone.0053707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349733	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900016
J	Newton, HJ; McDonough, JA; Roy, CR				Newton, Hayley J.; McDonough, Justin A.; Roy, Craig R.			Effector Protein Translocation by the Coxiella burnetii Dot/Icm Type IV Secretion System Requires Endocytic Maturation of the Pathogen-Occupied Vacuole	PLOS ONE			English	Article							LARGE-SCALE IDENTIFICATION; LEGIONELLA-PNEUMOPHILA; HOST-CELL; PARASITOPHOROUS VACUOLE; MACROPHAGES; INFECTION; APOPTOSIS; PATHWAYS; FAMILY; GROWTH	The human pathogen Coxiella burnetii encodes a type IV secretion system called Dot/Icm that is essential for intracellular replication. The Dot/Icm system delivers bacterial effector proteins into the host cytosol during infection. The effector proteins delivered by C. burnetii are predicted to have important functions during infection, but when these proteins are needed during infection has not been clearly defined. Here, we use a reporter system consisting of fusion proteins that have a beta-lactamase enzyme (BlaM) fused to C. burnetii effector proteins to study protein translocation by the Dot/Icm system. Translocation of BlaM fused to the effector proteins CBU0077, CBU1823 and CBU1524 was not detected until 8-hours after infection of HeLa cells, which are permissive for C. burnetii replication. Translocation of these effector fusion proteins by the Dot/Icm system required acidification of the Coxiella-containing vacuole. Silencing of the host genes encoding the membrane transport regulators Rab5 or Rab7 interfered with effector translocation, which indicates that effectors are not translocated until bacteria traffic to a late endocytic compartment in the host cell. Similar requirements for effector translocation were discerned in bone marrow macrophages derived from C57BL/6 mice, which are primary cells that restrict the intracellular replication of C. burnetii. In addition to requiring endocytic maturation of the vacuole for Dot/Icm-mediated translocation of effectors, bacterial transcription was required for this process. Thus, translocation of effector proteins by the C. burnetii Dot/Icm system occurs after acidification of the CCV and maturation of this specialized organelle to a late endocytic compartment. This indicates that creation of the specialized vacuole in which C. burnetii replicates represents a two-stage process mediated initially by host factors that regulate endocytic maturation and then by bacterial effectors delivered into host cells after bacteria establish residency in a lysosome-derived organelle.	[Newton, Hayley J.; McDonough, Justin A.; Roy, Craig R.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Newton, HJ (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	hayley.newton@yale.edu		Roy, Craig/0000-0003-4490-440X; Newton, Hayley/0000-0002-9240-2001	Australian National Health and Medical Research Council Overseas Training Fellowship; Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship [F32-AI0829272]; National Institutes of Health (NIH) [R01-AI064559]; Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI064559] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council Overseas Training Fellowship; Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an Australian National Health and Medical Research Council Overseas Training Fellowship to HJN, a Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship (F32-AI0829272) to JAM and by National Institutes of Health (NIH) grants (R01-AI064559 and Northeast Biodefense Center U54-AI057158-Lipkin) to CRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Beare PA, 2012, ADV EXP MED BIOL, V984, P249, DOI 10.1007/978-94-007-4315-1_13; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Beare PA, 2009, J BACTERIOL, V191, P1369, DOI 10.1128/JB.01580-08; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Charpentier X, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000501; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Delsing CE, 2011, ADV EXP MED BIOL, V719, P133, DOI 10.1007/978-1-4614-0204-6_12; HACKSTADT T, 1981, P NATL ACAD SCI-BIOL, V78, P3240, DOI 10.1073/pnas.78.5.3240; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; Howe D, 2000, INFECT IMMUN, V68, P3815, DOI 10.1128/IAI.68.7.3815-3821.2000; Howe D, 2003, ANN NY ACAD SCI, V990, P556, DOI 10.1111/j.1749-6632.2003.tb07426.x; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Luhrmann A, 2007, INFECT IMMUN, V75, P5282, DOI 10.1128/IAI.00863-07; MARRA A, 1992, P NATL ACAD SCI USA, V89, P9607, DOI 10.1073/pnas.89.20.9607; Morgan JK, 2010, FEMS MICROBIOL LETT, V311, P61, DOI 10.1111/j.1574-6968.2010.02072.x; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nakano N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001129; Newton HJ, 2011, MBIO, V2, DOI 10.1128/mBio.00226-11; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Ornsland A, 2008, J BACTERIOL, V190, P3203, DOI 10.1128/JB.01911-07; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Rodman JS, 2000, J CELL SCI, V113, P183; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Segal G, 1999, MOL MICROBIOL, V33, P669, DOI 10.1046/j.1365-2958.1999.01512.x; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Voth DE, 2007, INFECT IMMUN, V75, P4263, DOI 10.1128/IAI.00594-07; Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08; Zamboni DS, 2004, INFECT IMMUN, V72, P2395, DOI 10.1128/IAI.72.4.2395-2399.2004; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638; Zusman T, 2003, INFECT IMMUN, V71, P3714, DOI 10.1128/IAI.71.7.3714-3723.2003	42	84	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54566	10.1371/journal.pone.0054566	http://dx.doi.org/10.1371/journal.pone.0054566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349930	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900079
J	Pal, M; Wunderlich, CM; Spohn, G; Bronneke, HS; Schmidt-Supprian, M; Wunderlich, FT				Pal, Martin; Wunderlich, Claudia M.; Spohn, Gabriele; Broenneke, Hella S.; Schmidt-Supprian, Marc; Wunderlich, F. Thomas			Alteration of JNK-1 Signaling in Skeletal Muscle Fails to Affect Glucose Homeostasis and Obesity-Associated Insulin Resistance in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASES; JUN NH2-TERMINAL KINASE; NF-KAPPA-B; METABOLIC SYNDROME; IKK-BETA; RECEPTOR; PHOSPHORYLATION; INHIBITION; STRESS	Obesity and associated metabolic disturbances, such as increased circulating fatty acids cause prolonged low grade activation of inflammatory signaling pathways in liver, skeletal muscle, adipose tissue and even in the CNS. Activation of inflammatory pathways in turn impairs insulin signaling, ultimately leading to obesity-associated type 2 diabetes mellitus. Conventional JNK-1 knock out mice are protected from high fat diet-induced insulin resistance, characterizing JNK-1-inhibition as a potential approach to improve glucose metabolism in obese patients. However, the cell type-specific role of elevated JNK-1 signaling as present during the course of obesity has not been fully elucidated yet. To investigate the functional contribution of altered JNK-1 activation in skeletal muscle, we have generated a ROSA26 insertion mouse strain allowing for Cre-activatable expression of a JNK-1 constitutive active construct (JNK(C)). To examine the consequence of skeletal muscle-restricted JNK-1 overactivation in the development of insulin resistance and glucose metabolism, JNK(C) mice were crossed to Mck-Cre mice yielding JNK(SM-C) mice. However, despite increased muscle-specific JNK activation, energy homeostasis and glucose metabolism in JNK(SM-C) mice remained largely unaltered compared to controls. In line with these findings, obese mice with skeletal muscle specific disruption of JNK-1, did not affect energy and glucose homeostasis. These experiments indicate that JNK-1 activation in skeletal muscle does not account for the major effects on diet-induced, JNK-1-mediated deterioration of insulin action and points towards a so far underappreciated role of JNK-1 in other tissues than skeletal muscle during the development of obesity-associated insulin resistance.	[Pal, Martin; Wunderlich, Claudia M.; Spohn, Gabriele; Wunderlich, F. Thomas] Univ Cologne, Inst Genet, Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Pal, Martin; Wunderlich, Claudia M.; Spohn, Gabriele; Wunderlich, F. Thomas] CMMC, Cologne, Germany; [Broenneke, Hella S.] Cologne Excellence Cluster Cellular Stress Respon, Mouse Phenotyping Core Facil, Cologne, Germany; [Schmidt-Supprian, Marc] Max Planck Inst Biochem, Munich, Germany	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; Max Planck Society	Wunderlich, FT (corresponding author), Univ Cologne, Inst Genet, Max Planck Inst Neurol Res, D-50931 Cologne, Germany.	Thomas.wunderlich@uni-koeln.de	Schmidt-Supprian, Marc/F-5893-2011; Pal, Martin/AAL-8685-2020	Schmidt-Supprian, Marc/0000-0002-8543-6166; Pal, Martin/0000-0002-1563-5426	DFG [SFB 832 A15, Z3, BR 1492/7-1]; Center for Molecular Medicine Cologne (CMMC) [D1, B2]; Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD); European Union [FP7-HEALTH-2009-241592]; Competence Network for Adipositas (Neurotarget); Federal Ministry of Education and Research [FKZ01GIO845]	DFG(German Research Foundation (DFG)); Center for Molecular Medicine Cologne (CMMC); Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD); European Union(European Commission); Competence Network for Adipositas (Neurotarget); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the DFG through SFB 832 A15 to FTW and Z3 to JCB, the Center for Molecular Medicine Cologne (CMMC) (D1 to JCB, B2 to FTW), the Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), the European Union (FP7-HEALTH-2009-241592, EurOCHIP, to JCB), the DFG (BR 1492/7-1 to JCB), and the Competence Network for Adipositas (Neurotarget) funded by the Federal Ministry of Education and Research (FKZ01GIO845 to JCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Belgardt BF, P NATL ACAD SCI US, V107, P6028; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kyriakis JM, 1995, ANN NY ACAD SCI, V766, P303, DOI 10.1111/j.1749-6632.1995.tb26683.x; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Rohl M, 2004, J CLIN INVEST, V113, P474, DOI 10.1172/JCI200418712; Sabio G, MOL CELL BIOL, V30, P106; Sabio G, GENES DEV, V24, P256; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; Whitham M, J BIOL CHEM; Whitmarsh AJ, 2001, METHOD ENZYMOL, V332, P319; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	38	29	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54247	10.1371/journal.pone.0054247	http://dx.doi.org/10.1371/journal.pone.0054247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349837	gold, Green Published			2022-12-27	WOS:000313738900057
J	Alvarado-Esquivel, C				Alvarado-Esquivel, Cosme			Toxocariasis in Waste Pickers: A Case Control Seroprevalence Study	PLOS ONE			English	Article							ZOONOTIC INFECTIONS; TOXOPLASMA-GONDII; RISK-FACTORS; SEROEPIDEMIOLOGY; EPIDEMIOLOGY; COMMUNITIES; CITY	Background: The epidemiology of Toxocara infection in humans in Mexico has been poorly explored. There is a lack of information about Toxocara infection in waste pickers. Aims: Determine the seroepidemiology of Toxocara infection in waste pickers. Methods: Through a case control study design, the presence of anti-Toxocara IgG antibodies was determined in 90 waste pickers and 90 age-and gender-matched controls using an enzyme-linked immunoassay. Associations of Toxocara exposure with socio-demographic, work, clinical, and behavioral data of the waste pickers were also evaluated. Results: The seroprevalence of anti-Toxocara IgG antibodies was significantly higher in waste pickers (12/90: 13%) than in control subjects (1/90: 1%) (OR = 14; 95% CI: 2-288). The seroprevalence was not influenced by socio-demographic or work characteristics. In contrast, increased seroprevalence was found in waste pickers suffering from gastritis, and reflex and visual impairments. Multivariate analysis showed that Toxocara exposure was associated with a low frequency of eating out of home (OR = 26; 95% CI: 2-363) and negatively associated with consumption of chicken meat (OR = 0.03; 95% CI: 0.003-0.59). Other behavioral characteristics such as animal contacts or exposure to soil were not associated with Toxocara seropositivity. Conclusions: 1) Waste pickers are a risk group for Toxocara infection. 2) Toxocara is impacting the health of waste pickers. This is the first report of Toxocara exposure in waste pickers and of associations of gastritis and reflex impairment with Toxocara seropositivity. Results warrant for further research.	Juarez Univ Durango State, Fac Med & Nutr, Dept Infectol, Durango, Mexico	Universidad Juarez del Estado de Durango	Alvarado-Esquivel, C (corresponding author), Juarez Univ Durango State, Fac Med & Nutr, Dept Infectol, Durango, Mexico.	alvaradocosme@yahoo.com			Universidad Juarez del Estado de Durango	Universidad Juarez del Estado de Durango	The study was financially supported by the Universidad Juarez del Estado de Durango. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi OO, 2000, MEM I OSWALDO CRUZ, V95, P147, DOI 10.1590/S0074-02762000000200002; Alvarado-Esquivel C, 2008, ZOONOSES PUBLIC HLTH, V55, P306, DOI 10.1111/j.1863-2378.2008.01133.x; Alvarado-Esquivel C, 2011, J PARASITOL, V97, P40, DOI 10.1645/GE-2612.1; Cancrini G., 1998, Parassitologia (Rome), V40, P473; Chiodo P, 2006, MEM I OSWALDO CRUZ, V101, P397, DOI 10.1590/S0074-02762006000400009; Demirci M, 2010, IRAN J PARASITOL, V5, P52; Despommier D, 2003, CLIN MICROBIOL REV, V16, P265, DOI 10.1128/CMR.16.2.265-272.2003; El-Shazly Atef M., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P731; Espinoza YA, 2010, REV INST MED TROP SP, V52, P31, DOI 10.1590/S0036-46652010000100005; Fillaux J, 2007, AM J TROP MED HYG, V76, P1144, DOI 10.4269/ajtmh.2007.76.1144; Finsterer Josef, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P279, DOI 10.1590/S0036-46652007000500002; Guillot J, 2007, B ACAD NAT MED PARIS, V191, P67, DOI 10.1016/S0001-4079(19)33116-4; Jimenez JF, 1997, AM J TROP MED HYG, V56, P113, DOI 10.4269/ajtmh.1997.56.113; Magnaval Jean-Francois, 2001, Korean Journal of Parasitology, V39, P1, DOI 10.3347/kjp.2001.39.1.1; Malla N, 2002, NATL MED J INDIA, V15, P145; Messier V, 2012, ZOONOSES PUBLIC HLTH, V59, P107, DOI 10.1111/j.1863-2378.2011.01424.x; Overgaauw PAM, 1997, CRIT REV MICROBIOL, V23, P215, DOI 10.3109/10408419709115137; Park Hyun-Young, 2002, Korean Journal of Parasitology, V40, P113, DOI 10.3347/kjp.2002.40.3.113; Pelloux H, 2004, REV MED INTERNE, V25, P201, DOI 10.1016/S0248-8663(03)00258-3; Prestes-Carneiro LE, 2009, PARASITOLOGY, V136, P681, DOI 10.1017/S0031182009005769; Radman NE, 2000, MEM I OSWALDO CRUZ, V95, P281, DOI 10.1590/S0074-02762000000300001; Rai Shiba Kumar, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P286; Roldan WH, 2010, REV INST MED TROP SP, V52, P37, DOI 10.1590/S0036-46652010000100006; Rubinsky-Elefant G, 2010, ANN TROP MED PARASIT, V104, P3, DOI 10.1179/136485910X12607012373957; Rubinsky-Elefant G, 2008, AM J TROP MED HYG, V79, P93, DOI 10.4269/ajtmh.2008.79.93; Sampasa-Kanyinga H, 2012, VECTOR-BORNE ZOONOT, V12, P473, DOI 10.1089/vbz.2011.0739; Sariego I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001382; Smith H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/j.pt.2009.01.006; Stensvold CR, 2009, CLIN VACCINE IMMUNOL, V16, P1372, DOI 10.1128/CVI.00234-09; Won KY, 2008, AM J TROP MED HYG, V79, P552, DOI 10.4269/ajtmh.2008.79.552; Woodhall D, 2012, OPHTHALMOLO IN PRESS	31	15	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54897	10.1371/journal.pone.0054897	http://dx.doi.org/10.1371/journal.pone.0054897			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349987	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100109
J	Cade, F; Cruzat, A; Paschalis, EI; Santo, LE; Pineda, R				Cade, Fabiano; Cruzat, Andrea; Paschalis, Eleftherios I.; Santo, Lilian Espirito; Pineda, Roberto			Analysis of Four Aberrometers for Evaluating Lower and Higher Order Aberrations	PLOS ONE			English	Article							FOURIER-TRANSFORMS; WAVE-ABERRATION; PUPIL LOCATION; ZERNIKE; EYE; PRINCIPLES; LADARWAVE; HISTORY; QUALITY; ERRORS	Purpose: To compare the measurements of lower and higher order aberrations (HOA) of 4 commonly used aberrometers. Setting: Massachusetts Eye & Ear Infirmary, Boston, USA. Design: Prospective, cross-sectional study, in a controlled, single-blinded fashion. Methods: Multiple readings were obtained in 42 eyes of 21 healthy volunteers, at a single visit, with each of the following aberrometers: Alcon LADARWave (R), Visx WaveScan (R), B & L Zywave (R), and Wavelight Allegro Analyzer (R). Results were compared and analyzed in regards to the lower and HOA, to the different wavefront sensing devices and software, Tscherning and Hartmann-Shack and between the Fourier and Zernike algorithms. Statistical analysis included Bland-Altman plots, Intraclass Correlation Coefficient (ICC), multiple comparison tests with Analysis of Variance and Kruskal-Wallis. Significant level was set to p<0.05 and alpha level correction was adjusted under the Bonferroni criteria. Results: Most measurements of all 4 aberrometers were comparable. However, statistically significant differences were found between the aberrometers in total HOA (tHOA), spherical aberration (SA), horizontal coma and astigmatism (2,2). LADARwave and Wavescan showed significant differences in tHOA (P<0.001, ICC = 0.549, LoA = 0.19 +/- 0.5) and in SA (P<0.001, ICC = 0.733, LoA = 0.16 +/- 0.37). Wavescan showed a significant difference compared to Zywave (p<0.001, ICC = 0.920, LoA = 0.09 +/- 0.13) in SA. Comparisons between Allegro Analyzer and Zywave demonstrated significant differences in both Horizontal Coma (3,1) (p < 0.001, ICC = 20.207, LoA = -0.15 +/- 0.48) and Astigmatism (2,2) (P = 0.003, ICC = -0.965, LoA = 0.2 +/- 2.5). Allegro Analyzer also differed from Wavescan in Horizontal Coma (3,1) (P < 0.001, ICC = 0.725, LoA = -0.07 +/- 0.25). Conclusions: Although some measurements were comparable predominately in the lower order aberrations, significant differences were found in the tHOA, SA, horizontal coma and astigmatism. Our analysis suggests that sensor design contributes to agreement in lower order aberrations, and Fourier and Zernike expansion might disagree in higher order aberrations. Therefore, comparison between aberrometers was generally possible with some exceptions in higher order measurements.	[Cade, Fabiano; Cruzat, Andrea; Paschalis, Eleftherios I.; Santo, Lilian Espirito; Pineda, Roberto] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Paschalis, EI (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02115 USA.	Eleftherios_paschalis@meei.harvard.edu	Paschalis, Eleftherios/AAO-4613-2020	Cruzat, Andrea/0000-0002-3724-7037; Paschalis, Eleftherios/0000-0002-4544-4452	Alcon	Alcon(Novartis)	Financial support: R.P. (Alcon), unrestricted grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio JL, 2006, OPHTHALMOLOGY, V113, P191, DOI 10.1016/j.ophtha.2005.10.004; Awwad ST, 2006, J CATARACT REFR SURG, V32, P203, DOI 10.1016/j.jcrs.2005.08.058; Buhren J, 2009, J REFRACT SURG, V25, P559, DOI 10.3928/1081597X-20090610-01; Burakgazi AZ, 2006, J REFRACT SURG, V22, P898, DOI 10.3928/1081-597X-20061101-10; Burns SA, 2000, J REFRACT SURG, V16, pS566, DOI 10.3928/1081-597X-20000901-15; Carkeet A, 2003, INVEST OPHTH VIS SCI, V44, P3248, DOI 10.1167/iovs.02-1064; Cervino A, 2007, J REFRACT SURG, V23, P603, DOI 10.3928/1081-597X-20070601-12; Dai GM, 2006, J REFRACT SURG, V22, P943, DOI 10.3928/1081-597X-20061101-21; Dobos MJ, 2009, CLIN EXP OPTOM, V92, P238, DOI 10.1111/j.1444-0938.2009.00360.x; HOWLAND B, 1976, SCIENCE, V193, P580, DOI 10.1126/science.959814; Howland HC, 2000, J REFRACT SURG, V16, pS552; Klyce SD, 2004, J REFRACT SURG, V20, pS537; Knapp S, 2009, J REFRACT SURG, V25, P201, DOI 10.3928/1081597X-20090201-05; LAWRENCE GN, 1984, OPT LETT, V9, P267, DOI 10.1364/OL.9.000267; Liang CL, 2005, J CATARACT REFR SURG, V31, P2153, DOI 10.1016/j.jcrs.2005.04.040; Lombardo M, 2010, J CATARACT REFR SURG, V36, P313, DOI 10.1016/j.jcrs.2009.09.026; MacRae SM, 2001, AM J OPHTHALMOL, V132, P915, DOI 10.1016/S0002-9394(01)01319-8; Maeda N, 2009, CLIN EXP OPHTHALMOL, V37, P118, DOI 10.1111/j.1442-9071.2009.02005.x; Molebny VV, 2000, J REFRACT SURG, V16, pS572; Mrochen M, 2000, J REFRACT SURG, V16, pS570; Pepose JS, 2005, AM J OPHTHALMOL, V139, P335, DOI 10.1016/j.ajo.2004.11.010; Platt BC, 2001, J REFRACT SURG, V17, pS573; RODDIER F, 1991, APPL OPTICS, V30, P1325, DOI 10.1364/AO.30.001325; Rozema JJ, 2006, J CATARACT REFR SURG, V32, P33, DOI 10.1016/j.jcrs.2004.11.052; Rozema JJ, 2005, J CATARACT REFR SURG, V31, P1114, DOI 10.1016/j.jcrs.2004.11.051; Salmon TO, 2006, J CATARACT REFR SURG, V32, P2064, DOI 10.1016/j.jcrs.2006.07.022; Tabernero J, 2009, INVEST OPHTH VIS SCI, V50, P1964, DOI 10.1167/iovs.08-2111; Visser N, 2011, INVEST OPHTH VIS SCI, V52, P1302, DOI 10.1167/iovs.10-5841; WALSH G, 1984, J OPT SOC AM A, V1, P987, DOI 10.1364/JOSAA.1.000987; Yang YB, 2002, INVEST OPHTH VIS SCI, V43, P2508; Yoon G, 2008, J REFRACT SURG, V24, P582, DOI 10.3928/1081597X-20080601-06	31	21	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54990	10.1371/journal.pone.0054990	http://dx.doi.org/10.1371/journal.pone.0054990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349995	Green Submitted, gold, Green Published			2022-12-27	WOS:000314019100116
J	Johnson, S; Marro, J; Torres, JJ				Johnson, Samuel; Marro, J.; Torres, Joaquin J.			Robust Short-Term Memory without Synaptic Learning	PLOS ONE			English	Article							PERSISTENT ACTIVITY; WORKING-MEMORY; MODEL; INFORMATION; PLASTICITY; NETWORK; NEURONS; CURVES	Short-term memory in the brain cannot in general be explained the way long-term memory can - as a gradual modification of synaptic weights - since it takes place too quickly. Theories based on some form of cellular bistability, however, do not seem able to account for the fact that noisy neurons can collectively store information in a robust manner. We show how a sufficiently clustered network of simple model neurons can be instantly induced into metastable states capable of retaining information for a short time (a few seconds). The mechanism is robust to different network topologies and kinds of neural model. This could constitute a viable means available to the brain for sensory and/or short-term memory with no need of synaptic learning. Relevant phenomena described by neurobiology and psychology, such as local synchronization of synaptic inputs and power-law statistics of forgetting avalanches, emerge naturally from this mechanism, and we suggest possible experiments to test its viability in more biological settings.	[Johnson, Samuel] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Johnson, Samuel] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford, England; [Johnson, Samuel] Univ Oxford, Dept Phys, Oxford, England; [Marro, J.; Torres, Joaquin J.] Univ Granada, Dept Electromagnetismo & Fis Materia, Granada, Spain; [Marro, J.; Torres, Joaquin J.] Univ Granada, Inst Carlos Theoret & Computat Phys 1, Granada, Spain	Imperial College London; University of Oxford; University of Oxford; University of Granada; University of Granada	Johnson, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England.	samuel.johnson@imperial.ac.uk	Torres, Joaquín J./AAE-6228-2019; Johnson, Samuel/P-6780-2014; Johnson, Samuel/A-5144-2013; Torres, Joaquín J./C-1385-2012	Johnson, Samuel/0000-0002-8648-1735; Johnson, Samuel/0000-0002-8648-1735; Torres, Joaquín J./0000-0001-6175-9676	Junta de Andalucia [FQM-01505, P09-FQM4682]; joint Spanish Research Ministry (MEC); European Budget for the Regional Development (FEDER) [FIS2009-08451]; Granada Research of Excellence Initiative on Bio-Health (GREIB) of the Spanish Science and Innovation Ministry (MICINN) "Campus of International Excellence" [GREIB.PT_2011_19]; Oxford Centre for Integrative Systems Biology; European Commission under the Marie Curie Intra-European Fellowship [PIEF-GA-2010-276454]	Junta de Andalucia(Junta de Andalucia); joint Spanish Research Ministry (MEC); European Budget for the Regional Development (FEDER); Granada Research of Excellence Initiative on Bio-Health (GREIB) of the Spanish Science and Innovation Ministry (MICINN) "Campus of International Excellence"; Oxford Centre for Integrative Systems Biology; European Commission under the Marie Curie Intra-European Fellowship	This work was supported by Junta de Andalucia projects FQM-01505 and P09-FQM4682, by the joint Spanish Research Ministry (MEC) and the European Budget for the Regional Development (FEDER) project FIS2009-08451, and by the Granada Research of Excellence Initiative on Bio-Health (GREIB) traslational project GREIB.PT_2011_19 of the Spanish Science and Innovation Ministry (MICINN) "Campus of International Excellence." S.J. is grateful for financial support from the Oxford Centre for Integrative Systems Biology, and from the European Commission under the Marie Curie Intra-European Fellowship Programme PIEF-GA-2010-276454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit D. J., 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley Alan D., 1999, ESSENTIALS HUMAN MEM; Barak O, 2007, PLOS COMPUT BIOL, V3, P323, DOI 10.1371/journal.pcbi.0030035; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Chialvo DR, 2000, PHYS REV E, V61, P5654, DOI 10.1103/PhysRevE.61.5654; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; CONRAD R, 1964, BRIT J PSYCHOL, V55, P429, DOI 10.1111/j.2044-8295.1964.tb00928.x; CONRAD R, 1964, BRIT J PSYCHOL, V55, P75, DOI 10.1111/j.2044-8295.1964.tb00899.x; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Fraiman D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061922; Gnedenko B. V., 1954, LIMIT DISTRIBUTIONS; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hurtado PI, 2008, J STAT PHYS, V133, P29, DOI 10.1007/s10955-008-9602-3; Johnson S, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46006; Johnson S, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/03/P03003; Kleindienst T, 2011, NEURON, V72, P1012, DOI 10.1016/j.neuron.2011.10.015; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; Kohl MM, 2011, NAT NEUROSCI, V14, P1413, DOI 10.1038/nn.2915; LEE KS, 1980, J NEUROPHYSIOL, V44, P247, DOI 10.1152/jn.1980.44.2.247; Levine RD, 2005, MOL REACTION DYNAMIC, DOI 10.1017/CBO9780511614125; Lewis TJ, 2000, NETWORK-COMP NEURAL, V11, P299, DOI 10.1088/0954-898X/11/4/304; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Munoz MA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128701; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Roudi Y, 2007, PLOS COMPUT BIOL, V3, P1679, DOI 10.1371/journal.pcbi.0030141; Rozenfeld AF, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.218701; Shein-Idelson Mark, 2011, Front Neuroeng, V4, P10, DOI 10.3389/fneng.2011.00010; Sikstrom S, 2002, COGNITIVE PSYCHOL, V45, P95, DOI 10.1016/S0010-0285(02)00012-9; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Tarnow E, 2009, COGN NEURODYNAMICS, V3, P263, DOI 10.1007/s11571-009-9085-1; Teramae JN, 2005, J COMPUT NEUROSCI, V18, P105, DOI 10.1007/s10827-005-5474-6; Torres JJ, 2011, HDB NATURAL COMPUTIN; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; van Aerde KI, 2009, J PHYSIOL-LONDON, V587, P5177, DOI 10.1113/jphysiol.2009.178384; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x	48	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e50276	10.1371/journal.pone.0050276	http://dx.doi.org/10.1371/journal.pone.0050276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349664	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100006
J	Ravva, SV; Sarreal, CZ; Mandrell, RE				Ravva, Subbarao V.; Sarreal, Chester Z.; Mandrell, Robert E.			Altered Protozoan and Bacterial Communities and Survival of Escherichia coli O157:H7 in Monensin-Treated Wastewater from a Dairy Lagoon	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; MYCOBACTERIUM-AVIUM; O157-H7 SURVIVAL; RUMEN; GROWTH; POPULATIONS; MILK; COWS; PARATUBERCULOSIS; DEGRADATION	Surviving predation is a fitness trait of Escherichia coli O157:H7 (EcO157) that provides ample time for the pathogen to be transported from reservoirs (e.g. dairies and feedlots) to farm produce grown in proximity. Ionophore dietary supplements that inhibit rumen protozoa may provide such a selective advantage for EcO157 to proliferate in lagoons as the pathogen is released along with the undigested supplement as manure washings. This study evaluated the fate of an outbreak strain of EcO157, protozoan and bacterial communities in wastewater treated with monensin. Although total protozoa and native bacteria were unaffected by monensin, the time for 90% decrease in EcO157 increased from 0.8 to 5.1 days. 18S and 16S rRNA gene sequencing of wastewater samples revealed that monensin eliminated almost all colpodean and oligohymenophorean ciliates, probably facilitating the extended survival of EcO157. Total protozoan numbers remained high in treated wastewater as monensin enriched 94% of protozoan sequences undetected with untreated wastewater. Monensin stimulated 30-fold increases in Cyrtohymena citrina, a spirotrichean ciliate, and also biflagellate bicosoecids and cercozoans. Sequences of gram-negative Proteobacteria increased from 1% to 46% with monensin, but gram-positive Firmicutes decreased from 93% to 46%. It is noteworthy that EcO157 numbers increased significantly (P<0.01) in Sonneborn medium containing monensin, probably due to monensin-inhibited growth of Vorticella microstoma (P<0.05), a ciliate isolated from wastewater. We conclude that dietary monensin inhibits ciliate protozoa that feed on EcO157. Feed supplements or other methods that enrich these protozoa in cattle manure could be a novel strategy to control the environmental dissemination of EcO157 from dairies to produce production environments.	[Ravva, Subbarao V.; Sarreal, Chester Z.; Mandrell, Robert E.] ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA	United States Department of Agriculture (USDA)	Ravva, SV (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA.	subbarao.ravva@ars.usda.gov	Mandrell, Robert E/O-9814-2018		U.S. Department of Agriculture, Agricultural Research Service [5325-32000-005, 5325-42000-044]	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was funded by the U.S. Department of Agriculture, Agricultural Research Service under CRIS projects 5325-32000-005 and 5325-42000-044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; [Anonymous], 2010, THE JUDICIOUS USE OF; Artz RRE, 2002, FEMS MICROBIOL LETT, V216, P117, DOI 10.1016/S0378-1097(02)01002-9; Bach SJ, 2002, CAN VET J, V43, P718; Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1111/j.1574-6968.1999.tb13516.x; Caracciolo AB, 2010, FEMS MICROBIOL ECOL, V71, P127, DOI 10.1111/j.1574-6941.2009.00787.x; Brumbaugh GW, 2004, CAN J VET RES, V68, P175; Burow LC, 2005, LETT APPL MICROBIOL, V40, P117, DOI 10.1111/j.1472-765X.2004.01642.x; CHAPMAN PA, 1993, EPIDEMIOL INFECT, V111, P439, DOI 10.1017/S0950268800057162; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; DeWaal CS, 2009, OUTBREAK ALERT 2009; Dolliver HAS, 2008, J ENVIRON QUAL, V37, P1238, DOI 10.2134/jeq2007.0391; DONOHO AL, 1984, J ANIM SCI, V58, P1528, DOI 10.2527/jas1984.5861528x; Dorkov P, 2008, J INORG BIOCHEM, V102, P26, DOI 10.1016/j.jinorgbio.2007.06.033; Furtula V, 2010, POULTRY SCI, V89, P180, DOI 10.3382/ps.2009-00198; Gourabathini P, 2007, PHYTOPATHOLOGY, V97, pS141; Gourabathini P, 2008, APPL ENVIRON MICROB, V74, P2518, DOI 10.1128/AEM.02709-07; Grainger C, 2008, J DAIRY SCI, V91, P1159, DOI 10.3168/jds.2007-0319; Hernlem BJ, 2007, J ENVIRON MONITOR, V9, P1317, DOI 10.1039/b710512f; Herriott DE, 1998, J FOOD PROTECT, V61, P802, DOI 10.4315/0362-028X-61.7.802; Huws SA, 2008, FEMS MICROBIOL LETT, V282, P258, DOI 10.1111/j.1574-6968.2008.01123.x; Johnson EA, 2001, TOXICON, V39, P1703, DOI 10.1016/S0041-0101(01)00157-X; Karnati SKR, 2009, J DAIRY SCI, V92, P3861, DOI 10.3168/jds.2008-1437; KING CH, 1988, APPL ENVIRON MICROB, V54, P3023, DOI 10.1128/AEM.54.12.3023-3033.1988; Kisidayova S, 2009, FOLIA MICROBIOL, V54, P527, DOI 10.1007/s12223-009-0076-8; Kiss AK, 2009, EUR J PROTISTOL, V45, P121, DOI 10.1016/j.ejop.2008.08.002; Kohler B, 2000, MICROBIOL-UK, V146, P1085, DOI 10.1099/00221287-146-5-1085; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Mandrell R. E., 2009, MICROBIAL SAFETY FRE, P5; Martin-Cereceda M, 2001, MICROBIOL RES, V156, P225, DOI 10.1078/0944-5013-00105; McGarvey JA, 2004, APPL ENVIRON MICROB, V70, P4267, DOI 10.1128/AEM.70.7.4267-4275.2004; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; NEWBOLD CJ, 1993, J APPL BACTERIOL, V75, P129, DOI 10.1111/j.1365-2672.1993.tb02757.x; NEWBOLD CJ, 1988, APPL ENVIRON MICROB, V54, P544, DOI 10.1128/AEM.54.2.544-547.1988; Newsome AL, 1998, APPL ENVIRON MICROB, V64, P1688; PETZEL JP, 1985, APPL ENVIRON MICROB, V49, P925, DOI 10.1128/AEM.49.4.925-933.1985; PHILLIPS JD, 1986, J APPL BACTERIOL, V60, P491, DOI 10.1111/j.1365-2672.1986.tb01088.x; Priya M, 2008, BIODEGRADATION, V19, P179, DOI 10.1007/s10532-007-9124-8; Rasmussen MA, 2005, INFECT IMMUN, V73, P4668, DOI 10.1128/IAI.73.8.4668-4675.2005; Ravva SV, 2006, J APPL MICROBIOL, V101, P891, DOI 10.1111/j.1365-2672.2006.02956.x; Ravva SV, 2007, APPL ENVIRON MICROB, V73, P2191, DOI 10.1128/AEM.02213-06; Ravva SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017281; Ravva SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015671; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sassman SA, 2007, ENVIRON TOXICOL CHEM, V26, P1614, DOI 10.1897/07-073R.1; Shin EC, 2004, J APPL MICROBIOL, V97, P378, DOI 10.1111/j.1365-2672.2004.02304.x; Takahashi M, 2004, FEMS IMMUNOL MED MIC, V41, P219, DOI 10.1016/j.femsim.2004.03.010; USDA:APHIS:VS, 1994, ESCHERICHIA COLI O15, P88; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe N, 2008, J ENVIRON QUAL, V37, pS78, DOI 10.2134/jeq2007.0371; Weimer PJ, 2010, J DAIRY SCI, V93, P265, DOI 10.3168/jds.2009-2206; Weimer PJ, 2008, APPL MICROBIOL BIOT, V80, P135, DOI 10.1007/s00253-008-1528-9; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Wright ADG, 1997, J EUKARYOT MICROBIOL, V44, P61, DOI 10.1111/j.1550-7408.1997.tb05693.x; [No title captured]	61	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54782	10.1371/journal.pone.0054782	http://dx.doi.org/10.1371/journal.pone.0054782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349969	gold, Green Submitted, Green Published			2022-12-27	WOS:000314019100097
J	Yu, Y; Huang, YS; Zhang, LZ; Lin, ZB; Wang, GF				Yu, Yi; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu			Growth and Spectral Assessment of Yb3+-Doped KBaGd(MoO4)(3) Crystal: A Candidate for Ultrashort Pulse and Tunable Lasers	PLOS ONE			English	Article							GENERATION	In order to explore new more powerful ultrashort pulse laser and tunable laser for diode-pumping, this paper reports the growth and spectral assessment of Yb3+-doped KBaGd(MoO4)(3) crystal. An Yb3+:KBaGd(MoO4)(3) crystal with dimensions of 50x40x9 mm(3) was grown by the TSSG method from the K2Mo2O7 flux. The investigated spectral properties indicated that Yb3+:KBaGd(MoO4)(3) crystal exhibits broad absorption and emission bands, except the large emission and gain cross-sections. This feature of the broad absorption and emission bands is not only suitable for the diode pumping, but also for the production of ultrashort pulses and tunability. Therefore, Yb3+:KBaGd(MoO4)(3) crystal can be regarded as a candidate for the ultrashort pulse and tunable lasers.	[Yu, Yi; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu] Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China; [Yu, Yi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, GF (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China.	wgf@ms.fjirsm.ac.cn			National Natural Science Foundation of China [61108054]; National Natural Science Foundation of Fujian Province [2011J01376]; Scientific Research Foundation for Returned Scholars; Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Scientific Research Foundation for Returned Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Ministry of Education of China(Ministry of Education, China)	This work is supported by the National Natural Science Foundation of China (number 61108054), the National Natural Science Foundation of Fujian Province (number 2011J01376) and Scientific Research Foundation for Returned Scholars, Ministry of Education of China, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antic-Fidancev E, 2000, J ALLOY COMPD, V300, P2, DOI 10.1016/S0925-8388(99)00695-7; Brunner F, 2000, OPT LETT, V25, P1119, DOI 10.1364/OL.25.001119; Chen YF, 2012, OPT LETT, V37, P461, DOI 10.1364/OL.37.000461; DELOACH LD, 1993, IEEE J QUANTUM ELECT, V29, P1179, DOI 10.1109/3.214504; Druon F, 2000, OPT LETT, V25, P423, DOI 10.1364/OL.25.000423; Haumesser PH, 2002, J OPT SOC AM B, V19, P2365, DOI 10.1364/JOSAB.19.002365; Haumesser PH, 2001, J PHYS-CONDENS MAT, V13, P5427, DOI 10.1088/0953-8984/13/23/303; Honninger C, 1999, APPL PHYS B-LASERS O, V69, P3, DOI 10.1007/s003400050762; Jiang HD, 2002, CHEM PHYS LETT, V357, P15, DOI 10.1016/S0009-2614(02)00409-8; KOZHEVNIKOVA NM, 1990, ZH NEORG KHIM+, V35, P3157; Kuleshov NV, 1997, OPT LETT, V22, P1317, DOI 10.1364/OL.22.001317; Li H, 2010, CRYSTENGCOMM, V12, P1307, DOI 10.1039/b914641e; Meng XM, 2011, CRYSTENGCOMM, V13, P4069, DOI 10.1039/c0ce00922a; Mougel F, 1999, J OPT SOC AM B, V16, P164, DOI 10.1364/JOSAB.16.000164; Tang LY, 2005, J CRYST GROWTH, V282, P376, DOI 10.1016/j.jcrysgro.2005.05.024; Wang GJ, 2011, CRYST GROWTH DES, V11, P3895, DOI 10.1021/cg200438p; Xiao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040229; Xiao B, 2012, RSC ADV, V2, P5271, DOI 10.1039/c2ra00050d; Xie GQ, 2009, OPT LETT, V34, P103, DOI 10.1364/OL.34.000103; Yao G, 2008, J CRYST GROWTH, V310, P725, DOI 10.1016/j.jcrysgro.2007.11.106; Zhou M, 2009, OPT COMMUN, V282, P4109, DOI 10.1016/j.optcom.2009.07.009	21	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54450	10.1371/journal.pone.0054450	http://dx.doi.org/10.1371/journal.pone.0054450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349892	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100068
J	Benktander, J; Angstrom, J; Karlsson, H; Teymournejad, O; Linden, S; Lebens, M; Teneberg, S				Benktander, John; Angstrom, Jonas; Karlsson, Hasse; Teymournejad, Omid; Linden, Sara; Lebens, Michael; Teneberg, Susann			The Repertoire of Glycosphingolipids Recognized by Vibrio cholerae	PLOS ONE			English	Article							RABBIT ERYTHROCYTE-MEMBRANES; TOXIN-COREGULATED PILI; HUMAN SMALL-INTESTINE; BLOOD-GROUP; ESCHERICHIA-COLI; EPITHELIAL-CELLS; EL-TOR; CERAMIDE PENTADECASACCHARIDE; HELICOBACTER-PYLORI; MASS-SPECTROMETRY	The binding of cholera toxin to the ganglioside GM1 as the initial step in the process leading to diarrhea is nowadays textbook knowledge. In contrast, the knowledge about the mechanisms for attachment of Vibrio cholerae bacterial cells to the intestinal epithelium is limited. In order to clarify this issue, a large number of glycosphingolipid mixtures were screened for binding of El Tor V. cholerae. Several specific interactions with minor complex non-acid glycosphingolipids were thereby detected. After isolation of binding-active glycosphingolipids, characterization by mass spectrometry and proton NMR, and comparative binding studies, three distinct glycosphingolipid binding patterns were defined. Firstly, V. cholerae bound to complex lacto/neolacto glycosphingolipids with the GlcNAc beta 3Gal beta 4GlcNAc sequence as the minimal binding epitope. Secondly, glycosphingolipids with a terminal Gal alpha 3Gal alpha 3Gal moiety were recognized, and the third specificity was the binding to lactosylceramide and related compounds. V. cholerae binding to lacto/neolacto glycosphingolipids, and to the other classes of binding-active compounds, remained after deletion of the chitin binding protein GbpA. Thus, the binding of V. cholerae to chitin and to lacto/neolacto containing glycosphingolipids represents two separate binding specificities.	[Benktander, John; Angstrom, Jonas; Karlsson, Hasse; Teymournejad, Omid; Linden, Sara; Teneberg, Susann] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Lebens, Michael] Univ Gothenburg, Dept Med Microbiol & Immunol, Inst Biomed, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Teneberg, S (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se	Lindén, Sara K/A-3271-2011	Lindén, Sara K/0000-0002-7751-9586; Lebens, Michael/0000-0001-9458-9474; Teymournejad, Omid/0000-0001-8448-7896	Swedish Research Council [342-2004-4434]; Swedish Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This study was supported by the Swedish Research Council, the Swedish Cancer Foundation, and governmental grants to the Sahlgrenska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The use of the LTQ linear quadrupole ion trap mass spectrometer (obtained by a grant from the Swedish Research Council (No. 342-2004-4434) to Gunnar Hansson), and the Varian 600 MHz NMR spectrometer at the Swedish NMR Centre, Hasselblad Laboratory, Goteborg University, are gratefully acknowledged.	ANDERSSON B, 1983, J EXP MED, V158, P559, DOI 10.1084/jem.158.2.559; Angstrom J, 2004, GLYCOBIOLOGY, V14, P1, DOI 10.1093/glycob/cwh003; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; BJORK S, 1987, J BIOL CHEM, V262, P6758; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; DABROWSKI J, 1982, FEBS LETT, V142, P138, DOI 10.1016/0014-5793(82)80237-8; DABROWSKI U, 1984, J BIOL CHEM, V259, P7648; EGGE H, 1985, J BIOL CHEM, V260, P4927; ESKO JD, 1999, ESSENTIALS GLYCOBIOL, P429; FINNE J, 1989, J BIOL CHEM, V264, P5720; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; Guo BP, 2009, P NATL ACAD SCI USA, V106, P19280, DOI 10.1073/pnas.0905470106; HANFLAND P, 1984, EUR J BIOCHEM, V145, P531, DOI 10.1111/j.1432-1033.1984.tb08589.x; Harris JB, 2005, INFECT IMMUN, V73, P7422, DOI 10.1128/IAI.73.11.7422-7427.2005; Henry S, 1997, GLYCOCONJUGATE J, V14, P209, DOI 10.1023/A:1018541821819; HOLMGREN J, 1973, Scandinavian Journal of Infectious Diseases, V5, P77, DOI 10.3109/inf.1973.5.issue-1.15; ITO M, 1989, J BIOL CHEM, V264, P9510; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; JONSON G, 1992, INFECT IMMUN, V60, P4278, DOI 10.1128/IAI.60.10.4278-4284.1992; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; Karlsson KA, 1996, BIOORGAN MED CHEM, V4, P1919, DOI 10.1016/S0968-0896(96)00174-5; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Lebens M, 2011, VACCINE, V29, P7505, DOI 10.1016/j.vaccine.2011.06.121; LEVINE MM, 1988, INFECT IMMUN, V56, P161, DOI 10.1128/IAI.56.1.161-167.1988; Miller-Podraza H, 2005, J BIOL CHEM, V280, P19695, DOI 10.1074/jbc.M412688200; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; PRIEFER UB, 1985, J BACTERIOL, V163, P324, DOI 10.1128/JB.163.1.324-330.1985; Robbe C, 2004, RAPID COMMUN MASS SP, V18, P412, DOI 10.1002/rcm.1352; Roche N, 2004, INFECT IMMUN, V72, P1519, DOI 10.1128/IAI.72.3.1519-1529.2004; SANCHEZ J, 1989, P NATL ACAD SCI USA, V86, P481, DOI 10.1073/pnas.86.2.481; Sanchez J, 2011, INDIAN J MED RES, V133, P153; Schild S, 2005, INT J MED MICROBIOL, V295, P243, DOI 10.1016/j.ijmm.2005.05.002; STROUD MR, 1991, J BIOL CHEM, V266, P8439; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; TENEBERG S, 1994, J BIOL CHEM, V269, P8554; Teneberg S, 2004, GLYCOBIOLOGY, V14, P187, DOI 10.1093/glycob/cwh015; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373; World Health Organization, 2008, CHOL WHO FACT SHEET	44	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53999	10.1371/journal.pone.0053999	http://dx.doi.org/10.1371/journal.pone.0053999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349777	Green Published, gold, Green Submitted			2022-12-27	WOS:000313943000023
J	Littleton, RM; Haworth, KJ; Tang, H; Setchell, KDR; Nelson, S; Hove, JR				Littleton, Robert M.; Haworth, Kevin J.; Tang, Hong; Setchell, Kenneth D. R.; Nelson, Sandra; Hove, Jay R.			Automated In Vivo Platform for the Discovery of Functional Food Treatments of Hypercholesterolemia	PLOS ONE			English	Article							ANTIATHEROSCLEROTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ZEBRAFISH; EXTRACTS; VITRO; FRACTIONATION	The zebrafish is becoming an increasingly popular model system for both automated drug discovery and investigating hypercholesterolemia. Here we combine these aspects and for the first time develop an automated high-content confocal assay for treatments of hypercholesterolemia. We also create two algorithms for automated analysis of cardiodynamic data acquired by high-speed confocal microscopy. The first algorithm computes cardiac parameters solely from the frequency-domain representation of cardiodynamic data while the second uses both frequency-and time-domain data. The combined approach resulted in smaller differences relative to manual measurements. The methods are implemented to test the ability of a methanolic extract of the hawthorn plant (Crataegus laevigata) to treat hypercholesterolemia and its peripheral cardiovascular effects. Results demonstrate the utility of these methods and suggest the extract has both antihypercholesterolemic and postitively inotropic properties.	[Littleton, Robert M.; Hove, Jay R.] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45221 USA; [Hove, Jay R.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Haworth, Kevin J.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH USA; [Tang, Hong; Nelson, Sandra] Univ Cincinnati, Ctr Drug Discovery, Cincinnati, OH USA; [Setchell, Kenneth D. R.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Littleton, RM (corresponding author), Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45221 USA.	robert.littleton@nationwidechildrens.org	Haworth, Kevin J/D-1513-2009	Haworth, Kevin J/0000-0002-6578-2440	National Institute of Health [R01-RR023190-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR023190] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded through the National Institute of Health R01-RR023190-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Carten JD, 2009, CLIN LIPIDOL, V4, P501, DOI 10.2217/clp.09.40; Chan PK, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-11; Chang WT, 2005, AM J CHINESE MED, V33, P1, DOI 10.1142/S0192415X05002606; Clifton JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012386; Crawford AD, 2008, PLANTA MED, V74, P624, DOI 10.1055/s-2008-1034374; Fang LH, 2010, J BIOL CHEM, V285, P32343, DOI 10.1074/jbc.M110.137257; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Fink M, 2009, BIOTECHNIQUES, V37, P970; Jin S, 2011, FOOD CHEM TOXICOL, V49, P1521, DOI 10.1016/j.fct.2011.03.043; Jin S, 2011, J MED FOOD, V14, P247, DOI 10.1089/jmf.2009.1389; Kitambi Satish Srinivas, 2012, BMC Physiology, V12, P3, DOI 10.1186/1472-6793-12-3; Littleton RM, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-105; McCollum CW, 2011, BIRTH DEFECTS RES C, V93, P67, DOI 10.1002/bdrc.20210; Nahin Richard L, 2009, Natl Health Stat Report, P1; Nwodo UU, 2010, AFR J BIOTECHNOL, V9, P7108; Nwodo UU, 2011, MOLECULES, V16, P4818, DOI 10.3390/molecules16064818; Okoli S, 2005, AFR J BIOTECHNOL, V4, P946; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; Proakis J. G., 1996, DIGIT SIGNAL PROCESS; Smart EJ, 2004, P NATL ACAD SCI USA, V101, P3450, DOI 10.1073/pnas.0400441101; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Taylor J. R., 1997, INTRO ERROR ANAL; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Williams CH, 2011, INT J MOL SCI, V12, P2262, DOI 10.3390/ijms12042262	26	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e52409	10.1371/journal.pone.0052409	http://dx.doi.org/10.1371/journal.pone.0052409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349685	Green Submitted, gold, Green Published			2022-12-27	WOS:000313943000007
J	Maurice, AC; Abdelkrim, J; Cisel, M; Zavodna, M; Bardin, P; Matamoro, A; Dumez, R; Machon, N				Maurice, Anne-Claire; Abdelkrim, Jawad; Cisel, Matthieu; Zavodna, Monika; Bardin, Philippe; Matamoro, Alexis; Dumez, Richard; Machon, Nathalie			Mixing Plants from Different Origins to Restore a Declining Population: Ecological Outcomes and Local Perceptions 10 Years Later	PLOS ONE			English	Article							ARENARIA-GRANDIFLORA; REINTRODUCTION; RARE; CONSEQUENCES; EXTINCTION; SUCCESS; RISKS	Populations of the Large-flowered Sandwort (Arenaria grandiflora L.) in the Fontainebleau forest (France) have declined rapidly during the last century. Despite the initiation of a protection program in 1991, less than twenty individuals remained by the late 1990s. The low fitness of these last plants, which is likely associated with genetic disorders and inbreeding depression, highlighted the need for the introduction of non-local genetic material to increase genetic diversity and thus restore Fontainebleau populations. Consequently, A. grandiflora was introduced at three distant sites in the Fontainebleau forest in 1999. Each of these populations was composed of an identical mix of individuals of both local and non-local origin that were obtained through in vitro multiplication. After establishment, the population status (number of individuals, diameter of the plants, and number of flowers) of the introduced populations was monitored. At present, two populations (one of which is much larger than the other) persist, while the third one became extinct in 2004. Analyses of the ecological parameters of the introduction sites indicated that differences in soil pH and moisture might have contributed to the differences in population dynamics. This introduction plan and its outcome attracted interest of local community, with those who supported the plan and regarded its 10-year result as a biological success (i.e., persistent populations were created), but also those who expressed reservations or disapproval of the plan and its outcome. To understand this controversy, a sociological study involving 27 semi-structured interviews was carried out. From these interviews emerged three areas of controversy: alteration of the identity of the plant, alteration of the identity of its territory, and the biological and ethical consequences of the techniques used for the experimental conservation.	[Maurice, Anne-Claire; Abdelkrim, Jawad; Cisel, Matthieu; Zavodna, Monika; Matamoro, Alexis; Machon, Nathalie] Natl Museum Nat Hist, Unite Mixte Rech 7204, Unite Conservat Especes Restaurat & Suivi Populat, Paris, France; [Maurice, Anne-Claire; Dumez, Richard] Natl Museum Nat Hist, Unite Mixte Rech 7206, Unite Ecoanthropol & Ethnobiol, Paris, France; [Bardin, Philippe] Natl Museum Nat Hist, Conservatoire Bot Natl Bassin Parisien, Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN)	Machon, N (corresponding author), Natl Museum Nat Hist, Unite Mixte Rech 7204, Unite Conservat Especes Restaurat & Suivi Populat, Paris, France.	machon@mnhn.fr	MAURICE, Anne-Claire/ABG-7879-2020	MAURICE, Anne-Claire/0000-0002-8444-093X; Matamoro-Vidal, Alexis/0000-0002-9316-659X	Office National des Forets (ONF); CNRS; CEMAGREF	Office National des Forets (ONF); CNRS(Centre National de la Recherche Scientifique (CNRS)); CEMAGREF	Financial support for this research came from the Office National des Forets (ONF) and an interdisciplinary program on ecological engineering of the CNRS and the CEMAGREF (call for tenders 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal G, 1999, PLANTES PROTEGEES IL; Aubert G., 1978, METHODES ANAL SOLS; Benhammou F, 2008, NOROIS, V208, P75; Bobbe S, 2004, COMMUNICATIONS, P203, DOI [10.3406/comm.2004.2166, DOI 10.3406/COMM.2004.2166]; Bottin L, 2007, ECOSCIENCE, V14, P410, DOI 10.2980/1195-6860(2007)14[410:RTIEPA]2.0.CO;2; Delord J, 2007, STUD HIST PHI PART C, V38, P656, DOI 10.1016/j.shpsc.2007.06.004; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Fabiani Jean-Louis, 2000, REV EURO SCI SOC, V118, P15; Falk DA., 2001, INTRO RESTORATION GE; Fenster Charles B., 1994, P34, DOI 10.1017/CBO9780511623325.004; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Gardner W. H., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P493; Godefroid S, 2011, BIOL CONSERV, V144, P672, DOI 10.1016/j.biocon.2010.10.003; International Union for Conservation of Nature and Natural Resources (IUCN)/SSC Re-introduction Specialist Group, 1998, IUCN GUID REINTR; Jakson P., 1995, HDB BOT GARD REINTR; Jusaitis Manfred, 2005, Ecological Management & Restoration, V6, P61, DOI 10.1111/j.1442-8903.2005.00220.x; Kephart SR, 2004, CONSERV GENET, V5, P49, DOI 10.1023/B:COGE.0000014056.65197.c4; Knapp Eric E., 1998, P345; Krauss SL, 2002, CONSERV BIOL, V16, P986, DOI 10.1046/j.1523-1739.2002.01105.x; Lambinon J, 1997, INTRO NONNATIVE PLAN; Larrere R, 2005, BIODIVERSITES OBJETS, P174; Latour B, 2001, MET CHERCH REG ANTHR; Lizet B, 1997, COLLOQ INRA, P161; Lofflin DL, 2005, AM J BOT, V92, P1691, DOI 10.3732/ajb.92.10.1691; Matthies D, 2004, OIKOS, V105, P481, DOI 10.1111/j.0030-1299.2004.12800.x; MAUNDER M, 1992, BIODIVERS CONSERV, V1, P51, DOI 10.1007/BF00700250; Mauz I, 2005, GENS CORNES CROCS; Menges ES, 2008, AUST J BOT, V56, P187, DOI 10.1071/BT07173; Micoud A, 1993, NATURES SCI SOC, V1, P202; Morgan JW, 2000, CONSERV BIOL, V14, P780, DOI 10.1046/j.1523-1739.2000.98516.x; Olivier de Sardan J-P, 2008, RIGUEUR QUALITATIF C; PAVLIK BM, 1988, BIOL CONSERV, V46, P217, DOI 10.1016/0006-3207(88)90069-9; Pelosse V, 1992, EC RURALE, V208, P101, DOI 10.3406/ecoru.1992.14462; Pelosse V, 1993, ETUD RURALES, P9; R Core Team, 2020, R LANG ENV STAT COMP; Raabova J, 2009, PLANT BIOLOGY, V11, P829, DOI 10.1111/j.1438-8677.2008.00186.x; READING RP, 1993, CONSERV BIOL, V7, P569, DOI 10.1046/j.1523-1739.1993.07030569.x; Robichaux RH, 1997, CONSERV BIOL, V11, P1140, DOI 10.1046/j.1523-1739.1997.96314.x; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Skogen K, 2008, RURAL SOCIOL, V73, P105, DOI 10.1526/003601108783575916; Touraine A, 2000, J WORLD SYSTEMS RES, V6, P900, DOI DOI 10.5195/JWSR.2000.211; Vaillant S, 1723, BOT PARISIENSE OPERI; Vergeer P, 2005, PLANT BIOLOGY, V7, P509, DOI 10.1055/s-2005-865904; Vergeer P, 2004, CONSERV BIOL, V18, P812, DOI 10.1111/j.1523-1739.2004.00562.x; Vourc'h A, 1993, ETUD RURALES, P51; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Zavodna M, 2009, MOL ECOL RESOUR, V9, P628, DOI 10.1111/j.1755-0998.2008.02482.x	47	1	1	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e50934	10.1371/journal.pone.0050934	http://dx.doi.org/10.1371/journal.pone.0050934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349668	Green Submitted, gold, Green Published			2022-12-27	WOS:000313943000004
J	Coutinho, AE; Brown, JK; Yang, F; Brownstein, DG; Gray, M; Seckl, JR; Savill, JS; Chapman, KE				Coutinho, Agnes E.; Brown, Jeremy K.; Yang, Fu; Brownstein, David G.; Gray, Mohini; Seckl, Jonathan R.; Savill, John S.; Chapman, Karen E.			Mast Cells Express 11 beta-hydroxysteroid Dehydrogenase Type 1: A Role in Restraining Mast Cell Degranulation	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; IN-VIVO; GLUCOCORTICOIDS; INFLAMMATION; ACTIVATION; ARTHRITIS; MICE; 11-BETA-HSD1; HOMOLOGS; PROMOTES	Mast cells are key initiators of allergic, anaphylactic and inflammatory reactions, producing mediators that affect vascular permeability, angiogenesis and fibrosis. Glucocorticoid pharmacotherapy reduces mast cell number, maturation and activation but effects at physiological levels are unknown. Within cells, glucocorticoid concentration is modulated by the 11 beta-hydroxysteroid dehydrogenases ( 11 beta-HSDs). Here we show expression and activity of 11 beta-HSD1, but not 11 beta-HSD2, in mouse mast cells with 11 beta-HSD activity only in the keto-reductase direction, regenerating active glucocorticoids (cortisol, corticosterone) from inert substrates (cortisone, 11-dehydrocorticosterone). Mast cells from 11 beta-HSD1-deficient mice show ultrastructural evidence of increased activation, including piecemeal degranulation and have a reduced threshold for IgG immune complex-induced mast cell degranulation. Consistent with reduced intracellular glucocorticoid action in mast cells, levels of carboxypeptidase A3 mRNA, a glucocorticoid-inducible mast cell-specific transcript, are lower in peritoneal cells from 11 beta-HSD1-deficient than control mice. These findings suggest that 11 beta-HSD1-generated glucocorticoids may tonically restrain mast cell degranulation, potentially influencing allergic, anaphylactic and inflammatory responses.	[Coutinho, Agnes E.; Yang, Fu; Seckl, Jonathan R.; Chapman, Karen E.] Univ Edinburgh, Univ British Heart Fdn, Ctr Cardiovasc Res, Edinburgh, Midlothian, Scotland; [Coutinho, Agnes E.; Yang, Fu; Gray, Mohini; Savill, John S.] Univ Edinburgh, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Brownstein, David G.] Univ Edinburgh, Mouse Pathol Core Lab, Edinburgh, Midlothian, Scotland; [Brown, Jeremy K.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Chapman, KE (corresponding author), Univ Edinburgh, Univ British Heart Fdn, Ctr Cardiovasc Res, Edinburgh, Midlothian, Scotland.	Karen.Chapman@ed.ac.uk	Seckl, Jonathan R/C-3555-2013	Chapman, Karen/0000-0001-7777-6817	MRC [86642]; Wellcome Trust [083184, 064497]; Moray Endowment fund (University of Edinburgh); Arthritis Research Campaign Clinician Scientist Fellowship; Cancer Research UK [20035] Funding Source: researchfish; Medical Research Council [G9900991, G0802069, G0700704B, G0800235, MR/K026992/1] Funding Source: researchfish; MRC [G9900991, G0802069, G0800235] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Moray Endowment fund (University of Edinburgh); Arthritis Research Campaign Clinician Scientist Fellowship(Versus Arthritis); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an MRC project grant (KEC, MG, JSS, JRS, grant number 86642) and 2 Wellcome Trust Programme grants (JRS and KEC, grant number 083184 and separately, JSS, grant number 064497). Funding was also provided by the Moray Endowment fund (University of Edinburgh). MG is supported by an Arthritis Research Campaign Clinician Scientist Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER SA, 1997, IMMUNOLOGY METHODS M; Brown JK, 2003, CLIN EXP ALLERGY, V33, P132, DOI 10.1046/j.1365-2222.2003.01571.x; Bruley C, 2006, ENDOCRINOLOGY, V147, P2879, DOI 10.1210/en.2005-1621; Bryndova J, 2004, SCAND J GASTROENTERO, V39, P549, DOI 10.1080/00365520410004659; Carter RN, 2009, J NEUROENDOCRINOL, V21, P879, DOI 10.1111/j.1365-2826.2009.01899.x; Chapman KE, 2008, NEUROCHEM RES, V33, P624, DOI 10.1007/s11064-007-9504-9; Chapman KE, 2009, MOL CELL ENDOCRINOL, V301, P123, DOI 10.1016/j.mce.2008.09.031; Coutinho AE, 2012, ENDOCRINOLOGY, V153, P234, DOI 10.1210/en.2011-1398; Dvorak AM, 2005, J HISTOCHEM CYTOCHEM, V53, P1043, DOI 10.1369/jhc.5R6647.2005; Eklund KK, 1997, J IMMUNOL, V158, P4373; Ergang P, 2010, MOL CELL ENDOCRINOL, V323, P155, DOI 10.1016/j.mce.2010.03.003; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Finotto S, 1997, J CLIN INVEST, V99, P1721, DOI 10.1172/JCI119336; FLOWER RJ, 1988, BRIT J PHARMACOL, V94, P987, DOI 10.1111/j.1476-5381.1988.tb11614.x; Freeman L, 2005, BLOOD, V106, P2042, DOI 10.1182/blood-2005-01-0186; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Harbuz MS, 2003, ANN NY ACAD SCI, V992, P99, DOI 10.1111/j.1749-6632.2003.tb03141.x; HEIMAN AS, 1984, PROSTAGLANDINS, V27, P335, DOI 10.1016/0090-6980(84)90084-4; Kardon T, 2008, FEBS LETT, V582, P1809, DOI 10.1016/j.febslet.2008.04.045; Kinet JP, 2007, IMMUNOL REV, V217, P5, DOI 10.1111/j.1600-065X.2007.00528.x; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; McSweeney SJ, 2010, CARDIOVASC RES, V88, P159, DOI 10.1093/cvr/cvq149; MOISAN MP, 1992, MOL ENDOCRINOL, V6, P1082, DOI 10.1210/me.6.7.1082; Nigrovic PA, 2005, ARTHRITIS RES THER, V7, P1, DOI 10.1186/ar1446; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Peixoto RADS, 2008, ENDOCRINOLOGY, V149, P1861, DOI 10.1210/en.2007-1028; Pejler G, 2009, TRENDS IMMUNOL, V30, P401, DOI 10.1016/j.it.2009.04.008; Pemberton AD, 2006, PROTEOMICS, V6, P623, DOI 10.1002/pmic.200500211; PESCI A, 1993, AM REV RESPIR DIS, V147, P684, DOI 10.1164/ajrccm/147.3.684; Rider LG, 1996, J IMMUNOL, V157, P2374; Thieringer R, 2001, J IMMUNOL, V167, P30, DOI 10.4049/jimmunol.167.1.30; Weller CL, 2007, P NATL ACAD SCI USA, V104, P11712, DOI 10.1073/pnas.0701700104; Weller CL, 2005, J EXP MED, V201, P1961, DOI 10.1084/jem.20042407; Yau JLW, 2007, J NEUROSCI, V27, P10487, DOI 10.1523/JNEUROSCI.2190-07.2007; Zbankova S, 2007, J GASTROEN HEPATOL, V22, P1019, DOI 10.1111/j.1440-1746.2006.04529.x; Zhang TY, 2005, J IMMUNOL, V174, P879, DOI 10.4049/jimmunol.174.2.879	36	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54640	10.1371/journal.pone.0054640	http://dx.doi.org/10.1371/journal.pone.0054640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349944	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800067
J	Dong, YY; Chen, FX; Yu, YB; Du, C; Qi, QQ; Liu, H; Li, YQ				Dong, Yan-Yan; Chen, Fei-Xue; Yu, Yan-Bo; Du, Chao; Qi, Qing-Qing; Liu, Han; Li, Yan-Qing			A School-Based Study with Rome III Criteria on the Prevalence of Functional Gastrointestinal Disorders in Chinese College and University Students	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; COLD-WATER INTAKE; PSYCHOSOCIAL FACTORS; HOSPITAL ANXIETY; DEPRESSION SCALE; NATURAL-HISTORY; UNITED-STATES; DYSPEPSIA; EPIDEMIOLOGY	Background: Functional gastrointestinal disorders, including functional dyspepsia, irritable bowel syndrome and functional constipation are very common worldwide. Objective: This research aims to estimate the prevalence and associated factors involved in functional gastrointestinal disorders in Chinese college and university students using the Rome III criteria. Methods: A total of 5000 students from Shandong University in China were asked in January-May 2012 to complete questionnaires, including the Rome III questionnaire, hospital anxiety and depression scale, and negative life events scale. Results: Based on the 4638 students who completed the questionnaire, the prevalence of functional dyspepsia, irritable bowel syndrome and functional constipation in college and university students of North China worked out to be 9.25%, 8.34% and 5.45% respectively. They were more frequent in female students. The factors of anxiety (OR 1.07; 95% CI 0.99 to 1.16, P=0.002<0.05) and depression (OR 0.55; 95% CI 0.15 to 1.05, P=0.045<0.05) indicated a high risk of causing irritable bowel syndrome. Conclusion: Functional dyspepsia, irritable bowel syndrome and functional constipation were common in college and university students of North China. Psychological disorders such as anxiety and depression provide significant risk factors for irritable bowel syndrome patients.	[Dong, Yan-Yan; Chen, Fei-Xue; Yu, Yan-Bo; Du, Chao; Qi, Qing-Qing; Liu, Han; Li, Yan-Qing] Shandong Univ, Dept Gastroenterol, Qilu Hosp, Jinan, Shandong, Peoples R China; [Dong, Yan-Yan] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan, Shandong, Peoples R China; [Dong, Yan-Yan] Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, YQ (corresponding author), Shandong Univ, Dept Gastroenterol, Qilu Hosp, Jinan, Shandong, Peoples R China.	liyanqing@sdu.edu.cn	yu, yanbo/GZM-8474-2022; Liu, Han/GVT-8296-2022		Graduate Innovation Foundation of Shandong University [yyx10017]	Graduate Innovation Foundation of Shandong University	This study was supported by the Graduate Innovation Foundation of Shandong University (yyx10017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2011, GASTROENTEROL CLIN N, V40, P11, DOI 10.1016/j.gtc.2010.12.013; AGREUS L, 1995, GASTROENTEROLOGY, V109, P671, DOI 10.1016/0016-5085(95)90373-9; Chan YF, 2010, QUAL LIFE RES, V19, P865, DOI 10.1007/s11136-010-9645-1; Chang FY, 2012, ASIA PAC J CLIN NUTR, V21, P594; Chang FY, 2007, J GASTROEN HEPATOL, V22, P4, DOI 10.1111/j.1440-1746.2006.04672.x; Chang L, 2001, GASTROENTEROLOGY, V120, P1236; Dai N, 2008, DIGEST LIVER DIS, V40, P418, DOI 10.1016/j.dld.2008.01.019; Dorn SD, 2009, J CLIN GASTROENTEROL, V43, P214, DOI 10.1097/MCG.0b013e31815bd749; Drossman D, 2006, ROME 3 FUNCTIONAL GA; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; DROSSMAN DA, 1988, GASTROENTEROLOGY, V95, P701, DOI 10.1016/S0016-5085(88)80017-9; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; El-Serag HB, 2002, ALIMENT PHARM THER, V16, P1171, DOI 10.1046/j.1365-2036.2002.01290.x; Ersryd A, 2007, ALIMENT PHARM THERAP, V26, P953, DOI 10.1111/j.1365-2036.2007.03422.x; Faresjo A, 2007, EUR J EPIDEMIOL, V22, P473, DOI 10.1007/s10654-007-9133-2; Frank L, 2002, CLIN THER, V24, P675, DOI 10.1016/S0149-2918(02)85143-8; Golden-Kreutz DM, 2005, HEALTH PSYCHOL, V24, P288, DOI 10.1037/0278-6133.24.3.288; Gwee KA, 2004, AM J GASTROENTEROL, V99, P924, DOI 10.1111/j.1572-0241.2004.04161.x; Gwee KA, 2005, NEUROGASTROENT MOTIL, V17, P317, DOI 10.1111/j.1365-2982.2005.00627.x; Halder SLS, 2007, GASTROENTEROLOGY, V133, P799, DOI 10.1053/j.gastro.2007.06.010; Irvine EJ, 2002, AM J GASTROENTEROL, V97, P1986; Jeong LJ, 2008, WORLD J GASTROENTERO, V14, P6388, DOI 10.3748/wjg.14.6388; KATON W, 1991, AM J PSYCHIAT, V148, P34; Kawamura A, 2001, J GASTROEN HEPATOL, V16, P384, DOI 10.1046/j.1440-1746.2001.02454.x; Koloski NA, 2012, GUT, V61, P1284, DOI 10.1136/gutjnl-2011-300474; Li XJ, 2012, WORLD J GASTROENTERO, V18, P2561, DOI 10.3748/wjg.v18.i20.2561; Li YY, 2002, CHINESE MED J-PEKING, V115, P1082; Locke GR, 1998, BAILLIERE CLIN GASTR, V12, P435; Martin CR, 2004, PSYCHIAT RES, V129, P279, DOI 10.1016/j.psychres.2004.06.012; Matthews KA, 1997, AM PSYCHOL, V52, P101, DOI 10.1037/0003-066X.52.2.101; Nelhans Nick, 2010, Practitioner, V254, P22; Noh Young Wook, 2010, J Neurogastroenterol Motil, V16, P148, DOI 10.5056/jnm.2010.16.2.148; Park JM, 2011, J NEUROGASTROENTEROL, V17, P279, DOI 10.5056/jnm.2011.17.3.279; Pinto C, 2000, J Assoc Physicians India, V48, P589; Saito YA, 2002, AM J GASTROENTEROL, V97, P1910; SANDLER RS, 1990, GASTROENTEROLOGY, V99, P409, DOI 10.1016/0016-5085(90)91023-Y; Shen L, 2009, J GASTROEN HEPATOL, V24, P1885, DOI 10.1111/j.1440-1746.2009.05943.x; Sperber AD, 2007, EUR J GASTROEN HEPAT, V19, P441, DOI 10.1097/MEG.0b013e32801140e2; Stewart WF, 1999, AM J GASTROENTEROL, V94, P3530, DOI 10.1111/j.1572-0241.1999.01642.x; Tabbers MM, 2011, EUR J PEDIATR, V170, P955, DOI 10.1007/s00431-011-1515-5; Tack J, 2004, GASTROENTEROLOGY, V127, P1239, DOI 10.1053/j.gastro.2004.05.030; Talley NJ, 2007, REV GASTROENTEROL DI, V7, P97; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Vodermaier A, 2011, SUPPORT CARE CANCER, V19, P1899, DOI 10.1007/s00520-011-1251-4; Wang J, 2001, CLIN EPIDEMIOLOGY; White D, 1999, BRIT J PSYCHIAT, V175, P452, DOI 10.1192/bjp.175.5.452; Xiong LS, 2004, ALIMENT PHARM THER, V19, P1217, DOI 10.1111/j.1365-2036.2004.01939.x; Yao X, 2012, J GASTROEN HEPATOL, V27, P760, DOI 10.1111/j.1440-1746.2011.06930.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuo XL, 2007, J GASTROEN HEPATOL, V22, P2330, DOI 10.1111/j.1440-1746.2006.04772.x; Zuo XL, 2006, J GASTROENTEROL, V41, P311, DOI 10.1007/s00535-005-1766-x	51	43	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54183	10.1371/journal.pone.0054183	http://dx.doi.org/10.1371/journal.pone.0054183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GQ	23349820	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800031
J	Dupraz, S; Grassi, D; Karnas, D; Guil, AFN; Hicks, D; Quiroga, S				Dupraz, Sebastian; Grassi, Diego; Karnas, Diana; Nieto Guil, Alvaro F.; Hicks, David; Quiroga, Santiago			The Insulin-Like Growth Factor 1 Receptor Is Essential for Axonal Regeneration in Adult Central Nervous System Neurons	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; FACTOR-I; IGF-I; NEURITE REGENERATION; SURVIVAL; PIG; EXPRESSION; 3-KINASE; PROMOTE; BRAIN	Axonal regeneration is an essential condition to re-establish functional neuronal connections in the injured adult central nervous system (CNS) but efficient regrowth of severed axons has proven to be very difficult to achieve. Although significant progress has been made in identifying the intrinsic and extrinsic mechanisms involved many aspects remain unresolved. Axonal development in embryonic CNS (hippocampus) requires the obligate activation of the insulin-like growth factor 1 receptor (IGF-1R). Based on known similarities between axonal growth in fetal compared to mature CNS we decided to examine the expression of the IGF-1R using an antibody to the beta gc subunit or a polyclonal anti-peptide antibody directed to the IGF-R (C20) in an in vitro model of adult CNS axonal regeneration namely retinal ganglion cells (RGC) derived from adult rat retinas. Expression of both beta gc and the beta subunit recognized by C20 antibody were low in freshly isolated adult RGC but increased significantly after 4 days in vitro. As in embryonic axons beta gc was localised to distal regions and leading growth cones in RGC. IGF-1R-beta gc co-localised with activated p85 involved in the hosphatidylinositol-3 kinase (PI3K) signaling pathway upon stimulation with IGF-1. Blocking experiments using either an antibody which neutralises IGF-1R activation shRNA designed against the IGF-1R sequence or the PI3K pathway inhibitor LY294002 all significantly reduced axon regeneration from adult RGC in vitro (similar to 40% RGC possessed axons in controls vs 2-8% in the different blocking studies). Finally co-transfection of RGC with shRNA to silence IGF-1R together with a vector containing a constitutively active form of downstream PI3K (p110) fully restored axonal outgrowth in vitro. Hence these data demonstrate that axonal regeneration in adult CNS neurons requires re-expression and activation of IGF-1R and targeting this system may offer new therapeutic approaches to enhancing axonal regeneration following trauma.	[Dupraz, Sebastian; Grassi, Diego; Nieto Guil, Alvaro F.; Quiroga, Santiago] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina; [Dupraz, Sebastian; Grassi, Diego; Nieto Guil, Alvaro F.; Quiroga, Santiago] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Invest Quim Biol Cordoba CIQUIBIC, Cordoba, Argentina; [Karnas, Diana; Hicks, David] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, CNRS, UPR 3212, Strasbourg, France	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Quiroga, S (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina.	squiroga@fcq.unc.edu.ar	; Grassi, Davide/B-7916-2018	Grassi, Diego/0000-0002-4886-3046; Nieto Guil, Alvaro Fernando/0000-0002-9787-3486; Grassi, Davide/0000-0003-1653-3066	Mincyt-ECOS [A08S01]; FONCYT, Argentina [1733]; PICT [1442]	Mincyt-ECOS; FONCYT, Argentina(FONCyT); PICT(ANPCyT)	This work was supported by Mincyt-ECOS grant number A08S01 to SQ and DH (URL: http://www.mincyt.gov.ar/) and FONCYT, Argentina, PICT grants number 1733 and 1442 to SQ (URL: http://www.agencia.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahori Y, 1997, NEUROREPORT, V8, P2265, DOI 10.1097/00001756-199707070-00034; Aras MA, 2008, CURR PROTOC NEUROSCI, V7, P7181; Bohula EA, 2003, J BIOL CHEM, V278, P15991, DOI 10.1074/jbc.M300714200; Bonnet D, 2004, BRAIN RES, V1007, P142, DOI 10.1016/j.brainres.2004.02.023; Bouquet C, 2007, ADV EXP MED BIOL, V621, P1, DOI 10.1007/978-0-387-76715-4_1; Buffo A, 2003, EUR J NEUROSCI, V18, P2146, DOI 10.1046/j.1460-9568.2003.02940.x; Burren CP, 1996, INVEST OPHTH VIS SCI, V37, P1459; Caroni P, 1997, BIOESSAYS, V19, P767, DOI 10.1002/bies.950190906; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155; FORSTER V, 1999, IBRO HB S M, V18, P579; GAROFALO RS, 1989, MOL CELL BIOL, V9, P2806, DOI 10.1128/MCB.9.7.2806; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; GONZALEZ MD, 1994, J NEUROSCI, V14, P6121; Gutierrez-Ospina G, 2002, NEUROSCI LETT, V325, P207, DOI 10.1016/S0304-3940(02)00293-8; Guy J, 1998, P NATL ACAD SCI USA, V95, P13847, DOI 10.1073/pnas.95.23.13847; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hayreh SS, 2009, PROG RETIN EYE RES, V28, P34, DOI 10.1016/j.preteyeres.2008.11.002; Hirsch S, 1999, ADV EXP MED BIOL, V468, P199; Homma K, 2007, NEUROCHEM INT, V50, P741, DOI 10.1016/j.neuint.2007.01.011; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Kim JY, 2006, EXPERT OPIN BIOL TH, V6, P735, DOI 10.1517/14712598.6.8.735; Kimpinski K, 2001, J NEUROSCI RES, V63, P486, DOI 10.1002/jnr.1043; Kinkl N, 2003, MOL CELL NEUROSCI, V23, P39, DOI 10.1016/S1044-7431(03)00070-8; Koriyama Y, 2007, NEUROCHEM INT, V50, P749, DOI 10.1016/j.neuint.2007.01.012; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Lambooij AC, 2003, INVEST OPHTH VIS SCI, V44, P2192, DOI 10.1167/iovs.02-0410; Lebrun-Julien F, 2008, OPTOMETRY VISION SCI, V85, P417, DOI 10.1097/OPX.0b013e31817841f7; LEE WH, 1992, J NEUROSCI, V12, P4737; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P1096; Mascotti F, 1997, J NEUROSCI, V17, P1447; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Morera LP, 2012, EXP EYE RES, V101, P44, DOI 10.1016/j.exer.2012.05.010; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; QUIROGA S, 1995, P NATL ACAD SCI USA, V92, P4309, DOI 10.1073/pnas.92.10.4309; Romano C, 2007, PROG RETIN EYE RES, V26, P379, DOI 10.1016/j.preteyeres.2007.03.001; Rossi F, 2001, RESTOR NEUROL NEUROS, V19, P85; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Ruberte J, 2004, J CLIN INVEST, V113, P1149, DOI 10.1172/JCI200419478; Ruiz-Ederra J, 2004, MOL VIS, V10, P83; Sapieha PS, 2006, J NEUROSCI RES, V83, P985, DOI 10.1002/jnr.20803; Sapieha PS, 2003, MOL CELL NEUROSCI, V24, P656, DOI 10.1016/S1044-7431(03)00228-8; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Teng FYH, 2006, J NEUROCHEM, V96, P1501, DOI 10.1111/j.1471-4159.2006.03663.x; Tonges L, 2011, J NEUROCHEM, V117, P892, DOI 10.1111/j.1471-4159.2011.07257.x; Werner H, 1991, GROWTH FACTORS CYTOK, P17; Wu N, 2008, J INT MED RES, V36, P883, DOI 10.1177/147323000803600503; Yip HK, 2000, PROG RETIN EYE RES, V19, P559, DOI 10.1016/S1350-9462(00)00009-4	52	53	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54462	10.1371/journal.pone.0054462	http://dx.doi.org/10.1371/journal.pone.0054462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349896	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800055
J	He, D; Zhao, XQ; Chen, XG; Fang, Y; Singh, S; Talele, TT; Qiu, HJ; Liang, YJ; Wang, XK; Zhang, GQ; Chen, ZS; Fu, LW				He, Dan; Zhao, Xiao-qin; Chen, Xing-gui; Fang, Yi; Singh, Satyakam; Talele, Tanaji T.; Qiu, Hui-juan; Liang, Yong-ju; Wang, Xiao-kun; Zhang, Guo-qing; Chen, Zhe-sheng; Fu, Li-wu			BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells	PLOS ONE			English	Article							MEDIATED MULTIDRUG-RESISTANCE; SUBFAMILY-B MEMBER-1; P-GLYCOPROTEIN; MAP KINASE; DRUG-RESISTANCE; CANCER-CELLS; TRANSPORTERS; BINDING; REVERSAL; PATHWAY	ATP-binding-cassette family membrane proteins play an important role in multidrug resistance. In this study, we investigated BIRB796, an orally active inhibitor of p38 mitogen-activated protein kinase, reversed MDR induced by ABCB1, ABCG2 and ABCC1. Our results showed that BIRB796 could reverse ABCB1-mediated MDR in both the drug selected and transfected ABCB1-overexpressing cell models, but did not enhance the efficacy of substrate-chemotherapeutical agents in ABCC1 or ABCG2 overexpression cells and their parental sensitive cells. Furthermore, BIRB796 increased the intracellular accumulation of the ABCB1 substrates, such as rhodamine 123 and doxorubicin. Moreover, BIRB796 bidirectionally mediated the ATPase activity of ABCB1, stimulating at low concentration, inhibiting at high concentration. However, BIRB796 did not alter the expression of ABCB1 both at protein and mRNA level. The down-regulation of p38 by siRNA neither affected the expression of ABCB1 nor the cytotoxic effect of paclitaxel on KBV200. The binding model of BIRB796 within the large cavity of the transmembrane region of ABCB1 may form the basis for future lead optimization studies. Importantly, BIRB796 also enhanced the effect of paclitaxel on the inhibition of growth of the ABCB1-overexpressing KBV200 cell xenografts in nude mice. Overall, we conclude that BIRB796 reverses ABCB1-mediated MDR by directly inhibiting its transport function. These findings may be useful for cancer combinational therapy with BIRB796 in the clinic.	[He, Dan; Zhang, Guo-qing] Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Thorac Surg, Urumqi, Peoples R China; [Zhao, Xiao-qin; Chen, Xing-gui; Fang, Yi; Qiu, Hui-juan; Liang, Yong-ju; Wang, Xiao-kun; Fu, Li-wu] Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Singh, Satyakam; Talele, Tanaji T.; Chen, Zhe-sheng] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Queens, NY USA	Xinjiang Medical University; Sun Yat Sen University; Saint John's University	Zhang, GQ (corresponding author), Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Thorac Surg, Urumqi, Peoples R China.	zgqprofessor@sina.com; Fulw@mail.sysu.edu.cn	zhang, guoqing/GXG-4800-2022; Wang, Xiaokun/AAH-6815-2021; WANG, XIAOKUN/GQR-1904-2022; wang, xk/HGD-3115-2022; Fu, Liwu/AAE-8835-2020	Wang, Xiaokun/0000-0003-4148-5561; Singh, Satyakam/0000-0001-9115-3296; Chen, Zhe-Sheng/0000-0002-8289-097X	China 863 Program Foundation [2012AA02A303]; China 973 Program Foundation [2011CB504300]; China National Natural Sciences Foundation [81061160]	China 863 Program Foundation; China 973 Program Foundation; China National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC))	The work was supported by China 863 Program Foundation (No. 2012AA02A303 (http://program.most.gov.cn/), China 973 Program Foundation (No. 2011CB504300, http://www.973.gov.cn/), and China National Natural Sciences Foundation (No. 81061160, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Atadja P, 1998, CANCER METAST REV, V17, P163, DOI 10.1023/A:1006046201497; Bakos E, 2007, PFLUG ARCH EUR J PHY, V453, P621, DOI 10.1007/s00424-006-0160-8; Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Chen LM, 2004, J PHARM PHARMACOL, V56, P1061, DOI 10.1211/0022357043879; Crivori P, 2006, MOL PHARMACEUT, V3, P33, DOI 10.1021/mp050071a; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Ding PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019329; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Guo XL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-375; Hideshima T, 2004, ONCOGENE, V23, P8766, DOI 10.1038/sj.onc.1208118; Jamroziak Krzysztof, 2004, Hematology, V9, P91, DOI 10.1080/10245330310001638974; Klepsch F, 2010, CURR PHARM DESIGN, V16, P1742, DOI 10.2174/138161210791163992; Klopman G, 1997, MOL PHARMACOL, V52, P323, DOI 10.1124/mol.52.2.323; Krishna Rajesh, 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P163, DOI 10.2174/1568011013354705; Lage H, 2006, CURR DRUG TARGETS, V7, P813, DOI 10.2174/138945006777709566; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Osborn MT, 1999, ONCOGENE, V18, P5756, DOI 10.1038/sj.onc.1202943; Paillas S, 2011, CANCER RES, V71, P1041, DOI 10.1158/0008-5472.CAN-10-2726; Pajeva IK, 2009, CHEMMEDCHEM, V4, P1883, DOI 10.1002/cmdc.200900282; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Ranganathan AC, 2006, CANCER BIOL THER, V5, P729, DOI 10.4161/cbt.5.7.2968; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Regan J, 2003, J MED CHEM, V46, P4676, DOI 10.1021/jm030121k; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2011, CANCER RES, V71, P3029, DOI 10.1158/0008-5472.CAN-10-3820; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Tao LY, 2009, CANCER CHEMOTH PHARM, V64, P961, DOI 10.1007/s00280-009-0949-1; Teodori E, 2006, CURR DRUG TARGETS, V7, P893, DOI 10.2174/138945006777709520; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; WACHER VJ, 1995, MOL CARCINOGEN, V13, P129, DOI 10.1002/mc.2940130302; Wang F, 2012, MOL MED, V18, P887, DOI 10.2119/molmed.2011.00444; Wang F, 2012, CHIN J CANCER, V31, P150, DOI 10.5732/cjc.011.10310; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Zhao XQ, 2012, MOL PHARM; Zheng LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005172	47	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54181	10.1371/journal.pone.0054181	http://dx.doi.org/10.1371/journal.pone.0054181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349819	gold, Green Submitted, Green Published			2022-12-27	WOS:000313872800030
J	Stone, RC; Du, PC; Feng, D; Dhawan, K; Ronnblom, L; Eloranta, ML; Donnelly, R; Barnes, BJ				Stone, Rivka C.; Du, Peicheng; Feng, Di; Dhawan, Kopal; Ronnblom, Lars; Eloranta, Maija-Leena; Donnelly, Robert; Barnes, Betsy J.			RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON REGULATORY FACTOR; GREEN FLUORESCENT PROTEIN; GENETIC-VARIANTS; RISK HAPLOTYPE; DISEASE; ACTIVATION; ALPHA; ASSOCIATION; INTERFERON-REGULATORY-FACTOR-5	Polymorphisms in the interferon regulatory factor 5 (IRF5) gene have been consistently replicated and shown to confer risk for or protection from the development of systemic lupus erythematosus (SLE). IRF5 expression is significantly upregulated in SLE patients and upregulation associates with IRF5-SLE risk haplotypes. IRF5 alternative splicing has also been shown to be elevated in SLE patients. Given that human IRF5 exists as multiple alternatively spliced transcripts with distinct function(s), it is important to determine whether the IRF5 transcript profile expressed in healthy donor immune cells is different from that expressed in SLE patients. Moreover, it is not currently known whether an IRF5-SLE risk haplotype defines the profile of IRF5 transcripts expressed. Using standard molecular cloning techniques, we identified and isolated 14 new differentially spliced IRF5 transcript variants from purified monocytes of healthy donors and SLE patients to generate an IRF5 variant transcriptome. Next-generation sequencing was then used to perform in-depth and quantitative analysis of full-length IRF5 transcript expression in primary immune cells of SLE patients and healthy donors by next-generation sequencing. Evidence for additional alternatively spliced transcripts was obtained from de novo junction discovery. Data from these studies support the overall complexity of IRF5 alternative splicing in SLE. Results from next-generation sequencing correlated with cloning and gave similar abundance rankings in SLE patients thus supporting the use of this new technology for in-depth single gene transcript profiling. Results from this study provide the first proof that 1) SLE patients express an IRF5 transcript signature that is distinct from healthy donors, 2) an IRF5-SLE risk haplotype defines the top four most abundant IRF5 transcripts expressed in SLE patients, and 3) an IRF5 transcript signature enables clustering of SLE patients with the H2 risk haplotype.	[Stone, Rivka C.; Feng, Di; Barnes, Betsy J.] UMDNJ, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA; [Stone, Rivka C.; Feng, Di; Barnes, Betsy J.] UMDNJ, Univ Hosp Canc Ctr, New Jersey Med Sch, Newark, NJ USA; [Du, Peicheng] UMDNJ, Dept Informat Syst & Technol, Newark, NJ USA; [Dhawan, Kopal; Donnelly, Robert] UMDNJ, New Jersey Med Sch, Mol Resource Facil, Newark, NJ USA; [Ronnblom, Lars; Eloranta, Maija-Leena] Uppsala Univ, Rheumatol Sect, Dept Med Sci, Uppsala, Sweden	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Uppsala University	Barnes, BJ (corresponding author), UMDNJ, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA.	barnesbe@umdnj.edu		Stone, Rivka C./0000-0002-7489-2123	National Institute of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [5R03AR054070]; Arthritis Foundation; Swedish Research Council; Swedish Rheumatism Association; Torsten and Ragnar Soderberg Foundation; King Gustaf V 80-year Foundation Combine; Alliance for Lupus Research; King Gustaf V 80-year Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054070] Funding Source: NIH RePORTER	National Institute of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Arthritis Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; Torsten and Ragnar Soderberg Foundation; King Gustaf V 80-year Foundation Combine; Alliance for Lupus Research; King Gustaf V 80-year Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institute of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS; 5R03AR054070), the Arthritis Foundation and the Alliance for Lupus Research (to BJB), the Swedish Research Council, the Swedish Rheumatism Association, the Torsten and Ragnar Soderberg Foundation, the King Gustaf V 80-year Foundation and Combine, the Alliance for Lupus Research (to LR), and the King Gustaf V 80-year Foundation (to MLE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez E, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3343; Aringer M, 2003, ARTHRITIS RES THER, V5, P172, DOI 10.1186/ar770; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2003, J BIOL CHEM, V278, P16630, DOI 10.1074/jbc.M212609200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Demirci FYK, 2007, ANN HUM GENET, V71, P308, DOI 10.1111/j.1469-1809.2006.00336.x; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Feng D, 2010, ARTHRITIS RHEUM-US, V62, P562, DOI 10.1002/art.27223; Flesher DLT, 2010, EXPERT REV CLIN IMMU, V6, P461, DOI [10.1586/ECI.10.8, 10.1586/eci.10.8]; Graham DSC, 2007, HUM MOL GENET, V16, P579, DOI 10.1093/hmg/ddl469; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hiller D, 2009, BIOINFORMATICS, V25, P3056, DOI 10.1093/bioinformatics/btp544; Houseley J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012271; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu GD, 2009, J BIOL CHEM, V284, P2767, DOI 10.1074/jbc.M804744200; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jarvinen TM, 2012, RHEUMATOLOGY, V51, P87, DOI 10.1093/rheumatology/ker263; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Jiang X, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r81; Kozyrev SV, 2007, AUTOIMMUNITY, V40, P591, DOI 10.1080/08916930701510905; Kozyrev SV, 2007, ARTHRITIS RHEUM, V56, P1234, DOI 10.1002/art.22497; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauwerys BR, 2002, LUPUS, V11, P384, DOI 10.1191/0961203302lu213oa; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINKERISRAELI M, 1991, J IMMUNOL, V147, P117; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niewold TB, 2007, GENES IMMUN, V56, P3995; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richez C, 2010, J IMMUNOL, V184, P796, DOI 10.4049/jimmunol.0901748; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rullo OJ, 2010, ANN RHEUM DIS, V69, P611, DOI 10.1136/ard.2009.118315; Sambrook J, 2001, MOL CLONING LAB MANU, P1169; Savitsky DA, 2010, P NATL ACAD SCI USA, V107, P10154, DOI 10.1073/pnas.1005599107; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Shen H, 2010, J MOL CELL BIOL, V2, P284, DOI 10.1093/jmcb/mjq023; Shin HD, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2152; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Stone RC, 2012, ARTHRITIS RHEUM-US, V64, P788, DOI 10.1002/art.33395; Tada Y, 2011, ARTHRITIS RHEUM-US, V63, P738, DOI 10.1002/art.30183; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Wen F, 2011, AUTOIMMUNITY, V44, P82, DOI 10.3109/08916934.2010.491842; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876	65	37	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54487	10.1371/journal.pone.0054487	http://dx.doi.org/10.1371/journal.pone.0054487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349905	Green Published, gold			2022-12-27	WOS:000313872800058
J	Ferri, F; Ebisch, SJH; Costantini, M; Salone, A; Arciero, G; Mazzola, V; Ferro, FM; Romani, GL; Gallese, V				Ferri, Francesca; Ebisch, Sjoerd J. H.; Costantini, Marcello; Salone, Anatolia; Arciero, Giampiero; Mazzola, Viridiana; Ferro, Filippo Maria; Romani, Gian Luca; Gallese, Vittorio			Binding Action and Emotion in Social Understanding	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; NEURAL SYSTEMS; BRAIN-REGIONS; REPRESENTATION; MIRROR; COMMON; IMITATION; PREMOTOR; FMRI	In social life actions are tightly linked with emotions. The integration of affective- and action-related information has to be considered as a fundamental component of appropriate social understanding. The present functional magnetic resonance imaging study aimed at investigating whether an emotion (Happiness, Anger or Neutral) dynamically expressed by an observed agent modulates brain activity underlying the perception of his grasping action. As control stimuli, participants observed the same agent either only expressing an emotion or only performing a grasping action. Our results showed that the observation of an action embedded in an emotional context (agent's facial expression), compared with the observation of the same action embedded in a neutral context, elicits higher neural response at the level of motor frontal cortices, temporal and occipital cortices, bilaterally. Particularly, the dynamic facial expression of anger modulates the re-enactment of a motor representation of the observed action. This is supported by the evidence that observing actions embedded in the context of anger, but not happiness, compared with a neutral context, elicits stronger activity in the bilateral pre-central gyrus and inferior frontal gyrus, besides the pre-supplementary motor area, a region playing a central role in motor control. Angry faces not only seem to modulate the simulation of actions, but may also trigger motor reaction. These findings suggest that emotions exert a modulatory role on action observation in different cortical areas involved in action processing.	[Ferri, Francesca; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Ferri, Francesca; Ebisch, Sjoerd J. H.; Costantini, Marcello; Romani, Gian Luca] Fdn Univ G dAnnunzio, ITAB Inst Adv Biomed Technol, Chieti, Italy; [Ebisch, Sjoerd J. H.; Costantini, Marcello; Salone, Anatolia; Romani, Gian Luca] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Salone, Anatolia; Ferro, Filippo Maria] Univ G DAnnunzio, Inst Psychiat, Chieti, Italy; [Arciero, Giampiero; Mazzola, Viridiana] IPRA Ist Psicol & Psicoterapia Post Razionalista, Rome, Italy; [Gallese, Vittorio] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Istituto Italiano di Tecnologia - IIT	Ferri, F (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	francesca.ferri@nemo.unipr.it; vittorio.gallese@unipr.it	Ferri, Francesca/AAC-2527-2022; De Berardis, Domenico/HII-7444-2022; Costantini, Marcello/F-7083-2011; De Berardis, Domenico/F-9343-2018; Gallese, Vittorio/ABD-5097-2021	Ferri, Francesca/0000-0003-1821-5870; De Berardis, Domenico/0000-0003-4415-5058; Gallese, Vittorio/0000-0003-4815-3607; Costantini, Marcello/0000-0002-0504-1296	EU grant TESIS	EU grant TESIS	This work was supported by the EU grant TESIS to Vittorio Gallese. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cook R, 2012, P ROY SOC B-BIOL SCI, V279, P780, DOI 10.1098/rspb.2011.1024; Coombes SA, 2009, COGN AFFECT BEHAV NE, V9, P380, DOI 10.3758/CABN.9.4.380; Damasio A. R., 2003, LOOKING SPINOZA JOY; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Enticott PG, 2012, NEUROSCI LETT, V508, P56, DOI 10.1016/j.neulet.2011.12.018; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Frijda Nico H., 2006, LAWS EMOTIONS; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Galati G, 2011, EUR J NEUROSCI, V34, P1871, DOI 10.1111/j.1460-9568.2011.07885.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; Gallese V, 2011, J CONSCIOUSNESS STUD, V18, P117; Gallese V, 2009, PSYCHOL RES-PSYCH FO, V73, P486, DOI 10.1007/s00426-009-0232-4; Grecucci A, 2011, ACTA PSYCHOL, V138, P311, DOI 10.1016/j.actpsy.2011.07.005; Grosbras MH, 2006, CEREB CORTEX, V16, P1087; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hamilton AFD, 2008, CEREB CORTEX, V18, P1160, DOI 10.1093/cercor/bhm150; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Knutson KM, 2008, EXP BRAIN RES, V188, P187, DOI 10.1007/s00221-008-1352-6; Lee T, 2006, RACE ETHN POLIT, P1; Lestou V, 2008, J COGNITIVE NEUROSCI, V20, P324, DOI 10.1162/jocn.2008.20021; Molenberghs P, 2011, NEUROIMAGE; Morin O, 2008, NEUROPHYSIOL CLIN, V38, P189, DOI 10.1016/j.neucli.2008.02.005; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Pichon S, 2009, NEUROIMAGE, V47, P1873, DOI 10.1016/j.neuroimage.2009.03.084; Pichon S, 2008, SOC NEUROSCI-UK, V3, P199, DOI 10.1080/17470910701394368; Piefke M, 2009, HUM BRAIN MAPP, V30, P432, DOI 10.1002/hbm.20514; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2008, NATURE, V455, P589, DOI 10.1038/455589b; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Seitz RJ, 2006, NEUROPSYCHOLOGY, V20, P743, DOI 10.1037/0894-4105.20.6.743; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Thompson JC, 2007, NEUROIMAGE, V37, P966, DOI 10.1016/j.neuroimage.2007.05.058; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van de Riet WAC, 2009, SOC NEUROSCI-UK, V4, P101, DOI 10.1080/17470910701865367; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Wyk BCV, 2009, PSYCHOL SCI, V20, P771, DOI 10.1111/j.1467-9280.2009.02359.x	58	10	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54091	10.1371/journal.pone.0054091	http://dx.doi.org/10.1371/journal.pone.0054091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	073JI	23349792	Green Published, gold			2022-12-27	WOS:000313738900038
J	Zolla-Pazner, S; deCamp, AC; Cardozo, T; Karasavvas, N; Gottardo, R; Williams, C; Morris, DE; Tomaras, G; Rao, M; Billings, E; Berman, P; Shen, XY; Andrews, C; O'Connell, RJ; Ngauy, V; Nitayaphan, S; de Souza, M; Korber, B; Koup, R; Bailer, RT; Mascola, JR; Pinter, A; Montefiori, D; Haynes, BF; Robb, ML; Rerks-Ngarm, S; Michael, NL; Gilbert, PB; Kim, JH				Zolla-Pazner, Susan; deCamp, Allan C.; Cardozo, Timothy; Karasavvas, Nicos; Gottardo, Raphael; Williams, Constance; Morris, Daryl E.; Tomaras, Georgia; Rao, Mangala; Billings, Erik; Berman, Phillip; Shen, Xiaoying; Andrews, Charla; O'Connell, Robert J.; Ngauy, Viseth; Nitayaphan, Sorachai; de Souza, Mark; Korber, Bette; Koup, Richard; Bailer, Robert T.; Mascola, John R.; Pinter, Abraham; Montefiori, David; Haynes, Barton F.; Robb, Merlin L.; Rerks-Ngarm, Supachai; Michael, Nelson L.; Gilbert, Peter B.; Kim, Jerome H.			Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; QUATERNARY NEUTRALIZING EPITOPE; V1/V2 DOMAIN; HIV-1-INFECTED INDIVIDUALS; MONOCLONAL-ANTIBODIES; CHEMOKINE RECEPTOR; GP120; POTENT; INFECTION; REGIONS	The RV144 clinical trial of a prime/boost immunizing regimen using recombinant canary pox (ALVAC-HIV) and two gp120 proteins (AIDSVAX B and E) was previously shown to have a 31.2% efficacy rate. Plasma specimens from vaccine and placebo recipients were used in an extensive set of assays to identify correlates of HIV-1 infection risk. Of six primary variables that were studied, only one displayed a significant inverse correlation with risk of infection: the antibody (Ab) response to a fusion protein containing the V1 and V2 regions of gp120 (gp70-V1V2). This finding prompted a thorough examination of the results generated with the complete panel of 13 assays measuring various V2 Abs in the stored plasma used in the initial pilot studies and those used in the subsequent case-control study. The studies revealed that the ALVAC-HIV/AIDSVAX vaccine induced V2-specific Abs that cross-react with multiple HIV-1 subgroups and recognize both conformational and linear epitopes. The conformational epitope was present on gp70-V1V2, while the predominant linear V2 epitope mapped to residues 165-178, immediately N-terminal to the putative alpha 4 beta 7 binding motif in the mid-loop region of V2. Odds ratios (ORs) were calculated to compare the risk of infection with data from 12 V2 assays, and in 11 of these, the ORs were <= 1, reaching statistical significance for two of the variables: Ab responses to gp70-V1V2 and to overlapping V2 linear peptides. It remains to be determined whether anti-V2 Ab responses were directly responsible for the reduced infection rate in RV144 and whether anti-V2 Abs will prove to be important with other candidate HIV vaccines that show efficacy, however, the results support continued dissection of Ab responses to the V2 region which may illuminate mechanisms of protection from HIV-1 infection and may facilitate the development of an effective HIV-1 vaccine.	[Zolla-Pazner, Susan] Vet Affairs Med Ctr, Res Serv, New York, NY USA; [Zolla-Pazner, Susan; Cardozo, Timothy; Williams, Constance] NYU, Sch Med, Dept Pathol, New York, NY USA; [Zolla-Pazner, Susan; Cardozo, Timothy; Williams, Constance] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [deCamp, Allan C.; Gottardo, Raphael; Morris, Daryl E.; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent SCHARP, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Karasavvas, Nicos; Ngauy, Viseth; Nitayaphan, Sorachai; de Souza, Mark] USA, Mat Command, Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Tomaras, Georgia; Shen, Xiaoying; Montefiori, David; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC USA; [Rao, Mangala; Billings, Erik; Andrews, Charla; O'Connell, Robert J.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Berman, Phillip] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Korber, Bette] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM USA; [Koup, Richard; Bailer, Robert T.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Pinter, Abraham] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Gilbert, Peter B.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); New York University; New York University; Fred Hutchinson Cancer Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Duke University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California Santa Cruz; United States Department of Energy (DOE); Los Alamos National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; Rutgers State University Medical Center; Ministry of Public Health - Thailand; University of Washington; University of Washington Seattle	Zolla-Pazner, S (corresponding author), Vet Affairs Med Ctr, Res Serv, New York, NY USA.	zollas01@nyumc.org	Morris, Daryl E/H-2659-2013; Zolla-Pazner, Susan/S-1864-2019; Gottardo, Raphael/HCH-3169-2022; Tomaras, Georgia/J-5041-2016; Mascola, John/AAI-7193-2021	Zolla-Pazner, Susan/0000-0002-0750-2666; Korber, Bette/0000-0002-2026-5757; Gottardo, Raphael/0000-0002-3867-0232	NIH [HL59725, AI084119, U01, UM1AI-068618]; Military HIV Research Program (MHRP); Department of Veterans Affairs; Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); Interagency Agreement between the U.S. Army Medical Research and Material Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; cooperative agreement between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; Center for HIV/AIDS Vaccine Immunology [AI067854]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI002642, UM1AI068635, R01AI084119, U01AI067854, ZICAI005123, ZIAAI005073, UM1AI068618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Military HIV Research Program (MHRP); Department of Veterans Affairs(US Department of Veterans Affairs); Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); Interagency Agreement between the U.S. Army Medical Research and Material Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases; cooperative agreement between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the U.S. Department of Defense (DOD); Center for HIV/AIDS Vaccine Immunology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by NIH grants HL59725 (SZP) and AI084119 (TC), by a contract from the Military HIV Research Program (MHRP) to the Fred Hutchinson Cancer Research Center and NYU, by research funds from the Department of Veterans Affairs, the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD), grants to DCM, RK, BFH and SZP, and by an Interagency Agreement Y1-AI-2642-12 between the U.S. Army Medical Research and Material Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases. This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the U.S. Department of Defense (DOD), by a U01-grant from the NIH, AI067854 (the Center for HIV/AIDS Vaccine Immunology), and by NIH grant UM1AI-068618 to the HVTN Laboratory Program. The opinions herein are those of the authors and should not be construed as official or representing the views of the U.S. Department of Health and Human Services, National Institute for Allergy and Infectious Diseases, the Department of Defense, the Department of the Army, or the Department of Veterans Affairs. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gorny M.K., 1994, CELL BIOL LAB HDB, P276; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; GORNY MK, 1993, J IMMUNOL, V150, P635; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hill CM, 1997, J VIROL, V71, P6296, DOI 10.1128/JVI.71.9.6296-6304.1997; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Israel ZR, 1997, AIDS, V11, P128; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; KAYMAN SC, 1994, J VIROL, V68, P400, DOI 10.1128/JVI.68.1.400-410.1994; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Nakamura GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039045; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Nyambi PN, 2000, J VIROL, V74, P10670, DOI 10.1128/JVI.74.22.10670-10680.2000; Nyambi PN, 2000, J VIROL, V74, P7096, DOI 10.1128/JVI.74.15.7096-7107.2000; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Spurrier B, 2011, STRUCTURE, V19, P691, DOI 10.1016/j.str.2011.02.012; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; ZOLLAPAZNER S, 1995, J VIROL, V69, P3807, DOI 10.1128/JVI.69.6.3807-3815.1995	45	126	130	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53629	10.1371/journal.pone.0053629	http://dx.doi.org/10.1371/journal.pone.0053629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349725	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900015
J	Zorzi, F; Monteleone, I; Sarra, M; Calabrese, E; Marafini, I; Cretella, M; Sedda, S; Biancone, L; Pallone, F; Monteleone, G				Zorzi, Francesca; Monteleone, Ivan; Sarra, Massimiliano; Calabrese, Emma; Marafini, Irene; Cretella, Micaela; Sedda, Silvia; Biancone, Livia; Pallone, Francesco; Monteleone, Giovanni			Distinct Profiles of Effector Cytokines Mark the Different Phases of Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL COLITIS; TGF-BETA; CELLS; INTERLEUKIN-12; SMAD7; GAMMA; RECURRENCE; TGF-BETA-1	Objective: Crohn's Disease (CD)-associated inflammation is supposed to be driven by T helper (Th)1/Th17 cell-derived cytokines, even though there is evidence that the mucosal profile of cytokine may vary with the evolution of the disease. We aimed at comparing the pattern of effector cytokines in early and established lesions of CD. Design: Mucosal samples were taken from the neo-terminal ileum of CD patients undergoing ileocolonic resection, with (early lesions) or without post-operative recurrence, and terminal ileum of CD patients with long-standing disease undergoing intestinal resection (established lesions). Inflammatory cell infiltrate was examined by immunofluorescence and cytokine expression was analysed by real-time PCR, flow-cytometry and ELISA. Results: Before the appearance of endoscopic lesions, the mucosa of the neo-terminal ileum contained high number of T cells and macrophages, elevated levels of Th1-related cytokines and TNF-alpha and slightly increased IL-17A expression. Transition from this stage to endoscopic recurrence was marked by abundance of Th1 cytokines, marked increase in IL-17A, and induction of IL-6 and IL-23, two cytokines involved in the control of Th17 cell responses. In samples with established lesions, there was a mixed Th1/Th17 response with no TNF-alpha induction. Expression of IL-4 and IL-5 was up-regulated in both early and established lesions even though the fraction of IL-4-producing cells was lower than that of cells producing either interferon-gamma or IL-17A. Conclusions: Distinct mucosal profiles of cytokines are produced during the different phases of CD. A better understanding of the cytokines temporally regulated in CD tissue could help optimize therapeutic interventions in CD.	[Zorzi, Francesca; Monteleone, Ivan; Sarra, Massimiliano; Calabrese, Emma; Marafini, Irene; Cretella, Micaela; Sedda, Silvia; Biancone, Livia; Pallone, Francesco; Monteleone, Giovanni] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy	University of Rome Tor Vergata	Monteleone, G (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.	Gi.monteleone@med.uniroma2.it	Monteleone, Giovanni/AAE-1418-2021; Monteleone, Ivan/AEW-2892-2022; Calabrese, Emma/AHD-4752-2022	Monteleone, Ivan/0000-0002-3212-832X	"Fondazione Umberto Di MarioOnlus'' (Rome, Italy); Giuliani SpA, Milan, Italy	"Fondazione Umberto Di MarioOnlus'' (Rome, Italy); Giuliani SpA, Milan, Italy	This work was supported by "Fondazione Umberto Di MarioOnlus'' (Rome, Italy) and Giuliani SpA, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors state that this work was supported by "Fondazione Umberto Di Mario Onlus'' (Rome, Italy) and Giuliani SpA, Milan, Italy. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Biank V, 2007, INFLAMM BOWEL DIS, V13, P1430, DOI 10.1002/ibd.20213; Desreumaux P, 1997, GASTROENTEROLOGY, V113, P118, DOI 10.1016/S0016-5085(97)70116-1; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kugathasan S, 2007, GUT, V56, P1696, DOI 10.1136/gut.2006.116467; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; McLeod RS, 1997, GASTROENTEROLOGY, V113, P1823, DOI 10.1016/S0016-5085(97)70001-5; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; Monteleone G, 1999, J IMMUNOL, V163, P143; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; Monteleone G, 1998, GUT, V43, P620, DOI 10.1136/gut.43.5.620; Monteleone G, 2010, CLIN SCI, V118, P707, DOI 10.1042/CS20100027; Monteleone I, 2011, ANN MED, V43, P172, DOI 10.3109/07853890.2010.531758; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; OLAISON G, 1992, GUT, V33, P331, DOI 10.1136/gut.33.3.331; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Regueiro M, 2009, GASTROENTEROLOGY, V136, P441, DOI 10.1053/j.gastro.2008.10.051; Reinisch W, 2006, GUT, V55, P1138, DOI 10.1136/gut.2005.079434; Reinisch W, 2012, INFLAMM BOWEL DIS, V16, P233; Renna S, 2008, GASTROENTEROLOGY, V135, P1500, DOI 10.1053/j.gastro.2008.07.066; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P956, DOI 10.1016/0016-5085(90)90613-6; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1332, DOI 10.1002/ibd.21238; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Spencer DM, 2002, GASTROENTEROLOGY, V122, P94, DOI 10.1053/gast.2002.30308; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	37	67	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54562	10.1371/journal.pone.0054562	http://dx.doi.org/10.1371/journal.pone.0054562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349929	gold, Green Submitted, Green Published			2022-12-27	WOS:000313738900078
J	Tabong, PTN; Adongo, PB				Tabong, Philip Teg-Nefaah; Adongo, Philip Baba			Understanding the Social Meaning of Infertility and Childbearing: A Qualitative Study of the Perception of Childbearing and Childlessness in Northern Ghana	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; KASSENA-NANKANA; FERTILITY; CHILDREN; COUPLES	Background: Infertility is a major medical condition that affects many married couples in sub-Saharan African and as such associated with several social meanings. This study therefore explored community's perception of childbearing and childlessness in Northern Ghana using the Upper West Region as a case study. Methods: The study was exploratory and qualitative using in-depth and key informant interviews and focus group discussions. Fifteen marriage unions with infertility (childless), forty-five couples with children, and eight key informants were purposively sampled and interviewed using a semi-structured interview guides. Three focus group discussions were also carried out, one for childless women, one for women with children and one with men with children. The data collected were transcribed, coded, arranged, and analyzed for categories and themes and finally triangulated. Results: The study revealed that infertility was caused by both social and biological factors. Socially couples could become infertile through supernatural causes such as bewitchment, and disobediences of social norms. Abortion, masturbation and use of contraceptives were also identified as causes of infertility. Most childless couples seek treatment from spiritualist, traditional healers and hospital. These sources of treatment are used simultaneously. Conclusion: Childbearing is highly valued in the community and Childlessness is highly engendered, and stigmatised in this community with manifold social consequences. In such a community therefore, the concept of reproductive choice must encompass policies that make it possible for couples to aspire to have the number of children they wish.	[Tabong, Philip Teg-Nefaah] Brong Ahafo Reg Hosp, Ghana Hlth Serv, Sunyani, Ghana; [Adongo, Philip Baba] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Social & Behav Sci, Legon, Ghana	University of Ghana	Adongo, PB (corresponding author), Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Social & Behav Sci, Legon, Ghana.	philgh2001@yahoo.com	Tabong, Philip Teg-Nefaah/AAG-5478-2020	Tabong, Philip/0000-0001-9445-1643; Adongo, Philip Baba/0000-0002-0614-4756				Adongo P., 1998, AFR J REPROD HEALTH, V2, P25; Adongo PB, 1997, SOC SCI MED, V45, P1789, DOI 10.1016/S0277-9536(97)00110-X; Adongo PB, 1998, STUD FAMILY PLANN, V29, P23, DOI 10.2307/172179; [Anonymous], 2012, FERT ASS TREATM PEOP; Bharadwaj A, 2002, SEXUAL HLTH EXCHANGE, P14; Donkor Ernestina S, 2009, Afr J Reprod Health, V13, P81; Dyer SJ, 2007, J PSYCHOSOM OBST GYN, V28, P69, DOI 10.1080/01674820701409959; Dyer SJ, 2004, HUM REPROD, V19, P960, DOI 10.1093/humrep/deh195; FATHALLA MF, 1992, EARLY HUM DEV, V29, P35, DOI 10.1016/0378-3782(92)90055-L; FIANDER A, 1990, TROP DOCT, V20, P98, DOI 10.1177/004947559002000302; Fidler AT, 1999, PUBLIC HEALTH REP, V114, P494, DOI 10.1093/phr/114.6.494; Ford WCL, 2000, HUM REPROD, V15, P1703, DOI 10.1093/humrep/15.8.1703; Geelhoed DW, 2002, INT J GYNECOL OBSTET, V79, P137, DOI 10.1016/S0020-7292(02)00237-0; Gerrity D., 2001, FAMILY J, V9, P151, DOI [10.1177/1066480701092009, DOI 10.1177/1066480701092009]; Ghana Statistical Service, 2011, GHAN POP HOUS CENS R; Ghana Statistical Service (GSS) Noguchi Memorial Institute for Medical Research (NMIMR) and ORC Macro, 2004, GHAN DEM HLTH SURV 2; Gibson DM, 2002, J MENTAL HLTH COUNSE, V24, P68; Gocze PM, 2000, EUR J OBSTET GYN R B, V93, P77, DOI 10.1016/S0301-2115(00)00254-2; HAILE A, 1990, STUD FAMILY PLANN, V21, P110, DOI 10.2307/1966672; Haimes K, 2004, HUMAN REPROD, V8, P1039; HORTON R, 1993, LANCET, V342, P45, DOI 10.1016/0140-6736(93)91899-W; Larsen U, 2000, INT J EPIDEMIOL, V29, P285, DOI 10.1093/ije/29.2.285; McLachlan R, 2007, ANDROLOGY AUTRALIA, P1; MIALL CE, 1985, DEVIANT BEHAV, V6, P383, DOI 10.1080/01639625.1985.9967686; Naples NA, 2003, FEMINISM METHOD ETHN, P123; Okonofua FE, 1996, BRIT J OBSTET GYNAEC, V103, P957, DOI 10.1111/j.1471-0528.1996.tb09542.x; Roupa Z., 2009, HLTH SCI J, V3, P80; ROWE PJ, 1987, FERTIL STERIL, V47, P964; Sundby J, 1998, SOC SCI MED, V46, P891, DOI 10.1016/S0277-9536(97)00215-3; Warren C.A.B., 2015, DISCOVERING QUALITAT; Wischmann T, 2001, HUM REPROD, V16, P1753, DOI 10.1093/humrep/16.8.1753; World Health Organization (WHO), 1991, WHOMCH919	32	57	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54429	10.1371/journal.pone.0054429	http://dx.doi.org/10.1371/journal.pone.0054429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342158	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700116
J	Treguer, K; Faucheux, C; Veschambre, P; Fedou, S; Theze, N; Thiebaud, P				Treguer, Karine; Faucheux, Corinne; Veschambre, Philippe; Fedou, Sandrine; Theze, Nadine; Thiebaud, Pierre			Comparative Functional Analysis of ZFP36 Genes during Xenopus Development	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; AU-RICH ELEMENT; RNA-BINDING PROTEINS; MESSENGER-RNA; TRISTETRAPROLIN; EXPRESSION; PRONEPHROS; CLONING; FAMILY; KIDNEY	ZFP36 constitutes a small family of RNA binding proteins (formerly known as the TIS11 family) that target mRNA and promote their degradation. In mammals, ZFP36 proteins are encoded by four genes and, although they show similar activities in a cellular RNA destabilization assay, there is still a limited knowledge of their mRNA targets and it is not known whether or not they have redundant functions. In the present work, we have used the Xenopus embryo, a model system allowing gain- and loss-of-function studies, to investigate, whether individual ZFP36 proteins had distinct or redundant functions. We show that overexpression of individual amphibian zfp36 proteins leads to embryos having the same defects, with alteration in somites segmentation and pronephros formation. In these embryos, members of the Notch signalling pathway such as hairy2a or esr5 mRNA are down-regulated, suggesting common targets for the different proteins. We also show that mouse Zfp36 protein overexpression gives the same phenotype, indicating an evolutionary conserved property among ZFP36 vertebrate proteins. Morpholino oligonucleotide-induced loss-of-function leads to defects in pronephros formation, reduction in tubule size and duct coiling alterations for both zfp36 and zfp36l1, indicating no functional redundancy between these two genes. Given the conservation in gene structure and function between the amphibian and mammalian proteins and the conserved mechanisms for pronephros development, our study highlights a potential and hitherto unreported role of ZFP36 gene in kidney morphogenesis.	[Treguer, Karine; Faucheux, Corinne; Veschambre, Philippe; Fedou, Sandrine; Theze, Nadine; Thiebaud, Pierre] Univ Bordeaux, Bordeaux, France; [Treguer, Karine; Faucheux, Corinne; Veschambre, Philippe; Fedou, Sandrine; Theze, Nadine; Thiebaud, Pierre] CNRS, UMR 5164, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Thiebaud, P (corresponding author), Univ Bordeaux, Bordeaux, France.	pierre.thiebaud@u-bordeaux2.fr		THIEBAUD, Pierre/0000-0003-1174-1616; Philippe, Veschambre/0000-0001-6094-6795	University Bordeaux Segalen; CNRS (Centre national de la recherche scientifique); Association Francaise contre les Myopathies; French Ministry for Research and Education; NICHD	University Bordeaux Segalen; CNRS (Centre national de la recherche scientifique)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); French Ministry for Research and Education; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by fundings from the University Bordeaux Segalen, the CNRS (Centre national de la recherche scientifique) and the "Association Francaise contre les Myopathies". KT was supported by a PhD fellowship from the French Ministry for Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr Elizabeth Jones for the generous gift of 3G8 and 4A6 antibodies and Drs Susanne Kuhl, Muriel Perron, Eric Bellefroid, Bruno Della Gaspera, Sergei Sokol, Tomas Pieler for plasmids and advices with technical help. We thank Drs Isabelle Neant, Catherine Leclerc and Marc Moreau for their help with the pronephros animal cap inducing technique. We thank Dr Helene Boeuf for providing samples and Dr Tim Mohun for careful reading of the manuscript. The 12/101 antibody developed by J. P. Brockes was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences. We thank the SERCOMI for its help with scanning electronic microscopy analyses and Lionel Parra Iglesias for taking care of our Xenopus colony.	Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Chan TC, 2000, DEV BIOL, V228, P256, DOI 10.1006/dbio.2000.9951; Chan XY, 2011, DEV BIOL, V349, P102, DOI 10.1016/j.ydbio.2010.10.001; Cheng HT, 2005, KIDNEY INT, V68, P1951, DOI 10.1111/j.1523-1755.2005.00627.x; De J, 1999, GENE, V228, P133, DOI 10.1016/S0378-1119(98)00617-9; Della Gaspera B, 2006, DEV DYNAM, V235, P524, DOI 10.1002/dvdy.20628; Dichmann DS, 2008, DEV DYNAM, V237, P1755, DOI 10.1002/dvdy.21590; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Dudziak K, 2008, KIDNEY INT, V74, P210, DOI 10.1038/ki.2008.149; Gautier-Courteille C, 2004, DEVELOPMENT, V131, P6107, DOI 10.1242/dev.01528; Haldin CE, 2008, DEV BIOL, V322, P74, DOI 10.1016/j.ydbio.2008.07.012; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; HEXIMER SP, 1993, DNA CELL BIOL, V12, P73, DOI 10.1089/dna.1993.12.73; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Huot ME, 2005, MOL BIOL CELL, V16, P4350, DOI 10.1091/mbc.E05-04-0304; Jen WC, 1999, GENE DEV, V13, P1486, DOI 10.1101/gad.13.11.1486; Jen WC, 1997, DEVELOPMENT, V124, P1169; Kaneko T, 2003, BIOCHEM BIOPH RES CO, V308, P566, DOI 10.1016/S0006-291X(03)01419-0; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kronnie GT, 1999, DEV GENES EVOL, V209, P443, DOI 10.1007/s004270050276; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Leclerc C, 2008, DEV BIOL, V321, P357, DOI 10.1016/j.ydbio.2008.06.029; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; MA QF, 1994, ONCOGENE, V9, P3329; McCright B, 2001, DEVELOPMENT, V128, P491; McLaughlin KA, 2000, DEV BIOL, V227, P567, DOI 10.1006/dbio.2000.9913; Michel SLJ, 2003, BIOCHEMISTRY-US, V42, P4626, DOI 10.1021/bi034073h; Murugan S, 2012, EXP CELL RES, V318, P1134, DOI 10.1016/j.yexcr.2012.03.008; Naye F, 2007, INT J DEV BIOL, V51, P745, DOI 10.1387/ijdb.072375fn; Naylor RW, 2009, DEVELOPMENT, V136, P3585, DOI 10.1242/dev.042606; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Saka Y, 2001, DEV BIOL, V229, P307, DOI 10.1006/dbio.2000.0101; Sato A, 2000, MECH DEVELOP, V92, P273, DOI 10.1016/S0925-4773(99)00331-7; Saulnier DME, 2002, DEV BIOL, V248, P13, DOI 10.1006/dbio.2002.0712; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH JC, 1985, DIFFERENTIATION, V29, P109, DOI 10.1111/j.1432-0436.1985.tb00302.x; Stevens CJM, 1998, INT J DEV BIOL, V42, P181; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Taelman V, 2004, DEV BIOL, V276, P47, DOI 10.1016/j.ydbio.2004.08.019; Taelman V, 2006, DEVELOPMENT, V133, P2961, DOI 10.1242/dev.02458; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tecza A, 2011, BIOL CELL, V103, P483, DOI 10.1042/BC20110032; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; Van Campenhout C, 2006, DEV BIOL, V294, P203, DOI 10.1016/j.ydbio.2006.02.040; VARNUM BC, 1989, ONCOGENE, V4, P119; VIZE PD, 1995, DEV BIOL, V171, P531, DOI 10.1006/dbio.1995.1302; Wallingford JB, 1998, DEV BIOL, V202, P103, DOI 10.1006/dbio.1998.8989; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200	64	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54550	10.1371/journal.pone.0054550	http://dx.doi.org/10.1371/journal.pone.0054550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342169	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700124
J	Vrba, L; Munoz-Rodriguez, JL; Stampfer, MR; Futscher, BW				Vrba, Lukas; Munoz-Rodriguez, Jose L.; Stampfer, Martha R.; Futscher, Bernard W.			miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; FEEDBACK LOOP; EARLY EVENT; EXPRESSION; HYPERMETHYLATION; MICRORNAS; CELLS; INACTIVATION; MIR-34A; P53	miRNAs are important regulators of gene expression that are frequently deregulated in cancer, with aberrant DNA methylation being an epigenetic mechanism involved in this process. We previously identified miRNA promoter regions active in normal mammary cell types and here we analyzed which of these promoters are targets of aberrant DNA methylation in human breast cancer cell lines and breast tumor specimens. Using 5-methylcytosine immunoprecipitation coupled to miRNA tiling microarray hybridization, we performed comprehensive evaluation of DNA methylation of miRNA gene promoters in breast cancer. We found almost one third (55/167) of miRNA promoters were targets for aberrant methylation in breast cancer cell lines. Breast tumor specimens displayed DNA methylation of majority of these miRNA promoters, indicating that these changes in DNA methylation might be clinically relevant. Aberrantly methylated miRNA promoters were, similar to protein coding genes, enriched for promoters targeted by polycomb in normal cells. Detailed analysis of selected miRNA promoters revealed decreased expression of miRNA linked to increased promoter methylation for mir-31, mir-130a, let-7a-3/let-7b, mir-155, mir-137 and mir-34b/mir-34c genes. The proportion of miRNA promoters we found aberrantly methylated in breast cancer is several fold larger than that observed for protein coding genes, indicating an important role of DNA methylation in miRNA deregulation in cancer.	[Vrba, Lukas; Munoz-Rodriguez, Jose L.; Stampfer, Martha R.; Futscher, Bernard W.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA; [Munoz-Rodriguez, Jose L.; Futscher, Bernard W.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Stampfer, Martha R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Vrba, Lukas] Acad Sci Czech Republic, Inst Plant Mol Biol, Ctr Biol, Vvi, CR-37005 Ceske Budejovice, Czech Republic	Arizona Center Cancer Care; University of Arizona; University of Arizona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Futscher, BW (corresponding author), Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA.	bfutscher@azcc.arizona.edu	Rodríguez, Jose Manuel JMMR Muñoz/A-7323-2016; Vrba, Lukas/J-9268-2015	Rodríguez, Jose Manuel JMMR Muñoz/0000-0002-4688-6420; Vrba, Lukas/0000-0003-3042-6275	Margaret E. and Fenton L. Maynard Endowment for Breast Cancer Research;  [1U01CA153086];  [P30 CA023074];  [P30 ES006694]; NATIONAL CANCER INSTITUTE [U01CA153086, P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	Margaret E. and Fenton L. Maynard Endowment for Breast Cancer Research; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant 1U01CA153086; center grants P30 CA023074 and P30 ES006694; and Margaret E. and Fenton L. Maynard Endowment for Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Futscher BW, 2004, NEOPLASIA, V6, P380, DOI 10.1593/neo.04115; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GUAN XY, 1994, NAT GENET, V8, P155, DOI 10.1038/ng1094-155; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Oshiro MM, 2003, ONCOGENE, V22, P3624, DOI 10.1038/sj.onc.1206545; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435	39	99	114	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54398	10.1371/journal.pone.0054398	http://dx.doi.org/10.1371/journal.pone.0054398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342147	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700112
J	Ayala, E; Carnero, AM				Ayala, Elizabeth; Carnero, Andres M.			Determinants of Burnout in Acute and Critical Care Military Nursing Personnel: A Cross-Sectional Study from Peru	PLOS ONE			English	Article							CLINICAL VALIDITY; NURSES; STRESS; REGRESSION; INVENTORY; SYMPTOMS; MODEL; STAFF	Background: Evidence on the prevalence and determinants of burnout among military acute and critical care nursing personnel from developing countries is minimal, precluding the development of effective preventive measures for this high-risk occupational group. In this context, we aimed to examine the association between the dimensions of burnout and selected socio-demographic and occupational factors in military acute/critical care nursing personnel from Lima, Peru. Methods and Findings: We conducted a cross-sectional study in 93 nurses/nurse assistants from the acute and critical care departments of a large, national reference, military hospital in Lima, Peru, using a socio-demographic/occupational questionnaire and a validated Spanish translation of the Maslach Burnout Inventory. Total scores for each of the burnout dimensions were calculated for each participant. Higher emotional exhaustion and depersonalisation scores, and lower personal achievement scores, implied a higher degree of burnout. We used linear regression to evaluate the association between each of the burnout dimensions and selected socio-demographic and occupational characteristics, after adjusting for potential confounders. The associations of the burnout dimensions were heterogeneous for the different socio-demographic and occupational factors. Higher emotional exhaustion scores were independently associated with having children (p<0.05) and inversely associated with the time working in the current department (p<0.05). Higher depersonalization scores were independently associated with being single compared with being divorced, separated or widowed (p<0.01), working in the emergency room/intensive care unit compared with the recovery room (p<0.01), and inversely associated with age (p<0.05). Finally, higher personal achievement scores were independently associated with having children (p<0.05). Conclusion: Among Peruvian military acute and critical care nursing personnel, potential screening and preventive interventions should focus on younger/less experienced nurses/nurse assistants, who are single, have children, or work in the most acute critical care areas (e. g. the emergency room/intensive care unit).	[Ayala, Elizabeth] Hosp Cent Fuerza Aerea Peru, Crit Care Dept, Lima, Peru; [Carnero, Andres M.] Univ Peruana Cayetano Heredia, Postgrad Sch, Lima, Peru	Universidad Peruana Cayetano Heredia	Carnero, AM (corresponding author), Univ Peruana Cayetano Heredia, Postgrad Sch, Lima, Peru.	andrescarnero@gmail.com		Carnero, Andres/0000-0002-9372-0378				Adeb-Saeedi J, 2002, AUST EMERG NURS J, V5, P19, DOI DOI 10.1016/S1328-2743(02)80015-3; Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Azoulay E, 2009, AM J RESP CRIT CARE, V180, P853, DOI 10.1164/rccm.200810-1614OC; Bakir B, 2010, KLIN PSIKOFARMAKOL B, V20, P160, DOI 10.1080/10177833.2010.11790651; Bakker AB, 2005, J ADV NURS, V51, P276, DOI 10.1111/j.1365-2648.2005.03494.x; BARTZ C, 1986, RES NURS HEALTH, V9, P147, DOI 10.1002/nur.4770090210; Browning Laura, 2007, Psychol Health Med, V12, P248; Caceres-Bermejo GG, 2009, SANIDAD MILITAR, V65, P83; Cooper CE, 2002, J NURS ADMIN, V32, P162, DOI 10.1097/00005110-200203000-00009; Davey MM, 2009, J NURS MANAGE, V17, P312, DOI 10.1111/j.1365-2834.2008.00958.x; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demir A, 2003, INT J NURS STUD, V40, P807, DOI 10.1016/S0020-7489(03)00077-4; DePew CL, 1999, J BURN CARE REHABIL, V20, P515; Donchin Yoel, 2002, Curr Opin Crit Care, V8, P316, DOI 10.1097/00075198-200208000-00008; Elpern EH, 2005, AM J CRIT CARE, V14, P523, DOI 10.4037/ajcc2005.14.6.523; Embriaco N, 2007, CURR OPIN CRIT CARE, V13, P482, DOI 10.1097/MCC.0b013e3282efd28a; Figueiredo-Ferraz H, 2012, PSICOTHEMA, V24, P271; Fujimoto T, 2008, J CLIN NURS, V17, P3286, DOI 10.1111/j.1365-2702.2008.02643.x; Gibbons SW, 2012, J ADV NURS, V68, P3, DOI 10.1111/j.1365-2648.2011.05708.x; Gil-Monte PR, 2005, REV SAUDE PUBL, V39, P1, DOI 10.1590/S0034-89102005000100001; Gillespie M, 2003, J CLIN NURS, V12, P842, DOI 10.1046/j.1365-2702.2003.00802.x; Halbesleben JRB, 2010, J OCCUP HEALTH PSYCH, V15, P1, DOI 10.1037/a0017634; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; Jennings BM, 2008, PATIENT SAFETY QUALI, P1; Kashani M, 2010, MIL MED, V175, P96, DOI 10.7205/MILMED-D-09-00092; Kelley MA, 2004, CHEST, V125, P1514, DOI 10.1378/chest.125.4.1514; Kenny Deborah J, 2008, Crit Care Nurs Clin North Am, V20, P41, DOI 10.1016/j.ccell.2007.10.013; Lambert V A, 2001, Nurs Health Sci, V3, P161, DOI 10.1046/j.1442-2018.2001.00086.x; Lang GM, 2012, J NURS SCHOLARSHIP, V44, P274, DOI 10.1111/j.1547-5069.2012.01462.x; Lang GM, 2010, MIL MED, V175, P435, DOI 10.7205/MILMED-D-09-00284; Laposa Judith M, 2003, J Emerg Nurs, V29, P23, DOI 10.1067/men.2003.7; Leiter MP, 2009, J NURS MANAGE, V17, P331, DOI 10.1111/j.1365-2834.2009.01004.x; Leiter MP, 2005, ANXIETY STRESS COPIN, V18, P131, DOI 10.1080/10615800500082473; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; McVicar A, 2003, J ADV NURS, V44, P633, DOI 10.1046/j.0309-2402.2003.02853.x; Mealer ML, 2007, AM J RESP CRIT CARE, V175, P693, DOI 10.1164/rccm.200606-735OC; Patrician PA, 2010, RES NURS HEALTH, V33, P99, DOI 10.1002/nur.20370; Pearson A, 2001, Int J Nurs Pract, V7, pS21, DOI 10.1046/j.1440-172X.2001.00330.x; Poghosyan L, 2010, RES NURS HEALTH, V33, P288, DOI 10.1002/nur.20383; Poghosyan L, 2009, INT J NURS STUD, V46, P894, DOI 10.1016/j.ijnurstu.2009.03.004; Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC; ROBINSON SE, 1993, J ADV NURS, V18, P1146, DOI 10.1046/j.1365-2648.1993.18071146.x; Sahraian A, 2008, INT NURS REV, V55, P62, DOI 10.1111/j.1466-7657.2007.00582.x; Schaufeli W.B., 2003, HDB WORK HLTH PSYCHO, V2, P282, DOI DOI 10.1002/0470013400.CH19; Schaufeli WB, 2001, PSYCHOL HEALTH, V16, P565, DOI 10.1080/08870440108405527; SCHAUFELI WB, 1995, PSYCHOL REP, V76, P1083, DOI 10.2466/pr0.1995.76.3c.1083; Shirom A, 2005, INT REV IND ORGAN PS, V20, P269; Steinbrook R, 2002, NEW ENGL J MED, V346, P1757, DOI 10.1056/NEJM200205303462225; Suner-Soler R, 2013, J Psychiatr Ment Health Nurs, V20, P305, DOI 10.1111/j.1365-2850.2012.01897.x; Tekindal B, 2012, INT J NURS PRACT, V18, P68, DOI 10.1111/j.1440-172X.2011.01989.x; Vahey DC, 2004, MED CARE, V42, P57, DOI 10.1097/01.mlr.0000109126.50398.5a	55	46	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54408	10.1371/journal.pone.0054408	http://dx.doi.org/10.1371/journal.pone.0054408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23342152	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400161
J	Bar, M; Leibman, M; Schuster, S; Pitzhadza, H; Avni, A				Bar, Maya; Leibman, Meirav; Schuster, Silvia; Pitzhadza, Hilla; Avni, Adi			EHD1 Functions in Endosomal Recycling and Confers Salt Tolerance	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEINS; C-ELEGANS; VESICULAR TRAFFICKING; ENDOCYTIC PATHWAY; MAMMALIAN-CELLS; PLASMA-MEMBRANE; AUXIN TRANSPORT; ARABIDOPSIS; RECEPTOR; PLANTS	Endocytosis is a crucial process in all eukaryotic organisms including plants. We have previously shown that two Arabidopsis proteins, AtEHD1 and AtEHD2, are involved in endocytosis in plant systems. Knock-down of EHD1 was shown to have a delayed recycling phenotype in mammalians. There are many works in mammalian systems detailing the importance of the various domains in EHDs but, to date, the domains of plant EHD1 that are required for its activity have not been characterized. In this work we demonstrate that knock-down of EHD1 causes a delayed recycling phenotype and reduces Brefeldin A sensitivity in Arabidopsis seedlings. The EH domain of EHD1 was found to be crucial for the localization of EHD1 to endosomal structures. Mutant EHD1 lacking the EH domain did not localize to endosomal structures and showed a phenotype similar to that of EHD1 knock-down seedlings. Mutants lacking the coiled-coil domain, however, showed a phenotype similar to wild-type or EHD1 overexpression seedlings. Salinity stress is a major problem in current agriculture. Microarray data demonstrated that salinity stress enhances the expression of EHD1, and this was confirmed by semi quantitative RT-PCR. We demonstrate herein that transgenic plants over expressing EHD1 possess enhanced tolerance to salt stress, a property which also requires an intact EH domain.	[Bar, Maya; Leibman, Meirav; Schuster, Silvia; Pitzhadza, Hilla; Avni, Adi] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel	Tel Aviv University	Avni, A (corresponding author), Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel.	Lpavni@post.tau.ac.il	Avni, Adi/R-9048-2017	Avni, Adi/0000-0003-2092-9768; Bar, Maya/0000-0002-7823-9121	Israel Science Foundation [388/12]; Manna Center for Plant Biosciences, Tel Aviv University	Israel Science Foundation(Israel Science Foundation); Manna Center for Plant Biosciences, Tel Aviv University	This work was partly supported by the Israel Science Foundation administered by the Israel Academy of Science and Humanities no. 388/12 and the Manna Center for Plant Biosciences, Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2008, PLANT J, V55, P1025, DOI 10.1111/j.1365-313X.2008.03571.x; Bar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007973; Bar M, 2009, PLANT J, V59, P600, DOI 10.1111/j.1365-313X.2009.03897.x; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Carbone R, 1997, CANCER RES, V57, P5498; Chow CM, 2008, PLANT CELL, V20, P101, DOI 10.1105/tpc.107.052001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; DiFiore PP, 1997, TRENDS BIOCHEM SCI, V22, P411, DOI 10.1016/S0968-0004(97)01127-4; Dubrovsky JG, 2006, ANN BOT-LONDON, V97, P1127, DOI 10.1093/aob/mcl045; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Galperin E, 2000, GENOMICS UNPUB; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Irani NG, 2009, CURR OPIN PLANT BIOL, V12, P653, DOI 10.1016/j.pbi.2009.09.011; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kaye Y, 2011, PLANT PHYSIOL, V157, P229, DOI 10.1104/pp.111.176883; Kim SJ, 2011, PLANT PHYSIOL, V156, P514, DOI 10.1104/pp.110.168963; Kleine-Vehn J, 2008, ANNU REV CELL DEV BI, V24, P447, DOI 10.1146/annurev.cellbio.24.110707.175254; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Leborgne-Castel N, 2010, PROTOPLASMA, V247, P177, DOI 10.1007/s00709-010-0195-8; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lisboa S, 2008, PLANT CELL REP, V27, P21, DOI 10.1007/s00299-007-0437-1; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Muller J, 2007, PLANT PHYSIOL, V145, P293, DOI 10.1104/pp.107.102863; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murphy AS, 2005, ANNU REV PLANT BIOL, V56, P221, DOI 10.1146/annurev.arplant.56.032604.144150; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; Olswang-Kutz Y, 2009, J CELL SCI, V122, P471, DOI 10.1242/jcs.038521; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; Polo Simona, 2003, Sci STKE, V2003, pre17, DOI 10.1126/stke.2132003re17; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Robatzek S, 2007, CELL MICROBIOL, V9, P1, DOI 10.1111/j.1462-5822.2006.00829.x; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Samaj J, 2005, TRENDS CELL BIOL, V15, P425, DOI 10.1016/j.tcb.2005.06.006; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Silady RA, 2008, PLANT J, V53, P29, DOI 10.1111/j.1365-313X.2007.03314.x; Takac T, 2011, J PROTEOME RES, V10, P488, DOI 10.1021/pr100690f; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	60	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54533	10.1371/journal.pone.0054533	http://dx.doi.org/10.1371/journal.pone.0054533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342166	Green Published, gold			2022-12-27	WOS:000314759400167
J	Hall, JA; Melendez, LD; Jewell, DE				Hall, Jean A.; Melendez, Lynda D.; Jewell, Dennis E.			Using Gross Energy Improves Metabolizable Energy Predictive Equations for Pet Foods Whereas Undigested Protein and Fiber Content Predict Stool Quality	PLOS ONE			English	Article							DOG FOODS; CAT FOODS; CELLULOSE; DIGESTIBILITY; MICROBIOTA	Because animal studies are labor intensive, predictive equations are used extensively for calculating metabolizable energy (ME) concentrations of dog and cat pet foods. The objective of this retrospective review of digestibility studies, which were conducted over a 7-year period and based upon Association of American Feed Control Officials (AAFCO) feeding protocols, was to compare the accuracy and precision of equations developed from these animal feeding studies to commonly used predictive equations. Feeding studies in dogs and cats (331 and 227 studies, respectively) showed that equations using modified Atwater factors accurately predict ME concentrations in dog and cat pet foods (r(2) = 0.97 and 0.98, respectively). The National Research Council (NRC) equations also accurately predicted ME concentrations in pet foods (r(2) = 0.97 for dog and cat foods). For dogs, these equations resulted in an average estimate of ME within 0.16% and 2.24% of the actual ME measured (equations using modified Atwater factors and NRC equations, respectively); for cats these equations resulted in an average estimate of ME within 1.57% and 1.80% of the actual ME measured. However, better predictions of dietary ME in dog and cat pet foods were achieved using equations based on analysis of gross energy (GE) and new factors for moisture, protein, fat and fiber. When this was done there was less than 0.01% difference between the measured ME and the average predicted ME (r(2) = 0.99 and 1.00 in dogs and cats, respectively) whereas the absolute value of the difference between measured and predicted was reduced by approximately 50% in dogs and 60% in cats. Stool quality, which was measured by stool score, was influenced positively when dietary protein digestibility was high and fiber digestibility was low. In conclusion, using GE improves predictive equations for ME content of dog and cat pet foods. Nondigestible protein and fiber content of diets predicts stool quality.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Melendez, Lynda D.; Jewell, Dennis E.] Hills Pet Nutr Inc, Pet Nutr Ctr, Topeka, KS USA	Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu	Jewell, Dennis/AAS-8563-2020	Jewell, Dennis/0000-0003-2305-1014	Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	Two of the authors (LDM and DEJ) have an affiliation to the commercial funders of this research, as employees of Hill's Pet Nutrition. The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS (http://www.hillspet.com/our-company.html). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Atwater WO, 1902, USDA FARMERS B; Earle K E, 1998, J Nutr, V128, p2798S, DOI 10.1093/jn/128.12.2798S; GIESECKE D, 1982, J NUTR, V112, P1822, DOI 10.1093/jn/112.10.1822; Gross K.L, 2010, SMALL ANIMAL CLIN NU, P49; Hang I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-90; KENDALL PT, 1985, FELINE PRACT, V15, P38; KENDALL PT, 1982, J SCI FOOD AGR, V33, P823, DOI 10.1002/jsfa.2740330903; Kienzle E, 1998, J NUTR, V128, p2609S, DOI [10.1093/jn/128.12.2609S, 10.1093/jn/128.12.2598S, 10.1093/jn/128.12.2680S]; Kienzle E, 2002, J NUTR, V132, p1796S, DOI 10.1093/jn/132.6.1796S; Kienzle E, 2001, J ANIM PHYSIOL AN N, V85, P174, DOI 10.1046/j.1439-0396.2001.00315.x; KUHLMAN G, 1993, FELINE PRACT, V21, P16; Laflamme DP, 2001, J ANIM PHYSIOL AN N, V85, P222, DOI 10.1046/j.1439-0396.2001.00330.x; Lewis L.D., 1994, J NUTR, V124, p2716S; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; NRC (USA), 2006, NUTR REQ DOGS CATS A; Prola L, 2010, J ANIM PHYSIOL AN N, V94, P362, DOI 10.1111/j.1439-0396.2008.00916.x; Thatcher CD., 2010, SMALL ANIMAL CLIN NU, V5th ed., P3; Wichert B, 2002, J NUTR, V132, p1728S, DOI 10.1093/jn/132.6.1728S; Yamka RM, 2007, J ANIM SCI, V85, P204, DOI 10.2527/jas.2005-336; Zentek J, 2004, J NUTR, V134, p2158S, DOI 10.1093/jn/134.8.2158S	20	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54405	10.1371/journal.pone.0054405	http://dx.doi.org/10.1371/journal.pone.0054405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342151	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400160
J	Hung, HC; Yang, YC; Ou, HY; Wu, JS; Lu, FH; Chang, CJ				Hung, Hao-Chang; Yang, Yi-Ching; Ou, Horng-Yih; Wu, Jin-Shang; Lu, Feng-Hwa; Chang, Chih-Jen			The Association between Self-Reported Sleep Quality and Metabolic Syndrome	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; NONDIPPING HYPERTENSION; GLUCOSE-METABOLISM; NATIONAL-HEALTH; LONG SLEEPERS; RISK-FACTOR; POOR SLEEP; DURATION; ADULTS	Objectives: Short and long sleep duration are associated with metabolic syndrome. However, there is limited research on the association between sleep quality and metabolic syndrome, and thus the aim of this study is to investigate this relationship. Materials and Methods: The cross-sectional baseline data were collected from the decoded database of the Prevention Health Center of National Cheng Kung University Hospital from 2002 to 2006. The diagnosis of metabolic syndrome was according to the statement of the American Heart Association/National Heart, Lung, and Blood Institute. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). A higher global PSQI score indicates poorer sleep quality, and a global PSQI score greater than five differentiates poor from good sleepers. Results: Of the 3,435 subjects recruited, 899 (26.2%) had metabolic syndrome. Subjects with metabolic syndrome had higher PSQI and prevalence of poor sleepers than those without metabolic syndrome. The multivariate lineal regression analysis showed that female gender, metabolic syndrome, sleep duration, snoring, alcohol drinking, and habitual exercise were independent predictors of PSQI. When substituting metabolic syndrome with the five components, hyperglycemia and low high-density lipoprotein cholesterol (HDL-C) were positively associated with PSQI. The multivariate logistic regression analyses showed that female gender, metabolic syndrome, sleep duration, and snoring were independently associated with being poor sleepers. Of the five components, only low HDL-C was an independent predictor of being poor sleepers. Conclusions: Subjects with metabolic syndrome have higher global PSQI scores and a higher risk of being poor sleepers. Of the five components of metabolic syndrome, hyperglycemia and low HDL-C are independently associated with the global PSQI scores, while low HDL-C is an independent predictor of being poor sleepers.	[Hung, Hao-Chang; Ou, Horng-Yih] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Tainan 70428, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan; [Ou, Horng-Yih] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University	Chang, CJ (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.	changcj.ncku@gmail.com	; Yang, Yi-Ching/C-7033-2014	Hung, Hao-Chang/0000-0001-7584-2745; Yang, Yi-Ching/0000-0003-1391-8040	National Cheng Kung University Hospital [NCKUH-10002031, NCKUH-10102036]	National Cheng Kung University Hospital	This study was supported by grants from National Cheng Kung University Hospital (NCKUH-10002031, NCKUH-10102036). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbach D, 2003, J CLIN ENDOCR METAB, V88, P26, DOI 10.1210/jc.2002-020827; Bidulescu A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-581; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cagampang FR, 2011, BRAIN BEHAV IMMUN, V25, P214, DOI 10.1016/j.bbi.2010.09.005; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chao CY, 2011, METABOLISM, V60, P799, DOI 10.1016/j.metabol.2010.07.031; Choi KM, 2008, INT J OBESITY, V32, P1091, DOI 10.1038/ijo.2008.62; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Erden I, 2010, BLOOD PRESS MONIT, V15, P184, DOI 10.1097/MBP.0b013e32833a23a0; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hall MH, 2008, SLEEP, V31, P635, DOI 10.1093/sleep/31.5.635; Huang YL, 2011, BLOOD PRESS MONIT, V16, P117, DOI [10.1097/MBP.0b013e328346a8b4, 10.1097/MBP.0b013e32834c672d]; Hung HC, 2013, CLIN ENDOCRINOL, V78, P518, DOI 10.1111/j.1365-2265.2012.04423.x; Jennings JR, 2007, SLEEP, V30, P219, DOI 10.1093/sleep/30.2.219; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Kohatsu ND, 2006, ARCH INTERN MED, V166, P1701, DOI 10.1001/archinte.166.16.1701; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Lauderdale DS, 2009, AM J EPIDEMIOL, V170, P805, DOI 10.1093/aje/kwp230; Lo CMH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-72; Martins RC, 2008, BRAZ J MED BIOL RES, V41, P180, DOI 10.1590/S0100-879X2006005000194; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Patel SR, 2008, INT J OBESITY, V32, P1825, DOI 10.1038/ijo.2008.198; Patel SR, 2012, SLEEP, V35, P641, DOI 10.5665/sleep.1822; Rod NH, 2011, AM J EPIDEMIOL, V173, P300, DOI 10.1093/aje/kwq371; SICONOLFI SF, 1985, AM J EPIDEMIOL, V122, P101, DOI 10.1093/oxfordjournals.aje.a114068; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; van den Berg JF, 2008, INT J OBESITY, V32, P1083, DOI 10.1038/ijo.2008.57; Vgontzas AN, 2002, ENDOCRIN METAB CLIN, V31, P15, DOI 10.1016/S0889-8529(01)00005-6; Wu MC, 2012, PREV MED, V55, P305, DOI 10.1016/j.ypmed.2012.07.013; Yilmaz MB, 2007, BLOOD PRESSURE, V16, P101, DOI 10.1080/08037050701343225	43	50	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54304	10.1371/journal.pone.0054304	http://dx.doi.org/10.1371/journal.pone.0054304			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342127	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400146
J	Grodzki, ACG; Giulivi, C; Lein, PJ				Grodzki, Ana Cristina G.; Giulivi, Cecilia; Lein, Pamela J.			Oxygen Tension Modulates Differentiation and Primary Macrophage Functions in the Human Monocytic THP-1 Cell Line	PLOS ONE			English	Article							RESPONSIVE TRANSCRIPTION FACTORS; HYPOXIA-INDUCIBLE FACTOR-1; NF-KAPPA-B; IN-VITRO; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ALVEOLAR; RECEPTOR; GLUTATHIONE; SYNCHRONIZATION	The human THP-1 cell line is widely used as an in vitro model system for studying macrophage differentiation and function. Conventional culture conditions for these cells consist of ambient oxygen pressure (similar to 20% v/v) and medium supplemented with the thiol 2-mercaptoethanol (2-ME) and serum. In consideration of the redox activities of O-2 and 2-ME, and the extensive experimental evidence supporting a role for reactive oxygen species (ROS) in the differentiation and function of macrophages, we addressed the question of whether culturing THP-1 cells under a more physiologically relevant oxygen tension (5% O-2) in the absence of 2-ME and serum would alter THP-1 cell physiology. Comparisons of cultures maintained in 18% O-2 versus 5% O-2 indicated that reducing oxygen tension had no effect on the proliferation of undifferentiated THP-1 cells. However, decreasing the oxygen tension to 5% O-2 significantly increased the rate of phorbol ester-induced differentiation of THP-1 cells into macrophage-like cells as well as the metabolic activity of both undifferentiated and PMA-differentiated THP-1 cells. Removal of both 2-ME and serum from the medium decreased the proliferation of undifferentiated THP-1 cells but increased metabolic activity and the rate of differentiation under either oxygen tension. In differentiated THP-1 cells, lowering the oxygen tension to 5% O-2 decreased phagocytic activity, the constitutive release of beta-hexosaminidase and LPS-induced NF-kappa B activation but enhanced LPS-stimulated release of cytokines. Collectively, these data demonstrate that oxygen tension influences THP-1 cell differentiation and primary macrophage functions, and suggest that culturing these cells under tightly regulated oxygen tension in the absence of exogenous reducing agent and serum is likely to provide a physiologically relevant baseline from which to study the role of the local redox environment in regulating THP-1 cell physiology.	[Grodzki, Ana Cristina G.; Giulivi, Cecilia; Lein, Pamela J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis	Lein, PJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	pjlein@ucdavis.edu	Giulivi, Cecilia/ABB-7809-2020; Giulivi, Cecilia/AAV-6774-2021	Giulivi, Cecilia/0000-0003-1033-7435; Lein, Pamela/0000-0001-7665-7584	National Institutes of Health [R01 ES017592, T32 HL007013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funding from the National Institutes of Health (grant R01 ES017592 to PJL) and a postdoctoral fellowship to ACGG (T32 HL007013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Iborra B, 2009, J IMMUNOL, V182, P3155, DOI 10.4049/jimmunol.0801710; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; BABIOR BM, 1984, J CLIN INVEST, V73, P599, DOI 10.1172/JCI111249; Bunbury A, 2009, FASEB J, V23, P164, DOI 10.1096/fj.08-109439; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; COHEN AB, 1971, J CLIN INVEST, V50, P1390, DOI 10.1172/JCI106622; Cooper S, 2009, CELL BIOL INT, V33, P71, DOI 10.1016/j.cellbi.2008.09.009; COWAN DB, 1992, J MOL CELL CARDIOL, V24, P423, DOI 10.1016/0022-2828(92)93196-Q; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Elbarghati L, 2008, IMMUNOBIOLOGY, V213, P899, DOI 10.1016/j.imbio.2008.07.016; FrankeUllmann G, 1996, J IMMUNOL, V157, P3097; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goth SR, 2006, J IMMUNOL METHODS, V308, P179, DOI 10.1016/j.jim.2005.10.012; Haddad JJ, 2002, RESP RES, V3, DOI 10.1186/rr190; Harper Jane V., 2004, V296, P157; Hutter D, 2000, J CELL PHYSIOL, V183, P45, DOI 10.1002/(SICI)1097-4652(200004)183:1<45::AID-JCP6>3.3.CO;2-G; Johansson A, 1997, AM J RESP CELL MOL, V16, P582, DOI 10.1165/ajrcmb.16.5.9160840; Karagenc L, 2004, REPROD BIOMED ONLINE, V9, P409, DOI 10.1016/S1472-6483(10)61276-X; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Krieger JA, 1996, INT J IMMUNOPHARMACO, V18, P545, DOI 10.1016/S0192-0561(96)00057-4; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Napoli E, 2011, HUM MOL GENET, V20, P3079, DOI 10.1093/hmg/ddr211; Pasztoi M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2697; Pfau JC, 2004, AM J PHYSIOL-LUNG C, V286, pL354, DOI 10.1152/ajplung.00380.2002; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; ROSEN GM, 1995, FASEB J, V9, P200, DOI 10.1096/fasebj.9.2.7540156; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sasaki H, 2009, FREE RADICAL BIO MED, V47, P189, DOI 10.1016/j.freeradbiomed.2009.04.025; SCHNYDER J, 1978, J EXP MED, V148, P435, DOI 10.1084/jem.148.2.435; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; VANOTTEREN GM, 1995, AM J RESP CELL MOL, V13, P399, DOI 10.1165/ajrcmb.13.4.7546769; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yan HM, 2010, TOXICOL SCI, V117, P515, DOI 10.1093/toxsci/kfq208	48	26	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54926	10.1371/journal.pone.0054926	http://dx.doi.org/10.1371/journal.pone.0054926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355903	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500144
J	Chen, QJ; Huang, SP; Chen, JJ; Zhang, SQ; Chen, Z				Chen, Quanjiao; Huang, Shengping; Chen, Jianjun; Zhang, Shaoqiong; Chen, Ze			NA Proteins of Influenza A Viruses H1N1/2009, H5N1, and H9N2 Show Differential Effects on Infection Initiation, Virus Release, and Cell-Cell Fusion	PLOS ONE			English	Article							2.2-A RESOLUTION; CROSS-PROTECTION; PLASMID DNAS; NEURAMINIDASE; HEMAGGLUTININ; GLYCOPROTEIN; GENERATION; VACCINE; LENGTH	Two surface glycoproteins of influenza virus, haemagglutinin (HA) and neuraminidase (NA), play opposite roles in terms of their interaction with host sialic acid receptors. HA attaches to sialic acid on host cell surface receptors to initiate virus infection while NA removes these sialic acids to facilitate release of progeny virions. This functional opposition requires a balance. To explore what might happen when NA of an influenza virus was replaced by one from another isolate or subtype, in this study, we generated three recombinant influenza A viruses in the background of A/PR/8/34 (PR8) (H1N1) and with NA genes obtained respectively from the 2009 pandemic H1N1 virus, a highly pathogenic avian H5N1 virus, and a lowly pathogenic avian H9N2 virus. These recombinant viruses, rPR8-H1N1NA, rPR8-H5N1NA, and rPR8-H9N2NA, were shown to have similar growth kinetics in cells and pathogenicity in mice. However, much more rPR8-H5N1NA and PR8-wt virions were released from chicken erythrocytes than virions of rPR8-H1N1NA and rPR8-H9N2NA after 1 h. In addition, in MDCK cells, rPR8-H5N1NA and rPR8-H9N2NA infected a higher percentage of cells, and induced cell-cell fusion faster and more extensively than PR8-wt and rPR8-H1N1NA did in the early phase of infection. In conclusion, NA replacement in this study did not affect virus replication kinetics but had different effects on infection initiation, virus release and fusion of infected cells. These phenomena might be partially due to NA proteins' different specificity to alpha 2-3/2-6-sialylated carbohydrate chains, but the exact mechanism remains to be explored.	[Chen, Quanjiao; Huang, Shengping; Chen, Jianjun; Zhang, Shaoqiong; Chen, Ze] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Chen, Ze] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [Chen, Ze] Shanghai Inst Biol Prod, Shanghai, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Hunan Normal University	Chen, QJ (corresponding author), Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	chenqj@wh.iov.cn; chenze2005@hotmail.com			National 973 Project [2010CB530301]; National Natural Science Foundation of China [31070141, 31100132]	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the following research funds: National 973 Project (2010CB530301) and National Natural Science Foundation of China (31070141, 31100132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Chen JJ, 2010, J GEN VIROL, V91, P2474, DOI 10.1099/vir.0.022681-0; Chen QJ, 2009, VIRUS GENES, V38, P30, DOI 10.1007/s11262-008-0305-2; Chen Z, 1999, J GEN VIROL, V80, P2559, DOI 10.1099/0022-1317-80-10-2559; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Flint M, 1999, J VIROL, V73, P6782, DOI 10.1128/JVI.73.8.6782-6790.1999; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Iqbal M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005788; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2011, INFLUENZA OTHER RESP, V5, P157, DOI 10.1111/j.1750-2659.2011.00231.x; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Qiu MZ, 2006, BIOCHEM BIOPH RES CO, V343, P1124, DOI 10.1016/j.bbrc.2006.03.088; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Shtyrya Y, 2009, GLYCOCONJUGATE J, V26, P99, DOI 10.1007/s10719-008-9169-x; Sui ZW, 2010, VACCINE, V28, P7690, DOI 10.1016/j.vaccine.2010.09.019; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; World Health Organization, 2002, WHO MAN AN INFL DIAG; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Zhang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009167	35	11	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54334	10.1371/journal.pone.0054334	http://dx.doi.org/10.1371/journal.pone.0054334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349854	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100057
J	Huang, YP; Rao, RPN				Huang, Yanping; Rao, Rajesh P. N.			Reward Optimization in the Primate Brain: A Probabilistic Model of Decision Making under Uncertainty	PLOS ONE			English	Article							MOTION; NEURONS	A key problem in neuroscience is understanding how the brain makes decisions under uncertainty. Important insights have been gained using tasks such as the random dots motion discrimination task in which the subject makes decisions based on noisy stimuli. A descriptive model known as the drift diffusion model has previously been used to explain psychometric and reaction time data from such tasks but to fully explain the data, one is forced to make ad-hoc assumptions such as a time-dependent collapsing decision boundary. We show that such assumptions are unnecessary when decision making is viewed within the framework of partially observable Markov decision processes (POMDPs). We propose an alternative model for decision making based on POMDPs. We show that the motion discrimination task reduces to the problems of (1) computing beliefs (posterior distributions) over the unknown direction and motion strength from noisy observations in a Bayesian manner, and (2) selecting actions based on these beliefs to maximize the expected sum of future rewards. The resulting optimal policy (belief-to-action mapping) is shown to be equivalent to a collapsing decision threshold that governs the switch from evidence accumulation to a discrimination decision. We show that the model accounts for both accuracy and reaction time as a function of stimulus strength as well as different speed-accuracy conditions in the random dots task.	[Huang, Yanping; Rao, Rajesh P. N.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rao, RPN (corresponding author), Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA.	rao@cs.washington.edu		Rao, Rajesh P. N./0000-0003-0682-8952	National Science Foundation (NSF) Center for Sensorimotor Neural Engineering [EEC-1028725]; NSF [0930908]; Army Research Office (ARO) [W911NF-11-1-0307]; Office of Naval Research (ONR) [N000140910097]	National Science Foundation (NSF) Center for Sensorimotor Neural Engineering; NSF(National Science Foundation (NSF)); Army Research Office (ARO); Office of Naval Research (ONR)(Office of Naval Research)	This project was supported by the National Science Foundation (NSF) Center for Sensorimotor Neural Engineering (EEC-1028725), NSF grant 0930908, Army Research Office (ARO) award W911NF-11-1-0307, and Office of Naval Research (ONR) grant N000140910097. YH is a Howard Hughes Medical Institute International Student Research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2011, NEURAL COMPUT, V23, P817, DOI 10.1162/NECO_a_00103; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Casella G, 2001, STAT INFERENCE, V2nd; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Cisek P, 2009, J NEUROSCI, V29, P11560, DOI 10.1523/JNEUROSCI.1844-09.2009; Daw ND, 2006, NEURAL COMPUT, V18, P1637, DOI 10.1162/neco.2006.18.7.1637; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Doya K., 2007, BAYESIAN BRAIN PROBA; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Frazier PI, 2008, ADV NEURAL INFORM PR, P465; Frazier PL, 2007, ADV NEURAL INFORM PR, V20; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Hanks TD, 2011, J NEUROSCI, V31, P6339, DOI 10.1523/JNEUROSCI.5613-10.2011; Huang Y., 2012, ADV NEURAL INFORM PR, V25; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Knill DC, 1996, PERCEPTION BAYESIAN; LAI TL, 1988, ANN STAT, V16, P856, DOI 10.1214/aos/1176350840; Latham PE, 2007, SOCNEUROSCIABSTRACTS, V740; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Luce RD, 1986, RESPONSE TIMES THEIR; Ludwig CJH, 2009, VISION RES, V49, P2764, DOI 10.1016/j.visres.2009.08.012; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Rao R. P., 2002, PROBABILISTIC MODELS; Rao RPN, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00146; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Roitman JD, 2002, J NEUROSCI, V22, P9475; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 2001, J NEUROPHYSIOLOGY, V86; Shenoy P, 2012, ADV NEURAL INFORM PR, V25; Shenoy P, 2010, ADV NEURAL INFORM PR, V23; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Yu Angela J, 2008, Adv Neural Inf Process Syst, V21, P1873; Zemel RS, 1998, NEURAL COMPUTATION, P10	43	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53344	10.1371/journal.pone.0053344	http://dx.doi.org/10.1371/journal.pone.0053344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349707	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100019
J	Kobayashi, S; Tian, YM; Ohno, N; Yuji, K; Ishigaki, T; Isobe, M; Tsuda, M; Oyaizu, N; Watanabe, E; Watanabe, N; Tani, K; Tojo, A; Uchimaru, K				Kobayashi, Seiichiro; Tian, Yamin; Ohno, Nobuhiro; Yuji, Koichiro; Ishigaki, Tomohiro; Isobe, Masamichi; Tsuda, Mayuko; Oyaizu, Naoki; Watanabe, Eri; Watanabe, Nobukazu; Tani, Kenzaburo; Tojo, Arinobu; Uchimaru, Kaoru			The CD3 versus CD7 Plot in Multicolor Flow Cytometry Reflects Progression of Disease Stage in Patients Infected with HTLV-I	PLOS ONE			English	Article							T-CELL LEUKEMIA; VIRUS TYPE-I; CLINICAL ENTITY; CARRIERS; LYMPHOCYTES; LYMPHOMA; LOAD; EXPRESSION; RETROVIRUS; SUBSET	Purpose: In a recent study to purify adult T-cell leukemia-lymphoma (ATL) cells from acute-type patients by flow cytometry, three subpopulations were observed in a CD3 versus CD7 plot (H: CD3(high) CD7(high); D: CD3(dim) CD7(dim); L: CD3(dim) CD7(low)). The majority of leukemia cells were enriched in the L subpopulation and the same clone was included in the D and L subpopulations, suggesting clonal evolution. In this study, we analyzed patients with indolent-type ATL and human T-cell leukemia virus type I (HTLV-I) asymptomatic carriers (ACs) to see whether the CD3 versus CD7 profile reflected progression in the properties of HTLV-I-infected cells. Experimental Design: Using peripheral blood mononuclear cells from patient samples, we performed multi-color flow cytometry. Cells that underwent fluorescence-activated cell sorting were subjected to molecular analyses, including inverse long PCR. Results: In the D(%) versus L(%) plot, patient data could largely be categorized into three groups (Group 1: AC; Group 2: smoldering- and chronic-type ATL; and Group 3: acute-type ATL). Some exceptions, however, were noted (e.g., ACs in Group 2). In the follow-up of some patients, clinical disease progression correlated well with the CD3 versus CD7 profile. In clonality analysis, we clearly detected a major clone in the D and L subpopulations in ATL cases and, intriguingly, in some ACs in Group 2. Conclusion: We propose that the CD3 versus CD7 plot reflects progression of disease stage in patients infected with HTLV-I. The CD3 versus CD7 profile will be a new indicator, along with high proviral load, for HTLV-I ACs in forecasting disease progression.	[Kobayashi, Seiichiro; Tian, Yamin; Tojo, Arinobu] Univ Tokyo, Inst Med Sci, Div Mol Therapy, Tokyo, Japan; [Tian, Yamin; Tani, Kenzaburo] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 812, Japan; [Ohno, Nobuhiro; Yuji, Koichiro; Isobe, Masamichi; Tsuda, Mayuko; Tojo, Arinobu; Uchimaru, Kaoru] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Res Hosp, Tokyo, Japan; [Ishigaki, Tomohiro; Watanabe, Eri; Watanabe, Nobukazu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Lab Diagnost Med, Tokyo, Japan; [Oyaizu, Naoki] Univ Tokyo, Inst Med Sci, Res Hosp, Clin Lab, Tokyo, Japan	University of Tokyo; Kyushu University; University of Tokyo; University of Tokyo; University of Tokyo	Uchimaru, K (corresponding author), Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Res Hosp, Tokyo, Japan.	uchimaru@ims.u-tokyo.ac.jp		Kobayashi, Seiichiro/0000-0001-7853-4537	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, BLOOD, V104, P3672, DOI 10.1182/blood-2004-07-2540; AUTRAN B, 1995, J IMMUNOL, V154, P1408; Hisada M, 1998, BLOOD, V92, P3557, DOI 10.1182/blood.V92.10.3557.422k09_3557_3561; Imaizumi Y, 2005, BLOOD, V105, P903, DOI 10.1182/blood-2004-06-2489; Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410; KAMIHIRA S, 1994, CANCER, V73, P2753, DOI 10.1002/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X; LEGAC E, 1992, BLOOD, V79, P1746; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; MOCHIZUKI M, 1992, JPN J CANCER RES, V83, P236, DOI 10.1111/j.1349-7006.1992.tb00092.x; Mortreux F, 2003, LEUKEMIA, V17, P26, DOI 10.1038/sj.leu.2402777; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; OKAMOTO T, 1989, JPN J CANCER RES, V80, P191; OSAME M, 1986, LANCET, V1, P1031; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Reinhold U, 1997, J CLIN IMMUNOL, V17, P265, DOI 10.1023/A:1027318530127; REINHOLD U, 1993, J IMMUNOL, V150, P2081; Sasaki D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-81; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; Setoyama Mitsuru, 1999, Journal of Dermatology (Tokyo), V26, P785; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213; Takasaki Y, 2010, BLOOD, V115, P4337, DOI 10.1182/blood-2009-09-242347; Tian YM, 2011, CANCER SCI, V102, P569, DOI 10.1111/j.1349-7006.2010.01833.x; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; WILLARDGALLO KE, 1990, P NATL ACAD SCI USA, V87, P6713, DOI 10.1073/pnas.87.17.6713; Yamaguchi K, 2002, INT J HEMATOL, V76, P240, DOI 10.1007/BF03165123; YAMAGUCHI K, 1988, BRIT J HAEMATOL, V68, P169, DOI 10.1111/j.1365-2141.1988.tb06185.x; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Yoshida M, 2010, P JPN ACAD B-PHYS, V86, P117, DOI 10.2183/pjab.86.117	29	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53728	10.1371/journal.pone.0053728	http://dx.doi.org/10.1371/journal.pone.0053728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349737	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100028
J	Manera, V; Schouten, B; Verfaillie, K; Becchio, C				Manera, Valeria; Schouten, Ben; Verfaillie, Karl; Becchio, Cristina			Time Will Show: Real Time Predictions during Interpersonal Action Perception	PLOS ONE			English	Article							JOINT ACTION; BIOLOGICAL-MOTION; MOTOR CONTROL; ANTICIPATION; MOVEMENT; INTENTIONS; SIMULATION; BODY; CUES	Predictive processes are crucial not only for interpreting the actions of individual agents, but also to predict how, in the context of a social interaction between two agents, the actions of one agent relate to the actions of a second agent. In the present study we investigated whether, in the context of a communicative interaction between two agents, observers can use the actions of one agent to predict when the action of a second agent will take place. Participants observed point-light displays of two agents (A and B) performing separate actions. In the communicative condition, the action performed by agent B responded to a communicative gesture performed by agent A. In the individual condition, agent A's communicative action was substituted with a non-communicative action. For each condition, we manipulated the temporal coupling of the actions of the two agents, by varying the onset of agent A's action. Using a simultaneous masking detection task, we demonstrated that the timing manipulation had a critical effect on the communicative condition, with the visual discrimination of agent B increasing linearly while approaching the original interaction timing. No effect of the timing manipulation was found for the individual condition. Our finding complements and extends previous evidence for interpersonal predictive coding, suggesting that the communicative gestures of one agent can serve not only to predict what the second agent will do, but also when his/her action will take place.	[Manera, Valeria; Becchio, Cristina] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Schouten, Ben; Verfaillie, Karl] Katholieke Univ Leuven, Expt Psychol Lab, Louvain, Belgium	University of Turin; KU Leuven	Becchio, C (corresponding author), Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy.	cristina.becchio@unito.it	Manera, Valeria/O-3498-2016	Manera, Valeria/0000-0003-4490-4485; Becchio, Cristina/0000-0002-6845-0521	Regione Piemonte, bando Scienze Umane e Sociali [4/2006]; research fellowship "L'Oreal Italia per le Donne e la Scienza" for the project "La predizione delle intenzioni nell'autismo: studi comportamentali e fMRI"; Research Fund K.U. Leuven [PDMK/11/057]	Regione Piemonte, bando Scienze Umane e Sociali(Regione Piemonte); research fellowship "L'Oreal Italia per le Donne e la Scienza" for the project "La predizione delle intenzioni nell'autismo: studi comportamentali e fMRI"(L'Oreal Group); Research Fund K.U. Leuven(KU Leuven)	This work was supported by a grant from the Regione Piemonte, bando Scienze Umane e Sociali 2008, L.R. n. 4/2006 to C.B. V.M. was supported by the research fellowship "L'Oreal Italia per le Donne e la Scienza 2012" for the project "La predizione delle intenzioni nell'autismo: studi comportamentali e fMRI". B.S. was supported by a postdoctoral research fellowship of the Research Fund K.U. Leuven (PDMK/11/057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B, 2008, PERCEPTION, V37, P931, DOI 10.1068/p5340; Abernethy B, 2007, J MOTOR BEHAV, V39, P353, DOI 10.3200/JMBR.39.5.353-368; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Becchio C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00117; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; Blakemore SJ, 2005, NEUROPSYCHOLOGIA, V43, P260, DOI 10.1016/j.neuropsychologia.2004.11.012; Brown EC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00147; Davidson PR, 2003, CURR OPIN NEUROBIOL, V13, P232, DOI 10.1016/S0959-4388(03)00038-2; Dekeyser M, 2002, BEHAV RES METH INS C, V34, P375, DOI 10.3758/BF03195465; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Graf M, 2007, NEUROIMAGE, V36, pT22, DOI 10.1016/j.neuroimage.2007.03.017; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Huys R, 2008, PERCEPT PSYCHOPHYS, V70, P1217, DOI 10.3758/PP.70.7.1217; Keller PE, 2007, CONSCIOUS COGN, V16, P102, DOI 10.1016/j.concog.2005.12.004; Knoblich G, 2001, PSYCHOL SCI, V12, P467, DOI 10.1111/1467-9280.00387; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Macmillan NA, 2005, DETECTION THEORY USE; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022650; Manera V, 2011, EXP BRAIN RES, V211, P547, DOI 10.1007/s00221-011-2649-4; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; Manera V, 2010, BEHAV RES METHODS, V42, P168, DOI 10.3758/BRM.42.1.168; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Phillips-Silver J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00026; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Prinz W, 2006, CORTEX, V42, P515, DOI 10.1016/S0010-9452(08)70389-7; Sartori L, 2013, SOC COGN AFFECT NEUR, V8, P662, DOI 10.1093/scan/nss044; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; Sartori L, 2011, EXP BRAIN RES, V211, P557, DOI 10.1007/s00221-011-2650-y; Sartori L, 2011, COGNITION, V119, P242, DOI 10.1016/j.cognition.2011.01.014; Sartori L, 2009, CONSCIOUS COGN, V18, P766, DOI 10.1016/j.concog.2009.06.004; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Sebanz N, 2009, PSYCHON B REV, V16, P170, DOI 10.3758/PBR.16.1.170; Shim J, 2005, J MOTOR BEHAV, V37, P164, DOI 10.3200/JMBR.37.2.164-175; Smeeton NJ, 2011, HUM MOVEMENT SCI, V30, P957, DOI 10.1016/j.humov.2010.07.012; Sparenberg P, 2012, PSYCHOL RES-PSYCH FO, V76, P41, DOI 10.1007/s00426-011-0321-z; Springer A, 2011, BRAIN COGNITION, V76, P26, DOI 10.1016/j.bandc.2011.03.007; Springer A, 2010, Q J EXP PSYCHOL, V63, P2141, DOI 10.1080/17470211003721659; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	42	29	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54949	10.1371/journal.pone.0054949	http://dx.doi.org/10.1371/journal.pone.0054949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349992	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100113
J	Reye, AL; Stegniy, V; Mishaeva, NP; Velhin, S; Hubschen, JM; Ignatyev, G; Muller, CP				Reye, Anna L.; Stegniy, Valentina; Mishaeva, Nina P.; Velhin, Sviataslau; Huebschen, Judith M.; Ignatyev, George; Muller, Claude P.			Prevalence of Tick-Borne Pathogens in Ixodes ricinus and Dermacentor reticulatus Ticks from Different Geographical Locations in Belarus	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; FEVER GROUP RICKETTSIAE; GROUP SFG RICKETTSIAE; ANAPLASMA-PHAGOCYTOPHILUM; BORRELIA-BURGDORFERI; BARTONELLA-HENSELAE; COXIELLA-BURNETII; BABESIA-MICROTI; IXODIDAE; SPP.	Worldwide, ticks are important vectors of human and animal pathogens. Besides Lyme Borreliosis, a variety of other bacterial and protozoal tick-borne infections are of medical interest in Europe. In this study, 553 questing and feeding Ixodes ricinus (n = 327) and Dermacentor reticulatus ticks (n = 226) were analysed by PCR for Borrelia, Rickettsia, Anaplasma, Coxiella, Francisella and Babesia species. Overall, the pathogen prevalence in ticks was 30.6% for I. ricinus and 45.6% for D. reticulatus. The majority of infections were caused by members of the spotted-fever group rickettsiae (24.4%), 9.4% of ticks were positive for Borrelia burgdorferi sensu lato, with Borrelia afzelii being the most frequently detected species (40.4%). Pathogens with low prevalence rates in ticks were Anaplasma phagocytophilum (2.2%), Coxiella burnetii (0.9%), Francisella tularensis subspecies (0.7%), Bartonella henselae (0.7%), Babesia microti (0.5%) and Babesia venatorum (0.4%). On a regional level, hotspots of pathogens were identified for A. phagocytophilum (12.5-17.2%), F. tularensis ssp. (5.5%) and C. burnetii (9.1%), suggesting established zoonotic cycles of these pathogens at least at these sites. Our survey revealed a high burden of tick-borne pathogens in questing and feeding I. ricinus and D. reticulatus ticks collected in different regions in Belarus, indicating a potential risk for humans and animals. Identified hotspots of infected ticks should be included in future surveillance studies, especially when F. tularensis ssp. and C. burnetii are involved.	[Reye, Anna L.; Huebschen, Judith M.; Muller, Claude P.] Ctr Rech Publ Sante, Natl Publ Hlth Lab, Inst Immunol, Luxembourg, Luxembourg; [Stegniy, Valentina; Mishaeva, Nina P.; Velhin, Sviataslau; Ignatyev, George] Republican Res & Pract Ctr Epidemiol & Microbiol, Clin & Expt Lab Chron Neuroinfect, Minsk, BELARUS	Luxembourg Institute of Health	Muller, CP (corresponding author), Ctr Rech Publ Sante, Natl Publ Hlth Lab, Inst Immunol, Luxembourg, Luxembourg.	Claude.Muller@CRP-SANTE.LU	Hübschen, Judith/AAF-5113-2020; Hübschen, Judith/ABA-7931-2021	Hübschen, Judith/0000-0002-5001-2128; Ignatyev, George/0000-0002-9731-3681	Ministry of Foreign Affairs of the Grand-Duchy of Luxembourg; Centre de Recherche Public de la Sante; Republic Fond of Fundamental Research of the Academy of Science of Belarus; Bourse Formation Recherche; Aides a la Formation Recherche of the Fonds National de la Recherche Luxembourg [BFR 07/038, EXT-BFR07-038 TR]	Ministry of Foreign Affairs of the Grand-Duchy of Luxembourg; Centre de Recherche Public de la Sante; Republic Fond of Fundamental Research of the Academy of Science of Belarus; Bourse Formation Recherche; Aides a la Formation Recherche of the Fonds National de la Recherche Luxembourg(Luxembourg National Research Fund)	This study was funded by the Ministry of Foreign Affairs of the Grand-Duchy of Luxembourg, the Centre de Recherche Public de la Sante and the Republic Fond of Fundamental Research of the Academy of Science of Belarus. A.L. Reye was supported by a fellowship from the Bourse Formation Recherche and the Aides a la Formation Recherche of the Fonds National de la Recherche Luxembourg (BFR 07/038; EXT-BFR07-038 TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2005, APPL ENVIRON MICROB, V71, P6418, DOI 10.1128/AEM.71.10.6418-6422.2005; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Barns SM, 2005, APPL ENVIRON MICROB, V71, P5494, DOI 10.1128/AEM.71.9.5494-5500.2005; Begon Michael, 2008, P12; Bormane A, 2004, INT J MED MICROBIOL, V293, P36, DOI 10.1016/S1433-1128(04)80007-X; Casati S, 2006, ANN AGR ENV MED, V13, P65; Chmielewska-Badora J, 2012, ANN AGR ENV MED, V19, P271; Clark K, 2005, APPL ENVIRON MICROB, V71, P2616, DOI 10.1128/AEM.71.5.2616-2625.2005; De Bruin A, 2011, ZOONOSES PUBLIC HLTH; Dietrich F, 2010, APPL ENVIRON MICROB, V76, P1395, DOI 10.1128/AEM.02788-09; Dobson ADM, 2011, TICKS TICK-BORNE DIS, V2, P67, DOI 10.1016/j.ttbdis.2011.03.002; Estrada-Pena A., 2004, TICKS DOMESTIC ANIMA; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Franke J, 2010, APPL ENVIRON MICROB, V76, P6829, DOI 10.1128/AEM.01630-10; Grzeszczuk A, 2004, ANN AGR ENV MED, V11, P99; Grzeszczuk A, 2006, Adv Med Sci, V51, P283; Hubalek Z, 1997, Cent Eur J Public Health, V5, P199; Ignatovich V. F., 2001, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P14; Ishikura M, 2003, MICROBIOL IMMUNOL, V47, P823, DOI 10.1111/j.1348-0421.2003.tb03448.x; Karaban I., 2009, EpiNorth - Journal of the Network for Communicable Disease Control in Northern and Eastern Europe, V10, P48; Katargina O, 2012, CLIN MICROBIOL INFEC, V18, P40, DOI 10.1111/j.1469-0691.2010.03457.x; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; Lindgren E, 2006, LYME BORRELIOSIS EUR; Masuzawa T, 2008, J MED MICROBIOL, V57, P986, DOI 10.1099/jmm.0.47721-0; Matsumoto K, 2009, CLIN MICROBIOL INFEC, V15, P286, DOI 10.1111/j.1469-0691.2008.02238.x; Moniuszko A, 2011, VECTOR-BORNE ZOONOT, V11, P1399, DOI 10.1089/vbz.2010.0227; MOTIEJUNAS L, 1994, SCAND J INFECT DIS, V26, P149, DOI 10.3109/00365549409011778; Movila A, 2009, CLIN MICROBIOL INFEC, V15, P32, DOI 10.1111/j.1469-0691.2008.02152.x; Movila A, 2010, VECTOR BORNE ZOONOTI; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Podsiadly E, 2009, CLIN MICROBIOL INFEC, V15, P120, DOI 10.1111/j.1469-0691.2008.02196.x; Postic D, 1997, RES MICROBIOL, V148, P691, DOI 10.1016/S0923-2508(99)80068-0; Radzijevskaja J, 2008, INT J MED MICROBIOL, V298, P218, DOI 10.1016/j.ijmm.2008.01.008; Randolph SE, 1998, PARASITOL TODAY, V14, P186, DOI 10.1016/S0169-4758(98)01224-1; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Reis C, 2011, VECTOR-BORNE ZOONOT, V11, P907, DOI 10.1089/vbz.2010.0103; Reye AL, 2010, APPL ENVIRON MICROB, V76, P2923, DOI 10.1128/AEM.03061-09; Rieg S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-167; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Samoylenko I, 2009, CLIN MICROBIOL INFEC, V15, P305, DOI 10.1111/j.1469-0691.2008.02249.x; Smetanova K, 2006, ANN NY ACAD SCI, V1078, P312, DOI 10.1196/annals.1374.058; Spitalska E, 2003, EUR J EPIDEMIOL, V18, P263, DOI 10.1023/A:1023330222657; Spitalska E, 2012, EXP APPL ACAROL, V57, P189, DOI 10.1007/s10493-012-9539-8; Stanczak J, 2008, INT J MED MICROBIOL, V298, P231, DOI 10.1016/j.ijmm.2007.09.006; Stanczak J, 2006, ANN NY ACAD SCI, V1078, P512, DOI 10.1196/annals.1374.100; Stanczak J, 2006, INT J MED MICROBIOL, V296, P144, DOI 10.1016/j.ijmm.2006.01.014; To H, 1996, J CLIN MICROBIOL, V34, P647, DOI 10.1128/JCM.34.3.647-651.1996; Trofimov N. M., 1998, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, V0, P21; Wojcik-Fatla A, 2006, ANN AGR ENV MED, V13, P319; Wojcik-Fatla A, 2009, ANN AGR ENV MED, V16, P151; Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P1023, DOI 10.1128/JCM.40.3.1023-1030.2002; Zygner W, 2008, VET PARASITOL, V153, P139, DOI 10.1016/j.vetpar.2008.01.036	54	87	94	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54476	10.1371/journal.pone.0054476	http://dx.doi.org/10.1371/journal.pone.0054476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349900	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100071
J	van der Meij, E; Koning, GG; Vriens, PW; Peeters, MF; Meijer, CA; Kortekaas, KE; Dalman, RL; van Bockel, JH; Hanemaaijer, R; Kooistra, T; Kleemann, R; Lindeman, JHN				van der Meij, Evelien; Koning, Giel G.; Vriens, Patrick W.; Peeters, Marcel F.; Meijer, C. Arnoud; Kortekaas, Kim E.; Dalman, Ronald L.; van Bockel, J. Hajo; Hanemaaijer, Roeland; Kooistra, Teake; Kleemann, Robert; Lindeman, Jan H. N.			A Clinical Evaluation of Statin Pleiotropy: Statins Selectively and Dose-Dependently Reduce Vascular Inflammation	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; DENSITY-LIPOPROTEIN CHOLESTEROL; TRANSGENIC MICE; CATHEPSIN-K; MACROPHAGE POLARIZATION; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS; PATHOGENESIS; EXPRESSION; ASSOCIATION	Statins are thought to reduce vascular inflammation through lipid independent mechanisms. Evaluation of such an effect in atherosclerotic disease is complicated by simultaneous effects on lipid metabolism. Abdominal aortic aneurysms (AAA) are part of the atherosclerotic spectrum of diseases. Unlike atherosclerotic occlusive disease, AAA is not lipid driven, thus allowing direct evaluation of putative anti-inflammatory effects. The anti-inflammatory potency of increasing doses (0, 20 or 40 mg/day) simvastatin or atorvastatin was evaluated in 63 patients that were at least 6 weeks on statin therapy and who underwent open AAA repair. A comprehensive analysis using immunohistochemistry, mRNA and protein analyses was applied on aortic wall samples collected during surgery. The effect of statins on AAA growth was analyzed in a separate prospective study in incorporating 142 patients. Both statins equally effectively and dose-dependently reduced aortic wall expression of NFkB regulated mediators (i.e. IL-6 (P<0.001)and MCP-1 (P<0.001)); shifted macrophage polarization towards a M2 phenotype (P<0.0003); selectively reduced macrophage-related markers such as cathepsin K and S (P<0.009 and 0.0027 respectively), and ALOX5 (P<0.0009), and reduced vascular wall NF kappa B activity (40 mg/day group, P<0.016). No effect was found on other cell types. Evaluation of the clinical efficacy of statins to reduce AAA progression did not indicate an effect of statins on aneurysm growth (P<0.337). Hence, in the context of AAA the clinical relevance of statins pleiotropy appears minimal.	[van der Meij, Evelien; Meijer, C. Arnoud; Kortekaas, Kim E.; van Bockel, J. Hajo; Lindeman, Jan H. N.] Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands; [Koning, Giel G.; Vriens, Patrick W.] St Elizabeth Hosp, Dept Surg, Tilburg, Netherlands; [Hanemaaijer, Roeland; Kooistra, Teake; Kleemann, Robert] TNO Toegepast Nat Wetenschappelijk Onderzoek Qual, Dept Vasc & Metab Dis, Leiden, Netherlands; [Kortekaas, Kim E.; Dalman, Ronald L.] Stanford Med Sch, Stanford, CA USA; [Peeters, Marcel F.] St Elizabeth Hosp, Lab Med Microbiol, Tilburg, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Elisabeth-TweeSteden Ziekenhuis (ETZ); Netherlands Organization Applied Science Research; Stanford University; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Lindeman, JHN (corresponding author), Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands.	Lindeman@LUMC.nl		Meijer, Arnoud/0000-0001-5521-1575	The Netherlands Organisation for Scientific Research [VENI]	The Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Robert Kleemann recieved a VENI grant (The Netherlands Organisation for Scientific Research; http://www.nwo.nl/nwohome.nsf/pages/NWOP_5VTGL4_ENG) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussien H, 2007, AM J PATHOL, V170, P809, DOI 10.2353/ajpath.2007.060522; Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; BAN K, 1994, CARDIOVASC RES, V28, P1258, DOI 10.1093/cvr/28.8.1258; Buhling F, 2001, J PATHOL, V195, P375; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Dawson J, 2007, J VASC SURG, V45, P350, DOI 10.1016/j.jvs.2006.09.049; Diehm N, 2009, CIRCULATION, V119, P2134, DOI 10.1161/CIRCULATIONAHA.109.850180; Dunne JA, 2012, CURR VASC PHARM; Ferguson CD, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.016; Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goldstein LB, 2006, CIRCULATION, V113, pE873, DOI 10.1161/01.STR.0000223048.70103.F1; Haslinger B, 2003, KIDNEY INT, V63, P2065, DOI 10.1046/j.1523-1755.2003.t01-2-00004.x; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kinlay S, 2008, ARTERIOSCL THROM VAS, V28, P142, DOI 10.1161/ATVBAHA.107.151787; Kleemann R, 2003, BLOOD, V101, P545, DOI 10.1182/blood-2002-06-1762; Kleemann R, 2004, BLOOD, V103, P4188, DOI 10.1182/blood-2003-11-3791; Kleemann R, 2003, CIRCULATION, V108, P1368, DOI 10.1161/01.CIR.0000086460.55494.AF; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Lindeman JHN, 2008, CLIN SCI, V114, P687, DOI 10.1042/CS20070352; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Lu H, 2008, CURR HYPERTENS REP, V10, P99, DOI 10.1007/s11906-008-0020-3; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010; Radmark O, 2007, PROSTAG OTH LIPID M, V83, P162, DOI 10.1016/j.prostaglandins.2007.01.003; Rahman MA, 2011, ANN VASC SURG, V25, P32, DOI 10.1016/j.avsg.2010.06.006; Rizas KD, 2009, CARDIOL REV, V17, P201, DOI 10.1097/CRD.0b013e3181b04698; Robinson JG, 2008, AM J CARDIOL, V101, P1009, DOI 10.1016/j.amjcard.2007.11.060; Shaw SM, 2009, CARDIOLOGY, V112, P4, DOI 10.1159/000137692; Sukhova GK, 2006, ANN NY ACAD SCI, V1085, P161, DOI 10.1196/annals.1383.028; Sun JS, 2012, ARTERIOSCL THROM VAS, V32, P15, DOI 10.1161/ATVBAHA.111.235002; Takagi H, 2010, J VASC SURG, V52, P1675, DOI 10.1016/j.jvs.2010.04.082; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; WYNN TA, 2011, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1422S93; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110; Zhou Z, 2006, AM HEART J, V151, P273, DOI 10.1016/j.ahj.2005.04.003	43	70	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53882	10.1371/journal.pone.0053882	http://dx.doi.org/10.1371/journal.pone.0053882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349755	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100035
J	Chen, ZL; Chen, WJ; Chen, H; Zhou, YY; Tang, MQ; Fu, MQ; Jin, XF				Chen, Zi-Lin; Chen, Wei-Jie; Chen, Huan; Zhou, Ying-Ying; Tang, Mei-Qin; Fu, Meng-Qi; Jin, Xiao-Feng			Prunus pananensis (Rosaceae), a New Species from Pan'an of Central Zhejiang, China	PLOS ONE			English	Article							INTERNATIONAL BOTANICAL CONGRESS	Prunus pananensis Z. L. Chen, W. J. Chen & X. F. Jin, a new species of Rosaceae from central Zhejiang, China is described and illustrated. Micromorphological characters of the indumentum on young shoots, leaves, petioles and peduncles, including scanning electron microscope [SEM] images, are provided. This new species is morphologically similar to P. schneiderianae Koehne in having its young shoots, petioles and pedicels all densely villose, but differs in having bracts persistent, styles glabrous, stipules 8-9 mm long, stamens 28-30 of per flower, and drupes glabrous. The new species is also similar to P. discoidea (Yu & C. L. Li) Yu & C. L. Li ex Z. Wei & Y. B. Chang in having 2 or 3 flowers in an umbellate inflorescence, and bracts persistent and marginally glandular, but it differs in having young shoots and petioles densely covered with yellowish-brown villose trichomes; leaves rounded or slightly cordate at base, the mid-ribs and lateral veins abaxially densely covered with yellowish-brown villose trichomes; and hypanthium ca. 3 mm long, shorter than sepals. The atpB-rbcL and trnL-F intergenic chloroplast spacers are selected for identification of the new and its similar species.	[Chen, Zi-Lin; Chen, Wei-Jie; Zhou, Ying-Ying; Tang, Mei-Qin; Fu, Meng-Qi; Jin, Xiao-Feng] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Chen, Zi-Lin] Zhejiang Dapanshan Natl Nat Reserve, Panan, Zhejiang, Peoples R China; [Chen, Huan] Zhejiang Inst Microbiol, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Jin, XF (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	docxfjin@163.com	Chen, Huan/CAH-8180-2022		National Natural Science Foundation of China [31170183]; Science & Technology Department of Zhejiang Province [2010C33093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Department of Zhejiang Province	This work was supported by the National Natural Science Foundation of China (Grant No. 31170183) and the project of Science & Technology Department of Zhejiang Province (Grant No. 2010C33093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortiri E, 2002, AM J BOT, V89, P1697, DOI 10.3732/ajb.89.10.1697; Bortiri E, 2001, SYST BOT, V26, P797; Chang KS, 2007, BOT J LINN SOC, V154, P35, DOI 10.1111/j.1095-8339.2007.00631.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Hillier J, 2002, THE HILLIER MANUAL O; Huxley A, 1999, THE NEW ROYAL HORTIC, V3; Judd WS, 2008, PLANT SYSTEMATICS PH; Knapp S, 2011, SYST BOT, V36, P821, DOI 10.1600/036364411X604822; Koehne E, 1913, PLANTAE WILSONIANAE, V2, P196; KRUSSMANN G, 1986, CULTIVATED BROAD LEA, V3; Lahaye R, 2008, NATURE, V1896, P1; Li C, 2003, FLORA CHINA, V9; Liu KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038880; McNeill J, 2011, TAXON, V60, P1507, DOI 10.1002/tax.605034; Mishler BD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P44; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quan X, 2011, J SYST EVOL, V49, P138, DOI 10.1111/j.1759-6831.2010.00112.x; Ramos-Castro SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048822; Rehder A, 1940, MANUAL OF CULTIVATED; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yu T.-T., 1986, FLORA REIPUBLICAE PO, V38, P41	24	4	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54030	10.1371/journal.pone.0054030	http://dx.doi.org/10.1371/journal.pone.0054030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349780	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800021
J	Khurana, N; Chauhan, H; Khurana, P				Khurana, Neetika; Chauhan, Harsh; Khurana, Paramjit			Wheat Chloroplast Targeted sHSP26 Promoter Confers Heat and Abiotic Stress Inducible Expression in Transgenic Arabidopsis Plants	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTOR; UPSTREAM SEQUENCES; BETA-GLUCURONIDASE; CIS-ELEMENTS; GENE FUSION; PROTEIN; BINDING; TEMPERATURE; IDENTIFICATION; ACTIVATION	The small heat shock proteins (sHSPs) have been found to play a critical role in physiological stress conditions in protecting proteins from irreversible aggregation. To characterize the hloroplast targeted sHSP26 promoter in detail, deletion analysis of the promoter is carried out and analysed via transgenics in Arabidopsis. In the present study, complete assessment of the importance of CCAAT-box elements along with Heat shock elements (HSEs) in the promoter of sHSP26 was performed. Moreover, the importance of 5' untranslated region (UTR) has also been established in the promoter via Arabidopsis transgenics. An intense GUS expression was observed after heat stress in the transgenics harbouring a full-length promoter, confirming the heat-stress inducibility of the promoter. Transgenic plants without UTR showed reduced GUS expression when compared to transgenic plants with UTR as was confirmed at the RNA and protein levels by qRT-PCR and GUS histochemical assays, thus suggesting the possible involvement of some regulatory elements present in the UTR in heat-stress inducibility of the promoter. Promoter activity was also checked under different abiotic stresses and revealed differential expression in different deletion constructs. Promoter analysis based on histochemical assay, real-time qPCR and fluorimetric analysis revealed that HSEs alone could not transcribe GUS gene significantly in sHSP26 promoter and CCAAT box elements contribute synergistically to the transcription. Our results also provide insight into the importance of 5UTR of sHsp26 promoter thus emphasizing the probable role of imperfect CCAAT-box element or some novel cis-element with respect to heat stress.	[Khurana, Neetika; Chauhan, Harsh; Khurana, Paramjit] Univ Delhi, Dept Plant Mol Biol, New Delhi, India	University of Delhi	Khurana, P (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi, India.	param@genomeindia.org	Chauhan, Harsh/U-8270-2019; Chauhan, Harsh/AAB-2751-2021	Chauhan, Harsh/0000-0002-1396-5464	Department of Biotechnology, Government of India, New Delhi	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	This work was financially supported by Department of Biotechnology, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; AN GH, 1987, BIOESSAYS, V7, P211, DOI 10.1002/bies.950070505; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Carranco R, 1999, PLANT PHYSIOL, V121, P723, DOI 10.1104/pp.121.3.723; Chauhan H, 2012, PLANT CELL ENVIRON, V35, P1912, DOI 10.1111/j.1365-3040.2012.02525.x; Chauhan H, 2011, PLANT MOL BIOL, V75, P35, DOI 10.1007/s11103-010-9702-8; Chen J, 2010, J MOL BIOL, V398, P122, DOI 10.1016/j.jmb.2010.02.022; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crone D, 2001, PLANT CELL ENVIRON, V24, P869, DOI 10.1046/j.1365-3040.2001.00727.x; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Freeman J, 2011, PLANT BIOTECHNOL J, V9, P788, DOI 10.1111/j.1467-7652.2011.00588.x; Ganguly M, 2011, PLANT CELL REP, V30, P1617, DOI 10.1007/s00299-011-1072-4; Hamilton EW, 2001, PLANT PHYSIOL, V126, P1266, DOI 10.1104/pp.126.3.1266; Haralampidis K, 2002, PLANT PHYSIOL, V129, P1138, DOI 10.1104/pp.004044; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; ISHSHALOM D, 1990, EMBO J, V9, P2657, DOI 10.1002/j.1460-2075.1990.tb07450.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang CH, 2009, PLANT CELL ENVIRON, V32, P1046, DOI 10.1111/j.1365-3040.2009.01987.x; Jung HS, 2010, PLANT PHYSIOL, V152, P453, DOI 10.1104/pp.109.149070; Karthikeyan AS, 2009, PHYSIOL PLANTARUM, V136, P10, DOI 10.1111/j.1399-3054.2009.01207.x; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; LANDSBERGER N, 1995, MOL CELL BIOL, V15, P6013; Lee BH, 2000, GENE, V245, P283, DOI 10.1016/S0378-1119(00)00043-3; LEE JH, 1995, PLANT J, V8, P603, DOI 10.1046/j.1365-313X.1995.8040603.x; Lee SY, 1998, CURR MICROBIOL, V37, P403, DOI 10.1007/s002849900400; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lu SY, 2007, TRANSGENIC RES, V16, P177, DOI 10.1007/s11248-006-9035-1; Malik MK, 1999, PLANT J, V20, P89, DOI 10.1046/j.1365-313X.1999.00581.x; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MORGAN WD, 1987, MOL CELL BIOL, V7, P1129, DOI 10.1128/MCB.7.3.1129; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Moriwaki M, 1999, PLANT CELL REP, V19, P96, DOI 10.1007/s002990050717; Qu LQ, 2008, J EXP BOT, V59, P2417, DOI 10.1093/jxb/ern110; RIEPING M, 1992, MOL GEN GENET, V231, P226, DOI 10.1007/BF00279795; Rossel JB, 2002, PLANT PHYSIOL, V130, P1109, DOI 10.1104/pp.005595; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; Sato Y, 2008, PLANT CELL REP, V27, P329, DOI 10.1007/s00299-007-0470-0; Shoji W, 2008, DEV GROWTH DIFFER, V50, P401, DOI [10.1111/j.1440-169x.2008.01038.x, 10.1111/j.1440-169X.2008.01038.x]; Siderius M. H., 1997, YEAST STRESS RESPONS, P213; Sorkina A, 2011, PLANT CELL REP, V30, P1627, DOI 10.1007/s00299-011-1073-3; Storozhenko S, 1998, PLANT PHYSIOL, V118, P1005, DOI 10.1104/pp.118.3.1005; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; Sun YM, 2011, PLANT CELL REP, V30, P1661, DOI 10.1007/s00299-011-1075-1; TAKAHASHI T, 1992, PLANT J, V2, P751, DOI 10.1111/j.1365-313X.1992.tb00144.x; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Tsuwamoto R, 2011, PLANT CELL REP, V30, P1723, DOI 10.1007/s00299-011-1080-4; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; Volkov RA, 2005, PLANT MOL BIOL, V57, P487, DOI 10.1007/s11103-005-0339-y; Volkov RA, 2006, PLANT MOL BIOL, V61, P733, DOI 10.1007/s11103-006-0045-4; Wang DF, 2003, PLANT PHYSIOL, V133, P319, DOI 10.1104/pp.102.018309; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wu LM, 2011, PLANT CELL REP, V30, P75, DOI 10.1007/s00299-010-0945-2; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yokthongwattana K, 2001, PLANT CELL PHYSIOL, V42, P1389, DOI 10.1093/pcp/pce179; Yuan GF, 2010, SCI HORTIC-AMSTERDAM, V126, P103, DOI 10.1016/j.scienta.2010.06.014; ZARSKY V, 1995, PLANT CELL ENVIRON, V18, P139, DOI 10.1111/j.1365-3040.1995.tb00347.x	60	32	35	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54418	10.1371/journal.pone.0054418	http://dx.doi.org/10.1371/journal.pone.0054418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349883	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800052
J	Pinto, LM; Dheda, K; Theron, G; Allwood, B; Calligaro, G; van Zyl-Smit, R; Peter, J; Schwartzman, K; Menzies, D; Bateman, E; Pai, M; Dawson, R				Pinto, Lancelot M.; Dheda, Keertan; Theron, Grant; Allwood, Brian; Calligaro, Gregory; van Zyl-Smit, Richard; Peter, Jonathan; Schwartzman, Kevin; Menzies, Dick; Bateman, Eric; Pai, Madhukar; Dawson, Rodney			Development of a Simple Reliable Radiographic Scoring System to Aid the Diagnosis of Pulmonary Tuberculosis	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; CLINICAL PREDICTORS; RECORDING-SYSTEM; VALIDATION; INPATIENTS; PREVALENCE; DERIVATION; ASSAY; MODEL	Rationale: Chest radiography is sometimes the only method available for investigating patients with possible pulmonary tuberculosis (PTB) with negative sputum smears. However, interpretation of chest radiographs in this context lacks specificity for PTB, is subjective and is neither standardized nor reproducible. Efforts to improve the interpretation of chest radiography are warranted. Objectives: To develop a scoring system to aid the diagnosis of PTB, using features recorded with the Chest Radiograph Reading and Recording System (CRRS). Methods: Chest radiographs of outpatients with possible PTB, recruited over 3 years at clinics in South Africa were read by two independent readers using the CRRS method. Multivariate analysis was used to identify features significantly associated with culture-positive PTB. These were weighted and used to generate a score. Results: 473 patients were included in the analysis. Large upper lobe opacities, cavities, unilateral pleural effusion and adenopathy were significantly associated with PTB, had high inter-reader reliability, and received 2, 2, 1 and 2 points, respectively in the final score. Using a cut-off of 2, scores below this threshold had a high negative predictive value (91.5%, 95% CI 87.1,94.7), but low positive predictive value (49.4%, 95% CI 42.9,55.9). Among the 382 TB suspects with negative sputum smears, 229 patients had scores <2; the score correctly ruled out active PTB in 214 of these patients (NPV 93.4%; 95% CI 89.4,96.3). The score had a suboptimal negative predictive value in HIV-infected patients (NPV 86.4, 95% CI 75,94). Conclusions: The proposed scoring system is simple, and reliably ruled out active PTB in smear-negative HIV-uninfected patients, thus potentially reducing the need for further tests in high burden settings. Validation studies are now required.	[Pinto, Lancelot M.; Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Pinto, Lancelot M.; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Schwartzman, Kevin; Menzies, Dick] McGill Univ, Dept Med, Div Resp, Montreal, PQ, Canada; [Dheda, Keertan; Theron, Grant; Allwood, Brian; Calligaro, Gregory; van Zyl-Smit, Richard; Peter, Jonathan; Bateman, Eric; Dawson, Rodney] Univ Cape Town, Dept Med, Div Pulmonol, Lung Inst, ZA-7925 Cape Town, South Africa	McGill University; McGill University; McGill University; University of Cape Town	Dawson, R (corresponding author), Univ Cape Town, Dept Med, Div Pulmonol, Lung Inst, ZA-7925 Cape Town, South Africa.	rodney.dawson@uct.ac.za	Theron, Grant/ABB-1167-2020; Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020; Calligaro, Greg/U-7472-2019	Theron, Grant/0000-0002-9216-2415; Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X; Calligaro, Gregory/0000-0001-7324-0775; Pinto, Lancelot/0000-0002-5418-5448; van Zyl-Smit, Richard/0000-0002-4115-5362; Peter, Jonathan/0000-0002-2658-0723	European and Developing Countries Clinical Trials Partnership (TB-Novel and Emerging Technologies for Diagnosis); European Commission; Canadian Institutes of Health Research [CIHR-MOP-89918]; Shastri Indo-Canadian Institute; Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR); Grand Challenges Canada; South African National Research Foundation Research Chairs Initiative (SARChI); European and Developing Countries Clinical Trials Partnership (Trials of Excellence in Southern Africa and TB-Novel and Emerging Technologies for Diagnosis); Medical Research Council Career Development Award	European and Developing Countries Clinical Trials Partnership (TB-Novel and Emerging Technologies for Diagnosis); European Commission(European CommissionEuropean Commission Joint Research Centre); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Shastri Indo-Canadian Institute; Research Institute of the McGill University Health Centre; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Grand Challenges Canada(CGIAR); South African National Research Foundation Research Chairs Initiative (SARChI); European and Developing Countries Clinical Trials Partnership (Trials of Excellence in Southern Africa and TB-Novel and Emerging Technologies for Diagnosis); Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants from the The European and Developing Countries Clinical Trials Partnership (TB-Novel and Emerging Technologies for Diagnosis), European Commission (EU-FP7; Sustaining research momentum over the coming decades: mentoring the next generation of researchers for tuberculosis), and Canadian Institutes of Health Research (CIHR-MOP-89918). LMP is supported by fellowships from the Shastri Indo-Canadian Institute and the Research Institute of the McGill University Health Centre. MP is supported by a New Investigator Award by the Canadian Institutes of Health Research (CIHR), and Grand Challenges Canada. KD is supported by the South African National Research Foundation Research Chairs Initiative (SARChI), the European and Developing Countries Clinical Trials Partnership (Trials of Excellence in Southern Africa and TB-Novel and Emerging Technologies for Diagnosis) and an Medical Research Council Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agizew T, 2010, INT J TUBERC LUNG D, V14, P324; [Anonymous], 2011, GLOB TUB CONTR; Bock NN, 1996, AM J RESP CRIT CARE, V154, P1468, DOI 10.1164/ajrccm.154.5.8912766; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Cattamanchi A, 2011, AM J RESP CRIT CARE, V183, P547, DOI 10.1164/rccm.201008-1207OC; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; El-Solh AA, 1999, CHEST, V116, P968, DOI 10.1378/chest.116.4.968; ElSolh A, 1997, AM J RESP CRIT CARE, V155, P1711, DOI 10.1164/ajrccm.155.5.9154881; Koppaka R, 2004, TOMANS TUBERCULOSIS, P51; Lagrange-Xelot M, 2011, CLIN MICROBIOL INFEC, V17, P610, DOI 10.1111/j.1469-0691.2010.03259.x; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Le Minor O, 2008, JAIDS-J ACQ IMM DEF, V48, P620, DOI 10.1097/QAI.0b013e31817efb3c; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Moran GJ, 2009, ANN EMERG MED, V53, P625, DOI 10.1016/j.annemergmed.2008.07.027; Mylotte JM, 1997, INFECT CONT HOSP EP, V18, P554; Pinto LM, 2012, EUR RESP J; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rakoczy KS, 2008, INFECT CONT HOSP EP, V29, P927, DOI 10.1086/590667; Solari L, 2008, INT J TUBERC LUNG D, V12, P619; Soto A, 2008, BRAZ J INFECT DIS, V12, P128, DOI 10.1590/S1413-86702008000200006; Soto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018486; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; URBANCZIK R, 1985, ZBL BAKT-INT J MED M, V260, P81; Venkatesh KK, 2011, DRUGS, V71, P1133, DOI 10.2165/11591360-000000000-00000; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wisnivesky JP, 2000, ARCH INTERN MED, V160, P2471, DOI 10.1001/archinte.160.16.2471; Wisnivesky JP, 2005, ARCH INTERN MED, V165, P453, DOI 10.1001/archinte.165.4.453; World Health Organization, 2011, COUNTR HLTH PROF SA; Yoo SD, 2011, RESPIROLOGY, V16, P836, DOI 10.1111/j.1440-1843.2011.01981.x	33	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54235	10.1371/journal.pone.0054235	http://dx.doi.org/10.1371/journal.pone.0054235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349835	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800033
J	Bianco, L; Alagna, F; Baldoni, L; Finnie, C; Svensson, B; Perrotta, G				Bianco, Linda; Alagna, Fiammetta; Baldoni, Luciana; Finnie, Christine; Svensson, Birte; Perrotta, Gaetano			Proteome Regulation during Olea europaea Fruit Development	PLOS ONE			English	Article							GENE-EXPRESSION; OLIVE FRUIT; OLEUROPEIN; PROTEINS; IDENTIFICATION; BIOSYNTHESIS; ACCUMULATION; INVOLVEMENT; ETHYLENE; ANNEXIN	Background: Widespread in the Mediterranean basin, Olea europaea trees are gaining worldwide popularity for the nutritional and cancer-protective properties of the oil, mechanically extracted from ripe fruits. Fruit development is a physiological process with remarkable impact on the modulation of the biosynthesis of compounds affecting the quality of the drupes as well as the final composition of the olive oil. Proteomics offers the possibility to dig deeper into the major changes during fruit development, including the important phase of ripening, and to classify temporal patterns of protein accumulation occurring during these complex physiological processes. Methodology/Principal Findings: In this work, we started monitoring the proteome variations associated with olive fruit development by using comparative proteomics coupled to mass spectrometry. Proteins extracted from drupes at three different developmental stages were separated on 2-DE and subjected to image analysis. 247 protein spots were revealed as differentially accumulated. Proteins were identified from a total of 121 spots and discussed in relation to olive drupe metabolic changes occurring during fruit development. In order to evaluate if changes observed at the protein level were consistent with changes of mRNAs, proteomic data produced in the present work were compared with transcriptomic data elaborated during previous studies. Conclusions/Significance: This study identifies a number of proteins responsible for quality traits of cv. Coratina, with particular regard to proteins associated to the metabolism of fatty acids, phenolic and aroma compounds. Proteins involved in fruit photosynthesis have been also identified and their pivotal contribution in oleogenesis has been discussed. To date, this study represents the first characterization of the olive fruit proteome during development, providing new insights into fruit metabolism and oil accumulation process.	[Bianco, Linda; Perrotta, Gaetano] TRISAIA Res Ctr, Italian Natl Agcy New Technol Energy & Sustainabl, Rotondella, Matera, Italy; [Alagna, Fiammetta; Baldoni, Luciana] CNR Inst Plant Genet, Perugia, Italy; [Finnie, Christine; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Italian National Agency New Technical Energy & Sustainable Economics Development; Technical University of Denmark	Perrotta, G (corresponding author), TRISAIA Res Ctr, Italian Natl Agcy New Technol Energy & Sustainabl, Rotondella, Matera, Italy.	gaetano.perrotta@enea.it	Baldoni, Luciana/A-4411-2016; Alagna, Fiammetta/AAF-3169-2020	Baldoni, Luciana/0000-0002-3221-333X; Perrotta, Gaetano/0000-0003-2037-1063; Svensson, Birte/0000-0002-2993-8196; BALDONI, LUCIANA/0000-0002-6636-0055; Alagna, Fiammetta/0000-0003-1878-2023; Finnie, Christine/0000-0003-0657-5174	Italian Ministry of Agriculture (MIPAF)-Project OLEA; Danish Center for Advanced Food Science (LMC); Danish Research Council for Natural Sciences	Italian Ministry of Agriculture (MIPAF)-Project OLEA; Danish Center for Advanced Food Science (LMC); Danish Research Council for Natural Sciences(Danish Natural Science Research Council)	This work was supported by the Italian Ministry of Agriculture (MIPAF)-Project OLEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Silvia Mazzuca for her precious advice on protein extraction from drupes and Birgit Andersen for the assistance with mass spectrometry. The Bruker Ultraflex II mass spectrometer was in part funded by the Danish Center for Advanced Food Science (LMC), the Typhoon scanner was granted by the Danish Research Council for Natural Sciences. We thank CRA-OLI for accessing their Olive Cultivar Collection at the experimental farm of Collececco, Spoleto (Perugia, Italy).	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Amemiya T, 2006, PLANTA, V223, P1272, DOI 10.1007/s00425-005-0176-x; AMIOT MJ, 1989, PHYTOCHEMISTRY, V28, P67, DOI 10.1016/0031-9422(89)85009-5; Huerta-Ocampo JA, 2012, J PROTEOMICS, V75, P2160, DOI 10.1016/j.jprot.2012.01.015; Bian W., 2011, J BOT, V2011, P1, DOI DOI 10.1155/2011/289859; Bianco L, 2009, J PROTEOMICS, V72, P586, DOI 10.1016/j.jprot.2008.11.019; BLANKE MM, 1989, PLANT CELL ENVIRON, V12, P31, DOI 10.1111/j.1365-3040.1989.tb01914.x; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Buchhaupt M, 2012, APPL MICROBIOL BIOT, V93, P159, DOI 10.1007/s00253-011-3482-1; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carpentier SC, 2008, MASS SPECTROM REV, V27, P354, DOI 10.1002/mas.20170; Ciafardini G, 2001, ITAL J FOOD SCI, V13, P41; Clark GB, 2001, PLANT PHYSIOL, V126, P1072, DOI 10.1104/pp.126.3.1072; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Colomer Ramon, 2006, Clin Transl Oncol, V8, P15, DOI 10.1007/s12094-006-0090-0; Conde C, 2008, J PLANT PHYSIOL, V165, P1545, DOI 10.1016/j.jplph.2008.04.018; Connor D. J., 2004, Horticultural Reviews, V31, P155, DOI 10.1002/9780470650882.ch4; Corrado G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-86; Dierkes G, 2012, J AGR FOOD CHEM, V60, P394, DOI 10.1021/jf203406s; Esteve C, 2012, J PROTEOMICS, V75, P2396, DOI 10.1016/j.jprot.2012.02.020; Esteve C, 2011, ANAL CHIM ACTA, V690, P129, DOI 10.1016/j.aca.2011.02.005; Etienne C, 2002, PHYSIOL PLANTARUM, V114, P259, DOI 10.1034/j.1399-3054.2002.1140212.x; Faurobert M, 2007, PLANT PHYSIOL, V143, P1327, DOI 10.1104/pp.106.092817; Galla G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-128; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Giribaldi M, 2007, PROTEOMICS, V7, P3154, DOI 10.1002/pmic.200600974; Gomez-Jimenez MC, 2010, PLANTA, V232, P629, DOI 10.1007/s00425-010-1198-6; Gutierrez-Rosales F, 2012, J AGR FOOD CHEM, V60, P4348, DOI 10.1021/jf205209y; Gutierrez-Rosales F, 2010, J AGR FOOD CHEM, V58, P12924, DOI 10.1021/jf103083u; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Jimenez A, 2002, PLANTA, V214, P751, DOI 10.1007/s004250100667; Martinez-Esteso MJ, 2011, J EXP BOT, V62, P2521, DOI 10.1093/jxb/erq434; Jungblut PR, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-16; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Karp Natasha A, 2007, Proteomics, V7 Suppl 1, P42, DOI 10.1002/pmic.200700683; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Katz YS, 2006, PLANT MOL BIOL, V61, P255, DOI 10.1007/s11103-006-0009-8; Konopka-Postupolska D, 2007, PROTOPLASMA, V230, P203, DOI 10.1007/s00709-006-0234-7; Larsen MR, 2000, FRESEN J ANAL CHEM, V366, P677, DOI 10.1007/s002160051562; Lelievre JM, 1997, PHYSIOL PLANTARUM, V101, P727, DOI 10.1111/j.1399-3054.1997.tb01057.x; Liu JH, 2006, JARQ-JPN AGR RES Q, V40, P51, DOI 10.6090/jarq.40.51; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Nogueira SB, 2012, J PROTEOMICS, V75, P1428, DOI 10.1016/j.jprot.2011.11.015; OLIAS JM, 1993, J AGR FOOD CHEM, V41, P2368, DOI 10.1021/jf00036a029; Omar Syed Haris, 2010, Sci Pharm, V78, P133, DOI 10.3797/scipharm.0912-18; Padilla MN, 2009, J AGR FOOD CHEM, V57, P9097, DOI 10.1021/jf901777j; Paul V, 2012, J FOOD SCI TECH MYS, V49, P1, DOI 10.1007/s13197-011-0293-4; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; POPOV N, 1975, ACTA BIOL MED GER, V34, P1441; Proietti P, 2006, PHOTOSYNTHETICA, V44, P275, DOI 10.1007/s11099-006-0019-4; Proust J, 1996, FEBS LETT, V383, P208, DOI 10.1016/0014-5793(96)00252-9; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Rabilloud T, 2009, MASS SPECTROM REV, V28, P816, DOI 10.1002/mas.20204; Rocco M, 2006, PROTEOMICS, V6, P3781, DOI 10.1002/pmic.200600128; Sanchez J, 2002, EUR J LIPID SCI TECH, V104, P564, DOI 10.1002/1438-9312(200210)104:9/10<564::AID-EJLT564>3.0.CO;2-5; SANCHEZ J, 1994, PLANT LIPID METABOLISM, P564; Seals DF, 1997, PLANT PHYSIOL, V115, P753, DOI 10.1104/pp.115.2.753; Theiss C, 2002, PLANT PHYSIOL, V128, P1470, DOI 10.1104/pp.010896; Wechter WP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-275; WILKINSON JQ, 1995, PLANT MOL BIOL, V27, P1097, DOI 10.1007/BF00020883; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Zhang XM, 2007, PROTEOMICS, V7, P2340, DOI 10.1002/pmic.200600184	62	34	34	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53563	10.1371/journal.pone.0053563	http://dx.doi.org/10.1371/journal.pone.0053563			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349718	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900012
J	Limkakeng, A; Phadtare, A; Shah, J; Vaghasia, M; Wei, DY; Shah, A; Pietrobon, R				Limkakeng, Alexander; Phadtare, Amruta; Shah, Jatin; Vaghasia, Meenakshi; Wei, Ding Ying; Shah, Anand; Pietrobon, Ricardo			Willingness to Participate in Clinical Trials among Patients of Chinese Heritage: A Meta-Synthesis	PLOS ONE			English	Article							SOUTH ASIAN PATIENTS; CANCER; ENROLLMENT; BARRIERS; RECRUITMENT; EMERGENCY; ATTITUDES; WOMEN; VIEWS; GLOBALIZATION	Background: Subjects of Chinese heritage have been found to participate in clinical research at lower rates than other groups despite growing in numbers as a population. While much research has examined research participants' motivation, there has not been a comprehensive synthesis of this information with respect to participants of Chinese descent. We sought to identify the factors that promote and hinder participation in clinical research among participants of Chinese heritage. Methodology/Principal Findings: We conducted a systematic review of the literature in Pubmed, OpenJGATE, SCIRUS, and COCHRANE databases and performed a meta-synthesis of retrieved articles. We extracted qualitative data, such as quotes to identify emerging themes. We identified five studies that met our selection criteria. Of them, only one (1/5) was conducted in China while other studies involved Chinese emigrants in USA (3/5) and Singapore (1/5). Participants from China were similar to emigrants with regard to factors that either promoted or decreased research participation. Four studies reported data exclusively on Chinese subjects. Three of the five studies involved qualitative interviews while the others were conducted using a survey design. Six themes favoring research participation were identified: Personal Benefit to Participants, Financial Incentives, Participant Sense of Altruism, Family or Physician Recommendations, Advertisements, and Convenience to the Participant. Five factors were seen as a barrier to participation in clinical trials: Mistrust of Researchers, Language Barrier, Lack of Financial and Other Support, Cultural and Social Barriers, Lack of Knowledge about Clinical Trials. Conclusions/Significance: Chinese heritage clinical research participants value personal benefit, financial incentives, the ability to help others, recommendations of others, advertisements, and convenience when considering clinical research participation. In addition, the establishment of trust and addressing knowledge deficits are important factors to them. Investigators seeking to optimize enrolment in these populations should incorporate these findings into their study design and subject handouts.	[Limkakeng, Alexander; Pietrobon, Ricardo] Duke Univ, Dept Surg, Div Emergency Med, Durham, NC 27708 USA; [Shah, Anand] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Wei, Ding Ying] Natl Canc Ctr, Singapore, Singapore	Duke University; University of Pennsylvania; National Cancer Centre Singapore (NCCS)	Pietrobon, R (corresponding author), Duke Univ, Dept Surg, Div Emergency Med, Durham, NC 27708 USA.	rpietro@duke.edu	Shah, Jatin/B-6039-2011; Limkakeng, Alexander T./AAH-7733-2020	Shah, Jatin/0000-0002-2457-491X; Limkakeng, Alexander T./0000-0002-9822-5595				Alexander GA, 2000, ANN EPIDEMIOL, V10, pS61, DOI 10.1016/S1047-2797(00)00198-8; Annas GJ, 2009, NEW ENGL J MED, V360, P2050, DOI 10.1056/NEJMp0901474; [Anonymous], 2007, YB IMM STAT HOM SEC; [Anonymous], 2001, NIH GUID INCL WOM MI; Brugge Doug, 2005, J Immigr Health, V7, P93, DOI 10.1007/s10903-005-2642-8; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Buchwald D, 2006, J GEN INTERN MED, V21, P648, DOI 10.1111/j.1525-1497.2006.00449.x; Cambron JA, 2001, J MANIP PHYSIOL THER, V24, P79, DOI 10.1067/mmt.2001.112567; Catania C, 2008, ONCOLOGY-BASEL, V74, P177, DOI 10.1159/000151365; Chan MY, 2011, AM HEART J, V162, P291, DOI 10.1016/j.ahj.2011.05.016; Clark J., 2003, PEER REV HLTH SCI, V2nd ed.; Gitanjali B, 2003, J Postgrad Med, V49, P109; Glickman SW, 2008, ANN EMERG MED, V51, P775, DOI 10.1016/j.annemergmed.2007.11.002; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Hussain-Gambles M, 2004, FAM PRACT, V21, P636, DOI 10.1093/fampra/cmh611; Hussain-Gambles M, 2004, HEALTH TECHNOL ASSES, V8, P1; Hussain-Gambles M, 2006, HEALTH POLICY, V77, P149, DOI 10.1016/j.healthpol.2005.07.022; Jolly Kate, 2005, BMC Med Res Methodol, V5, P18, DOI 10.1186/1471-2288-5-18; Jones JM, 2006, J CANCER EDUC, V21, P237; Kasner SE, 2011, ANN EMERG MED, V57, P346, DOI 10.1016/j.annemergmed.2010.07.009; Kimmick GG, 2005, J CLIN ONCOL, V23, P2201, DOI 10.1200/JCO.2005.01.222; King WD, 2007, AIDS PATIENT CARE ST, V21, P551, DOI 10.1089/apc.2006.0173; Lara PN, 2001, J CLIN ONCOLOGY OFFI; LaVallie DL, 2008, ETHNIC DIS, V18, P210; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Lin J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-423; Lin JS, 2005, J COMMUN HEALTH, V30, P451, DOI 10.1007/s10900-005-7280-5; Paradis C, 2010, J MED ETHICS, V36, P580, DOI 10.1136/jme.2009.032904; Pietrobon Ricardo, 2004, BMC Med Res Methodol, V4, P29, DOI 10.1186/1471-2288-4-29; Russell KM, 2008, APPL NURS RES, V21, P90, DOI 10.1016/j.apnr.2006.05.001; Shah A, 2012, INT J RAD ONCOLOGY B; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; Shah JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010730; Shavers VL, 2002, ANN EPIDEMIOL, V12, P248, DOI 10.1016/S1047-2797(01)00265-4; Shaw PH, 2007, J PEDIAT HEMATOL ONC, V29, P811, DOI 10.1097/MPH.0b013e31815814f3; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Tu SP, 2005, CANCER-AM CANCER SOC, V104, P2999, DOI 10.1002/cncr.21524; Umutyan A, 2008, CANCER-AM CANCER SOC, V112, P212, DOI 10.1002/cncr.23170; Unson CG, 2004, J AGING HEALTH, V16, P426, DOI 10.1177/0898264304264211; Wallace K, 2006, J CLIN ONCOL, V24, P4158, DOI 10.1200/JCO.2006.06.3875; Wenzel L, 2008, COMMUNITY GENET, V11, P234, DOI 10.1159/000116884; Wong ML, 2004, COMMUNITY GENET, V7, P44, DOI 10.1159/000080303; Wood CG, 2006, AM J CLIN ONCOL-CANC, V29, P593, DOI 10.1097/01.coc.0000236213.61427.84; Yin L, 2008, VACCINE, V26, P762, DOI 10.1016/j.vaccine.2007.11.091; Zammar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014368	45	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e51328	10.1371/journal.pone.0051328	http://dx.doi.org/10.1371/journal.pone.0051328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	073JI	23349672	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900002
J	Albuquerque, D; Nobrega, C; Manco, L				Albuquerque, David; Nobrega, Clevio; Manco, Licinio			Association of FTO Polymorphisms with Obesity and Obesity-Related Outcomes in Portuguese Children	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; EARLY-ONSET; COMMON VARIATION; FAT MASS; GENE; RISK; POPULATION; PREVALENCE; CHILDHOOD	Background: Several studies have reported an association between single nucleotide polymorphisms in the first intron of the FTO gene and body mass index (BMI) or obesity. However, this association has not yet been studied among the Portuguese population. This study aims to assess the association of three FTO polymorphisms (rs1861868, rs1421085 and rs9939609) with obesity-related outcomes in a sample of Portuguese children. Methods: We examined a total of 730 children, 256 normal-weight (55.9% girls), 320 overweight (45.3% girls) and 154 obese (53.2% girls), aging from 6 to 12-years-old, recruited randomly from public schools in the central region of Portugal. DNA samples were genotyped for the three polymorphisms by allelic discrimination TaqMan assay. Association of the FTO polymorphisms with several anthropometric traits was investigated. Additionally, we tested association with the risk of obesity using overweight and obese vs. normal-weight children. Results: We found significant associations of rs9939609 and rs1421085 polymorphisms with weight, BMI, BMI Z-score, waist circumference and hip circumference, even after age and gender adjustment (p<0.05 in all traits). For rs1861868 polymorphism, marginally significant associations were obtained with weight (p = 0.081) and BMI (p = 0.096) after adjustment for age and gender. In case-control studies, both rs9939609 and rs1421085 polymorphisms were significantly associated with obesity (OR 1.97; 95% CI, 1.08-3.59; p = 0.026; OR 2.11; 95% CI, 1.17-3.81; p = 0.013, respectively) but not with overweight (p>0.05). Haplotype analyses identified two combinations (ACA and GCA) associated with a higher risk of obesity (OR 1.53; 95% CI, 1.06-2.22; p = 0.023; OR 1.73; 95% CI, 1.06-2.87; p = 0.030, respectively). Conclusions: This study provides the first evidence for the association of FTO polymorphisms with anthropometric traits and risk of obesity in Portuguese children.	[Albuquerque, David; Manco, Licinio] Univ Coimbra, Dept Life Sci, Res Ctr Anthropol & Hlth CIAS, Coimbra, Portugal; [Nobrega, Clevio] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Manco, L (corresponding author), Univ Coimbra, Dept Life Sci, Res Ctr Anthropol & Hlth CIAS, Coimbra, Portugal.	lmanco@antrop.uc.pt	Manco, Licinio/M-4746-2013; Nobrega, Clévio/M-6047-2013; Albuquerque, David/S-5586-2017	Manco, Licinio/0000-0002-2636-0288; Nobrega, Clévio/0000-0002-8312-5292; Albuquerque, David/0000-0001-8899-9020	Research Centre for Anthropology and Health (CIAS); University of Coimbra; FCT [PEst-OE/SADG/UI0283/2011, SFRH/BD/68774/2010]	Research Centre for Anthropology and Health (CIAS); University of Coimbra; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was performed with the support of the Research Centre for Anthropology and Health (CIAS), University of Coimbra and FCT (PEst-OE/SADG/UI0283/2011). David Albuquerque has a PhD grant (SFRH/BD/68774/2010) from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque D, 2012, ACTA MEDICA PORT, V25, P169; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang HY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-136; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Gonzalez JR, 2012, OBESITY, V20, P909, DOI 10.1038/oby.2011.325; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Karns R, 2012, ANN HUM GENET, V76, P17, DOI 10.1111/j.1469-1809.2011.00686.x; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Macekova S, 2012, AM J PHYS ANTHROPOL, V147, P30, DOI 10.1002/ajpa.21604; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Neel JV, 1962, B WORLD HEALTH ORGAN, V77, P694; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Padez C, 2004, AM J HUM BIOL, V16, P670, DOI 10.1002/ajhb.20080; Paquot N, 2012, Rev Med Liege, V67, P332; Price RA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-4; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Rodriguez-Lopez Raquel, 2010, Endocrinol Nutr, V57, P203, DOI 10.1016/j.endonu.2010.03.002; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Song YQ, 2008, OBESITY, V16, P2472, DOI 10.1038/oby.2008.408; Tung YCL, 2011, ANN NY ACAD SCI, V1220, P162, DOI 10.1111/j.1749-6632.2010.05903.x; Weber WW, 1999, MOL DIAGN, V4, P299, DOI 10.1016/S1084-8592(99)80006-X; Zavattari P, 2011, ANN HUM GENET, V75, P648, DOI 10.1111/j.1469-1809.2011.00674.x	33	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54370	10.1371/journal.pone.0054370	http://dx.doi.org/10.1371/journal.pone.0054370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342142	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400157
J	Koning, GG; Wetterslev, J; Van Laarhoven, CJHM; Keus, F				Koning, G. G.; Wetterslev, J.; Van Laarhoven, C. J. H. M.; Keus, F.			The Totally Extraperitoneal Method versus Lichtenstein's Technique for Inguinal Hernia Repair: A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Clinical Trials	PLOS ONE			English	Review							OPEN TENSION-FREE; MONITORING BOUNDARIES; MESH REPAIR; BIAS; QUALITY; HERNIOPLASTY; COST	Background: Lichtenstein's technique is considered the reference technique for inguinal hernia repair. Recent trials suggest that the totally extraperitoneal (TEP) technique may lead to reduced proportions of chronic pain. A systematic review evaluating the benefits and harms of the TEP compared with Lichtenstein's technique is needed. Methodology/Principal Findings: The review was performed according to the 'Cochrane Handbook for Systematic Reviews'. Searches were conducted until January 2012. Patients with primary uni- or bilateral inguinal hernias were included. Only trials randomising patients to TEP and Lichtenstein were included. Bias evaluation and trial sequential analysis (TSA) were performed. The error matrix was constructed to minimise the risk of systematic and random errors. Thirteen trials randomized 5404 patients. There was no significant effect of the TEP compared with the Lichtenstein on the number of patients with chronic pain in a random-effects model risk ratio (RR 0.80; 95% confidence interval (CI) 0.61 to 1.04; p = 0.09). There was also no significant effect on number of patients with recurrences in a random-effects model (RR 1.41; 95% CI 0.72 to 2.78; p = 0.32) and the TEP technique may or may not be associated with less severe adverse events (random-effects model RR 0.91; 95% CI 0.73 to 1.12; p = 0.37). TSA showed that the required information size was far from being reached for patient important outcomes. Conclusions/Significance: TEP versus Lichtenstein for inguinal hernia repair has been evaluated by 13 trials with high risk of bias. The review with meta-analyses, TSA and error matrix approach shows no conclusive evidence of a difference between TEP and Lichtenstein on the primary outcomes chronic pain, recurrences, and severe adverse events.	[Koning, G. G.; Van Laarhoven, C. J. H. M.; Keus, F.] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6525 ED Nijmegen, Netherlands; [Wetterslev, J.; Keus, F.] Univ Copenhagen, Rigshosp, Ctr Clin Intervent Res, CTU, DK-2100 Copenhagen, Denmark	Radboud University Nijmegen; Rigshospitalet; University of Copenhagen	Koning, GG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6525 ED Nijmegen, Netherlands.	g.koning@chir.umcn.nl	van Laarhoven, C.J.H.M./H-8065-2014; Wetterslev, Jørn/ABF-1251-2020	Wetterslev, Jørn/0000-0001-7778-1771				Amid PK, 1996, EUR J SURG, V162, P447; Andersson B, 2003, SURGERY, V133, P464, DOI 10.1067/msy.2003.98; [Anonymous], 2008, VERS 5 1 WIND; [Anonymous], 2003, NVVH; Berrevoet F, 2010, LANGENBECK ARCH SURG, V395, P557, DOI 10.1007/s00423-009-0544-2; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Colak T, 2003, SURG LAPARO ENDO PER, V13, P3; McCormack K, 2008, COCHRANE LIB; Deeks JJ, 2003, HLTH TECHNOL ASSESS, V7; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eklund A, 2006, BRIT J SURG, V93, P1060, DOI 10.1002/bjs.5405; Eklund A, 2010, BRIT J SURG, V97, P765, DOI 10.1002/bjs.6945; Eklund A, 2010, BRIT J SURG, V97, P600, DOI 10.1002/bjs.6904; Eklund AS, 2009, ANN SURG, V249, P33, DOI 10.1097/SLA.0b013e31819255d0; Gokalp A, 2003, ACTA CHIR BELG, V103, P502; Grant A M, 2002, Hernia, V6, P2; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Heikkinen T, 2004, SURG ENDOSC, V18, P518, DOI 10.1007/s00464-003-9119-4; Heikkinen TJ, 1998, SURG ENDOSC-ULTRAS, V12, P1199, DOI 10.1007/s004649900820; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hildebrandt J, 2003, CHIRURG, V74, P915, DOI 10.1007/s00104-003-0687-6; Keus F, 2009, AM J GASTROENTEROL, V104, P546, DOI 10.1038/ajg.2008.22; Keus F, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-90; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Koning GG, 2011, HERNIA, V15, P19, DOI 10.1007/s10029-010-0744-2; Koning G. G., 2011, PROTOCOL TOTALLY EXT; Koning GG, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-89; Lal P, 2003, SURG ENDOSC, V17, P850, DOI 10.1007/s00464-002-8575-6; Langeveld HR, 2010, ANN SURG, V251, P819, DOI 10.1097/SLA.0b013e3181d96c32; Lau H, 2006, SURG ENDOSC, V20, P76, DOI 10.1007/s00464-005-0203-9; LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Merello J, 1997, SURG ENDOSC, V11, P545; Moher D, 1996, INT J TECHNOL ASSESS, V12, P195, DOI 10.1017/S0266462300009570; Moreno- Egea A, 1999, CIRUGIA ESPAFIOLA, V66, P53; Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093; Pogue J, 1998, LANCET, V351, P47, DOI 10.1016/S0140-6736(97)08461-4; Pogue JM, 1997, CONTROL CLIN TRIALS, V18, P580, DOI 10.1016/S0197-2456(97)00051-2; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shi Yulong, 2010, Front Med China, V4, P463, DOI 10.1007/s11684-010-0050-5; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; VOELLER GR, 1995, SCAND J GASTROENTERO, V30, P67, DOI 10.3109/00365529509107765; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Wright DM, 1996, SURGERY, V119, P552, DOI 10.1016/S0039-6060(96)80266-2	50	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52599	10.1371/journal.pone.0052599	http://dx.doi.org/10.1371/journal.pone.0052599			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23349689	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800022
J	Bjerg, A; Ekerljung, L; Eriksson, J; Olafsdottir, IS; Middelveld, R; Franklin, KA; Forsberg, B; Larsson, K; Lotvall, J; Toren, K; Dahlen, SE; Lundback, B; Janson, C				Bjerg, Anders; Ekerljung, Linda; Eriksson, Jonas; Olafsdottir, Inga Sif; Middelveld, Roelinde; Franklin, Karl A.; Forsberg, Bertil; Larsson, Kjell; Lotvall, Jan; Toren, Kjell; Dahlen, Sven-Erik; Lundback, Bo; Janson, Christer			Higher Risk of Wheeze in Female than Male Smokers. Results from the Swedish GA(2)LEN Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NORD-TRONDELAG HEALTH; LUNG-FUNCTION; BRONCHIAL HYPERRESPONSIVENESS; METHACHOLINE REACTIVITY; RESPIRATORY SYMPTOMS; GENDER-DIFFERENCES; CIGARETTE-SMOKING; WOMEN; COPD	Background: Women who smoke have higher risk of lung function impairment, COPD and lung cancer than smoking men. An influence of sex hormones has been demonstrated, but the mechanisms are unclear and the associations often subject to confounding. This was a study of wheeze in relation to smoking and sex with adjustment for important confounders. Methods: In 2008 the Global Allergy and Asthma European Network (GA(2)LEN) questionnaire was mailed to 45.000 Swedes (age 16-75 years), and 26.851 (60%) participated. "Any wheeze'': any wheeze during the last 12 months. "Asthmatic wheeze'': wheeze with breathlessness apart from colds. Results: Any wheeze and asthmatic wheeze was reported by 17.3% and 7.1% of women, vs. 15.8% and 6.1% of men (both p<0.001). Although smoking prevalence was similar in both sexes, men had greater cumulative exposure, 16.2 pack-years vs. 12.8 in women (p<0.001). Most other exposures and characteristics associated with wheeze were significantly overrepresented in men. Adjusted for these potential confounders and pack-years, current smoking was a stronger risk factor for any wheeze in women aged <53 years, adjusted odds ratio (aOR) 1.85 (1.56-2.19) vs. 1.60 (1.30-1.96) in men. Cumulative smoke exposure and current smoking each interacted significantly with female sex, aOR 1.02 per pack-year (p<0.01) and aOR 1.28 (p = 0.04) respectively. Female compared to male current smokers also had greater risk of asthmatic wheeze, aOR 1.53 vs. 1.03, interaction aOR 1.52 (p = 0.02). These interactions were not seen in age >= 53 years. Discussion: In addition to the increased risk of COPD and lung cancer female, compared to male, smokers are at greater risk of significant wheezing symptoms in younger age. This became clearer after adjustment for important confounders including cumulative smoke exposure. Estrogen has previously been shown to increase the bioactivation of several compounds in tobacco smoke, which may enhance smoke-induced airway inflammation in fertile women.	[Bjerg, Anders; Ekerljung, Linda; Eriksson, Jonas; Lotvall, Jan; Lundback, Bo] Univ Gothenburg, Dept Internal Med, Krefting Res Ctr, Gothenburg, Sweden; [Bjerg, Anders] Sunderby Cent Hosp Norrbotten, OLIN Studies, Dept Med, Lulea, Sweden; [Olafsdottir, Inga Sif] Univ Gothenburg, Sahlgrenska Sch Publ Hlth, Gothenburg, Sweden; [Middelveld, Roelinde; Dahlen, Sven-Erik] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Middelveld, Roelinde; Larsson, Kjell; Toren, Kjell; Dahlen, Sven-Erik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Franklin, Karl A.] Umea Univ, Dept Surg, Umea, Sweden; [Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Toren, Kjell] Sahlgrens Univ Hosp, Dept Resp Med & Allergol, Gothenburg, Sweden; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden	University of Gothenburg; University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Umea University; Umea University; Sahlgrenska University Hospital; Uppsala University	Bjerg, A (corresponding author), Univ Gothenburg, Dept Internal Med, Krefting Res Ctr, Gothenburg, Sweden.	anders.bjerg@gu.se	Bjerg, Anders/GRR-3443-2022	Franklin, Karl/0000-0002-5306-1697; Lotvall, Jan/0000-0001-9195-9249	EU [FOOD-CT-2004-506378]; Swedish Heart and Lung Foundation; Swedish Asthma and Allergy Foundation; Swedish Association against Heart and Lung Diseases; VBG Group Centre for Asthma and Allergy Research	EU(European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma and Allergy Foundation; Swedish Association against Heart and Lung Diseases; VBG Group Centre for Asthma and Allergy Research	This study was carried out as part of the GA2LEN survey and was financially supported by the EU Sixth Framework programme for research, contract no. FOOD-CT-2004-506378. The study was also financially supported by the Swedish Heart and Lung Foundation, the Swedish Asthma and Allergy Foundation and the Swedish Association against Heart and Lung Diseases. The Gothenburg part of the study was mainly funded by VBG Group Centre for Asthma and Allergy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Benowitz NL, 2006, CLIN PHARMACOL THER, V79, P480, DOI 10.1016/j.clpt.2006.01.008; Bjerg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016082; BJORNSSON E, 1994, EUR RESPIR J, V7, P2146, DOI 10.1183/09031936.94.07122146; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; BURNEY PGJ, 1989, EUR RESPIR J, V2, P940; Cohen SBZ, 2007, AM J RESP CRIT CARE, V176, P113, DOI 10.1164/rccm.20011-1655PP; de Marco R, 1998, EUR RESPIR J, V11, P599; de Meer G, 2005, ALLERGY, V60, P1499, DOI 10.1111/j.1398-9995.2005.00930.x; Fokkens W, 2007, RHINOLOGY, V45, P97; Gold DR, 1996, NEW ENGL J MED, V335, P931, DOI 10.1056/NEJM199609263351304; Greaves Lorraine J, 2007, Proc Am Thorac Soc, V4, P675, DOI 10.1513/pats.200706-079SD; Holmen TL, 2002, RESP MED, V96, P796, DOI 10.1053/rmed.2002.1350; Langhammer A, 2000, J EPIDEMIOL COMMUN H, V54, P917, DOI 10.1136/jech.54.12.917; Langhammer A, 2003, EUR RESPIR J, V21, P1017, DOI 10.1183/09031936.03.00053202; Leynaert B, 1997, AM J RESP CRIT CARE, V156, P1413, DOI 10.1164/ajrccm.156.5.9701060; LUNDBACK B, 1993, ALLERGY, V48, P117, DOI 10.1111/j.1398-9995.1993.tb00696.x; McCormack VA, 2010, INT J CANCER, V127, P2402, DOI 10.1002/ijc.25252; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; PAOLETTI P, 1995, AM J RESP CRIT CARE, V151, P1770, DOI 10.1164/ajrccm.151.6.7767519; Prescott E, 1997, EUR RESPIR J, V10, P822; Rodstrom K, 2003, MENOPAUSE, V10, P538, DOI 10.1097/01.GME.0000094395.59028.0F; Ronmark EP, 2009, RESP MED, V103, P1807, DOI 10.1016/j.rmed.2009.07.014; Sorheim IC, 2010, THORAX, V65, P480, DOI 10.1136/thx.2009.122002; Spivack SD, 2003, CLIN CANCER RES, V9, P6002; Tashkin DP, 1996, AM J RESP CRIT CARE, V153, P1802, DOI 10.1164/ajrccm.153.6.8665038; Wilson AS, 1996, TOXICOLOGY, V114, P233, DOI 10.1016/S0300-483X(96)03515-9; XU X, 1994, EUR RESPIR J, V7, P477, DOI 10.1183/09031936.94.07030477; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Zorrilla-Torras B, 2005, EUR J PUBLIC HEALTH, V15, P43, DOI 10.1093/eurpub/cki110	30	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54137	10.1371/journal.pone.0054137	http://dx.doi.org/10.1371/journal.pone.0054137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23357876	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600034
J	Coleman, CI; Sidovar, MF; Roberts, MS; Kohn, C				Coleman, Craig I.; Sidovar, Matthew F.; Roberts, Matthew S.; Kohn, Christine			Impact of Mobility Impairment on Indirect Costs and Health-Related Quality of Life in Multiple Sclerosis	PLOS ONE			English	Article							DISABILITY	This study was conducted to estimate the indirect costs and health-related quality of life (HRQoL) (utilities) of multiple sclerosis (MS) patients in the United States (US), and to determine the impact of worsening mobility on these parameters. In collaboration with the North American Research Committee on Multiple Sclerosis (NARCOMS) registry we conducted a cross-sectional study of participants who completed the biannual update and supplemental spring 2010 survey. Demographic, employment status, income, mobility impairment, and health utility data were collected from a sample of registry participants who met the study criteria and agreed to participate in the supplemental Mobility Study. Mean annual indirect costs per participant in 2011US$ and mean utilities for the population and for cohorts reporting different levels of mobility impairment were estimated. Analyses included 3,484 to 3,611 participants, based on survey completeness. Thirty-seven percent of registrants were not working or attending school and 46.7% of these reported retiring early. Indirect costs per participant per year, not including informal caregiver cost, were estimated at $30,601+/-31,184. The largest relative increase in indirect costs occurred at earlier mobility impairment stages, regardless of the measure used. Participants' mean utility score (0.73+/-0.18) was lower than that of a similarly aged sample from the general US population (0.87). As with indirect costs, larger decrements in utility were seen at earlier mobility impairment stages. These results suggest that mobility impairment may contribute to increases in indirect costs and declines in HRQoL in MS patients.	[Coleman, Craig I.; Kohn, Christine] Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT USA; [Coleman, Craig I.; Roberts, Matthew S.] Hartford Hosp, Dept Pharm, Hartford, CT 06115 USA; [Sidovar, Matthew F.] Acorda Therapeut Inc, Clin Dev & Med Affairs, Ardsley, NY USA	University of Connecticut; Hartford Hospital	Coleman, CI (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT USA.	ccolema@harthosp.org		Coleman, Craig/0000-0003-4868-7158	Acorda Therapeutics, Inc.; Agency for Healthcare Research and Quality (AHRQ)	Acorda Therapeutics, Inc.; Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was funded by Acorda Therapeutics, Inc. Other major potential conflicts of interest are as follows: Craig Coleman has received research funding from the Agency for Healthcare Research and Quality (AHRQ) and Acorda Therapeutics, Inc. Matthew Sidovar is an employee of Acorda Therapeutics, Inc. Matthew Roberts and Christine Kohn have no conflicts of interest to report. These competing interests do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bethoux Francois, 2011, Int J MS Care, V13, P4, DOI 10.7224/1537-2073-13.1.4; Bureau of Labor Statistics, 2011, EMPL COSTS EMPL COMP; Cohen JT, 2010, EXPERT REV PHARM OUT, V10, P595, DOI [10.1586/erp.10.60, 10.1586/ERP.10.60]; Consortium of Multiple Sclerosis Centers, CMSC NARCOMS INF; Fisk JD, 2005, J NEUROL NEUROSUR PS, V76, P58, DOI 10.1136/jnnp.2003.017897; Frohman EM, 2003, MED CLIN N AM, V87, P867, DOI 10.1016/S0025-7125(03)00008-7; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Hohol MJ, 1999, MULT SCLER, V5, P349, DOI 10.1177/135245859900500508; Kobelt G, 2006, J NEUROL NEUROSUR PS, V77, P918, DOI 10.1136/jnnp.2006.090365; Kobelt G, 2006, NEUROLOGY, V66, P1696, DOI 10.1212/01.wnl.0000218309.01322.5c; Kobelt Gisela, 2000, 398 SSE EFI; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; Marrie RA, 2007, MULT SCLER J, V13, P1176, DOI 10.1177/1352458507078388; Naci H, 2010, PHARMACOECONOMICS, V28, P363, DOI 10.2165/11532230-000000000-00000; Nortvedt MW, 1999, NEUROLOGY, V53, P1098, DOI 10.1212/WNL.53.5.1098; Patwardhan MB, 2005, MULT SCLER J, V11, P232, DOI 10.1191/1352458505ms1137oa; Salter AR, 2010, CURR MED RES OPIN, V26, P493, DOI 10.1185/03007990903500649; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	18	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54756	10.1371/journal.pone.0054756	http://dx.doi.org/10.1371/journal.pone.0054756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355896	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500121
J	Szczesny, P; Mykowiecka, A; Pawlowski, K; Grynberg, M				Szczesny, Pawel; Mykowiecka, Agnieszka; Pawlowski, Krzysztof; Grynberg, Marcin			Distinct Protein Classes in Human Red Cell Proteome Revealed by Similarity of Phylogenetic Profiles	PLOS ONE			English	Article							DATABASE	The minimal set of proteins necessary to maintain a vertebrate cell forms an interesting core of cellular machinery. The known proteome of human red blood cell consists of about 1400 proteins. We treated this protein complement of one of the simplest human cells as a model and asked the questions on its function and origins. The proteome was mapped onto phylogenetic profiles, i.e. vectors of species possessing homologues of human proteins. A novel clustering approach was devised, utilising similarity in the phylogenetic spread of homologues as distance measure. The clustering based on phylogenetic profiles yielded several distinct protein classes differing in phylogenetic taxonomic spread, presumed evolutionary history and functional properties. Notably, small clusters of proteins common to vertebrates or Metazoa and other multicellular eukaryotes involve biological functions specific to multicellular organisms, such as apoptosis or cell-cell signaling, respectively. Also, a eukaryote-specific cluster is identified, featuring GTP-ase signalling and ubiquitination. Another cluster, made up of proteins found in most organisms, including bacteria and archaea, involves basic molecular functions such as oxidation-reduction and glycolysis. Approximately one third of erythrocyte proteins do not fall in any of the clusters, reflecting the complexity of protein evolution in comparison to our simple model. Basically, the clustering obtained divides the proteome into old and new parts, the former originating from bacterial ancestors, the latter from inventions within multicellular eukaryotes. Thus, the model human cell proteome appears to be made up of protein sets distinct in their history and biological roles. The current work shows that phylogenetic profiles concept allows protein clustering in a way relevant both to biological function and evolutionary history.	[Szczesny, Pawel; Grynberg, Marcin] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Szczesny, Pawel] Univ Warsaw, Dept Plant Mol Biol, Inst Expt Plant Biol, Warsaw, Poland; [Pawlowski, Krzysztof] Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland; [Pawlowski, Krzysztof] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; Warsaw University of Life Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Pawlowski, K (corresponding author), Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland.	k.pawlowski@nencki.gov.pl; greenb@ibb.waw.pl	Pawłowski, Krzysztof/C-2949-2013	Pawłowski, Krzysztof/0000-0002-5367-0935; Szczesny, Pawel/0000-0001-8442-0157; Grynberg, Marcin/0000-0003-1887-7209	Polish Ministry of Science and Higher Education [N N401 3126 33]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	MG and PS were supported by a grant from Polish Ministry of Science and Higher Education number N N401 3126 33 (2008-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Basu MK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-434; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; D'Amici GM, 2012, NAT PROTOC, V7, P36, DOI 10.1038/nprot.2011.427; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gershon H, 1997, ARCH GERONTOL GERIAT, V24, P157, DOI 10.1016/S0167-4943(96)00748-0; Gerstein M, 1997, J MOL BIOL, V274, P562, DOI 10.1006/jmbi.1997.1412; Goodman SR, 2007, EXP BIOL MED, V232, P1391, DOI 10.3181/0706-MR-156; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Kurland CG, 2007, BIOCHIMIE, V89, P1454, DOI 10.1016/j.biochi.2007.09.004; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liepke C, 2003, J CHROMATOGR B, V791, P345, DOI 10.1016/S1570-0232(03)00245-9; Montel-Hagen A, 2009, CURR OPIN HEMATOL, V16, P165, DOI 10.1097/MOH.0b013e328329905c; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perez-Gordones MC, 2009, ARCH BIOCHEM BIOPHYS, V489, P55, DOI 10.1016/j.abb.2009.07.010; Sackmann E., 1995, STRUCTURE DYNAMICS M, V1, P1, DOI DOI 10.1016/S1383-8121(06)80018-7; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205; Weber RE, 2011, ACTA PHYSIOL, V202, P549, DOI 10.1111/j.1748-1716.2010.02204.x; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108	25	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54471	10.1371/journal.pone.0054471	http://dx.doi.org/10.1371/journal.pone.0054471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349899	Green Published, Green Submitted, gold			2022-12-27	WOS:000313943000040
J	Kaitaniemi, S; Gron, K; Elovaara, H; Salmi, M; Jalkanen, S; Elima, K				Kaitaniemi, Sam; Gron, Kirsi; Elovaara, Heli; Salmi, Marko; Jalkanen, Sirpa; Elima, Kati			Functional Modulation of Vascular Adhesion Protein-1 by a Novel Splice Variant	PLOS ONE			English	Article							SENSITIVE AMINE OXIDASE; SMOOTH-MUSCLE-CELLS; MESSENGER-RNA DECAY; SERUM RESPONSE FACTOR; ENDOTHELIAL-CELLS; SIGNALING PATHWAYS; LYMPHOCYTE BINDING; GENE-EXPRESSION; RECEPTOR; INFLAMMATION	Vascular Adhesion Protein-1 (VAP-1) is an endothelial adhesion molecule belonging to the primary amine oxidases. Upon inflammation it takes part in the leukocyte extravasation cascade facilitating transmigration of leukocytes into the inflamed tissue. Screening of a human lung cDNA library revealed the presence of an alternatively spliced shorter transcript of VAP-1, VAP-1 Delta 3. Here, we have studied the functional and structural characteristics of VAP-1 Delta 3, and show that the mRNA for this splice variant is expressed in most human tissues studied. In comparison to the parent molecule this carboxy-terminally truncated isoform lacks several of the amino acids important in the formation of the enzymatic groove of VAP-1. In addition, the conserved His684, which takes part in coordinating the active site copper, is missing from VAP-1 Delta 3. Assays using the prototypic amine substrates methylamine and benzylamine demonstrated that VAP-1 Delta 3 is indeed devoid of the semicarbazide-sensitive amine oxidase (SSAO) activity characteristic to VAP-1. When VAP-1 Delta 3-cDNA is transfected into cells stably expressing VAP-1, the surface expression of the full-length molecule is reduced. Furthermore, the SSAO activity of the co-transfectants is diminished in comparison to transfectants expressing only VAP-1. The observed down-regulation of both the expression and enzymatic activity of VAP-1 may result from a dominant-negative effect caused by heterodimerization between VAP-1 and VAP-1 Delta 3, which was detected in co-immunoprecipitation studies. This alternatively spliced transcript adds thus to the repertoire of potential regulatory mechanisms through which the cell-surface expression and enzymatic activity of VAP-1 can be modulated.	[Kaitaniemi, Sam; Gron, Kirsi; Elovaara, Heli; Salmi, Marko; Jalkanen, Sirpa; Elima, Kati] Univ Turku, Med Res Lab, Turku, Finland; [Kaitaniemi, Sam; Jalkanen, Sirpa] Univ Turku, Dept Microbiol & Immunol, Turku, Finland; [Salmi, Marko; Elima, Kati] Univ Turku, Dept Med Biochem & Genet, Turku, Finland	University of Turku; University of Turku; University of Turku	Elima, K (corresponding author), Univ Turku, Med Res Lab, Turku, Finland.	kati.elima@utu.fi			Academy of Finland; Sigrid Juselius Foundation; Varsinais-Suomi Regional Fund of the Finnish Cultural Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; Orion-Farmos Research Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Varsinais-Suomi Regional Fund of the Finnish Cultural Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; Orion-Farmos Research Foundation	This work was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Varsinais-Suomi Regional Fund of the Finnish Cultural Foundation, the Emil Aaltonen Foundation, the Finnish Medical Foundation, and the Orion-Farmos Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airenne TT, 2005, PROTEIN SCI, V14, P1964, DOI 10.1110/ps.051438105; Belaguli NS, 1999, MOL CELL BIOL, V19, P4582; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Davies JQ, 2007, J BIOL CHEM, V282, P27343, DOI 10.1074/jbc.M704096200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elovaara H, 2011, BIOCHEMISTRY-US, V50, P5507, DOI 10.1021/bi200117z; Ernberg K, 2010, ACTA CRYSTALLOGR F, V66, P1572, DOI 10.1107/S1744309110041515; Gokturk C, 2003, AM J PATHOL, V163, P1921, DOI 10.1016/S0002-9440(10)63550-X; Gomes AR, 2008, MOL CELL NEUROSCI, V37, P323, DOI 10.1016/j.mcn.2007.10.008; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Harada N, 2008, AM J PHYSIOL-ENDOC M, V294, pE61, DOI 10.1152/ajpendo.00358.2007; Hiltunen MO, 2000, CIRCULATION, V102, P2262; Irjala H, 2003, EUR J IMMUNOL, V33, P815, DOI 10.1002/eji.200323859; Jaakkola K, 1999, AM J PATHOL, V155, P1953, DOI 10.1016/S0002-9440(10)65514-9; Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JALKANEN S, 1987, J CELL BIOL, V105, P983, DOI 10.1083/jcb.105.2.983; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kaitaniemi S, 2009, CELL MOL LIFE SCI, V66, P2743, DOI 10.1007/s00018-009-0076-5; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kanadia RN, 2010, GENE DEV, V24, P229, DOI 10.1101/gad.1847110; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kino T, 2009, CELL MOL LIFE SCI, V66, P3435, DOI 10.1007/s00018-009-0098-z; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Laitinen M, 1998, HUM GENE THER, V9, P1481, DOI 10.1089/hum.1998.9.10-1481; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lorenz M, 2007, FASEB J, V21, P1556, DOI 10.1096/fj.06-7434com; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mathys KC, 2002, BIOCHEM BIOPH RES CO, V297, P863, DOI 10.1016/S0006-291X(02)02293-3; Matsunami H, 2004, BIOCHEMISTRY-US, V43, P2178, DOI 10.1021/bi0361923; McElvaine AT, 2006, ENDOCRINOLOGY, V147, P1884, DOI 10.1210/en.2005-1488; Mercier N, 2001, BIOCHEM J, V358, P335, DOI 10.1042/0264-6021:3580335; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Salmi M, 1998, J IMMUNOL, V160, P5629; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Salmi M, 1996, J EXP MED, V183, P569, DOI 10.1084/jem.183.2.569; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Sunmonu NA, 2011, J CELL PHYSIOL, V226, P1722, DOI 10.1002/jcp.22587; Sztainberg Y, 2009, FASEB J, V23, P2186, DOI 10.1096/fj.08-128066; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; van der Vaart Michiel, 2009, Nucl Recept Signal, V7, pe007, DOI 10.1621/nrs.07007; van Rijn RM, 2008, BIOCHEM J, V414, P121, DOI 10.1042/BJ20071583; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200; Zhang X, 2007, GENE, V400, P131, DOI 10.1016/j.gene.2007.06.008; Zorzano A, 2003, BBA-PROTEINS PROTEOM, V1647, P3, DOI 10.1016/S1570-9639(03)00039-6	54	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54151	10.1371/journal.pone.0054151	http://dx.doi.org/10.1371/journal.pone.0054151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349812	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800028
J	Ruiz-Villalba, A; Ziogas, A; Ehrbar, M; Perez-Pomares, JM				Ruiz-Villalba, Adrian; Ziogas, Algirdas; Ehrbar, Martin; Perez-Pomares, Jose M.			Characterization of Epicardial-Derived Cardiac Interstitial Cells: Differentiation and Mobilization of Heart Fibroblast Progenitors	PLOS ONE			English	Article							QUAIL-CHICK CHIMERA; STEM-CELLS; SUBEPICARDIAL MESENCHYME; EMBRYONIC EPICARDIUM; MESOTHELIAL CELLS; RETINOIC ACID; CONTRIBUTE; ORIGIN; MYOCARDIUM; EXPRESSION	The non-muscular cells that populate the space found between cardiomyocyte fibers are known as 'cardiac interstitial cells' (CICs). CICs are heterogeneous in nature and include different cardiac progenitor/stem cells, cardiac fibroblasts and other cell types. Upon heart damage CICs soon respond by initiating a reparative response that transforms with time into extensive fibrosis and heart failure. Despite the biomedical relevance of CICs, controversy remains on the ontogenetic relationship existing between the different cell kinds homing at the cardiac interstitium, as well as on the molecular signals that regulate their differentiation, maturation, mutual interaction and role in adult cardiac homeostasis and disease. Our work focuses on the analysis of epicardial-derived cells, the first cell type that colonizes the cardiac interstitium. We present here a characterization and an experimental analysis of the differentiation potential and mobilization properties of a new cell line derived from mouse embryonic epicardium (EPIC). Our results indicate that these cells express some markers associated with cardiovascular stemness and retain part of the multipotent properties of embryonic epicardial derivatives, spontaneously differentiating into smooth muscle, and fibroblast/myofibroblast-like cells. Epicardium-derived cells are also shown to initiate a characteristic response to different growth factors, to display a characteristic proteolytic expression profile and to degrade biological matrices in 3D in vitro assays. Taken together, these data indicate that EPICs are relevant to the analysis of epicardial-derived CICs, and are a god model for the research on cardiac fibroblasts and the role these cells play in ventricular remodeling in both ischemic or non/ischemic myocardial disease.	[Ruiz-Villalba, Adrian; Perez-Pomares, Jose M.] Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain; [Ziogas, Algirdas; Ehrbar, Martin] Univ Zurich Hosp, Dept Obstet, CH-8091 Zurich, Switzerland	Universidad de Malaga; University of Zurich; University Zurich Hospital	Perez-Pomares, JM (corresponding author), Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain.	jmperezp@uma.es	Perez-Pomares, Jose/G-7885-2015; Ruiz-Villalba, Adrián/AAP-6130-2020; Ehrbar, Martin/O-4130-2019; Ehrbar, Martin/F-4578-2012	Perez-Pomares, Jose/0000-0001-5487-7252; Ehrbar, Martin/0000-0003-2707-4870; Ehrbar, Martin/0000-0003-2707-4870; , Adrian/0000-0001-8063-0317	EU FP6 [LSHM-CT-2005-018630]; 'CardioNet' (EU FP7 Marie Curie Programme ITNs); Junta de Andalucia, Spain [P08-CTS-03618]; Spanish Ministry of Economy (MINECO) [BFU2009-07929, RD06/0010/0015]	EU FP6(European Commission); 'CardioNet' (EU FP7 Marie Curie Programme ITNs); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); Spanish Ministry of Economy (MINECO)	This work was funded by grants LSHM-CT-2005-018630 ('HeartRepair', EU FP6), 'CardioNet' (EU FP7 Marie Curie Programme ITNs), P08-CTS-03618 (Junta de Andalucia, Spain) and the Spanish Ministry of Economy (MINECO) grants BFU2009-07929 and RD06/0010/0015 (TERCEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Guadix JA, 2011, DEVELOPMENT, V138, P1093, DOI 10.1242/dev.044594; Azambuja AP, 2010, CIRC RES, V107, P204, DOI 10.1161/CIRCRESAHA.109.214650; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; del Monte G, 2011, CIRC RES, V108, P824, DOI 10.1161/CIRCRESAHA.110.229062; EID H, 1992, CIRC RES, V71, P40, DOI 10.1161/01.RES.71.1.40; Ferreira-Martins J, 2012, CIRC RES, V110, P701, DOI 10.1161/CIRCRESAHA.111.259507; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Goichberg P, 2011, CIRC RES, V108, P1071, DOI 10.1161/CIRCRESAHA.110.239459; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Guadix JA, 2006, DEV DYNAM, V235, P1014, DOI 10.1002/dvdy.20685; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Kanekar S, 1998, CARDIOVASC PATHOL, V7, P127, DOI 10.1016/S1054-8807(97)00119-1; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Laeremans H, 2010, CARDIOVASC RES, V87, P514, DOI 10.1093/cvr/cvq067; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li P, 2011, DEVELOPMENT, V138, P1795, DOI 10.1242/dev.054338; Manner J, 1999, ANAT RECORD, V255, P212; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Neth P, 2006, STEM CELLS, V24, P1892, DOI 10.1634/stemcells.2005-0503; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Perez-Pomares JM, 2002, DEV BIOL, V247, P307, DOI 10.1006/dbio.2002.0706; Perez-Pomares JM, 1998, DEV BIOL, V200, P57, DOI 10.1006/dbio.1998.8949; PerezPomares JM, 1997, DEV DYNAM, V210, P96, DOI 10.1002/(SICI)1097-0177(199710)210:2<96::AID-AJA3>3.0.CO;2-4; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Torella D, 2005, TRENDS CARDIOVAS MED, V15, P229, DOI 10.1016/j.tcm.2005.06.006; Tummala PE, 1999, CIRCULATION, V100, P1223, DOI 10.1161/01.CIR.100.11.1223; van Wijk B, 2009, CIRC RES, V105, P431, DOI 10.1161/CIRCRESAHA.109.203083; VLIEGEN HW, 1991, EUR HEART J, V12, P488, DOI 10.1093/oxfordjournals.eurheartj.a059928; Wada AM, 2003, CIRC RES, V92, P525, DOI 10.1161/01.RES.0000060484.11032.0B; Wengerhoff SM, 2010, DEV DYNAM, V239, P598, DOI 10.1002/dvdy.22163; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wexler R, 2009, AM FAM PHYSICIAN, V79, P778; Wu GD, 2008, J BIOCHEM, V144, P571, DOI 10.1093/jb/mvn106; Yang MC, 2010, BIOMATERIALS, V31, P854, DOI 10.1016/j.biomaterials.2009.09.096; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8	54	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53694	10.1371/journal.pone.0053694	http://dx.doi.org/10.1371/journal.pone.0053694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349729	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000313872800011
J	Simpson, SJ; Siu, KKW; Yagi, N; Whitley, JC; Lewis, RA; Frappell, PB				Simpson, Shannon J.; Siu, Karen K. W.; Yagi, Naoto; Whitley, Jane C.; Lewis, Robert A.; Frappell, Peter B.			Phase Contrast Imaging Reveals Low Lung Volumes and Surface Areas in the Developing Marsupial	PLOS ONE			English	Article							NEWBORN TAMMAR WALLABY; POSTNATAL-DEVELOPMENT; GAS-EXCHANGE; RESPIRATORY SYSTEM; MORPHOMETRIC-ANALYSIS; SETONIX-BRACHYURUS; LIQUID CLEARANCE; MACROPUS-EUGENII; METABOLIC-RATE; MOUSE LUNG	Marsupials are born with immature lungs when compared to eutherian mammals and rely, to various extents, on cutaneous gas exchange in order to meet metabolic requirements. Indeed, the fat-tailed dunnart is born with lungs in the canalicular stage of development and relies almost entirely on the skin for gas exchange at birth; consequently undergoing the majority of lung development in air. Plane radiographs and computed tomography data sets were acquired using phase contrast imaging with a synchrotron radiation source for two marsupial species, the fat-tailed dunnart and the larger tammar wallaby, during the first weeks of postnatal life. Phase contrast imaging revealed that only two lung sacs contain air after the first hour of life in the fat-tailed dunnart. While the lung of the tammar wallaby was comparatively more developed, both species demonstrated massive increases in air sac number and architectural complexity during the postnatal period. In addition, both the tammar wallaby and fat-tailed dunnart had lower lung volumes and parenchymal surface areas than were expected from morphometrically determined allometric equations relating these variables to body mass during the neonatal period. However, lung volume is predicted to scale with mass as expected after the neonatal marsupial reaches a body mass of similar to 1 g and no longer relies on the skin for gas exchange. Decreased lung volume in the marsupial neonate further supports the maxim that cutaneous gas exchange occurs in the marsupial neonate because the respiratory apparatus is not yet capable of meeting the gas exchange requirements of the newborn.	[Simpson, Shannon J.; Frappell, Peter B.] Univ Tasmania, Hobart, Tas, Australia; [Siu, Karen K. W.; Lewis, Robert A.] Monash Univ, Ctr Synchrotron Sci, Clayton, Vic 3800, Australia; [Yagi, Naoto] SPring 8 JASRI, Sayo, Hyogo, Japan; [Whitley, Jane C.] Dept Primary Ind, Attwood, Vic, Australia	University of Tasmania; Monash University; Japan Synchrotron Radiation Research Institute	Frappell, PB (corresponding author), Univ Tasmania, Hobart, Tas, Australia.	peter.frappell@utas.edu.au	simpson, shannon/C-4651-2013; Siu, Karen K W/C-1472-2008	simpson, shannon/0000-0002-4895-0975; 	Australian National Nuclear Research and Development Organisation	Australian National Nuclear Research and Development Organisation	This work was supported by Australian National Nuclear Research and Development Organisation (http://www.ansto.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT D, 1977, RESP PHYSIOL, V29, P193, DOI 10.1016/0034-5687(77)90092-5; BENNETT JH, 1990, AUST J ZOOL, V37, P207, DOI 10.1071/ZO9890207; BURRI PH, 1974, ANAT REC, V178, P711, DOI 10.1002/ar.1091780405; Burri PH, 2003, RESP PHYSIOL NEUROBI, V138, P309, DOI 10.1016/S1569-9048(03)00197-6; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; CASTLEMAN WL, 1990, AM J VET RES, V51, P789; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; DAVIES P, 1988, ANAT RECORD, V220, P281, DOI 10.1002/ar.1092200308; FARBER JP, 1972, RESP PHYSIOL, V14, P278, DOI 10.1016/0034-5687(72)90034-5; FARBER JP, 1978, RESP PHYSIOL, V35, P189, DOI 10.1016/0034-5687(78)90021-X; Frappell PB, 2006, RESP PHYSIOL NEUROBI, V154, P252, DOI 10.1016/j.resp.2006.05.001; FRAPPELL PB, 1989, RESP PHYSIOL, V76, P25, DOI 10.1016/0034-5687(89)90015-7; Frappell PB, 2000, RESP PHYSIOL, V120, P35, DOI 10.1016/S0034-5687(99)00103-6; Frappell PB, 2008, COMP BIOCHEM PHYS A, V150, P181, DOI 10.1016/j.cbpa.2008.02.017; Greenlee KJ, 2009, AM J PHYSIOL-REG I, V297, pR1343, DOI 10.1152/ajpregu.00231.2009; Gureyev TE, 2002, J SYNCHROTRON RADIAT, V9, P148, DOI 10.1107/S0909049502004971; Hooper SB, 2007, FASEB J, V21, P3329, DOI 10.1096/fj.07-8208com; Hooper SB, 2009, CLIN EXP PHARMACOL P, V36, P117, DOI 10.1111/j.1440-1681.2008.05109.x; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; Kitchen MJ, 2005, BRIT J RADIOL, V78, P1018, DOI 10.1259/bjr/13024611; Kitchen MJ, 2004, PHYS MED BIOL, V49, P4335, DOI 10.1088/0031-9155/49/18/010; KOSCH PC, 1984, J APPL PHYSIOL, V57, P1126, DOI 10.1152/jappl.1984.57.4.1126; LECHNER AJ, 1982, AM J ANAT, V163, P235, DOI 10.1002/aja.1001630304; Lewis RA, 2005, PHYS MED BIOL, V50, P5031, DOI 10.1088/0031-9155/50/21/006; Lewis RA, 2003, BRIT J RADIOL, V76, P301, DOI 10.1259/bjr/32889803; MacFarlane PM, 2002, J EXP BIOL, V205, P533; MacFarlane PM, 2001, RESP PHYSIOL, V126, P221, DOI 10.1016/S0034-5687(01)00227-4; Makanya AN, 2007, J ANAT, V211, P26, DOI 10.1111/j.1469-7580.2007.00744.x; Makanya AN, 2003, RESP PHYSIOL NEUROBI, V134, P43, DOI 10.1016/S1569-9048(02)00204-5; Miller NJ, 2001, J EXP BIOL, V204, P4031; MORTOLA JP, 1987, PHYSIOL REV, V67, P187, DOI 10.1152/physrev.1987.67.1.187; Mortola JP, 1999, NATURE, V397, P660, DOI 10.1038/17713; MORTOLA JP, 1982, J APPL PHYSIOL, V52, P1209, DOI 10.1152/jappl.1982.52.5.1209; Mund SI, 2008, DEV DYNAM, V237, P2108, DOI 10.1002/dvdy.21633; Porra L, 2004, J APPL PHYSIOL, V96, P1899, DOI 10.1152/japplphysiol.00866.2003; RIBBONS KA, 1989, RESP PHYSIOL, V75, P1, DOI 10.1016/0034-5687(89)90081-9; Runciman SIC, 1998, RESP PHYSIOL, V111, P177, DOI 10.1016/S0034-5687(97)00114-X; Runciman SIC, 1996, ANAT REC, V244, P193, DOI 10.1002/(SICI)1097-0185(199602)244:2<193::AID-AR7>3.0.CO;2-2; Runciman SIC, 1998, RESP PHYSIOL, V112, P325, DOI 10.1016/S0034-5687(98)00034-6; Runciman SIC, 1999, RESP PHYSIOL, V118, P61, DOI 10.1016/S0034-5687(99)00068-7; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Sera Toshihiro, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P465, DOI 10.2114/jpa.24.465; Simpson SJ, 2011, PHYSIOL BIOCHEM ZOOL, V84, P634, DOI 10.1086/662557; Socha JJ, 2008, J EXP BIOL, V211, P3409, DOI 10.1242/jeb.019877; West JB, 1995, RESP PHYSL ESSENTIAL; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008; Yagi N, 1999, MED PHYS, V26, P2190, DOI 10.1118/1.598735; ZELTNER TB, 1987, RESP PHYSIOL, V67, P269, DOI 10.1016/0034-5687(87)90058-2; ZELTNER TB, 1987, RESP PHYSIOL, V67, P247, DOI 10.1016/0034-5687(87)90057-0	49	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53805	10.1371/journal.pone.0053805	http://dx.doi.org/10.1371/journal.pone.0053805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349744	Green Published, gold			2022-12-27	WOS:000313872800013
J	Sureshan, V; Deshpande, CN; Boucher, Y; Koenig, JE; Stokes, HW; Harrop, SJ; Curmi, PMG; Mabbutt, BC				Sureshan, Visaahini; Deshpande, Chandrika N.; Boucher, Yan; Koenig, Jeremy E.; Stokes, H. W.; Harrop, Stephen J.; Curmi, Paul M. G.; Mabbutt, Bridget C.		Midwest Ctr Struct Genomics	Integron Gene Cassettes: A Repository of Novel Protein Folds with Distinct Interaction Sites	PLOS ONE			English	Article							SP-NOV.; FAMILY; INTEGRATION; METAGENOME; DIVERSITY; EVOLUTION; RESOURCE; INSIGHTS; GENOMES; SYSTEM	Mobile gene cassettes captured within integron arrays encompass a vast and diverse pool of genetic novelty. In most cases, functional annotation of gene cassettes directly recovered by cassette-PCR is obscured by their characteristically high sequence novelty. This inhibits identification of those specific functions or biological features that might constitute preferential factors for lateral gene transfer via the integron system. A structural genomics approach incorporating x-ray crystallography has been utilised on a selection of cassettes to investigate evolutionary relationships hidden at the sequence level. Gene cassettes were accessed from marine sediments (pristine and contaminated sites), as well as a range of Vibrio spp. We present six crystal structures, a remarkably high proportion of our survey of soluble proteins, which were found to possess novel folds. These entirely new structures are diverse, encompassing all-alpha, alpha+beta and alpha/beta fold classes, and many contain clear binding pocket features for small molecule substrates. The new structures emphasise the large repertoire of protein families encoded within the integron cassette metagenome and which remain to be characterised. Oligomeric association is a notable recurring property common to these new integron-derived proteins. In some cases, the protein-protein contact sites utilised in homomeric assembly could instead form suitable contact points for heterogeneous regulator/activator proteins or domains. Such functional features are ideal for a flexible molecular componentry needed to ensure responsive and adaptive bacterial functions.	[Sureshan, Visaahini; Deshpande, Chandrika N.; Mabbutt, Bridget C.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Boucher, Yan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Koenig, Jeremy E.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Midwest Ctr Struct Genomics] Univ Toronto, Toronto, ON, Canada; [Stokes, H. W.] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia; [Harrop, Stephen J.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Curmi, Paul M. G.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia	Macquarie University; University of Alberta; Dalhousie University; University of Toronto; University of Technology Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney	Mabbutt, BC (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	bridget.mabbutt@mq.edu.au	Curmi, Paul/G-7185-2011; Boucher, Yann Felix/H-4576-2019	Curmi, Paul/0000-0001-5762-7638; Boucher, Yann Felix/0000-0002-0036-6083; Labbate, Maurizio/0000-0003-1428-3382; Deshpande, Chandrika/0000-0002-5557-519X	Midwest Center for Structural Genomics (MCSG); APA (Australian Federal Government); MQRES (Macquarie University); EIPRS (Australian Federal Government); National Health and Medical Research Council (Australia) [488502]; National Institutes of Health [GM074942, GM094568]; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094568, U54GM094585, U54GM074942] Funding Source: NIH RePORTER	Midwest Center for Structural Genomics (MCSG); APA (Australian Federal Government); MQRES (Macquarie University); EIPRS (Australian Federal Government); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Aled Edwards and Andrej Joachimiak for supporting this collaboration with the Midwest Center for Structural Genomics (MCSG). The complete list of authors from the MCSG is: R. Di Leo, O. Kagan, S. Gebert, V. Egorova, E. Evdokimova, X. Xu, M. Kudrytska, H. Cui, J. Osipiuk, C. Chang, K. Tan, M. Cuff, A. Edwards, A. Joachimiak and A. Savchenko.; The authors also thank Maurizio Labbate (University of Technology Sydney), Ian Paulsen and Robert Willows (Macquarie University) for useful discussions, and David Langley for some additional synchrotron data acquisition (Australian Synchrotron, Melbourne). VS acknowledges receipt of an APA (Australian Federal Government) scholarship. CND acknowledges receipt of a MQRES (Macquarie University) and EIPRS (Australian Federal Government) scholarship.; This work was supported by the following sources: National Health and Medical Research Council (Australia) grant 488502, National Institutes of Health grants GM074942 and GM094568, and the US Department of Energy, Office of Biological and Environmental Research (contract DE-AC02-06CH11357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel C, 2007, P NATL ACAD SCI USA, V104, P6394, DOI 10.1073/pnas.0611019104; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Borek D, 2003, ACTA CRYSTALLOGR D, V59, P2031, DOI 10.1107/S0907444903020924; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Brown HJ, 1996, J BACTERIOL, V178, P4429, DOI 10.1128/jb.178.15.4429-4437.1996; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Cohen O, 2011, MOL BIOL EVOL, V28, P1481, DOI 10.1093/molbev/msq333; Cole BJ, 2009, PROTEIN SCI, V18, P1602, DOI 10.1002/pro.182; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Deshpande CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016934; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; DONOVAN TJ, 1995, INT J FOOD MICROBIOL, V26, P77, DOI 10.1016/0168-1605(95)00015-C; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao HC, 2006, INT J SYST EVOL MICR, V56, P1911, DOI 10.1099/ijs.0.64354-0; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Joss MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-118; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KOBAYASHI TOSHIKAZU, 1963, JAPAN JOUR BACTERIOL, V18, P387; Koenig JE, 2008, ENVIRON MICROBIOL, V10, P1024, DOI 10.1111/j.1462-2920.2007.01524.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labbate M, 2007, MICROBIOL-SGM, V153, P1488, DOI 10.1099/mic.0.2006/001065-0; Labbate Maurizio, 2009, V532, P103, DOI 10.1007/978-1-60327-853-9_6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski Roman A., 2003, Journal of Structural and Functional Genomics, V4, P167, DOI 10.1023/A:1026127927612; Lehmann C, 2003, PROTEINS, V50, P249, DOI 10.1002/prot.10260; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; Marri PR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S8; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Michael CA, 2004, AM NAT, V164, P1, DOI 10.1086/421733; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Najmanovich R, 2008, BIOINFORMATICS, V24, pI105, DOI 10.1093/bioinformatics/btn263; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Robinson A, 2005, J MOL BIOL, V346, P1229, DOI 10.1016/j.jmb.2004.12.035; Robinson A, 2007, MOL MICROBIOL, V66, P610, DOI 10.1111/j.1365-2958.2007.05932.x; Robinson Andrew, 2008, V426, P589, DOI 10.1007/978-1-60327-058-8_39; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Weon HY, 2006, INT J SYST EVOL MICR, V56, P659, DOI 10.1099/ijs.0.63749-0; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	59	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e52934	10.1371/journal.pone.0052934	http://dx.doi.org/10.1371/journal.pone.0052934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349695	gold, Green Submitted, Green Published			2022-12-27	WOS:000313872800005
J	Mariani, F; Sena, P; Pedroni, M; Benatti, P; Manni, P; Di Gregorio, C; Manenti, A; Palumbo, C; de Leon, MP; Roncucci, L				Mariani, Francesco; Sena, Paola; Pedroni, Monica; Benatti, Piero; Manni, Paola; Di Gregorio, Carmela; Manenti, Antonio; Palumbo, Carla; de Leon, Maurizio Ponz; Roncucci, Luca			Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ABERRANT CRYPT FOCI; LINEAGE DIFFERENTIATION; POSITIVE SELECTION; MUCOSAL IMMUNITY; GENE-EXPRESSION; CANCER PATIENTS; LYTIC FUNCTION; HUMAN COLON; LYMPHOCYTES	We purposed to evaluate the role of Th inducing POZ-Kruppel Factor (ThPOK), a transcriptional regulator of T cell fate, in tumour-induced immune system plasticity in colorectal carcinogenesis. The amounts of CD4+, CD8+ and CD56+ and ThPOK+ cells infiltrate in normal colorectal mucosa (NM), in dysplastic aberrant crypt foci (microadenomas, MA), the earliest detectable lesions in colorectal carcinogenesis, and in colorectal carcinomas (CRC), were measured, and the colocalization of ThPOK with the above-mentioned markers of immune cells was evaluated using confocal microscopy. Interestingly, ThPOK showed a prominent increase since MA. A strong colocalization of ThPOK with CD4 both in NM and in MA was observed, weaker in carcinomas. Surprisingly, there was a peak in the colocalization levels of ThPOK with CD8 in MA, which was evident, although to a lesser extent, in carcinomas, too. In conclusion, according to the data of the present study, ThPOK may be considered a central regulator of the earliest events in the immune system during colorectal cancer development, decreasing the immune response against cancer cells.	[Mariani, Francesco; Pedroni, Monica; Benatti, Piero; de Leon, Maurizio Ponz; Roncucci, Luca] Univ Modena & Reggio Emilia, Dept Internal Med, Modena, Italy; [Sena, Paola; Palumbo, Carla] Univ Modena & Reggio Emilia, Dept Morphol Sci, Modena, Italy; [Manni, Paola; Di Gregorio, Carmela] Univ Modena & Reggio Emilia, Dept Serv Diagnost Lab & Med Legale, Modena, Italy; [Manenti, Antonio] Univ Modena & Reggio Emilia, Dept Surg, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Roncucci, L (corresponding author), Univ Modena & Reggio Emilia, Dept Internal Med, Modena, Italy.	luca.roncucci@unimore.it	Benatti, Piero/C-1052-2015; Roncucci, Luca/L-1392-2016; de Leon, Maurizio Ponz/A-9356-2015; Pedroni, Monica/C-9384-2015; Sena, Paola/G-9394-2016; Palumbo, Carla/E-5802-2012; Palumbo, Carla/V-5905-2019	Benatti, Piero/0000-0002-6826-1480; Roncucci, Luca/0000-0002-0410-1760; de Leon, Maurizio Ponz/0000-0003-4465-1043; Pedroni, Monica/0000-0001-5374-5362; Sena, Paola/0000-0003-4724-8786; Palumbo, Carla/0000-0003-0587-0112; Palumbo, Carla/0000-0003-0587-0112; Mariani, Francesco/0000-0002-0650-3253	Fondazione Umberto Veronesi	Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	This work was supported by the Fondazione Umberto Veronesi (which supported the grant for Dott. Francesco Mariani). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Betts G, 2011, GUT; Bindea G, 2011, SEMIN IMMUNOPATHOL, V33, P335, DOI 10.1007/s00281-011-0264-x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Diederichsen ACP, 2003, CANCER IMMUNOL IMMUN, V52, P423, DOI 10.1007/s00262-003-0388-5; DiGregori C, 1997, HISTOPATHOLOGY, V30, P328, DOI 10.1046/j.1365-2559.1997.d01-626.x; Disis ML, 2009, LANCET, V373, P673, DOI 10.1016/S0140-6736(09)60404-9; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006; Frey AB, 2006, J LEUKOCYTE BIOL, V79, P652, DOI 10.1189/jlb.1105628; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Guidoboni M, 2001, AM J PATHOL, V159, P297, DOI 10.1016/S0002-9440(10)61695-1; Gulubova M, 2009, APMIS, V117, P870, DOI 10.1111/j.1600-0463.2009.02547.x; Guven H, 2003, LEUKEMIA, V17, P1973, DOI 10.1038/sj.leu.2403083; Halama N, 2011, CLIN CANCER RES, V17, P678, DOI 10.1158/1078-0432.CCR-10-2173; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Knaapen AM, 2006, MUTAGENESIS, V21, P225, DOI 10.1093/mutage/gel032; Koch M, 2006, ANN SURG, V244, P986, DOI 10.1097/01.sla.0000247058.43243.7b; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Lin YC, 2013, INT J CANCER, V132, P1341, DOI 10.1002/ijc.27784; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; Ma C, 2011, SCAND J IMMUNOL, V74, P47, DOI 10.1111/j.1365-3083.2011.02539.x; Mariani F, 2009, CANCER LETT, V279, P221, DOI 10.1016/j.canlet.2009.02.001; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Monu N, 2007, CANCER RES, V67, P11447, DOI 10.1158/0008-5472.CAN-07-1441; Mulder WMC, 1997, GUT, V40, P113, DOI 10.1136/gut.40.1.113; O'Keeffe J, 2004, EUR J IMMUNOL, V34, P2110, DOI 10.1002/eji.200424958; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Parmiani G, 2005, NEW ENGL J MED, V353, P2640, DOI 10.1056/NEJMp058236; Radoja S, 2000, MOL MED, V6, P465, DOI 10.1007/BF03401788; RONCUCCI L, 1991, CANCER EPIDEM BIOMAR, V1, P57; Sena P, 2010, CANCER EPIDEM BIOMAR, V19, P351, DOI 10.1158/1055-9965.EPI-09-0438; Setoguchi R, 2009, J IMMUNOL, V183, P4467, DOI 10.4049/jimmunol.0901428; Soong R, 2009, BRIT J CANCER, V100, P676, DOI 10.1038/sj.bjc.6604899; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Walzer T, 2007, CURR OPIN IMMUNOL, V19, P365, DOI 10.1016/j.coi.2007.04.004; Wang L, 2010, EUR J IMMUNOL, V40, P2385, DOI 10.1002/eji.201040534; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; WATT AG, 1978, CANCER, V41, P279, DOI 10.1002/1097-0142(197801)41:1<279::AID-CNCR2820410139>3.0.CO;2-B	50	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54488	10.1371/journal.pone.0054488	http://dx.doi.org/10.1371/journal.pone.0054488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349906	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900070
J	Okada, M; Matsuda, H; Okimura, Y				Okada, Masayoshi; Matsuda, Hiroko; Okimura, Yasuhiko			Lentiviral and Moloney Retroviral Expression of Green Fluorescent Protein in Somatotrophs In Vivo	PLOS ONE			English	Article							GROWTH-HORMONE GENE; LOCUS-CONTROL REGION; RAT ANTERIOR-PITUITARY; ORGANOTYPIC CULTURES; CELLS; VECTORS; TISSUE; PIT-1; PROLIFERATION; ACTIVATION	Previous studies have shown that the locus control region (LCR) and the promoter of the growth hormone (GH) gene can control the expression of GH. Therefore, lenti- and retro-viral vectors with these elements might be useful to monitor the activation of the GH gene and the development of newborn somatotrophs. To test this, we first constructed a lentiviral vector, which expresses green fluorescent protein (GFP) under the control of these elements, and injected them into rat pituitaries in situ and in vivo. The lentiviral vector expressed GFP specifically in the anterior lobe, and nearly all GFP-positive cells were anti-GH immunoreactive. The GFP expression was upregulated by the administration of growth hormone releasing hormone and an IGF-1 receptor blocker. Furthermore, the social isolation stress, which was shown to decrease the GH secretion, decreased the GFP expression. Second, we injected the retroviral vector into neonatal rat pituitaries in vivo. At 30 days postinjection (DPI), almost all GFP-positive cells were anti-GH positive and anti-prolactin negative as the lentiviral expression. However, GFP was transiently expressed by developing lactotrophs at 8 and 16 DPI, suggesting that our vector lacks an element(s) which suppresses the expression. Meanwhile, the retrovirally labeled cells tended to cluster with the cells of same type. An analysis of cell numbers in each cluster revealed some features of cell proliferation. These viral vectors are shown to be useful tools to monitor the activation of the GH gene and the development of somatotrophs.	[Okada, Masayoshi; Matsuda, Hiroko] Kansai Med Univ, Dept Physiol, Moriguchi, Osaka 570, Japan; [Okimura, Yasuhiko] Kobe Womens Univ, Kobe, Hyogo, Japan	Kansai Medical University	Okada, M (corresponding author), Kansai Med Univ, Dept Physiol, Moriguchi, Osaka 570, Japan.	mokada-tky@umin.ac.jp	Okada, Masayoshi/ABE-9020-2020	Okada, Masayoshi/0000-0001-8515-7143	Foundation for Growth Science	Foundation for Growth Science	This study is supported by the Foundation for Growth Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen LE, 1999, J CLIN INVEST, V104, P1123, DOI 10.1172/JCI7308; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; FRAWLEY LS, 1991, ENDOCR REV, V12, P337, DOI 10.1210/edrv-12-4-337; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Goodman HM, 2009, BASIC MEDICAL ENDOCRINOLOGY, 4TH EDITION, P1; Guerineau NC, 1997, J NEUROSCI METH, V73, P169, DOI 10.1016/S0165-0270(97)02224-3; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; JONES BK, 1995, MOL CELL BIOL, V15, P7010; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kishimoto M, 2002, J BIOL CHEM, V277, P45141, DOI 10.1074/jbc.M202991200; KUHN CM, 1978, SCIENCE, V201, P1034, DOI 10.1126/science.684424; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagasaki H, 2006, J MOL ENDOCRINOL, V37, P39, DOI 10.1677/jme.1.01932; Niiori-Onishi A, 1999, ENDOCRINOLOGY, V140, P344, DOI 10.1210/en.140.1.344; Okada M, 2008, NEUROSCIENCE, V156, P289, DOI 10.1016/j.neuroscience.2008.07.038; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; PERITZ LN, 1988, J BIOL CHEM, V263, P5005; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Sarac MS, 2002, ENDOCRINOLOGY, V143, P2314, DOI 10.1210/en.143.6.2314; SHEPARD AR, 1994, J BIOL CHEM, V269, P1804; Shewchuk BM, 1999, J BIOL CHEM, V274, P35725, DOI 10.1074/jbc.274.50.35725; Shewchuk BM, 2002, P NATL ACAD SCI USA, V99, P11784, DOI 10.1073/pnas.182418199; Skuse D, 1996, LANCET, V348, P353, DOI 10.1016/S0140-6736(96)01358-X; Southgate TD, 2000, ENDOCRINOLOGY, V141, P3493, DOI 10.1210/en.141.9.3493; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Taniguchi Y, 2001, ANAT EMBRYOL, V204, P469, DOI 10.1007/s429-001-8003-x; WEISS RA, 1977, VIROLOGY, V76, P808, DOI 10.1016/0042-6822(77)90261-6; YEE JK, 1987, P NATL ACAD SCI USA, V84, P5197, DOI 10.1073/pnas.84.15.5197	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54437	10.1371/journal.pone.0054437	http://dx.doi.org/10.1371/journal.pone.0054437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342159	gold, Green Submitted, Green Published			2022-12-27	WOS:000313682700117
J	Yilmazer, A; de Lazaro, I; Bussy, C; Kostarelos, K				Yilmazer, Acelya; de Lazaro, Irene; Bussy, Cyrill; Kostarelos, Kostas			In Vivo Cell Reprogramming towards Pluripotency by Virus-Free Overexpression of Defined Factors	PLOS ONE			English	Article							HYDRODYNAMICS-BASED TRANSFECTION; STEM-CELLS; CARDIAC FIBROBLASTS; EXPRESSION; MOUSE; GENERATION; HEPATOCYTES; LIVER	The ability to induce the reprogramming of somatic mammalian cells to a pluripotent state by the forced expression of specific transcription factors has helped redefine the rules of cell fate and plasticity, as well as open possibilities for disease modeling, drug screening and regenerative medicine. Here, we hypothesized that the non-viral forced expression of the four originally discovered defined factors (OKSM) in adult mice could result in in vivo reprogramming of cells in the transfected tissue in situ. We show that a single hydrodynamic tail-vein (HTV) injection of two plasmids encoding for Oct3/4, Sox2, Klf4 and c-Myc respectively, are highly expressed in the liver tissue of Balb/C adult mice. Hallmark pluripotency markers were upregulated within 24-48 h after injection, followed by down-regulation of all major hepatocellular markers. Generation of transcriptionally reprogrammed cells in vivo was further confirmed by positive staining of liver tissue sections for all major pluripotency markers in Balb/C mice and the Nanog-GFP reporter transgenic strain (TNG-A) with concomitant upregulation of GFP expression in situ. No signs of physiological or anatomical abnormalities or teratoma formation were observed in the liver examined up to 120 days. These findings indicate that virus-free expression of OKSM factors in vivo can transcriptionally reprogram cells in situ rapidly, efficiently and transiently, absent of host tissue damage or teratoma formation.	[Yilmazer, Acelya; de Lazaro, Irene; Bussy, Cyrill; Kostarelos, Kostas] UCL, UCL Sch Life & Med Sci, UCL Sch Pharm, Nanomed Lab, London, England	University of London; University College London	Kostarelos, K (corresponding author), UCL, UCL Sch Life & Med Sci, UCL Sch Pharm, Nanomed Lab, Brunswick Sq, London, England.	k.kostarelos@ucl.ac.uk	Bussy, Cyrill/C-7190-2008; Yilmazer, Acelya/L-4562-2013; de Lázaro, Irene/AAH-7605-2019; Kostarelos, Kostas/AAP-6879-2021	Bussy, Cyrill/0000-0001-8870-443X; Yilmazer, Acelya/0000-0003-2712-7450; de Lázaro, Irene/0000-0002-2775-0173; Kostarelos, Kostas/0000-0002-2224-6672	Engineering and Physical Sciences Research Council (EPSRC, Swindon, United Kingdom); European Commission FP-7 Program NANONEUROHOP [PIEF-GA-2010-276051]; European Commission FP-7 Program ANTICARB [HEALTH-2008-20157]; Ministry of Education (Turkey); British Council; CAIXA Foundation (Spain)	Engineering and Physical Sciences Research Council (EPSRC, Swindon, United Kingdom); European Commission FP-7 Program NANONEUROHOP; European Commission FP-7 Program ANTICARB; Ministry of Education (Turkey)(Ministry of National Education - Turkey); British Council(The British Council in India); CAIXA Foundation (Spain)	This work was partially supported by the Engineering and Physical Sciences Research Council (EPSRC, Swindon, United Kingdom) and the European Commission FP-7 Programs NANONEUROHOP (PIEF-GA-2010-276051) and ANTICARB (HEALTH-2008-20157). AY was supported by a full-time PhD scholarship from the Ministry of Education (Turkey) and IL acknowledges partial support from the British Council and the CAIXA Foundation (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianaivo F, 2004, J GENE MED, V6, P877, DOI 10.1002/jgm.574; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dolgin E, 2011, NATURE, V470, P13, DOI 10.1038/470013a; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; tenHagen TLM, 1996, J IMMUNOL METHODS, V193, P81, DOI 10.1016/0022-1759(96)00045-2; Vivien C, 2012, J BIOL CHEM, V287, P7427, DOI 10.1074/jbc.M111.324368; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	36	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54754	10.1371/journal.pone.0054754	http://dx.doi.org/10.1371/journal.pone.0054754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355895	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500120
J	Alonso, M; Marimon, JM; Ercibengoa, M; Perez-Yarza, EG; Perez-Trallero, E				Alonso, Marta; Marimon, Jose M.; Ercibengoa, Maria; Perez-Yarza, Eduardo G.; Perez-Trallero, Emilio			Dynamics of Streptococcus pneumoniae Serotypes Causing Acute Otitis Media Isolated from Children with Spontaneous Middle-Ear Drainage over a 12-Year Period (1999-2010) in a Region of Northern Spain	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; MOLECULAR CHARACTERIZATION; INVASIVE DISEASE; PREVALENCE; CARRIAGE; CLONES; TRENDS	The aim of this study was to determine the serotype and clonal distribution of pneumococci causing acute otitis media (AOM) and their relationship with recurrences and mixed infections with other microorganisms under the influence of the 7-valent pneumococcal conjugate vaccine (PCV7). To do this, all pneumococcal isolates collected from the spontaneous middle-ear drainage of children,5 years old diagnosed of AOM by their pediatrician or their general practitioner from 1999 to 2010 were phenotypically characterized and the most frequent serotypes were genotyped. In the 12-year study, 818 episodes of pneumococcal AOM were detected, mostly (70.5%) in children younger than 2 years old. In 262 episodes (32%), the pneumococci were isolated with another bacterium, mainly (n = 214) Haemophilus influenzae. Mixed infections were similar in children under or over 2 years old. The most frequent serotypes were 19A (n = 227, 27.8%), 3 (n = 92, 11.2%) and 19F (n = 74, 9%). Serotypes included in the PCV7 sharply decreased from 62.4% in the pre-vaccination (1999-2001) to 2.2% in the late post-vaccination period (2008-2010). Serotype diversity steadily increased after the introduction of the PCV7 but decreased from 2008-2010 due to the predominant role of serotype 19A isolates, mostly ST276 and ST320. The prevalence of serotype 3 doubled from 6.1% (20/326) in 1999-2004 to 14.6% (72/492) in 2005-2010. Relapses mainly occurred in male infants infected with isolates with diminished antimicrobial susceptibility. Reinfections caused by isolates with the same serotype but different genotype were frequent, highlighting the need for genetic studies to differentiate among similar strains. In conclusion, the main change in pneumococcal AOM observed after the introduction of the PCV7 was the sharp decrease in vaccine serotypes. Also notable was the high burden of serotype 19A in total pneumococcal AOM before and especially after the introduction of the PCV7, as well as in relapses and reinfections.	[Alonso, Marta; Marimon, Jose M.; Ercibengoa, Maria; Perez-Trallero, Emilio] Hosp Univ Donostia, Inst Biodonostia, Dept Microbiol, San Sebastian, Spain; [Marimon, Jose M.; Perez-Trallero, Emilio] Biomed Res Ctr Network Resp Dis, San Sebastian, Spain; [Perez-Yarza, Eduardo G.] Hosp Univ Donostia, Inst Biodonostia, Dept Pediat, San Sebastian, Spain; [Perez-Yarza, Eduardo G.; Perez-Trallero, Emilio] Univ Basque Country, Fac Med, San Sebastian, Spain	Instituto de Investigacion Sanitaria Biodonostia; Instituto de Investigacion Sanitaria Biodonostia; University of Basque Country	Perez-Trallero, E (corresponding author), Hosp Univ Donostia, Inst Biodonostia, Dept Microbiol, San Sebastian, Spain.	mikrobiol@terra.es	Ercibengoa, María/ABH-9481-2020; MARIMON, JOSE MARIA/AAM-5581-2021	MARIMON, JOSE MARIA/0000-0002-2787-7094; Alonso, Marta/0000-0002-8909-4968; Perez-Yarza, Eduardo G./0000-0002-8004-7110	University of the Basque Country (UPV/EHU) [GIU 09/59]; Department of Health, Basque Country [2009-111 012]	University of the Basque Country (UPV/EHU); Department of Health, Basque Country	This work was supported in part by grants from the University of the Basque Country (UPV/EHU; grant no. GIU 09/59) and from the Department of Health, Basque Country (grant 2009-111 012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguedas A, 2010, INT J PEDIATR OTORHI, V74, P1419, DOI 10.1016/j.ijporl.2010.09.022; Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; *CLIN LAB STAND I, 2011, M100S21 CLSI; Couloigner V, 2012, PEDIATR INFECT DIS J, V31, P154, DOI 10.1097/INF.0b013e3182357c8d; Ercibengoa M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-69; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Fenoll A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-239; Fischer T, 2007, ACAD EMERG MED, V14, P1172, DOI 10.1197/j.aem.2007.07.011; Guevara S, 2012, VACCINE, V30, P3857, DOI 10.1016/j.vaccine.2012.04.010; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Hanage WP, 2004, INFECT IMMUN, V72, P76, DOI 10.1128/IAI.72.1.76-81.2004; Hausdorff WP, 2002, PEDIATR INFECT DIS J, V21, P1008, DOI 10.1097/00006454-200211000-00007; Kaur R, 2011, PEDIATR INFECT DIS J, V30, P645, DOI 10.1097/INF.0b013e31821c2d8b; Kilpi Terhi, 2008, P301; Leibovitz E, 2004, PEDIATR INFECT DIS J, V23, P1142, DOI 10.1097/01.inf.0000148233.57296.90; Leibovitz E, 2009, PEDIATR INFECT DIS J, V28, P381, DOI 10.1097/INF.0b013e318194e783; Lujan M, 2010, EUR RESPIR J, V36, P1073, DOI 10.1183/09031936.00176309; Marimon JM, 2012, EUR J CLIN MICROBIOL, V31, P1009, DOI 10.1007/s10096-011-1399-3; Marimon JM, 2010, EUR J CLIN MICROBIOL, V29, P1035, DOI 10.1007/s10096-010-0947-6; Marimon JM, 2010, J MICROBIOL METH, V80, P274, DOI 10.1016/j.mimet.2010.01.011; Marimon JM, 2003, MICROB DRUG RESIST, V9, P133, DOI 10.1089/107662903765826714; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; Mintegi S, 2006, PEDIATR EMERG CARE, V22, P566, DOI 10.1097/01.pec.0000230550.79046.68; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Palmu AAI, 2004, CLIN INFECT DIS, V38, P234, DOI 10.1086/380642; Pelton SI, 2009, PEDIATR INFECT DIS J, V28, pS133, DOI 10.1097/INF.0b013e3181b6d81a; Perez-Trallero E, 2009, EUR J CLIN MICROBIOL, V28, P731, DOI 10.1007/s10096-008-0693-1; Perez-Trallero Emilio, 2012, Antimicrob Agents Chemother, V56, P3989, DOI 10.1128/AAC.00501-12; Perez-Trallero E, 2011, ANTIMICROB AGENTS CH, V55, P2729, DOI 10.1128/AAC.01546-10; Pimenta FC, 2009, J CLIN MICROBIOL, V47, P2353, DOI 10.1128/JCM.00704-09; Shouval DS, 2006, PEDIATR INFECT DIS J, V25, P602, DOI 10.1097/01.inf.0000220231.79968.f6; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Xu QF, 2011, DIAGN MICR INFEC DIS, V69, P200, DOI 10.1016/j.diagmicrobio.2010.09.019	36	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54333	10.1371/journal.pone.0054333	http://dx.doi.org/10.1371/journal.pone.0054333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349853	Green Published, gold			2022-12-27	WOS:000314019100056
J	Chou, KM; Lee, CC; Chen, CH; Sun, CY				Chou, Kuei-Mei; Lee, Chin-Chan; Chen, Chih-Huang; Sun, Chiao-Yin			Clinical Value of NGAL, L-FABP and Albuminuria in Predicting GFR Decline in Type 2 Diabetes Mellitus Patients	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACID-BINDING PROTEIN; TUBULAR MARKERS; RENAL-FUNCTION; NEPHROPATHY; KIDNEY; BIOMARKER; PATHOGENESIS; PROGRESSION; RISK	Objectives: Neutrophil gelatinase-associated lipocalin (NGAL) and liver-type fatty acid binding protein (L-FABP) are emerging as excellent biomarkers in the urine and plasma for the early prediction of acute and chronic kidney injury. The aims of this prospective study were to determine the role of albuminuria, and that of serum and urine levels of NGAL and L-FABP as predictors of a decline in the glomerular filtration rate (GFR) in patients with type 2 diabetes. Methods: A longitudinal cohort study with one hundred forty type 2 diabetic patients was conducted. Serum and urine levels of NGAL and L-FABP, and the urine albumin excretion rate were determined. The correlation between the kidney injury biomarkers and rate of GFR decline was analyzed. Results: The eGFR of study subjects decreased significantly as the study progressed (86.4 +/- 31.1 vs. 74.4 +/- 27.3 ml/min/ 1.73 m(2), P<0.001), and the urine albumin excretion rate increased significantly (264.9 +/- 1060.3 vs. 557.7 +/- 2092.5 mg/day, P = 0.009). The baseline urine albumin excretion rate and serum L-FABP level were significantly correlated with baseline eGFR (P<0.05). The results of regression analysis for the correlations between the rate of eGFR change and the baseline levels of NGAL and L-FABP, and the urine albumin excretion rate showed that only the urine albumin excretion rate was significantly correlated with the rate of eGFR change (standardized coefficients: -0.378; t: -4.298; P<0.001). Conclusions: Tubular markers, such as NGAL and L-FABP, may not be predictive factors associated with GFR decline in type 2 diabetic patients.	[Chou, Kuei-Mei; Chen, Chih-Huang] Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Keelung, Taiwan; [Lee, Chin-Chan; Sun, Chiao-Yin] Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Sun, CY (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Keelung, Taiwan.	fish3970@gmail.com			Chang Gung Memorial Hospital research grant	Chang Gung Memorial Hospital research grant(Chang Gung Memorial Hospital)	This study was supported by the Chang Gung Memorial Hospital research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Adler S, 2004, KIDNEY INT, V66, P2095, DOI 10.1111/j.1523-1755.2004.00988.x; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Bataille A, 2011, TRANSPLANTATION, V92, P1024, DOI 10.1097/TP.0b013e318230c079; Bhavsar NA, 2012, AM J KIDNEY DIS, V60, P233, DOI 10.1053/j.ajkd.2012.02.336; BOHLE A, 1991, PATHOL RES PRACT, V187, P251; Bolignano D, 2009, KIDNEY BLOOD PRESS R, V32, P91, DOI 10.1159/000209379; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; de Zeeuw D, 2006, KIDNEY INT, V69, P1675, DOI 10.1038/sj.ki.5000326; Deferrari G, 1998, NEPHROL DIAL TRANSPL, V13, P11; Devarajan P, 2010, BIOMARK MED, V4, P265, DOI [10.2217/bmm.10.12, 10.2217/BMM.10.12]; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; FIORETTO P, 1992, AM J KIDNEY DIS, V20, P549, DOI 10.1016/S0272-6386(12)70217-2; Fu WJ, 2012, ENDOCRINE, V41, P82, DOI 10.1007/s12020-011-9509-7; Fu WJ, 2012, DIABETES RES CLIN PR, V95, P105, DOI 10.1016/j.diabres.2011.09.031; Gray SP, 2011, NAT REV NEPHROL, V7, P71, DOI 10.1038/nrneph.2010.176; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Kamijo A, 2006, MOL CELL BIOCHEM, V284, P175, DOI 10.1007/s11010-005-9047-9; Kim SS, 2012, DIABETES RES CLIN PR, V97, P251, DOI 10.1016/j.diabres.2012.02.019; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; McMahon BA, 2010, KIDNEY INT, V77, P657, DOI 10.1038/ki.2010.5; Najafian B, 2011, CONTRIB NEPHROL, V170, P36, DOI 10.1159/000324942; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Nauta FL, 2011, DIABETES CARE, V34, P975, DOI 10.2337/dc10-1545; Nickolas TL, 2008, CURR OPIN NEPHROL HY, V17, P127, DOI 10.1097/MNH.0b013e3282f4e525; Nielsen SE, 2010, DIABETIC MED, V27, P1144, DOI 10.1111/j.1464-5491.2010.03083.x; Nielsen SE, 2011, KIDNEY INT, V79, P1113, DOI 10.1038/ki.2010.554; Nielsen SE, 2011, NEPHRON CLIN PRACT, V118, pC130, DOI 10.1159/000320615; Nielsen SE, 2010, DIABETES CARE, V33, P1320, DOI 10.2337/dc09-2242; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Phillips AO, 2002, HISTOL HISTOPATHOL, V17, P247, DOI 10.14670/HH-17.247; Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y; Ruggenenti P, 2006, KIDNEY INT, V70, P1214, DOI 10.1038/sj.ki.5001729; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Yamazaki Masatoshi, 1991, Journal of Diabetic Complications, V5, P138, DOI 10.1016/0891-6632(91)90047-S; Yang J, 2003, AM J PHYSIOL-RENAL, V285, pF9, DOI 10.1152/ajprenal.00008.2003	38	42	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54863	10.1371/journal.pone.0054863	http://dx.doi.org/10.1371/journal.pone.0054863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349979	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100102
J	Cobine, PA; Cruz, LF; Navarrete, F; Duncan, D; Tygart, M; De La Fuente, L				Cobine, Paul A.; Cruz, Luisa F.; Navarrete, Fernando; Duncan, Daniel; Tygart, Melissa; De La Fuente, Leonardo			Xylella fastidiosa Differentially Accumulates Mineral Elements in Biofilm and Planktonic Cells	PLOS ONE			English	Article							COPPER RESISTANCE; PIERCES-DISEASE; BACTERIAL PATHOGEN; VIRULENCE FACTORS; OXIDATIVE STRESS; ZINC UPTAKE; AGGREGATION; GENES; HOST; IDENTIFICATION	Xylella fastidiosa is a bacterial plant pathogen that infects numerous plant hosts. Disease develops when the bacterium colonizes the xylem vessels and forms a biofilm. Inductively coupled plasma optical emission spectroscopy was used to examine the mineral element content of this pathogen in biofilm and planktonic states. Significant accumulations of copper (30-fold), manganese (6-fold), zinc (5-fold), calcium (2-fold) and potassium (2-fold) in the biofilm compared to planktonic cells were observed. Other mineral elements such as sodium, magnesium and iron did not significantly differ between biofilm and planktonic cells. The distribution of mineral elements in the planktonic cells loosely mirrors the media composition; however the unique mineral element distribution in biofilm suggests specific mechanisms of accumulation from the media. A cell-to-surface attachment assay shows that addition of 50 to 100 mu M Cu to standard X. fastidiosa media increases biofilm, while higher concentrations (> 200 mu M) slow cell growth and prevent biofilm formation. Moreover cell-to-surface attachment was blocked by specific chelation of copper. Growth of X. fastidiosa in microfluidic chambers under flow conditions showed that addition of 50 mu M Cu to the media accelerated attachment and aggregation, while 400 mu M prevented this process. Supplementation of standard media with Mn showed increased biofilm formation and cell-to-cell attachment. In contrast, while the biofilm accumulated Zn, supplementation to the media with this element caused inhibited growth of planktonic cells and impaired biofilm formation. Collectively these data suggest roles for these minerals in attachment and biofilm formation and therefore the virulence of this pathogen.	[Cobine, Paul A.; Duncan, Daniel; Tygart, Melissa] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Cruz, Luisa F.; Navarrete, Fernando; Duncan, Daniel; De La Fuente, Leonardo] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Cobine, PA (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	paul.cobine@auburn.edu	Cobine, Paul A/G-3107-2011; Cruz, Luisa/AAA-5729-2020; De La Fuente, Leonardo/A-2012-2013; Cobine, Paul/AAH-6619-2020	Cobine, Paul A/0000-0001-6012-0985; De La Fuente, Leonardo/0000-0002-0027-4840; Cobine, Paul/0000-0001-6012-0985; Navarrete, Fernando/0000-0003-1971-441X	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2010-65108-20633]; Department of Entomology and Plant Pathology; National Science Foundation NSF-DMS [112-2343]; Division Of Mathematical Sciences [1122434] Funding Source: National Science Foundation	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture; Department of Entomology and Plant Pathology; National Science Foundation NSF-DMS(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Agriculture and Food Research Initiative Competitive Grants Program Grant no. 2010-65108-20633 from the USDA National Institute of Food and Agriculture. The authors also acknowledge funds provided by the Department of Entomology and Plant Pathology, and from the National Science Foundation NSF-DMS 112-2343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2004, CURR MICROBIOL, V48, P368, DOI 10.1007/s00284-003-4219-x; Andersen PC, 2007, FEMS MICROBIOL LETT, V274, P210, DOI 10.1111/j.1574-6968.2007.00827.x; Arirachakaran P, 2007, CARIES RES, V41, P503, DOI 10.1159/000110883; Behlau F, 2011, APPL ENVIRON MICROB, V77, P4089, DOI 10.1128/AEM.03043-10; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; Choat B, 2009, PHYSIOL PLANTARUM, V136, P384, DOI 10.1111/j.1399-3054.2009.01231.x; COOKSEY DA, 1990, APPL ENVIRON MICROB, V56, P431, DOI 10.1128/AEM.56.2.431-435.1990; Cruz LF, 2012, APPL ENVIRON MICROB, V78, P1321, DOI 10.1128/AEM.06501-11; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; DAVIS MJ, 1980, PHYTOPATHOLOGY, V70, P425, DOI 10.1094/Phyto-70-425; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; Fedatto LM, 2006, MICROBIOL RES, V161, P263, DOI 10.1016/j.micres.2005.10.001; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; FLETCHER M, 1988, J BACTERIOL, V170, P2027, DOI 10.1128/jb.170.5.2027-2030.1988; Guerinot ML, 1999, CURR OPIN PLANT BIOL, V2, P244, DOI 10.1016/S1369-5266(99)80042-9; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Leary SC, 2009, BBA-MOL CELL RES, V1793, P146, DOI 10.1016/j.bbamcr.2008.05.002; Leite B, 2002, BRAZ J MED BIOL RES, V35, P645, DOI 10.1590/S0100-879X2002000600003; Lewis DA, 1999, INFECT IMMUN, V67, P5060, DOI 10.1128/IAI.67.10.5060-5068.1999; Mackie KA, 2012, ENVIRON POLLUT, V167, P16, DOI 10.1016/j.envpol.2012.03.023; Muranaka LS, 2012, J BACTERIOL, V194, P4561, DOI 10.1128/JB.00436-12; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; Ordax M, 2010, RES MICROBIOL, V161, P549, DOI 10.1016/j.resmic.2010.05.003; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Rodrigues CM, 2008, APPL MICROBIOL BIOT, V77, P1145, DOI 10.1007/s00253-007-1232-1; Rogers EE, 2012, MOL PLANT MICROBE IN, V25, P747, DOI 10.1094/MPMI-11-10-0270; Rose RK, 2000, BBA-GEN SUBJECTS, V1475, P76, DOI 10.1016/S0304-4165(00)00048-9; Ryan RP, 2007, FEMS MICROBIOL LETT, V268, P40, DOI 10.1111/j.1574-6968.2006.00592.x; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Silva MS, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-58; Srinandan CS, 2010, BIOFOULING, V26, P449, DOI 10.1080/08927011003739760; Tang DJ, 2005, MOL PLANT MICROBE IN, V18, P652, DOI 10.1094/MPMI-18-0652; Thorne ET, 2006, AM J ENOL VITICULT, V57, P1; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Veyrier FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002261; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; White PJ, 2012, NEW PHYTOL, V196, P101, DOI 10.1111/j.1469-8137.2012.04228.x; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wu HJ, 2006, MOL MICROBIOL, V60, P401, DOI 10.1111/j.1365-2958.2006.05079.x; Wu HJ, 2010, J PROTEOMICS, V73, P899, DOI 10.1016/j.jprot.2009.12.001; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zaini PA, 2008, J BACTERIOL, V190, P2368, DOI 10.1128/JB.01495-07; Zaini PA, 2009, FEMS MICROBIOL LETT, V295, P129, DOI 10.1111/j.1574-6968.2009.01597.x	46	57	57	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54936	10.1371/journal.pone.0054936	http://dx.doi.org/10.1371/journal.pone.0054936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349991	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100112
J	Shi, D; Funayama, T; Mashima, Y; Takano, Y; Shimizu, A; Yamamoto, K; Mengkegale, M; Miyazawa, A; Yasuda, N; Fukuchi, T; Abe, H; Ideta, H; Nishida, K; Nakazawa, T; Richards, JE; Fuse, N				Shi, Dong; Funayama, Tomoyo; Mashima, Yukihiko; Takano, Yoshimasa; Shimizu, Ai; Yamamoto, Kotaro; Mengkegale, MinGe; Miyazawa, Akiko; Yasuda, Noriko; Fukuchi, Takeo; Abe, Haruki; Ideta, Hidenao; Nishida, Kohji; Nakazawa, Toru; Richards, Julia E.; Fuse, Nobuo			Association of HK2 and NCK2 with Normal Tension Glaucoma in the Japanese Population	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OXYGEN SPECIES GENERATION; AMINO-ACID SUBSTITUTIONS; GENOME-WIDE ASSOCIATION; HEXOKINASE-II GENE; MOLECULAR-GENETICS; INSULIN-RESISTANCE; NIDDM; VARIANTS; LOCI	Although family studies and genome-wide association studies have shown that genetic factors play a role in glaucoma, it has been difficult to identify the specific genetic variants involved. We tested 669 single nucleotide polymorphisms (SNPs) from the region of chromosome 2 that includes the GLC1B glaucoma locus for association with primary open-angle glaucoma (POAG) and normal tension glaucoma (NTG) in the Japanese population. We performed a two-stage case-control study. The first cohort consisted of 123 POAG cases, 121 NTG cases and 120 controls: the second cohort consisted of 187 POAG cases, 286 NTG cases, and 271 controls. Out of six SNPs showing significant association with POAG in the first round screening, seven SNPs were tested in the second round. Rs678350 in the HK2 gene coding sequence showed significant allelic (p = 0.0027 in Stage Two, 2.7XE-4 in meta-analysis) association with POAG, and significant allelic (p = 4.7XE-4 in Stage Two, 1.0XE-5 in meta-analysis) association with NTG. Although alleles in the TMEM182 gene did not show significant association with glaucoma in the second round, subjects with the A/A allele in TMEM182 rs869833 showed worse visual field mean deviation (p = 0.01). Even though rs2033008 in the NCK2 gene coding sequence did not show significant association in the first round, it had previously shown association with NTG so it was tested for association with NTG in round 2 (p = 0.0053 in Stage Two). Immunohistochemistry showed that both HK2 and NCK2 are expressed in the retinal ganglion cell layer. Once multi-testing was taken into account, only HK2 showed significant association with POAG and NTG in Stage Two. Our data also support previous reports of NCK2 association with NTG, and raise questions about what role TMEM182 might play	[Shi, Dong; Takano, Yoshimasa; Shimizu, Ai; Yamamoto, Kotaro; Mengkegale, MinGe; Miyazawa, Akiko; Nakazawa, Toru; Fuse, Nobuo] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Shi, Dong] China Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Shenyang, Liaoning, Peoples R China; [Funayama, Tomoyo] Bunkyo Univ, Fac Educ, Dept Chem, Koshigaya, Saitama, Japan; [Mashima, Yukihiko] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan; [Yasuda, Noriko] Tokyo Metropolitan Police Hosp, Dept Ophthalmol, Tokyo, Japan; [Fukuchi, Takeo; Abe, Haruki] Niigata Univ, Grad Sch Med & Dent Sci, Div Ophthalmol & Visual Sci, Niigata, Japan; [Ideta, Hidenao] Ideta Eye Hosp, Kumamoto, Japan; [Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan; [Richards, Julia E.] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Richards, Julia E.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Fuse, Nobuo] Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan	Tohoku University; China Medical University; Keio University; Niigata University; Osaka University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fuse, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan.	fusen@oph.med.tohoku.ac.jp	Shi, Dongquan/ABG-6949-2021; shi, dongquan/ABH-3078-2021	shi, dongquan/0000-0002-4769-7816; Nishida, Kohji/0000-0001-9069-3610	Ministry of Education, Science, and Culture of the Japanese Government, Tokyo, Japan [C-22591928)]; Ministry of Health, Labor and Welfare of Japan; Tohoku Medical Megabank Project; Japan-China Medical Association; National Eye Institute at the National Institutes of Health, Bethesda, MD, USA [R01-EY011671]; Research to Prevent Blindness, New York, NY, USA; NATIONAL EYE INSTITUTE [R01EY011671] Funding Source: NIH RePORTER	Ministry of Education, Science, and Culture of the Japanese Government, Tokyo, Japan; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Tohoku Medical Megabank Project; Japan-China Medical Association; National Eye Institute at the National Institutes of Health, Bethesda, MD, USA; Research to Prevent Blindness, New York, NY, USA(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by a Grant-In-Aid for Scientific Research from the Ministry of Education, Science, and Culture of the Japanese Government (C-22591928), Tokyo, Japan (NF); by a grant from the Ministry of Health, Labor and Welfare of Japan (NF); by Tohoku Medical Megabank Project (NF); by a grant from the Japan-China Medical Association (DS); by a grant R01-EY011671 from the National Eye Institute at the National Institutes of Health (JER), Bethesda, MD, USA; and a grant from Research to Prevent Blindness, New York, NY, USA (JER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2008, BRIT J OPHTHALMOL, V92, P1293, DOI 10.1136/bjo.2008.139980; Anderson DR., 1999, AUTOMATED STATIC PER; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; ECHWALD SM, 1995, DIABETES, V44, P347, DOI 10.2337/diabetes.44.3.347; Funayama T, 2004, INVEST OPHTH VIS SCI, V45, P4359, DOI 10.1167/iovs.03-1403; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; HITCHINGS RA, 1983, BRIT J OPHTHALMOL, V67, P818, DOI 10.1136/bjo.67.12.818; HITCHINGS RA, 1992, BRIT J OPHTHALMOL, V76, P494, DOI 10.1136/bjo.76.8.494; Inagaki Y, 2006, JPN J OPHTHALMOL, V50, P128, DOI 10.1007/s10384-005-0290-0; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; LAAKSO M, 1995, DIABETOLOGIA, V38, P617, DOI 10.1007/s001250050328; LAAKSO M, 1995, DIABETES, V44, P330, DOI 10.2337/diabetes.44.3.330; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Raymond V, 1997, AM J HUM GENET, V60, P272; Santiago APSA, 2008, BIOCHIMIE, V90, P1566, DOI 10.1016/j.biochi.2008.06.013; Sarfarazi M, 1997, HUM MOL GENET, V6, P1667, DOI 10.1093/hmg/6.10.1667; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Suzuki S, 2002, BIOCHEM BIOPH RES CO, V294, P1087, DOI 10.1016/S0006-291X(02)00606-X; VIDALPUIG A, 1995, DIABETES, V44, P340, DOI 10.2337/diabetes.44.3.340; Werner EB, 1996, NORMAL TENSION GLAUC; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wu Yu, 2008, BMC Res Notes, V1, P85, DOI 10.1186/1756-0500-1-85	31	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54115	10.1371/journal.pone.0054115	http://dx.doi.org/10.1371/journal.pone.0054115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349798	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100044
J	Kinehara, M; Kawamura, S; Tateyama, D; Suga, M; Matsumura, H; Mimura, S; Hirayama, N; Hirata, M; Uchio-Yamada, K; Kohara, A; Yanagihara, K; Furue, MK				Kinehara, Masaki; Kawamura, Suguru; Tateyama, Daiki; Suga, Mika; Matsumura, Hiroko; Mimura, Sumiyo; Hirayama, Noriko; Hirata, Mitsuhi; Uchio-Yamada, Kozue; Kohara, Arihiro; Yanagihara, Kana; Furue, Miho K.			Protein Kinase C Regulates Human Pluripotent Stem Cell Self-Renewal	PLOS ONE			English	Article							HUMAN EMBRYONIC STEM; SERUM-FREE MEDIUM; MAINTAIN PLURIPOTENCY; WNT/BETA-CATENIN; GROWTH-FACTOR; EPSILON-PKC; DIFFERENTIATION; CULTURE; MAINTENANCE; INDUCTION	Background: The self-renewal of human pluripotent stem (hPS) cells including embryonic stem and induced pluripotent stem cells have been reported to be supported by various signal pathways. Among them, fibroblast growth factor-2 (FGF-2) appears indispensable to maintain self-renewal of hPS cells. However, downstream signaling of FGF-2 has not yet been clearly understood in hPS cells. Methodology/Principal Findings: In this study, we screened a kinase inhibitor library using a high-throughput alkaline phosphatase (ALP) activity-based assay in a minimal growth factor-defined medium to understand FGF-2-related molecular mechanisms regulating self-renewal of hPS cells. We found that in the presence of FGF-2, an inhibitor of protein kinase C (PKC), GF109203X (GFX), increased ALP activity. GFX inhibited FGF-2-induced phosphorylation of glycogen synthase kinase-3 beta (GSK-3 beta), suggesting that FGF-2 induced PKC and then PKC inhibited the activity of GSK-3 beta. Addition of activin A increased phosphorylation of GSK-3 beta and extracellular signal-regulated kinase-1/2 (ERK-1/2) synergistically with FGF-2 whereas activin A alone did not. GFX negated differentiation of hPS cells induced by the PKC activator, phorbol 12-myristate 13-acetate whereas Go6976, a selective inhibitor of PKC alpha, beta, and gamma isoforms could not counteract the effect of PMA. Intriguingly, functional gene analysis by RNA interference revealed that the phosphorylation of GSK-3 beta was reduced by siRNA of PKC delta, PKC epsilon, and zeta, the phosphorylation of ERK-1/2 was reduced by siRNA of PKC epsilon and zeta, and the phosphorylation of AKT was reduced by PKCe in hPS cells. Conclusions/Significance: Our study suggested complicated cross-talk in hPS cells that FGF-2 induced the phosphorylation of phosphatidylinositol-3 kinase (PI3K)/AKT, mitogen-activated protein kinase/ERK-1/2 kinase (MEK), PKC/ERK-1/2 kinase, and PKC/GSK-3 beta. Addition of GFX with a MEK inhibitor, U0126, in the presence of FGF-2 and activin A provided a long-term stable undifferentiated state of hPS cells even though hPS cells were dissociated into single cells for passage. This study untangles the cross-talk between molecular mechanisms regulating self-renewal and differentiation of hPS cells.	[Kinehara, Masaki; Kawamura, Suguru; Tateyama, Daiki; Suga, Mika; Matsumura, Hiroko; Mimura, Sumiyo; Hirata, Mitsuhi; Yanagihara, Kana; Furue, Miho K.] Natl Inst Biomed Innovat, Dept Dis Bioresources Res, Lab Stem Cell Cultures, Osaka, Japan; [Hirayama, Noriko; Kohara, Arihiro] Natl Inst Biomed Innovat, Dept Dis Bioresources Res, Lab Cell Cultures, Osaka, Japan; [Uchio-Yamada, Kozue] Natl Inst Biomed Innovat, Dept Dis Bioresources Res, Lab Anim Models Human Dis, Osaka, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan	Furue, MK (corresponding author), Natl Inst Biomed Innovat, Dept Dis Bioresources Res, Lab Stem Cell Cultures, Osaka, Japan.	mkfurue@nibio.go.jp		Furue, Miho/0000-0001-5032-9953	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by grants-in-aid from the Ministry of Health, Labor and Welfare of Japan to M. K. F. and A. K., the Ministry of Education, Culture, Sports, Science and Technology of Japan to M. K. F. and M. K. and the Japan Science and Technology Agency to M.K.F.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aihara Y, 2010, INT J DEV BIOL, V54, P1287, DOI 10.1387/ijdb.103173ya; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Avery S, 2006, STEM CELLS DEV, V15, P729, DOI 10.1089/scd.2006.15.729; Barbaric I, 2010, STEM CELL RES, V5, P104, DOI 10.1016/j.scr.2010.04.006; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Boersema PJ, 2010, MOL CELL PROTEOMICS, V9, P84, DOI 10.1074/mcp.M900291-MCP200; Brandman R, 2007, J BIOL CHEM, V282, P4113, DOI 10.1074/jbc.M608521200; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Ding VMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017538; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Feng XZ, 2012, STEM CELLS, V30, P461, DOI 10.1002/stem.1018; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Furue MK, 2010, IN VITRO CELL DEV-AN, V46, P573, DOI 10.1007/s11626-010-9317-z; GOODE N, 1992, J BIOL CHEM, V267, P16878; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hayashi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014099; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mochly-Rosen D, 1998, FASEB J, V12, P35; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Na J, 2010, STEM CELL RES, V5, P157, DOI 10.1016/j.scr.2010.06.002; Nakanishi M, 2009, FASEB J, V23, P114, DOI 10.1096/fj.08-111203; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Okamoto R, 2004, TISSUE CULTURE RES C, V23, P36; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyoda M, 2011, GENES CELLS, V16, P1, DOI 10.1111/j.1365-2443.2010.01459.x; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	62	49	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54122	10.1371/journal.pone.0054122	http://dx.doi.org/10.1371/journal.pone.0054122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349801	Green Published, gold, Green Submitted			2022-12-27	WOS:000313943000026
J	Charpentier, C; Lambert-Niclot, S; Alteri, C; Storto, A; Flandre, P; Svicher, V; Perno, F; Brun-Vezinet, F; Calvez, V; Marcelin, AG; Ceccherini-Silberstein, F; Descamps, D				Charpentier, Charlotte; Lambert-Niclot, Sidonie; Alteri, Claudia; Storto, Alexandre; Flandre, Philippe; Svicher, Valentina; Perno, Federico; Brun-Vezinet, Francoise; Calvez, Vincent; Marcelin, Anne-Genevieve; Ceccherini-Silberstein, Francesca; Descamps, Diane			Description of the L76V Resistance Protease Mutation in HIV-1 B and "Non-B" Subtypes	PLOS ONE			English	Article							NAIVE HIV-1-INFECTED PATIENTS; DRUG-RESISTANCE; TREATMENT FAILURE; TYPE-1; LOPINAVIR/RITONAVIR; PREVALENCE; PATTERNS; RITONAVIR; EFFICACY; SAFETY	Objective: To describe the prevalence of the L76V protease inhibitors resistance-associated mutation (PI-RAM) in relation with patients' characteristics and protease genotypic background in HIV-1 B-and "non-B"-infected patients. Methods: Frequency of the L76V mutation between 1998 and 2010 was surveyed in the laboratory database of 3 clinical centers. Major PI-RAMs were identified according to the IAS-USA list. Fisher's and Wilcoxon tests were used to compare variables. Results: Among the overall 29,643 sequences analyzed, the prevalence of L76V was 1.50%, while was 5.42% in PI-resistant viruses. Since 2008 the prevalence of L76V was higher in "non-B"-infected than in B-infected patients each year. Median time since diagnosis of HIV-1 infection and median time under antiretroviral-based regimen were both shorter in "non-B" than in B-infected patients (8 vs 11 years, P<0.0001; and 7 vs 8 years, P = 0.004). In addition, "non-B"-infected patients had been pre-exposed to a lower number of PI (2 vs 3, P = 0.016). The L76V was also associated with a lower number of major PI-RAMs in "non-B" vs B samples (3 vs 4, P=0.0001), and thus it was more frequent found as single major PI-RAM in "non-B" vs B subtype (10% vs 2%, P=0.014). Conclusions: We showed an impact of viral subtype on the selection of the L76V major PI-RAM with a higher prevalence in "non-B" subtypes observed since 2008. In addition, in "non-B"-infected patients this mutation appeared more rapidly and was associated with less PI-RAM.	[Charpentier, Charlotte; Storto, Alexandre; Brun-Vezinet, Francoise; Descamps, Diane] Univ Paris 07, Virol Lab, Grp Hosp Bichat Claude Bernard, AP HP,HUPNVS,PRES Sorbonne Paris Cite,EA4409, Paris, France; [Lambert-Niclot, Sidonie; Calvez, Vincent; Marcelin, Anne-Genevieve] Univ Paris 06, INSERM, UMR S943, Hop Pitie Salpetriere,AP HP,Lab Virol, Paris, France; [Alteri, Claudia; Svicher, Valentina; Perno, Federico; Ceccherini-Silberstein, Francesca] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Flandre, Philippe] Univ Paris 06, INSERM, UMR S 943, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Rome Tor Vergata; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Charpentier, C (corresponding author), Univ Paris 07, Virol Lab, Grp Hosp Bichat Claude Bernard, AP HP,HUPNVS,PRES Sorbonne Paris Cite,EA4409, Paris, France.	charlotte.charpentier@bch.aphp.fr	Alteri, Claudia/AAB-9956-2019; Alteri, Claudia/J-9116-2016; Flandre, Philippe/N-6314-2017; perno, carlo federico/O-1544-2016; Charpentier, Charlotte/C-3579-2019; Marcelin, Anne-Genevieve/D-8272-2014; Ceccherini-Silberstein, Francesca/K-4762-2016; Di Maio, Velia Chiara/AGH-2628-2022	Alteri, Claudia/0000-0003-4270-5079; Alteri, Claudia/0000-0003-4270-5079; Flandre, Philippe/0000-0002-2612-3522; Marcelin, Anne-Genevieve/0000-0003-4808-8999; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; PERNO, CARLO FEDERICO/0000-0002-0825-5388; SVICHER, VALENTINA/0000-0002-2377-504X	French National Agency for Research on AIDS and viral hepatitis (Agence Nationale de Recherches sur le SIDA et les hepatites virales [ANRS]); European Community [223131]; Aviralia Foundation	French National Agency for Research on AIDS and viral hepatitis (Agence Nationale de Recherches sur le SIDA et les hepatites virales [ANRS])(ANRS); European Community(European Commission); Aviralia Foundation	The study was supported by French National Agency for Research on AIDS and viral hepatitis (Agence Nationale de Recherches sur le SIDA et les hepatites virales [ANRS]) and from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" (grant no. 223131) and Aviralia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-111; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Ceccherini-Silberstein F, 2004, AIDS, V18, pF11, DOI 10.1097/01.aids.0000131394.76221.02; Champenois K, 2011, J MED VIROL, V83, P1677, DOI 10.1002/jmv.22161; Charpentier C, 2012, 19 C RETR OPP INF SE; Charpentier C, 2011, AIDS RES HUM RETROV, V27, P221, DOI 10.1089/aid.2010.0103; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; de Mendoza C, 2008, AIDS, V22, P311, DOI 10.1097/QAD.0b013e3282f4244f; Delaugerre C, 2009, ANTIMICROB AGENTS CH, V53, P2934, DOI 10.1128/AAC.01643-08; Deshpande A, 2007, AIDS RES HUM RETROV, V23, P335, DOI 10.1089/aid.2006.0183; Ghosn J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024798; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Lambert-Niclot S, 2008, ANTIMICROB AGENTS CH, V52, P491, DOI 10.1128/AAC.00909-07; Maiga AI, 2009, ANTIVIR THER, V14, P123; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; Mitsuya Y, 2007, J INFECT DIS, V196, P1177, DOI 10.1086/521624; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Nijhuis M, 2007, PLOS MED, V4, P152, DOI 10.1371/journal.pmed.0040036; Nijhuis M, 2009, J INFECT DIS, V200, P698, DOI 10.1086/605329; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Tartaglia A, 2009, ANTIMICROB AGENTS CH, V53, P1724, DOI 10.1128/AAC.01693-08; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Wiesmann F, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-7; Young TP, 2010, ANTIMICROB AGENTS CH, V54, P4903, DOI 10.1128/AAC.00906-10	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54381	10.1371/journal.pone.0054381	http://dx.doi.org/10.1371/journal.pone.0054381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349869	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800045
J	Meng, JJ; Yu, HD; Ma, J; Wang, JH; Banerjee, S; Charboneau, R; Barke, RA; Roy, S				Meng, Jingjing; Yu, Haidong; Ma, Jing; Wang, Jinghua; Banerjee, Santanu; Charboneau, Rick; Barke, Roderick A.; Roy, Sabita			Morphine Induces Bacterial Translocation in Mice by Compromising Intestinal Barrier Function in a TLR-Dependent Manner	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LIGHT-CHAIN KINASE; EPITHELIAL BARRIER; RECEPTOR; LIPOPOLYSACCHARIDE; SEPSIS; PHOSPHORYLATION	Opiates are among the most prescribed drugs for pain management. However, morphine use or abuse results in significant gut bacterial translocation and predisposes patients to serious infections with gut origin. The mechanism underlying this defect is still unknown. In this report, we investigated the mechanisms underlying compromised gut immune function and bacterial translocation following morphine treatment. We demonstrate significant bacterial translocation to mesenteric lymph node (MLN) and liver following morphine treatment in wild-type (WT) animals that was dramatically and significantly attenuated in Toll-like receptor (TLR2 and 4) knockout mice. We further observed significant disruption of tight junction protein organization only in the ileum but not in the colon of morphine treated WT animals. Inhibition of myosin light chain kinase (MLCK) blocked the effects of both morphine and TLR ligands, suggesting the role of MLCK in tight junction modulation by TLR. This study conclusively demonstrates that morphine induced gut epithelial barrier dysfunction and subsequent bacteria translocation are mediated by TLR signaling and thus TLRs can be exploited as potential therapeutic targets for alleviating infections and even sepsis in morphine-using or abusing populations.	[Meng, Jingjing; Roy, Sabita] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Yu, Haidong; Ma, Jing; Wang, Jinghua; Banerjee, Santanu; Roy, Sabita] Univ Minnesota, Sch Med, Dept Surg, Div Infect Inflammat & Vasc Biol, Minneapolis, MN 55455 USA; [Charboneau, Rick; Barke, Roderick A.] Vet Affairs Med Ctr, Dept Surg, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Roy, S (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	royxx002@umn.edu	ma, jing/B-5493-2013		National Institutes of Health [RO1DA031202, RO1DA12104, RO1DA022935, KO2DA15349, P50DA11806]; Minneapolis Veterans Affairs Medical Center; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022935, P50DA011806, R01DA031202, R01DA012104, K05DA033881, K02DA015349, R01DA034582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minneapolis Veterans Affairs Medical Center; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by National Institutes of Health Grants RO1DA031202, RO1DA12104, RO1DA022935, KO2DA15349, P50DA11806 (to S. R.) and by funds from the Minneapolis Veterans Affairs Medical Center (R. A. B.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Alexander M, 2005, J SURG RES, V129, P161, DOI 10.1016/j.jss.2005.04.028; Babrowski T, 2012, ANN SURG, V255, P386, DOI 10.1097/SLA.0b013e3182331870; Bonnet MP, 2008, ANESTH ANALG, V106, P1142, DOI 10.1213/ane.0b013e318165de89; Breslow JM, 2011, J NEUROIMMUNE PHARM, V6, P551, DOI 10.1007/s11481-011-9303-6; Breslow JM, 2010, MICROB PATHOGENESIS, V49, P330, DOI 10.1016/j.micpath.2010.07.006; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; BRYANT HU, 1988, EUR J PHARMACOL, V149, P165, DOI 10.1016/0014-2999(88)90057-X; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chabot S, 2006, J IMMUNOL, V176, P4275, DOI 10.4049/jimmunol.176.7.4275; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Feng P, 2006, INFECT IMMUN, V74, P5221, DOI 10.1128/IAI.00208-06; Forsythe RM, 2002, SHOCK, V17, P180, DOI 10.1097/00024382-200203000-00004; Glattard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008791; Goldblum SE, 2011, FASEB J, V25, P144, DOI 10.1096/fj.10-158972; Greeneltch KM, 2004, BRAIN BEHAV IMMUN, V18, P476, DOI 10.1016/j.bbi.2003.12.001; Hilburger ME, 1997, J INFECT DIS, V176, P183, DOI 10.1086/514021; Huppert J, 2010, FASEB J, V24, P1023, DOI 10.1096/fj.09-141978; KUEPPERS PM, 1993, ANN SURG, V217, P286, DOI 10.1097/00000658-199303000-00011; LESLIE KA, 1994, CAN J SURG, V37, P143; Liu XXJ, 2012, DIG DIS SCI JUL; MacFarlane AS, 2000, J INFECT DIS, V181, P1350, DOI 10.1086/315403; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Mason KL, 2008, OVERVIEW OF GUT IMMU; Moriez R, 2005, AM J PATHOL, V167, P1071, DOI 10.1016/S0002-9440(10)61196-0; Ocasio FM, 2004, J NEUROIMMUNOL, V149, P90, DOI 10.1016/j.jneuroim.2003.12.016; Quintana JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-24; Regan LCA, 2012, EMERG MED J; Ripamonti C, 1991, J Palliat Care, V7, P30; Ross GR, 2008, J PHARMACOL EXP THER, V327, P561, DOI 10.1124/jpet.108.143438; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Roy S, 1999, J NEUROIMMUNOL, V95, P107, DOI 10.1016/S0165-5728(98)00265-3; Roy S, 1998, MOL BRAIN RES, V61, P190, DOI 10.1016/S0169-328X(98)00212-5; Roy S. M., 2011, J NEUROIMMUNE PHARM, P1; RUNKEL NSF, 1993, DIGEST DIS SCI, V38, P1530, DOI 10.1007/BF01308616; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Shifflett DE, 2005, LAB INVEST, V85, P1308, DOI 10.1038/labinvest.3700330; Xiao WD, 2011, MOL CELL NEUROSCI, V46, P527, DOI 10.1016/j.mcn.2010.12.007	42	117	124	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54040	10.1371/journal.pone.0054040	http://dx.doi.org/10.1371/journal.pone.0054040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349783	gold, Green Submitted, Green Published			2022-12-27	WOS:000313872800022
J	Oerlecke, I; Bauer, E; Dittmer, A; Leyh, B; Dittmer, J				Oerlecke, Ilka; Bauer, Elke; Dittmer, Angela; Leyh, Benjamin; Dittmer, Juergen			Cyclic AMP Enhances TGF beta Responses of Breast Cancer Cells by Upregulating TGF beta Receptor I Expression	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HORMONE-RELATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; BINDING PROTEIN; BONE METASTASES; MESSENGER-RNA; CAMP; INHIBITION; PATHWAY	Cellular functions are regulated by complex networks of many different signaling pathways. The TGF beta and cAMP pathways are of particular importance in tumor progression. We analyzed the cross-talk between these pathways in breast cancer cells in 2D and 3D cultures. We found that cAMP potentiated TGF beta-dependent gene expression by enhancing Smad3 phosphorylation. Higher levels of total Smad3, as observed in 3D-cultured cells, blocked this effect. Two Smad3 regulating proteins, YAP (Yes-associated protein) and T beta RI (TGF beta receptor 1), were responsive to cAMP. While YAP had little effect on TGF beta-dependent expression and Smad3 phosphorylation, a constitutively active form of T beta RI mimicked the cAMP effect on TGF beta signaling. In 3D-cultured cells, which show much higher levels of T beta RI and cAMP, T beta RI was unresponsive to cAMP. Upregulation of T beta RI expression by cAMP was dependent on transcription. A proximal T beta RI promoter fragment was moderately, but significantly activated by cAMP suggesting that cAMP increases T beta RI expression at least partially by activating T beta RI transcription. Neither the cAMP-responsive element binding protein (CREB) nor the T beta RI-regulating transcription factor Six1 was required for the cAMP effect. An inhibitor of histone deacetylases alone or together with cAMP increased T beta RI expression by a similar extent as cAMP alone suggesting that cAMP may exert its effect by interfering with histone acetylation. Along with an additive stimulatory effect of cAMP and TGF beta on p21 expression an additive inhibitory effect of these agents on proliferation was observed. Finally, we show that mesenchymal stem cells that interact with breast cancer cells can simultaneously activate the cAMP and TGF beta pathways. In summary, these data suggest that combined effects of cAMP and TGF beta, as e.g. induced by mesenchymal stem cells, involve the upregulation of T beta RI expression on the transcriptional level, likely due to changes in histone acetylation. As a consequence, cancer cell functions such as proliferation are affected.	[Oerlecke, Ilka; Bauer, Elke; Dittmer, Angela; Leyh, Benjamin; Dittmer, Juergen] Univ Halle, Klin Gynakol, Halle, Germany	Martin Luther University Halle Wittenberg	Dittmer, J (corresponding author), Univ Halle, Klin Gynakol, Halle, Germany.	juergen.dittmer@medizin.uni-halle.de	Dittmer, Juergen/G-1160-2011		Deutsche Krebshilfe [109271]; Land Sachsen-Anhalt (Medical Faculty of the University of Halle) [FKZ VF1/A8]	Deutsche Krebshilfe(Deutsche Krebshilfe); Land Sachsen-Anhalt (Medical Faculty of the University of Halle)	The work was supported by 1. Deutsche Krebshilfe grant no. 109271 (external funding) http://www.krebshilfe.de/wir-foerdern.html), and 2. Land Sachsen-Anhalt (Wilhelm-Roux-funding) grant FKZ VF1/A8 (internal funding of the Medical Faculty of the University of Halle, no URL available, because the Wilhelm-Roux-Funding-Program is not accessible for the public outside the University). The salary for Ilka Oerlecke was payed by the University grant FKZ VF1/A8. The salary for Benjamin Leyh was payed by the Deutsche Krebshilfe grant 109271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammanamanchi S, 2004, J BIOL CHEM, V279, P32620, DOI 10.1074/jbc.M402691200; Badve S, 2012, LANCET ONCOL, V13, pE43, DOI 10.1016/S1470-2045(11)70191-7; Beyer TA, 2012, BIOCH BIOPH IN PRESS; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chhabra A, 2007, ONCOL REP, V18, P953; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Dai M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3322; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; del Valle-Perez B, 2004, FEBS LETT, V569, P105, DOI 10.1016/j.febslet.2004.05.058; Ditte P, 2011, CANCER RES, V71, P7558, DOI 10.1158/0008-5472.CAN-11-2520; Dittmer A, 2008, CANCER LETT, V260, P56, DOI 10.1016/j.canlet.2007.10.020; Dittmer A, 2006, J BIOL CHEM, V281, P14563, DOI 10.1074/jbc.M510527200; Dittmer A, 2009, CELL MOL LIFE SCI, V66, P3053, DOI 10.1007/s00018-009-0089-0; Dittmer J, 2011, BREAST CANC FOCUSING, P247; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Han J, 2012, ONCOL REP, V27, P517, DOI 10.3892/or.2011.1511; Hardt O, 2012, CANCER LETT, V325, P165, DOI 10.1016/j.canlet.2012.06.010; Heaton JH, 2001, J BIOL CHEM, V276, P3341, DOI 10.1074/jbc.M006538200; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hiraga T, 2006, CANCER RES, V66, P2067, DOI 10.1158/0008-5472.CAN-05-2012; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Iwanaga R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3219; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Lei XF, 2002, ONCOGENE, V21, P7514, DOI 10.1038/sj.onc.1205966; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Li JR, 2011, J CLIN INVEST, V121, P4655, DOI 10.1172/JCI46134; Lindemann Ralph K, 2003, Mol Cancer, V2, P20, DOI 10.1186/1476-4598-2-20; Lindemann RK, 2001, J BIOL CHEM, V276, P46661, DOI 10.1074/jbc.M105816200; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Micalizzi DS, 2010, CANCER RES, V70, P10371, DOI 10.1158/0008-5472.CAN-10-1354; Ragazzon B, 2009, CANCER RES, V69, P7278, DOI 10.1158/0008-5472.CAN-09-1601; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schmitt M, 2011, EXPERT REV MOL DIAGN, V11, P617, DOI [10.1586/ERM.11.47, 10.1586/erm.11.47]; Scollen S, 2011, CANCER EPIDEM BIOMAR, V20, P1112, DOI 10.1158/1055-9965.EPI-11-0062; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Son J, 2010, BIOCHEM BIOPH RES CO, V398, P309, DOI 10.1016/j.bbrc.2010.06.087; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; Tarasewicz E, 2012, CELL CYCLE, V11, P2443, DOI 10.4161/cc.20546; THALACKER FW, 1992, BIOCHEM J, V287, P855, DOI 10.1042/bj2870855; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu QQ, 2008, ARTHRITIS RHEUM-US, V58, P3132, DOI 10.1002/art.23946; Xing DM, 2009, INVEST OPHTH VIS SCI, V50, P626, DOI 10.1167/iovs.08-2444; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yoo S, 2012, Z NATURFORSCH C, V67, P222, DOI 10.5560/ZNC.2012.67c0222; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	63	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54261	10.1371/journal.pone.0054261	http://dx.doi.org/10.1371/journal.pone.0054261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349840	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800034
J	Storvall, H; Ramskold, D; Sandberg, R				Storvall, Helena; Ramskold, Daniel; Sandberg, Rickard			Efficient and Comprehensive Representation of Uniqueness for Next-Generation Sequencing by Minimum Unique Length Analyses	PLOS ONE			English	Article								As next generation sequencing technologies are getting more efficient and less expensive, RNA-Seq is becoming a widely used technique for transcriptome studies. Computational analysis of RNA-Seq data often starts with the mapping of millions of short reads back to the genome or transcriptome, a process in which some reads are found to map equally well to multiple genomic locations (multimapping reads). We have developed the Minimum Unique Length Tool (MULTo), a framework for efficient and comprehensive representation of mappability information, through identification of the shortest possible length required for each genomic coordinate to become unique in the genome and transcriptome. Using the minimum unique length information, we have compared different uniqueness compensation approaches for transcript expression level quantification and demonstrate that the best compensation is achieved by discarding multimapping reads and correctly adjusting gene model lengths. We have also explored uniqueness within specific regions of the mouse genome and enhancer mapping experiments. Finally, by making MULTo available to the community we hope to facilitate the use of uniqueness compensation in RNA-Seq analysis and to eliminate the need to make additional mappability files.	[Sandberg, Rickard] Karolinska Inst, Ludwig Inst Canc Res, Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet	Sandberg, R (corresponding author), Karolinska Inst, Ludwig Inst Canc Res, Stockholm, Sweden.	Rickard.Sandberg@ki.se		Ramskold, Daniel/0000-0003-2892-673X; Sandberg, Rickard/0000-0001-6473-1740	European Research Council [243066]; Swedish Research Council [2008-4562]; Swedish Foundation for Strategic Research [FFL09-0130]	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by a European Research Council Starting Grant [243066], the Swedish Research Council [2008-4562] and the Swedish Foundation for Strategic Research [FFL09-0130]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Koehler R, 2011, BIOINFORMATICS, V27, P272, DOI 10.1093/bioinformatics/btq640; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	16	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53822	10.1371/journal.pone.0053822	http://dx.doi.org/10.1371/journal.pone.0053822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349747	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800014
J	Fremgen, S; Williams, A; Furusawa, G; Dziewanowska, K; Settles, M; Hartzell, P				Fremgen, Sarah; Williams, Amanda; Furusawa, Gou; Dziewanowska, Katarzyna; Settles, Matthew; Hartzell, Patricia			MasABK Proteins Interact with Proteins of the Type IV Pilin System to Affect Social Motility of Myxococcus Xanthus	PLOS ONE			English	Article							GLIDING MOTILITY; PSEUDOMONAS-AERUGINOSA; CHEMOTAXIS HOMOLOGS; PILUS RETRACTION; LOCALIZATION; GENE; EXPRESSION; PREDICTION; REGULATOR; DELETIONS	Gliding motility is critical for normal development of spore-filled fruiting bodies in the soil bacterium Myxococcus xanthus. Mutations in mgl block motility and development but one mgl allele can be suppressed by a mutation in masK, the last gene in an operon adjacent to the mgl operon. Deletion of the entire 5.5 kb masABK operon crippled gliding and fruiting body development and decreased sporulation. Expression of pilAGHI, which encodes type IV pili (TFP) components essential for social (S) gliding, several cryptic pil genes, and a LuxR family protein were reduced significantly in the Delta mas mutant while expression of the myxalamide operon was increased significantly. Localization and two-hybrid analysis suggest that the three Mas proteins form a membrane complex. MasA-PhoA fusions confirmed that MasA is an integral cytoplasmic membrane protein with a approximate to 100 amino acid periplasmic domain. Results from yeast two-hybrid assays showed that MasA interacts with the lipoprotein MasB and MasK, a protein kinase and that MasB and MasK interact with one another. Additionally, yeast two-hybrid analysis revealed a physical interaction between two gene products of the mas operon, MasA and MasB, and PilA. Deletion of mas may be accompanied by compensatory mutations since complementation of the Delta mas social gliding and developmental defects required addition of both pilA and masABK.	[Fremgen, Sarah; Williams, Amanda; Furusawa, Gou; Dziewanowska, Katarzyna; Settles, Matthew; Hartzell, Patricia] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho	Hartzell, P (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	hartzell@uidaho.edu	Settles, Matthew L/F-2031-2011	Settles, Matthew L/0000-0002-3424-1086	NIH-INBRE [P20RR016454]; IBEST Graduate Student Fellowship; National Institutes of Health (NIH) from the COBRE Program of the National Center for Research Resources [P20RR016448];  [GM075242]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454, P20RR016448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075242] Funding Source: NIH RePORTER	NIH-INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IBEST Graduate Student Fellowship; National Institutes of Health (NIH) from the COBRE Program of the National Center for Research Resources; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM075242 (to PH), P20RR016454 (NIH-INBRE) (to AW and GF), and an IBEST Graduate Student Fellowship, National Institutes of Health (NIH) Grant P20RR016448 from the COBRE Program of the National Center for Research Resources to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Alm RA, 1996, MOL MICROBIOL, V22, P161; Astling DP, 2006, MOL MICROBIOL, V59, P45, DOI 10.1111/j.1365-2958.2005.04926.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bhat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027475; Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004; Bode HB, 2007, CHEMBIOCHEM, V8, P2139, DOI 10.1002/cbic.200700401; Bonner PJ, 2006, J BACTERIOL, V188, P4585, DOI 10.1128/JB.00237-06; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; DANA JR, 1993, J BACTERIOL, V175, P3636, DOI 10.1128/jb.175.11.3636-3647.1993; Fremgen SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-295; Furusawa G, 2011, MOL MICROBIOL, V81, P784, DOI 10.1111/j.1365-2958.2011.07732.x; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Hofmann K., 1993, BIOL CHEM HOPPE SEYL, V374; Jakovljevic V, 2008, J BACTERIOL, V190, P2411, DOI 10.1128/JB.01793-07; James P, 1996, GENETICS, V144, P1425; Jelsbak L, 2005, J BACTERIOL, V187, P2105, DOI 10.1128/JB.187.6.2105-2112.2005; JIN SG, 1994, MOL MICROBIOL, V14, P1049, DOI 10.1111/j.1365-2958.1994.tb01338.x; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; Kearns DB, 2002, J BACTERIOL, V184, P1678, DOI 10.1128/JB.184.6.1678-1684.2002; Leonardy S, 2008, MOL BIOSYST, V4, P1009, DOI 10.1039/b806640j; Lu A, 2005, MOL MICROBIOL, V55, P206, DOI 10.1111/j.1365-2958.2004.04369.x; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; Mauriello EMF, 2010, EMBO J, V29, P315, DOI 10.1038/emboj.2009.356; Mauriello EMF, 2009, MOL MICROBIOL, V72, P964, DOI 10.1111/j.1365-2958.2009.06697.x; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Overgaard M, 2006, J BACTERIOL, V188, P4384, DOI 10.1128/JB.00189-06; Pasquier C, 1999, PROTEIN ENG, V12, P381, DOI 10.1093/protein/12.5.381; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; SPORMANN AM, 1995, J BACTERIOL, V177, P5846, DOI 10.1128/jb.177.20.5846-5852.1995; STEPHENS K, 1989, J BACTERIOL, V171, P819, DOI 10.1128/jb.171.2.819-830.1989; Tanenbaum D, 2010, JCVI STANDARD OPERAT; Thomasson B, 2002, MOL MICROBIOL, V46, P1399, DOI 10.1046/j.1365-2958.2002.03258.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Ward MJ, 2000, MOL MICROBIOL, V37, P1357, DOI 10.1046/j.1365-2958.2000.02079.x; Weimer RM, 1998, J BACTERIOL, V180, P5357, DOI 10.1128/JB.180.20.5357-5368.1998; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Wu SS, 1996, J BACTERIOL, V178, P5817, DOI 10.1128/jb.178.19.5817-5821.1996; Wu SS, 1998, MOL MICROBIOL, V29, P1249, DOI 10.1046/j.1365-2958.1998.01013.x; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Xu QA, 2011, J BACTERIOL, V193, P759, DOI 10.1128/JB.00944-10; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004; Yang Z, 2010, MOL MICROBIOL, V76, P1500, DOI 10.1111/j.1365-2958.2010.07180.x; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	55	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54557	10.1371/journal.pone.0054557	http://dx.doi.org/10.1371/journal.pone.0054557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342171	Green Submitted, gold, Green Published			2022-12-27	WOS:000313682700126
J	Denis, V; Mezaki, T; Tanaka, K; Kuo, CY; De Palmas, S; Keshavmurthy, S; Chen, CA				Denis, Vianney; Mezaki, Takuma; Tanaka, Kouki; Kuo, Chao-Yang; De Palmas, Stephane; Keshavmurthy, Shashank; Chen, Chaolun Allen			Coverage, Diversity, and Functionality of a High-Latitude Coral Community (Tatsukushi, Shikoku Island, Japan)	PLOS ONE			English	Article							RANGE SHIFTS; PHASE-SHIFTS; REEF; CLIMATE; PATTERNS; ALGAE; PRODUCTIVITY; TEMPERATURE; RESILIENCE; HERBIVORY	Background: Seawater temperature is the main factor restricting shallow-water zooxanthellate coral reefs to low latitudes. As temperatures increase, coral species and perhaps reefs may move into higher-latitude waters, increasing the chances of coral reef ecosystems surviving despite global warming. However, there is a growing need to understand the structure of these high-latitude coral communities in order to analyze their future dynamics and to detect any potential changes. Methodology/Principal Findings: The high-latitude (32.75 degrees N) community surveyed was located at Tatsukushi, Shikoku Island, Japan. Coral cover was 60 +/- 2% and was composed of 73 scleractinian species partitioned into 7 functional groups. Although only 6% of species belonged to the 'plate-like' functional group, it was the major contributor to species coverage. This was explained by the dominance of plate-like species such as Acropora hyacinthus and A. solitaryensis. Comparison with historical data suggests a relatively recent colonization/development of A. hyacinthus in this region and a potential increase in coral diversity over the last century. Low coverage of macroalgae (2% of the benthic cover) contrasted with the low abundance of herbivorous fishes, but may be reasonably explained by the high density of sea urchins (12.9 +/- 3.3 individuals m(-2)). Conclusions/Significance: The structure and composition of this benthic community are relatively remarkable for a site where winter temperature can durably fall below the accepted limit for coral reef development. Despite limited functionalities and functional redundancy, the current benthic structure might provide a base upon which a reef could eventually develop, as characterized by opportunistic and pioneer frame-building species. In addition to increasing seawater temperatures, on-going management actions and sea urchin density might also explain the observed state of this community. A focus on such 'marginal' communities should be a priority, as they can provide important insights into how tropical corals might cope with environmental changes.	[Denis, Vianney; Kuo, Chao-Yang; De Palmas, Stephane; Keshavmurthy, Shashank; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Mezaki, Takuma; Tanaka, Kouki] Kuroshio Biol Res Fdn, Kochi, Japan; [Chen, Chaolun Allen] Acad Sinica, Taiwan Int Grad Program Biodivers, Taipei 115, Taiwan; [Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Chen, CA (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	cac@gate.sinica.edu.tw	Keshavmurthy, Shashank/C-3672-2013; , de PALMAS Stéphane/AAS-8982-2021; Denis, Vianney/E-6868-2013	Keshavmurthy, Shashank/0000-0002-2235-9132; , de PALMAS Stéphane/0000-0002-2567-1789; Denis, Vianney/0000-0002-0914-5586	Academia Sinica Thematic Grants; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship	Academia Sinica Thematic Grants; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship(Academia Sinica - Taiwan)	This study was partly funded by Academia Sinica Thematic Grants (2011-2013) to CAC. VD was supported by a National Science Council postdoctoral fellowship (2011-2012), and SK by Academia Sinica postdoctoral fellowship (2010-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akimichi T, 2004, CORAL REEFS JAPAN; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BRAITHWAITE CJ, 1973, AM ASSOC PETR GEOL B, V57, P1100; Brown-Saracino J, 2007, CORAL REEFS, V26, P71, DOI 10.1007/s00338-006-0159-9; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Buddemeier R., 2004, CORAL REEFS GLOBAL C, V15, P17789; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; CHEN C.A., 2009, KUROSHIO SCI, V3, P15; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Choat J.H., 1991, P120; CHOAT JH, 1982, J EXP MAR BIOL ECOL, V60, P129, DOI 10.1016/0022-0981(82)90155-1; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; COYER JA, 1993, J EXP MAR BIOL ECOL, V167, P21, DOI 10.1016/0022-0981(93)90181-M; CROSSLAND CJ, 1984, MAR ECOL PROG SER, V15, P135, DOI 10.3354/meps015135; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; FROESE R, 2000, FISHBASE 2000 CONCEP; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Grigg R.W., 1982, Coral Reefs, V1, P29, DOI 10.1007/BF00286537; Guillemot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026735; Harriott VJ, 1999, CORAL REEFS, V18, P281, DOI 10.1007/s003380050195; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; HATCHER BG, 1988, TRENDS ECOL EVOL, V3, P106, DOI 10.1016/0169-5347(88)90117-6; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hongo C, 2011, MAR GEOL, V279, P162, DOI 10.1016/j.margeo.2010.10.023; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Iwase F, 1995, SCLERACTINIAN CORAL, P20; Japan Meteorological Agency, 2012, LONG TERM SEA SURF T; JOHANNES RE, 1983, MAR ECOL PROG SER, V11, P105, DOI 10.3354/meps011105; KIMURA T, 2004, STATUS CORAL REEFS W, P277; Kleypas JA, 1999, AM ZOOL, V39, P146; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Lybolt M, 2011, FRONT ECOL ENVIRON, V9, P154, DOI 10.1890/090176; Marine Parks Center, 1970, SUMM 1 MAR PARKS, V13, P8; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Ministry of the Environment, 2012, REST PROJ TATS 2011; Ministry of the Environment, 2011, REST PROJ TATS 2010; Misaki H, 1984, MARINE PAVILLION, V13, P1; Montaggioni LF, 2005, EARTH-SCI REV, V71, P1, DOI 10.1016/j.earscirev.2005.01.002; Moothien Pillay R, 2002, FIELD GUIDE CORALS M; Nishihira M., 1995, HERMATYPIC CORALS JA; Nomura K., 2005, KUROSHIO BIOSPHERE, V2, P29; Nozawa Y, 2008, MAR ECOL PROG SER, V358, P151, DOI 10.3354/meps07342; Nozawa Y, 2011, ZOOL STUD, V50, P53; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Rogelj J, 2011, NAT CLIM CHANGE, V1, P413, DOI 10.1038/NCLIMATE1258; Sakamoto TT, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023384; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; Schuhmacher H., 1988, P379; Shirai S, 1971, SEASCAPES KASHINISHI, P6; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Sugiyama T, 1937, SCI REPORTS TOHOKU I, V26, P1; TRIBBLE GW, 1986, CORAL REEFS, V4, P151, DOI 10.1007/BF00427936; Utinomi H., 1965, Publications of the Seto Marine Biological Laboratory, V13, P243; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Veron J. E. N., 1992, Pacific Science, V46, P405; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J.E.N., 1986, CORALS AUSTR INDOPAC; Veron J. E. N., 1992, HERMATYPIC CORALS JA; VERON JEN, 1992, CONT SHELF RES, V12, P835, DOI 10.1016/0278-4343(92)90047-N; VERON JEN, 1995, CORALS SPACE TIME BI; Veron John E.N., 2011, P497; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Woodroffe Colin D., 2011, P813; YABE H., 1935, JOURN PAL, V9, P183; Yabe H, 1931, SCI REPORTS TOHOKU I, V16, P143; Yamano H, 2012, CORAL REEFS, V31, P663, DOI 10.1007/s00338-012-0893-0; Yamano H, 2001, CORAL REEFS, V20, P9; Yamano H, 2012, GEOLOGY, V40, P835, DOI 10.1130/G33293.1; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	75	30	32	5	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54330	10.1371/journal.pone.0054330	http://dx.doi.org/10.1371/journal.pone.0054330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342135	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400150
J	Olea, PP; Mateo-Tomas, P				Olea, Pedro P.; Mateo-Tomas, Patricia			Assessing Species Habitat Using Google Street View: A Case Study of Cliff-Nesting Vultures	PLOS ONE			English	Article							BIODIVERSITY	The assessment of a species' habitat is a crucial issue in ecology and conservation. While the collection of habitat data has been boosted by the availability of remote sensing technologies, certain habitat types have yet to be collected through costly, on-ground surveys, limiting study over large areas. Cliffs are ecosystems that provide habitat for a rich biodiversity, especially raptors. Because of their principally vertical structure, however, cliffs are not easy to study by remote sensing technologies, posing a challenge for many researches and managers working with cliff-related biodiversity. We explore the feasibility of Google Street View, a freely available on-line tool, to remotely identify and assess the nesting habitat of two cliff-nesting vultures (the griffon vulture and the globally endangered Egyptian vulture) in northwestern Spain. Two main usefulness of Google Street View to ecologists and conservation biologists were evaluated: i) remotely identifying a species' potential habitat and ii) extracting fine-scale habitat information. Google Street View imagery covered 49% (1,907 km) of the roads of our study area (7,000 km(2)). The potential visibility covered by on-ground surveys was significantly greater (mean: 97.4%) than that of Google Street View (48.1%). However, incorporating Google Street View to the vulture's habitat survey would save, on average, 36% in time and 49.5% in funds with respect to the on-ground survey only. The ability of Google Street View to identify cliffs (overall accuracy = 100%) outperformed the classification maps derived from digital elevation models (DEMs) (62-95%). Nonetheless, high-performance DEM maps may be useful to compensate Google Street View coverage limitations. Through Google Street View we could examine 66% of the vultures' nesting-cliffs existing in the study area (n = 148): 64% from griffon vultures and 65% from Egyptian vultures. It also allowed us the extraction of fine-scale features of cliffs. This World Wide Web-based methodology may be a useful, complementary tool to remotely map and assess the potential habitat of cliff-dependent biodiversity over large geographic areas, saving survey-related costs.	[Olea, Pedro P.; Mateo-Tomas, Patricia] Univ Castilla La Mancha, Consejo Super Invest Cient, Inst Invest Recursos Cineget, E-13071 Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Olea, PP (corresponding author), Univ Castilla La Mancha, Consejo Super Invest Cient, Inst Invest Recursos Cineget, E-13071 Ciudad Real, Spain.	olea.pedro1@gmail.com	Olea, Pedro P/M-1502-2014; Mateo-Tomás, Patricia/L-8471-2014	Olea, Pedro P/0000-0001-5387-9598; Mateo-Tomás, Patricia/0000-0001-6762-9514	Junta de Comunidades de Castilla-La Mancha; Fondo Social Europeo	Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Fondo Social Europeo(European Social Fund (ESF)European Commission)	PMT was supported by a postdoctoral grant funded by Junta de Comunidades de Castilla-La Mancha and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, ASSESSING ACCURACY R; Arroyo B., 1990, CENSO NACL BUITRE LE; Benham Phred M., 2011, Endangered Species Research, V13, P145, DOI 10.3354/esr00323; BirdLife International, 2008, NEOPHR PERCN IUCN 20; BirdLife International, 2008, GYPS FULV IUCN 2011; Butler D, 2006, NATURE, V439, P776, DOI 10.1038/439776a; Duro D, 2007, PROG PHYS GEOG, V31, P235, DOI 10.1177/0309133307079054; Camp RJ, 1998, CONSERV BIOL, V12, P1302, DOI 10.1046/j.1523-1739.1998.97363.x; Cao SX, 2010, LANDSCAPE URBAN PLAN, V94, P228, DOI 10.1016/j.landurbplan.2009.10.007; Ceballos O., 1988, MUNIBE, V40, P3; Del Moral J. C., 2009, BUITRE LEONADO ESPAN; Del Moral J. C., 2009, ALIMOCHE COMUN ESPAN; DELMORAL J, 2002, ALIMOCHE COMUN ESPAN; Devaux A, 2010, P INT C MULT, P903; Donazar J.A., 1993, BUITRES IBERICOS BIO; Franklin J, 2009, MAPPING SPECIES DIST; Gamer M, 2012, IRR VARIOUS COEFFICI; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guralnick RP, 2007, ECOL LETT, V10, P663, DOI 10.1111/j.1461-0248.2007.01063.x; Jubete F, 1997, ATLAS AVES NIDIFICAN; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Krajick K, 1999, SCIENCE, V283, P1623, DOI 10.1126/science.283.5408.1623; Krebs CJ, 2001, ECOLOGY EXPT ANAL DI; Laurance WF, 2010, CONSERVATION BIOLOGY FOR ALL, P73; Lengyel S, 2008, BIODIVERS CONSERV, V17, P3327, DOI 10.1007/s10531-008-9395-3; Marti R., 2001, BUITRE LEONADO PENIN; Mateo-Tomas P, 2011, IBIS, V153, P832, DOI 10.1111/j.1474-919X.2011.01154.x; Mateo-Tomas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012374; Mateo-Tomas P, 2010, ORYX, V44, P434, DOI 10.1017/S0030605310000505; Mateo-Tomas P, 2009, ACTA OECOL, V35, P489, DOI 10.1016/j.actao.2009.03.004; Mawdsley JR, 2008, J INSECT CONSERV, V12, P689, DOI 10.1007/s10841-007-9113-6; McMillan MA, 2002, CONSERV BIOL, V16, P389, DOI 10.1046/j.1523-1739.2002.00377.x; Olea PP, 2011, DIVERS DISTRIB, V17, P714, DOI 10.1111/j.1472-4642.2011.00777.x; Olea Pedro P., 1999, Ardeola, V46, P81; Ozuag E, 2011, MACH LEARN SIGN PROC, P1; Pearce JM, 2007, RESOUR CONSERV RECY, V51, P435, DOI 10.1016/j.resconrec.2006.10.010; R Development Core Team, 2012, R LANG ENV STAT COMP; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; SEO, 1981, ARDEOLA, V26, p165 312; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Stock GM, 2012, EARTH SURF PROC LAND, V37, P546, DOI 10.1002/esp.3192; Svensson L., 2010, COLLINS BIRD GUIDE, V2nd ed.; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wulder MA, 2004, BIOSCIENCE, V54, P511, DOI 10.1641/0006-3568(2004)054[0511:HSRRSD]2.0.CO;2	46	33	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54582	10.1371/journal.pone.0054582	http://dx.doi.org/10.1371/journal.pone.0054582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355880	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500089
J	Chaudhary, S; Panda, AK; Mishra, DR; Mishra, SK				Chaudhary, Sanjib; Panda, Aditya K.; Mishra, Dipti Ranjan; Mishra, Sandip K.			Association of+331G/A PgR Polymorphism with Susceptibility to Female Reproductive Cancer: Evidence from a Meta-Analysis	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR GENE; BREAST-CANCER; ENDOMETRIAL CANCER; HORMONE-THERAPY; RISK; OVARIAN; ESTROGEN; EXPRESSION; PROMOTER; METABOLISM	The progesterone receptor (PgR), a sex steroid hormone receptor that binds progesterone is critical for normal breast development. The PgR (+331G/A, rs10895068) promoter polymorphism is associated with cancer risk possibly by altering the expression of progesterone receptor B isoform. Previous studies have provided inconsistent results. To validate the association between the PgR +331G/A polymorphism and female reproductive cancer risk (breast, endometrial and ovarian cancer), we performed a meta-analysis of 19 studies (19,978 cases and 24,525 controls) by using the CMA Version 2 software. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the associations. The overall results indicated that the variant allele and genotypes were associated with a mild increase in overall female reproductive cancer risk (A vs. G: OR = 1.063, 95% CI = 1.001-1.129; AA+AG vs. GG: OR = 1.067, 95% CI = 1.002-1.136). The results suggest that the PgR +331G/A polymorphism might be associated with an increased female reproductive cancer risk.	[Chaudhary, Sanjib; Mishra, Dipti Ranjan; Mishra, Sandip K.] Inst Life Sci, Dept Gene Funct & Regulat, Canc Biol Lab, Bhubaneswar, Orissa, India; [Panda, Aditya K.] Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Orissa, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Mishra, SK (corresponding author), Inst Life Sci, Dept Gene Funct & Regulat, Canc Biol Lab, Bhubaneswar, Orissa, India.	sandipkmishra@hotmail.com	Panda, Aditya K/E-1267-2012	Panda, Aditya K/0000-0002-1192-1978; Mishra, Sandip/0000-0002-0776-6581	Department of Biotechnology; Council of Scientific and Industrial Research; Indian Council of Medical Research; Institute of Life Sciences, Department of Biotechnology, Government of India	Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Institute of Life Sciences, Department of Biotechnology, Government of India	SC, AKP and DRM were supported by Department of Biotechnology, Council of Scientific and Industrial Research and Indian Council of Medical Research respectively. This work was supported by intramural grant of Institute of Life Sciences, Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2012, CANC FACTS FIG 2012; Amos W, 2010, CANDIDATE GENES VERS, DOI [10.1098/rspb.2010.1920, DOI 10.1098/RSPB.2010.1920]; Anderson E, 2002, BREAST CANCER RES, V4, P197, DOI 10.1186/bcr452; Berchuck A, 2004, CANCER EPIDEM BIOMAR, V13, P2141; Cheon YP, 2002, MOL ENDOCRINOL, V16, P2853, DOI 10.1210/me.2002-0270; CONNEELY OM, 1987, BIOCHEM BIOPH RES CO, V149, P493, DOI 10.1016/0006-291X(87)90395-0; De Vivo I, 2002, P NATL ACAD SCI USA, V99, P12263, DOI 10.1073/pnas.192172299; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diergaarde B, 2008, CANCER EPIDEM BIOMAR, V17, P1751, DOI 10.1158/1055-9965.EPI-08-0168; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feigelson HS, 2004, CANCER EPIDEM BIOMAR, V13, P1084; Fernandez LP, 2006, INT J CANCER, V119, P467, DOI 10.1002/ijc.21847; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huggins GS, 2006, CANCER RES, V66, P1384, DOI 10.1158/0008-5472.CAN-05-2715; Ismail PM, 2003, STEROIDS, V68, P779, DOI 10.1016/S0039-128X(03)00133-8; Ismail PM, 2004, J ENDOCRINOL, V180, P287, DOI 10.1677/joe.0.1800287; Ito K, 2007, ENDOCR J, V54, P667, DOI 10.1507/endocrj.KR-114; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Johnatty SE, 2008, BREAST CANCER RES TR, V109, P91, DOI 10.1007/s10549-007-9627-3; Kariagina A, 2008, CRIT REV EUKAR GENE, V18, P11, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.20; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kotsopoulos J, 2009, INT J CANCER, V125, P1685, DOI 10.1002/ijc.24477; Lee E, 2010, CARCINOGENESIS, V31, P1392, DOI 10.1093/carcin/bgq113; Li AJ, 2003, AM J OBSTET GYNECOL, V189, P22, DOI 10.1067/mob.2003.328; Ludwig AH, 2009, ENDOCR-RELAT CANCER, V16, P1005, DOI 10.1677/ERC-08-0135; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MANTEL N, 1959, J NATL CANCER I, V22, P719; Migliore L, 2002, MUTAT RES-REV MUTAT, V512, P135, DOI 10.1016/S1383-5742(02)00046-7; Mote PA, 2008, ERNST SCHERING FOUND, V1, P77, DOI 10.1007/2789_2008_076; Mote PA, 2000, HUM REPROD, V15, P48, DOI 10.1093/humrep/15.suppl_3.48; O'Mara TA, 2011, CARCINOGENESIS, V32, P331, DOI 10.1093/carcin/bgq263; Panda AK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-309; Panda AK, 2012, HUMAN IMMUNOLOGY, DOI [10.1016/j.humimm, DOI 10.1016/J.HUMIMM]; Pearce CL, 2005, JNCI-J NATL CANCER I, V97, P51, DOI 10.1093/jnci/dji007; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Pijnenborg JMA, 2005, J PATHOL, V205, P597, DOI 10.1002/path.1738; Pooley KA, 2006, CANCER EPIDEM BIOMAR, V15, P675, DOI 10.1158/1055-9965.EPI-05-0679; Reding KW, 2009, AM J EPIDEMIOL, V170, P1241, DOI 10.1093/aje/kwp298; Risch HA, 2006, CANCER EPIDEM BIOMAR, V15, P1738, DOI 10.1158/1055-9965.EPI-06-0272; Rockwell LC, 2012, AM J HUM BIOL, V24, P42, DOI 10.1002/ajhb.21233; Romano A, 2006, GYNECOL ONCOL, V101, P287, DOI 10.1016/j.ygyno.2005.10.040; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Terry KL, 2005, AM J EPIDEMIOL, V161, P442, DOI 10.1093/aje/kwi064; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Wallace AE, 2010, J ENDOCRINOL, V206, P141, DOI 10.1677/JOE-10-0072; Yang DS, 2010, CANCER GENET CYTOGEN, V196, P194, DOI 10.1016/j.cancergencyto.2009.10.005; Yu KD, 2010, BREAST CANCER RES TR, V122, P853, DOI 10.1007/s10549-010-0738-x	51	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53308	10.1371/journal.pone.0053308	http://dx.doi.org/10.1371/journal.pone.0053308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349706	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100018
J	Cox, RFA; Hasselman, F				Cox, Ralf F. A.; Hasselman, Fred			The Case of Watson vs. James: Effect-Priming Studies Do Not Support Ideomotor Theory	PLOS ONE			English	Article							PERCEPTION; FRAMEWORK; INTEGRATION; IMITATION; PRINCIPLE; TEC	In this paper we show that response facilitation in choice reaction tasks achieved by priming the (previously perceived) effect is based on stimulus-response associations rather than on response-effect associations. The reduced key-press response time is not accounted for by earlier established couplings between the key-press movement and its subsequent effect, but instead results from couplings between this effect and the contingent key-release movement. This key-release movement is an intrinsic part of the entire performed response action in each trial of a reaction-time task, and always spontaneously follows the key-press movement. Eliminating the key-release movement from the task leads to the disappearance of the response facilitation, which raises the question whether response-effect associations actually play a role in studies that use the effect-priming paradigm. Together the three experiments presented in the paper cast serious doubts on the claim that action-effect couplings are acquired and utilized by the cognitive system in the service of action selection, and that the priming paradigm by itself can provide convincing evidence for this claim. As a corollary, we question whether the related two-step model for the ideomotor principle holds a satisfying explanation for how anticipation of future states guides action planning. The results presented here may have profound implications for priming studies in other disciplines of psychology as well.	[Cox, Ralf F. A.] Univ Groningen, Heymans Inst, Groningen, Netherlands; [Hasselman, Fred] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	University of Groningen; Radboud University Nijmegen	Cox, RFA (corresponding author), Univ Groningen, Heymans Inst, Groningen, Netherlands.	r.f.a.cox@rug.nl	Hasselman, Fred/P-2479-2019	Hasselman, Fred/0000-0003-1384-8361				Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen RH, 2010, INT J PSYCHOL RES, V3, P12; Bird G, 2007, J EXP PSYCHOL HUMAN, V33, P1158, DOI 10.1037/0096-1523.33.5.1158; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Bretz F., 2010, MULTIPLE COMP USING; Chaminade T, 2001, BEHAV BRAIN SCI, V24, P879, DOI 10.1017/S0140525X01230106; Cox RFA, 2008, THEOR PSYCHOL, V18, P317, DOI 10.1177/0959354308089788; Elsner B, 2004, PSYCHOL RES-PSYCH FO, V68, P138, DOI 10.1007/s00426-003-0151-8; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; FAGEN JW, 1976, J EXP CHILD PSYCHOL, V21, P349, DOI 10.1016/0022-0965(76)90048-5; GREENWALD AG, 1970, PSYCHOL REV, V77, P73, DOI 10.1037/h0028689; Herwig A, 2007, Q J EXP PSYCHOL, V60, P1540, DOI 10.1080/17470210601119134; Herwig A, 2009, Q J EXP PSYCHOL, V62, P219, DOI 10.1080/17470210802373290; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 1996, PSYCHOL RES-PSYCH FO, V59, P176, DOI 10.1007/BF00425832; Hommel Bernhard, 2003, ScientificWorldJournal, V3, P593; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P512, DOI 10.1007/s00426-009-0234-2; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Kello CT, 2007, J EXP PSYCHOL GEN, V136, P551, DOI 10.1037/0096-3445.136.4.551; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Melcher T, 2008, NEUROIMAGE, V39, P1274, DOI 10.1016/j.neuroimage.2007.09.049; Pavlov I.P., 1927, CONDITIONED REFLEXES; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; R Core Team, 2012, R LANG ENV STAT COMP; ROVEE CK, 1969, J EXP CHILD PSYCHOL, V8, P33, DOI 10.1016/0022-0965(69)90025-3; Sarkar D., 2019, NLME LINEAR NONLINEA; Sauser EL, 2006, NEURAL NETWORKS, V19, P285, DOI 10.1016/j.neunet.2006.02.003; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Stock A, 2004, PSYCHOL RES-PSYCH FO, V68, P176, DOI 10.1007/s00426-003-0154-5; Tsai CC, 2006, EXP BRAIN RES, V175, P353, DOI 10.1007/s00221-006-0557-9; Van der Loo MPJ, EXTREMEVALUES R PACK; Van Der Loo MPJ, 2010, DISTRIBUTION BASED O; Watson JB, 1913, PSYCHOL REV, V20, P158, DOI 10.1037/h0074428; Wheeler SC, 2001, PSYCHOL BULL, V127, P797, DOI 10.1037//0033-2909.127.6.797; Wohlschlager A, 2001, PHILOS T R SOC B, V358, P501; Yong E., 2012, NAT NEWS	38	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54094	10.1371/journal.pone.0054094	http://dx.doi.org/10.1371/journal.pone.0054094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349793	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100042
J	Fendri, I; Abdou, L; Trotter, V; Dedieu, L; Maamar, H; Minton, NP; Tardif, C				Fendri, Imen; Abdou, Laetitia; Trotter, Valentine; Dedieu, Luc; Maamar, Hedia; Minton, Nigel P.; Tardif, Chantal			Regulation of cel Genes of C. cellulolyticum: Identification of GlyR2, a Transcriptional Regulator Regulating cel5D Gene Expression	PLOS ONE			English	Article							SCAFFOLDING PROTEIN CIPC; CLOSTRIDIUM-CELLULOLYTICUM; SEQUENCE-ANALYSIS; ENDOGLUCANASE-A; CELLULOSOME; SYSTEM; METABOLISM; CLUSTER; OPERON	Transcription and expression regulation of some individual cel genes (cel5A, cel5I, cel5D and cel44O) of Clostridium cellulolyticum were investigated. Unlike the cip-cel operon, these genes are transcribed as monocistronic units of transcription, except cel5D. The location of the transcription initiation sites was determined using RT-PCR and the mRNA 5'-end extremities were detected using primer extension experiments. Similarly to the cip-cel operon, cel5A and cel5I expressions are regulated by a carbon catabolite repression mechanism, whereas cel44O and cel5D expressions do not seem to be submitted to this regulation. The role of the putative transcriptional regulator GlyR2 in the regulation of cel5D expression was investigated. The recombinant protein GlyR2 was produced and was shown to bind in vitro to the cel5D and glyR2 promoter regions, suggesting that besides regulating its own expression, GlyR2 may regulate cel5D expression. To test this hypothesis in vivo, an insertional glyR2 mutant was generated and the effect of this disruption on cel5D expression was evaluated. Levels of cel5D mRNAs in the mutant were 16 fold lower than that of the wild-type strain suggesting that GlyR2 acts as an activator of cel5D expression.	[Fendri, Imen; Abdou, Laetitia; Trotter, Valentine; Dedieu, Luc; Maamar, Hedia; Tardif, Chantal] IMM, CNRS UMR 7283, Chim Bacterienne Lab, Marseille, France; [Trotter, Valentine; Tardif, Chantal] Aix Marseille Univ, Marseille, France; [Minton, Nigel P.] Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Clostridia Res Grp, Nottingham NG7 2RD, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Nottingham	Tardif, C (corresponding author), IMM, CNRS UMR 7283, Chim Bacterienne Lab, Marseille, France.	tardif@imm.cnrs.fr	Trotter, Valentine/A-9374-2018	Trotter, Valentine/0000-0002-1784-9487; FENDRI, Imen/0000-0002-4071-5444; Minton, Nigel/0000-0002-9277-1261	Centre National de la Recherche Scientifique; Biotechnology and Biological Sciences Research Council [BB/G016224/1] Funding Source: researchfish; BBSRC [BB/G016224/1] Funding Source: UKRI	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou L, 2008, J BACTERIOL, V190, P1499, DOI 10.1128/JB.01160-07; Antunes A, 2012, NUCL AC RES IN PRESS; BAGNARATARDIF C, 1992, GENE, V119, P17, DOI 10.1016/0378-1119(92)90062-T; Blouzard JC, 2009, THESIS; Blouzard JC, 2007, J BACTERIOL, V189, P2300, DOI 10.1128/JB.00917-06; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Desvaux M, 2001, APPL ENVIRON MICROB, V67, P3837, DOI 10.1128/AEM.67.9.3837-3845.2001; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; FAURE E, 1989, GENE, V84, P39, DOI 10.1016/0378-1119(89)90137-6; Fendri I, 2009, FEBS J, V276, P3076, DOI 10.1111/j.1742-4658.2009.07025.x; FIEROBE HP, 1991, J BACTERIOL, V173, P7956, DOI 10.1128/jb.173.24.7956-7962.1991; Fierobe HP, 1999, BIOCHEMISTRY-US, V38, P12822, DOI 10.1021/bi9911740; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gal L, 1997, APPL ENVIRON MICROB, V63, P903, DOI 10.1128/AEM.63.3.903-909.1997; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maamar H, 2004, MOL MICROBIOL, V51, P589, DOI 10.1046/j.1365-2958.2003.03859.x; Maamar H, 2006, J BACTERIOL, V188, P2614, DOI 10.1128/JB.188.7.2614-2624.2006; Maamar H, 2003, THESIS; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Mosbah A, 2002, J BIOMOL NMR, V23, P157, DOI 10.1023/A:1016354623398; Newcomb M, 2007, P NATL ACAD SCI USA, V104, P3747, DOI 10.1073/pnas.0700087104; Pages S, 1999, J BACTERIOL, V181, P1801; Pages S, 1996, J BACTERIOL, V178, P2279, DOI 10.1128/jb.178.8.2279-2286.1996; ReverbelLeroy C, 1996, MICROBIOL-SGM, V142, P1013, DOI 10.1099/00221287-142-4-1013; SHIMA S, 1993, APPL MICROBIOL BIOT, V38, P750, DOI 10.1007/BF00167140; Tardif C, 2001, J IND MICROBIOL BIOT, V27, P271, DOI 10.1038/sj.jim.7000081; TARDIF C, 2006, CELLULOSOME, P221; Tobes R, 2002, NUCLEIC ACIDS RES, V30, P318, DOI 10.1093/nar/30.1.318	29	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e44708	10.1371/journal.pone.0044708	http://dx.doi.org/10.1371/journal.pone.0044708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349658	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100001
J	Uebel, KE; Joubert, G; Wouters, E; Mollentze, WF; van Rensburg, DHCJ				Uebel, Kerry E.; Joubert, Gina; Wouters, Edwin; Mollentze, Willie F.; van Rensburg, Dingie H. C. J.			Integrating HIV Care into Primary Care Services: Quantifying Progress of an Intervention in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT OUTCOMES; FREE STATE PROVINCE; STREAMLINING TASKS; EXPANDING ACCESS; HEALTH-SERVICES; SCALE-UP; THERAPY; COMMUNITY; STRETCH; NURSES	Background: Integration of human immunodeficiency virus (HIV) care into primary care services is one strategy proposed to achieve universal access to antiretroviral treatment (ART) for HIV-positive patients in high burden countries. There is a need for controlled studies of programmes to integrate HIV care with details of the services being integrated. Methods: A semi-quantitative questionnaire was developed in consultation with clinic staff, tested for internal consistency using Cronbach's alpha coefficients and checked for inter-observer reliability. It was used to conduct four assessments of the integration of HIV care into referring primary care clinics (mainstreaming HIV) and into the work of all nurses within ART clinics (internal integration) and the integration of pre-ART and ART care during the Streamlining Tasks and Roles to Expand Treatment and Care for HIV (STRETCH) trial in South Africa. Mean total integration and four component integration scores at intervention and control clinics were compared using one way analysis of variance (ANOVA). Repeated measures ANOVA was used to analyse changes in scores during the trial. Results: Cronbach's alpha coefficients for total integration, pre-ART and ART integration and mainstreaming HIV and internal integration scores showed good internal consistency. Mean total integration, mainstreaming HIV and ART integration scores increased significantly at intervention clinics by the third assessment. Mean pre-ART integration scores were almost maximal at the first assessment and showed no further change. There was no change in mean internal integration score. Conclusion: The questionnaire developed in this study is a valid tool with potential for monitoring integration of HIV care in other settings. The STRETCH trial interventions resulted in increased integration of HIV care, particularly ART care, by providing HIV care at referring primary care clinics, but had no effect on integrating HIV care into the work of all nurses with the ART clinic.	[Uebel, Kerry E.; Mollentze, Willie F.] Univ Orange Free State, Fac Hlth Sci, Dept Internal Med, Bloemfontein, South Africa; [Joubert, Gina] Univ Orange Free State, Fac Hlth Sci, Dept Biostat, Bloemfontein, South Africa; [Wouters, Edwin] Univ Antwerp, Dept Sociol, Antwerp, Belgium; [Wouters, Edwin] Univ Antwerp, Res Ctr Longitudinal & Life Course Studies, Antwerp, Belgium; [Wouters, Edwin; van Rensburg, Dingie H. C. J.] Univ Orange Free State, Ctr Hlth Syst Res & Dev, Bloemfontein, South Africa	University of the Free State; University of the Free State; University of Antwerp; University of Antwerp; University of the Free State	Uebel, KE (corresponding author), Univ Orange Free State, Fac Hlth Sci, Dept Internal Med, Bloemfontein, South Africa.	uebelke@fshealth.gov.za	Wouters, Edwin/AAE-1649-2021; Joubert, Gina/I-2985-2018	Wouters, Edwin/0000-0003-2268-3829; Joubert, Gina/0000-0002-3728-6925	National Research Fund of South Africa	National Research Fund of South Africa	The National Research Fund of South Africa was the source of a doctoral bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Barker PM, 2007, J INFECT DIS, V196, pS457, DOI 10.1086/521110; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Briggs CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub2; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Colvin CJ, 2010, SAMJ S AFR MED J, V100, P210, DOI 10.7196/SAMJ.4124; Dudley L, 2010, COCHRANE DB SYST REV, V7; El-Sadr WM, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000298105.79484.62; Engelbrecht MC, 2008, S AFR J ECON, V76, pS15, DOI 10.1111/j.1813-6982.2008.00164.x; English Rene G, 2008, Prim Care Respir J, V17, P156, DOI 10.3132/pcrj.2008.00044; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fairall LR, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-21; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Fredlund VG, 2007, J INFECT DIS, V196, pS469, DOI 10.1086/521115; Friedland G, 2007, J INFECT DIS, V196, pS114, DOI 10.1086/518664; Georgeu D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-66; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; McCoy D, 2005, AM J PUBLIC HEALTH, V95, P18, DOI 10.2105/AJPH.2004.040121; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Shigayeva A, 2010, HEALTH POLICY PLANN, V25, pi4, DOI 10.1093/heapol/czq060; Shisana O, 2009, S AFRICAN NATL HIV P; Statistics South Africa, 2011, MIDY POP EST; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522; Uebel KE, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-86; Uebel KE, 2010, SAMJ S AFR MED J, V100, P589, DOI 10.7196/SAMJ.3897; VARIAVA E, 2006, SOUTH AFR J HIV  JUN, P35; World Health Organisation, 2007, TASK SHIFT RAT RED T; World Health Organization, 2004, ANT THER PRIM HLTH E; World Health Organization, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2003, ANT THER PRIM HLTH C; Wouters E, 2009, SOC SCI MED, V69, P1177, DOI 10.1016/j.socscimed.2009.07.034; Wouters E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-103; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	40	11	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54266	10.1371/journal.pone.0054266	http://dx.doi.org/10.1371/journal.pone.0054266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077HS	23349843	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100054
J	Yin, MZ; Hou, Y; Zhang, T; Cui, C; Zhou, XH; Sun, FY; Li, HY; Li, X; Zheng, J; Chen, XW; Li, C; Ning, XM; Li, K; Lou, G				Yin, Mingzhu; Hou, Yan; Zhang, Tao; Cui, Changyi; Zhou, Xiaohua; Sun, Fengyu; Li, Huiyan; Li, Xia; Zheng, Jian; Chen, Xiuwei; Li, Cong; Ning, Xiaoming; Li, Kang; Lou, Ge			Evaluation of Chemotherapy Response with Serum Squamous Cell Carcinoma Antigen Level in Cervical Cancer Patients: A Prospective Cohort Study	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; RADICAL HYSTERECTOMY; MAGNETIC-RESONANCE; HIGH-RISK; PROGNOSTIC-SIGNIFICANCE; RADIOTHERAPY TREATMENT; TUMOR-ANTIGEN; PREDICTION; THERAPY; SURGERY	MRI does not always reflect tumor response after chemotherapy. Therefore, it is necessary to explore additional parameters to more accurately evaluate tumor response for the subsequent clinical determination about radiotherapy or radical surgery. A training cohort and an external validation cohort were used to examine the predictive performance of SCC-ag to evaluate tumor response from teaching hospital of Harbin Medical University. The study included 397 women with SCC (age: 28-73 years). Patients consecutively enrolled between August 2008 and January 2010 (n = 205) were used as training cohort. Patients consecutively enrolled between February 2010 and May 2011 (n = 192) were used as validation cohort. A multivariate regression analysis of the data from the training cohort indicated that serum SCC-ag level is an independent factor for neo-adjuvant chemotherapy (NACT) response. Analysis of the data from the validation cohort suggested that chemotherapy response could be more accurately predicted by SCC-ag than by magnetic resonance imaging (MRI) (sensitivity (Se): 0.944 vs. 0.794; specificity (Sp): 0.727 vs. 0.636; positive predictive value (PPV): 0.869 vs. 0.806; negative predictive value (NPV): 0.873 vs. 0.618; the area under ROC curve (AUC): 0.898 vs. 0.734). Combining SCC-ag with MRI was more powerful than MRI alone (Se: 0.952 vs. 0.794; Sp: 0.833 vs. 0.636; PPV: 0.916 vs. 0.806; NPV: 0.902 vs. 0.618; AUC: 0.950 vs. 0.734). Our study indicates that serum SCC-ag level is a sensitive and reliable measure to evaluate cervical cancer response to chemotherapy. Using SCC-ag in combination with MRI findings further improves the predictive power.	[Yin, Mingzhu; Chen, Xiuwei; Lou, Ge] Harbin Med Univ, Tumor Hosp, Dept Gynecol & Oncol, Harbin, Heilongjiang Pr, Peoples R China; [Hou, Yan; Zhang, Tao; Sun, Fengyu; Li, Kang] Harbin Med Univ, Dept Epidemiol & Biostat, Harbin, Heilongjiang Pr, Peoples R China; [Cui, Changyi] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; [Zhou, Xiaohua] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Li, Huiyan; Zheng, Jian] Harbin Med Univ, Tumor Hosp, Dept Radiotherapy Oncol, Harbin, Heilongjiang Pr, Peoples R China; [Li, Xia] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin, Heilongjiang Pr, Peoples R China; [Li, Cong; Ning, Xiaoming] Harbin Med Univ, Tumor Hosp, Dept Pathol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, K (corresponding author), Harbin Med Univ, Dept Epidemiol & Biostat, Harbin, Heilongjiang Pr, Peoples R China.	likang@ems.hrbmu.edu.cn; louge@ems.hrbmu.edu.cn	Chen, Xiuwei/AAH-6695-2021; Cui, Chang-Yi/AAO-8984-2021; Zhang, Tao/K-3238-2019	Zhang, Tao/0000-0003-1048-4443; Zhou, Xiaohua/0000-0001-7935-1222; Cui, Chang-Yi/0000-0002-9856-9427	National Natural Science Foundation of China [NSFC 81172453, 81172767]; Wu LianDe Youth Innovation Fund [WLD-QN1105]; Tumor Hospital of Harbin Medical University Fund [JJZ2011-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wu LianDe Youth Innovation Fund; Tumor Hospital of Harbin Medical University Fund	The study was supported by grants from the National Natural Science Foundation of China (NSFC 81172453 and 81172767), Wu LianDe Youth Innovation Fund (WLD-QN1105) and the Tumor Hospital of Harbin Medical University Fund (JJZ2011-08).	Bae SN, 1997, GYNECOL ONCOL, V64, P418, DOI 10.1006/gyno.1996.4589; BenedettiPanici P, 1996, CANCER-AM CANCER SOC, V78, P2359, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2359::AID-CNCR14>3.0.CO;2-#; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borgia JA, 2009, J THORAC ONCOL, V4, P338, DOI 10.1097/JTO.0b013e3181982abf; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CHOU CY, 1994, CANCER, V74, P2497, DOI 10.1002/1097-0142(19941101)74:9<2497::AID-CNCR2820740917>3.0.CO;2-L; deSouza NM, 2004, BRIT J CANCER, V90, P2326, DOI 10.1038/sj.bjc.6601870; Dimitrakopoulou-Strauss A, 2010, J NUCL MED, V51, P551, DOI 10.2967/jnumed.109.070862; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Er F, 2011, PLOS ONE, V5; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; Hashimoto K, 2011, EUR J OBSTET GYN R B, V159, P394, DOI 10.1016/j.ejogrb.2011.07.001; Huttmann EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027467; Iwasaka T, 1998, GYNECOL ONCOL, V70, P236, DOI 10.1006/gyno.1998.5079; KATO H, 1982, CANCER, V50, P1294, DOI 10.1002/1097-0142(19821001)50:7<1294::AID-CNCR2820500712>3.0.CO;2-K; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Khondoker Mizanur R., 2010, Journal of Bioinformatics and Computational Biology, V8, P945, DOI 10.1142/S0219720010005063; Kim BG, 1996, GYNECOL ONCOL, V63, P105, DOI 10.1006/gyno.1996.0287; Koh D, 2003, NEW ENGL J MED, V348, P2487, DOI 10.1056/NEJMp030048; Kwee TC, 2008, EUR RADIOL, V18, P1937, DOI 10.1007/s00330-008-0968-z; Massuger LFAG, 1997, GYNECOL ONCOL, V64, P473, DOI 10.1006/gyno.1996.4581; Micheletti E, 1997, AM J CLIN ONCOL-CANC, V20, P613, DOI 10.1097/00000421-199712000-00017; NGAN HYS, 1990, GYNECOL ONCOL, V37, P260, DOI 10.1016/0090-8258(90)90344-K; Ohara K, 2002, OBSTET GYNECOL, V100, P781, DOI 10.1016/S0029-7844(02)02204-4; PANICI PB, 1991, CANCER, V67, P372, DOI 10.1002/1097-0142(19910115)67:2<372::AID-CNCR2820670210>3.0.CO;2-5; Park DC, 2004, GYNECOL ONCOL, V92, P59, DOI 10.1016/j.ygyno.2003.09.015; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Reesink-Peters N, 2005, J CLIN ONCOL, V23, P1455, DOI 10.1200/JCO.2005.02.123; SCAMBIA G, 1994, J CLIN ONCOL, V12, P2309, DOI 10.1200/JCO.1994.12.11.2309; Strauss HG, 2002, EUR J CANCER, V38, P1987, DOI 10.1016/S0959-8049(02)00159-4; Vincens E, 2008, CANCER-AM CANCER SOC, V113, P2158, DOI 10.1002/cncr.23817; YAZIGI R, 1991, GYNECOL ONCOL, V41, P135, DOI 10.1016/0090-8258(91)90272-7; Yin MZ, 2011, INT J GYNECOL CANCER, V21, P92, DOI 10.1111/IGC.0b013e3181fe8b6e	33	16	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54969	10.1371/journal.pone.0054969	http://dx.doi.org/10.1371/journal.pone.0054969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349993	gold, Green Submitted, Green Published			2022-12-27	WOS:000314019100114
J	Cohen, E; Avrahami, D; Frid, K; Canello, T; Lahad, EL; Zeligson, S; Perlberg, S; Chapman, J; Cohen, OS; Kahana, E; Lavon, I; Gabizon, R				Cohen, Eran; Avrahami, Dana; Frid, Kati; Canello, Tamar; Lahad, Ephrat Levy; Zeligson, Sharon; Perlberg, Shira; Chapman, Joab; Cohen, Oren S.; Kahana, Esther; Lavon, Iris; Gabizon, Ruth			Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; LIBYAN JEWS; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; MOUSE MODEL; PROTEIN; MUTATION; STRESS; GENE; IDENTIFICATION	Since preventive treatments for prion disease require early identification of subjects at risk, we searched for surrogate peripheral markers characterizing the asymptomatic phases of such conditions. To this effect, we subjected blood mRNA from E200K PrP CJD patients and corresponding family members to global arrays and found that the expression of Snord3A, a non-coding RNA transcript, was elevated several times in CJD patients as compared to controls, while asymptomatic carriers presented intermediate Snord3A levels. In the brains of TgMHu2ME199K mice, a mouse model mimicking for E200K CJD, Snord 3A levels were elevated in an age and disease severity dependent manner, as was the case for brains of these mice in which disease was exacerbated by copper administration. Snord3A expression was also elevated in scrapie infected mice, but not in PrP0/0 mice, indicating that while the expression levels of this transcript may reflect diverse prion etiologies, they are not related to the loss of PrPC's function. Elevation of Snord3A was consistent with the activation of ATF6, representing one of the arms of the unfolded protein response system. Indeed, SnoRNAs were associated with reduced resistance to oxidative stress, and with ER stress in general, factors playing a significant role in this and other neurodegenerative conditions. We hypothesize that in addition to its function as a disease marker, Snord3A may play an important role in the mechanism of prion disease manifestation and progression.	[Cohen, Eran; Avrahami, Dana; Frid, Kati; Canello, Tamar; Lavon, Iris; Gabizon, Ruth] Hadassah Med Ctr, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel; [Lahad, Ephrat Levy; Zeligson, Sharon; Perlberg, Shira] Shaare Zedek Med Ctr, Inst Med Genet, Jerusalem, Israel; [Lahad, Ephrat Levy; Zeligson, Sharon; Perlberg, Shira] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel; [Chapman, Joab; Cohen, Oren S.] Tel Aviv Univ, Dept Neurol, Sheba Med Ctr, Sackler Fac, Tel Aviv, Israel; [Kahana, Esther] Barzilai Govt Hosp, Dept Neurol, Ashqelon, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Tel Aviv University; Ben Gurion University; Barzilai Medical Center	Gabizon, R (corresponding author), Hadassah Med Ctr, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, Kiryat Haddasah, IL-91120 Jerusalem, Israel.	gabizonr@hadassah.org.il	Chapman, Joab/E-4598-2010; Levy-Lahad, Ephrat/F-2186-2018; Lavon, Iris/ABE-6651-2021	Levy-Lahad, Ephrat/0000-0002-2637-1921; Kahana, Esther/0000-0002-3863-3271; Chapman, Joab/0000-0002-2161-9764	Israeli Science foundation, Agnes Ginges Center for human neurogenetics	Israeli Science foundation, Agnes Ginges Center for human neurogenetics	Israeli Science foundation, Agnes Ginges Center for human neurogenetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt S, 2002, NEUROBIOL DIS, V10, P150, DOI 10.1006/nbdi.2002.0496; Avrahami D, 2011, NEUROBIOL AGING, V32, P2006, DOI 10.1016/j.neurobiolaging.2009.12.015; BASERGA SJ, 1991, EMBO J, V10, P2645, DOI 10.1002/j.1460-2075.1991.tb07807.x; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Canello T, 2012, NEUROBIOL DIS, V45, P1010, DOI 10.1016/j.nbd.2011.12.020; Canello T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000977; CHAPMAN J, 1993, J NEUROL NEUROSUR PS, V56, P1109, DOI 10.1136/jnnp.56.10.1109; Dalma-Weiszhausz DD, 2002, GENET EPIDEMIOL, V23, P4, DOI 10.1002/gepi.216; DeArmond SJ, 2002, TOXICOLOGY, V181, P9, DOI 10.1016/S0300-483X(02)00249-4; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; Friedman-Levi Y, PLOS PATHOG, V7; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Hamacher M, 2007, EXPERT REV PROTEOMIC, V4, P591, DOI 10.1586/14789450.4.5.591; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P212, DOI 10.1159/000334536; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; KAHANA E, 1974, SCIENCE, V183, P90, DOI 10.1126/science.183.4120.90; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kong DH, 2012, J MOL NEUROSCI, V47, P595, DOI 10.1007/s12031-011-9688-y; Lee HS, 1999, AM J HUM GENET, V64, P1063, DOI 10.1086/302340; LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442; Mandel S, 2005, ANN NY ACAD SCI, V1053, P356, DOI 10.1196/annals.1344.031; Meiner Z, 1997, MEDICINE, V76, P227, DOI 10.1097/00005792-199707000-00001; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Quaglio E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019339; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SPUDICH S, 1995, MOL MED, V1, P607, DOI 10.1007/BF03401601; Sultana R, 2009, METHODS MOL BIOL, V566, P123, DOI 10.1007/978-1-59745-562-6_9; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Wehner KA, 2002, BRAIN RES, V945, P160, DOI 10.1016/S0006-8993(02)02750-6; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang M, 2010, J NEUROSCI RES, V88, P686, DOI 10.1002/jnr.22230	45	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54433	10.1371/journal.pone.0054433	http://dx.doi.org/10.1371/journal.pone.0054433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349890	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000038
J	Jourdain, I; Brzezinska, EA; Toda, T				Jourdain, Isabelle; Brzezinska, Elspeth A.; Toda, Takashi			Fission Yeast Nod1 Is a Component of Cortical Nodes Involved in Cell Size Control and Division Site Placement	PLOS ONE			English	Article							CYTOKINETIC CONTRACTILE RING; SCHIZOSACCHAROMYCES-POMBE; MITOTIC COMMITMENT; FAMILY KINASE; POLO KINASE; MYOSIN-II; MID1P; MITOSIS; GENE; MECHANISM	Most cells enter mitosis once they have reached a defined size. In the fission yeast Schizosaccharomyces pombe, mitotic entry is orchestrated by a geometry-sensing mechanism that involves the Cdk1/Cdc2-inhibiting Wee1 kinase. The factors upstream of Wee1 gather together in interphase to form a characteristic medial and cortical belt of nodes. Nodes are also considered to be precursors of the cytokinesis contractile actomyosin ring (CAR). Here we describe a new component of the interphase nodes and cytokinesis rings, which we named Nod1. Consistent with its role in cell size control at division, nod1D cells were elongated and epistatic with regulators of Wee1. Through biochemical and localisation studies, we placed Nod1 in a complex with the Rho-guanine nucleotide exchange factor Gef2. Nod1 and Gef2 mutually recruited each other in nodes and Nod1 also assembles Gef2 in rings. Like gef2 Delta, nod1 Delta cells showed a mild displacement of their division plane and this phenotype was severely exacerbated when the parallel Polo kinase pathway was also compromised. We conclude that Nod1 specifies the division site by localising Gef2 to the mitotic cell middle. Previous work showed that Gef2 in turn anchors factors that control the spatio-temporal recruitment of the actin nucleation machinery. It is believed that the actin filaments originated from the nodes pull nodes together into a single contractile ring. Surprisingly however, we found that node proteins could form pre-ring helical filaments in a cdc12-112 mutant in which nucleation of the actin ring is impaired. Furthermore, the deletion of either nod1 or gef2 created an un-expected situation where different ring components were recruited sequentially rather than simultaneously. At later stages of cytokinesis, these various rings appeared inter-fitted rather than merged. This study brings a new slant to the understanding of CAR assembly and function.	[Jourdain, Isabelle; Brzezinska, Elspeth A.; Toda, Takashi] Canc Res UK, London Res Inst, Cell Regulat Lab, London, England	Cancer Research UK	Jourdain, I (corresponding author), Canc Res UK, London Res Inst, Cell Regulat Lab, London, England.	Isabelle.Jourdain@cancer.org.uk; Takashi.Toda@cancer.org.uk		Brzezinska, Elspeth/0000-0002-6729-6825	Core grant from Cancer Research UK (United Kingdom); Cancer Research UK [15670] Funding Source: researchfish	Core grant from Cancer Research UK (United Kingdom); Cancer Research UK(Cancer Research UK)	This work was supported by a Core grant from Cancer Research UK (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonacid M, 2011, CURR BIOL, V21, P473, DOI 10.1016/j.cub.2011.02.003; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bathe M, 2010, TRENDS MICROBIOL, V18, P38, DOI 10.1016/j.tim.2009.10.002; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Coffman VC, 2009, MOL BIOL CELL, V20, P5195, DOI 10.1091/mbc.E09-05-0428; Guzman-Vendrell M, 2013, MOL CELL BIOL, V33, P418, DOI 10.1128/MCB.01286-12; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Huang YY, 2008, J CELL BIOL, V183, P979, DOI 10.1083/jcb.200806151; Ikebe C, 2011, BIOSCI BIOTECH BIOCH, V75, P2364, DOI 10.1271/bbb.110558; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Laporte D, 2012, MOL BIOL CELL, V23, P3094, DOI 10.1091/mbc.E12-02-0123; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; MacIver FH, 2003, GENE DEV, V17, P1507, DOI 10.1101/gad.256003; Martin SG, 2009, CELL CYCLE, V8, P3643, DOI 10.4161/cc.8.22.9891; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; Moseley JB, 2010, CELL, V142, P189, DOI 10.1016/j.cell.2010.07.004; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Motegi F, 2004, J CELL BIOL, V165, P685, DOI 10.1083/jcb.200402097; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Rincon SA, 2012, CYTOSKELETON, V69, P764, DOI 10.1002/cm.21056; Saha S, 2012, MOL CELL BIOCHEM, V366, P1, DOI 10.1007/s11010-012-1274-2; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Sohrmann M, 1996, GENE DEV, V10, P2707, DOI 10.1101/gad.10.21.2707; Takaine M, 2009, EMBO J, V28, P3117, DOI 10.1038/emboj.2009.252; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0; Ye YF, 2012, MOL BIOL CELL, V23, P1181, DOI 10.1091/mbc.E11-09-0800	37	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54142	10.1371/journal.pone.0054142	http://dx.doi.org/10.1371/journal.pone.0054142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349808	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900044
J	Khodayari, S; Moharramipour, S; Larvor, V; Hidalgo, K; Renault, D				Khodayari, Samira; Moharramipour, Saeid; Larvor, Vanessa; Hidalgo, Kevin; Renault, David			Deciphering the Metabolic Changes Associated with Diapause Syndrome and Cold Acclimation in the Two-Spotted Spider Mite Tetranychus urticae	PLOS ONE			English	Article							EARTHWORM DENDROBAENA-OCTAEDRA; AMINO-ACID POOLS; FREEZE-TOLERANT; INSECT DIAPAUSE; CRYOPROTECTANT SYNTHESIS; SUPERCOOLING CAPACITY; OVERWINTERING LARVAE; DROSOPHILID FLY; CORN-BORER; HARDINESS	Diapause is a common feature in several arthropod species that are subject to unfavorable growing seasons. The range of environmental cues that trigger the onset and termination of diapause, in addition to associated hormonal, biochemical, and molecular changes, have been studied extensively in recent years; however, such information is only available for a few insect species. Diapause and cold hardening usually occur together in overwintering arthropods, and can be characterized by recording changes to the wealth of molecules present in the tissue, hemolymph, or whole body of organisms. Recent technological advances, such as high throughput screening and quantification of metabolites via chromatographic analyses, are able to identify such molecules. In the present work, we examined the survival ability of diapausing and non-diapausing females of the two-spotted spider mite, Tetranychus urticae, in the presence (0 or 5 degrees C) or absence of cold acclimation. Furthermore, we examined the metabolic fingerprints of these specimens via gas chromatography-mass spectrophotometry (GC-MS). Partial Least Square Discriminant Analysis (PLS-DA) of metabolites revealed that major metabolic variations were related to diapause, indicating in a clear cut-off between diapausing and non-diapausing females, regardless of acclimation state. Signs of metabolic depression were evident in diapausing females, with most amino acids and TCA cycle intermediates being significantly reduced. Out of the 40 accurately quantified metabolites, seven metabolites remained elevated or were accumulated in diapausing mites, i.e. cadaverine, gluconolactone, glucose, inositol, maltose, mannitol and sorbitol. The capacity to accumulate winter polyols during cold-acclimation was restricted to diapausing females. We conclude that the induction of increased cold hardiness in this species is associated with the diapause syndrome, rather than being a direct effect of low temperature. Our results provide novel information about biochemical events related to the cold hardening process in the two-spotted spider mite.	[Khodayari, Samira; Moharramipour, Saeid] Tarbiat Modares Univ, Fac Agr, Dept Entomol, Tehran, Iran; [Larvor, Vanessa; Hidalgo, Kevin; Renault, David] Univ Rennes 1, UMR CNRS Ecobio 6553, Rennes, France	Tarbiat Modares University; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Renault, D (corresponding author), Univ Rennes 1, UMR CNRS Ecobio 6553, Rennes, France.		Moharramipour, Saeid/AAB-7252-2019; Moharramipour, Saeid/AAE-8151-2021	Moharramipour, Saeid/0000-0001-8389-8861; Hidalgo, Kevin/0000-0001-5923-3130; RENAULT, David/0000-0003-3644-1759	Tarbiat Modares University (Tehran, Iran)	Tarbiat Modares University (Tehran, Iran)	The authors thank the Tarbiat Modares University (Tehran, Iran) that funded the experiments and the travel of S. Khodayari to France. University of Rennes 1 (Action Incitative de Recherche 2012-Collaborations Internationales) assisted the stay of S. Khodayari in France. We thank one anonymous referee, David Denlinger (Ohio State University, Columbus, USA) and Vladimir Kostal (Institute of Entomology, Biology Centre AS CR, Ceske Budejovice, Czech Republic) for helpful comments on an earlier version of the paper. We are grateful to Marie Chauris for technical assistance.; The authors thank the Tarbiat Modares University (Tehran, Iran) that funded the experiments and the travel of S. Khodayari to France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atapour M, 2009, ENVIRON ENTOMOL, V38, P260, DOI 10.1603/022.038.0132; BAUST JG, 1982, COMP BIOCHEM PHYS A, V73, P563, DOI 10.1016/0300-9629(82)90263-8; Berkvens N, 2010, J INSECT PHYSIOL, V56, P438, DOI 10.1016/j.jinsphys.2009.11.019; Calderon S, 2009, J EXP BIOL, V212, P859, DOI 10.1242/jeb.026864; Colinet H, 2012, FUNCT ECOL, V26, P711, DOI 10.1111/j.1365-2435.2012.01985.x; Colinet H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032606; Colinet H, 2010, PHYSIOL ENTOMOL, V35, P301, DOI 10.1111/j.1365-3032.2010.00743.x; COSTANZO JP, 1993, AM J PHYSIOL, V265, pR721, DOI 10.1152/ajpregu.1993.265.4.R721; DANKS HV, 1987, BIOL SURVEY CANADA M, V1; DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239, DOI 10.1146/annurev.en.31.010186.001323; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; EVANS DE, 1981, AUST J ZOOL, V29, P483, DOI 10.1071/ZO9810483; FURUSAWA T, 1982, J COMP PHYSIOL, V147, P21, DOI 10.1007/BF00689286; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Goto M, 1998, J INSECT PHYSIOL, V44, P87, DOI 10.1016/S0022-1910(97)00098-X; Goto M, 2001, J INSECT PHYSIOL, V47, P709, DOI 10.1016/S0022-1910(00)00164-5; Goto M, 2001, J INSECT PHYSIOL, V47, P157, DOI 10.1016/S0022-1910(00)00099-8; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hendrix DL, 1998, COMP BIOCHEM PHYS A, V120, P487, DOI 10.1016/S1095-6433(98)10058-2; Hodkova M, 2004, EUR J ENTOMOL, V101, P445, DOI 10.14411/eje.2004.064; Holmstrup M, 2007, SOIL BIOL BIOCHEM, V39, P2640, DOI 10.1016/j.soilbio.2007.05.018; Khodayari S, 2012, J THERM BIOL, V37, P419, DOI 10.1016/j.jtherbio.2012.04.005; Kost'al V, 2000, J INSECT PHYSIOL, V46, P887, DOI 10.1016/S0022-1910(99)00195-X; Kostal V, 2007, J INSECT PHYSIOL, V53, P580, DOI 10.1016/j.jinsphys.2007.02.009; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2000, J INSECT PHYSIOL, V46, P417, DOI 10.1016/S0022-1910(99)00124-9; Kostal V, 2004, J INSECT PHYSIOL, V50, P303, DOI 10.1016/j.jinsphys.2004.01.006; KOSTAL V, 1995, J INSECT PHYSIOL, V41, P627, DOI 10.1016/0022-1910(94)00124-Y; Kostal V, 2001, COMP BIOCHEM PHYS B, V130, P365, DOI 10.1016/S1096-4959(01)00441-9; Kostal V, 2008, J INSECT PHYSIOL, V54, P77, DOI 10.1016/j.jinsphys.2007.08.004; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Kostal V, 2009, INSECT BIOCHEM MOLEC, V39, P875, DOI 10.1016/j.ibmb.2009.10.004; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Laparie M, 2012, COMP BIOCHEM PHYS A, V162, P406, DOI 10.1016/j.cbpa.2012.04.022; LEE RE, 1987, J INSECT PHYSIOL, V33, P587, DOI 10.1016/0022-1910(87)90074-6; LEE RE, 1980, J INSECT PHYSIOL, V26, P135, DOI 10.1016/0022-1910(80)90053-0; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; MacMillan HA, 2009, J INSECT PHYSIOL, V55, P243, DOI 10.1016/j.jinsphys.2008.11.015; MASAKI S, 1980, ANNU REV ENTOMOL, V25, P1, DOI 10.1146/annurev.en.25.010180.000245; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; MOREAU R, 1981, COMP BIOCHEM PHYS B, V68, P95, DOI 10.1016/0305-0491(81)90185-1; MORGAN TD, 1983, J INSECT PHYSIOL, V29, P735, DOI 10.1016/0022-1910(83)90001-X; Okasaki T, 1981, J SERICULT SIC JPN, V50, P190; OSANAI M, 1986, INSECT BIOCHEM, V16, P373, DOI 10.1016/0020-1790(86)90050-8; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; PULLIN AS, 1989, COMP BIOCHEM PHYS A, V94, P499, DOI 10.1016/0300-9629(89)90128-X; Pullin AS, 1996, EUR J ENTOMOL, V93, P121; R Core Team, 2018, R LANG ENV STAT COMP; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Saeidi F, ENV ENTOMOL IN PRESS; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; Salvucci ME, 2000, J THERM BIOL, V25, P353, DOI 10.1016/S0306-4565(99)00107-2; Slachta M, 2002, J INSECT PHYSIOL, V48, P1031, DOI 10.1016/S0022-1910(02)00191-9; Soudi S, 2012, J THERM BIOL, V37, P384, DOI 10.1016/j.jtherbio.2012.02.003; STOREY JM, 1990, J COMP PHYSIOL B, V160, P77; STOREY KB, 1993, J INSECT PHYSIOL, V39, P737, DOI 10.1016/0022-1910(93)90048-V; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; STOREY KB, 1982, INSECT BIOCHEM, V12, P501, DOI 10.1016/0020-1790(82)90018-X; Szymanski J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007441; Tanaka K, 1997, J INSECT PHYSIOL, V43, P271, DOI 10.1016/S0022-1910(96)00091-1; Teets NM, 2012, PHYSIOL GENOMICS, V44, P764, DOI 10.1152/physiolgenomics.00042.2012; Veerman A., 1985, P279; Wang XH, 2005, J INSECT PHYSIOL, V51, P1277, DOI 10.1016/j.jinsphys.2005.07.010; Watanabe M, 1999, J INSECT PHYSIOL, V45, P167, DOI 10.1016/S0022-1910(98)00111-5; Wolschin F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006394; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; YAGINUMA T, 1979, INSECT BIOCHEM, V9, P547, DOI 10.1016/0020-1790(79)90075-1; Zhang QR, 2011, P NATL ACAD SCI USA, V108, P16922, DOI 10.1073/pnas.1113863108	71	53	53	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54025	10.1371/journal.pone.0054025	http://dx.doi.org/10.1371/journal.pone.0054025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349779	Green Published, gold			2022-12-27	WOS:000313738900032
J	Trihn, M; Ge, XC; Dobson, A; Kitten, T; Munro, CL; Xu, P				My Trihn; Ge, Xiuchun; Dobson, Alleson; Kitten, Todd; Munro, Cindy L.; Xu, Ping			Two-Component System Response Regulators Involved in Virulence of Streptococcus pneumoniae TIGR4 in Infective Endocarditis	PLOS ONE			English	Article							BACTERIAL-ENDOCARDITIS; IDENTIFICATION; CIAR; SANGUINIS; REGULON; GENOME	Streptococci resident in the oral cavity have been linked to infective endocarditis (IE). While other viridans streptococci are commonly studied in relation to IE, less research has been focused on Streptococcus pneumoniae. We established for the first time an animal model of S. pneumoniae IE, and examined the virulence of the TIGR4 strain in this model. We hypothesized that two-component systems (TCS) may mediate S. pneumoniae TIGR4 strain virulence in IE and examined TCS response regulator (RR) mutants of TIGR4 in vivo with the IE model. Thirteen of the 14 RR protein genes were mutagenized, excluding only the essential gene SP_1227. The requirement of the 13 RRs for S. pneumoniae competitiveness in the IE model was assessed in vivo through use of quantitative real-time PCR (qPCR) and competitive index assays. Using real-time PCR, several RR mutants were detected at significantly lower levels in infected heart valves compared with a control strain suggesting the respective RRs are candidate virulence factors for IE. The virulence reduction of the Delta ciaR mutant was further confirmed by competitive index assay. Our data suggest that CiaR is a virulence factor of S. pneumoniae strain TIGR4 for IE.	[My Trihn; Ge, Xiuchun; Dobson, Alleson; Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, VCU Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA; [Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Munro, Cindy L.] Univ S Florida, Coll Nursing, Tampa, FL USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; State University System of Florida; University of South Florida	Xu, P (corresponding author), Virginia Commonwealth Univ, VCU Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA.	pxu@vcu.edu	Kitten, Todd/O-6531-2014	Kitten, Todd/0000-0001-6097-7583	National Institutes of Health [R01DE018138, R56AI085195]; Virginia Commonwealth University Presidential Research Incentive Program (PRIP) [144602-3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018138, R01DE023078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University Presidential Research Incentive Program (PRIP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants R01DE018138 (PX) and R56AI085195 (TK) from the National Institutes of Health, and in part by the Virginia Commonwealth University Presidential Research Incentive Program (PRIP) 144602-3 (PX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddour LM, 1998, CLIN INFECT DIS, V26, P66, DOI 10.1086/516266; Bashore TM, 2006, CURR PROB CARDIOLOGY, V31, P274, DOI 10.1016/j.cpcardiol.2005.12.001; Bent CJ, 2004, J BACTERIOL, V186, P2872, DOI 10.1128/JB.186.9.2872-2879.2004; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Bricker AL, 1999, FEMS MICROBIOL LETT, V172, P131, DOI 10.1016/S0378-1097(99)00027-0; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Dajani AS, 1997, JAMA-J AM MED ASSOC, V277, P1794, DOI 10.1001/jama.277.22.1794; DURACK DT, 1972, BRIT J EXP PATHOL, V53, P44; Ferrieri P, 2002, CIRCULATION, V105, P2115, DOI 10.1161/01.CIR.0000013073.22415.90; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; Halfmann A, 2007, MOL MICROBIOL, V66, P110, DOI 10.1111/j.1365-2958.2007.05900.x; Henriques MX, 2011, MOL MICROBIOL, V82, P515, DOI 10.1111/j.1365-2958.2011.07828.x; Ibrahim YM, 2004, J BACTERIOL, V186, P5258, DOI 10.1128/JB.186.16.5258-5266.2004; Kim Yong-Min, 2011, J Cardiovasc Ultrasound, V19, P35, DOI 10.4250/jcu.2011.19.1.35; Leday TV, 2008, INFECT IMMUN, V76, P4659, DOI 10.1128/IAI.00597-08; Liu YL, 2009, J BACTERIOL, V191, P7363, DOI 10.1128/JB.01054-09; Mascher T, 2003, J BACTERIOL, V185, P60, DOI 10.1128/JB.185.1.60-70.2003; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Paterson GK, 2006, J MED MICROBIOL, V55, P355, DOI 10.1099/jmm.0.46423-0; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Rueda Adriana M, 2010, Medicine (Baltimore), V89, P331, DOI 10.1097/MD.0b013e3181f2b824; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Strom BL, 1998, ANN INTERN MED, V129, P761, DOI 10.7326/0003-4819-129-10-199811150-00002; Tran-Winkler HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002361; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125	28	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54320	10.1371/journal.pone.0054320	http://dx.doi.org/10.1371/journal.pone.0054320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342132	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700108
J	Sanfiorenzo, C; Ilie, MI; Belaid, A; Barlesi, F; Mouroux, J; Marquette, CH; Brest, P; Hofman, P				Sanfiorenzo, Celine; Ilie, Marius I.; Belaid, Amine; Barlesi, Fabrice; Mouroux, Jerome; Marquette, Charles-Hugo; Brest, Patrick; Hofman, Paul			Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; BREAST-CANCER; TUMOR-MARKERS; EXPRESSION; SERUM; DIAGNOSIS; SURVIVAL; PROGNOSIS; SIGNATURES; ASSOCIATION	The diagnosis of non-small cell lung carcinoma (NSCLC) at an early stage, as well as better prediction of outcome remains clinically challenging due to the lack of specific and robust non-invasive markers. The discovery of microRNAs (miRNAs), particularly those found in the bloodstream, has opened up new perspectives for tumor diagnosis and prognosis. The aim of our study was to determine whether expression profiles of specific miRNAs in plasma could accurately discriminate between NSCLC patients and controls, and whether they are able to predict the prognosis of resectable NSCLC patients. We therefore evaluated a series of seventeen NSCLC-related miRNAs by quantitative real-time (qRT)-PCR in plasma from 52 patients with I-IIIA stages NSCLC, 10 patients with chronic obstructive pulmonary disease (COPD) and 20-age, sex and smoking status-matched healthy individuals. We identified an eleven-plasma miRNA panel that could distinguish NSCLC patients from healthy subjects (AUC = 0.879). A six-plasma miRNA panel was able to discriminate between NSCLC patients and COPD patients (AUC = 0.944). Furthermore, we identified a three-miRNA plasma signature (high miR-155-5p, high miR-223- 3p, and low miR-126-3p) that significantly associated with a higher risk for progression in adenocarcinoma patients. In addition, a three-miRNA plasma panel (high miR-20a-5p, low miR-152-3p, and low miR-199a-5p) significantly predicted survival of squamous cell carcinoma patients. In conclusion, we identified two plasma miRNA expression profiles that may be useful for predicting the outcome of patients with resectable NSCLC.	[Sanfiorenzo, Celine; Ilie, Marius I.; Belaid, Amine; Mouroux, Jerome; Marquette, Charles-Hugo; Brest, Patrick; Hofman, Paul] CNRS, INSERM, Inst Res Canc & Ageing Nice IRCAN, U1081,UMR 7284,Team 3, F-06034 Nice, France; [Sanfiorenzo, Celine; Marquette, Charles-Hugo] Pasteur Hosp, Univ Hosp Ctr Nice, Dept Pneumol, Nice, France; [Sanfiorenzo, Celine; Ilie, Marius I.; Mouroux, Jerome; Marquette, Charles-Hugo; Brest, Patrick; Hofman, Paul] Univ Nice Sophia Antipolis, Fac Med, Team 3, Nice, France; [Ilie, Marius I.; Hofman, Paul] Pasteur Hosp, Univ Hosp Ctr Nice, Lab Clin & Expt Pathol, Nice, France; [Ilie, Marius I.; Hofman, Paul] Pasteur Hosp, Univ Hosp Ctr Nice, Human Biobank, Nice, France; [Barlesi, Fabrice] Aix Marseille Univ, Assistance Publ Hop Marseille, Multidisciplinary Oncol & Therapeut Innovat Dept, Marseille, France; [Mouroux, Jerome] Pasteur Hosp, Univ Hosp Ctr Nice, Dept Thorac Surg, Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Nice	Hofman, P (corresponding author), CNRS, INSERM, Inst Res Canc & Ageing Nice IRCAN, U1081,UMR 7284,Team 3, F-06034 Nice, France.	hofman.p@chu-nice.fr	Marquette, Charles Hugo/O-4084-2016; Hofman, Paul/P-7654-2018; Ilié, Marius/M-7964-2019; brest, patrick/B-7311-2012	Marquette, Charles Hugo/0000-0002-0846-9941; Hofman, Paul/0000-0003-0431-9353; Ilié, Marius/0000-0002-2014-1236; brest, patrick/0000-0002-1252-4747; Mouroux, Jerome/0000-0003-0877-4679	Canceropole PACA; Fondation ARC pour la recherche sur le cancer [ARC SL220110603478]	Canceropole PACA(Region Grand-Est); Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was partly supported by grants from the Canceropole PACA (Axe C, 2011 and 2012), and by the "Fondation ARC pour la recherche sur le cancer'' ARC SL220110603478 (PH, PB, MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbas F, 2012, EXP LUNG RES, V38, P286, DOI 10.3109/01902148.2012.689088; Appaiah HN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2943; Blanchon F, 2006, LANCET ONCOL, V7, P829, DOI 10.1016/S1470-2045(06)70868-3; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Celli Bartolome R, 2012, Proc Am Thorac Soc, V9, P74, DOI 10.1513/pats.201107-039MS; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Chirieac LR, 2010, ARCH PATHOL LAB MED, V134, P41, DOI 10.1043/1543-2165-134.1.41; Dannemann M, 2012, GENOME BIOL EVOL, V4, P552, DOI 10.1093/gbe/evs033; Donnem T, 2011, CANCER-AM CANCER SOC, V117, P3193, DOI 10.1002/cncr.25907; Donnem T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-6; Duffy MJ, 2007, EUR J INTERN MED, V18, P175, DOI 10.1016/j.ejim.2006.12.001; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang W, 2012, AM J RESP CRIT CARE; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang F, 2010, CANCER PREV RES, V3, P1571, DOI 10.1158/1940-6207.CAPR-10-0128; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kalscheuer S, 2008, CARCINOGENESIS, V29, P2394, DOI 10.1093/carcin/bgn209; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Leidinger P, 2011, LUNG CANCER, V74, P41, DOI 10.1016/j.lungcan.2011.02.003; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2012, CARCINOGENESIS, V33, P1046, DOI 10.1093/carcin/bgs100; MARGOLIS ML, 1994, CANCER, V73, P605, DOI 10.1002/1097-0142(19940201)73:3<605::AID-CNCR2820730317>3.0.CO;2-T; McDermott AM, 2011, PHARM RES-DORDR, V28, P3016, DOI 10.1007/s11095-011-0550-2; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Nisman B, 1998, CANCER-AM CANCER SOC, V82, P1850, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1850::AID-CNCR6>3.0.CO;2-R; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xie Y, 2010, LUNG CANCER, V67, P170, DOI 10.1016/j.lungcan.2009.04.004; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zheng DL, 2011, INT J CLIN EXP PATHO, V4, P575	48	139	144	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54596	10.1371/journal.pone.0054596	http://dx.doi.org/10.1371/journal.pone.0054596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342174	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700129
J	Takahashi, N; Nomura, T; Takahara, Y; Yamamoto, H; Shiino, T; Takeda, A; Inoue, M; Iida, A; Hara, H; Shu, T; Hasegawa, M; Sakawaki, H; Miura, T; Igarashi, T; Koyanagi, Y; Naruse, TK; Kimura, A; Matano, T				Takahashi, Naofumi; Nomura, Takushi; Takahara, Yusuke; Yamamoto, Hiroyuki; Shiino, Teiichiro; Takeda, Akiko; Inoue, Makoto; Iida, Akihiro; Hara, Hiroto; Shu, Tsugumine; Hasegawa, Mamoru; Sakawaki, Hiromi; Miura, Tomoyuki; Igarashi, Tatsuhiko; Koyanagi, Yoshio; Naruse, Taeko K.; Kimura, Akinori; Matano, Tetsuro			A Novel Protective MHC-I Haplotype Not Associated with Dominant Gag-Specific CD8(+) T-Cell Responses in SIVmac239 Infection of Burmese Rhesus Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-REPLICATION; LYMPHOCYTE-BASED CONTROL; HLA-B; MAMU-B-ASTERISK-08-POSITIVE MACAQUES; IMMUNE CONTROL; SENDAI-VIRUS; AIDS VACCINE; VIRAL LOAD; VIREMIA; HIV	Several major histocompatibility complex class I (MHC-I) alleles are associated with lower viral loads and slower disease progression in human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections. Immune-correlates analyses in these MHC-I-related HIV/SIV controllers would lead to elucidation of the mechanism for viral control. Viral control associated with some protective MHC-I alleles is attributed to CD8(+) T-cell responses targeting Gag epitopes. We have been trying to know the mechanism of SIV control in multiple groups of Burmese rhesus macaques sharing MHC-I genotypes at the haplotype level. Here, we found a protective MHC-I haplotype, 90-010-Id (D), which is not associated with dominant Gag-specific CD8(+) T-cell responses. Viral loads in five D+ animals became significantly lower than those in our previous cohorts after 6 months. Most D+ animals showed predominant Nef-specific but not Gag-specific CD8(+) T-cell responses after SIV challenge. Further analyses suggested two Nef-epitope- specific CD8(+) T-cell responses exerting strong suppressive pressure on SIV replication. Another set of five D+ animals that received a prophylactic vaccine using a Gag-expressing Sendai virus vector showed significantly reduced viral loads compared to unvaccinated D+ animals at 3 months, suggesting rapid SIV control by Gag-specific CD8(+) T-cell responses in addition to Nef-specific ones. These results present a pattern of SIV control with involvement of non-Gag antigen-specific CD8(+) T-cell responses.	[Takahashi, Naofumi; Nomura, Takushi; Takahara, Yusuke; Yamamoto, Hiroyuki; Shiino, Teiichiro; Takeda, Akiko; Matano, Tetsuro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Takahashi, Naofumi; Nomura, Takushi; Takahara, Yusuke; Matano, Tetsuro] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Inoue, Makoto; Iida, Akihiro; Hara, Hiroto; Shu, Tsugumine; Hasegawa, Mamoru] DNAVEC Corp, Tsukuba, Ibaraki, Japan; [Sakawaki, Hiromi; Miura, Tomoyuki; Igarashi, Tatsuhiko; Koyanagi, Yoshio] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Naruse, Taeko K.; Kimura, Akinori] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo, Japan	National Institute of Infectious Diseases (NIID); University of Tokyo; DNAVEC Corporation; Kyoto University; Tokyo Medical & Dental University (TMDU)	Matano, T (corresponding author), Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan.	tmatano@nih.go.jp	Naruse, Taeko/ABA-3089-2021; Kimura, Akinori/I-5989-2018	Kimura, Akinori/0000-0002-4933-2132; Inoue, Makoto/0000-0003-0804-7439	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, and grants-in-aid from the Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Budde ML, 2012, J VIROL, V86, P7596, DOI 10.1128/JVI.00716-12; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Ishii H, 2012, J VIROL, V86, P738, DOI 10.1128/JVI.06226-11; Iwamoto N, 2010, AIDS, V24, P2777, DOI 10.1097/QAD.0b013e3283402206; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kawada M, 2006, J VIROL, V80, P1949, DOI 10.1128/JVI.80.4.1949-1958.2006; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; Naruse TK, 2010, IMMUNOGENETICS, V62, P601, DOI 10.1007/s00251-010-0462-z; Nomura T, 2012, J VIROL, V86, P6481, DOI 10.1128/JVI.07077-11; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Shibata R, 1997, J INFECT DIS, V176, P362, DOI 10.1086/514053; Takeda A, 2003, J VIROL, V77, P9710, DOI 10.1128/JVI.77.17.9710-9715.2003; Tanaka-Takahashi Y, 2007, ELECTROPHORESIS, V28, P918, DOI 10.1002/elps.200600586; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09; VOSS G, 1992, J VIROL METHODS, V39, P185, DOI 10.1016/0166-0934(92)90137-3; Yamamoto H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000540; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	50	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54300	10.1371/journal.pone.0054300	http://dx.doi.org/10.1371/journal.pone.0054300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342126	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400145
J	Yoda, M; Kimura, T; Tohmonda, T; Morioka, H; Matsumoto, M; Okada, Y; Toyama, Y; Horiuchi, K				Yoda, Masaki; Kimura, Tokuhiro; Tohmonda, Takahide; Morioka, Hideo; Matsumoto, Morio; Okada, Yasunori; Toyama, Yoshiaki; Horiuchi, Keisuke			Systemic Overexpression of TNF alpha-converting Enzyme Does Not Lead to Enhanced Shedding Activity In Vivo	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CUTTING EDGE; ADAM17; EGFR; EXPRESSION; RECEPTOR; TACE; DISINTEGRIN; ACTIVATION; METALLOPROTEINASE	TNF alpha-converting enzyme (TACE/ADAM17) is a membrane-bound proteolytic enzyme with a diverse set of target molecules. Most importantly, TACE is indispensable for the release and activation of pro-TNF alpha and the ligands for epidermal growth factor receptor in vivo. Previous studies suggested that the overproduction of TACE is causally related to the pathogenesis of inflammatory diseases and cancers. To test this hypothesis, we generated a transgenic line in which the transcription of exogenous Tace is driven by a CAG promoter. The Tace-transgenic mice were viable and exhibited no overt defects, and the quantitative RT-PCR and Western blot analyses confirmed that the transgenically introduced Tace gene was highly expressed in all of the tissues examined. The Tace-transgenic mice were further crossed with Tace(-/+) mice to abrogate the endogenous TACE expression, and the Tace-transgenic mice lacking endogenous Tace gene were also viable without any apparent defects. Furthermore, there was no difference in the serum TNF alpha levels after lipopolysaccharide injection between the transgenic mice and control littermates. These observations indicate that TACE activity is not necessarily dependent on transcriptional regulation and that excess TACE does not necessarily result in aberrant proteolytic activity in vivo.	[Yoda, Masaki; Kimura, Tokuhiro; Tohmonda, Takahide; Okada, Yasunori; Horiuchi, Keisuke] Keio Univ, Sch Med, Tokyo, Japan; [Yoda, Masaki; Tohmonda, Takahide; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan	Keio University; Keio University	Horiuchi, K (corresponding author), Keio Univ, Sch Med, Tokyo, Japan.	horiuchi@z3.keio.jp	Toyama, Yoshiaki/K-5743-2013; Matsumoto, Morio M/L-6227-2013; Okada, Yasunori/B-5550-2014; Horiuchi, Keisuke/L-2277-2013	Okada, Yasunori/0000-0001-9208-4755; Horiuchi, Keisuke/0000-0001-7063-9609	Keio University Kanrinmaru project; MEXT KAKENHI [24390358, 23592230]; Health Labour Sciences Research Grant; Nakatomi Foundation	Keio University Kanrinmaru project; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Nakatomi Foundation	This work was supported in part by Keio University Kanrinmaru project, the Nakatomi Foundation, MEXT KAKENHI (24390358 and 23592230), and the Health Labour Sciences Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Ding X, 2004, WORLD J GASTROENTERO, V10, P2735, DOI 10.3748/wjg.v10.i18.2735; Dreymueller D, 2011, EUR J CELL BIOL; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Fukaya S, 2012, LAB INVEST; Hall KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031600; Horiuchi K, 2007, J IMMUNOL, V179, P6715, DOI 10.4049/jimmunol.179.10.6715; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nelson KK, 1999, BIOCHEM J, V343, P673, DOI 10.1042/0264-6021:3430673; Ohta S, 2001, J RHEUMATOL, V28, P1756; Patel IR, 1998, J IMMUNOL, V160, P4570; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Sisto M, 2010, HISTOCHEM CELL BIOL, V134, P345, DOI 10.1007/s00418-010-0735-5; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Solomon KA, 1999, J IMMUNOL, V163, P4105; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	39	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54412	10.1371/journal.pone.0054412	http://dx.doi.org/10.1371/journal.pone.0054412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342154	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400163
J	Lakshmi, PS; Verma, D; Yang, XD; Lloyd, B; Daniell, H				Lakshmi, Priya Saikumar; Verma, Dheeraj; Yang, Xiangdong; Lloyd, Bethany; Daniell, Henry			Low Cost Tuberculosis Vaccine Antigens in Capsules: Expression in Chloroplasts, Bio-Encapsulation, Stability and Functional Evaluation In Vitro	PLOS ONE			English	Article							TOXIN-B-SUBUNIT; HEAT-LABILE ENTEROTOXIN; MYCOBACTERIUM-TUBERCULOSIS; ORAL DELIVERY; ESCHERICHIA-COLI; CHOLERA-TOXIN; FUSION PROTEIN; THERAPEUTIC PROTEINS; TOBACCO CHLOROPLASTS; POLYPROTEIN VACCINE	Tuberculosis (TB) caused by Mycobacterium tuberculosis is one of the leading fatal infectious diseases. The development of TB vaccines has been recognized as a major public health priority by the World Health Organization. In this study, three candidate antigens, ESAT-6 (6kDa early secretory antigenic target) and Mtb72F (a fusion polyprotein from two TB antigens, Mtb32 and Mtb39) fused with cholera toxin B-subunit (CTB) and LipY (a cell wall protein) were expressed in tobacco and/or lettuce chloroplasts to facilitate bioencapsulation/oral delivery. Site-specific transgene integration into the chloroplast genome was confirmed by Southern blot analysis. In transplastomic leaves, CTB fusion proteins existed in soluble monomeric or multimeric forms of expected sizes and their expression levels varied depending upon the developmental stage and time of leaf harvest, with the highest-level of accumulation in mature leaves harvested at 6PM. The CTB-ESAT6 and CTB-Mtb72F expression levels reached up to 7.5% and 1.2% of total soluble protein respectively in mature tobacco leaves. Transplastomic CTB-ESAT6 lettuce plants accumulated up to 0.75% of total leaf protein. Western blot analysis of lyophilized lettuce leaves stored at room temperature for up to six months showed that the CTB-ESAT6 fusion protein was stable and preserved proper folding, disulfide bonds and assembly into pentamers for prolonged periods. Also, antigen concentration per gram of leaf tissue was increased 22 fold after lyophilization. Hemolysis assay with purified CTB-ESAT6 protein showed partial hemolysis of red blood cells and confirmed functionality of the ESAT-6 antigen. GM1-binding assay demonstrated that the CTB-ESAT6 fusion protein formed pentamers to bind with the GM1-ganglioside receptor. The expression of functional Mycobacterium tuberculosis antigens in transplastomic plants should facilitate development of a cost-effective and orally deliverable TB booster vaccine with potential for long-term storage at room temperature. To our knowledge, this is the first report of expression of TB vaccine antigens in chloroplasts.	[Lakshmi, Priya Saikumar; Verma, Dheeraj; Yang, Xiangdong; Lloyd, Bethany; Daniell, Henry] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Daniell, H (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	Henry.Daniell@ucf.edu	Daniell, Henry/L-3655-2019	Daniell, Henry/0000-0003-4485-1176; Saikumar lakshmi, Priya/0000-0001-9446-5770	National Institutes of Health [NIH R01 GM 63879, NIH R01 HL 107904]; Bill and Melinda Gates Foundation [OPP 1031406]; JDRF [17-2011-286]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); JDRF(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Institutes of Health NIH R01 GM 63879, NIH R01 HL 107904, Bill and Melinda Gates Foundation Global Health grant OPP 1031406 and JDRF grant 17-2011-286 to Dr. Henry Daniell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2001, VACCINE, V19, P2298, DOI 10.1016/S0264-410X(00)00519-3; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; [Anonymous], 2011, GLOB TUB CONTR; Arlen PA, 2008, INFECT IMMUN, V76, P3640, DOI 10.1128/IAI.00050-08; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Boehm R, 2007, ANN NY ACAD SCI, V1102, P121, DOI 10.1196/annals.1408.009; Boyhan D, 2011, PLANT BIOTECHNOL J, V9, P585, DOI 10.1111/j.1467-7652.2010.00582.x; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brennan MJ, 2012, VACCINE, V30, P2811, DOI 10.1016/j.vaccine.2012.02.036; BREWER TF, 1995, CLIN INFECT DIS, V20, P126, DOI 10.1093/clinids/20.1.126; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Cheng L, 2010, PLANT CELL REP, V29, P371, DOI 10.1007/s00299-010-0828-6; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Coler RN, 2009, VACCINE, V27, P223, DOI 10.1016/j.vaccine.2008.10.056; Cramer CL, 1999, CURR TOP MICROBIOL, V240, P95; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Daniell H, 2007, P NATL ACAD SCI USA, V104, P6879, DOI 10.1073/pnas.0702219104; Daniell Henry, 2006, Biotechnology Journal, V1, P1071, DOI 10.1002/biot.200600145; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; Davoodi-Semiromi A, 2010, PLANT BIOTECHNOL J, V8, P223, DOI 10.1111/j.1467-7652.2009.00479.x; De Haan L, 1998, IMMUNOLOGY, V94, P424, DOI 10.1046/j.1365-2567.1998.00535.x; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Derrick SC, 2004, VACCINE, V23, P780, DOI 10.1016/j.vaccine.2004.07.036; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023360; Doherty TM, 2007, EXPERT OPIN BIOL TH, V7, P1539, DOI 10.1517/14712598.7.10.1539; Dorokhov YL, 2007, TUBERCULOSIS, V87, P218, DOI 10.1016/j.tube.2006.10.001; Soria-Guerra RE, 2009, PLANTA, V229, P1293, DOI 10.1007/s00425-009-0918-2; Gisby MF, 2011, PLANT BIOTECHNOL J, V9, P618, DOI 10.1111/j.1467-7652.2011.00619.x; Glenz K, 2006, NAT BIOTECHNOL, V24, P76, DOI 10.1038/nbt1170; Hamasur B, 2003, VACCINE, V21, P4081, DOI 10.1016/S0264-410X(03)00274-3; Holmgren J, 2005, IMMUNOL LETT, V97, P181, DOI 10.1016/j.imlet.2004.11.009; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Koya V, 2005, INFECT IMMUN, V73, P8266, DOI 10.1128/IAI.73.12.8266-8274.2005; Kumar M, 2010, TUBERCULOSIS, V90, P60, DOI 10.1016/j.tube.2009.10.003; Kupferschmidt K, 2011, SCIENCE, V334, P1488, DOI 10.1126/science.334.6062.1488; Kwon KC, 2012, ADV DRUG DELIV REV; Kwon KC, 2013, PLANT BIOTECHNOL J, V11, P77, DOI 10.1111/pbi.12008; Langridge W, 2010, CURR OPIN INVEST DR, V11, P919; Limaye A, 2006, FASEB J, V20, P959, DOI 10.1096/fj.05-5134fje; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Obembe OO, 2011, BIOTECHNOL ADV, V29, P210, DOI 10.1016/j.biotechadv.2010.11.004; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Ozeki Y, 2011, VACCINE, V29, P6881, DOI 10.1016/j.vaccine.2011.07.051; Penney CA, 2011, PLANT CELL REP, V30, P789, DOI 10.1007/s00299-010-0995-5; Pniewski T, 2011, J APPL GENET, V52, P125, DOI 10.1007/s13353-010-0001-5; Rigano MM, 2004, PLANT CELL REP, V22, P502, DOI 10.1007/s00299-003-0718-2; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; Roth AE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c671; Rubio-Infante N, 2012, PLANT MOL BIOL, V78, P337, DOI 10.1007/s11103-011-9870-1; Ruddock LW, 1996, J BIOL CHEM, V271, P19118, DOI 10.1074/jbc.271.32.19118; Ruhlman T, 2007, PLANT BIOTECHNOL J, V5, P495, DOI 10.1111/j.1467-7652.2007.00259.x; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Scotti N, 2012, BIOTECHNOL ADV, V30, P387, DOI 10.1016/j.biotechadv.2011.07.019; Sereinig S, 2006, CLIN VACCINE IMMUNOL, V13, P898, DOI 10.1128/CVI.00056-06; Singh N. Dolendro, 2009, V483, P163, DOI 10.1007/978-1-59745-407-0_10; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; STERN DB, 1987, CELL, V51, P1145, DOI 10.1016/0092-8674(87)90600-3; Streatfield Stephen J, 2003, Expert Rev Vaccines, V2, P763, DOI 10.1586/14760584.2.6.763; Tinker JK, 2003, INFECT IMMUN, V71, P4093, DOI 10.1128/IAI.71.7.4093-4101.2003; Triccas James A, 2010, Bioeng Bugs, V1, P110, DOI 10.4161/bbug.1.2.10483; Tsenova L, 2006, INFECT IMMUN, V74, P2392, DOI 10.1128/IAI.74.4.2392-2401.2006; TSUJI T, 1995, MICROBIOL IMMUNOL, V39, P817, DOI 10.1111/j.1348-0421.1995.tb03262.x; Tyagi AK, 2011, TUBERCULOSIS, V91, P469, DOI 10.1016/j.tube.2011.01.003; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Verma D, 2010, P NATL ACAD SCI USA, V107, P7101, DOI 10.1073/pnas.0912181107; Webster DE, 2006, VACCINE, V24, P3538, DOI 10.1016/j.vaccine.2006.02.002; Wilkins MR, 1999, METH MOL B, V112, P531; Xing Z, 2006, TUBERCULOSIS, V86, P211, DOI 10.1016/j.tube.2006.01.017; Yacono MD, 2012, PLANT BIOTECHNOL J, V10, P1136, DOI 10.1111/pbi.12001; Zelada AM, 2006, TUBERCULOSIS, V86, P263, DOI 10.1016/j.tube.2006.01.003	75	89	97	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54708	10.1371/journal.pone.0054708	http://dx.doi.org/10.1371/journal.pone.0054708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355891	Green Published, gold			2022-12-27	WOS:000314021500113
J	Akhtar, S; Grizenkova, J; Wenborn, A; Hummerich, H; de Marco, MF; Brandner, S; Collinge, J; Lloyd, SE				Akhtar, Shaheen; Grizenkova, Julia; Wenborn, Adam; Hummerich, Holger; de Marco, Mar Fernandez; Brandner, Sebastian; Collinge, John; Lloyd, Sarah E.			Sod1 Deficiency Reduces Incubation Time in Mouse Models of Prion Disease	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CREUTZFELDT-JAKOB-DISEASE; PROTEIN; GENE; MICE; SUSCEPTIBILITY; IDENTIFICATION; RESISTANT; PERIOD; STRAINS	Prion infections, causing neurodegenerative conditions such as Creutzfeldt-Jakob disease and kuru in humans, scrapie in sheep and BSE in cattle are characterised by prolonged and variable incubation periods that are faithfully reproduced in mouse models. Incubation time is partly determined by genetic factors including polymorphisms in the prion protein gene. Quantitative trait loci studies in mice and human genome-wide association studies have confirmed that multiple genes are involved. Candidate gene approaches have also been used and identified App, Il1-r1 and Sod1 as affecting incubation times. In this study we looked for an association between App, Il1-r1 and Sod1 representative SNPs and prion disease incubation time in the Northport heterogeneous stock of mice inoculated with the Chandler/RML prion strain. No association was seen with App, however, significant associations were seen with Il1-r1 (P = 0.02) and Sod1 (P<0.0001) suggesting that polymorphisms at these loci contribute to the natural variation observed in incubation time. Furthermore, following challenge with Chandler/RML, ME7 and MRC2 prion strains, Sod1 deficient mice showed highly significant reductions in incubation time of 20, 13 and 24%, respectively. No differences were detected in Sod1 expression or activity. Our data confirm the protective role of endogenous Sod1 in prion disease.	[Lloyd, Sarah E.] UCL, Inst Neurol, Med Res Council Prion Unit, London, England; UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of London; University College London	Lloyd, SE (corresponding author), UCL, Inst Neurol, Med Res Council Prion Unit, London, England.	s.lloyd@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342	UK Medical Research Council; Medical Research Council [MC_U123192748, MC_U123160652] Funding Source: researchfish; MRC [MC_U123192748, MC_U123160652] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CARLSON GA, 1993, GENETICS, V133, P979; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; Grizenkova J, 2012, P NATL ACAD SCI USA, V109, P13722, DOI 10.1073/pnas.1208917109; Grizenkova J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015019; HITZEMANN B, 1994, J PHARMACOL EXP THER, V271, P969; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee DW, 1999, FREE RADICAL RES, V30, P499, DOI 10.1080/10715769900300541; Lloyd SE, 2010, NEUROGENETICS, V11, P185, DOI 10.1007/s10048-009-0219-8; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; Lloyd SE, 2005, CURR GENOMICS, V6, P1, DOI 10.2174/1389202053202166; Lloyd SE, 2004, J GEN VIROL, V85, P2471, DOI 10.1099/vir.0.79889-0; Lloyd SE, 2004, MAMM GENOME, V15, P383, DOI 10.1007/s00335-004-3041-5; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2012, HUM MOL GENET, V21, P1897, DOI 10.1093/hmg/ddr607; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Moreno CR, 2003, GENETICS, V165, P2085; Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208; O'Shea M, 2008, SEMIN PERINATOL, V32, P1, DOI 10.1053/j.semperi.2007.12.002; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6	45	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54454	10.1371/journal.pone.0054454	http://dx.doi.org/10.1371/journal.pone.0054454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349894	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100070
J	He, YL; Liu, DD; Fang, YJ; Zhan, XQ; Yao, JJ; Mei, YA				He, Yan-Lin; Liu, Dong-Dong; Fang, Yan-Jia; Zhan, Xiao-Qin; Yao, Jin-Jing; Mei, Yan-Ai			Exposure to Extremely Low-Frequency Electromagnetic Fields Modulates Na+ Currents in Rat Cerebellar Granule Cells through Increase of AA/PGE(2) and EP Receptor-Mediated cAMP/PKA Pathway	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ACTIVATED PROTEIN-KINASE; GATED SODIUM-CHANNELS; 50 HZ; ARACHIDONIC-ACID; NEURONAL APOPTOSIS; MAGNETIC-FIELDS; CULTURED-CELLS; IN-VITRO; RELEASE	Although the modulation of Ca2+ channel activity by extremely low-frequency electromagnetic fields (ELF-EMF) has been studied previously, few reports have addressed the effects of such fields on the activity of voltage-activated Na+ channels (Na-v). Here, we investigated the effects of ELF-EMF on Na-v activity in rat cerebellar granule cells (GCs). Our results reveal that exposing cerebellar GCs to ELF-EMF for 10-60 min significantly increased Na-v currents (I-Na) by 30-125% in a time- and intensity-dependent manner. The Na-v channel steady-state activation curve, but not the steady-state inactivation curve, was significantly shifted ( by 5.2 mV) towards hyperpolarization by ELF-EMF stimulation. This phenomenon is similar to the effect of intracellular application of arachidonic acid ( AA) and prostaglandin E-2 (PGE(2)) on I-Na in cerebellar GCs. Increases in intracellular AA, PGE(2) and phosphorylated PKA levels in cerebellar GCs were observed following ELF-EMF exposure. Western blottings indicated that the Na-V 1.2 protein on the cerebellar GCs membrane was increased, the total expression levels of Na-V 1.2 protein were not affected after exposure to ELF-EMF. Cyclooxygenase inhibitors and PGE(2) receptor (EP) antagonists were able to eliminate this ELF-EMF-induced increase in phosphorylated PKA and I-Na. In addition, ELFEMF exposure significantly enhanced the activity of PLA(2) in cerebellar GCs but did not affect COX-1 or COX-2 activity. Together, these data demonstrate for the first time that neuronal I-Na is significantly increased by ELFEMF exposure via a cPLA2 AA PGE(2) EP receptors PKA signaling pathway.	[Mei, Yan-Ai] Fudan Univ, Inst Brain Sci, Sch Life Sci, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Mei, YA (corresponding author), Fudan Univ, Inst Brain Sci, Sch Life Sci, Shanghai 200433, Peoples R China.	yamei@fudan.edu.cn		He, Yanlin/0000-0002-5471-9016	National Basic Research Program of China [2011CB503703]; Shanghai Leading Academic Discipline Project [B111]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by a grant from the National Basic Research Program of China (2011CB503703) and the Shanghai Leading Academic Discipline Project [B111]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinucci C, 2009, TOXICOL IND HEALTH, V25, P249, DOI 10.1177/0748233709103031; Arendash GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035751; Banasiak KJ, 2004, NEUROSCIENCE, V126, P31, DOI 10.1016/S0306-4522(03)00425-1; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; COSTA MRC, 1984, J BIOL CHEM, V259, P8210; Cuccurazzu B, 2010, EXP NEUROL, V226, P173, DOI 10.1016/j.expneurol.2010.08.022; Cui YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032196; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; De Mattei M, 2009, OSTEOARTHR CARTILAGE, V17, P252, DOI 10.1016/j.joca.2008.06.002; Dibirdik I, 1998, J BIOL CHEM, V273, P4035, DOI 10.1074/jbc.273.7.4035; Ding YN, 2008, J CELL PHYSIOL, V215, P77, DOI 10.1002/jcp.21289; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; Fang YJ, 2011, BIOCHEM J, V438, P203, DOI 10.1042/BJ20110569; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Fulton AM, 2006, CANCER RES, V66, P9794, DOI 10.1158/0008-5472.CAN-06-2067; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gold MS, 1998, J NEUROSCI, V18, P10345; GONZALEZ B, 1992, P NATL ACAD SCI USA, V89, P9627, DOI 10.1073/pnas.89.20.9627; Grassi C, 2004, CELL CALCIUM, V35, P307, DOI 10.1016/j.ceca.2003.09.001; Hu CL, 2008, J NEUROCHEM, V106, P1125, DOI 10.1111/j.1471-4159.2008.05449.x; Jiao S, 2007, J NEUROCHEM, V100, P979, DOI 10.1111/j.1471-4159.2006.04261.x; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lisi A, 2005, J CELL PHYSIOL, V204, P532, DOI 10.1002/jcp.20322; Liu Z, 2008, J NEUROCHEM, V106, P2463, DOI 10.1111/j.1471-4159.2008.05562.x; Luukkonen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018021; Marchionni I, 2006, BBA-BIOMEMBRANES, V1758, P597, DOI 10.1016/j.bbamem.2006.03.014; Morelli A, 2005, ARCH BIOCHEM BIOPHYS, V441, P191, DOI 10.1016/j.abb.2005.07.011; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Ongaro A, 2012, J CELL PHYSIOL, V227, P2461, DOI 10.1002/jcp.22981; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Ramundo-Orlando A, 2000, BIOELECTROMAGNETICS, V21, P499, DOI 10.1002/1521-186X(200010)21:7<499::AID-BEM3>3.0.CO;2-9; Ravera S, 2010, BIOELECTROMAGNETICS, V31, P270, DOI 10.1002/bem.20563; REYNOLDS JD, 1992, J DEV PHYSIOL, V18, P243; Richard D, 2002, MOL CELL BIOCHEM, V232, P133, DOI 10.1023/A:1014802005672; Rosen AD, 2003, BIOELECTROMAGNETICS, V24, P517, DOI 10.1002/bem.10124; Schaller KL, 2003, CEREBELLUM, V2, P2, DOI 10.1080/14734220309424; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Song HS, 2010, KOREAN J PHYSIOL PHA, V14, P427, DOI 10.4196/kjpp.2010.14.6.427; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Sun WJ, 2001, ELECTRO MAGNETOBIOL, V20, P415, DOI 10.1081/JBC-100108579; Thumm S, 1999, RADIAT ENVIRON BIOPH, V38, P195, DOI 10.1007/s004110050155; Varani K, 2010, BIOELECTROMAGNETICS; Waxman SG, 2007, NAT NEUROSCI, V10, P405, DOI 10.1038/nn1857; Yao HL, 2009, J NEUROCHEM, V108, P909, DOI 10.1111/j.1471-4159.2008.05834.x; Zahner G, 2009, BIOCHEM J, V422, P563, DOI 10.1042/BJ20090420; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200	48	30	35	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54376	10.1371/journal.pone.0054376	http://dx.doi.org/10.1371/journal.pone.0054376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349866	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100061
J	Weng, S; Sprague, JE; Oh, J; Riek, AE; Chin, K; Garcia, M; Bernal-Mizrachi, C				Weng, Sherry; Sprague, Jennifer E.; Oh, Jisu; Riek, Amy E.; Chin, Kathleen; Garcia, Miguel; Bernal-Mizrachi, Carlos			Vitamin D Deficiency Induces High Blood Pressure and Accelerates Atherosclerosis in Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MACROPHAGE DIFFERENTIATION; INSULIN-RESISTANCE; NATIONAL-HEALTH; RISK; 25-HYDROXYVITAMIN-D; HYPERTENSION; ACTIVATION; CALCIUM; CELLS	Multiple epidemiological studies link vitamin D deficiency to increased cardiovascular disease (CVD), but causality and possible mechanisms underlying these associations are not established. To clarify the role of vitamin D-deficiency in CVD in vivo, we generated mouse models of diet-induced vitamin D deficiency in two backgrounds (LDL receptor-and ApoE-null mice) that resemble humans with diet-induced hypertension and atherosclerosis. Mice were fed vitamin D-deficient or sufficient chow for 6 weeks and then switched to high fat (HF) vitamin D-deficient or -sufficient diet for 8-10 weeks. Mice with diet-induced vitamin D deficiency showed increased systolic and diastolic blood pressure, high plasma renin, and decreased urinary sodium excretion. Hypertension was reversed and renin was suppressed by returning chow-fed vitamin D-deficient mice to vitamin D-sufficient chow diet for 6 weeks. On a HF diet, vitamin D-deficient mice had similar to 2-fold greater atherosclerosis in the aortic arch and similar to 2-8-fold greater atherosclerosis in the thoracic and abdominal aorta compared to vitamin D-sufficient mice. In the aortic root, HF-fed vitamin D-deficient mice had increased macrophage infiltration with increased fat accumulation and endoplasmic reticulum (ER) stress activation, but a lower prevalence of the M1 macrophage phenotype within atherosclerotic plaques. Similarly, peritoneal macrophages from vitamin D-deficient mice displayed an M2-predominant phenotype with increased foam cell formation and ER stress. Treatment of vitamin D-deficient mice with the ER stress reliever PBA during HF feeding suppressed atherosclerosis, decreased peritoneal macrophage foam cell formation, and downregulated ER stress proteins without changing blood pressure. Thus, we suggest that vitamin D deficiency activates both the renin angiotensin system and macrophage ER stress to contribute to the development of hypertension and accelerated atherosclerosis, highlighting vitamin D replacement as a potential therapy to reduce blood pressure and atherosclerosis.	[Weng, Sherry] Washington Univ, Dept Anesthesiol, St Louis, MO USA; [Sprague, Jennifer E.] Washington Univ, Div Pediat Endocrinol & Diabet, St Louis, MO USA; [Oh, Jisu; Riek, Amy E.; Chin, Kathleen; Garcia, Miguel; Bernal-Mizrachi, Carlos] Washington Univ, Div Endocrinol Metab & Lipid Res, St Louis, MO 63130 USA; [Bernal-Mizrachi, Carlos] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bernal-Mizrachi, C (corresponding author), Washington Univ, Div Endocrinol Metab & Lipid Res, St Louis, MO 63130 USA.	cbernal@dom.wustl.edu		Bernal-Mizrachi, Carlos/0000-0002-8991-7522	National Institutes of Health (NIH) [R01HL094818-0, P30DK079333, P60 DK 20569, P30 DK56341]; Children's Discovery Institute [CH-II-2012-209]; NIH under Ruth L. Kirschstein National Research Service Award from the NICHD [2 T32 HD043010]; NIH from the National Center for Advancing Translational Sciences (NCATS) [UL1TR000448, KL2TR000450]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333, P30DK056341, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NIH under Ruth L. Kirschstein National Research Service Award from the NICHD; NIH from the National Center for Advancing Translational Sciences (NCATS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) R01HL094818-0, P30DK079333, P60 DK 20569, P30 DK56341 and the Children's Discovery Institute CH-II-2012-209. JES is supported by the NIH under Ruth L. Kirschstein National Research Service Award 2 T32 HD043010 from the NICHD. AER is supported by NIH UL1TR000448/Sub-Award KL2TR000450 from the National Center for Advancing Translational Sciences (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Bernal-Mizrachi C, 2002, ARTERIOSCL THROM VAS, V22, P961, DOI 10.1161/01.ATV.0000019404.65403.71; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; Bernal-Mizrachi C, 2007, CELL METAB, V5, P91, DOI 10.1016/j.cmet.2006.12.010; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Borges ACR, 1999, HYPERTENSION, V34, P897, DOI 10.1161/01.HYP.34.4.897; Borges ACR, 1999, BRIT J PHARMACOL, V127, P772, DOI 10.1038/sj.bjp.0702581; Bories G, 2012, DIABETES VASC DIS RE, V9, P189, DOI 10.1177/1479164111430242; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; CHOBANIAN AV, 1989, HYPERTENSION, V14, P203, DOI 10.1161/01.HYP.14.2.203; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dickhout JG, 2008, FASEB J, V22; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gonzalez-Navarro H, 2007, FRONT BIOSCI-LANDMRK, V12, P4439, DOI 10.2741/2400; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kim DH, 2008, AM J CARDIOL, V102, P1540, DOI 10.1016/j.amjcard.2008.06.067; Krause R, 1998, LANCET, V352, P709, DOI 10.1016/S0140-6736(05)60827-6; Kreisberg RA, 2002, J CLIN ENDOCR METAB, V87, P423, DOI 10.1210/jc.87.2.423; Launay S, 1999, BLOOD, V93, P4395, DOI 10.1182/blood.V93.12.4395.412k06_4395_4405; Li YC, 2003, J CELL BIOCHEM, V88, P327, DOI 10.1002/jcb.10343; Ma YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035835; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nagao T, 2007, ARTERIOSCL THROM VAS, V27, P1596, DOI 10.1161/ATVBAHA.107.145086; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Oh J, 2009, CIRCULATION, V120, P687, DOI 10.1161/CIRCULATIONAHA.109.856070; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Rader DJ, 2005, CELL METAB, V1, P223, DOI 10.1016/j.cmet.2005.03.005; Raffai RL, 2005, ARTERIOSCL THROM VAS, V25, P436, DOI 10.1161/01.ATV.0000152613.83243.12; Riek AE, 2012, J BIOL CHEM, V287, P38482, DOI 10.1074/jbc.M112.386912; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; Schmidt N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035316; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Schrier RW, 2010, NAT REV NEPHROL, V6, P61, DOI 10.1038/nrneph.2009.228; Stienstra R, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Szeto FL, 2012, MOL ENDOCRINOL, V26, P1091, DOI 10.1210/me.2011-1329; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Weiss D, 2001, CIRCULATION, V103, P448; Wilson HM, 2010, J CELL MOL MED, V14, P2055, DOI 10.1111/j.1582-4934.2010.01121.x; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zittermann A, 2003, BRIT J NUTR, V89, P552, DOI 10.1079/BJN2003837	70	94	100	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54625	10.1371/journal.pone.0054625	http://dx.doi.org/10.1371/journal.pone.0054625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349943	Green Published, gold			2022-12-27	WOS:000314019100086
J	Dorenkamp, M; Morguet, AJ; Sticherling, C; Behrens, S; Zabel, M				Dorenkamp, Marc; Morguet, Andreas J.; Sticherling, Christian; Behrens, Steffen; Zabel, Markus			Long-Term Prognostic Value of Restitution Slope in Patients with Ischemic and Dilated Cardiomyopathies	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; PROGRAMMED VENTRICULAR STIMULATION; MONOPHASIC ACTION-POTENTIALS; T-WAVE ALTERNANS; ELECTRICAL RESTITUTION; CYCLE LENGTH; CARDIAC RESTITUTION; IN-VIVO; FIBRILLATION; HEART	Background: An action potential duration (APD) restitution curve with a steep slope >= 1 has been associated with increased susceptibility for malignant ventricular arrhythmias. We aimed to evaluate the "restitution hypothesis" and tested ventricular APD restitution slope as well as effective refractory period (ERP)/APD ratio for long-term prognostic value in patients with ischemic (ICM) or dilated cardiomyopathy (DCM). Methodology/Principal Findings: Monophasic action potentials were recorded in patients with ICM (n = 32) and DCM (n = 42) undergoing routine programmed ventricular stimulation (PVS). Left ventricular ejection fraction was 32 +/- 7% and 28 +/- 9%, respectively. APD and ERP were measured at baseline stimulation (S-1) and upon introduction of one to three extrastimuli (S-2-S-4). ERP/APD ratios and the APD restitution curve were calculated and the maximum restitution slope was determined. After a mean follow-up of 6.1 +/- 3.0 years, the combined end-point of mortality and and/or implantable cardioverter-defibrillator shock was not predicted by restitution slope or ERP/APD ratios. Comparing S-2 vs. S-3 vs. S-4 extrastimuli for restitution slope (1.5 +/- 0.6 vs. 1.4 +/- 0.4 vs. 1.3 +/- 0.5; p = NS), additional extrastimuli did not lead to a steepening restitution slope. ERP/APD ratio decreased with additional extrastimuli (0.98 +/- 0.09 [S-1] vs. 0.97 +/- 0.10 [S-2] vs. 0.93 +/- 0.11 [S-3]; p = 0.03 S-1 vs. S-3). Positive PVS was strongly predictive of outcome (p = 0.006). Conclusions/Significance: Neither ventricular APD restitution slope nor ERP/APD ratios predict outcome in patients with ICM or DCM.	[Dorenkamp, Marc] Charite, Dept Cardiol, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Morguet, Andreas J.] Charite, Dept Cardiol & Pulmonol, Campus Benjamin Franklin, D-13353 Berlin, Germany; [Sticherling, Christian] Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland; [Behrens, Steffen] Vivantes Humboldt Klinikum, Dept Cardiol, Berlin, Germany; [Zabel, Markus] Univ Gottingen, Ctr Heart, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Basel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Dorenkamp, M (corresponding author), Charite, Dept Cardiol, Campus Virchow Klinikum, D-13353 Berlin, Germany.	marc.dorenkamp@charite.de	Sticherling, Christian/AAY-4435-2021	Sticherling, Christian/0000-0001-8428-7050				Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bloomfield DM, 2002, J CARDIOVASC ELECTR, V13, P502, DOI 10.1046/j.1540-8167.2002.00502.x; Bode F, 2002, J AM COLL CARDIOL, V40, P731, DOI 10.1016/S0735-1097(02)02008-9; Bode F, 2001, J AM COLL CARDIOL, V37, P920, DOI 10.1016/S0735-1097(00)01189-X; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Cao JM, 1999, CIRC RES, V84, P1318, DOI 10.1161/01.RES.84.11.1318; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; FRANZ MR, 1995, PACE, V18, P1666, DOI 10.1111/j.1540-8159.1995.tb06988.x; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Franz MR, 2003, J CARDIOVASC ELECTR, V14, pS140, DOI 10.1046/j.1540.8167.90303.x; Garfinkel A, 2000, P NATL ACAD SCI USA, V97, P6061, DOI 10.1073/pnas.090492697; Gelzer ARM, 2008, CIRCULATION, V118, P1123, DOI 10.1161/CIRCULATIONAHA.107.738013; Gilmour RF, 2002, J CARDIOVASC ELECTR, V13, P1150, DOI 10.1046/j.1540-8167.2002.01150.x; Grimm W, 1998, J AM COLL CARDIOL, V32, P739, DOI 10.1016/S0735-1097(98)00306-4; HAWS CW, 1990, CIRCULATION, V81, P281, DOI 10.1161/01.CIR.81.1.281; HUMMEL JD, 1994, CIRCULATION, V90, P2827, DOI 10.1161/01.CIR.90.6.2827; KOLLER BS, 1995, CIRCULATION, V91, P2378, DOI 10.1161/01.CIR.91.9.2378; Koller ML, 2005, CIRCULATION, V112, P1542, DOI 10.1161/CIRCULATIONAHA.104.502831; Koller ML, 1998, AM J PHYSIOL-HEART C, V275, pH1635, DOI 10.1152/ajpheart.1998.275.5.H1635; KURZ RW, 1994, EUR HEART J, V15, P547, DOI 10.1093/oxfordjournals.eurheartj.a060541; KURZ RW, 1993, EUR HEART J, V14, P1410, DOI 10.1093/eurheartj/14.10.1410; Lee SD, 1997, J AM COLL CARDIOL, V29, P100, DOI 10.1016/S0735-1097(96)00423-8; MADIT Executive Committee Multicenter Automatic Defibrillator, 1991, PACE, V14, P920; Narayan SM, 2007, J AM COLL CARDIOL, V50, P2385, DOI 10.1016/j.jacc.2007.10.011; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Pak HN, 2004, J CARDIOVASC ELECTR, V15, P1357, DOI 10.1046/j.1540-8167.2004.03569.x; Pruvot EJ, 2004, CIRC RES, V94, P1083, DOI 10.1161/01.RES.0000125629.72053.95; Qu ZL, 2000, BIOPHYS J, V78, P2761, DOI 10.1016/S0006-3495(00)76821-4; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; Selvaraj RJ, 2007, AM J PHYSIOL-HEART C, V292, pH1262, DOI 10.1152/ajpheart.00913.2006; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Weiss JN, 2000, CIRC RES, V87, P1103, DOI 10.1161/01.RES.87.12.1103; Xie FG, 2004, J CLIN INVEST, V113, P686, DOI 10.1172/JCI200417341; Yue AM, 2005, J AM COLL CARDIOL, V46, P1067, DOI 10.1016/j.jacc.2005.05.074; Zaitsev AV, 2003, CIRC RES, V92, P546, DOI 10.1161/01.RES.0000061917.23107.F7; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233; Zrenner B, 2000, PACE, V23, P54, DOI 10.1111/j.1540-8159.2000.tb00650.x	38	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54768	10.1371/journal.pone.0054768	http://dx.doi.org/10.1371/journal.pone.0054768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349967	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800077
J	Geiser, E; Gabrieli, JDE				Geiser, Eveline; Gabrieli, John D. E.			Influence of Rhythmic Grouping on Duration Perception: A Novel Auditory Illusion	PLOS ONE			English	Article							OMISSION EVOKED-POTENTIALS; STREAM SEGREGATION; TEMPORAL PATTERNS; TIME PERCEPTION; DISCRIMINATION; MUSICIANS; NONMUSICIANS; REPRESENTATION; SHRINKING; METER	This study investigated a potential auditory illusion in duration perception induced by rhythmic temporal contexts. Listeners with or without musical training performed a duration discrimination task for a silent period in a rhythmic auditory sequence. The critical temporal interval was presented either within a perceptual group or between two perceptual groups. We report the just-noticeable difference (difference limen, DL) for temporal intervals and the point of subjective equality (PSE) derived from individual psychometric functions based on performance of a two-alternative forced choice task. In musically untrained individuals, equal temporal intervals were perceived as significantly longer when presented between perceptual groups than within a perceptual group (109.25% versus 102.5% of the standard duration). Only the perceived duration of the between-group interval was significantly longer than its objective duration. Musically trained individuals did not show this effect. However, in both musically trained and untrained individuals, the relative difference limens for discriminating the comparison interval from the standard interval were larger in the between-groups condition than in the within-group condition (7.3% vs. 5.6% of the standard duration). Thus, rhythmic grouping affected sensitivity to duration changes in all listeners, with duration differences being harder to detect at boundaries of rhythm groups than within rhythm groups. Our results show for the first time that temporal Gestalt induces auditory duration illusions in typical listeners, but that musical experts are not susceptible to this effect of rhythmic grouping.	[Geiser, Eveline] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Geiser, E (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	egeiser@mit.edu	Gabrieli, John/AAJ-2869-2020		Ellison Medical Foundation; Swiss National Science Foundation [PA00P1_131448/1]; McGovern Institute at Massachusetts Institute of Technology	Ellison Medical Foundation(Lawrence Ellison Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); McGovern Institute at Massachusetts Institute of Technology	This research was supported by a grant from the Ellison Medical Foundation. During the preparation of this manuscript EG was supported by the Swiss National Science Foundation (PA00P1_131448/1) and the McGovern Institute at Massachusetts Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton T.L., 1894, AM J PSYCHOL, V6, P145, DOI [10.2307/1410948, DOI 10.2307/1410948]; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1978, J EXP PSYCHOL HUMAN, V4, P380, DOI 10.1037/0096-1523.4.3.380; Bregman AS, 1999, PERCEPT PSYCHOPHYS, V61, P195, DOI 10.3758/BF03206882; Desain P, 2003, PERCEPTION, V32, P341, DOI 10.1068/p3370; DRAKE C, 1993, PERCEPT PSYCHOPHYS, V53, P25, DOI 10.3758/BF03211712; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Ehrle N, 2005, BRAIN COGNITION, V58, P133, DOI 10.1016/j.bandc.2004.09.014; FITZGIBBONS PJ, 1974, PERCEPT PSYCHOPHYS, V16, P522, DOI 10.3758/BF03198581; Frazier L, 2006, TRENDS COGN SCI, V10, P244, DOI 10.1016/j.tics.2006.04.002; FRIBERG A, 1995, J ACOUST SOC AM, V98, P2524, DOI 10.1121/1.413218; Geiser E, 2010, EUR J NEUROSCI, V32, P1979, DOI 10.1111/j.1460-9568.2010.07462.x; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 2009, ATTEN PERCEPT PSYCHO, V71, P1649, DOI 10.3758/APP.71.7.1649; HALPERN AR, 1982, PERCEPT PSYCHOPHYS, V31, P86, DOI 10.3758/BF03206204; HANDEL S, 1992, PERCEPT PSYCHOPHYS, V52, P497, DOI 10.3758/BF03206711; Jongsma MLA, 2005, PSYCHOPHYSIOLOGY, V42, P191, DOI 10.1111/j.1469-8986.2005.00269.x; Jongsma MLA, 2004, NEUROSCI LETT, V355, P189, DOI 10.1016/j.neulet.2003.10.070; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Kleiner M., 2007, PERC 36 ECVP S; Kolakoski W., 1965, AM MATH MON, V72, P674; KRISTOFFERSON AB, 1980, PERCEPT PSYCHOPHYS, V27, P300, DOI 10.3758/BF03206118; Matthews WJ, 2012, ATTEN PERCEPT PSYCHO, V74, P1056, DOI 10.3758/s13414-012-0282-3; McDougall R, 1903, PSYCHOL REV S, V4, P309; NAKAJIMA Y, 1991, MUSIC PERCEPT, V8, P431; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POVEL DJ, 1981, J EXP PSYCHOL HUMAN, V7, P3, DOI 10.1037/0096-1523.7.1.3; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Rammsayer T, 2006, MUSIC PERCEPT, V24, P37, DOI 10.1525/mp.2006.24.1.37; ROSE D, 1995, PERCEPTION, V24, P1177, DOI 10.1068/p241177; Sasaki T, 2002, PERCEPT PSYCHOPHYS, V64, P919, DOI 10.3758/BF03196796; Sasaki T, 2010, ATTEN PERCEPT PSYCHO, V72, P1404, DOI 10.3758/APP.72.5.1404; SCHULZE HH, 1989, PSYCHOL RES-PSYCH FO, V51, P10, DOI 10.1007/BF00309270; Snyder JS, 2009, J EXP PSYCHOL HUMAN, V35, P1232, DOI 10.1037/a0012741; Ten Hoopen G, 2006, MUSIC PERCEPT, V24, P1; Ten Hoopen G, 2011, ATTEN PERCEPT PSYCHO, V73, P2249, DOI 10.3758/s13414-011-0171-1; ten Hoopen G, 2008, PSYCHOLOGY OF TIME, P139, DOI 10.1016/B978-0-08046-977-5.00005-3; THORPE LA, 1989, DEV PSYCHOL, V25, P122, DOI 10.1037/0012-1649.25.1.122; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; Wertheimer M., 1938, SOURCE BOOK GESTALT, P71, DOI [10.1037/11496-005, DOI 10.1037/11496-005]	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54273	10.1371/journal.pone.0054273	http://dx.doi.org/10.1371/journal.pone.0054273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GQ	23349845	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800036
J	Harper, MT; van den Bosch, MTJ; Hers, I; Poole, AW				Harper, Matthew T.; van den Bosch, Marion T. J.; Hers, Ingeborg; Poole, Alastair W.			Absence of Platelet Phenotype in Mice Lacking the Motor Protein Myosin Va	PLOS ONE			English	Article							RANGE VESICLE TRANSPORT; MELANOSOME TRANSPORT; PLASMA-MEMBRANE; DENSE GRANULES; MELANOCYTES; SECRETION; RAB27A; CELLS; SLAC2-A/MELANOPHILIN; MUNC13-4	Background: The motor protein myosin Va plays an important role in the trafficking of intracellular vesicles. Mutation of the Myo5a gene causes Griscelli syndrome type 1 in humans and the dilute phenotype in mice, which are both characterised by pigment dilution and neurological defects as a result of impaired vesicle transport in melanocytes and neuroendocrine cells. The role of myosin Va in platelets is currently unknown. Rab27 has been shown to be associated with myosin Va cargo vesicles and is known to be important in platelet dense granule biogenesis and secretion, a crucial event in thrombus formation. Therefore, we hypothesised that myosin Va may regulate granule secretion or formation in platelets. Methodology/Principal Findings: Platelet function was studied in vitro using a novel Myo5a gene deletion mouse model. Myo5a(-/-) platelets were devoid of myosin Va, as determined by immunoblotting, and exhibited normal expression of surface markers. We assessed dense granule, alpha-granule and lysosomal secretion, integrin alpha(IIb)beta(3) activation, Ca2+ signalling, and spreading on fibrinogen in response to collagen-related peptide or the PAR4 agonist, AYPGKF in washed mouse platelets lacking myosin Va or wild-type platelets. Surprisingly, Myo5a(-/-) platelets showed no significant functional defects in these responses, or in the numbers of dense and a-granules expressed. Conclusion: Despite the importance of myosin Va in vesicle transport in other cells, our data demonstrate this motor protein has no non-redundant role in the secretion of dense and alpha-granules or other functional responses in platelets.	[Harper, Matthew T.; van den Bosch, Marion T. J.; Hers, Ingeborg; Poole, Alastair W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol	Poole, AW (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	a.poole@bris.ac.uk	Hers, Ingeborg/ABG-3357-2020; Harper, Matthew T/G-5630-2013	Harper, Matthew T/0000-0002-4740-637X; Poole, Alastair/0000-0002-0868-297X; van den Bosch, Marion/0000-0002-4635-4416; Hers, Ingeborg/0000-0002-6467-5715	British Heart Foundation [FS/09/009/26444, FS/11/62/28934, RG/10/006/28299, PG/08/056/25325]; British Heart Foundation [PG/10/100/28658, FS/12/3/29232, FS/11/62/28934, PG/08/056/25325, RG/10/006/28299] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Financial support for this work was from the British Heart Foundation (FS/09/009/26444, FS/11/62/28934, RG/10/006/28299, PG/08/056/25325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Bond LM, 2011, MOL BIOL CELL, V22, P54, DOI 10.1091/mbc.E10-06-0553; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Harper MT, 2010, J BIOL CHEM, V285, P19865, DOI 10.1074/jbc.M109.085654; Jacobs DT, 2009, MOL BIOL CELL, V20, P4471, DOI 10.1091/mbc.E08-08-0865; Konopatskaya O, 2011, BLOOD, V118, P416, DOI 10.1182/blood-2010-10-312199; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Marchelletta RR, 2008, AM J PHYSIOL-CELL PH, V295, pC13, DOI 10.1152/ajpcell.00330.2007; MAUPIN P, 1994, J CELL SCI, V107, P3077; Novak EK, 2002, BLOOD, V100, P128, DOI 10.1182/blood.V100.1.128; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Shin JW, 2011, P NATL ACAD SCI USA, V108, P11458, DOI 10.1073/pnas.1017474108; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53239	10.1371/journal.pone.0053239	http://dx.doi.org/10.1371/journal.pone.0053239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349704	gold, Green Published, Green Submitted			2022-12-27	WOS:000313872800008
J	Talaveron, R; Matarredona, ER; de la Cruz, RR; Pastor, AM				Talaveron, Rocio; Matarredona, Esperanza R.; de la Cruz, Rosa R.; Pastor, Angel M.			Neural Progenitor Cell Implants Modulate Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor Expression in Rat Axotomized Neurons	PLOS ONE			English	Article							ABDUCENS INTERNUCLEAR NEURONS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; STEM-CELLS; MESSENGER-RNA; ADULT CAT; EXTRAOCULAR MOTONEURONS; CORTICOSPINAL NEURONS; SYNAPTIC COMPOSITION; SUBVENTRICULAR ZONE	Axotomy of central neurons leads to functional and structural alterations which largely revert when neural progenitor cells (NPCs) are implanted in the lesion site. The new microenvironment created by NPCs in the host tissue might modulate in the damaged neurons the expression of a high variety of molecules with relevant roles in the repair mechanisms, including neurotrophic factors. In the present work, we aimed to analyze changes in neurotrophic factor expression in axotomized neurons induced by NPC implants. For this purpose, we performed immunofluorescence followed by confocal microscopy analysis for the detection of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and nerve growth factor (NGF) on brainstem sections from rats with axotomy of abducens internuclear neurons that received NPC implants (implanted group) or vehicle injections (axotomized group) in the lesion site. Control abducens internuclear neurons were strongly immunoreactive to VEGF and BDNF but showed a weak staining for NT-3 and NGF. Comparisons between groups revealed that lesioned neurons from animals that received NPC implants showed a significant increase in VEGF content with respect to animals receiving vehicle injections. However, the immunoreactivity for BDNF, which was increased in the axotomized group as compared to control, was not modified in the implanted group. The modifications induced by NPC implants on VEGF and BDNF content were specific for the population of axotomized abducens internuclear neurons since the neighboring abducens motoneurons were not affected. Similar levels of NT-3 and NGF immunolabeling were obtained in injured neurons from axotomized and implanted animals. Among all the analyzed neurotrophic factors, only VEGF was expressed by the implanted cells in the lesion site. Our results point to a role of NPC implants in the modulation of neurotrophic factor expression by lesioned central neurons, which might contribute to the restorative effects of these implants.	[Talaveron, Rocio; Matarredona, Esperanza R.; de la Cruz, Rosa R.; Pastor, Angel M.] Univ Seville, Fac Biol, Dept Fisiol, Lab Fisiol & Plasticidad Neuronal, Seville, Spain	University of Sevilla	Pastor, AM (corresponding author), Univ Seville, Fac Biol, Dept Fisiol, Lab Fisiol & Plasticidad Neuronal, Seville, Spain.	ampastor@us.es	Matarredona, Esperanza R./E-6859-2010; Pastor, Angel M. M/A-6385-2010; Talaveron, Rocio/AAG-8792-2021	Pastor, Angel M. M/0000-0002-6213-7454; Matarredona, Esperanza R./0000-0002-2226-4686; Talaveron, Rocio/0000-0002-5068-9171; Rodriguez de la Cruz, Rosa Maria/0000-0001-5301-5108	Spain MEC-FEDER [BFU2009-07121]; Junta de Andalucia-FEDER [CVI-6053]	Spain MEC-FEDER; Junta de Andalucia-FEDER(Junta de Andalucia)	The study was funded by grants in Spain BFU2009-07121 and BFU2012-33975 from MEC-FEDER and CVI-6053 from Junta de Andalucia-FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Benitez-Temino B, 2004, J COMP NEUROL, V473, P538, DOI 10.1002/cne.20095; Benitez-Temino B, 2003, NEUROSCIENCE, V118, P611, DOI 10.1016/S0306-4522(03)00003-4; Benitez-Temino B, 2002, J COMP NEUROL, V444, P324, DOI 10.1002/cne.10147; Buttner-Ennever JA, 2006, NEUROANATOMY OCULOMO; Capone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000373; Conner JM, 1997, J NEUROSCI, V17, P2295; de Carrizosa MADL, 2010, J NEUROSCI, V30, P8308, DOI 10.1523/JNEUROSCI.0719-10.2010; de Carrizosa MADL, 2009, J NEUROSCI, V29, P575, DOI 10.1523/JNEUROSCI.5312-08.2009; de la Cruz RR, 2000, J COMP NEUROL, V427, P391, DOI 10.1002/1096-9861(20001120)427:3<391::AID-CNE6>3.0.CO;2-E; de la Cruz RR, 1998, J COMP NEUROL, V390, P377, DOI 10.1002/(SICI)1096-9861(19980119)390:3<377::AID-CNE6>3.0.CO;2-Z; DUGICHDJORDJEVIC MM, 1995, EUR J NEUROSCI, V7, P1831, DOI 10.1111/j.1460-9568.1995.tb00703.x; Duprey-Diaz MV, 2003, BRAIN RES, V982, P54, DOI 10.1016/S0006-8993(03)02948-2; Fagerlund M, 2012, CELL TRANSPLANT, V21, P739, DOI 10.3727/096368911X612459; Giehl KM, 2001, REV NEUROSCIENCE, V12, P79; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Gulino R, 2004, BRAIN RES, V1013, P174, DOI 10.1016/j.brainres.2004.03.055; Imitola J, 2004, PHILOS T R SOC B, V359, P823, DOI 10.1098/rstb.2004.1474; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Lambrechts D, 2006, BBA-MOL BASIS DIS, V1762, P1109, DOI 10.1016/j.bbadis.2006.04.005; Lee PG, 2001, MOL BRAIN RES, V87, P31, DOI 10.1016/S0169-328X(00)00277-1; Li XL, 2007, NEUROPEPTIDES, V41, P135, DOI 10.1016/j.npep.2007.02.001; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Madhavan L, 2008, STEM CELLS, V26, P254, DOI 10.1634/stemcells.2007-0221; Maurer MH, 2003, NEUROSCI LETT, V344, P165, DOI 10.1016/S0304-3940(03)00407-5; McCloskey DP, 2008, BRAIN RES BULL, V76, P36, DOI 10.1016/j.brainresbull.2007.11.018; McCloskey DP, 2005, J NEUROSCI, V25, P8889, DOI 10.1523/JNEUROSCI.2577-05.2005; Morado-Diaz CJ, 2011, ABSTR SOC NEUROSCI; Morcuende S, 2011, J COMP NEUROL, V519, P2335, DOI 10.1002/cne.22630; Nicoletti JN, 2008, NEUROSCIENCE, V151, P232, DOI 10.1016/j.neuroscience.2007.09.083; Pastor AM, 2000, J COMP NEUROL, V427, P370, DOI 10.1002/1096-9861(20001120)427:3<370::AID-CNE5>3.0.CO;2-M; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pluchino S, 2010, ARCH ITAL BIOL, V148, P173; Qin DX, 2006, NEUROSCI LETT, V410, P222, DOI 10.1016/j.neulet.2006.10.006; Rieux C, 2002, J BIOL RHYTHM, V17, P121, DOI 10.1177/074873002129002410; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; TITMUS MJ, 1990, PROG NEUROBIOL, V35, P1, DOI 10.1016/0301-0082(90)90039-J; Tonchev AB, 2007, NEUROSCIENCE, V144, P1425, DOI 10.1016/j.neuroscience.2006.10.052; Tonra JR, 1998, J NEUROSCI, V18, P4374; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Venero JL, 2000, EXP NEUROL, V161, P38, DOI 10.1006/exnr.1999.7243; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Zhang HT, 2007, J HISTOCHEM CYTOCHEM, V55, P1, DOI 10.1369/jhc.6A6952.2006; ZHOU XF, 1994, BRAIN RES, V643, P162, DOI 10.1016/0006-8993(94)90022-1	47	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54519	10.1371/journal.pone.0054519	http://dx.doi.org/10.1371/journal.pone.0054519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349916	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800059
J	Blevin, P; Carravieri, A; Jaeger, A; Chastel, O; Bustamante, P; Cherel, Y				Blevin, Pierre; Carravieri, Alice; Jaeger, Audrey; Chastel, Olivier; Bustamante, Paco; Cherel, Yves			Wide Range of Mercury Contamination in Chicks of Southern Ocean Seabirds	PLOS ONE			English	Article							STABLE-ISOTOPE SIGNATURES; GULLS LARUS-ARGENTATUS; TERNS STERNA-HIRUNDO; HEAVY-METAL CONCENTRATIONS; SKUAS CATHARACTA-SKUA; KERGUELEN-ISLANDS; COMMON TERNS; INDIAN-OCEAN; TROPHIC POSITION; FEEDING ECOLOGY	Using top predators as sentinels of the marine environment, Hg contamination was investigated within the large subantarctic seabird community of Kerguelen Islands, a remote area from the poorly known Southern Indian Ocean. Chicks of 21 sympatric seabirds presented a wide range of Hg concentrations, with the highest contaminated species containing similar to 102 times more feather Hg than the less contaminated species. Hence, Kerguelen seabirds encompass the whole range of chick feather Hg values that were previously collected worldwide in poorly industrialized localities. Using stable isotopes, the effects of foraging habitats (reflected by delta C-13) and trophic positions (reflected by delta N-15) on Hg concentrations were investigated. Species-related Hg variations were highly and positively linked to feather delta N-15 values, thus highlighting the occurrence of efficient Hg biomagnification processes within subantarctic marine trophic webs. By contrast, Hg contamination overall correlated poorly with feeding habitats, because of the pooling of species foraging within different isotopic gradients corresponding to distinct seabird habitats (benthic, pelagic, neritic and oceanic). However, when focusing on oceanic seabirds, Hg concentration was related to feather delta C-13 values, with species feeding in colder waters (lower delta C-13 values) south of Kerguelen Islands being less prone to be contaminated than species feeding in northern warmer waters (higher delta C-13 values). Within the context of continuous increase in global Hg emissions, Kerguelen Islands that are located far away from anthropogenic sources can be considered as an ideal study site to monitor the temporal trend of global Hg contamination. The present work helps selecting some seabird species as sentinels of environmental pollution according to their high Hg concentrations and their contrasted foraging ecology.	[Blevin, Pierre; Carravieri, Alice; Jaeger, Audrey; Chastel, Olivier; Cherel, Yves] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Bustamante, Paco] Univ La Rochelle, CNRS, La Rochelle, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite	Cherel, Y (corresponding author), CNRS, Ctr Etud Biol Chize, Villiers En Bois, France.	cherel@cebc.cnrs.fr	Bustamante, Paco/G-5833-2011	Bustamante, Paco/0000-0003-3877-9390; Jaeger, Audrey/0000-0002-5649-0315	Agence Nationale de la Recherche (program POLARTOP); Institut Polaire Francais Paul Emile Victor (IPEV) [109]; Terres Australes et Antarctiques Francaises (TAAF)	Agence Nationale de la Recherche (program POLARTOP)(French National Research Agency (ANR)); Institut Polaire Francais Paul Emile Victor (IPEV); Terres Australes et Antarctiques Francaises (TAAF)	Financial support was provided by the Agence Nationale de la Recherche (program POLARTOP, O. Chastel), the Institut Polaire Francais Paul Emile Victor (IPEV, program no. 109, H. Weimerskirch), and the Terres Australes et Antarctiques Francaises (TAAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2008, ECOTOXICOLOGY, V17, P789, DOI 10.1007/s10646-008-0237-6; Akaike H., 1973, P 2 INT S INF THEOR, V1, P267; Anderson ORJ, 2009, MAR ECOL PROG SER, V375, P277, DOI 10.3354/meps07784; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Bargagli R, 1998, MAR ECOL PROG SER, V169, P65, DOI 10.3354/meps169065; Bearhop S, 2000, MAR POLLUT BULL, V40, P181, DOI 10.1016/S0025-326X(99)00205-2; Bearhop S, 2000, MAR ECOL PROG SER, V195, P261, DOI 10.3354/meps195261; Becker Peter H., 2000, Ornitologia Neotropical, V11, P165; BECKER PH, 1994, ARCH ENVIRON CON TOX, V27, P162; Becker PH, 2002, MAR ECOL PROG SER, V243, P261, DOI 10.3354/meps243261; Bocher P, 2003, POLAR BIOL, V26, P759, DOI 10.1007/s00300-003-0552-6; Bocher P, 2000, MAR ECOL PROG SER, V208, P249, DOI 10.3354/meps208249; Bond AL, 2009, SCI TOTAL ENVIRON, V407, P4340, DOI 10.1016/j.scitotenv.2009.04.018; Bond AL, 2009, ARCH ENVIRON CON TOX, V56, P286, DOI 10.1007/s00244-008-9185-7; Bost CA, 2002, MAR ECOL PROG SER, V227, P51, DOI 10.3354/meps227051; BURGER J, 1995, ENVIRON TOXICOL CHEM, V14, P1233, DOI 10.1002/etc.5620140716; BURGER J, 1992, ARCH ENVIRON CON TOX, V23, P105; Burger J, 1996, AUK, V113, P399, DOI 10.2307/4088906; BURGER J, 1993, ENVIRON MONIT ASSESS, V24, P181, DOI 10.1007/BF00547986; BURGER J, 1994, ARCH ENVIRON CON TOX, V26, P351; Burger J, 1995, ENVIRON MONIT ASSESS, V38, P37, DOI 10.1007/BF00547125; Burger J, 1997, ENVIRON MONIT ASSESS, V48, P285, DOI 10.1023/A:1005760321417; Burger J, 2001, ENVIRON MONIT ASSESS, V71, P71, DOI 10.1023/A:1011695829296; Burger J, 1999, ENVIRON TOXICOL CHEM, V18, P673, DOI 10.1002/etc.5620180413; Burger J, 2000, ARCH ENVIRON CON TOX, V38, P254, DOI 10.1007/s002449910033; Burger J, 2000, ENVIRON RES, V82, P207, DOI 10.1006/enrs.1999.4015; Burger J, 2000, SCI TOTAL ENVIRON, V257, P37, DOI 10.1016/S0048-9697(00)00496-4; Burger J, 1997, ENVIRON RES, V75, P160, DOI 10.1006/enrs.1997.3778; Burger J.., 2004, ECOHEALTH, V1, P263, DOI [10.1007/s10393-004-0096-4, DOI 10.1007/S10393-004-0096-4]; Burger J, 2009, ENVIRON MONIT ASSESS, V152, P179, DOI 10.1007/s10661-008-0306-6; Burger Joanna, 1994, Reviews in Environmental Toxicology, V5, P203; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bustamante P, 2003, SCI TOTAL ENVIRON, V313, P25, DOI 10.1016/S0048-9697(03)00265-1; Catry T, 2008, MAR BIOL, V155, P637, DOI 10.1007/s00227-008-1060-6; Cherel Y, 2000, MAR ECOL PROG SER, V207, P183, DOI 10.3354/meps207183; Cherel Y, 2002, MAR ECOL PROG SER, V228, P263, DOI 10.3354/meps228263; Cherel Y, 2002, MAR ECOL PROG SER, V228, P283, DOI 10.3354/meps228283; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Connan M, 2008, MAR ECOL PROG SER, V373, P123, DOI 10.3354/meps07723; Cossa D, 2011, GEOCHIM COSMOCHIM AC, V75, P4037, DOI 10.1016/j.gca.2011.05.001; Delord Karine, 2010, Endangered Species Research, V13, P1, DOI 10.3354/esr00309; Ebinghaus R, 2002, ENVIRON SCI TECHNOL, V36, P1238, DOI 10.1021/es015710z; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; Fitzgerald WF, 1998, ENVIRON SCI TECHNOL, V32, P1, DOI 10.1021/es970284w; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; FURNESS RW, 1995, HELGOLANDER MEERESUN, V49, P605, DOI 10.1007/BF02368386; FURNESS RW, 1986, MAR POLLUT BULL, V17, P27, DOI 10.1016/0025-326X(86)90801-5; GOCHFELD M, 1980, ENVIRON POLLUT A, V22, P197, DOI 10.1016/0143-1471(80)90014-8; GOCHFELD M, 1980, MAR POLLUT BULL, V11, P362, DOI 10.1016/0025-326X(80)90284-2; Gochfeld M, 1999, ENVIRON MONIT ASSESS, V59, P343, DOI 10.1023/A:1006134125236; Goutner V, 2000, ARCH ENVIRON CON TOX, V39, P200, DOI 10.1007/s002440010097; Grandjean P, 2010, ENVIRON HEALTH PERSP, V118, P1137, DOI 10.1289/ehp.0901757; Hindell MA, 1999, POLAR BIOL, V22, P102, DOI 10.1007/s003000050396; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kahle S, 1999, CHEMOSPHERE, V39, P2451, DOI 10.1016/S0045-6535(99)00154-X; Kim EY, 1996, ARCH ENVIRON CON TOX, V30, P259; Kojadinovic J, 2007, SCI TOTAL ENVIRON, V384, P194, DOI 10.1016/j.scitotenv.2007.05.018; Lancelot R., 2005, SELECTION MODELES AV; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lescroel A, 2005, MAR ECOL PROG SER, V302, P245, DOI 10.3354/meps302245; LEWIS SA, 1991, ARCH ENVIRON CON TOX, V21, P316, DOI 10.1007/BF01055352; LOCK JW, 1992, ENVIRON POLLUT, V75, P289, DOI 10.1016/0269-7491(92)90129-X; MONTEIRO LR, 1995, ARCH ENVIRON CON TOX, V28, P304, DOI 10.1007/BF00213106; Monteiro LR, 1996, MAR ECOL PROG SER, V141, P21, DOI 10.3354/meps141021; MONTEIRO LR, 1995, WATER AIR SOIL POLL, V80, P851, DOI 10.1007/BF01189736; Monteiro LR, 1999, MAR ENVIRON RES, V47, P137, DOI 10.1016/S0141-1136(98)00110-X; Monticelli D, 2008, WATERBIRDS, V31, P231, DOI 10.1675/1524-4695(2008)31[231:DAFEOR]2.0.CO;2; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; Moreno R, 2011, MAR ECOL PROG SER, V442, P229, DOI 10.3354/meps09420; Mougeot F, 1998, J ZOOL, V244, P429, DOI 10.1017/S0952836998003136; MUIRHEAD SJ, 1988, MAR POLLUT BULL, V19, P278, DOI 10.1016/0025-326X(88)90599-1; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Nisbet ICT, 2002, MAR ECOL PROG SER, V242, P267, DOI 10.3354/meps242267; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Park YH, 1997, DEEP-SEA RES PT II, V44, P963, DOI 10.1016/S0967-0645(97)00004-0; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Development Core Team, 2008, LANG ENV STAT COMP; Ridoux Vincent, 1994, Marine Ornithology, V22, P1; Sanpera C, 2007, CONDOR, V109, P268, DOI 10.1650/0010-5422(2007)109[268:MASIIF]2.0.CO;2; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Selin NE, 2009, ANNU REV ENV RESOUR, V34, P43, DOI 10.1146/annurev.environ.051308.084314; Stahl J.-C., 1986, Oiseau et la Revue Francaise d'Ornithologie, V56, P287; Stewart FM, 1997, MAR ECOL PROG SER, V151, P237, DOI 10.3354/meps151237; Stewart FM, 1999, MAR ECOL PROG SER, V178, P295, DOI 10.3354/meps178295; Streets DG, 2009, ENVIRON SCI TECHNOL, V43, P2983, DOI 10.1021/es802474j; Tavares PC, 2007, ARDEOLA, V54, P275; Tavares PC, 2005, B ENVIRON CONTAM TOX, V74, P177, DOI 10.1007/s00128-004-0565-z; THOMPSON DR, 1993, POLAR BIOL, V13, P239; THOMPSON DR, 1989, MAR POLLUT BULL, V20, P577, DOI 10.1016/0025-326X(89)90361-5; THOMPSON DR, 1993, J APPL ECOL, V30, P316, DOI 10.2307/2404633; THOMPSON DR, 1991, J APPL ECOL, V28, P672, DOI 10.2307/2404575; Tremblay Y, 2000, MAR ECOL PROG SER, V204, P257, DOI 10.3354/meps204257; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Watanabe YY, 2011, J EXP BIOL, V214, P412, DOI 10.1242/jeb.050161; WEIMERSKIRCH H, 1989, EMU, V89, P15, DOI 10.1071/MU9890015; WENZEL C, 1995, ARCH ENVIRON CON TOX, V29, P198	100	86	86	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54508	10.1371/journal.pone.0054508	http://dx.doi.org/10.1371/journal.pone.0054508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349912	Green Submitted, Green Published, gold			2022-12-27	WOS:000313738900074
J	Charpentier, C; Fagard, C; Colin, C; Katlama, C; Molina, JM; Jacomet, C; Visseaux, B; Taburet, AM; Brun-Vezinet, F; Chene, G; Yazdanpanah, Y; Descamps, D				Charpentier, Charlotte; Fagard, Catherine; Colin, Celine; Katlama, Christine; Molina, Jean-Michel; Jacomet, Christine; Visseaux, Benoit; Taburet, Anne-Marie; Brun-Vezinet, Francoise; Chene, Genevieve; Yazdanpanah, Yazdan; Descamps, Diane		ANRS139 TRIO Trial Study Grp	Role of Baseline HIV-1 DNA Level in Highly-Experienced Patients Receiving Raltegravir, Etravirine and Darunavir/Ritonavir Regimen (ANRS139 TRIO Trial)	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; INFECTION; REPLICATION; EFFICACY; CELLS; DECAY	Objective: In the ANRS 139 TRIO trial, the use of 3 new active drugs (raltegravir, etravirine, and darunavir/ritonavir), resulted in a potent and sustained inhibition of viral replication in multidrug-resistant treatment-experienced patients. The aim of this virological sub-study of the ANRS 139 TRIO trial was to assess: (i) the evolution of HIV-1 DNA over the first year; and (ii) the association between baseline HIV-1 DNA and virological outcome. Methods: Among the 103 HIV-1-infected patients included in the ANRS-139 TRIO trial, HIV-1 DNA specimens were available for 92, 84, 88, and 83 patients at Week (W)0, W12, W24, and W48, respectively. Quantification of total HIV-1 DNA was performed by using the commercial kit "Generic HIV DNA Cell" (Biocentric, Bandol, France). Results: Baseline median HIV-1 DNA of patients displaying virological success (n = 61), viral blip (n = 20), and virological failure (n = 11) were 2.34 log(10) copies/10(6) PBMC (IQR = 2.15-2.66), 2.42 (IQR = 2.12-2.48), and 2.68 (IQR = 2.46-2.83), respectively. Although not statistically significant, patients exhibiting virological success or viral blip had a tendency to display lower baseline HIV-1 DNA than patients experiencing virological failure (P = 0.06). Median decrease of HIV-1 DNA between baseline and W48 was -0.13 log(10) copies/10(6) PBMC (IQR = -0.34 to +0.10), mainly explained by the evolution from W0 to W4. No more changes were observed in the W4-W48 period. Conclusions: In highly-experienced multidrug-resistant patients, HIV-1 DNA slightly decreased during the first month and then remained stable during the first year of highly potent antiretroviral regimen. In this population, baseline HIV-1 DNA might help to better predict the virological response and to tailor clinical therapeutic management as more aggressive therapeutic choices in patients with higher baseline HIV-1 DNA.	[Charpentier, Charlotte; Visseaux, Benoit; Brun-Vezinet, Francoise; Descamps, Diane] Univ Paris 07, AP HP, Grp Hosp Bichat Claude Bernard, Lab Virol,HUPNVS,PRES,EA4409, Paris, France; [Fagard, Catherine; Colin, Celine; Chene, Genevieve] Univ Bordeaux, INSERM, Ctr Epidemiol Stat, ISPED,U897, Bordeaux, France; [Jacomet, Christine] UPMC, INSERM U943, AP HP, Hop Pitie Salpetriere,Serv Malad Infect, Paris, France; [Molina, Jean-Michel] Univ Paris 07, Hop St Louis, Serv Malad Infect, AP HP, Paris, France; [Jacomet, Christine] Hop Gabriel Montpied, Clermont Ferrand, France; [Taburet, Anne-Marie] Hop Univ Paris Sud, Hop Bicetre, AP HP, Pharm Serv Pharm Clin,CHU Bicetre, Le Kremlin Bicetre, France; [Chene, Genevieve] CHU Bordeaux, Serv Informat Med, Bordeaux, France; [Yazdanpanah, Yazdan] Univ Paris 07, Grp Hosp Bichat Claude Bernard, AP HP, HUPNVS,Serv Malad Infect, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Charpentier, C (corresponding author), Univ Paris 07, AP HP, Grp Hosp Bichat Claude Bernard, Lab Virol,HUPNVS,PRES,EA4409, Paris, France.	charlotte.charpentier@bch.aphp.fr	Charpentier, Charlotte/C-3579-2019; chene, genevieve/H-8665-2014	chene, genevieve/0000-0002-8368-6460	ANRS; European Community's Seventh Framework Programme (FP7) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" [223131]	ANRS(ANRSFrench National Research Agency (ANR)); European Community's Seventh Framework Programme (FP7) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)"	The authors thank Merck Sharp & Dohme-Chibret for providing raltegravir; and Tibotec, a division of Janssen-Cilag, for providing etravirine. The research leading to these results has received funding from the ANRS, and the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" (grant no. 223131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has received funding from the ANRS, and the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" (grant no. 223131).	Charpentier C, 2012, EUR J CLIN MICROBIOL, V31, P129, DOI 10.1007/s10096-011-1284-0; Fagard C, 2012, JAIDS-J ACQ IMM DEF, V59, P489, DOI 10.1097/QAI.0b013e31824bb720; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Lambert-Niclot S, 2011, J INFECT DIS, V204, P1211, DOI 10.1093/infdis/jir518; Morand-Doubert L, 2005, JAIDS-J ACQ IMM DEF, V38, P268; Ngo-Giang-Huong N, 2001, AIDS, V15, P665, DOI 10.1097/00002030-200104130-00001; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Reigadas S, 2010, J ANTIMICROB CHEMOTH, V65, P434, DOI 10.1093/jac/dkp473; Rong LB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000533; Rouzioux C, 2005, J INFECT DIS, V192, P46, DOI 10.1086/430610; Yazdanpanah Y, 2009, CLIN INFECT DIS, V49, P1441, DOI 10.1086/630210; Yerly S, 2000, AIDS, V14, P2805, DOI 10.1097/00002030-200012220-00001	12	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53621	10.1371/journal.pone.0053621	http://dx.doi.org/10.1371/journal.pone.0053621			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349724	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900014
J	de Jong, A; Hansen, ME; Kuipers, OP; Kilstrup, M; Kok, J				de Jong, Anne; Hansen, Morten E.; Kuipers, Oscar P.; Kilstrup, Mogens; Kok, Jan			The Transcriptional and Gene Regulatory Network of Lactococcus lactis MG1363 during Growth in Milk	PLOS ONE			English	Article							BACILLUS-SUBTILIS; NUCLEOTIDE-METABOLISM; EXPRESSION; SOFTWARE; GENOMICS; REGULON; IDENTIFICATION; VISUALIZATION; ENVIRONMENT; ADAPTATION	In the present study we examine the changes in the expression of genes of Lactococcus lactis subspecies cremoris MG1363 during growth in milk. To reveal which specific classes of genes (pathways, operons, regulons, COGs) are important, we performed a transcriptome time series experiment. Global analysis of gene expression over time showed that L. lactis adapted quickly to the environmental changes. Using upstream sequences of genes with correlated gene expression profiles, we uncovered a substantial number of putative DNA binding motifs that may be relevant for L. lactis fermentative growth in milk. All available novel and literature-derived data were integrated into network reconstruction building blocks, which were used to reconstruct and visualize the L. lactis gene regulatory network. This network enables easy mining in the chrono-transcriptomics data. A freely available website at http://milkts.molgenrug.nl gives full access to all transcriptome data, to the reconstructed network and to the individual network building blocks.	[de Jong, Anne; Kuipers, Oscar P.; Kok, Jan] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Groningen, Netherlands; [Hansen, Morten E.; Kilstrup, Mogens] Tech Univ Denmark, Inst Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark	University of Groningen; Technical University of Denmark	Kilstrup, M (corresponding author), Tech Univ Denmark, Inst Syst Biol, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark.	mki@bio.dtu.dk	Kok, Jan/C-9972-2012; Kilstrup, Mogens/AAV-2030-2021; Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735; Kilstrup, Mogens/0000-0002-3900-723X; Ejby, Morten/0000-0003-2099-3591	Danish Dairy Research Foundation	Danish Dairy Research Foundation	Morten Ejby was supported by a grant from the Danish Dairy Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahdesmaki M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-117; Ahdesmaki M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-233; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Beyer NH, 2003, PROTEOMICS, V3, P786, DOI 10.1002/pmic.200300416; Blom EJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-535; Bonner ER, 2001, NUCLEIC ACIDS RES, V29, P4851, DOI 10.1093/nar/29.23.4851; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Carlson JM, 2007, NUCLEIC ACIDS RES, V35, pW259, DOI 10.1093/nar/gkm310; Cretenet M, 2011, APPL ENVIRON MICROB, V77, P247, DOI 10.1128/AEM.01174-10; de Jong A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-299; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; Doeven MK, 2005, MOL MICROBIOL, V57, P640, DOI 10.1111/j.1365-2958.2005.04698.x; Dressaire C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S18; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Foucaud-Scheunemann C, 2003, FEMS MICROBIOL LETT, V224, P53, DOI 10.1016/S0378-1097(03)00419-1; GASSON MJ, 1983, J BACTERIOL, V154, P1; Guedon E, 2005, MICROBIOL-SGM, V151, P3895, DOI 10.1099/mic.0.28186-0; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jendresen CB, 2012, MICROBIOL-SGM, V158, P2026, DOI 10.1099/mic.0.059576-0; JUILLARD V, 1995, APPL ENVIRON MICROB, V61, P3024, DOI 10.1128/AEM.61.8.3024-3030.1995; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Kilstrup M, 1998, J BACTERIOL, V180, P3907, DOI 10.1128/JB.180.15.3907-3916.1998; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Klaenhammer TR, 2007, J NUTR, V137, p748S, DOI 10.1093/jn/137.3.748S; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kok J, 2005, FEMS MICROBIOL REV, V29, P411, DOI 10.1016/j.femsre.2005.04.004; Larsen R, 2005, J BIOL CHEM, V280, P19319, DOI 10.1074/jbc.M413983200; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Martirani L, 2001, FEMS MICROBIOL LETT, V198, P177, DOI 10.1016/S0378-1097(01)00142-2; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Pfeiler EA, 2007, TRENDS MICROBIOL, V15, P546, DOI 10.1016/j.tim.2007.09.010; Picard F, 2009, CR BIOL, V332, P958, DOI 10.1016/j.crvi.2009.09.005; Saal LH, 2002, GENOME BIOL, V3; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Scott C, 2000, MOL MICROBIOL, V35, P1383, DOI 10.1046/j.1365-2958.2000.01799.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siezen RJ, 2011, MICROB BIOTECHNOL, V4, P383, DOI 10.1111/j.1751-7915.2011.00247.x; Singhal M, 2007, COMPUT BIOL CHEM, V31, P222, DOI 10.1016/j.compbiolchem.2007.03.006; Sperandio B, 2005, J BACTERIOL, V187, P3762, DOI 10.1128/JB.187.11.3762-3778.2005; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; van Hijum SAFT, 2009, MICROBIOL MOL BIOL R, V73, P481, DOI 10.1128/MMBR.00037-08; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	50	24	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53085	10.1371/journal.pone.0053085	http://dx.doi.org/10.1371/journal.pone.0053085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349698	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900007
J	Streets, AM; Sourigues, Y; Kopito, RR; Melki, R; Quake, SR				Streets, Aaron M.; Sourigues, Yannick; Kopito, Ron R.; Melki, Ronald; Quake, Stephen R.			Simultaneous Measurement of Amyloid Fibril Formation by Dynamic Light Scattering and Fluorescence Reveals Complex Aggregation Kinetics	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; MUTANT HUNTINGTIN; THIOFLAVIN-T; MECHANISM; NUCLEATION; PROTEINS; PROTOFIBRILS; INCLUSIONS; BINDING; FUSION	An apparatus that combines dynamic light scattering and Thioflavin T fluorescence detection is used to simultaneously probe fibril formation in polyglutamine peptides, the aggregating subunit associated with Huntington's disease, in vitro. Huntington's disease is a neurodegenerative disorder in a class of human pathologies that includes Alzheimer's and Parkinson's disease. These pathologies are all related by the propensity of their associated protein or polypeptide to form insoluble, beta-sheet rich, amyloid fibrils. Despite the wide range of amino acid sequence in the aggregation prone polypeptides associated with these diseases, the resulting amyloids display strikingly similar physical structure, an observation which suggests a physical basis for amyloid fibril formation. Thioflavin T fluorescence reports beta-sheet fibril content while dynamic light scattering measures particle size distributions. The combined techniques allow elucidation of complex aggregation kinetics and are used to reveal multiple stages of amyloid fibril formation.	[Streets, Aaron M.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Sourigues, Yannick; Melki, Ronald] Ctr Natl Rech Sci, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Centre National de la Recherche Scientifique (CNRS); Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	quake@stanford.edu			Stanford DARE Fellowship; Agence Nationale de la Recherche [ANR-08-NEUR-001-01, ANR-09-MNPS-013-01]; CNRS; NINDS; Human Frontier Science Program; Huntington's Disease Society of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842] Funding Source: NIH RePORTER	Stanford DARE Fellowship; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontier Science Program(Human Frontier Science Program); Huntington's Disease Society of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	AMS was supported by the Stanford DARE Fellowship. YS and RM were supported by the Agence Nationale de la Recherche (ANR-08-NEUR-001-01 and ANR-09-MNPS-013-01) and the CNRS. This work was also supported by grants from the NINDS, the Human Frontier Science Program, and the Huntington's Disease Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Georgalis Y, 1998, P NATL ACAD SCI USA, V95, P6118, DOI 10.1073/pnas.95.11.6118; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Jayaraman M, 2011, METHODS, V53, P246, DOI 10.1016/j.ymeth.2011.01.001; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Pecora R, 2000, DYNAMIC LIGHT SCATTE; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; RICKA J, 1993, APPL OPTICS, V32, P2860, DOI 10.1364/AO.32.002860; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Streets AM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178102; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	33	57	57	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54541	10.1371/journal.pone.0054541	http://dx.doi.org/10.1371/journal.pone.0054541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349924	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900076
J	Arque, G; Casanovas, A; Dierssen, M				Arque, Gloria; Casanovas, Anna; Dierssen, Mara			Dyrk1A Is Dynamically Expressed on Subsets of Motor Neurons and in the Neuromuscular Junction: Possible Role in Down Syndrome	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; CEREBELLAR PHENOTYPES; SYNDROME CHILDREN; CRITICAL REGION; MOUSE MODEL; MICE; BRAIN; MNB/DYRK1A; MINIBRAIN; MOTONEURONS	Individuals with Down syndrome (DS) present important motor deficits that derive from altered motor development of infants and young children. DYRK1A, a candidate gene for DS abnormalities has been implicated in motor function due to its expression in motor nuclei in the adult brain, and its overexpression in DS mouse models leads to hyperactivity and altered motor learning. However, its precise role in the adult motor system, or its possible involvement in postnatal locomotor development has not yet been clarified. During the postnatal period we observed time-specific expression of Dyrk1A in discrete subsets of brainstem nuclei and spinal cord motor neurons. Interestingly, we describe for the first time the presence of Dyrk1A in the presynaptic terminal of the neuromuscular junctions and its axonal transport from the facial nucleus, suggesting a function for Dyrk1A in these structures. Relevant to DS, Dyrk1A overexpression in transgenic mice (TgDyrk1A) produces motor developmental alterations possibly contributing to DS motor phenotypes and modifies the numbers of motor cholinergic neurons, suggesting that the kinase may have a role in the development of the brainstem and spinal cord motor system.	[Arque, Gloria; Dierssen, Mara] Pompeu Fabra Univ, CRG, Genes & Dis Program, Barcelona, Spain; [Arque, Gloria; Dierssen, Mara] CIBER Enfermedades Raras CIBERER, Barcelona, Spain; [Casanovas, Anna] Univ Lleida, Sch Med, Dept Expt Med, Lleida, Catalonia, Spain; [Casanovas, Anna] Univ Lleida, Sch Med, IRBLLEIDA, Lleida, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universitat de Lleida; Universitat de Lleida	Dierssen, M (corresponding author), Pompeu Fabra Univ, CRG, Genes & Dis Program, PRBB, Barcelona, Spain.	mara.dierssen@crg.eu	Arque, Gloria/AHD-3561-2022; Llorens, Ana Maria Casanovas/C-3984-2011; Arque, Gloria/AAT-7266-2020; Dierssen, Mara/G-3552-2015	Llorens, Ana Maria Casanovas/0000-0001-8766-5555; Arque, Gloria/0000-0002-8039-3726; Dierssen, Mara/0000-0003-0853-6865	Departament d'Universitats, Recerca i Societat de la Informacio (DURSI) [09 2009SGR1313]; Fondo de Investigacion Sanitaria (FIS) [PI 082038]; Marato TV3; Jerome Lejeune Foundation; Reina Sofia Foundation; Areces Foundation; EU [LSHG-CT-2006-037627]; CureFXS ERare-EU/FIS [PS09102673];  [FCT-08-0782];  [SAF2007-60827];  [SAF2010-16427];  [SAF2007-31093-E]	Departament d'Universitats, Recerca i Societat de la Informacio (DURSI); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Marato TV3; Jerome Lejeune Foundation; Reina Sofia Foundation; Areces Foundation; EU(European Commission); CureFXS ERare-EU/FIS; ; ; ; 	The laboratory of MD is supported by Departament d'Universitats, Recerca i Societat de la Informacio (DURSI) (Grups consolidats 09 2009SGR1313). This work was supported by FCT-08-0782, SAF2007-60827, SAF2010-16427, SAF2007-31093-E, Fondo de Investigacion Sanitaria (FIS) (PI 082038), Marato TV3, Jerome Lejeune, Reina Sofia and Areces Foundations and EU (LSHG-CT-2006-037627; CureFXS ERare-EU/FIS PS09102673). The CIBER of Enfermedades Raras is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Altafaj X, 2008, NEUROBIOL DIS; Arque G, 2009, NEUROBIOL DIS, V36, P312, DOI 10.1016/j.nbd.2009.07.027; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; BECKER L, 1991, PROG CLIN BIOL RES, V373, P133; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; CALDERO J, 1992, NEUROSCIENCE, V48, P449, DOI 10.1016/0306-4522(92)90504-U; Casanovas A, 2001, J NEUROSCI RES, V63, P469, DOI 10.1002/jnr.1041; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; de Lagran MM, 2007, GENES BRAIN BEHAV, V6, P569, DOI 10.1111/j.1601-183X.2006.00285.x; de Lagran MM, 2004, NEUROBIOL DIS, V15, P132, DOI 10.1016/j.nbd.2003.10.002; Dierssen M, 2002, PHARMACOL BIOCHEM BE, V73, P19, DOI 10.1016/S0091-3057(02)00792-X; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Fotaki V, 2004, BEHAV NEUROSCI, V118, P815, DOI 10.1037/0735-7044.118.4.815; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Galante M, 2009, HUM MOL GENET, V18, P1449, DOI 10.1093/hmg/ddp055; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; HENDERSON SE, 1981, J CHILD PSYCHOL PSYC, V22, P233, DOI 10.1111/j.1469-7610.1981.tb00549.x; Huang Y, 2004, BIOCHEMISTRY-US, V43, P10173, DOI 10.1021/bi036060+; Latash ML, 2006, PHYS THER, V86, P1151, DOI 10.1093/ptj/86.8.1151; LATASH ML, 1991, AM J MENT RETARD, V96, P189; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; MORRIS AF, 1982, J MENT DEFIC RES, V26, P41; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olson LE, 2004, DEV DYNAM, V230, P581, DOI 10.1002/dvdy.20079; Ortiz-Abalia J, 2008, AM J HUM GENET, V83, P479, DOI 10.1016/j.ajhg.2008.09.010; Palisano RJ, 2001, ARCH PHYS MED REHAB, V82, P494, DOI 10.1053/apmr.2001.21956; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shapiro BL, 2001, J NEURAL TRANSM-SUPP, P11; Singh D N, 1982, Prog Clin Biol Res, V84, P353; STREIT WJ, 1989, NEUROSCI LETT, V101, P143, DOI 10.1016/0304-3940(89)90521-1; Wegiel J, 2004, BRAIN RES, V1010, P69, DOI 10.1016/j.brainres.2004.03.008	36	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54285	10.1371/journal.pone.0054285	http://dx.doi.org/10.1371/journal.pone.0054285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342120	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700103
J	Hadicke, J; Engelmann, M				Haedicke, Jana; Engelmann, Mario			Social Investigation and Long-Term Recognition Memory Performance in 129S1/SvImJ and C57BL/6JOlaHsd Mice and Their Hybrids	PLOS ONE			English	Article							INBRED MOUSE STRAINS; QUANTITATIVE TRAIT LOCI; IMPAIRED FEAR EXTINCTION; MAIN OLFACTORY SYSTEM; VAGINOCERVICAL STIMULATION; MATERNAL-CARE; FEMALE RATS; DISCRIMINATION PROCEDURE; BEHAVIORAL-DIFFERENCES; LOCOMOTOR-ACTIVITY	When tested for their behavioural performance, the mixed genetic background of transgenic mice is a critical, but often ignored, issue. Such issues can arise because of the significant differences in defined behavioural parameters between embryonic stem cell donor and recipient strains. In this context, the commonly used stem cell donor strain '129' shows 'deficits' in different paradigms for learning and long-term memory. We investigated the long-term social recognition memory performance and the investigative behaviour in commercially available 129S1/SvImJ and C57BL/6JOlaHsd mice and two F1-hybrids (129S1/SvImJ6C57BL/6JOlaHsd) by using the social discrimination procedure and its modification, the volatile fraction cage (VFC). Our data revealed an unimpaired olfactory long-term recognition memory not only in female and male 129S1/SvImJ and C57BL/6JOlaHsd mice but also in the two hybrid lines (129S1/SvImJxC57BL/6JOlaHsd) when the full 'olfactory signature' of the 'to-be-recognized' conspecific was presented. Under these conditions we also failed to detect differences in the long-term recognition memory between male and female mice of the tested strains and revealed that the oestrus cycle did not affect the performance in this memory task. The performance in the VFC, based only on the volatile components of the 'olfactory signature' of the 'to-be-recognized' conspecific, was similar to that observed under direct exposure except that females of one F1 hybrid group failed to show an intact long-term memory. Thus, the social discrimination procedure allowing direct access between the experimental subject and the stimulus animal(s) is highly suitable to investigate the impact of genetic manipulations on long-term memory in male and female mice of the strain 129S1/SvImJ, C57BL/6JOlaHsd and 129S1/SvImJxC57BL/6JOlaHsd hybrids.	[Haedicke, Jana; Engelmann, Mario] Otto Von Guericke Univ, Inst Biochem & Zellbiol, Magdeburg, Germany; [Engelmann, Mario] Ctr Behav Brain Sci, Magdeburg, Germany	Otto von Guericke University	Engelmann, M (corresponding author), Otto Von Guericke Univ, Inst Biochem & Zellbiol, Magdeburg, Germany.	mario.engelmann@med.ovgu.de			German Research Foundation (DFG) [EN 366/6-1, 366/8-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	ME was supported by the German Research Foundation (DFG) (EN 366/6-1 and 366/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balogh SA, 1999, BRAIN RES, V836, P38, DOI 10.1016/S0006-8993(99)01586-3; Baum MJ, 2009, HORM BEHAV, V55, P579, DOI 10.1016/j.yhbeh.2009.02.008; BLUTHE RM, 1990, BRAIN RES, V535, P301, DOI 10.1016/0006-8993(90)91613-L; Bothe GWM, 2005, COMPARATIVE MED, V55, P326; Bredy TW, 2003, NEUROSCIENCE, V118, P571, DOI 10.1016/S0306-4522(02)00918-1; Camp M, 2009, GENES BRAIN BEHAV, V8, P744, DOI 10.1111/j.1601-183X.2009.00519.x; CARR WJ, 1976, J COMP PHYSIOL PSYCH, V90, P821, DOI 10.1037/h0077266; Chesler EJ, 2012, MAMM GENOME, V23, P305, DOI 10.1007/s00335-012-9394-2; Contet C, 2001, BEHAV BRAIN RES, V124, P33, DOI 10.1016/S0166-4328(01)00231-5; Cook MN, 2002, BEHAV NEUROSCI, V116, P600, DOI 10.1037//0735-7044.116.4.600; Crawley JN, 1996, TRENDS NEUROSCI, V19, P181, DOI 10.1016/S0166-2236(96)20021-9; Crawley JN, 1996, TRENDS NEUROSCI, V19, P188; Crusio WE, 1996, TRENDS NEUROSCI, V19, P186, DOI 10.1016/S0166-2236(96)20023-2; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Crusio WE, 1996, TRENDS NEUROSCI, V19, P188; DANTZER R, 1987, PSYCHOPHARMACOLOGY, V91, P363, DOI 10.1007/BF00518192; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; Engelmann M, 1998, BEHAV BRAIN RES, V90, P89, DOI 10.1016/S0166-4328(97)00084-3; ENGELMANN M, 1995, PHYSIOL BEHAV, V58, P315, DOI 10.1016/0031-9384(95)00053-L; Engelmann M, 2011, NAT PROTOC, V6, P1152, DOI 10.1038/nprot.2011.353; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Guevara-Guzman R, 2001, BRAIN RES, V898, P303, DOI 10.1016/S0006-8993(01)02207-7; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Homanics GE, 1999, PHARMACOL BIOCHEM BE, V63, P21, DOI 10.1016/S0091-3057(98)00232-9; Keller M, 2006, EUR J NEUROSCI, V23, P521, DOI 10.1111/j.1460-9568.2005.04589.x; Korol DL, 2002, BEHAV NEUROSCI, V116, P411, DOI 10.1037//0735-7044.116.3.411; Larrazolo-Lopez A, 2008, NEUROSCIENCE, V152, P585, DOI 10.1016/j.neuroscience.2008.01.024; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Logue SF, 1997, NEUROSCIENCE, V80, P1075, DOI 10.1016/S0306-4522(97)00164-4; Macbeth AH, 2009, GENES BRAIN BEHAV, V8, P558, DOI 10.1111/j.1601-183X.2009.00506.x; Maggi A, 2004, ANNU REV PHYSIOL, V66, P291, DOI 10.1146/annurev.physiol.66.032802.154945; Markham JA, 2007, PHYSIOL BEHAV, V92, P881, DOI 10.1016/j.physbeh.2007.06.020; MATOCHIK JA, 1988, PHYSIOL BEHAV, V42, P217, DOI 10.1016/0031-9384(88)90073-X; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; Montkowski A, 1997, BRAIN RES, V762, P12, DOI 10.1016/S0006-8993(97)00370-3; Noack J, 2010, NEUROBIOL LEARN MEM, V94, P568, DOI 10.1016/j.nlm.2010.09.013; Otsuka T, 2001, EUR J NEUROSCI, V13, P1833, DOI 10.1046/j.0953-816x.2001.01557.x; Owen EH, 1997, NEUROSCIENCE, V80, P1087, DOI 10.1016/S0306-4522(97)00165-6; Paulus MP, 1999, BRAIN RES, V835, P27, DOI 10.1016/S0006-8993(99)01137-3; Richter K, 2005, LEARN MEMORY, V12, P407, DOI 10.1101/lm.97505; Sanchez-Andrade G, 2009, BEHAV BRAIN RES, V200, P323, DOI 10.1016/j.bbr.2008.12.021; SAWYER TF, 1984, BEHAV NEUROSCI, V98, P908, DOI 10.1037/0735-7044.98.5.908; Silberstein GB, 2006, J ENDOCRINOL, V190, P225, DOI 10.1677/joe.1.06725; Sinai L, 2012, GENES BRAIN BEHAV, V11, P559, DOI 10.1111/j.1601-183X.2012.00775.x; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tobin VA, 2010, NATURE, V464, P413, DOI 10.1038/nature08826; Walf AA, 2009, BEHAV BRAIN RES, V196, P254, DOI 10.1016/j.bbr.2008.09.016; WARREN JM, 1988, BEHAV GENET, V18, P167, DOI 10.1007/BF01067838; Whittle N, 2010, J NEUROSCI, V30, P13586, DOI 10.1523/JNEUROSCI.0849-10.2010; Wilkins JF, 2005, TRENDS GENET, V21, P356, DOI 10.1016/j.tig.2005.04.005	53	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54427	10.1371/journal.pone.0054427	http://dx.doi.org/10.1371/journal.pone.0054427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342157	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700115
J	Alkhedir, H; Karlovsky, P; Vidal, S				Alkhedir, Hussein; Karlovsky, Petr; Vidal, Stefan			Relationship between Water Soluble Carbohydrate Content, Aphid Endosymbionts and Clonal Performance of Sitobion avenae on Cocksfoot Cultivars	PLOS ONE			English	Article							HOST-PLANT SPECIALIZATION; PEA APHID; ACYRTHOSIPHON-PISUM; AMINO-ACIDS; CEREAL APHIDS; INSECT; SYMBIONTS; POPULATIONS; DACTYLIS; SUCROSE	Aphids feed on plant phloem sap, rich in sugars but poor in essential amino acids. However, sugars cause osmotic regulation problems for aphids, which they overcome by hydrolysing the sugars in their gut and polymerising the hydrolysis products into oligosaccharides, excreted with honeydew. Aphids harbour primary bacterial endosymbionts, which supply them with essential amino acids necessary for survival. They also harbour secondary (facultative) endosymbionts (sfS), some of which have a positive impact on life history traits, although it is not yet known whether they also play a role in providing effective tolerance to differing levels of water soluble carbohydrates (WSCs). We investigated the relationship between WSC content of cocksfoot cultivars and performance of clones of the English grain aphid Sitobion avenae F. We evaluated how clone genotype and their sfS modulate performance on these different cultivars. We therefore examined the performance of genetically defined clones of S. avenae, collected from different host plants, harbouring different sfS. The performance was tested on 10 Dactylis glomerata L. cultivars with varying WSC content. D. glomerata is known as a wild host plant for S. avenae and is also commercially planted. We found that high WSCs levels are responsible for the resistance of D. glomerata cultivars to specific S. avenae clones. The minimum level of WSCs conferring resistance to D. glomerata cultivars was 1.7% dw. Cultivars with a WSC content of 2.2% or higher were resistant to S. avenae and did not allow reproduction. Our results further indicate that sfS modulate to some extend host plant cultivar adaptation in S. avenae. This is the first study revealing the importance of WSCs for aphid performance. Cocksfoot cultivars with a high content of WSCs might be therefore considered for aphid control or used for resistance breeding in this and other grass species, including cereals.	[Alkhedir, Hussein; Vidal, Stefan] Univ Gottingen, Dept Crop Sci, D-37073 Gottingen, Germany; [Karlovsky, Petr] Univ Gottingen, Dept Crop Sci Mol Phytopathol & Mycotoxin Res, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Vidal, S (corresponding author), Univ Gottingen, Dept Crop Sci, D-37073 Gottingen, Germany.	svidal@gwdg.de	Vidal, Stefan/AAC-3130-2020	Vidal, Stefan/0000-0002-1673-4055; Karlovsky, Petr/0000-0002-6532-5856				Ashford DA, 2000, J INSECT PHYSIOL, V46, P335, DOI 10.1016/S0022-1910(99)00186-9; BLACKMAN R.L., 1984, ORIENT INSECTS; CHATTERTON NJ, 1990, NEW PHYTOL, V114, P167, DOI 10.1111/j.1469-8137.1990.tb00387.x; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Ciepiela AP, 1999, J APPL ENTOMOL, V123, P491, DOI 10.1046/j.1439-0418.1999.00401.x; DEBARRO PJ, 1995, OECOLOGIA, V104, P379, DOI 10.1007/BF00328374; Dietrich D, 2003, ANAL BIOANAL CHEM, V376, P399, DOI 10.1007/s00216-003-1847-8; Douglas AE, 2006, PHYSIOL ENTOMOL, V31, P262, DOI 10.1111/j.1365-3032.2006.00516.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Douglas AE, 2006, J EXP BIOL, V209, P1395, DOI 10.1242/jeb.02148; DOWNING N, 1978, J EXP BIOL, V77, P247; Eleftherianos I, 2006, J APPL ENTOMOL, V130, P15, DOI 10.1111/j.1439-0418.2005.01017.x; Fisher DB, 2000, LONG DISTANCE TRANSP, P730; GEIGER DR, 1994, ANNU REV PLANT PHYS, V45, P235, DOI 10.1146/annurev.pp.45.060194.001315; Kehr J, 1998, PLANT J, V16, P497, DOI 10.1046/j.1365-313x.1998.00318.x; Kerepesi I, 2000, CROP SCI, V40, P482, DOI 10.2135/cropsci2000.402482x; Leonardo TE, 2004, ECOL LETT, V7, P461, DOI 10.1111/j.1461-0248.2004.00602.x; Leonardo TE, 2003, P ROY SOC B-BIOL SCI, V270, pS209, DOI 10.1098/rsbl.2003.0064; Lushai G, 2002, B ENTOMOL RES, V92, P159, DOI 10.1079/BER2001138; Massey FP, 2006, J ANIM ECOL, V75, P595, DOI 10.1111/j.1365-2656.2006.01082.x; Mayland HF, 2000, AGRON J, V92, P1203, DOI 10.2134/agronj2000.9261203x; Mika V, 2005, PLANT SOIL ENVIRON, V51, P506, DOI 10.17221/3624-PSE; Miller LA, 2001, GRASS FORAGE SCI, V56, P383, DOI 10.1046/j.1365-2494.2001.00288.x; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P307, DOI 10.1016/j.ibmb.2006.12.005; Rhodes JD, 1997, PHYSIOL ENTOMOL, V22, P373, DOI 10.1111/j.1365-3032.1997.tb01182.x; Rhodes JD, 1996, J EXP BIOL, V199, P1269; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Sanada Y, 2004, AUST J AGR RES, V55, P1183, DOI 10.1071/AR04033; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Smith KF, 1997, GRASS FORAGE SCI, V52, P167, DOI 10.1046/j.1365-2494.1997.00067.x; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Sunnucks P, 1996, GENETICS, V144, P747; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Urbanska A, 1998, ENTOMOL EXP APPL, V86, P197, DOI 10.1023/A:1003119900578; Vialatte A, 2005, P ROY SOC B-BIOL SCI, V272, P1075, DOI 10.1098/rspb.2004.3033; VICKERMAN GP, 1979, B ENTOMOL RES, V69, P1, DOI 10.1017/S0007485300017855; Wangai AW, 2000, J PHYTOPATHOL, V148, P33, DOI 10.1111/j.1439-0434.2000.tb04621.x; Wilkinson TL, 1997, J EXP BIOL, V200, P2137; WINTER H, 1992, PLANT PHYSIOL, V99, P996, DOI 10.1104/pp.99.3.996	40	23	24	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54327	10.1371/journal.pone.0054327	http://dx.doi.org/10.1371/journal.pone.0054327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342134	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400149
J	King, EM; Chivers, JE; Rider, CF; Minnich, A; Giembycz, MA; Newton, R				King, Elizabeth M.; Chivers, Joanna E.; Rider, Christopher F.; Minnich, Anne; Giembycz, Mark A.; Newton, Robert			Glucocorticoid Repression of Inflammatory Gene Expression Shows Differential Responsiveness by Transactivation- and Transrepression-Dependent Mechanisms	PLOS ONE			English	Article							NF-KAPPA-B; AIRWAY EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; ADENOVIRAL-MEDIATED DELIVERY; ACTIVATED PROTEIN-KINASE; INDUCED LEUCINE-ZIPPER; NECROSIS-FACTOR-ALPHA; MOLECULAR-MECHANISMS; RECEPTOR-BINDING; GM-CSF	Binding of glucocorticoid to the glucocorticoid receptor (GR/NR3C1) may repress inflammatory gene transcription via direct, protein synthesis-independent processes (transrepression), or by activating transcription (transactivation) of multiple anti-inflammatory/repressive factors. Using human pulmonary A549 cells, we showed that 34 out of 39 IL-1 beta-inducible mRNAs were repressed to varying degrees by the synthetic glucocorticoid, dexamethasone. Whilst these repressive effects were GR-dependent, they did not correlate with either the magnitude of IL-1 beta-inducibility or the NF-kappa B-dependence of the inflammatory genes. This suggests that induction by IL-1 beta and repression by dexamethasone are independent events. Roles for transactivation were investigated using the protein synthesis inhibitor, cycloheximide. However, cycloheximide reduced the IL-1 beta-dependent expression of 13 mRNAs, which, along with the 5 not showing repression by dexamethasone, were not analysed further. Of the remaining 21 inflammatory mRNAs, cycloheximide significantly attenuated the dexamethasone-dependent repression of 11 mRNAs that also showed a marked time-dependence to their repression. Such effects are consistent with repression occurring via the de novo synthesis of a new product, or products, which subsequently cause repression (i.e., repression via a transactivation mechanism). Conversely, 10 mRNAs showed completely cycloheximide-independent, and time-independent, repression by dexamethasone. This is consistent with direct GR transrepression. Importantly, the inflammatory mRNAs showing attenuated repression by dexamethasone in the presence of cycloheximide also showed a significantly greater extent of repression and a higher potency to dexamethasone compared to those mRNAs showing cycloheximide-independent repression. This suggests that the repression of inflammatory mRNAs by GR transactivation-dependent mechanisms accounts for the greatest levels of repression and the most potent repression by dexamethasone. In conclusion, our data indicate roles for both transrepression and transactivation in the glucocorticoid-dependent repression of inflammatory gene expression. However, transactivation appears to account for the more potent and efficacious mechanism of repression by glucocorticoids on these IL-1 beta-induced genes.	[King, Elizabeth M.; Chivers, Joanna E.; Rider, Christopher F.; Giembycz, Mark A.; Newton, Robert] Univ Calgary, Airways Inflammat Res Grp, Snyder Inst Chron Dis, Fac Med, Calgary, AB, Canada; [Minnich, Anne] Bristol Myers Squibb Co, Clin Biomarkers Immunol, Princeton, NJ USA	University of Calgary; Bristol-Myers Squibb	Newton, R (corresponding author), Univ Calgary, Airways Inflammat Res Grp, Snyder Inst Chron Dis, Fac Med, Calgary, AB, Canada.	rnewton@ucalgary.ca	Rider, Christopher F/H-7073-2019; Newton, Robert/C-6814-2012	Rider, Christopher F/0000-0003-0399-5931; Newton, Robert/0000-0002-4919-8498	Alberta Innovates - Health Solutions (AI-HS); Canadian Institutes of Health Research (CIHR); AstraZeneca; GlaxoSmithKline; Canadian Fund for Innovation (CFI); Alberta Science and Research Authority	Alberta Innovates - Health Solutions (AI-HS); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Canadian Fund for Innovation (CFI)(Canada Foundation for Innovation); Alberta Science and Research Authority	This research was supported by an Alberta Innovates - Health Solutions (AI-HS) start-up grant and operating grants from the Canadian Institutes of Health Research (CIHR), as well as funding from AstraZeneca and GlaxoSmithKline. RN was a CIHR New Investigator and is an AI-HS Scholar. EMK held an AI-HS studentship award. CFR holds an AI-HS studentship award. MAG holds a Tier 1 Canada Research Chair in Pulmonary Pharmacology. Real-time PCR was performed using an equipment and infrastructure grant from the Canadian Fund for Innovation (CFI) and the Alberta Science and Research Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Bartholomew W R, 1990, Immunol Ser, V52, P33; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; Brostjan C, 1996, J BIOL CHEM, V271, P19612, DOI 10.1074/jbc.271.32.19612; Catley MC, 2006, MOL PHARMACOL, V70, P697, DOI 10.1124/mol.106.023150; Catley MC, 2005, BRIT J PHARMACOL, V145, P114, DOI 10.1038/sj.bjp.0706170; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Cornish AL, 2009, NAT REV RHEUMATOL, V5, P554, DOI 10.1038/nrrheum.2009.178; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Hofmann TG, 2002, BIOL CHEM, V383, P1947, DOI 10.1515/BC.2002.219; Holden NS, 2007, BRIT J PHARMACOL, V152, P891, DOI 10.1038/sj.bjp.0707457; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kelly M, 2011, BR J PHARM; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; KWON OJ, 1994, IMMUNOLOGY, V81, P389; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Newton R, 1998, EUR J BIOCHEM, V254, P81, DOI 10.1046/j.1432-1327.1998.2540081.x; Newton R, 2002, EUR J PHARMACOL, V441, P193, DOI 10.1016/S0014-2999(01)01624-7; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Peeters BWMM, 2008, ANN NY ACAD SCI, V1148, P536, DOI 10.1196/annals.1410.072; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Ray KP, 1997, BIOCHEM J, V328, P707; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Stellato Cristiana, 2004, Proc Am Thorac Soc, V1, P255, DOI 10.1513/pats.200402-015MS; Sukkar MB, 2004, AM J PHYSIOL-LUNG C, V287, pL1230, DOI 10.1152/ajplung.00014.2004; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Taube C, 2006, P NATL ACAD SCI USA, V103, P8084, DOI 10.1073/pnas.0602357103; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Vereecke L, 2011, BIOCHEM SOC T, V39, P1086, DOI 10.1042/BST0391086; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang YS, 1997, J IMMUNOL, V159, P534; Webster JC, 2002, ENDOCRINOLOGY, V143, P3866, DOI 10.1210/en.2002-220188	64	57	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53936	10.1371/journal.pone.0053936	http://dx.doi.org/10.1371/journal.pone.0053936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23349769	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400101
J	de Voux, A; Chan, MC; Folefoc, AT; Madziva, MT; Flanagan, CA				de Voux, Alex; Chan, Mei-Chi; Folefoc, Asongna T.; Madziva, Michael T.; Flanagan, Colleen A.			Constitutively Active CCR5 Chemokine Receptors Differ in Mediating HIV Envelope-dependent Fusion	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; IMMUNODEFICIENCY-VIRUS TYPE-1; BETA(2) ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL INSTABILITY; DRY MOTIF; BETA(2)-ADRENERGIC RECEPTOR; TRANSMEMBRANE HELIX-2; INDUCED ACTIVATION; SMALL-MOLECULE	The CCR5 chemokine receptor is a rhodopsin-like G protein-coupled receptor that mediates the effects of pro-inflammatory beta-chemokines. CCR5 is also the major co-receptor for entry of human immunodeficiency virus (HIV) into human cells. G protein-coupled receptors exist in ensembles of active and inactive conformations. Active receptor conformations can be stabilized by mutations. Although binding of the HIV envelope protein to CCR5 stimulates cellular signaling, the CCR5 conformation that induces fusion of the viral membrane with cellular membranes is not known. We mutated conserved amino acids to generate constitutively active CCR5 receptors, which are stabilized in active conformations, and tested the ability of constitutively active CCR5 receptors to mediate HIV envelope-directed membrane fusion. Mutation of the Asp(3.49(125)) and Arg(6.32(225)) residues of CCR5 did not cause constitutive activity, but Lys or Pro substitutions for Thr(2.56(82)), in the TxP motif, caused high basal inositol phosphate signaling. Signaling did not increase in response to MIP-1 beta, suggesting that the Thr(2.56(82)) mutants were fully stabilized in active conformations. The Thr(2.56(82)) Lys mutation severely decreased cell surface CCR5 expression. Combining the Thr(2.56(82)) Lys mutation with an Arg(6.32(225)) Gln mutation partially reversed the decrease in expression. Mutants with Thr(2.56(82)) Lys substitutions were poor mediators of HIV envelope-directed membrane fusion, but mutants with the Thr(2.65(82)) Pro substitution exhibited full co-receptor function. Our results suggest that the Thr(2.65(82)) Lys and Thr(2.65(82)) Pro mutations stabilize distinct constitutively active CCR5 conformations. Lys in position 2.65(82) stabilizes activated receptor conformations that appear to be constitutively internalized and do not induce envelope-dependent membrane fusion, whereas Pro stabilizes activated conformations that are not constitutively internalized and fully mediate envelope-directed membrane fusion.	[de Voux, Alex; Chan, Mei-Chi; Folefoc, Asongna T.] Univ Cape Town, Fac Hlth Sci, Med Res Council Receptor Biol Res Unit, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Madziva, Michael T.; Flanagan, Colleen A.] Univ Witwatersrand, Sch Physiol, Med Res Council Receptor Biol Res Unit, Johannesburg, South Africa	University of Cape Town; University of Witwatersrand	Flanagan, CA (corresponding author), Univ Witwatersrand, Sch Physiol, Med Res Council Receptor Biol Res Unit, Johannesburg, South Africa.	Colleen.Flanagan@wits.ac.za	Flanagan, Colleen/ABG-2109-2020	Flanagan, Colleen A./0000-0003-2803-8986	South African Medical Research Council; National Research Foundation; Polio research Foundation; Mandela Rhodes Foundation	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation; Polio research Foundation; Mandela Rhodes Foundation	This work was supported by grants from the South African Medical Research Council, the National Research Foundation and the Polio research Foundation. Alex de Voux was supported by scholarships from the Mandela Rhodes Foundation and the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Alewijnse AE, 2000, MOL PHARMACOL, V57, P890; Amara A, 2003, J VIROL, V77, P2550, DOI 10.1128/JVI.77.4.2550-2558.2003; Arias DA, 2003, J BIOL CHEM, V278, P36513, DOI 10.1074/jbc.M303739200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Beinborn M, 2004, MOL PHARMACOL, V65, P753, DOI 10.1124/mol.65.3.753; Buontempo PJ, 2009, VIROLOGY, V395, P268, DOI 10.1016/j.virol.2009.09.029; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DALBEY RE, 1990, TRENDS BIOCHEM SCI, V15, P253, DOI 10.1016/0968-0004(90)90047-F; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Flanagan CA, 1998, ENDOCRINOLOGY, V139, P4115, DOI 10.1210/en.139.10.4115; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Folefoc AT, 2010, JAIDS-J ACQ IMM DEF, V54, P352, DOI 10.1097/QAI.0b013e3181e0c7b2; Freedman BD, 2003, IMMUNOL RES, V27, P261, DOI 10.1385/IR:27:2-3:261; Fromme BJ, 2008, AIDS RES HUM RETROV, V24, P1527, DOI 10.1089/aid.2008.0105; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Gosling J, 1997, P NATL ACAD SCI USA, V94, P5061, DOI 10.1073/pnas.94.10.5061; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jenkinson S, 2003, RECEPTOR CHANNEL, V9, P117, DOI 10.1080/10606820308248; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; Millar R, 1995, METH NEUROSCI, P145; Milligan G, 1997, TRENDS PHARMACOL SCI, V18, P468, DOI 10.1016/S0165-6147(97)90685-4; Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Springael JY, 2007, CELL SIGNAL, V19, P1446, DOI 10.1016/j.cellsig.2007.01.022; Tilton JC, 2010, AIDS RES HUM RETROV, V26, P13, DOI 10.1089/aid.2009.0132; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Vaidehi N, 2010, CURR OPIN PHARMACOL, V10, P775, DOI 10.1016/j.coph.2010.09.004; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	64	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54532	10.1371/journal.pone.0054532	http://dx.doi.org/10.1371/journal.pone.0054532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355876	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500083
J	Goulart, M; Da Costa, N; Santos, A; Takase, E; Da Silva, S				Goulart, Marco; Da Costa, Newton, Jr.; Santos, Andre; Takase, Emilio; Da Silva, Sergio			Psychophysiological Correlates of the Disposition Effect	PLOS ONE			English	Article								We assess the psychophysiological characteristics underlying the disposition effect and find that subjects showing greater disposition effect are those who sweat more and present lower body temperature and heart rate.	[Goulart, Marco; Da Costa, Newton, Jr.; Santos, Andre; Da Silva, Sergio] Univ Fed Santa Catarina, Grad Program Econ, BR-88040900 Florianopolis, SC, Brazil; [Takase, Emilio] Univ Fed Santa Catarina, Grad Program Psychol, BR-88040900 Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Goulart, M (corresponding author), Univ Fed Santa Catarina, Grad Program Econ, BR-88040900 Florianopolis, SC, Brazil.	marcofloripa@gmail.com	Da Silva, Sergio/A-2477-2008; da Costa Jr., Newton C. A./AAZ-4155-2020; Goulart, Marco/HIK-2688-2022; Santos, Andre A. P./V-3051-2018	Da Silva, Sergio/0000-0002-7987-4098; da Costa Jr., Newton C. A./0000-0001-7723-2676; Goulart, Marco/0000-0002-8705-1446; Santos, Andre A. P./0000-0001-6134-8930	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [475085/2008-6, 014/2008- Universal]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Research funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/MCT/CNPq No 014/2008- Universal) (Process number: 475085/2008-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Brooks AM, 2012, NEUROIMAGE, V59, P4086, DOI 10.1016/j.neuroimage.2011.10.081; Da Costa N, 2008, APPL ECON LETT, V15, P411, DOI 10.1080/13504850600706560; Dhar R, 2006, MANAGE SCI, V52, P726, DOI 10.1287/mnsc.1040.0473; Kahneman D., 2011, THINKING FAST SLOW; Lo AW, 2002, J COGNITIVE NEUROSCI, V14, P323, DOI 10.1162/089892902317361877; Odean T, 1998, J FINANC, V53, P1775, DOI 10.1111/0022-1082.00072; RimmKaufman SE, 1996, MOTIV EMOTION, V20, P63, DOI 10.1007/BF02251007; Weber M, 1998, J ECON BEHAV ORGAN, V33, P167, DOI 10.1016/S0167-2681(97)00089-9	9	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54542	10.1371/journal.pone.0054542	http://dx.doi.org/10.1371/journal.pone.0054542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23355877	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500085
J	Amit, L; Ben-Aharon, I; Vidal, L; Leibovici, L; Stemmer, S				Amit, Limor; Ben-Aharon, Irit; Vidal, Liat; Leibovici, Leonard; Stemmer, Salomon			The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review	PLOS ONE			English	Review							PHASE-III TRIAL; CELL LUNG-CANCER; ENDOTHELIAL GROWTH-FACTOR; PACLITAXEL PLUS BEVACIZUMAB; ADVANCED COLORECTAL-CANCER; 1ST-LINE TREATMENT; NEOADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; BREAST-CANCER; DOUBLE-BLIND	Purpose: To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patients with metastatic solid tumors. Design: A systematic literature search to identify randomized trials comparing chemotherapy with and without Bevacizumab in metastatic cancer. The primary end point was overall survival (OS) and the secondary end points were progression free survival (PFS) and toxicity. A meta-analysis was performed for each tumor type and for the combination of all tumors. Results: 24 randomized trials with 8 different types of malignancies were included in this meta-analysis. Patients treated with Bevacizumab had an OS benefit, hazard ratio (HR) 0.89 (95% CI 0.84-0.93, P, 0.00001 I-2-4%). The combined analysis showed a PFS benefit with a HR 0.71 (95% CI 0.68-0.74, P, 0.00001, I-2-54%). The toxicity analysis showed a statistically significant increase in fatal adverse events (FAEs) in the Bevacizumab treatment arm, risk ratio (RR) 1.47 (95% CI 1.1-1.98). A separate analysis of the lung cancer trials showed an increased risk of fatal pulmonary hemorrhage with a RR of 5.65 (95% CI 1.26-25.26). The risk of G3-4 adverse events was increased: RR 1.2 (95% CI 1.15-1.24). Conclusion: in this combined analysis Bevacizumab improved OS (with little heterogeneity) and PFS. These results should be considered in the light of lack of markers predictive of response and the increased severe and fatal toxicity seen with Bevacizumab treatment.	[Amit, Limor; Ben-Aharon, Irit; Stemmer, Salomon] Rabin Med Ctr, Davidoff Ctr, Inst Oncol, Petah Tiqwa, Israel; [Amit, Limor; Ben-Aharon, Irit; Vidal, Liat; Leibovici, Leonard; Stemmer, Salomon] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Vidal, Liat] Rabin Med Ctr, Davidoff Ctr, Inst Hematol, Petah Tiqwa, Israel; [Leibovici, Leonard] Med E Rabin Med Ctr, Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	Amit, L (corresponding author), Rabin Med Ctr, Davidoff Ctr, Inst Oncol, Beilinson Campus, Petah Tiqwa, Israel.	limor.amit@gmail.com						Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Bono P, 2009, ANN ONCOL, V20, P393, DOI 10.1093/annonc/mdn729; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Brufsky A, 2009, SABCS; Brufsky A, 2010, J CLIN ONCOL S, V28, p15s; Brufsky A, 2010, ANGIOGENESIS INHIBIT; Brufsky AM, 2012, JCO S27, V30, P27; Chan A, 2010, ANN ONCOL, V21, P2305, DOI 10.1093/annonc/mdq122; Dahlberg SE, 2010, J CLIN ONCOL, V28, P949, DOI 10.1200/JCO.2009.25.4482; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Eskens FALM, 2008, EUR J CANCER, V44, P2350, DOI 10.1016/j.ejca.2008.07.042; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Golfinopoulos V, 2007, LANCET ONCOL, V8, P898, DOI 10.1016/S1470-2045(07)70281-4; Gray R, 2009, J CLIN ONCOL, V27, P4966, DOI 10.1200/JCO.2008.21.6630; Gridelli C, 2007, ONCOLOGIST, V12, P1183, DOI 10.1634/theoncologist.12-10-1183; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz HI, 2011, J CLIN ONCOL, V29, P1757, DOI 10.1200/JCO.2010.32.3220; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3706, DOI 10.1200/JCO.2005.00.232; Kelly WK, 2012, J CLIN ONCOL, V30, P1534, DOI 10.1200/JCO.2011.39.4767; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim KB, 2012, J CLIN ONCOL, V30, P34, DOI 10.1200/JCO.2011.34.6270; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Linderholm B, 2000, J CLIN ONCOL, V18, P1423, DOI 10.1200/JCO.2000.18.7.1423; Loupakis F, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-58; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; O'Shaughnessy J, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.1005; Ocana A, 2011, J CLIN ONCOL, V29, P254, DOI 10.1200/JCO.2010.32.0275; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Rini B.I., 2010, JCO, V28, P1; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Robert A, 2009, SABCS 2009; Robert NJ, 2009, J CLIN ONCOL, V27; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Rosen LS, 2010, ONCOLOGIST, V15, P216, DOI 10.1634/theoncologist.2009-0145; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Scartozzi M, 2009, ANN ONCOL, V20, P227, DOI 10.1093/annonc/mdn637; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; Shah MA, 2006, J CLIN ONCOL, V24, P5201, DOI 10.1200/JCO.2006.08.0887; Tebbutt NC, 2010, J CLIN ONCOL, V28, P3191, DOI 10.1200/JCO.2009.27.7723; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Wagner AD, 2009, COCHRANE DB SYST REV, V8, P3, DOI DOI 10.1002/14651858; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Welch S, 2010, ANN ONCOL, V21, P1152, DOI 10.1093/annonc/mdp533; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Zhu JY, 2012, JAMA-J AM MED ASSOC, V307, P1593, DOI 10.1001/jama.2012.454	59	63	66	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e51780	10.1371/journal.pone.0051780	http://dx.doi.org/10.1371/journal.pone.0051780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349675	Green Submitted, gold, Green Published			2022-12-27	WOS:000314019100008
J	Ariesandi, W; Chang, CF; Chen, TE; Chen, YR				Ariesandi, Winny; Chang, Chi-Fon; Chen, Tseng-Erh; Chen, Yun-Ru			Temperature-Dependent Structural Changes of Parkinson's Alpha-Synuclein Reveal the Role of Pre-Existing Oligomers in Alpha-Synuclein Fibrillization	PLOS ONE			English	Article							AMYLOID FIBRILS; DISEASE; FIBRILLATION; AGGREGATION; PROTEINS; PHOSPHORYLATION; IDENTIFICATION; NEUROTOXICITY; DISSOCIATION; PATHOGENESIS	Amyloid fibrils of alpha-synuclein are the main constituent of Lewy bodies deposited in substantial nigra of Parkinson's disease brains. alpha-Synuclein is an intrinsically disordered protein lacking compact secondary and tertiary structures. To enhance the understanding of its structure and function relationship, we utilized temperature treatment to study alpha-synuclein conformational changes and the subsequent effects. We found that after 1 hr of high temperature pretreatment, >80 degrees C, alpha-synuclein fibrillization was significantly inhibited. However, the temperature melting coupled with circular dichroism spectra showed that alpha-synuclein was fully reversible and the NMR studies showed no observable structural changes of alpha-synuclein after 95 degrees C treatment. By using cross-linking and analytical ultracentrifugation, rare amount of pre-existing alpha-synuclein oligomers were found to decrease after the high temperature treatment. In addition, a small portion of C-terminal truncation of alpha-synuclein also occurred. The reduction of pre-existing oligomers of alpha-synuclein may contribute to less seeding effect that retards the kinetics of amyloid fibrillization. Overall, our results showed that the pre-existing oligomeric species is a key factor contributing to alpha-synuclein fibrillization. Our results facilitate the understanding of alpha-synuclein fibrillization.	[Ariesandi, Winny; Chang, Chi-Fon; Chen, Tseng-Erh; Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Ariesandi, Winny; Chen, Yun-Ru] Acad Sinica, Taiwan Int Grad Program, Taipei 115, Taiwan; [Ariesandi, Winny] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Tsing Hua University	Chen, YR (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	yrchen@gate.sinica.edu.tw	Chen, Yun-Ru/C-9304-2014	Chen, Yun-Ru/0000-0002-6596-6338; Chang, Chi-Fon/0000-0002-2961-0748	Genomics Research Center, Academia Sinica, Taiwan; National Science Council, Taiwan [98-2320-B-001-020-MY3, 101-2320-B-001-035]	Genomics Research Center, Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The funding for the research is from the Genomics Research Center, Academia Sinica, Taiwan and National Science Council, Taiwan (98-2320-B-001-020-MY3 and 101-2320-B-001-035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bonini NM, 2005, CELL, V123, P359, DOI 10.1016/j.cell.2005.10.017; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Gast K, 2003, EUR BIOPHYS J BIOPHY, V31, P586, DOI 10.1007/s00249-002-0254-y; Giehm L, 2010, J MOL BIOL, V401, P115, DOI 10.1016/j.jmb.2010.05.060; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hokenson MJ, 2004, BIOCHEMISTRY-US, V43, P4621, DOI 10.1021/bi049979h; Hong DP, 2011, FEBS LETT, V585, P561, DOI 10.1016/j.febslet.2011.01.009; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kim HY, 2008, ANGEW CHEM INT EDIT, V47, P5046, DOI 10.1002/anie.200800342; Kjaergaard M, 2010, PROTEIN SCI, V19, P1555, DOI 10.1002/pro.435; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Li HT, 2006, PROTEIN PEPTIDE LETT, V13, P385, DOI 10.2174/092986606775974384; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maiti NC, 2004, J AM CHEM SOC, V126, P2399, DOI 10.1021/ja0356176; Malm J, 2007, FEBS J, V274, P4503, DOI 10.1111/j.1742-4658.2007.05979.x; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Munishkina LA, 2009, CURR ALZHEIMER RES, V6, P252, DOI 10.2174/156720509788486491; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Park SM, 2002, J BIOL CHEM, V277, P28512, DOI 10.1074/jbc.M111971200; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Sidhu A, 2004, FASEB J, V18, P637, DOI 10.1096/fj.03-1112rev; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vadysirisack DD, 2007, J BIOL CHEM, V282, P36820, DOI 10.1074/jbc.M706817200; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200	53	23	24	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53487	10.1371/journal.pone.0053487	http://dx.doi.org/10.1371/journal.pone.0053487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349712	gold, Green Submitted, Green Published			2022-12-27	WOS:000314019100021
J	Gallo, A; Russo, GL; Tosti, E				Gallo, Alessandra; Russo, Gian Luigi; Tosti, Elisabetta			T-Type Ca2+Current Activity during Oocyte Growth and Maturation in the Ascidian Styela plicata	PLOS ONE			English	Article							EARLY DEVELOPMENTAL-STAGES; CALCIUM-CHANNELS; MEIOSIS REINITIATION; MEIOTIC MATURATION; CA2+ CHANNELS; ION CURRENTS; CELL-CYCLE; RUDITAPES-PHILIPPINARUM; FERTILIZATION CURRENT; SIGNALING PATHWAYS	Voltage-dependent calcium currents play a fundamental role during oocyte maturation, mostly L-type calcium currents, whereas T-type calcium currents are involved in sperm physiology and cell growth. In this paper, using an electrophysiological and pharmacological approach, we demonstrated, for the first time in oocytes, that T-type calcium currents are present with functional consequences on the plasma membrane of growing immature oocytes of the ascidian Styela plicata. We classified three subtypes of immature oocytes at the germinal vesicle stage on the basis of their size, morphology and accessory cellular structures. These stages were clearly associated with an increased activity of T-type calcium currents and hyperpolarization of the plasma membrane. We also observed that T-type calcium currents oscillate in the post-fertilization embryonic stages, with minimal amplitude of the currents in the zygote and maximal at 8-cell stage. In addition, chemical inhibition of T-type calcium currents, obtained by applying specific antagonists, induced a significant reduction in the rate of cleavage and absence of larval formation. We suggest that calcium entry via T-type calcium channels may act as a potential pacemaker in regulating cytosolic calcium involved in fertilization and early developmental events.	[Gallo, Alessandra; Russo, Gian Luigi; Tosti, Elisabetta] Stn Zool Anton Dohrn, Anim Physiol & Evolut Lab, Naples, Italy; [Russo, Gian Luigi] CNR, Inst Food Sci, Avellino, Italy	Stazione Zoologica Anton Dohrn di Napoli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Tosti, E (corresponding author), Stn Zool Anton Dohrn, Anim Physiol & Evolut Lab, Naples, Italy.	tosti@szn.it	RUSSO, GIAN LUIGI/GQB-0962-2022; Gallo, Alessandra/AAA-3132-2022	RUSSO, GIAN LUIGI/0000-0001-9321-1613; Gallo, Alessandra/0000-0002-2558-4722	Stazione Zoologica Anton Dohrn	Stazione Zoologica Anton Dohrn	Institutional funds from Stazione Zoologica Anton Dohrn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOULT C, 1994, J MEMBRANE BIOL, V137, P127; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bezzaouia A, 2012, ZYGOTE IN PRESS; Boni R, 2002, BIOL REPROD, V66, P836, DOI 10.1095/biolreprod66.3.836; Boni R, 2007, THERIOGENOLOGY, V68, pS156, DOI 10.1016/j.theriogenology.2007.05.048; BOSMA MM, 1990, J MEMBRANE BIOL, V114, P231, DOI 10.1007/BF01869217; BROWNLEE C, 1990, PROC R SOC SER B-BIO, V239, P321, DOI 10.1098/rspb.1990.0019; Cantiello HF, 1997, J EXP ZOOL, V279, P425, DOI 10.1002/(SICI)1097-010X(19971201)279:5<425::AID-JEZ4>3.0.CO;2-Q; Capiod T, 2011, BIOCHIMIE, V93, P2075, DOI 10.1016/j.biochi.2011.07.015; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; Colas P, 1998, SEMIN CELL DEV BIOL, V9, P539, DOI 10.1006/scdb.1998.0248; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Corbo JC, 2001, CELL, V106, P535, DOI 10.1016/S0092-8674(01)00481-0; Cui XS, 2007, REPROD FERT DEVELOP, V19, P25, DOI 10.1071/RD06128; Cuomo A, 2006, MOL REPROD DEV, V73, P501, DOI 10.1002/mrd.20404; Cuomo A, 2005, J EXP ZOOL PART A, V303A, P193, DOI 10.1002/jez.a.152; Dale, 1997, IN VITRO FERTILIZATI; DALE B, 1991, EXP CELL RES, V192, P302, DOI 10.1016/0014-4827(91)90190-6; DALE B, 1983, FERTILIZATION ANIMAL; Dale B., 2011, OOCYTE MATURATION FE, P104; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; Darszon A, 2006, CELL CALCIUM, V40, P241, DOI 10.1016/j.ceca.2006.04.028; Day ML, 1998, PFLUG ARCH EUR J PHY, V436, P834, DOI 10.1007/s004240050712; DUBE F, 1992, BIOCHEM BIOPH RES CO, V189, P79, DOI 10.1016/0006-291X(92)91528-X; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; Ertel SI, 1997, CARDIOVASC DRUG THER, V11, P723, DOI 10.1023/A:1007706022381; GUERRIER P, 1993, DEV BIOL, V159, P474, DOI 10.1006/dbio.1993.1257; HAGIWARA S, 1979, ANNU REV BIOPHYS BIO, V8, P385, DOI 10.1146/annurev.bb.08.060179.002125; HIRANO T, 1984, J PHYSIOL-LONDON, V347, P327, DOI 10.1113/jphysiol.1984.sp015068; HOMA ST, 1995, MOL REPROD DEV, V40, P122, DOI 10.1002/mrd.1080400116; Hotsuliak Ia M, 2002, Fiziol Zh, V48, P98; Huc S, 2009, BBA-MOL CELL RES, V1793, P947, DOI 10.1016/j.bbamcr.2008.11.003; Jaffe L.F., 1980, Annals of the New York Academy of Sciences, V339, P86, DOI 10.1111/j.1749-6632.1980.tb15971.x; Jagannathan S, 2002, REPRODUCTION, V123, P203, DOI 10.1530/rep.0.1230203; JEFFERY WR, 1978, DEV BIOL, V67, P152, DOI 10.1016/0012-1606(78)90306-8; Kumano G, 2007, DEV DYNAM, V236, P1732, DOI 10.1002/dvdy.21108; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lambert CC, 2005, DEV GROWTH DIFFER, V47, P265; Lambert CC, 2011, MOL REPROD DEV, V78, P726, DOI 10.1002/mrd.21349; Leclerc C, 2000, BIOL CELL, V92, P285, DOI 10.1016/S0248-4900(00)01069-8; Lee JH, 2011, J ASSIST REPROD GEN, V28, P23, DOI 10.1007/s10815-010-9480-x; Lee JH, 2004, MOL REPROD DEV, V69, P174, DOI 10.1002/mrd.20162; Lemaire P, 2011, DEVELOPMENT, V138, P2143, DOI 10.1242/dev.048975; Machaca K, 2007, J CELL PHYSIOL, V213, P331, DOI 10.1002/jcp.21194; McGivern JG, 2006, CNS NEUROL DISORD-DR, V5, P587, DOI 10.2174/187152706779025535; Menezo Y.R., 2011, OOCYTE MATURATION FE, P64; Moody WJ, 1998, CURR TOP DEV BIOL, V39, P159, DOI 10.1016/S0070-2153(08)60455-X; Moreau M, 1996, ZYGOTE, V4, P151, DOI 10.1017/S0967199400003038; Murnane JM, 1993, ZYGOTE, V1, P50, DOI 10.1017/S0967199400001295; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Russo GL, 1998, SEMIN CELL DEV BIOL, V9, P559, DOI 10.1006/scdb.1998.0250; SAKAIRI K, 1991, DEV GROWTH DIFFER, V33, P155; Satoh N., 1994, DEV BIOL ASCIDIAN; Silvestre F, 2009, MOL REPROD DEV, V76, P1084, DOI 10.1002/mrd.21073; SIMONCINI L, 1988, SCIENCE, V242, P1572, DOI 10.1126/science.2849207; *STAT AN SYST I, 1988, US GUID STAT REL 6 0; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Tomkowiak M, 1997, J CELL BIOCHEM, V64, P152, DOI 10.1002/(SICI)1097-4644(199701)64:1<152::AID-JCB17>3.0.CO;2-N; Tosti E, 2004, HUM REPROD UPDATE, V10, P53, DOI 10.1093/humupd/dmh006; Tosti E, 2003, MOL REPROD DEV, V66, P72, DOI 10.1002/mrd.10332; Tosti E, 2000, AM J PHYSIOL-CELL PH, V279, pC1795, DOI 10.1152/ajpcell.2000.279.6.C1795; Tosti E., 2011, OOCYTE MATURATION FE; Tosti E, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-26; Tosti E, 2011, MOL REPROD DEV, V78, P854, DOI 10.1002/mrd.21316; Tosti E, 2010, MOL REPROD DEV, V77, P856, DOI 10.1002/mrd.21215; Ullrich N, 1997, AM J PHYSIOL-CELL PH, V273, pC1290, DOI 10.1152/ajpcell.1997.273.4.C1290; Yamashita M, 2000, Prog Cell Cycle Res, V4, P115; YAMASHITA N, 1982, J PHYSIOL-LONDON, V329, P263, DOI 10.1113/jphysiol.1982.sp014302; Yanagimachi R., 1994, PHYSL REPROD; YAZAKI I, 1995, DEVELOPMENT, V121, P1827	72	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54604	10.1371/journal.pone.0054604	http://dx.doi.org/10.1371/journal.pone.0054604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349937	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100083
J	Yeka, A; Tibenderana, J; Achan, J; D'Alessandro, U; Talisuna, AO				Yeka, Adoke; Tibenderana, James; Achan, Jane; D'Alessandro, Umberto; Talisuna, Ambrose O.			Efficacy of Quinine, Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine as Rescue Treatment for Uncomplicated Malaria in Ugandan Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; COMBINATION THERAPY; POPULATION PHARMACOKINETICS; ARTEMISININ RESISTANCE; ORAL QUININE; CHLOROQUINE; DRUG; CLINDAMYCIN; MONOTHERAPY; TRIAL	Background: The treatment of falciparum malaria poses unique challenges in settings where malaria transmission intensity is high because recurrent infections are common. These could be new infections, recrudescences, or a combination of the two. Though several African countries continue to use quinine as the second line treatment for patients with recurrent infections, there is little information on its efficacy when used for rescue therapy. Moreover, such practice goes against the World Health Organisation (WHO) recommendation to use combination therapy for uncomplicated malaria. Methods: We conducted a nested, randomized, open label, three-arm clinical trial of rescue therapy in children 6-59 months old with recurrent malaria infection during 28 days post treatment with artemisinin combination treatment (ACT). Patients were randomly assigned to receive either quinine, artemether-lumefantrine (AL) or dihydroartemisinin-piperaquine (DHAPQ), and actively followed up for 28 days. Findings: Among 220 patients enrolled, 217 (98.6%) were assigned an efficacy outcome and 218 (99.1%) were assessed for safety. The risk of recurrent infection was significantly higher in patients treated with quinine (70%, 74/110, HR = 3.9; 95% CI: 2.4-6.7, p<0.0001) and AL (60%, 21/35, HR = 3.3; 95% CI: 1.8-6.3, p<0.0002), compared to DHAPQ (25%, 18/72). Recrudescence tended to be lower in the DHAPQ (1%, 1/72) than in the quinine (7%, 8/110) or AL (6%, 2/35) group, though it was not statistically significant. No serious adverse events were reported. Conclusion: Recurrent infections observed after the administration of an ACT can be successfully treated with an alternative ACT rather than with quinine.	[Yeka, Adoke; Achan, Jane] Uganda Malaria Surveillance Project, Kampala, Uganda; [Tibenderana, James] Malaria Consortium, Kampala, Uganda; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [Talisuna, Ambrose O.] Univ Oxford, KEMRI, Wellcome Trust Res Programme, World Wide Antimalarial Resistance Network, Nairobi, Kenya	Institute of Tropical Medicine (ITM)	Yeka, A (corresponding author), Uganda Malaria Surveillance Project, Kampala, Uganda.	yadoke@yahoo.com	D'Alessandro, Umberto/D-3457-2015; Tibenderana, James Kananura/M-2272-2018	D'Alessandro, Umberto/0000-0001-6341-5009; Tibenderana, James Kananura/0000-0002-0755-4597	European & Developing Countries Clinical Trials Partnership Project [NCT00393679]; Institute of Tropical Medicine, Antwerp, Belgium [3 DGCD-ITM 2008-2013]; Institute of Tropical Medicine, Antwerp	European & Developing Countries Clinical Trials Partnership Project; Institute of Tropical Medicine, Antwerp, Belgium; Institute of Tropical Medicine, Antwerp	This investigation received financial support from the European & Developing Countries Clinical Trials Partnership Project Number NCT00393679, and from the Institute of Tropical Medicine, Antwerp, Belgium embedded in the Framework Agreement 3 DGCD-ITM 2008-2013, and labelled "Capacity Strengthening for Health Systems Research and HealthPolicy Development in Uganda. Dihydroartemisinin-piperaquine (Eurartesim) study drugs were provided free of charge by Sigma-Tau, Italy. Artemether lumefantrine was provided free of charge by the Uganda Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We thank the clinical study team of Kibuuka Afizi, Lukwago Robinson, Mudhanga Fred, Christopher Eruaga, Buyi Benzamin, Ambayo William, Grace Musimenta, Katoko Agnes and Anna Adeke. We also thank Evi Pockele for the genotyping work, the Institute of Tropical Medicine, Antwerp for the financial support, and the study participants and their parents/guardians.	Achan J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-144; Adegnika AA, 2005, AM J TROP MED HYG, V73, P263, DOI 10.4269/ajtmh.2005.73.263; [Anonymous], ASS MON ANT DRUG EFF; [Anonymous], 2007, METHODS TECHNIQUES C; Arinaitwe E, 2009, CLIN INFECT DIS, V49, P1629, DOI 10.1086/647946; Atwine D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001119; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007; Bunnag Danai, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P15; Cohen JL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-83; Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004; Dondorp Arjen M, 2011, N Engl J Med, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Faucher J F, 2006, Med Trop (Mars), V66, P292; Hung TY, 2004, BRIT J CLIN PHARMACO, V57, P253, DOI 10.1111/j.1365-2125.2003.02004.x; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; KREMSNER PG, 1994, J INFECT DIS, V169, P467, DOI 10.1093/infdis/169.2.467; Lawford H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-281; Lemma H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-349; Lin Jessica T, 2010, Curr Infect Dis Rep, V12, P165, DOI 10.1007/s11908-010-0099-y; Ndiaye JLA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-237; Ndong JMM, 2003, TROP MED INT HEALTH, V8, P25, DOI 10.1046/j.1365-3156.2003.00967.x; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Olliaro P, 2008, TROP MED INT HEALTH, V13, P83, DOI 10.1111/j.1365-3156.2007.01977.x; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Price RN, 2009, CLIN INFECT DIS, V49, P1638, DOI 10.1086/647947; Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P2395, DOI 10.1128/AAC.44.9.2395-2398.2000; Quashie NB, 2007, ANN TROP MED PARASIT, V101, P391, DOI 10.1179/136485907X176553; Reyburn H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2066; Rijken MJ, 2008, AM J TROP MED HYG, V78, P543, DOI 10.4269/ajtmh.2008.78.543; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; SUPANARANOND W, 1991, EUR J CLIN PHARMACOL, V40, P49, DOI 10.1007/BF00315138; Tinto H, 2006, T ROY SOC TROP MED H, V100, P509, DOI 10.1016/j.trstmh.2005.09.018; Uganda Ministry of Health [MoH], 2005, MAN UNC MAL PRACT GU; WATT G, 1992, AM J TROP MED HYG, V47, P108, DOI 10.4269/ajtmh.1992.47.108; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; WHO, 2010, GUID TREATM MAL, V2nd; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; Yeka A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002390; Yeka A, 2009, LANCET INFECT DIS, V9, P448, DOI 10.1016/S1473-3099(09)70109-4	44	22	22	61	257	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53772	10.1371/journal.pone.0053772	http://dx.doi.org/10.1371/journal.pone.0053772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349741	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100030
J	Otero, JM; Cimini, D; Patil, KR; Poulsen, SG; Olsson, L; Nielsen, J				Otero, Jose Manuel; Cimini, Donatella; Patil, Kiran R.; Poulsen, Simon G.; Olsson, Lisbeth; Nielsen, Jens			Industrial Systems Biology of Saccharomyces cerevisiae Enables Novel Succinic Acid Cell Factory	PLOS ONE			English	Article							SCALE METABOLIC MODEL; IN-SILICO; RECONSTRUCTION; STRAINS; GROWTH; YEAST; BIOTECHNOLOGY; VALIDATION; BIOETHANOL; PRODUCTS	Saccharomyces cerevisiae is the most well characterized eukaryote, the preferred microbial cell factory for the largest industrial biotechnology product (bioethanol), and a robust commerically compatible scaffold to be exploitted for diverse chemical production. Succinic acid is a highly sought after added-value chemical for which there is no native pre-disposition for production and accmulation in S. cerevisiae. The genome-scale metabolic network reconstruction of S. cerevisiae enabled in silico gene deletion predictions using an evolutionary programming method to couple biomass and succinate production. Glycine and serine, both essential amino acids required for biomass formation, are formed from both glycolytic and TCA cycle intermediates. Succinate formation results from the isocitrate lyase catalyzed conversion of isocitrate, and from the alpha-keto-glutarate dehydrogenase catalyzed conversion of alpha-keto-glutarate. Succinate is subsequently depleted by the succinate dehydrogenase complex. The metabolic engineering strategy identified included deletion of the primary succinate consuming reaction, Sdh3p, and interruption of glycolysis derived serine by deletion of 3-phosphoglycerate dehydrogenase, Ser3p/Ser33p. Pursuing these targets, a multi-gene deletion strain was constructed, and directed evolution with selection used to identify a succinate producing mutant. Physiological characterization coupled with integrated data analysis of transcriptome data in the metabolically engineered strain were used to identify 2nd-round metabolic engineering targets. The resulting strain represents a 30-fold improvement in succinate titer, and a 43-fold improvement in succinate yield on biomass, with only a 2.8-fold decrease in the specific growth rate compared to the reference strain. Intuitive genetic targets for either over-expression or interruption of succinate producing or consuming pathways, respectively, do not lead to increased succinate. Rather, we demonstrate how systems biology tools coupled with directed evolution and selection allows non-intuitive, rapid and substantial re-direction of carbon fluxes in S. cerevisiae, and hence show proof of concept that this is a potentially attractive cell factory for over-producing different platform chemicals.	[Otero, Jose Manuel; Olsson, Lisbeth; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Otero, Jose Manuel; Patil, Kiran R.; Poulsen, Simon G.; Olsson, Lisbeth; Nielsen, Jens] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Cimini, Donatella] Univ Naples 2, Dept Expt Med, Naples, Italy	Chalmers University of Technology; Technical University of Denmark; Universita della Campania Vanvitelli	Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Patil, Kiran R/B-9709-2009; Nielsen, Jens/Q-1347-2017	Patil, Kiran R/0000-0002-6166-8640; /0000-0002-0827-5442; Nielsen, Jens/0000-0002-9955-6003	Merck Doctoral Fellowship; Merck Research Labs, Merck Co., Inc. USA.	Merck Doctoral Fellowship; Merck Research Labs, Merck Co., Inc. USA.	This work was in part supported by a Merck Doctoral Fellowship to J.M.O. from Merck Research Labs, Merck & Co., Inc. USA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrio JL, 2006, FEMS MICROBIOL REV, V30, P187, DOI 10.1111/j.1574-6976.2005.00009.x; Aliverdieva DA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P39, DOI 10.1134/S0006297906010056; Bro C, 2006, METAB ENG, V8, P102, DOI 10.1016/j.ymben.2005.09.007; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cimini D, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-17; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Fazio A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-341; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Jantama K, 2008, BIOTECHNOL BIOENG, V99, P1140, DOI 10.1002/bit.21694; Lee PC, 2002, APPL MICROBIOL BIOT, V58, P663, DOI 10.1007/s00253-002-0935-6; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; McKinlay JB, 2007, APPL MICROBIOL BIOT, V76, P727, DOI 10.1007/s00253-007-1057-y; Nielsen J, 2001, APPL MICROBIOL BIOT, V55, P263, DOI 10.1007/s002530000511; Nielsen J, 2008, FEMS YEAST RES, V8, P122, DOI 10.1111/j.1567-1364.2007.00302.x; Nookaew I, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-71; Otero JM, 2007, ADV BIOCHEM ENG BIOT, V108, P1, DOI 10.1007/10_2007_071; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Sauer M, 2008, TRENDS BIOTECHNOL, V26, P100, DOI 10.1016/j.tibtech.2007.11.006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Wattanachaisaereekul S, 2008, METAB ENG, V10, P246, DOI 10.1016/j.ymben.2008.04.005; Willke T, 2004, APPL MICROBIOL BIOT, V66, P131, DOI 10.1007/s00253-004-1733-0; Zeikus JG, 1999, APPL MICROBIOL BIOT, V51, P545, DOI 10.1007/s002530051431; Zelle RM, 2008, APPL ENVIRON MICROB, V74, P2766, DOI 10.1128/AEM.02591-07	36	113	121	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54144	10.1371/journal.pone.0054144	http://dx.doi.org/10.1371/journal.pone.0054144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349810	Green Submitted, Green Published, gold			2022-12-27	WOS:000313943000027
J	Storz, SS; Tovin, A; Mracek, P; Alon, S; Foulkes, NS; Gothilf, Y				Storz, Sima Smadja; Tovin, Adi; Mracek, Philipp; Alon, Shahar; Foulkes, Nicholas S.; Gothilf, Yoav			Casein Kinase 1 delta Activity: A Key Element in the Zebrafish Circadian Timing System	PLOS ONE			English	Article							DROSOPHILA CLOCK GENE; DOUBLE-TIME; CKI-DELTA; EXPRESSION; PERIOD; MUTATION; PHASE; INHIBITION; RHYTHM	Zebrafish have become a popular model for studies of the circadian timing mechanism. Taking advantage of its rapid development of a functional circadian clock and the availability of light-entrainable clock-containing cell lines, much knowledge has been gained about the circadian clock system in this species. However, the post-translational modifications of clock proteins, and in particular the phosphorylation of PER proteins by Casein kinase I delta and epsilon (CK1 delta and CK1 epsilon), have so far not been examined in the zebrafish. Using pharmacological inhibitors for CK1 delta and CK1 epsilon, a pan-CK1 delta/epsilon inhibitor PF-670462, and a CK1 epsilon -selective inhibitor PF-4800567, we show that CK1 delta activity is crucial for the functioning of the circadian timing mechanism of zebrafish, while CK1 epsilon plays a minor role. The CK1 delta/epsilon inhibitor disrupted circadian rhythms of promoter activity in the circadian clock-containing zebrafish cell line, PAC-2, while the CK1 epsilon inhibitor had no effect. Zebrafish larvae that were exposed to the CK1 delta/epsilon inhibitor showed no rhythms of locomotor activity while the CK1 epsilon inhibitor had only a minor effect on locomotor activity. Moreover, the addition of the CK1 delta/epsilon inhibitor disrupted rhythms of aanat2 mRNA expression in the pineal gland. The pineal gland is considered to act as a central clock organ in fish, delivering a rhythmic hormonal signal, melatonin, which is regulated by AANAT2 enzymatic activity. Therefore, CK1 delta plays a key role in the circadian timing system of the zebrafish. Furthermore, the effect of CK1 delta inhibition on rhythmic locomotor activity may reflect its effect on the function of the central clock in the pineal gland as well as its regulation of peripheral clocks.	[Storz, Sima Smadja; Tovin, Adi; Alon, Shahar; Gothilf, Yoav] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Alon, Shahar; Gothilf, Yoav] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Mracek, Philipp; Foulkes, Nicholas S.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany	Tel Aviv University; Tel Aviv University; Helmholtz Association; Karlsruhe Institute of Technology	Storz, SS (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	simasmadja@gmail.com	Foulkes, Nicholas S/K-7003-2013	Foulkes, Nicholas S/0000-0002-1794-9891; Gothilf, Yoav/0000-0002-6054-4128	Israel Science Foundation, Jerusalem [1200.08]	Israel Science Foundation, Jerusalem(Israel Science Foundation)	This research was supported by Grant No 1200.08 from the Israel Science Foundation, Jerusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2009, BIOINFORMATICS, V25, P559, DOI 10.1093/bioinformatics/btp031; Bae K, 2006, J BIOCHEM, V140, P609, DOI 10.1093/jb/mvj198; Brady AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025072; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Cahill Gregory M, 2007, Methods Mol Biol, V362, P83; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Carr AJF, 2006, CHRONOBIOL INT, V23, P91, DOI 10.1080/07420520500464395; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Hirayama J, 2005, METHOD ENZYMOL, V393, P186, DOI 10.1016/S0076-6879(05)93005-X; Hirota T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000559; Hoadley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019755; Hurd MW, 2002, J BIOL RHYTHM, V17, P307, DOI 10.1177/074873002129002618; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Long A, 2012, J MED CHEM, V55, P956, DOI 10.1021/jm201387s; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Minamoto T, 2010, J BIOCHEM, V147, P175, DOI 10.1093/jb/mvp160; Pando MP, 2002, BIOESSAYS, V24, P419, DOI 10.1002/bies.10091; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; Reitzel AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012805; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tovin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003116; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; Vallone D, 2005, ZEBRAFISH, V2, P171, DOI 10.1089/zeb.2005.2.171; Vallone Daniela, 2007, Methods Mol Biol, V362, P429; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Vuilleumier R, 2006, ENDOCRINOLOGY, V147, P2273, DOI 10.1210/en.2005-1565; Walton KM, 2009, J PHARMACOL EXP THER, V330, P430, DOI 10.1124/jpet.109.151415; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Wilcockson DC, 2011, J COMP NEUROL, V519, P562, DOI 10.1002/cne.22533; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	46	21	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54189	10.1371/journal.pone.0054189	http://dx.doi.org/10.1371/journal.pone.0054189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349822	Green Submitted, Green Published, gold			2022-12-27	WOS:000313943000029
J	Koh, PO				Koh, Phil-Ok			Ferulic Acid Attenuates the Injury-Induced Decrease of Protein Phosphatase 2A Subunit B in Ischemic Brain Injury	PLOS ONE			English	Article							OXIDATIVE GLUTAMATE TOXICITY; PHOSPHORYLATION; RATS; EXPRESSION; APOPTOSIS; PREVENTS; ISOFORMS; DISEASE; TAU	Background: Ferulic acid provides a neuroprotective effect during cerebral ischemia through its anti-oxidant function. Protein phosphatase 2A (PP2A) is a serine and threonine phosphatase that contributes broadly to normal brain function. This study investigated whether ferulic acid regulates PP2A subunit B in a middle cerebral artery occlusion (MCAO) animal model and glutamate toxicity-induced neuronal cell death. Methodology/Principal Findings: MCAO was surgically induced to yield permanent cerebral ischemic injury in rats. The rats were treated with either vehicle or ferulic acid (100 mg/kg, i.v.) immediately after MCAO, and cerebral cortex tissues were collected 24 h after MCAO. A proteomics approach, RT-PCR, and Western blot analyses performed to identification of PP2A subunit B expression levels. Ferulic acid significantly reduced the MCAO-induced infarct volume of the cerebral cortex. A proteomics approach elucidated the reduction of PP2A subunit B in MCAO-induced animals, and ferulic acid treatment prevented the injury-induced reduction in PP2A subunit B levels. RT-PCR and Western blot analyses also showed that ferulic acid treatment attenuates the injury-induced decrease in PP2A subunit B levels. Moreover, the number of PP2A subunit B-positive cells was reduced in MCAO-induced animals, and ferulic acid prevented these decreases. In cultured neuronal cells, ferulic acid treatment protected cells against glutamate toxicity and prevented the glutamate-induced decrease in PP2A subunit B. Conclusions/Significance: These results suggest that the maintenance of PP2A subunit B by ferulic acid in ischemic brain injury plays an important role for the neuroprotective function of ferulic acid.	Gyeongsang Natl Univ, Life Sci Res Inst, Coll Vet Med, Dept Anat, Jinju, South Korea	Gyeongsang National University	Koh, PO (corresponding author), Gyeongsang Natl Univ, Life Sci Res Inst, Coll Vet Med, Dept Anat, Jinju, South Korea.	pokoh@gnu.ac.kr			National Research Foundation of Korea(NRF); Korea government(MEST) [2010-0007881]; Next-Generation BioGreen 21 Program, RDA, Republic of Korea [PJ008075]	National Research Foundation of Korea(NRF)(National Research Foundation of Korea); Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Next-Generation BioGreen 21 Program, RDA, Republic of Korea	This work was partially supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MEST)(No.2010 0007881) and supported by a grant from the Next-Generation BioGreen 21 Program (No.PJ008075), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Cheng CY, 2008, BRAIN RES, V1209, P136, DOI 10.1016/j.brainres.2008.02.090; Cheng CY, 2008, AM J CHINESE MED, V36, P1105, DOI 10.1142/S0192415X08006570; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Koh PO, 2012, NEUROSCI LETT, V511, P101, DOI 10.1016/j.neulet.2012.01.049; Koh PO, 2012, NEUROSCI LETT, V507, P156, DOI 10.1016/j.neulet.2011.12.012; Koh Phil-Ok, 2011, Lab Anim Res, V27, P73, DOI 10.5625/lar.2011.27.1.73; Li SY, 2009, J VIROL, V83, P8340, DOI 10.1128/JVI.00711-09; Liu Rong, 2009, Pathophysiology, V16, P273, DOI 10.1016/j.pathophys.2009.02.008; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Maher P, 1996, J NEUROSCI, V16, P6394; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Noh HS, 2006, J NEUROSCI RES, V83, P702, DOI 10.1002/jnr.20736; SIM ATR, 1991, MOL NEUROBIOL, V5, P229, DOI 10.1007/BF02935548; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Srinivasan M, 2006, TOXICOLOGY, V228, P249, DOI 10.1016/j.tox.2006.09.004; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; Strack S, 1998, J COMP NEUROL, V392, P515; Sung JH, 2012, J VET MED SCI, V74, P1401, DOI 10.1292/jvms.12-0063; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	25	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54217	10.1371/journal.pone.0054217	http://dx.doi.org/10.1371/journal.pone.0054217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349830	gold, Green Published, Green Submitted			2022-12-27	WOS:000313738900053
J	Liu, CM; Teng, ZQ; McQuate, AL; Jobe, EM; Christ, CC; von Hoyningen-Huene, SJ; Reyes, MD; Polich, ED; Xing, YN; Li, Y; Guo, WX; Zhao, XY				Liu, Changmei; Teng, Zhao-Qian; McQuate, Andrea L.; Jobe, Emily M.; Christ, Christa C.; von Hoyningen-Huene, Sergei J.; Reyes, Marie D.; Polich, Eric D.; Xing, Yina; Li, Yue; Guo, Weixiang; Zhao, Xinyu			An Epigenetic Feedback Regulatory Loop Involving MicroRNA-195 and MBD1 Governs Neural Stem Cell Differentiation	PLOS ONE			English	Article							METHYL-CPG BINDING-PROTEIN-1; ADULT NEUROGENESIS; RETT-SYNDROME; MOUSE MODEL; SUPPRESSES TUMORIGENICITY; GENE-EXPRESSION; MECP2; HIPPOCAMPUS; MATURATION; NEURONS	Background: Epigenetic mechanisms, including DNA methylation, histone modification, and microRNAs, play pivotal roles in stem cell biology. Methyl-CpG binding protein 1 (MBD1), an important epigenetic regulator of adult neurogenesis, controls the proliferation and differentiation of adult neural stem/progenitor cells (aNSCs). We recently demonstrated that MBD1 deficiency in aNSCs leads to altered expression of several noncoding microRNAs (miRNAs). Methodology/Principal Findings: Here we show that one of these miRNAs, miR-195, and MBD1 form a negative feedback loop. While MBD1 directly represses the expression of miR-195 in aNSCs, high levels of miR-195 in turn repress the expression of MBD1. Both gain-of-function and loss-of-function investigations show that alterations of the MBD1-miR-195 feedback loop tip the balance between aNSC proliferation and differentiation. Conclusions/Significance: Therefore the regulatory loop formed by MBD1 and miR-195 is an important component of the epigenetic network that controls aNSC fate.	[Jobe, Emily M.; Zhao, Xinyu] Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI 53715 USA; [Liu, Changmei; Teng, Zhao-Qian; McQuate, Andrea L.; Christ, Christa C.; von Hoyningen-Huene, Sergei J.; Reyes, Marie D.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Jobe, Emily M.; Polich, Eric D.; Xing, Yina; Li, Yue; Guo, Weixiang; Zhao, Xinyu] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Zhao, Xinyu] Univ Wisconsin, Dept Neurosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of New Mexico; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhao, XY (corresponding author), Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI 53715 USA.	xzhao69@wisc.edu	Li, Kevin/AAX-1664-2020; Teng, Zhao-Qian/AAD-1033-2021; Teng, Zhao-Qian/J-6260-2015	Li, Kevin/0000-0001-8198-9911; Teng, Zhao-Qian/0000-0002-7232-3381; Teng, Zhao-Qian/0000-0002-7232-3381; McQuate, Andrea/0000-0002-2052-2004; Jobe, Emily/0000-0001-8712-4767	National Institutes of Health (NIH) [MH080434, MH07897, P30HD03352, T32 GM07215]; International Rett Syndrome Foundation (IRSF); Postbaccalaureate Research and Education Program fellowships (PREP) [NIH/R25 GM075149]; Minority Access to Research Careers fellowship (MARC) [NIH/T34 GM008510]; University of Wisconsin-Madison Center for Stem Cells and Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075149, T32GM007215, T34GM008751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078972, R01MH080434] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation (IRSF); Postbaccalaureate Research and Education Program fellowships (PREP); Minority Access to Research Careers fellowship (MARC); University of Wisconsin-Madison Center for Stem Cells and Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (NIH) (MH080434, MH07897) and the International Rett Syndrome Foundation (IRSF) to X.Z.; a center grant from the NIH to the Waisman Center (P30HD03352); Postbaccalaureate Research and Education Program fellowships (PREP; NIH/R25 GM075149) to C.C.C. and A.L.M.; an NIH Molecular Biosciences Training grant (MBTG: T32 GM07215) to E.M.J.; a Minority Access to Research Careers fellowship (MARC, NIH/T34 GM008510) to M.D.R; and a postdoctoral fellowship from University of Wisconsin-Madison Center for Stem Cells and Regenerative Medicine to W.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Barkho BZ, 2011, CURR STEM CELL RES T, V6, P327; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cukier HN, 2010, NEUROGENETICS, V11, P291, DOI 10.1007/s10048-009-0228-7; Dai YM, 2011, HEAD NECK-J SCI SPEC, V33, P786, DOI 10.1002/hed.21540; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Gatto S, 2010, EPIGENETICS-US, V5, P427, DOI 10.4161/epi.5.5.11999; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Guo WX, 2012, HUM MOL GENET, V21, P681, DOI 10.1093/hmg/ddr501; Guo WX, 2011, NEURON, V70, P924, DOI 10.1016/j.neuron.2011.03.027; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Jobe E, 2012, FRONTIERS N IN PRESS; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li H, 2005, BRAIN DEV-JPN, V27, P321, DOI 10.1016/j.braindev.2004.08.003; Li XK, 2008, J BIOL CHEM, V283, P27644, DOI 10.1074/jbc.M804899200; Li XK, 2008, STEM CELLS DEV, V17, P1043, DOI 10.1089/scd.2008.0036; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Liu G, 2009, NEUROMOLECULAR MED; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shen Q, 2009, NAT NEUROSCI, V12, P369, DOI 10.1038/nn0409-369; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Urdinguio RG, 2010, EPIGENETICS-US, V5, P656, DOI 10.4161/epi.5.7.13055; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wu H, 2010, P NATL ACAD SCI USA, V107, P18161, DOI 10.1073/pnas.1005595107; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	53	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e51436	10.1371/journal.pone.0051436	http://dx.doi.org/10.1371/journal.pone.0051436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349673	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900003
J	Schafer, E; Tarantola, M; Polo, E; Westendorf, C; Oikawa, N; Bodenschatz, E; Geil, B; Janshoff, A				Schaefer, Edith; Tarantola, Marco; Polo, Elena; Westendorf, Christian; Oikawa, Noriko; Bodenschatz, Eberhard; Geil, Burkhard; Janshoff, Andreas			Chemotaxis of Dictyostelium discoideum: Collective Oscillation of Cellular Contacts	PLOS ONE			English	Article							CYCLIC-AMP; SIGNAL-TRANSDUCTION; AGGREGATION; CELLS; ADHESION; BEHAVIOR; NETWORK; PROPAGATION; DYNAMICS	Chemotactic responses of Dictyostelium discoideum cells to periodic self-generated signals of extracellular cAMP comprise a large number of intricate morphological changes on different length scales. Here, we scrutinized chemotaxis of single Dictyostelium discoideum cells under conditions of starvation using a variety of optical, electrical and acoustic methods. Amebas were seeded on gold electrodes displaying impedance oscillations that were simultaneously analyzed by optical video microscopy to relate synchronous changes in cell density, morphology, and distance from the surface to the transient impedance signal. We found that starved amebas periodically reduce their overall distance from the surface producing a larger impedance and higher total fluorescence intensity in total internal reflection fluorescence microscopy. Therefore, we propose that the dominant sources of the observed impedance oscillations observed on electric cell-substrate impedance sensing electrodes are periodic changes of the overall cell-substrate distance of a cell. These synchronous changes of the cell-electrode distance were also observed in the oscillating signal of acoustic resonators covered with amebas. We also found that periodic cell-cell aggregation into transient clusters correlates with changes in the cell-substrate distance and might also contribute to the impedance signal. It turned out that cell-cell contacts as well as cell-substrate contacts form synchronously during chemotaxis of Dictyostelium discoideum cells.	[Schaefer, Edith; Polo, Elena; Geil, Burkhard; Janshoff, Andreas] Univ Gottingen, Inst Phys Chem, Gottingen, Germany; [Tarantola, Marco; Westendorf, Christian; Oikawa, Noriko; Bodenschatz, Eberhard] Max Planck Inst Dynam & Self Org, Lab Fluid Dynam Pattern Format & Biocomplex LFPB, Gottingen, Germany; [Bodenschatz, Eberhard] Univ Gottingen, Inst Nonlinear Dynam, D-37073 Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Janshoff, A (corresponding author), Univ Gottingen, Inst Phys Chem, Tammannstr 6, Gottingen, Germany.	ajansho@gwdg.de	Oikawa, Noriko/S-4313-2017	Janshoff, Andreas/0000-0002-0773-2963; Westendorf, Christian/0000-0001-7663-6150; Bodenschatz, Eberhard/0000-0002-2901-0144	DFG [SFB 937]	DFG(German Research Foundation (DFG))	The work has been supported by the DFG (SFB 937). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCANTARA F, 1974, J GEN MICROBIOL, V85, P321, DOI 10.1099/00221287-85-2-321; Alonso-Latorre B, 2011, CELL MOL BIOENG, V4, P603, DOI 10.1007/s12195-011-0184-9; Anger P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.113002; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Chisholm RL, 2004, NAT REV MOL CELL BIO, V5, P531, DOI 10.1038/nrm1427; Coates JC, 2001, J CELL SCI, V114, P4349; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; DEVREOTES PN, 1983, DEV BIOL, V96, P405, DOI 10.1016/0012-1606(83)90178-1; DINAUER MC, 1980, J CELL BIOL, V86, P537, DOI 10.1083/jcb.86.2.537; Dormann D, 1998, BIOPHYS CHEM, V72, P21, DOI 10.1016/S0301-4622(98)00120-3; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; FAIX J, 1990, EMBO J, V9, P2709, DOI 10.1002/j.1460-2075.1990.tb07457.x; FUTRELLE RP, 1982, J CELL BIOL, V92, P807, DOI 10.1083/jcb.92.3.807; Gabriel D, 1999, J CELL SCI, V112, P3995; GERISCH G, 1974, P NATL ACAD SCI USA, V71, P2118, DOI 10.1073/pnas.71.5.2118; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; HARLOFF C, 1989, GENE DEV, V3, P2011, DOI 10.1101/gad.3.12a.2011; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Janshoff A, 2010, J ADHES SCI TECHNOL, V24, P2079, DOI 10.1163/016942410X507939; Kessin RH., 2001, DICTYOSTELIUM EVOLUT, P1; Laub MT, 1998, MOL BIOL CELL, V9, P3521, DOI 10.1091/mbc.9.12.3521; McCann CP, 2010, J CELL SCI, V123, P1724, DOI 10.1242/jcs.060137; Mehta P, 2010, CURR OPIN GENET DEV, V20, P574, DOI 10.1016/j.gde.2010.09.004; Nanjundiah V, 1998, BIOPHYS CHEM, V72, P1, DOI 10.1016/S0301-4622(98)00118-5; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Reiss B, 2003, LANGMUIR, V19, P1816, DOI 10.1021/la0261747; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Schafer E, 2011, SMALL, V7, P723, DOI 10.1002/smll.201001955; SIEGERT F, 1989, J CELL SCI, V93, P325; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tani T, 1999, J EXP BIOL, V202, P1; Tarantola M, 2011, CHEM RES TOXICOL, V24, P1494, DOI 10.1021/tx200115q; Tarantola M, 2010, INTEGR BIOL-UK, V2, P139, DOI 10.1039/b920815a; Tarantola M, 2009, ACS NANO, V3, P213, DOI 10.1021/nn800721j; van Haastert PJM, 2007, BIOPHYS J, V93, P1787, DOI 10.1529/biophysj.107.104356; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vicker MG, 2008, EUR J CELL BIOL, V87, P845, DOI 10.1016/j.ejcb.2008.03.010; Wang CJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002449; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; WURSTER B, 1989, DIFFERENTIATION, V41, P1, DOI 10.1111/j.1432-0436.1989.tb00725.x	46	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54172	10.1371/journal.pone.0054172	http://dx.doi.org/10.1371/journal.pone.0054172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349816	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900049
J	Warrington, NM; Wu, YY; Pennell, CE; Marsh, JA; Beilin, LJ; Palmer, LJ; Lye, SJ; Briollais, L				Warrington, Nicole M.; Wu, Yan Yan; Pennell, Craig E.; Marsh, Julie A.; Beilin, Lawrence J.; Palmer, Lyle J.; Lye, Stephen J.; Briollais, Laurent			Modelling BMI Trajectories in Children for Genetic Association Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; QUALITY-OF-LIFE; OBESE CHILDREN; FTO GENE; WAIST CIRCUMFERENCE; COMMON VARIANTS; ADULT OBESITY; CHILDHOOD; LOCI	Background: The timing of associations between common genetic variants and changes in growth patterns over childhood provide insight into the development of obesity in later life. To address this question, it is important to define appropriate statistical models to allow for the detection of genetic effects influencing longitudinal childhood growth. Methods and Results: Children from The Western Australian Pregnancy Cohort (Raine; n = 1,506) Study were genotyped at 17 genetic loci shown to be associated with childhood obesity (FTO, MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, ETV5, SEC16B, LYPLAL1, TFAP2B, MTCH2, BCDIN3D, NRXN3, SH2B1, MRSA) and an obesity-risk-allele-score was calculated as the total number of 'risk alleles' possessed by each individual. To determine the statistical method that fits these data and has the ability to detect genetic differences in BMI growth profile, four methods were investigated: linear mixed effects model, linear mixed effects model with skew-t random errors, semi-parametric linear mixed models and a non-linear mixed effects model. Of the four methods, the semi-parametric linear mixed model method was the most efficient for modelling childhood growth to detect modest genetic effects in this cohort. Using this method, three of the 17 loci were significantly associated with BMI intercept or trajectory in females and four in males. Additionally, the obesity-risk-allele score was associated with increased average BMI (female: beta = 0.0049, P = 0.0181; male: beta = 0.0071, P = 0.0001) and rate of growth (female: beta = 0.0012, P = 0.0006; male: beta = 0.0008, P = 0.0068) throughout childhood. Conclusions: Using statistical models appropriate to detect genetic variants, variations in adult obesity genes were associated with childhood growth. There were also differences between males and females. This study provides evidence of genetic effects that may identify individuals early in life that are more likely to rapidly increase their BMI through childhood, which provides some insight into the biology of childhood growth.	[Warrington, Nicole M.; Pennell, Craig E.; Marsh, Julie A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Warrington, Nicole M.; Wu, Yan Yan; Palmer, Lyle J.; Lye, Stephen J.; Briollais, Laurent] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Beilin, Lawrence J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada	University of Western Australia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Western Australia; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Briollais, L (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	laurent@lunenfeld.ca	Study, Raine/K-4517-2013; Pennell, Craig/ABD-6902-2020; Study, Raine/G-9547-2015; Warrington, Nicole/P-4868-2014; Wu, Yanyan/H-1356-2017; Palmer, Lyle John/N-1948-2019; Briollais, Laurent/A-2941-2013; Lye, Stephen J/E-7269-2013; Palmer, Lyle John/K-3196-2014	Pennell, Craig/0000-0002-0937-6165; Warrington, Nicole/0000-0003-4195-775X; Wu, Yanyan/0000-0003-1553-1392; Palmer, Lyle John/0000-0002-1628-3055; Lye, Stephen J/0000-0002-3305-4406; Palmer, Lyle John/0000-0002-1628-3055; Marsh, Julie/0000-0001-8984-6907	University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine; Dentistry and Health Sciences; Telethon Institute for Child Health Research, Curtin University; Women and Infants Research Foundation; National Health and Medical Research Council of Australia [403981, 003209]; Canadian Institutes of Health Research [MOP-82893]; Australian Postgraduate Award from Australian Government of Innovation, Industry, Science and Research; Raine Study PhD Top-Up Scholarship	University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine; Dentistry and Health Sciences; Telethon Institute for Child Health Research, Curtin University; Women and Infants Research Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Australian Postgraduate Award from Australian Government of Innovation, Industry, Science and Research; Raine Study PhD Top-Up Scholarship	The following institutions provide funding for Core Management of the Raine Study: The University of Western Australia (UWA), Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences, The Telethon Institute for Child Health Research, Curtin University and Women and Infants Research Foundation. This study was supported by project grants from the National Health and Medical Research Council of Australia (Grant ID 403981 and ID 003209; http://www.nhmrc.gov.au/) and the Canadian Institutes of Health Research (Grant ID MOP-82893; http://www.cihr-irsc.gc.ca/e/193.html). Ms. Warrington is funded by an Australian Postgraduate Award from the Australian Government of Innovation, Industry, Science and Research and a Raine Study PhD Top-Up Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalini A, 1999, J ROY STAT SOC B, V61, P579, DOI 10.1111/1467-9868.00194; Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227; Bradford NF, 2009, PRIMARY CARE, V36, P319, DOI 10.1016/j.pop.2009.01.002; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; den Hoed M, 2010, DIABETES, V59, P2980, DOI 10.2337/db10-0370; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; DONNELLY CA, 1995, J AM STAT ASSOC, V90, P984, DOI 10.2307/2291334; Efron B., 1994, INTRO BOOTSTRAP; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Evans S, 1996, EARLY HUM DEV, V45, P203, DOI 10.1016/0378-3782(96)01728-8; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; GASSER T, 1984, ANN HUM BIOL, V11, P397, DOI 10.1080/03014468400007311; GOLDSTEIN H, 1986, ANN HUM BIOL, V13, P129, DOI 10.1080/03014468600008271; Griffiths LJ, 2010, INT J PEDIATR OBES, V5, P282, DOI 10.3109/17477160903473697; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Hinney A, 2009, OBESITY FACTS, V2, P3, DOI 10.1159/000200020; Huang RC, 2006, INT J OBES RES; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Jiao H, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-51; Kindblom JM, 2009, DIABETES, V58, P867, DOI 10.2337/db08-0606; Lachos VH, 2010, STAT SINICA, V20, P303; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lawlor DA, 2005, ARCH DIS CHILD, V90, P692, DOI 10.1136/adc.2004.062919; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Milani S, 1989, Acta Paediatr Scand Suppl, V350, P95; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; PREECE MA, 1978, ANN HUM BIOL, V5, P1, DOI 10.1080/03014467800002601; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; RICE JA, 1991, J ROY STAT SOC B MET, V53, P233; Sawyer MG, 2006, AMBUL PEDIATR, V6, P306, DOI 10.1016/j.ambp.2006.08.005; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Song PXK, 2007, STAT SINICA, V17, P929; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Srinivasan SR, 2006, HYPERTENSION, V48, P33, DOI 10.1161/01.HYP.0000226410.11198.f4; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tsiros MD, 2009, INT J OBESITY, V33, P387, DOI 10.1038/ijo.2009.42; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	58	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53897	10.1371/journal.pone.0053897	http://dx.doi.org/10.1371/journal.pone.0053897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349760	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900025
J	Raynaud, CM; Halabi, N; Elliott, DA; Pasquier, J; Elefanty, AG; Stanley, EG; Rafii, A				Raynaud, Christophe M.; Halabi, Najeeb; Elliott, David A.; Pasquier, Jennifer; Elefanty, Andrew G.; Stanley, Edouard G.; Rafii, Arash			Human Embryonic Stem Cell Derived Mesenchymal Progenitors Express Cardiac Markers but Do Not Form Contractile Cardiomyocytes	PLOS ONE			English	Article							BONE-MARROW; CARDIOMYOGENIC DIFFERENTIATION; MYOCARDIAL-INFARCTION; RAT HEARTS; IN-VITRO; TRANSPLANTATION; TISSUE; REGENERATION; GROWTH; FIBROBLASTS	Mesenchymal progenitors or stromal cells have shown promise as a therapeutic strategy for a range of diseases including heart failure. In this context, we explored the growth and differentiation potential of mesenchymal progenitors (MPs) derived in vitro from human embryonic stem cells (hESCs). Similar to MPs isolated from bone marrow, hESC derived MPs (hESC-MPs) efficiently differentiated into archetypical mesenchymal derivatives such as chondrocytes and adipocytes. Upon treatment with 5-Azacytidine or TGF-beta 1, hESC-MPs modified their morphology and up-regulated expression of key cardiac transcription factors such as NKX2-5, MEF2C, HAND2 and MYOCD. Nevertheless, NKX2-5(+) hESC-MP derivatives did not form contractile cardiomyocytes, raising questions concerning the suitability of these cells as a platform for cardiomyocyte replacement therapy. Gene profiling experiments revealed that, although hESC-MP derived cells expressed a suite of cardiac related genes, they lacked the complete repertoire of genes associated with bona fide cardiomyocytes. Our results suggest that whilst agents such as TGF-beta 1 and 5-Azacytidine can induce expression of cardiac related genes, but treated cells retain a mesenchymal like phenotype.	[Raynaud, Christophe M.; Halabi, Najeeb; Pasquier, Jennifer; Rafii, Arash] Qatar Fdn, Weill Cornell Med Coll Qatar Educ City, Stem Cell & Microenvironm Lab, Doha, Qatar; [Raynaud, Christophe M.; Halabi, Najeeb; Pasquier, Jennifer; Rafii, Arash] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Elliott, David A.; Elefanty, Andrew G.; Stanley, Edouard G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Elliott, David A.; Elefanty, Andrew G.; Stanley, Edouard G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Rafii, A (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar Educ City, Stem Cell & Microenvironm Lab, Doha, Qatar.	jat2021@qatar-med.cornell.edu	Halabi, Najeeb/AAX-8250-2020; Elliott, David/H-3334-2012; Rafii, Arash/E-4106-2013; Stanley, Ed G/A-2985-2013; Elefanty, Andrew G/A-6066-2008; Raynaud, Christophe/AAQ-9426-2020	Halabi, Najeeb/0000-0002-9345-6132; Elliott, David/0000-0003-1052-7407; Stanley, Ed G/0000-0002-6389-3665; Raynaud, Christophe/0000-0003-1551-8075; Pasquier, Jennifer/0000-0002-2465-7942; Elefanty, Andrew/0000-0001-6448-8314	Qatar-Foundation NPRP Grant [08-663-3-140]; Qatar foundation UREP Grant [06-116-1-023]; Qatar Foundation; Qatar Technology Transfer Grant; National Health and Medical Research Council of Australia; NPRP [09-1099-3-279]	Qatar-Foundation NPRP Grant(Qatar National Research Fund (QNRF)); Qatar foundation UREP Grant(Qatar National Research Fund (QNRF)); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Qatar Technology Transfer Grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NPRP	This work was funded by Qatar-Foundation NPRP Grant 08-663-3-140 and NPRP 09-1099-3-279 Qatar foundation UREP Grant 06-116-1-023, Qatar Foundation, Qatar Technology Transfer Grant and the National Health and Medical Research Council of Australia. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Qatar National Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cashman TJ, 2012, STEM CELL REV; Chacko SM, 2009, AM J PHYSIOL-HEART C, V296, pH1263, DOI 10.1152/ajpheart.01311.2008; Chi NH, 2012, BIOMATERIALS, V33, P5541, DOI 10.1016/j.biomaterials.2012.04.030; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Elnakish MT, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/646038; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fukuda K, 2003, CYTOTECHNOLOGY, V41, P165, DOI 10.1023/A:1024882908173; Fukuda K, 2002, CR BIOL, V325, P1027, DOI 10.1016/S1631-0691(02)01524-X; Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x; Gwak SJ, 2009, CELL BIOCHEM FUNCT, V27, P148, DOI 10.1002/cbf.1547; Hakuno D, 2002, CIRCULATION, V105, P380, DOI 10.1161/hc0302.102593; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Karlsson C, 2009, STEM CELL RES; Kim YS, 2011, CELLS TISSUES ORGANS; Koninckx R, 2009, CYTOTHERAPY, V11, P778, DOI 10.3109/14653240902988818; Li XH, 2012, MOL BIOL REP, V39, P1333, DOI 10.1007/s11033-011-0867-2; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; Ling SK, 2011, BIOTECHNOL PROGR, V27, P473, DOI 10.1002/btpr.558; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mohanty S, 2011, INT J CARDIOL; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Ramkisoensing AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024164; Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X; Richardson JD, 2012, STEM CELL REV; Shi Bei, 2011, Zhonghua Yi Xue Za Zhi, V91, P2269; Siegel G, 2012, STEM CELLS DEV; Siegel G, 2012, STEM CELLS DEV, V21, P2457, DOI 10.1089/scd.2011.0626; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Stojkovic P, 2005, STEM CELLS, V23, P306, DOI 10.1634/stemcells.2004-0137; Strauer BE, 2005, J AM COLL CARDIOL, V46, P1651, DOI 10.1016/j.jacc.2005.01.069; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; Xing YJ, 2012, MOL CELL BIOCHEM, V360, P279, DOI 10.1007/s11010-011-1067-z; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Yamada Y, 2007, STEM CELLS, V25, P1326, DOI 10.1634/stemcells.2006-0588; Yang G, 2011, CELL TRANSPLANT; Yoo KJ, 2008, CAN J SURG, V51, P269	46	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54524	10.1371/journal.pone.0054524	http://dx.doi.org/10.1371/journal.pone.0054524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342164	Green Published, gold			2022-12-27	WOS:000313682700121
J	Tipples, J; Brattan, V; Johnston, P				Tipples, Jason; Brattan, Victoria; Johnston, Pat			Neural Bases for Individual Differences in the Subjective Experience of Short Durations (Less than 2 Seconds)	PLOS ONE			English	Article							TIME PERCEPTION; ACCUMULATOR HYPOTHESIS; CYTOARCHITECTONIC MAPS; FACIAL EXPRESSIONS; TEMPORAL COGNITION; BISECTION TASK; INTERNAL CLOCK; INTERVAL; MECHANISMS; EMOTION	The current research was designed to establish whether individual differences in timing performance predict neural activation in the areas that subserve the perception of short durations ranging between 400 and 1600 milliseconds. Seventeen participants completed both a temporal bisection task and a control task, in a mixed fMRI design. In keeping with previous research, there was increased activation in a network of regions typically active during time perception including the right supplementary motor area (SMA) and right pre-SMA and basal ganglia (including the putamen and right pallidum). Furthermore, correlations between neural activity in the right inferior frontal gyrus and SMA and timing performance corroborate the results of a recent meta-analysis and are further evidence that the SMA forms part of a neural clock that is responsible for the accumulation of temporal information. Specifically, subjective lengthening of the perceived duration were associated with increased activation in both the right SMA (and right pre-SMA) and right inferior frontal gyrus.	[Tipples, Jason] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England; [Brattan, Victoria; Johnston, Pat] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of Hull; University of York - UK	Tipples, J (corresponding author), Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England.	J.Tipples@hull.ac.uk	Johnston, Patrick/P-3158-2014; Tipples, Jason/H-3082-2015	Johnston, Patrick/0000-0001-7703-1073; 	University of York; C2D2 Research Priming Grant	University of York(European Commission); C2D2 Research Priming Grant	This research was funded by the University of York. VB was partially supported by a C2D2 Research Priming Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN LG, 1991, LEARN MOTIV, V22, P39, DOI 10.1016/0023-9690(91)90016-2; Brett M, 2002, NEUROIMAGE, V16; BROWN SW, 1995, PERCEPTION, V24, P525, DOI 10.1068/p240525; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P204, DOI 10.1162/jocn.2008.20017; Bueti D, 2011, NEUROIMAGE, V57, P1251, DOI 10.1016/j.neuroimage.2011.05.014; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Calder AJ, 2011, PHILOS T R SOC B, V366, P1684, DOI 10.1098/rstb.2010.0362; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; CHURCH RM, 1977, J EXP PSYCHOL ANIM B, V3, P216, DOI 10.1037/0097-7403.3.3.216; Coull JT, 2008, J COGNITIVE NEUROSCI, V20, P2185, DOI 10.1162/jocn.2008.20153; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Devue C, 2009, PERCEPTION, V38, P552, DOI 10.1068/p6049; Dormal V, 2011, HUM BRAIN MAPP; Droit-Volet S, 2004, COGNITION EMOTION, V18, P849, DOI 10.1080/02699930341000194; Effron DA, 2006, EMOTION, V6, P1, DOI 10.1037/1528-3542.6.1.1; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Gilaie-Dotan S, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00076; Grahn JA, 2009, NEUROIMAGE, V47, P1894, DOI 10.1016/j.neuroimage.2009.04.039; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Harrington DL, 2004, COGNITIVE BRAIN RES, V21, P193, DOI 10.1016/j.cogbrainres.2004.01.010; Jech R, 2005, NEUROREPORT, V16, P1467, DOI 10.1097/01.wnr.0000175616.00936.1c; Kopec CD, 2010, BRAIN COGNITION, V74, P262, DOI 10.1016/j.bandc.2010.08.006; Lejeune H, 1998, BEHAV PROCESS, V44, P127, DOI 10.1016/S0376-6357(98)00045-X; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Morillon B, 2009, J NEUROSCI, V29, P14803, DOI 10.1523/JNEUROSCI.3222-09.2009; Moss HE, 2005, CEREB CORTEX, V15, P1723, DOI 10.1093/cercor/bhi049; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Ortega L, 2008, BEHAV PROCESS, V78, P380, DOI 10.1016/j.beproc.2008.02.004; Portnova GV, 2007, ZH VYSSH NERV DEYAT+, V57, P450; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Sysoeva OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012650; Tipples J, 2008, EMOTION, V8, P127, DOI 10.1037/1528-3542.8.1.127; Tipples J, 2011, EMOTION, V11, P74, DOI 10.1037/a0022015; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Wearden JH, 2008, Q J EXP PSYCHOL, V61, P263, DOI 10.1080/17470210601154610; WEARDEN JH, 1991, Q J EXP PSYCHOL-B, V43, P59; Wearden JH, 2003, BEHAV PROCESS, V61, P47, DOI 10.1016/S0376-6357(02)00159-6; Wencil EB, 2010, J NEUROPHYSIOL, V104, P160, DOI 10.1152/jn.00029.2009; Wiener M, 2011, J COGNITIVE NEUROSCI, V23, P2811, DOI 10.1162/jocn.2011.21626; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wittmann M, 2011, BRAIN RES, V1406, P43, DOI 10.1016/j.brainres.2011.06.048; Wittmann M, 2010, NEUROPSYCHOLOGIA, V48, P3110, DOI 10.1016/j.neuropsychologia.2010.06.023; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604	59	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54669	10.1371/journal.pone.0054669	http://dx.doi.org/10.1371/journal.pone.0054669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342176	Green Published, gold, Green Accepted			2022-12-27	WOS:000313682700131
J	Dykstra, KM; Ulengin, I; DelRose, N; Lee, TH				Dykstra, Kaitlyn M.; Ulengin, Idil; DelRose, Nicholas; Lee, Tina H.			Identification of Discrete Sites in Yip1A Necessary for Regulation of Endoplasmic Reticulum Structure	PLOS ONE			English	Article							GOLGI MEMBRANE-PROTEIN; CELLS; COMPLEX; ER; TRANSPORT; BIOGENESIS; INTERACTS; REVEALS; ORGANIZATION; REDUCTASE	The endoplasmic reticulum (ER) of specialized cells can undergo dramatic changes in structural organization, including formation of concentric whorls. We previously reported that depletion of Yip1A, an integral membrane protein conserved between yeast and mammals, caused ER whorl formation reminiscent of that seen in specialized cells. Yip1A and its yeast homologue Yip1p cycle between the ER and early Golgi, have been implicated in a number of distinct trafficking steps, and interact with a conserved set of binding partners including Yif1p/Yif1A and the Ypt1/Ypt31 Rab GTPases. Here, we carried out a mutational analysis of Yip1A to obtain insight into how it regulates ER whorl formation. Most of the Yip1A cytoplasmic domain was dispensable, whereas the transmembrane (TM) domain, especially residues within predicted TM helices 3 and 4, were sensitive to mutagenesis. Comprehensive analysis revealed two discrete functionally required determinants. One was E95 and flanking residues L92 and L96 within the cytoplasmic domain; the other was K146 and nearby residue V152 within the TM domain. Notably, the identified determinants correspond closely to two sites previously found to be essential for yeast viability (E76 and K130 in Yip1p corresponding to E95 and K146 in Yip1A, respectively). In contrast, a third site (E89) also essential for yeast viability (E70 in Yip1p) was dispensable for regulation of whorl formation. Earlier work showed that E76 (E95) was dispensable for binding Yif1p or Ypt1p/Ypt31p, whereas E70 (E89) was required. Collectively, these findings suggest that the ability of Yip1A to bind its established binding partners may be uncoupled from its ability to control ER whorl formation. In support, Yif1A knockdown did not cause ER whorl formation. Thus Yip1A may use the sites identified herein to interact with a novel binding partner to regulate ER membrane organization.	[Dykstra, Kaitlyn M.; Ulengin, Idil; DelRose, Nicholas; Lee, Tina H.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Lee, TH (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	thl@andrew.cmu.edu		Dykstra, Kaitlyn/0000-0002-8447-8364	National Institutes of Health (NIH) [R21DK088280]; ACS [CSM-112734]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK088280] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a National Institutes of Health (NIH) exploratory research grant R21DK088280 and an ACS research scholar grant CSM-112734. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Barrowman J, 2003, J BIOL CHEM, V278, P19878, DOI 10.1074/jbc.M302406200; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Calero M, 2001, J BIOL CHEM, V276, P12100, DOI 10.1074/jbc.M008439200; CARR I, 1962, ANAT REC, V144, P143, DOI 10.1002/ar.1091440209; Chen CZ, 2004, GENETICS, V168, P1827, DOI 10.1534/genetics.104.032888; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; Dykstra KM, 2010, MOL BIOL CELL, V21, P1556, DOI 10.1091/mbc.E09-12-1002; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Heidtman M, 2005, MOL BIOL CELL, V16, P1673, DOI 10.1091/mbc.E04-10-0873; Heidtman M, 2003, J CELL BIOL, V163, P57, DOI 10.1083/jcb.200306118; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kano F, 2009, J CELL SCI, V122, P2218, DOI 10.1242/jcs.043414; Kapetanovich L, 2005, MOL BIOL CELL, V16, P835, DOI 10.1091/mbc.e04-09-0785; KING JC, 1974, CELL TISSUE RES, V153, P497; Koning AJ, 1996, MOL BIOL CELL, V7, P769, DOI 10.1091/mbc.7.5.769; LEE C, 1989, J CELL BIOL, V109, P2045, DOI 10.1083/jcb.109.5.2045; Lorente-Rodriguez A, 2009, J CELL SCI, V122, P1540, DOI 10.1242/jcs.042457; Matern H, 2000, EMBO J, V19, P4485, DOI 10.1093/emboj/19.17.4485; NICKERSO.PA, 1969, J CELL BIOL, V40, P859, DOI 10.1083/jcb.40.3.859; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; RAJASEKARAN AK, 1993, J CELL SCI, V105, P333; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Tang BL, 2001, J BIOL CHEM, V276, P40008, DOI 10.1074/jbc.M106189200; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Yamamoto A, 1996, J CELL SCI, V109, P1727; Yang XP, 1998, EMBO J, V17, P4954, DOI 10.1093/emboj/17.17.4954; Yoshida Y, 2008, EXP CELL RES, V314, P3427, DOI 10.1016/j.yexcr.2008.07.023	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54413	10.1371/journal.pone.0054413	http://dx.doi.org/10.1371/journal.pone.0054413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342155	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400164
J	Khan, AR; Riaz, M; Bin Abdulhak, AA; Al-Tannir, MA; Garbati, MA; Erwin, PJ; Baddour, LM; Tleyjeh, IM				Khan, Abdur Rahman; Riaz, Muhammad; Bin Abdulhak, Aref A.; Al-Tannir, Mohamad A.; Garbati, Musa A.; Erwin, Patricia J.; Baddour, Larry M.; Tleyjeh, Imad M.			The Role of Statins in Prevention and Treatment of Community Acquired Pneumonia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							GASTRIC-ACID SUPPRESSANTS; PUBLICATION BIAS; PNEUMOCOCCAL PNEUMONIA; ACE-INHIBITORS; MORTALITY; RISK; ASSOCIATION; OUTCOMES; COHORT; HEART	Background: Emerging epidemiological evidence suggests that statins may reduce the risk of community-acquired pneumonia (CAP) and its complications. Purpose: Performed a systematic review to address the role of statins in the prevention or treatment of CAP. Data Source: Ovid MEDLINE, Cochrane, EMBASE, ISI Web of Science, and Scopus from inception through December 2011 were searched for randomized clinical trials, cohort and case-control studies. Study Selection: Two authors independently reviewed studies that examined the role of statins in CAP. Data Extraction: Data about study characteristics, adjusted effect-estimates and quality characteristics was extracted. Data Synthesis: Eighteen studies corresponding to 21 effect-estimates (eight and 13 of which addressed the preventive and therapeutic roles of statins, respectively) were included. All studies were of good methodological quality. Random-effects meta-analyses of adjusted effect-estimates were used. Statins were associated with a lower risk of CAP, 0.84 (95% CI, 0.74-0.95), I-2 = 90.5% and a lower short-term mortality in patients with CAP, 0.68 (95% CI, 0.59-0.78), I-2 = 75.7%. Meta-regression did not identify sources of heterogeneity. A funnel plot suggested publication bias in the treatment group, which was adjusted by a novel regression method with a resultant effect-estimate of 0.85 (95% CI, 0.77-0.93). Sensitivity analyses using the rule-out approach showed that it is unlikely that the results were due to an unmeasured confounder. Conclusions: Our meta-analysis reveals a beneficial role of statins for the risk of development and mortality associated with CAP. However, the results constitute very low quality evidence as per the GRADE framework due to observational study design, heterogeneity and publication bias.	[Khan, Abdur Rahman] Univ Toledo, Med Ctr, Dept Internal Med, Toledo, OH 43606 USA; [Riaz, Muhammad; Al-Tannir, Mohamad A.] King Fahad Med City, Res & Sci Publicat Ctr, Riyadh, Saudi Arabia; [Bin Abdulhak, Aref A.] Univ Missouri, Dept Internal Med, Kansas City, MO 64110 USA; [Garbati, Musa A.; Tleyjeh, Imad M.] King Fahad Med City, Dept Internal Med, Riyadh, Saudi Arabia; [Erwin, Patricia J.] Mayo Clin, Mayo Med Lib, Rochester, MN USA; [Baddour, Larry M.; Tleyjeh, Imad M.] Mayo Clin, Div Infect Dis, Rochester, MN USA; [Tleyjeh, Imad M.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Tleyjeh, Imad M.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia	University System of Ohio; University of Toledo; King Fahad Medical City; University of Missouri System; University of Missouri Kansas City; King Fahad Medical City; Mayo Clinic; Mayo Clinic; Mayo Clinic; Alfaisal University	Tleyjeh, IM (corresponding author), King Fahad Med City, Dept Internal Med, Riyadh, Saudi Arabia.	itleyjeh@kfmc.med.sa	Riaz, Muhammad/AAA-5500-2021; Bin Abdulhak, Aref/AAM-9492-2020; Bin Abdulhak, Aref/AAK-4348-2020	Riaz, Muhammad/0000-0002-5512-1745; Bin Abdulhak, Aref/0000-0001-9988-8609; Garbati, Musa/0000-0003-3438-421X; Al-Tannir, Mohamad/0000-0002-7739-8446; Tleyjeh, Imad/0000-0002-5551-0353				[Anonymous], 2012, IMPACT STATINS CYTOK; Antunes G, 2002, EUR RESPIR J, V20, P990, DOI 10.1183/09031936.02.00295102; Bjorkhem-Bergman L, 2010, PLOS ONE, V19; Catron DM, 2004, INFECT IMMUN, V72, P1036, DOI 10.1128/IAI.72.2.1036-1042.2004; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Chiou CCC, 2006, CURR OPIN CRIT CARE, V12, P470; Chopra V, 2012, AM J MED; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Corrales-Medina VF, 2009, MEDICINE, V88, P154, DOI 10.1097/MD.0b013e3181a692f0; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Douglas I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1642; Dublin S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2137; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fernandez-Serrano S, 2003, CLIN DIAGN LAB IMMUN, V10, P813, DOI 10.1128/CDLI.10.5.813-820.2003; Fleming DM, 2010, EPIDEMIOL INFECT, V138, P1281, DOI 10.1017/S0950268810000105; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Glynn RJ, 2006, J CLIN EPIDEMIOL, V59, P819, DOI 10.1016/j.jclinepi.2005.12.012; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Janda Surinder, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2010.02.013; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Kwok CS, 2012, EUR J CLIN PHARMACOL, V68, P747, DOI 10.1007/s00228-011-1159-4; Kwong JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008087; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Mendall MA, 1997, HEART, V78, P273, DOI 10.1136/hrt.78.3.273; Menendez R, 2008, THORAX, V63, P447, DOI 10.1136/thx.2007.086785; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Mortensen EM, 2003, CLIN INFECT DIS, V37, P1617, DOI 10.1086/379712; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Mortensen EM, 2008, EUR RESP J, V31, P611; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P697, DOI 10.1002/pds.1769; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P269, DOI 10.1002/pds.1715; Perry TW, 2011, AM J MED, V124, P244, DOI 10.1016/j.amjmed.2010.11.014; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Rothberg MB, 2011, J GEN INTERN MED; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schunemann H, 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch11, DOI 10.1002/9780470712184.CH11]; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Steiner S, 2005, CIRCULATION, V111, P1841, DOI 10.1161/01.CIR.0000158665.27783.0C; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TADDIO A, 1994, CAN MED ASSOC J, V150, P1611; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Torres A, 2010, AM J RESP CRIT CARE, V181, P782, DOI 10.1164/rccm.201001-0030UP; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; van den Hoek HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7281; Vinogradova Y, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606654; Wang HL, 2008, AM J EMERG MED, V26, P711, DOI 10.1016/j.ajem.2007.10.031; Waterer GW, 2004, AM J RESP CRIT CARE, V169, P910, DOI 10.1164/rccm.200310-1448OC; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Yende S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022847; Yende S, 2011, CRIT CARE MED, V39, P1871, DOI 10.1097/CCM.0b013e31821b8290; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	67	51	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2013	8	1							e52929	10.1371/journal.pone.0052929	http://dx.doi.org/10.1371/journal.pone.0052929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IS	23349694	Green Accepted, Green Published, gold			2022-12-27	WOS:000313429100019
J	Levy, DJ; Thavikulwat, AC; Glimcher, PW				Levy, Dino J.; Thavikulwat, Amalie C.; Glimcher, Paul W.			State Dependent Valuation: The Effect of Deprivation on Risk Preferences	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; FORAGING PREFERENCES; REINFORCING VALUE; DECISION-MAKING; FOOD; REPRESENTATION; SENSITIVITY; AVERSION; MONEY	The internal state of an organism affects its choices. Previous studies in various non-human animals have demonstrated a complex, and in some cases non-monotonic, interaction between internal state and risk preferences. Our aim was to examine the systematic effects of deprivation on human decision-making across various reward types. Using both a non-parametric approach and a classical economic analysis, we asked whether the risk attitudes of human subjects towards money, food and water rewards would change as a function of their internal metabolic state. Our findings replicate some previous work suggesting that, on average, humans become more risk tolerant in their monetary decisions, as they get hungry. However, our specific approach allowed us to make two novel observations about the complex interaction between internal state and risk preferences. First, we found that the change in risk attitude induced by food deprivation is a general phenomenon, affecting attitudes towards both monetary and consumable rewards. But much more importantly, our data indicate that rather than each subject becoming more risk tolerant as previously hypothesized based on averaging across subjects, we found that as a population of human subjects becomes food deprived the heterogeneity of their risk attitudes collapses towards a fixed point. Thus subjects who show high-risk aversion while satiated shift towards moderate risk aversion when deprived but subjects who are risk tolerant become more risk averse. These findings demonstrate a more complicated interaction between internal state and risk preferences and raise some interesting implications for both day-to-day decisions and financial market structures.	[Levy, Dino J.] Tel Aviv Univ, Recanati Fac Management, IL-69978 Tel Aviv, Israel; [Levy, Dino J.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Thavikulwat, Amalie C.; Glimcher, Paul W.] NYU, Ctr Neural Sci, New York, NY 10003 USA	Tel Aviv University; Tel Aviv University; New York University	Levy, DJ (corresponding author), Tel Aviv Univ, Recanati Fac Management, IL-69978 Tel Aviv, Israel.	dinolevy@post.tau.ac.il			National Institute of Health Grant [R01-NS054775]; Div Of Biological Infrastructure [1004172] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054775] Funding Source: NIH RePORTER	National Institute of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grant R01-NS054775 (P.W.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SP, 1953, FDN EC ANAL; Bateson M, 1996, BEHAV ECOL, V7, P341, DOI 10.1093/beheco/7.3.341; Bateson M, 2002, P NUTR SOC, V61, P509, DOI 10.1079/PNS2002181; Bednekoff PA, 1996, AM ZOOL, V36, P471; Bialkowski J, 2012, J BANK FINANC, V36, P835, DOI 10.1016/j.jbankfin.2011.09.014; Briers B, 2006, PSYCHOL SCI, V17, P939, DOI 10.1111/j.1467-9280.2006.01808.x; CARACO T, 1981, BEHAV ECOL SOCIOBIOL, V8, P213, DOI 10.1007/BF00299833; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Epstein LH, 2003, PHYSIOL BEHAV, V78, P221, DOI 10.1016/S0031-9384(02)00978-2; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Glimcher P.W., 2010, FDN NEUROECONOMIC AN; Holt CA, 2005, AM ECON REV, V95, P902, DOI 10.1257/0002828054201459; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; HOUSTON AI, 1991, J EXP ANAL BEHAV, V56, P585, DOI 10.1901/jeab.1991.56-585; Kacelnik A, 1997, TRENDS COGN SCI, V1, P304, DOI 10.1016/S1364-6613(97)01093-0; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; LAPPALAINEN R, 1990, APPETITE, V14, P81, DOI 10.1016/0195-6663(90)90002-P; Levy D. J., 2012, CURRENT OPINION NEUR; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; MCNAMARA JM, 1992, B MATH BIOL, V54, P355; McNamara JM, 1996, AM ZOOL, V36, P484; Nelson LD, 2005, PSYCHOL SCI, V16, P167, DOI 10.1111/j.0956-7976.2005.00798.x; Plott C.R., 2008, HDB EXPT EC RESULTS, V1; Raynor HA, 2003, APPETITE, V40, P15, DOI 10.1016/S0195-6663(02)00161-7; Seyyed FJ, 2005, RES INT BUS FINANC, V19, P374, DOI 10.1016/j.ribaf.2004.12.010; Smallwood PD, 1996, AM ZOOL, V36, P392; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Stephens DW, 2008, COGN AFFECT BEHAV NE, V8, P475, DOI 10.3758/CABN.8.4.475; Symmonds M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011090; von Neumann J., 1947, THEORY GAMES EC BEHA, V2; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414	31	40	41	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53978	10.1371/journal.pone.0053978	http://dx.doi.org/10.1371/journal.pone.0053978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23358126	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600025
J	Marquez, JC; Kolasa, J				Marquez, Juan C.; Kolasa, Jurek			Local and Regional Processes in Community Assembly	PLOS ONE			English	Article							ALTERNATIVE STABLE STATES; NULL MODEL ANALYSIS; ECOLOGICAL COMMUNITIES; SPECIES-DIVERSITY; METACOMMUNITY STRUCTURE; DISPERSAL LIMITATION; NEUTRAL THEORY; ROCK POOLS; RULES; DYNAMICS	Controversy on whether local (deterministic) or regional (stochastic) factors control the structure of communities persists after decades of research. The main reason for why it has not been resolved may lie in the nature of evidence which largely comes from realized natural communities. In such communities assembly history leaves a mark that may support either set of factors. To avoid the confounding effects of assembly history we controlled for these effects experimentally. We created a null community by mixing 17 rock pool communities. We then divided the null community into replicates and distributed among treatments representing a gradient of factors from local to regional. We hypothesized that if deterministic factors dominate the assembly of communities, community structures should show a corresponding gradient from being very similar and convergent to dissimilar and divergent. In contrast, if local processes are predominantly stochastic in nature, such a gradient of community configurations should emerge even in the homogeneous setting. Our results appear to partially support both hypotheses and thus suggest that both deterministic and stochastic processes contribute to the assembly of communities. Furthermore, we found that to satisfactorily explain patterns observed in natural communities environmental heterogeneity and regional processes must also be considered. In conclusion, although deterministic mechanisms seem to be important in the assembly of communities, in natural systems their signal may be diluted and masked whenever other factors exert meaningful influence. Such factors increase the number of possible paths to the point that the number of paths equals the number of communities in a metacommunity.	[Marquez, Juan C.; Kolasa, Jurek] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University	Marquez, JC (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	juancmarquezh@gmail.com		Kolasa, Jurek/0000-0003-0910-8950	Natural Science and Engineering Research Council of Canada [NSERC 5-31314-6100]; Colfuturo grant for graduate studies	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Colfuturo grant for graduate studies	This study was funded by the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), grant number NSERC 5-31314-6100 to Jurek Kolasa and the Colfuturo grant for graduate studies (http://www.colfuturo.org/) to Juan Marquez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Beisner Beatrix E., 2005, P321; Belyea L.R., 2004, ASSEMBLY RULES RESTO, P115; Borrvall C, 2006, ECOL LETT, V9, P435, DOI 10.1111/j.1461-0248.2006.00893.x; Brown JH, 2002, AM NAT, V160, P815, DOI 10.1086/343882; Buenau KE, 2007, ECOLOGY, V88, P3022, DOI 10.1890/06-1850.1; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; Chase JM, 2005, FUNCT ECOL, V19, P182, DOI 10.1111/j.0269-8463.2005.00937.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2005, MECOMMUNITIES SPATIA; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Diamond J.M., 1975, P342; DIAMOND JM, 1982, OECOLOGIA, V52, P64, DOI 10.1007/BF00349013; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fox BJ, 1987, EVOL ECOL, V1, P201, DOI 10.1007/BF02067551; FOX BJ, 1995, OIKOS, V73, P125, DOI 10.2307/3545735; Fox BJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P19, DOI 10.1046/j.1365-2699.2000.00184.x; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 1997, OIKOS, V80, P311, DOI 10.2307/3546599; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Hu XS, 2007, AM NAT, V170, P844, DOI 10.1086/522935; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Jenkins DG, 2006, ECOLOGY, V87, P1523, DOI 10.1890/0012-9658(2006)87[1523:ISOQEI]2.0.CO;2; Jenkins DG, 2011, PHILOS T R SOC B, V366, P2331, DOI 10.1098/rstb.2011.0064; Jenkins DG, 1998, ECOL MONOGR, V68, P421, DOI 10.1890/0012-9615(1998)068[0421:DSCDIS]2.0.CO;2; Jiang L, 2011, J ANIM ECOL, V80, P577, DOI 10.1111/j.1365-2656.2010.01799.x; Jocque M, 2010, FRESHWATER BIOL, V55, P1587, DOI 10.1111/j.1365-2427.2010.02402.x; Kolasa J, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P212; Mouquet N, 2006, OIKOS, V113, P481, DOI 10.1111/j.2006.0030-1299.14582.x; Mouquet N, 2003, OIKOS, V103, P618, DOI 10.1034/j.1600-0706.2003.12772.x; Mutshinda CM, 2009, P ROY SOC B-BIOL SCI, V276, P2923, DOI 10.1098/rspb.2009.0523; RAUP DM, 1979, J PALEONTOL, V53, P1213; Ricklefs RE, 2011, PHILOS T R SOC B, V366, P2438, DOI 10.1098/rstb.2011.0066; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Romanuk TN, 2001, ECOSCIENCE, V8, P259, DOI 10.1080/11956860.2001.11682652; Shurin JB, 2000, ECOLOGY, V81, P3062, DOI 10.2307/177401; Shurin JB, 2000, ECOLOGY, V81, P3074, DOI 10.2307/177402; Simberloff D, 2004, AM NAT, V163, P787, DOI 10.1086/420777; Therriault Thomas W., 2002, Aquatic Ecology, V36, P529, DOI 10.1023/A:1021178629707; Therriault TW, 2001, ISR J ZOOL, V47, P477, DOI 10.1560/BWWA-DTXB-LBJK-5GV5; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Ulrich W, 2004, OIKOS, V107, P603, DOI 10.1111/j.0030-1299.2004.12981.x; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Verdy A, 2010, J THEOR BIOL, V262, P116, DOI 10.1016/j.jtbi.2009.09.011; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056	57	21	22	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54580	10.1371/journal.pone.0054580	http://dx.doi.org/10.1371/journal.pone.0054580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355879	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500088
J	Huang, SD; Yuan, Y; Tang, H; Liu, XH; Fu, CG; Cheng, HZ; Bi, JW; Yu, YW; Gong, DJ; Zhang, W; Chen, J; Xu, ZY				Huang, Sheng-Dong; Yuan, Yang; Tang, Hao; Liu, Xiao-Hong; Fu, Chuan-Gang; Cheng, He-Zhong; Bi, Jian-Wei; Yu, Yong-Wei; Gong, De-Jun; Zhang, Wei; Chen, Jie; Xu, Zhi-Yun			Tumor Cells Positive and Negative for the Common Cancer Stem Cell Markers Are Capable of Initiating Tumor Growth and Generating Both Progenies	PLOS ONE			English	Article							MELANOMA-CELLS; GLIOMA-CELLS; IDENTIFICATION; LEUKEMIA; CD133(+); HETEROGENEITY; POPULATIONS; PERSISTENCE	The cancer stem cell (CSC) model depicts that tumors are hierarchically organized and maintained by CSCs lying at the apex. CSCs have been "identified" in a variety of tumors through the tumor-forming assay, in which tumor cells distinguished by a certain cell surface marker (known as a CSC marker) were separately transplanted into immunodeficient mice. In such assays, tumor cells positive but not negative for the CSC marker (hereby defined as CSC+ and CSC- cells, respectively) have the ability of tumor-forming and generating both progenies. However, here we show that CSC+ and CSC- cells exhibit similar proliferation in the native states. Using a cell tracing method, we demonstrate that CSC- cells exhibit similar tumorigenesis and proliferation as CSC+ cells when they were co-transplanted into immunodeficient mice. Through serial single-cell derived subline construction, we further demonstrated that CSC+ and CSC- cells from CSC marker expressing tumors could invariably generate both progenies, and their characteristics are maintained among different generations irrespective of the origins (CSC+-derived or CSC--derived). These findings demonstrate that tumorigenic cells cannot be distinguished by common CSC markers alone and we propose that cautions should be taken when using these markers independently to identify cancer stem cells due to the phenotypic plasticity of tumor cells.	[Huang, Sheng-Dong; Yuan, Yang; Tang, Hao; Liu, Xiao-Hong; Cheng, He-Zhong; Gong, De-Jun; Xu, Zhi-Yun] Second Mil Med Univ, Inst Cardiothorac Surg, Changhai Hosp, Shanghai, Peoples R China; [Fu, Chuan-Gang; Zhang, Wei] Second Mil Med Univ, Dept Colorectal Surg, Changhai Hosp, Shanghai, Peoples R China; [Bi, Jian-Wei] Second Mil Med Univ, Dept Gen Surg, Changhai Hosp, Shanghai, Peoples R China; [Yu, Yong-Wei] Second Mil Med Univ, Dept Pathol, Changhai Hosp, Shanghai, Peoples R China; [Chen, Jie] Second Mil Med Univ, Dept Hematol, Changhai Hosp, Shanghai, Peoples R China; [Xu, Zhi-Yun] Second Mil Med Univ, Dept Cardiothorac Surg, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Huang, SD (corresponding author), Second Mil Med Univ, Inst Cardiothorac Surg, Changhai Hosp, Shanghai, Peoples R China.	huangsd@smmu.edu.cn; zhiyunxu@smmu.edu.cn			National Natural Science Foundation of China [30471718, 30801094, 30872552]; Shanghai Municipal Natural Science Foundation [10140902300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation	This work was supported by the National Natural Science Foundation of China (grants 30471718, 30801094, and 30872552) and the Shanghai Municipal Natural Science Foundation (grant 10140902300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Becker MW, 2011, BLOOD REV, V25, P75, DOI 10.1016/j.blre.2010.11.001; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cammareri P, 2010, CANCER RES, V70, P4655, DOI 10.1158/0008-5472.CAN-09-3953; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Guzman Monica L, 2004, Cancer Control, V11, P97; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Holyoake TL, 2002, LEUKEMIA, V16, P549, DOI 10.1038/sj.leu.2402444; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Maugeri-Sacca M, 2011, CLIN CANCER RES, V17, P4942, DOI 10.1158/1078-0432.CCR-10-2538; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Mueller Maria-Theresa, 2010, Front Biosci (Elite Ed), V2, P602, DOI 10.2741/e117; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oravecz-Wilson KI, 2009, CANCER CELL, V16, P137, DOI 10.1016/j.ccr.2009.06.007; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wu A, 2008, STEM CELLS DEV, V17, P173, DOI 10.1089/scd.2007.0133; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	48	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54579	10.1371/journal.pone.0054579	http://dx.doi.org/10.1371/journal.pone.0054579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349932	gold, Green Submitted, Green Published			2022-12-27	WOS:000313943000045
J	Hua, PY; Zhang, LB; Guo, TT; Flanders, J; Zhang, SY				Hua, Panyu; Zhang, Libiao; Guo, Tingting; Flanders, Jon; Zhang, Shuyi			Dispersal, Mating Events and Fine-Scale Genetic Structure in the Lesser Flat-Headed Bats	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; SPATIAL AUTOCORRELATION ANALYSIS; LONG-EARED BAT; TYLONYCTERIS-PACHYPUS; SWARMING SITES; HABITAT FRAGMENTATION; ROBUSTULA CHIROPTERA; POPULATION-STRUCTURE; MICROSATELLITE LOCI; SOCIAL-ORGANIZATION	Population genetic structure has important consequences in evolutionary processes and conservation genetics in animals. Fine-scale population genetic structure depends on the pattern of landscape, the permanent movement of individuals, and the dispersal of their genes during temporary mating events. The lesser flat-headed bat (Tylonycteris pachypus) is a nonmigratory Asian bat species that roosts in small groups within the internodes of bamboo stems and the habitats are fragmented. Our previous parentage analyses revealed considerable extra-group mating in this species. To assess the spatial limits and sex-biased nature of gene flow in the same population, we used 20 microsatellite loci and mtDNA sequencing of the ND2 gene to quantify genetic structure among 54 groups of adult flat-headed bats, at nine localities in South China. AMOVA and F-ST estimates revealed significant genetic differentiation among localities. Alternatively, the pairwise F-ST values among roosting groups appeared to be related to the incidence of associated extra-group breeding, suggesting the impact of mating events on fine-scale genetic structure. Global spatial autocorrelation analyses showed positive genetic correlation for up to 3 km, indicating the role of fragmented habitat and the specialized social organization as a barrier in the movement of individuals among bamboo forests. The male-biased dispersal pattern resulted in weaker spatial genetic structure between localities among males than among females, and fine-scale analyses supported that relatedness levels within internodes were higher among females than among males. Finally, only females were more related to their same sex roost mates than to individuals from neighbouring roosts, suggestive of natal philopatry in females.	[Hua, Panyu; Guo, Tingting; Zhang, Shuyi] E China Normal Univ, Inst Adv Studies Multidisciplinary Sci & Technol, Shanghai 200062, Peoples R China; [Hua, Panyu] E China Normal Univ, Shanghai Key Lab Urban Ecol Proc & Ecorestorat, Shanghai 200062, Peoples R China; [Zhang, Libiao] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Flanders, Jon] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	East China Normal University; East China Normal University; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; University of Bristol	Zhang, SY (corresponding author), E China Normal Univ, Inst Adv Studies Multidisciplinary Sci & Technol, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn		Flanders, Jon/0000-0001-7296-9601	National Science Foundation of China [30900159, 30800102, 31172077]; National Research Foundation for the Doctoral Program of Higher Education of China [20090076120018]; Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration [SHUES201205]; Key Construction Program of the National '211' Project	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration; Key Construction Program of the National '211' Project	This work was funded by the National Science Foundation of China (30900159, 30800102, 31172077), the National Research Foundation for the Doctoral Program of Higher Education of China (20090076120018), Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration (SHUES201205), and a grant under the Key Construction Program of the National '211' Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2008, MOL ECOL, V17, P2666, DOI 10.1111/j.1365-294X.2008.03797.x; Arnold BD, 2007, AM MIDL NAT, V157, P374, DOI 10.1674/0003-0031(2007)157[374:PSASDI]2.0.CO;2; Beck NR, 2008, MOL ECOL, V17, P4346, DOI 10.1111/j.1365-294X.2008.03906.x; Belkhir K, 2004, GENETIX 4 05 LOGICIE; BRADBURY JW, 1976, BEHAV ECOL SOCIOBIOL, V1, P337, DOI 10.1007/BF00299399; Burland TM, 1999, P ROY SOC B-BIOL SCI, V266, P975, DOI 10.1098/rspb.1999.0732; Burland TM, 2001, MOL ECOL, V10, P1309, DOI 10.1046/j.1365-294X.2001.01273.x; Burland TM, 2001, BIOL REV, V76, P389, DOI 10.1017/S1464793101005747; Chen SF, 2008, J ZOOL, V274, P207, DOI 10.1111/j.1469-7998.2007.00391.x; CHESSER RK, 1991, GENETICS, V127, P437; Crochet PA, 2000, MOL ECOL, V9, P1463, DOI 10.1046/j.1365-294x.2000.01026.x; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Gibbs JP, 2001, BIOL CONSERV, V100, P15, DOI 10.1016/S0006-3207(00)00203-2; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Heckel G, 2002, BEHAV ECOL, V13, P750, DOI 10.1093/beheco/13.6.750; Heckel G, 1999, BEHAVIOUR, V136, P1173, DOI 10.1163/156853999501829; Hua PY, 2007, MOL ECOL NOTES, V7, P486, DOI 10.1111/j.1471-8286.2006.01629.x; Hua PY, 2011, MOL ECOL, V20, P3669, DOI 10.1111/j.1365-294X.2011.05192.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johansson M, 2007, MOL ECOL, V16, P2693, DOI 10.1111/j.1365-294X.2007.03357.x; Kerth G, 2000, MOL ECOL, V9, P793, DOI 10.1046/j.1365-294x.2000.00934.x; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; MEDWAY, 1972, ZOOL J LINN SOC-LOND, V51, P33; MEDWAY L, 1970, J ZOOL, V161, P237; MEDWAY L, 1972, J ZOOL, V168, P463; Nagy M, 2007, P ROY SOC B-BIOL SCI, V274, P3019, DOI 10.1098/rspb.2007.1008; Ortega J, 2002, ETHOLOGY, V108, P1077, DOI 10.1046/j.1439-0310.2002.00836.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2008, MOL ECOL, V4, P135; Petit E, 1999, P ROY SOC B-BIOL SCI, V266, P1717, DOI 10.1098/rspb.1999.0837; Petit E, 2001, EVOLUTION, V55, P635, DOI 10.1554/0014-3820(2001)055[0635:SBDIAM]2.0.CO;2; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Rossiter SJ, 2005, NATURE, V437, P408, DOI 10.1038/nature03965; Rossiter SJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P510, DOI 10.1007/s00265-002-0467-1; Rossiter SJ, 2012, MOL ECOL, V21, P647, DOI 10.1111/j.1365-294X.2011.05391.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Sokal RR, 1998, BIOL J LINN SOC, V65, P41, DOI 10.1111/j.1095-8312.1998.tb00350.x; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Storz JF, 2001, EVOLUTION, V55, P1215; Struebig MJ, 2011, ECOL LETT, V14, P582, DOI 10.1111/j.1461-0248.2011.01623.x; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; Yin JX, 2009, CONSERV GENET, V10, P1061, DOI 10.1007/s10592-008-9688-9; Zamudio KR, 2007, MOL ECOL, V16, P257, DOI 10.1111/j.1365-294X.2006.03139.x; Zhang L, 2007, J ZOOL, V271, P344, DOI 10.1111/j.1469-7998.2006.00210.x; Zhang LB, 2005, ACTA CHIROPTEROL, V7, P91, DOI 10.3161/1733-5329(2005)7[91:DOVITF]2.0.CO;2; Zhang LB, 2005, J MAMMAL, V86, P61, DOI 10.1644/1545-1542(2005)086<0061:DOFBTP>2.0.CO;2; Zhang Li-biao, 2004, Acta Zoologica Sinica, V50, P326; Zhang Libiao, 2011, Acta Theriologica Sinica, V31, P244	65	6	7	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54428	10.1371/journal.pone.0054428	http://dx.doi.org/10.1371/journal.pone.0054428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349888	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800054
J	Standaert, B; Gomez, JA; Raes, M; Debrus, S; Velazquez, FR; Postma, MJ				Standaert, Baudouin; Gomez, Jorge A.; Raes, Marc; Debrus, Serge; Raul Velazquez, F.; Postma, Maarten J.			Impact of Rotavirus Vaccination on Hospitalisations in Belgium: Comparing Model Predictions with Observed Data	PLOS ONE			English	Article							COST-EFFECTIVENESS; CHILDREN; ENGLAND; DISEASE; GASTROENTERITIS; INFECTION; EFFICACY; DIARRHEA; RIX4414; BURDEN	Background: Published economic assessments of rotavirus vaccination typically use modelling, mainly static Markov cohort models with birth cohorts followed up to the age of 5 years. Rotavirus vaccination has now been available for several years in some countries, and data have been collected to evaluate the real-world impact of vaccination on rotavirus hospitalisations. This study compared the economic impact of vaccination between model estimates and observed data on disease-specific hospitalisation reductions in a country for which both modelled and observed datasets exist (Belgium). Methods: A previously published Markov cohort model estimated the impact of rotavirus vaccination on the number of rotavirus hospitalisations in children aged <5 years in Belgium using vaccine efficacy data from clinical development trials. Data on the number of rotavirus-positive gastroenteritis hospitalisations in children aged <5 years between 1 June 2004 and 31 May 2006 (pre-vaccination study period) or 1 June 2007 to 31 May 2010 (post-vaccination study period) were analysed from nine hospitals in Belgium and compared with the modelled estimates. Results: The model predicted a smaller decrease in hospitalisations over time, mainly explained by two factors. First, the observed data indicated indirect vaccine protection in children too old or too young for vaccination. This herd effect is difficult to capture in static Markov cohort models and therefore was not included in the model. Second, the model included a 'waning' effect, i.e. reduced vaccine effectiveness over time. The observed data suggested this waning effect did not occur during that period, and so the model systematically underestimated vaccine effectiveness during the first 4 years after vaccine implementation. Conclusions: Model predictions underestimated the direct medical economic value of rotavirus vaccination during the first 4 years of vaccination by approximately 10% when assessing hospitalisation rates as compared with observed data in Belgium.	[Standaert, Baudouin] GlaxoSmithKline Vaccines, Hlth Econ, Wavre, Belgium; [Gomez, Jorge A.] GlaxoSmithKline Vaccines Latin Amer, Dept Med, Victoria, Buenos Aires, Argentina; [Raes, Marc] Jessa Hosp, Dept Pediat, Hasselt, Belgium; [Debrus, Serge] GlaxoSmithKline Vaccines, Vaccine Dev & Discovery, Wavre, Belgium; [Raul Velazquez, F.] Mexican Inst Social Secur IMSS, Med Res Unit Infect Dis, Pediat Hosp, Natl Med Ctr Century XXI, Mexico City, DF, Mexico; [Postma, Maarten J.] Univ Groningen, Unit Pharmacoepidemiol & Pharmacoecon PE2, Dept Pharm, Groningen, Netherlands	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Instituto Mexicano del Seguro Social; University of Groningen	Standaert, B (corresponding author), GlaxoSmithKline Vaccines, Hlth Econ, Wavre, Belgium.	baudouin.a.standaert@gsk.com		Postma, Maarten/0000-0002-6306-3653	GlaxoSmithKline Biologicals SA; GlaxoSmithKline group of companies; MSD; Pfizer; Sanofi-Pasteur MSD	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); GlaxoSmithKline group of companies(GlaxoSmithKline); MSD; Pfizer(Pfizer); Sanofi-Pasteur MSD	This study, including preparation of the manuscript, was funded by GlaxoSmithKline Biologicals SA, which was involved in: design and conduct of the study; data collection, analysis and interpretation; manuscript preparation, review and decision to submit for publication.; BS, SD and JG are employees of the GlaxoSmithKline group of companies and own stock in the GlaxoSmithKline group of companies. MR's institution received a research grant from the GlaxoSmithKline group of companies for conducting the present study, received funding from the GlaxoSmithKline group of companies for membership of an expert board, and has received funding for travel, accommodation and meetings expenses from the GlaxoSmithKline group of companies, MSD and Pfizer. FRV has received lecture fees, and his institution has received research grants, from the GlaxoSmithKline group of companies. MJP received research grants, honoraria, travel grants and consultancy fees from various pharmaceutical companies (including both companies involved in the production of both rotavirus vaccines; i.e. the GlaxoSmithKline group of companies and Sanofi-Pasteur MSD) for investigations into the economics of vaccines, drugs and methodologies. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Atchison C, 2010, VACCINE, V28, P3118, DOI 10.1016/j.vaccine.2010.02.060; Atkins KE, 2012, VACCINE, V30, P552, DOI 10.1016/j.vaccine.2011.11.064; Bilcke J, 2009, PHARMACOECONOMICS, V27, P281, DOI 10.2165/00019053-200927040-00002; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Desselberger U, 2011, J INFECT DIS, V203, P188, DOI 10.1093/infdis/jiq031; Dewar DM, 2009, ESSENTIALS HLTH EC; Fischer TK, 2002, J INFECT DIS, V186, P593, DOI 10.1086/342294; Fruytier A, 2006, VALUE HEALTH, V9, pA253, DOI 10.1016/S1098-3015(10)63361-X; Garnett GP, 2002, SEX TRANSM INFECT, V78, P7, DOI 10.1136/sti.78.1.7; Harris JP, 2007, VACCINE, V25, P3962, DOI 10.1016/j.vaccine.2007.02.072; do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024; Jit M, 2009, VACCINE, V27, P6121, DOI 10.1016/j.vaccine.2009.08.030; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; Martin A, 2009, VACCINE, V27, P4520, DOI 10.1016/j.vaccine.2009.05.006; Melliez H, 2005, MED MALADIES INFECT, V35, P492, DOI 10.1016/j.medmal.2005.08.007; Paulke-Korinek M, 2010, PEDIATR INFECT DIS J, V29, P319, DOI 10.1097/INF.0b013e3181c18434; Quintanar-Solares M, 2011, PEDIATR INFECT DIS J, V30, pS11, DOI 10.1097/INF.0b013e3181fefb32; Raes M, 2011, EUR SOC PAED INF DIS; Raes M, 2011, PEDIATR INFECT DIS J, V30, pE120, DOI 10.1097/INF.0b013e318214b811; Velazguez FR, 2009, PEDIATR INFECT DIS J, V28, pS54, DOI 10.1097/INF.0b013e3181967c03; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Rozenbaum MH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-462; Standaert B, 2009, APPL HLTH EC HLTH PO, V6, P199; Standaert B, 2008, PEDIATR INFECT DIS J, V27, pS20, DOI 10.1097/INF.0b013e31815eee1a; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS56, DOI 10.1097/INF.0b013e3181fefdc0; van Effelterre T, 2010, EPIDEMIOL INFECT, V138, P884, DOI 10.1017/S0950268809991245; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664	29	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53864	10.1371/journal.pone.0053864	http://dx.doi.org/10.1371/journal.pone.0053864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349754	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800016
J	Picard-Jean, F; Bougie, I; Shuto, S; Bisaillon, M				Picard-Jean, Frederic; Bougie, Isabelle; Shuto, Satoshi; Bisaillon, Martin			The Immunosuppressive Agent Mizoribine Monophosphate Is an Inhibitor of the Human RNA Capping Enzyme	PLOS ONE			English	Article							POLYMERASE-II; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; GUANYLYLTRANSFERASE; MECHANISM; RIBAVIRIN; CELLS; CAP; DEHYDROGENASE	Mizoribine monophosphate (MZP) is a specific inhibitor of the cellular inosine-5'-monophosphate dehydrogenase (IMPDH), the enzyme catalyzing the rate-limiting step of de novo guanine nucleotide biosynthesis. MZP is a highly potent antagonistic inhibitor of IMPDH that blocks the proliferation of T and B lymphocytes that use the de novo pathway of guanine nucleotide synthesis almost exclusively. In the present study, we investigated the ability of MZP to directly inhibit the human RNA capping enzyme (HCE), a protein harboring both RNA 5'-triphosphatase and RNA guanylyltransferase activities. HCE is involved in the synthesis of the cap structure found at the 5' end of eukaryotic mRNAs, which is critical for the splicing of the cap-proximal intron, the transport of mRNAs from the nucleus to the cytoplasm, and for both the stability and translation of mRNAs. Our biochemical studies provide the first insight that MZP can inhibit the formation of the RNA cap structure catalyzed by HCE. In the presence of MZP, the RNA 5'-triphosphatase activity appears to be relatively unaffected while the RNA guanylyltransferase activity is inhibited, indicating that the RNA guanylyltransferase activity is the main target of MZP inhibition. Kinetic studies reveal that MZP is a non-competitive inhibitor that likely targets an allosteric site on HCE. Mizoribine also impairs mRNA capping in living cells, which could account for the global mechanism of action of this therapeutic agent. Together, our study clearly demonstrates that mizoribine monophosphate inhibits the human RNA guanylyltransferase in vitro and impair mRNA capping in cellulo.	[Picard-Jean, Frederic; Bougie, Isabelle; Bisaillon, Martin] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Quebec City, PQ, Canada; [Shuto, Satoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan	University of Sherbrooke; Hokkaido University	Bisaillon, M (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Quebec City, PQ, Canada.	Martin.Bisaillon@USherbrooke.ca	Shuto, Satoshi/AAH-4998-2020	Shuto, Satoshi/0000-0001-7850-8064	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) and the Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Doherty AJ, 1997, ACTA CRYSTALLOGR D, V53, P482, DOI 10.1107/S090744499700231X; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; HAGER PW, 1995, BIOCHEM PHARMACOL, V49, P1323, DOI 10.1016/0006-2952(95)00026-V; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1998, MOL CELL BIOL, V18, P5189, DOI 10.1128/MCB.18.9.5189; Ishida K, 2009, BIOL PHARM BULL, V32, P741, DOI 10.1248/bpb.32.741; Issur M, 2011, WIRES RNA, V2, P184, DOI 10.1002/wrna.43; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Jimeno-Gonzalez S, 2010, MOL CELL, V37, P580, DOI 10.1016/j.molcel.2010.01.019; Kim HJ, 2004, MOL CELL BIOL, V24, P6184, DOI 10.1128/MCB.24.14.6184-6193.2004; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KOYAMA H, 1983, BIOCHEM PHARMACOL, V32, P3547, DOI 10.1016/0006-2952(83)90301-5; Li GD, 1998, ENDOCRINOLOGY, V139, P3752, DOI 10.1210/en.139.9.3752; Liu D, 2005, TRANSPL INT, V18, P401, DOI 10.1111/j.1432-2277.2004.00042.x; Mao XD, 1996, MOL CELL BIOL, V16, P475; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; MIZUMOTO K, 1987, PROG NUCLEIC ACID RE, V34, P1, DOI 10.1016/S0079-6603(08)60491-2; MIZUNO K, 1974, J ANTIBIOT, V27, P775, DOI 10.7164/antibiotics.27.775; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Saijo M, 2005, ANTIVIR RES, V66, P159, DOI 10.1016/j.antiviral.2005.01.003; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seo KW, 2005, TRANSPL P, V37, P155, DOI 10.1016/j.transproceed.2005.01.020; SHIBAGAKI Y, 1992, J BIOL CHEM, V267, P9521; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Souliere MF, 2008, BIOCHEMISTRY-US, V47, P3863, DOI 10.1021/bi702054a; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V239, P116, DOI 10.1006/bbrc.1997.7439; Tsuzuki K, 2002, PEDIATR INT, V44, P224, DOI 10.1046/j.1328-8067.2001.01531.x; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Weber G, 1976, Adv Enzyme Regul, V14, P3, DOI 10.1016/0065-2571(76)90005-4; Wen YX, 1998, P NATL ACAD SCI USA, V95, P12226, DOI 10.1073/pnas.95.21.12226; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Yan YF, 2005, RNA, V11, P1238, DOI 10.1261/rna.2930805; Yokota S, 2002, PEDIATR INT, V44, P196, DOI 10.1046/j.1328-8067.2002.01536.x; Yoshioka K, 2000, KIDNEY INT, V58, P317, DOI 10.1046/j.1523-1755.2000.00168.x; Zhong Binbin, 2005, Mod Rheumatol, V15, P264, DOI 10.1007/s10165-005-0406-x	41	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54621	10.1371/journal.pone.0054621	http://dx.doi.org/10.1371/journal.pone.0054621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349942	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900082
J	Boessenecker, RW; Churchill, M				Boessenecker, Robert W.; Churchill, Morgan			A Reevaluation of the Morphology, Paleoecology, and Phylogenetic Relationships of the Enigmatic Walrus Pelagiarctos	PLOS ONE			English	Article							BODY SIZES; CARNIVORA; MAMMALIA; ORIGIN; PREDATORS; EMPHASIS; CETACEA	Background: A number of aberrant walruses (Odobenidae) have been described from the Neogene of the North Pacific, including specialized suction-feeding and generalist fish-eating taxa. At least one of these fossil walruses has been hypothesized to have been a specialized predator of other marine mammals, the middle Miocene walrus Pelagiarctos thomasi from the Sharktooth Hill Bonebed of California (16.1-14.5 Ma). Methodology/Principal Findings: A new specimen of Pelagiarctos from the middle Miocene "Topanga" Formation of southern California (17.5-15 Ma) allows a reassessment of the morphology and feeding ecology of this extinct walrus. The mandibles of this new specimen are robust with large canines, bulbous premolars with prominent paraconid, metaconid, hypoconid cusps, crenulated lingual cingula with small talonid basins, M-2 present, double-rooted P-3-M-1, single-rooted P-1 and M-2, and a P-2 with a bilobate root. Because this specimen lacks a fused mandibular symphysis like Pelagiarctos thomasi, it is instead referred to Pelagiarctos sp. This specimen is more informative than the fragmentary holotype of Pelagiarctos thomasi, permitting Pelagiarctos to be included within a phylogenetic analysis for the first time. Analysis of a matrix composed of 90 cranial, dental, mandibular and postcranial characters indicates that Pelagiarctos is an early diverging walrus and sister to the late Miocene walrus Imagotaria downsi. We reevaluate the evidence for a macropredatory lifestyle for Pelagiarctos, and we find no evidence of specialization towards a macrophagous diet, suggesting that Pelagiarctos was a generalist feeder with the ability to feed on large prey. Conclusions/Significance: This new specimen of Pelagiarctos adds to the knowledge of this problematic taxon. The phylogenetic analysis conclusively demonstrates that Pelagiarctos is an early diverging walrus. Pelagiarctos does not show morphological specializations associated with macrophagy, and was likely a generalist predator, feeding on fish, invertebrates, and the occasional warm-blooded prey item.	[Boessenecker, Robert W.] Univ Otago, Dept Geol, Dunedin, Otago, New Zealand; [Boessenecker, Robert W.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Churchill, Morgan] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; [Churchill, Morgan] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA	University of Otago; University of California System; University of California Berkeley; University of Wyoming; University of Wyoming	Boessenecker, RW (corresponding author), Univ Otago, Dept Geol, Dunedin, Otago, New Zealand.	robert.boessenecker@otago.ac.nz			University of Otago Doctoral Scholarship; Paleontological Society Research Grant; Geological Society of America Graduate Student Research Grant; National Science Foundation (NSF)	University of Otago Doctoral Scholarship; Paleontological Society Research Grant; Geological Society of America Graduate Student Research Grant; National Science Foundation (NSF)(National Science Foundation (NSF))	RWB was supported during part of this study by a University of Otago Doctoral Scholarship. MC was supported during this study by a Paleontological Society Research Grant, a Geological Society of America Graduate Student Research Grant, and a National Science Foundation (NSF) East Asian Pacific Rim Summer Institute Fellowship. Funders webpages: http://www.otago.ac.nz/study/scholarships/database/otago014687.html; http://www.geosociety.org/grants/gradgrants.htm; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5284; http://www.palass.org/modules.php?name = palaeo&page = 168&sec = awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Peter J., 2002, Oryctos, V4, P83; Aranda-Manteca Francisco J., 1994, Proceedings of the San Diego Society of Natural History, V29, P191; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Barnes L.G., 1972, University of California Publications in Geological Sciences, V89, P1; Barnes L. G., 1988, CONTR SCI MUS NAT HI, V396, P1; Barnes L.G., 1971, PALEOBIOS, V11, P1; Barnes L. G., 1991, CONTR SCI MUS NAT HI, V426, P1, DOI DOI 10.7717/PEERJ.3316; Barnes L. G., 1995, ISL ARC, V3, P329, DOI DOI 10.1111/J.1440-1738.1994; Barnes L. G., 1998, PUBLICACION ESPECIAL, P26; Barnes LG, 1989, CONTRIBUTIONS SCI NA, V403, P1; Berkoff M, 1998, PALEOBIOS, V18, P1; BERTA A, 1986, Transactions of the San Diego Society of Natural History, V21, P111; Berta A., 1991, SMITHSON CONTRIB PAL, V69, P1; Berta A., 1994, SMITHSONIAN CONTRIB, V78, P1, DOI [10.5479/si.00810266.78.1, DOI 10.5479/SI.00810266.78.1]; Berta Annalisa, 1994, Proceedings of the San Diego Society of Natural History, V29, P33; Bininda-Emonds O.R.P., 1996, Bonner Zoologische Monographien, V41, P1; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Boessenecker RW, 2011, J VERTEBR PALEONTOL, V31, P454, DOI 10.1080/02724634.2011.550362; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Condon T., 1906, U OREGON B LETIN, V3, P1; Davit-Beal T, 2009, J ANAT, V214, P477, DOI 10.1111/j.1469-7580.2009.01060.x; de Muizon C, 2002, SM C PALEOB, P223; de Muizon Christian, 1993, Bulletin de l'Institut Francais d'Etudes Andines, V22, P671; Debey LB, 2013, MAR MAMMAL SCI, V29, P48, DOI 10.1111/j.1748-7692.2011.00545.x; Delisle I, 2005, MOL PHYLOGENET EVOL, V37, P192, DOI 10.1016/j.ympev.2005.04.025; Demere T.A., 1984, MIOCENE CRETACEOUS D, V54, P47; Demere TA, 2003, B AM MUS NAT HIST, P32, DOI 10.1206/0003-0090(2003)279<0032:C>2.0.CO;2; Demere TA, 2001, J VERTEBR PALEONTOL, V21, P279, DOI 10.1671/0272-4634(2001)021[0279:AROPRF]2.0.CO;2; Demere Thomas A., 2005, Bulletin of the Florida Museum of Natural History, V45, P379; Demere Thomas A., 1994, Proceedings of the San Diego Society of Natural History, V29, P77; Demere Thomas A., 1994, Proceedings of the San Diego Society of Natural History, V29, P99; Dubrovo IA, 1981, DOKLADY EARTH SCI SE, V256, P202; Fay FH, 1982, N AM FAUNA, DOI DOI 10.3996/NAFA.74.0001; Ferreira JM, 2008, POLAR BIOL, V31, P303, DOI 10.1007/s00300-007-0358-z; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Flynn JJ, 1998, MOL PHYLOGENET EVOL, V9, P414, DOI 10.1006/mpev.1998.0504; Fulton T. L., 2009, P R SOC B, V277, P1065; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GORDON KR, 1984, J MORPHOL, V182, P179, DOI 10.1002/jmor.1051820206; Harris DE, 2006, NORTHEAST NAT, V13, P403, DOI 10.1656/1092-6194(2006)13[403:GAOISS]2.0.CO;2; Horikawa H., 1995, ISL ARC, V3, P309, DOI DOI 10.1111/J.1440-1738.1994.TB00118.X; Howard H, 1987, NAT HIST MUS LOS ANG, V383, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ISHIYAMA M, 1987, SCANNING MICROSCOPY, V1, P1071; Kellogg R., 1922, University of California Publications in Geology, V13, P23; Kohno N, 2006, J VERTEBR PALEONTOL, V26, P411, DOI 10.1671/0272-4634(2006)26[411:ANMOMC]2.0.CO;2; KOHNO N, 1994, J VERTEBR PALEONTOL, V14, P414, DOI 10.1080/02724634.1994.10011568; Kohno N., 1995, ISL ARC, V3, P285, DOI DOI 10.1111/J.1440-1738.1994.TB00117.X; Kohno Naoki, 1996, Transactions and Proceedings of the Palaeontological Society of Japan New Series, V181, P388; Levermann Nette, 2003, BMC Ecology, V3, P1; Lindenfors P, 2002, BEHAV ECOL SOCIOBIOL, V52, P188, DOI 10.1007/s00265-002-0507-x; LOWRY LF, 1984, POLAR BIOL, V3, P11, DOI 10.1007/BF00265562; LOWRY LF, 1988, POLAR BIOL, V8, P475, DOI 10.1007/BF00264724; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Memmott J, 2000, J ANIM ECOL, V69, P1, DOI 10.1046/j.1365-2656.2000.00367.x; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; MILLER EH, 1975, CAN J ZOOL, V53, P590, DOI 10.1139/z75-073; Mitchell E., 1973, Bulletin Am Mus nat Hist, V151, P203; MITCHELL EDWARD, 1966, UNIV CALIF PUBLICATIONS GEOL SCI, V61, P1; NORES C, 1988, J ZOOL, V216, P593, DOI 10.1111/j.1469-7998.1988.tb02457.x; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pyenson ND, 2009, GEOLOGY, V37, P519, DOI 10.1130/G25509A.1; Raschke RE, 1984, MEMOIRS NATURAL HIST, V1, P61; Repenning C. A., 1977, UNITED STATE GEOLOGI, V992, P1; Rybczynski N, 2009, NATURE, V458, P1021, DOI 10.1038/nature07985; Sato JJ, 2004, ZOOL SCI, V21, P111; SCAPINO R, 1981, J MORPHOL, V167, P339, DOI 10.1002/jmor.1051670308; Scott JE, 2012, J EVOLUTION BIOL, V25, P661, DOI 10.1111/j.1420-9101.2012.02457.x; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tedford Richard H., 2004, P169; Turner D. L., 1970, GEOLOGICAL SOC AM SP, P91, DOI DOI 10.1130/SPE124-P91; Whistler DP, 2003, B AM MUS NAT HIST, P231; Wilson JW, 2006, POLAR BIOL, V29, P905, DOI 10.1007/s00300-006-0187-5; Yerkes RF, 1979, US GEOLOGICAL SURV E, V1457, pE1	75	38	39	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54311	10.1371/journal.pone.0054311	http://dx.doi.org/10.1371/journal.pone.0054311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342129	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700106
J	Dean, MC; Cole, TJ				Dean, M. Christopher; Cole, Tim J.			Human Life History Evolution Explains Dissociation between the Timing of Tooth Eruption and Peak Rates of Root Growth	PLOS ONE			English	Article							COMPARATIVE DENTAL DEVELOPMENT; PAN-TROGLODYTES; COMMON CHIMPANZEE; EARLIEST EVIDENCE; CROSS-STRIATIONS; EXTENSION-RATES; AGE-CHANGES; HUMAN-TEETH; ENAMEL; MOLAR	We explored the relationship between growth in tooth root length and the modern human extended period of childhood. Tooth roots provide support to counter chewing forces and so it is advantageous to grow roots quickly to allow teeth to erupt into function as early as possible. Growth in tooth root length occurs with a characteristic spurt or peak in rate sometime between tooth crown completion and root apex closure. Here we show that in Pan troglodytes the peak in root growth rate coincides with the period of time teeth are erupting into function. However, the timing of peak root velocity in modern humans occurs earlier than expected and coincides better with estimates for tooth eruption times in Homo erectus. With more time to grow longer roots prior to eruption and smaller teeth that now require less support at the time they come into function, the root growth spurt no longer confers any advantage in modern humans. We suggest that a prolonged life history schedule eventually neutralised this adaptation some time after the appearance of Homo erectus. The root spurt persists in modern humans as an intrinsic marker event that shows selection operated, not primarily on tooth tissue growth, but on the process of tooth eruption. This demonstrates the overarching influence of life history evolution on several aspects of dental development. These new insights into tooth root growth now provide an additional line of enquiry that may contribute to future studies of more recent life history and dietary adaptations within the genus Homo.	[Dean, M. Christopher] UCL, London, England; [Cole, Tim J.] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England	University of London; University College London; University of London; University College London	Dean, MC (corresponding author), UCL, Gower St, London, England.	ucgacrd@ucl.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	Leverhulme Trust [F/07 134/F]; Medical Research Council [MR/J004839/1]; MRC [MR/J004839/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants to MCD from The Leverhulme Trust (F/07 134/F) and TJC from the Medical Research Council (MR/J004839/1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson D L, 1976, J Forensic Sci, V21, P191; ANEMONE RL, 1991, AM J PHYS ANTHROPOL, V86, P229, DOI 10.1002/ajpa.1330860211; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Arathi R, 2006, J INDIAN SOC PEDOD P, pS16; BERKOVITZ BK, 1971, ARCH ORAL BIOL, V16, P1033, DOI 10.1016/0003-9969(71)90208-1; BERKOVITZ BKB, 1976, J DENT RES, V55, P460, DOI 10.1177/00220345760550032601; Berkovitz BKB., 2018, ORAL ANATOMY HISTOLO, V5th ed.; Berkovitz BKB, 1989, HDB MICROSCOPIC ANAT, V6, P21; de Castro JMB, 2010, P NATL ACAD SCI USA, V107, P11739, DOI 10.1073/pnas.1006772107; Berna F, 2012, P NATL ACAD SCI USA, V109, pE1215, DOI 10.1073/pnas.1117620109; Beynon AD, 1998, J HUM EVOL, V35, P163, DOI 10.1006/jhev.1998.0230; Bogin B, 2009, AM J HUM BIOL, V21, P567, DOI 10.1002/ajhb.20895; Boughner JC, 2004, J HUM EVOL, V46, P255, DOI 10.1016/j.jhevol.2003.11.007; BOYDE A, 1979, J DENT RES, V58, P981, DOI 10.1177/00220345790580025101; BOYDE A, 1990, MG PRIMATOL, V14, P229; Boyde A, 1964, THESIS U LONDON; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; BROMAGE TG, 1991, AM J PHYS ANTHROPOL, V86, P205, DOI 10.1002/ajpa.1330860209; Cahill DR, 1988, BIOL MECHANISMS TOOT, P1; Cobb SN, 2011, J ANAT, V218, P96, DOI 10.1111/j.1469-7580.2010.01321.x; Cobb SN, 2009, FRONT ORAL BIOL, V13, P121, DOI 10.1159/000242403; Cole TJ, 2008, BIOSTATISTICS, V9, P159, DOI 10.1093/biostatistics/kxm020; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; Craddock HL, 2004, BRIT DENT J, V197, P385, DOI 10.1038/sj.bdj.4811712; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean MC, 2007, J HUM EVOL, V53, P635, DOI 10.1016/j.jhevol.2007.04.009; Dean MC, 2008, J HUM EVOL, V54, P258, DOI 10.1016/j.jhevol.2007.09.021; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; Dean M Christopher, 2012, Methods Mol Biol, V915, P89, DOI 10.1007/978-1-61779-977-8_5; Dean M. Christopher, 2012, V62, P268; Dean MC, 2012, J HUM EVOL, V62, P174, DOI 10.1016/j.jhevol.2011.10.003; Dean MC, 2010, PHILOS T R SOC B, V365, P3397, DOI 10.1098/rstb.2010.0052; Dean MC, 2009, FRONT ORAL BIOL, V13, P68, DOI 10.1159/000242394; Dean M. Christopher, 2009, P101, DOI 10.1007/978-1-4020-9980-9_10; Dean MC, 2004, ANN ANAT, V186, P405; Dean MC, 1998, ARCH ORAL BIOL, V43, P1009, DOI 10.1016/S0003-9969(98)00069-7; Dean MC, 2005, 13 INT S DENT MORPH, P371; Dean MC, 1999, HUMAN GROWTH STUDIES, P11; Dean MC., 1995, STRUCTURE FUNCTION E, P239; DEMIRJIAN A, 1973, HUM BIOL, V45, P211; Ekrtrand KM, 2003, COMMUNITY DENT ORAL, V31, P344, DOI 10.1034/j.1600-0528.2003.00016.x; Estrela C, 2010, DENT PRESS J ORTHOD, V15, P44; FEASBY WH, 1981, AM J ORTHOD DENTOFAC, V80, P554, DOI 10.1016/0002-9416(81)90250-5; Fleischmannova J, 2010, J DENT RES, V89, P108, DOI 10.1177/0022034509355440; Fujiwara N, 2009, J EXP ZOOL PART B, V312B, P486, DOI 10.1002/jez.b.21268; Gleiser I, 1955, AM J PHYS ANTHROP-NE, V13, P253, DOI 10.1002/ajpa.1330130206; GORSKI JP, 1992, CRIT REV ORAL BIOL M, V3, P185, DOI 10.1177/10454411920030030201; Guatelli-Steinberg D, 2012, J HUM EVOL, V63, P475, DOI 10.1016/j.jhevol.2012.05.006; Guatelli-Steinberg D, 2009, EVOL ANTHROPOL, V18, P9, DOI 10.1002/evan.20190; Haavikko K, 1970, P FINNISH DENT SOC, V66, P104; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; Harris EF, 2002, DENT ANTHR J, V16, P15, DOI 10.26575/daj.v16i1.165; Hogg RT, 2011, ANAT REC, V294, P2193, DOI 10.1002/ar.21503; JERNVALL J, 1994, INT J DEV BIOL, V38, P463; Kelley J, 2009, FRONT ORAL BIOL, V13, P128, DOI 10.1159/000242404; Kelley J, 2010, P NATL ACAD SCI USA, V107, P1035, DOI 10.1073/pnas.0906206107; KOVACS I, 1979, Ossa, V6, P181; Kovacs I., 1971, DENT MORPHOLOGY EVOL, P211; KRAEMER H C, 1982, Primates, V23, P393, DOI 10.1007/BF02381322; Kupczik K, 2008, J HUM EVOL, V54, P196, DOI 10.1016/j.jhevol.2007.09.013; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Kuykendall KL, 1996, AM J PHYS ANTHROPOL, V99, P135, DOI 10.1002/(SICI)1096-8644(199601)99:1<135::AID-AJPA8>3.0.CO;2-#; KUYKENDALL KL, 1992, AM J PHYS ANTHROPOL, V89, P379, DOI 10.1002/ajpa.1330890310; Lacruz RS, 2012, J BIOL RHYTHM, V27, P237, DOI 10.1177/0748730412442830; Le Cabec A, 2012, J HUM EVOL, V63, P667, DOI 10.1016/j.jhevol.2012.07.003; Liu SS-Y, 2001, AM J ORTHOD DENT ORT, V139, P745; Liversidge H, 1998, DENT ANTHR FUNDAMENT, P420; Liversidge HM, 2008, ANN HUM BIOL, V35, P294, DOI 10.1080/03014460801971445; Liversidge HM, 2006, ANN HUM BIOL, V33, P454, DOI 10.1080/03014460600802387; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Marks SC, 1996, ANAT RECORD, V245, P374, DOI 10.1002/(SICI)1097-0185(199606)245:2<374::AID-AR18>3.0.CO;2-M; MARKS SC, 1984, ARCH ORAL BIOL, V29, P311, DOI 10.1016/0003-9969(84)90105-5; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; MOXHAM BJ, 1974, ARCH ORAL BIOL, V19, P903, DOI 10.1016/0003-9969(74)90053-3; Nielsen M, 2012, J COMP PSYCHOL, V126, P170, DOI 10.1037/a0025168; NISSEN HW, 1964, AM J PHYS ANTHROPOL, V22, P285, DOI 10.1002/ajpa.1330220315; Organ C, 2011, P NATL ACAD SCI USA, V108, P14555, DOI 10.1073/pnas.1107806108; Parner ET, 2002, J DENT RES, V81, P451, DOI 10.1177/154405910208100703; PICTON DCA, 1989, EUR J ORTHODONT, V11, P430, DOI 10.1093/oxfordjournals.ejo.a036015; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Reid DJ, 1998, J HUM EVOL, V35, P427, DOI 10.1006/jhev.1998.0248; Roberts GJ, 2008, BRIT DENT J, V204, DOI 10.1038/bdj.2008.21; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Sadakatsu S, 1990, ERUPTION PERMANENT T, P100; Schwartz GT, 2006, INT J PRIMATOL, V27, P1201, DOI 10.1007/s10764-006-9051-2; Shackelford LL, 2012, AM J PHYS ANTHROPOL, V147, P227, DOI 10.1002/ajpa.21639; Shaweesh AI, 2012, INT J STOMATOL OCCLU, V5, P70, DOI 10.1007/s12548-012-0041-z; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P697, DOI 10.1016/0003-9969(84)90175-4; Shellis RP, 1998, J HUM EVOL, V35, P387, DOI 10.1006/jhev.1998.0260; Shinoda H, 1984, CHEM TODAY, V162, P34; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Smith B. Holly, 1993, P195; Smith BH, 2011, J HUM EVOL, V60, P34, DOI 10.1016/j.jhevol.2010.08.006; SMITH BH, 1995, ANNU REV ANTHROPOL, V24, P257, DOI 10.1146/annurev.an.24.100195.001353; SMITH BH, 1989, EVOLUTION, V43, P683, DOI 10.1111/j.1558-5646.1989.tb04266.x; SMITH BH, 1986, NATURE, V323, P327, DOI 10.1038/323327a0; Smith SL, 2009, AM J HUM BIOL, V21, P623, DOI 10.1002/ajhb.20873; Smith TM, 2007, J HUM EVOL, V52, P201, DOI 10.1016/j.jhevol.2006.09.004; Smith TM, 2006, J ANAT, V208, P125, DOI 10.1111/j.1469-7580.2006.00500.x; Spencer MA, 2003, AM J PHYS ANTHROPOL, V122, P325, DOI 10.1002/ajpa.10288; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; STACK MV, 1967, J DENT RES, V46, P879, DOI 10.1177/00220345670460054501; Tafforeau P, 2012, J HUM EVOL, V62, P424, DOI 10.1016/j.jhevol.2012.01.001; Takeshima Takahiro, 2004, World J Orthod, V5, P332; Thesleff I, 2009, TOOTH ORGANOGENESIS, DOI [10.3824/stembook.1.37.1, DOI 10.3824/STEMBOOK.1.37.1]; Tummers M, 2003, DEVELOPMENT, V130, P1049, DOI 10.1242/dev.00332; Tummers M, 2008, EVOL DEV, V10, P187, DOI 10.1111/j.1525-142X.2008.00226.x; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Wise GE, 2002, CRIT REV ORAL BIOL M, V13, P323, DOI 10.1177/154411130201300403; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B., 1991, HOMINID CRANIAL REMA, V4; Zihlman A, 2004, P NATL ACAD SCI USA, V101, P10541, DOI 10.1073/pnas.0402635101; Zuckerman S, 1928, P ZOOL SOC LOND, V1928, P1	116	43	43	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54534	10.1371/journal.pone.0054534	http://dx.doi.org/10.1371/journal.pone.0054534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342167	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400168
J	Kedenge, SV; Kangwana, BP; Waweru, EW; Nyandigisi, AJ; Pandit, J; Brooker, SJ; Snow, RW; Goodman, CA				Kedenge, Sarah V.; Kangwana, Beth P.; Waweru, Evelyn W.; Nyandigisi, Andrew J.; Pandit, Jayesh; Brooker, Simon J.; Snow, Robert W.; Goodman, Catherine A.			Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector - Results from Focus Group Discussions in Rural Kenya	PLOS ONE			English	Article							LUMEFANTRINE TREATMENT POLICY; ARTEMETHER-LUMEFANTRINE; MALARIA TREATMENT; CASE-MANAGEMENT; 6-DOSE REGIMEN; GLOBAL SUBSIDY; AVAILABILITY; ADHERENCE; INTERVENTIONS; KNOWLEDGE	Background: There is considerable interest in the potential of private sector subsidies to increase availability and affordability of artemisinin-based combination therapies (ACTs) for malaria treatment. A cluster randomized trial of such subsidies was conducted in 3 districts in Kenya, comprising provision of subsidized packs of paediatric ACT to retail outlets, training of retail staff, and community awareness activities. The results demonstrated a substantial increase in ACT availability and coverage, though patient counselling and adherence were suboptimal. We conducted a qualitative study in order to understand why these successes and limitations occurred. Methodology/Principal Findings: Eighteen focus group discussions were conducted, 9 with retailers and 9 with caregivers, to document experiences with the intervention. Respondents were positive about intervention components, praising the focused retailer training, affordable pricing, strong promotional activities, dispensing job aids, and consumer friendly packaging, which are likely to have contributed to the positive access and coverage outcomes observed. However, many retailers still did not stock ACT, due to insufficient supplies, lack of capital and staff turnover. Advice to caregivers was poor due to insufficient time, and poor recall of instructions. Adherence by caregivers to dosing guidelines was sub-optimal, because of a wish to save tablets for other episodes, doses being required at night, stopping treatment when the child felt better, and the number and bitter taste of the tablets. Caregivers used a number of strategies to obtain paediatric ACT for older age groups. Conclusions/Significance: This study has highlighted that important components of a successful ACT subsidy intervention are regular retailer training, affordable pricing, a reliable supply chain and community mobilization emphasizing patient adherence and when to seek further care.	[Kedenge, Sarah V.; Kangwana, Beth P.; Waweru, Evelyn W.; Brooker, Simon J.; Snow, Robert W.; Goodman, Catherine A.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth Grp, Nairobi, Kenya; [Nyandigisi, Andrew J.] Minist Publ Hlth & Sanitat, Div Malaria Control, Nairobi, Kenya; [Pandit, Jayesh] Pharm & Poisons Board, Nairobi, Kenya; [Brooker, Simon J.; Goodman, Catherine A.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Kedenge, SV (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth Grp, Nairobi, Kenya.	skedenge@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022; Waweru, Everlyn/AAL-4943-2020	Snow, Robert William/0000-0003-3725-6088; Waweru, Everlyn/0000-0002-4599-8973; Goodman, Catherine/0000-0002-2241-3485	Department for International Development, United Kingdom (DFID); United States Agency for International Development (USAID); Wellcome Trust, United Kingdom; Kenya Medical Research Institute (KEMRI); Wellcome Trust Master's Fellowship in Public Health and Tropical Medicine [092766]; Wellcome Trust [0811673, 092654]; United Kingdom Department for International Development	Department for International Development, United Kingdom (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Wellcome Trust, United Kingdom(Wellcome Trust); Kenya Medical Research Institute (KEMRI); Wellcome Trust Master's Fellowship in Public Health and Tropical Medicine(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Department for International Development	This work was financially supported by the Department for International Development, United Kingdom (DFID), the United States Agency for International Development (USAID), the Wellcome Trust, United Kingdom, and the Kenya Medical Research Institute (KEMRI). SVK is supported by a Wellcome Trust Master's Fellowship in Public Health and Tropical Medicine (#092766), RWS is a Principal Wellcome Trust Fellow (#079080), SJB is supported by a Research Career Development Fellowship from the Wellcome Trust (#0811673), and CAG was a member of the Consortium for Research on Equitable Health Systems, which was supported by the United Kingdom Department for International Development. SVK, BBK, SJB, RWS and CAG acknowledge support from the Wellcome Trust core grant (#092654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya T, 2009, AM J TROP MED HYG, V80, P905, DOI 10.4269/ajtmh.2009.80.905; Abuya TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008937; Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; Chuma J, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-15; Clinton Health Access Initiative (CHAI), 2012, PRIC SUBS INCR US PR; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Gerstl S, 2010, T ROY SOC TROP MED H, V104, P328, DOI 10.1016/j.trstmh.2009.12.008; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Kachur SP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-25; Kangwana B, 2012, IMPACT RETAIL SECTOR; Kangwana B, 2010, IMPACT RETAIL SECTOR; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Kedenge S, 2011, IMPACT RETAIL SECTOR; Laxminarayan R, 2009, HEALTH AFFAIR, V28, P949, DOI 10.1377/hlthaff.28.4.949; Lemma H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-349; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-328; Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Ministry of Public Health and Sanitation M.o.M.S., 2010, GUID DET REG PROC GE; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Smith N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-316; Sudoi RK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-37; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; Tougher S, 2012, LANCET; Tren R, 2011, LANCET, V377, P810, DOI 10.1016/S0140-6736(11)60302-4; Wasunna B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-29; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO, 2009, WORLD MAL REP; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54371	10.1371/journal.pone.0054371	http://dx.doi.org/10.1371/journal.pone.0054371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342143	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000314759400158
J	Martin, JA				Martin H, Jose Antonio			Solving Hard Computational Problems Efficiently: Asymptotic Parametric Complexity 3-Coloring Algorithm	PLOS ONE			English	Article							4-REGULAR PLANAR GRAPHS; PERFORMANCE GUARANTEE; CO-NP; MAP	Many practical problems in almost all scientific and technological disciplines have been classified as computationally hard (NP-hard or even NP-complete). In life sciences, combinatorial optimization problems frequently arise in molecular biology, e. g., genome sequencing; global alignment of multiple genomes; identifying siblings or discovery of dysregulated pathways. In almost all of these problems, there is the need for proving a hypothesis about certain property of an object that can be present if and only if it adopts some particular admissible structure (an NP-certificate) or be absent (no admissible structure), however, none of the standard approaches can discard the hypothesis when no solution can be found, since none can provide a proof that there is no admissible structure. This article presents an algorithm that introduces a novel type of solution method to "efficiently" solve the graph 3-coloring problem; an NP-complete problem. The proposed method provides certificates (proofs) in both cases: present or absent, so it is possible to accept or reject the hypothesis on the basis of a rigorous proof. It provides exact solutions and is polynomial-time (i.e., efficient) however parametric. The only requirement is sufficient computational power, which is controlled by the parameter alpha is an element of N. Nevertheless, here it is proved that the probability of requiring a value of alpha>k to obtain a solution for a random graph decreases exponentially: P(alpha>k) <= 2(-(k+1)), making tractable almost all problem instances. Thorough experimental analyses were performed. The algorithm was tested on random graphs, planar graphs and 4-regular planar graphs. The obtained experimental results are in accordance with the theoretical expected results.	Univ Complutense Madrid, Madrid, Spain	Complutense University of Madrid	Martin, JA (corresponding author), Univ Complutense Madrid, Madrid, Spain.	jamartinh@fdi.ucm.es		Martin H, Jose Antonio/0000-0002-0874-2194	Universidad Complutense de Madrid	Universidad Complutense de Madrid	The author has declared that there is no other particular funder apart from his institution (Universidad Complutense de Madrid) through his current contract as an assistant professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abfalter I, 2005, THESIS U WIEN; [Anonymous], 2004, J GRAPH ALGORITHMS A, DOI DOI 10.7155/JGAA.00091; APPEL K, 1977, ILLINOIS J MATH, V21, P429, DOI 10.1215/ijm/1256049011; APPEL K, 1977, ILLINOIS J MATH, V21, P491, DOI 10.1215/ijm/1256049012; Arora S, 2009, COMPUTATIONAL COMPLEXITY: A MODERN APPROACH, P1, DOI 10.1017/CBO9780511804090; Arora S., 2006, STOC'06. Proceedings of the 38th Annual ACM Symposium on Theory of Computing, P215, DOI 10.1145/1132516.1132548; BERGER B, 1990, ALGORITHMICA, V5, P459, DOI 10.1007/BF01840398; Bes JN, 2005, TOOLS ART INT 2005 I, P2, DOI [10.1109/ICTAI.2005.102, DOI 10.1109/ICTAI.2005.102]; Blum A, 1994, J ACM JACM, V41, P516; Bodirsky M, 2003, AUTOMATA LANGUAGES P, P191; Boettcher S, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066703; BOPPANA RB, 1987, INFORM PROCESS LETT, V25, P127, DOI 10.1016/0020-0190(87)90232-8; Borodin OV, 2009, J COMB THEORY B, V99, P668, DOI 10.1016/j.jctb.2008.11.001; Borodin OV, 1996, J GRAPH THEOR, V21, P183; Borodin OV, 2005, J COMB THEORY B, V93, P303, DOI 10.1016/j.jctb.2004.11.001; BROERSMA HJ, 1993, J GRAPH THEOR, V17, P613, DOI 10.1002/jgt.3190170508; Chartrand G., 2008, CHROMATIC GRAPH THEO; Cook S. A., 1971, Proceedings of the 3rd annual ACM symposium on theory of computing, P151; Culberson J, 2001, THEOR COMPUT SCI, V265, P227, DOI 10.1016/S0304-3975(01)00164-5; DAILEY DP, 1980, DISCRETE MATH, V30, P289, DOI 10.1016/0012-365X(80)90236-8; Denise A, 1996, C NUMERANTIUM, P61; Downey R, 1999, PARAMETERIZED COMPLE, V5; Erdos P., 1976, C INT TEOR COMB, V17, P19; Erdos P, 1960, PUBLICATIONS TKE MAT, V5; Flum J., 2006, TEXT THEORET COMP S, DOI 10.1007/3-540-29953-X; FORTNOW L, 1988, INFORM PROCESS LETT, V28, P249, DOI 10.1016/0020-0190(88)90199-8; Garey M.R., 1979, COMPUTERS INTRACTABI; GAREY MR, 1976, J ACM, V23, P43, DOI 10.1145/321921.321926; Goldreich O, 2008, COMPUTATIONAL COMPLEXITY: A CONCEPTUAL PERSPECTIVE, P1, DOI 10.1017/CBO9780511804106; HALLDORSSON MM, 1993, INFORM PROCESS LETT, V45, P19, DOI 10.1016/0020-0190(93)90246-6; Heawood P.J., 1898, Q J PURE APPL MATH, V29, P270; Hochstattler W, 2010, CATBOX INTERACTIVE C, DOI [10.1007/978-3-642-03822-8, DOI 10.1007/978-3-642-03822-8]; Hogg T, 1996, ARTIF INTELL, V81, P1, DOI 10.1016/0004-3702(95)00044-5; Jensen TR, 1995, WILEY INTERSCIENCE S, VXIX; Johnson D. S., 2002, Data structures, near neighbor searches, and methodology: Fifth and sixth DIMACS implementation challenges. Papers related to the DIMACS challenge on dictionaries and priority queues (1995-1996) and the DIMACS challenge on near neighbor searches (1998-1999), P215; Johnson D. S., 1974, P 5 SE C COMB GRAPH, P513; JOHNSON DS, 1974, J COMPUT SYST SCI, V9, P256, DOI 10.1016/S0022-0000(74)80044-9; Jones M, 2008, COMPUTER SCI; Karp R. M., 1972, P COMPL COMP COMP, P85; Karp RM, 2011, J COMPUT SYST SCI, V77, P122, DOI 10.1016/j.jcss.2010.06.009; Khanna S, 2000, COMBINATORICA, V20, P393, DOI 10.1007/s004930070013; LEHEL J, 1981, J GRAPH THEOR, V5, P423, DOI 10.1002/jgt.3190050412; Levin L, 1973, PROBLEMY PEREDACI IN, V9, P115; Malaguti E, 2010, INT T OPER RES, V17, P1, DOI 10.1111/j.1475-3995.2009.00696.x; MANCA P, 1979, J GRAPH THEOR, V3, P357, DOI 10.1002/jgt.3190030406; Martin H JA, 2011, ABS11040510 CORR; Mizuno K, 2008, DISCRETE APPL MATH, V156, P218, DOI 10.1016/j.dam.2006.07.015; Mulet R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268701; Park T, 1996, J OPER RES SOC JPN, V39, P258, DOI 10.15807/jorsj.39.258; Pevzner P. A., 1995, Proceedings Third Israel Symposium on the Theory of Computing and Systems, P158, DOI 10.1109/ISTCS.1995.377035; Ramani A, 2004, DESIGN, AUTOMATION AND TEST IN EUROPE CONFERENCE AND EXHIBITION, VOLS 1 AND 2, PROCEEDINGS, P324, DOI 10.1109/DATE.2004.1268868; Selman B, 1996, ARTIF INTELL, V81, P17, DOI 10.1016/0004-3702(95)00045-3; Steinberg R., 1993, ANN DISCR M, V55, P211, DOI DOI 10.1016/S0167-5060(08)70391-1; Stockmeyer L., 1973, ACM SIGACT NEWS, V5, P19, DOI [10.1145/1008293.1008294, DOI 10.1145/1008293.1008294]; THOMASSEN C, 1994, J COMB THEORY B, V62, P268, DOI 10.1006/jctb.1994.1069; van Rossum G, 2012, PYTHON LANGUAGE WEBS; Wang WF, 2007, SCI CHINA SER A, V50, P1552, DOI 10.1007/s11425-007-0106-4; WIGDERSON A, 1983, J ACM, V30, P729, DOI 10.1145/2157.2158; Zdeborova L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031131	60	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53437	10.1371/journal.pone.0053437	http://dx.doi.org/10.1371/journal.pone.0053437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23349711	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400044
J	Wheelock, A; Eisingerich, AB; Ananworanich, J; Gomez, GB; Hallett, TB; Dybul, MR; Piot, P				Wheelock, Ana; Eisingerich, Andreas B.; Ananworanich, Jintanat; Gomez, Gabriela B.; Hallett, Timothy B.; Dybul, Mark R.; Piot, Peter			Are Thai MSM Willing to Take PrEP for HIV Prevention? An Analysis of Attitudes, Preferences and Acceptance	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; SEXUAL-BEHAVIOR; RISK BEHAVIOR; CONDOM USE; MEN; INFECTION; ADHERENCE; STRATEGIES; EXPERIENCE; IMPACT	Objective: We aimed to understand the attitudes, preferences and acceptance of oral and parenteral PrEP among men who have sex with men (MSM) in Thailand. Background: Pre-exposure prophylaxis (PrEP), the use of antiretrovirals to prevent HIV acquisition, has shown promising results in recent trials. To assess the potential impact of this new HIV prevention method, in addition to efficacy data, we need to understand which psychosocial factors are likely to determine its uptake among members of potential user groups. Methods and Findings: Surveys of willingness to use PrEP products were administered to MSM. Spearman's rank tests were used to uncover associations between questionnaire items. Mann-Whitney tests were performed to ascertain differences between groups. Conjoint analysis was used to examine the attitudes and preferences of MSM towards PrEP attributes. Most participants were willing to consider taking PrEP (39.2% "yes, definitely'' and 49.2% "yes, probably'') and perceived PrEP as giving them new possibilities in their lives (38.5% "a lot of hope'' and 55.8% "some hope''), even after being instructed of potential side effects and costs. HIV testing was considered the most important attribute and a daily pill and longer lasting injection in the arm were the preferred routes of administration. Conclusions: Despite its multiple challenges, MSM in Thailand would be willing to take PrEP, even if they had to experience inconvenience and expense. If PrEP were to be implemented in Thailand, our findings show that its uptake could be considerable.	[Wheelock, Ana] Univ London Imperial Coll Sci Technol & Med, Ctr Patient Safety & Serv Qual, London, England; [Eisingerich, Andreas B.] Univ London Imperial Coll Sci Technol & Med, Sch Business, London, England; [Ananworanich, Jintanat] Chulalongkorn Univ, Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Ananworanich, Jintanat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Gomez, Gabriela B.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Gomez, Gabriela B.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Dybul, Mark R.] Georgetown ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Dybul, Mark R.] George W Bush Inst, Washington, DC USA; [Piot, Peter] London Sch Hyg & Trop Med, London WC1, England	Imperial College London; Imperial College London; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Wheelock, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Patient Safety & Serv Qual, London, England.	a.wheelock@imperial.ac.uk	Ananworanich, Jintanat/AAC-6348-2021; Wheelock, Ana/AAE-9248-2019	Ananworanich, Jintanat/0000-0003-1369-3224; Hallett, Timothy/0000-0002-9681-0424; Wheelock, Ana/0000-0003-0855-7252	Bill & Melinda Gates Foundation; Medical Research Council [MR/K010174/1, MR/K010174/1B, G0600719B] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The sponsor of the study, the Bill & Melinda Gates Foundation, had no role in study design, data collection, data analysis, decision to publish, or write up of the paper.; We are very grateful to all those who participated in this study, and the Bill & Melinda Gates Foundation, in particular Blair Hanewall and Stephen Becker, for funding our research. We would also like to thank Emily Gray, Kate Duxbury and the Ipsos MORI team, as well as Ipsos Thailand, for their valuable input and management support throughout this study. The authors would finally like to thank Marisa Miraldo and Anam Parand (Imperial College) for their advice, and Geoffrey Garnett (Imperial College) and Joep Lange (Amsterdam Institute for Global Health and Development) for their guidance at the beginning of this study.	Amon Joseph, 2009, Sur, Rev. int. direitos human., V6, P162; AVAC, 2012, PREP DEM PROJ; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Bekker L. G., 2012, Southern African Journal of HIV Medicine, V13, P40; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Beyrer C, 2011, J ACQ IMMUN DEF SYND, V57, P96; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Bridges John F P, 2003, Appl Health Econ Health Policy, V2, P213; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Frost LJ, 2009, HEALTH AFFAIR, V28, P962, DOI 10.1377/hlthaff.28.4.962; Geronimus AT, 1996, J AM STAT ASSOC, V91, P529, DOI 10.2307/2291645; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Hanck SE, 2008, SEX TRANSM DIS, V35, P489, DOI 10.1097/OLQ.0b013e3181653433; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Ickovics JR, 1997, J CLIN EPIDEMIOL, V50, P385, DOI 10.1016/S0895-4356(97)00041-3; Jackson T, 2012, AIDS BEHAV, P1; Kelesidis Theodoros, 2011, Curr HIV/AIDS Rep, V8, P94, DOI 10.1007/s11904-011-0078-4; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; KROSNICK JA, 1993, AM J POLIT SCI, V37, P941, DOI 10.2307/2111580; KROSNICK JA, 1991, APPL COGNITIVE PSYCH, V5, P213, DOI 10.1002/acp.2350050305; Li A, 2009, AIDS BEHAV, V13, P318, DOI 10.1007/s10461-008-9448-3; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; National Institute of Allergy and Infectious Diseases (NIAID), 2011, TREAT HIV INF PEOPL; Paxton LA, 2007, LANCET, V370, P89, DOI 10.1016/S0140-6736(07)61053-8; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Ryan M, 2001, HLTH TECHNOL ASSESS, V5; San Francisco City Clinic, 2012, SAN FRANC PREP DEM P; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Sudman S, 1999, J ACAD MARKET SCI, V27, P269, DOI 10.1177/0092070399272010; U.S. Food and Drug Administration, 2012, FDA APPR 1 MED RED H; UNAIDS WHO, 2011, GLOB HIV AIDS RESP E; United Nations Development Programme, 2004, THAIL RESP HIV AIDS; van Griensven F, 2005, AIDS, V19, P521, DOI 10.1097/01.aids.0000162341.50933.e8; van Griensven F., 2006, Morbidity and Mortality Weekly Report, V55, P844; van Griensven F, 2010, JAIDS-J ACQ IMM DEF, V53, P234, DOI 10.1097/QAI.0b013e3181c2fc86; Wheelock A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001234; World Health Organization, 2012, RAP ADV GUID OR PREE	44	65	66	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54288	10.1371/journal.pone.0054288	http://dx.doi.org/10.1371/journal.pone.0054288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23342121	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000314759400141
J	Zurcher, NR; Donnelly, N; Rogier, O; Russo, B; Hippolyte, L; Hadwin, J; Lemonnier, E; Hadjikhani, N				Zuercher, Nicole R.; Donnelly, Nick; Rogier, Ophelie; Russo, Britt; Hippolyte, Loyse; Hadwin, Julie; Lemonnier, Eric; Hadjikhani, Nouchine			It's All in the Eyes: Subcortical and Cortical Activation during Grotesqueness Perception in Autism	PLOS ONE			English	Article							FACE PERCEPTION; FUNCTIONAL NEUROANATOMY; THATCHER ILLUSION; CHILDREN; GAZE; SPECTRUM; RECOGNITION; INVERSION; BRAIN; INDIVIDUALS	Atypical face processing plays a key role in social interaction difficulties encountered by individuals with autism. In the current fMRI study, the Thatcher illusion was used to investigate several aspects of face processing in 20 young adults with high-functioning autism spectrum disorder (ASD) and 20 matched neurotypical controls. "Thatcherized" stimuli were modified at either the eyes or the mouth and participants discriminated between pairs of faces while cued to attend to either of these features in upright and inverted orientation. Behavioral data confirmed sensitivity to the illusion and intact configural processing in ASD. Directing attention towards the eyes vs. the mouth in upright faces in ASD led to (1) improved discrimination accuracy; (2) increased activation in areas involved in social and emotional processing; (3) increased activation in subcortical face-processing areas. Our findings show that when explicitly cued to attend to the eyes, activation of cortical areas involved in face processing, including its social and emotional aspects, can be enhanced in autism. This suggests that impairments in face processing in autism may be caused by a deficit in social attention, and that giving specific cues to attend to the eye-region when performing behavioral therapies aimed at improving social skills may result in a better outcome.	[Zuercher, Nicole R.; Rogier, Ophelie; Russo, Britt; Hippolyte, Loyse; Hadjikhani, Nouchine] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Donnelly, Nick; Hadwin, Julie] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Lemonnier, Eric] CHRU Brest Hop Bohars, Ctr Ressources Autisme Bretagne, Bohars, France; [Lemonnier, Eric] Univ Brest, CHRU Brest Hop Bohars, Bohars, France; [Hadjikhani, Nouchine] Harvard Univ, Sch Med, MGH HMS MIT A Martinos Ctr Biomed Imaging, Charlestown, MA USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Southampton; CHU Brest; CHU Brest; Universite de Bretagne Occidentale; Harvard University	Hadjikhani, N (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	nouchine@nmr.mgh.harvard.edu	Hadjikhani, Nouchine/C-2018-2008; lemonnier, eric/K-1084-2016; Zurcher, Nicole/AGF-1440-2022	Hadjikhani, Nouchine/0000-0003-4075-3106; Zurcher, Nicole/0000-0003-0271-6304; Donnelly, Nick/0000-0002-3577-5434	Swiss National Science Foundation [PP00P3-130191]; Velux Stiftung; Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards Foundation; Jeantet Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Stiftung; Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards Foundation; Jeantet Foundation	This work was supported by the Swiss National Science Foundation (PP00P3-130191 to NH) and by the Velux Stiftung; by the Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Swiss Federal Institute of Technology Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG) and the Leenaards and the Jeantet Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 2000, DIAGN STAT MAN MENT; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Batki A, 2000, INFANT BEHAV DEV, V23, P223, DOI 10.1016/S0163-6383(01)00037-6; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; Bouvier SE, 2006, CEREB CORTEX, V16, P183, DOI 10.1093/cercor/bhi096; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Carbon CC, 2005, PERCEPTION, V34, P1117, DOI 10.1068/p5192; Carbon CC, 2005, COGNITIVE BRAIN RES, V24, P544, DOI 10.1016/j.cogbrainres.2005.03.008; Carbon CC, 2007, PERCEPTION, V36, P1635, DOI 10.1068/p5467; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Cornes K, 2008, THESIS U SOUTHAMPTON; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; de Gelder BC, 2003, P NATL ACAD SCI USA, V100, P13105, DOI 10.1073/pnas.1735530100; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Donnelly N, 2012, ATTEN PERCEPT PSYCHO, V74, P1475, DOI 10.3758/s13414-012-0330-z; Donnelly N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023340; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Elsabbagh M, 2009, BIOL PSYCHIAT, V65, P31, DOI 10.1016/j.biopsych.2008.09.034; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Grice SJ, 2005, CORTEX, V41, P342, DOI 10.1016/S0010-9452(08)70271-5; Hadjikhani N, 2004, NEUROIMAGE, V22, P1141, DOI 10.1016/j.neuroimage.2004.03.025; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Hadjikhani N, 2007, HUM BRAIN MAPP, V28, P441, DOI 10.1002/hbm.20283; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; HILLIARD R D, 1973, Cortex, V9, P246; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JOHNSON M, 2005, NAT NEUROSCI REV, V6, P2; Joseph RM, 2003, J CHILD PSYCHOL PSYC, V44, P529, DOI 10.1111/1469-7610.00142; Joseph RM, 2008, J INT NEUROPSYCH SOC, V14, P947, DOI 10.1017/S1355617708081344; Kingstone A, 2004, BRAIN COGNITION, V55, P269, DOI 10.1016/j.bandc.2004.02.037; Kliemann D, 2012, J NEUROSCI, V32, P9469, DOI 10.1523/JNEUROSCI.5294-11.2012; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kylliainen A, 2006, EUR J NEUROSCI, V24, P2679, DOI 10.1111/j.1460-9568.2006.05132.x; Kylliainen A, 2006, J AUTISM DEV DISORD, V36, P517, DOI 10.1007/s10803-006-0091-4; Lahaie A, 2006, NEUROPSYCHOLOGY, V20, P30, DOI 10.1037/0894-4105.20.1.30; LANGDELL T, 1978, J CHILD PSYCHOL PSYC, V19, P255, DOI 10.1111/j.1469-7610.1978.tb00468.x; Lopez B, 2004, VIS COGN, V11, P673, DOI 10.1080/13506280344000437; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Malcolm GL, 2004, PERCEPTION, V33, P1221, DOI 10.1068/p5372; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Meng M, 2012, P ROY SOC B-BIOL SCI, V279, P2052, DOI 10.1098/rspb.2011.1784; Mestry N, 2012, NEUROPSYCHOLOGIA; Mohanty A, 2009, J NEUROSCI, V29, P10563, DOI 10.1523/JNEUROSCI.1170-09.2009; Morris JP, 2007, SOC COGN AFFECT NEUR, V2, P31, DOI 10.1093/scan/nsl023; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Nishimura M, 2008, VIS COGN, V16, P859, DOI 10.1080/13506280701538514; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; PERRETT DI, 1988, BEHAV BRAIN RES, V29, P245, DOI 10.1016/0166-4328(88)90029-0; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Raven J., 2004, MANUAL RAVENS PROGR; Riby DM, 2009, Q J EXP PSYCHOL, V62, P189, DOI 10.1080/17470210701855629; Ristic J, 2005, COGNITIVE BRAIN RES, V24, P715, DOI 10.1016/j.cogbrainres.2005.02.007; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Rouse H, 2004, J CHILD PSYCHOL PSYC, V45, P1246, DOI 10.1111/j.1469-7610.2004.00317.x; SCAPINELLO KF, 1970, PSYCHON SCI, V21, P329, DOI 10.3758/BF03335807; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Senju A, 2005, NEUROPSYCHOLOGIA, V43, P1297, DOI 10.1016/j.neuropsychologia.2004.12.002; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorger B, 2007, NEUROIMAGE, V35, P836, DOI 10.1016/j.neuroimage.2006.09.051; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; Sturzel F, 2000, PERCEPTION, V29, P937, DOI 10.1068/p2888; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2006, WECHSLER NONVERBAL S; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Winston JS, 2003, CURR BIOL, V13, P1824, DOI 10.1016/j.cub.2003.09.038; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Yarbus A.L., 1967, EYE MOVEMENT VISION; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	99	32	33	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54313	10.1371/journal.pone.0054313	http://dx.doi.org/10.1371/journal.pone.0054313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23342130	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000314759400147
J	Kebschull, M; Haupt, M; Jepsen, S; Deschner, J; Nickenig, G; Werner, N				Kebschull, Moritz; Haupt, Manuela; Jepsen, Soren; Deschner, James; Nickenig, Georg; Werner, Nikos			Mobilization of Endothelial Progenitors by Recurrent Bacteremias with a Periodontal Pathogen	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS INFECTION; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; STEM-CELL NICHE; OSTEOPROTEGERIN EXPRESSION; SYSTEMIC INFLAMMATION; APOLIPOPROTEIN-E; IMMUNE-RESPONSE; ORAL INFECTION; ATHEROSCLEROSIS	Background: Periodontal infections are independent risk factors for atherosclerosis. However, the exact mechanisms underlying this link are yet unclear. Here, we evaluate the in vivo effects of bacteremia with a periodontal pathogen on endothelial progenitors, bone marrow-derived cells capable of endothelial regeneration, and delineate the critical pathways for these effects. Methods: 12-week old C57bl6 wildtype or toll-like receptor (TLR)-2 deficient mice were repeatedly intravenously challenged with 10(9) live P. gingivalis 381 or vehicle. Numbers of Sca1+/flk1+ progenitors, circulating angiogenic cells, CFU-Hill, and late-outgrowth EPC were measured by FACS/culture. Endothelial function was assessed using isolated organ baths, reendothelization was measured in a carotid injury model. RANKL/osteoprotegerin levels were assessed by ELISA/qPCR. Results: In wildtype mice challenged with intravenous P. gingivalis, numbers of Sca1+/flk1+ progenitors, CAC, CFU-Hill, and late-outgrowth EPC were strongly increased in peripheral circulation and spleen, whereas Sca1+/flk1+ progenitor numbers in bone marrow decreased. Circulating EPCs were functional, as indicated by improved endothelial function and improved reendothelization in infected mice. The osteoprotegerin/RANKL ratio was increased after P. gingivalis challenge in the bone marrow niche of wildtype mice and late-outgrowth EPC in vitro. Conversely, in mice deficient in TLR2, no increase in progenitor mobilization or osteoprotegerin/RANKL ratio was detected. Conclusion: Recurrent transient bacteremias, a feature of periodontitis, increase peripheral EPC counts and decrease EPC pools in the bone marrow, thereby possibly reducing overall endothelial regeneration capacity, conceivably explaining proatherogenic properties of periodontal infections. These effects are seemingly mediated by toll-like receptor (TLR)-2.	[Kebschull, Moritz; Jepsen, Soren; Deschner, James] Univ Bonn, Dept Periodontol Operat & Prevent Dent, Bonn, Germany; [Kebschull, Moritz; Haupt, Manuela; Nickenig, Georg; Werner, Nikos] Univ Bonn, Dept Internal Med 2, Bonn, Germany	University of Bonn; University of Bonn	Werner, N (corresponding author), Univ Bonn, Dept Internal Med 2, Bonn, Germany.	nikos.werner@ukb.uni-bonn.de	Kebschull, Moritz/F-7207-2010; DESCHNER, JAMES/AAW-3998-2021	Kebschull, Moritz/0000-0003-1863-0679; 	German Research Foundation [DFG KFO208 TP6, DFG KFO208 TP9]	German Research Foundation(German Research Foundation (DFG))	The study was funded by the German Research Foundation (DFG KFO208 TP6 & TP9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2003, ARTERIOSCL THROM VAS, V23, P1245, DOI 10.1161/01.ATV.0000078603.90302.4A; Banerjee S, 2006, ATHEROSCLEROSIS, V189, P70, DOI 10.1016/j.atherosclerosis.2006.04.026; Belibasakis GN, 2010, INFLAMMATION; Benslimane-Ahmim Z, 2011, J THROMB HAEMOST; Borden WB, 2009, REV CARDIOVASC MED, V10, P63; Brehm M, 2009, CLIN RES CARDIOL, V98, P477, DOI 10.1007/s00392-009-0021-5; Brouchet L, 2001, CIRCULATION, V103, P423; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cole JE, 2010, EXPERT REV CARDIOVAS, V8, P1619, DOI 10.1586/ERC.10.149; D'Amelio P, 2009, J Endocrinol Invest, V32, P6; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; de Villeroche VJ, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2934; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Gibson FC, 2007, CURR PHARM DESIGN, V13, P3665, DOI 10.2174/138161207783018554; Goussetis E, 2009, BLOOD CELL MOL DIS, V42, P294, DOI 10.1016/j.bcmd.2009.01.003; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Hajishengallis G, 2008, J IMMUNOL, V181, P4141, DOI 10.4049/jimmunol.181.6.4141; Hajishengallis G, 2009, PERIODONTOL 2000, V51, P181, DOI 10.1111/j.1600-0757.2009.00304.x; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; Hayashi C, 2010, J INNATE IMMUN, V2, P334, DOI 10.1159/000314686; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Honda T, 2005, ORAL MICROBIOL IMMUN, V20, P82, DOI 10.1111/j.1399-302X.2004.00193.x; Hujoel PP, 2001, J PERIODONTAL RES, V36, P48, DOI 10.1034/j.1600-0765.2001.00011.x; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Ito H, 1999, CANCER RES, V59, P5875; Iwai T, 2009, J PERIODONTAL RES, V44, P689, DOI 10.1111/j.1600-0765.2008.01165.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kinane DF, 2005, J CLIN PERIODONTOL, V32, P708, DOI 10.1111/j.1600-051X.2005.00741.x; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Leone AM, 2005, EUR HEART J, V26, P1196, DOI 10.1093/eurheartj/ehi164; Li XA, 2011, J CLIN PERIODONTOL, V38, P148, DOI 10.1111/j.1600-051X.2010.01651.x; Li X, 2009, J CLIN PERIODONTOL, V36, P933, DOI 10.1111/j.1600-051X.2009.01481.x; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Lockhart PB, 2012, CIRCULATION; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Lu HK, 2008, ORAL MICROBIOL IMMUN, V23, P220, DOI 10.1111/j.1399-302X.2007.00415.x; Madan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003204; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; McGonigle JS, 2009, ANGIOGENESIS, V12, P35, DOI 10.1007/s10456-008-9127-z; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Mercanoglu F, 2004, J PERIODONTOL, V75, P1694, DOI 10.1902/jop.2004.75.12.1694; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Padfield GJ, 2010, AM J PHYSIOL-HEART C, V298, pH2054, DOI 10.1152/ajpheart.00921.2009; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pollreisz A, 2010, J PERIODONTAL RES, V45, P239, DOI 10.1111/j.1600-0765.2009.01225.x; Reddi D, 2008, MICROBES INFECT, V10, P1459, DOI 10.1016/j.micinf.2008.08.007; Rodrigues PH, 2008, FRONT BIOSCI-LANDMRK, V13, P178, DOI 10.2741/2668; Roth GA, 2007, FEMS MICROBIOL LETT, V272, P106, DOI 10.1111/j.1574-6968.2007.00736.x; Secchiero P, 2008, BLOOD, V111, P1287, DOI 10.1182/blood-2007-05-092031; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Sommers Marilyn Sawyer, 2003, Crit Care Nurs Clin North Am, V15, P13, DOI 10.1016/S0899-5885(02)00046-1; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; Taubman MA, 2005, J PERIODONTOL, V76, P2033, DOI 10.1902/jop.2005.76.11-S.2033; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Wassmann S, 2006, CIRC RES, V99, pE74, DOI 10.1161/01.RES.0000246095.90247.d4; Werner N, 2006, J CELL MOL MED, V10, P318, DOI 10.1111/j.1582-4934.2006.tb00402.x; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2007, BASIC RES CARDIOL, V102, P565, DOI 10.1007/s00395-007-0680-1; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang JF, 2002, FEBS LETT, V521, P180, DOI 10.1016/S0014-5793(02)02872-7; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	70	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54860	10.1371/journal.pone.0054860	http://dx.doi.org/10.1371/journal.pone.0054860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355901	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500137
J	Kruger, IM; Kruger, MC; Doak, CM; Schutte, AE; Huisman, HW; Van Rooyen, JM; Schutte, R; Malan, L; Malan, NT; Fourie, CMT; Kruger, A				Kruger, Iolanthe M.; Kruger, Marlena C.; Doak, Colleen M.; Schutte, Aletta E.; Huisman, Hugo W.; Van Rooyen, Johannes M.; Schutte, Rudolph; Malan, Leone; Malan, Nicolaas T.; Fourie, Carla M. T.; Kruger, Annamarie			The Association of 25(OH)D with Blood Pressure, Pulse Pressure and Carotid-Radial Pulse Wave Velocity in African Women	PLOS ONE			English	Article							VITAMIN-D STATUS; 3RD NATIONAL-HEALTH; ARTERIAL STIFFNESS; D DEFICIENCY; DISEASE; RISK; HOMOCYSTEINE; CALCIFICATION; DETERMINANTS; CALCIUM	High susceptibility of the African population to develop cardiovascular disease obliges us to investigate possible contributing risk factors. Our aim was to determine whether low 25(OH)D status is associated with increased blood pressure and carotid-radial pulse wave velocity in black South African women. We studied 291 urban women (mean age: 57.56 +/- 9.00 yrs.). 25(OH)D status was determined by serum 25(OH)D levels. Women were stratified into sufficient (>30 ng/ ml), and insufficient/deficient (<30 ng/ml) groups. Cardiovascular variables were compared between groups. Women with low 25(OH)D levels had significantly higher SBP (150.8 +/- 27.1 vs. 137.6 +/- 21.0), DBP (94.7 +/- 14.5 vs. 89.3 +/- 12.3) and PP (53.15(50.7;55.7) vs. 46.3(29.4;84.6)) compared to women with sufficient levels. No significant difference was observed with regards to c-rPWV. ANCOVA analyses still revealed significant differences between the two groups with regards to SBP, DBP as well as PP. Partial correlations revealed significant inverse association between SBP and 25(OH)D (p = .04; r = -.12). Women with low 25(OH)D levels were similar to 2 times more likely to have high SBP (95% CI: 3.23; 1.05). To conclude, women with deficient/insufficient 25(OH)D had significantly higher SBP compared to women with a sufficient 25(OH) status.	[Kruger, Iolanthe M.; Kruger, Annamarie] North West Univ, Africa Unit Transdisciplinary Hlth Res AUTHeR, Potchefstroom, South Africa; [Kruger, Marlena C.] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Doak, Colleen M.] Vrije Univ Amsterdam, Dept Nutr & Hlth, Inst Hlth Sci, Amsterdam, Netherlands; [Schutte, Aletta E.; Huisman, Hugo W.; Van Rooyen, Johannes M.; Schutte, Rudolph; Malan, Leone; Malan, Nicolaas T.; Fourie, Carla M. T.] North West Univ, HART, Potchefstroom, South Africa	North West University - South Africa; Massey University; Vrije Universiteit Amsterdam; North West University - South Africa	Kruger, IM (corresponding author), North West Univ, Africa Unit Transdisciplinary Hlth Res AUTHeR, Potchefstroom Campus, Potchefstroom, South Africa.	lanthe.kruger@nwu.ac.za	Malan, Leoné/D-7203-2014; Kruger, Iolanthe M/G-8698-2015; Doak, Colleen/R-4229-2019; Schutte, Aletta E/E-5126-2018; Malan, Leone/AFQ-8773-2022; Fourie, Carla/AAJ-6506-2020; Malan, Leone/Q-8187-2019	Malan, Leoné/0000-0003-3187-2410; Kruger, Iolanthe M/0000-0002-8636-7174; Schutte, Aletta E/0000-0001-9217-4937; Malan, Leone/0000-0003-3187-2410; Huisman, Hugo/0000-0002-2114-4789	South Africa-Netherlands Research Programme on Alternatives in Development; South African National Research Foundation (NRF GUN) [2069139, FA2006040700010]; North-West University; South African Medical Research Council	South Africa-Netherlands Research Programme on Alternatives in Development; South African National Research Foundation (NRF GUN)(National Research Foundation - South Africa); North-West University; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by South Africa-Netherlands Research Programme on Alternatives in Development, South African National Research Foundation (NRF GUN nos. 2069139 and FA2006040700010), North-West University, and the South African Medical Research Council. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mheid I, 2011, J AM COLL CARDIOL, V58, P186, DOI 10.1016/j.jacc.2011.02.051; Atkinson J, 2009, ARTERY RES, V3, P132, DOI 10.1016/j.artres.2009.10.183; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Duprez DA, 2004, AM J HYPERTENS, V17, P647, DOI 10.1016/j.amjhyper.2004.03.671; Duprez DA, 2009, ETHNIC DIS, V19, P243; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grey E, 2003, AM J HYPERTENS, V16, P265, DOI 10.1016/S0895-7061(02)03271-5; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Hui S, 2010, SOUTH MED J, V103, P729, DOI 10.1097/SMJ.0b013e3181e6d389; Kato S, 2000, J BIOCHEM, V127, P717, DOI 10.1093/oxfordjournals.jbchem.a022662; Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033; Kriebitzsch C, 2011, J BONE MINER RES, V26, P2991, DOI 10.1002/jbmr.493; Kriebitzsch C, 2010, BONE, V46, pS51, DOI 10.1016/j.bone.2010.01.117; Kruger MC, 2011, NUTR RES, V31, P748, DOI 10.1016/j.nutres.2011.09.012; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Li YC, 2012, CURR OPIN NEPHROL HY, V21, P72, DOI 10.1097/MNH.0b013e32834de4ee; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Malinowska A, 2009, NUTR RES, V29, P685, DOI 10.1016/j.nutres.2009.09.018; Malloy PJ, 2010, ENDOCRIN METAB CLIN, V39, P333, DOI 10.1016/j.ecl.2010.02.004; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Morris Howard A, 2010, Clin Biochem Rev, V31, P129; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Perez-Lopez FR, 2011, MATURITAS, V69, P27, DOI 10.1016/j.maturitas.2011.02.014; Pirro M, 2012, J ATHEROSCLER THROMB, V19, P924, DOI 10.5551/jat.13128; Reis JP, 2008, AM J CLIN NUTR, V88, P1469, DOI 10.3945/ajcn.2008.26447; Renzaho AMN, 2011, NUTRITION, V27, P868, DOI 10.1016/j.nut.2010.12.014; Rodrigo R, 2003, J CLIN PHARMACOL, V43, P1299, DOI 10.1177/0091270003258190; Safar Michel E, 2008, Ther Adv Cardiovasc Dis, V2, P13, DOI 10.1177/1753944707086652; Schutte AE, 2011, CLIN EXP HYPERTENS, V33, P511, DOI 10.3109/10641963.2011.561897; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Springbett P, 2010, J PHOTOCH PHOTOBIO B, V101, P160, DOI 10.1016/j.jphotobiol.2010.03.006; Tare M, 2011, J PHYSIOL-LONDON, V589, P4777, DOI 10.1113/jphysiol.2011.214726; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Wentzel-Viljoen E, 2011, S AFR J CLIN NUTR, V24, P143; Zagura M, 2011, EUR J VASC ENDOVASC, V42, P689, DOI 10.1016/j.ejvs.2011.07.027; Zittermann A, 2008, MOL ASPECTS MED, V29, P423, DOI 10.1016/j.mam.2008.04.002	40	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54554	10.1371/journal.pone.0054554	http://dx.doi.org/10.1371/journal.pone.0054554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23355878	gold, Green Published			2022-12-27	WOS:000314021500086
J	Eissmann, K; Mueller, S; Sticht, H; Jung, SS; Zou, P; Jiang, SB; Gross, A; Eichler, J; Fleckenstein, B; Reil, H				Eissmann, Kristin; Mueller, Sebastian; Sticht, Heinrich; Jung, Susan; Zou, Peng; Jiang, Shibo; Gross, Andrea; Eichler, Jutta; Fleckenstein, Bernhard; Reil, Heide			HIV-1 Fusion Is Blocked through Binding of GB Virus C E2D Peptides to the HIV-1 gp41 Disulfide Loop	PLOS ONE			English	Article							HEPATITIS-G VIRUS; ENVELOPE GLYCOPROTEIN; ENTRY INHIBITORS; 6-HELIX BUNDLE; CORE STRUCTURE; T-LYMPHOCYTE; TYPE-1 GP41; INFECTION; PROTEIN; COINFECTION	A strategy for antiviral drug discovery is the elucidation and imitation of viral interference mechanisms. HIV-1 patients benefit from a coinfection with GB Virus C (GBV-C), since HIV-positive individuals with long-term GBV-C viraemia show better survival rates than HIV-1 patients without persisting GBV-C. A direct influence of GBV-C on HIV-1 replication has been shown in coinfection experiments. GBV-C is a human non-pathogenic member of the flaviviridae family that can replicate in T and B cells. Therefore, GBV-C shares partly the same ecological niche with HIV-1. In earlier work we have demonstrated that recombinant glycoprotein E2 of GBV-C and peptides derived from the E2 N-terminus interfere with HIV entry. In this study we investigated the underlying mechanism. Performing a virus-cell fusion assay and temperature-arrested HIV-infection kinetics, we provide evidence that the HIV-inhibitory E2 peptides interfere with late HIV-1 entry steps after the engagement of gp120 with CD4 receptor and coreceptor. Binding and competition experiments revealed that the N-terminal E2 peptides bind to the disulfide loop region of HIV-1 transmembrane protein gp41. In conjunction with computational analyses, we identified sequence similarities between the N-termini of GBV-C E2 and the HIV-1 glycoprotein gp120. This similarity appears to enable the GBV-C E2 N-terminus to interact with the HIV-1 gp41 disulfide loop, a crucial domain involved in the gp120-gp41 interface. Furthermore, the results of the present study provide initial proof of concept that peptides targeted to the gp41 disulfide loop are able to inhibit HIV fusion and should inspire the development of this new class of HIV-1 entry inhibitors.	[Eissmann, Kristin; Mueller, Sebastian; Jung, Susan; Fleckenstein, Bernhard; Reil, Heide] Univ Erlangen Nurnberg, Inst Virol, D-91054 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Zou, Peng; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Educ, Shanghai Med Coll,Inst Med Microbiol, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Hlth, Shanghai Med Coll,Inst Med Microbiol, Shanghai 200433, Peoples R China	University of Erlangen Nuremberg; University of Erlangen Nuremberg; New York Blood Center; Fudan University; Fudan University	Reil, H (corresponding author), Univ Erlangen Nurnberg, Inst Virol, D-91054 Erlangen, Germany.	heide.reil@viro.med.uni-erlangen.de	Eichler, Jutta/H-7847-2018; Jiang, Shibo/L-4500-2014	Eichler, Jutta/0000-0001-6683-9456; Jiang, Shibo/0000-0001-8283-7135; Sticht, Heinrich/0000-0001-5644-045X	Akademie der Wissenschaften und Literatur zu Mainz [2 1.223]; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) [Teilprojekt B16]; Deutsche Forschungsgemeinschaft [GRK1071, A5, A7]; Bayerisches Staatsministerium fur Wissenschaft; Forschung und Kunst: "Forderung der Chancengleichheit fur Frauen in Forschung und Lehre''; Sonderforschungsbereich [A5, 796, A2]; National Natural Science Foundation of China [NSFC-81173098]	Akademie der Wissenschaften und Literatur zu Mainz; Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerisches Staatsministerium fur Wissenschaft; Forschung und Kunst: "Forderung der Chancengleichheit fur Frauen in Forschung und Lehre''; Sonderforschungsbereich(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants of the Akademie der Wissenschaften und Literatur zu Mainz, project 2 1.223 (HR), the Interdisziplinares Zentrum fur Klinische Forschung (IZKF): Teilprojekt B16 (HR), Deutsche Forschungsgemeinschaft: GRK1071, projects A5 (KE), A7 (AG), Bayerisches Staatsministerium fur Wissenschaft, Forschung und Kunst: "Forderung der Chancengleichheit fur Frauen in Forschung und Lehre'' (KE, SJ), the Sonderforschungsbereich 796: project A2 (HS), A5 (JE), and the National Natural Science Foundation of China (NSFC-81173098) to ShJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Barbouche R, 2005, MOL PHARMACOL, V67, P1111, DOI 10.1124/mol.104.008276; Belyaev AS, 1998, J VIROL, V72, P868, DOI 10.1128/JVI.72.1.868-872.1998; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Earl PL, 1997, J VIROL, V71, P2674, DOI 10.1128/JVI.71.4.2674-2684.1997; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Feucht HH, 1999, J CLIN MICROBIOL, V37, P1294, DOI 10.1128/JCM.37.5.1294-1297.1999; Feucht HH, 1997, LANCET, V349, P435, DOI 10.1016/S0140-6736(97)80062-1; George SL, 2006, J INFECT DIS, V193, P451, DOI 10.1086/499435; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Henderson HI, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-36; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Herrera E, 2010, J MED CHEM, V53, P6054, DOI 10.1021/jm100452c; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Jacobs A, 2007, J BIOL CHEM, V282, P32406, DOI 10.1074/jbc.M705577200; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Jung S, 2005, AIDS, V19, P1267, DOI 10.1097/01.aids.0000180097.50393.df; Jung S, 2007, AIDS, V21, P645, DOI 10.1097/QAD.0b013e32803277c7; Kim S, 2008, J MOL BIOL, V376, P786, DOI 10.1016/j.jmb.2007.12.001; Koedel Y, 2011, J VIROL, V85, P7037, DOI 10.1128/JVI.02366-10; Labrosse B, 2000, J VIROL, V74, P2142, DOI 10.1128/JVI.74.5.2142-2150.2000; Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;60::AID-JMV10&gt;3.0.CO;2-A; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Lefrere JJ, 1999, TRANSFUSION, V39, P83, DOI 10.1046/j.1537-2995.1999.39199116899.x; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Maidana-Giret MT, 2009, AIDS, V23, P2277, DOI 10.1097/QAD.0b013e32832d7a11; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Moenkemeyer M, 2008, J MED VIROL, V80, P1933, DOI 10.1002/jmv.21305; Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Murray EJ, 2010, J VIROL, V84, P7288, DOI 10.1128/JVI.00535-10; Nattermann J, 2003, AIDS, V17, P1457, DOI 10.1097/00002030-200307040-00006; Nunnari G, 2003, ANN INTERN MED, V139, P26, DOI 10.7326/0003-4819-139-1-200307010-00009; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rydze RT, 2012, J INFECT DIS, V206, P69, DOI 10.1093/infdis/jis312; Sanchez R, 2000, METH MOL B, V143, P97; Schwarze-Zander C, 2010, ANTIVIR THER, V15, P745, DOI 10.3851/IMP1602; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Supapol WB, 2008, J INFECT DIS, V197, P1369, DOI 10.1086/587488; Tacke M, 1997, HEPATOLOGY, V26, P1626, DOI 10.1002/hep.510260635; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Vahidnia F, 2012, CLIN INFECT DIS, V55, P1012, DOI 10.1093/cid/cis589; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2006, P NATL ACAD SCI USA, V103, P15570, DOI 10.1073/pnas.0604728103; Xiang JH, 2012, VIROLOGY, V430, P53, DOI 10.1016/j.virol.2012.04.019; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	77	21	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54452	10.1371/journal.pone.0054452	http://dx.doi.org/10.1371/journal.pone.0054452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349893	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100069
J	Gonzalez-Quintela, A; Alonso, M; Campos, J; Vizcaino, L; Loidi, L; Gude, F				Gonzalez-Quintela, Arturo; Alonso, Manuela; Campos, Joaquin; Vizcaino, Luis; Loidi, Lourdes; Gude, Francisco			Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population: The Role of Obesity	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; GAMMA-GLUTAMYL-TRANSFERASE; ALCOHOL-CONSUMPTION; PLASMA-LEVELS; HIGH-DENSITY; THE-159C/T POLYMORPHISM; BACTERIAL-ENDOTOXIN; INCREASING PROTEIN; PROMOTER REGION; POTENTIAL ROLE	Background and Aim: Assessment of serum concentration of lipopolysaccharide (LPS)-binding protein (LBP) has been suggested as a useful biomarker to indicate activation of innate immune responses to microbial products. We investigated LBP concentrations and associations with demographics, lifestyle factors, and common metabolic abnormalities in adults. We also examined if LBP concentrations were associated with common polymorphisms in genes coding for LBP (rs2232618), CD14 (rs2569190), and TLR4 (rs4986790), the molecules responsible for the innate immune response to LPS, or serum levels of soluble CD14 (sCD14) and proinflammatory cytokines. Methods: Serum LBP was measured with a commercial immunoassay in a random sample of the adult population (n = 420, 45% males, age 18-92 years) from a single municipality. Results: Serum LBP concentrations increased with age (P<0.001) and were higher in individuals who were overweight or obese than in normal-weight individuals (P<0.001). Similarly, LBP concentrations were higher in individuals with metabolic syndrome than in individuals without it (P<0.001). Among metabolic syndrome components, LBP concentrations were independently associated with abdominal obesity (P=0.002) and low concentrations of HDL-cholesterol (P<0.001). Serum LBP concentrations tended to be independently associated with smoking (P=0.05), but not with alcohol consumption. Likewise, there was not significant association between LBP concentrations and gene polymorphisms. Concentrations of LBP significantly correlated with serum levels of proinflammatory cytokines (IL-6 and IL-8), sCD14, and with liver enzymes. Conclusions: Serum LBP concentrations increased with age. Overweight, obesity, and having metabolic syndrome (particularly, low HDL cholesterol levels) were associated with higher LBP concentrations. These findings are consistent with microbial exposure playing a role in these inflammatory, metabolic abnormalities.	[Gonzalez-Quintela, Arturo; Alonso, Manuela; Campos, Joaquin] Complejo Hosp Univ, Dept Internal Med, Santiago De Compostela, Spain; [Vizcaino, Luis] Complejo Hosp Univ, Dept Biochem, Santiago De Compostela, Spain; [Loidi, Lourdes] Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain; [Gude, Francisco] Complejo Hosp Univ, Dept Clin Epidemiol, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Gonzalez-Quintela, A (corresponding author), Complejo Hosp Univ, Dept Internal Med, Santiago De Compostela, Spain.	arturo.gonzalez.quintela@usc.es	Alonso, Manuela/F-7682-2016; Campos-Franco, Joaquin/S-5489-2019	Campos-Franco, Joaquin/0000-0003-1629-5424; Gonzalez-Quintela, Arturo/0000-0002-6909-1807	Xunta de Galicia, Spain [PGIDIT06PXIB918313, 10CSA918028PR]	Xunta de Galicia, Spain(Xunta de Galicia)	This study was supported by the Xunta de Galicia (www.xunta.es), Spain (project no. PGIDIT06PXIB918313 and 10CSA918028PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Barnes RL, 2007, NICOTINE TOB RES, V9, P995, DOI 10.1080/14622200701488392; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; BAZIL V, 1991, J IMMUNOL, V147, P1567; Berbee JFP, 2005, J ENDOTOXIN RES, V11, P97, DOI 10.1179/096805105X35215; Bosshart H, 2007, ANN NY ACAD SCI, V1096, P1, DOI 10.1196/annals.1397.064; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Campos J, 2006, ALCOHOL CLIN EXP RES, V30, P7, DOI 10.1111/j.1530-0277.2006.00007.x; Campos J, 2005, ALCOHOL CLIN EXP RES, V29, P1206, DOI 10.1097/01.ALC.0000171977.25531.7A; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen J, 2000, INTENS CARE MED, V26, pS51, DOI 10.1007/s001340051119; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Gonzalez-Quintela A, 2003, CLIN EXP ALLERGY, V33, P199, DOI 10.1046/j.1365-2222.2003.01582.x; Gonzalez-Quintela A, 2008, ALCOHOL, V42, P513, DOI 10.1016/j.alcohol.2008.04.008; Gonzalez-Quintela A, 2007, CYTOKINE, V38, P54, DOI 10.1016/j.cyto.2007.05.006; Gonzalez-Quintela A, 2010, CLIN CHEM LAB MED, V48, P701, DOI 10.1515/CCLM.2010.124; Gubern C, 2006, DIABETES, V55, P216, DOI 10.2337/diabetes.55.1.216; Gude F, 2009, CLIN CHIM ACTA, V407, P67, DOI 10.1016/j.cca.2009.06.034; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hubacek JA, 1997, BIOCHEM BIOPH RES CO, V236, P427, DOI 10.1006/bbrc.1997.6970; Hudgins LC, 2003, J LIPID RES, V44, P1489, DOI 10.1194/jlr.M200440-JLR200; Kirschning CJ, 1997, GENOMICS, V46, P416, DOI 10.1006/geno.1997.5030; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Lepper PM, 2007, J AM COLL CARDIOL, V50, P25, DOI 10.1016/j.jacc.2007.02.070; Lequier LL, 2000, CHEST, V117, P1706, DOI 10.1378/chest.117.6.1706; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Levels JHM, 2005, INFECT IMMUN, V73, P2321, DOI 10.1128/IAI.73.4.2321-2326.2005; Levels JHM, 2001, INFECT IMMUN, V69, P2821, DOI 10.1128/IAI.69.5.2821-2828.2001; MA TY, 1992, EXP GERONTOL, V27, P321, DOI 10.1016/0531-5565(92)90059-9; Morange PE, 2004, EUR J HUM GENET, V12, P1041, DOI 10.1038/sj.ejhg.5201277; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; Murch O, 2007, INTENS CARE MED, V33, P13, DOI 10.1007/s00134-006-0432-y; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Novitsky TJ, 1998, ANN NY ACAD SCI, V851, P416, DOI 10.1111/j.1749-6632.1998.tb09018.x; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Pauly JL, 2011, J ONCOL, V2011, DOI 10.1155/2011/819129; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Ruiz AG, 2007, OBES SURG, V17, P1374; SAWEIRS WM, 1985, AGE AGEING, V14, P312, DOI 10.1093/ageing/14.5.312; Schafer C, 2002, ALCOHOL ALCOHOLISM, V37, P81, DOI 10.1093/alcalc/37.1.81; Schroder NWJ, 2005, J ENDOTOXIN RES, V11, P237, DOI 10.1179/096805105X37420; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Schumann RR, 2000, CHEM IMMUNOL, V74, P42; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Targher G, 2010, CLIN CHEM LAB MED, V48, P147, DOI 10.1515/CCLM.2010.031; TOBIAS PS, 1993, IMMUNOBIOLOGY, V187, P227, DOI 10.1016/S0171-2985(11)80341-4; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Vainas T, 2006, J VASC SURG, V44, P326, DOI 10.1016/j.jvs.2006.04.035; Vercelli D, 2010, CURR OPIN ALLERGY CL, V10, P145, DOI 10.1097/ACI.0b013e32833653d7; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82; Zeng L, 2012, ANN SURG, V255, P147, DOI 10.1097/SLA.0b013e3182389515	68	127	131	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54600	10.1371/journal.pone.0054600	http://dx.doi.org/10.1371/journal.pone.0054600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349936	Green Published, gold			2022-12-27	WOS:000314019100082
J	Lagergren, K; Lindam, A; Lagergren, J				Lagergren, Katarina; Lindam, Anna; Lagergren, Jesper			Dietary Proportions of Carbohydrates, Fat, and Protein and Risk of Oesophageal Cancer by Histological Type	PLOS ONE			English	Article							GASTRIC CARDIA; BARRETTS-ESOPHAGUS; ADENOCARCINOMA; REPRODUCIBILITY; VALIDITY; PATTERNS; SUBTYPES; HUMANS; REFLUX	Background: Dietary habits influence the risk of cancer of the oesophagus and oesophago-gastric junction, but the role of proportions of the main dietary macronutrients carbohydrates, fats and proteins is uncertain. Methods: Data was derived from a nationwide Swedish population-based case-control study conducted in 1995-1997, in which case ascertainment was rapid, and all cases were uniformly classified. Information on the subjects' history of dietary intake was collected in personal interviews. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression, with adjustment for potentially confounding factors. Results: Included were 189 oesophageal adenocarcinomas, 262 oesophago-gastric adenocarcinomas, 167 oesophageal squamous cell carcinomas, and 820 control subjects. Regarding oesophageal or oesophago-gastric junctional adenocarcinoma, a high dietary proportion of carbohydrates decreased the risk (OR 0.50, CI 0.34-0.73), and a high portion of fat increased the risk (OR 1.96, CI 1.34-2.87), while a high proportion of protein did not influence the risk (OR 1.08, 95% CI 0.75-1.56). Regarding oesophageal squamous cell carcinoma, the single macronutrients did not influence the risk statistically significantly. Conclusions: A diet with a low proportion of carbohydrates and a high proportion of fat might increase the risk of oesophageal adenocarcinoma.	[Lagergren, Katarina; Lindam, Anna; Lagergren, Jesper] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Karolinska Institutet; University of London; King's College London	Lagergren, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	jesper.lagergren@ki.se		Lindam, Anna/0000-0002-6230-0354; Lagergren, Jesper/0000-0002-5143-5448	Swedish Research Council [80749601]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by the Swedish Research Council (ID 80749601; http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berretta Massimiliano, 2012, Front Biosci (Elite Ed), V4, P351; Bravi F, 2011, ANN ONCOL; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Karhunen LJ, 2008, REGUL PEPTIDES, V149, P70, DOI 10.1016/j.regpep.2007.10.008; Khani BR, 2004, J NUTR, V134, P1541, DOI 10.1093/jn/134.6.1541; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Lagergren J, 2000, INT J CANCER, V85, P340; Lagergren J, 2011, INT J CANC; Lagergren J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6280; Levitan EB, 2007, AM J CLIN NUTR, V85, P548, DOI 10.1093/ajcn/85.2.548; Murphy SJ, 2010, J NUTR, V140, P1757, DOI 10.3945/jn.110.124362; O'Doherty MG, 2011, INT J CANCER, V129, P1493, DOI 10.1002/ijc.26108; Rothman KJ, 2002, EPIDEMIOLOGY INTRO, P95; Sharma P, 2009, NEW ENGL J MED, V361, P2548, DOI 10.1056/NEJMcp0902173; Silvera SAN, 2008, INT J CANCER, V123, P852, DOI 10.1002/ijc.23544; Silvera SAN, 2011, ANN EPIDEMIOL, V21, P543, DOI 10.1016/j.annepidem.2010.11.019; Terry P, 2001, EUR J CANCER PREV, V10, P365, DOI 10.1097/00008469-200108000-00010; Weiderpass Vainio E, 2012, GUT; Wolk A, 1997, NUTR CANCER, V29, P234, DOI 10.1080/01635589709514630; Ye WM, 2004, JNCI-J NATL CANCER I, V96, P388, DOI 10.1093/jnci/djh057	21	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54913	10.1371/journal.pone.0054913	http://dx.doi.org/10.1371/journal.pone.0054913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349988	gold, Green Published, Green Submitted			2022-12-27	WOS:000314019100110
J	Wijaya, E; Frith, MC; Horton, P; Asai, K				Wijaya, Edward; Frith, Martin C.; Horton, Paul; Asai, Kiyoshi			Finding Protein-Coding Genes through Human Polymorphisms	PLOS ONE			English	Article							DATABASE; PREDICTION; SEQUENCE; TRANSCRIPTS; PROJECT	Human gene catalogs are fundamental to the study of human biology and medicine. But they are all based on open reading frames (ORFs) in a reference genome sequence (with allowance for introns). Individual genomes, however, are polymorphic: their sequences are not identical. There has been much research on how polymorphism affects previously-identified genes, but no research has been done on how it affects gene identification itself. We computationally predict protein-coding genes in a straightforward manner, by finding long ORFs in mRNA sequences aligned to the reference genome. We systematically test the effect of known polymorphisms with this procedure. Polymorphisms can not only disrupt ORFs, they can also create long ORFs that do not exist in the reference sequence. We found 5,737 putative protein-coding genes that do not exist in the reference, whose protein-coding status is supported by homology to known proteins. On average 10% of these genes are located in the genomic regions devoid of annotated genes in 12 other catalogs. Our statistical analysis showed that these ORFs are unlikely to occur by chance.	[Wijaya, Edward; Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Wijaya, Edward; Frith, Martin C.; Horton, Paul; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Wijaya, E (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	e-wijaya@cb.k.u-tokyo.ac.jp	Edward, Wijaya/G-6209-2013; Asai, Kiyoshi/AAT-8344-2020	Asai, Kiyoshi/0000-0003-0909-4982; Frith, Martin/0000-0003-0998-2859	Japanese Ministry of Education, Sport, Science and Technology (MEXT) [221S002]	Japanese Ministry of Education, Sport, Science and Technology (MEXT)	Financial support for this study was provided by a Grant-in-Aid for Scientific Research on Innovative Areas (221S002) from Japanese Ministry of Education, Sport, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Blanco E, 2002, CURRENT PROTOCOLS BI; Brent MR, 2005, GENOME RES, V15, P1777, DOI 10.1101/gr.3866105; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Durbin R, 2011, NATURE, V470, P59; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frith Martin C, 2006, RNA Biol, V3, P40; Frith MC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1212; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Knowles D, 2009, GENOME RES, V21, P487; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 2002, GENE, V10, P1752; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shimada MK, 2009, NUCLEIC ACIDS RES, V37, pD810, DOI 10.1093/nar/gkn798; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; van Baren MJ, 2006, GENOME RES, V16, P678, DOI 10.1101/gr.4766206; Wiehe T, 2001, GENOME RES, V11, P1574, DOI 10.1101/gr.177401; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Wilson BA, 2011, GENOME BIOL EVOL, V3, P1245, DOI 10.1093/gbe/evr099; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Yamaguchi-Kabata Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003393; Yamasaki C, 2010, NUCLEIC ACIDS RES, V38, pD626, DOI 10.1093/nar/gkp1020	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54210	10.1371/journal.pone.0054210	http://dx.doi.org/10.1371/journal.pone.0054210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349826	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100050
J	Zhang, H; Berel, D; Wang, YP; Li, P; Bhowmick, NA; Figlin, RA; Kim, HL				Zhang, Hao; Berel, Dror; Wang, Yanping; Li, Ping; Bhowmick, Neil A.; Figlin, Robert A.; Kim, Hyung L.			A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models	PLOS ONE			English	Article							COMPETITIVE MAMMALIAN TARGET; HYPOXIA-INDUCIBLE FACTORS; RAPAMYCIN MTOR; INTERFERON-ALPHA; KINASE INHIBITOR; CANCER; THERAPY; TUMORS; TRIAL; EVEROLIMUS	Rapamycin analogs, temsirolimus and everolimus, are approved for the treatment of advance renal cell carcinoma (RCC). Currently approved agents inhibit mechanistic target of rapamycin (mTOR) complex 1 (mTORC1). However, the mTOR kinase exists in two distinct multiprotein complexes, mTORC1 and mTORC2, and both complexes may be critical regulators of cell metabolism, growth and proliferation. Furthermore, it has been proposed that drug resistance develops due to compensatory activation of mTORC2 signaling during treatment with temsirolimus or everolimus. We evaluated Ku0063794, which is a small molecule that inhibits both mTOR complexes. Ku0063794 was compared to temsirolimus in preclinical models for renal cell carcinoma. Ku0063794 was effective in inhibiting the phosphorylation of signaling proteins downstream of both mTORC1 and mTORC2, including p70 S6K, 4E-BP1 and Akt. Ku0063794 was more effective than temsirolimus in decreasing the viability and growth of RCC cell lines, Caki-1 and 786-O, in vitro by inducing cell cycle arrest and autophagy, but not apoptosis. However, in a xenograft model there was no difference in the inhibition of tumor growth by Ku0063794 or temsirolimus. A potential explanation is that temsirolimus has additional effects on the tumor microenvironment. Consistent with this possibility, temsirolimus, but not Ku0063794, decreased tumor angiogenesis in vivo, and decreased the viability of HUVEC (Human Umbilical Vein Endothelial Cells) cells in vitro at pharmacologically relevant concentrations. Furthermore, expression levels of VEGF and PDGF were lower in Caki-1 and 786-O cells treated with temsirolimus than cells treated with Ku0063794.	[Zhang, Hao; Wang, Yanping; Li, Ping; Kim, Hyung L.] Cedars Sinai Med Ctr, Dept Surg, Div Urol, Los Angeles, CA 90048 USA; [Berel, Dror] Cedars Sinai Med Ctr, Biostat Core, Los Angeles, CA 90048 USA; [Bhowmick, Neil A.; Figlin, Robert A.] Cedars Sinai Med Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA; [Berel, Dror; Kim, Hyung L.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Kim, HL (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Urol, Los Angeles, CA 90048 USA.	kimhl@cshs.org	Zhang, Hao/L-3197-2015; Bhowmick, Neil/AAA-7302-2019; Kim, Hyung/F-5129-2017	Bhowmick, Neil/0000-0001-8747-5989; Kim, Hyung/0000-0003-2085-6140	Winnick Family Foundation; AUA foundation/NCI/NIDDK; NIH/NCI [K23CA120075]; Kure It Cancer Research Foundation; Lauhlere Family Fund; NATIONAL CANCER INSTITUTE [R01CA133072, K23CA120075] Funding Source: NIH RePORTER	Winnick Family Foundation; AUA foundation/NCI/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kure It Cancer Research Foundation; Lauhlere Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Winnick Family Foundation, AUA foundation/NCI/NIDDK, and NIH/NCI grant K23CA120075 (http://grants.nih.gov/grants/oer.htm), Kure It Cancer Research Foundation, and Lauhlere Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Creighton CJ, 2007, ONCOGENE, V26, P4648, DOI 10.1038/sj.onc.1210245; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Furge KA, 2010, LANCET ONCOL, V11, P571, DOI 10.1016/S1470-2045(09)70380-8; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Glenn ST, 2007, BIOTECHNIQUES, V43, P639, DOI 10.2144/000112562; Glenn ST, 2010, J BIOMOL SCREEN, V15, P80, DOI 10.1177/1087057109355059; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Hidalgo M, 2006, CLIN CANCER RES, V12, P5755, DOI 10.1158/1078-0432.CCR-06-0118; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kuhn JG, 2007, CLIN CANCER RES, V13, P7401, DOI 10.1158/1078-0432.CCR-07-0781; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Liu QS, 2012, J BIOL CHEM, V287, P9742, DOI 10.1074/jbc.M111.304485; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, J CLIN ONCOL, V25, P3958, DOI 10.1200/JCO.2006.10.5916; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Y, 2011, BRIT J CANCER, V104, P643, DOI 10.1038/bjc.2011.15; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	37	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54918	10.1371/journal.pone.0054918	http://dx.doi.org/10.1371/journal.pone.0054918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349989	Green Submitted, gold, Green Published			2022-12-27	WOS:000314019100111
J	Love, SA; Petrini, K; Cheng, A; Pollick, FE				Love, Scott A.; Petrini, Karin; Cheng, Adam; Pollick, Frank E.			A Psychophysical Investigation of Differences between Synchrony and Temporal Order Judgments	PLOS ONE			English	Article							VISUAL SPEECH-PERCEPTION; AUDIOVISUAL SYNCHRONY; SIMULTANEITY; INTEGRATION; ASYNCHRONY; MOTION; IMPROVES; ILLUSION; MUSIC	Background: Synchrony judgments involve deciding whether cues to an event are in synch or out of synch, while temporal order judgments involve deciding which of the cues came first. When the cues come from different sensory modalities these judgments can be used to investigate multisensory integration in the temporal domain. However, evidence indicates that that these two tasks should not be used interchangeably as it is unlikely that they measure the same perceptual mechanism. The current experiment further explores this issue across a variety of different audiovisual stimulus types. Methodology/Principal Findings: Participants were presented with 5 audiovisual stimulus types, each at 11 parametrically manipulated levels of cue asynchrony. During separate blocks, participants had to make synchrony judgments or temporal order judgments. For some stimulus types many participants were unable to successfully make temporal order judgments, but they were able to make synchrony judgments. The mean points of subjective simultaneity for synchrony judgments were all video-leading, while those for temporal order judgments were all audio-leading. In the within participants analyses no correlation was found across the two tasks for either the point of subjective simultaneity or the temporal integration window. Conclusions: Stimulus type influenced how the two tasks differed; nevertheless, consistent differences were found between the two tasks regardless of stimulus type. Therefore, in line with previous work, we conclude that synchrony and temporal order judgments are supported by different perceptual mechanisms and should not be interpreted as being representative of the same perceptual process.	[Love, Scott A.; Cheng, Adam; Pollick, Frank E.] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland; [Love, Scott A.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Petrini, Karin] UCL, Inst Ophthalmol, London, England	University of Glasgow; Indiana University System; Indiana University Bloomington; University of London; University College London	Love, SA (corresponding author), Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland.	love.a.scott@gmail.com	Pollick, Frank/F-3186-2011; Love, Scott A./F-2986-2010	Pollick, Frank/0000-0002-7212-4622; Love, Scott A./0000-0001-7416-9210; Petrini, Karin/0000-0001-5354-5600	Economic and Social Research Council [RES-060-25-0010]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	KP was supported by an Economic and Social Research Council Grant (http://www.esrc.ac.uk/): RES-060-25-0010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011283; ALLAN LG, 1975, PERCEPT PSYCHOPHYS, V18, P29, DOI 10.3758/BF03199363; Arrighi R, 2006, J VISION, V6, P260, DOI 10.1167/6.3.6; Bertelson P, 2003, INT J PSYCHOPHYSIOL, V50, P147, DOI 10.1016/S0167-8760(03)00130-2; Boenke LT, 2009, EXP BRAIN RES, V198, P233, DOI 10.1007/s00221-009-1917-z; BRAINARD DH, 1989, COLOR RES APPL, V14, P23, DOI 10.1002/col.5080140107; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Conrey B, 2006, J ACOUST SOC AM, V119, P4065, DOI 10.1121/1.2195091; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Fujisaki W, 2007, VISION RES, V47, P1075, DOI 10.1016/j.visres.2007.01.021; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Grant KW, 2004, SPEECH COMMUN, V44, P43, DOI 10.1016/j.specom.2004.06.004; HIRSH IJ, 1959, J ACOUST SOC AM, V31, P759, DOI 10.1121/1.1907782; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Koppen C, 2007, BRAIN RES, V1186, P224, DOI 10.1016/j.brainres.2007.09.076; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Maier JX, 2011, J EXP PSYCHOL HUMAN, V37, P245, DOI 10.1037/a0019952; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Mossbridge JA, 2006, J NEUROSCI, V26, P12708, DOI 10.1523/JNEUROSCI.2254-06.2006; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrini K, 2011, NEUROIMAGE, V56, P1480, DOI 10.1016/j.neuroimage.2011.03.009; Petrini K, 2010, J VISION, V10, DOI 10.1167/10.5.2; Petrini K, 2009, EXP BRAIN RES, V198, P339, DOI 10.1007/s00221-009-1817-2; Petrini K, 2009, COGNITION, V110, P432, DOI 10.1016/j.cognition.2008.11.015; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Santangelo V, 2009, EXP BRAIN RES, V194, P577, DOI 10.1007/s00221-009-1734-4; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Soto-Faraco S, 2007, NEUROREPORT, V18, P347, DOI 10.1097/WNR.0b013e32801776f9; Soto-Faraco S, 2009, J EXP PSYCHOL HUMAN, V35, P580, DOI 10.1037/a0013483; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Stein BE., 1993, MERGING SENSES; Stevenson RA, 2010, NEUROIMAGE, V49, P3308, DOI 10.1016/j.neuroimage.2009.12.001; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; van der Burg E, 2008, J VISION, V8, DOI 10.1167/8.5.2; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vatakis A, 2006, NEUROSCI LETT, V393, P40, DOI 10.1016/j.neulet.2005.09.032; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P298, DOI 10.3758/BF03193751; Vatakis A, 2006, BRAIN RES, V1111, P134, DOI 10.1016/j.brainres.2006.05.078; Vroomen J, 2011, COGNITION, V118, P75, DOI 10.1016/j.cognition.2010.10.002; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Zampini M, 2003, INT J PSYCHOPHYSIOL, V50, P165, DOI 10.1016/S0167-8760(03)00132-6; Zampini M, 2003, EXP BRAIN RES, V152, P198, DOI 10.1007/s00221-003-1536-z	47	65	65	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54798	10.1371/journal.pone.0054798	http://dx.doi.org/10.1371/journal.pone.0054798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	076FX	23349971	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000313943000050
J	Tian, TH				Tian, Tianhai			Chemical Memory Reactions Induced Bursting Dynamics in Gene Expression	PLOS ONE			English	Article							EXACT STOCHASTIC SIMULATION; P53-MDM2 FEEDBACK LOOP; REGULATORY NETWORKS; BIOLOGICAL ROBUSTNESS; ESCHERICHIA-COLI; INDIVIDUAL CELLS; TOGGLE SWITCH; SINGLE-CELL; TIME DELAYS; DNA-DAMAGE	Memory is a ubiquitous phenomenon in biological systems in which the present system state is not entirely determined by the current conditions but also depends on the time evolutionary path of the system. Specifically, many memorial phenomena are characterized by chemical memory reactions that may fire under particular system conditions. These conditional chemical reactions contradict to the extant stochastic approaches for modeling chemical kinetics and have increasingly posed significant challenges to mathematical modeling and computer simulation. To tackle the challenge, I proposed a novel theory consisting of the memory chemical master equations and memory stochastic simulation algorithm. A stochastic model for single-gene expression was proposed to illustrate the key function of memory reactions in inducing bursting dynamics of gene expression that has been observed in experiments recently. The importance of memory reactions has been further validated by the stochastic model of the p53-MDM2 core module. Simulations showed that memory reactions is a major mechanism for realizing both sustained oscillations of p53 protein numbers in single cells and damped oscillations over a population of cells. These successful applications of the memory modeling framework suggested that this innovative theory is an effective and powerful tool to study memory process and conditional chemical reactions in a wide range of complex biological systems.	Monash Univ, Sch Math Sci, Melbourne, Vic 3004, Australia	Monash University	Tian, TH (corresponding author), Monash Univ, Sch Math Sci, Melbourne, Vic 3004, Australia.	Tianhai.Tian@monash.edu	Tian, Tianhai/AAU-2335-2021	Tian, Tianhai/0000-0001-6191-0209	Australian Research Council (ARC) Discovery Projects [DP1094181, DP120104460]; Australian Research Council Future Fellowship [FT100100748]	Australian Research Council (ARC) Discovery Projects(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by the Australian Research Council (ARC) Discovery Projects (DP1094181 and DP120104460). T. T. is also a recipient of the Australian Research Council Future Fellowship (FT100100748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Agrawal S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000390; Arkin A, 1998, GENETICS, V149, P1633; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Becskei A, 2004, NAT CELL BIOL, V6, P451, DOI 10.1038/ncb1124; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Burrill DR, 2010, CELL, V140, P13, DOI 10.1016/j.cell.2009.12.034; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Casadesus J, 2002, BIOESSAYS, V24, P512, DOI 10.1002/bies.10102; Chen LY, 2005, CELL, V120, P37, DOI 10.1016/j.cell.2004.11.030; Chubb JR, 2010, CURR OPIN GENET DEV, V20, P478, DOI 10.1016/j.gde.2010.06.009; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hsu C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1687; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Kelemen JZ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000332; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Leier A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919124; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Marquez-Lago TT, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-19; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ribeiro A, 2006, J COMPUT BIOL, V13, P1630, DOI 10.1089/cmb.2006.13.1630; Roussel MR, 2006, PHYS BIOL, V3, P274, DOI 10.1088/1478-3975/3/4/005; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tian TH, 2007, J COMPUT APPL MATH, V205, P696, DOI 10.1016/j.cam.2006.02.063; Tian TH, 2006, P NATL ACAD SCI USA, V103, P8372, DOI 10.1073/pnas.0507818103; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhang JJ, 2012, BIOPHYS J, V102, P1247, DOI 10.1016/j.bpj.2012.02.001; Zhu R, 2007, J THEOR BIOL, V246, P725, DOI 10.1016/j.jtbi.2007.01.021	63	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e52029	10.1371/journal.pone.0052029	http://dx.doi.org/10.1371/journal.pone.0052029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349679	Green Published, Green Submitted, gold			2022-12-27	WOS:000313943000006
J	Barreto, RE; Miyai, CA; Sanches, FHC; Giaquinto, PC; Delicio, HC; Volpato, GL				Barreto, Rodrigo Egydio; Miyai, Caio Akira; Carretero Sanches, Fabio Henrique; Giaquinto, Percilia Cardoso; Delicio, Helton Carlos; Volpato, Gilson Luiz			Blood Cues Induce Antipredator Behavior in Nile Tilapia Conspecifics	PLOS ONE			English	Article							CHEMICAL ALARM CUES; PREDATION RISK; PHYSIOLOGICAL-RESPONSES; FATHEAD MINNOWS; SKIN EXTRACT; SIGNALS; CELLS; INFORMATION; ODORS	In this study, we show that the fish Nile tilapia displays an antipredator response to chemical cues present in the blood of conspecifics. This is the first report of alarm response induced by blood-borne chemical cues in fish. There is a body of evidence showing that chemical cues from epidermal 'club' cells elicit an alarm reaction in fish. However, the chemical cues of these 'club' cells are restricted to certain species of fish. Thus, as a parsimonious explanation, we assume that an alarm response to blood cues is a generalized response among animals because it occurs in mammals, birds and protostomian animals. Moreover, our results suggest that researchers must use caution when studying chemically induced alarm reactions because it is difficult to separate club cell cues from traces of blood.	[Barreto, Rodrigo Egydio; Miyai, Caio Akira; Carretero Sanches, Fabio Henrique; Giaquinto, Percilia Cardoso; Delicio, Helton Carlos; Volpato, Gilson Luiz] UNESP Univ Estadual Paulista, Dept Fisiol, Inst Biociencias, BR-18618970 Sao Paulo, Brazil	Universidade Estadual Paulista	Barreto, RE (corresponding author), UNESP Univ Estadual Paulista, Dept Fisiol, Inst Biociencias, Campus Botucatu Rubiao Jr, BR-18618970 Sao Paulo, Brazil.	rebarreto@yahoo.com	Delicio, Helton/B-5443-2014; Giaquinto, Percilia/A-8395-2018; Volpato, Gilson/B-2304-2008; Barreto, Rodrigo E/A-3440-2013; Miyai, Caio A/J-7498-2013; Sanches, Fabio H C/K-3526-2013	Giaquinto, Percilia/0000-0003-4591-4415; Barreto, Rodrigo E/0000-0002-4611-0059; Miyai, Caio A/0000-0002-6116-3159; Sanches, Fabio H C/0000-0002-1105-4894	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil [2010/11319-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The present study received financial support from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil (2010/11319-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa A, 2012, PHYSIOL BEHAV, V105, P784, DOI 10.1016/j.physbeh.2011.10.007; Barbosa A, 2010, ACTA ETHOL, V13, P119, DOI 10.1007/s10211-010-0081-6; Barreto RE, 2012, AQUAT BIOL, V15, P205, DOI 10.3354/ab00429; Barreto RE, 2010, MAR FRESHW BEHAV PHY, V43, P75, DOI 10.1080/10236241003654139; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Carreau-Green ND, 2008, J FISH BIOL, V73, P2390, DOI 10.1111/j.1095-8649.2008.02092.x; Chivers DP, 2007, P ROY SOC B-BIOL SCI, V274, P2611, DOI 10.1098/rspb.2007.0709; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Foam PE, 2005, BEHAVIOUR, V142, P129, DOI 10.1163/1568539053627631; Forward RB, 2000, J EXP MAR BIOL ECOL, V245, P277, DOI 10.1016/S0022-0981(99)00169-0; Giaquinto PC, 2001, BEHAVIOUR, V138, P1205, DOI 10.1163/15685390152822175; Barcellos LJG, 2011, PHYSIOL BEHAV, V103, P372, DOI 10.1016/j.physbeh.2011.03.009; Goodale E, 2012, ANIM BEHAV, V84, P919, DOI 10.1016/j.anbehav.2012.07.016; Halbgewachs CF, 2009, BIOL J LINN SOC, V98, P891, DOI 10.1111/j.1095-8312.2009.01328.x; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; HAZLETT BA, 1994, J CHEM ECOL, V20, P1525, DOI 10.1007/BF02059878; Henley WF, 2001, AM MALACOL BULL, V16, P131; HIDALGO J, 1987, HISTOCHEMISTRY, V88, P65, DOI 10.1007/BF00490170; HORNBUCKLE PA, 1974, BEHAV BIOL, V12, P573, DOI 10.1016/S0091-6773(74)92531-0; Ide LM, 2003, J FISH BIOL, V63, P332, DOI 10.1046/j.1095-8649.2003.00152.x; Jacobsen HP, 2004, OIKOS, V104, P43, DOI 10.1111/j.0030-1299.2004.12369.x; JONES RB, 1979, BEHAV NEURAL BIOL, V27, P319, DOI 10.1016/S0163-1047(79)92384-7; Jordao LC, 2000, BEHAVIOUR, V137, P681, DOI 10.1163/156853900502286; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kristensen EA, 2004, J FISH BIOL, V64, P643, DOI 10.1111/j.1095-8649.2004.00328.x; MATHIS A, 1993, ANIM BEHAV, V46, P645, DOI 10.1006/anbe.1993.1241; Morishita VR, 2011, MAR ECOL PROG SER, V435, P173, DOI 10.3354/meps09253; PFEIFFER W, 1977, COPEIA, P653, DOI 10.2307/1443164; PFEIFFER W, 1963, EXPERIENTIA, V19, P113, DOI 10.1007/BF02171582; Rahman YJ, 2000, J CHEM ECOL, V26, P679, DOI 10.1023/A:1005428221952; Shabani S, 2008, J EXP BIOL, V211, P2600, DOI 10.1242/jeb.016667; Smee DL, 2006, J CHEM ECOL, V32, P605, DOI 10.1007/s10886-005-9021-8; Smith R.J.F., 1992, Reviews in Fish Biology and Fisheries, V2, P33, DOI 10.1007/BF00042916; Smith R. Jan F., 1999, P475; SMITH RJF, 1979, CAN J ZOOL, V57, P1278, DOI 10.1139/z79-164; STEVENS DA, 1973, BEHAV BIOL, V8, P75, DOI 10.1016/S0091-6773(73)80008-2; Stickney R.R., 1994, PRINCIPLES AQUACULTU; Terlouw EMC, 1998, APPL ANIM BEHAV SCI, V57, P9, DOI 10.1016/S0168-1591(97)00122-6; von Frisch K, 1941, Z VERGL PHYSIOL, V29, P46; Weissburg MJ, 2002, J CHEM ECOL, V28, P1953, DOI 10.1023/A:1020741710060; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668; Yao M, 2009, EVOL BIOL, V36, P267, DOI 10.1007/s11692-009-9069-4; Zimmer RK, 2000, BIOL BULL, V198, P168, DOI 10.2307/1542522	43	24	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54642	10.1371/journal.pone.0054642	http://dx.doi.org/10.1371/journal.pone.0054642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349945	Green Published, Green Submitted, gold			2022-12-27	WOS:000313872800068
J	Chafin, D; Theiss, A; Roberts, E; Boriee, G; Otter, M; Baird, GS				Chafin, David; Theiss, Abbey; Roberts, Esteban; Boriee, Grace; Otter, Michael; Baird, Geoffrey S.			Rapid Two-Temperature Formalin Fixation	PLOS ONE			English	Article							ANTIGEN RETRIEVAL; MICROWAVE IRRADIATION; FORMALDEHYDE FIXATION; BREAST-CANCER; TISSUE; SPECIMENS; ULTRASOUND; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; STANDARDIZATION	Formalin fixation is a mainstay of modern histopathologic analysis, yet the practice is poorly standardized and a significant potential source of preanalytical errors. Concerns of workflow and turnaround time drive interest in developing shorter fixation protocols, but rapid protocols can lead to poor histomorphology or inadequate downstream assay results. Additionally, assays such as immunohistochemistry for phosphorylated epitopes have historically been challenging in the context of formalin-fixed tissue, indicating that there may be room for improvement in this process that is fundamental to the practice of anatomic pathology. With these issues in mind, we studied basic formalin biochemistry to develop a novel formalin fixation protocol that involves a pre-incubation in subambient temperature formalin prior to a brief exposure to heated formalin. This new protocol is more rapid than standard protocols yet preserves histomorphology and yields tissue that is compatible with an expanded set of downstream clinical and research assays, including immunohistochemistry for phosphorylated epitopes.	[Chafin, David; Theiss, Abbey; Roberts, Esteban; Otter, Michael] Ventana Med Syst Inc, Tucson, AZ USA; [Boriee, Grace; Baird, Geoffrey S.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Baird, Geoffrey S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Roche Holding; Ventana Medical Systems, Inc.; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Baird, GS (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	gbaird@u.washington.edu			Ventana Medical Systems, Inc.	Ventana Medical Systems, Inc.(Roche Holding)	DC, AT, ER and MO are full-time employees of Ventana Medical. G. Baird has received research funding from Ventana Medical Systems, Inc. DC, AT, ER and MO have filed for patent protection on the 2+2 method, patent application number 2012/0214195(A1). There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allred DC, 1998, MODERN PATHOL, V11, P155; Bai YL, 2011, LAB INVEST, V91, P1253, DOI 10.1038/labinvest.2011.75; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Baloglu G, 2008, APPL IMMUNOHISTO M M, V16, P485, DOI 10.1097/PAI.0b013e31815dffa6; BEROD A, 1981, J HISTOCHEM CYTOCHEM, V29, P844, DOI 10.1177/29.7.6167611; Bonnas C, 2011, INT J CANC; BOON ME, 1986, HISTOPATHOLOGY, V10, P303, DOI 10.1111/j.1365-2559.1986.tb02484.x; BOON ME, 1988, HISTOCHEM J, V20, P313, DOI 10.1007/BF01002723; BOON ME, 1991, EUR J MORPHOL, V29, P184; Boon ME, 1996, EUR J MORPHOL, V34, P375, DOI 10.1076/ejom.34.5.375.13053; Bussolati G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021043; Chen Q, 2007, ULTRASONICS, V47, P78, DOI 10.1016/j.ultras.2007.07.006; Chu WS, 2006, J HISTOCHEM CYTOCHEM, V54, P503, DOI 10.1369/jhc.5A6802.2005; Chu WS, 2005, MODERN PATHOL, V18, P850, DOI 10.1038/modpathol.3800354; Cox ML, 2006, EXP MOL PATHOL, V80, P183, DOI 10.1016/j.yexmp.2005.10.002; DAWSON IMP, 1972, HISTOCHEM J, V4, P381, DOI 10.1007/BF01005011; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; DURGUNYUCEL B, 1992, ACTA MED OKAYAMA, V46, P75; ERICSSON JL, 1967, LAB INVEST, V17, P281; Ferris AM, 2009, J NEUROSCI METH, V182, P157, DOI 10.1016/j.jneumeth.2009.06.002; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Fowler CB, 2008, LAB INVEST, V88, P785, DOI 10.1038/labinvest.2008.43; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Fracasso T, 2009, INT J LEGAL MED, V123, P521, DOI 10.1007/s00414-009-0368-1; Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X; Hafajee ZAM, 2004, PATHOLOGY, V36, P325, DOI 10.1080/00313020410001722374; Iesurum A, 2006, AM J FOREN MED PATH, V27, P178, DOI 10.1097/01.paf.0000221050.64572.01; KERNER H, 1986, HISTOPATHOLOGY, V10, P621, DOI 10.1111/j.1365-2559.1986.tb02515.x; KOK LP, 1990, HISTOCHEM J, V22, P381, DOI 10.1007/BF01003174; Leong ASY, 2011, METHODS MOL BIOL, V724, P37, DOI 10.1007/978-1-61779-055-3_3; LEONG ASY, 1985, J PATHOL, V146, P313, DOI 10.1002/path.1711460404; LEONG ASY, 1988, PATHOL ANNU, V23, P213; LEONG ASY, 1986, PATHOLOGY, V18, P222, DOI 10.3109/00313028609059463; Looi Lai-Meng, 2005, Malays J Pathol, V27, P23; Nadji M, 2005, APPL IMMUNOHISTO M M, V13, P277, DOI 10.1097/01.pai.0000146544.51771.79; O'Leary TJ, 2001, APPL IMMUNOHISTO M M, V9, P3, DOI 10.1097/00022744-200103000-00002; Pierceall WE, 2011, ANAL CELL PATHOL, V34, P159, DOI [10.1155/2011/583182, 10.3233/ACP-2011-014]; Pinhel IF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2719; Rait VK, 2004, LAB INVEST, V84, P300, DOI 10.1038/labinvest.3700041; Rait VK, 2004, LAB INVEST, V84, P292, DOI 10.1038/labinvest.3700045; Rolls G, 2008, ASSESSING QUALITY TI; Ruijter ET, 1997, J PATHOL, V183, P369; Siddiqui S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2782; Sompuram SR, 2004, AM J CLIN PATHOL, V121, P190, DOI 10.1309/BRN7CTX1E84NWWPL; Titford M, 2012, ARCH PATHOL LAB MED, V136, P137, DOI 10.5858/arpa.2011-0363-LE; Umlas J, 2004, HUM PATHOL, V35, P1058, DOI 10.1016/j.humpath.2004.04.013; Uneyama C, 2002, J HISTOCHEM CYTOCHEM, V50, P1237, DOI 10.1177/002215540205000911; Winkelman JGM, 2002, CHEM ENG SCI, V57, P4067, DOI 10.1016/S0009-2509(02)00358-5; Zou N, 2011, BIOTECH HISTOCHEM, V86, P413, DOI 10.3109/10520295.2010.518830	49	35	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e54138	10.1371/journal.pone.0054138	http://dx.doi.org/10.1371/journal.pone.0054138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349806	Green Published, gold, Green Submitted			2022-12-27	WOS:000313872800027
J	Zhang, ZW; Liu, XW; Xu, BC; Wang, SY; Li, L; Kang, YY; Guo, YF				Zhang, Zhe-wen; Liu, Xiao-wen; Xu, Bai-cheng; Wang, Su-yang; Li, Li; Kang, Ying-ying; Guo, Yu-fen			Analysis of Quality of Clinical Practice Guidelines for Otorhinolaryngology in China	PLOS ONE			English	Article								Objective: To evaluate the quality of clinical practice guidelines (CPGs) for otorhinolaryngology in China. Materials and Methods: A systematic search of relevant literature databases (CBM, WANFANG, VIP, CNKI, China Guideline Clearinghouse) published between 1978 and March 2012 was undertaken to identify and select CPGs related to otorhinolaryngology. Four independent reviewers assessed the eligible guidelines using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument. Their degree of agreement was evaluated using the intraclass correlation coefficient (ICC). Result: From 170 citations, 21 relevant guidelines were included. The overall agreement among reviewers was moderate (ICC = 0.87; 95% confidence interval [CI], 0.78-0.91). The scores for each of the AGREE domains were the following: "scope and purpose" (mean +/- standard error [SE] = 45.4 +/- 4.4; ICC = 0.92), "stakeholder involvement" (mean +/- SE = 30.4 +/- 3.1; ICC = 0.81), "rigor of development" (mean +/- SE = 20.9 +/- 2.8; ICC = 0.87), "clarity of presentation" (mean +/- SE = 48.8 +/- 3.7; ICC = 0.80), "applicability'' (mean +/- SE = 12.6 +/- 1.7; ICC = 0.72), and "editorial independence'' (mean +/- SE = 6.2 +/- 0.8; ICC = 0.76). Three guidelines (14%) mentioned updates, and the average update frequency was 7 years. None used the GRADE system. Conclusion: The quality of otorhinolaryngology guidelines in China is low. Greater efforts are needed to provide high-quality guidelines that serve as a useful and reliable tool for clinical decision-making in this field.	[Zhang, Zhe-wen; Kang, Ying-ying] Lanzhou Univ, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Liu, Xiao-wen; Xu, Bai-cheng; Wang, Su-yang; Guo, Yu-fen] Lanzhou Univ, Hosp 2, Dept Otolaryngol Head & Neck Surg, Lanzhou 730000, Peoples R China; [Guo, Yu-fen] Minist Hlth, Lanzhou, Gansu, Peoples R China; [Li, Li] Gan Su Prov Hosp, Dept Otolaryngol Head & Neck Surg, Lanzhou, Peoples R China	Lanzhou University; Lanzhou University	Guo, YF (corresponding author), Lanzhou Univ, Hosp 2, Dept Otolaryngol Head & Neck Surg, Lanzhou 730000, Peoples R China.	ldeyebh@163.com						AGREE Next Steps Consortium, 2009, THE AGREE II INSTRUM; Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; Boluyt N, 2005, PEDIATRICS, V115, P1378, DOI 10.1542/peds.2004-0575; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Burgers JS, 2003, INT J TECHNOL ASSESS, V19, P148, DOI 10.1017/S026646230300014X; Burls A, 2010, LANCET, V376, P1128, DOI 10.1016/S0140-6736(10)61034-3; Chen YL, 2012, CHINESE MED J-PEKING, V125, P3660, DOI 10.3760/cma.j.issn.0366-6999.2012.20.011; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; De Haas E, 2007, J EUR ACAD DERMATOL, V21, P1193, DOI 10.1111/j.1468-3083.2007.02216.x; Geusens PP, 2005, J EVAL CLIN PRACT, V12, P539; Harpole LH, 2003, CHEST, V123, p7S, DOI 10.1378/chest.123.1_suppl.7S; Institute of Medicine, 2011, CLINICAL PRACTICE GU; Klein WW, 2002, HEART, V87, P497, DOI 10.1136/heart.87.6.497; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P28, DOI 10.1186/1478-4505-4-28; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Straus S, 2010, CAN MED ASSOC J, V182, P13, DOI 10.1503/cmaj.081849; Vlayen J, 2005, INT J QUAL HEALTH C, V17, P235, DOI 10.1093/intqhc/mzi027; World Health Organization, 2003, GUIDELINES FOR WHO G; [张伶俐 ZHANG Ling-li], 2011, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V11, P991	20	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53566	10.1371/journal.pone.0053566	http://dx.doi.org/10.1371/journal.pone.0053566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349719	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800010
J	Al-Ansary, LA; Tricco, AC; Adi, Y; Bawazeer, G; Perrier, L; Al-Ghonaim, M; AlYousefi, N; Tashkandi, M; Straus, SE				Al-Ansary, Lubna A.; Tricco, Andrea C.; Adi, Yaser; Bawazeer, Ghada; Perrier, Laure; Al-Ghonaim, Mohammed; AlYousefi, Nada; Tashkandi, Mariam; Straus, Sharon E.			A Systematic Review of Recent Clinical Practice Guidelines on the Diagnosis, Assessment and Management of Hypertension	PLOS ONE			English	Review							RISK-ASSESSMENT; QUALITY; RECOMMENDATIONS; PREVENTION; AWARENESS; VALIDITY; SOCIETY	Background: Despite the availability of clinical practice guidelines (CPGs), optimal hypertension control is not achieved in many parts of the world; one of the challenges is the volume of guidelines on this topic and their variable quality. To systematically review the quality, methodology, and consistency of recommendations of recently-developed national CPGs on the diagnosis, assessment and the management of hypertension. Methodology/Principal Findings: MEDLINE, EMBASE, guidelines' websites and Google were searched for CPGs written in English on the general management of hypertension in any clinical setting published between January 2006 and September 2011. Four raters independently appraised each CPG using the AGREE-II instrument and 2 reviewers independently extracted the data. Conflicts were resolved by discussion or the involvement of an additional reviewer. Eleven CPGs were identified. The overall quality ranged from 2.5 to 6 out of 7 on the AGREE-II tool. The highest scores were for "clarity of presentation'' (44.4% - 88.9%) and the lowest were for "rigour of development'' (8.3% - 30% for 9 CGPs). None of them clearly reported being newly developed or adapted. Only one reported having a patient representative in its development team. Systematic reviews were not consistently used and only 2 up-to-date Cochrane reviews were cited. Two CPGs graded some recommendations and related that to levels (but not quality) of evidence. The CPGs' recommendations on assessment and non-pharmacological management were fairly consistent. Guidelines varied in the selection of first-line treatment, adjustment of therapy and drug combinations. Important specific aspects of care (e. g. resistant hypertension) were ignored by 6/11 CPGs. The CPGs varied in methodological quality, suggesting that their implementation might not result in less variation of care or in better health-related outcomes. Conclusions/Significance: More efforts are needed to promote the realistic approach of localization or local adaptation of existing high-quality CPGs to the national context.	[Al-Ansary, Lubna A.; AlYousefi, Nada] King Saud Univ, Coll Med, Dept Family & Community Med, Riyadh 11461, Saudi Arabia; [Al-Ansary, Lubna A.; Bawazeer, Ghada; Perrier, Laure] King Saud Univ, Coll Med, Shaikh Bahamdans Res Chair Evidence Based Hlth Ca, Riyadh 11461, Saudi Arabia; [Tricco, Andrea C.; Perrier, Laure; Straus, Sharon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Bawazeer, Ghada] King Saud Univ, Coll Pharm, Riyadh 11461, Saudi Arabia; [Al-Ghonaim, Mohammed] King Saud Univ, Coll Med, Dept Internal Med, Prince Salman Bin Abdulaziz Chair Kidney Dis, Riyadh 11461, Saudi Arabia; [Tashkandi, Mariam] St Michaels Hosp, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada; [Straus, Sharon E.] Univ Toronto, Div Geriatr, Toronto, ON, Canada	King Saud University; King Saud University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; King Saud University; King Saud University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Al-Ansary, LA (corresponding author), King Saud Univ, Coll Med, Dept Family & Community Med, Riyadh 11461, Saudi Arabia.	lalansary@ksu.edu.sa	Adi, Yaser A/S-5100-2016; Tricco, Andrea/B-9920-2011; Bawazeer, Ghada/AAL-1590-2020; Alyousefi, Nada/AAX-4274-2021; Perrier, Laure/D-4638-2011	Adi, Yaser A/0000-0002-3989-2873; Tricco, Andrea/0000-0002-4114-8971; Alyousefi, Nada/0000-0002-9142-425X; Perrier, Laure/0000-0001-9941-7129; Al-Ansary, Lubna/0000-0001-7127-914X	King Saud University; Li Ka Shing Institute at St Michael's Hospital	King Saud University(King Saud University); Li Ka Shing Institute at St Michael's Hospital	The whole work was partly funded through research training collaboration between King Saud University and the Li Ka Shing Institute at St Michael's Hospital but the sponsors had no role at all in study design, in the data collection and analysis, interpretation of data, writing of the article or in the decision to submit it for publication.	[Advanced Analytics L Excel AfM], 2011, AGREESTAT 2011 2 MS; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Alderson PTT, 2011, COCHRANE LIB    0810; Alonso-Coello P., 2010, QUAL SAF HEALTH CARE, V19, P1, DOI DOI 10.1136/QSHC.2010.042077; Alsuwaida A, 2011, CLIN EXP HYPERTENS, V33, P354, DOI 10.3109/10641963.2010.531857; Brouwers MC, 2011, J CLIN EPIDEMIOLOGY; Brouwers MC, 2009, APPRAISAL GUIDELINES; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Cai L, 2011, CLIN EXP HYPERTENS, V0, P1; Campbell F, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-47; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CPG Secretariat HU Medical Development Division Ministry of Health of Malaysia, 2008, CLIN PRACT GUID MAN; Davis D, 2007, CMA HDB CLIN PRACTIC; Ellis CJ, 2011, NEW ZEAL MED J, V124, P13; Elward KS, 2010, POSTGRAD MED, V122, P192, DOI 10.3810/pgm.2010.07.2186; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Fervers B, 2005, INT J QUAL HEALTH C, V17, P123, DOI 10.1093/intqhc/mzi011; Fervers B, 2011, BMJ QUAL SAF, V20, P228, DOI 10.1136/bmjqs.2010.043257; Foundation NH, 2010, GUID MAN HYP 2008 AS; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, DOI DOI 10.1016/J.APRIM.2008.09.006; Hodgkinson J, 2011, BMJ, V342, pd3621, DOI 10.1136/bmj.d3621; Julius S, 2009, PROG CARDIOVASC DIS, V52, P26, DOI 10.1016/j.pcad.2009.06.002; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Matheny M, 2011, SYSTEMATIC REV CARDI; Mendis S., 2011, GLOB ATL CARD DIS PR; Misso ML, 2008, MED J AUSTRALIA, V189, P394, DOI 10.5694/j.1326-5377.2008.tb02086.x; Morrison A, 2009, ENGLISH LANGUAGE RES; Mulrow Cynthia D, 2000, COCHRANE DATABASE SY; Musini Vijaya M, 2009, COCHRANE DATABASE SY; Nagy E, 2008, CLIN CHEM, V54, P1872, DOI 10.1373/clinchem.2008.109082; National Institute for Health and Clinical Excellence, 2011, COST EFF AN PHARM TR, P421; National Institute for Health and Clinical Excellence, 2009, GUID MAN 2009; National Institute for Health and Clinical Excellence, 2011, CLIN MAN PRIM HYP AD; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P12, DOI 10.1186/1478-4505-4-12; Pentheroudakis G, 2008, ANN ONCOL, V19, P2067, DOI 10.1093/annonc/mdn418; Rabi DM, 2011, CAN J CARDIOL, V27, P415, DOI 10.1016/j.cjca.2011.03.015; Sanchez RA, 2009, J HYPERTENS, V27, P905, DOI 10.1097/HJH.0b013e32832aa6d2; Scottish Intercollegiate Guidelines Network, 2011, SIGN 50 GUID DEV HDB; Seedat YK, 2006, SAMJ S AFR MED J, V96, P337; Shah S, 2007, INDIAN HYPERTENSION; Shekelle P, 2001, BMJ-BRIT MED J, V323, P155, DOI 10.1136/bmj.323.7305.155; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Society SHM, 2011, SAUD HYP MAN SOC GUI; The ADAPTE Collaboration, 2009, ADAPTE PROC RES TOOL; Tykarski A, 2007, KARDIOL POL, V65, P1137; Wang YR, 2007, ARCH INTERN MED, V167, P141, DOI 10.1001/archinte.167.2.141; Watine J, 2006, CLIN CHEM, V52, P65, DOI 10.1373/clinchem.2005.056952; Watine JC, 2008, CLIN BIOCHEM, V41, P459, DOI 10.1016/j.clinbiochem.2007.12.020; Whelton PK, 2004, J HUM HYPERTENS, V18, P545, DOI 10.1038/sj.jhh.1001701; White HD, 2011, NEW ZEAL MED J, V124, P5; Wright James M, 2009, COCHRANE DATABASE SY	57	50	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e53744	10.1371/journal.pone.0053744	http://dx.doi.org/10.1371/journal.pone.0053744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349738	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900019
J	Oakenfull, RJ; Baxter, R; Knight, MR				Oakenfull, Rachael J.; Baxter, Robert; Knight, Marc R.			A C-Repeat Binding Factor Transcriptional Activator (CBF/DREB1) from European Bilberry (Vaccinium myrtillus) Induces Freezing Tolerance When Expressed in Arabidopsis thaliana	PLOS ONE			English	Article							COLD-ACCLIMATION; GENE-EXPRESSION; DNA-BINDING; GROWTH; CBF1; OVEREXPRESSION; FLUORESCENCE; PATHWAYS; STRESS; MOTIFS	Freezing stress affects all plants from temperate zones to the poles. Global climate change means such freezing events are becoming less predictable. This in turn reduces the ability of plants to predict the approaching low temperatures and cold acclimate. This has consequences for crop yields and distribution of wild plant species. C-repeat binding factors (CBFs) are transcription factors previously shown to play a vital role in the acclimation process of Arabidopsis thaliana, controlling the expression of hundreds of genes whose products are necessary for freezing tolerance. Work in other plant species cements CBFs as key determinants in the trait of freezing tolerance in higher plants. To test the function of CBFs from highly freezing tolerant plants species we cloned and sequenced CBF transcription factors from three Vaccinium species (Vaccinium myrtillus, Vaccinium uliginosum and Vaccinium vitis-idaea) which we collected in the Arctic. We tested the activity of CBF transcription factors from the three Vaccinium species by producing transgenic Arabidopsis lines overexpressing them. Only the Vaccinium myrtillus CBF was able to substantially activate COR (CBF-target) gene expression in the absence of cold. Correspondingly, only the lines expressing the Vaccinium myrtillus CBF were constitutively freezing tolerant. The basis for the differences in potency of the three Vaccinium CBFs was tested by observing cellular localisation and protein levels. All three CBFs were correctly targeted to the nucleus, but Vaccinium uliginosum CBF appeared to be relatively unstable. The reasons for lack of potency for Vaccinium vitis-idaea CBF were not due to stability or targeting, and we speculate that this was due to altered transcription factor function.	[Oakenfull, Rachael J.; Knight, Marc R.] Univ Durham, Durham Ctr Crop Improvement Technol, Durham, England; [Oakenfull, Rachael J.; Baxter, Robert; Knight, Marc R.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Durham University; Durham University	Knight, MR (corresponding author), Univ Durham, Durham Ctr Crop Improvement Technol, Durham, England.	m.r.knight@durham.ac.uk	Baxter, Robert/C-7688-2012	Baxter, Robert/0000-0002-7504-6797; Knight, Marc/0000-0002-4830-8608	UK Biotechnology and Biological Sciences Research Council; Natural Environment Research Council [NE/D005760/1] Funding Source: researchfish; NERC [NE/D005760/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The UK Biotechnology and Biological Sciences Research Council partly funded the PhD studentship of the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Badawi M, 2007, MOL GENET GENOMICS, V277, P533, DOI 10.1007/s00438-006-0206-9; Bokhorst S, 2012, AMBIO, V41, P246, DOI 10.1007/s13280-012-0310-5; Canella D, 2010, BBA-GENE REGUL MECH, V1799, P454, DOI 10.1016/j.bbagrm.2009.11.017; Chivasa S, 2009, PLANT J, V60, P436, DOI 10.1111/j.1365-313X.2009.03968.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Harberd NP, 2009, PLANT CELL, V21, P1328, DOI 10.1105/tpc.109.066969; Jaakola L, 2001, MOL BIOTECHNOL, V19, P201, DOI 10.1385/MB:19:2:201; Jacquemart AL, 1996, J ECOL, V84, P771, DOI 10.2307/2261339; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Kreyling J, 2012, OECOLOGIA, V168, P577, DOI 10.1007/s00442-011-2092-z; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Moffat CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035995; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Oxborough K, 2004, J EXP BOT, V55, P1195, DOI 10.1093/jxb/erh145; Polashock JJ, 2010, J AM SOC HORTIC SCI, V135, P40, DOI 10.21273/JASHS.135.1.40; Rinke A, 2008, GLOBAL PLANET CHANGE, V62, P173, DOI 10.1016/j.gloplacha.2008.01.004; RITCHIE JC, 1956, J ECOL, V44, P291, DOI 10.2307/2257181; RITCHIE JC, 1955, J ECOL, V43, P701, DOI 10.2307/2257030; SONESSON M, 1974, OIKOS, V25, P121, DOI 10.2307/3543633; SONESSON M, 1991, ARCTIC, V44, P95; Tahkokorpi M, 2007, ENVIRON EXP BOT, V61, P85, DOI 10.1016/j.envexpbot.2007.03.003; Taulavuori K, 2011, ENVIRON EXP BOT, V72, P397, DOI 10.1016/j.envexpbot.2011.02.009; Waadt R, 2008, PLANTA VISUALIZATION; Walworth AE, 2012, MOL BREEDING, V30, P1313, DOI 10.1007/s11032-012-9718-7; Wang QJ, 2010, PLANT CELL TISS ORG, V101, P211, DOI 10.1007/s11240-010-9678-8; Wang ZB, 2005, PLANT MOL BIOL, V58, P543, DOI 10.1007/s11103-005-6760-4; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whalley HJ, 2011, PLANT CELL, V23, P4079, DOI 10.1105/tpc.111.090480; Zhou MQ, 2011, CRIT REV BIOTECHNOL, V31, P186, DOI 10.3109/07388551.2010.505910	41	24	30	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54119	10.1371/journal.pone.0054119	http://dx.doi.org/10.1371/journal.pone.0054119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349799	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000313738900041
J	Roberts, AL; Rosario, M; Corliss, HL; Wypij, D; Lightdale, JR; Austin, SB				Roberts, Andrea L.; Rosario, Margaret; Corliss, Heather L.; Wypij, David; Lightdale, Jenifer R.; Austin, S. Bryn			Sexual Orientation and Functional Pain in US Young Adults: The Mediating Role of Childhood Abuse	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS; SOCIAL SUPPORT; MINORITY ADULTS; RISK; TRAUMA; GAY; VICTIMIZATION; RELIABILITY; EXPERIENCES; PREVALENCE	Objective: Pain without known pathology, termed "functional pain," causes much school absenteeism, medication usage, and medical visits. Yet which adolescents are at risk is not well understood. Functional pain has been linked to childhood abuse, and sexual orientation minority youth (gay, lesbian, bisexual, "mostly heterosexual," and heterosexual with same-sex sexual contact) are more likely to be victims of childhood abuse than heterosexuals, thus may be at greater risk of functional pain. Methods: We examined sexual orientation differences in past-year prevalence of functional headache, pelvic, and abdominal pain and multiple sites of pain in 9,864 young adults (mean age = 23 years) from a large U. S. cohort. We examined whether childhood abuse accounted for possible increased risk of functional pain in sexual minority youth. Results: Sexual minority youth, except for gays and lesbians, were at higher risk of functional pelvic and abdominal pain and multiple sites of pain than heterosexuals. Gay and lesbian youth had elevated prevalence only of abdominal pain. Childhood abuse accounted for 14% to 33% of increased experience of multiple sites of pain in minority youth. Conclusions: Youth who identify as "mostly heterosexual'' or bisexual or who identify as heterosexual and have had same-sex partners comprised 18% of our sample. Clinicians should be aware that patients with these orientations are at elevated risk of functional pain and may be in need of treatment for sequelae of childhood abuse. Conventional categorization of sexual orientation as heterosexual or homosexual may fail to distinguish a large number of youth who do not wholly identify with either group and may be at elevated risk of health problems.	[Roberts, Andrea L.; Austin, S. Bryn] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Rosario, Margaret] CUNY City Coll, Dept Psychol, New York, NY 10031 USA; [Rosario, Margaret] CUNY, Grad Ctr, New York, NY USA; [Corliss, Heather L.; Austin, S. Bryn] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Boston, MA USA; [Corliss, Heather L.; Wypij, David; Lightdale, Jenifer R.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Corliss, Heather L.; Austin, S. Bryn] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med, Boston, MA 02115 USA; [Wypij, David] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wypij, David] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Lightdale, Jenifer R.] Boston Childrens Hosp, Div Gastroenterol & Nutr, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Roberts, AL (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	aroberts@hsph.harvard.edu		Corliss, Heather/0000-0002-2553-6165; Wypij, David/0000-0001-8367-8711; Roberts, Andrea/0000-0001-5023-4399	National Institutes of Health [HD057368, HD049889]; Leadership Education in Adolescent Health project; Maternal and Child Health Bureau; HRSA [6T71-MC00009-17]; NIDA [K01 DA023610]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057368] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA023610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leadership Education in Adolescent Health project; Maternal and Child Health Bureau; HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by grants HD057368 and HD049889 from the National Institutes of Health. A. L. Roberts is supported by HD057368. S. B. Austin and H. L. Corliss are supported by the Leadership Education in Adolescent Health project, Maternal and Child Health Bureau, HRSA grant 6T71-MC00009-17, and H. L. Corliss is supported by NIDA Career Development Award K01 DA023610. The authors acknowledge the Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School for its management of the Growing Up Today Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin SB, 2008, AM J PUBLIC HEALTH, V98, P1015, DOI 10.2105/AJPH.2006.099473; Balsam KF, 2007, J COUNS PSYCHOL, V54, P306, DOI 10.1037/0022-0167.54.3.306; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bontempo DE, 2002, J ADOLESCENT HEALTH, V30, P364, DOI 10.1016/S1054-139X(01)00415-3; Cochran SD, 2007, AM J PUBLIC HEALTH, V97, P2048, DOI 10.2105/AJPH.2006.087254; Corliss HL, 2008, ARCH PEDIAT ADOL MED, V162, P1071, DOI 10.1001/archpedi.162.11.1071; Corliss HL, 2009, J WOMENS HEALTH, V18, P2005, DOI 10.1089/jwh.2009.1488; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; Field AE, 1999, J AM ACAD CHILD PSY, V38, P754, DOI 10.1097/00004583-199906000-00024; Grossman AH, 2000, J GERONTOL B-PSYCHOL, V55, pP171, DOI 10.1093/geronb/55.3.P171; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Herek GM, 2009, J INTERPERS VIOLENCE, V24, P54, DOI 10.1177/0886260508316477; Hertzmark E, 2009, SAS MEDIATE MACRO; Holmes WC, 1998, JAMA-J AM MED ASSOC, V280, P1855, DOI 10.1001/jama.280.21.1855; Katon W, 2001, ANN INTERN MED, V134, P917, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00017; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; KOSS MP, 1985, J CONSULT CLIN PSYCH, V53, P422, DOI 10.1037/0022-006X.53.3.422; Levy RL, 2001, GASTROENTEROLOGY, V121, P799, DOI 10.1053/gast.2001.27995; Massachusetts Department of Education, 2004, 2003 YOUTH RISK BEH; Ramchandani PG, 2007, ACTA PAEDIATR, V96, P697, DOI 10.1111/j.1651-2227.2007.00291.x; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; REMAFEDI G, 1992, PEDIATRICS, V89, P714; Roberts AL, 2012, AM J PUBLIC HLTH; Roberts AL, 2012, AM J PUBLIC HEALTH, V102, P1587, DOI 10.2105/AJPH.2011.300530; Roberts AL, 2012, PEDIATRICS, V129, P410, DOI 10.1542/peds.2011-1804; Roberts AL, 2010, AM J PUBLIC HEALTH, V100, P2433, DOI 10.2105/AJPH.2009.168971; SAS Institute, 2002, SAS 9 2 WIND; Schwille IJD, 2009, CLIN GASTROENTEROL H, V7, P1062, DOI 10.1016/j.cgh.2009.07.002; Sheets RL, 2009, J COUNS PSYCHOL, V56, P152, DOI 10.1037/0022-0167.56.1.152; Wingenfeld K, 2009, J PSYCHOSOM OBST GYN, V30, P282, DOI 10.3109/01674820903254732; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	32	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54702	10.1371/journal.pone.0054702	http://dx.doi.org/10.1371/journal.pone.0054702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23355890	Green Published, gold			2022-12-27	WOS:000314021500110
J	Chang, SLY; Liu, YC; Chen, SY; Huang, TH; Liu, PT; Liu, FC				Chang, Sunny Li-Yun; Liu, Ya-Chi; Chen, Shih-Yun; Huang, Ting-Hao; Liu, Pei-Tsen; Liu, Fu-Chin			Identification of Two Evolutionarily Conserved 5 ' cis-Elements Involved in Regulating Spatiotemporal Expression of Nolz-1 during Mouse Embryogenesis	PLOS ONE			English	Article							GENE; FAMILY; DROSOPHILA; MORPHOGENESIS; DOMAINS; SIGNALS; REGION; ELBOW	Proper development of vertebrate embryos depends not only on the crucial funtions of key evolutionarily conserved transcriptional regulators, but also on the precisely spatiotemporal expression of these transcriptional regulators. The mouse Nolz-1/Znf503/Zfp503 gene is a mammalian member of the conserved zinc-finger containing NET family. The expression pattern of Nolz-1 in mouse embryos is highly correlated with that of its homologues in different species. To study the spatiotemporal regulation of Nolz-1, we first identified two evolutionarily conserved cis-elements, UREA and UREB, in 5' upstream regions of mouse Nolz-1 locus. We then generated UREA-LacZ and UREB-LacZ transgenic reporter mice to characterize the putative enhancer activity of UREA and UREB. The results indicated that both UREA and UREB contained tissue-specific enhancer activity for directing LacZ expression in selective tissue organs during mouse embryogensis. UREA directed LacZ expression preferentially in selective regions of developing central nervous system, including the forebrain, hindbrain and spinal cord, whereas UREB directed LacZ expression mainly in other developing tissue organs such as the Nolz-1 expressing branchial arches and its derivatives, the apical ectodermal ridge of limb buds and the urogenital tissues. Both UREA and UREB directed strong LacZ expression in the lateral plate mesoderm where endogenous Nolz-1 was also expressed. Despite that the LacZ expression pattern did not full recapitulated the endogenous Nolz-1 expression and some mismatched expression patterns were observed, co-expression of LacZ and Nolz-1 did occur in many cells of selective tissue organs, such as in the ventrolateral cortex and ventral spinal cord of UREA-LacZ embryos, and the urogenital tubes of UREB-LacZ embryos. Taken together, our study suggests that UREA and UREB may function as evolutionarily conserved cis-regulatory elements that coordinate with other cis-elements to regulate spatiotemporal expression of Nolz-1 in different tissue organs during mouse embryogenesis.	[Chang, Sunny Li-Yun; Liu, Ya-Chi; Liu, Pei-Tsen] China Med Univ, Inst Mol Syst Biomed, Taichung, Taiwan; [Chen, Shih-Yun; Huang, Ting-Hao; Liu, Fu-Chin] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	China Medical University Taiwan; National Yang Ming Chiao Tung University	Chang, SLY (corresponding author), China Med Univ, Inst Mol Syst Biomed, Taichung, Taiwan.	liyunchang@mail.cmu.edu.tw; fuchin@ym.edu.tw			National Science Council [NSC99-2311-B-010-005-MY3, NSC97-2320-B-039-038, NSC-98-2320-B-039-034-MY3]; China Medical University [CMU97-224]; Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Ministry of Education	This work was supported by grants from National Science Council (http://web1.nsc.gov.tw/mp.aspx?mp = 7), Grant numbers: NSC99-2311-B-010-005-MY3 (F.-C. L.), NSC97-2320-B-039-038 (S.L.-Y.C) and NSC-98-2320-B-039-034-MY3 (S.L.-Y.C.) and also supported by China Medical University (http://english.cmu.edu.tw/), Grant number CMU97-224 (S.L.-Y.C.) and Ministry of Education (http://english.moe.gov.tw/mp.asp?mp = 1), Talent Researchers Recruitment Program for University and College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-44; Brown JD, 2009, P NATL ACAD SCI USA, V106, P1462, DOI 10.1073/pnas.0812017106; Chang CW, 2004, P NATL ACAD SCI USA, V101, P2613, DOI 10.1073/pnas.0308645100; Chang SLY, 2011, GENE EXPR PATTERNS, V11, P525, DOI 10.1016/j.gep.2011.09.003; CHEAH PY, 1994, MOL CELL BIOL, V14, P1487, DOI 10.1128/MCB.14.2.1487; Dorfman R, 2002, DEVELOPMENT, V129, P3585; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Hoyle J, 2004, DEV DYNAM, V229, P835, DOI 10.1002/dvdy.20001; Ji SJ, 2009, DEVELOPMENT, V136, P231, DOI 10.1242/dev.028043; Lee AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020088; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; McGlinn E, 2008, DEV DYNAM, V237, P1172, DOI 10.1002/dvdy.21508; Nakamura M, 2004, J CELL BIOCHEM, V93, P887, DOI 10.1002/jcb.20255; Runko AP, 2004, J BIOL CHEM, V279, P11917, DOI 10.1074/jbc.M310076200; Runko AP, 2003, DEV BIOL, V262, P254, DOI 10.1016/S0012-1606(03)00388-9; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Slorach EM, 2011, GENE DEV, V25, P471, DOI 10.1101/gad.1998111; Stenman J, 2003, J NEUROSCI, V23, P167; Tseng ASK, 2002, GENETICS, V162, P229; Weihe U, 2004, DEVELOPMENT, V131, P767, DOI 10.1242/dev.00979; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Woolfe A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r53; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582; Zaki PA, 2003, CURR OPIN GENET DEV, V13, P423, DOI 10.1016/S0959-437X(03)00084-4; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhao XJ, 2002, DEVELOPMENT, V129, P1497	27	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54485	10.1371/journal.pone.0054485	http://dx.doi.org/10.1371/journal.pone.0054485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349903	Green Submitted, Green Published, gold			2022-12-27	WOS:000314019100074
J	Mankovich, AR; Lee, CY; Heinrich, V				Mankovich, Alexander R.; Lee, Cheng-Yuk; Heinrich, Volkmar			Differential Effects of Serum Heat Treatment on Chemotaxis and Phagocytosis by Human Neutrophils	PLOS ONE			English	Article							BINDING LECTIN SITE; MAC-1 CD11B/CD18; LABILE OPSONINS; CROSS-LINKING; COMPLEMENT; ADHESION; DOMAIN; AGGREGATION; SPECIFICITY; INFECTIONS	Neutrophils, in cooperation with serum, are vital gatekeepers of a host's microbiome and frontline defenders against invading microbes. Yet because human neutrophils are not amenable to many biological techniques, the mechanisms governing their immunological functions remain poorly understood. We here combine state-of-the-art single-cell experiments with flow cytometry to examine how temperature-dependent heat treatment of serum affects human neutrophil interactions with "target" particles of the fungal model zymosan. Assessing separately both the chemotactic as well as the phagocytic neutrophil responses to zymosan, we find that serum heat treatment modulates these responses in a differential manner. Whereas serum treatment at 52 degrees C impairs almost all chemotactic activity and reduces cell-target adhesion, neutrophils still readily engulf target particles that are maneuvered into contact with the cell surface under the same conditions. Higher serum-treatment temperatures gradually suppress phagocytosis even after enforced cell-target contact. Using fluorescent staining, we correlate the observed cell behavior with the amounts of C3b and IgG deposited on the zymosan surface in sera treated at the respective temperatures. This comparison not only affirms the critical role of complement in chemotactic and adhesive neutrophil interactions with fungal surfaces, but also unmasks an important participation of IgGs in the phagocytosis of yeast-like fungal particles. In summary, this study presents new insight into fundamental immune mechanisms, including the chemotactic recruitment of immune cells, the adhesive capacity of cell-surface receptors, the role of IgGs in fungal recognition, and the opsonin-dependent phagocytosis morphology of human neutrophils. Moreover, we show how, by fine-tuning the heat treatment of serum, one can selectively study chemotaxis or phagocytosis under otherwise identical conditions. These results not only refine our understanding of a widely used laboratory method, they also establish a basis for new applications of this method.	[Mankovich, Alexander R.; Lee, Cheng-Yuk; Heinrich, Volkmar] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Heinrich, V (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	vheinrich@ucdavis.edu		Heinrich, Volkmar/0000-0002-4932-5012	National Institutes of Health, USA [R01 A1072391]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072391] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health, USA, grant R01 A1072391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; BOULANGER P., 1960, CANADIAN JOUR COMP MED AND VET SCI, V24, P262; Casals J, 1941, J EXP MED, V74, P409, DOI 10.1084/jem.74.5.409; Chiani P, 2009, VACCINE, V27, P513, DOI 10.1016/j.vaccine.2008.11.030; DAHL MV, 1979, J IMMUNOL METHODS, V29, P301, DOI 10.1016/0022-1759(79)90001-2; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Ecker EE, 1943, J IMMUNOL, V47, P181; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; FERRANTE A, 1979, SABOURAUDIA, V17, P293; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Garcia-Garcia E, 2009, J IMMUNOL, V182, P4547, DOI 10.4049/jimmunol.0801468; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hamburger HJ, 1927, HDB BIOL ARBEITSME 4, P953; HED J, 1982, IMMUNOLOGY, V45, P727; Heinrich V, 2005, LANGMUIR, V21, P1962, DOI 10.1021/la047801q; Heinrich V, 2011, J CELL SCI, V124, P3041, DOI 10.1242/jcs.086413; Herant M, 2005, J CELL SCI, V118, P1789, DOI 10.1242/jcs.02275; Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876; Herant M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001068; JUNGKIND DL, 1986, J CLIN MICROBIOL, V23, P381, DOI 10.1128/JCM.23.2.381-382.1986; Kocher M, 1997, J IMMUNOL, V159, P3940; Lam J, 2009, BIOPHYS J, V96, P248, DOI 10.1529/biophysj.108.139154; Lee CY, 2011, J CELL SCI, V124, P1106, DOI 10.1242/jcs.078592; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Murphy K., 2007, JANEWAYS IMMUNOBIOLO; Pillemer L, 1941, J BIOL CHEM, V137, P139; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; PUTNAM FW, 1987, PLASMA PROTEINS STRU; Rivas-Fuentes S, 2010, CELL IMMUNOL, V263, P114, DOI 10.1016/j.cellimm.2010.03.006; Ross GD, 2002, IMMUNOL RES, V25, P219, DOI 10.1385/IR:25:3:219; Rudnicki MA, 1987, TERATOCARCINOMAS EMB, P19; SCRIBNER DJ, 1976, J IMMUNOL, V116, P892; SIMON SI, 1995, J IMMUNOL, V155, P1502; SMITH MR, 1969, P NATL ACAD SCI USA, V63, P1151, DOI 10.1073/pnas.63.4.1151; SOLTIS RD, 1979, IMMUNOLOGY, V36, P37; Thornton BP, 1996, J IMMUNOL, V156, P1235; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; VANEPPS DE, 1976, INFECT IMMUN, V13, P741, DOI 10.1128/IAI.13.3.741-749.1976; VERHOEF J, 1977, IMMUNOLOGY, V33, P191; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Wang G R, 1997, Zhonghua Yi Xue Za Zhi (Taipei), V59, P325; Weatherby D, 2004, BLOOD CHEM CBC ANAL; Weiss S A, 1995, Methods Mol Biol, V39, P65; Xia Y, 1999, J IMMUNOL, V162, P7285; Zhelev DV, 2004, BIOPHYS J, V87, P688, DOI 10.1529/biophysj.103.036699; Zhelev DV, 1996, CELL MOTIL CYTOSKEL, V35, P331	49	17	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54735	10.1371/journal.pone.0054735	http://dx.doi.org/10.1371/journal.pone.0054735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349959	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100093
J	Sonstegard, TS; Cole, JB; VanRaden, PM; Van Tassell, CP; Null, DJ; Schroeder, SG; Bickhart, D; McClure, MC				Sonstegard, Tad S.; Cole, John B.; VanRaden, Paul M.; Van Tassell, Curtis P.; Null, Daniel J.; Schroeder, Steven G.; Bickhart, Derek; McClure, Matthew C.			Identification of a Nonsense Mutation in CWC15 Associated with Decreased Reproductive Efficiency in Jersey Cattle	PLOS ONE			English	Article							CALVES; GENE; NUCLEOTIDE; EXPRESSION; HAPLOTYPES; FERTILITY; DISCOVERY; ALIGNMENT; COMPLEX; MARKERS	With the recent advent of genomic tools for cattle, several recessive conditions affecting fertility have been identified and selected against, such as deficiency of uridine monophosphate synthase, complex vertebral malformation, and brachyspina. The current report refines the location of a recessive haplotype affecting fertility in Jersey cattle using crossover haplotypes, discovers the causative mutation using whole genome sequencing, and examines the gene's role in embryo loss. In an attempt to identify unknown recessive lethal alleles in the current dairy population, a search using deep Mendelian sampling of 5,288 Jersey cattle was conducted for high-frequency haplotypes that have a deficit of homozygotes at the population level. This search led to the discovery of a putative recessive lethal in Jersey cattle on Bos taurus autosome 15. The haplotype, denoted JH1, was associated with reduced fertility, and further investigation identified one highly-influential Jersey bull as the putative source ancestor. By combining SNP analysis of whole-genome sequences aligned to the JH1 interval and subsequent SNP validation a nonsense mutation in CWC15 was identified as the likely causative mutation underlying the fertility phenotype. No homozygous recessive individuals were found in 749 genotyped animals, whereas all known carriers and carrier haplotypes possessed one copy of the mutant allele. This newly identified lethal has been responsible for a substantial number of spontaneous abortions in Jersey dairy cattle throughout the past half-century. With the mutation identified, selection against the deleterious allele in breeding schemes will aid in reducing the incidence of this defect in the population. These results also show that carrier status can be imputed with high accuracy. Whole-genome resequencing proved to be a powerful strategy to rapidly identify a previously mapped deleterious mutation in a known carrier of a recessive lethal allele.	[Cole, John B.; VanRaden, Paul M.; Null, Daniel J.] ARS, Anim Improvement Programs Labs, USDA, Beltsville, MD USA	United States Department of Agriculture (USDA)	Cole, JB (corresponding author), ARS, Anim Improvement Programs Labs, USDA, Beltsville, MD USA.	john.cole@ars.usda.gov	Van Tassell, Curtis P./O-4247-2019; Cole, John B./J-8571-2014; Kushnir, Irina/D-8583-2016	Van Tassell, Curtis P./0000-0002-8416-2087; Cole, John B./0000-0003-1242-4401; Kushnir, Irina/0000-0002-8575-3970; Bickhart, Derek/0000-0003-2223-9285; Schroeder, Steven/0000-0001-9103-5150	American Jersey Cattle Association; Bovine Functional Genomics Laboratories [1265-31000-096-00, 1265-31000-098-00]	American Jersey Cattle Association; Bovine Functional Genomics Laboratories	The American Jersey Cattle Association provided funding for genome sequencing. The contribution by scientists in the Animal Improvement Programs and Bovine Functional Genomics Laboratories are supported by appropriated projects 1265-31000-096-00 and 1265-31000-098-00, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2006, J VET DIAGN INVEST, V18, P418, DOI 10.1177/104063870601800421; Agerholm JS, 2001, J VET DIAGN INVEST, V13, P283, DOI 10.1177/104063870101300401; [Anonymous], 2011, INTERBULL B; Center for Bioinformatics and Computatonal Biology, 2010, BOS TAURUS ASSEMBLY; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Cingolani P, 2012, ISO 2; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Drogemuller C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001079; Duan Jia-Zhong, 2010, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V26, P637; ELDRIDGE FE, 1951, J HERED, V42, P241, DOI 10.1093/oxfordjournals.jhered.a106217; ELHAMIDI M, 1989, J VET MED A, V36, P731, DOI 10.1111/j.1439-0442.1989.tb00786.x; Georges M, 2010, International Patent Publ. No, Patent No. [W0201.0/012690., 2010012690, W02010/012690 Al, 02010012690]; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; HAFNER A, 1993, J VET MED B, V40, P413, DOI 10.1111/j.1439-0450.1993.tb00158.x; Harhay GP, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r102; Harpestad GW, 1987, J HERED, V75, P337; LEIPOLD HW, 1973, VET MED SM ANIM CLIN, V68, P645; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIEN S, 1993, ANIM GENET, V24, P373, DOI 10.1111/j.1365-2052.1993.tb00343.x; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Michelizzi VN, 2011, INT J BIOL SCI, V7, P18, DOI 10.7150/ijbs.7.18; Page BT, 2004, J ANIM SCI, V82, P3474; Seichter D, 2011, ANIM GENET, V42, P544, DOI 10.1111/j.1365-2052.2010.02167.x; SHUSTER DE, 1992, P NATL ACAD SCI USA, V89, P9225, DOI 10.1073/pnas.89.19.9225; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; VanRaden PM, 2004, J DAIRY SCI, V87, P2285, DOI 10.3168/jds.S0022-0302(04)70049-1; Wetterstrand KA, 2012, DNA SEQUENCING COSTS; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707	37	75	77	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54872	10.1371/journal.pone.0054872	http://dx.doi.org/10.1371/journal.pone.0054872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349982	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100105
J	Vakorin, VA; Misic, B; Krakovska, O; Bezgin, G; McIntosh, AR				Vakorin, Vasily A.; Misic, Bratislav; Krakovska, Olga; Bezgin, Gleb; McIntosh, Anthony R.			Confounding Effects of Phase Delays on Causality Estimation	PLOS ONE			English	Article							STATISTICAL ASSESSMENT; GRANGER CAUSALITY; EEG; SYNCHRONIZATION; CONNECTIVITY	Linear and non-linear techniques for inferring causal relations between the brain signals representing the underlying neuronal systems have become a powerful tool to extract the connectivity patterns in the brain. Typically these tools employ the idea of Granger causality, which is ultimately based on the temporal precedence between the signals. At the same time, phase synchronization between coupled neural ensembles is considered a mechanism implemented in the brain to integrate relevant neuronal ensembles to perform a cognitive or perceptual task. Phase synchronization can be studied by analyzing the effects of phase-locking between the brain signals. However, we should expect that there is no one-to-one mapping between the observed phase lag and the time precedence as specified by physically interacting systems. Specifically, phase lag observed between two signals may interfere with inferring causal relations. This could be of critical importance for the coupled non-linear oscillating systems, with possible time delays in coupling, when classical linear cross-spectrum strategies for solving phase ambiguity are not efficient. To demonstrate this, we used a prototypical model of coupled non-linear systems, and compared three typical pipelines of inferring Granger causality, as established in the literature. Specifically, we compared the performance of the spectral and information-theoretic Granger pipelines as well as standard Granger causality in their relations to the observed phase differences for frequencies at which the signals become synchronized to each other. We found that an information-theoretic approach, which takes into account different time lags between the past of one signal and the future of another signal, was the most robust to phase effects.	[Vakorin, Vasily A.; Misic, Bratislav; Bezgin, Gleb; McIntosh, Anthony R.] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Misic, Bratislav; McIntosh, Anthony R.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Krakovska, Olga] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; York University - Canada	Vakorin, VA (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	vvakorin@research.baycrest.org	Vakorin, Vasily/AAY-3249-2021	Vakorin, Vasily/0000-0003-0489-1552; McIntosh, Anthony/0000-0002-1784-5662	J.S. McDonnell Foundation	J.S. McDonnell Foundation	This research was supported by research grants from the J.S. McDonnell Foundation to Dr. Anthony R. McIntosh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blinowska KJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050902; Brovelli A., 2004, PNAS, V101; Buzsaki G., 2006, RHYTHMS BRAIN; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Ghosh A, 2008, COGN NEURODYNAMICS, V2, P115, DOI 10.1007/s11571-008-9044-2; GOTMAN J, 1981, EPILEPSIA, V22, P453, DOI 10.1111/j.1528-1157.1981.tb06156.x; GOTMAN J, 1983, ELECTROEN CLIN NEURO, V56, P501, DOI 10.1016/0013-4694(83)90235-3; Gourevitch B, 2006, BIOL CYBERN, V95, P349, DOI 10.1007/s00422-006-0098-0; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hadjipapas A, 2009, NEUROIMAGE, V44, P1290, DOI 10.1016/j.neuroimage.2008.10.035; HAKEN H, 1996, PRINCIPLES BRAIN FUN, DOI [10.1007/978-3-642-79570-1_11, DOI 10.1007/978-3-642-79570-1_11]; Hinrichs H, 2006, NEUROIMAGE, V31, P1051, DOI 10.1016/j.neuroimage.2006.01.038; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Keil A, 2009, HUM BRAIN MAPP, V30, P532, DOI 10.1002/hbm.20521; Lachaux EP, 1991, HUMAN BRAIN MAPPING, V8, P194; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Nagasaka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022561; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Oppenheim A.V.B., 2001, DISCRETE TIME SIGNAL, VVolume 2; Palus M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046211; Palus M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056211; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; PRICHARD D, 1995, PHYSICA D, V84, P476, DOI 10.1016/0167-2789(95)00041-2; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Seth A., 2007, SCHOLARPEDIA, V2, P1667, DOI [DOI 10.4249/SCHOLARPEDIA.1667, 10.4249/ scholarpedia.1667]; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Small M, 2002, PHYSICA, V164; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Vakorin VA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00096; Vakorin VA, 2010, NEUROIMAGE, V49, P1593, DOI 10.1016/j.neuroimage.2009.08.027; Vakorin VA, 2009, J NEUROSCI METH, V184, P152, DOI 10.1016/j.jneumeth.2009.07.014; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Zeitler M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.065203	41	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53588	10.1371/journal.pone.0053588	http://dx.doi.org/10.1371/journal.pone.0053588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349720	Green Published, Green Submitted, gold			2022-12-27	WOS:000313943000013
J	Lee, JM; Lee, J; Kim, T; Lee, SK				Lee, Jae Myung; Lee, Junhyeong; Kim, Taesung; Lee, Sung Kuk			Switchable Gene Expression in Escherichia coli Using a Miniaturized Photobioreactor	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; HETEROLOGOUS PROTEINS; PHAGE-LAMBDA; BACTERIA; LIGHT; PROMOTER; SYSTEM; ACTIVATION; CELLS; K-12	We present a light-switchable gene expression system for both inducible and switchable control of gene expression at a single cell level in Escherichia coli using a previously constructed light-sensing system. The lambda cl repressor gene with an LVA degradation tag was expressed under the control of the ompC promoter on the chromosome. The green fluorescent protein (GFP) gene fused to a lambda repressor-repressible promoter was used as a reporter. This light-switchable system allows rapid and reversible induction or repression of expression of the target gene at any desired time. This system also ensures homogenous expression across the entire cell population. We also report the design of a miniaturized photobioreactor to be used in combination with the light-switchable gene expression system. The miniaturized photobioreactor helps to reduce unintended induction of the light receptor due to environmental disturbances and allows precise control over the duration of induction. This system would be a good tool for switchable, homogenous, strong, and highly regulatable expression of target genes over a wide range of induction times. Hence, it could be applied to study gene function, optimize metabolic pathways, and control biological systems both spatially and temporally.	[Lee, Jae Myung; Lee, Junhyeong; Kim, Taesung; Lee, Sung Kuk] Ulsan Natl Inst Sci & Technol UNIST, Sch Nanobiosci & Chem Engn, Ulsan, South Korea; [Kim, Taesung] UNIST, Sch Mech & Adv Mat Engn, Ulsan, South Korea; [Lee, Sung Kuk] UNIST, Sch Urban & Environm Engn, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST)	Kim, T (corresponding author), Ulsan Natl Inst Sci & Technol UNIST, Sch Nanobiosci & Chem Engn, Ulsan, South Korea.	tskim@unist.ac.kr; sklee@unist.ac.kr	Lee, Junhyeong/F-8245-2013; Lee, Sung K/HGC-6832-2022; Kim, Taesung/E-9308-2010; Lee, Sung K/E-6525-2010	Lee, Junhyeong/0000-0002-1826-1116; Kim, Taesung/0000-0001-9827-7531; 	National Research Foundation of Korea (NRF); Korean Government (MEST) [NRF-2009-C1AAA0012009-0093479, NRF-2010-0006436]; Next-Generation BioGreen 21 Program (SSAC) [PJ0099058]; Rural Development Administration, Republic of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Next-Generation BioGreen 21 Program (SSAC)(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean Government (MEST) (NRF-2009-C1AAA0012009-0093479, NRF-2010-0006436) and by the Next-Generation BioGreen 21 Program (SSAC, grant PJ0099058), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cho HS, 2012, BIOTECHNOL BIOENG, V109, P2612, DOI 10.1002/bit.24532; Chou CJ, 2010, CHEMBIOCHEM, V11, P972, DOI 10.1002/cbic.201000041; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Drepper T, 2011, APPL MICROBIOL BIOT, V90, P23, DOI 10.1007/s00253-011-3141-6; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; Joseph S, 2001, MOL CLONING LAB MANU; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Lee SK, 2005, APPL ENVIRON MICROB, V71, P6856, DOI 10.1128/AEM.71.11.6856-6862.2005; Lee SK, 2006, BIOTECHNOL BIOENG, V93, P912, DOI 10.1002/bit.20784; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Menart V, 2003, BIOTECHNOL BIOENG, V83, P181, DOI 10.1002/bit.10660; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Na D, 2010, BIOINFORMATICS, V26, P2633, DOI 10.1093/bioinformatics/btq458; Ohlendorf R, 2012, J MOL BIOL, V416, P534, DOI 10.1016/j.jmb.2012.01.001; Rinas U, 1996, BIOTECHNOL PROGR, V12, P196, DOI 10.1021/bp9600039; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Valdez-Cruz NA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-18; Young DD, 2007, ANGEW CHEM INT EDIT, V46, P4290, DOI 10.1002/anie.200700057; Zhou L, 2012, METAB ENG, V14, P560, DOI 10.1016/j.ymben.2012.05.004	28	50	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e52382	10.1371/journal.pone.0052382	http://dx.doi.org/10.1371/journal.pone.0052382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349683	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900005
J	Aroca-Aguilar, JD; Martinez-Redondo, F; Martin-Gil, A; Pintor, J; Coca-Prados, M; Escribano, J				Aroca-Aguilar, Jose-Daniel; Martinez-Redondo, Francisco; Martin-Gil, Alba; Pintor, Jesus; Coca-Prados, Miguel; Escribano, Julio			Bicarbonate-Dependent Secretion and Proteolytic Processing of Recombinant Myocilin	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; MUTATIONS; CLEAVAGE; GENE; IDENTIFICATION; TRAFFICKING; PROTEINS; PH	Myocilin is an extracellular glycoprotein of poorly understood function. Mutations of this protein are involved in glaucoma, an optic neuropathy characterized by a progressive and irreversible visual loss and frequently associated with elevated intraocular pressure. We previously showed that recombinant myocilin undergoes an intracellular proteolytic processing by calpain II which cleaves the central region of the protein, releasing one N- and one C-terminal fragment. Myocilin cleavage is reduced by glaucoma mutations and it has been proposed to participate in intraocular pressure modulation. To identify possible factors regulating the proteolytic processing of recombinant myocilin, we used a cellular model in which we analyzed how different culture medium parameters (i.e., culture time, cell density, pH, bicarbonate concentration, etc.) affect the presence of the extracellular C-terminal fragment. Extracellular bicarbonate depletion associated with culture medium acidification produced a reversible intracellular accumulation of full-length recombinant myocilin and incremented its intracellular proteolytic processing, raising the extracellular C-terminal fragment percentage. It was also determined that myocilin intracellular accumulation depends on its N- terminal region. These data suggest that aqueous humor bicarbonate variations could also modulate the secretion and cleavage of myocilin present in ocular tissues.	[Aroca-Aguilar, Jose-Daniel; Martinez-Redondo, Francisco; Escribano, Julio] Univ Castilla La Mancha, Fac Med, Inst Invest Discapacidades Neurol IDINE, Lab Genet Mol Humana, Albacete, Spain; [Martin-Gil, Alba; Pintor, Jesus] Univ Complutense Madrid, Dept Bioquim & Biol Mol 4, EU Opt, Madrid, Spain; [Coca-Prados, Miguel] Fdn Invest Oftalmol, Inst Oftalmol Fernandez Vega, Oviedo, Spain; [Coca-Prados, Miguel] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA	Universidad de Castilla-La Mancha; Complutense University of Madrid; Yale University	Escribano, J (corresponding author), Univ Castilla La Mancha, Fac Med, Inst Invest Discapacidades Neurol IDINE, Lab Genet Mol Humana, Albacete, Spain.	julio.escribano@uclm.es	Aroca-Aguilar, Jose Daniel/R-5513-2019; Aroca-Aguilar, J.Daniel/B-7842-2008; Escribano, Julio/D-9742-2015; Martin-Gil, Alba/C-8176-2019	Aroca-Aguilar, Jose Daniel/0000-0001-6487-1612; Aroca-Aguilar, J.Daniel/0000-0001-6487-1612; Escribano, Julio/0000-0002-8919-8134; Pintor, Jesus/0000-0002-9191-7679; Martin-Gil, Alba/0000-0001-8641-2169	Spanish Ministry of Science and Innovation; Regional Ministry of Health; Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha" [SAF2008-02228, GCS-2006_C/12, PAI-05-002, PCI08-0036, RD07/0062/0004, RD07/0062/0014]; Regional Ministry of Science and Technology of the Board of the Communities of "Instituto de Salud Carlos III" [SAF2008-02228, GCS-2006_C/12, PAI-05-002, PCI08-0036, RD07/0062/0004, RD07/0062/0014]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Ministry of Health; Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha"; Regional Ministry of Science and Technology of the Board of the Communities of "Instituto de Salud Carlos III"	This study was funded by research grants from the Spanish Ministry of Science and Innovation, the Regional Ministry of Health and the Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha", and "Instituto de Salud Carlos III" (SAF2008-02228; GCS-2006_C/12; PAI-05-002 and PCI08-0036; RD07/0062/0004 and RD07/0062/0014). MC-P is "Catedratico Rafael del Pino" in the "Fundacion de Investigacion Oftalmologica, Instituto Oftalmologico Fernandez-Vega", Oviedo, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Aroca-Aguilar JD, 2010, INVEST OPHTH VIS SCI, V51, P72, DOI 10.1167/iovs.09-4118; Aroca-Aguilar JD, 2008, MOL VIS, V14, P2097; Caballero M, 2000, BBA-MOL BASIS DIS, V1502, P447, DOI 10.1016/S0925-4439(00)00068-5; Campos-Mollo E, 2007, MOL VIS, V13, P1666; Dismuke WM, 2012, BIOCHEMISTRY-US, V51, P3606, DOI 10.1021/bi300073r; Fautsch MP, 2004, MOL VIS, V10, P417; Fautsch MP, 2001, INVEST OPHTH VIS SCI, V42, P2324; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Huang W, 2000, Ophthalmic Genet, V21, P155, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT155; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Kennedy KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu DW, 2001, J OCUL PHARMACOL TH, V17, P343, DOI 10.1089/108076801753162753; NEURATH H, 1991, ENZYME, V45, P239, DOI 10.1159/000468898; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Russell P, 2001, INVEST OPHTH VIS SCI, V42, P983; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Stamer WD, 2006, EXP EYE RES, V83, P1386, DOI 10.1016/j.exer.2006.07.018; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tsai PSJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032603; YAMAMOTO F, 1992, EXP EYE RES, V55, P279, DOI 10.1016/0014-4835(92)90192-U	26	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54385	10.1371/journal.pone.0054385	http://dx.doi.org/10.1371/journal.pone.0054385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342144	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700109
J	Herve, PY; Razafimandimby, A; Jobard, G; Tzourio-Mazoyer, N				Herve, Pierre-Yves; Razafimandimby, Annick; Jobard, Gael; Tzourio-Mazoyer, Nathalie			A Shared Neural Substrate for Mentalizing and the Affective Component of Sentence Comprehension	PLOS ONE			English	Article							TEMPORO-PARIETAL JUNCTION; THEORY-OF-MIND; PARKINSONS-DISEASE; FUNCTIONAL CONNECTIVITY; SOCIAL COGNITION; PREFRONTAL CORTEX; FRONTAL-CORTEX; BRAIN; GENERATION; NETWORKS	Using event-related fMRI in a sample of 42 healthy participants, we compared the cerebral activity maps obtained when classifying spoken sentences based on the mental content of the main character (belief, deception or empathy) or on the emotional tonality of the sentence (happiness, anger or sadness). To control for the effects of different syntactic constructions (such as embedded clauses in belief sentences), we subtracted from each map the BOLD activations obtained during plausibility judgments on structurally matching sentences, devoid of emotions or ToM. The obtained theory of mind (ToM) and emotional speech comprehension networks overlapped in the bilateral temporo-parietal junction, posterior cingulate cortex, right anterior temporal lobe, dorsomedial prefrontal cortex and in the left inferior frontal sulcus. These regions form a ToM network, which contributes to the emotional component of spoken sentence comprehension. Compared with the ToM task, in which the sentences were enounced on a neutral tone, the emotional sentence classification task, in which the sentences were play-acted, was associated with a greater activity in the bilateral superior temporal sulcus, in line with the presence of emotional prosody. Besides, the ventromedial prefrontal cortex was more active during emotional than ToM sentence processing. This region may link mental state representations with verbal and prosodic emotional cues. Compared with emotional sentence classification, ToM was associated with greater activity in the caudate nucleus, paracingulate cortex, and superior frontal and parietal regions, in line with behavioral data showing that ToM sentence comprehension was a more demanding task.	[Herve, Pierre-Yves; Jobard, Gael; Tzourio-Mazoyer, Nathalie] Univ Bordeaux, UMR 5296, Grp Imagerie Neurofonct, Bordeaux, Aquitaine, France; [Herve, Pierre-Yves; Jobard, Gael; Tzourio-Mazoyer, Nathalie] CNRS, UMR 5296, Grp Imagerie Neurofonct, Bordeaux, Aquitaine, France; [Herve, Pierre-Yves; Jobard, Gael; Tzourio-Mazoyer, Nathalie] CEA, UMR 5296, Grp Imagerie Neurofonct, Bordeaux, Aquitaine, France; [Razafimandimby, Annick] Univ Caen Basse Normandie, CNRS, CEA, Unite Mixte Rech 6301, Caen, Basse Normandie, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie	Tzourio-Mazoyer, N (corresponding author), Univ Bordeaux, UMR 5296, Grp Imagerie Neurofonct, Bordeaux, Aquitaine, France.	nathalie.tzourio@u-bordeaux2.fr	Jobard, Gaël/M-2970-2019; Jobard, Gaël/C-3166-2014; Tzourio-Mazoyer, Nathalie/B-5598-2008	Jobard, Gaël/0000-0003-4536-0643; Jobard, Gaël/0000-0003-4536-0643; Tzourio-Mazoyer, Nathalie/0000-0002-6236-4390; Herve, Pierre-Yves/0000-0002-5525-1750	Grant Agence Nationale de la Recherche [ANR-05-NEURO-034-01]	Grant Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Grant Agence Nationale de la Recherche ANR-05-NEURO-034-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Apperly IA, 2005, TRENDS COGN SCI, V9, P572, DOI 10.1016/j.tics.2005.10.004; Beaucousin V, 2007, CEREB CORTEX, V17, P339, DOI 10.1093/cercor/bhj151; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bodden ME, 2010, PARKINSONISM RELAT D, V16, P466, DOI 10.1016/j.parkreldis.2010.04.014; BROTHERS L, 1992, J COGNITIVE NEUROSCI, V4, P107, DOI 10.1162/jocn.1992.4.2.107; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cabeza R, 2012, TRENDS COGN SCI, V16, P338, DOI 10.1016/j.tics.2012.04.008; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Ferstl EC, 2002, NEUROIMAGE, V17, P1599, DOI 10.1006/nimg.2002.1247; Fossati P, 2012, EUR NEUROPSYCHOPHARM, V22, pS487, DOI 10.1016/j.euroneuro.2012.07.008; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Goel V, 1997, NEUROREPORT, V8, P1305, DOI 10.1097/00001756-199703240-00049; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Herve PY, 2012, NEUROIMAGE, V61, P1255, DOI 10.1016/j.neuroimage.2012.03.073; January D, 2009, J COGNITIVE NEUROSCI, V21, P2434, DOI 10.1162/jocn.2008.21179; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Peron J, 2009, NEUROPSYCHOLOGIA, V47, P406, DOI 10.1016/j.neuropsychologia.2008.09.008; Poletti M, 2011, BEHAV BRAIN RES, V219, P342, DOI 10.1016/j.bbr.2011.01.010; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robinson JL, 2012, NEUROIMAGE, V60, P117, DOI 10.1016/j.neuroimage.2011.12.010; Roca M, 2010, COGN BEHAV NEUROL, V23, P152, DOI 10.1097/WNN.0b013e3181e078de; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Rueschemeyer SA, 2006, NEUROIMAGE, V31, P354, DOI 10.1016/j.neuroimage.2005.11.047; Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.bandc.2003.04.002; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2006, BRAIN RES, V1079, P57, DOI 10.1016/j.brainres.2006.01.001; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Simmons WK, 2010, CEREB CORTEX, V20, P813, DOI 10.1093/cercor/bhp149; Spotorno N, 2012, NEUROIMAGE, V63, P25, DOI 10.1016/j.neuroimage.2012.06.046; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Uchiyama HT, 2012, CORTEX, V48, P563, DOI 10.1016/j.cortex.2011.01.004; van Ackeren MJ, 2012, J COGNITIVE NEUROSCI, V24, P2237, DOI 10.1162/jocn_a_00274; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wende KC, 2012, NEUROIMAGE, V62, P1399, DOI 10.1016/j.neuroimage.2012.06.003; Willems RM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00203; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yu RL, 2012, PARKINSONISM RELAT D, V18, P21, DOI 10.1016/j.parkreldis.2011.08.003; Zaitchik D, 2010, NEUROPSYCHOLOGIA, V48, P2528, DOI 10.1016/j.neuropsychologia.2010.04.031; Zhang S, 2012, CEREB CORTEX, V22, P99, DOI 10.1093/cercor/bhr088	48	13	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54400	10.1371/journal.pone.0054400	http://dx.doi.org/10.1371/journal.pone.0054400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342148	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700113
J	Pongratz, G; Hochrinner, H; Straub, RH; Lang, S; Brunnler, T				Pongratz, Georg; Hochrinner, Hannah; Straub, Rainer H.; Lang, Stefanie; Bruennler, Tanja			B Cell Activating Factor of the Tumor Necrosis Factor Family (BAFF) Behaves as an Acute Phase Reactant in Acute Pancreatitis	PLOS ONE			English	Article							SEVERITY; PROCALCITONIN; PREDICTION; MANAGEMENT	Objective: To determine if B cell activating factor of the tumor necrosis factor family (BAFF) acts as an acute phase reactant and predicts severity of acute pancreatitis. Methods: 40 patients with acute pancreatitis were included in this single center cohort pilot study. Whole blood and serum was analyzed on day of admission and nine consecutive days for BAFF, c-reactive protein (CRP), interleukin-6 (IL-6), procalcitonin (PCT), and leucocyte numbers. Different severity Scores (Ranson, APACHE II, SAPS II, SAPS III) and the clinical course of the patient (treatment, duration of stay, duration ICU) were recorded. Results: Serum BAFF correlates with CRP, an established marker of severity in acute pancreatitis at day of admission with a timecourse profil similar to IL-6 over the first nine days. Serum BAFF increases with Ranson score (Kruskal-Wallis: Chi2 = 10.8; p = 0.03) similar to CRP (Kruskal-Wallis: Chi2 = 9.4; p = 0.05). Serum BAFF, IL-6, and CRP levels are elevated in patients that need intensive care for more than seven days and in patients with complicated necrotizing pancreatitis. Discriminant analysis and receiver operator characteristics show that CRP (wilks-lambda = 0.549; ROC: AUC 0.948) and BAFF (wilks-lambda = 0.907; ROC: AUC 0.843) serum levels at day of admission best predict severe necrotizing pancreatitis or death, outperforming IL-6, PCT, and number of leucocytes. Conclusion: This study establishes for the first time BAFF as an acute phase reactant with predictive value for the course of acute pancreatitis. BAFF outperforms established markers in acute pancreatitis, like IL-6 and PCT underscoring the important role of BAFF in the acute inflammatory response.	[Pongratz, Georg; Hochrinner, Hannah; Straub, Rainer H.; Lang, Stefanie; Bruennler, Tanja] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany; [Bruennler, Tanja] Hosp Order St John God Regensburg, Emergency Ctr, Regensburg, Germany	University of Regensburg	Pongratz, G (corresponding author), Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany.	georg.pongratz@ukr.de	Pongratz, Georg/F-5472-2016	Pongratz, Georg/0000-0002-2185-8458; Straub, Rainer H/0000-0003-1165-4555	University Hospital Regensburg; Deutsche Forschungsgemeinschaft [PO 801/4-1]	University Hospital Regensburg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	In part internal institutional funding, University Hospital Regensburg. In part Deutsche Forschungsgemeinschaft (PO 801/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAlero I, 2010, DISCOV MED, V10, P416; Davidson A, 2010, CURR OPIN IMMUNOL, V22, P732, DOI 10.1016/j.coi.2010.09.010; Dervenis C, 1999, INT J PANCREATOL, V25, P195; Fabris M, 2007, SCAND J GASTROENTERO, V42, P1434, DOI 10.1080/00365520701452225; Kylanpaa-Back ML, 2001, CRIT CARE MED, V29, P63, DOI 10.1097/00003246-200101000-00016; Kylanpaa-Back ML, 2001, BRIT J SURG, V88, P222, DOI 10.1046/j.1365-2168.2001.01673.x; Lam QLK, 2008, P NATL ACAD SCI USA, V105, P14993, DOI 10.1073/pnas.0806044105; Lied GA, 2011, SCAND J IMMUNOL, V73, P1, DOI 10.1111/j.1365-3083.2010.02470.x; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mayer JM, 2002, BRIT J SURG, V89, P163, DOI 10.1046/j.1365-2168.2002.01972.x; Muller CA, 2000, GUT, V46, P233, DOI 10.1136/gut.46.2.233; Nagatani K, 2007, ARTHRITIS RHEUM-US, V56, P3554, DOI 10.1002/art.22929; Pongratz G, 2010, CLIN EXP RHEUMATOL, V28, P813; RANSON JHC, 1977, J SURG RES, V22, P79, DOI 10.1016/0022-4804(77)90045-2; RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69; Werner J, 2003, PANCREATOLOGY, V3, P115, DOI 10.1159/000070079; WILSON C, 1990, BRIT J SURG, V77, P1260, DOI 10.1002/bjs.1800771120; Yamanishi H, 2011, PANCREAS, V40, P840, DOI 10.1097/MPA.0b013e3182143b10	18	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54297	10.1371/journal.pone.0054297	http://dx.doi.org/10.1371/journal.pone.0054297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342125	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400144
J	Sun, T; Tian, H; Wang, CQ; Yin, P; Zhu, YQ; Chen, XH; Tang, ZD				Sun, Ting; Tian, Hua; Wang, Changqian; Yin, Ping; Zhu, Yaqin; Chen, Xianghua; Tang, Zhengde			A Survey of Congenital Heart Disease and Other Organic Malformations Associated with Different Types of Orofacial Clefts in Eastern China	PLOS ONE			English	Article							BIRTH-DEFECTS; ORAL CLEFTS; PALATE; LIP; ANOMALIES	Background: A high incidence of orofacial clefts is reported in China, but no data has shown the relation between cleft types and the incidence of other defects so far. The aim of this study is to assess the incidence of congenital heart diseases and other organic defects associated with different types of orofacial clefts. Methodology and Principal Findings: All children with orofacial clefts, which were sought out from the Health Information System of Shanghai Ninth People's Hospital between 1st Jan 2009 and 30th Dec 2011, were enrolled in this study. All subjects underwent a thorough examination and grouped by the cleft phenotype. The numbers and types of other organic defects were recorded and analyzed statistically using SPSS 17.0. Of 2180 cases reported as having orofacial clefts, 657 (30.1%) had other congenital abnormalities, which were significantly more common in cleft palate (47.9% (329/687)) than that in cleft lip (10.6% (80/755)) or cleft lip and palate (33.6% (248/738)) (P<0.01). In subgroups, unilateral cleft lip and palate had a statistically higher incidence of associated abnormalities than bilateral cleft lip and palate (P<0.01). The most common malformation was congenital heart disease, which counted 45.1% (296/657) of all malformations. Disorders of the central nervous system (14.3%(94/657)) and Skeletal anomalies (13.1%(86/657)) were also frequently associated. Additionally, the most common defect in heart was atrial septal defect, which was 39.7% (118/296) of all congenital heart diseases. Conclusions and Significance: As the high incidence of heart defects and other organic abnormalities in the children with cleft palate in Eastern China, special attention should be paid to them and echocardiography should be a proposed examination in the evaluation of children with cleft palate before any surgical correction being executed.	[Sun, Ting; Wang, Changqian; Yin, Ping; Zhu, Yaqin; Chen, Xianghua; Tang, Zhengde] Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Tian, Hua] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, T (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	beibeisun2008@163.com; changqianwang@hotmail.com			Specialized Research Fund for the Doctoral Program of Higher Education of China [20110073120105]; Research Project of Shanghai Municipal Health Bureau [2011169]	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research Project of Shanghai Municipal Health Bureau	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education of China (20110073120105) Research Project of Shanghai Municipal Health Bureau (2011169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunhan H, 2012, BRIT J ORAL MAX SURG, V50, P541, DOI 10.1016/j.bjoms.2011.08.001; Aqrabawi H E, 2008, East Mediterr Health J, V14, P356; Barbosa MM, 2003, PEDIATR CARDIOL, V24, P369, DOI 10.1007/s00246-002-0335-9; Beriaghi S, 2009, J CLIN PEDIATR DENT, V33, P207, DOI 10.17796/jcpd.33.3.c244761467507721; Dai L, 2010, BIRTH DEFECTS RES A, V88, P41, DOI 10.1002/bdra.20607; Genisca AE, 2009, AM J MED GENET A, V149A, P1149, DOI 10.1002/ajmg.a.32854; Han J, 2006, TOXICOL LETT, V166, P248, DOI 10.1016/j.toxlet.2006.07.308; Liang Chi-Di, 1999, Acta Paediatrica Taiwanica, V40, P414; Luijsterburg AJM, 2011, CLEFT PALATE-CRAN J, V48, P173, DOI 10.1597/08-150; Rittler M, 2008, CLEFT PALATE-CRAN J, V45, P525, DOI 10.1597/06-250.1; Sarkozi Andrea, 2005, BMC Oral Health, V5, P4, DOI 10.1186/1472-6831-5-4; Shafi T, 2003, BRIT J PLAST SURG, V56, P106, DOI 10.1016/S0007-1226(03)00044-4; SHPRINTZEN RJ, 1985, AM J MED GENET, V20, P585, DOI 10.1002/ajmg.1320200404; Slator Rona, 2009, J Fam Health Care, V19, P101; Vallino-Napoli LD, 2006, CLEFT PALATE-CRAN J, V43, P571, DOI 10.1597/05-123; Yang XY, 2009, CHINESE MED J-PEKING, V122, P1128, DOI 10.3760/cma.j.issn.0366-6999.2009.10.002; Yi N. N., 1999, Annals Academy of Medicine Singapore, V28, P655	17	42	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54726	10.1371/journal.pone.0054726	http://dx.doi.org/10.1371/journal.pone.0054726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349958	Green Submitted, gold, Green Published			2022-12-27	WOS:000313943000048
J	Cheng, LM; Sage, EH; Yan, Q				Cheng, Lamei; Sage, E. Helene; Yan, Qi			SPARC Fusion Protein Induces Cellular Adhesive Signaling	PLOS ONE			English	Article							GROWTH-FACTOR; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; FOCAL ADHESIONS; MELANOMA-CELLS; DNA-SYNTHESIS; LENS CAPSULE; IN-VITRO; BINDING; ATTACHMENT	Secreted protein, acidic and rich in cysteine (SPARC) has been described as a counteradhesive matricellular protein with a diversity of biological functions associated with morphogenesis, remodeling, cellular migration, and proliferation. We have produced mouse SPARC with a FLAG-tag at the N-terminus of SPARC (Flag-SPARC, FSP) in a Bac-to-Bac baculoviral expression system. After affinity purification, this procedure yields SPARC of high purity, with an electrophoretic mobility of similar to 44 kDa under reducing conditions, and similar to 38-39 kDa under non-reducing conditions. Unexpectedly, FSP adsorbed to plastic supported cell attachment and spreading, in a calcium-dependent manner. The adhesive activity of native FSP was inhibited by prior incubation with anti-SPARC IgG. Cell adhesion to FSP induced the formation of filopodia and lamellipodia but not focal adhesions that were prominent on cells that were attached to fibronectin. In addition, FSP induced the tyrosine phosphorylation of FAK and paxillin in attached epithelial cells. Erk1/2 and Rac were also activated in cells attached to FSP, but at a lower level in comparison to cells on fibronectin. This study provides new insight into the biological functions of SPARC, a matricellular protein with important roles in cell-extracellualr matrix interactions.	[Cheng, Lamei; Sage, E. Helene; Yan, Qi] Benaroya Res Inst, Seattle, WA USA; [Sage, E. Helene; Yan, Qi] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA; [Cheng, Lamei] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China	Benaroya Research Institute; University of Washington; University of Washington Seattle; Central South University	Yan, Q (corresponding author), Benaroya Res Inst, Seattle, WA USA.	qyanresearch@gmail.com	; Brestic, Marian/A-8263-2012	Brestic, Marian/0000-0002-6597-7838; Brestic, Marian/0000-0003-3470-6100	National Institutes of Health [EY014150, GM40711]; NATIONAL EYE INSTITUTE [R01EY014150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant EY014150 and GM40711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassuk JA, 1996, INT J BIOCHEM CELL B, V28, P1031, DOI 10.1016/1357-2725(96)00036-2; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw Amy D., 2000, Molecular Cell Biology Research Communications, V3, P345, DOI 10.1006/mcbr.2000.0237; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; FUNK SE, 1993, J CELL PHYSIOL, V154, P53, DOI 10.1002/jcp.1041540108; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Girard JP, 1996, J BIOL CHEM, V271, P4511; Haber CL, 2008, INT J CANCER, V122, P1465, DOI 10.1002/ijc.23216; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; HARLAN JM, 1983, LAB INVEST, V48, P269; Huynh MH, 2011, DEV GENES EVOL, V220, P315, DOI 10.1007/s00427-010-0349-x; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; McClung HM, 2012, CARCINOGENESIS, V33, P275, DOI 10.1093/carcin/bgr276; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Nagaraju GPC, 2011, CANCER TREAT REV, V37, P559, DOI 10.1016/j.ctrv.2010.12.001; NISCHT R, 1991, EUR J BIOCHEM, V200, P529, DOI 10.1111/j.1432-1033.1991.tb16214.x; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Rempel SA, 2001, J NEURO-ONCOL, V53, P149, DOI 10.1023/A:1012201300188; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Schaller MD, 1996, J ENDOCRINOL, V150, P1, DOI 10.1677/joe.0.1500001; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SRIRAMARAO P, 1993, J CELL SCI, V105, P1001; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; TUSZYNSKI GP, 1987, SCIENCE, V236, P1570, DOI 10.1126/science.2438772; VARANI J, 1986, EXP CELL RES, V167, P376, DOI 10.1016/0014-4827(86)90178-3; Yan Q, 2005, INVEST OPHTH VIS SCI, V46, P4652, DOI 10.1167/iovs.05-0460; Yan Q, 2005, GRAEF ARCH CLIN EXP, V243, P1253, DOI 10.1007/s00417-005-1181-2; Yan Q, 2002, J CELL SCI, V115, P2747	35	68	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53202	10.1371/journal.pone.0053202	http://dx.doi.org/10.1371/journal.pone.0053202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349702	gold, Green Published, Green Submitted			2022-12-27	WOS:000313943000011
J	Zhang, Q; Zhu, YX; Zhou, WB; Gao, L; Yuan, L; Han, X				Zhang, Qiang; Zhu, Yunxia; Zhou, Wenbo; Gao, Lu; Yuan, Li; Han, Xiao			Serotonin Receptor 2C and Insulin Secretion	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BETA-CELLS; PANCREATIC-ISLETS; 5-HT RECEPTORS; IN-VIVO; MICE; ACID; BIOSYNTHESIS; EXPRESSION; DOPAMINE	Type 2 diabetes mellitus (T2DM) describes a group of metabolic disorders characterized by defects in insulin secretion and insulin sensitivity. Insulin secretion from pancreatic beta-cells is an important factor in the etiology of T2DM, though the complex regulation and mechanisms of insulin secretion from beta-cells remains to be fully elucidated. High plasma levels of serotonin (5-hydroxytryptamine; 5-HT) have been reported in T2DM patients, though the potential effect on insulin secretion is unclear. However, it is known that the 5-HT receptor 2C (5-HT2CR) agonist, mCPP, decreases plasma insulin concentration in mice. As such, we aimed to investigate the expression of the 5-HT2CR in pancreatic islets of diabetic mice and the role of 5-HT2CR signaling in insulin secretion from pancreatic beta-cells. We found that 5-HT2CR expression was significantly increased in pancreatic islets of db/db mice. Furthermore, treatment with a 5-HT2CR antagonist (SB242084) increased insulin secretion from pancreatic islets isolated from db/db mice in a dose-dependent manner, but had no effect in islets from control mice. The effect of a 5-HT2CR agonist (mCPP) and antagonist (SB242084) were further studied in isolated pancreatic islets from mice and Min-6 cells. We found that mCPP significantly inhibited insulin secretion in Min-6 cells and isolated islets in a dose-dependent manner, which could be reversed by SB242084 or RNA interference against 5-HT2CR. We also treated Min-6 cells with palmitic acid for 24 h, and found that the expression of 5-HT2CR increased in a dose-dependent manner; furthermore, the inhibition of insulin secretion in Min-6 cells induced by palmitic acid could be reversed by SB242084 or RNA interference against 5-HT2CR. Taken together, our data suggests that increased expression of 5-HT2CR in pancreatic beta-cells might inhibit insulin secretion. This unique observation increases our understanding of T2DM and suggests new avenues for potential treatment.	[Zhang, Qiang; Zhu, Yunxia; Zhou, Wenbo; Gao, Lu; Yuan, Li; Han, Xiao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Qiang; Zhu, Yunxia; Zhou, Wenbo; Gao, Lu; Yuan, Li; Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yuan, L (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	Yuanli621@sohu.com; hanxiao@njmu.edu.cn	Zhu, Yunxia/G-6273-2014		National Basic Research Program of China (973 Program) [2011CB504003, 2012CB524901]; National Natural Science Foundation of China [30971403]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Basic Research Program of China (973 Program, 2011CB504003 and 2012CB524901, to XH, http://www.973.gov.cn), and the National Natural Science Foundation of China (30971403, http://www.nsfc.gov.cn) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Andreazzi AE, 2011, EXP DIABETES RES, DOI 10.1155/2011/947917; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Baruah MP, 2012, RECENT PATENTS ENDOC, V6, P129, DOI 10.2174/187221412800604563; de Souza SL, 2008, EUR J NEUROSCI, V27, P1400, DOI 10.1111/j.1460-9568.2008.06105.x; Deeney JT, 2007, FEBS LETT, V581, P4080, DOI 10.1016/j.febslet.2007.07.052; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Di Giovanni G, 2000, SYNAPSE, V35, P53, DOI 10.1002/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2; Du J, 2010, PHARMAZIE, V65, P231, DOI 10.1691/ph.2010.9607; Erdmann J, 2012, HORM METAB RES, V44, P60, DOI 10.1055/s-0031-1295414; Farag YMK, 2011, NEPHROL DIAL TRANSPL, V26, P28, DOI 10.1093/ndt/gfq576; GRAHAMES.DG, 1967, BIOCHEM J, V105, P351, DOI 10.1042/bj1050351; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Hara K, 2011, DIABETES RES CLIN PR, V94, P167, DOI 10.1016/j.diabres.2011.06.020; Harvey JA, 2004, PSYCHOPHARMACOLOGY, V172, P435, DOI 10.1007/s00213-003-1687-4; HASHIMOTO Y, 1985, BIOCHIM BIOPHYS ACTA, V841, P283, DOI 10.1016/0304-4165(85)90070-4; Hattersley AT, 2004, J CLIN INVEST, V114, P314, DOI 10.1172/jcj200422506; Hay-Schmidt A, 2000, P ROY SOC B-BIOL SCI, V267, P1071, DOI 10.1098/rspb.2000.1111; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Holness MJ, 2011, CURR DIABETES REV, V7, P336, DOI 10.2174/157339911797415602; Huang XF, 2004, MOL BRAIN RES, V127, P39, DOI 10.1016/j.molbrainres.2004.05.008; Iwasawa Takamasa, 2002, J Cardiol, V40, P19; Jiang ZE, 2011, KOREAN J PHYSIOL PHA, V15, P307, DOI 10.4196/kjpp.2011.15.5.307; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kolar J, 2005, J PINEAL RES, V39, P333, DOI 10.1111/j.1600-079X.2005.00276.x; Kong Kok Choi, 2011, Commun Integr Biol, V4, P489, DOI 10.4161/cib.4.4.15716; LECHIN F, 1975, ACTA PHYSIOL LAT AM, V25, P339; Marchetti P, 2010, ADV EXP MED BIOL, V654, P501, DOI 10.1007/978-90-481-3271-3_22; Monti JM, 2011, SLEEP MED REV, V15, P269, DOI 10.1016/j.smrv.2010.11.003; Moore MC, 2004, DIABETES, V53, P14, DOI 10.2337/diabetes.53.1.14; Nekrep N, 2008, DEVELOPMENT, V135, P2151, DOI 10.1242/dev.015859; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Nonogaki K, 2006, ENDOCRINOLOGY, V147, P5893, DOI 10.1210/en.2006-0418; Pozzi L, 2002, J NEUROCHEM, V82, P93, DOI 10.1046/j.1471-4159.2002.00947.x; PRISCO S, 1994, J PHARMACOL EXP THER, V271, P83; QUICKEL KE, 1971, ENDOCRINOLOGY, V89, P1295, DOI 10.1210/endo-89-5-1295; RAJAN AS, 1990, DIABETES CARE, V13, P340, DOI 10.2337/diacare.13.3.340; Rodriguez-Diaz R, 2011, CELL METAB, V14, P45, DOI 10.1016/j.cmet.2011.05.008; Roep BO, 2007, NATURE, V450, P799, DOI 10.1038/450799a; Saini V, 2010, WORLD J DIABETES, V1, P68, DOI 10.4239/wjd.v1.i3.68; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Watanabe H, 2010, ENDOCRINOLOGY, V151, P4776, DOI 10.1210/en.2009-1349; Watanabe RLH, 2010, CELL MOL NEUROBIOL, V30, P1025, DOI 10.1007/s10571-010-9533-9; Weiger WA, 1997, BIOL REV, V72, P61, DOI 10.1017/S0006323196004975; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; ZHANG HJ, 1989, DIABETES, V38, P44, DOI 10.2337/diabetes.38.1.44; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	52	147	153	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54250	10.1371/journal.pone.0054250	http://dx.doi.org/10.1371/journal.pone.0054250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349838	Green Published, Green Submitted, gold			2022-12-27	WOS:000313738900058
J	Shen, ZY; Chen, L; Xu, L				Shen, Zhenyao; Chen, Lei; Xu, Liang			A Topography Analysis Incorporated Optimization Method for the Selection and Placement of Best Management Practices	PLOS ONE			English	Article							NONPOINT-SOURCE POLLUTION; PARAMETER UNCERTAINTY ANALYSIS; GORGES RESERVOIR REGION; WATER ASSESSMENT-TOOL; SWAT MODEL; DIFFUSE POLLUTION; QUALITY; STORMWATER; AREA; SOIL	Best Management Practices (BMPs) are one of the most effective methods to control nonpoint source (NPS) pollution at a watershed scale. In this paper, the use of a topography analysis incorporated optimization method (TAIOM) was proposed, which integrates topography analysis with cost-effective optimization. The surface status, slope and the type of land use were evaluated as inputs for the optimization engine. A genetic algorithm program was coded to obtain the final optimization. The TAIOM was validated in conjunction with the Soil and Water Assessment Tool (SWAT) in the Yulin watershed in Southwestern China. The results showed that the TAIOM was more cost-effective than traditional optimization methods. The distribution of selected BMPs throughout landscapes comprising relatively flat plains and gentle slopes, suggests the need for a more operationally effective scheme, such as the TAIOM, to determine the practicability of BMPs before widespread adoption. The TAIOM developed in this study can easily be extended to other watersheds to help decision makers control NPS pollution.	[Shen, Zhenyao; Chen, Lei; Xu, Liang] Beijing Normal Univ, State Key Lab Water Environm Simulat, Sch Environm, Beijing 100875, Peoples R China	Beijing Normal University	Shen, ZY (corresponding author), Beijing Normal Univ, State Key Lab Water Environm Simulat, Sch Environm, Beijing 100875, Peoples R China.	zyshen@bnu.edu.cn	Xu, Lu/X-4357-2019; Chen, Lei/AAD-3766-2019	Chen, Lei/0000-0001-8415-3896; Shen, Zhenyao/0000-0002-6620-1943	National Science Foundation for Distinguished Young Scholars [51025933]; National Science Foundation for Innovative Research Group [51121003]; National Basic Research Program of China (973 Project) [2010CB429003]	National Science Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science Foundation for Innovative Research Group; National Basic Research Program of China (973 Project)(National Basic Research Program of China)	This study was supported through funding from the National Science Foundation for Distinguished Young Scholars (No. 51025933), the National Science Foundation for Innovative Research Group (No. 51121003) and the National Basic Research Program of China (973 Project, 2010CB429003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour KC, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007615; Arabi M, 2006, WATER RESOUR RES, V42, DOI 10.1029/2006WR004931; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Barragan F, 2011, PLOS ONE, V6; Bekele EG, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR004090; Brezonik PL, 1999, WATER SCI TECHNOL, V39, P323, DOI 10.1016/S0273-1223(99)00350-9; Cha SM, 2012, DESALIN WATER TREAT, V38, P389, DOI 10.5004/dwt.2012.3594; Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016909; Cisneros JM, 2011, AGR WATER MANAGE, V98, P1545, DOI 10.1016/j.agwat.2011.05.009; Cools J, 2011, ENVIRON MODELL SOFTW, V26, P44, DOI 10.1016/j.envsoft.2010.04.017; Douglas-Mankin KR, 2010, T ASABE, V53, P1423; Eckley CS, 2011, SCI TOTAL ENVIRON, V409, P514, DOI 10.1016/j.scitotenv.2010.10.024; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Giri S, 2012, J ENVIRON MANAGE, V103, P24, DOI 10.1016/j.jenvman.2012.02.033; Gitau MW, 2008, T ASABE, V51, P1925, DOI 10.13031/2013.25398; Gitau MW, 2004, T ASAE, V47, P1923, DOI 10.13031/2013.17805; Holland J.H., 1975, ADAPTATION NATURAL A; Hsieh C-D, 2007, J ENVIRON MANAGE, V85, P10; Islam N, 2011, ENVIRON REV, V19, P68, DOI [10.1139/A11-001, 10.1139/a11-001]; Jenkins JG, 2012, J SOIL WATER CONSERV, V67, P134, DOI [10.2489/jswc.67.2.134, 10.2489/jSWC.67.2.134]; Kaini P, 2012, WATER RESOUR MANAG, V26, P1827, DOI 10.1007/s11269-012-9989-0; Keatley BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015913; Kim HC, 2010, WATER SCI TECHNOL, V62, P1003, DOI 10.2166/wst.2010.333; Kollat JB, 2007, ENVIRON MODELL SOFTW, V22, P1691, DOI 10.1016/j.envsoft.2007.02.001; Lam QD, 2011, ENVIRON MONIT ASSESS, V183, P351, DOI 10.1007/s10661-011-1926-9; Lee JG, 2012, ENVIRON MODELL SOFTW, V37, P6, DOI 10.1016/j.envsoft.2012.04.011; Leh MD, 2008, HYDROL PROCESS, V22, P4190, DOI 10.1002/hyp.7021; Liu X., 2001, B SOIL WATER CONSERV, V21, P4, DOI DOI 10.3969/J.ISSN.1000-288X.2001.01.015; Maringanti C, 2011, ENVIRON MANAGE, V48, P448, DOI 10.1007/s00267-011-9696-2; Maringanti C, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007094; McCarron CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025635; Meals DW, 2010, J ENVIRON QUAL, V39, P85, DOI 10.2134/jeq2009.0108; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nelson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038558; Nikolaidis NP, 2009, ECOL MODEL, V220, P383, DOI 10.1016/j.ecolmodel.2008.10.003; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Panagopoulos Y, 2012, ENVIRON MODELL SOFTW, V30, P57, DOI 10.1016/j.envsoft.2011.11.006; Qi HH, 2008, J AM WATER RESOUR AS, V44, P866, DOI 10.1111/j.1752-1688.2008.00209.x; Qi HH, 2011, WATER RESOUR MANAG, V25, P565, DOI 10.1007/s11269-010-9714-9; Rabotyagov S, 2010, ECOL APPL, V20, P1542, DOI 10.1890/08-0680.1; RITZEL BJ, 1994, WATER RESOUR RES, V30, P1589, DOI 10.1029/93WR03511; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shen ZY, 2012, HYDROL EARTH SYST SC, V16, P121, DOI 10.5194/hess-16-121-2012; Shen ZY, 2010, SCI TOTAL ENVIRON, V408, P1971, DOI 10.1016/j.scitotenv.2009.12.007; Shen ZY, 2008, SCI TOTAL ENVIRON, V405, P195, DOI 10.1016/j.scitotenv.2008.06.009; Short JS, 2012, ENVIRON SCI TECHNOL, V46, P1316, DOI 10.1021/es2020499; Sivertun A, 2003, ENVIRON MODELL SOFTW, V18, P887, DOI 10.1016/S1364-8152(03)00107-5; Srinivasan MS, 2009, J HYDROL, V379, P54, DOI 10.1016/j.jhydrol.2009.09.044; Srivastava P, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000365; Srivastava P, 2007, T ASABE, V50, P1683, DOI 10.13031/2013.23961; Studds CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035969; Tomer MD, 2003, J SOIL WATER CONSERV, V58, P198; Turpin N, 2005, ENVIRON MODELL SOFTW, V20, P187, DOI 10.1016/j.envsoft.2003.09.004; Woznicki SA, 2011, T ASABE, V54, P171; Wu J, 2006, J AM WATER RESOUR AS, V42, P1193, DOI 10.1111/j.1752-1688.2006.tb05606.x; Xu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039762; Young KD, 2011, J WATER RES PL-ASCE, V137, P268, DOI 10.1061/(ASCE)WR.1943-5452.0000110; Zhang T, 2010, ENVIRON MODEL ASSESS, V15, P569, DOI 10.1007/s10666-010-9225-3; Zhang XD, 2009, AGR WATER MANAGE, V96, P1723, DOI 10.1016/j.agwat.2009.07.011; Zhen J, 2006, J ENVIRON SCI HEAL A, V41, P1391, DOI 10.1080/10934520600657172	61	64	75	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54520	10.1371/journal.pone.0054520	http://dx.doi.org/10.1371/journal.pone.0054520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	24324548	Green Published, gold, Green Submitted			2022-12-27	WOS:000313943000044
J	Schoning, JM; Cerny, N; Prohaska, S; Wittenbrink, MM; Smith, NH; Bloemberg, G; Pewsner, M; Schiller, I; Origgi, FC; Ryser-Degiorgis, MP				Schoening, Janne Marie; Cerny, Nadine; Prohaska, Sarah; Wittenbrink, Max M.; Smith, Noel H.; Bloemberg, Guido; Pewsner, Mirjam; Schiller, Irene; Origgi, Francesco C.; Ryser-Degiorgis, Marie-Pierre			Surveillance of Bovine Tuberculosis and Risk Estimation of a Future Reservoir Formation in Wildlife in Switzerland and Liechtenstein	PLOS ONE			English	Article							BADGER MELES-MELES; BOAR SUS-SCROFA; SUBMAXILLARY LYMPH-NODES; MOUNTAIN NATIONAL-PARK; WHITE-TAILED DEER; MYCOBACTERIUM-BOVIS; RED DEER; RHODOCOCCUS-EQUI; AFRICAN BUFFALO; CERVUS-ELAPHUS	Bovine tuberculosis (bTB) caused by Mycobacterium bovis or M. caprae has recently (re-) emerged in livestock and wildlife in all countries bordering Switzerland (CH) and the Principality of Liechtenstein (FL). Comprehensive data for Swiss and Liechtenstein wildlife are not available so far, although two native species, wild boar (Sus scrofa) and red deer (Cervus elaphus elaphus), act as bTB reservoirs elsewhere in continental Europe. Our aims were (1) to assess the occurrence of bTB in these wild ungulates in CH/FL and to reinforce scanning surveillance in all wild mammals; (2) to evaluate the risk of a future bTB reservoir formation in wild boar and red deer in CH/FL. Tissue samples collected from 2009 to 2011 from 434 hunted red deer and wild boar and from eight diseased ungulates with tuberculosis-like lesions were tested by direct real-time PCR and culture to detect mycobacteria of the Mycobacterium tuberculosis complex (MTBC). Identification of suspicious colonies was attempted by real-time PCR, genotyping and spoligotyping. Information on risk factors for bTB maintenance within wildlife populations was retrieved from the literature and the situation regarding identified factors was assessed for our study areas. Mycobacteria of the MTBC were detected in six out of 165 wild boar (3.6%; 95% CI: 1.4-7.8) but none of the 269 red deer (0%; 0-1.4). M. microti was identified in two MTBC-positive wild boar, while species identification remained unsuccessful in four cases. Main risk factors for bTB maintenance worldwide, including different causes of aggregation often resulting from intensive wildlife management, are largely absent in CH and FL. In conclusion, M. bovis and M. caprae were not detected but we report for the first time MTBC mycobacteria in Swiss wild boar. Present conditions seem unfavorable for a reservoir emergence, nevertheless increasing population numbers of wild ungulates and offal consumption may represent a risk.	[Schoening, Janne Marie; Pewsner, Mirjam; Origgi, Francesco C.; Ryser-Degiorgis, Marie-Pierre] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland; [Cerny, Nadine; Prohaska, Sarah; Wittenbrink, Max M.] Univ Zurich, Vetsuisse Fac, IVB, Zurich, Switzerland; [Smith, Noel H.] AHVLA, New Haw, Surrey, England; [Bloemberg, Guido] Univ Zurich, Fac Med, IMM, Zurich, Switzerland; [Schiller, Irene] Div Anim Hlth, Fed Vet Off, Bern, Switzerland	University of Bern; University of Zurich; University of Geneva; University of Zurich	Ryser-Degiorgis, MP (corresponding author), Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland.	marie-pierre.ryser@vetsuisse.unibe.ch	Bloemberg, Guido/AAC-4914-2020; Smith, Noel H/C-6708-2011; Ryser-Degiorgis, Marie-Pierre/AAN-5249-2020	Ryser-Degiorgis, Marie-Pierre/0000-0003-1062-870X; Baker, Joseph/0000-0002-5686-1737; Schorer, Jorg/0000-0002-4888-7048	Swiss Federal Veterinary Office (FVO) [1.10.07]; Universitiy of Bern; Universitiy of Zurich	Swiss Federal Veterinary Office (FVO); Universitiy of Bern; Universitiy of Zurich	The study was funded by the Swiss Federal Veterinary Office (FVO; www.bvet.admin.ch; contract nr. 1.10.07;), with a contribution of the Universities of Bern and Zurich (salary of mentors, infrastructure). It is always part of contracts with the FVO that study results should be published, as the FVO wants to encourage the large distribution of research results. However, the FVO has no influence on the studies' outcome or on the prepared manuscripts.	Acevedo P, 2007, EPIDEMIOL INFECT, V135, P519, DOI 10.1017/S0950268806007059; Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Amanfu W, 2006, TUBERCULOSIS, V86, P330, DOI 10.1016/j.tube.2006.01.007; Aranaz A, 2003, INT J SYST EVOL MICR, V53, P1785, DOI 10.1099/ijs.0.02532-0; Ashford RW, 2003, EMERG INFECT DIS, V9, P1495; Ashford RW, 1997, BELG J ZOOL, V127, P85; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Balseiro A, 2009, VET REC, V164, P468, DOI 10.1136/vr.164.15.468; Balseiro A, 2011, VET J, V90, pe21; Blanchong JA, 2007, BIOL LETT-UK, V3, P103, DOI 10.1098/rsbl.2006.0547; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; Bollo E, 2000, J VET MED B, V47, P337, DOI 10.1046/j.1439-0450.2000.00354.x; Bouakaze C, 2011, J CLIN MICROBIOL, V49, P3292, DOI 10.1128/JCM.00744-11; BOUVIER G., 1957, Schweizer Archiv fur Tierheilkunde, V99, P461; Bouvier G, 1963, B OFF INT EPIZOOT, V59, P433; Briones V, 2000, EMERG INFECT DIS, V6, P189, DOI 10.3201/eid0602.000214; Buijtels PCA, 2005, J MICROBIOL METH, V62, P83, DOI 10.1016/j.mimet.2005.01.010; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Carstensen Michelle, 2011, Veterinary Medicine International, P413240, DOI 10.4061/2011/413240; Casaubon J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-204; Cassidy JP, 2006, VET MICROBIOL, V112, P151, DOI 10.1016/j.vetmic.2005.11.031; Castillo L, 2011, PREV VET MED, V98, P58, DOI 10.1016/j.prevetmed.2010.11.008; Causse M, 2011, J CLIN MICROBIOL, V49, P3065, DOI 10.1128/JCM.00491-11; Cavanagh R, 2002, J CLIN MICROBIOL, V40, P3281, DOI 10.1128/JCM.40.9.3281-3285.2002; CHEESEMAN CL, 1981, J APPL ECOL, V18, P795, DOI 10.2307/2402370; CLIFTONHADLEY RS, 1995, EPIDEMIOL INFECT, V114, P179, DOI 10.1017/S0950268800052031; COLEMAN JD, 1994, NEW ZEAL VET J, V42, P128, DOI 10.1080/00480169.1994.35802; Contzen M, 2011, ZOONOSES PUBLIC HLTH, V58, P479, DOI 10.1111/j.1863-2378.2011.01396.x; Corner LAL, 2011, J COMP PATHOL, V144, P1, DOI 10.1016/j.jcpa.2010.10.003; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; Cvetnic Z, 2007, INT J TUBERC LUNG D, V11, P652; Cvetnic Z, 2007, ACTA VET HUNG, V55, P1, DOI 10.1556/AVet.55.2007.1.1; de Jong E, 2009, J CLIN MICROBIOL, V47, P3038, DOI 10.1128/JCM.00772-09; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; De Vos V, 2001, ONDERSTEPOORT J VET, V68, P119; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Dini V, 2004, J MT ECOL, V7, P145; Dondo A., 2007, Epidemiologie et Sante Animale, P35; Entstrasser-Muller C, 2011, TBC OBEREN LECHTAL G; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; European Food Safety Authority European Centre for Disease Prevention and Control, 2011, EFSA J, V9, DOI DOI 10.2903/J.EFSA.2011.2090.2090; Frank W, 2009, WIEN KLIN WOCHENSCHR, V121, P282, DOI 10.1007/s00508-009-1164-0; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Gavier-Widen D, 2009, NEW ZEAL VET J, V57, P122, DOI 10.1080/00480169.2009.36891; GEORGII B, 1983, OECOLOGIA, V58, P238, DOI 10.1007/BF00399224; Gerstmair E, 2011, THESIS LUDWIG MAXIMI; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Gortazar C, 2011, VET MICROBIOL, V151, P170, DOI 10.1016/j.vetmic.2011.02.041; GRIFFIN JFT, 1994, VET MICROBIOL, V40, P193, DOI 10.1016/0378-1135(94)90055-8; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Hickling G. J., 2002, 3363 MICH DEP NAT RE, P1; Johnston WT, 2005, BIOL LETT-UK, V1, P53, DOI 10.1098/rsbl.2004.0249; Joly DO, 2004, J ANIM ECOL, V73, P623, DOI 10.1111/j.0021-8790.2004.00836.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kim JH, 2011, J CLIN MICROBIOL, V49, P173, DOI 10.1128/JCM.00694-10; Komijn RE, 1999, J CLIN MICROBIOL, V37, P1254, DOI 10.1128/JCM.37.5.1254-1259.1999; Komijn RE, 2007, VET MICROBIOL, V120, P352, DOI 10.1016/j.vetmic.2006.10.031; Kremer K, 1998, J CLIN MICROBIOL, V36, P2793, DOI 10.1128/JCM.36.9.2793-2794.1998; Kuiken T, 2011, REV SCI TECH OIE, V30, P755; Lees VW, 2004, CAN VET J, V45, P28; Lees VW, 2003, CAN VET J, V44, P830; Leuenberger R, 2004, THESIS U BASEL SWITZ; LoBue PA, 2010, INT J TUBERC LUNG D, V14, P1075; Makrai L, 2005, J CLIN MICROBIOL, V43, P1246, DOI 10.1128/JCM.43.3.1246-1250.2005; Makrai L, 2008, VET MICROBIOL, V131, P318, DOI 10.1016/j.vetmic.2008.04.009; Marsan A., 1995, IBEX J MT ECOL, V3, P219; Martin-Atance P, 2005, J WILDLIFE DIS, V41, P435, DOI 10.7589/0090-3558-41.2.435; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Michel AL, 2006, VET MICROBIOL, V112, P91, DOI 10.1016/j.vetmic.2005.11.035; Michel AL, 2007, BMC VET RES, V3, P23, DOI DOI 10.1186/1746-6148-3-23; Miller R, 2003, J WILDLIFE DIS, V39, P84, DOI 10.7589/0090-3558-39.1.84; Morris RS, 1995, NEW ZEAL VET J, V43, P256, DOI 10.1080/00480169./1995.35904; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nishi JS, 2006, VET MICROBIOL, V112, P325, DOI 10.1016/j.vetmic.2005.11.013; NORTON JH, 1984, AUST VET J, V61, P75, DOI 10.1111/j.1751-0813.1984.tb15521.x; Nugent G, 2011, VET MICROBIOL, V151, P34, DOI 10.1016/j.vetmic.2011.02.023; O'Brien DJ, 2008, J WILDLIFE DIS, V44, P802, DOI 10.7589/0090-3558-44.4.802; O'Brien DJ, 2011, VET MICROBIOL, V151, P179, DOI 10.1016/j.vetmic.2011.02.042; O'Brien DJ, 2006, VET MICROBIOL, V112, P313, DOI 10.1016/j.vetmic.2005.11.014; Oevermann A, 2004, J CLIN MICROBIOL, V42, P1818, DOI 10.1128/JCM.42.4.1818-1821.2004; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Prodinger WM, 2002, J CLIN MICROBIOL, V40, P2270, DOI 10.1128/JCM.40.6.2270-2272.2002; Rodriguez E, 2009, INT J TUBERC LUNG D, V13, P1536; Rodwell TC, 2001, J WILDLIFE DIS, V37, P258, DOI 10.7589/0090-3558-37.2.258; Rogers LM, 1997, J ZOOL, V242, P705, DOI 10.1111/j.1469-7998.1997.tb05821.x; Rohonczy EB, 1996, CAN J VET RES, V60, P108; Santos N, 2009, J WILDLIFE DIS, V45, P1048, DOI 10.7589/0090-3558-45.4.1048; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Schmitt SM, 1997, J WILDLIFE DIS, V33, P749, DOI 10.7589/0090-3558-33.4.749; Shitaye JE, 2006, VET MED-CZECH, V51, P497, DOI 10.17221/5584-VETMED; Shury Todd K, 2011, Vet Med Int, V2011, P591980, DOI 10.4061/2011/591980; Sleeman DP, 2009, EUR J WILDLIFE RES, V55, P333, DOI 10.1007/s10344-008-0244-1; Smith NH, 2009, J CLIN MICROBIOL, V47, P2551, DOI 10.1128/JCM.00638-09; Smith NH, 2011, INFECT GENET EVOL; Sobrino R, 2008, VET REC, V163, P159, DOI 10.1136/vr.163.5.159; Taylor C, 2006, VET REC, V159, P59, DOI 10.1136/vr.159.2.59-a; Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567; van Soolingen D, 1998, J CLIN MICROBIOL, V36, P1840, DOI 10.1128/JCM.36.7.1840-1845.1998; Vicente J, 2007, J ANIM ECOL, V76, P348, DOI 10.1111/j.1365-2656.2006.01199.x; Vicente J, 2007, OECOLOGIA, V152, P655, DOI 10.1007/s00442-007-0690-6; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Vieira-Pinto M, 2011, EUR J WILDLIFE RES, V57, P1189, DOI 10.1007/s10344-011-0532-z; Witmer G, 2010, J WILDLIFE DIS, V46, P368, DOI 10.7589/0090-3558-46.2.368; Wobeser G, 2009, CAN VET J, V50, P1169; Wu N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-116; Wu N, 2011, J WILDLIFE DIS, V47, P868, DOI 10.7589/0090-3558-47.4.868; Wyss D, 2000, VET REC, V147, P713; Zanella G, 2008, VET REC, V163, P43, DOI 10.1136/vr.163.2.43; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99; Zanolari P, 2009, J VET INTERN MED, V23, P1266, DOI 10.1111/j.1939-1676.2009.0377.x	112	62	67	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e54253	10.1371/journal.pone.0054253	http://dx.doi.org/10.1371/journal.pone.0054253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23637745	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000313943000032
J	Xu, L; Wu, M; Han, ZJ				Xu, Lu; Wu, Min; Han, Zhaojun			Overexpression of Multiple Detoxification Genes in Deltamethrin Resistant Laodelphax striatellus (Hemiptera: Delphacidae) in China	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; SMALL BROWN PLANTHOPPER; TIME QUANTITATIVE PCR; IN-FIELD POPULATIONS; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; CYTOCHROME-P450 GENES; KNOCKDOWN RESISTANCE; BLATTELLA-GERMANICA; FIPRONIL RESISTANCE	Background: The small brown planthopper (SBPH), Laodelphax striatellus (Fallen), is one of the major rice pests in Asia and has developed resistance to multiple classes of insecticides. Understanding resistance mechanisms is essential to the management of this pest. Biochemical and molecular assays were performed in this study to systematically characterize deltamethrin resistance mechanisms with laboratory-selected resistant and susceptible strains of SBPH. Methodology/Principal Findings: Deltamethrin resistant strains of SBPH (JH-del) were derived from a field population by continuously selections (up to 30 generations) in the laboratory, while a susceptible strain (JHS) was obtained from the same population by removing insecticide pressure for 30 generations. The role of detoxification enzymes in the resistance was investigated using synergism and enzyme activity assays with strains of different resistant levels. Furthermore, 71 cytochrome P450, 93 esterases and 12 glutathione-S-transferases cDNAs were cloned based on transcriptome data of a field collected population. Semi-quantitative RT-PCR screening analysis of 176 identified detoxification genes demonstrated that multiple P450 and esterase genes were overexpressed (>2-fold) in JH-del strains (G4 and G30) when compared to that in JHS, and the results of quantitative PCR coincided with the semi-quantitative RT-PCR results. Target mutation at IIS3-IIS6 regions encoded by the voltage-gated sodium channel gene was ruled out for conferring the observed resistance. Conclusion/Significance: As the first attempt to discover genes potentially involved in SBPH pyrethroid resistance, this study putatively identified several candidate genes of detoxification enzymes that were significantly overexpressed in the resistant strain, which matched the synergism and enzyme activity testing. The biochemical and molecular evidences suggest that the high level pyrethroid resistance in L. striatellus could be due to enhanced detoxification rather than target insensitivity. The findings lay a solid ground for further resistance mechanism elucidation studies.	[Xu, Lu; Wu, Min; Han, Zhaojun] Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Han, ZJ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.	zjhan@njau.edu.cn	Xu, Lu/X-4357-2019; Chen, Lei/AAD-3766-2019	Chen, Lei/0000-0001-8415-3896; Shen, Zhenyao/0000-0002-6620-1943	Projects of Development Plan of the State Key Fundamental Research (973 Projects) [2010CB126204]; National Natural Science Foundation of China (NSFC) [31130045]	Projects of Development Plan of the State Key Fundamental Research (973 Projects)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the Projects of Development Plan of the State Key Fundamental Research (973 Projects, Grant No. 2010CB126204) and National Natural Science Foundation of China (NSFC, Grant No. 31130045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Brun-Barale A, 2010, PEST MANAG SCI, V66, P900, DOI 10.1002/ps.1960; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Enayati AA, 2010, PESTIC BIOCHEM PHYS, V97, P243, DOI 10.1016/j.pestbp.2010.03.003; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Gao BL, 2008, INT J PEST MANAGE, V54, P13, DOI 10.1080/09670870701553303; Gong MQ, 2005, ACTA BIOCH BIOPH SIN, V37, P317, DOI 10.1111/j.1745-7270.2005.00042.x; Haddi K, 2012, INSECT BIOCHEM MOLEC, V42, P506, DOI 10.1016/j.ibmb.2012.03.008; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hougard JM, 2002, J MED ENTOMOL, V39, P526, DOI 10.1603/0022-2585-39.3.526; Huang SJ, 2007, PESTIC BIOCHEM PHYS, V87, P14, DOI 10.1016/j.pestbp.2006.05.002; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Karunker I, 2009, INSECT BIOCHEM MOLEC, V39, P697, DOI 10.1016/j.ibmb.2009.08.006; Kasai S, 2000, INSECT BIOCHEM MOLEC, V30, P163, DOI 10.1016/S0965-1748(99)00114-9; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024323; KISIMOTO R, 1989, APPL ENTOMOL ZOOL, V24, P157, DOI 10.1303/aez.24.157; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Kranthi KR, 2001, J ECON ENTOMOL, V94, P253, DOI 10.1603/0022-0493-94.1.253; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu N., 2011, PLOS ONE, V6; Liu ZW, 2003, PEST MANAG SCI, V59, P1355, DOI 10.1002/ps.768; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller RJ, 1999, J MED ENTOMOL, V36, P533, DOI 10.1093/jmedent/36.5.533; Miyazaki M, 1996, MOL GEN GENET, V252, P61, DOI 10.1007/BF02173205; Moores GD, 1998, PESTIC BIOCHEM PHYS, V62, P164, DOI 10.1006/pest.1998.2373; Morin S, 2002, INSECT BIOCHEM MOLEC, V32, P1781, DOI 10.1016/S0965-1748(02)00137-6; Nakao T, 2011, J ECON ENTOMOL, V104, P646, DOI 10.1603/EC10391; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; OPPENOORTH FJ, 1979, PESTIC BIOCHEM PHYS, V11, P176, DOI 10.1016/0048-3575(79)90057-9; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Shen B, 2003, PESTIC BIOCHEM PHYS, V75, P19, DOI 10.1016/S0048-3575(03)00014-2; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Tan J, 2002, INSECT BIOCHEM MOLEC, V32, P445, DOI 10.1016/S0965-1748(01)00122-9; Tang J, 2010, PEST MANAG SCI, V66, P121, DOI 10.1002/ps.1836; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Wang Li-Hua, 2008, Acta Entomologica Sinica, V51, P930; Wang LH, 2010, PEST MANAG SCI, V66, P1096, DOI 10.1002/ps.1984; WHEELOCK GD, 1992, PESTIC BIOCHEM PHYS, V43, P67, DOI 10.1016/0048-3575(92)90020-Z; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Yang YH, 2008, PESTIC BIOCHEM PHYS, V92, P101, DOI 10.1016/j.pestbp.2008.07.001; Yang YH, 2006, J ECON ENTOMOL, V99, P1784, DOI 10.1603/0022-0493-99.5.1784; Zeng JW, 2012, SCI HORTIC-AMSTERDAM, V134, P32, DOI 10.1016/j.scienta.2011.10.018; Zhai, 2006, B ENTOMOL, P141; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang YL, 2012, PESTIC BIOCHEM PHYS, V104, P277, DOI 10.1016/j.pestbp.2012.10.002; Zhu F, 2008, INSECT MOL BIOL, V17, P27, DOI 10.1111/j.1365-2583.2008.00777.x; Zhu YC, 2003, INSECT MOL BIOL, V12, P39, DOI 10.1046/j.1365-2583.2003.00385.x; Zhu Yu Cheng, 2012, PLoS One, V7, pe37586, DOI 10.1371/journal.pone.0037586; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zimmer CT, 2011, PESTIC BIOCHEM PHYS, V100, P264, DOI 10.1016/j.pestbp.2011.04.011	65	64	75	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79443	10.1371/journal.pone.0079443	http://dx.doi.org/10.1371/journal.pone.0079443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24324548	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400115
J	Bauer, M; Metzler, R				Bauer, Maximilian; Metzler, Ralf			In Vivo Facilitated Diffusion Model	PLOS ONE			English	Article							REPRESSOR-OPERATOR INTERACTION; ANOMALOUS DIFFUSION; PROTEIN TRANSLOCATION; DRIVEN MECHANISMS; NUCLEIC-ACIDS; DNA; KINETICS; SEARCH; CONFINEMENT; DYNAMICS	Under dilute in vitro conditions transcription factors rapidly locate their target sequence on DNA by using the facilitated diffusion mechanism. However, whether this strategy of alternating between three-dimensional bulk diffusion and one-dimensional sliding along the DNA contour is still beneficial in the crowded interior of cells is highly disputed. Here we use a simple model for the bacterial genome inside the cell and present a semi-analytical model for the in vivo target search of transcription factors within the facilitated diffusion framework. Without having to resort to extensive simulations we determine the mean search time of a lac repressor in a living E. coli cell by including parameters deduced from experimental measurements. The results agree very well with experimental findings, and thus the facilitated diffusion picture emerges as a quantitative approach to gene regulation in living bacteria cells. Furthermore we see that the search time is not very sensitive to the parameters characterizing the DNA configuration and that the cell seems to operate very close to optimal conditions for target localization. Local searches as implied by the colocalization mechanism are only found to mildly accelerate the mean search time within our model.	[Bauer, Maximilian; Metzler, Ralf] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Bauer, Maximilian] Tech Univ Munich, Dept Phys, Garching, Germany; [Metzler, Ralf] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland	University of Potsdam; Technical University of Munich; Tampere University	Metzler, R (corresponding author), Univ Potsdam, Inst Phys & Astron, Potsdam, Germany.	rmetzler@uni-potsdam.de	Metzler, Ralf/J-9088-2013; Stefanadis, Christodoulos/ABH-2232-2020	Metzler, Ralf/0000-0002-6013-7020; Liao, Ronglih/0000-0002-9598-9020; Stefanadis, Christodoulos/0000-0001-5974-6454; Cheng, Susan/0000-0002-4977-036X	Academy of Finland (FiDiPro scheme); German Federal Ministry for Education and Research	Academy of Finland (FiDiPro scheme)(Academy of Finland); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by Academy of Finland (FiDiPro scheme): www.aka.fi/eng; and German Federal Ministry for Education and Research: www.bmbf.de/en/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Barkai E, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1677; Bauer M, 2012, BIOPHYS J, V102, P2321, DOI 10.1016/j.bpj.2012.04.008; Benichou O, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.038102; Benichou O, 2010, NAT CHEM, V2, P472, DOI [10.1038/nchem.622, 10.1038/NCHEM.622]; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; Buenemann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013806; Coppey M, 2004, BIOPHYS J, V87, P1640, DOI 10.1529/biophysj.104.045773; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Foffano G, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021919; Fritsche M, 2012, NUCLEIC ACIDS RES, V40, P972, DOI 10.1093/nar/gkr779; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Guigas G, 2008, BIOPHYS J, V94, P90, DOI 10.1529/biophysj.107.117044; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hellmann M, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/58004; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Jun S, 2010, NAT REV MICROBIOL, V8, P600, DOI 10.1038/nrmicro2391; Jung Y, 2012, SOFT MATTER, V8, P2095, DOI 10.1039/c1sm05706e; Junier I, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000678; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; Kolesov G, 2007, P NATL ACAD SCI USA, V104, P13948, DOI 10.1073/pnas.0700672104; Kolomeisky AB, 2011, PHYS CHEM CHEM PHYS, V13, P2088, DOI 10.1039/c0cp01966f; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Koslover EF, 2011, BIOPHYS J, V101, P856, DOI 10.1016/j.bpj.2011.06.066; Kuhn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022962; Lomholt MA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.200603; Lomholt MA, 2009, P NATL ACAD SCI USA, V106, P8204, DOI 10.1073/pnas.0903293106; MADRAS N, 1990, J STAT PHYS, V58, P159, DOI 10.1007/BF01020290; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Meyer B, 2010, PHYS REV E, V83; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Morelli MJ, 2011, BIOPHYS J, V101, P2882, DOI 10.1016/j.bpj.2011.10.053; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Reingruber J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/6/065103; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Romantsov T, 2007, BIOPHYS J, V92, P2875, DOI 10.1529/biophysj.106.095729; Sereshki LE, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/20008; Sheinman M, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/2/026601; Sheinman M, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016003; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Sokolov IM, 2005, BIOPHYS J, V89, P895, DOI 10.1529/biophysj.104.057612; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; van den Broek B, 2008, P NATL ACAD SCI USA, V105, P15738, DOI 10.1073/pnas.0804248105; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; von Smoluchowski M, 1916, PHYS Z, V17, P557; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; Wunderlich Z, 2008, NUCLEIC ACIDS RES, V36, P3570, DOI 10.1093/nar/gkn173; Zhou HX, 2011, P NATL ACAD SCI USA, V108, P8651, DOI 10.1073/pnas.1101555108	55	80	81	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2013	8	1							e53956	10.1371/journal.pone.0053956	http://dx.doi.org/10.1371/journal.pone.0053956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GQ	23349772	Green Submitted, Green Published, gold			2022-12-27	WOS:000313872800019
J	Lee, YA; Kim, YH; Kim, BJ; Kim, BG; Kim, KJ; Auh, JH; Schmidt, JA; Ryu, BY				Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Kim, Byung-Gak; Kim, Ki-Jung; Auh, Joong-Hyuck; Schmidt, Jonathan A.; Ryu, Buom-Yong			Cryopreservation in Trehalose Preserves Functional Capacity of Murine Spermatogonial Stem Cells	PLOS ONE			English	Article							FLOW-CYTOMETRIC DETECTION; MOUSE TESTES; GERM-CELLS; PHOSPHATIDYLSERINE EXPRESSION; HEMATOPOIETIC-CELLS; TESTICULAR TISSUE; CANCER-TREATMENT; A SPERMATOGONIA; SELF-RENEWAL; ANNEXIN-V	Development of techniques to isolate, culture, and transplant human spermatogonial stem cells (SSCs) has the future potential to treat male infertility. To maximize the efficiency of these techniques, methods for SSC cryopreservation need to be developed to bank SSCs for extended periods of time. Although, it has been demonstrated that SSCs can reinitiate spermatogenesis after freezing, optimal cryopreservation protocols that maximize SSC proliferative capacity post-thaw have not been identified. The objective of this study was to develop an efficient cryopreservation technique for preservation of SSCs. To identify efficient cryopreservation methods for long-term preservation of SSCs, isolated testis cells enriched for SSCs were placed in medium containing dimethyl sulfoxide (DMSO) or DMSO and trehalose (50 mM, 100 mM, or 200 mM), and frozen in liquid nitrogen for 1 week, 1 month, or 3 months. Freezing in 50 mM trehalose resulted in significantly higher cell viability compared to DMSO at all thawing times and a higher proliferation rate compared to DMSO for the 1 week freezing period. Freezing in 200 mM trehalose did not result in increased cell viability; however, proliferation activity was significantly higher and percentage of apoptotic cells was significantly lower compared to DMSO after freezing for 1 and 3 months. To confirm the functionality of SSCs frozen in 200 mM trehalose, SSC transplantation was performed. Donor SSCs formed spermatogenic colonies and sperm capable of generating normal progeny. Collectively, these results indicate that freezing in DMSO with 200 mM trehalose serves as an efficient method for the cryopreservation of SSCs.	[Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Kim, Byung-Gak; Kim, Ki-Jung; Ryu, Buom-Yong] Chung Ang Univ, Dept Anim Sci & Technol, Ansung, Gyeonggi Do, South Korea; [Auh, Joong-Hyuck] Chung Ang Univ, Dept Food Sci & Technol, Ansung, Gyeonggi Do, South Korea; [Schmidt, Jonathan A.] Spokane Community Coll, Dept Sci, Spokane, WA USA	Chung Ang University; Chung Ang University	Ryu, BY (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Ansung, Gyeonggi Do, South Korea.	byryu@cau.ac.kr	Auh, Joong Hyuck/ABG-9137-2021	Auh, Joong Hyuck/0000-0001-9425-2599; Park, Chankyu/0000-0003-4855-2210; Lee, Yong-An/0000-0001-7253-2397	Next-Generation BioGreen 21 Program [PJ0080482012]; Rural Development Administration, a National Research Foundation of Korea; Ministry of Education, Science and Technology [2012-0006786]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, a National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work has been supported by the Next-Generation BioGreen 21 Program (No.PJ0080482012) and Rural Development Administration, a National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (2012-0006786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagla EME, 2003, BIOL REPROD, V69, P1245, DOI 10.1095/biolreprod.103.017889; Araki Y, 2010, BIOL REPROD, V83, P951, DOI 10.1095/biolreprod.109.082800; Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693; Brook PF, 2001, FERTIL STERIL, V75, P269, DOI 10.1016/S0015-0282(00)01721-0; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; De Rooij DG, 2000, J ANDROL, V21, P776; De Rooij DG, 1992, ANN NY ACAD SCI, V364, P140; Dirami G, 1999, BIOL REPROD, V61, P225, DOI 10.1095/biolreprod61.1.225; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Erdag G, 2002, CRYOBIOLOGY, V44, P218, DOI 10.1016/S0011-2240(02)00023-8; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Eroglu A, 2001, CRYOBIOLOGY, V43, P320; Ewing L L, 1980, Int Rev Physiol, V22, P41; FOSSA SD, 1989, BRIT J UROL, V64, P524, DOI 10.1111/j.1464-410X.1989.tb05292.x; Frederickx V, 2004, HUM REPROD, V19, P948, DOI 10.1093/humrep/deh154; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Izadyar F, 2002, J ANDROL, V23, P537; Ji L, 2004, BIOTECHNOL BIOENG, V88, P299, DOI 10.1002/bit.20243; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2003, HUM REPROD, V18, P2660, DOI 10.1093/humrep/deg483; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Kim BG, 2010, BIOL REPROD, V82, P1162, DOI 10.1095/biolreprod.109.079558; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lass A, 2001, HUM REPROD UPDATE, V7, P370, DOI 10.1093/humupd/7.4.370; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MAZUR P, 1988, ANN NY ACAD SCI, V541, P514, DOI 10.1111/j.1749-6632.1988.tb22288.x; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano M, 2002, FERTIL STERIL, V78, P1225, DOI 10.1016/S0015-0282(02)04345-5; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Ogawa T, 2004, ARCH HISTOL CYTOL, V67, P297, DOI 10.1679/aohc.67.297; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Royere D, 1996, HUM REPROD UPDATE, V2, P553, DOI 10.1093/humupd/2.6.553; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sasnoor LM, 2005, TRANSPLANTATION, V80, P1251, DOI 10.1097/01.tp.0000169028.01327.90; Schlatt S, 2002, HUM REPROD, V17, P55, DOI 10.1093/humrep/17.1.55; Schmidt JA, 2011, BIOL REPROD, V84, P698, DOI 10.1095/biolreprod.110.088229; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; vanPelt AMM, 1996, BIOL REPROD, V55, P439, DOI 10.1095/biolreprod55.2.439; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wu X, 2012, HUM REPROD, V27, P1249, DOI 10.1093/humrep/des077	54	73	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54889	10.1371/journal.pone.0054889	http://dx.doi.org/10.1371/journal.pone.0054889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23675467	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100108
J	Zhu, JY; Yang, P; Zhang, Z; Wu, GX; Yang, B				Zhu, Jia-Ying; Yang, Pu; Zhang, Zhong; Wu, Guo-Xing; Yang, Bin			Transcriptomic Immune Response of Tenebrio molitor Pupae to Parasitization by Scleroderma guani	PLOS ONE			English	Article							GENE-EXPRESSION; HELIOTHIS-VIRESCENS; INNATE IMMUNITY; PIERIS-RAPAE; RECOGNITION PROTEINS; MOLECULAR-CLONING; TRICHOPLUSIA-NI; STORAGE PROTEIN; ENZYME-ACTIVITY; VENOM PROTEINS	Background: Host and parasitoid interaction is one of the most fascinating relationships of insects, which is currently receiving an increasing interest. Understanding the mechanisms evolved by the parasitoids to evade or suppress the host immune system is important for dissecting this interaction, while it was still poorly known. In order to gain insight into the immune response of Tenebrio molitor to parasitization by Scleroderma guani, the transcriptome of T. molitor pupae was sequenced with focus on immune-related gene, and the non-parasitized and parasitized T. molitor pupae were analyzed by digital gene expression (DGE) analysis with special emphasis on parasitoid-induced immune-related genes using Illumina sequencing. Methodology/Principal Findings: In a single run, 264,698 raw reads were obtained. De novo assembly generated 71,514 unigenes with mean length of 424 bp. Of those unigenes, 37,373 (52.26%) showed similarity to the known proteins in the NCBI nr database. Via analysis of the transcriptome data in depth, 430 unigenes related to immunity were identified. DGE analysis revealed that parasitization by S. guani had considerable impacts on the transcriptome profile of T. molitor pupae, as indicated by the significant up-or down-regulation of 3,431 parasitism-responsive transcripts. The expression of a total of 74 unigenes involved in immune response of T. molitor was significantly altered after parasitization. Conclusions/Significance: obtained T. molitor transcriptome, in addition to establishing a fundamental resource for further research on functional genomics, has allowed the discovery of a large group of immune genes that might provide a meaningful framework to better understand the immune response in this species and other beetles. The DGE profiling data provides comprehensive T. molitor immune gene expression information at the transcriptional level following parasitization, and sheds valuable light on the molecular understanding of the host-parasitoid interaction.	[Zhu, Jia-Ying; Yang, Bin] SW Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China; [Yang, Pu] Chinese Acad Forestry, Res Inst Resource Insects, Kunming, Peoples R China; [Zhang, Zhong] Taishan Med Univ, Dept Pathogen Biol, Tai An, Shandong, Peoples R China; [Wu, Guo-Xing] Yunnan Agr Univ, Coll Plant Protect, Kunming, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Shandong First Medical University & Shandong Academy of Medical Sciences; Yunnan Agricultural University	Zhu, JY (corresponding author), SW Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China.	jyzhu001@gmail.com	Yang, Pu/L-1442-2019; Yang, Bin/AAW-9583-2021	Yang, Bin/0000-0002-9290-7288; li, wan feng/0000-0003-0834-5479	Key Project of Chinese Ministry of Education [211171]; Applied Basic Research Programs of Yunnan Province [2010CD063]; National Natural Science Foundation of China [31260449]	Key Project of Chinese Ministry of Education(Ministry of Education, China); Applied Basic Research Programs of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Project of Chinese Ministry of Education (211171), Applied Basic Research Programs of Yunnan Province (2010CD063), and National Natural Science Foundation of China (31260449). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, INSECT BIOCHEM MOLEC, V38, P136, DOI 10.1016/j.ibmb.2007.10.001; Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Asgari S, 2004, J INSECT PHYSIOL, V50, P687, DOI 10.1016/j.jinsphys.2004.05.003; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barat-Houari M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-160; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Benassi V, 2000, ARCH INSECT BIOCHEM, V43, P64, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;64::AID-ARCH2&gt;3.0.CO;2-I; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Chen Jun, 2000, Chinese Journal of Biological Control, V16, P166; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Coudron TA, 1997, COMP BIOCHEM PHYS B, V116, P197, DOI 10.1016/S0305-0491(96)00217-9; COUDRON TA, 1994, ARCH INSECT BIOCHEM, V26, P97, DOI 10.1002/arch.940260204; Coustau C, 1996, INSECT MOL BIOL, V5, P167, DOI 10.1111/j.1365-2583.1996.tb00050.x; Dong K, 1996, ARCH INSECT BIOCHEM, V32, P237, DOI 10.1002/(SICI)1520-6327(1996)32:2&lt;237::AID-ARCH7&gt;3.0.CO;2-V; Doucet D, 2008, ARCH INSECT BIOCHEM, V67, P188, DOI 10.1002/arch.20227; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Fearon DT, 1977, NATURE, V388, P323, DOI DOI 10.1038/40967; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; HARA S, 1995, J BIOL CHEM, V270, P29923, DOI 10.1074/jbc.270.50.29923; Hartzer KL, 2005, ARCH INSECT BIOCHEM, V59, P67, DOI 10.1002/arch.20056; HAYAKAWA Y, 1994, J BIOL CHEM, V269, P14536; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Hughes Austin L, 2012, Immunogenetics, V64, P549, DOI 10.1007/s00251-012-0610-8; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kraaijeveld AR, 2009, ADV PARASIT, V70, P257, DOI 10.1016/S0065-308X(09)70010-7; KUNKEL JG, 1990, ARCH INSECT BIOCHEM, V13, P117, DOI 10.1002/arch.940130111; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XR, 2011, INT J BIOL SCI, V7, P848, DOI 10.7150/ijbs.7.848; Lourenco AP, 2009, ARCH INSECT BIOCHEM, V71, P70, DOI 10.1002/arch.20301; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; Moreau SJM, 2005, INSECT BIOCHEM MOLEC, V35, P1209, DOI 10.1016/j.ibmb.2005.07.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nicolas E, 1996, DEV COMP IMMUNOL, V20, P175, DOI 10.1016/0145-305X(96)00017-1; Ourth DD, 2005, BIOCHEM BIOPH RES CO, V335, P1085, DOI 10.1016/j.bbrc.2005.07.189; Pal S, 2009, FLY, V3, P121, DOI 10.4161/fly.8827; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pick C, 2009, FEBS J, V276, P1930, DOI 10.1111/j.1742-4658.2009.06918.x; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Qin X, 1982, SCI SILVAE SINICAE, V18, P209; Quicke D. L. J., 1997, PARASITIC WASPS; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmidt O, 2006, ARCH INSECT BIOCHEM, V61, P107, DOI 10.1002/arch.20110; Schmidt O, 1989, Subcell Biochem, V15, P91; SHELBY KS, 1994, J GEN VIROL, V75, P2285, DOI 10.1099/0022-1317-75-9-2285; Shelby KS, 1997, INSECT BIOCHEM MOLEC, V27, P263, DOI 10.1016/S0965-1748(96)00095-1; Shelby KS, 1999, J INSECT PHYSIOL, V45, P507, DOI 10.1016/S0022-1910(98)00144-9; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Takeda T, 2006, PESTIC BIOCHEM PHYS, V86, P15, DOI 10.1016/j.pestbp.2005.11.012; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang L, 1980, SCI SILVAE SINICAE, V16, P41; Zhang YH, 2012, GENOMICS, V100, P35, DOI 10.1016/j.ygeno.2012.05.002; Zhang ZT, 2012, DEV COMP IMMUNOL, V38, P262, DOI 10.1016/j.dci.2012.05.003; Zhu JY, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/491748; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291; Zhu JY, 2011, J ZHEJIANG UNIV-SC B, V12, P103, DOI 10.1631/jzus.B1000275; Zhu JY, 2009, INSECT SCI, V16, P227, DOI 10.1111/j.1744-7917.2009.01252.x; Zhu JY, 2009, J ZHEJIANG UNIV-SC B, V10, P445, DOI 10.1631/jzus.B0820314; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	90	198	208	5	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54411	10.1371/journal.pone.0054411	http://dx.doi.org/10.1371/journal.pone.0054411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23301042	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400162
J	Zhu, JF; Zhang, LF; Li, WF; Han, SY; Yang, WH; Qi, LW				Zhu, Jianfeng; Zhang, Lifeng; Li, Wanfeng; Han, Suying; Yang, Wenhua; Qi, Liwang			Reference Gene Selection for Quantitative Real-time PCR Normalization in Caragana intermedia under Different Abiotic Stress Conditions	PLOS ONE			English	Article							RT-PCR; HOUSEKEEPING GENES; TRANSCRIPTION FACTOR; INTERNAL CONTROL; EXPRESSION NORMALIZATION; VALIDATION; ARABIDOPSIS; IDENTIFICATION; DROUGHT; RICE	Quantitative real-time reverse transcription polymerase chain reaction (qPCR), a sensitive technique for gene expression analysis, depends on the stability of the reference genes used for data normalization. Caragana intermedia, a native desert shrub with strong drought-resistance, sand-fixing capacity and high forage value that is widespread in the desert land of west and northwest China, has not been investigated regarding the identification of reference genes suitable for the normalization of qPCR data. In this study, 10 candidate reference genes were analyzed in C. intermedia subjected to different abiotic (osmotic, salt, cold and heat) stresses, in two distinct plant organs (roots and leaves). The expression stability of these genes was assessed using geNorm, NormFinder and BestKeeper algorithms. The best-ranked reference genes differed across the different sets of samples, but UNK2, PP2A and SAND were the most stable across all tested samples. UNK2 and SAND would be appropriate for normalizing gene expression data for salt-treated roots, whereas the combination of UNK2, SAND and EF-1 alpha would be appropriate for salt-treated leaves. UNK1, UNK2 and PP2A would be appropriate for PEG-treated (osmotic) roots, whereas the combination of TIP41 and PP2A was the most suitable for PEG-treated leaves. SAND, PP2A and TIP41 exhibited the most stable expression in heat-treated leaves. In cold-treated leaves, SAND and EF-1 alpha were the most stably expressed. To further validate the suitability of the reference genes identified in this study, the expression levels of DREB1 and DREB2 (homologs of AtDREB1 and AtDREB2) were studied in parallel. This study is the first systematic analysis for the selection of superior reference genes for qPCR in C. intermedia under different abiotic stress conditions, and will benefit future studies on gene expression in C. intermedia and other species of the leguminous genus Caragana.	[Zhu, Jianfeng; Zhang, Lifeng; Li, Wanfeng; Yang, Wenhua; Qi, Liwang] Chinese Acad Forestry, Res Inst Forestry, Cell Biol Lab, Beijing, Peoples R China; [Han, Suying] Chinese Acad Forestry, Res Inst Forest Ecol & Protect, Key Lab, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Qi, LW (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Cell Biol Lab, Beijing, Peoples R China.	lwqi@caf.ac.cn	Yang, Pu/L-1442-2019; Yang, Bin/AAW-9583-2021	Yang, Bin/0000-0002-9290-7288; li, wan feng/0000-0003-0834-5479	National Basic Research Program of China [2009CB119106]; National High Technology Research and Development Program of China [2011AA100203]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (2009CB119106) and the National High Technology Research and Development Program of China (2011AA100203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Coito Joao L, 2012, BMC Res Notes, V5, P220, DOI 10.1186/1756-0500-5-220; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guo WH, 2010, AGROFOREST SYST, V80, P423, DOI 10.1007/s10457-010-9337-4; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portieles R, 2010, PLANT BIOTECHNOL J, V8, P678, DOI 10.1111/j.1467-7652.2010.00501.x; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Shi SQ, 2010, PLANT CELL ENVIRON, V33, P149, DOI 10.1111/j.1365-3040.2009.02065.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang XM, 2011, MOL BIOL REP, V38, P2801, DOI 10.1007/s11033-010-0425-3; Xu ZZ, 2007, PLANT SOIL, V301, P87, DOI 10.1007/s11104-007-9424-0; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	44	198	208	5	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e53196	10.1371/journal.pone.0053196	http://dx.doi.org/10.1371/journal.pone.0053196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23301042	gold, Green Published, Green Submitted			2022-12-27	WOS:000313320900067
J	Zhao, Z; Su, TJ; Chesters, D; Wang, SD; Ho, SYW; Zhu, CD; Chen, XL; Zhang, CT				Zhao, Zhe; Su, Tian-juan; Chesters, Douglas; Wang, Shi-di; Ho, Simon Y. W.; Zhu, Chao-dong; Chen, Xiao-lin; Zhang, Chun-tian			The Mitochondrial Genome of Elodia flavipalpis Aldrich (Diptera: Tachinidae) and the Evolutionary Timescale of Tachinid Flies	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DNA CONTROL REGION; TRANSFER-RNA GENE; CALYPTRATAE DIPTERA; MOLECULAR PHYLOGENY; FRUIT-FLY; AGROMYZIDAE; PHYLOGEOGRAPHY; REARRANGEMENT; ORGANIZATION	Tachinid flies are natural enemies of many lepidopteran and coleopteran pests of forests, crops, and fruit trees. In order to address the lack of genetic data in this economically important group, we sequenced the complete mitochondrial genome of the Palaearctic tachinid fly Elodia flavipalpis Aldrich, 1933. Usually found in Northern China and Japan, this species is one of the primary natural enemies of the leaf-roller moths (Tortricidae), which are major pests of various fruit trees. The 14,932-bp mitochondrial genome was typical of Diptera, with 13 protein-coding genes, 22 tRNA genes, and 2 rRNA genes. However, its control region is only 105 bp in length, which is the shortest found so far in flies. In order to estimate dipteran evolutionary relationships, we conducted a phylogenetic analysis of 58 mitochondrial genomes from 23 families. Maximum-likelihood and Bayesian methods supported the monophyly of both Tachinidae and superfamily Oestroidea. Within the subsection Calyptratae, Muscidae was inferred as the sister group to Oestroidea. Within Oestroidea, Calliphoridae and Sarcophagidae formed a sister clade to Oestridae and Tachinidae. Using a Bayesian relaxed clock calibrated with fossil data, we estimated that Tachinidae originated in the middle Eocene.	[Zhao, Zhe; Wang, Shi-di; Zhang, Chun-tian] Shenyang Normal Univ, Liaoning Key Lab Evolut & Biodivers, Shenyang, Liaoning, Peoples R China; [Zhao, Zhe; Su, Tian-juan; Chesters, Douglas; Zhu, Chao-dong; Chen, Xiao-lin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Ho, Simon Y. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Shenyang Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Sydney	Zhu, CD (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	zhucd@ioz.ac.cn; xlchen@ioz.ac.cn; chuntianzhang@yahoo.cn	Su, Tianjuan/AAJ-6290-2021; ZHU, Chao-Dong/E-5961-2011; Ho, Simon YW/A-8417-2008; Chesters, Douglas/AAF-7926-2019	ZHU, Chao-Dong/0000-0002-9347-3178; Ho, Simon YW/0000-0002-0361-2307; 	Knowledge Innovation Program of Chinese Academy of Sciences [KSXC2-EW-B-02]; Public Welfare Project from the Ministry of Agriculture, China [201103024]; National Science Foundation, China [30870268, 31172048, J0930004, 31093430, 31272279]; National Special Science and Technology Foundation of China [2012FY111100]; NHLBI NIH HHS [R01 HL97979, R01 HL097979] Funding Source: Medline	Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Public Welfare Project from the Ministry of Agriculture, China; National Science Foundation, China(National Natural Science Foundation of China (NSFC)); National Special Science and Technology Foundation of China; NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported mainly by a grant from the Knowledge Innovation Program of Chinese Academy of Sciences (grant KSXC2-EW-B-02), Public Welfare Project from the Ministry of Agriculture, China (grant 201103024), and the National Science Foundation, China (grants 30870268, 31172048, J0930004) to Chao-dong Zhu; the National Science Foundation, China (grants 31093430, 31272279) to Chun-tian Zhang; National Special Science and Technology Foundation of China (2012FY111100) to Xiao-lin Chen and Chao-dong Zhu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aldrich JM, 1933, P ENTOMOLOGICAL SOC, V35, P21; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Beckenbach AT, 2009, GENOME BIOL EVOL, V1, P278, DOI 10.1093/gbe/evp027; Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Chao CM, 2009, FAUNA HEBEI PROVINCE, p[1, 555]; Chatterjee S, 2005, GENETICA, V125, P1, DOI 10.1007/s10709-004-6192-0; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Griffiths G.C.D., 1972, Series Ent, V8, P1; Grimaldi David, 2005, pi; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han HY, 2000, BIOCHEM SYST ECOL, V28, P501, DOI 10.1016/S0305-1978(99)00097-6; HENNIG W, 1976, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), P1; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Krzeminski Wieslaw, 1994, Acta Zoologica Cracoviensia, V37, P95; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Krzywinski J, 2011, MOL PHYLOGENET EVOL, V58, P469, DOI 10.1016/j.ympev.2011.01.003; Kutty SN, 2010, SYST ENTOMOL, V35, P614, DOI 10.1111/j.1365-3113.2010.00536.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessinger AC, 2000, MED VET ENTOMOL, V14, P71, DOI 10.1046/j.1365-2915.2000.00209.x; Lessinger AC, 2004, GENE, V339, P1, DOI 10.1016/j.gene.2004.06.041; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; LIU YQ, 2002, FAUNA SINICA INSECT, V27, P315; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; McAlpine JF, 1989, MONOGRAPH, V3, P1397; MITCHELL SE, 1993, GENOME, V36, P1058, DOI 10.1139/g93-141; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Nelson LA, 2012, MITOCHONDR DNA, V23, P42, DOI 10.3109/19401736.2011.644042; Nelson LA, 2011, MITOCHONDR DNA, V22, P197, DOI 10.3109/19401736.2011.632896; Nirmala X, 2001, INSECT MOL BIOL, V10, P475, DOI 10.1046/j.0962-1075 .2001.00286.x; O'Hara JE, 2009, ZOOTAXA, P1; O'Hara JE, 2010, WORLD GENERA TACHINI; Oliveira MT, 2006, J MED ENTOMOL, V43, P636, DOI 10.1603/0022-2585(2006)43[636:IATTCR]2.0.CO;2; Oliveira MT, 2007, J MOL EVOL, V64, P519, DOI 10.1007/s00239-006-0099-6; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PAPE T, 1992, Tijdschrift voor Entomologie, V135, P43; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2007, TRACER V1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P991, DOI 10.1603/0013-8746(2006)99[991:MPOTVP]2.0.CO;2; Shao YJ, 2012, MOL BIOL REP, V39, P11023, DOI 10.1007/s11033-012-2005-1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stireman JO, 2002, SYST ENTOMOL, V27, P409, DOI 10.1046/j.1365-3113.2002.00187.x; Tachi T, 2010, SYST ENTOMOL, V35, P148, DOI 10.1111/j.1365-3113.2009.00497.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres TT, 2009, NUCLEIC ACIDS RES, V37, P7509, DOI 10.1093/nar/gkp856; von Tschirnhaus Michael, 2009, Denisia, P171; Wang S., 2009, MOL BIOL REP, V38, P687; Weigl S, 2010, MED VET ENTOMOL, V24, P329, DOI 10.1111/j.1365-2915.2010.00873.x; Wiegmann BM, 2003, SYST BIOL, V52, P745, DOI [10.1080/10635150390250965, 10.1093/sysbio/52.6.745]; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Winkler IS, 2010, J PALEONTOL, V84, P935, DOI 10.1666/09-163.1; Yang F, 2011, GENE, V485, P7, DOI 10.1016/j.gene.2011.05.030; Ye Jun, 2010, Plant Quarantine (Shanghai), V24, P11; Yeates DK, 2007, ZOOTAXA, P565, DOI 10.11646/zootaxa.1668.1.27; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zhao JL, 2011, MOL BIOL REP, V38, P3757, DOI 10.1007/s11033-010-0491-6; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	71	141	147	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61814	10.1371/journal.pone.0061814	http://dx.doi.org/10.1371/journal.pone.0061814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626734	Green Published, Green Submitted, gold			2022-12-27	WOS:000318008400098
J	Liu, XQ; Zhou, CL; Li, YJ; Ji, Y; Xu, GP; Wang, XT; Yan, JL				Liu, Xiaoqi; Zhou, Changlong; Li, Yanjing; Ji, Ye; Xu, Gongping; Wang, Xintao; Yan, Jinglong			SDF-1 Promotes Endochondral Bone Repair during Fracture Healing at the Traumatic Brain Injury Condition	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEAD-INJURY; ENHANCED OSTEOGENESIS; IN-VITRO; MYOCARDIAL-INFARCTION; MARROW; GROWTH; MIGRATION; MODEL; RATS	Purposes: The objective of this study was to investigate the role of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, on bone healing and whether SDF-1 contributes to accelerating bone repair in traumatic brain injury (TBI)/fracture model. Materials and Methods: Real-time polymerase chain reaction and immunohistochemical analysis were used to detect the expression of SDF-1 during the repair of femoral bone in TBI/fracture model. The TBI/fracture model was treated with anti-SDF-1 neutralizing antibody or AMD3100, an antagonist for CXCR4, and evaluated by histomorphometry. In vitro and in vivo migration assays were used to evaluate the functional effect of SDF-1 on primary mesenchymal stem cells. Results: The expression of SDF1 and CXCR4 messenger RNA was increased during the bone healing in TBI/fracture model but was less increased in fracture only model. High expression of SDF-1 protein was observed in the surrounding tissue of the damaged bone. Treated with anti-SDF-1 antibody or AMD3100 could inhibit new bone formation. SDF-1 increased mesenchymal stem cell chemotaxis in vitro in a dose-dependent manner. The in vivo migration study demonstrated that mesenchymal stem cells recruited by SDF-1 participate in endochondral bone repair. Conclusion: The SDF-1/CXCR4 axis plays a crucial role in the accelerating fracture healing under the condition of TBI and contributes to endochondral bone repair.	[Liu, Xiaoqi; Zhou, Changlong; Li, Yanjing; Ji, Ye; Xu, Gongping; Wang, Xintao; Yan, Jinglong] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Peoples R China	Harbin Medical University	Yan, JL (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Peoples R China.	yanjlhyd@hotmail.com		John, Ciny/0000-0003-3688-0751; Liu, Geoffrey/0000-0002-2603-7296	National Natural Science Foundation of China [100334]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (100334) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Guo ZK, 2006, STEM CELLS, V24, P992, DOI 10.1634/stemcells.2005-0224; HaraIrie F, 1996, BONE, V18, P29, DOI 10.1016/8756-3282(95)00425-4; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Khare G N, 1995, Indian J Med Sci, V49, P281; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Liu XQ, 2012, BIOTECHNOL LETT, V34, P387, DOI 10.1007/s10529-011-0757-7; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mori T, 2004, MOL CANCER THER, V3, P29; Otfinowski Janusz, 1993, Patologia Polska, V44, P133; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; SPENCER RF, 1990, S AFR J SURG, V28, P51; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; Tiyapatanaputi P, 2004, J ORTHOP RES, V22, P1254, DOI 10.1016/j.orthres.2004.03.017; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Wieczorek G, 2003, CELL TISSUE RES, V311, P227, DOI 10.1007/s00441-002-0671-3; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013	35	100	110	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54077	10.1371/journal.pone.0054077	http://dx.doi.org/10.1371/journal.pone.0054077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	24130878	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100041
J	Li, S; Jin, XK; Guo, XN; Yu, AQ; Wu, MH; Tan, SJ; Zhu, YT; Li, WW; Wang, Q				Li, Shuang; Jin, Xing-Kun; Guo, Xiao-Nv; Yu, Ai-Qing; Wu, Min-Hao; Tan, Shang-Jian; Zhu, You-Ting; Li, Wei-Wei; Wang, Qun			A Double WAP Domain-Containing Protein Es-DWD1 from Eriocheir sinensis Exhibits Antimicrobial and Proteinase Inhibitory Activities	PLOS ONE			English	Article							WHEY ACIDIC PROTEIN; CHINESE MITTEN CRAB; CRUSTIN-LIKE GENE; C-TYPE LECTIN; MOLECULAR-CLONING; WHITE SHRIMP; ALPHA-2-MACROGLOBULIN ALPHA-2-M; RECOMBINANT EXPRESSION; ANTIBACTERIAL PROTEINS; PEPTIDE	Whey acidic proteins (WAP) belong to a large gene family of antibacterial peptides, which are critical in the host immune response against microbial invasion. The common feature of these proteins is a single WAP domain maintained by at least one four-disulfide core (4-DSC) structure rich in cysteine residues. In this study, a double WAP domain (DWD)-containing protein, Es-DWD1, was first cloned from the Chinese mitten crab (Eriocheir sinensis). The full-length Es-DWD1cDNA was 1193 bp, including a 411 bp open reading frame (ORF) encoding 136 amino acids with a signal peptide of 22 amino acids in the N-terminus. A comparison with other reported invertebrate and vertebrate sequences revealed the presence of WAP domains characteristic of WAP superfamilies. As determined by quantitative real-time RT-PCR, Es-DWD1 transcripts were ubiquitously expressed in all tissues, but it was upregulated in hemocytes post-challenge with pathogen-associated molecular patterns (PAMPs). The mature recombinant Es-DWD1 (rEs-DWD1) protein exhibited different binding activities to bacteria and fungus. Moreover, rEs-DWD1 could exert agglutination activities against Bacillus subtilis and Pichia pastoris and demonstrated inhibitory activities against the growth of Staphylococcus aureus, Aeromonas hydrophila and P. pastoris. Furthermore, rEs-DWD1 showed a specific protease inhibitory activity in B. subtilis. Coating of rEs-DWD1 onto agarose beads enhanced encapsulation of the beads by crab hemocytes. Collectively, the results suggest that Es-DWD1 is a double WAP domain containing protein with antimicrobial and proteinase inhibitory activities, which play significant roles in the immunity of crustaceans.	[Li, Shuang; Jin, Xing-Kun; Guo, Xiao-Nv; Yu, Ai-Qing; Wu, Min-Hao; Tan, Shang-Jian; Zhu, You-Ting; Li, Wei-Wei; Wang, Qun] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Wang, Q (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	qwang@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013; Zhang, Quanfa/H-1922-2011; LI, WEIWEI/J-3538-2013; Jin, Xingkun/H-4366-2013; Li, Siyue/DCN-3040-2022; Li, Siyue/E-8297-2012	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; Li, Siyue/0000-0002-3097-6819; Li, Siyue/0000-0002-3097-6819; li, si yue/0000-0002-4550-892X	National Natural Science Foundation of China [31172393]; National Science and Technology Support Program of China [2012BAD26B04-04]; Innovation Program of Shanghai Municipal Education Commission [13zz031]; National Research Foundation for the Doctoral Program of Higher Education of China [20110076110016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by grants from the National Natural Science Foundation of China (No. 31172393), the National Science and Technology Support Program of China (2012BAD26B04-04), the Innovation Program of Shanghai Municipal Education Commission (13zz031) and the National Research Foundation for the Doctoral Program of Higher Education of China (20110076110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2008, DEV COMP IMMUNOL, V32, P1497, DOI 10.1016/j.dci.2008.06.005; Amparyup P, 2008, MOL IMMUNOL, V45, P1085, DOI 10.1016/j.molimm.2007.07.031; ARAKI K, 1989, BIOCHEM BIOPH RES CO, V164, P496, DOI 10.1016/0006-291X(89)91747-6; AVIDOR Y, 1953, J BACTERIOL, V66, P1, DOI 10.1002/path.1700660103; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Chen A, 2008, FISH SHELLFISH IMMUN, V25, P775, DOI 10.1016/j.fsi.2008.02.017; CORONEL CE, 1990, J BIOL CHEM, V265, P6854; Davey GC, 2001, GENE, V263, P121, DOI 10.1016/S0378-1119(00)00587-4; DEAR TN, 1988, CANCER RES, V48, P5203; Du ZQ, 2009, COMP BIOCHEM PHYS B, V154, P203, DOI 10.1016/j.cbpb.2009.06.004; Du ZQ, 2010, FISH SHELLFISH IMMUN, V28, P134, DOI 10.1016/j.fsi.2009.10.009; DYAR MT, 1946, J BACTERIOL, V51, P149, DOI 10.1128/JB.51.2.149-167.1946; Gollas-Galvan T, 2003, COMP BIOCHEM PHYS C, V134, P431, DOI 10.1016/S1532-0456(03)00002-4; Gowda NM, 2008, J INVERTEBR PATHOL, V99, P141, DOI 10.1016/j.jip.2008.04.003; Hagiwara K, 2003, J IMMUNOL, V170, P1973, DOI 10.4049/jimmunol.170.4.1973; HALL M, 1989, FEBS LETT, V254, P111, DOI 10.1016/0014-5793(89)81019-1; Hauton C, 2006, MOL IMMUNOL, V43, P1490, DOI 10.1016/j.molimm.2005.07.029; He L, PLOS ONE, V20127; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Hiemstra PS, 1996, INFECT IMMUN, V64, P4520, DOI 10.1128/IAI.64.11.4520-4524.1996; Jia YP, 2008, AQUACULTURE, V284, P246, DOI 10.1016/j.aquaculture.2008.07.046; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jimenez-Vega F, 2005, DEV COMP IMMUNOL, V29, P385, DOI 10.1016/j.dci.2004.10.001; Jimenez-Vega F, 2007, FISH SHELLFISH IMMUN, V23, P1119, DOI 10.1016/j.fsi.2007.06.006; JOHANSSON MW, 1994, EUR J BIOCHEM, V223, P389, DOI 10.1111/j.1432-1033.1994.tb19005.x; Krusong K, 2012, DEV COMP IMMUNOL, V36, P208, DOI 10.1016/j.dci.2011.08.002; Li FM, 2012, DEV COMP IMMUNOL, V36, P183, DOI 10.1016/j.dci.2011.07.003; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; LIANG ZC, 1995, COMP BIOCHEM PHYS B, V112, P385, DOI 10.1016/0305-0491(95)00105-0; Lin YC, 2008, DEV COMP IMMUNOL, V32, P317, DOI 10.1016/j.dci.2007.07.002; Lin YC, 2007, MOL IMMUNOL, V44, P1065, DOI 10.1016/j.molimm.2006.08.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mu CK, 2011, FISH SHELLFISH IMMUN, V31, P142, DOI 10.1016/j.fsi.2011.04.013; Mu CK, 2010, DEV COMP IMMUNOL, V34, P734, DOI 10.1016/j.dci.2010.02.001; Nile CJ, 2006, MOL IMMUNOL, V43, P388, DOI 10.1016/j.molimm.2005.02.015; Pech LL, 1996, J CELL SCI, V109, P2053; Ranganathan S, 1999, J MOL GRAPH MODEL, V17, P106, DOI 10.1016/S1093-3263(99)00023-6; Rattanachai A, 2004, FISH SHELLFISH IMMUN, V16, P599, DOI 10.1016/j.fsi.2003.09.011; Ren Q, 2009, FISH SHELLFISH IMMUN, V27, P739, DOI 10.1016/j.fsi.2009.09.007; Sallenave JM, 2002, BIOCHEM SOC T, V30, P111, DOI 10.1042/BST0300111; Smith VJ, 2008, DEV COMP IMMUNOL, V32, P758, DOI 10.1016/j.dci.2007.12.002; Smith VJ, 2011, BIOCHEM SOC T, V39, P1403, DOI 10.1042/BST0391403; Smith VJ, 2001, ADV EXP MED BIOL, V484, P95; Snedecor G., 1971, STAT METHODS; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Somprasong N, 2006, DEV COMP IMMUNOL, V30, P998, DOI 10.1016/j.dci.2006.01.004; Sperstad SV, 2009, DEV COMP IMMUNOL, V33, P583, DOI 10.1016/j.dci.2008.10.010; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Tomee JFC, 1997, J INFECT DIS, V176, P740, DOI 10.1086/514098; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Vargas-Albores F, 2004, COMP BIOCHEM PHYS B, V138, P415, DOI 10.1016/j.cbpc.2004.05.007; Wang W, 2004, RES MICROBIOL, V155, P630, DOI 10.1016/j.resmic.2004.04.010; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Wu HX, 2004, J INVERTEBR PATHOL, V86, P59, DOI 10.1016/j.jip.2004.03.010; Yang JL, 2010, DEV COMP IMMUNOL, V34, P1274, DOI 10.1016/j.dci.2010.07.004; Yang WL, 2005, CHIN J FRESHWATER FI, V35, P62; Yenugu S, 2004, BIOL REPROD, V71, P1484, DOI 10.1095/biolreprod.104.031567; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zhang JQ, 2007, J BIOTECHNOL, V127, P605, DOI 10.1016/j.jbiotec.2006.08.013; Zhang Shu-yong, 2002, Virologica Sinica, V17, P263	61	177	190	4	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73563	10.1371/journal.pone.0073563	http://dx.doi.org/10.1371/journal.pone.0073563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967346	gold, Green Published, Green Submitted			2022-12-27	WOS:000323115800122
J	Zhao, ZG; Zhang, JW; He, J; Zeng, GH				Zhao, Zhigang; Zhang, Jingwei; He, Jun; Zeng, Guohua			Clinical Utility of the UPOINT Phenotype System in Chinese Males with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A Prospective Study	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; ERECTILE DYSFUNCTION; SYMPTOM INDEX; MEN; PREVALENCE; CLASSIFICATION; MULTICENTER; MECHANISMS; DISEASE; IMPACT	Background: Recent data showed that a six-domain UPOINT is a flexible and responsive new classification system that has the clinical applicability in CP/CPPS. However, the utility of UPOINT algorithm in men in China with CP/CPPS has not been comprehensively studied. For international validation and adoption, we evaluated this clinical phenotype system for a large cohort of Chinese CP/CPPS patients and correlated it with patient symptoms and erectile dysfunction (ED). We also investigated the addition of an ED domain in regard to symptom correlation. Methods: A total of 389 Chinese males with CP/CPPS were prospectively collected and classified in each domain of the UPOINT system. Symptom severity was measured using the NIH-CPSI and IPSS. The erectile function was evaluated using the IIEF-5. Clinically relevant associations were calculated. Results: The percentage of patients positive for each domain was 54.0%, 42.1%, 41.9%, 20.8%, 26.7%, and 40.4% for the Urinary, Psychosocial, Organ-specific, Infection, Neurological/systemic, and Tenderness, respectively. There were significant correlations between the number of positive UPOINT domains and total NIH-CPSI (r = 0.706, p<0.001), IPSS (r = 0.682, p<0.001) and IIEF-5 scores (r = 0.631, P = 0.007) in Chinese cohort. Except for patients age, symptom duration was associated with a significantly greater number of positive domains (r = 0.638, P = 0.005). After adding an ED domain to create a modified UPOINT system, the correlation between the number of phenotypic domains and symptom severity was improved (0.706 to 0.844, p<0.001). Conclusions: The clinical applicability of using UPOINT phenotyping system has been validated in the Chinese patients with CP/CPPS. In our cohort, the number of positive domains was also correlated with ED symptoms and the significant association between the number of UPOINT domains and NIH-CPSI scores was further refined by adding a domain for ED. Our findings presented here support the utility of using ED as a stand-alone item in the UPOINT domain.	[Zhao, Zhigang; Zhang, Jingwei; He, Jun; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Urol, Dept Urol & Androl,Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Urol, Dept Urol & Androl,Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China.	zgzhaodr@yahoo.com.cn	Su, Tianjuan/AAJ-6290-2021; ZHU, Chao-Dong/E-5961-2011; Ho, Simon YW/A-8417-2008; Chesters, Douglas/AAF-7926-2019	ZHU, Chao-Dong/0000-0002-9347-3178; Ho, Simon YW/0000-0002-0361-2307; 	NHLBI NIH HHS [R01 HL97979, R01 HL097979] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RU, 2006, J UROLOGY, V176, P1534, DOI 10.1016/j.juro.2006.06.010; Bartoletti R, 2007, J UROLOGY, V178, P2411, DOI 10.1016/j.juro.2007.08.046; Calhoun EA, 2004, ARCH INTERN MED, V164, P1231; Chou YH., 2011, INCONT PELVIC FLOOR, V5, P31; Chung SD, 2012, BJU INT, V110, P726, DOI 10.1111/j.1464-410X.2011.10807.x; Collins MM, 2001, J GEN INTERN MED, V16, P656; Davis SNP, 2009, J SEX MARITAL THER, V35, P182, DOI 10.1080/00926230802716310; Eryildirim B, 2010, INT J IMPOT RES, V22, P349, DOI 10.1038/ijir.2010.26; Gonen M, 2005, J ANDROL, V26, P601, DOI 10.2164/jandrol.04159; Hedelin HH, 2009, SCAND J UROL NEPHROL, V43, P373, DOI 10.3109/00365590903164514; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 2002, UROLOGY, V60, P959, DOI 10.1016/S0090-4295(02)01963-5; Lee SWH, 2008, UROLOGY, V71, P79, DOI 10.1016/j.urology.2007.08.043; Liang CZ, 2009, J UROLOGY, V182, P558, DOI 10.1016/j.juro.2009.04.011; Liang CZ, 2004, BJU INT, V93, P568, DOI 10.1111/j.1464-410X.2003.04662.x; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Magri V, 2010, J UROLOGY, V184, P2339, DOI 10.1016/j.juro.2010.08.025; Magri Vittorio, 2008, Arch Ital Urol Androl, V80, P172; Muller Alexander, 2006, Curr Urol Rep, V7, P307, DOI 10.1007/s11934-996-0010-4; Perlmutter AE, 2011, INTERNET J UROLOGY, V9, P1, DOI [10.5580/c54, DOI 10.5580/C54]; Pontari MA, 2004, J UROLOGY, V172, P839, DOI 10.1097/01.ju.0000136002.76898.04; Pontari MA, 2008, J UROLOGY, V179, pS61, DOI 10.1016/j.juro.2008.03.139; Propert KJ, 2006, QUAL LIFE RES, V15, P299, DOI 10.1007/s11136-005-1317-1; Propert KJ, 2006, J UROLOGY, V175, P619, DOI 10.1016/S0022-5347(05)00233-8; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Samplaski MK, 2011, UROLOGY, V78, P653, DOI 10.1016/j.urology.2011.04.016; Schaeffer AJ, 2006, 6 INT C NEW DEV PROS, P343; Shoskes DA, 2009, PROSTATE CANCER P D, V12, P177, DOI 10.1038/pcan.2008.42; Shoskes DA, 2012, CURR UROL REP, V13, P263, DOI 10.1007/s11934-012-0254-0; Shoskes DA, 2011, J UROLOGY, V186, P907, DOI 10.1016/j.juro.2011.04.063; Shoskes DA, 2010, UROLOGY, V75, P1249, DOI 10.1016/j.urology.2010.01.021; Shoskes DA, 2009, UROLOGY, V73, P538, DOI 10.1016/j.urology.2008.09.074; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Tan HM, 2012, J SEX MED, V9, P663, DOI 10.1111/j.1743-6109.2011.02582.x; Trinchieri Alberto, 2007, Arch Ital Urol Androl, V79, P67; Tuncel A, 2006, INT UROL NEPHROL, V38, P583, DOI 10.1007/s11255-006-0087-1; Wagenlehner FME, 2009, EUR UROL, V56, P544, DOI 10.1016/j.eururo.2009.05.046	37	141	147	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e52044	10.1371/journal.pone.0052044	http://dx.doi.org/10.1371/journal.pone.0052044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23626734	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900004
J	Li, SY; Xia, XL; Tan, X; Zhang, QF				Li, Siyue; Xia, Xiaoling; Tan, Xiang; Zhang, Quanfa			Effects of Catchment and Riparian Landscape Setting on Water Chemistry and Seasonal Evolution of Water Quality in the Upper Han River Basin, China	PLOS ONE			English	Article							MAJOR-ELEMENT CHEMISTRY; LAND-USE; ALPINE/SUBALPINE BASINS; ION COMPOSITIONS; GEOCHEMISTRY; COVER; NITROGEN; IMPACT; FLUXES; RATES	Six-year (2005-2010) evolution of water chemistry (Cl-, NO3-, SO42-, HCO3-, Na+, K+, Ca2+ and Mg2+) and their interactions with morphological properties (i.e., slope and area), land cover, and hydrological seasonality were examined to identify controlling factors and processes governing patterns of stream water quality in the upper Han River, China. Correlation analysis and stepwise multiple regression models revealed significant correlations between ions (i.e., Cl-, SO42-, Na+ and K+) and land cover (i.e., vegetation and bare land) over the entire catchment in both high-and low-flow periods, and in the buffer zone the correlation was much more stronger in the low-flow period. Catchment with steeper slope (>15 degrees) was negatively correlated with major ions, largely due to multicollinearity of basin characteristics. Land cover within the buffer zone explained slightly less of major elements than at catchment scale in the rainy season, whereas in the dry season, land cover along the river networks in particular this within 100 m riparian zone much better explained major elements rather than this over the entire catchment. Anthropogenic land uses (i.e., urban and agriculture) however could not explain water chemical variables, albeit EC, TDS, anthropogenic markers (Cl-, NO3-, SO42), Na+, K+ and Ca2+ significantly increased during 2005-2010, which was corroborated by principal component analyses (PCA) that indicated anthropogenic inputs. Observations demonstrated much higher solute concentrations in the industrial-polluted river. Our results suggested that seasonal evolution of water quality in combined with spatial analysis at multiple scales should be a vital part of identifying the controls on spatio-temporal patterns of water quality.	[Li, Siyue; Xia, Xiaoling; Tan, Xiang; Zhang, Quanfa] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Li, SY (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.	lisiyue@wbgcas.cn; qzhang@wbgcas.cn	Wang, Qun/I-7778-2013; Zhang, Quanfa/H-1922-2011; LI, WEIWEI/J-3538-2013; Jin, Xingkun/H-4366-2013; Li, Siyue/DCN-3040-2022; Li, Siyue/E-8297-2012	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; Li, Siyue/0000-0002-3097-6819; Li, Siyue/0000-0002-3097-6819; li, si yue/0000-0002-4550-892X	National Natural Science Foundation of China [31100347, 31130010]; Youth Innovation Promotion Association; Chinese Academy of Sciences, China [Y129431C06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association; Chinese Academy of Sciences, China(Chinese Academy of Sciences)	The research is funded by the National Natural Science Foundation of China (31100347 and 31130010) and Youth Innovation Promotion Association, the Chinese Academy of Sciences, China (Y129431C06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Anshumali, 2007, APPL GEOCHEM, V22, P1736, DOI 10.1016/j.apgeochem.2007.03.045; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Chen JS, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002325; Chen JS, 2002, CHEM GEOL, V187, P231, DOI 10.1016/S0009-2541(02)00032-3; Chinese Ministry of Health, 2006, GB5749 CHIN MIN HLTH; Clow DW, 2000, WATER RESOUR RES, V36, P49, DOI 10.1029/1999WR900294; Dodds WK, 1998, WATER RES, V32, P1455, DOI 10.1016/S0043-1354(97)00370-9; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Garcia-Esteves J, 2007, APPL GEOCHEM, V22, P230, DOI 10.1016/j.apgeochem.2006.09.013; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; HU MH, 1982, NATURE, V298, P550, DOI 10.1038/298550a0; HUNSAKER CT, 1995, BIOSCIENCE, V45, P193, DOI 10.2307/1312558; Iqbal J, 2011, J HAZARD MATER, V192, P887, DOI 10.1016/j.jhazmat.2011.05.105; Johnson LB, 1997, FRESHWATER BIOL, V37, P193, DOI 10.1046/j.1365-2427.1997.d01-539.x; Li SY, 2009, J HAZARD MATER, V162, P1340, DOI 10.1016/j.jhazmat.2008.06.059; Li SY, 2008, CATENA, V75, P216, DOI 10.1016/j.catena.2008.06.005; Li SY, 2009, J HAZARD MATER, V170, P605, DOI 10.1016/j.jhazmat.2009.05.022; Li SY, 2009, CHEM GEOL, V264, P89, DOI 10.1016/j.chemgeo.2009.02.021; Li SY, 2008, APPL GEOCHEM, V23, P3535, DOI 10.1016/j.apgeochem.2008.08.012; Li SY, 2009, J HAZARD MATER, V165, P317, DOI 10.1016/j.jhazmat.2008.09.123; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; Meybeck M, 2005, TREATISE GEOCHEM, V5, P207; Meynendonckx J, 2006, HYDROL EARTH SYST SC, V10, P913, DOI 10.5194/hess-10-913-2006; OSBORNE LL, 1988, J ENVIRON MANAGE, V26, P9; PEIERLS BL, 1991, NATURE, V350, P386, DOI 10.1038/350386b0; Pratt B, 2012, J HAZARD MATER, V209, P48, DOI 10.1016/j.jhazmat.2011.12.068; PROSPERO JM, 1989, NATURE, V339, P687, DOI 10.1038/339687a0; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; Stark JM, 1997, NATURE, V385, P61, DOI 10.1038/385061a0; Sueker JK, 2001, HYDROL PROCESS, V15, P2749, DOI 10.1002/hyp.265; Varol M, 2011, J HAZARD MATER, V195; Varol M, 2012, CATENA, V92, P11, DOI 10.1016/j.catena.2011.11.013; WHO, 2006, GUID DRINK WAT QUAL, V1; Wu WH, 2008, CHEM GEOL, V249, P307, DOI 10.1016/j.chemgeo.2008.01.025; ZHANG J, 1995, J HYDROL, V168, P173, DOI 10.1016/0022-1694(94)02635-O; Zhang LA, 2011, APPL GEOCHEM, V26, P293, DOI 10.1016/j.apgeochem.2010.12.002; Zhang SR, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000493	40	177	190	4	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53163	10.1371/journal.pone.0053163	http://dx.doi.org/10.1371/journal.pone.0053163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23967346	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100016
J	Zhang, XY; Sun, Q; Shan, M; Niu, M; Liu, T; Xia, BS; Liang, XS; Wei, W; Sun, SS; Zhang, YX; Liu, XS; Song, QB; Yang, YM; Ma, YY; Liu, Y; Yang, L; Ren, YL; Zhang, GQ; Pang, D				Zhang, Xianyu; Sun, Qian; Shan, Ming; Niu, Ming; Liu, Tong; Xia, Bingshu; Liang, Xiaoshuan; Wei, Wei; Sun, Shanshan; Zhang, Youxue; Liu, Xiaolong Sean; Song, Qingbin; Yang, Yanmei; Ma, Yuyan; Liu, Yang; Yang, Long; Ren, Yanlv; Zhang, Guoqiang; Pang, Da			Promoter Hypermethylation of ARID1A Gene Is Responsible for Its Low mRNA Expression in Many Invasive Breast Cancers	PLOS ONE			English	Article							CLEAR-CELL CARCINOMA; SOMATIC MUTATIONS; SWI/SNF COMPLEXES; PROTEIN P270; EPIGENETICS; COMPONENT	ARID1A (AT-rich interactive domain 1A) has recently been identified as a tumor suppressor gene. Its mRNA expression is significantly low in many breast cancers; this is often associated with more aggressive phenotypes. However, the underlying molecular mechanism for its low expression has not been fully understood. This study was undertaken to evaluate the contribution of gene copy number variation, mutations, promoter methylation and histone modification to ARID1A's low expression. 38 pairs of breast invasive ductal carcinomas and their normal breast tissue counterparts from the same patients were randomly selected for gene expression and copy number variation detection. Promoter methylation and histone modification levels were evaluated by MeDIP-qPCR and ChIP-qPCR, respectively. PCR product Sanger sequencing was carried out to detect the exon mutation rate. Twenty-two out of 38 invasive ductal carcinomas in the study (57.9%) revealed ARID1A mRNA low expression by realtime RT-PCR. The relative promoter methylation level was, significantly higher in ARID1A mRNA low expression group compared with its high expression group (p<0.001). In the low expression group, nineteen out of 22 invasive ductal carcinomas (86.4%) exhibited ARID1A promoter hypermthylation. In addition, the promoter hypermethylation was accompanied with repressive histone modification (H3K27Me3). Although five out of 38 invasive ductal carcinomas (13.2%) exhibited loss of ARID1A gene copy number by realtime PCR and nine exon novel mutations are seen from eight out of 33 invasive ductal carcinomas (24.2%), there was no statistically significant difference in both ARID1A mRNA low and high expression groups (p = 0.25, and p = 0.68, respectively). We demonstrate that promoter hypermethylation was the main culprit for ARID1A mRNA low expression in invasive ductal carcinomas. The influence of mutation and copy number variation on the expression were statistically insignificant at mRNA level, and were, therefore, not considered the main causes for ARID1A mRNA low expression in invasive breast cancer.	[Zhang, Xianyu; Sun, Qian; Shan, Ming; Niu, Ming; Liu, Tong; Xia, Bingshu; Liang, Xiaoshuan; Wei, Wei; Sun, Shanshan; Zhang, Youxue; Ren, Yanlv; Zhang, Guoqiang; Pang, Da] Harbin Med Univ, Dept Breast Surg, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China; [Liu, Xiaolong Sean] Harbin Med Univ, Dept Pathol, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China; [Song, Qingbin] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Yang, Yanmei; Ma, Yuyan; Pang, Da] Heilongjiang Inst Canc Res, Key Lab, Harbin, Heilongjiang, Peoples R China; [Yang, Long] Life Technol Corp, ICFC Custom Serv, Beijing, Peoples R China	Harbin Medical University; Harbin Medical University; Icahn School of Medicine at Mount Sinai; Thermo Fisher Scientific	Pang, D (corresponding author), Harbin Med Univ, Dept Breast Surg, Affiliated Hosp 3, Harbin, Heilongjiang, Peoples R China.	pangda@ems.hrbmu.edu.cn	Zhang, Guo-Qiang/AAG-6817-2019; Liu, Wei/N-4465-2017	Zhang, Guo-Qiang/0000-0001-6439-019X; Liu, Wei/0000-0001-9819-3178; Wu, Chongming/0000-0003-2898-370X; LIU, TONG/0000-0001-9234-1328	National Natural Science Foundation of China [81172498/H1622]; Harbin Science and Technology bureau [2011RFXYS056]; Postgraduate Innovation Research Fund of Heilongjiang Province [YJSCX2011-332-HLJ]; Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University [JJ2010-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Science and Technology bureau; Postgraduate Innovation Research Fund of Heilongjiang Province; Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University	This work was supported by National Natural Science Foundation of China (81172498/H1622), Harbin Science and Technology bureau (2011RFXYS056), Postgraduate Innovation Research Fund of Heilongjiang Province (YJSCX2011-332-HLJ) and Research initiation Fund of the Third Affiliated Hospital of Harbin Medical University (JJ2010-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornen S., 2012, ONCOGENE; Dallas PB, 2000, MOL CELL BIOL, V20, P3137, DOI 10.1128/MCB.20.9.3137-3146.2000; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Katagiri A, 2012, MODERN PATHOL, V25, P282, DOI 10.1038/modpathol.2011.161; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Zhang XY, 2012, CANCER EPIDEMIOL, V36, P288, DOI 10.1016/j.canep.2011.07.006	21	711	732	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53931	10.1371/journal.pone.0053931	http://dx.doi.org/10.1371/journal.pone.0053931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23556003	Green Submitted, Green Published, gold			2022-12-27	WOS:000313943000021
J	Zhang, ZZ; Wang, W; Li, WL				Zhang, Zhengzhi; Wang, Wei; Li, Wanlong			Genetic Interactions Underlying the Biosynthesis and Inhibition of beta-Diketones in Wheat and Their Impact on Glaucousness and Cuticle Permeability	PLOS ONE			English	Article							CUTICULAR WAX BIOSYNTHESIS; FATTY-ACID ELONGASE; DROUGHT TOLERANCE; EPICUTICULAR WAXES; CONDENSING ENZYME; ABC TRANSPORTER; CELL EXPANSION; COA REDUCTASE; PISUM-SATIVUM; SURFACE WAXES	Cuticular wax composition greatly impacts plant responses to dehydration. Two parallel pathways exist in Triticeae for manipulating wax composition: the acyl elongation, reduction, and decarbonylation pathway that is active at the vegetative stage and yields primary alcohols and alkanes, and the beta-diketone pathway that predominates at the reproductive stage and synthesizes beta-diketones. Variation in glaucousness during the reproductive stage of wheat is mainly controlled by the wax production genes, W1 and W2, and wax inhibitor genes, Iw1 and Iw2. Little is known about the metabolic and physiological effects of the genetic interactions among these genes and their roles in shifting wax composition during plant development. We characterized the effect of W1, W2, Iw1, and Iw2 and analyzed their interaction using a set of six near-isogenic lines (NILs) by metabolic, molecular and physiological approaches. Loss of functional alleles of both W genes or the presence of either Iw gene depletes beta-diketones and results in the nonglaucous phenotype. Elimination of beta-diketones is compensated for by an increase in aldehydes and primary alcohols in the Iw NILs. Accordingly, transcription of CER4-6, which encodes an alcohol-forming fatty acyl-CoA reductase, was elevated 120-fold in Iw1/Iw2. CER4-6 was transcribed at much higher levels in seedlings than in adult plants, and showed little difference between the glaucous and nonglaucous NILs, suggesting that Iw2 counteracts the developmental repression of CER4-6 at the reproductive stage. While W1 and W2 redundantly function in beta-diketone biosynthesis, a combination of both functional alleles led to the beta-diketone hydroxylation. Consistent with this, transcription of MAH1-9, which encodes a mid-chain alkane hydroxylase, increased seven-fold only in W1W2. In parallel with the hydroxyl-beta-diketone production patterns, glaucousness was intensified and cuticle permeability was reduced significantly in W1W2 compared to the other NILs. This suggests that both W1 and W2 are required for enhancing drought tolerance.	[Zhang, Zhengzhi; Wang, Wei; Li, Wanlong] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Li, Wanlong] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Li, WL (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	wanlong.li@sdstate.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this research was provided by South Dakota Agricultural Experiment Station and South Dakota Wheat Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; BARBER HN, 1968, PHYTOCHEMISTRY, V7, P2089, DOI 10.1016/S0031-9422(00)85661-7; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BIANCHI G, 1984, CEREAL CHEM, V61, P45; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Bianchi G., 1995, WAXES CHEM MOL BIOL, P175; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dudnikov AJ, 2012, MOL BIOL REP, V39, P2355, DOI 10.1007/s11033-011-0986-9; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hansen JD, 1997, PLANT PHYSIOL, V113, P1091, DOI 10.1104/pp.113.4.1091; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Javelle M, 2011, PLANT PHYSIOL, V157, P790, DOI 10.1104/pp.111.182147; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; JENKS M. A., 2010, HORTICULTURAL REV, V23, P1, DOI [10.1002/9780470650752.ch1, DOI 10.1002/9780470650752.CH1]; JOHNSON DA, 1983, CROP SCI, V23, P318, DOI 10.2135/cropsci1983.0011183X002300020033x; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Kosma DK, 2010, PLANT J, V63, P31, DOI 10.1111/j.1365-313X.2010.04229.x; Lam P, 2012, PLANT PHYSIOL, V159, P1385, DOI 10.1104/pp.112.199646; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Liu Q, 2007, EUPHYTICA, V155, P71, DOI 10.1007/s10681-006-9302-5; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; MIKKELSEN JD, 1978, CARLSBERG RES COMMUN, V43, P15, DOI 10.1007/BF02906546; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Monneveux P, 2004, J AGRON CROP SCI, V190, P395, DOI 10.1111/j.1439-037X.2004.00116.x; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nawrath Christiane, 2002, Arabidopsis Book, V1, pe0021, DOI 10.1199/tab.0021; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Richards R.A., 1984, P 6 INT WHEAT GEN S, P447; RICHARDS RA, 1986, AUST J PLANT PHYSIOL, V13, P465, DOI 10.1071/PP9860465; Richardson A, 2007, PLANTA, V226, P1459, DOI 10.1007/s00425-007-0585-0; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Simmonds JR, 2008, EUPHYTICA, V159, P333, DOI 10.1007/s10681-007-9514-3; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Tacke E, 1995, PLANT J, V8, P907, DOI 10.1046/j.1365-313X.1995.8060907.x; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; TULLOCH AP, 1980, CAN J BOT, V58, P2602, DOI 10.1139/b80-302; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2225, DOI 10.1016/0031-9422(73)85124-6; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; von Wettstein-Knowles P., 1995, WAXES CHEM MOL BIOL, P91; VONWETTSTEINKNOWLES P, 1980, CARLSBERG RES COMMUN, V45, P125, DOI 10.1007/BF02906514; VONWETTSTEINKNOWLES P, 1972, PLANTA, V106, P113, DOI 10.1007/BF00383991; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Xu XJ, 1997, PLANT PHYSIOL, V115, P501, DOI 10.1104/pp.115.2.501; Xue GP, 2006, PLANT MOL BIOL, V61, P863, DOI 10.1007/s11103-006-0055-2; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang JY, 2007, PLANT MOL BIOL, V64, P265, DOI 10.1007/s11103-007-9150-2; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	75	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54129	10.1371/journal.pone.0054129	http://dx.doi.org/10.1371/journal.pone.0054129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349804	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900042
J	Zhang, ZH; Liu, ZH; Cui, ZT; Hu, YM; Wang, B; Tang, JH				Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua			Genetic Analysis of Grain Filling Rate Using Conditional QTL Mapping in Maize	PLOS ONE			English	Article							KERNEL WATER RELATIONS; WEIGHT RESPONSE; SINK; GROWTH; EXPRESSION; ENDOSPERM; TEMPERATURE; DISSECTION; DURATION; ENCODES	The grain filling rate (GFR) is an important dynamic trait that determines the final grain yield and is controlled by a network of genes and environment factors. To determine the genetic basis of the GFR, a conditional quantitative trait locus (QTL) analysis method was conducted using time-related phenotypic values of the GFR collected from a set of 243 immortalized F-2 (IF2) population, which were evaluated at two locations over 2 years. The GFR gradually rose in the 0-15 days after pollination (DAP) and 16-22 DAP, reaching a maximum at 23-29 DAP, and then gradually decreasing. The variation of kernel weight (KW) was mainly decided by the GFR, and not by the grain filling duration (GFD). Thirty-three different unconditional QTLs were identified for the GFR at the six sampling stages over 2 years. Among them, QTLs qGFR7b, qGFR9 and qGFR6d were identified at the same stages at two locations over 2 years. In addition, 14 conditional QTLs for GFR were detected at five stages. The conditional QTL qGFR7c was identified at stage V|IV (37-43 DAP) at two locations over 2 years, and qGFR7b was detected at the sixth stage (44-50 DAP) in all four environments, except at Anyang location in 2009. QTLs qQTL7b and qQTL6f were identified by unconditional and conditional QTL mapping at the same stages, and might represent major QTLs for regulating the GFR in maize in the IF2 population. Moreover, most of the QTLs identified were co-located with QTLs from previous studies that were associated with GFR, enzyme activities of starch synthesis, soluble carbohydrates, and grain filling related genes. These results indicated that the GFR is regulated by many genes, which are specifically expressed at different grain filling stages, and the specific expression of the genes between 16-35 DAP might be very important for deciding the final kernel weight.	[Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Tang, JH (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	tangjihua1@163.com	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Project 973 of China [2012CB723001]; National High Technology Research and Development Program of China [2012AA10A305]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Project 973 of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Project 973 of China (2012CB723001) and the National High Technology Research and Development Program of China (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blewley JD, 1985, SEEDS PHYSL DEV GERM, P41; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2001, CROP SCI, V41, P1816, DOI 10.2135/cropsci2001.1816; Borras L, 2009, CROP SCI, V49, P999, DOI 10.2135/cropsci2008.08.0475; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Carlson SJ, 1999, PLANT PHYSIOL, V121, P1025, DOI 10.1104/pp.121.3.1025; CAVALIERI AJ, 1985, CROP SCI, V25, P856, DOI 10.2135/cropsci1985.0011183X002500050031x; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Gambin BL, 2007, FIELD CROP RES, V101, P1, DOI 10.1016/j.fcr.2006.09.001; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hua JP, 2002, GENETICS, V162, P1885; Li ShaoChang, 2003, Acta Agronomica Sinica, V29, P775; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZongHua, 2007, Acta Agronomica Sinica, V33, P782; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; PRIOUL JL, 1994, PLANT PHYSIOL, V104, P179, DOI 10.1104/pp.104.1.179; SAS Institute, 2009, SAS STAT 9 2 US GUID; SEKA D, 1995, CROP SCI, V35, P74, DOI 10.2135/cropsci1995.0011183X003500010013x; SEKA D, 1995, CROP SCI, V35, P80, DOI 10.2135/cropsci1995.0011183X003500010014x; Setter TL, 2001, J EXP BOT, V52, P1401, DOI 10.1093/jexbot/52.360.1401; Stewart DW, 1998, AGRON J, V90, P73, DOI 10.2134/agronj1998.00021962009000010014x; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Vilhar B, 2002, PLANT PHYSIOL, V129, P23, DOI 10.1104/pp.001826; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang GL, 1999, FIELD CROP RES, V61, P211, DOI 10.1016/S0378-4290(98)00163-4; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x; Wu W, 2002, THEOR APPL GENET, V105, P1043, DOI 10.1007/s00122-002-1052-8; Wu WR, 1999, GENETICS, V151, P297; Yan HB, 2009, THEOR APPL GENET, V119, P815, DOI 10.1007/s00122-009-1091-5; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng H, 2001, J MAIZE SCI, V9, P69; ZHU J, 1995, GENETICS, V141, P1633	44	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56344	10.1371/journal.pone.0056344	http://dx.doi.org/10.1371/journal.pone.0056344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23349804	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200037
J	Zhang, HD; Song, J; Ren, H; Xu, ZR; Wang, XN; Shan, LF; Fang, J				Zhang, Huidan; Song, Jin; Ren, Hui; Xu, Zhangrun; Wang, Xiaonan; Shan, Lianfeng; Fang, Jin			Detection of Low-Abundance KRAS Mutations in Colorectal Cancer Using Microfluidic Capillary Electrophoresis-Based Restriction Fragment Length Polymorphism Method with Optimized Assay Conditions	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; K-RAS MUTATIONS; CONTEMPORARY SAMPLE STACKING; REAL-TIME PCR; MICROCHIP ELECTROPHORESIS; FLUORESCENCE DETECTION; 1ST-LINE TREATMENT; ANTIBODY THERAPY; ENERGY-TRANSFER; DNA	Constitutively active KRAS mutations have been found to be involved in various processes of cancer development, and render tumor cells resistant to EGFR-targeted therapies. Mutation detection methods with higher sensitivity will increase the possibility of choosing the correct individual therapy. Here, we established a highly sensitive and efficient microfluidic capillary electrophoresis-based restriction fragment length polymorphism (mu CE-based RFLP) platform for low-abundance KRAS genotyping with the combination of mu CE and RFLP techniques. By using our self-built sensitive laser induced fluorescence (LIF) detector and a new DNA intercalating dye YOYO-1, the separation conditions of mu CE for Phi 174 HaeIII DNA marker were first optimized. Then, a Mav I digested 107-bp KRAS gene fragment was directly introduced into the microfluidic device and analyzed by mu CE, in which field amplified sample stacking (FASS) technique was employed to obtain the enrichment of the RFLP digestion products and extremely improved the sensitivity. The accurate analysis of KRAS statuses in HT29, LS174T, CCL187, SW480, Clone A, and CX-1 colorectal cancer (CRC) cell lines by mu CE-based RFLP were achieved in 5 min with picoliter-scale sample consumption, and as low as 0.01% of mutant KRAS could be identified from a large excess of wild-type genomic DNA (gDNA). In 98 paraffin-embedded CRC tissues, KRAS codon 12 mutations were discovered in 28 (28.6%), significantly higher than that obtained by direct sequencing (13, 13.3%). Clone sequencing confirmed these results and showed this system could detect at least 0.4% of the mutant KRAS in CRC tissue slides. Compared with direct sequencing, the new finding of the mu CE-based RFLP platform was that KRAS mutations in codon 12 were correlated with the patient's age. In conclusion, we established a sensitive, fast, and cost-effective screening method for KRAS mutations, and successfully detected low-abundance KRAS mutations in clinical samples, which will allow provision of more precise individualized cancer therapy.	[Zhang, Huidan; Song, Jin; Wang, Xiaonan; Fang, Jin] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang, Peoples R China; [Zhang, Huidan; Song, Jin; Wang, Xiaonan; Fang, Jin] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Ren, Hui] Shenyang Anal Rectum Hosp, Dept Colon Surg, Shenyang, Peoples R China; [Xu, Zhangrun] Northeastern Univ, Res Ctr Analyt Sci, Shenyang, Peoples R China; [Shan, Lianfeng] China Med Univ, Coll Basic Med Sci, Dept Math, Shenyang, Peoples R China	China Medical University; China Medical University; Northeastern University - China; China Medical University	Fang, J (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang, Peoples R China.	jfang61@gmail.com	Zhang, Huidan/K-8399-2015; Zhang, Hai-Lin/H-2715-2017	Chen, Guifen/0000-0002-5459-660X; Zhang, Hai-Lin/0000-0002-7426-2885	National Natural Science Foundation of China [30901727, 20975019, 20875103, 20375047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No. 30901727, 20975019, 20875103, 20375047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine R, 2009, J PHARMACEUT BIOMED, V50, P947, DOI 10.1016/j.jpba.2009.06.034; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Assenat E, 2011, ONCOLOGIST, V16, P1557, DOI 10.1634/theoncologist.2011-0141; Beard NR, 2003, ELECTROPHORESIS, V24, P732, DOI 10.1002/elps.200390088; BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5720, DOI 10.1093/nar/21.24.5720; BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5727, DOI 10.1093/nar/21.24.5727; Bornholdt J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-53; CAPELLA G, 1991, ENVIRON HEALTH PERSP, V93, P125, DOI 10.2307/3431180; Cavallini A, 2010, ANTICANCER RES, V30, P5251; Chowdhury J, 2007, J MOL DIAGN, V9, P521, DOI 10.2353/jmoldx.2007.070014; DELATTRE O, 1989, LANCET, V2, P353; Evenhuis CJ, 2009, ELECTROPHORESIS, V30, P897, DOI 10.1002/elps.200800643; Fang Q, 2002, ANAL CHEM, V74, P1223, DOI 10.1021/ac010925c; Gebauer P, 2009, ELECTROPHORESIS, V30, pS27, DOI 10.1002/elps.200900053; Gotz S, 2007, ANAL BIOANAL CHEM, V387, P183, DOI 10.1007/s00216-006-0820-8; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia ZJ, 2004, ANAL CHEM, V76, P5597, DOI 10.1021/ac0494477; Jiang GF, 2000, BIOSENS BIOELECTRON, V14, P861, DOI 10.1016/S0956-5663(99)00056-1; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kleparnik K, 2007, CHEM REV, V107, P5279, DOI 10.1021/cr0101860; Ko JMY, 1998, CANCER LETT, V134, P169, DOI 10.1016/S0304-3835(98)00257-2; Lanthaler AJ, 2011, DIAGN MOL PATHOL, V20, P90, DOI 10.1097/PDM.0b013e31820e5f9a; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; LODA M, 1994, HUM PATHOL, V25, P564, DOI 10.1016/0046-8177(94)90220-8; Loupakis F, 2012, CANCER-AM CANCER SOC, V118, P1523, DOI 10.1002/cncr.26460; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mala Z, 2009, J CHROMATOGR A, V1051, P147; Mala Z, 2007, ELECTROPHORESIS, V28, P243, DOI 10.1002/elps.200600397; Mala Z, 2009, ELECTROPHORESIS, V30, P215, DOI 10.1002/elps.200800433; Mao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036653; Marchetti A, 2009, NEW ENGL J MED, V360, P833, DOI 10.1056/NEJMc082346; Mayo Skye C, 2009, Expert Rev Gastroenterol Hepatol, V3, P131, DOI 10.1586/egh.09.8; Milano G, 2008, ANN ONCOL, V19, P2033, DOI 10.1093/annonc/mdn416; Minucci A, 2008, J SEP SCI, V31, P2694, DOI 10.1002/jssc.200800216; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Nachamkin I, 2001, J CLIN MICROBIOL, V39, P754, DOI 10.1128/JCM.39.2.754-757.2001; Nishikawa T, 2002, CLIN CHIM ACTA, V318, P107, DOI 10.1016/S0009-8981(01)00806-3; Ohno K, 2008, ELECTROPHORESIS, V29, P4443, DOI 10.1002/elps.200800121; OUDEJANS JJ, 1991, INT J CANCER, V49, P875, DOI 10.1002/ijc.2910490613; Petersen NJ, 2004, ELECTROPHORESIS, V25, P253, DOI 10.1002/elps.200305747; Qin JH, 2005, ELECTROPHORESIS, V26, P219, DOI 10.1002/elps.200406158; Sarasqueta AF, 2011, J MOL DIAGN, V13, P199, DOI 10.1016/j.jmoldx.2010.10.006; Schimanski CC, 2010, INT J COLORECTAL DIS, V25, P181, DOI 10.1007/s00384-009-0843-7; Schimanski CC, 1999, CANCER RES, V59, P5169; Scholtka B, 2009, CANCER EPIDEMIOL, V33, P123, DOI 10.1016/j.canep.2009.05.001; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sood A, 2012, CLIN COLORECTAL CANC, V11, P143, DOI 10.1016/j.clcc.2011.12.001; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Waldner MJ, 2010, MOL ASPECTS MED, V31, P171, DOI 10.1016/j.mam.2010.02.005; Weidlich S, 2011, BRIT J CANCER, V105, P246, DOI 10.1038/bjc.2011.197; Winder T, 2010, CANCER TREAT REV, V36, P550, DOI 10.1016/j.ctrv.2010.03.005; Wu CM, 2005, CANCER GENET CYTOGEN, V158, P55, DOI 10.1016/j.cancergencyto.2004.08.030; Xiao SX, 1997, PROG BIOCHEM BIOPHYS, V24, P375; Xu F, 2004, J CHROMATOGR A, V1051, P147, DOI 10.1016/j.chroma.2004.05.019; Yang YZ, 2006, ANAL CHEM, V78, P4752, DOI 10.1021/ac051735v; Zhang HD, 2011, LAB INVEST, V91, P788, DOI 10.1038/labinvest.2010.200; Zou HZ, 2009, GASTROENTEROLOGY, V136, P459, DOI 10.1053/j.gastro.2008.10.023	61	203	206	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54510	10.1371/journal.pone.0054510	http://dx.doi.org/10.1371/journal.pone.0054510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23750250	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500082
J	Kim, SO; Sakchaisri, K; Thimmegowda, NR; Soung, NK; Jang, JH; Kim, YS; Lee, KS; Kwon, YT; Asami, Y; Ahn, JS; Erikson, RL; Kim, BY				Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Kim, Young Sang; Lee, Kyung Sang; Kwon, Yong Tae; Asami, Yukihiro; Ahn, Jong Seog; Erikson, Raymond Leo; Kim, Bo Yeon			STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G(2) Arrest in the Absence of DNA Damage	PLOS ONE			English	Article							CDC25 PHOSPHATASES; CELL-CYCLE; I INHIBITORS; G2/M TRANSITION; CANCER-THERAPY; HISTONE H3; PHOSPHORYLATION; CHECKPOINT; CAMPTOTHECIN; MECHANISM	STK295900, a small synthetic molecule belonging to a class of symmetric bibenzimidazoles, exhibits antiproliferative activity against various human cancer cell lines from different origins. Examining the effect of STK295900 in HeLa cells indicates that it induces G(2) phase arrest without invoking DNA damage. Further analysis shows that STK295900 inhibits DNA relaxation that is mediated by topoisomerase 1 (Top 1) and topoisomerase 2 (Top 2) in vitro. In addition, STK295900 also exhibits protective effect against DNA damage induced by camptothecin. However, STK295900 does not affect etoposide-induced DNA damage. Moreover, STK295900 preferentially exerts cytotoxic effect on cancer cell lines while camptothecin, etoposide, and Hoechst 33342 affected both cancer and normal cells. Therefore, STK295900 has a potential to be developed as an anticancer chemotherapeutic agent.	[Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Ahn, Jong Seog; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea; [Kim, Sun-Ok; Kim, Young Sang] Chungnam Natl Univ, Coll Nat Sci, Dept Biochem, Taejon, South Korea; [Lee, Kyung Sang] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kwon, Yong Tae] Seoul Natl Univ, World Class Univ, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Asami, Yukihiro] RIKEN Adv Sci Inst, Dept Biol Chem, Wako, Saitama, Japan; [Erikson, Raymond Leo] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RIKEN; Harvard University	Ahn, JS (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea.	jsahn@kribb.re.kr; bykim@kribb.re.kr	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	World Class Institute [2009-002]; Global RD Center (GRDC); World Class University [R31-2008-000-10103-0]; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea	World Class Institute; Global RD Center (GRDC); World Class University; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the World Class Institute (2009-002), Global R&D Center (GRDC), World Class University (R31-2008-000-10103-0) programs and a grant from KRIBB Research Initiative program funded by the Ministry of Education, Science and Technology (MEST) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Cai XM, 2009, CANCER TREAT REV, V35, P437, DOI 10.1016/j.ctrv.2009.02.004; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chiu CC, 2005, CANCER LETT, V223, P249, DOI 10.1016/j.canlet.2004.10.049; Clifford B, 2003, CANCER RES, V63, P4074; Dale AG, 2012, BIOCHEMISTRY; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; He L, 2007, CELL SIGNAL, V19, P1713, DOI 10.1016/j.cellsig.2007.03.006; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Jin S, 2000, BIOORG MED CHEM LETT, V10, P719, DOI 10.1016/S0960-894X(00)00087-1; JORDAN MA, 1992, J CELL SCI, V102, P401; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Mann J, 2001, J MED CHEM, V44, P138, DOI 10.1021/jm000297b; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Narasimhan B, 2012, MED CHEM RES, V21, P269, DOI 10.1007/s00044-010-9533-9; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Patel S, 2000, MOL PHARMACOL, V58, P560, DOI 10.1124/mol.58.3.560; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903; TSAO YP, 1992, CANCER RES, V52, P1823; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7	46	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53908	10.1371/journal.pone.0053908	http://dx.doi.org/10.1371/journal.pone.0053908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349762	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000314019100036
J	Zhang, ZG; Vu, GP; Gong, H; Xia, C; Chen, YC; Liu, FY; Wu, JG; Lu, SW				Zhang, Zhigang; Vu, Gia-Phong; Gong, Hao; Xia, Chuan; Chen, Yuan-Chuan; Liu, Fenyong; Wu, Jianguo; Lu, Sangwei			Engineered External Guide Sequences Are Highly Effective in Inhibiting Gene Expression and Replication of Hepatitis B Virus in Cultured Cells	PLOS ONE			English	Article							P-MEDIATED INHIBITION; RNASE-P; ATTENUATED SALMONELLA; MESSENGER-RNA; CLEAVAGE; TYPHIMURIUM; STABILITY; SELECTION; DELIVERY; VECTORS	External guide sequences (EGSs) are RNA molecules that consist of a sequence complementary to a target mRNA and recruit intracellular ribonuclease P (RNase P), a tRNA processing enzyme, for specific degradation of the target mRNA. We have previously used an in vitro selection procedure to generate EGS variants that efficiently induce human RNase P to cleave a target mRNA in vitro. In this study, we constructed EGSs from a variant to target the overlapping region of the S mRNA, pre-S/L mRNA, and pregenomic RNA (pgRNA) of hepatitis B virus (HBV), which are essential for viral replication and infection. The EGS variant was about 50-fold more efficient in inducing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Following Salmonella-mediated gene delivery, the EGSs were expressed in cultured HBV-carrying cells. A reduction of about 97% and 75% in the level of HBV RNAs and proteins and an inhibition of about 6,000- and 130-fold in the levels of capsid-associated HBV DNA were observed in cells treated with Salmonella vectors carrying the expression cassette for the variant and the tRNA-derived EGS, respectively. Our study provides direct evidence that the EGS variant is more effective in blocking HBV gene expression and DNA replication than the tRNA-derived EGS. Furthermore, these results demonstrate the feasibility of developing Salmonella-mediated gene delivery of highly active EGS RNA variants as a novel approach for gene-targeting applications such as anti-HBV therapy.	[Zhang, Zhigang; Xia, Chuan; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China; [Vu, Gia-Phong; Chen, Yuan-Chuan; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Gong, Hao; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, FY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China.	liu_fy@berkeley.edu; jwu@whu.edu.cn; sangwei@berkeley.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 31230005, 812111146]; NIH [RO1-AI041927, RO1-AI091536, RO1-DE014842]; University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by grants from National Basic Research Program of China (973 Program; No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, 31230005, and 812111146) and NIH (RO1-AI041927, RO1-AI091536, and RO1-DE014842). G. V. and Y. C. were partially supported by a predoctoral Block grant from University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman S., 1999, RNA WORLD, P351; ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Belongia E A, 2008, NIH Consens State Sci Statements, V25, P1; Block TM, 2013, ANTIVIR RES, V98, P27, DOI 10.1016/j.antiviral.2013.01.006; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; GOPALAN V, 2006, RNA WORLD; Grillot-Courvalin C, 1999, CURR OPIN BIOTECH, V10, P477, DOI 10.1016/S0958-1669(99)00013-0; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hnatyszyn HJ, 2001, GENE THER, V8, P1863, DOI 10.1038/sj.gt.3301606; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; LEVINE MM, 1987, J CLIN INVEST, V79, P888, DOI 10.1172/JCI112899; Li HJ, 2006, RNA, V12, P63, DOI 10.1261/rna.2184706; Liu FY, 2010, PROTEIN REV, V10, P257, DOI 10.1007/978-1-4419-1142-1_14; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Ma M, 2000, NAT BIOTECHNOL, V18, P58, DOI 10.1038/71924; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Paglia P, 2000, GENE THER, V7, P1725, DOI 10.1038/sj.gt.3301290; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Seegar C., 2007, FIELDS VIROLOGY, P2978; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werner M, 1998, RNA, V4, P847, DOI 10.1017/S1355838298980323; Xia C, 2013, MOL THER, V21, P995, DOI 10.1038/mt.2013.37; Yang Nan, 2008, Cancer Biol Ther, V7, P145; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; Zhang L, 2007, CANCER RES, V67, P5859, DOI 10.1158/0008-5472.CAN-07-0098; Zhou TH, 2002, J BIOL CHEM, V277, P30112, DOI 10.1074/jbc.M200183200; Zhu JM, 2004, P NATL ACAD SCI USA, V101, P9073, DOI 10.1073/pnas.0403164101	51	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65268	10.1371/journal.pone.0065268	http://dx.doi.org/10.1371/journal.pone.0065268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23349804	Green Submitted, gold, Green Published			2022-12-27	WOS:000320322400011
J	Kim, SYH; Kim, HM; Ryan, KA; Appelbaum, PS; Knopman, DS; Damschroder, L; De Vries, R				Kim, Scott Y. H.; Kim, H. Myra; Ryan, Kerry A.; Appelbaum, Paul S.; Knopman, David S.; Damschroder, Laura; De Vries, Raymond			How Important Is 'Accuracy' of Surrogate Decision-Making for Research Participation?	PLOS ONE			English	Article							DEMENTIA-RESEARCH; ADVANCE DIRECTIVES; CARE RESEARCH; CONSENT; DELIBERATION; BIOETHICS; CAPACITY; DISEASE; MAKERS; FAMILY	Background: There is a longstanding concern about the accuracy of surrogate consent in representing the health care and research preferences of those who lose their ability to decide for themselves. We sought informed, deliberative views of the older general public (>= 50 years old) regarding their willingness to participate in dementia research and to grant leeway to future surrogates to choose an option contrary to their stated wishes. Methodology/Principal Findings: 503 persons aged 50+ recruited by random digit dialing were randomly assigned to one of three groups: deliberation, education, or control. The deliberation group attended an all-day education/peer deliberation session; the education group received written information only. Participants were surveyed at baseline, after the deliberation session (or equivalent time), and one month after the session, regarding their willingness to participate in dementia research and to give leeway to surrogates, regarding studies of varying risk-benefit profiles (a lumbar puncture study, a drug randomized controlled trial, a vaccine randomized controlled trial, and an early phase gene transfer trial). At baseline, 48% (gene transfer scenario) to 92% (drug RCT) were willing to participate in future dementia research. A majority of respondents (57-71% depending on scenario) were willing to give leeway to future surrogate decision-makers. Democratic deliberation increased willingness to participate in all scenarios, to grant leeway in 3 of 4 scenarios (lumbar puncture, vaccine, and gene transfer), and to enroll loved ones in research in all scenarios. On average, respondents were more willing to volunteer themselves for research than to enroll their loved ones. Conclusions/Significance: Most people were willing to grant leeway to their surrogates, and this willingness was either sustained or increased after democratic deliberation, suggesting that the attitude toward leeway is a reliable opinion. Eliciting a person's current preferences about future research participation should also involve eliciting his or her leeway preferences.	[Kim, Scott Y. H.; Ryan, Kerry A.; De Vries, Raymond] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Kim, Scott Y. H.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kim, H. Myra] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Appelbaum, Paul S.] Columbia Univ, Dept Psychiat, Div Law Eth & Psychiat, New York, NY USA; [Appelbaum, Paul S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Damschroder, Laura] Ann Arbor VA Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; New York State Psychiatry Institute; Mayo Clinic	Kim, SYH (corresponding author), Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.	scottkim@med.umich.edu	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	National Institute of Health [R01AG029550]; Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Supported by National Institute of Health R01AG029550 and the Greenwall Foundation Faculty Scholars Award in Bioethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Scott Kim, H. Myra Kim, Kerry Ryan, Paul Appelbaum, Laura Damschroder, and Raymond De Vries have declared that they have no competing interests. David Knopman has read the journal's policy and has the following conflicts: he serves as Deputy Editor for Neurology (R); serves on a Data Safety Monitoring Board for Lilly Pharmaceuticals; is an investigator in clinical trials sponsored by Janssen Pharmaceuticals, and receives research support from the National Institute of Health. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ciroldi M, 2007, INTENS CARE MED, V33, P807, DOI 10.1007/s00134-007-0582-6; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; De Vries R, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.3.3; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Karlawish J, 2009, AM J PSYCHIAT, V166, P182, DOI 10.1176/appi.ajp.2008.08050645; Kim SYH, 2011, NEUROLOGY, V77, P2097, DOI 10.1212/WNL.0b013e31823648cb; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Kim SYH, 2011, ARCH GEN PSYCHIAT, V68, P214, DOI 10.1001/archgenpsychiatry.2010.191; Kim SYH, 2010, ALZHEIMERS DEMENT, V6, P342, DOI 10.1016/j.jalz.2009.06.001; Kim SYH, 2009, J EMPIR RES HUM RES, V4, P3, DOI 10.1525/jer.2009.4.4.3; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Kirchhoff KT, 2010, J AM GERIATR SOC, V58, P1233, DOI 10.1111/j.1532-5415.2010.02760.x; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Wendler D, 2002, AM J PSYCHIAT, V159, P585, DOI 10.1176/appi.ajp.159.4.585	19	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54790	10.1371/journal.pone.0054790	http://dx.doi.org/10.1371/journal.pone.0054790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23349762	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600042
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400065
